ID   A0A0A0MRT6_HUMAN        Unreviewed;       475 AA.
AC   A0A0A0MRT6;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   28-FEB-2018, entry version 33.
DE   SubName: Full=Abl interactor 1 {ECO:0000313|Ensembl:ENSP00000365330};
GN   Name=ABI1 {ECO:0000313|Ensembl:ENSP00000365330};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000365330, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000365330, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [3] {ECO:0000213|PubMed:18088087}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schutz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [9] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large scale characterization of plant versus mammal
RT   proteins reveals similar and idiosyncratic N-alpha-acetylation
RT   features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13] {ECO:0000313|Ensembl:ENSP00000365330}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000365330}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL139404; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390961; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005252390.1; XM_005252333.3.
DR   UniGene; Hs.508148; -.
DR   ProteinModelPortal; A0A0A0MRT6; -.
DR   EPD; A0A0A0MRT6; -.
DR   MaxQB; A0A0A0MRT6; -.
DR   PeptideAtlas; A0A0A0MRT6; -.
DR   PRIDE; A0A0A0MRT6; -.
DR   Ensembl; ENST00000376160; ENSP00000365330; ENSG00000136754.
DR   GeneID; 10006; -.
DR   UCSC; uc057sjb.1; human.
DR   CTD; 10006; -.
DR   EuPathDB; HostDB:ENSG00000136754.16; -.
DR   HGNC; HGNC:11320; ABI1.
DR   OpenTargets; ENSG00000136754; -.
DR   GeneTree; ENSGT00390000003756; -.
DR   ChiTaRS; ABI1; human.
DR   GenomeRNAi; 10006; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000136754; -.
DR   ExpressionAtlas; A0A0A0MRT6; baseline and differential.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:InterPro.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; IEA:InterPro.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 1.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 1.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00202};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MRT6,
KW   ECO:0000213|MaxQB:A0A0A0MRT6, ECO:0000213|PeptideAtlas:A0A0A0MRT6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192}.
FT   DOMAIN       45    107       T-SNARE coiled-coil homology.
FT                                {ECO:0000259|PROSITE:PS50192}.
FT   DOMAIN      413    472       SH3. {ECO:0000259|PROSITE:PS50002}.
SQ   SEQUENCE   475 AA;  51770 MW;  198820E31BB455D4 CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKHGNNQP ARTGTLSRTN PPTQKPPSPP
     MSGRGTLGRN TPYKTLEPVK PPTVPNDYMT SPARLGSQHS PGRTASLNQR PRTHSGSSGG
     SGSRENSGSS SIGIPIAVPT PSPPTIGPAP GSAPGSQYGT MTRQISRHNS TTSSTSSGGY
     RRTPSVTAQF SAQPHVNGGP LYSQNSISIA PPPPPMPQLT PQIPLTGFVA RVQENIADSP
     TPPPPPPPDD IPMFDDSPPP PPPPPVDYED EEAAVVQYND PYADGDPAWA PKNYIEKVVA
     IYDYTKDKDD ELSFMEGAII YVIKKNDDGW YEGVCNRVTG LFPGNYVESI MHYTD
//
ID   B6VEX3_HUMAN            Unreviewed;       422 AA.
AC   B6VEX3;
DT   16-DEC-2008, integrated into UniProtKB/TrEMBL.
DT   16-DEC-2008, sequence version 1.
DT   31-JAN-2018, entry version 56.
DE   SubName: Full=Abl-interactor 1 variant 41 {ECO:0000313|EMBL:ACJ12783.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ12783.1};
RN   [1] {ECO:0000313|EMBL:ACJ12783.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Gautreau A.;
RT   "The Wave complex is intrinsically inactive.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ380057; ACJ12783.1; -; mRNA.
DR   RefSeq; NP_001171593.1; NM_001178122.1.
DR   UniGene; Hs.508148; -.
DR   ProteinModelPortal; B6VEX3; -.
DR   SMR; B6VEX3; -.
DR   PRIDE; B6VEX3; -.
DR   GeneID; 10006; -.
DR   CTD; 10006; -.
DR   EuPathDB; HostDB:ENSG00000136754.16; -.
DR   PharmGKB; PA36144; -.
DR   eggNOG; ENOG410IPCV; Eukaryota.
DR   eggNOG; ENOG410XQ3Y; LUCA.
DR   HOGENOM; HOG000293213; -.
DR   HOVERGEN; HBG050446; -.
DR   GenomeRNAi; 10006; -.
DR   Bgee; ENSG00000136754; -.
DR   ExpressionAtlas; B6VEX3; baseline and differential.
DR   Genevisible; B6VEX3; HS.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:InterPro.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; IEA:InterPro.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 2.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 2.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00202};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192}.
FT   DOMAIN       45    107       T-SNARE coiled-coil homology.
FT                                {ECO:0000259|PROSITE:PS50192}.
FT   DOMAIN      360    419       SH3. {ECO:0000259|PROSITE:PS50002}.
SQ   SEQUENCE   422 AA;  46386 MW;  16FAAB5B29D7E506 CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKWLKAKH GNNQPARTGT LSRTNPPTQK
     PPSPPMSGRG TLGRNTPYKT LEPVKPPTVP NDYMTSPARL GSQHSPGRTA SLNQRPRTHS
     GSSGGSGSRE NSGSSSIGIP IAVPTPSPPT IGPVSIAPPP PPMPQLTPQI PLTGFVARVQ
     ENIADSPTPP PPPPPDDIPM FDDSPPPPPP PPVDYEDEEA AVVQYNDPYA DGDPAWAPKN
     YIEKVVAIYD YTKDKDDELS FMEGAIIYVI KKNDDGWYEG VCNRVTGLFP GNYVESIMHY
     TD
//
ID   B6VEX4_HUMAN            Unreviewed;       393 AA.
AC   B6VEX4; F5H1G9;
DT   16-DEC-2008, integrated into UniProtKB/TrEMBL.
DT   16-DEC-2008, sequence version 1.
DT   28-FEB-2018, entry version 67.
DE   SubName: Full=Abl interactor 1 {ECO:0000313|Ensembl:ENSP00000439646};
DE   SubName: Full=Abl-interactor 1 variant 21 {ECO:0000313|EMBL:ACJ12784.1};
GN   Name=ABI1 {ECO:0000313|Ensembl:ENSP00000439646};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ12784.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000439646, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [3] {ECO:0000213|PubMed:18088087}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schutz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000313|EMBL:ACJ12784.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Gautreau A.;
RT   "The Wave complex is intrinsically inactive.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [10] {ECO:0000313|Ensembl:ENSP00000439646}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [11] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large scale characterization of plant versus mammal
RT   proteins reveals similar and idiosyncratic N-alpha-acetylation
RT   features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL139404; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390961; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ380058; ACJ12784.1; -; mRNA.
DR   RefSeq; NP_001171594.1; NM_001178123.1.
DR   UniGene; Hs.508148; -.
DR   PeptideAtlas; B6VEX4; -.
DR   Ensembl; ENST00000536334; ENSP00000439646; ENSG00000136754.
DR   GeneID; 10006; -.
DR   UCSC; uc010qdk.2; human.
DR   CTD; 10006; -.
DR   EuPathDB; HostDB:ENSG00000136754.16; -.
DR   HGNC; HGNC:11320; ABI1.
DR   OpenTargets; ENSG00000136754; -.
DR   PharmGKB; PA36144; -.
DR   eggNOG; ENOG410IPCV; Eukaryota.
DR   eggNOG; ENOG410XQ3Y; LUCA.
DR   GeneTree; ENSGT00390000003756; -.
DR   HOVERGEN; HBG050446; -.
DR   ChiTaRS; ABI1; human.
DR   GenomeRNAi; 10006; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000136754; -.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:InterPro.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; IEA:InterPro.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 2.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 2.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 2.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00202};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:B6VEX4,
KW   ECO:0000213|MaxQB:B6VEX4, ECO:0000213|PeptideAtlas:B6VEX4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192}.
FT   DOMAIN       45    107       T-SNARE coiled-coil homology.
FT                                {ECO:0000259|PROSITE:PS50192}.
FT   DOMAIN      331    390       SH3. {ECO:0000259|PROSITE:PS50002}.
SQ   SEQUENCE   393 AA;  43295 MW;  4230F3E09401E859 CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKWLKAKH GNNQPARTGT LSRTNPPTQK
     PPSPPMSGRG TLGRNTPYKT LEPVKPPTVP NDYMTSPARL GSQHSPGRTA SLNQRPRTHS
     GSSGGSGSRE NSGSSSIGIP IAVPTPSPPT IGPVADSPTP PPPPPPDDIP MFDDSPPPPP
     PPPVDYEDEE AAVVQYNDPY ADGDPAWAPK NYIEKVVAIY DYTKDKDDEL SFMEGAIIYV
     IKKNDDGWYE GVCNRVTGLF PGNYVESIMH YTD
//
ID   B6VEX5_HUMAN            Unreviewed;       388 AA.
AC   B6VEX5;
DT   16-DEC-2008, integrated into UniProtKB/TrEMBL.
DT   16-DEC-2008, sequence version 1.
DT   31-JAN-2018, entry version 43.
DE   SubName: Full=Abl-interactor 1 variant 72 {ECO:0000313|EMBL:ACJ12785.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ12785.1};
RN   [1] {ECO:0000313|EMBL:ACJ12785.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Gautreau A.;
RT   "The Wave complex is intrinsically inactive.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ380059; ACJ12785.1; -; mRNA.
DR   RefSeq; NP_001171595.1; NM_001178124.1.
DR   UniGene; Hs.508148; -.
DR   PeptideAtlas; B6VEX5; -.
DR   PRIDE; B6VEX5; -.
DR   GeneID; 10006; -.
DR   CTD; 10006; -.
DR   eggNOG; ENOG410IPCV; Eukaryota.
DR   eggNOG; ENOG410XQ3Y; LUCA.
DR   HOVERGEN; HBG050446; -.
DR   GenomeRNAi; 10006; -.
DR   Genevisible; B6VEX5; HS.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:InterPro.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; IEA:InterPro.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 2.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 2.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 2.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00202};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192}.
FT   DOMAIN       45    107       T-SNARE coiled-coil homology.
FT                                {ECO:0000259|PROSITE:PS50192}.
FT   DOMAIN      326    385       SH3. {ECO:0000259|PROSITE:PS50002}.
SQ   SEQUENCE   388 AA;  42638 MW;  8BFFDB219C618E57 CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKHGNNQP ARTGTLSRTN PPTQKPPSPP
     MSGRGTLGRN TPYKTLEPVK PPTVPNDYMT SPARLGSQHS PGRTASLNQR PRTHGGSSGG
     SGSRENSGSS SIGIPIAVPT PSPPTIGPVA DSPTPPPPPP PDDIPMFDDS PPPPPPPPVD
     YEDEEAAVVQ YNDPYADGDP AWAPKNYIEK VVAIYDYTKD KDDELSFMEG AIIYVIKKND
     DGWYEGVCNR VTGLFPGNYV ESIMHYTD
//
ID   ABI1_HUMAN              Reviewed;         508 AA.
AC   Q8IZP0; A9Z1Y6; B3KX62; B4DQ58; H7BXI6; O15147; O76049; O95060;
AC   Q5T2R3; Q5T2R4; Q5T2R6; Q5T2R7; Q5T2R9; Q5W070; Q5W072; Q8TB63;
AC   Q96S81; Q9NXZ9; Q9NYB8;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   28-FEB-2018, entry version 164.
DE   RecName: Full=Abl interactor 1;
DE   AltName: Full=Abelson interactor 1;
DE            Short=Abi-1;
DE   AltName: Full=Abl-binding protein 4;
DE            Short=AblBP4;
DE   AltName: Full=Eps8 SH3 domain-binding protein;
DE            Short=Eps8-binding protein;
DE   AltName: Full=Nap1-binding protein;
DE            Short=Nap1BP;
DE   AltName: Full=Spectrin SH3 domain-binding protein 1;
DE   AltName: Full=e3B1;
GN   Name=ABI1 {ECO:0000312|HGNC:HGNC:11320}; Synonyms=SSH3BP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), PHOSPHORYLATION, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH EPS8 AND ABL1.
RX   PubMed=9010225; DOI=10.1038/sj.onc.1200822;
RA   Biesova Z., Piccoli C., Wong W.T.;
RT   "Isolation and characterization of e3B1, an eps8 binding protein that
RT   regulates cell growth.";
RL   Oncogene 14:233-241(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORMS
RP   3; 7; 8 AND 9), AND INTERACTION WITH SPTA1.
RX   PubMed=9593709; DOI=10.1074/jbc.273.22.13681;
RA   Ziemnicka-Kotula D., Xu J., Gu H., Potempska A., Kim K.S.,
RA   Jenkins E.C., Trenkner E., Kotula L.;
RT   "Identification of a candidate human spectrin Src homology 3 domain-
RT   binding protein suggests a general mechanism of association of
RT   tyrosine kinases with the spectrin-based membrane skeleton.";
RL   J. Biol. Chem. 273:13681-13692(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND
RP   INTERACTION WITH ABL1; NAP1 AND NCK1.
RX   PubMed=11418237; DOI=10.1016/S0378-1119(01)00521-2;
RA   Yamamoto A., Suzuki T., Sakaki Y.;
RT   "Isolation of hNap1BP which interacts with human Nap 1 (NCKAP1) whose
RT   expression is down-regulated in Alzheimer's disease.";
RL   Gene 271:159-169(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND INTERACTION WITH NCF1.
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=12681507; DOI=10.1016/S0014-5793(03)00262-X;
RA   Gu Y., Souza R.F., Wu R.F., Xu Y.C., Terada L.S.;
RT   "Induction of colonic epithelial cell apoptosis by p47-dependent
RT   oxidants(1).";
RL   FEBS Lett. 540:195-200(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=T-cell;
RA   Wilson L.A., Fields D., Cruz L., Friesen J., Siminovitch K.A.;
RT   "A new member of the Abl interactor protein family, AblBP4.";
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Chikri M.M., Boutin M.P., Vaxillaire M.M., Froguel M.P.;
RT   "In silico cloning of the human SSH3BP1/e3B1 gene.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Quackenbush R.C., Pendergast A.M.;
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 11 AND 12).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 2-17.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-17; 139-154; 229-237 AND 451-477, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Hepatoma;
RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [14]
RP   FUNCTION, AND INTERACTION WITH SOS1; SOS2 AND GRB2.
RX   PubMed=11003655; DOI=10.1128/MCB.20.20.7591-7601.2000;
RA   Fan P.-D., Goff S.P.;
RT   "Abl interactor 1 binds to sos and inhibits epidermal growth
RT   factor- and v-Abl-induced activation of extracellular signal-regulated
RT   kinases.";
RL   Mol. Cell. Biol. 20:7591-7601(2000).
RN   [15]
RP   ALTERNATIVE SPLICING (ISOFORMS 2 AND 10), AND CHROMOSOMAL
RP   TRANSLOCATION WITH KMT2A.
RX   PubMed=9694699;
RA   Taki T., Shibuya N., Taniwaki M., Hanada R., Morishita K., Bessho F.,
RA   Yanagisawa M., Hayashi Y.;
RT   "ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene
RT   in acute myeloid leukemia with t(10;11)(p11.2;q23).";
RL   Blood 92:1125-1130(1998).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [17]
RP   IDENTIFICATION IN THE WAVE2 COMPLEX.
RX   PubMed=16417406; DOI=10.1371/journal.pbio.0040038;
RA   Weiner O.D., Rentel M.C., Ott A., Brown G.E., Jedrychowski M.,
RA   Yaffe M.B., Gygi S.P., Cantley L.C., Bourne H.R., Kirschner M.W.;
RT   "Hem-1 complexes are essential for Rac activation, actin
RT   polymerization, and myosin regulation during neutrophil chemotaxis.";
RL   PLoS Biol. 4:E38-E38(2006).
RN   [18]
RP   FUNCTION, AND PHOSPHORYLATION AT TYR-213.
RX   PubMed=18328268; DOI=10.1016/j.bbamcr.2008.01.028;
RA   Xiong X., Cui P., Hossain S., Xu R., Warner B., Guo X., An X.,
RA   Debnath A.K., Cowburn D., Kotula L.;
RT   "Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase
RT   by phosphopeptides derived from Abi1/Hssh3bp1.";
RL   Biochim. Biophys. Acta 1783:737-747(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183 AND SER-216, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   INTERACTION WITH FNBP1L; WASF2 AND CDC42.
RX   PubMed=19798448; DOI=10.1371/journal.pgen.1000675;
RA   Giuliani C., Troglio F., Bai Z., Patel F.B., Zucconi A.,
RA   Malabarba M.G., Disanza A., Stradal T.B., Cassata G., Confalonieri S.,
RA   Hardin J.D., Soto M.C., Grant B.D., Scita G.;
RT   "Requirements for F-BAR proteins TOCA-1 and TOCA-2 in actin dynamics
RT   and membrane trafficking during Caenorhabditis elegans oocyte growth
RT   and embryonic epidermal morphogenesis.";
RL   PLoS Genet. 5:E1000675-E1000675(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225 AND THR-507, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222; SER-225 AND
RP   SER-323, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; TYR-213; SER-225;
RP   SER-319 AND SER-323, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   INTERACTION WITH HUMAN CYTOMEGALOVIRUS PROTEIN UL135.
RX   PubMed=25121749; DOI=10.1016/j.chom.2014.07.005;
RA   Stanton R.J., Prod'homme V., Purbhoo M.A., Moore M., Aicheler R.J.,
RA   Heinzmann M., Bailer S.M., Haas J., Antrobus R., Weekes M.P.,
RA   Lehner P.J., Vojtesek B., Miners K.L., Man S., Wilkie G.S.,
RA   Davison A.J., Wang E.C., Tomasec P., Wilkinson G.W.;
RT   "HCMV pUL135 remodels the actin cytoskeleton to impair immune
RT   recognition of infected cells.";
RL   Cell Host Microbe 16:201-214(2014).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-174; THR-178; SER-183;
RP   SER-187; SER-222 AND SER-225, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May act in negative regulation of cell growth and
CC       transformation by interacting with nonreceptor tyrosine kinases
CC       ABL1 and/or ABL2. May play a role in regulation of EGF-induced Erk
CC       pathway activation. Involved in cytoskeletal reorganization and
CC       EGFR signaling. Together with EPS8 participates in transduction of
CC       signals from Ras to Rac. In vitro, a trimeric complex of ABI1,
CC       EPS8 and SOS1 exhibits Rac specific guanine nucleotide exchange
CC       factor (GEF) activity and ABI1 seems to act as an adapter in the
CC       complex. Regulates ABL1/c-Abl-mediated phosphorylation of ENAH.
CC       Recruits WASF1 to lamellipodia and there seems to regulate WASF1
CC       protein level. In brain, seems to regulate the dendritic outgrowth
CC       and branching as well as to determine the shape and number of
CC       synaptic contacts of developing neurons.
CC       {ECO:0000269|PubMed:11003655, ECO:0000269|PubMed:18328268}.
CC   -!- SUBUNIT: Interacts with ABL1, ENAH, STX1A, SNAP25, VAMP2, EPS8,
CC       and through its N-terminus with WASF1. Part of a complex
CC       consisting of ABI1, STX1A and SNAP25. Part of a complex consisting
CC       of ABI1, EPS8 and SOS1 (By similarity). Interacts with SOS1, SOS2,
CC       GRB2, SPTA1 and the first SH3 domain of NCK1. Isoform 6 does not
CC       interact with NCK1. Component of the WAVE2 complex composed of
CC       ABI1, CYFIP1/SRA1, NCKAP1/NAP1 (NCKAP1l/HEM1 in hematopoietic
CC       cells) and WASF2/WAVE2 (PubMed:16417406). Interacts (via SH3
CC       domain) with SHANK2 and SHANK3, but not SHANK1; the interaction is
CC       direct. Interacts with the heterodimer MYC:MAX; the interaction
CC       may enhance MYC:MAX transcriptional activity. Interacts with human
CC       cytomegalovirus protein UL135. Interacts with FNBP1L (via the SH3
CC       domain), WASF2, and CDC42, but only in the presence of FNBP1L
CC       (PubMed:19798448). {ECO:0000250, ECO:0000269|PubMed:11003655,
CC       ECO:0000269|PubMed:11418237, ECO:0000269|PubMed:12681507,
CC       ECO:0000269|PubMed:16417406, ECO:0000269|PubMed:19798448,
CC       ECO:0000269|PubMed:25121749, ECO:0000269|PubMed:9010225,
CC       ECO:0000269|PubMed:9593709}.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=11; IntAct=EBI-375446, EBI-375543;
CC       P00520-4:Abl1 (xeno); NbExp=5; IntAct=EBI-8593095, EBI-8593082;
CC       P42684:ABL2; NbExp=2; IntAct=EBI-375446, EBI-1102694;
CC       O00555:CACNA1A; NbExp=2; IntAct=EBI-375446, EBI-766279;
CC       P22681:CBL; NbExp=3; IntAct=EBI-7358775, EBI-518228;
CC       Q08509:Eps8 (xeno); NbExp=2; IntAct=EBI-375446, EBI-375596;
CC       P13612:ITGA4; NbExp=2; IntAct=EBI-7358775, EBI-703044;
CC       P14598:NCF1; NbExp=5; IntAct=EBI-375446, EBI-395044;
CC       Q9Y2A7:NCKAP1; NbExp=3; IntAct=EBI-375446, EBI-389845;
CC       P27986:PIK3R1; NbExp=8; IntAct=EBI-375446, EBI-79464;
CC       P26450:Pik3r1 (xeno); NbExp=3; IntAct=EBI-375446, EBI-641764;
CC       Q92569:PIK3R3; NbExp=2; IntAct=EBI-375446, EBI-79893;
CC       P20936:RASA1; NbExp=2; IntAct=EBI-375446, EBI-1026476;
CC       O14512:SOCS7; NbExp=2; IntAct=EBI-375446, EBI-1539606;
CC       P02549:SPTA1; NbExp=2; IntAct=EBI-375446, EBI-375617;
CC       P15498:VAV1; NbExp=2; IntAct=EBI-375446, EBI-625518;
CC       P52735:VAV2; NbExp=2; IntAct=EBI-375446, EBI-297549;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Cell projection, lamellipodium {ECO:0000250}. Cell
CC       projection, filopodium {ECO:0000250}. Cell projection, growth cone
CC       {ECO:0000250}. Cell junction, synapse, postsynaptic cell membrane,
CC       postsynaptic density {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}. Note=Localized to protruding lamellipodia and
CC       filopodia tips. Also localized to neuronal growth cones and
CC       synaptosomes. May shuttle from the postsynaptic densities to the
CC       nucleus (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=12;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q8IZP0-1; Sequence=Displayed;
CC       Name=2; Synonyms=long, B48;
CC         IsoId=Q8IZP0-2; Sequence=VSP_010749, VSP_010750, VSP_010751,
CC                                  VSP_010752;
CC       Name=3;
CC         IsoId=Q8IZP0-3; Sequence=VSP_010750, VSP_010752;
CC       Name=4;
CC         IsoId=Q8IZP0-4; Sequence=VSP_010750, VSP_010751, VSP_010752;
CC       Name=5;
CC         IsoId=Q8IZP0-5; Sequence=VSP_010749, VSP_010750;
CC       Name=6;
CC         IsoId=Q8IZP0-6; Sequence=VSP_010750, VSP_010751;
CC       Name=7; Synonyms=4;
CC         IsoId=Q8IZP0-7; Sequence=VSP_010750, VSP_010751, VSP_010754,
CC                                  VSP_010755;
CC       Name=8; Synonyms=5;
CC         IsoId=Q8IZP0-8; Sequence=VSP_010750, VSP_010751, VSP_010754,
CC                                  VSP_010752;
CC       Name=9; Synonyms=2;
CC         IsoId=Q8IZP0-9; Sequence=VSP_010750;
CC       Name=10; Synonyms=B30;
CC         IsoId=Q8IZP0-10; Sequence=VSP_010749, VSP_010750, VSP_010751,
CC                                   VSP_010754, VSP_010752, VSP_010753;
CC       Name=11;
CC         IsoId=Q8IZP0-11; Sequence=VSP_043403, VSP_010750, VSP_010751,
CC                                   VSP_010754, VSP_010752, VSP_010753;
CC         Note=No experimental confirmation available.;
CC       Name=12;
CC         IsoId=Q8IZP0-12; Sequence=VSP_044604, VSP_010752;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest expression in
CC       brain. {ECO:0000269|PubMed:11418237}.
CC   -!- DOMAIN: The t-SNARE coiled-coil homology domain is necessary and
CC       sufficient for interaction with STX1A. {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine residues after serum stimulation
CC       or induction by v-Abl. Seems to be phosphorylated at Tyr-53 by
CC       ABL1, required for nuclear but not for synaptic localization.
CC       {ECO:0000269|PubMed:18328268, ECO:0000269|PubMed:9010225}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ABI1 is a cause
CC       of acute leukemias. Translocation t(10;11)(p11.2;q23) with
CC       KMT2A/MLL1. ABI1 isoform 2 was found to be present in acute
CC       leukemia KMT2A/MLL1-ABI1 fusion transcript.
CC       {ECO:0000269|PubMed:9694699}.
CC   -!- SIMILARITY: Belongs to the ABI family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ABI1ID233.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF006516; AAB62569.1; -; mRNA.
DR   EMBL; U87166; AAC39757.1; -; mRNA.
DR   EMBL; AB040151; BAB55675.1; -; mRNA.
DR   EMBL; AF540955; AAN28379.1; -; mRNA.
DR   EMBL; AF001628; AAD00897.1; -; mRNA.
DR   EMBL; AJ277065; CAB88006.1; -; Genomic_DNA.
DR   EMBL; AJ277066; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277067; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277068; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277069; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277070; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277071; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277072; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277073; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277074; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AF260262; AAF70309.1; -; mRNA.
DR   EMBL; AK126803; BAG54374.1; -; mRNA.
DR   EMBL; AK298646; BAG60820.1; -; mRNA.
DR   EMBL; AK291823; BAF84512.1; -; mRNA.
DR   EMBL; AL139404; CAH73112.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73112.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73113.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73113.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73114.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73114.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73115.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73115.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73116.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73116.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73117.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73117.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73118.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73118.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73119.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73119.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17272.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17272.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17273.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17273.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17274.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17274.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17275.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17275.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17276.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17276.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17277.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17277.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17278.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17278.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17279.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17279.1; JOINED; Genomic_DNA.
DR   EMBL; CH471072; EAW86079.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86080.1; -; Genomic_DNA.
DR   EMBL; BC024254; AAH24254.1; -; mRNA.
DR   CCDS; CCDS31169.1; -. [Q8IZP0-5]
DR   CCDS; CCDS31170.1; -. [Q8IZP0-3]
DR   CCDS; CCDS31171.1; -. [Q8IZP0-9]
DR   CCDS; CCDS53497.1; -. [Q8IZP0-11]
DR   CCDS; CCDS53498.1; -. [Q8IZP0-2]
DR   CCDS; CCDS53499.1; -. [Q8IZP0-4]
DR   CCDS; CCDS53500.1; -. [Q8IZP0-6]
DR   CCDS; CCDS53501.1; -. [Q8IZP0-12]
DR   CCDS; CCDS7150.1; -. [Q8IZP0-1]
DR   CCDS; CCDS73077.1; -. [Q8IZP0-8]
DR   CCDS; CCDS73078.1; -. [Q8IZP0-7]
DR   RefSeq; NP_001012768.1; NM_001012750.2. [Q8IZP0-9]
DR   RefSeq; NP_001012769.1; NM_001012751.2. [Q8IZP0-3]
DR   RefSeq; NP_001012770.1; NM_001012752.2. [Q8IZP0-5]
DR   RefSeq; NP_001171587.1; NM_001178116.1. [Q8IZP0-12]
DR   RefSeq; NP_001171590.1; NM_001178119.1. [Q8IZP0-6]
DR   RefSeq; NP_001171591.1; NM_001178120.1. [Q8IZP0-4]
DR   RefSeq; NP_001171592.1; NM_001178121.1. [Q8IZP0-2]
DR   RefSeq; NP_001171593.1; NM_001178122.1. [Q8IZP0-7]
DR   RefSeq; NP_001171594.1; NM_001178123.1.
DR   RefSeq; NP_001171595.1; NM_001178124.1. [Q8IZP0-10]
DR   RefSeq; NP_001171596.1; NM_001178125.1. [Q8IZP0-11]
DR   RefSeq; NP_005461.2; NM_005470.3. [Q8IZP0-1]
DR   UniGene; Hs.508148; -.
DR   ProteinModelPortal; Q8IZP0; -.
DR   SMR; Q8IZP0; -.
DR   BioGrid; 115324; 67.
DR   CORUM; Q8IZP0; -.
DR   DIP; DIP-31118N; -.
DR   ELM; Q8IZP0; -.
DR   IntAct; Q8IZP0; 108.
DR   MINT; Q8IZP0; -.
DR   STRING; 9606.ENSP00000365312; -.
DR   iPTMnet; Q8IZP0; -.
DR   PhosphoSitePlus; Q8IZP0; -.
DR   BioMuta; ABI1; -.
DR   DMDM; 50400546; -.
DR   EPD; Q8IZP0; -.
DR   MaxQB; Q8IZP0; -.
DR   PaxDb; Q8IZP0; -.
DR   PeptideAtlas; Q8IZP0; -.
DR   PRIDE; Q8IZP0; -.
DR   Ensembl; ENST00000346832; ENSP00000279599; ENSG00000136754. [Q8IZP0-12]
DR   Ensembl; ENST00000359188; ENSP00000352114; ENSG00000136754. [Q8IZP0-6]
DR   Ensembl; ENST00000376137; ENSP00000365307; ENSG00000136754. [Q8IZP0-7]
DR   Ensembl; ENST00000376138; ENSP00000365308; ENSG00000136754. [Q8IZP0-3]
DR   Ensembl; ENST00000376139; ENSP00000365309; ENSG00000136754. [Q8IZP0-5]
DR   Ensembl; ENST00000376140; ENSP00000365310; ENSG00000136754. [Q8IZP0-9]
DR   Ensembl; ENST00000376142; ENSP00000365312; ENSG00000136754. [Q8IZP0-1]
DR   Ensembl; ENST00000376166; ENSP00000365336; ENSG00000136754. [Q8IZP0-2]
DR   Ensembl; ENST00000376170; ENSP00000365340; ENSG00000136754. [Q8IZP0-4]
DR   Ensembl; ENST00000490841; ENSP00000440101; ENSG00000136754. [Q8IZP0-11]
DR   GeneID; 10006; -.
DR   KEGG; hsa:10006; -.
DR   UCSC; uc001isx.4; human. [Q8IZP0-1]
DR   CTD; 10006; -.
DR   DisGeNET; 10006; -.
DR   EuPathDB; HostDB:ENSG00000136754.16; -.
DR   GeneCards; ABI1; -.
DR   HGNC; HGNC:11320; ABI1.
DR   HPA; CAB008375; -.
DR   HPA; HPA029973; -.
DR   HPA; HPA068407; -.
DR   MIM; 603050; gene.
DR   neXtProt; NX_Q8IZP0; -.
DR   OpenTargets; ENSG00000136754; -.
DR   PharmGKB; PA36144; -.
DR   eggNOG; ENOG410IPCV; Eukaryota.
DR   eggNOG; ENOG410XQ3Y; LUCA.
DR   GeneTree; ENSGT00390000003756; -.
DR   HOGENOM; HOG000293213; -.
DR   HOVERGEN; HBG050446; -.
DR   InParanoid; Q8IZP0; -.
DR   OMA; VGHGVKE; -.
DR   OrthoDB; EOG091G0AN8; -.
DR   PhylomeDB; Q8IZP0; -.
DR   TreeFam; TF314303; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   SignaLink; Q8IZP0; -.
DR   SIGNOR; Q8IZP0; -.
DR   ChiTaRS; ABI1; human.
DR   GeneWiki; ABI1; -.
DR   GenomeRNAi; 10006; -.
DR   PRO; PR:Q8IZP0; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000136754; -.
DR   ExpressionAtlas; Q8IZP0; baseline and differential.
DR   Genevisible; Q8IZP0; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0030426; C:growth cone; IEA:UniProtKB-SubCell.
DR   GO; GO:0005622; C:intracellular; IDA:MGI.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031209; C:SCAR complex; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0008092; F:cytoskeletal protein binding; TAS:ProtInc.
DR   GO; GO:0032403; F:protein complex binding; IDA:UniProtKB.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:Ensembl.
DR   GO; GO:0017124; F:SH3 domain binding; IPI:UniProtKB.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; NAS:UniProtKB.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0072673; P:lamellipodium morphogenesis; IEA:Ensembl.
DR   GO; GO:0035855; P:megakaryocyte development; IEA:Ensembl.
DR   GO; GO:0006928; P:movement of cell or subcellular component; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:MGI.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 1.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 1.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Host-virus interaction; Membrane; Nucleus; Phosphoprotein;
KW   Polymorphism; Postsynaptic cell membrane; Reference proteome;
KW   SH3 domain; Synapse.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.13}.
FT   CHAIN         2    508       Abl interactor 1.
FT                                /FTId=PRO_0000191787.
FT   DOMAIN       45    107       t-SNARE coiled-coil homology.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00202}.
FT   DOMAIN      446    505       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   REGION       18     79       Required for binding to WASF1.
FT                                {ECO:0000250}.
FT   COMPBIAS    260    418       Pro-rich.
FT   SITE         95     96       Breakpoint for translocation to form
FT                                KMT2A/MLL1-ABI1.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.13}.
FT   MOD_RES      53     53       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9QZM5}.
FT   MOD_RES     174    174       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     178    178       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     183    183       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     187    187       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     213    213       Phosphotyrosine; by ABL1.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:18328268}.
FT   MOD_RES     215    215       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8CBW3}.
FT   MOD_RES     216    216       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     222    222       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     225    225       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     319    319       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     455    455       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q8CBW3}.
FT   MOD_RES     466    466       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QZM5}.
FT   MOD_RES     507    507       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ      38     38       I -> IQRHGFAVLLCLLSNSWP (in isoform 12).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044604.
FT   VAR_SEQ      96    159       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043403.
FT   VAR_SEQ     154    158       Missing (in isoform 2, isoform 5 and
FT                                isoform 10).
FT                                {ECO:0000303|PubMed:12681507,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_010749.
FT   VAR_SEQ     274    300       Missing (in isoform 2, isoform 3, isoform
FT                                4, isoform 5, isoform 6, isoform 7,
FT                                isoform 8, isoform 9, isoform 10 and
FT                                isoform 11).
FT                                {ECO:0000303|PubMed:11418237,
FT                                ECO:0000303|PubMed:12681507,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9010225,
FT                                ECO:0000303|Ref.5, ECO:0000303|Ref.7}.
FT                                /FTId=VSP_010750.
FT   VAR_SEQ     301    301       Missing (in isoform 2, isoform 4, isoform
FT                                6, isoform 7, isoform 8, isoform 10 and
FT                                isoform 11).
FT                                {ECO:0000303|PubMed:12681507,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9010225,
FT                                ECO:0000303|Ref.5, ECO:0000303|Ref.7}.
FT                                /FTId=VSP_010751.
FT   VAR_SEQ     302    359       Missing (in isoform 7, isoform 8, isoform
FT                                10 and isoform 11).
FT                                {ECO:0000303|PubMed:12681507,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_010754.
FT   VAR_SEQ     360    388       Missing (in isoform 2, isoform 3, isoform
FT                                4, isoform 8, isoform 10, isoform 11 and
FT                                isoform 12).
FT                                {ECO:0000303|PubMed:11418237,
FT                                ECO:0000303|PubMed:12681507,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.5, ECO:0000303|Ref.7}.
FT                                /FTId=VSP_010752.
FT   VAR_SEQ     360    360       I -> V (in isoform 7).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_010755.
FT   VAR_SEQ     389    389       I -> V (in isoform 10 and isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_010753.
FT   VARIANT     331    331       G -> A (in dbSNP:rs2306236).
FT                                /FTId=VAR_048159.
FT   CONFLICT    177    177       P -> L (in Ref. 2; AAC39757).
FT                                {ECO:0000305}.
FT   CONFLICT    410    410       S -> F (in Ref. 2; AAC39757 and 4;
FT                                AAN28379). {ECO:0000305}.
FT   CONFLICT    437    437       D -> G (in Ref. 8; BAG54374).
FT                                {ECO:0000305}.
SQ   SEQUENCE   508 AA;  55081 MW;  2D76F305934127CB CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKWLKAKH GNNQPARTGT LSRTNPPTQK
     PPSPPMSGRG TLGRNTPYKT LEPVKPPTVP NDYMTSPARL GSQHSPGRTA SLNQRPRTHS
     GSSGGSGSRE NSGSSSIGIP IAVPTPSPPT IGPENISVPP PSGAPPAPPL APLLPVSTVI
     AAPGSAPGSQ YGTMTRQISR HNSTTSSTSS GGYRRTPSVT AQFSAQPHVN GGPLYSQNSI
     SIAPPPPPMP QLTPQIPLTG FVARVQENIA DSPTPPPPPP PDDIPMFDDS PPPPPPPPVD
     YEDEEAAVVQ YNDPYADGDP AWAPKNYIEK VVAIYDYTKD KDDELSFMEG AIIYVIKKND
     DGWYEGVCNR VTGLFPGNYV ESIMHYTD
//
ID   A0A0S2Z536_HUMAN        Unreviewed;       759 AA.
AC   A0A0S2Z536;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 18.
DE   SubName: Full=Rho GTPase activating protein 26 isoform 1 {ECO:0000313|EMBL:ALQ34019.1};
DE   Flags: Fragment;
GN   Name=ARHGAP26 {ECO:0000313|EMBL:ALQ34019.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ34019.1};
RN   [1] {ECO:0000313|EMBL:ALQ34019.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178561; ALQ34019.1; -; mRNA.
DR   RefSeq; NP_001129080.1; NM_001135608.1.
DR   UniGene; Hs.654668; -.
DR   SMR; A0A0S2Z536; -.
DR   GeneID; 23092; -.
DR   CTD; 23092; -.
DR   ChiTaRS; ARHGAP26; human.
DR   ExpressionAtlas; A0A0S2Z536; baseline and differential.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IEA:InterPro.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd07636; BAR_GRAF; 1.
DR   CDD; cd12064; SH3_GRAF; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR030061; GRAF.
DR   InterPro; IPR035483; GRAF_BAR.
DR   InterPro; IPR035481; GRAF_SH3.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR12552:SF4; PTHR12552:SF4; 2.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTPase activation {ECO:0000256|SAAS:SAAS00805150};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS00989295}.
FT   DOMAIN      265    369       PH. {ECO:0000259|PROSITE:PS50003}.
FT   DOMAIN      383    568       Rho-GAP. {ECO:0000259|PROSITE:PS50238}.
FT   DOMAIN      701    759       SH3. {ECO:0000259|PROSITE:PS50002}.
FT   COILED       22     42       {ECO:0000256|SAM:Coils}.
FT   COILED      232    252       {ECO:0000256|SAM:Coils}.
FT   NON_TER     759    759       {ECO:0000313|EMBL:ALQ34019.1}.
SQ   SEQUENCE   759 AA;  86165 MW;  8FA48FDF1DCAFB7F CRC64;
     MGLPALEFSD CCLDSPHFRE TLKSHEAELD KTNKFIKELI KDGKSLISAL KNLSSAKRKF
     ADSLNEFKFQ CIGDAETDDE MCIARSLQEF ATVLRNLEDE RIRMIENASE VLITPLEKFR
     KEQIGAAKEA KKKYDKETEK YCGILEKHLN LSSKKKESQL QEADSQVDLV RQHFYEVSLE
     YVFKVQEVQE RKMFEFVEPL LAFLQGLFTF YHHGYELAKD FGDFKTQLTI SIQNTRNRFE
     GTRSEVESLM KKMKENPLEH KTISPYTMEG YLYVQEKRHF GTSWVKHYCT YQRDSKQITM
     VPFDQKSGGK GGEDESVILK SCTRRKTDSI EKRFCFDVEA VDRPGVITMQ ALSEEDRRLW
     MEAMDGREPV YNSNKDSQSE GTAQLDSIGF SIIRKCIHAV ETRGINEQGL YRIVGVNSRV
     QKLLSVLMDP KTASETETDI CAEWEIKTIT SALKTYLRML PGPLMMYQFQ RSFIKAAKLE
     NQESRVSEIH SLVHRLPEKN RQMLQLLMNH LANVANNHKQ NLMTVANLGV VFGPTLLRPQ
     EETVAAIMDI KFQNIVIEIL IENHEKIFNT VPDMPLTNAQ LHLSRKKSSD SKPPSCSERP
     LTLFHTVQST EKQEQRNSII NSSLESVSSN PNSILNSSSS LQPNMNSSDP DLAVVKPTRP
     NSLPPNPSPT SPLSPSWPMF SAPSSPMPTS STSSDSSPVS TPFRKAKALY ACKAEHDSEL
     SFTAGTVFDN VHPSQEPGWL EGTLNGKTGL IPENYVEFL
//
ID   RHG26_HUMAN             Reviewed;         814 AA.
AC   Q9UNA1; O75117; Q5D035; Q9BYS6; Q9BYS7; Q9UJ00;
DT   11-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   28-FEB-2018, entry version 174.
DE   RecName: Full=Rho GTPase-activating protein 26;
DE   AltName: Full=GTPase regulator associated with focal adhesion kinase;
DE   AltName: Full=Oligophrenin-1-like protein;
DE   AltName: Full=Rho-type GTPase-activating protein 26;
GN   Name=ARHGAP26; Synonyms=GRAF, KIAA0621, OPHN1L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart, Liver, and Placenta;
RA   Xia J.H., Tang X.X., Yu K.P., Pan Q., Dai H.P.;
RT   "Molecular cloning of human oligophrenin-1 like (OPHN1L) gene,
RT   complete CDS.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2), DISEASE, AND VARIANT
RP   JMML SER-417.
RX   PubMed=10908648; DOI=10.1073/pnas.150079597;
RA   Borkhardt A., Bojesen S., Haas O.A., Fuchs U., Bartelheimer D.,
RA   Loncarevic I.F., Bohle R.M., Harbott J., Repp R., Jaeger U.,
RA   Viehmann S., Henn T., Korth P., Scharr D., Lampert F.;
RT   "The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and
RT   both alleles are disrupted in three cases of myelodysplastic
RT   syndrome/acute myeloid leukemia with a deletion 5q.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9168-9173(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 53-785.
RA   Bojesen S.E., Link C., Borkhardt A.;
RT   "Genomic structure of the human GRAF gene.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 62-814 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   STRUCTURE BY NMR OF 754-814.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SH3 domain of human oligophrenin-1-like
RT   protein (KIAA0621).";
RL   Submitted (DEC-2003) to the PDB data bank.
CC   -!- FUNCTION: GTPase-activating protein for RHOA and CDC42.
CC   -!- SUBUNIT: Interacts with NYAP1, NYAP2 and MYO16 (By similarity).
CC       Binds to the C-terminus of PTK2/FAK1. {ECO:0000250}.
CC   -!- INTERACTION:
CC       O14613:CDC42EP2; NbExp=3; IntAct=EBI-16430964, EBI-3438291;
CC       Q6P5Z2:PKN3; NbExp=4; IntAct=EBI-1390913, EBI-1384335;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion {ECO:0000250}.
CC       Cytoplasm, cytoskeleton {ECO:0000250}. Note=Colocalizes with actin
CC       stress fibers and cortical actin structures. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UNA1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UNA1-2; Sequence=VSP_001659;
CC   -!- DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An
CC       aggressive pediatric myelodysplastic syndrome/myeloproliferative
CC       disorder characterized by malignant transformation in the
CC       hematopoietic stem cell compartment with proliferation of
CC       differentiated progeny. Patients have splenomegaly, enlarged lymph
CC       nodes, rashes, and hemorrhages. Note=The gene represented in this
CC       entry is involved in disease pathogenesis. A chromosomal
CC       translocation t(5;11)(q31;q23) with KMT2A/MLL1 has been found in
CC       leukemic cells from JMML patients, also carrying inactivating
CC       mutations on the second allele (PubMed:10908648).
CC       {ECO:0000269|PubMed:10908648}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GRAFID291.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Graf1 entry;
CC       URL="https://en.wikipedia.org/wiki/Graf1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF141884; AAD39482.1; -; mRNA.
DR   EMBL; Y10388; CAA71414.2; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61876.1; -; Genomic_DNA.
DR   EMBL; BC068555; AAH68555.1; -; mRNA.
DR   EMBL; AJ309466; CAC29145.2; -; Genomic_DNA.
DR   EMBL; AJ309467; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309468; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309469; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309470; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309471; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309472; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309473; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309474; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309475; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309476; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309477; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309478; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309479; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309480; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309481; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309482; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309483; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309484; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309485; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309486; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309487; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309466; CAC29146.2; -; Genomic_DNA.
DR   EMBL; AJ309467; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309468; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309469; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309470; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309471; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309472; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309473; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309474; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309475; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309476; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309477; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309478; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309479; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309480; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309481; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309482; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309483; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309484; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309485; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309487; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AB014521; BAA31596.1; -; mRNA.
DR   CCDS; CCDS4277.1; -. [Q9UNA1-1]
DR   CCDS; CCDS47297.1; -. [Q9UNA1-2]
DR   PIR; F59430; F59430.
DR   RefSeq; NP_001129080.1; NM_001135608.1. [Q9UNA1-2]
DR   RefSeq; NP_055886.1; NM_015071.4. [Q9UNA1-1]
DR   UniGene; Hs.654668; -.
DR   PDB; 1UGV; NMR; -; A=756-814.
DR   PDBsum; 1UGV; -.
DR   ProteinModelPortal; Q9UNA1; -.
DR   SMR; Q9UNA1; -.
DR   BioGrid; 116720; 22.
DR   IntAct; Q9UNA1; 8.
DR   MINT; Q9UNA1; -.
DR   STRING; 9606.ENSP00000274498; -.
DR   iPTMnet; Q9UNA1; -.
DR   PhosphoSitePlus; Q9UNA1; -.
DR   SwissPalm; Q9UNA1; -.
DR   BioMuta; ARHGAP26; -.
DR   DMDM; 21759332; -.
DR   EPD; Q9UNA1; -.
DR   PaxDb; Q9UNA1; -.
DR   PeptideAtlas; Q9UNA1; -.
DR   PRIDE; Q9UNA1; -.
DR   Ensembl; ENST00000274498; ENSP00000274498; ENSG00000145819. [Q9UNA1-1]
DR   Ensembl; ENST00000378004; ENSP00000367243; ENSG00000145819. [Q9UNA1-2]
DR   GeneID; 23092; -.
DR   KEGG; hsa:23092; -.
DR   UCSC; uc003lmt.4; human. [Q9UNA1-1]
DR   CTD; 23092; -.
DR   DisGeNET; 23092; -.
DR   EuPathDB; HostDB:ENSG00000145819.15; -.
DR   GeneCards; ARHGAP26; -.
DR   H-InvDB; HIX0005269; -.
DR   HGNC; HGNC:17073; ARHGAP26.
DR   HPA; HPA035106; -.
DR   HPA; HPA035107; -.
DR   MalaCards; ARHGAP26; -.
DR   MIM; 605370; gene.
DR   MIM; 607785; phenotype.
DR   neXtProt; NX_Q9UNA1; -.
DR   OpenTargets; ENSG00000145819; -.
DR   PharmGKB; PA134946198; -.
DR   eggNOG; KOG1451; Eukaryota.
DR   eggNOG; ENOG410YJPS; LUCA.
DR   GeneTree; ENSGT00890000139322; -.
DR   HOGENOM; HOG000018767; -.
DR   HOVERGEN; HBG067993; -.
DR   InParanoid; Q9UNA1; -.
DR   KO; K20071; -.
DR   OMA; KDFGDFK; -.
DR   OrthoDB; EOG091G01TT; -.
DR   PhylomeDB; Q9UNA1; -.
DR   TreeFam; TF316851; -.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   ChiTaRS; ARHGAP26; human.
DR   EvolutionaryTrace; Q9UNA1; -.
DR   GeneWiki; ARHGAP26; -.
DR   GenomeRNAi; 23092; -.
DR   PRO; PR:Q9UNA1; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000145819; -.
DR   CleanEx; HS_ARHGAP26; -.
DR   ExpressionAtlas; Q9UNA1; baseline and differential.
DR   Genevisible; Q9UNA1; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:Reactome.
DR   GO; GO:0005543; F:phospholipid binding; IDA:FlyBase.
DR   GO; GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd07636; BAR_GRAF; 1.
DR   CDD; cd12064; SH3_GRAF; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR030061; GRAF.
DR   InterPro; IPR035483; GRAF_BAR.
DR   InterPro; IPR035481; GRAF_SH3.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR12552:SF4; PTHR12552:SF4; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF50044; SSF50044; 2.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Disease mutation; GTPase activation; Proto-oncogene;
KW   Reference proteome; SH3 domain.
FT   CHAIN         1    814       Rho GTPase-activating protein 26.
FT                                /FTId=PRO_0000056718.
FT   DOMAIN      265    369       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      383    568       Rho-GAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00172}.
FT   DOMAIN      756    814       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   COMPBIAS    584    701       Ser-rich.
FT   VAR_SEQ     700    754       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001659.
FT   VARIANT     417    417       N -> S (in JMML; somatic mutation;
FT                                dbSNP:rs121918546).
FT                                {ECO:0000269|PubMed:10908648}.
FT                                /FTId=VAR_013623.
FT   CONFLICT    355    355       E -> G (in Ref. 2; CAA71414 and 3;
FT                                CAC29145/CAC29146). {ECO:0000305}.
FT   STRAND      761    765       {ECO:0000244|PDB:1UGV}.
FT   STRAND      771    774       {ECO:0000244|PDB:1UGV}.
FT   STRAND      782    785       {ECO:0000244|PDB:1UGV}.
FT   STRAND      794    801       {ECO:0000244|PDB:1UGV}.
FT   STRAND      803    807       {ECO:0000244|PDB:1UGV}.
FT   HELIX       808    810       {ECO:0000244|PDB:1UGV}.
FT   STRAND      811    813       {ECO:0000244|PDB:1UGV}.
SQ   SEQUENCE   814 AA;  92235 MW;  5C81DBDECB32B18A CRC64;
     MGLPALEFSD CCLDSPHFRE TLKSHEAELD KTNKFIKELI KDGKSLISAL KNLSSAKRKF
     ADSLNEFKFQ CIGDAETDDE MCIARSLQEF ATVLRNLEDE RIRMIENASE VLITPLEKFR
     KEQIGAAKEA KKKYDKETEK YCGILEKHLN LSSKKKESQL QEADSQVDLV RQHFYEVSLE
     YVFKVQEVQE RKMFEFVEPL LAFLQGLFTF YHHGYELAKD FGDFKTQLTI SIQNTRNRFE
     GTRSEVESLM KKMKENPLEH KTISPYTMEG YLYVQEKRHF GTSWVKHYCT YQRDSKQITM
     VPFDQKSGGK GGEDESVILK SCTRRKTDSI EKRFCFDVEA VDRPGVITMQ ALSEEDRRLW
     MEAMDGREPV YNSNKDSQSE GTAQLDSIGF SIIRKCIHAV ETRGINEQGL YRIVGVNSRV
     QKLLSVLMDP KTASETETDI CAEWEIKTIT SALKTYLRML PGPLMMYQFQ RSFIKAAKLE
     NQESRVSEIH SLVHRLPEKN RQMLQLLMNH LANVANNHKQ NLMTVANLGV VFGPTLLRPQ
     EETVAAIMDI KFQNIVIEIL IENHEKIFNT VPDMPLTNAQ LHLSRKKSSD SKPPSCSERP
     LTLFHTVQST EKQEQRNSII NSSLESVSSN PNSILNSSSS LQPNMNSSDP DLAVVKPTRP
     NSLPPNPSPT SPLSPSWPMF SAPSSPMPTS STSSDSSPVR SVAGFVWFSV AAVVLSLARS
     SLHAVFSLLV NFVPCHPNLH LLFDRPEEAV HEDSSTPFRK AKALYACKAE HDSELSFTAG
     TVFDNVHPSQ EPGWLEGTLN GKTGLIPENY VEFL
//
ID   B4E2K6_HUMAN            Unreviewed;      1278 AA.
AC   B4E2K6;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 72.
DE   SubName: Full=cDNA FLJ60405, highly similar to Rho guanine nucleotide exchange factor 12 {ECO:0000313|EMBL:BAG65168.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65168.1};
RN   [1] {ECO:0000313|EMBL:BAG65168.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG65168.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK304316; BAG65168.1; -; mRNA.
DR   RefSeq; NP_001185594.1; NM_001198665.1.
DR   RefSeq; NP_056128.1; NM_015313.2.
DR   UniGene; Hs.24598; -.
DR   ProteinModelPortal; B4E2K6; -.
DR   PeptideAtlas; B4E2K6; -.
DR   PRIDE; B4E2K6; -.
DR   DNASU; 23365; -.
DR   GeneID; 23365; -.
DR   KEGG; hsa:23365; -.
DR   CTD; 23365; -.
DR   eggNOG; KOG3520; Eukaryota.
DR   eggNOG; COG5422; LUCA.
DR   HOGENOM; HOG000034046; -.
DR   HOVERGEN; HBG050571; -.
DR   KO; K07532; -.
DR   GenomeRNAi; 23365; -.
DR   Genevisible; B4E2K6; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd13390; PH_LARG; 1.
DR   CDD; cd08754; RGS_LARG; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR037801; ARHGEF12_PH.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR037884; LARG_RGS.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR015212; RGS-like_dom.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF09128; RGS-like; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       53    117       PDZ. {ECO:0000259|PROSITE:PS50106}.
FT   DOMAIN      768    958       DH. {ECO:0000259|PROSITE:PS50010}.
FT   DOMAIN     1000   1113       PH. {ECO:0000259|PROSITE:PS50003}.
FT   COILED      187    207       {ECO:0000256|SAM:Coils}.
FT   COILED      213    240       {ECO:0000256|SAM:Coils}.
FT   COILED      474    494       {ECO:0000256|SAM:Coils}.
FT   NON_TER    1278   1278       {ECO:0000313|EMBL:BAG65168.1}.
SQ   SEQUENCE   1278 AA;  143947 MW;  A6279845201B370A CRC64;
     MSGTQSTITD RFPLKKPIRH GSILNRESPT DKKQKVERIA SHDFDPTGLV QRCVIIQKDD
     NGFGLTVSGD NPVFVQSVKE DGAAMRAGVQ TGDRIIKVNG TLVTHSNHLE VVKLIKSGSY
     VALTVQGRPP GSPQIPLADS EVEPSVIGHM SPIMTSPHSP GASGNMERIT SPVLMGEENN
     VVHNQKVEIL RKMLQKEQER LQLLQEDYNR TPAQRLLKEI QEAKKHIPQL QEQLSKATGS
     AQDGAVVTPS RPLGDTLTVS EAETDPGDVL GRTDCSSGDA SRPSSDNADS PKSGPKERIY
     LEENPEKSET IQDTDTQSLV GSPSTRIAPH IIGAEDDDFG TEHEQINGQC SCFQSIELLK
     SRPAHLAVFL HHVVSQFDPA TLLCYLYSDL YKHTNSKETR RIFLEFHQFF LDRSAHLKVS
     VPDEMSADLE KRRPELIPED LHRHYIQTMQ ERVHPEVQRH LEDFRQKRSM GLTLAESELT
     KLDAERDKDR LTLEKERTCA EQIVAKIEEV LMTAQAVEED KSSTMQYVIL MYMKHLGVKV
     KEPRNLEHKR GRIGFLPKIK QSMKKDKEGE EKGKRRGFPS ILGPPRRPSR HDNSAIGRAM
     ELQKARHPKH LSTPSSVSPE PQDSAKLRQS GLANEGTDAG YLPANSMSSV ASGASFSQEG
     GKENDTGSKQ VGETSAPGDT LDGTPRTLNT VFDFPPPPLD QVQEEECEVE RVTEHGTPKP
     FRKFDSVAFG ESQSEDEQFE NDLETDPPNW QQLVSREVLL GLKPCEIKRQ EVINELFYTE
     RAHVRTLKVL DQVFYQRVSR EGILSPSELR KIFSNLEDIL QLHIGLNEQM KAVRKRNETS
     VIDQIGEDLL TWFSGPGEEK LKHAAATFCS NQPFALEMIK SRQKKDSRFQ TFVQDAESNP
     LCRRLQLKDI IPTQMQRLTK YPLLLDNIAK YTEWPTEREK VKKAADHCRQ ILNYVNQAVK
     EAENKQRLED YQRRLDTSSL KLSEYPNVEE LRNLDLTKRK MIHEGPLVWK VNRDKTIDLY
     TLLLEDILVL LQKQDDRLVL RCHSKILAST ADSKHTFSPV IKLSTVLVRQ VATDNKALFV
     ISMSDNGAQI YELVAQTVSE KTVWQDLICR MAASVKEQST KPIPLPQSTP GEGDNDEEDP
     SKLKEEQHGI SVTGLQSPDR DLGLESTLIS SKPQSHSLST SGKSEVRDLF VAERQFAKEQ
     HTDGTLKEVG EDYQIAIPDS HLPVSEERWA LDALRNLGLL KQLLVQQLGL TEKSVQEDWQ
     HFPRYRTASQ GPQTDSVI
//
ID   E9PMR6_HUMAN            Unreviewed;      1441 AA.
AC   E9PMR6;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-FEB-2018, entry version 62.
DE   SubName: Full=Rho guanine nucleotide exchange factor 12 {ECO:0000313|Ensembl:ENSP00000432984};
GN   Name=ARHGEF12 {ECO:0000313|Ensembl:ENSP00000432984};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000432984, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000432984, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y.,
RA   Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [3] {ECO:0000213|PubMed:18088087}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schutz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000313|Ensembl:ENSP00000432984}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000432984}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP000659; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000758; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001150; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001288013.1; NM_001301084.1.
DR   RefSeq; XP_011541022.1; XM_011542720.2.
DR   RefSeq; XP_016872910.1; XM_017017421.1.
DR   UniGene; Hs.24598; -.
DR   ProteinModelPortal; E9PMR6; -.
DR   EPD; E9PMR6; -.
DR   MaxQB; E9PMR6; -.
DR   PeptideAtlas; E9PMR6; -.
DR   PRIDE; E9PMR6; -.
DR   Ensembl; ENST00000532993; ENSP00000432984; ENSG00000196914.
DR   GeneID; 23365; -.
DR   UCSC; uc009zau.2; human.
DR   CTD; 23365; -.
DR   EuPathDB; HostDB:ENSG00000196914.8; -.
DR   HGNC; HGNC:14193; ARHGEF12.
DR   OpenTargets; ENSG00000196914; -.
DR   eggNOG; KOG3520; Eukaryota.
DR   eggNOG; COG5422; LUCA.
DR   GeneTree; ENSGT00760000119193; -.
DR   ChiTaRS; ARHGEF12; human.
DR   GenomeRNAi; 23365; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000196914; -.
DR   ExpressionAtlas; E9PMR6; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd13390; PH_LARG; 1.
DR   CDD; cd08754; RGS_LARG; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR037801; ARHGEF12_PH.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR037884; LARG_RGS.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR015212; RGS-like_dom.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF09128; RGS-like; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Guanine-nucleotide releasing factor {ECO:0000256|SAAS:SAAS00982760};
KW   Proteomics identification {ECO:0000213|MaxQB:E9PMR6,
KW   ECO:0000213|PeptideAtlas:E9PMR6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        1     33       PDZ. {ECO:0000259|PROSITE:PS50106}.
FT   DOMAIN      684    874       DH. {ECO:0000259|PROSITE:PS50010}.
FT   DOMAIN      916   1029       PH. {ECO:0000259|PROSITE:PS50003}.
FT   COILED      103    123       {ECO:0000256|SAM:Coils}.
FT   COILED      129    156       {ECO:0000256|SAM:Coils}.
FT   COILED      390    410       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1441 AA;  161909 MW;  7343555DCD901EDD CRC64;
     MRAGVQTGDR IIKVNGTLVT HSNHLEVVKL IKSGSYVALT VQGRPPGSPQ IPLADSEVEP
     SVIGHMSPIM TSPHSPGASG NMERITSPVL MGEENNVVHN QKVEILRKML QKEQERLQLL
     QEDYNRTPAQ RLLKEIQEAK KHIPQLQEQL SKATGSAQDG AVVTPSRPLG DTLTVSEAET
     DPGDVLGRTD CSSGDASRPS SDNADSPKSG PKERIYLEEN PEKSETIQDT DTQSLVGSPS
     TRIAPHIIGA EDDDFGTEHE QINGQCSCFQ SIELLKSRPA HLAVFLHHVV SQFDPATLLC
     YLYSDLYKHT NSKETRRIFL EFHQFFLDRS AHLKVSVPDE MSADLEKRRP ELIPEDLHRH
     YIQTMQERVH PEVQRHLEDF RQKRSMGLTL AESELTKLDA ERDKDRLTLE KERTCAEQIV
     AKIEEVLMTA QAVEEDKSST MQYVILMYMK HLGVKVKEPR NLEHKRGRIG FLPKIKQSMK
     KDKEGEEKGK RRGFPSILGP PRRPSRHDNS AIGRAMELQK ARHPKHLSTP SSVSPEPQDS
     AKLRQSGLAN EGTDAGYLPA NSMSSVASGA SFSQEGGKEN DTGSKQVGET SAPGDTLDGT
     PRTLNTVFDF PPPPLDQVQE EECEVERVTE HGTPKPFRKF DSVAFGESQS EDEQFENDLE
     TDPPNWQQLV SREVLLGLKP CEIKRQEVIN ELFYTERAHV RTLKVLDQVF YQRVSREGIL
     SPSELRKIFS NLEDILQLHI GLNEQMKAVR KRNETSVIDQ IGEDLLTWFS GPGEEKLKHA
     AATFCSNQPF ALEMIKSRQK KDSRFQTFVQ DAESNPLCRR LQLKDIIPTQ MQRLTKYPLL
     LDNIAKYTEW PTEREKVKKA ADHCRQILNY VNQAVKEAEN KQRLEDYQRR LDTSSLKLSE
     YPNVEELRNL DLTKRKMIHE GPLVWKVNRD KTIDLYTLLL EDILVLLQKQ DDRLVLRCHS
     KILASTADSK HTFSPVIKLS TVLVRQVATD NKALFVISMS DNGAQIYELV AQTVSEKTVW
     QDLICRMAAS VKEQSTKPIP LPQSTPGEGD NDEEDPSKLK EEQHGISVTG LQSPDRDLGL
     ESTLISSKPQ SHSLSTSGKS EVRDLFVAER QFAKEQHTDG TLKEVGEDYQ IAIPDSHLPV
     SEERWALDAL RNLGLLKQLL VQQLGLTEKS VQEDWQHFPR YRTASQGPQT DSVIQNSENI
     KAYHSGEGHM PFRTGTGDIA TCYSPRTSTE SFAPRDSVGL APQDSQASNI LVMDHMIMTP
     EMPTMEPEGG LDDSGEHFFD AREAHSDENP SEGDGAVNKE EKDVNLRISG NYLILDGYDP
     VQESSTDEEV ASSLTLQPMT GIPAVESTHQ QQHSPQNTHS DGAISPFTPE FLVQQRWGAM
     EYSCFEIQSP SSCADSQSQI MEYIHKIEAD LEHLKKVEES YTILCQRLAG SALTDKHSDK
     S
//
ID   ARHGC_HUMAN             Reviewed;        1544 AA.
AC   Q9NZN5; O15086; Q6P526;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 161.
DE   RecName: Full=Rho guanine nucleotide exchange factor 12;
DE   AltName: Full=Leukemia-associated RhoGEF;
GN   Name=ARHGEF12; Synonyms=KIAA0382, LARG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND CHROMOSOMAL
RP   TRANSLOCATION.
RC   TISSUE=Prostate;
RX   PubMed=10681437; DOI=10.1073/pnas.040569197;
RA   Kourlas P.J., Strout M.P., Becknell B., Veronese M.L., Croce C.M.,
RA   Theil K.S., Krahe R., Ruutu T., Knuutila S., Bloomfield C.D.,
RA   Caligiuri M.A.;
RT   "Identification of a gene at 11q23 encoding a guanine nucleotide
RT   exchange factor: evidence for its fusion with MLL in acute myeloid
RT   leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:2145-2150(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-584 (ISOFORM 2).
RC   TISSUE=Thyroid;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 102-1544, AND VARIANT
RP   PHE-973.
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [4]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION, AND INTERACTION WITH RHOA; GNA12 AND GNA13.
RX   PubMed=11094164; DOI=10.1016/S0014-5793(00)02224-9;
RA   Fukuhara S., Chikumi H., Gutkind J.S.;
RT   "Leukemia-associated Rho guanine nucleotide exchange factor (LARG)
RT   links heterotrimeric G proteins of the G(12) family to Rho.";
RL   FEBS Lett. 485:183-188(2000).
RN   [6]
RP   INTERACTION WITH IGF1R.
RX   PubMed=11724822; DOI=10.1083/jcb.200106139;
RA   Taya S., Inagaki N., Sengiku H., Makino H., Iwamatsu A., Urakawa I.,
RA   Nagao K., Kataoka S., Kaibuchi K.;
RT   "Direct interaction of insulin-like growth factor-1 receptor with
RT   leukemia-associated RhoGEF.";
RL   J. Cell Biol. 155:809-820(2001).
RN   [7]
RP   INTERACTION WITH PLXNB1 AND PLXNB2.
RX   PubMed=12372594; DOI=10.1016/S0014-5793(02)03323-9;
RA   Driessens M.H.E., Olivo C., Nagata K., Inagaki M., Collard J.G.;
RT   "B plexins activate Rho through PDZ-RhoGEF.";
RL   FEBS Lett. 529:168-172(2002).
RN   [8]
RP   INTERACTION WITH PLXNB1 AND PLXNB2.
RX   PubMed=12183458; DOI=10.1074/jbc.M206005200;
RA   Perrot V., Vazquez-Prado J., Gutkind J.S.;
RT   "Plexin B regulates Rho through the guanine nucleotide exchange
RT   factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF.";
RL   J. Biol. Chem. 277:43115-43120(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-736, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341, PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-41 (ISOFORM 2), AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   INTERACTION WITH GCSAM.
RX   PubMed=20844236; DOI=10.1182/blood-2010-04-281568;
RA   Jiang X., Lu X., McNamara G., Liu X., Cubedo E., Sarosiek K.A.,
RA   Sanchez-Garcia I., Helfman D.M., Lossos I.S.;
RT   "HGAL, a germinal center specific protein, decreases lymphoma cell
RT   motility by modulation of the RhoA signaling pathway.";
RL   Blood 116:5217-5227(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; SER-309; SER-341;
RP   SER-637; THR-736 AND SER-1288, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309; SER-637; SER-1327;
RP   SER-1377; SER-1457 AND SER-1541, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-41 (ISOFORM 2), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.13 ANGSTROMS) OF 766-1138 IN COMPLEX WITH
RP   RHOA, AND SUBUNIT.
RX   PubMed=15331592; DOI=10.1074/jbc.M406056200;
RA   Kristelly R., Gao G., Tesmer J.J.;
RT   "Structural determinants of RhoA binding and nucleotide exchange in
RT   leukemia-associated Rho guanine-nucleotide exchange factor.";
RL   J. Biol. Chem. 279:47352-47362(2004).
RN   [21]
RP   STRUCTURE BY NMR OF 67-151 IN COMPLEX WITH PLXNB1, AND SUBUNIT.
RX   PubMed=18411422; DOI=10.1110/ps.073416508;
RA   Liu J., Zhang J., Yang Y., Huang H., Shen W., Hu Q., Wang X., Wu J.,
RA   Shi Y.;
RT   "Conformational change upon ligand binding and dynamics of the PDZ
RT   domain from leukemia-associated Rho guanine nucleotide exchange
RT   factor.";
RL   Protein Sci. 17:1003-1014(2008).
CC   -!- FUNCTION: May play a role in the regulation of RhoA GTPase by
CC       guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13).
CC       Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase
CC       and may act as GTPase-activating protein (GAP) for GNA12 and
CC       GNA13. {ECO:0000269|PubMed:11094164}.
CC   -!- SUBUNIT: Interacts with GNA12 and GNA13, probably through the RGS-
CC       like domain. Interacts with RHOA, PLXNB1 and PLXNB2. Interacts
CC       through its PDZ domain with IGF1R beta subunit. Interacts with
CC       GCSAM. {ECO:0000269|PubMed:11094164, ECO:0000269|PubMed:11724822,
CC       ECO:0000269|PubMed:12183458, ECO:0000269|PubMed:12372594,
CC       ECO:0000269|PubMed:15331592, ECO:0000269|PubMed:18411422,
CC       ECO:0000269|PubMed:20844236}.
CC   -!- INTERACTION:
CC       P08069:IGF1R; NbExp=7; IntAct=EBI-821440, EBI-475981;
CC       P61793:Lpar1 (xeno); NbExp=3; IntAct=EBI-821440, EBI-7512335;
CC       P61586:RHOA; NbExp=2; IntAct=EBI-821440, EBI-446668;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Membrane
CC       {ECO:0000305}. Note=Translocated to the membrane upon stimulation.
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NZN5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NZN5-2; Sequence=VSP_008131;
CC         Note=Contains a phosphoserine at position 41.
CC         {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:24275569};
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 2 is found in
CC       jejunum and testis.
CC   -!- DISEASE: Note=A chromosomal aberration involving ARHGEF12 may be a
CC       cause of acute leukemia. Translocation t(11;11)(q23;23) with
CC       KMT2A/MLL1. {ECO:0000269|PubMed:10681437}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH63117.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LARGID243.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF180681; AAF36817.1; -; mRNA.
DR   EMBL; AB002380; BAA20836.2; -; mRNA.
DR   EMBL; BC063117; AAH63117.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS41727.1; -. [Q9NZN5-1]
DR   CCDS; CCDS55794.1; -. [Q9NZN5-2]
DR   RefSeq; NP_001185594.1; NM_001198665.1. [Q9NZN5-2]
DR   RefSeq; NP_001288013.1; NM_001301084.1.
DR   RefSeq; NP_056128.1; NM_015313.2. [Q9NZN5-1]
DR   RefSeq; XP_011541022.1; XM_011542720.2.
DR   RefSeq; XP_016872910.1; XM_017017421.1.
DR   UniGene; Hs.24598; -.
DR   PDB; 1TXD; X-ray; 2.13 A; A=766-1138.
DR   PDB; 1X86; X-ray; 3.22 A; A/C/E/G=766-1138.
DR   PDB; 2OMJ; NMR; -; A=67-151.
DR   PDB; 2OS6; NMR; -; A=67-151.
DR   PDBsum; 1TXD; -.
DR   PDBsum; 1X86; -.
DR   PDBsum; 2OMJ; -.
DR   PDBsum; 2OS6; -.
DR   ProteinModelPortal; Q9NZN5; -.
DR   SMR; Q9NZN5; -.
DR   BioGrid; 116945; 31.
DR   DIP; DIP-37887N; -.
DR   IntAct; Q9NZN5; 16.
DR   MINT; Q9NZN5; -.
DR   STRING; 9606.ENSP00000380942; -.
DR   iPTMnet; Q9NZN5; -.
DR   PhosphoSitePlus; Q9NZN5; -.
DR   BioMuta; ARHGEF12; -.
DR   DMDM; 34395525; -.
DR   EPD; Q9NZN5; -.
DR   MaxQB; Q9NZN5; -.
DR   PaxDb; Q9NZN5; -.
DR   PeptideAtlas; Q9NZN5; -.
DR   PRIDE; Q9NZN5; -.
DR   DNASU; 23365; -.
DR   Ensembl; ENST00000356641; ENSP00000349056; ENSG00000196914. [Q9NZN5-2]
DR   Ensembl; ENST00000397843; ENSP00000380942; ENSG00000196914. [Q9NZN5-1]
DR   GeneID; 23365; -.
DR   KEGG; hsa:23365; -.
DR   UCSC; uc001pxl.3; human. [Q9NZN5-1]
DR   CTD; 23365; -.
DR   DisGeNET; 23365; -.
DR   EuPathDB; HostDB:ENSG00000196914.8; -.
DR   GeneCards; ARHGEF12; -.
DR   H-InvDB; HIX0010202; -.
DR   H-InvDB; HIX0036240; -.
DR   HGNC; HGNC:14193; ARHGEF12.
DR   HPA; CAB025581; -.
DR   HPA; HPA018911; -.
DR   MalaCards; ARHGEF12; -.
DR   MIM; 604763; gene.
DR   neXtProt; NX_Q9NZN5; -.
DR   OpenTargets; ENSG00000196914; -.
DR   PharmGKB; PA24969; -.
DR   eggNOG; KOG3520; Eukaryota.
DR   eggNOG; COG5422; LUCA.
DR   GeneTree; ENSGT00760000119193; -.
DR   HOGENOM; HOG000034046; -.
DR   HOVERGEN; HBG050571; -.
DR   InParanoid; Q9NZN5; -.
DR   KO; K07532; -.
DR   OMA; EWPTERE; -.
DR   OrthoDB; EOG091G0CZH; -.
DR   PhylomeDB; Q9NZN5; -.
DR   TreeFam; TF106495; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-416572; Sema4D induced cell migration and growth-cone collapse.
DR   SIGNOR; Q9NZN5; -.
DR   ChiTaRS; ARHGEF12; human.
DR   EvolutionaryTrace; Q9NZN5; -.
DR   GeneWiki; ARHGEF12; -.
DR   GenomeRNAi; 23365; -.
DR   PRO; PR:Q9NZN5; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000196914; -.
DR   CleanEx; HS_ARHGEF12; -.
DR   ExpressionAtlas; Q9NZN5; baseline and differential.
DR   Genevisible; Q9NZN5; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IDA:MGI.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:MGI.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   CDD; cd13390; PH_LARG; 1.
DR   CDD; cd08754; RGS_LARG; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR037801; ARHGEF12_PH.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR037884; LARG_RGS.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR015212; RGS-like_dom.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF09128; RGS-like; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Chromosomal rearrangement; Coiled coil; Complete proteome; Cytoplasm;
KW   GTPase activation; Guanine-nucleotide releasing factor; Membrane;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2   1544       Rho guanine nucleotide exchange factor
FT                                12.
FT                                /FTId=PRO_0000080930.
FT   DOMAIN       72    151       PDZ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00143}.
FT   DOMAIN      367    558       RGSL.
FT   DOMAIN      787    977       DH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00062}.
FT   DOMAIN     1019   1132       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   COILED      194    262       {ECO:0000255}.
FT   SITE        308    309       Breakpoint for translocation to form
FT                                KMT2A/MLL1-ARHGEF12 oncogene.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      41     41       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     309    309       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     341    341       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     637    637       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     736    736       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1288   1288       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1327   1327       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1377   1377       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1457   1457       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1541   1541       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      48     66       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10681437,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008131.
FT   VARIANT     973    973       Y -> F (in dbSNP:rs2305013).
FT                                {ECO:0000269|PubMed:9205841}.
FT                                /FTId=VAR_020191.
FT   STRAND       70     76       {ECO:0000244|PDB:2OMJ}.
FT   STRAND       85     87       {ECO:0000244|PDB:2OMJ}.
FT   STRAND       89     91       {ECO:0000244|PDB:2OMJ}.
FT   STRAND       93     96       {ECO:0000244|PDB:2OMJ}.
FT   HELIX       102    106       {ECO:0000244|PDB:2OMJ}.
FT   STRAND      112    119       {ECO:0000244|PDB:2OMJ}.
FT   TURN        122    124       {ECO:0000244|PDB:2OS6}.
FT   HELIX       127    135       {ECO:0000244|PDB:2OMJ}.
FT   STRAND      137    145       {ECO:0000244|PDB:2OMJ}.
FT   HELIX       769    772       {ECO:0000244|PDB:1TXD}.
FT   HELIX       775    778       {ECO:0000244|PDB:1TXD}.
FT   HELIX       783    812       {ECO:0000244|PDB:1TXD}.
FT   HELIX       814    820       {ECO:0000244|PDB:1TXD}.
FT   HELIX       825    832       {ECO:0000244|PDB:1TXD}.
FT   HELIX       835    853       {ECO:0000244|PDB:1TXD}.
FT   STRAND      857    860       {ECO:0000244|PDB:1X86}.
FT   HELIX       865    872       {ECO:0000244|PDB:1TXD}.
FT   HELIX       875    889       {ECO:0000244|PDB:1TXD}.
FT   HELIX       891    904       {ECO:0000244|PDB:1TXD}.
FT   HELIX       906    917       {ECO:0000244|PDB:1TXD}.
FT   HELIX       919    921       {ECO:0000244|PDB:1TXD}.
FT   HELIX       926    929       {ECO:0000244|PDB:1TXD}.
FT   HELIX       932    949       {ECO:0000244|PDB:1TXD}.
FT   HELIX       954    993       {ECO:0000244|PDB:1TXD}.
FT   STRAND     1001   1003       {ECO:0000244|PDB:1X86}.
FT   HELIX      1005   1007       {ECO:0000244|PDB:1X86}.
FT   HELIX      1008   1011       {ECO:0000244|PDB:1TXD}.
FT   HELIX      1015   1017       {ECO:0000244|PDB:1TXD}.
FT   STRAND     1020   1033       {ECO:0000244|PDB:1TXD}.
FT   STRAND     1038   1053       {ECO:0000244|PDB:1TXD}.
FT   STRAND     1056   1058       {ECO:0000244|PDB:1TXD}.
FT   STRAND     1078   1081       {ECO:0000244|PDB:1TXD}.
FT   HELIX      1082   1084       {ECO:0000244|PDB:1TXD}.
FT   STRAND     1085   1089       {ECO:0000244|PDB:1TXD}.
FT   STRAND     1091   1093       {ECO:0000244|PDB:1X86}.
FT   STRAND     1096   1102       {ECO:0000244|PDB:1TXD}.
FT   STRAND     1107   1113       {ECO:0000244|PDB:1TXD}.
FT   HELIX      1117   1137       {ECO:0000244|PDB:1TXD}.
SQ   SEQUENCE   1544 AA;  173232 MW;  0B7E319CF7C7A224 CRC64;
     MSGTQSTITD RFPLKKPIRH GSILNRESPT DKKQKVERIA SHDFDPTDSS SKKTKSSSEE
     SRSEIYGLVQ RCVIIQKDDN GFGLTVSGDN PVFVQSVKED GAAMRAGVQT GDRIIKVNGT
     LVTHSNHLEV VKLIKSGSYV ALTVQGRPPG SPQIPLADSE VEPSVIGHMS PIMTSPHSPG
     ASGNMERITS PVLMGEENNV VHNQKVEILR KMLQKEQERL QLLQEDYNRT PAQRLLKEIQ
     EAKKHIPQLQ EQLSKATGSA QDGAVVTPSR PLGDTLTVSE AETDPGDVLG RTDCSSGDAS
     RPSSDNADSP KSGPKERIYL EENPEKSETI QDTDTQSLVG SPSTRIAPHI IGAEDDDFGT
     EHEQINGQCS CFQSIELLKS RPAHLAVFLH HVVSQFDPAT LLCYLYSDLY KHTNSKETRR
     IFLEFHQFFL DRSAHLKVSV PDEMSADLEK RRPELIPEDL HRHYIQTMQE RVHPEVQRHL
     EDFRQKRSMG LTLAESELTK LDAERDKDRL TLEKERTCAE QIVAKIEEVL MTAQAVEEDK
     SSTMQYVILM YMKHLGVKVK EPRNLEHKRG RIGFLPKIKQ SMKKDKEGEE KGKRRGFPSI
     LGPPRRPSRH DNSAIGRAME LQKARHPKHL STPSSVSPEP QDSAKLRQSG LANEGTDAGY
     LPANSMSSVA SGASFSQEGG KENDTGSKQV GETSAPGDTL DGTPRTLNTV FDFPPPPLDQ
     VQEEECEVER VTEHGTPKPF RKFDSVAFGE SQSEDEQFEN DLETDPPNWQ QLVSREVLLG
     LKPCEIKRQE VINELFYTER AHVRTLKVLD QVFYQRVSRE GILSPSELRK IFSNLEDILQ
     LHIGLNEQMK AVRKRNETSV IDQIGEDLLT WFSGPGEEKL KHAAATFCSN QPFALEMIKS
     RQKKDSRFQT FVQDAESNPL CRRLQLKDII PTQMQRLTKY PLLLDNIAKY TEWPTEREKV
     KKAADHCRQI LNYVNQAVKE AENKQRLEDY QRRLDTSSLK LSEYPNVEEL RNLDLTKRKM
     IHEGPLVWKV NRDKTIDLYT LLLEDILVLL QKQDDRLVLR CHSKILASTA DSKHTFSPVI
     KLSTVLVRQV ATDNKALFVI SMSDNGAQIY ELVAQTVSEK TVWQDLICRM AASVKEQSTK
     PIPLPQSTPG EGDNDEEDPS KLKEEQHGIS VTGLQSPDRD LGLESTLISS KPQSHSLSTS
     GKSEVRDLFV AERQFAKEQH TDGTLKEVGE DYQIAIPDSH LPVSEERWAL DALRNLGLLK
     QLLVQQLGLT EKSVQEDWQH FPRYRTASQG PQTDSVIQNS ENIKAYHSGE GHMPFRTGTG
     DIATCYSPRT STESFAPRDS VGLAPQDSQA SNILVMDHMI MTPEMPTMEP EGGLDDSGEH
     FFDAREAHSD ENPSEGDGAV NKEEKDVNLR ISGNYLILDG YDPVQESSTD EEVASSLTLQ
     PMTGIPAVES THQQQHSPQN THSDGAISPF TPEFLVQQRW GAMEYSCFEI QSPSSCADSQ
     SQIMEYIHKI EADLEHLKKV EESYTILCQR LAGSALTDKH SDKS
//
ID   ARI1A_HUMAN             Reviewed;        2285 AA.
AC   O14497; D3DPL1; Q53FK9; Q5T0W1; Q5T0W2; Q5T0W3; Q8NFD6; Q96T89;
AC   Q9BY33; Q9HBJ5; Q9UPZ1;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 3.
DT   28-FEB-2018, entry version 183.
DE   RecName: Full=AT-rich interactive domain-containing protein 1A;
DE            Short=ARID domain-containing protein 1A;
DE   AltName: Full=B120;
DE   AltName: Full=BRG1-associated factor 250;
DE            Short=BAF250;
DE   AltName: Full=BRG1-associated factor 250a;
DE            Short=BAF250A;
DE   AltName: Full=Osa homolog 1;
DE            Short=hOSA1;
DE   AltName: Full=SWI-like protein;
DE   AltName: Full=SWI/SNF complex protein p270;
DE   AltName: Full=SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;
DE   AltName: Full=hELD;
GN   Name=ARID1A; Synonyms=BAF250, BAF250A, C1orf4, OSA1, SMARCF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE,
RP   TISSUE SPECIFICITY, AND IDENTIFICATION IN THE BAF COMPLEX.
RX   PubMed=11073988; DOI=10.1128/MCB.20.23.8879-8888.2000;
RA   Nie Z., Xue Y., Yang D., Zhou S., Deroo B.J., Archer T.K., Wang W.;
RT   "A specificity and targeting subunit of a human SWI/SNF family-related
RT   chromatin-remodeling complex.";
RL   Mol. Cell. Biol. 20:8879-8888(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 287-2285 (ISOFORM 1), TISSUE
RP   SPECIFICITY, INTERACTION WITH SMARCA2 AND SMARCA4, AND IDENTIFICATION
RP   IN A SWI/SNF COMPLEX WITH ARID1B.
RX   PubMed=12200431; DOI=10.1074/jbc.M205961200;
RA   Inoue H., Furukawa T., Giannakopoulos S., Zhou S., King D.S.,
RA   Tanese N.;
RT   "Largest subunits of the human SWI/SNF chromatin-remodeling complex
RT   promote transcriptional activation by steroid hormone receptors.";
RL   J. Biol. Chem. 277:41674-41685(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 347-2285 (ISOFORM 1), IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND IDENTIFICATION IN THE BAF COMPLEX.
RC   TISSUE=Brain;
RX   PubMed=11734557; DOI=10.1074/jbc.M108702200;
RA   Kato H., Tjernberg A., Zhang W., Krutchinsky A.N., An W., Takeuchi T.,
RA   Ohtsuki Y., Sugano S., de Bruijn D.R., Chait B.T., Roeder R.G.;
RT   "SYT associates with human SNF/SWI complexes and the C-terminal region
RT   of its fusion partner SSX1 targets histones.";
RL   J. Biol. Chem. 277:5498-5505(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 358-2285 (ISOFORM 1), AND MUTAGENESIS OF
RP   TRP-1073 AND TYR-1096.
RX   PubMed=10757798; DOI=10.1128/MCB.20.9.3137-3146.2000;
RA   Dallas P.B., Pacchione S., Wilsker D., Bowrin V., Kobayashi R.,
RA   Moran E.;
RT   "The human SWI-SNF complex protein p270 is an ARID family member with
RT   non-sequence-specific DNA binding activity.";
RL   Mol. Cell. Biol. 20:3137-3146(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-1585 (ISOFORM 3).
RX   PubMed=9434167; DOI=10.1016/S0378-1119(97)00525-8;
RA   Takeuchi T., Chen B.-K., Qiu Y., Sonobe H., Ohtsuki Y.;
RT   "Molecular cloning and expression of a novel human cDNA containing CAG
RT   repeats.";
RL   Gene 204:71-77(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 380-1515.
RA   Takeuchi T., Misaki A.;
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 384-2285 (ISOFORM 2), ALTERNATIVE
RP   SPLICING (ISOFORM 1), SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11318604; DOI=10.1006/geno.2001.6477;
RA   Kozmik Z., Machon O., Kralova J., Kreslova J., Paces J., Vlcek C.;
RT   "Characterization of mammalian orthologues of the Drosophila osa gene:
RT   cDNA cloning, expression, chromosomal localization, and direct
RT   physical interaction with Brahma chromatin-remodeling complex.";
RL   Genomics 73:140-148(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1104-2285 (ISOFORM 1).
RC   TISSUE=Gastric mucosa;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   IDENTIFICATION IN SWI/SNF COMPLEXES.
RX   PubMed=8804307; DOI=10.1101/gad.10.17.2117;
RA   Wang W., Xue Y., Zhou S., Kuo A., Cairns B.R., Crabtree G.R.;
RT   "Diversity and specialization of mammalian SWI/SNF complexes.";
RL   Genes Dev. 10:2117-2130(1996).
RN   [12]
RP   IDENTIFICATION IN A SWI/SNF COMPLEX.
RX   PubMed=11780067; DOI=10.1038/414924a;
RA   Lemon B., Inouye C., King D.S., Tjian R.;
RT   "Selectivity of chromatin-remodelling cofactors for ligand-activated
RT   transcription.";
RL   Nature 414:924-928(2001).
RN   [13]
RP   IDENTIFICATION IN A SWI/SNF-LIKE COMPLEX WITH ARID1A.
RX   PubMed=11988099;
RA   Hurlstone A.F., Olave I.A., Barker N., van Noort M., Clevers H.;
RT   "Cloning and characterization of hELD/OSA1, a novel BRG1 interacting
RT   protein.";
RL   Biochem. J. 364:255-264(2002).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-696; SER-698 AND
RP   SER-702, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-772, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-286; SER-301; SER-696;
RP   SER-698; SER-764; SER-772 AND SER-1944, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79; THR-286; SER-363;
RP   SER-604; SER-696; SER-698; SER-702; SER-772 AND SER-1184, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1612 AND LYS-1905, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-772, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363; SER-696; SER-702
RP   AND SER-1604, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [25]
RP   INVOLVEMENT IN CSS2.
RX   PubMed=22426308; DOI=10.1038/ng.2219;
RA   Tsurusaki Y., Okamoto N., Ohashi H., Kosho T., Imai Y., Hibi-Ko Y.,
RA   Kaname T., Naritomi K., Kawame H., Wakui K., Fukushima Y., Homma T.,
RA   Kato M., Hiraki Y., Yamagata T., Yano S., Mizuno S., Sakazume S.,
RA   Ishii T., Nagai T., Shiina M., Ogata K., Ohta T., Niikawa N.,
RA   Miyatake S., Okada I., Mizuguchi T., Doi H., Saitsu H., Miyake N.,
RA   Matsumoto N.;
RT   "Mutations affecting components of the SWI/SNF complex cause Coffin-
RT   Siris syndrome.";
RL   Nat. Genet. 44:376-378(2012).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-233; SER-363;
RP   SER-382; SER-604; SER-696; SER-698; SER-702; SER-764; SER-772;
RP   SER-1184; SER-1235; SER-1604; SER-1751; SER-1754; THR-1888; SER-1929
RP   AND SER-1944, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363; SER-696 AND
RP   SER-1751, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [29]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-429 AND ARG-1276, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [30]
RP   REVIEW ON SWI/SNF CHROMATIN REMODELING COMPLEXES.
RX   PubMed=12672490; DOI=10.1016/S0959-437X(03)00022-4;
RA   Martens J.A., Winston F.;
RT   "Recent advances in understanding chromatin remodeling by SWI/SNF
RT   complexes.";
RL   Curr. Opin. Genet. Dev. 13:136-142(2003).
RN   [31]
RP   IDENTIFICATION IN A SWI/SNF-LIKE EBAFA COMPLEX, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=12665591; DOI=10.1128/MCB.23.8.2942-2952.2003;
RA   Nie Z., Yan Z., Chen E.H., Sechi S., Ling C., Zhou S., Xue Y.,
RA   Yang D., Murray D., Kanakubo E., Cleary M.L., Wang W.;
RT   "Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage
RT   leukemia chromosomal translocation partner.";
RL   Mol. Cell. Biol. 23:2942-2952(2003).
RN   [32]
RP   IDENTIFICATION IN SWI/SNF COMPLEXES, AND INTERACTION WITH SMARCA2;
RP   SMARCA4 AND SMARCC1.
RX   PubMed=15170388; DOI=10.1042/BJ20040524;
RA   Wang X., Nagl N.G., Wilsker D., Van Scoy M., Pacchione S., Yaciuk P.,
RA   Dallas P.B., Moran E.;
RT   "Two related ARID family proteins are alternative subunits of human
RT   SWI/SNF complexes.";
RL   Biochem. J. 383:319-325(2004).
RN   [33]
RP   IDENTIFICATION IN THE BAF COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=18765789; DOI=10.1101/gad.471408;
RA   Lange M., Kaynak B., Forster U.B., Toenjes M., Fischer J.J., Grimm C.,
RA   Schlesinger J., Just S., Dunkel I., Krueger T., Mebus S., Lehrach H.,
RA   Lurz R., Gobom J., Rottbauer W., Abdelilah-Seyfried S., Sperling S.;
RT   "Regulation of muscle development by DPF3, a novel histone acetylation
RT   and methylation reader of the BAF chromatin remodeling complex.";
RL   Genes Dev. 22:2370-2384(2008).
RN   [34]
RP   REVIEW ON SWI/SNF CHROMATIN REMODELING COMPLEXES.
RX   PubMed=22952240; DOI=10.1074/jbc.R111.309302;
RA   Euskirchen G., Auerbach R.K., Snyder M.;
RT   "SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse
RT   functions.";
RL   J. Biol. Chem. 287:30897-30905(2012).
RN   [35]
RP   REVIEW ON SWI/SNF CHROMATIN REMODELING COMPLEXES.
RX   PubMed=26601204; DOI=10.1126/sciadv.1500447;
RA   Kadoch C., Crabtree G.R.;
RT   "Mammalian SWI/SNF chromatin remodeling complexes and cancer:
RT   Mechanistic insights gained from human genomics.";
RL   Sci. Adv. 1:E1500447-E1500447(2015).
RN   [36]
RP   SUBCELLULAR LOCATION, NUCLEAR LOCALIZATION SIGNAL, AND MUTAGENESIS OF
RP   1370-LYS-ARG-1371; ARG-1383 AND 1656-ARG--ARG-1658.
RX   PubMed=26614907; DOI=10.1016/j.bbrc.2015.11.080;
RA   Bateman N.W., Shoji Y., Conrads K.A., Stroop K.D., Hamilton C.A.,
RA   Darcy K.M., Maxwell G.L., Risinger J.I., Conrads T.P.;
RT   "Identification and functional characterization of a novel bipartite
RT   nuclear localization sequence in ARID1A.";
RL   Biochem. Biophys. Res. Commun. 469:114-119(2016).
RN   [37]
RP   STRUCTURE BY NMR OF 1000-1159.
RX   PubMed=14722072; DOI=10.1074/jbc.M312115200;
RA   Kim S., Zhang Z., Upchurch S., Isern N., Chen Y.;
RT   "Structure and DNA-binding sites of the SWI1 AT-rich interaction
RT   domain (ARID) suggest determinants for sequence-specific DNA
RT   recognition.";
RL   J. Biol. Chem. 279:16670-16676(2004).
RN   [38]
RP   VARIANTS LYS-1020 AND PRO-2089.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
RN   [39]
RP   VARIANTS TRP-1658; PHE-1907 AND ARG-2087.
RX   PubMed=22009941; DOI=10.1002/humu.21633;
RA   Jones S., Li M., Parsons D.W., Zhang X., Wesseling J., Kristel P.,
RA   Schmidt M.K., Markowitz S., Yan H., Bigner D., Hruban R.H.,
RA   Eshleman J.R., Iacobuzio-Donahue C.A., Goggins M., Maitra A.,
RA   Malek S.N., Powell S., Vogelstein B., Kinzler K.W., Velculescu V.E.,
RA   Papadopoulos N.;
RT   "Somatic mutations in the chromatin remodeling gene ARID1A occur in
RT   several tumor types.";
RL   Hum. Mutat. 33:100-103(2012).
RN   [40]
RP   VARIANT SER-120.
RX   PubMed=23906836; DOI=10.1093/hmg/ddt366;
RA   Wieczorek D., Boegershausen N., Beleggia F., Steiner-Haldenstaett S.,
RA   Pohl E., Li Y., Milz E., Martin M., Thiele H., Altmueller J.,
RA   Alanay Y., Kayserili H., Klein-Hitpass L., Boehringer S.,
RA   Wollstein A., Albrecht B., Boduroglu K., Caliebe A., Chrzanowska K.,
RA   Cogulu O., Cristofoli F., Czeschik J.C., Devriendt K., Dotti M.T.,
RA   Elcioglu N., Gener B., Goecke T.O., Krajewska-Walasek M.,
RA   Guillen-Navarro E., Hayek J., Houge G., Kilic E., Simsek-Kiper P.O.,
RA   Lopez-Gonzalez V., Kuechler A., Lyonnet S., Mari F., Marozza A.,
RA   Mathieu Dramard M., Mikat B., Morin G., Morice-Picard F., Ozkinay F.,
RA   Rauch A., Renieri A., Tinschert S., Utine G.E., Vilain C.,
RA   Vivarelli R., Zweier C., Nuernberg P., Rahmann S., Vermeesch J.,
RA   Luedecke H.J., Zeschnigk M., Wollnik B.;
RT   "A comprehensive molecular study on Coffin-Siris and Nicolaides-
RT   Baraitser syndromes identifies a broad molecular and clinical spectrum
RT   converging on altered chromatin remodeling.";
RL   Hum. Mol. Genet. 22:5121-5135(2013).
CC   -!- FUNCTION: Involved in transcriptional activation and repression of
CC       select genes by chromatin remodeling (alteration of DNA-nucleosome
CC       topology). Component of SWI/SNF chromatin remodeling complexes
CC       that carry out key enzymatic activities, changing chromatin
CC       structure by altering DNA-histone contacts within a nucleosome in
CC       an ATP-dependent manner. Binds DNA non-specifically. Belongs to
CC       the neural progenitors-specific chromatin remodeling complex
CC       (npBAF complex) and the neuron-specific chromatin remodeling
CC       complex (nBAF complex). During neural development a switch from a
CC       stem/progenitor to a postmitotic chromatin remodeling mechanism
CC       occurs as neurons exit the cell cycle and become committed to
CC       their adult state. The transition from proliferating neural
CC       stem/progenitor cells to postmitotic neurons requires a switch in
CC       subunit composition of the npBAF and nBAF complexes. As neural
CC       progenitors exit mitosis and differentiate into neurons, npBAF
CC       complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are
CC       exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B
CC       or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The
CC       npBAF complex is essential for the self-renewal/proliferative
CC       capacity of the multipotent neural stem cells. The nBAF complex
CC       along with CREST plays a role regulating the activity of genes
CC       essential for dendrite growth (By similarity).
CC       {ECO:0000250|UniProtKB:A2BH40, ECO:0000303|PubMed:12672490,
CC       ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.
CC   -!- SUBUNIT: Component of SWI/SNF chromatin remodeling complexes, in
CC       some of which it can be mutually exclusive with ARID1B/BAF250B.
CC       The canonical complex contains a catalytic subunit (either
CC       SMARCA4/BRG1/BAF190A or SMARCA2/BRM/BAF190B) and at least SMARCE1,
CC       ACTL6A/BAF53, SMARCC1/BAF155, SMARCC2/BAF170, and
CC       SMARCB1/SNF5/BAF47. Other subunits specific to each of the
CC       complexes may also be present permitting several possible
CC       combinations developmentally and tissue specific (PubMed:22952240,
CC       PubMed:26601204, PubMed:12200431, PubMed:8804307, PubMed:11780067,
CC       PubMed:11988099, PubMed:15170388). Component of the BAF (SWI/SNF-
CC       A) complex, which includes at least actin (ACTB), ARID1A/BAF250A,
CC       ARID1B/BAF250B, SMARCA2/BRM, SMARCA4/BRG1/BAF190A, ACTL6A/BAF53,
CC       ACTL6B/BAF53B, SMARCE1/BAF57, SMARCC1/BAF155, SMARCC2/BAF170,
CC       SMARCB1/SNF5/INI1, and one or more SMARCD1/BAF60A, SMARCD2/BAF60B,
CC       or SMARCD3/BAF60C (PubMed:12200431, PubMed:11734557,
CC       PubMed:18765789,). In muscle cells, the BAF complex also contains
CC       DPF3. Component of neural progenitors-specific chromatin
CC       remodeling complex (npBAF complex) composed of at least,
CC       ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A, SMARCD3/BAF60C,
CC       SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A, SMARCB1/BAF47,
CC       SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170, PHF10/BAF45A,
CC       ACTL6A/BAF53A and actin. Component of neuron-specific chromatin
CC       remodeling complex (nBAF complex) composed of at least,
CC       ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A, SMARCD3/BAF60C,
CC       SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A, SMARCB1/BAF47,
CC       SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170, DPF1/BAF45B,
CC       DPF3/BAF45C, ACTL6B/BAF53B and actin (By similarity). Component of
CC       a SWI/SNF-like EBAFa complex, at least composed of
CC       SMARCA4/BRG1/BAF190A, SMARCB1/BAF47/SNF5, ACTL6A/BAF53A,
CC       SMARCE1/BAF57, SMARCD1/BAF60A, SMARCC1/BAF155, SMARCC2/BAF170,
CC       BAF250A and MLLT1/ENL (PubMed:12665591). Interacts through its C-
CC       terminus with SMARCA2/BRM/BAF190B and SMARCA4/BRG1/BAF190A
CC       (PubMed:12200431, PubMed:15170388). Interacts with SMARCC1/BAF155
CC       (PubMed:15170388). {ECO:0000250|UniProtKB:A2BH40,
CC       ECO:0000269|PubMed:11734557, ECO:0000269|PubMed:11780067,
CC       ECO:0000269|PubMed:11988099, ECO:0000269|PubMed:12200431,
CC       ECO:0000269|PubMed:12665591, ECO:0000269|PubMed:15170388,
CC       ECO:0000269|PubMed:18765789, ECO:0000269|PubMed:8804307,
CC       ECO:0000303|PubMed:12672490, ECO:0000303|PubMed:22952240,
CC       ECO:0000303|PubMed:26601204}.
CC   -!- INTERACTION:
CC       Q14526:HIC1; NbExp=2; IntAct=EBI-637887, EBI-2507362;
CC       P51531:SMARCA2; NbExp=3; IntAct=EBI-637887, EBI-679562;
CC       P51532:SMARCA4; NbExp=22; IntAct=EBI-637887, EBI-302489;
CC       P11388:TOP2A; NbExp=2; IntAct=EBI-15956509, EBI-539628;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00355, ECO:0000269|PubMed:11318604,
CC       ECO:0000269|PubMed:26614907}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O14497-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14497-2; Sequence=VSP_015225;
CC       Name=3;
CC         IsoId=O14497-3; Sequence=VSP_037157;
CC   -!- TISSUE SPECIFICITY: Highly expressed in spleen, thymus, prostate,
CC       testis, ovary, small intestine, colon, and PBL, and at a much
CC       lower level in heart, brain, placenta, lung, liver, skeletal
CC       muscle, kidney, and pancreas. {ECO:0000269|PubMed:11073988,
CC       ECO:0000269|PubMed:11318604, ECO:0000269|PubMed:12200431}.
CC   -!- DISEASE: Coffin-Siris syndrome 2 (CSS2) [MIM:614607]: A form of
CC       Coffin-Siris syndrome, a congenital multiple malformation syndrome
CC       with broad phenotypic and genetic variability. Cardinal features
CC       are intellectual disability, coarse facial features,
CC       hypertrichosis, and hypoplastic or absent fifth digit nails or
CC       phalanges. Additional features include malformations of the
CC       cardiac, gastrointestinal, genitourinary, and/or central nervous
CC       systems. Sucking/feeding difficulties, poor growth, ophthalmologic
CC       abnormalities, hearing impairment, and spinal anomalies are common
CC       findings. Both autosomal dominant and autosomal recessive
CC       inheritance patterns have been reported.
CC       {ECO:0000269|PubMed:22426308}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF75765.1; Type=Frameshift; Positions=374; Evidence={ECO:0000305};
CC       Sequence=AAG33967.1; Type=Frameshift; Positions=872, 885; Evidence={ECO:0000305};
CC       Sequence=BAA23269.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=BAA83073.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAA83073.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF231056; AAG33967.1; ALT_FRAME; mRNA.
DR   EMBL; AL512408; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL034380; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07795.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07796.1; -; Genomic_DNA.
DR   EMBL; AF521670; AAN03446.1; -; mRNA.
DR   EMBL; AF219114; AAG17549.2; -; mRNA.
DR   EMBL; AF265208; AAF75765.1; ALT_FRAME; mRNA.
DR   EMBL; AB001895; BAA23269.1; ALT_FRAME; mRNA.
DR   EMBL; AB024075; BAA83073.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF268913; AAK54505.1; -; mRNA.
DR   EMBL; AK223275; BAD96995.1; -; mRNA.
DR   CCDS; CCDS285.1; -. [O14497-1]
DR   CCDS; CCDS44091.1; -. [O14497-2]
DR   PIR; T00022; T00022.
DR   RefSeq; NP_006006.3; NM_006015.4. [O14497-1]
DR   RefSeq; NP_624361.1; NM_139135.2. [O14497-2]
DR   UniGene; Hs.468972; -.
DR   PDB; 1RYU; NMR; -; A=1000-1119.
DR   PDBsum; 1RYU; -.
DR   ProteinModelPortal; O14497; -.
DR   SMR; O14497; -.
DR   BioGrid; 113894; 69.
DR   CORUM; O14497; -.
DR   DIP; DIP-33016N; -.
DR   IntAct; O14497; 17.
DR   MINT; O14497; -.
DR   STRING; 9606.ENSP00000320485; -.
DR   iPTMnet; O14497; -.
DR   PhosphoSitePlus; O14497; -.
DR   BioMuta; ARID1A; -.
DR   EPD; O14497; -.
DR   MaxQB; O14497; -.
DR   PaxDb; O14497; -.
DR   PeptideAtlas; O14497; -.
DR   PRIDE; O14497; -.
DR   Ensembl; ENST00000324856; ENSP00000320485; ENSG00000117713. [O14497-1]
DR   Ensembl; ENST00000374152; ENSP00000363267; ENSG00000117713. [O14497-3]
DR   Ensembl; ENST00000457599; ENSP00000387636; ENSG00000117713. [O14497-2]
DR   GeneID; 8289; -.
DR   KEGG; hsa:8289; -.
DR   UCSC; uc001bmu.2; human. [O14497-1]
DR   CTD; 8289; -.
DR   DisGeNET; 8289; -.
DR   EuPathDB; HostDB:ENSG00000117713.17; -.
DR   GeneCards; ARID1A; -.
DR   GeneReviews; ARID1A; -.
DR   HGNC; HGNC:11110; ARID1A.
DR   HPA; CAB016334; -.
DR   HPA; HPA005456; -.
DR   MalaCards; ARID1A; -.
DR   MIM; 603024; gene.
DR   MIM; 614607; phenotype.
DR   neXtProt; NX_O14497; -.
DR   OpenTargets; ENSG00000117713; -.
DR   Orphanet; 1465; Coffin-Siris syndrome.
DR   PharmGKB; PA35960; -.
DR   eggNOG; KOG2510; Eukaryota.
DR   eggNOG; ENOG410Y034; LUCA.
DR   GeneTree; ENSGT00550000074575; -.
DR   HOVERGEN; HBG058196; -.
DR   InParanoid; O14497; -.
DR   KO; K11653; -.
DR   OMA; YSTMVRF; -.
DR   OrthoDB; EOG091G00GP; -.
DR   PhylomeDB; O14497; -.
DR   TreeFam; TF320364; -.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   SIGNOR; O14497; -.
DR   ChiTaRS; ARID1A; human.
DR   EvolutionaryTrace; O14497; -.
DR   GeneWiki; ARID1A; -.
DR   GenomeRNAi; 8289; -.
DR   PRO; PR:O14497; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117713; -.
DR   ExpressionAtlas; O14497; baseline and differential.
DR   Genevisible; O14497; HS.
DR   GO; GO:0071565; C:nBAF complex; ISS:UniProtKB.
DR   GO; GO:0071564; C:npBAF complex; ISS:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:UniProtKB.
DR   GO; GO:0016514; C:SWI/SNF complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:BHF-UCL.
DR   GO; GO:0031491; F:nucleosome binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0043044; P:ATP-dependent chromatin remodeling; IEA:Ensembl.
DR   GO; GO:0003205; P:cardiac chamber development; IEA:Ensembl.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0006338; P:chromatin remodeling; IDA:BHF-UCL.
DR   GO; GO:0048096; P:chromatin-mediated maintenance of transcription; TAS:UniProtKB.
DR   GO; GO:0016569; P:covalent chromatin modification; IEA:UniProtKB-KW.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0001704; P:formation of primary germ layer; IEA:Ensembl.
DR   GO; GO:0042921; P:glucocorticoid receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006344; P:maintenance of chromatin silencing; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL.
DR   GO; GO:0042766; P:nucleosome mobilization; TAS:UniProtKB.
DR   GO; GO:0003408; P:optic cup formation involved in camera-type eye development; IEA:Ensembl.
DR   GO; GO:0060674; P:placenta blood vessel development; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL.
DR   GO; GO:0019827; P:stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:1901998; P:toxin transport; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.150.60; -; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR001606; ARID_dom.
DR   InterPro; IPR036431; ARID_dom_sf.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR021906; BAF250/Osa.
DR   InterPro; IPR033388; BAF250_C.
DR   InterPro; IPR030094; BAF250a.
DR   PANTHER; PTHR12656; PTHR12656; 1.
DR   PANTHER; PTHR12656:SF12; PTHR12656:SF12; 1.
DR   Pfam; PF01388; ARID; 1.
DR   Pfam; PF12031; BAF250_C; 1.
DR   SMART; SM00501; BRIGHT; 1.
DR   SUPFAM; SSF46774; SSF46774; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS51011; ARID; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Complete proteome; Direct protein sequencing; DNA-binding;
KW   Mental retardation; Methylation; Neurogenesis; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2   2285       AT-rich interactive domain-containing
FT                                protein 1A.
FT                                /FTId=PRO_0000200575.
FT   DOMAIN     1017   1108       ARID. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00355}.
FT   MOTIF       295    299       LXXLL.
FT   MOTIF      1368   1387       Nuclear localization signal.
FT                                {ECO:0000269|PubMed:26614907}.
FT   MOTIF      1709   1713       LXXLL.
FT   MOTIF      1967   1971       LXXLL.
FT   MOTIF      2085   2089       LXXLL.
FT   COMPBIAS    479    482       Poly-Gln.
FT   COMPBIAS    561    567       Poly-Gln.
FT   COMPBIAS    998   1001       Poly-Ser.
FT   COMPBIAS   1327   1404       Gln-rich.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      58     58       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      79     79       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     233    233       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     286    286       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     363    363       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     382    382       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     429    429       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     604    604       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     696    696       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     698    698       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     702    702       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     730    730       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2BH40}.
FT   MOD_RES     764    764       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     772    772       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1184   1184       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1235   1235       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1276   1276       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1604   1604       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1612   1612       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1751   1751       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1754   1754       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1888   1888       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1905   1905       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1929   1929       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1944   1944       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    383       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9434167}.
FT                                /FTId=VSP_037157.
FT   VAR_SEQ    1367   1583       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11318604}.
FT                                /FTId=VSP_015225.
FT   VARIANT     120    120       P -> S (in dbSNP:rs571264557).
FT                                {ECO:0000269|PubMed:23906836}.
FT                                /FTId=VAR_076938.
FT   VARIANT    1020   1020       R -> K (found in a clear cell renal
FT                                carcinoma; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064695.
FT   VARIANT    1658   1658       R -> W (found in a gastric cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:22009941}.
FT                                /FTId=VAR_068021.
FT   VARIANT    1907   1907       I -> F (found in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs139230162).
FT                                {ECO:0000269|PubMed:22009941}.
FT                                /FTId=VAR_068022.
FT   VARIANT    2087   2087       G -> R (found in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:22009941}.
FT                                /FTId=VAR_068023.
FT   VARIANT    2089   2089       L -> P (found in a clear cell renal
FT                                carcinoma case; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064696.
FT   MUTAGEN    1073   1073       W->A: Partial loss of DNA-binding
FT                                activity. Complete loss of activity; when
FT                                associated with A-1096.
FT                                {ECO:0000269|PubMed:10757798}.
FT   MUTAGEN    1096   1096       Y->A: Partial loss of DNA-binding
FT                                activity. Complete loss of activity; when
FT                                associated with A-1073.
FT                                {ECO:0000269|PubMed:10757798}.
FT   MUTAGEN    1370   1371       KR->TT: Displays nucleocytoplasmic
FT                                localization and increased stability;
FT                                when associated with T-1383.
FT                                {ECO:0000269|PubMed:26614907}.
FT   MUTAGEN    1383   1383       R->T: Displays nucleocytoplasmic
FT                                localization and increased stability;
FT                                when associated with 1370-T-T-1371.
FT                                {ECO:0000269|PubMed:26614907}.
FT   MUTAGEN    1656   1658       RRR->TTT: No effect on subcellular
FT                                localization.
FT                                {ECO:0000269|PubMed:26614907}.
FT   CONFLICT    410    410       G -> D (in Ref. 1; AAG33967, 7; BAA23269
FT                                and 8; BAA83073). {ECO:0000305}.
FT   CONFLICT    434    434       M -> V (in Ref. 1; AAG33967, 7; BAA23269
FT                                and 8; BAA83073). {ECO:0000305}.
FT   CONFLICT    636    636       P -> T (in Ref. 9; AAK54505).
FT                                {ECO:0000305}.
FT   CONFLICT    732    732       Q -> S (in Ref. 1; AAG33967, 5; AAG17549
FT                                and 7; BAA23269). {ECO:0000305}.
FT   CONFLICT    750    750       R -> RG (in Ref. 8; BAA83073).
FT                                {ECO:0000305}.
FT   CONFLICT    757    757       P -> S (in Ref. 1; AAG33967, 5; AAG17549
FT                                and 7; BAA23269). {ECO:0000305}.
FT   CONFLICT    776    776       P -> L (in Ref. 1; AAG33967, 5; AAG17549
FT                                and 7; BAA23269). {ECO:0000305}.
FT   CONFLICT    858    858       M -> V (in Ref. 9; AAK54505).
FT                                {ECO:0000305}.
FT   CONFLICT    871    871       N -> T (in Ref. 7; BAA23269).
FT                                {ECO:0000305}.
FT   CONFLICT    875    875       M -> I (in Ref. 9; AAK54505).
FT                                {ECO:0000305}.
FT   CONFLICT   1017   1017       E -> G (in Ref. 1; AAG33967, 5; AAG17549
FT                                and 7; BAA23269). {ECO:0000305}.
FT   CONFLICT   1180   1180       Missing (in Ref. 10; BAD96995).
FT                                {ECO:0000305}.
FT   CONFLICT   1307   1307       P -> S (in Ref. 1; AAG33967, 5; AAG17549
FT                                and 7; BAA23269). {ECO:0000305}.
FT   CONFLICT   1389   1389       Y -> F (in Ref. 5; AAG17549).
FT                                {ECO:0000305}.
FT   CONFLICT   1399   1399       Q -> L (in Ref. 1; AAG33967 and 7;
FT                                BAA23269). {ECO:0000305}.
FT   CONFLICT   1416   1416       Q -> P (in Ref. 1; AAG33967 and 7;
FT                                BAA23269). {ECO:0000305}.
FT   CONFLICT   1532   1532       M -> V (in Ref. 1; AAG33967).
FT                                {ECO:0000305}.
FT   CONFLICT   1638   1638       D -> A (in Ref. 9; AAK54505).
FT                                {ECO:0000305}.
FT   CONFLICT   1789   1789       A -> T (in Ref. 10; BAD96995).
FT                                {ECO:0000305}.
FT   CONFLICT   1839   1839       S -> R (in Ref. 9; AAK54505).
FT                                {ECO:0000305}.
FT   CONFLICT   2131   2131       N -> D (in Ref. 9; AAK54505).
FT                                {ECO:0000305}.
FT   CONFLICT   2143   2143       R -> H (in Ref. 9; AAK54505).
FT                                {ECO:0000305}.
FT   CONFLICT   2159   2159       K -> E (in Ref. 9; AAK54505).
FT                                {ECO:0000305}.
FT   CONFLICT   2182   2182       A -> T (in Ref. 10; BAD96995).
FT                                {ECO:0000305}.
FT   HELIX      1010   1012       {ECO:0000244|PDB:1RYU}.
FT   STRAND     1014   1016       {ECO:0000244|PDB:1RYU}.
FT   HELIX      1018   1033       {ECO:0000244|PDB:1RYU}.
FT   STRAND     1045   1048       {ECO:0000244|PDB:1RYU}.
FT   HELIX      1051   1061       {ECO:0000244|PDB:1RYU}.
FT   HELIX      1066   1068       {ECO:0000244|PDB:1RYU}.
FT   HELIX      1072   1079       {ECO:0000244|PDB:1RYU}.
FT   HELIX      1087   1099       {ECO:0000244|PDB:1RYU}.
FT   TURN       1100   1107       {ECO:0000244|PDB:1RYU}.
FT   TURN       1109   1111       {ECO:0000244|PDB:1RYU}.
SQ   SEQUENCE   2285 AA;  242045 MW;  85BC5B6061625D8E CRC64;
     MAAQVAPAAA SSLGNPPPPP PSELKKAEQQ QREEAGGEAA AAAAAERGEM KAAAGQESEG
     PAVGPPQPLG KELQDGAESN GGGGGGGAGS GGGPGAEPDL KNSNGNAGPR PALNNNLTEP
     PGGGGGGSSD GVGAPPHSAA AALPPPAYGF GQPYGRSPSA VAAAAAAVFH QQHGGQQSPG
     LAALQSGGGG GLEPYAGPQQ NSHDHGFPNH QYNSYYPNRS AYPPPAPAYA LSSPRGGTPG
     SGAAAAAGSK PPPSSSASAS SSSSSFAQQR FGAMGGGGPS AAGGGTPQPT ATPTLNQLLT
     SPSSARGYQG YPGGDYSGGP QDGGAGKGPA DMASQCWGAA AAAAAAAAAS GGAQQRSHHA
     PMSPGSSGGG GQPLARTPQP SSPMDQMGKM RPQPYGGTNP YSQQQGPPSG PQQGHGYPGQ
     PYGSQTPQRY PMTMQGRAQS AMGGLSYTQQ IPPYGQQGPS GYGQQGQTPY YNQQSPHPQQ
     QQPPYSQQPP SQTPHAQPSY QQQPQSQPPQ LQSSQPPYSQ QPSQPPHQQS PAPYPSQQST
     TQQHPQSQPP YSQPQAQSPY QQQQPQQPAP STLSQQAAYP QPQSQQSQQT AYSQQRFPPP
     QELSQDSFGS QASSAPSMTS SKGGQEDMNL SLQSRPSSLP DLSGSIDDLP MGTEGALSPG
     VSTSGISSSQ GEQSNPAQSP FSPHTSPHLP GIRGPSPSPV GSPASVAQSR SGPLSPAAVP
     GNQMPPRPPS GQSDSIMHPS MNQSSIAQDR GYMQRNPQMP QYSSPQPGSA LSPRQPSGGQ
     IHTGMGSYQQ NSMGSYGPQG GQYGPQGGYP RQPNYNALPN ANYPSAGMAG GINPMGAGGQ
     MHGQPGIPPY GTLPPGRMSH ASMGNRPYGP NMANMPPQVG SGMCPPPGGM NRKTQETAVA
     MHVAANSIQN RPPGYPNMNQ GGMMGTGPPY GQGINSMAGM INPQGPPYSM GGTMANNSAG
     MAASPEMMGL GDVKLTPATK MNNKADGTPK TESKSKKSSS STTTNEKITK LYELGGEPER
     KMWVDRYLAF TEEKAMGMTN LPAVGRKPLD LYRLYVSVKE IGGLTQVNKN KKWRELATNL
     NVGTSSSAAS SLKKQYIQCL YAFECKIERG EDPPPDIFAA ADSKKSQPKI QPPSPAGSGS
     MQGPQTPQST SSSMAEGGDL KPPTPASTPH SQIPPLPGMS RSNSVGIQDA FNDGSDSTFQ
     KRNSMTPNPG YQPSMNTSDM MGRMSYEPNK DPYGSMRKAP GSDPFMSSGQ GPNGGMGDPY
     SRAAGPGLGN VAMGPRQHYP YGGPYDRVRT EPGIGPEGNM STGAPQPNLM PSNPDSGMYS
     PSRYPPQQQQ QQQQRHDSYG NQFSTQGTPS GSPFPSQQTT MYQQQQQNYK RPMDGTYGPP
     AKRHEGEMYS VPYSTGQGQP QQQQLPPAQP QPASQQQAAQ PSPQQDVYNQ YGNAYPATAT
     AATERRPAGG PQNQFPFQFG RDRVSAPPGT NAQQNMPPQM MGGPIQASAE VAQQGTMWQG
     RNDMTYNYAN RQSTGSAPQG PAYHGVNRTD EMLHTDQRAN HEGSWPSHGT RQPPYGPSAP
     VPPMTRPPPS NYQPPPSMQN HIPQVSSPAP LPRPMENRTS PSKSPFLHSG MKMQKAGPPV
     PASHIAPAPV QPPMIRRDIT FPPGSVEATQ PVLKQRRRLT MKDIGTPEAW RVMMSLKSGL
     LAESTWALDT INILLYDDNS IMTFNLSQLP GLLELLVEYF RRCLIEIFGI LKEYEVGDPG
     QRTLLDPGRF SKVSSPAPME GGEEEEELLG PKLEEEEEEE VVENDEEIAF SGKDKPASEN
     SEEKLISKFD KLPVKIVQKN DPFVVDCSDK LGRVQEFDSG LLHWRIGGGD TTEHIQTHFE
     SKTELLPSRP HAPCPPAPRK HVTTAEGTPG TTDQEGPPPD GPPEKRITAT MDDMLSTRSS
     TLTEDGAKSS EAIKESSKFP FGISPAQSHR NIKILEDEPH SKDETPLCTL LDWQDSLAKR
     CVCVSNTIRS LSFVPGNDFE MSKHPGLLLI LGKLILLHHK HPERKQAPLT YEKEEEQDQG
     VSCNKVEWWW DCLEMLRENT LVTLANISGQ LDLSPYPESI CLPVLDGLLH WAVCPSAEAQ
     DPFSTLGPNA VLSPQRLVLE TLSKLSIQDN NVDLILATPP FSRLEKLYST MVRFLSDRKN
     PVCREMAVVL LANLAQGDSL AARAIAVQKG SIGNLLGFLE DSLAATQFQQ SQASLLHMQN
     PPFEPTSVDM MRRAARALLA LAKVDENHSE FTLYESRLLD ISVSPLMNSL VSQVICDVLF
     LIGQS
//
ID   A2TDT2_HUMAN            Unreviewed;       157 AA.
AC   A2TDT2;
DT   06-MAR-2007, integrated into UniProtKB/TrEMBL.
DT   06-MAR-2007, sequence version 1.
DT   22-NOV-2017, entry version 51.
DE   SubName: Full=Mutant B-cell CLL/lymphoma 10 {ECO:0000313|EMBL:ABN09569.1};
GN   Name=BCL10 {ECO:0000313|EMBL:ABN09569.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABN09569.1};
RN   [1] {ECO:0000313|EMBL:ABN09569.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Ocular adnexal MALT lymphomas {ECO:0000313|EMBL:ABN09569.1};
RX   PubMed=23661444; DOI=10.4238/2013.April.12.6;
RA   Zhu J., Wei R.L., Pi Y.L., Guo Q.;
RT   "Significance of Bcl10 gene mutations in the clinical diagnosis of
RT   MALT-type ocular adnexal lymphoma in the Chinese population.";
RL   Genet. Mol. Res. 12:1194-1204(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF189176; ABN09569.1; -; mRNA.
DR   RefSeq; NP_001307644.1; NM_001320715.1.
DR   UniGene; Hs.193516; -.
DR   PeptideAtlas; A2TDT2; -.
DR   PRIDE; A2TDT2; -.
DR   GeneID; 8915; -.
DR   CTD; 8915; -.
DR   HOVERGEN; HBG050680; -.
DR   ChiTaRS; BCL10; human.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:InterPro.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:InterPro.
DR   InterPro; IPR033238; BCL10/E10.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   PANTHER; PTHR34920; PTHR34920; 1.
DR   Pfam; PF00619; CARD; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50209; CARD; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       13     87       CARD. {ECO:0000259|PROSITE:PS50209}.
SQ   SEQUENCE   157 AA;  18221 MW;  CD0AE33364933B1F CRC64;
     MEPTAPSLTE EDLTEVKKDA LENLRVYLCE KIIAERHFDH LRAKKILSRE DTEEISCRTS
     SRKRAGKLLD YLQENPKGLD TLVESIRREK TQNFLIQKIT DEVLKLRNIK LEHLKDGATN
     NLSRSNSDES NFSEKLRAST VMYHPEGESS TTPFFFY
//
ID   BCL10_HUMAN             Reviewed;         233 AA.
AC   O95999; Q5VUF1;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   28-FEB-2018, entry version 163.
DE   RecName: Full=B-cell lymphoma/leukemia 10;
DE   AltName: Full=B-cell CLL/lymphoma 10;
DE            Short=Bcl-10;
DE   AltName: Full=CARD-containing molecule enhancing NF-kappa-B;
DE   AltName: Full=CARD-like apoptotic protein;
DE            Short=hCLAP;
DE   AltName: Full=CED-3/ICH-1 prodomain homologous E10-like regulator;
DE            Short=CIPER;
DE   AltName: Full=Cellular homolog of vCARMEN;
DE            Short=cCARMEN;
DE   AltName: Full=Cellular-E10;
DE            Short=c-E10;
DE   AltName: Full=Mammalian CARD-containing adapter molecule E10;
DE            Short=mE10;
GN   Name=BCL10; Synonyms=CIPER, CLAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INVOLVEMENT IN MALTOMA, AND VARIANTS
RP   ILE-52; GLY-58; GLU-210 DEL AND PHE-218.
RC   TISSUE=Lymphoma;
RX   PubMed=9989495; DOI=10.1016/S0092-8674(00)80957-5;
RA   Willis T.G., Jadayel D.M., Du M.-Q., Peng H., Perry A.R.,
RA   Abdul-Rauf M., Price H., Karran L., Majekodunmi O., Wlodarska I.,
RA   Pan L., Crook T., Hamoudi R., Isaacson P., Dyer M.J.S.;
RT   "Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and
RT   mutated in multiple tumor types.";
RL   Cell 96:35-45(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS OF LEU-41 AND GLY-78.
RX   PubMed=10187770; DOI=10.1074/jbc.274.15.9955;
RA   Koseki T., Inohara N., Chen S., Carrio R., Merino J., Hottiger M.O.,
RA   Nabel G.J., Nunez G.;
RT   "CIPER, a novel NF kappaB-activating protein containing a caspase
RT   recruitment domain with homology to Herpesvirus-2 protein E10.";
RL   J. Biol. Chem. 274:9955-9961(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10187771; DOI=10.1074/jbc.274.15.9962;
RA   Thome M., Martinon F., Hofmann K., Rubio V., Steiner V., Schneider P.,
RA   Mattmann C., Tschopp J.;
RT   "Equine herpesvirus-2 E10 gene product, but not its cellular
RT   homologue, activates NF-kappaB transcription factor and c-Jun N-
RT   terminal kinase.";
RL   J. Biol. Chem. 274:9962-9968(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS OF LEU-28; LEU-41; ILE-46;
RP   LEU-47; GLU-53 AND ILE-55.
RX   PubMed=10187815; DOI=10.1074/jbc.274.15.10287;
RA   Yan M., Lee J., Schilbach S., Goddard A., Dixit V.M.;
RT   "mE10, a novel caspase recruitment domain-containing proapoptotic
RT   molecule.";
RL   J. Biol. Chem. 274:10287-10292(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10364242; DOI=10.1074/jbc.274.25.17946;
RA   Srinivasula S.M., Ahmad M., Lin J.-H., Poyet J.-L.,
RA   Fernandes-Alnemri T., Tsichlis P.N., Alnemri E.S.;
RT   "CLAP, a novel caspase recruitment domain-containing protein in the
RT   tumor necrosis factor receptor pathway, regulates NF-kappaB activation
RT   and apoptosis.";
RL   J. Biol. Chem. 274:17946-17954(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spleen;
RX   PubMed=10400625; DOI=10.1074/jbc.274.29.20127;
RA   Costanzo A., Guiet C., Vito P.;
RT   "c-E10 is a caspase-recruiting domain-containing protein that
RT   interacts with components of death receptors signaling pathway and
RT   activates nuclear factor-kappaB.";
RL   J. Biol. Chem. 274:20127-20132(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANTS SER-5; GLU-16;
RP   GLU-31; ARG-57; LYS-64; GLU-101; PRO-134; ALA-168; SER-174; GLU-213
RP   AND ILE-230.
RX   PubMed=10319863; DOI=10.1038/8767;
RA   Zhang Q., Siebert R., Yan M., Hinzmann B., Cui X., Xue L.,
RA   Rakestraw K.M., Naeve C.W., Beckmann G., Weisenburger D.D.,
RA   Sanger W.G., Nowotny H., Vesely M., Callet-Bauchu E., Salles G.,
RA   Dixit V.M., Rosenthal A., Schlegelberger B., Morris S.W.;
RT   "Inactivating mutations and overexpression of BCL10, a caspase
RT   recruitment domain-containing gene, in MALT lymphoma with
RT   t(1;14)(p22;q32).";
RL   Nat. Genet. 22:63-68(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PHOSPHORYLATION.
RX   PubMed=11466612; DOI=10.1038/sj.onc.1204576;
RA   Yui D., Yoneda T., Oono K., Katayama T., Imaizumi K., Tohyama M.;
RT   "Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates
RT   apoptosis signaling.";
RL   Oncogene 20:4317-4323(2001).
RN   [13]
RP   IDENTIFICATION IN A MEMBRANE RAFT COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=17287217; DOI=10.1074/jbc.M609157200;
RA   Ohnuma K., Uchiyama M., Yamochi T., Nishibashi K., Hosono O.,
RA   Takahashi N., Kina S., Tanaka H., Lin X., Dang N.H., Morimoto C.;
RT   "Caveolin-1 triggers T-cell activation via CD26 in association with
RT   CARMA1.";
RL   J. Biol. Chem. 282:10117-10131(2007).
RN   [14]
RP   PHOSPHORYLATION BY IKBKB/IKKB, AND MUTAGENESIS OF 81-THR--SER-85.
RX   PubMed=17213322; DOI=10.1073/pnas.0606982104;
RA   Lobry C., Lopez T., Israel A., Weil R.;
RT   "Negative feedback loop in T cell activation through IkappaB kinase-
RT   induced phosphorylation and degradation of Bcl10.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:908-913(2007).
RN   [15]
RP   FUNCTION, AND MUTAGENESIS OF ARG-228.
RX   PubMed=18264101; DOI=10.1038/ni1568;
RA   Rebeaud F., Hailfinger S., Posevitz-Fejfar A., Tapernoux M., Moser R.,
RA   Rueda D., Gaide O., Guzzardi M., Iancu E.M., Rufer N., Fasel N.,
RA   Thome M.;
RT   "The proteolytic activity of the paracaspase MALT1 is key in T cell
RT   activation.";
RL   Nat. Immunol. 9:272-281(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   FUNCTION, AND INVOLVEMENT IN IMD37.
RX   PubMed=25365219; DOI=10.1172/JCI77493;
RA   Torres J.M., Martinez-Barricarte R., Garcia-Gomez S., Mazariegos M.S.,
RA   Itan Y., Boisson B., Rholvarez R., Jimenez-Reinoso A., Del Pino L.,
RA   Rodriguez-Pena R., Ferreira A., Hernandez-Jimenez E., Toledano V.,
RA   Cubillos-Zapata C., Diaz-Almiron M., Lopez-Collazo E.,
RA   Unzueta-Roch J.L., Sanchez-Ramon S., Regueiro J.R., Lopez-Granados E.,
RA   Casanova J.L., Perez de Diego R.;
RT   "Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic
RT   immunity.";
RL   J. Clin. Invest. 124:5239-5248(2014).
RN   [20]
RP   SUBUNIT.
RX   PubMed=27113748; DOI=10.15252/embr.201642109;
RA   Afonina I.S., Van Nuffel E., Baudelet G., Driege Y., Kreike M.,
RA   Staal J., Beyaert R.;
RT   "The paracaspase MALT1 mediates CARD14-induced signaling in
RT   keratinocytes.";
RL   EMBO Rep. 17:914-927(2016).
RN   [21]
RP   INTERACTION WITH CARD11 AND MALT1.
RX   PubMed=28628108; DOI=10.1038/ng.3898;
RA   Ma C.A., Stinson J.R., Zhang Y., Abbott J.K., Weinreich M.A.,
RA   Hauk P.J., Reynolds P.R., Lyons J.J., Nelson C.G., Ruffo E.,
RA   Dorjbal B., Glauzy S., Yamakawa N., Arjunaraja S., Voss K.,
RA   Stoddard J., Niemela J., Zhang Y., Rosenzweig S.D., McElwee J.J.,
RA   DiMaggio T., Matthews H.F., Jones N., Stone K.D., Palma A.,
RA   Oleastro M., Prieto E., Bernasconi A.R., Dubra G., Danielian S.,
RA   Zaiat J., Marti M.A., Kim B., Cooper M.A., Romberg N., Meffre E.,
RA   Gelfand E.W., Snow A.L., Milner J.D.;
RT   "Germline hypomorphic CARD11 mutations in severe atopic disease.";
RL   Nat. Genet. 49:1192-1201(2017).
RN   [22]
RP   VARIANTS SER-5; MET-162 AND GLU-213.
RX   PubMed=10582682;
RA   Lee S.H., Shin M.S., Kim H.S., Park W.S., Kim S.Y., Lee H.K.,
RA   Park J.Y., Oh R.R., Jang J.J., Park K.M., Han J.Y., Kang C.S.,
RA   Lee J.Y., Yoo N.J.;
RT   "Point mutations and deletions of the Bcl10 gene in solid tumors and
RT   malignant lymphomas.";
RL   Cancer Res. 59:5674-5677(1999).
RN   [23]
RP   VARIANTS SER-5; GLN-45; GLN-58; SER-93; VAL-153; GLU-213 AND PHE-218.
RX   PubMed=10380921; DOI=10.1016/S0092-8674(02)09765-9;
RA   Apostolou S., de Rienzo A., Murthy S.S., Jhanwar S.C., Testa J.R.;
RT   "Absence of BCL10 mutations in human malignant mesothelioma.";
RL   Cell 97:684-686(1999).
CC   -!- FUNCTION: Involved in adaptive immune response (PubMed:25365219).
CC       Promotes apoptosis, pro-caspase-9 maturation and activation of NF-
CC       kappa-B via NIK and IKK. May be an adapter protein between
CC       upstream TNFR1-TRADD-RIP complex and the downstream NIK-IKK-IKAP
CC       complex. Is a substrate for MALT1 (PubMed:18264101).
CC       {ECO:0000269|PubMed:18264101, ECO:0000269|PubMed:25365219}.
CC   -!- SUBUNIT: Found in a membrane raft complex, at least composed of
CC       BCL10, CARD11, DPP4 and IKBKB. Self-associates by CARD-CARD
CC       interaction and forms a tight complex with MALT1. Interacts with
CC       other CARD-proteins such as CARD9, CARD10, CARD11 and CARD14.
CC       Forms a complex with CARD14 and MALT1; resulting in the formation
CC       of a CBM (CARD14-BCL10-MALT1) complex (PubMed:27113748). Binds
CC       caspase-9 with its C-terminal domain. Interacts with TRAF2 and
CC       BIRC2/c-IAP2. Interacts with PELI2 and SOCS3; these interactions
CC       may be mutually exclusive (By similarity). Interacts with CARD11
CC       and MALT1; as part of a CBM (CARD11-BCL10-MALT1) complex involved
CC       in NF-kappa-B activation. {ECO:0000250|UniProtKB:Q9Z0H7,
CC       ECO:0000269|PubMed:27113748}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-958922, EBI-958922;
CC       P31749:AKT1; NbExp=5; IntAct=EBI-958922, EBI-296087;
CC       P20749:BCL3; NbExp=3; IntAct=EBI-958922, EBI-958997;
CC       Q9BXL7:CARD11; NbExp=7; IntAct=EBI-958922, EBI-7006141;
CC       Q9H257:CARD9; NbExp=6; IntAct=EBI-958922, EBI-751319;
CC       Q9Y2V7:COG6; NbExp=4; IntAct=EBI-958922, EBI-3866319;
CC       Q66677:E10 (xeno); NbExp=2; IntAct=EBI-958922, EBI-11709474;
CC       Q9Y6K9:IKBKG; NbExp=7; IntAct=EBI-958922, EBI-81279;
CC       Q9UDY8:MALT1; NbExp=18; IntAct=EBI-958922, EBI-1047372;
CC       Q05513:PRKCZ; NbExp=3; IntAct=EBI-958922, EBI-295351;
CC       Q12933:TRAF2; NbExp=8; IntAct=EBI-958922, EBI-355744;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:17287217}. Membrane raft
CC       {ECO:0000269|PubMed:17287217}. Note=Appears to have a perinuclear,
CC       compact and filamentous pattern of expression. Also found in the
CC       nucleus of several types of tumor cells. Colocalized with DPP4 in
CC       membrane rafts.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Phosphorylated. Phosphorylation results in dissociation from
CC       TRAF2 and binding to BIRC2/c-IAP2. Phosphorylated by IKBKB/IKKB.
CC       {ECO:0000269|PubMed:11466612, ECO:0000269|PubMed:17213322}.
CC   -!- DISEASE: Note=A chromosomal aberration involving BCL10 is
CC       recurrent in low-grade mucosa-associated lymphoid tissue (MALT
CC       lymphoma). Translocation t(1;14)(p22;q32). Although the BCL10/IgH
CC       translocation leaves the coding region of BCL10 intact, frequent
CC       BCL10 mutations could be attributed to the Ig somatic
CC       hypermutation mechanism resulting in nucleotide transitions.
CC   -!- DISEASE: Immunodeficiency 37 (IMD37) [MIM:616098]: A form of
CC       primary combined immunodeficiency, a group of disorders
CC       characterized by severe recurrent infections, with normal numbers
CC       or an absence of T and B lymphocytes, and impaired cellular and
CC       humoral immunity. IMD37 is characterized by hypogammaglobulinemia
CC       without lymphopenia, but with profoundly reduced memory B cells
CC       and memory T cells, and increased numbers of circulating naive
CC       lymphocytes. Inheritance is autosomal recessive.
CC       {ECO:0000269|PubMed:25365219}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Lymphoma, mucosa-associated lymphoid type (MALTOMA)
CC       [MIM:137245]: A subtype of non-Hodgkin lymphoma, originating in
CC       mucosa-associated lymphoid tissue. MALT lymphomas occur most
CC       commonly in the gastro-intestinal tract but have been described in
CC       a variety of extranodal sites including the ocular adnexa,
CC       salivary gland, thyroid, lung, thymus, and breast. Histologically,
CC       they are characterized by an infiltrate of small to medium-sized
CC       lymphocytes with abundant cytoplasm and irregularly shaped nuclei.
CC       Scattered transformed blasts (large cells) also are present. Non-
CC       malignant reactive follicles are observed frequently. A pivotal
CC       feature is the presence of lymphoepithelial lesions, with invasion
CC       and partial destruction of mucosal glands and crypts by aggregates
CC       of tumor cells. {ECO:0000269|PubMed:9989495}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BCL10ID222ch1p22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ006288; CAA06955.1; -; mRNA.
DR   EMBL; AF057700; AAD15800.1; -; mRNA.
DR   EMBL; AF100338; AAD16428.1; -; mRNA.
DR   EMBL; AF127386; AAD32597.1; -; mRNA.
DR   EMBL; AF134395; AAD39147.1; -; mRNA.
DR   EMBL; AF105066; AAF06894.1; -; mRNA.
DR   EMBL; AF082283; AAC99767.1; -; mRNA.
DR   EMBL; AF097732; AAD24918.1; -; Genomic_DNA.
DR   EMBL; AK291346; BAF84035.1; -; mRNA.
DR   EMBL; AL590113; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471097; EAW73208.1; -; Genomic_DNA.
DR   EMBL; BC053617; AAH53617.1; -; mRNA.
DR   CCDS; CCDS704.1; -.
DR   RefSeq; NP_003912.1; NM_003921.4.
DR   UniGene; Hs.193516; -.
DR   PDB; 2MB9; NMR; -; A=1-115.
DR   PDBsum; 2MB9; -.
DR   ProteinModelPortal; O95999; -.
DR   SMR; O95999; -.
DR   BioGrid; 114429; 66.
DR   CORUM; O95999; -.
DR   DIP; DIP-29740N; -.
DR   IntAct; O95999; 39.
DR   MINT; O95999; -.
DR   STRING; 9606.ENSP00000271015; -.
DR   iPTMnet; O95999; -.
DR   PhosphoSitePlus; O95999; -.
DR   BioMuta; BCL10; -.
DR   EPD; O95999; -.
DR   PaxDb; O95999; -.
DR   PeptideAtlas; O95999; -.
DR   PRIDE; O95999; -.
DR   DNASU; 8915; -.
DR   Ensembl; ENST00000370580; ENSP00000359612; ENSG00000142867.
DR   GeneID; 8915; -.
DR   KEGG; hsa:8915; -.
DR   UCSC; uc021opd.3; human.
DR   CTD; 8915; -.
DR   DisGeNET; 8915; -.
DR   EuPathDB; HostDB:ENSG00000142867.12; -.
DR   GeneCards; BCL10; -.
DR   HGNC; HGNC:989; BCL10.
DR   HPA; CAB001944; -.
DR   HPA; HPA017925; -.
DR   MalaCards; BCL10; -.
DR   MIM; 137245; phenotype.
DR   MIM; 603517; gene.
DR   MIM; 616098; phenotype.
DR   neXtProt; NX_O95999; -.
DR   OpenTargets; ENSG00000142867; -.
DR   PharmGKB; PA25299; -.
DR   eggNOG; ENOG410IVMM; Eukaryota.
DR   eggNOG; ENOG4111JRA; LUCA.
DR   GeneTree; ENSGT00490000043442; -.
DR   HOGENOM; HOG000008671; -.
DR   HOVERGEN; HBG050680; -.
DR   InParanoid; O95999; -.
DR   KO; K07368; -.
DR   OMA; RHYLCDK; -.
DR   OrthoDB; EOG091G0UTQ; -.
DR   PhylomeDB; O95999; -.
DR   TreeFam; TF328636; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   SignaLink; O95999; -.
DR   SIGNOR; O95999; -.
DR   ChiTaRS; BCL10; human.
DR   GeneWiki; BCL10; -.
DR   GenomeRNAi; 8915; -.
DR   PRO; PR:O95999; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000142867; -.
DR   CleanEx; HS_BCL10; -.
DR   ExpressionAtlas; O95999; baseline and differential.
DR   Genevisible; O95999; HS.
DR   GO; GO:0032449; C:CBM complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0051059; F:NF-kappaB binding; IDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:BHF-UCL.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0043422; F:protein kinase B binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0043621; F:protein self-association; IPI:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IMP:UniProtKB.
DR   GO; GO:0001783; P:B cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0008219; P:cell death; IDA:UniProtKB.
DR   GO; GO:0006968; P:cellular defense response; IEA:Ensembl.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:0016064; P:immunoglobulin mediated immune response; IEA:Ensembl.
DR   GO; GO:0045087; P:innate immune response; IEP:UniProtKB.
DR   GO; GO:0042226; P:interleukin-6 biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0042109; P:lymphotoxin A biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0002906; P:negative regulation of mature B cell apoptotic process; IDA:UniProtKB.
DR   GO; GO:0001843; P:neural tube closure; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB.
DR   GO; GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0032765; P:positive regulation of mast cell cytokine production; NAS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IDA:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0050870; P:positive regulation of T cell activation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB.
DR   GO; GO:0051259; P:protein oligomerization; IPI:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0050856; P:regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0032094; P:response to food; IDA:UniProtKB.
DR   GO; GO:0009620; P:response to fungus; IEA:Ensembl.
DR   GO; GO:0002237; P:response to molecule of bacterial origin; IEP:UniProtKB.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070231; P:T cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; IC:UniProtKB.
DR   InterPro; IPR033238; BCL10/E10.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   PANTHER; PTHR34920; PTHR34920; 1.
DR   Pfam; PF00619; CARD; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50209; CARD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Apoptosis; Chromosomal rearrangement;
KW   Complete proteome; Cytoplasm; Disease mutation; Immunity; Membrane;
KW   Phosphoprotein; Reference proteome; Tumor suppressor.
FT   CHAIN         1    233       B-cell lymphoma/leukemia 10.
FT                                /FTId=PRO_0000144074.
FT   DOMAIN       13    101       CARD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00046}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   VARIANT       5      5       A -> S (found in a MALT lymphoma sample;
FT                                unknown pathological significance;
FT                                dbSNP:rs12037217).
FT                                {ECO:0000269|PubMed:10319863,
FT                                ECO:0000269|PubMed:10380921,
FT                                ECO:0000269|PubMed:10582682}.
FT                                /FTId=VAR_013208.
FT   VARIANT      16     16       V -> E (found in a MALT lymphoma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:10319863}.
FT                                /FTId=VAR_013209.
FT   VARIANT      31     31       K -> E (found in a MALT lymphoma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:10319863}.
FT                                /FTId=VAR_013210.
FT   VARIANT      45     45       K -> Q. {ECO:0000269|PubMed:10380921}.
FT                                /FTId=VAR_013211.
FT   VARIANT      52     52       T -> I (found in a mesothelioma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:9989495}.
FT                                /FTId=VAR_013212.
FT   VARIANT      57     57       C -> R (found in a MALT lymphoma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:10319863}.
FT                                /FTId=VAR_013213.
FT   VARIANT      58     58       R -> G (found in a germ cell tumor
FT                                sample; unknown pathological
FT                                significance; dbSNP:rs121918314).
FT                                {ECO:0000269|PubMed:9989495}.
FT                                /FTId=VAR_013214.
FT   VARIANT      58     58       R -> Q. {ECO:0000269|PubMed:10380921}.
FT                                /FTId=VAR_013215.
FT   VARIANT      64     64       R -> K (found in a MALT lymphoma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:10319863}.
FT                                /FTId=VAR_013216.
FT   VARIANT      93     93       N -> S. {ECO:0000269|PubMed:10380921}.
FT                                /FTId=VAR_013217.
FT   VARIANT     101    101       D -> E (found in a MALT lymphoma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:10319863}.
FT                                /FTId=VAR_013218.
FT   VARIANT     134    134       S -> P (found in a MALT lymphoma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:10319863}.
FT                                /FTId=VAR_013219.
FT   VARIANT     153    153       M -> V. {ECO:0000269|PubMed:10380921}.
FT                                /FTId=VAR_013220.
FT   VARIANT     162    162       T -> M (found in a testicular teratoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs200837308).
FT                                {ECO:0000269|PubMed:10582682}.
FT                                /FTId=VAR_077898.
FT   VARIANT     168    168       T -> A (found in a MALT lymphoma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:10319863}.
FT                                /FTId=VAR_013221.
FT   VARIANT     174    174       L -> S (found in a MALT lymphoma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:10319863}.
FT                                /FTId=VAR_013222.
FT   VARIANT     210    210       Missing (found in a follicular lymphoma
FT                                sample; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:9989495}.
FT                                /FTId=VAR_013223.
FT   VARIANT     213    213       G -> E (found in a MALT lymphoma sample;
FT                                unknown pathological significance;
FT                                dbSNP:rs3768235).
FT                                {ECO:0000269|PubMed:10319863,
FT                                ECO:0000269|PubMed:10380921,
FT                                ECO:0000269|PubMed:10582682}.
FT                                /FTId=VAR_013224.
FT   VARIANT     218    218       S -> F (found in a germ cell tumor and
FT                                other cancer cell lines; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:10380921,
FT                                ECO:0000269|PubMed:9989495}.
FT                                /FTId=VAR_013225.
FT   VARIANT     230    230       V -> I (found in a MALT lymphoma sample;
FT                                unknown pathological significance).
FT                                {ECO:0000269|PubMed:10319863}.
FT                                /FTId=VAR_013226.
FT   MUTAGEN      28     28       L->A: Abolishes cell death-inducing
FT                                capability.
FT                                {ECO:0000269|PubMed:10187815}.
FT   MUTAGEN      41     41       L->A: Abolishes cell death-inducing
FT                                capability. {ECO:0000269|PubMed:10187770,
FT                                ECO:0000269|PubMed:10187815}.
FT   MUTAGEN      41     41       L->Q: Abolishes NF-kappa-B activation and
FT                                homo/hetero-dimerization.
FT                                {ECO:0000269|PubMed:10187770,
FT                                ECO:0000269|PubMed:10187815}.
FT   MUTAGEN      46     46       I->A: Abolishes cell death-inducing
FT                                capability.
FT                                {ECO:0000269|PubMed:10187815}.
FT   MUTAGEN      47     47       L->A: Abolishes cell death-inducing
FT                                capability.
FT                                {ECO:0000269|PubMed:10187815}.
FT   MUTAGEN      53     53       E->A: Abolishes cell death-inducing
FT                                capability.
FT                                {ECO:0000269|PubMed:10187815}.
FT   MUTAGEN      55     55       I->A: Abolishes cell death-inducing
FT                                capability.
FT                                {ECO:0000269|PubMed:10187815}.
FT   MUTAGEN      78     78       G->R: Abolishes NF-kappa-B activation.
FT                                {ECO:0000269|PubMed:10187770}.
FT   MUTAGEN      81     85       TLVES->ALVEA: Complete loss of
FT                                IKBKB/IKKB-mediated phosphorylation.
FT                                {ECO:0000269|PubMed:17213322}.
FT   MUTAGEN     228    228       R->G: Abolishes MALT1-mediated cleavage.
FT                                {ECO:0000269|PubMed:18264101}.
FT   MUTAGEN     231    231       S->A: Promotes NF-kappa-B activation.
FT   HELIX        11     14       {ECO:0000244|PDB:2MB9}.
FT   HELIX        17     28       {ECO:0000244|PDB:2MB9}.
FT   TURN         29     31       {ECO:0000244|PDB:2MB9}.
FT   STRAND       32     38       {ECO:0000244|PDB:2MB9}.
FT   HELIX        39     42       {ECO:0000244|PDB:2MB9}.
FT   HELIX        49     53       {ECO:0000244|PDB:2MB9}.
FT   TURN         54     57       {ECO:0000244|PDB:2MB9}.
FT   HELIX        61     72       {ECO:0000244|PDB:2MB9}.
FT   TURN         76     79       {ECO:0000244|PDB:2MB9}.
FT   HELIX        80     86       {ECO:0000244|PDB:2MB9}.
FT   STRAND       89     92       {ECO:0000244|PDB:2MB9}.
FT   HELIX        94    105       {ECO:0000244|PDB:2MB9}.
FT   HELIX       107    113       {ECO:0000244|PDB:2MB9}.
SQ   SEQUENCE   233 AA;  26252 MW;  F87C97F2B784BA4B CRC64;
     MEPTAPSLTE EDLTEVKKDA LENLRVYLCE KIIAERHFDH LRAKKILSRE DTEEISCRTS
     SRKRAGKLLD YLQENPKGLD TLVESIRREK TQNFLIQKIT DEVLKLRNIK LEHLKGLKCS
     SCEPFPDGAT NNLSRSNSDE SNFSEKLRAS TVMYHPEGES STTPFFSTNS SLNLPVLEVG
     RTENTIFSST TLPRPGDPGA PPLPPDLQLE EEGTCANSSE MFLPLRSRTV SRQ
//
ID   BCOR_HUMAN              Reviewed;        1755 AA.
AC   Q6W2J9; D3DWB3; D3DWB4; Q29RF6; Q6P4B6; Q7Z2K7; Q8TEB4; Q96DB3;
AC   Q9H232; Q9H233; Q9HCJ7; Q9NXF2;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 142.
DE   RecName: Full=BCL-6 corepressor;
DE            Short=BCoR;
GN   Name=BCOR; Synonyms=KIAA1575;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), FUNCTION, INTERACTION
RP   WITH BCL6; HDAC1; HDAC3 AND HDAC5, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Frontal cortex;
RX   PubMed=10898795;
RA   Huynh K.D., Fischle W., Verdin E., Bardwell V.J.;
RT   "BCoR, a novel corepressor involved in BCL-6 repression.";
RL   Genes Dev. 14:1810-1823(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND VARIANT MCOPS2
RP   LEU-85.
RX   PubMed=15004558; DOI=10.1038/ng1321;
RA   Ng D., Thakker N., Corcoran C.M., Donnai D., Perveen R., Schneider A.,
RA   Hadley D.W., Tifft C., Zhang L., Wilkie A.O., van der Smagt J.J.,
RA   Gorlin R.J., Burgess S.M., Bardwell V.J., Black G.C.M.,
RA   Biesecker L.G.;
RT   "Oculofaciocardiodental and Lenz microphthalmia syndromes result from
RT   distinct classes of mutations in BCOR.";
RL   Nat. Genet. 36:411-416(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1395-1755 (ISOFORM 1).
RC   TISSUE=Liver, Lymph, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 217-1755 (ISOFORM 4), AND
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1328-1755.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   INTERACTION WITH PCGF1 AND KDM2B, AND IDENTIFICATION IN A COMPLEX WITH
RP   RYBP; PCGF1; RING1; RNF2; KDM2B AND SKP1.
RX   PubMed=16943429; DOI=10.1128/MCB.00630-06;
RA   Gearhart M.D., Corcoran C.M., Wamstad J.A., Bardwell V.J.;
RT   "Polycomb group and SCF ubiquitin ligases are found in a novel BCOR
RT   complex that is recruited to BCL6 targets.";
RL   Mol. Cell. Biol. 26:6880-6889(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-423 AND SER-1410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   FUNCTION.
RX   PubMed=19578371; DOI=10.1038/ncb1913;
RA   Fan Z., Yamaza T., Lee J.S., Yu J., Wang S., Fan G., Shi S.,
RA   Wang C.-Y.;
RT   "BCOR regulates mesenchymal stem cell function by epigenetic
RT   mechanisms.";
RL   Nat. Cell Biol. 11:1002-1009(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1139, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-392, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-336; SER-340; SER-365;
RP   SER-367 AND SER-423, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-423, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   FUNCTION AS COREPRESSOR, INTERACTION WITH BCL6, AND IDENTIFICATION IN
RP   A COMPLEX WITH BCL6 AND SMRT.
RX   PubMed=23911289; DOI=10.1016/j.celrep.2013.06.016;
RA   Hatzi K., Jiang Y., Huang C., Garrett-Bakelman F., Gearhart M.D.,
RA   Giannopoulou E.G., Zumbo P., Kirouac K., Bhaskara S., Polo J.M.,
RA   Kormaksson M., Mackerell A.D. Jr., Xue F., Mason C.E., Hiebert S.W.,
RA   Prive G.G., Cerchietti L., Bardwell V.J., Elemento O., Melnick A.;
RT   "A hybrid mechanism of action for BCL6 in B cells defined by formation
RT   of functionally distinct complexes at enhancers and promoters.";
RL   Cell Rep. 4:578-588(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-423; SER-1139; SER-1290
RP   AND SER-1410, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH PCGF1.
RX   PubMed=26687479; DOI=10.1038/srep18388;
RA   Oliviero G., Munawar N., Watson A., Streubel G., Manning G.,
RA   Bardwell V., Bracken A.P., Cagney G.;
RT   "The variant Polycomb Repressor Complex 1 component PCGF1 interacts
RT   with a pluripotency sub-network that includes DPPA4, a regulator of
RT   embryogenesis.";
RL   Sci. Rep. 5:18388-18388(2015).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-786; LYS-872; LYS-1256 AND
RP   LYS-1413, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1634-1748 IN COMPLEX WITH
RP   PCGF1, INTERACTION WITH PCGF1, AND MUTAGENESIS OF LEU-1706.
RX   PubMed=23523425; DOI=10.1016/j.str.2013.02.013;
RA   Junco S.E., Wang R., Gaipa J.C., Taylor A.B., Schirf V.,
RA   Gearhart M.D., Bardwell V.J., Demeler B., Hart P.J., Kim C.A.;
RT   "Structure of the polycomb group protein PCGF1 in complex with BCOR
RT   reveals basis for binding selectivity of PCGF homologs.";
RL   Structure 21:665-671(2013).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 498-514 IN COMPLEX WITH BCL6,
RP   FUNCTION, AND MUTAGENESIS OF SER-507; SER-508; TRP-509 AND VAL-511.
RX   PubMed=18280243; DOI=10.1016/j.molcel.2007.12.026;
RA   Ghetu A.F., Corcoran C.M., Cerchietti L., Bardwell V.J., Melnick A.,
RA   Prive G.G.;
RT   "Structure of a BCOR corepressor peptide in complex with the BCL6 BTB
RT   domain dimer.";
RL   Mol. Cell 29:384-391(2008).
CC   -!- FUNCTION: Transcriptional corepressor. May specifically inhibit
CC       gene expression when recruited to promoter regions by sequence-
CC       specific DNA-binding proteins such as BCL6 and MLLT3. This
CC       repression may be mediated at least in part by histone deacetylase
CC       activities which can associate with this corepressor. Involved in
CC       the repression of TFAP2A; impairs binding of BCL6 and KDM2B to
CC       TFAP2A promoter regions. Via repression of TFAP2A acts as a
CC       negative regulator of osteo-dentiogenic capacity in adult stem
CC       cells; the function implies inhibition of methylation on histone
CC       H3 'Lys-4' (H3K4me3) and 'Lys-36' (H3K36me2).
CC       {ECO:0000269|PubMed:10898795, ECO:0000269|PubMed:15004558,
CC       ECO:0000269|PubMed:18280243, ECO:0000269|PubMed:19578371,
CC       ECO:0000269|PubMed:23911289}.
CC   -!- SUBUNIT: Interacts with BCL6; the interaction is direct
CC       (PubMed:10898795). Forms ternary complexes with BCL6 and
CC       SMRT/NCOR2 on selected target genes promoters; potently repress
CC       expression (PubMed:23911289, PubMed:18280243). Can interact with
CC       HDAC1, HDAC3 and HDAC5 (PubMed:10898795). Interacts with PCGF1;
CC       the interaction is direct (PubMed:16943429, PubMed:23523425,
CC       PubMed:26687479). Interacts with KDM2B. Component of an
CC       approximately 800 kDa repressive BCOR complex at least composed of
CC       BCOR, RYBP, PCGF1, RING1, RNF2/RING2, KDM2B and SKP1
CC       (PubMed:16943429). Interacts with CPNE4 (via VWFA domain) (By
CC       similarity). Isoform 1 may interact with MLLT3/AF9 (By
CC       similarity). {ECO:0000250|UniProtKB:Q8CGN4,
CC       ECO:0000269|PubMed:10898795, ECO:0000269|PubMed:16943429,
CC       ECO:0000269|PubMed:18280243, ECO:0000269|PubMed:23523425,
CC       ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:26687479}.
CC   -!- INTERACTION:
CC       Q9HC52:CBX8; NbExp=9; IntAct=EBI-950027, EBI-712912;
CC       Q8NHM5:KDM2B; NbExp=4; IntAct=EBI-950027, EBI-3955564;
CC       P42568:MLLT3; NbExp=2; IntAct=EBI-16028932, EBI-716132;
CC       P41227:NAA10; NbExp=3; IntAct=EBI-10208579, EBI-747693;
CC       Q9BSM1:PCGF1; NbExp=13; IntAct=EBI-950027, EBI-749901;
CC       Q9BSM1-1:PCGF1; NbExp=7; IntAct=EBI-16028932, EBI-16041863;
CC       Q3KNV8:PCGF3; NbExp=3; IntAct=EBI-10208579, EBI-2339807;
CC       Q86SE9:PCGF5; NbExp=3; IntAct=EBI-10208579, EBI-2827999;
CC       Q93009:USP7; NbExp=3; IntAct=EBI-950027, EBI-302474;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10898795}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long;
CC         IsoId=Q6W2J9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6W2J9-2; Sequence=VSP_012557;
CC       Name=3; Synonyms=Short;
CC         IsoId=Q6W2J9-3; Sequence=VSP_012554, VSP_012556;
CC       Name=4;
CC         IsoId=Q6W2J9-4; Sequence=VSP_012555, VSP_012557;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:10898795}.
CC   -!- DISEASE: Microphthalmia, syndromic, 2 (MCOPS2) [MIM:300166]: A
CC       very rare multiple congenital anomaly syndrome characterized by
CC       eye anomalies (congenital cataract, microphthalmia, or secondary
CC       glaucoma), facial abnormalities (long narrow face, high nasal
CC       bridge, pointed nose with cartilages separated at the tip, cleft
CC       palate, or submucous cleft palate), cardiac anomalies (atrial
CC       septal defect, ventricular septal defect, or floppy mitral valve)
CC       and dental abnormalities (canine radiculomegaly, delayed
CC       dentition, oligodontia, persistent primary teeth, or variable root
CC       length). Microphthalmia is a disorder of eye formation, ranging
CC       from small size of a single eye to complete bilateral absence of
CC       ocular tissues (anophthalmia). In many cases,
CC       microphthalmia/anophthalmia occurs in association with syndromes
CC       that include non-ocular abnormalities.
CC       {ECO:0000269|PubMed:15004558}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the BCOR family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH63536.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Presence of complementary strand sequence in the clone.; Evidence={ECO:0000305};
CC       Sequence=BAA91061.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=BAB13401.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB85037.1; Type=Frameshift; Positions=1353; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF317391; AAG41429.1; -; mRNA.
DR   EMBL; AF317392; AAG41430.1; -; mRNA.
DR   EMBL; AY316592; AAR08265.1; -; mRNA.
DR   EMBL; AB046795; BAB13401.2; ALT_INIT; mRNA.
DR   EMBL; CH471141; EAW59425.1; -; Genomic_DNA.
DR   EMBL; CH471141; EAW59427.1; -; Genomic_DNA.
DR   EMBL; CH471141; EAW59428.1; -; Genomic_DNA.
DR   EMBL; CH471141; EAW59430.1; -; Genomic_DNA.
DR   EMBL; BC009675; AAH09675.2; -; mRNA.
DR   EMBL; BC063536; AAH63536.1; ALT_SEQ; mRNA.
DR   EMBL; BC114220; AAI14221.1; -; mRNA.
DR   EMBL; AK000292; BAA91061.1; ALT_SEQ; mRNA.
DR   EMBL; AK074286; BAB85037.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS14250.1; -. [Q6W2J9-2]
DR   CCDS; CCDS48092.1; -. [Q6W2J9-4]
DR   CCDS; CCDS48093.1; -. [Q6W2J9-1]
DR   RefSeq; NP_001116855.1; NM_001123383.1. [Q6W2J9-2]
DR   RefSeq; NP_001116856.1; NM_001123384.1. [Q6W2J9-4]
DR   RefSeq; NP_001116857.1; NM_001123385.1. [Q6W2J9-1]
DR   RefSeq; NP_060215.4; NM_017745.5. [Q6W2J9-2]
DR   RefSeq; XP_005272673.1; XM_005272616.1. [Q6W2J9-1]
DR   RefSeq; XP_005272675.1; XM_005272618.3. [Q6W2J9-1]
DR   RefSeq; XP_005272677.1; XM_005272620.3. [Q6W2J9-4]
DR   RefSeq; XP_006724599.1; XM_006724536.3. [Q6W2J9-1]
DR   RefSeq; XP_011542231.1; XM_011543929.2. [Q6W2J9-1]
DR   RefSeq; XP_011542232.1; XM_011543930.1. [Q6W2J9-1]
DR   RefSeq; XP_011542233.1; XM_011543931.2. [Q6W2J9-1]
DR   RefSeq; XP_016885104.1; XM_017029615.1. [Q6W2J9-2]
DR   UniGene; Hs.659681; -.
DR   PDB; 2N1L; NMR; -; A=1634-1748.
DR   PDB; 3BIM; X-ray; 2.60 A; I/J/K/L/M/N/O/P=498-514.
DR   PDB; 4HPL; X-ray; 2.00 A; A=1634-1748.
DR   PDBsum; 2N1L; -.
DR   PDBsum; 3BIM; -.
DR   PDBsum; 4HPL; -.
DR   ProteinModelPortal; Q6W2J9; -.
DR   SMR; Q6W2J9; -.
DR   BioGrid; 120228; 111.
DR   CORUM; Q6W2J9; -.
DR   DIP; DIP-50009N; -.
DR   IntAct; Q6W2J9; 65.
DR   STRING; 9606.ENSP00000367705; -.
DR   iPTMnet; Q6W2J9; -.
DR   PhosphoSitePlus; Q6W2J9; -.
DR   BioMuta; BCOR; -.
DR   EPD; Q6W2J9; -.
DR   MaxQB; Q6W2J9; -.
DR   PaxDb; Q6W2J9; -.
DR   PeptideAtlas; Q6W2J9; -.
DR   PRIDE; Q6W2J9; -.
DR   DNASU; 54880; -.
DR   Ensembl; ENST00000342274; ENSP00000345923; ENSG00000183337. [Q6W2J9-2]
DR   Ensembl; ENST00000378444; ENSP00000367705; ENSG00000183337. [Q6W2J9-1]
DR   Ensembl; ENST00000378455; ENSP00000367716; ENSG00000183337. [Q6W2J9-4]
DR   Ensembl; ENST00000397354; ENSP00000380512; ENSG00000183337. [Q6W2J9-2]
DR   GeneID; 54880; -.
DR   KEGG; hsa:54880; -.
DR   UCSC; uc004dem.5; human. [Q6W2J9-1]
DR   CTD; 54880; -.
DR   DisGeNET; 54880; -.
DR   EuPathDB; HostDB:ENSG00000183337.16; -.
DR   GeneCards; BCOR; -.
DR   GeneReviews; BCOR; -.
DR   HGNC; HGNC:20893; BCOR.
DR   HPA; HPA056308; -.
DR   HPA; HPA066234; -.
DR   MalaCards; BCOR; -.
DR   MIM; 300166; phenotype.
DR   MIM; 300485; gene.
DR   neXtProt; NX_Q6W2J9; -.
DR   OpenTargets; ENSG00000183337; -.
DR   Orphanet; 568; Microphthalmia, Lenz type.
DR   Orphanet; 2712; Oculofaciocardiodental syndrome.
DR   PharmGKB; PA134921737; -.
DR   eggNOG; ENOG410IHDH; Eukaryota.
DR   eggNOG; ENOG410YT00; LUCA.
DR   GeneTree; ENSGT00760000119090; -.
DR   HOVERGEN; HBG050682; -.
DR   InParanoid; Q6W2J9; -.
DR   OMA; ERVRMCG; -.
DR   OrthoDB; EOG091G0R1A; -.
DR   PhylomeDB; Q6W2J9; -.
DR   TreeFam; TF333317; -.
DR   SIGNOR; Q6W2J9; -.
DR   ChiTaRS; BCOR; human.
DR   EvolutionaryTrace; Q6W2J9; -.
DR   GeneWiki; BCOR; -.
DR   GenomeRNAi; 54880; -.
DR   PRO; PR:Q6W2J9; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000183337; -.
DR   ExpressionAtlas; Q6W2J9; baseline and differential.
DR   Genevisible; Q6W2J9; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031072; F:heat shock protein binding; IDA:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IMP:UniProtKB.
DR   GO; GO:0007507; P:heart development; IMP:UniProtKB.
DR   GO; GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0030502; P:negative regulation of bone mineralization; IMP:UniProtKB.
DR   GO; GO:0000415; P:negative regulation of histone H3-K36 methylation; IMP:UniProtKB.
DR   GO; GO:0051572; P:negative regulation of histone H3-K4 methylation; IMP:UniProtKB.
DR   GO; GO:0070171; P:negative regulation of tooth mineralization; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0042476; P:odontogenesis; IMP:UniProtKB.
DR   GO; GO:0060021; P:palate development; IMP:UniProtKB.
DR   GO; GO:0065001; P:specification of axis polarity; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR031628; BCOR.
DR   InterPro; IPR032365; PUFD.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF15808; BCOR; 1.
DR   Pfam; PF16553; PUFD; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ANK repeat;
KW   Chromatin regulator; Complete proteome; Disease mutation;
KW   Isopeptide bond; Microphthalmia; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1   1755       BCL-6 corepressor.
FT                                /FTId=PRO_0000066978.
FT   REPEAT     1462   1495       ANK 1.
FT   REPEAT     1496   1525       ANK 2.
FT   REPEAT     1529   1558       ANK 3.
FT   REGION      498    514       Interaction with BCL6.
FT   REGION     1634   1748       Necessary and sufficient for interaction
FT                                with PCGF1.
FT   COMPBIAS    634    711       Pro-rich.
FT   COMPBIAS   1625   1631       Poly-Asp.
FT   MOD_RES     336    336       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     340    340       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     365    365       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     367    367       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     392    392       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     423    423       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1127   1127       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CGN4}.
FT   MOD_RES    1139   1139       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1290   1290       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1345   1345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CGN4}.
FT   MOD_RES    1410   1410       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    786    786       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    872    872       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1256   1256       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1413   1413       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ    1000   1017       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012555.
FT   VAR_SEQ    1000   1004       MEGLQ -> VSPPT (in isoform 3).
FT                                {ECO:0000303|PubMed:10898795,
FT                                ECO:0000303|PubMed:10997877}.
FT                                /FTId=VSP_012554.
FT   VAR_SEQ    1005   1755       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10898795,
FT                                ECO:0000303|PubMed:10997877}.
FT                                /FTId=VSP_012556.
FT   VAR_SEQ    1168   1201       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:10898795,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012557.
FT   VARIANT      85     85       P -> L (in MCOPS2; dbSNP:rs121434618).
FT                                {ECO:0000269|PubMed:15004558}.
FT                                /FTId=VAR_020921.
FT   MUTAGEN     507    507       S->A: Abolishes interaction with BCL6 and
FT                                inhibits BCL6 corepression activity; when
FT                                associated with A-509 and A-511.
FT                                {ECO:0000269|PubMed:18280243}.
FT   MUTAGEN     508    508       S->A: Diminishes interaction with BCL6.
FT                                {ECO:0000269|PubMed:18280243}.
FT   MUTAGEN     509    509       W->A: Abolishes interaction with BCL6 and
FT                                inhibits BCL6 corepression activity; when
FT                                associated with A-507 and A-511.
FT                                {ECO:0000269|PubMed:18280243}.
FT   MUTAGEN     511    511       V->A: Abolishes interaction with BCL6 and
FT                                inhibits BCL6 corepression activity; when
FT                                associated with A-507 and A-509.
FT                                {ECO:0000269|PubMed:18280243}.
FT   MUTAGEN    1706   1706       L->D,R: Slightly inhibits interaction
FT                                with PCGF1.
FT                                {ECO:0000269|PubMed:23523425}.
FT   CONFLICT    406    406       V -> A (in Ref. 6; BAB85037).
FT                                {ECO:0000305}.
FT   CONFLICT    596    596       Q -> L (in Ref. 6; BAB85037).
FT                                {ECO:0000305}.
FT   CONFLICT   1459   1459       N -> S (in Ref. 6; BAA91061).
FT                                {ECO:0000305}.
FT   CONFLICT   1577   1577       K -> R (in Ref. 6; BAA91061).
FT                                {ECO:0000305}.
FT   STRAND      500    503       {ECO:0000244|PDB:3BIM}.
FT   STRAND     1637   1644       {ECO:0000244|PDB:4HPL}.
FT   STRAND     1650   1653       {ECO:0000244|PDB:4HPL}.
FT   TURN       1656   1658       {ECO:0000244|PDB:4HPL}.
FT   STRAND     1660   1665       {ECO:0000244|PDB:4HPL}.
FT   HELIX      1666   1673       {ECO:0000244|PDB:4HPL}.
FT   HELIX      1677   1683       {ECO:0000244|PDB:4HPL}.
FT   STRAND     1689   1693       {ECO:0000244|PDB:4HPL}.
FT   HELIX      1694   1702       {ECO:0000244|PDB:4HPL}.
FT   HELIX      1705   1707       {ECO:0000244|PDB:4HPL}.
FT   HELIX      1710   1712       {ECO:0000244|PDB:4HPL}.
FT   TURN       1713   1715       {ECO:0000244|PDB:4HPL}.
FT   STRAND     1723   1728       {ECO:0000244|PDB:4HPL}.
FT   HELIX      1731   1736       {ECO:0000244|PDB:4HPL}.
FT   STRAND     1740   1744       {ECO:0000244|PDB:4HPL}.
SQ   SEQUENCE   1755 AA;  192189 MW;  A80CFCD5618EE717 CRC64;
     MLSATPLYGN VHSWMNSERV RMCGASEDRK ILVNDGDASK ARLELREENP LNHNVVDAST
     AHRIDGLAAL SMDRTGLIRE GLRVPGNIVY SSLCGLGSEK GREAATSTLG GLGFSSERNP
     EMQFKPNTPE TVEASAVSGK PPNGFSAIYK TPPGIQKSAV ATAEALGLDR PASDKQSPLN
     INGASYLRLP WVNPYMEGAT PAIYPFLDSP NKYSLNMYKA LLPQQSYSLA QPLYSPVCTN
     GERFLYLPPP HYVGPHIPSS LASPMRLSTP SASPAIPPLV HCADKSLPWK MGVSPGNPVD
     SHAYPHIQNS KQPRVPSAKA VTSGLPGDTA LLLPPSPRPS PRVHLPTQPA ADTYSEFHKH
     YARISTSPSV ALSKPYMTVS SEFPAARLSN GKYPKAPEGG EGAQPVPGHA RKTAVQDRKD
     GSSPPLLEKQ TVTKDVTDKP LDLSSKVVDV DASKADHMKK MAPTVLVHSR AGSGLVLSGS
     EIPKETLSPP GNGCAIYRSE IISTAPSSWV VPGPSPNEEN NGKSMSLKNK ALDWAIPQQR
     SSSCPRMGGT DAVITNVSGS VSSAGRPASA SPAPNANADG TKTSRSSVET TPSVIQHVGQ
     PPATPAKHSS STSSKGAKAS NPEPSFKANE NGLPPSSIFL SPNEAFRSPP IPYPRSYLPY
     PAPEGIAVSP LSLHGKGPVY PHPVLLPNGS LFPGHLAPKP GLPYGLPTGR PEFVTYQDAL
     GLGMVHPMLI PHTPIEITKE EKPERRSRSH ERARYEDPTL RNRFSEILET SSTKLHPDVP
     TDKNLKPNPN WNQGKTVVKS DKLVYVDLLR EEPDAKTDTN VSKPSFAAES VGQSAEPPKP
     SVEPALQQHR DFIALREELG RISDFHETYT FKQPVFTVSK DSVLAGTNKE NLGLPVSTPF
     LEPPLGSDGP AVTFGKTQED PKPFCVGSAP PSVDVTPTYT KDGADEAESN DGKVLKPKPS
     KLAKRIANSA GYVGDRFKCV TTELYADSSQ LSREQRALQM EGLQEDSILC LPAAYCERAM
     MRFSELEMKE REGGHPATKD SEMCKFSPAD WERLKGNQDK KPKSVTLEEA IAEQNESERC
     EYSVGNKHRD PFEAPEDKDL PVEKYFVERQ PVSEPPADQV ASDMPHSPTL RVDRKRKVSG
     DSSHTETTAE EVPEDPLLKA KRRRVSKDDW PEREMTNSSS NHLEDPHYSE LTNLKVCIEL
     TGLHPKKQRH LLHLRERWEQ QVSAADGKPG RQSRKEVTQA TQPEAIPQGT NITEEKPGRK
     RAEAKGNRSW SEESLKPSDN EQGLPVFSGS PPMKSLSSTS AGGKKQAQPS CAPASRPPAK
     QQKIKENQKT DVLCADEEED CQAASLLQKY TDNSEKPSGK RLCKTKHLIP QESRRGLPLT
     GEYYVENADG KVTVRRFRKR PEPSSDYDLS PAKQEPKPFD RLQQLLPASQ STQLPCSSSP
     QETTQSRPMP PEARRLIVNK NAGETLLQRA ARLGYEEVVL YCLENKICDV NHRDNAGYCA
     LHEACARGWL NIVRHLLEYG ADVNCSAQDG TRPLHDAVEN DHLEIVRLLL SYGADPTLAT
     YSGRTIMKMT HSELMEKFLT DYLNDLQGRN DDDASGTWDF YGSSVCEPDD ESGYDVLANP
     PGPEDQDDDD DAYSDVFEFE FSETPLLPCY NIQVSVAQGP RNWLLLSDVL KKLKMSSRIF
     RCNFPNVEIV TIAEAEFYRQ VSASLLFSCS KDLEAFNPES KELLDLVEFT NEIQTLLGSS
     VEWLHPSDLA SDNYW
//
ID   BTG1_HUMAN              Reviewed;         171 AA.
AC   P62324; P31607;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 115.
DE   RecName: Full=Protein BTG1;
DE   AltName: Full=B-cell translocation gene 1 protein;
GN   Name=BTG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Lymphoblastoma;
RX   PubMed=1373383;
RA   Rouault J.-P., Rimokh R., Tessa C., Paranhos G., Ffrench M., Duret L.,
RA   Garoccio M., Germain D., Samarut J., Magaud J.-P.;
RT   "BTG1, a member of a new family of antiproliferative genes.";
RL   EMBO J. 11:1663-1670(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-139 AND GLU-141.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH CNOT7.
RX   PubMed=9712883; DOI=10.1074/jbc.273.35.22563;
RA   Rouault J.P., Prevot D., Berthet C., Birot A.M., Billaud M.,
RA   Magaud J.P., Corbo L.;
RT   "Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1,
RT   the murine homolog of a component of the yeast CCR4 transcriptional
RT   regulatory complex.";
RL   J. Biol. Chem. 273:22563-22569(1998).
RN   [6]
RP   INTERACTION WITH CNOT8.
RX   PubMed=11136725; DOI=10.1074/jbc.M008201200;
RA   Prevot D., Morel A.P., Voeltzel T., Rostan M.C., Rimokh R.,
RA   Magaud J.P., Corbo L.;
RT   "Relationships of the antiproliferative proteins BTG1 and BTG2 with
RT   CAF1, the human homolog of a component of the yeast CCR4
RT   transcriptional complex: involvement in estrogen receptor alpha
RT   signaling pathway.";
RL   J. Biol. Chem. 276:9640-9648(2001).
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION WITH MYC.
RX   PubMed=2069907; DOI=10.1002/gcc.2870030106;
RA   Rimokh R., Rouault J.P., Wahbi K., Gadoux M., Lafage M.,
RA   Archimbaud E., Charrin C., Gentilhomme O., Germain D., Samarut J.;
RT   "A chromosome 12 coding region is juxtaposed to the MYC protooncogene
RT   locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic
RT   lymphocytic leukemia.";
RL   Genes Chromosomes Cancer 3:24-36(1991).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Anti-proliferative protein.
CC       {ECO:0000269|PubMed:1373383}.
CC   -!- SUBUNIT: Interacts with CNOT7 and CNOT8.
CC       {ECO:0000269|PubMed:11136725, ECO:0000269|PubMed:9712883}.
CC   -!- INTERACTION:
CC       Q9UFF9:-; NbExp=4; IntAct=EBI-742279, EBI-742299;
CC       Q9UIV1:CNOT7; NbExp=4; IntAct=EBI-742279, EBI-2105113;
CC       Q60809:Cnot7 (xeno); NbExp=5; IntAct=EBI-742279, EBI-2104739;
CC   -!- DEVELOPMENTAL STAGE: Its expression is associated with the early
CC       G1 phase of the cell cycle. {ECO:0000269|PubMed:1373383}.
CC   -!- DISEASE: Note=A chromosomal aberration involving BTG1 may be a
CC       cause of a form of B-cell chronic lymphocytic leukemia.
CC       Translocation t(8;12)(q24;q22) with MYC.
CC       {ECO:0000269|PubMed:2069907}.
CC   -!- SIMILARITY: Belongs to the BTG family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/btg1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61123; CAA43435.1; -; mRNA.
DR   EMBL; BT019840; AAV38643.1; -; mRNA.
DR   EMBL; AY850133; AAV97814.1; -; Genomic_DNA.
DR   EMBL; BC016759; AAH16759.1; -; mRNA.
DR   EMBL; BC064953; AAH64953.1; -; mRNA.
DR   CCDS; CCDS9043.1; -.
DR   PIR; S20947; S20947.
DR   RefSeq; NP_001722.1; NM_001731.2.
DR   UniGene; Hs.255935; -.
DR   ProteinModelPortal; P62324; -.
DR   SMR; P62324; -.
DR   BioGrid; 107159; 18.
DR   IntAct; P62324; 8.
DR   MINT; P62324; -.
DR   STRING; 9606.ENSP00000256015; -.
DR   iPTMnet; P62324; -.
DR   PhosphoSitePlus; P62324; -.
DR   BioMuta; BTG1; -.
DR   DMDM; 59799172; -.
DR   EPD; P62324; -.
DR   PaxDb; P62324; -.
DR   PeptideAtlas; P62324; -.
DR   PRIDE; P62324; -.
DR   DNASU; 694; -.
DR   Ensembl; ENST00000256015; ENSP00000256015; ENSG00000133639.
DR   GeneID; 694; -.
DR   KEGG; hsa:694; -.
DR   CTD; 694; -.
DR   DisGeNET; 694; -.
DR   EuPathDB; HostDB:ENSG00000133639.4; -.
DR   GeneCards; BTG1; -.
DR   HGNC; HGNC:1130; BTG1.
DR   HPA; HPA005972; -.
DR   MIM; 109580; gene.
DR   neXtProt; NX_P62324; -.
DR   OpenTargets; ENSG00000133639; -.
DR   PharmGKB; PA25450; -.
DR   eggNOG; KOG4006; Eukaryota.
DR   eggNOG; ENOG410ZZC0; LUCA.
DR   GeneTree; ENSGT00550000074461; -.
DR   HOGENOM; HOG000290200; -.
DR   HOVERGEN; HBG004907; -.
DR   InParanoid; P62324; -.
DR   KO; K14443; -.
DR   OMA; GHVNDRQ; -.
DR   OrthoDB; EOG091G0RS0; -.
DR   PhylomeDB; P62324; -.
DR   TreeFam; TF105272; -.
DR   SIGNOR; P62324; -.
DR   ChiTaRS; BTG1; human.
DR   GeneWiki; BTG1; -.
DR   GenomeRNAi; 694; -.
DR   PRO; PR:P62324; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000133639; -.
DR   CleanEx; HS_BTG1; -.
DR   ExpressionAtlas; P62324; baseline and differential.
DR   Genevisible; P62324; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; NAS:UniProtKB.
DR   GO; GO:0003712; F:transcription cofactor activity; NAS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; NAS:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:0045603; P:positive regulation of endothelial cell differentiation; IMP:UniProtKB.
DR   GO; GO:2000271; P:positive regulation of fibroblast apoptotic process; IMP:UniProtKB.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; IDA:MGI.
DR   GO; GO:0006479; P:protein methylation; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   InterPro; IPR002087; Anti_prolifrtn.
DR   InterPro; IPR036054; BTG-like_sf.
DR   InterPro; IPR033330; BTG1.
DR   PANTHER; PTHR22978:SF30; PTHR22978:SF30; 1.
DR   Pfam; PF07742; BTG; 1.
DR   PRINTS; PR00310; ANTIPRLFBTG1.
DR   SMART; SM00099; btg1; 1.
DR   SUPFAM; SSF160696; SSF160696; 1.
DR   PROSITE; PS00960; BTG_1; 1.
DR   PROSITE; PS01203; BTG_2; 1.
PE   1: Evidence at protein level;
KW   Chromosomal rearrangement; Complete proteome; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome.
FT   CHAIN         1    171       Protein BTG1.
FT                                /FTId=PRO_0000143800.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     139    139       N -> S (in dbSNP:rs28399541).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021345.
FT   VARIANT     141    141       Q -> E (in dbSNP:rs28399542).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021346.
SQ   SEQUENCE   171 AA;  19209 MW;  EFED8BE09013BE60 CRC64;
     MHPFYTRAAT MIGEIAAAVS FISKFLRTKG LTSERQLQTF SQSLQELLAE HYKHHWFPEK
     PCKGSGYRCI RINHKMDPLI GQAAQRIGLS SQELFRLLPS ELTLWVDPYE VSYRIGEDGS
     ICVLYEASPA GGSTQNSTNV QMVDSRISCK EELLLGRTSP SKNYNMMTVS G
//
ID   Q6IBC8_HUMAN            Unreviewed;       171 AA.
AC   Q6IBC8;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 114.
DE   SubName: Full=B-cell translocation gene 1, anti-proliferative {ECO:0000313|EMBL:AAV38642.1};
DE   SubName: Full=B-cell translocation gene 1, anti-proliferative, isoform CRA_b {ECO:0000313|EMBL:EAW97467.1};
DE   SubName: Full=BTG1 {ECO:0000313|EMBL:AAA08538.1};
DE   SubName: Full=BTG1 protein {ECO:0000313|EMBL:CAG33157.1};
DE   SubName: Full=cDNA, FLJ93822, Homo sapiens B-cell translocation gene 1, anti-proliferative(BTG1), mRNA {ECO:0000313|EMBL:BAG36114.1};
GN   Name=BTG1 {ECO:0000313|EMBL:CAG33157.1};
GN   ORFNames=hCG_21188 {ECO:0000313|EMBL:EAW97467.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG33157.1};
RN   [1] {ECO:0000313|EMBL:AAA08538.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=1373383;
RA   Rouault J.-P., Rimokh R., Tessa C., Paranhos G., Ffrench M., Duret L.,
RA   Garoccio M., Germain D., Samarut J., Magaud J.-P.;
RT   "BTG1, a member of a new family of antiproliferative genes.";
RL   EMBO J. 11:1663-1670(1992).
RN   [2] {ECO:0000313|EMBL:EAW97467.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:CAG33157.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:CAG46581.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:AAV38642.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:EAW97467.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000313|EMBL:BAG36114.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach {ECO:0000313|EMBL:BAG36114.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q9UFF9:-; NbExp=3; IntAct=EBI-10250021, EBI-742299;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AH000334; AAA08538.1; -; Genomic_DNA.
DR   EMBL; S38424; AAA08538.1; JOINED; Genomic_DNA.
DR   EMBL; BT019839; AAV38642.1; -; mRNA.
DR   EMBL; BT019841; AAV38644.1; -; mRNA.
DR   EMBL; AK313309; BAG36114.1; -; mRNA.
DR   EMBL; CR456876; CAG33157.1; -; mRNA.
DR   EMBL; CR541782; CAG46581.1; -; mRNA.
DR   EMBL; CH471054; EAW97467.1; -; Genomic_DNA.
DR   RefSeq; NP_001722.1; NM_001731.2.
DR   UniGene; Hs.255935; -.
DR   IntAct; Q6IBC8; 2.
DR   DNASU; 694; -.
DR   GeneID; 694; -.
DR   KEGG; hsa:694; -.
DR   UCSC; uc001tby.3; human.
DR   CTD; 694; -.
DR   EuPathDB; HostDB:ENSG00000133639.4; -.
DR   PharmGKB; PA25450; -.
DR   eggNOG; KOG4006; Eukaryota.
DR   eggNOG; ENOG410ZZC0; LUCA.
DR   HOVERGEN; HBG004907; -.
DR   KO; K14443; -.
DR   OMA; GHVNDRQ; -.
DR   OrthoDB; EOG091G0RS0; -.
DR   ChiTaRS; BTG1; human.
DR   GenomeRNAi; 694; -.
DR   Bgee; ENSG00000133639; -.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0006479; P:protein methylation; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   InterPro; IPR002087; Anti_prolifrtn.
DR   InterPro; IPR036054; BTG-like_sf.
DR   InterPro; IPR033330; BTG1.
DR   PANTHER; PTHR22978:SF30; PTHR22978:SF30; 1.
DR   Pfam; PF07742; BTG; 1.
DR   PRINTS; PR00310; ANTIPRLFBTG1.
DR   SMART; SM00099; btg1; 1.
DR   SUPFAM; SSF160696; SSF160696; 1.
DR   PROSITE; PS00960; BTG_1; 1.
DR   PROSITE; PS01203; BTG_2; 1.
PE   1: Evidence at protein level;
FT   DOMAIN       52     72       Anti_prolifrtn.
FT                                {ECO:0000259|PROSITE:PS00960}.
FT   DOMAIN       98    117       Anti_prolifrtn.
FT                                {ECO:0000259|PROSITE:PS01203}.
FT   NON_TER     171    171       {ECO:0000313|EMBL:CAG46581.1}.
SQ   SEQUENCE   171 AA;  19209 MW;  EFED8BE09013BE60 CRC64;
     MHPFYTRAAT MIGEIAAAVS FISKFLRTKG LTSERQLQTF SQSLQELLAE HYKHHWFPEK
     PCKGSGYRCI RINHKMDPLI GQAAQRIGLS SQELFRLLPS ELTLWVDPYE VSYRIGEDGS
     ICVLYEASPA GGSTQNSTNV QMVDSRISCK EELLLGRTSP SKNYNMMTVS G
//
ID   CMTA1_HUMAN             Reviewed;        1673 AA.
AC   Q9Y6Y1; A7MBM4; G3V3Z7; Q5VUE1; Q6V701; Q8WYI3; Q96S92;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 4.
DT   31-JAN-2018, entry version 145.
DE   RecName: Full=Calmodulin-binding transcription activator 1;
GN   Name=CAMTA1; Synonyms=KIAA0833; ORFNames=MSTP023;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Li N., Zhang M., Wan T., Zhang W., Cao X.;
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1422-1673 (ISOFORM 2).
RC   TISSUE=Heart;
RA   Xu Y.Y., Sun L.Z., Wu Q.Y., Liu Y.Q., Liu B., Zhao B., Wang X.Y.,
RA   Song L., Ye J., Sheng H., Gao Y., Zhang C.L., Zhang J., Wei Y.J.,
RA   Sun Y.H., Jiang Y.X., Zhao X.W., Liu S., Liu L.S., Ding J.F.,
RA   Gao R.L., Qiang B.Q., Yuan J.G., Liew C.C., Zhao M.S., Hui R.T.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1437-1673 (ISOFORM 2).
RA   Li H., Li S., Yu R., Shen C., Zhou G., Ke R., Lin L., Yang S.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   FUNCTION, SUBUNIT, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11925432; DOI=10.1074/jbc.M200268200;
RA   Bouche N., Scharlat A., Snedden W., Bouchez D., Fromm H.;
RT   "A novel family of calmodulin-binding transcription activators in
RT   multicellular organisms.";
RL   J. Biol. Chem. 277:21851-21861(2002).
RN   [10]
RP   INDUCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15138581;
RA   Nakatani K., Nishioka J., Itakura T., Nakanishi Y., Horinouchi J.,
RA   Abe Y., Wada H., Nobori T.;
RT   "Cell cycle-dependent transcriptional regulation of calmodulin-binding
RT   transcription activator 1 in neuroblastoma cells.";
RL   Int. J. Oncol. 24:1407-1412(2004).
RN   [11]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15709179;
RA   Barbashina V., Salazar P., Holland E.C., Rosenblum M.K., Ladanyi M.;
RT   "Allelic losses at 1p36 and 19q13 in gliomas: correlation with
RT   histologic classification, definition of a 150-kb minimal deleted
RT   region on 1p36, and evaluation of CAMTA1 as a candidate tumor
RT   suppressor gene.";
RL   Clin. Cancer Res. 11:1119-1128(2005).
RN   [12]
RP   INVOLVEMENT IN CANPMR.
RX   PubMed=22693284; DOI=10.1136/jmedgenet-2012-100856;
RA   Thevenon J., Lopez E., Keren B., Heron D., Mignot C., Altuzarra C.,
RA   Beri-Dexheimer M., Bonnet C., Magnin E., Burglen L., Minot D.,
RA   Vigneron J., Morle S., Anheim M., Charles P., Brice A., Gallagher L.,
RA   Amiel J., Haffen E., Mach C., Depienne C., Doummar D., Bonnet M.,
RA   Duplomb L., Carmignac V., Callier P., Marle N., Mosca-Boidron A.L.,
RA   Roze V., Aral B., Razavi F., Jonveaux P., Faivre L.,
RA   Thauvin-Robinet C.;
RT   "Intragenic CAMTA1 rearrangements cause non-progressive congenital
RT   ataxia with or without intellectual disability.";
RL   J. Med. Genet. 49:400-408(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 872-953.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Crystal structure of the TIG domain of human calmodulin-binding
RT   transcription activator 1 (CAMTA1).";
RL   Submitted (DEC-2005) to the PDB data bank.
RN   [14]
RP   VARIANTS LYS-1177; THR-1218 AND ILE-1336.
RX   PubMed=17222547; DOI=10.1016/j.ejca.2006.09.023;
RA   Henrich K.-O., Claas A., Praml C., Benner A., Mollenhauer J.,
RA   Poustka A., Schwab M., Westermann F.;
RT   "Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted
RT   region at 1p36 in neuroblastoma.";
RL   Eur. J. Cancer 43:607-616(2007).
CC   -!- FUNCTION: Transcriptional activator. May act as a tumor
CC       suppressor. {ECO:0000269|PubMed:11925432,
CC       ECO:0000269|PubMed:15709179}.
CC   -!- SUBUNIT: May interact with calmodulin. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9Y6Y1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6Y1-2; Sequence=VSP_035936, VSP_035937;
CC       Name=3;
CC         IsoId=Q9Y6Y1-3; Sequence=VSP_043842, VSP_043843;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9Y6Y1-4; Sequence=VSP_046358, VSP_046359;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Normally expressed in non-neoplastic adult
CC       central nervous system tissues: detected in whole brain,
CC       cerebellum, brain cortex, occipital lobe, frontal lobe, temporal
CC       lobe, putamen. Expression levels are low in oligodendroglial
CC       tumors, and are reduced by half in oligodendroglioma and
CC       astrocytoma cases with 1p loss of heterozygosity. Detected in
CC       neuroblastic-type cultured neuroblastoma cells. Expressed in heart
CC       and kidney. {ECO:0000269|PubMed:11925432,
CC       ECO:0000269|PubMed:15138581, ECO:0000269|PubMed:15709179}.
CC   -!- INDUCTION: Detected at low levels at interphase and in resting
CC       cells. Up-regulated during S phase and mitosis. Levels decrease at
CC       the end of mitosis. {ECO:0000269|PubMed:15138581}.
CC   -!- DISEASE: Cerebellar ataxia, non-progressive, with mental
CC       retardation (CANPMR) [MIM:614756]: A neurodevelopmental disorder
CC       characterized by mildly delayed psychomotor development, early
CC       onset of cerebellar ataxia, and intellectual disability later in
CC       childhood and adult life. Other features may include neonatal
CC       hypotonia, dysarthria, and dysmetria. Brain imaging in some
CC       patients shows cerebellar atrophy. Dysmorphic facial features are
CC       variable. {ECO:0000269|PubMed:22693284}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: A very small segment of 1p36 located within CAMTA1
CC       is deleted in all oligodendroglial tumors with 1p LOH. This
CC       minimal deleted region (MDR) also overlaps the neuroblastoma 1p36
CC       MDR. CAMTA1 shows no evidence of inactivation by somatic
CC       mutations.
CC   -!- SIMILARITY: Belongs to the CAMTA family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL39006.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA74856.3; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=EAW71580.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CAMTA1ID908ch1p36.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB020640; BAA74856.3; ALT_INIT; mRNA.
DR   EMBL; AY037153; AAK67633.1; -; mRNA.
DR   EMBL; AL590128; CAH72347.1; -; Genomic_DNA.
DR   EMBL; AL359881; CAH72347.1; JOINED; Genomic_DNA.
DR   EMBL; AL365194; CAH72347.1; JOINED; Genomic_DNA.
DR   EMBL; AL596210; CAH72347.1; JOINED; Genomic_DNA.
DR   EMBL; Z97635; CAH72347.1; JOINED; Genomic_DNA.
DR   EMBL; Z98052; CAH72347.1; JOINED; Genomic_DNA.
DR   EMBL; Z98884; CAH72347.1; JOINED; Genomic_DNA.
DR   EMBL; AL359881; CAH72663.1; -; Genomic_DNA.
DR   EMBL; AL365194; CAH72663.1; JOINED; Genomic_DNA.
DR   EMBL; AL590128; CAH72663.1; JOINED; Genomic_DNA.
DR   EMBL; AL596210; CAH72663.1; JOINED; Genomic_DNA.
DR   EMBL; Z97635; CAH72663.1; JOINED; Genomic_DNA.
DR   EMBL; Z98884; CAH72663.1; JOINED; Genomic_DNA.
DR   EMBL; Z98052; CAH72663.1; JOINED; Genomic_DNA.
DR   EMBL; AL596210; CAI17064.1; -; Genomic_DNA.
DR   EMBL; AL359881; CAI17064.1; JOINED; Genomic_DNA.
DR   EMBL; AL365194; CAI17064.1; JOINED; Genomic_DNA.
DR   EMBL; AL590128; CAI17064.1; JOINED; Genomic_DNA.
DR   EMBL; Z97635; CAI17064.1; JOINED; Genomic_DNA.
DR   EMBL; Z98052; CAI17064.1; JOINED; Genomic_DNA.
DR   EMBL; Z98884; CAI17064.1; JOINED; Genomic_DNA.
DR   EMBL; Z97635; CAI20961.1; -; Genomic_DNA.
DR   EMBL; Z98884; CAI20961.1; JOINED; Genomic_DNA.
DR   EMBL; Z98052; CAI20961.1; JOINED; Genomic_DNA.
DR   EMBL; AL596210; CAI20961.1; JOINED; Genomic_DNA.
DR   EMBL; AL590128; CAI20961.1; JOINED; Genomic_DNA.
DR   EMBL; AL365194; CAI20961.1; JOINED; Genomic_DNA.
DR   EMBL; AL359881; CAI20961.1; JOINED; Genomic_DNA.
DR   EMBL; Z98884; CAI21433.1; -; Genomic_DNA.
DR   EMBL; Z98052; CAI21433.1; JOINED; Genomic_DNA.
DR   EMBL; Z97635; CAI21433.1; JOINED; Genomic_DNA.
DR   EMBL; AL359881; CAI21433.1; JOINED; Genomic_DNA.
DR   EMBL; AL365194; CAI21433.1; JOINED; Genomic_DNA.
DR   EMBL; AL596210; CAI21433.1; JOINED; Genomic_DNA.
DR   EMBL; AL590128; CAI21433.1; JOINED; Genomic_DNA.
DR   EMBL; Z98052; CAI21596.1; -; Genomic_DNA.
DR   EMBL; Z98884; CAI21596.1; JOINED; Genomic_DNA.
DR   EMBL; Z97635; CAI21596.1; JOINED; Genomic_DNA.
DR   EMBL; AL359881; CAI21596.1; JOINED; Genomic_DNA.
DR   EMBL; AL596210; CAI21596.1; JOINED; Genomic_DNA.
DR   EMBL; AL590128; CAI21596.1; JOINED; Genomic_DNA.
DR   EMBL; AL365194; CAI21596.1; JOINED; Genomic_DNA.
DR   EMBL; AL365194; CAI21790.1; -; Genomic_DNA.
DR   EMBL; AL359881; CAI21790.1; JOINED; Genomic_DNA.
DR   EMBL; AL590128; CAI21790.1; JOINED; Genomic_DNA.
DR   EMBL; AL596210; CAI21790.1; JOINED; Genomic_DNA.
DR   EMBL; Z97635; CAI21790.1; JOINED; Genomic_DNA.
DR   EMBL; Z98052; CAI21790.1; JOINED; Genomic_DNA.
DR   EMBL; Z98884; CAI21790.1; JOINED; Genomic_DNA.
DR   EMBL; CH471130; EAW71580.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC116457; AAI16458.1; -; mRNA.
DR   EMBL; BC151835; AAI51836.1; -; mRNA.
DR   EMBL; CD103791; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF111804; AAL39006.1; ALT_INIT; mRNA.
DR   EMBL; AY349360; AAQ56724.1; -; mRNA.
DR   CCDS; CCDS30576.1; -. [Q9Y6Y1-1]
DR   CCDS; CCDS55574.1; -. [Q9Y6Y1-3]
DR   CCDS; CCDS55575.1; -. [Q9Y6Y1-4]
DR   RefSeq; NP_001182492.1; NM_001195563.1. [Q9Y6Y1-3]
DR   RefSeq; NP_001229630.1; NM_001242701.1. [Q9Y6Y1-4]
DR   RefSeq; NP_056030.1; NM_015215.3. [Q9Y6Y1-1]
DR   UniGene; Hs.397705; -.
DR   UniGene; Hs.671020; -.
DR   PDB; 2CXK; X-ray; 1.85 A; A/B/C/D/E=872-953.
DR   PDBsum; 2CXK; -.
DR   ProteinModelPortal; Q9Y6Y1; -.
DR   SMR; Q9Y6Y1; -.
DR   BioGrid; 116863; 2.
DR   IntAct; Q9Y6Y1; 1.
DR   STRING; 9606.ENSP00000306522; -.
DR   iPTMnet; Q9Y6Y1; -.
DR   PhosphoSitePlus; Q9Y6Y1; -.
DR   BioMuta; CAMTA1; -.
DR   DMDM; 97046872; -.
DR   PaxDb; Q9Y6Y1; -.
DR   PeptideAtlas; Q9Y6Y1; -.
DR   PRIDE; Q9Y6Y1; -.
DR   Ensembl; ENST00000303635; ENSP00000306522; ENSG00000171735. [Q9Y6Y1-1]
DR   Ensembl; ENST00000473578; ENSP00000451388; ENSG00000171735. [Q9Y6Y1-3]
DR   Ensembl; ENST00000557126; ENSP00000451510; ENSG00000171735. [Q9Y6Y1-4]
DR   GeneID; 23261; -.
DR   KEGG; hsa:23261; -.
DR   UCSC; uc001aoh.4; human. [Q9Y6Y1-1]
DR   CTD; 23261; -.
DR   DisGeNET; 23261; -.
DR   EuPathDB; HostDB:ENSG00000171735.18; -.
DR   GeneCards; CAMTA1; -.
DR   HGNC; HGNC:18806; CAMTA1.
DR   HPA; HPA036342; -.
DR   HPA; HPA036343; -.
DR   MalaCards; CAMTA1; -.
DR   MIM; 611501; gene.
DR   MIM; 614756; phenotype.
DR   neXtProt; NX_Q9Y6Y1; -.
DR   OpenTargets; ENSG00000171735; -.
DR   Orphanet; 314647; Non-progressive cerebellar ataxia with intellectual disability.
DR   PharmGKB; PA38688; -.
DR   eggNOG; KOG0520; Eukaryota.
DR   eggNOG; ENOG410XS5M; LUCA.
DR   GeneTree; ENSGT00390000001446; -.
DR   HOGENOM; HOG000111813; -.
DR   HOVERGEN; HBG080107; -.
DR   InParanoid; Q9Y6Y1; -.
DR   KO; K21596; -.
DR   OMA; AYMHVAE; -.
DR   OrthoDB; EOG091G01MB; -.
DR   PhylomeDB; Q9Y6Y1; -.
DR   TreeFam; TF323452; -.
DR   ChiTaRS; CAMTA1; human.
DR   EvolutionaryTrace; Q9Y6Y1; -.
DR   GeneWiki; CAMTA1; -.
DR   GenomeRNAi; 23261; -.
DR   PRO; PR:Q9Y6Y1; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000171735; -.
DR   CleanEx; HS_CAMTA1; -.
DR   ExpressionAtlas; Q9Y6Y1; baseline and differential.
DR   Genevisible; Q9Y6Y1; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005559; CG-1_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF03859; CG-1; 1.
DR   Pfam; PF00612; IQ; 1.
DR   Pfam; PF01833; TIG; 1.
DR   SMART; SM01076; CG-1; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS51437; CG_1; 1.
DR   PROSITE; PS50096; IQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; ANK repeat;
KW   Complete proteome; Cytoplasm; Mental retardation; Nucleus;
KW   Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation.
FT   CHAIN         1   1673       Calmodulin-binding transcription
FT                                activator 1.
FT                                /FTId=PRO_0000235820.
FT   DOMAIN      873    953       IPT/TIG.
FT   REPEAT     1064   1093       ANK 1.
FT   REPEAT     1109   1129       ANK 2.
FT   REPEAT     1143   1172       ANK 3.
FT   DOMAIN     1547   1576       IQ 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN     1577   1599       IQ 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN     1600   1622       IQ 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DNA_BIND     63    188       CG-1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00767}.
FT   MOTIF       112    119       Nuclear localization signal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00767}.
FT   COMPBIAS    499    502       Poly-Gly.
FT   COMPBIAS   1038   1041       Poly-Val.
FT   VAR_SEQ      79    101       EIAAYLITFEKHEEWLTTSPKTR -> ALTTHLFMGAAKKR
FT                                DPQSWSHEG (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046358.
FT   VAR_SEQ      79     80       EI -> RS (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_043842.
FT   VAR_SEQ      81   1673       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_043843.
FT   VAR_SEQ     102   1673       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046359.
FT   VAR_SEQ    1458   1471       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.7, ECO:0000303|Ref.8}.
FT                                /FTId=VSP_035936.
FT   VAR_SEQ    1653   1673       SPLVDHRLYKRSERIEKGQGT -> RVKELKKAKELEDIQQ
FT                                HPLAM (in isoform 2). {ECO:0000303|Ref.7,
FT                                ECO:0000303|Ref.8}.
FT                                /FTId=VSP_035937.
FT   VARIANT    1177   1177       N -> K (in dbSNP:rs41278952).
FT                                {ECO:0000269|PubMed:17222547}.
FT                                /FTId=VAR_047824.
FT   VARIANT    1218   1218       N -> T (in dbSNP:rs41278954).
FT                                {ECO:0000269|PubMed:17222547}.
FT                                /FTId=VAR_047825.
FT   VARIANT    1336   1336       T -> I (in dbSNP:rs137974312).
FT                                {ECO:0000269|PubMed:17222547}.
FT                                /FTId=VAR_047826.
FT   STRAND      875    877       {ECO:0000244|PDB:2CXK}.
FT   STRAND      879    881       {ECO:0000244|PDB:2CXK}.
FT   STRAND      888    894       {ECO:0000244|PDB:2CXK}.
FT   STRAND      902    906       {ECO:0000244|PDB:2CXK}.
FT   STRAND      909    912       {ECO:0000244|PDB:2CXK}.
FT   STRAND      914    917       {ECO:0000244|PDB:2CXK}.
FT   STRAND      920    924       {ECO:0000244|PDB:2CXK}.
FT   STRAND      930    939       {ECO:0000244|PDB:2CXK}.
FT   STRAND      948    952       {ECO:0000244|PDB:2CXK}.
SQ   SEQUENCE   1673 AA;  183672 MW;  008AA6A906374C00 CRC64;
     MWRAEGKWLP KTSRKSVSQS VFCGTSTYCV LNTVPPIEDD HGNSNSSHVK IFLPKKLLEC
     LPKCSSLPKE RHRWNTNEEI AAYLITFEKH EEWLTTSPKT RPQNGSMILY NRKKVKYRKD
     GYCWKKRKDG KTTREDHMKL KVQGVECLYG CYVHSSIIPT FHRRCYWLLQ NPDIVLVHYL
     NVPAIEDCGK PCGPILCSIN TDKKEWAKWT KEELIGQLKP MFHGIKWTCS NGNSSSGFSV
     EQLVQQILDS HQTKPQPRTH NCLCTGSLGA GGSVHHKCNS AKHRIISPKV EPRTGGYGSH
     SEVQHNDVSE GKHEHSHSKG SSREKRNGKV AKPVLLHQSS TEVSSTNQVE VPDTTQSSPV
     SISSGLNSDP DMVDSPVVTG VSGMAVASVM GSLSQSATVF MSEVTNEAVY TMSPTAGPNH
     HLLSPDASQG LVLAVSSDGH KFAFPTTGSS ESLSMLPTNV SEELVLSTTL DGGRKIPETT
     MNFDPDCFLN NPKQGQTYGG GGLKAEMVSS NIRHSPPGER SFSFTTVLTK EIKTEDTSFE
     QQMAKEAYSS SAAAVAASSL TLTAGSSLLP SGGGLSPSTT LEQMDFSAID SNKDYTSSFS
     QTGHSPHIHQ TPSPSFFLQD ASKPLPVEQN THSSLSDSGG TFVMPTVKTE ASSQTSSCSG
     HVETRIESTS SLHLMQFQAN FQAMTAEGEV TMETSQAAEG SEVLLKSGEL QACSSEHYLQ
     PETNGVIRSA GGVPILPGNV VQGLYPVAQP SLGNASNMEL SLDHFDISFS NQFSDLINDF
     ISVEGGSSTI YGHQLVSGDS TALSQSEDGA RAPFTQAEMC LPCCSPQQGS LQLSSSEGGA
     STMAYMHVAE VVSAASAQGT LGMLQQSGRV FMVTDYSPEW SYPEGGVKVL ITGPWQEASN
     NYSCLFDQIS VPASLIQPGV LRCYCPAHDT GLVTLQVAFN NQIISNSVVF EYKARALPTL
     PSSQHDWLSL DDNQFRMSIL ERLEQMERRM AEMTGSQQHK QASGGGSSGG GSGSGNGGSQ
     AQCASGTGAL GSCFESRVVV VCEKMMSRAC WAKSKHLIHS KTFRGMTLLH LAAAQGYATL
     IQTLIKWRTK HADSIDLELE VDPLNVDHFS CTPLMWACAL GHLEAAVVLY KWDRRAISIP
     DSLGRLPLGI ARSRGHVKLA ECLEHLQRDE QAQLGQNPRI HCPASEEPST ESWMAQWHSE
     AISSPEIPKG VTVIASTNPE LRRPRSEPSN YYSSESHKDY PAPKKHKLNP EYFQTRQEKL
     LPTALSLEEP NIRKQSPSSK QSVPETLSPS EGVRDFSREL SPPTPETAAF QASGSQPVGK
     WNSKDLYIGV STVQVTGNPK GTSVGKEAAP SQVRPREPMS VLMMANREVV NTELGSYRDS
     AENEECGQPM DDIQVNMMTL AEHIIEATPD RIKQENFVPM ESSGLERTDP ATISSTMSWL
     ASYLADADCL PSAAQIRSAY NEPLTPSSNT SLSPVGSPVS EIAFEKPNLP SAADWSEFLS
     ASTSEKVENE FAQLTLSDHE QRELYEAARL VQTAFRKYKG RPLREQQEVA AAVIQRCYRK
     YKQYALYKKM TQAAILIQSK FRSYYEQKKF QQSRRAAVLI QKYYRSYKKC GKRRQARRTA
     VIVQQKLRSS LLTKKQDQAA RKIMRFLRRC RHSPLVDHRL YKRSERIEKG QGT
//
ID   A0A024RCG3_HUMAN        Unreviewed;       748 AA.
AC   A0A024RCG3;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 36.
DE   SubName: Full=Cysteinyl-tRNA synthetase, isoform CRA_a {ECO:0000313|EMBL:EAX02540.1};
GN   Name=CARS {ECO:0000313|EMBL:EAX02540.1};
GN   ORFNames=hCG_16441 {ECO:0000313|EMBL:EAX02540.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX02540.1};
RN   [1] {ECO:0000313|EMBL:EAX02540.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX02540.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471158; EAX02536.1; -; Genomic_DNA.
DR   EMBL; CH471158; EAX02540.1; -; Genomic_DNA.
DR   RefSeq; NP_001742.1; NM_001751.5.
DR   UniGene; Hs.274873; -.
DR   SMR; A0A024RCG3; -.
DR   GeneID; 833; -.
DR   KEGG; hsa:833; -.
DR   CTD; 833; -.
DR   EuPathDB; HostDB:ENSG00000110619.16; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   KO; K01883; -.
DR   ChiTaRS; CARS; human.
DR   GenomeRNAi; 833; -.
DR   Bgee; ENSG00000110619; -.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IEA:InterPro.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IEA:InterPro.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   3: Inferred from homology;
KW   Aminoacyl-tRNA synthetase {ECO:0000313|EMBL:EAX02540.1};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Ligase {ECO:0000313|EMBL:EAX02540.1}.
FT   DOMAIN       44    452       tRNA-synt_1e. {ECO:0000259|Pfam:PF01406}.
FT   COILED      647    683       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   748 AA;  85473 MW;  D0B7A29EC03AA87F CRC64;
     MADSSGQQGK GRRVQPQWSP PAGTQPCRLH LYNSLTRNKE VFIPQDGKKV TWYCCGPTVY
     DASHMGHARS YISFDILRRV LKDYFKFDVF YCMNITDIDD KIIKRARQNH LFEQYREKRP
     EAAQLLEDVQ AALKPFSVKL NETTDPDKKQ MLERIQHAVQ LATEPLEKAV QSRLTGEEVN
     SCVEVLLEEA KDLLSDWLDS TLGCDVTDNS IFSKLPKFWE GDFHRDMEAL NVLPPDVLTR
     VSEYVPEIVN FVQKIVDNGY GYVSNGSVYF DTAKFASSEK HSYGKLVPEA VGDQKALQEG
     EGDLSISADR LSEKRSPNDF ALWKASKPGE PSWPCPWGKG RPGWHIECSA MAGTLLGASM
     DIHGGGFDLR FPHHDNELAQ SEAYFENDCW VRYFLHTGHL TIAGCKMSKS LKNFITIKDA
     LKKHSARQLR LAFLMHSWKD TLDYSSNTME SALQYEKFLN EFFLNVKDIL RAPVDITGQF
     EKWGEEEAEL NKNFYDKKTA IHKALCDNVD TRTVMEEMRA LVSQCNLYMA ARKAVRKRPN
     QALLENIALY LTHMLKIFGA VEEDSSLGFP VGGPGTSLSL EATVMPYLQV LSEFREGVRK
     IAREQKVPEI LQLSDALRDN ILPELGVRFE DHEGLPTVVK LVDRNTLLKE REEKRRVEEE
     KRKKKEEAAR RKQEQEAAKL AKMKIPPSEM FLSETDKYSK FDENGLPTHD MEGKELSKGQ
     AKKLKKLFEA QEKLYKEYLQ MAQNGSFQ
//
ID   A8MVQ3_HUMAN            Unreviewed;       738 AA.
AC   A8MVQ3;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   28-FEB-2018, entry version 91.
DE   SubName: Full=Cysteinyl-tRNA synthetase, isoform CRA_b {ECO:0000313|EMBL:EAX02537.1};
DE   SubName: Full=cDNA FLJ38994 fis, clone NT2RI2009259, highly similar to Cysteinyl-tRNA synthetase (EC 6.1.1.16) {ECO:0000313|EMBL:BAG53256.1};
GN   Name=CARS {ECO:0000313|EMBL:EAX02537.1};
GN   ORFNames=hCG_16441 {ECO:0000313|EMBL:EAX02537.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG53256.1};
RN   [1] {ECO:0000313|EMBL:EAX02537.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAG53256.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3] {ECO:0000313|EMBL:EAX02537.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK096313; BAG53256.1; -; mRNA.
DR   EMBL; CH471158; EAX02537.1; -; Genomic_DNA.
DR   RefSeq; XP_006718404.1; XM_006718341.3.
DR   UniGene; Hs.274873; -.
DR   MaxQB; A8MVQ3; -.
DR   PeptideAtlas; A8MVQ3; -.
DR   GeneID; 833; -.
DR   CTD; 833; -.
DR   PharmGKB; PA26079; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   HOGENOM; HOG000245252; -.
DR   HOVERGEN; HBG002089; -.
DR   ChiTaRS; CARS; human.
DR   GenomeRNAi; 833; -.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IEA:InterPro.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IEA:InterPro.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   2: Evidence at transcript level;
KW   Aminoacyl-tRNA synthetase {ECO:0000313|EMBL:BAG53256.1};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Ligase {ECO:0000313|EMBL:BAG53256.1}.
FT   DOMAIN       34    442       tRNA-synt_1e. {ECO:0000259|Pfam:PF01406}.
FT   COILED      637    673       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   738 AA;  84472 MW;  D193831EAB32F00E CRC64;
     MQTPPLQQPH QEQVFLAFLV IVIPSFLTKE VFIPQDGKKV TWYCCGPTVY DASHMGHARS
     YISFDILRRV LKDYFKFDVF YCMNITDIDD KIIKRARQNH LFEQYREKRP EAAQLLEDVQ
     AALKPFSVKL NETTDPDKKQ MLERIQHAVQ LATEPLEKAV QSRLTGEEVN SCVEVLLEEA
     KDLLSDWLDS TLGCDVTDNS IFSKLPKFWE GDFHRDMEAL NVLPPDVLTR VSEYVPEIVN
     FVQKIVDNGY GYVSNGSVYF DTAKFASSEK HSYGKLVPEA VGDQKALQEG EGDLSISADR
     LSEKRSPNDF ALWKASKPGE PSWPCPWGKG RPGWHIECSA MAGTLLGASM DIHGGGFDLR
     FPHHDNELAQ SEAYFENDCW VRYFLHTGHL TIAGCKMSKS LKNFITIKDA LKKHSARQLR
     LAFLMHSWKD TLDYSSNTME SALQYEKFLN EFFLNVKDIL RAPVDITGQF EKWGEEEAEL
     NKNFYDKKTA IHKALCDNVD TRTVMEEMRA LVSQCNLYMA ARKAVRKRPN QALLENIALY
     LTHMLKIFGA VEEDSSLGFP VGGPGTSLSL EATVMPYLQV LSEFREGVRK IAREQKVPEI
     LQLSDALRDN ILPELGVRFE DHEGLPTVVK LVDRNTLLKE REEKRRVEEE KRKKKEEAAR
     RKQEQEAAKL AKMKIPPSEM FLSETDKYSK FDENGLPTHD MEGKELSKGQ AKKLKKLFEA
     QEKLYKEYLQ MAQNGSFQ
//
ID   B4DKY1_HUMAN            Unreviewed;       739 AA.
AC   B4DKY1; E9PPK8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 77.
DE   SubName: Full=Cysteine--tRNA ligase, cytoplasmic {ECO:0000313|Ensembl:ENSP00000432619};
DE   SubName: Full=cDNA FLJ59563, highly similar to Cysteinyl-tRNA synthetase (EC 6.1.1.16) {ECO:0000313|EMBL:BAG59343.1};
GN   Name=CARS {ECO:0000313|Ensembl:ENSP00000432619};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59343.1};
RN   [1] {ECO:0000213|PubMed:15592455}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000432619, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000313|EMBL:BAG59343.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAG59343.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000432619}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9] {ECO:0000313|Ensembl:ENSP00000488062}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (AUG-2015) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC001228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108448; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131971; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK296763; BAG59343.1; -; mRNA.
DR   RefSeq; XP_016873881.1; XM_017018392.1.
DR   UniGene; Hs.274873; -.
DR   MaxQB; B4DKY1; -.
DR   Ensembl; ENST00000529772; ENSP00000432619; ENSG00000110619.
DR   Ensembl; ENST00000633563; ENSP00000488062; ENSG00000278191.
DR   GeneID; 833; -.
DR   UCSC; uc010qxp.3; human.
DR   CTD; 833; -.
DR   EuPathDB; HostDB:ENSG00000110619.16; -.
DR   HGNC; HGNC:1493; CARS.
DR   OpenTargets; ENSG00000110619; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   GeneTree; ENSGT00390000006347; -.
DR   HOGENOM; HOG000245252; -.
DR   HOVERGEN; HBG002089; -.
DR   ChiTaRS; CARS; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110619; -.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IEA:InterPro.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IEA:InterPro.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   1: Evidence at protein level;
KW   Aminoacyl-tRNA synthetase {ECO:0000313|EMBL:BAG59343.1};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Ligase {ECO:0000313|EMBL:BAG59343.1};
KW   Proteomics identification {ECO:0000213|EPD:B4DKY1,
KW   ECO:0000213|MaxQB:B4DKY1, ECO:0000213|PeptideAtlas:B4DKY1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       57    465       tRNA-synt_1e. {ECO:0000259|Pfam:PF01406}.
FT   COILED      660    696       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   739 AA;  84278 MW;  E15B22AA0661A14E CRC64;
     MEPTSGPFRT DLGYHLVGCS SGKGRRVQPQ WSPPAGTQPC RLHLYNSLTR NKEVFIPQDG
     KKVTWYCCGP TVYDASHMGH ARSYISFDIL RRVLKDYFKF DVFYCMNITD IDDKIIKRAR
     QNHLFEQYRE KRPEAAQLLE DVQAALKPFS VKLNETTDPD KKQMLERIQH AVQLATEPLE
     KAVQSRLTGE EVNSCVEVLL EEAKDLLSDW LDSTLGCDVT DNSIFSKLPK FWEGDFHRDM
     EALNVLPPDV LTRVSEYVPE IVNFVQKIVD NGYGYVSNGS VYFDTAKFAS SEKHSYGKLV
     PEAVGDQKAL QEGEGDLSIS ADRLSEKRSP NDFALWKASK PGEPSWPCPW GKGRPGWHIE
     CSAMAGTLLG ASMDIHGGGF DLRFPHHDNE LAQSEAYFEN DCWVRYFLHT GHLTIAGCKM
     SKSLKNFITI KDALKKHSAR QLRLAFLMHS WKDTLDYSSN TMESALQYEK FLNEFFLNVK
     DILRAPVDIT GQFEKWGEEE AELNKNFYDK KTAIHKALCD NVDTRTVMEE MRALVSQCNL
     YMAARKAVRK RPNQALLENI ALYLTHMLKI FGAVEEDSSL GFPVGGPGTS LSLEATVMPY
     LQVLSEFREG VRKIAREQKV PEILQLSDAL RDNILPELGV RFEDHEGLPT VVKLVDRNTL
     LKEREEKRRV EEEKRKKKEE AARRKQEQEA AKLAKMKIPP SEMFLSETDK YSKFDENVSM
     VCPHMTWRAK SSAKGKPRS
//
ID   B4DPV7_HUMAN            Unreviewed;       809 AA.
AC   B4DPV7;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 62.
DE   SubName: Full=cDNA FLJ54534, highly similar to Homo sapiens cysteinyl-tRNA synthetase (CARS), transcript variant 3, mRNA {ECO:0000313|EMBL:BAG60719.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG60719.1};
RN   [1] {ECO:0000313|EMBL:BAG60719.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK298514; BAG60719.1; -; mRNA.
DR   RefSeq; NP_001181926.1; NM_001194997.1.
DR   UniGene; Hs.274873; -.
DR   PeptideAtlas; B4DPV7; -.
DR   PRIDE; B4DPV7; -.
DR   DNASU; 833; -.
DR   GeneID; 833; -.
DR   CTD; 833; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   HOVERGEN; HBG002089; -.
DR   GenomeRNAi; 833; -.
DR   Genevisible; B4DPV7; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IEA:InterPro.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IEA:InterPro.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   2: Evidence at transcript level;
KW   Aminoacyl-tRNA synthetase {ECO:0000313|EMBL:BAG60719.1};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Ligase {ECO:0000313|EMBL:BAG60719.1}.
FT   DOMAIN      127    535       tRNA-synt_1e. {ECO:0000259|Pfam:PF01406}.
FT   COILED      730    766       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   809 AA;  92019 MW;  C05376F3F04FD266 CRC64;
     MADSSGQQAP DYRSILSISD EAARAQALNE HLSTRSYVQG YSLSQADVDA FRQLSAPPAD
     PQLFHVARWF RHIEALLGSP CGKGQPCRLQ ASKGRRVQPQ WSPPAGTQPC RLHLYNSLTR
     NKEVFIPQDG KKVTWYCCGP TVYDASHMGH ARSYISFDIL RRVLKDYFKF DVFYCMNITD
     IDDKIIKRAR QNHLFEQYRE KRPEAAQLLE DVQAALKPFS VKLNETTDPD KKQMLERIQH
     AVQLATEPLE KAVQSRLTGE EVNSCVEVLL EEAKDLLSDW LDSTFGCDVT DNSIFSKLPK
     FWEGDFHRDM EALNVLPPDV LTRVSEYVPE IVNFVQKIVD NGYGYVSNGS VYFDTAKFAS
     SEKHSYGKLV PEAVGDQKAL QEGEGDLSIS ADRLSEKRSP NDFALWKASK PGEPSWPCPW
     GKGRPGWHIE CSAMAGTLLG ASMDIHGGGF DLRFPHHDNE LAQSEAYFEN DCWVRYFLHT
     GHLTIAGCKM SKSLKNFITI KDALKKHSAR QLRLAFLMHS WKDTLDYSSN TMESALQYEK
     FLNEFFLNVK DILRAPVDIT GQFEKWGEEE AELNKNFYDK KTAIHKALCD NVDTRTVMEE
     MRASVSQCNL YMAARKAVRK RPNQALLENI ALYLTHMLKI FGAVEEDSSL GFPVGGPGTS
     LSLEATVMPY LQVLSEFREG VRKIAREQKV PEILQLSDAL RDNILPELGV RFEDHEGLPT
     VVKLVDRNTL LKEREEKRRV EEEKRKKKEE AARRKQEQEA AKLAKMKIPP SEMFLSETDK
     YSKFDENVSM VCPHMTWRAK SSAKGKPRS
//
ID   SYCC_HUMAN              Reviewed;         748 AA.
AC   P49589; Q53XI8; Q5HYE4; Q9HD24; Q9HD25;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 3.
DT   28-FEB-2018, entry version 170.
DE   RecName: Full=Cysteine--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.16;
DE   AltName: Full=Cysteinyl-tRNA synthetase;
DE            Short=CysRS;
GN   Name=CARS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=7987009; DOI=10.3109/10425179409020847;
RA   Cruzen M.E., Arfin S.M.;
RT   "Nucleotide and deduced amino acid sequence of human cysteinyl-tRNA
RT   synthetase.";
RL   DNA Seq. 4:243-248(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=11347887; DOI=10.1515/BC.2001.049;
RA   Davidson E., Caffarella J., Vitseva O., Hou Y.M., King M.P.;
RT   "Isolation of two cDNAs encoding functional human cytoplasmic
RT   cysteinyl-tRNA synthetase.";
RL   Biol. Chem. 382:399-406(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION WITH ALK.
RX   PubMed=12112524; DOI=10.1002/gcc.10033;
RA   Cools J., Wlodarska I., Somers R., Mentens N., Pedeutour F., Maes B.,
RA   De Wolf-Peeters C., Pauwels P., Hagemeijer A., Marynen P.;
RT   "Identification of novel fusion partners of ALK, the anaplastic
RT   lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory
RT   myofibroblastic tumor.";
RL   Genes Chromosomes Cancer 34:354-362(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-746, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-503, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-746, PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-79 (ISOFORM 3), AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-307, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-305 AND SER-307,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: ATP + L-cysteine + tRNA(Cys) = AMP +
CC       diphosphate + L-cysteinyl-tRNA(Cys).
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P49589-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49589-2; Sequence=VSP_006312;
CC         Note=Found in 20% of the mRNAs.;
CC       Name=3;
CC         IsoId=P49589-3; Sequence=VSP_043571;
CC         Note=Contains a phosphoserine at position 79.
CC         {ECO:0000244|PubMed:20068231};
CC   -!- DISEASE: Note=A chromosomal aberration involving CARS is
CC       associated with inflammatory myofibroblastic tumors (IMTs).
CC       Translocation t(2;11)(p23;p15) with ALK.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA73901.1; Type=Frameshift; Positions=619; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CARSID484.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L06845; AAA73901.1; ALT_FRAME; mRNA.
DR   EMBL; AF288206; AAG00578.1; -; mRNA.
DR   EMBL; AF288207; AAG00579.1; -; mRNA.
DR   EMBL; BT009913; AAP88915.1; -; mRNA.
DR   EMBL; AK302644; BAG63885.1; -; mRNA.
DR   EMBL; BX647906; CAI46108.1; -; mRNA.
DR   EMBL; AC108448; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131971; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471158; EAX02541.1; -; Genomic_DNA.
DR   EMBL; BC002880; AAH02880.1; -; mRNA.
DR   CCDS; CCDS41600.1; -. [P49589-3]
DR   CCDS; CCDS41602.1; -. [P49589-2]
DR   CCDS; CCDS7742.1; -. [P49589-1]
DR   RefSeq; NP_001014437.1; NM_001014437.2. [P49589-3]
DR   RefSeq; NP_001742.1; NM_001751.5. [P49589-1]
DR   RefSeq; NP_644802.1; NM_139273.3. [P49589-2]
DR   UniGene; Hs.274873; -.
DR   ProteinModelPortal; P49589; -.
DR   SMR; P49589; -.
DR   BioGrid; 107283; 50.
DR   IntAct; P49589; 10.
DR   MINT; P49589; -.
DR   STRING; 9606.ENSP00000369897; -.
DR   DrugBank; DB00151; L-Cysteine.
DR   iPTMnet; P49589; -.
DR   PhosphoSitePlus; P49589; -.
DR   SwissPalm; P49589; -.
DR   BioMuta; CARS; -.
DR   DMDM; 20141641; -.
DR   EPD; P49589; -.
DR   MaxQB; P49589; -.
DR   PaxDb; P49589; -.
DR   PeptideAtlas; P49589; -.
DR   PRIDE; P49589; -.
DR   DNASU; 833; -.
DR   Ensembl; ENST00000278224; ENSP00000278224; ENSG00000110619. [P49589-2]
DR   Ensembl; ENST00000380525; ENSP00000369897; ENSG00000110619. [P49589-3]
DR   Ensembl; ENST00000397111; ENSP00000380300; ENSG00000110619. [P49589-1]
DR   Ensembl; ENST00000612826; ENSP00000482336; ENSG00000278191. [P49589-3]
DR   Ensembl; ENST00000632612; ENSP00000487923; ENSG00000278191. [P49589-2]
DR   Ensembl; ENST00000633248; ENSP00000488657; ENSG00000278191. [P49589-1]
DR   GeneID; 833; -.
DR   KEGG; hsa:833; -.
DR   UCSC; uc001lxf.4; human. [P49589-1]
DR   CTD; 833; -.
DR   DisGeNET; 833; -.
DR   EuPathDB; HostDB:ENSG00000110619.16; -.
DR   GeneCards; CARS; -.
DR   H-InvDB; HIX0128660; -.
DR   HGNC; HGNC:1493; CARS.
DR   HPA; CAB075734; -.
DR   HPA; CAB075735; -.
DR   HPA; CAB075736; -.
DR   HPA; CAB075737; -.
DR   HPA; HPA002383; -.
DR   HPA; HPA002384; -.
DR   MalaCards; CARS; -.
DR   MIM; 123859; gene.
DR   neXtProt; NX_P49589; -.
DR   OpenTargets; ENSG00000110619; -.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   PharmGKB; PA26079; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   GeneTree; ENSGT00390000006347; -.
DR   HOGENOM; HOG000245252; -.
DR   HOVERGEN; HBG002089; -.
DR   InParanoid; P49589; -.
DR   KO; K01883; -.
DR   OMA; MNEFFLN; -.
DR   OrthoDB; EOG091G03N1; -.
DR   PhylomeDB; P49589; -.
DR   TreeFam; TF300384; -.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   ChiTaRS; CARS; human.
DR   GenomeRNAi; 833; -.
DR   PRO; PR:P49589; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110619; -.
DR   CleanEx; HS_CARS; -.
DR   ExpressionAtlas; P49589; baseline and differential.
DR   Genevisible; P49589; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0000049; F:tRNA binding; IDA:UniProtKB.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IDA:UniProtKB.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Aminoacyl-tRNA synthetase;
KW   ATP-binding; Chromosomal rearrangement; Complete proteome; Cytoplasm;
KW   Ligase; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Protein biosynthesis; Proto-oncogene; Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    748       Cysteine--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000159550.
FT   MOTIF        57     67       "HIGH" region.
FT   MOTIF       406    410       "KMSKS" region.
FT   METAL        55     55       Zinc. {ECO:0000250}.
FT   METAL       348    348       Zinc. {ECO:0000250}.
FT   METAL       373    373       Zinc. {ECO:0000250}.
FT   METAL       377    377       Zinc. {ECO:0000250}.
FT   BINDING     409    409       ATP. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      19     19       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     305    305       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     307    307       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     503    503       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     746    746       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ       9      9       G -> APDYRSILSISDEAARAQALNEHLSTRSYVQGYSLS
FT                                QADVDAFRQLSAPPADPQLFHVARWFRHIEALLGSPCGKGQ
FT                                PCRLQAS (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_043571.
FT   VAR_SEQ     705    748       GLPTHDMEGKELSKGQAKKLKKLFEAQEKLYKEYLQMAQNG
FT                                SFQ -> VSMVCPHMTWRAKSSAKGKPRS (in isoform
FT                                2). {ECO:0000303|PubMed:11347887,
FT                                ECO:0000303|PubMed:7987009}.
FT                                /FTId=VSP_006312.
SQ   SEQUENCE   748 AA;  85473 MW;  D0B7A29EC03AA87F CRC64;
     MADSSGQQGK GRRVQPQWSP PAGTQPCRLH LYNSLTRNKE VFIPQDGKKV TWYCCGPTVY
     DASHMGHARS YISFDILRRV LKDYFKFDVF YCMNITDIDD KIIKRARQNH LFEQYREKRP
     EAAQLLEDVQ AALKPFSVKL NETTDPDKKQ MLERIQHAVQ LATEPLEKAV QSRLTGEEVN
     SCVEVLLEEA KDLLSDWLDS TLGCDVTDNS IFSKLPKFWE GDFHRDMEAL NVLPPDVLTR
     VSEYVPEIVN FVQKIVDNGY GYVSNGSVYF DTAKFASSEK HSYGKLVPEA VGDQKALQEG
     EGDLSISADR LSEKRSPNDF ALWKASKPGE PSWPCPWGKG RPGWHIECSA MAGTLLGASM
     DIHGGGFDLR FPHHDNELAQ SEAYFENDCW VRYFLHTGHL TIAGCKMSKS LKNFITIKDA
     LKKHSARQLR LAFLMHSWKD TLDYSSNTME SALQYEKFLN EFFLNVKDIL RAPVDITGQF
     EKWGEEEAEL NKNFYDKKTA IHKALCDNVD TRTVMEEMRA LVSQCNLYMA ARKAVRKRPN
     QALLENIALY LTHMLKIFGA VEEDSSLGFP VGGPGTSLSL EATVMPYLQV LSEFREGVRK
     IAREQKVPEI LQLSDALRDN ILPELGVRFE DHEGLPTVVK LVDRNTLLKE REEKRRVEEE
     KRKKKEEAAR RKQEQEAAKL AKMKIPPSEM FLSETDKYSK FDENGLPTHD MEGKELSKGQ
     AKKLKKLFEA QEKLYKEYLQ MAQNGSFQ
//
ID   KNL1_HUMAN              Reviewed;        2342 AA.
AC   Q8NG31; Q8NHE1; Q8WXA6; Q9HCK2; Q9NR92;
DT   24-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 3.
DT   28-FEB-2018, entry version 132.
DE   RecName: Full=Kinetochore scaffold 1;
DE   AltName: Full=ALL1-fused gene from chromosome 15q14 protein;
DE            Short=AF15q14;
DE   AltName: Full=Bub-linking kinetochore protein;
DE            Short=Blinkin;
DE   AltName: Full=Cancer susceptibility candidate gene 5 protein;
DE   AltName: Full=Cancer/testis antigen 29;
DE            Short=CT29;
DE   AltName: Full=Kinetochore-null protein 1;
DE   AltName: Full=Protein CASC5;
DE   AltName: Full=Protein D40/AF15q14;
GN   Name=KNL1 {ECO:0000312|HGNC:HGNC:24054}; Synonyms=CASC5, KIAA1570;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 4), CHROMOSOMAL
RP   TRANSLOCATION WITH KMT2A/MLL1, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND VARIANTS SER-486; THR-598; GLY-936; GLU-1285 AND
RP   ALA-1473.
RX   PubMed=10980622; DOI=10.1038/sj.onc.1203789;
RA   Hayette S., Tigaud I., Vanier A., Martel S., Corbo L., Charrin C.,
RA   Beillard E., Deleage G., Magaud J.-P., Rimokh R.;
RT   "AF15q14, a novel partner gene fused to the MLL gene in an acute
RT   myeloid leukaemia with a t(11;15)(q23;q14).";
RL   Oncogene 19:4446-4450(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND
RP   VARIANTS THR-43; ALA-113; SER-486; THR-598 AND GLY-936.
RC   TISSUE=Testis;
RX   PubMed=12087463; DOI=10.1038/sj.bjc.6600328;
RA   Takimoto M., Wei G., Dosaka-Akita H., Mao P., Kondo S., Sakuragi N.,
RA   Chiba I., Miura T., Itoh N., Sasao T., Koya R.C., Tsukamoto T.,
RA   Fujimoto S., Kato H., Kuzumaki N.;
RT   "Frequent expression of new cancer/testis gene D40/AF15q14 in lung
RT   cancer of smokers.";
RL   Br. J. Cancer 86:1757-1762(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH
RP   KMT2A/MLL1, TISSUE SPECIFICITY, AND VARIANTS THR-598 AND GLY-936.
RX   PubMed=12618768; DOI=10.1038/sj.onc.1206272;
RA   Kuefer M.U., Chinwalla V., Zeleznik-Le N.J., Behm F.G., Naeve C.W.,
RA   Rakestraw K.M., Mukatira S.T., Raimondi S.C., Morris S.W.;
RT   "Characterization of the MLL partner gene AF15q14 involved in
RT   t(11;15)(q23;q14).";
RL   Oncogene 22:1418-1424(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 983-2342.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH KMT2A.
RX   PubMed=12618766; DOI=10.1038/sj.onc.1206273;
RA   Chinwalla V., Chien A., Odero M., Neilly M.B., Zeleznik-Le N.J.,
RA   Rowley J.D.;
RT   "A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene
RT   MPFYVE on chromosome 15.";
RL   Oncogene 22:1400-1410(2003).
RN   [7]
RP   INTERACTION WITH DSN1 AND MIS12, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND FUNCTION.
RX   PubMed=15502821; DOI=10.1038/ncb1187;
RA   Obuse C., Iwasaki O., Kiyomitsu T., Goshima G., Toyoda Y.,
RA   Yanagida M.;
RT   "A conserved Mis12 centromere complex is linked to heterochromatic HP1
RT   and outer kinetochore protein Zwint-1.";
RL   Nat. Cell Biol. 6:1135-1141(2004).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15579588; DOI=10.1530/rep.1.00312;
RA   Sasao T., Itoh N., Takano H., Watanabe S., Wei G., Tsukamoto T.,
RA   Kuzumaki N., Takimoto M.;
RT   "The protein encoded by cancer/testis gene D40/AF15q14 is localized in
RT   spermatocytes, acrosomes of spermatids and ejaculated spermatozoa.";
RL   Reproduction 128:709-716(2004).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH BUB1; BUB1B;
RP   NSL1; DSN1 AND ZWINT.
RX   PubMed=17981135; DOI=10.1016/j.devcel.2007.09.005;
RA   Kiyomitsu T., Obuse C., Yanagida M.;
RT   "Human Blinkin/AF15q14 is required for chromosome alignment and the
RT   mitotic checkpoint through direct interaction with Bub1 and BubR1.";
RL   Dev. Cell 13:663-676(2007).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18045986; DOI=10.1091/mbc.E07-10-1051;
RA   Cheeseman I.M., Hori T., Fukagawa T., Desai A.;
RT   "KNL1 and the CENP-H/I/K complex coordinately direct kinetochore
RT   assembly in vertebrates.";
RL   Mol. Biol. Cell 19:587-594(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1076, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; SER-60; SER-1076;
RP   SER-1773 AND SER-1845, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19450515; DOI=10.1016/j.cell.2009.03.035;
RA   Wan X., O'Quinn R.P., Pierce H.L., Joglekar A.P., Gall W.E.,
RA   DeLuca J.G., Carroll C.W., Liu S.-T., Yen T.J., McEwen B.F.,
RA   Stukenberg P.T., Desai A., Salmon E.D.;
RT   "Protein architecture of the human kinetochore microtubule attachment
RT   site.";
RL   Cell 137:672-684(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1076, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-539; SER-956; SER-1076
RP   AND SER-1831, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; SER-60; THR-539;
RP   SER-578; SER-584; THR-586; SER-767; SER-956; SER-1039; SER-1076;
RP   SER-1088; SER-1448; SER-1675; SER-1845 AND SER-1860, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-598.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
RN   [18]
RP   VARIANT MCPH4 ILE-2041.
RX   PubMed=22983954; DOI=10.1093/hmg/dds386;
RA   Genin A., Desir J., Lambert N., Biervliet M., Van Der Aa N.,
RA   Pierquin G., Killian A., Tosi M., Urbina M., Lefort A., Libert F.,
RA   Pirson I., Abramowicz M.;
RT   "Kinetochore KMN network gene CASC5 mutated in primary microcephaly.";
RL   Hum. Mol. Genet. 21:5306-5317(2012).
RN   [19]
RP   VARIANT MCPH4 ILE-2041.
RX   PubMed=26626498; DOI=10.1007/s10048-015-0468-7;
RA   Saadi A., Verny F., Siquier-Pernet K., Bole-Feysot C., Nitschke P.,
RA   Munnich A., Abada-Dendib M., Chaouch M., Abramowicz M., Colleaux L.;
RT   "Refining the phenotype associated with CASC5 mutation.";
RL   Neurogenetics 17:71-78(2016).
CC   -!- FUNCTION: Performs two crucial functions during mitosis: it is
CC       essential for spindle-assembly checkpoint signaling and for
CC       correct chromosome alignment. Required for attachment of the
CC       kinetochores to the spindle microtubules. Directly links BUB1 and
CC       BUB1B to kinetochores. Part of the MIS12 complex, which may be
CC       fundamental for kinetochore formation and proper chromosome
CC       segregation during mitosis. Acts in coordination with CENPK to
CC       recruit the NDC80 complex to the outer kinetochore.
CC       {ECO:0000269|PubMed:15502821, ECO:0000269|PubMed:17981135,
CC       ECO:0000269|PubMed:18045986}.
CC   -!- SUBUNIT: Interacts with DSN1, MIS12, BUB1, BUB1B, NSL1 and ZWINT.
CC       {ECO:0000269|PubMed:15502821, ECO:0000269|PubMed:17981135}.
CC   -!- INTERACTION:
CC       O43683:BUB1; NbExp=2; IntAct=EBI-10973816, EBI-748936;
CC       O60566:BUB1B; NbExp=10; IntAct=EBI-10973816, EBI-1001438;
CC       P62136:PPP1CA; NbExp=2; IntAct=EBI-1001161, EBI-357253;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere,
CC       kinetochore. Note=Weakly expressed in interphase nuclei.
CC       Expression increases from prophase to late anaphase, but greatly
CC       diminishes from the telophase and cytokinesis to early G1 phase of
CC       cell cycle.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8NG31-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NG31-2; Sequence=VSP_013795;
CC       Name=3;
CC         IsoId=Q8NG31-3; Sequence=VSP_013795, VSP_013796, VSP_013797;
CC       Name=4;
CC         IsoId=Q8NG31-4; Sequence=VSP_013795, VSP_018524, VSP_018525;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis, where it is
CC       localized in germ cells, in particular in spermatocytes and in the
CC       pre-acrosome of round spermatids. Detected in the acrosome of
CC       ejaculated spermatozoa. Detected in adult thymus, bone marrow,
CC       colon, small intestine, appendix and placenta, and in fetal liver
CC       and thymus. {ECO:0000269|PubMed:10980622,
CC       ECO:0000269|PubMed:12087463, ECO:0000269|PubMed:12618768}.
CC   -!- DISEASE: Note=A chromosomal aberration involving KNL1 is
CC       associated with acute myeloblastic leukemia (AML). Translocation
CC       t(11;15)(q23;q14) with KMT2A. May give rise to a KMT2A-KNL1 fusion
CC       protein. {ECO:0000269|PubMed:12618766}.
CC   -!- DISEASE: Microcephaly 4, primary, autosomal recessive (MCPH4)
CC       [MIM:604321]: A disease defined as a head circumference more than
CC       3 standard deviations below the age-related mean. Brain weight is
CC       markedly reduced and the cerebral cortex is disproportionately
CC       small. Despite this marked reduction in size, the gyral pattern is
CC       relatively well preserved, with no major abnormality in cortical
CC       architecture. Affected individuals are mentally retarded. Primary
CC       microcephaly is further defined by the absence of other syndromic
CC       features or significant neurological deficits due to degenerative
CC       brain disorder. {ECO:0000269|PubMed:22983954,
CC       ECO:0000269|PubMed:26626498}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF15q14ID318.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF248041; AAF97513.1; -; mRNA.
DR   EMBL; AF461041; AAL67803.1; -; mRNA.
DR   EMBL; AB022190; BAC05691.1; -; mRNA.
DR   EMBL; AF173994; AAM45143.1; -; mRNA.
DR   EMBL; AC022405; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB046790; BAB13396.1; -; mRNA.
DR   CCDS; CCDS42023.1; -. [Q8NG31-1]
DR   CCDS; CCDS42024.1; -. [Q8NG31-2]
DR   RefSeq; NP_653091.3; NM_144508.4. [Q8NG31-2]
DR   RefSeq; NP_733468.3; NM_170589.4. [Q8NG31-1]
DR   UniGene; Hs.181855; -.
DR   PDB; 3SI5; X-ray; 2.20 A; X/Y=234-252.
DR   PDB; 4A1G; X-ray; 2.60 A; E/F/G/H=176-226.
DR   PDB; 4NF9; X-ray; 2.80 A; A/B=2117-2337.
DR   PDB; 4NFA; X-ray; 2.50 A; A=2131-2337.
DR   PDBsum; 3SI5; -.
DR   PDBsum; 4A1G; -.
DR   PDBsum; 4NF9; -.
DR   PDBsum; 4NFA; -.
DR   ProteinModelPortal; Q8NG31; -.
DR   SMR; Q8NG31; -.
DR   BioGrid; 121354; 49.
DR   DIP; DIP-36474N; -.
DR   ELM; Q8NG31; -.
DR   IntAct; Q8NG31; 46.
DR   MINT; Q8NG31; -.
DR   STRING; 9606.ENSP00000335463; -.
DR   iPTMnet; Q8NG31; -.
DR   PhosphoSitePlus; Q8NG31; -.
DR   DMDM; 223590239; -.
DR   EPD; Q8NG31; -.
DR   MaxQB; Q8NG31; -.
DR   PaxDb; Q8NG31; -.
DR   PeptideAtlas; Q8NG31; -.
DR   PRIDE; Q8NG31; -.
DR   DNASU; 57082; -.
DR   Ensembl; ENST00000346991; ENSP00000335463; ENSG00000137812. [Q8NG31-1]
DR   Ensembl; ENST00000399668; ENSP00000382576; ENSG00000137812. [Q8NG31-2]
DR   GeneID; 57082; -.
DR   KEGG; hsa:57082; -.
DR   UCSC; uc010bbs.2; human. [Q8NG31-1]
DR   CTD; 57082; -.
DR   DisGeNET; 57082; -.
DR   EuPathDB; HostDB:ENSG00000137812.19; -.
DR   GeneCards; KNL1; -.
DR   GeneReviews; CASC5; -.
DR   HGNC; HGNC:24054; KNL1.
DR   HPA; HPA026624; -.
DR   HPA; HPA049647; -.
DR   MalaCards; KNL1; -.
DR   MIM; 604321; phenotype.
DR   MIM; 609173; gene.
DR   neXtProt; NX_Q8NG31; -.
DR   OpenTargets; ENSG00000137812; -.
DR   Orphanet; 2512; Autosomal recessive primary microcephaly.
DR   PharmGKB; PA142672201; -.
DR   eggNOG; ENOG410IF9C; Eukaryota.
DR   eggNOG; ENOG410XZXJ; LUCA.
DR   GeneTree; ENSGT00410000025918; -.
DR   HOGENOM; HOG000246954; -.
DR   HOVERGEN; HBG080986; -.
DR   InParanoid; Q8NG31; -.
DR   KO; K11542; -.
DR   OMA; MEITRSH; -.
DR   OrthoDB; EOG091G0YZU; -.
DR   PhylomeDB; Q8NG31; -.
DR   TreeFam; TF335517; -.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   SIGNOR; Q8NG31; -.
DR   ChiTaRS; KNL1; human.
DR   EvolutionaryTrace; Q8NG31; -.
DR   GeneWiki; CASC5; -.
DR   GenomeRNAi; 57082; -.
DR   PRO; PR:Q8NG31; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000137812; -.
DR   CleanEx; HS_CASC5; -.
DR   ExpressionAtlas; Q8NG31; baseline and differential.
DR   Genevisible; Q8NG31; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:UniProtKB.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IDA:WormBase.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0001675; P:acrosome assembly; NAS:UniProtKB.
DR   GO; GO:0008608; P:attachment of spindle microtubules to kinetochore; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0034080; P:CENP-A containing nucleosome assembly; TAS:Reactome.
DR   GO; GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0034501; P:protein localization to kinetochore; IDA:MGI.
DR   GO; GO:0007062; P:sister chromatid cohesion; TAS:Reactome.
DR   InterPro; IPR037388; Blinkin.
DR   PANTHER; PTHR16520; PTHR16520; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell division;
KW   Centromere; Chromosomal rearrangement; Chromosome;
KW   Chromosome partition; Coiled coil; Complete proteome;
KW   Disease mutation; Kinetochore; Mental retardation; Mitosis; Nucleus;
KW   Phosphoprotein; Polymorphism; Primary microcephaly;
KW   Reference proteome; Repeat.
FT   CHAIN         1   2342       Kinetochore scaffold 1.
FT                                /FTId=PRO_0000089327.
FT   REPEAT      885    989       1.
FT   REPEAT     1099   1201       2.
FT   REGION        1    728       Interaction with BUB1 and BUB1B.
FT                                {ECO:0000269|PubMed:17981135}.
FT   REGION      855   1201       2 X 104 AA approximate repeats.
FT   REGION     1834   2316       Necessary for kinetochore localization
FT                                and for interaction with NSL1 and DSN1.
FT                                {ECO:0000269|PubMed:17981135}.
FT   COILED     1942   2133       {ECO:0000255}.
FT   MOTIF      1789   1803       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   SITE       1818   1819       Breakpoint for translocation to form
FT                                KMT2A-KNL1.
FT                                {ECO:0000269|PubMed:12618766}.
FT   MOD_RES      32     32       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     539    539       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     578    578       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     584    584       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     586    586       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     767    767       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     956    956       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1039   1039       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1076   1076       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1088   1088       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1448   1448       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1675   1675       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1773   1773       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1831   1831       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1845   1845       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1860   1860       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      84    109       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:10980622,
FT                                ECO:0000303|PubMed:12087463}.
FT                                /FTId=VSP_013795.
FT   VAR_SEQ    1764   1772       LIETYQKEI -> VGTRRRRYS (in isoform 3).
FT                                {ECO:0000303|PubMed:12087463}.
FT                                /FTId=VSP_013796.
FT   VAR_SEQ    1773   2342       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12087463}.
FT                                /FTId=VSP_013797.
FT   VAR_SEQ    1819   1859       IFDHHTEEDIDKSANSVLIKNLSRTPSSCSSSLDSIKADGT
FT                                -> VSSVLNQRMFLNFGFCFVFLNCGYSQILILVSGRQKII
FT                                IST (in isoform 4).
FT                                {ECO:0000303|PubMed:10980622}.
FT                                /FTId=VSP_018524.
FT   VAR_SEQ    1860   2342       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:10980622}.
FT                                /FTId=VSP_018525.
FT   VARIANT      43     43       R -> T (in dbSNP:rs7177192).
FT                                {ECO:0000269|PubMed:12087463}.
FT                                /FTId=VAR_026428.
FT   VARIANT      70     70       T -> A (in dbSNP:rs16970874).
FT                                /FTId=VAR_026429.
FT   VARIANT     113    113       T -> A (in dbSNP:rs12911738).
FT                                {ECO:0000269|PubMed:12087463}.
FT                                /FTId=VAR_026430.
FT   VARIANT     177    177       M -> V (in dbSNP:rs35146555).
FT                                /FTId=VAR_061568.
FT   VARIANT     486    486       A -> S (in dbSNP:rs2412541).
FT                                {ECO:0000269|PubMed:10980622,
FT                                ECO:0000269|PubMed:12087463}.
FT                                /FTId=VAR_026431.
FT   VARIANT     598    598       M -> T (in dbSNP:rs11858113).
FT                                {ECO:0000269|PubMed:10980622,
FT                                ECO:0000269|PubMed:12087463,
FT                                ECO:0000269|PubMed:12618768,
FT                                ECO:0000269|PubMed:18987736}.
FT                                /FTId=VAR_054342.
FT   VARIANT     936    936       R -> G (in dbSNP:rs8040502).
FT                                {ECO:0000269|PubMed:10980622,
FT                                ECO:0000269|PubMed:12087463,
FT                                ECO:0000269|PubMed:12618768}.
FT                                /FTId=VAR_026432.
FT   VARIANT    1190   1190       L -> V (in dbSNP:rs58614880).
FT                                /FTId=VAR_061569.
FT   VARIANT    1285   1285       K -> E (in dbSNP:rs17747633).
FT                                {ECO:0000269|PubMed:10980622}.
FT                                /FTId=VAR_026433.
FT   VARIANT    1473   1473       T -> A (in dbSNP:rs16970911).
FT                                {ECO:0000269|PubMed:10980622}.
FT                                /FTId=VAR_026434.
FT   VARIANT    2041   2041       M -> I (in MCPH4; may inactivate an
FT                                exonic splicing enhancer and result in
FT                                abnormal splicing; dbSNP:rs763915472).
FT                                {ECO:0000269|PubMed:22983954,
FT                                ECO:0000269|PubMed:26626498}.
FT                                /FTId=VAR_069085.
FT   VARIANT    2338   2338       C -> Y (in dbSNP:rs61164860).
FT                                /FTId=VAR_061570.
FT   CONFLICT     37     37       L -> H (in Ref. 3; AAM45143).
FT                                {ECO:0000305}.
FT   CONFLICT   1332   1332       P -> A (in Ref. 2; BAC05691).
FT                                {ECO:0000305}.
FT   CONFLICT   1357   1357       N -> H (in Ref. 2; BAC05691).
FT                                {ECO:0000305}.
FT   CONFLICT   1756   1756       N -> Y (in Ref. 2; BAC05691).
FT                                {ECO:0000305}.
FT   HELIX       205    211       {ECO:0000244|PDB:4A1G}.
FT   HELIX       241    250       {ECO:0000244|PDB:3SI5}.
FT   HELIX      2123   2130       {ECO:0000244|PDB:4NF9}.
FT   STRAND     2136   2140       {ECO:0000244|PDB:4NFA}.
FT   STRAND     2146   2151       {ECO:0000244|PDB:4NFA}.
FT   STRAND     2154   2162       {ECO:0000244|PDB:4NFA}.
FT   TURN       2168   2170       {ECO:0000244|PDB:4NFA}.
FT   HELIX      2172   2174       {ECO:0000244|PDB:4NF9}.
FT   STRAND     2177   2184       {ECO:0000244|PDB:4NFA}.
FT   TURN       2188   2190       {ECO:0000244|PDB:4NF9}.
FT   HELIX      2193   2210       {ECO:0000244|PDB:4NFA}.
FT   TURN       2213   2215       {ECO:0000244|PDB:4NF9}.
FT   HELIX      2219   2221       {ECO:0000244|PDB:4NF9}.
FT   HELIX      2222   2249       {ECO:0000244|PDB:4NFA}.
FT   HELIX      2250   2253       {ECO:0000244|PDB:4NFA}.
FT   STRAND     2255   2261       {ECO:0000244|PDB:4NFA}.
FT   STRAND     2264   2271       {ECO:0000244|PDB:4NFA}.
FT   TURN       2272   2275       {ECO:0000244|PDB:4NFA}.
FT   STRAND     2276   2283       {ECO:0000244|PDB:4NFA}.
FT   TURN       2286   2289       {ECO:0000244|PDB:4NFA}.
FT   STRAND     2295   2302       {ECO:0000244|PDB:4NFA}.
FT   HELIX      2306   2315       {ECO:0000244|PDB:4NFA}.
FT   HELIX      2322   2334       {ECO:0000244|PDB:4NFA}.
SQ   SEQUENCE   2342 AA;  265391 MW;  8E29150CA4F5B5C1 CRC64;
     MDGVSSEANE ENDNIERPVR RRHSSILKPP RSPLQDLRGG NERVQESNAL RNKKNSRRVS
     FADTIKVFQT ESHMKIVRKS EMEGCSAMVP SQLQLLPPGF KRFSCLSLPE TETGENLLLI
     QNKKLEDNYC EITGMNTLLS APIHTQMQQK EFSIIEHTRE RKHANDQTVI FSDENQMDLT
     SSHTVMITKG LLDNPISEKS TKIDTTSFLA NLKLHTEDSR MKKEVNFSVD QNTSSENKID
     FNDFIKRLKT GKCSAFPDVP DKENFEIPIY SKEPNSASST HQMHVSLKED ENNSNITRLF
     REKDDGMNFT QCHTANIQTL IPTSSETNSR ESKGNDITIY GNDFMDLTFN HTLQILPATG
     NFSEIENQTQ NAMDVTTGYG TKASGNKTVF KSKQNTAFQD LSINSADKIH ITRSHIMGAE
     THIVSQTCNQ DARILAMTPE SIYSNPSIQG CKTVFYSSCN DAMEMTKCLS NMREEKNLLK
     HDSNYAKMYC NPDAMSSLTE KTIYSGEENM DITKSHTVAI DNQIFKQDQS NVQIAAAPTP
     EKEMMLQNLM TTSEDGKMNV NCNSVPHVSK ERIQQSLSNP LSISLTDRKT ELLSGENMDL
     TESHTSNLGS QVPLAAYNLA PESTSESHSQ SKSSSDECEE ITKSRNEPFQ RSDIIAKNSL
     TDTWNKDKDW VLKILPYLDK DSPQSADCNQ EIATSHNIVY CGGVLDKQIT NRNTVSWEQS
     LFSTTKPLFS SGQFSMKNHD TAISSHTVKS VLGQNSKLAE PLRKSLSNPT PDYCHDKMII
     CSEEEQNMDL TKSHTVVIGF GPSELQELGK TNLEHTTGQL TTMNRQIAVK VEKCGKSPIE
     KSGVLKSNCI MDVLEDESVQ KPKFPKEKQN VKIWGRKSVG GPKIDKTIVF SEDDKNDMDI
     TKSYTIEINH RPLLEKRDCH LVPLAGTSET ILYTCRQDDM EITRSHTTAL ECKTVSPDEI
     TTRPMDKTVV FVDNHVELEM TESHTVFIDY QEKERTDRPN FELSQRKSLG TPTVICTPTE
     ESVFFPGNGE SDRLVANDSQ LTPLEEWSNN RGPVEVADNM ELSKSATCKN IKDVQSPGFL
     NEPLSSKSQR RKSLKLKNDK TIVFSENHKN DMDITQSCMV EIDNESALED KEDFHLAGAS
     KTILYSCGQD DMEITRSHTT ALECKTLLPN EIAIRPMDKT VLFTDNYSDL EVTDSHTVFI
     DCQATEKILE ENPKFGIGKG KNLGVSFPKD NSCVQEIAEK QALAVGNKIV LHTEQKQQLF
     AATNRTTNEI IKFHSAAMDE KVIGKVVDQA CTLEKAQVES CQLNNRDRRN VDFTSSHATA
     VCGSSDNYSC LPNVISCTDN LEGSAMLLCD KDEEKANYCP VQNDLAYAND FASEYYLESE
     GQPLSAPCPL LEKEEVIQTS TKGQLDCVIT LHKDQDLIKD PRNLLANQTL VYSQDLGEMT
     KLNSKRVSFK LPKDQMKVYV DDIYVIPQPH FSTDQPPLPK KGQSSINKEE VILSKAGNKS
     LNIIENSSAP ICENKPKILN SEEWFAAACK KELKENIQTT NYNTALDFHS NSDVTKQVIQ
     THVNAGEAPD PVITSNVPCF HSIKPNLNNL NGKTGEFLAF QTVHLPPLPE QLLELGNKAH
     NDMHIVQATE IHNINIISSN AKDSRDEENK KSHNGAETTS LPPKTVFKDK VRRCSLGIFL
     PRLPNKRNCS VTGIDDLEQI PADTTDINHL ETQPVSSKDS GIGSVAGKLN LSPSQYINEE
     NLPVYPDEIN SSDSINIETE EKALIETYQK EISPYENKMG KTCNSQKRTW VQEEEDIHKE
     KKIRKNEIKF SDTTQDREIF DHHTEEDIDK SANSVLIKNL SRTPSSCSSS LDSIKADGTS
     LDFSTYRSSQ MESQFLRDTI CEESLREKLQ DGRITIREFF ILLQVHILIQ KPRQSNLPGN
     FTVNTPPTPE DLMLSQYVYR PKIQIYREDC EARRQKIEEL KLSASNQDKL LVDINKNLWE
     KMRHCSDKEL KAFGIYLNKI KSCFTKMTKV FTHQGKVALY GKLVQSAQNE REKLQIKIDE
     MDKILKKIDN CLTEMETETK NLEDEEKNNP VEEWDSEMRA AEKELEQLKT EEEELQRNLL
     ELEVQKEQTL AQIDFMQKQR NRTEELLDQL SLSEWDVVEW SDDQAVFTFV YDTIQLTITF
     EESVVGFPFL DKRYRKIVDV NFQSLLDEDQ APPSSLLVHK LIFQYVEEKE SWKKTCTTQH
     QLPKMLEEFS LVVHHCRLLG EEIEYLKRWG PNYNLMNIDI NNNELRLLFS SSAAFAKFEI
     TLFLSAYYPS VPLPSTIQNH VGNTSQDDIA TILSKVPLEN NYLKNVVKQI YQDLFQDCHF
     YH
//
ID   MTG16_HUMAN             Reviewed;         653 AA.
AC   O75081; D3DX78; O60615; O60616; O60617; O75082; O75107; O75108;
AC   Q0P5Z6; Q6P5W6;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   28-FEB-2018, entry version 137.
DE   RecName: Full=Protein CBFA2T3;
DE   AltName: Full=MTG8-related protein 2;
DE   AltName: Full=Myeloid translocation gene on chromosome 16 protein;
DE            Short=hMTG16;
DE   AltName: Full=Zinc finger MYND domain-containing protein 4;
GN   Name=CBFA2T3; Synonyms=MTG16, MTGR2, ZMYND4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2),
RP   CHROMOSOMAL TRANSLOCATION WITH RUNX1, TISSUE SPECIFICITY, AND VARIANT
RP   GLY-429.
RC   TISSUE=Brain;
RX   PubMed=9596646;
RA   Gamou T., Kitamura E., Hosoda F., Shimuzu K., Hayashi Y., Nagase T.,
RA   Yokoyama Y., Ohki M.;
RT   "The partner gene of AML1 in t(16;21) myeloid malignancies is a novel
RT   member of the MTG8(ETO) family.";
RL   Blood 91:4028-4037(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 128-297 AND 492-604, NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 341-431, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9790752; DOI=10.1006/geno.1998.5429;
RA   Calabi F., Cilli V.;
RT   "CBFA2T1, a gene rearranged in human leukemia, is a member of a
RT   multigene family.";
RL   Genomics 52:332-341(1998).
RN   [5]
RP   CHROMOSOMAL TRANSLOCATION WITH RUNX1.
RX   PubMed=10995019; DOI=10.1038/sj.leu.2401885;
RA   Salomon-Nguyen F., Busson-Le Coniat M., Lafage Pochitaloff M.,
RA   Mozziconacci J., Berger R., Bernard O.A.;
RT   "AML1-MTG16 fusion gene in therapy-related acute leukemia with
RT   t(16;21)(q24;q22): two new cases.";
RL   Leukemia 14:1704-1705(2000).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH RUNX1.
RX   PubMed=11224496;
RA   La Starza R., Sambani C., Crescenzi B., Matteucci C., Martelli M.F.,
RA   Mecucci C.;
RT   "AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in
RT   treatment-induced leukemia after breast cancer.";
RL   Haematologica 86:212-213(2001).
RN   [7]
RP   INTERACTION WITH HDAC1; HDAC2; HDAC3; HDAC6; HDAC8; NCOR1 AND NCOR2.
RX   PubMed=11533236; DOI=10.1128/MCB.21.19.6470-6483.2001;
RA   Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N.,
RA   Downing J.R., Meyers S., Hiebert S.W.;
RT   "ETO, a target of t(8;21) in acute leukemia, makes distinct contacts
RT   with multiple histone deacetylases and binds mSin3A through its
RT   oligomerization domain.";
RL   Mol. Cell. Biol. 21:6470-6483(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=12183414;
RA   Kochetkova M., McKenzie O.L.D., Bais A.J., Martin J.M., Secker G.A.,
RA   Seshadri R., Powell J.A., Hinze S.J., Gardner A.E., Spendlove H.E.,
RA   O'Callaghan N.J., Cleton-Jansen A.-M., Cornelisse C., Whitmore S.A.,
RA   Crawford J., Kremmidiotis G., Sutherland G.R., Callen D.F.;
RT   "CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the
RT   breast cancer loss of heterozygosity region at 16q24.3.";
RL   Cancer Res. 62:4599-4604(2002).
RN   [9]
RP   FUNCTION (ISOFORM 2), INTERACTION WITH PRKAR2A, MUTAGENESIS OF
RP   VAL-494, AND SUBCELLULAR LOCATION (ISOFORM 2).
RX   PubMed=11823486; DOI=10.4049/jimmunol.168.4.1590;
RA   Schillace R.V., Andrews S.F., Liberty G.A., Davey M.P., Carr D.W.;
RT   "Identification and characterization of myeloid translocation gene 16b
RT   as a novel a kinase anchoring protein in T lymphocytes.";
RL   J. Immunol. 168:1590-1599(2002).
RN   [10]
RP   ALTERNATIVE SPLICING (ISOFORMS 3 AND 4), SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH CBFA2T2; HDAC1; HDAC3 AND RUNX1T1.
RX   PubMed=12242670; DOI=10.1038/sj.onc.1205882;
RA   Hoogeveen A.T., Rossetti S., Stoyanova V., Schonkeren J., Fenaroli A.,
RA   Schiaffonati L., van Unen L., Sacchi N.;
RT   "The transcriptional corepressor MTG16a contains a novel nucleolar
RT   targeting sequence deranged in t(16; 21)-positive myeloid
RT   malignancies.";
RL   Oncogene 21:6703-6712(2002).
RN   [11]
RP   REVIEW.
RX   PubMed=12559562; DOI=10.1016/S0378-1119(02)01172-1;
RA   Davis J.N., McGhee L., Meyers S.;
RT   "The ETO (MTG8) gene family.";
RL   Gene 303:1-10(2003).
RN   [12]
RP   FUNCTION, INTERACTION WITH NCOR1, AND TISSUE SPECIFICITY.
RX   PubMed=15231665; DOI=10.1158/0008-5472.CAN-03-3689;
RA   Ibanez V., Sharma A., Buonamici S., Verma A., Kalakonda S., Wang J.,
RA   Kadkol S., Saunthararajah Y.;
RT   "AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor
RT   corepressor, an effect that impairs granulocyte differentiation.";
RL   Cancer Res. 64:4547-4554(2004).
RN   [13]
RP   REVIEW.
RX   PubMed=15203199; DOI=10.1016/j.ygeno.2004.02.011;
RA   Rossetti S., Hoogeveen A.T., Sacchi N.;
RT   "The MTG proteins: chromatin repression players with a passion for
RT   networking.";
RL   Genomics 84:1-9(2004).
RN   [14]
RP   INTERACTION WITH PDE4A AND PDE7A.
RX   PubMed=15470020; DOI=10.4049/jimmunol.173.8.4806;
RA   Asirvatham A.L., Galligan S.G., Schillace R.V., Davey M.P., Vasta V.,
RA   Beavo J.A., Carr D.W.;
RT   "A-kinase anchoring proteins interact with phosphodiesterases in T
RT   lymphocyte cell lines.";
RL   J. Immunol. 173:4806-4814(2004).
RN   [15]
RP   INDUCTION.
RX   PubMed=15676213; DOI=10.1016/j.exphem.2004.10.011;
RA   Lindberg S.R., Olsson A., Persson A.-M., Olsson I.;
RT   "The leukemia-associated ETO homologues are differently expressed
RT   during hematopoietic differentiation.";
RL   Exp. Hematol. 33:189-198(2005).
RN   [16]
RP   INTERACTION WITH AML1-MTG8/ETO.
RX   PubMed=16616331; DOI=10.1016/j.ccr.2006.03.012;
RA   Liu Y., Cheney M.D., Gaudet J.J., Chruszcz M., Lukasik S.M.,
RA   Sugiyama D., Lary J., Cole J., Dauter Z., Minor W., Speck N.A.,
RA   Bushweller J.H.;
RT   "The tetramer structure of the Nervy homology two domain, NHR2, is
RT   critical for AML1/ETO's activity.";
RL   Cancer Cell 9:249-260(2006).
RN   [17]
RP   INTERACTION WITH ERBB4.
RX   PubMed=16815842; DOI=10.1074/jbc.M603998200;
RA   Linggi B., Carpenter G.;
RT   "ErbB-4 s80 intracellular domain abrogates ETO2-dependent
RT   transcriptional repression.";
RL   J. Biol. Chem. 281:25373-25380(2006).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH ZNF652.
RX   PubMed=16966434; DOI=10.1158/1541-7786.MCR-05-0249;
RA   Kumar R., Manning J., Spendlove H.E., Kremmidiotis G., McKirdy R.,
RA   Lee J., Millband D.N., Cheney K.M., Stampfer M.R., Dwivedi P.P.,
RA   Morris H.A., Callen D.F.;
RT   "ZNF652, a novel zinc finger protein, interacts with the putative
RT   breast tumor suppressor CBFA2T3 to repress transcription.";
RL   Mol. Cancer Res. 4:655-665(2006).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   INTERACTION WITH PLXNA1; PLXNA3 AND PRKAR1A.
RX   PubMed=20138877; DOI=10.1016/j.febslet.2010.02.007;
RA   Fiedler S.E., Schillace R.V., Daniels C.J., Andrews S.F., Carr D.W.;
RT   "Myeloid translocation gene 16b is a dual A-kinase anchoring protein
RT   that interacts selectively with plexins in a phospho-regulated
RT   manner.";
RL   FEBS Lett. 584:873-877(2010).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH ZBTB4; ZBTB33 AND ZBTB38.
RX   PubMed=23251453; DOI=10.1371/journal.pone.0051205;
RA   Barrett C.W., Smith J.J., Lu L.C., Markham N., Stengel K.R.,
RA   Short S.P., Zhang B., Hunt A.A., Fingleton B.M., Carnahan R.H.,
RA   Engel M.E., Chen X., Beauchamp R.D., Wilson K.T., Hiebert S.W.,
RA   Reynolds A.B., Williams C.S.;
RT   "Kaiso directs the transcriptional corepressor MTG16 to the Kaiso
RT   binding site in target promoters.";
RL   PLoS ONE 7:E51205-E51205(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457; SER-459 AND
RP   THR-479, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   FUNCTION, AND REGIONS NHR2 AND NHR3.
RX   PubMed=23840896; DOI=10.1371/journal.pone.0068502;
RA   Kumar P., Sharoyko V.V., Spegel P., Gullberg U., Mulder H., Olsson I.,
RA   Ajore R.;
RT   "The transcriptional co-repressor myeloid translocation gene 16
RT   inhibits glycolysis and stimulates mitochondrial respiration.";
RL   PLoS ONE 8:E68502-E68502(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637; SER-641 AND
RP   THR-650, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH HIF1A AND EGLN1.
RX   PubMed=25974097; DOI=10.1371/journal.pone.0123725;
RA   Kumar P., Gullberg U., Olsson I., Ajore R.;
RT   "Myeloid translocation gene-16 co-repressor promotes degradation of
RT   hypoxia-inducible factor 1.";
RL   PLoS ONE 10:E0123725-E0123725(2015).
RN   [26]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-306; LYS-518 AND VAL-534.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Transcriptional corepressor which facilitates
CC       transcriptional repression via its association with DNA-binding
CC       transcription factors and recruitment of other corepressors and
CC       histone-modifying enzymes (PubMed:12559562, PubMed:15203199). Can
CC       repress the expression of MMP7 in a ZBTB33-dependent manner
CC       (PubMed:23251453). Reduces the protein levels and stability of the
CC       transcriptinal regulator HIF1A; interacts with EGLN1 and promotes
CC       the HIF1A prolyl hydroxylation-dependent ubiquitination and
CC       proteasomal degradation pathway (PubMed:25974097). Contributes to
CC       inhibition of glycolysis and stimulation of mitochondrial
CC       respiration by down-regulating the expression of glycolytic genes
CC       including PFKFB3, PFKFB4, PDK1, PFKP, LDHA and HK1 which are
CC       direct targets of HIF1A (PubMed:23840896, PubMed:25974097).
CC       Regulates the proliferation and the differentiation of erythroid
CC       progenitors by repressing the expression of TAL1 target genes (By
CC       similarity). Plays a role in granulocyte differentiation
CC       (PubMed:15231665). {ECO:0000250|UniProtKB:O54972,
CC       ECO:0000269|PubMed:12183414, ECO:0000269|PubMed:15231665,
CC       ECO:0000269|PubMed:16966434, ECO:0000269|PubMed:23251453,
CC       ECO:0000269|PubMed:23840896, ECO:0000269|PubMed:25974097,
CC       ECO:0000303|PubMed:12559562, ECO:0000303|PubMed:15203199}.
CC   -!- FUNCTION: Isoform 2 functions as an A-kinase-anchoring protein
CC       (PubMed:11823486). {ECO:0000269|PubMed:11823486}.
CC   -!- SUBUNIT: Homooligomer. Homotetramerization is mediated by nervy
CC       homology region 2 (NRH2) (By similarity). Can interact with
CC       RUNX1T1 and CBFA2T2; heterotetramerization between members of the
CC       CBFA2T family is proposed (PubMed:12242670). Component of a TAL-1
CC       complex composed at least of CBFA2T3, LDB1, TAL1 and TCF3 (By
CC       similarity). Interacts with ERBB4, HDAC1, HDAC2, HDAC3, HDAC6,
CC       HDAC8, NCOR1, NCOR2, and ZNF652. According to PubMed:12242670, may
CC       not interact with HDAC6. Interacts with PLXNA1, PLXNA3 and
CC       PRKAR1A. Isoform 2 interacts with PRKAR2A, PDE7A and probably
CC       PDE4A. Interacts with ZBTB4, ZBTB38 and ZBTB33. Interacts with
CC       HIF1A and EGLN1. Interacts with the AML1-MTG8/ETO fusion protein.
CC       {ECO:0000250|UniProtKB:O54972, ECO:0000250|UniProtKB:Q06455,
CC       ECO:0000269|PubMed:11533236, ECO:0000269|PubMed:11823486,
CC       ECO:0000269|PubMed:12242670, ECO:0000269|PubMed:15231665,
CC       ECO:0000269|PubMed:15470020, ECO:0000269|PubMed:16616331,
CC       ECO:0000269|PubMed:16815842, ECO:0000269|PubMed:16966434,
CC       ECO:0000269|PubMed:20138877, ECO:0000269|PubMed:23251453,
CC       ECO:0000269|PubMed:25974097}.
CC   -!- INTERACTION:
CC       P51805:PLXNA3; NbExp=2; IntAct=EBI-1190217, EBI-7135904;
CC       Q9Y2D9:ZNF652; NbExp=2; IntAct=EBI-1190217, EBI-1190229;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Nucleus, nucleolus. Note=The
CC       RUNX1-CBFA2T3 fusion protein localizes to the nucleoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:11823486}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:11823486}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=CBFA2T3A, MTG16a;
CC         IsoId=O75081-1; Sequence=Displayed;
CC       Name=2; Synonyms=CBFA2T3B, MTG16b;
CC         IsoId=O75081-2; Sequence=VSP_028620, VSP_028624;
CC       Name=3; Synonyms=MTG16c;
CC         IsoId=O75081-4; Sequence=VSP_028621;
CC         Note=No experimental confirmation available.;
CC       Name=4; Synonyms=MTG16HEL;
CC         IsoId=O75081-5; Sequence=VSP_028622, VSP_028623;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed with higher expression in
CC       heart, pancreas, skeletal muscle, spleen, thymus and peripheral
CC       blood leukocytes. Expressed in hematopoietic cells (at protein
CC       level). {ECO:0000269|PubMed:15231665, ECO:0000269|PubMed:9596646,
CC       ECO:0000269|PubMed:9790752}.
CC   -!- INDUCTION: Down-regulated by all-trans retinoic acid (ATRA).
CC       {ECO:0000269|PubMed:15676213}.
CC   -!- DOMAIN: Nervy homology region 2 (NHR2) mediates homo- and possibly
CC       heterotypic oligomerization by forming a four-helix bundle
CC       tetrameric structure. {ECO:0000250|UniProtKB:Q06455}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CBFA2T3 is found
CC       in therapy-related myeloid malignancies. Translocation
CC       t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein.
CC       {ECO:0000269|PubMed:10995019, ECO:0000269|PubMed:11224496,
CC       ECO:0000269|PubMed:9596646}.
CC   -!- SIMILARITY: Belongs to the CBFA2T family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH62624.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=BAA31276.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAA31277.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CBFA2T3ID428ch16q24.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB010419; BAA29061.1; -; mRNA.
DR   EMBL; AB010420; BAA29062.1; -; mRNA.
DR   EMBL; AB013286; BAA31276.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AB013286; BAA31277.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471184; EAW66748.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66752.1; -; Genomic_DNA.
DR   EMBL; BC047019; AAH47019.1; -; mRNA.
DR   EMBL; BC062624; AAH62624.1; ALT_SEQ; mRNA.
DR   EMBL; AF052217; AAC64701.1; -; Genomic_DNA.
DR   EMBL; AF052216; AAC64701.1; JOINED; Genomic_DNA.
DR   EMBL; AF052215; AAC64702.1; -; Genomic_DNA.
DR   EMBL; AF052213; AAC64702.1; JOINED; Genomic_DNA.
DR   EMBL; AF052214; AAC64702.1; JOINED; Genomic_DNA.
DR   EMBL; AF052220; AAC64698.1; -; mRNA.
DR   CCDS; CCDS10972.1; -. [O75081-1]
DR   CCDS; CCDS10973.1; -. [O75081-2]
DR   RefSeq; NP_005178.4; NM_005187.5. [O75081-1]
DR   RefSeq; NP_787127.1; NM_175931.2. [O75081-2]
DR   UniGene; Hs.513811; -.
DR   ProteinModelPortal; O75081; -.
DR   SMR; O75081; -.
DR   BioGrid; 107311; 26.
DR   DIP; DIP-48898N; -.
DR   IntAct; O75081; 15.
DR   MINT; O75081; -.
DR   STRING; 9606.ENSP00000268679; -.
DR   iPTMnet; O75081; -.
DR   PhosphoSitePlus; O75081; -.
DR   BioMuta; CBFA2T3; -.
DR   EPD; O75081; -.
DR   MaxQB; O75081; -.
DR   PaxDb; O75081; -.
DR   PeptideAtlas; O75081; -.
DR   PRIDE; O75081; -.
DR   DNASU; 863; -.
DR   Ensembl; ENST00000268679; ENSP00000268679; ENSG00000129993. [O75081-1]
DR   Ensembl; ENST00000327483; ENSP00000332122; ENSG00000129993. [O75081-2]
DR   GeneID; 863; -.
DR   KEGG; hsa:863; -.
DR   UCSC; uc002fml.3; human. [O75081-1]
DR   CTD; 863; -.
DR   DisGeNET; 863; -.
DR   EuPathDB; HostDB:ENSG00000129993.14; -.
DR   GeneCards; CBFA2T3; -.
DR   H-InvDB; HIX0013342; -.
DR   HGNC; HGNC:1537; CBFA2T3.
DR   HPA; HPA059931; -.
DR   HPA; HPA062423; -.
DR   HPA; HPA065890; -.
DR   MalaCards; CBFA2T3; -.
DR   MIM; 603870; gene.
DR   neXtProt; NX_O75081; -.
DR   OpenTargets; ENSG00000129993; -.
DR   Orphanet; 329469; Acute megakaryoblastic leukemia without Down syndrome.
DR   PharmGKB; PA26113; -.
DR   eggNOG; ENOG410IG1Z; Eukaryota.
DR   eggNOG; ENOG410XR30; LUCA.
DR   GeneTree; ENSGT00390000013479; -.
DR   HOVERGEN; HBG000169; -.
DR   InParanoid; O75081; -.
DR   OMA; MAMAHHF; -.
DR   OrthoDB; EOG091G0EIC; -.
DR   PhylomeDB; O75081; -.
DR   TreeFam; TF106303; -.
DR   SIGNOR; O75081; -.
DR   ChiTaRS; CBFA2T3; human.
DR   GeneWiki; CBFA2T3; -.
DR   GenomeRNAi; 863; -.
DR   PRO; PR:O75081; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000129993; -.
DR   ExpressionAtlas; O75081; baseline and differential.
DR   Genevisible; O75081; HS.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0030851; P:granulocyte differentiation; IDA:MGI.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045820; P:negative regulation of glycolytic process; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:1903715; P:regulation of aerobic respiration; IDA:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR013289; CBFA2T1/2/3.
DR   InterPro; IPR013292; CBFA2T3.
DR   InterPro; IPR014896; NHR2.
DR   InterPro; IPR037249; TAFH/NHR1_dom_sf.
DR   InterPro; IPR003894; TAFH_NHR1.
DR   InterPro; IPR002893; Znf_MYND.
DR   PANTHER; PTHR10379; PTHR10379; 1.
DR   Pfam; PF08788; NHR2; 1.
DR   Pfam; PF07531; TAFH; 1.
DR   Pfam; PF01753; zf-MYND; 1.
DR   PRINTS; PR01875; ETOFAMILY.
DR   PRINTS; PR01878; MTG16PROTEIN.
DR   SMART; SM00549; TAFH; 1.
DR   SUPFAM; SSF158553; SSF158553; 1.
DR   PROSITE; PS51119; TAFH; 1.
DR   PROSITE; PS01360; ZF_MYND_1; 1.
DR   PROSITE; PS50865; ZF_MYND_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Differentiation; Golgi apparatus; Membrane;
KW   Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN         1    653       Protein CBFA2T3.
FT                                /FTId=PRO_0000307173.
FT   DOMAIN      171    266       TAFH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00440}.
FT   ZN_FING     556    592       MYND-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00134}.
FT   REGION        1    435       Mediates localization to the nucleus.
FT                                {ECO:0000250}.
FT   REGION        1    430       Mediates interaction with PDE7A (in
FT                                isoform 2).
FT   REGION        1    127       Required for nucleolar targeting (in
FT                                isoform 1).
FT   REGION      145    242       Interaction with ZBTB33.
FT                                {ECO:0000269|PubMed:23251453}.
FT   REGION      176    268       Interaction with HIF1A.
FT                                {ECO:0000269|PubMed:25974097}.
FT   REGION      394    412       Nervy homology region 2 (NHR2); essential
FT                                for down-regulation of PFKFB3, PFKFB4 and
FT                                PDK1 expression.
FT                                {ECO:0000269|PubMed:23840896}.
FT   REGION      485    533       Nervy homology region 3 (NHR3); essential
FT                                for down-regulation of PFKFB3, PFKFB4 and
FT                                PDK1 expression.
FT                                {ECO:0000269|PubMed:23840896}.
FT   REGION      485    506       Mediates interaction with PRKAR2A.
FT                                {ECO:0000269|PubMed:11823486}.
FT   COILED      488    543       {ECO:0000255}.
FT   COMPBIAS     42     99       Pro-rich.
FT   SITE         51     52       Breakpoint for translocation to form
FT                                type-1 RUNX1-CBFA2T3 fusion protein.
FT   SITE        127    128       Breakpoint for translocation to form
FT                                type-2 RUNX1-CBFA2T3 fusion protein.
FT   MOD_RES     457    457       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     459    459       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     479    479       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     637    637       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     641    641       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     650    650       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     61       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9596646}.
FT                                /FTId=VSP_028620.
FT   VAR_SEQ      51    127       APVDRKAKASAMPDSPAEVKTQPRSTPPSMPPPPPAASQGA
FT                                TRPPSFTPHTHREDGPATLPHGRFHGCLKWSMVCLL -> V
FT                                (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_028621.
FT   VAR_SEQ      51     51       A -> GKPALAAAGAPALCTPGQADARPVLGPA (in
FT                                isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_028622.
FT   VAR_SEQ      52    653       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_028623.
FT   VAR_SEQ     102    126       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9596646}.
FT                                /FTId=VSP_028624.
FT   VARIANT     306    306       R -> H (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs745972870).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035447.
FT   VARIANT     429    429       E -> G (in dbSNP:rs1053526).
FT                                {ECO:0000269|PubMed:9596646}.
FT                                /FTId=VAR_035374.
FT   VARIANT     518    518       E -> K (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs774310781).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035448.
FT   VARIANT     534    534       A -> V (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs553618592).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035449.
FT   MUTAGEN     494    494       V->P,A: Loss of interaction with PRKAR2A.
FT                                {ECO:0000269|PubMed:11823486}.
FT   CONFLICT    231    231       F -> L (in Ref. 3; AAH47019).
FT                                {ECO:0000305}.
FT   CONFLICT    295    295       T -> S (in Ref. 4; AAC64702).
FT                                {ECO:0000305}.
FT   CONFLICT    305    305       D -> E (in Ref. 1; BAA29061).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       R -> P (in Ref. 4; AAC64698).
FT                                {ECO:0000305}.
FT   CONFLICT    420    420       L -> V (in Ref. 4; AAC64698).
FT                                {ECO:0000305}.
FT   CONFLICT    542    542       A -> D (in Ref. 4; AAC64701).
FT                                {ECO:0000305}.
SQ   SEQUENCE   653 AA;  71192 MW;  0B72B602120FA5DE CRC64;
     MPASRLRDRA ASSASGSTCG SMSQTHPVLE SGLLASAGCS APRGPRKGGP APVDRKAKAS
     AMPDSPAEVK TQPRSTPPSM PPPPPAASQG ATRPPSFTPH THREDGPATL PHGRFHGCLK
     WSMVCLLMNG SSHSPTAING APCTPNGFSN GPATSSTASL STQHLPPACG ARQLSKLKRF
     LTTLQQFGSD ISPEIGERVR TLVLGLVNST LTIEEFHSKL QEATNFPLRP FVIPFLKANL
     PLLQRELLHC ARLAKQTPAQ YLAQHEQLLL DASASSPIDS SELLLEVNEN GKRRTPDRTK
     ENGSDRDPLH PEHLSKRPCT LNPAQRYSPS NGPPQPTPPP HYRLEDIAMA HHFRDAYRHP
     DPRELRERHR PLVVPGSRQE EVIDHKLTER EWAEEWKHLN NLLNCIMDMV EKTRRSLTVL
     RRCQEADREE LNHWARRYSD AEDTKKGPAP AAARPRSSSA GPEGPQLDVP REFLPRTLTG
     YVPEDIWRKA EEAVNEVKRQ AMSELQKAVS DAERKAHELI TTERAKMERA LAEAKRQASE
     DALTVINQQE DSSESCWNCG RKASETCSGC NAARYCGSFC QHRDWEKHHH VCGQSLQGPT
     AVVADPVPGP PEAAHSLGPS LPVGAASPSE AGSAGPSRPG SPSPPGPLDT VPR
//
ID   A0A024R6X2_HUMAN        Unreviewed;       182 AA.
AC   A0A024R6X2;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 22.
DE   SubName: Full=Core-binding factor, beta subunit, isoform CRA_b {ECO:0000313|EMBL:EAW83069.1};
GN   Name=CBFB {ECO:0000313|EMBL:EAW83069.1};
GN   ORFNames=hCG_28838 {ECO:0000313|EMBL:EAW83069.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW83069.1};
RN   [1] {ECO:0000313|EMBL:EAW83069.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW83069.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471092; EAW83069.1; -; Genomic_DNA.
DR   RefSeq; NP_001746.1; NM_001755.2.
DR   UniGene; Hs.460988; -.
DR   ProteinModelPortal; A0A024R6X2; -.
DR   SMR; A0A024R6X2; -.
DR   PRIDE; A0A024R6X2; -.
DR   GeneID; 865; -.
DR   KEGG; hsa:865; -.
DR   CTD; 865; -.
DR   EuPathDB; HostDB:ENSG00000067955.13; -.
DR   eggNOG; KOG4785; Eukaryota.
DR   eggNOG; ENOG410Z04Q; LUCA.
DR   PhylomeDB; A0A024R6X2; -.
DR   ChiTaRS; CBFB; human.
DR   GenomeRNAi; 865; -.
DR   Bgee; ENSG00000067955; -.
DR   ExpressionAtlas; A0A024R6X2; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   Gene3D; 2.40.250.10; -; 1.
DR   InterPro; IPR003417; CBF_beta.
DR   InterPro; IPR036552; CBF_bsu_sf.
DR   PANTHER; PTHR10276; PTHR10276; 1.
DR   Pfam; PF02312; CBF_beta; 1.
DR   SUPFAM; SSF50723; SSF50723; 1.
PE   4: Predicted;
SQ   SEQUENCE   182 AA;  21508 MW;  20FB1CC05FBFE4FB CRC64;
     MPRVVPDQRS KFENEEFFRK LSRECEIKYT GFRDRPHEER QARFQNACRD GRSEIAFVAT
     GTNLSLQFFP ASWQGEQRQT PSREYVDLER EAGKVYLKAP MILNGVCVIW KGWIDLQRLD
     GMGCLEFDEE RAQQEDALAQ QAFEEARRRT REFEDRDRSH REEMEVRVSQ LLAVTGKKTT
     RP
//
ID   PEBB_HUMAN              Reviewed;         182 AA.
AC   Q13951; A8K347; Q13124; Q9HCT2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   28-FEB-2018, entry version 168.
DE   RecName: Full=Core-binding factor subunit beta;
DE            Short=CBF-beta;
DE   AltName: Full=Polyomavirus enhancer-binding protein 2 beta subunit;
DE            Short=PEA2-beta;
DE            Short=PEBP2-beta;
DE   AltName: Full=SL3-3 enhancer factor 1 subunit beta;
DE   AltName: Full=SL3/AKV core-binding factor beta subunit;
GN   Name=CBFB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Liu P.P.;
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-26 (ISOFORMS 1/2).
RX   PubMed=7607682; DOI=10.1016/0888-7543(95)80177-N;
RA   Hajra A., Collins F.S.;
RT   "Structure of the leukemia-associated human CBFB gene.";
RL   Genomics 26:571-579(1995).
RN   [7]
RP   ERRATUM.
RX   PubMed=9064279; DOI=10.1006/geno.1996.0603;
RA   Hajra A., Collins F.S.;
RL   Genomics 38:107-107(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-182 (ISOFORM 1), AND CHROMOSOMAL
RP   INVERSION.
RC   TISSUE=Brain;
RX   PubMed=8351518; DOI=10.1126/science.8351518;
RA   Liu P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M.,
RA   Siciliano M.J., Collins F.S.;
RT   "Fusion between transcription factor CBF beta/PEBP2 beta and a myosin
RT   heavy chain in acute myeloid leukemia.";
RL   Science 261:1041-1044(1993).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 2-135 IN COMPLEX WITH RUNX1.
RX   PubMed=10856244; DOI=10.1093/emboj/19.12.3004;
RA   Warren A.J., Bravo J., Williams R.L., Rabbitts T.H.;
RT   "Structural basis for the heterodimeric interaction between the acute
RT   leukaemia-associated transcription factors AML1 and CBFbeta.";
RL   EMBO J. 19:3004-3015(2000).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 2-135 IN COMPLEX WITH RUNX1
RP   AND DNA.
RX   PubMed=11276260; DOI=10.1038/86264;
RA   Bravo J., Li Z., Speck N.A., Warren A.J.;
RT   "The leukemia-associated AML1 (Runx1) -- CBF beta complex functions as
RT   a DNA-induced molecular clamp.";
RL   Nat. Struct. Biol. 8:371-378(2001).
RN   [15]
RP   STRUCTURE BY NMR OF 4-141.
RX   PubMed=10404215; DOI=10.1038/10664;
RA   Goger M., Gupta V., Kim W.Y., Shigesada K., Ito Y., Werner M.H.;
RT   "Molecular insights into PEBP2/CBF beta-SMMHC associated acute
RT   leukemia revealed from the structure of PEBP2/CBF beta.";
RL   Nat. Struct. Biol. 6:620-623(1999).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-100.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: CBF binds to the core site, 5'-PYGPYGGT-3', of a number
CC       of enhancers and promoters, including murine leukemia virus,
CC       polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-
CC       CSF promoters. CBFB enhances DNA binding by RUNX1.
CC   -!- SUBUNIT: Heterodimer with RUNX1. Interacts with COPRS (By
CC       similarity). Found in a complex with PRMT5, RUNX1 and CBFB (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9NVM9:INTS13; NbExp=2; IntAct=EBI-718750, EBI-741429;
CC       P11137:MAP2; NbExp=2; IntAct=EBI-718750, EBI-2682460;
CC       Q01196:RUNX1; NbExp=3; IntAct=EBI-718750, EBI-925904;
CC       P12504:vif (xeno); NbExp=10; IntAct=EBI-718750, EBI-779991;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13951-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13951-2; Sequence=VSP_036044;
CC         Note=Contains a phosphoserine at position 173.
CC         {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:20068231};
CC   -!- DISEASE: Note=A chromosomal aberration involving CBFB is
CC       associated with acute myeloid leukemia of M4EO subtype.
CC       Pericentric inversion inv(16)(p13;q22). The inversion produces a
CC       fusion protein that consists of the 165 N-terminal residues of
CC       CBF-beta (PEPB2) with the tail region of MYH11.
CC       {ECO:0000269|PubMed:8351518}.
CC   -!- SIMILARITY: Belongs to the CBF-beta family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CBFbID45.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF294326; AAG01553.1; -; mRNA.
DR   EMBL; BT006862; AAP35508.1; -; mRNA.
DR   EMBL; AK290462; BAF83151.1; -; mRNA.
DR   EMBL; CH471092; EAW83067.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW83068.1; -; Genomic_DNA.
DR   EMBL; BC018509; AAH18509.1; -; mRNA.
DR   EMBL; L20298; AAA02868.1; -; mRNA.
DR   CCDS; CCDS10827.1; -. [Q13951-1]
DR   CCDS; CCDS45508.1; -. [Q13951-2]
DR   PIR; A56840; A56840.
DR   PIR; I59579; I59579.
DR   RefSeq; NP_001746.1; NM_001755.2. [Q13951-1]
DR   RefSeq; NP_074036.1; NM_022845.2. [Q13951-2]
DR   UniGene; Hs.460988; -.
DR   PDB; 1CL3; NMR; -; A=4-141.
DR   PDB; 1E50; X-ray; 2.60 A; B/D/F/H=2-135.
DR   PDB; 1H9D; X-ray; 2.60 A; B/D=2-135.
DR   PDB; 4N9F; X-ray; 3.30 A; 0/6/F/L/N/R/a/c/i/k/o/u=1-170.
DR   PDBsum; 1CL3; -.
DR   PDBsum; 1E50; -.
DR   PDBsum; 1H9D; -.
DR   PDBsum; 4N9F; -.
DR   ProteinModelPortal; Q13951; -.
DR   SMR; Q13951; -.
DR   BioGrid; 107313; 28.
DR   CORUM; Q13951; -.
DR   DIP; DIP-36772N; -.
DR   IntAct; Q13951; 26.
DR   MINT; Q13951; -.
DR   STRING; 9606.ENSP00000415151; -.
DR   BindingDB; Q13951; -.
DR   ChEMBL; CHEMBL1615386; -.
DR   iPTMnet; Q13951; -.
DR   PhosphoSitePlus; Q13951; -.
DR   BioMuta; CBFB; -.
DR   DMDM; 2498753; -.
DR   EPD; Q13951; -.
DR   MaxQB; Q13951; -.
DR   PaxDb; Q13951; -.
DR   PeptideAtlas; Q13951; -.
DR   PRIDE; Q13951; -.
DR   DNASU; 865; -.
DR   Ensembl; ENST00000290858; ENSP00000290858; ENSG00000067955. [Q13951-1]
DR   Ensembl; ENST00000412916; ENSP00000415151; ENSG00000067955. [Q13951-2]
DR   GeneID; 865; -.
DR   KEGG; hsa:865; -.
DR   UCSC; uc002era.4; human. [Q13951-1]
DR   CTD; 865; -.
DR   DisGeNET; 865; -.
DR   EuPathDB; HostDB:ENSG00000067955.13; -.
DR   GeneCards; CBFB; -.
DR   HGNC; HGNC:1539; CBFB.
DR   HPA; HPA038852; -.
DR   MalaCards; CBFB; -.
DR   MIM; 121360; gene.
DR   neXtProt; NX_Q13951; -.
DR   OpenTargets; ENSG00000067955; -.
DR   Orphanet; 98829; 'Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)'.
DR   PharmGKB; PA26114; -.
DR   eggNOG; KOG4785; Eukaryota.
DR   eggNOG; ENOG410Z04Q; LUCA.
DR   GeneTree; ENSGT00390000018132; -.
DR   HOGENOM; HOG000008040; -.
DR   HOVERGEN; HBG000541; -.
DR   InParanoid; Q13951; -.
DR   OMA; CCEGHTE; -.
DR   OrthoDB; EOG091G0VFL; -.
DR   PhylomeDB; Q13951; -.
DR   TreeFam; TF314675; -.
DR   Reactome; R-HSA-8877330; RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs).
DR   Reactome; R-HSA-8878166; Transcriptional regulation by RUNX2.
DR   Reactome; R-HSA-8931987; RUNX1 regulates estrogen receptor mediated transcription.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-HSA-8935964; RUNX1 regulates expression of components of tight junctions.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939242; RUNX1 regulates transcription of genes involved in differentiation of keratinocytes.
DR   Reactome; R-HSA-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   Reactome; R-HSA-8939245; RUNX1 regulates transcription of genes involved in BCR signaling.
DR   Reactome; R-HSA-8939246; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells.
DR   Reactome; R-HSA-8939247; RUNX1 regulates transcription of genes involved in interleukin signaling.
DR   Reactome; R-HSA-8939256; RUNX1 regulates transcription of genes involved in WNT signaling.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8940973; RUNX2 regulates osteoblast differentiation.
DR   Reactome; R-HSA-8941284; RUNX2 regulates chondrocyte maturation.
DR   Reactome; R-HSA-8941326; RUNX2 regulates bone development.
DR   Reactome; R-HSA-8941332; RUNX2 regulates genes involved in cell migration.
DR   Reactome; R-HSA-8941333; RUNX2 regulates genes involved in differentiation of myeloid cells.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8949275; RUNX3 Regulates Immune Response and Cell Migration.
DR   Reactome; R-HSA-8951430; RUNX3 regulates WNT signaling.
DR   Reactome; R-HSA-8951911; RUNX3 regulates RUNX1-mediated transcription.
DR   Reactome; R-HSA-8951936; RUNX3 regulates p14-ARF.
DR   SIGNOR; Q13951; -.
DR   ChiTaRS; CBFB; human.
DR   EvolutionaryTrace; Q13951; -.
DR   GeneWiki; CBFB; -.
DR   GenomeRNAi; 865; -.
DR   PRO; PR:Q13951; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000067955; -.
DR   CleanEx; HS_CBFB; -.
DR   ExpressionAtlas; Q13951; baseline and differential.
DR   Genevisible; Q13951; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003677; F:DNA binding; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0060216; P:definitive hemopoiesis; IEA:Ensembl.
DR   GO; GO:0030098; P:lymphocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030099; P:myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0000209; P:protein polyubiquitination; IMP:CACAO.
DR   GO; GO:0050855; P:regulation of B cell receptor signaling pathway; TAS:Reactome.
DR   GO; GO:2000810; P:regulation of bicellular tight junction assembly; TAS:Reactome.
DR   GO; GO:0001959; P:regulation of cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:1902036; P:regulation of hematopoietic stem cell differentiation; TAS:Reactome.
DR   GO; GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045616; P:regulation of keratinocyte differentiation; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0045637; P:regulation of myeloid cell differentiation; TAS:Reactome.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; TAS:Reactome.
DR   GO; GO:0030111; P:regulation of Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   Gene3D; 2.40.250.10; -; 1.
DR   InterPro; IPR003417; CBF_beta.
DR   InterPro; IPR036552; CBF_bsu_sf.
DR   PANTHER; PTHR10276; PTHR10276; 1.
DR   Pfam; PF02312; CBF_beta; 1.
DR   SUPFAM; SSF50723; SSF50723; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Complete proteome; Nucleus; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome.
FT   CHAIN         1    182       Core-binding factor subunit beta.
FT                                /FTId=PRO_0000058301.
FT   SITE        165    166       Breakpoint for translocation to form CBF-
FT                                beta-MYH11 oncogene in AML, subtype M4EO.
FT   VAR_SEQ     166    182       VRVSQLLAVTGKKTTRP -> ARRQQDPSPGSNLGGGDDLK
FT                                LR (in isoform 2). {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_036044.
FT   VARIANT     100    100       P -> A (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036226.
FT   HELIX         8     14       {ECO:0000244|PDB:1E50}.
FT   HELIX        16     19       {ECO:0000244|PDB:1E50}.
FT   STRAND       25     29       {ECO:0000244|PDB:1E50}.
FT   STRAND       33     35       {ECO:0000244|PDB:1E50}.
FT   HELIX        37     49       {ECO:0000244|PDB:1E50}.
FT   STRAND       52     57       {ECO:0000244|PDB:1E50}.
FT   TURN         58     61       {ECO:0000244|PDB:1E50}.
FT   STRAND       65     67       {ECO:0000244|PDB:1E50}.
FT   HELIX        71     73       {ECO:0000244|PDB:4N9F}.
FT   TURN         83     85       {ECO:0000244|PDB:1E50}.
FT   STRAND       86     91       {ECO:0000244|PDB:1E50}.
FT   STRAND       94    103       {ECO:0000244|PDB:1E50}.
FT   STRAND      106    115       {ECO:0000244|PDB:1E50}.
FT   TURN        116    118       {ECO:0000244|PDB:1E50}.
FT   STRAND      119    127       {ECO:0000244|PDB:1E50}.
FT   HELIX       129    134       {ECO:0000244|PDB:1E50}.
FT   HELIX       137    148       {ECO:0000244|PDB:4N9F}.
SQ   SEQUENCE   182 AA;  21508 MW;  20FB1CC05FBFE4FB CRC64;
     MPRVVPDQRS KFENEEFFRK LSRECEIKYT GFRDRPHEER QARFQNACRD GRSEIAFVAT
     GTNLSLQFFP ASWQGEQRQT PSREYVDLER EAGKVYLKAP MILNGVCVIW KGWIDLQRLD
     GMGCLEFDEE RAQQEDALAQ QAFEEARRRT REFEDRDRSH REEMEVRVSQ LLAVTGKKTT
     RP
//
ID   Q05CP8_HUMAN            Unreviewed;       334 AA.
AC   Q05CP8;
DT   14-NOV-2006, integrated into UniProtKB/TrEMBL.
DT   14-NOV-2006, sequence version 1.
DT   20-DEC-2017, entry version 54.
DE   SubName: Full=CCDC6 protein {ECO:0000313|EMBL:AAH22284.1};
DE   Flags: Fragment;
GN   Name=CCDC6 {ECO:0000313|EMBL:AAH22284.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH22284.1};
RN   [1] {ECO:0000313|EMBL:AAH22284.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung {ECO:0000313|EMBL:AAH22284.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC022284; AAH22284.1; -; mRNA.
DR   RefSeq; NP_005427.2; NM_005436.4.
DR   UniGene; Hs.591360; -.
DR   MaxQB; Q05CP8; -.
DR   PeptideAtlas; Q05CP8; -.
DR   PRIDE; Q05CP8; -.
DR   GeneID; 8030; -.
DR   KEGG; hsa:8030; -.
DR   CTD; 8030; -.
DR   PharmGKB; PA134904022; -.
DR   HOGENOM; HOG000091755; -.
DR   HOVERGEN; HBG050823; -.
DR   KO; K09288; -.
DR   ChiTaRS; CCDC6; human.
DR   GenomeRNAi; 8030; -.
DR   Genevisible; Q05CP8; HS.
DR   InterPro; IPR019152; DUF2046.
DR   PANTHER; PTHR15276; PTHR15276; 1.
DR   Pfam; PF09755; DUF2046; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED       56    104       {ECO:0000256|SAM:Coils}.
FT   COILED      120    140       {ECO:0000256|SAM:Coils}.
FT   COILED      142    212       {ECO:0000256|SAM:Coils}.
FT   COILED      214    234       {ECO:0000256|SAM:Coils}.
FT   COILED      262    289       {ECO:0000256|SAM:Coils}.
FT   NON_TER     334    334       {ECO:0000313|EMBL:AAH22284.1}.
SQ   SEQUENCE   334 AA;  38164 MW;  4DA022DF2550140D CRC64;
     MADSASESDT DGAGGNSSSS AAMQSSCSST SGGGGGGGGG GGGGKSGGIV ISPFRLEELT
     NRLASLQQEN KVLKIELETY KLKCKALQEE NRDLRKASVT IQARAEQEEE FISNTLFKKI
     QALQKEKETL AVNYEKEEEF LTNELSRKLM QLQHEKAELE QHLEQEQEFQ VNKLMKKIKK
     LENDTISKQL TLEQLRREKI DLENTLEQEQ EALVNRLWKR MDKLEAEKRI LQEKLDQPVS
     APPSPRDISM EIDSPENMMR HIRFLKNEVE RLKKQLRAAQ LQHSEKMAQY LEEERHMREE
     RGRRGKMAAT KRKRRGGFAV QAKKPKKKKK KKKK
//
ID   CCDC6_HUMAN             Reviewed;         474 AA.
AC   Q16204; Q15250; Q6GSG7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 2.
DT   28-FEB-2018, entry version 164.
DE   RecName: Full=Coiled-coil domain-containing protein 6;
DE   AltName: Full=Papillary thyroid carcinoma-encoded protein;
DE   AltName: Full=Protein H4;
GN   Name=CCDC6; Synonyms=D10S170, TST1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-470.
RC   TISSUE=Thyroid;
RX   PubMed=8058316;
RA   Grieco M., Cerrato A., Santoro M., Fusco A., Melillo R.M., Vecchio G.;
RT   "Cloning and characterization of H4 (D10S170), a gene involved in RET
RT   rearrangements in vivo.";
RL   Oncogene 9:2531-2535(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-470.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-470.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-470.
RC   TISSUE=Blood, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-101, AND CHROMOSOMAL TRANSLOCATION
RP   WITH RET.
RC   TISSUE=Thyroid papillary carcinoma;
RX   PubMed=2406025; DOI=10.1016/0092-8674(90)90659-3;
RA   Grieco M., Santoro M., Berlingieri M.T., Melillo R.M., Donghi R.,
RA   Bongarzone I., Pierotti M.A., Della Porta G., Fusco A., Vecchio G.;
RT   "PTC is a novel rearranged form of the ret proto-oncogene and is
RT   frequently detected in vivo in human thyroid papillary carcinomas.";
RL   Cell 60:557-563(1990).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-240 AND SER-244,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; THR-349; SER-363 AND
RP   SER-367, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-240; SER-244;
RP   SER-254 AND SER-367, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-240; SER-244;
RP   SER-249; SER-254; SER-284 AND SER-323, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-244 AND
RP   SER-323, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-240; SER-244;
RP   SER-254; SER-323; SER-395 AND SER-413, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- INTERACTION:
CC       Q969H0:FBXW7; NbExp=9; IntAct=EBI-1045350, EBI-359574;
CC       Q13526:PIN1; NbExp=4; IntAct=EBI-1045350, EBI-714158;
CC       Q15311:RALBP1; NbExp=4; IntAct=EBI-1045350, EBI-749285;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton
CC       {ECO:0000305}. Note=May be a cytoskeletal protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- DOMAIN: The protein has mostly an alpha helical conformation
CC       similar to myosin heavy-chain tail that might adopt a coiled-coil
CC       conformation.
CC   -!- DISEASE: Note=A chromosomal aberration involving CCDC6 is found in
CC       papillary thyroid carcinomas (PTCs). Inversion inv(10)(q11.2;q21)
CC       generates the RET/CCDC6 (PTC1) oncogene.
CC       {ECO:0000269|PubMed:2406025}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC60637.1; Type=Frameshift; Positions=456; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/H4ID280.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S72869; AAC60637.1; ALT_FRAME; mRNA.
DR   EMBL; AK292593; BAF85282.1; -; mRNA.
DR   EMBL; AC060231; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023904; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54196.1; -; Genomic_DNA.
DR   EMBL; BC036757; AAH36757.2; -; mRNA.
DR   EMBL; BC064391; AAH64391.1; -; mRNA.
DR   EMBL; M31213; AAA36524.1; ALT_TERM; mRNA.
DR   CCDS; CCDS7257.1; -.
DR   PIR; I58403; I58403.
DR   RefSeq; NP_005427.2; NM_005436.4.
DR   UniGene; Hs.591360; -.
DR   ProteinModelPortal; Q16204; -.
DR   SMR; Q16204; -.
DR   BioGrid; 113725; 68.
DR   IntAct; Q16204; 38.
DR   MINT; Q16204; -.
DR   STRING; 9606.ENSP00000263102; -.
DR   iPTMnet; Q16204; -.
DR   PhosphoSitePlus; Q16204; -.
DR   BioMuta; CCDC6; -.
DR   DMDM; 292494979; -.
DR   EPD; Q16204; -.
DR   MaxQB; Q16204; -.
DR   PaxDb; Q16204; -.
DR   PeptideAtlas; Q16204; -.
DR   PRIDE; Q16204; -.
DR   Ensembl; ENST00000263102; ENSP00000263102; ENSG00000108091.
DR   GeneID; 8030; -.
DR   KEGG; hsa:8030; -.
DR   UCSC; uc001jks.5; human.
DR   CTD; 8030; -.
DR   DisGeNET; 8030; -.
DR   EuPathDB; HostDB:ENSG00000108091.10; -.
DR   GeneCards; CCDC6; -.
DR   H-InvDB; HIX0008848; -.
DR   HGNC; HGNC:18782; CCDC6.
DR   HPA; HPA019049; -.
DR   HPA; HPA019051; -.
DR   MalaCards; CCDC6; -.
DR   MIM; 601985; gene.
DR   neXtProt; NX_Q16204; -.
DR   OpenTargets; ENSG00000108091; -.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   PharmGKB; PA134904022; -.
DR   eggNOG; KOG2129; Eukaryota.
DR   eggNOG; ENOG410XR5H; LUCA.
DR   GeneTree; ENSGT00390000013594; -.
DR   HOGENOM; HOG000091755; -.
DR   HOVERGEN; HBG050823; -.
DR   InParanoid; Q16204; -.
DR   KO; K09288; -.
DR   OMA; QNRCYAC; -.
DR   OrthoDB; EOG091G07PT; -.
DR   PhylomeDB; Q16204; -.
DR   TreeFam; TF321211; -.
DR   SIGNOR; Q16204; -.
DR   ChiTaRS; CCDC6; human.
DR   GeneWiki; CCDC6; -.
DR   GenomeRNAi; 8030; -.
DR   PRO; PR:Q16204; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000108091; -.
DR   CleanEx; HS_CCDC6; -.
DR   Genevisible; Q16204; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   InterPro; IPR019152; DUF2046.
DR   PANTHER; PTHR15276; PTHR15276; 2.
DR   Pfam; PF09755; DUF2046; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Methylation;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome;
KW   Repeat; SH3-binding.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    474       Coiled-coil domain-containing protein 6.
FT                                /FTId=PRO_0000089398.
FT   REPEAT      106    134       1.
FT   REPEAT      135    163       2.
FT   REPEAT      164    192       3.
FT   REPEAT      193    206       4; approximate.
FT   REPEAT      207    235       5.
FT   REGION      106    235       5 X 29 AA tandem repeats.
FT   COILED       53    237       {ECO:0000255}.
FT   COILED      253    332       {ECO:0000255}.
FT   MOTIF       442    451       SH3-binding. {ECO:0000255}.
FT   COMPBIAS     17     20       Poly-Ser.
FT   COMPBIAS     32     44       Poly-Gly.
FT   COMPBIAS    440    448       Poly-Pro.
FT   SITE        101    102       Breakpoint for translocation to form RET-
FT                                CCDC6 oncogene.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     240    240       Phosphoserine.
FT                                {ECO:0000244|PubMed:15144186,
FT                                ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     244    244       Phosphoserine.
FT                                {ECO:0000244|PubMed:15144186,
FT                                ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     249    249       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     254    254       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     284    284       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     349    349       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     363    363       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     367    367       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     387    387       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:D3YZP9}.
FT   MOD_RES     395    395       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     413    413       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     470    470       P -> T (in dbSNP:rs1053266).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8058316,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_062971.
FT   CONFLICT    157    157       A -> G (in Ref. 1; AAC60637).
FT                                {ECO:0000305}.
FT   CONFLICT    228    228       K -> T (in Ref. 1; AAC60637).
FT                                {ECO:0000305}.
SQ   SEQUENCE   474 AA;  53291 MW;  DF055DBF20304D26 CRC64;
     MADSASESDT DGAGGNSSSS AAMQSSCSST SGGGGGGGGG GGGGKSGGIV ISPFRLEELT
     NRLASLQQEN KVLKIELETY KLKCKALQEE NRDLRKASVT IQARAEQEEE FISNTLFKKI
     QALQKEKETL AVNYEKEEEF LTNELSRKLM QLQHEKAELE QHLEQEQEFQ VNKLMKKIKK
     LENDTISKQL TLEQLRREKI DLENTLEQEQ EALVNRLWKR MDKLEAEKRI LQEKLDQPVS
     APPSPRDISM EIDSPENMMR HIRFLKNEVE RLKKQLRAAQ LQHSEKMAQY LEEERHMREE
     NLRLQRKLQR EMERREALCR QLSESESSLE MDDERYFNEM SAQGLRPRTV SSPIPYTPSP
     SSSRPISPGL SYASHTVGFT PPTSLTRAGM SYYNSPGLHV QHMGTSHGIT RPSPRRSNSP
     DKFKRPTPPP SPNTQTPVQP PPPPPPPPMQ PTVPSAATSQ PTPSQHSAHP SSQP
//
ID   CIP1_HUMAN              Reviewed;         277 AA.
AC   Q9NPC3;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 149.
DE   RecName: Full=E3 ubiquitin-protein ligase CCNB1IP1;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:12612082};
DE   AltName: Full=Cyclin-B1-interacting protein 1;
DE   AltName: Full=Human enhancer of invasion 10;
DE   AltName: Full=RING-type E3 ubiquitin transferase CCNB1IP1 {ECO:0000305};
GN   Name=CCNB1IP1; Synonyms=C14orf18, HEI10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF CYS-28; HIS-30 AND CYS-33,
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH UBE2L3 AND CCNB1,
RP   UBIQUITINATION, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12612082; DOI=10.1128/MCB.23.6.2109-2122.2003;
RA   Toby G.G., Gherraby W., Coleman T.R., Golemis E.A.;
RT   "A novel RING finger protein, human enhancer of invasion 10, alters
RT   mitotic progression through regulation of cyclin B levels.";
RL   Mol. Cell. Biol. 23:2109-2122(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal brain, and Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH NF2.
RX   PubMed=16532029; DOI=10.1038/sj.onc.1209475;
RA   Gronholm M., Muranen T., Toby G.G., Utermark T., Hanemann C.O.,
RA   Golemis E.A., Carpen O.;
RT   "A functional association between merlin and HEI10, a cell cycle
RT   regulator.";
RL   Oncogene 25:4389-4398(2006).
RN   [7]
RP   FUNCTION.
RX   PubMed=17297447; DOI=10.1038/sj.onc.1210282;
RA   Singh M.K., Nicolas E., Gherraby W., Dadke D., Lessin S.,
RA   Golemis E.A.;
RT   "HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1
RT   and other promotility proteins.";
RL   Oncogene 26:4825-4832(2007).
CC   -!- FUNCTION: Ubiquitin E3 ligase that acts as a limiting factor for
CC       crossing-over during meiosis: required during zygonema to limit
CC       the colocalization of RNF212 with MutS-gamma-associated
CC       recombination sites and thereby establish early differentiation of
CC       crossover and non-crossover sites. Later, it is directed by MutL-
CC       gamma to stably accumulate at designated crossover sites. Probably
CC       promotes the dissociation of RNF212 and MutS-gamma to allow the
CC       progression of recombination and the implementation of the final
CC       steps of crossing over (By similarity). Modulates cyclin-B levels
CC       and participates in the regulation of cell cycle progression
CC       through the G2 phase. Overexpression causes delayed entry into
CC       mitosis. {ECO:0000250, ECO:0000269|PubMed:12612082,
CC       ECO:0000269|PubMed:17297447}.
CC   -!- FUNCTION: E3 ubiquitin-protein ligase. Modulates cyclin B levels
CC       and participates in the regulation of cell cycle progression
CC       through the G2 phase. Overexpression causes delayed entry into
CC       mitosis.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:12612082}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with CCNB1, UBE2L3 and NF2.
CC       {ECO:0000269|PubMed:12612082, ECO:0000269|PubMed:16532029}.
CC   -!- INTERACTION:
CC       P62972:- (xeno); NbExp=2; IntAct=EBI-745269, EBI-412964;
CC       P14635:CCNB1; NbExp=2; IntAct=EBI-745269, EBI-495332;
CC       Q7L775:EPM2AIP1; NbExp=3; IntAct=EBI-745269, EBI-6255981;
CC       Q14145:KEAP1; NbExp=3; IntAct=EBI-745269, EBI-751001;
CC       P19012:KRT15; NbExp=3; IntAct=EBI-745269, EBI-739566;
CC       P54646:PRKAA2; NbExp=3; IntAct=EBI-745269, EBI-1383852;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Associates to the
CC       synaptonemal complex.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart. Detected at
CC       intermediate levels in liver and kidney, and at low levels in
CC       placenta, brain and lung. {ECO:0000269|PubMed:12612082}.
CC   -!- PTM: Ubiquitinated; autoubiquitinated.
CC       {ECO:0000269|PubMed:12612082}.
CC   -!- PTM: Phosphorylated by CDK1 on serine or threonine residues (in
CC       vitro). {ECO:0000269|PubMed:12612082}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF216381; AAF36386.1; -; mRNA.
DR   EMBL; AL161994; CAB82326.1; -; mRNA.
DR   EMBL; AK026233; BAB15403.1; -; mRNA.
DR   EMBL; BX161423; CAD61896.1; -; mRNA.
DR   EMBL; BX161424; CAD61897.1; -; mRNA.
DR   EMBL; BX247978; CAD62312.1; -; mRNA.
DR   EMBL; BC000369; AAH00369.1; -; mRNA.
DR   EMBL; BC001218; AAH01218.1; -; mRNA.
DR   EMBL; BC004435; AAH04435.1; -; mRNA.
DR   CCDS; CCDS9547.1; -.
DR   PIR; T47153; T47153.
DR   RefSeq; NP_067001.3; NM_021178.4.
DR   RefSeq; NP_878269.1; NM_182849.2.
DR   RefSeq; NP_878272.1; NM_182852.3.
DR   UniGene; Hs.107003; -.
DR   UniGene; Hs.741214; -.
DR   ProteinModelPortal; Q9NPC3; -.
DR   SMR; Q9NPC3; -.
DR   BioGrid; 121779; 12.
DR   IntAct; Q9NPC3; 11.
DR   STRING; 9606.ENSP00000337396; -.
DR   iPTMnet; Q9NPC3; -.
DR   PhosphoSitePlus; Q9NPC3; -.
DR   BioMuta; CCNB1IP1; -.
DR   DMDM; 37078756; -.
DR   PaxDb; Q9NPC3; -.
DR   PeptideAtlas; Q9NPC3; -.
DR   PRIDE; Q9NPC3; -.
DR   DNASU; 57820; -.
DR   Ensembl; ENST00000353689; ENSP00000337396; ENSG00000100814.
DR   Ensembl; ENST00000358932; ENSP00000351810; ENSG00000100814.
DR   Ensembl; ENST00000398160; ENSP00000381226; ENSG00000100814.
DR   Ensembl; ENST00000398163; ENSP00000381229; ENSG00000100814.
DR   Ensembl; ENST00000398169; ENSP00000381235; ENSG00000100814.
DR   Ensembl; ENST00000437553; ENSP00000409896; ENSG00000100814.
DR   GeneID; 57820; -.
DR   KEGG; hsa:57820; -.
DR   UCSC; uc001vwv.5; human.
DR   CTD; 57820; -.
DR   EuPathDB; HostDB:ENSG00000100814.17; -.
DR   GeneCards; CCNB1IP1; -.
DR   HGNC; HGNC:19437; CCNB1IP1.
DR   MIM; 608249; gene.
DR   neXtProt; NX_Q9NPC3; -.
DR   OpenTargets; ENSG00000100814; -.
DR   PharmGKB; PA134863884; -.
DR   eggNOG; ENOG410IE9K; Eukaryota.
DR   eggNOG; ENOG410XTEP; LUCA.
DR   GeneTree; ENSGT00390000002849; -.
DR   HOGENOM; HOG000111677; -.
DR   HOVERGEN; HBG050962; -.
DR   InParanoid; Q9NPC3; -.
DR   KO; K10639; -.
DR   OMA; IANHEGT; -.
DR   OrthoDB; EOG091G0RN7; -.
DR   PhylomeDB; Q9NPC3; -.
DR   TreeFam; TF328863; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; CCNB1IP1; human.
DR   GeneWiki; CCNB1IP1; -.
DR   GenomeRNAi; 57820; -.
DR   PRO; PR:Q9NPC3; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100814; -.
DR   CleanEx; HS_CCNB1IP1; -.
DR   ExpressionAtlas; Q9NPC3; baseline and differential.
DR   Genevisible; Q9NPC3; HS.
DR   GO; GO:0000795; C:synaptonemal complex; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0001825; P:blastocyst formation; IEA:Ensembl.
DR   GO; GO:0051026; P:chiasma assembly; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0007131; P:reciprocal meiotic recombination; ISS:UniProtKB.
DR   GO; GO:0007286; P:spermatid development; IEA:Ensembl.
DR   InterPro; IPR001841; Znf_RING.
DR   Pfam; PF14634; zf-RING_5; 1.
PE   1: Evidence at protein level;
KW   Chromosome; Coiled coil; Complete proteome; Meiosis; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    277       E3 ubiquitin-protein ligase CCNB1IP1.
FT                                /FTId=PRO_0000055874.
FT   ZN_FING       4     51       RING-type; atypical.
FT   COILED      127    182       {ECO:0000255}.
FT   MUTAGEN      28     28       C->A: Abrogates induction of filamentous
FT                                growth in yeast; when associated with A-
FT                                30 and A-33.
FT                                {ECO:0000269|PubMed:12612082}.
FT   MUTAGEN      30     30       H->A: Abrogates induction of filamentous
FT                                growth in yeast; when associated with A-
FT                                28 and A-33.
FT                                {ECO:0000269|PubMed:12612082}.
FT   MUTAGEN      33     33       C->A: Abrogates induction of filamentous
FT                                growth in yeast; when associated with A-
FT                                28 and A-30.
FT                                {ECO:0000269|PubMed:12612082}.
SQ   SEQUENCE   277 AA;  31544 MW;  885723B01A35225A CRC64;
     MSLCEDMLLC NYRKCRIKLS GYAWVTACSH IFCDQHGSGE FSRSPAICPA CNSTLSGKLD
     IVRTELSPSE EYKAMVLAGL RPEIVLDISS RALAFWTYQV HQERLYQEYN FSKAEGHLKQ
     MEKIYTQQIQ SKDVELTSMK GEVTSMKKVL EEYKKKFSDI SEKLMERNRQ YQKLQGLYDS
     LRLRNITIAN HEGTLEPSMI AQSGVLGFPL GNNSKFPLDN TPVRNRGDGD GDFQFRPFFA
     GSPTAPEPSN SFFSFVSPSR ELEQQQVSSR AFKVKRI
//
ID   Q0GN75_HUMAN            Unreviewed;       127 AA.
AC   Q0GN75;
DT   03-OCT-2006, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2006, sequence version 1.
DT   31-JAN-2018, entry version 53.
DE   SubName: Full=CD274 {ECO:0000313|EMBL:ABI16084.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABI16084.1};
RN   [1] {ECO:0000313|EMBL:ABI16084.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Huang G., Zhang L., Zhang L., Song M., Bai Y.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ836393; ABI16084.1; -; mRNA.
DR   RefSeq; NP_001254635.1; NM_001267706.1.
DR   RefSeq; NP_001300958.1; NM_001314029.1.
DR   UniGene; Hs.521989; -.
DR   ProteinModelPortal; Q0GN75; -.
DR   PeptideAtlas; Q0GN75; -.
DR   GeneID; 29126; -.
DR   CTD; 29126; -.
DR   eggNOG; ENOG410IIBU; Eukaryota.
DR   eggNOG; ENOG4111V14; LUCA.
DR   HOVERGEN; HBG098817; -.
DR   GenomeRNAi; 29126; -.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07686; V-set; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19    127       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004172848.
FT   DOMAIN       33    127       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   NON_TER     127    127       {ECO:0000313|EMBL:ABI16084.1}.
SQ   SEQUENCE   127 AA;  14775 MW;  7BE13D4ADE4884BE CRC64;
     MRIFAVFIFM TYWHLLNAFT VTVPKDLYVV EYGSNMTIEC KFPVEKQLDL AALIVYWEME
     DKNIIQFVHG EEDLKVQHSS YRQRARLLKD QLSLGNAALQ ITDVKLQDAG VFRCMISYGG
     ADYKRIT
//
ID   PD1L1_HUMAN             Reviewed;         290 AA.
AC   Q9NZQ7; B2RBA2; B4DU27; Q14CJ2; Q2V8D5; Q66RK1; Q6WEX4; Q9NUZ5;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 157.
DE   RecName: Full=Programmed cell death 1 ligand 1;
DE            Short=PD-L1;
DE            Short=PDCD1 ligand 1;
DE            Short=Programmed death ligand 1;
DE   AltName: Full=B7 homolog 1;
DE            Short=B7-H1;
DE   AltName: CD_antigen=CD274;
DE   Flags: Precursor;
GN   Name=CD274; Synonyms=B7H1, PDCD1L1, PDCD1LG1, PDL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND INDUCTION.
RX   PubMed=10581077; DOI=10.1038/70932;
RA   Dong H., Zhu G., Tamada K., Chen L.;
RT   "B7-H1, a third member of the B7 family, co-stimulates T-cell
RT   proliferation and interleukin-10 secretion.";
RL   Nat. Med. 5:1365-1369(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   PDCD1, TISSUE SPECIFICITY, AND INDUCTION.
RC   TISSUE=Placenta;
RX   PubMed=11015443; DOI=10.1084/jem.192.7.1027;
RA   Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T.,
RA   Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C.,
RA   Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M.,
RA   Collins M., Wood C.R., Honjo T.;
RT   "Engagement of the PD-1 immunoinhibitory receptor by a novel B7-family
RT   member leads to negative regulation of lymphocyte activation.";
RL   J. Exp. Med. 192:1027-1034(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND SUBCELLULAR
RP   LOCATION (ISOFORMS 1 AND 2).
RX   PubMed=15780196; DOI=10.1111/j.1745-7254.2005.00086.x;
RA   He X.-H., Xu L.-H., Liu Y.;
RT   "Identification of a novel splice variant of human PD-L1 mRNA encoding
RT   an isoform-lacking Igv-like domain.";
RL   Acta Pharmacol. Sin. 26:462-468(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Gastric carcinoma;
RA   Chi X.-Y., Zha Q.-B., Xu L.-H., Jia Q.-T., Li F.-Y., He X.-H.;
RT   "Expression and significance of PD-L1 variant within tissues of human
RT   gastric carcinoma.";
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-192.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.64 ANGSTROMS) OF 18-239 IN COMPLEX WITH MOUSE
RP   PDCD1, AND DISULFIDE BONDS.
RX   PubMed=18287011; DOI=10.1073/pnas.0712278105;
RA   Lin D.Y., Tanaka Y., Iwasaki M., Gittis A.G., Su H.P., Mikami B.,
RA   Okazaki T., Honjo T., Minato N., Garboczi D.N.;
RT   "The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of
RT   antibodies and T cell receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3011-3016(2008).
CC   -!- FUNCTION: Involved in the costimulatory signal, essential for T-
CC       cell proliferation and production of IL10 and IFNG, in an IL2-
CC       dependent and a PDCD1-independent manner. Interaction with PDCD1
CC       inhibits T-cell proliferation and cytokine production.
CC       {ECO:0000269|PubMed:10581077, ECO:0000269|PubMed:11015443}.
CC   -!- SUBUNIT: Interacts with PDCD1. {ECO:0000269|PubMed:11015443,
CC       ECO:0000269|PubMed:18287011}.
CC   -!- INTERACTION:
CC       P33681:CD80; NbExp=3; IntAct=EBI-4314282, EBI-1031024;
CC       Q8IZR5:CMTM4; NbExp=3; IntAct=EBI-4314282, EBI-3925367;
CC       Q9NX76:CMTM6; NbExp=11; IntAct=EBI-4314282, EBI-1054315;
CC       Q15116:PDCD1; NbExp=2; IntAct=EBI-15686469, EBI-4314328;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane
CC       {ECO:0000269|PubMed:15780196}; Single-pass type I membrane protein
CC       {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Endomembrane system
CC       {ECO:0000269|PubMed:15780196}; Single-pass type I membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=PD-L1I;
CC         IsoId=Q9NZQ7-1; Sequence=Displayed;
CC       Name=2; Synonyms=PD-L1II;
CC         IsoId=Q9NZQ7-2; Sequence=VSP_013735;
CC       Name=3;
CC         IsoId=Q9NZQ7-3; Sequence=VSP_013736, VSP_013737;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the heart, skeletal
CC       muscle, placenta and lung. Weakly expressed in the thymus, spleen,
CC       kidney and liver. Expressed on activated T- and B-cells, dendritic
CC       cells, keratinocytes and monocytes. {ECO:0000269|PubMed:10581077,
CC       ECO:0000269|PubMed:11015443}.
CC   -!- INDUCTION: Up-regulated on T- and B-cells, dendritic cells,
CC       keratinocytes and monocytes after LPS and IFNG activation. Up-
CC       regulated in B-cells activated by surface Ig cross-linking.
CC       {ECO:0000269|PubMed:10581077, ECO:0000269|PubMed:11015443}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. BTN/MOG
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91966.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF177937; AAF25807.1; -; mRNA.
DR   EMBL; AF233516; AAG18508.1; -; mRNA.
DR   EMBL; AY254342; AAP13470.1; -; mRNA.
DR   EMBL; AY291313; AAP42144.1; -; mRNA.
DR   EMBL; AY714881; AAU09634.1; -; mRNA.
DR   EMBL; DQ286582; ABB90152.1; -; mRNA.
DR   EMBL; AK001894; BAA91966.1; ALT_INIT; mRNA.
DR   EMBL; AK300470; BAG62189.1; -; mRNA.
DR   EMBL; AK314567; BAG37149.1; -; mRNA.
DR   EMBL; AL162253; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58763.1; -; Genomic_DNA.
DR   EMBL; BC069381; AAH69381.1; -; mRNA.
DR   EMBL; BC074984; AAH74984.1; -; mRNA.
DR   EMBL; BC113734; AAI13735.1; -; mRNA.
DR   EMBL; BC113736; AAI13737.1; -; mRNA.
DR   CCDS; CCDS59118.1; -. [Q9NZQ7-2]
DR   CCDS; CCDS6464.1; -. [Q9NZQ7-1]
DR   RefSeq; NP_001254635.1; NM_001267706.1. [Q9NZQ7-2]
DR   RefSeq; NP_054862.1; NM_014143.3. [Q9NZQ7-1]
DR   UniGene; Hs.521989; -.
DR   PDB; 3BIK; X-ray; 2.65 A; A=18-239.
DR   PDB; 3BIS; X-ray; 2.64 A; A/B=18-239.
DR   PDB; 3FN3; X-ray; 2.70 A; A/B=19-238.
DR   PDB; 3SBW; X-ray; 2.28 A; C=19-239.
DR   PDB; 4Z18; X-ray; 1.95 A; A/B=19-239.
DR   PDB; 4ZQK; X-ray; 2.45 A; A=18-132.
DR   PDB; 5C3T; X-ray; 1.80 A; A=18-134.
DR   PDB; 5GGT; X-ray; 2.80 A; A=18-134.
DR   PDB; 5GRJ; X-ray; 3.21 A; A=18-238.
DR   PDB; 5IUS; X-ray; 2.89 A; C/D=18-239.
DR   PDB; 5J89; X-ray; 2.20 A; A/B/C/D=2-134.
DR   PDB; 5J8O; X-ray; 2.30 A; A/B=18-134.
DR   PDB; 5JDR; X-ray; 2.70 A; A/B=18-239.
DR   PDB; 5JDS; X-ray; 1.70 A; A=18-132.
DR   PDB; 5N2D; X-ray; 2.35 A; A/B/C/D=2-134.
DR   PDB; 5N2F; X-ray; 1.70 A; A/B=18-134.
DR   PDB; 5NIU; X-ray; 2.01 A; A/B/C/D=18-134.
DR   PDB; 5NIX; X-ray; 2.20 A; A/B/C/D=18-134.
DR   PDB; 5O45; X-ray; 0.99 A; A=17-134.
DR   PDB; 5O4Y; X-ray; 2.30 A; B/C/E=18-132.
DR   PDB; 5X8L; X-ray; 3.10 A; A/B/C/D/E=18-134.
DR   PDB; 5X8M; X-ray; 2.66 A; A=18-134.
DR   PDB; 5XXY; X-ray; 2.90 A; A=18-133.
DR   PDBsum; 3BIK; -.
DR   PDBsum; 3BIS; -.
DR   PDBsum; 3FN3; -.
DR   PDBsum; 3SBW; -.
DR   PDBsum; 4Z18; -.
DR   PDBsum; 4ZQK; -.
DR   PDBsum; 5C3T; -.
DR   PDBsum; 5GGT; -.
DR   PDBsum; 5GRJ; -.
DR   PDBsum; 5IUS; -.
DR   PDBsum; 5J89; -.
DR   PDBsum; 5J8O; -.
DR   PDBsum; 5JDR; -.
DR   PDBsum; 5JDS; -.
DR   PDBsum; 5N2D; -.
DR   PDBsum; 5N2F; -.
DR   PDBsum; 5NIU; -.
DR   PDBsum; 5NIX; -.
DR   PDBsum; 5O45; -.
DR   PDBsum; 5O4Y; -.
DR   PDBsum; 5X8L; -.
DR   PDBsum; 5X8M; -.
DR   PDBsum; 5XXY; -.
DR   ProteinModelPortal; Q9NZQ7; -.
DR   SMR; Q9NZQ7; -.
DR   BioGrid; 118891; 48.
DR   DIP; DIP-29731N; -.
DR   IntAct; Q9NZQ7; 6.
DR   STRING; 9606.ENSP00000370989; -.
DR   BindingDB; Q9NZQ7; -.
DR   ChEMBL; CHEMBL3580522; -.
DR   DrugBank; DB11595; Atezolizumab.
DR   iPTMnet; Q9NZQ7; -.
DR   PhosphoSitePlus; Q9NZQ7; -.
DR   BioMuta; CD274; -.
DR   DMDM; 83287884; -.
DR   MaxQB; Q9NZQ7; -.
DR   PaxDb; Q9NZQ7; -.
DR   PeptideAtlas; Q9NZQ7; -.
DR   PRIDE; Q9NZQ7; -.
DR   Ensembl; ENST00000381573; ENSP00000370985; ENSG00000120217. [Q9NZQ7-2]
DR   Ensembl; ENST00000381577; ENSP00000370989; ENSG00000120217. [Q9NZQ7-1]
DR   GeneID; 29126; -.
DR   KEGG; hsa:29126; -.
DR   UCSC; uc003zje.4; human. [Q9NZQ7-1]
DR   CTD; 29126; -.
DR   DisGeNET; 29126; -.
DR   EuPathDB; HostDB:ENSG00000120217.13; -.
DR   GeneCards; CD274; -.
DR   HGNC; HGNC:17635; CD274.
DR   HPA; CAB030018; -.
DR   MIM; 605402; gene.
DR   neXtProt; NX_Q9NZQ7; -.
DR   OpenTargets; ENSG00000120217; -.
DR   PharmGKB; PA134915280; -.
DR   eggNOG; ENOG410IIBU; Eukaryota.
DR   eggNOG; ENOG4111V14; LUCA.
DR   GeneTree; ENSGT00650000093373; -.
DR   HOGENOM; HOG000130048; -.
DR   HOVERGEN; HBG082112; -.
DR   InParanoid; Q9NZQ7; -.
DR   KO; K06745; -.
DR   OMA; IWTSSDH; -.
DR   OrthoDB; EOG091G0F5W; -.
DR   PhylomeDB; Q9NZQ7; -.
DR   TreeFam; TF331083; -.
DR   Reactome; R-HSA-389948; PD-1 signaling.
DR   SIGNOR; Q9NZQ7; -.
DR   EvolutionaryTrace; Q9NZQ7; -.
DR   GeneWiki; PD-L1; -.
DR   GenomeRNAi; 29126; -.
DR   PRO; PR:Q9NZQ7; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000120217; -.
DR   CleanEx; HS_CD274; -.
DR   Genevisible; Q9NZQ7; HS.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006955; P:immune response; IDA:UniProtKB.
DR   GO; GO:0046007; P:negative regulation of activated T cell proliferation; IMP:UniProtKB.
DR   GO; GO:0032689; P:negative regulation of interferon-gamma production; IMP:UniProtKB.
DR   GO; GO:0032693; P:negative regulation of interleukin-10 production; IMP:UniProtKB.
DR   GO; GO:1903556; P:negative regulation of tumor necrosis factor superfamily cytokine production; IMP:UniProtKB.
DR   GO; GO:1905404; P:positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process; IDA:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:2001181; P:positive regulation of interleukin-10 secretion; IDA:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; TAS:UniProtKB.
DR   GO; GO:0034097; P:response to cytokine; IDA:AgBase.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0031295; P:T cell costimulation; IDA:UniProtKB.
DR   GO; GO:1901998; P:toxin transport; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF08205; C2-set_2; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 2.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    290       Programmed cell death 1 ligand 1.
FT                                /FTId=PRO_0000014553.
FT   TOPO_DOM     19    238       Extracellular. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical. {ECO:0000255}.
FT   TOPO_DOM    260    290       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       19    127       Ig-like V-type.
FT   DOMAIN      133    225       Ig-like C2-type.
FT   CARBOHYD     35     35       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    192    192       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    200    200       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    219    219       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     40    114       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:18287011}.
FT   DISULFID    155    209       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:18287011}.
FT   VAR_SEQ      19    132       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15780196,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_013735.
FT   VAR_SEQ     178    178       K -> D (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15780196}.
FT                                /FTId=VSP_013736.
FT   VAR_SEQ     179    290       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15780196}.
FT                                /FTId=VSP_013737.
FT   STRAND       26     31       {ECO:0000244|PDB:5O45}.
FT   STRAND       36     41       {ECO:0000244|PDB:5O45}.
FT   STRAND       45     47       {ECO:0000244|PDB:5C3T}.
FT   HELIX        50     52       {ECO:0000244|PDB:5O45}.
FT   STRAND       54     59       {ECO:0000244|PDB:5O45}.
FT   STRAND       62     68       {ECO:0000244|PDB:5O45}.
FT   HELIX        74     76       {ECO:0000244|PDB:5O45}.
FT   HELIX        79     81       {ECO:0000244|PDB:5O45}.
FT   TURN         82     84       {ECO:0000244|PDB:5O45}.
FT   STRAND       85     87       {ECO:0000244|PDB:5O45}.
FT   HELIX        89     94       {ECO:0000244|PDB:5O45}.
FT   STRAND       96    103       {ECO:0000244|PDB:5O45}.
FT   HELIX       106    108       {ECO:0000244|PDB:5O45}.
FT   STRAND      110    131       {ECO:0000244|PDB:5O45}.
FT   STRAND      138    145       {ECO:0000244|PDB:4Z18}.
FT   TURN        146    149       {ECO:0000244|PDB:4Z18}.
FT   STRAND      150    161       {ECO:0000244|PDB:4Z18}.
FT   STRAND      164    169       {ECO:0000244|PDB:4Z18}.
FT   STRAND      177    183       {ECO:0000244|PDB:4Z18}.
FT   STRAND      185    187       {ECO:0000244|PDB:4Z18}.
FT   STRAND      191    200       {ECO:0000244|PDB:4Z18}.
FT   STRAND      206    213       {ECO:0000244|PDB:4Z18}.
FT   TURN        214    217       {ECO:0000244|PDB:4Z18}.
FT   STRAND      218    225       {ECO:0000244|PDB:4Z18}.
SQ   SEQUENCE   290 AA;  33275 MW;  FE957086E62A31A8 CRC64;
     MRIFAVFIFM TYWHLLNAFT VTVPKDLYVV EYGSNMTIEC KFPVEKQLDL AALIVYWEME
     DKNIIQFVHG EEDLKVQHSS YRQRARLLKD QLSLGNAALQ ITDVKLQDAG VYRCMISYGG
     ADYKRITVKV NAPYNKINQR ILVVDPVTSE HELTCQAEGY PKAEVIWTSS DHQVLSGKTT
     TTNSKREEKL FNVTSTLRIN TTTNEIFYCT FRRLDPEENH TAELVIPELP LAHPPNERTH
     LVILGAILLC LGVALTFIFR LRKGRMMDVK KCGIQDTNSK KQSDTHLEET
//
ID   H3BUU9_HUMAN            Unreviewed;       670 AA.
AC   H3BUU9;
DT   18-APR-2012, integrated into UniProtKB/TrEMBL.
DT   18-APR-2012, sequence version 1.
DT   28-FEB-2018, entry version 53.
DE   SubName: Full=Cadherin-11 {ECO:0000313|Ensembl:ENSP00000457812};
GN   Name=CDH11 {ECO:0000313|Ensembl:ENSP00000457812};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000457812, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000457812, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000457812}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       {ECO:0000256|RuleBase:RU004357}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000256|RuleBase:RU003318, ECO:0000256|SAAS:SAAS00544042};
CC       Single-pass type I membrane protein
CC       {ECO:0000256|RuleBase:RU003318, ECO:0000256|SAAS:SAAS00544042}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000457812}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC010533; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC137643; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317505.1; NM_001330576.1.
DR   UniGene; Hs.116471; -.
DR   UniGene; Hs.596112; -.
DR   ProteinModelPortal; H3BUU9; -.
DR   MaxQB; H3BUU9; -.
DR   PeptideAtlas; H3BUU9; -.
DR   PRIDE; H3BUU9; -.
DR   Ensembl; ENST00000566827; ENSP00000457812; ENSG00000140937.
DR   GeneID; 1009; -.
DR   UCSC; uc010vin.3; human.
DR   CTD; 1009; -.
DR   EuPathDB; HostDB:ENSG00000140937.13; -.
DR   HGNC; HGNC:1750; CDH11.
DR   OpenTargets; ENSG00000140937; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00760000118954; -.
DR   ChiTaRS; CDH11; human.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000140937; -.
DR   ExpressionAtlas; H3BUU9; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR002126; Cadherin.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   Pfam; PF00028; Cadherin; 3.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 4.
DR   SUPFAM; SSF49313; SSF49313; 4.
DR   PROSITE; PS00232; CADHERIN_1; 3.
PE   1: Evidence at protein level;
KW   Calcium {ECO:0000256|RuleBase:RU003318,
KW   ECO:0000256|SAAS:SAAS00806088};
KW   Cell adhesion {ECO:0000256|RuleBase:RU003318,
KW   ECO:0000256|SAAS:SAAS00490458};
KW   Cell membrane {ECO:0000256|SAAS:SAAS00490505};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAAS:SAAS00490505,
KW   ECO:0000256|SAAS:SAAS00806105, ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:H3BUU9,
KW   ECO:0000213|PeptideAtlas:H3BUU9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00814379};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00806105,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00806105,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    493    514       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       55    140       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      164    256       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      279    360       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      387    474       CA. {ECO:0000259|SMART:SM00112}.
SQ   SEQUENCE   670 AA;  73793 MW;  F8CBF4E3BD77712D CRC64;
     MAQAVDRDTN RPLEPPSEFI VKVQDINDNP PEFLHETYHA NVPERSNVGT SVIQVTASDA
     DDPTYGNSAK LVYSILEGQP YFSVEAQTGI IRTALPNMDR EAKEEYHVVI QAKDMGGHMG
     GLSGTTKVTI TLTDVNDNPP KFPQSVYQMS VSEAAVPGEE VGRVKAKDPD IGENGLVTYN
     IVDGDGMESF EITTDYETQE GVIKLKKPVD FETKRAYSLK VEAANVHIDP KFISNGPFKD
     TVTVKISVED ADEPPMFLAP SYIHEVQENA AAGTVVGRVH AKDPDAANSP IRYSIDRHTD
     LDRFFTINPE DGFIKTTKPL DREETAWLNI TVFAAEIHNR HQEAKVPVAI RVLDVNDNAP
     KFAAPYEGFI CESDQTKPLS NQPIVTISAD DKDDTANGPR FIFSLPPEII HNPNFTVRDN
     RDNTAGVYAR RGGFSRQKQD LYLLPIVISD GGIPPMSSTN TLTIKVCGCD VNGALLSCNA
     EAYILNAGLS TGALIAILAC IVILLVIVVL FVTLRRQKKE PLIVFEEEDV RENIITYDDE
     GGGEEDTEAF DIATLQNPDG INGFIPRKDI KPEYQYMPRP GLRPAPNSVD VDDFINTRIQ
     EADNDPTAPP YDSIQIYGYE GRGSVAGSLS SLESATTDSD LDYDYLQNWG PRFKKLADLY
     GSKDTFDDDS
//
ID   CAD11_HUMAN             Reviewed;         796 AA.
AC   P55287; A8K5D6; A8MZC8; B7WP28; Q15065; Q15066; Q9UQ93; Q9UQ94;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   28-FEB-2018, entry version 152.
DE   RecName: Full=Cadherin-11;
DE   AltName: Full=OSF-4;
DE   AltName: Full=Osteoblast cadherin;
DE            Short=OB-cadherin;
DE   Flags: Precursor;
GN   Name=CDH11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=7982033;
RA   Tanihara H., Sano K., Heimark R.L., St John T., Suzuki S.;
RT   "Cloning of five human cadherins clarifies characteristic features of
RT   cadherin extracellular domain and provides further evidence for two
RT   structurally different types of cadherin.";
RL   Cell Adhes. Commun. 2:15-26(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANTS ILE-275
RP   AND ALA-373.
RC   TISSUE=Osteosarcoma;
RX   PubMed=8163513;
RA   Okazaki M., Takeshita S., Kawai S., Kikuno R., Tsujimura A., Kudo A.,
RA   Amann E.;
RT   "Molecular cloning and characterization of OB-cadherin, a new member
RT   of cadherin family expressed in osteoblasts.";
RL   J. Biol. Chem. 269:12092-12098(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ALA-373.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 269-796 (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=2059658;
RA   Suzuki S., Sano K., Tanihara H.;
RT   "Diversity of the cadherin family: evidence for eight new cadherins in
RT   nervous tissue.";
RL   Cell Regul. 2:261-270(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 600-668.
RA   Kools P.F.J., Hogendoorn P.C.W., Bovee J.V.M.G., van Roy F.;
RT   "Alternative cadherin-11 transcripts encoding truncated adhesion
RT   molecules are detectable in both human cancer and normal cells.";
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION WITH USP6.
RX   PubMed=15026324; DOI=10.1158/0008-5472.CAN-03-2827;
RA   Oliveira A.M., Hsi B.L., Weremowicz S., Rosenberg A.E., Dal Cin P.,
RA   Joseph N., Bridge J.A., Perez-Atayde A.R., Fletcher J.A.;
RT   "USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst.";
RL   Cancer Res. 64:1920-1923(2004).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       They preferentially interact with themselves in a homophilic
CC       manner in connecting cells; cadherins may thus contribute to the
CC       sorting of heterogeneous cell types.
CC   -!- SUBUNIT: Interacts with PCDH8. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P55287-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P55287-2; Sequence=VSP_000640, VSP_000641;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in brain but also found in
CC       other tissues. Expressed in neuroblasts.
CC   -!- DOMAIN: Three calcium ions are usually bound at the interface of
CC       each cadherin domain and rigidify the connections, imparting a
CC       strong curvature to the full-length ectodomain. {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CDH11 is a common
CC       genetic feature of aneurysmal bone cyst, a benign osseous
CC       neoplasm. Translocation t(16;17)(q22;p13) with USP6. The
CC       translocation generates a fusion gene in which the strong CDH11
CC       promoter is fused to the entire USP6 coding sequence, resulting in
CC       USP6 transcriptional up-regulation.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L34056; AAA35622.1; -; mRNA.
DR   EMBL; D21254; BAA04798.1; -; mRNA.
DR   EMBL; D21255; BAA04799.1; -; mRNA.
DR   EMBL; AK291251; BAF83940.1; -; mRNA.
DR   EMBL; AC010533; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF060370; AAD27755.1; -; Genomic_DNA.
DR   EMBL; AF060369; AAD27755.1; JOINED; Genomic_DNA.
DR   EMBL; AF060370; AAD27756.1; -; Genomic_DNA.
DR   EMBL; AF060369; AAD27756.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS10803.1; -. [P55287-1]
DR   CCDS; CCDS81993.1; -. [P55287-2]
DR   PIR; A38992; A38992.
DR   RefSeq; NP_001295321.1; NM_001308392.1. [P55287-2]
DR   RefSeq; NP_001788.2; NM_001797.3. [P55287-1]
DR   RefSeq; XP_005255818.1; XM_005255761.3. [P55287-1]
DR   RefSeq; XP_005255819.1; XM_005255762.2. [P55287-1]
DR   RefSeq; XP_005255820.1; XM_005255763.2. [P55287-1]
DR   RefSeq; XP_011521105.1; XM_011522803.2. [P55287-1]
DR   UniGene; Hs.116471; -.
DR   UniGene; Hs.596112; -.
DR   ProteinModelPortal; P55287; -.
DR   BioGrid; 107444; 4.
DR   CORUM; P55287; -.
DR   IntAct; P55287; 5.
DR   MINT; P55287; -.
DR   STRING; 9606.ENSP00000268603; -.
DR   iPTMnet; P55287; -.
DR   PhosphoSitePlus; P55287; -.
DR   BioMuta; CDH11; -.
DR   DMDM; 146345381; -.
DR   MaxQB; P55287; -.
DR   PaxDb; P55287; -.
DR   PeptideAtlas; P55287; -.
DR   PRIDE; P55287; -.
DR   Ensembl; ENST00000268603; ENSP00000268603; ENSG00000140937. [P55287-1]
DR   Ensembl; ENST00000394156; ENSP00000377711; ENSG00000140937. [P55287-2]
DR   GeneID; 1009; -.
DR   KEGG; hsa:1009; -.
DR   UCSC; uc002eoi.4; human. [P55287-1]
DR   CTD; 1009; -.
DR   DisGeNET; 1009; -.
DR   EuPathDB; HostDB:ENSG00000140937.13; -.
DR   GeneCards; CDH11; -.
DR   H-InvDB; HIX0013098; -.
DR   HGNC; HGNC:1750; CDH11.
DR   HPA; CAB013072; -.
DR   MIM; 600023; gene.
DR   neXtProt; NX_P55287; -.
DR   OpenTargets; ENSG00000140937; -.
DR   PharmGKB; PA26284; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00760000118954; -.
DR   HOVERGEN; HBG005217; -.
DR   InParanoid; P55287; -.
DR   KO; K06803; -.
DR   OMA; HENYHAN; -.
DR   OrthoDB; EOG091G0241; -.
DR   PhylomeDB; P55287; -.
DR   TreeFam; TF329887; -.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   SIGNOR; P55287; -.
DR   ChiTaRS; CDH11; human.
DR   GeneWiki; CDH11; -.
DR   GenomeRNAi; 1009; -.
DR   PRO; PR:P55287; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000140937; -.
DR   CleanEx; HS_CDH11; -.
DR   ExpressionAtlas; P55287; baseline and differential.
DR   Genevisible; P55287; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0034332; P:adherens junction organization; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0021957; P:corticospinal tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   GO; GO:0001503; P:ossification; NAS:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR002126; Cadherin.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   Pfam; PF00028; Cadherin; 4.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 5.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 3.
DR   PROSITE; PS50268; CADHERIN_2; 5.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Cell adhesion; Cell membrane;
KW   Chromosomal rearrangement; Cleavage on pair of basic residues;
KW   Complete proteome; Glycoprotein; Membrane; Metal-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   PROPEP       23     53       {ECO:0000255}.
FT                                /FTId=PRO_0000003785.
FT   CHAIN        54    796       Cadherin-11.
FT                                /FTId=PRO_0000003786.
FT   TOPO_DOM     54    617       Extracellular. {ECO:0000255}.
FT   TRANSMEM    618    640       Helical. {ECO:0000255}.
FT   TOPO_DOM    641    796       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       54    159       Cadherin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      160    268       Cadherin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      269    383       Cadherin 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      384    486       Cadherin 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      487    612       Cadherin 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   MOD_RES     788    788       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P55288}.
FT   MOD_RES     791    791       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P55288}.
FT   CARBOHYD    455    455       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    540    540       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     632    693       VIVVLFVTLRRQKKEPLIVFEEEDVRENIITYDDEGGGEED
FT                                TEAFDIATLQNPDGINGFIPR -> GCPSLMEPPSPREDMR
FT                                LLYLGFQLMLFSYVKVNRRFCLLGVFIKLPFLYVVATESPT
FT                                TLTSL (in isoform 2).
FT                                {ECO:0000303|PubMed:8163513}.
FT                                /FTId=VSP_000640.
FT   VAR_SEQ     694    796       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8163513}.
FT                                /FTId=VSP_000641.
FT   VARIANT     255    255       T -> M (in dbSNP:rs35195).
FT                                /FTId=VAR_031945.
FT   VARIANT     275    275       M -> I (in dbSNP:rs1130821).
FT                                {ECO:0000269|PubMed:8163513}.
FT                                /FTId=VAR_031946.
FT   VARIANT     373    373       S -> A (in dbSNP:rs35213).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:8163513}.
FT                                /FTId=VAR_031947.
FT   CONFLICT    271    272       SV -> RL (in Ref. 1; AAA35622 and 5; no
FT                                nucleotide entry). {ECO:0000305}.
FT   CONFLICT    340    340       K -> E (in Ref. 1; AAA35622 and 5; no
FT                                nucleotide entry). {ECO:0000305}.
FT   CONFLICT    471    471       K -> Q (in Ref. 1; AAA35622 and 5; no
FT                                nucleotide entry). {ECO:0000305}.
SQ   SEQUENCE   796 AA;  87965 MW;  E17090EC95C59936 CRC64;
     MKENYCLQAA LVCLGMLCHS HAFAPERRGH LRPSFHGHHE KGKEGQVLQR SKRGWVWNQF
     FVIEEYTGPD PVLVGRLHSD IDSGDGNIKY ILSGEGAGTI FVIDDKSGNI HATKTLDREE
     RAQYTLMAQA VDRDTNRPLE PPSEFIVKVQ DINDNPPEFL HETYHANVPE RSNVGTSVIQ
     VTASDADDPT YGNSAKLVYS ILEGQPYFSV EAQTGIIRTA LPNMDREAKE EYHVVIQAKD
     MGGHMGGLSG TTKVTITLTD VNDNPPKFPQ SVYQMSVSEA AVPGEEVGRV KAKDPDIGEN
     GLVTYNIVDG DGMESFEITT DYETQEGVIK LKKPVDFETK RAYSLKVEAA NVHIDPKFIS
     NGPFKDTVTV KISVEDADEP PMFLAPSYIH EVQENAAAGT VVGRVHAKDP DAANSPIRYS
     IDRHTDLDRF FTINPEDGFI KTTKPLDREE TAWLNITVFA AEIHNRHQEA KVPVAIRVLD
     VNDNAPKFAA PYEGFICESD QTKPLSNQPI VTISADDKDD TANGPRFIFS LPPEIIHNPN
     FTVRDNRDNT AGVYARRGGF SRQKQDLYLL PIVISDGGIP PMSSTNTLTI KVCGCDVNGA
     LLSCNAEAYI LNAGLSTGAL IAILACIVIL LVIVVLFVTL RRQKKEPLIV FEEEDVRENI
     ITYDDEGGGE EDTEAFDIAT LQNPDGINGF IPRKDIKPEY QYMPRPGLRP APNSVDVDDF
     INTRIQEADN DPTAPPYDSI QIYGYEGRGS VAGSLSSLES ATTDSDLDYD YLQNWGPRFK
     KLADLYGSKD TFDDDS
//
ID   CDX2_HUMAN              Reviewed;         313 AA.
AC   Q99626; O00503; Q5VTU7; Q969L8; Q9UD92;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   28-FEB-2018, entry version 169.
DE   RecName: Full=Homeobox protein CDX-2;
DE   AltName: Full=CDX-3;
DE   AltName: Full=Caudal-type homeobox protein 2;
GN   Name=CDX2; Synonyms=CDX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-293.
RX   PubMed=9459001; DOI=10.1017/S0003480097006465;
RA   Drummond F.J., Putt W., Fox M., Edwards Y.H.;
RT   "Cloning and chromosome assignment of the human CDX2 gene.";
RL   Ann. Hum. Genet. 61:393-400(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-293.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9036867;
RX   DOI=10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1;
RA   Mallo G.V., Rechreche H., Frigerio J.-M., Rocha D., Zweibaum A.,
RA   Lacasa M., Jordan B.R., Dusetti N.J., Dagorn J.-C., Iovanna J.L.;
RT   "Molecular cloning, sequencing and expression of the mRNA encoding
RT   human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA
RT   expression during colorectal carcinogenesis.";
RL   Int. J. Cancer 74:35-44(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-293.
RX   PubMed=11161380; DOI=10.1054/bjoc.2000.1544;
RA   Sivagnanasundaram S., Islam I., Talbot I., Drummond F., Walters J.R.,
RA   Edwards Y.H.;
RT   "The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.";
RL   Br. J. Cancer 84:218-225(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-293.
RA   Tanizawa Y., Ueda K., Inoue H., Ayame H., Aoki M., Kuwano A.,
RA   German M.S., Liu L., Donis-Keller H., Permutt M.A., Oka Y.;
RT   "Isolation, characterization, and linkage mapping of the human caudal-
RT   type homeobox gene, CDX2/3.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-293.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 205-232.
RC   TISSUE=T-cell;
RX   PubMed=8105782; DOI=10.1006/bbrc.1993.2235;
RA   Inamori K., Takeshita K., Chiba S., Yazaki Y., Hirai H.;
RT   "Identification of homeobox genes expressed in human T-lymphocytes.";
RL   Biochem. Biophys. Res. Commun. 196:203-208(1993).
CC   -!- FUNCTION: Involved in the transcriptional regulation of multiple
CC       genes expressed in the intestinal epithelium. Important in broad
CC       range of functions from early differentiation to maintenance of
CC       the intestinal epithelial lining of both the small and large
CC       intestine.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: Phosphorylation of Ser-60 mediates the transactivation
CC       capacity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the Caudal homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CDX2ID326.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y13709; CAA74038.1; -; mRNA.
DR   EMBL; U51096; AAB40603.1; -; mRNA.
DR   EMBL; AJ278431; CAB94779.1; -; Genomic_DNA.
DR   EMBL; AJ278432; CAB94779.1; JOINED; Genomic_DNA.
DR   EMBL; AJ278434; CAB94779.1; JOINED; Genomic_DNA.
DR   EMBL; AF007886; AAD05200.1; -; Genomic_DNA.
DR   EMBL; AF007884; AAD05200.1; JOINED; Genomic_DNA.
DR   EMBL; AF007885; AAD05200.1; JOINED; Genomic_DNA.
DR   EMBL; AL591024; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014461; AAH14461.1; -; mRNA.
DR   CCDS; CCDS9328.1; -.
DR   PIR; PN0625; PN0625.
DR   RefSeq; NP_001256.3; NM_001265.4.
DR   UniGene; Hs.127383; -.
DR   UniGene; Hs.174249; -.
DR   UniGene; Hs.740844; -.
DR   PDB; 5LTY; X-ray; 2.66 A; K/M=185-255.
DR   PDBsum; 5LTY; -.
DR   ProteinModelPortal; Q99626; -.
DR   SMR; Q99626; -.
DR   BioGrid; 107475; 15.
DR   IntAct; Q99626; 3.
DR   MINT; Q99626; -.
DR   STRING; 9606.ENSP00000370408; -.
DR   iPTMnet; Q99626; -.
DR   PhosphoSitePlus; Q99626; -.
DR   BioMuta; Cdx2; -.
DR   DMDM; 311033469; -.
DR   MaxQB; Q99626; -.
DR   PaxDb; Q99626; -.
DR   PeptideAtlas; Q99626; -.
DR   PRIDE; Q99626; -.
DR   DNASU; 1045; -.
DR   Ensembl; ENST00000381020; ENSP00000370408; ENSG00000165556.
DR   GeneID; 1045; -.
DR   KEGG; hsa:1045; -.
DR   UCSC; uc001urv.5; human.
DR   CTD; 1045; -.
DR   DisGeNET; 1045; -.
DR   EuPathDB; HostDB:ENSG00000165556.9; -.
DR   GeneCards; CDX2; -.
DR   HGNC; HGNC:1806; CDX2.
DR   HPA; CAB002221; -.
DR   HPA; HPA045669; -.
DR   HPA; HPA049580; -.
DR   MIM; 600297; gene.
DR   neXtProt; NX_Q99626; -.
DR   OpenTargets; ENSG00000165556; -.
DR   PharmGKB; PA26352; -.
DR   eggNOG; KOG0848; Eukaryota.
DR   eggNOG; ENOG4111W2J; LUCA.
DR   GeneTree; ENSGT00910000143983; -.
DR   HOGENOM; HOG000115975; -.
DR   HOVERGEN; HBG005302; -.
DR   InParanoid; Q99626; -.
DR   KO; K22234; -.
DR   OMA; GPSWPSP; -.
DR   OrthoDB; EOG091G0LXJ; -.
DR   PhylomeDB; Q99626; -.
DR   TreeFam; TF351605; -.
DR   Reactome; R-HSA-381771; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1).
DR   SIGNOR; Q99626; -.
DR   GeneWiki; CDX2; -.
DR   GenomeRNAi; 1045; -.
DR   PRO; PR:Q99626; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000165556; -.
DR   CleanEx; HS_CDX2; -.
DR   Genevisible; Q99626; HS.
DR   GO; GO:0000794; C:condensed nuclear chromosome; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0009948; P:anterior/posterior axis specification; IBA:GO_Central.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008333; P:endosome to lysosome transport; IEA:Ensembl.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0060575; P:intestinal epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0060711; P:labyrinthine layer development; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0014807; P:regulation of somitogenesis; ISS:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   GO; GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR006820; Caudal_activation_dom.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF04731; Caudal_act; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    313       Homeobox protein CDX-2.
FT                                /FTId=PRO_0000048849.
FT   DNA_BIND    186    245       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     46     53       Poly-Ala.
FT   COMPBIAS     85     92       Poly-Ala.
FT   COMPBIAS    250    256       Poly-Gln.
FT   COMPBIAS    257    270       Poly-Pro.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P43241}.
FT   VARIANT     293    293       P -> S (in dbSNP:rs1805107).
FT                                {ECO:0000269|PubMed:11161380,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9036867,
FT                                ECO:0000269|PubMed:9459001,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014530.
FT   CONFLICT     52     53       AA -> Q (in Ref. 2; AAB40603).
FT                                {ECO:0000305}.
FT   CONFLICT     89     89       Missing (in Ref. 2; AAB40603).
FT                                {ECO:0000305}.
FT   CONFLICT     95     95       G -> A (in Ref. 2; AAB40603).
FT                                {ECO:0000305}.
FT   HELIX       195    207       {ECO:0000244|PDB:5LTY}.
FT   HELIX       213    223       {ECO:0000244|PDB:5LTY}.
FT   HELIX       227    254       {ECO:0000244|PDB:5LTY}.
SQ   SEQUENCE   313 AA;  33520 MW;  B5724F1F7CA569AF CRC64;
     MYVSYLLDKD VSMYPSSVRH SGGLNLAPQN FVSPPQYPDY GGYHVAAAAA AAANLDSAQS
     PGPSWPAAYG APLREDWNGY APGGAAAAAN AVAHGLNGGS PAAAMGYSSP ADYHPHHHPH
     HHPHHPAAAP SCASGLLQTL NPGPPGPAAT AAAEQLSPGG QRRNLCEWMR KPAQQSLGSQ
     VKTRTKDKYR VVYTDHQRLE LEKEFHYSRY ITIRRKAELA ATLGLSERQV KIWFQNRRAK
     ERKINKKKLQ QQQQQQPPQP PPPPPQPPQP QPGPLRSVPE PLSPVSSLQA SVPGSVPGVL
     GPTGGVLNPT VTQ
//
ID   A0A087X2I7_HUMAN        Unreviewed;      1131 AA.
AC   A0A087X2I7;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 30.
DE   SubName: Full=MHC class II transactivator {ECO:0000313|Ensembl:ENSP00000485010};
GN   Name=CIITA {ECO:0000313|Ensembl:ENSP00000485010};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000485010, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000485010, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000485010}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000485010}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC133065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459560; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001273331.1; NM_001286402.1.
DR   RefSeq; XP_011520794.1; XM_011522492.2.
DR   UniGene; Hs.592051; -.
DR   UniGene; Hs.701991; -.
DR   ProteinModelPortal; A0A087X2I7; -.
DR   PeptideAtlas; A0A087X2I7; -.
DR   PRIDE; A0A087X2I7; -.
DR   Ensembl; ENST00000618327; ENSP00000485010; ENSG00000179583.
DR   GeneID; 4261; -.
DR   UCSC; uc002daj.4; human.
DR   CTD; 4261; -.
DR   EuPathDB; HostDB:ENSG00000179583.17; -.
DR   HGNC; HGNC:7067; CIITA.
DR   OpenTargets; ENSG00000179583; -.
DR   eggNOG; KOG4308; Eukaryota.
DR   eggNOG; ENOG410ZBX3; LUCA.
DR   GeneTree; ENSGT00860000133673; -.
DR   OMA; VSRAWAC; -.
DR   OrthoDB; EOG091G01CG; -.
DR   ChiTaRS; CIITA; human.
DR   GenomeRNAi; 4261; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000179583; -.
DR   ExpressionAtlas; A0A087X2I7; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0071360; P:cellular response to exogenous dsRNA; IEA:Ensembl.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0045348; P:positive regulation of MHC class II biosynthetic process; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008095; MHC_II_transact.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13516; LRR_6; 3.
DR   PRINTS; PR01719; MHCIIACTVATR.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50837; NACHT; 1.
PE   4: Predicted;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00700025};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00700025};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00508757}.
FT   DOMAIN      415    725       NACHT. {ECO:0000259|PROSITE:PS50837}.
SQ   SEQUENCE   1131 AA;  123529 MW;  75EF94F4CEC4AB3A CRC64;
     MRCLAPRPAG SYLSEPQGSS QCATMELGPL EGGYLELLNS DADPLCLYHF YDQMDLAGEE
     EIELYSEPDT DTINCDQFSR LLCDMEGDEE TREAYANIAE LDQYVFQDSQ LEGLSKDIFI
     EHIGPDEVIG ESMEMPAEVG QKSQKRPFPE ELPADLKHWK PAEPPTVVTG SLLVGPVSDC
     STLPCLPLPA LFNQEPASGQ MRLEKTDQIP MPFSSSSLSC LNLPEGPIQF VPTISTLPHG
     LWQISEAGTG VSSIFIYHGE VPQASQVPPP SGFTVHGLPT SPDRPGSTSP FAPSATDLPS
     MPEPALTSRA NMTEHKTSPT QCPAAGEVSN KLPKWPEPVE QFYRSLQDTY GAEPAGPDGI
     LVEVDLVQAR LERSSSKSLE RELATPDWAE RQLAQGGLAE VLLAAKEHRR PRETRVIAVL
     GKAGQGKSYW AGAVSRAWAC GRLPQYDFVF SVPCHCLNRP GDAYGLQDLL FSLGPQPLVA
     ADEVFSHILK RPDRVLLILD GFEELEAQDG FLHSTCGPAP AEPCSLRGLL AGLFQKKLLR
     GCTLLLTARP RGRLVQSLSK ADALFELSGF SMEQAQAYVM RYFESSGMTE HQDRALTLLR
     DRPLLLSHSH SPTLCRAVCQ LSEALLELGE DAKLPSTLTG LYVGLLGRAA LDSPPGALAE
     LAKLAWELGR RHQSTLQEDQ FPSADVRTWA MAKGLVQHPP RAAESELAFP SFLLQCFLGA
     LWLALSGEIK DKELPQYLAL TPRKKRPYDN WLEGVPRFLA GLIFQPPARC LGALLGPSAA
     ASVDRKQKVL ARYLKRLQPG TLRARQLLEL LHCAHEAEEA GIWQHVVQEL PGRLSFLGTR
     LTPPDAHVLG KALEAAGQDF SLDLRSTGIC PSGLGSLVGL SCVTRFRAAL SDTVALWESL
     QQHGETKLLQ AAEEKFTIEP FKAKSLKDVE DLGKLVQTQR TRSSSEDTAG ELPAVRDLKK
     LEFALGPVSG PQAFPKLVRI LTAFSSLQHL DLDALSENKI GDEGVSQLSA TFPQLKSLET
     LNLSQNNITD LGAYKLAEAL PSLAASLLRL SLYNNCICDV GAESLARVLP DMVSLRVMDV
     QYNKFTAAGA QQLAASLRRC PHVETLAMWT PTIPFSVQEH LQQQDSRISL R
//
ID   A0A0B4J1S1_HUMAN        Unreviewed;      1130 AA.
AC   A0A0B4J1S1;
DT   04-MAR-2015, integrated into UniProtKB/TrEMBL.
DT   04-MAR-2015, sequence version 1.
DT   28-FEB-2018, entry version 28.
DE   SubName: Full=MHC class II transactivator {ECO:0000313|Ensembl:ENSP00000316328};
GN   Name=CIITA {ECO:0000313|Ensembl:ENSP00000316328};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000316328, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000316328, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000316328}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2015) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000316328}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC133065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459560; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_000237.2; NM_000246.3.
DR   RefSeq; XP_011520795.1; XM_011522493.2.
DR   UniGene; Hs.592051; -.
DR   UniGene; Hs.701991; -.
DR   ProteinModelPortal; A0A0B4J1S1; -.
DR   PeptideAtlas; A0A0B4J1S1; -.
DR   PRIDE; A0A0B4J1S1; -.
DR   Ensembl; ENST00000324288; ENSP00000316328; ENSG00000179583.
DR   GeneID; 4261; -.
DR   KEGG; hsa:4261; -.
DR   CTD; 4261; -.
DR   EuPathDB; HostDB:ENSG00000179583.17; -.
DR   HGNC; HGNC:7067; CIITA.
DR   OpenTargets; ENSG00000179583; -.
DR   eggNOG; KOG4308; Eukaryota.
DR   eggNOG; ENOG410ZBX3; LUCA.
DR   GeneTree; ENSGT00860000133673; -.
DR   KO; K08060; -.
DR   PhylomeDB; A0A0B4J1S1; -.
DR   ChiTaRS; CIITA; human.
DR   GenomeRNAi; 4261; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000179583; -.
DR   ExpressionAtlas; A0A0B4J1S1; baseline and differential.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008095; MHC_II_transact.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13516; LRR_6; 3.
DR   PRINTS; PR01719; MHCIIACTVATR.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50837; NACHT; 1.
PE   4: Predicted;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00700025};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00700025};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00508757}.
FT   DOMAIN      414    724       NACHT. {ECO:0000259|PROSITE:PS50837}.
SQ   SEQUENCE   1130 AA;  123415 MW;  D698094576546509 CRC64;
     MRCLAPRPAG SYLSEPQGSS QCATMELGPL EGGYLELLNS DADPLCLYHF YDQMDLAGEE
     EIELYSEPDT DTINCDQFSR LLCDMEGDEE TREAYANIAE LDQYVFQDSQ LEGLSKDIFK
     HIGPDEVIGE SMEMPAEVGQ KSQKRPFPEE LPADLKHWKP AEPPTVVTGS LLVGPVSDCS
     TLPCLPLPAL FNQEPASGQM RLEKTDQIPM PFSSSSLSCL NLPEGPIQFV PTISTLPHGL
     WQISEAGTGV SSIFIYHGEV PQASQVPPPS GFTVHGLPTS PDRPGSTSPF APSATDLPSM
     PEPALTSRAN MTEHKTSPTQ CPAAGEVSNK LPKWPEPVEQ FYRSLQDTYG AEPAGPDGIL
     VEVDLVQARL ERSSSKSLER ELATPDWAER QLAQGGLAEV LLAAKEHRRP RETRVIAVLG
     KAGQGKSYWA GAVSRAWACG RLPQYDFVFS VPCHCLNRPG DAYGLQDLLF SLGPQPLVAA
     DEVFSHILKR PDRVLLILDG FEELEAQDGF LHSTCGPAPA EPCSLRGLLA GLFQKKLLRG
     CTLLLTARPR GRLVQSLSKA DALFELSGFS MEQAQAYVMR YFESSGMTEH QDRALTLLRD
     RPLLLSHSHS PTLCRAVCQL SEALLELGED AKLPSTLTGL YVGLLGRAAL DSPPGALAEL
     AKLAWELGRR HQSTLQEDQF PSADVRTWAM AKGLVQHPPR AAESELAFPS FLLQCFLGAL
     WLALSGEIKD KELPQYLALT PRKKRPYDNW LEGVPRFLAG LIFQPPARCL GALLGPSAAA
     SVDRKQKVLA RYLKRLQPGT LRARQLLELL HCAHEAEEAG IWQHVVQELP GRLSFLGTRL
     TPPDAHVLGK ALEAAGQDFS LDLRSTGICP SGLGSLVGLS CVTRFRAALS DTVALWESLQ
     QHGETKLLQA AEEKFTIEPF KAKSLKDVED LGKLVQTQRT RSSSEDTAGE LPAVRDLKKL
     EFALGPVSGP QAFPKLVRIL TAFSSLQHLD LDALSENKIG DEGVSQLSAT FPQLKSLETL
     NLSQNNITDL GAYKLAEALP SLAASLLRLS LYNNCICDVG AESLARVLPD MVSLRVMDVQ
     YNKFTAAGAQ QLAASLRRCP HVETLAMWTP TIPFSVQEHL QQQDSRISLR
//
ID   C2TA_HUMAN              Reviewed;        1130 AA.
AC   P33076; A0N0N9; D3DUG0; E9PFE0; Q29675; Q8SNB8; Q96KL4;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   28-FEB-2018, entry version 175.
DE   RecName: Full=MHC class II transactivator;
DE            Short=CIITA;
DE            EC=2.3.1.-;
DE            EC=2.7.11.1;
GN   Name=CIITA; Synonyms=MHC2TA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS BLS2 LYS-120 DEL
RP   ILE-GLU INS AND 940-THR--ALA-963 DEL, AND VARIANTS GLY-174; ALA-500
RP   AND ARG-900.
RX   PubMed=8402893; DOI=10.1016/S0092-8674(05)80090-X;
RA   Steimle V., Otten L.A., Zufferey M., Mach B.;
RT   "Complementation cloning of an MHC class II transactivator mutated in
RT   hereditary MHC class II deficiency (or bare lymphocyte syndrome).";
RL   Cell 75:135-146(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), VARIANTS BLS2 LYS-120
RP   DEL ILE-GLU INS; GLY-174; ALA-500 AND ARG-900, AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=7749984; DOI=10.1016/1074-7613(95)90033-0;
RA   Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M.;
RT   "Activation of class II MHC genes requires both the X box region and
RT   the class II transactivator (CIITA).";
RL   Immunity 2:533-543(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), VARIANT ARG-900, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=12919287; DOI=10.1046/j.1365-2370.2003.00397.x;
RA   Quinn G., Bower R., Dos-Santos Cruz G., Giovino M., Xu Y.,
RA   Patience C., Schuurman H.J.;
RT   "Structural and functional characteristics of a dominant-negative
RT   isoform of porcine MHC class II transactivator.";
RL   Eur. J. Immunogenet. 30:259-270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), VARIANTS GLY-174 AND ALA-500,
RP   AND ALTERNATIVE SPLICING.
RX   PubMed=12859996; DOI=10.1016/S0145-2126(03)00072-9;
RA   Day N.E., Ugai H., Yokoyama K.K., Ichiki A.T.;
RT   "K-562 cells lack MHC class II expression due to an alternatively
RT   spliced CIITA transcript with a truncated coding region.";
RL   Leuk. Res. 27:1027-1038(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLY-174 AND ARG-900.
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   GTP-BINDING, AND MUTAGENESIS OF 420-GLY-LYS-421 AND ASP-561.
RX   PubMed=10464099; DOI=10.1126/science.285.5432.1402;
RA   Harton J.A., Cressman D.E., Chin K.C., Der C.J., Ting J.P.;
RT   "GTP binding by class II transactivator: role in nuclear import.";
RL   Science 285:1402-1405(1999).
RN   [9]
RP   FUNCTION AS ACETYLTRANSFERASE, GTP-BINDING, AND ACETYLTRANSFERASE
RP   REGION.
RX   PubMed=11172716; DOI=10.1016/S1097-2765(01)00159-9;
RA   Raval A., Howcroft T.K., Weissman J.D., Kirshner S., Zhu X.S.,
RA   Yokoyama K., Ting J., Singer D.S.;
RT   "Transcriptional coactivator, CIITA, is an acetyltransferase that
RT   bypasses a promoter requirement for TAF(II)250.";
RL   Mol. Cell 7:105-115(2001).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH ZXDA AND ZXDC.
RX   PubMed=17493635; DOI=10.1016/j.jmb.2007.04.033;
RA   Al-Kandari W., Koneni R., Navalgund V., Aleksandrova A.,
RA   Jambunathan S., Fontes J.D.;
RT   "The zinc finger proteins ZXDA and ZXDC form a complex that binds
RT   CIITA and regulates MHC II gene transcription.";
RL   J. Mol. Biol. 369:1175-1187(2007).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH ZXDC.
RX   PubMed=16600381; DOI=10.1016/j.molimm.2006.02.029;
RA   Al-Kandari W., Jambunathan S., Navalgund V., Koneni R., Freer M.,
RA   Parimi N., Mudhasani R., Fontes J.D.;
RT   "ZXDC, a novel zinc finger protein that binds CIITA and activates MHC
RT   gene transcription.";
RL   Mol. Immunol. 44:311-321(2007).
RN   [12]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PML.
RX   PubMed=23007646; DOI=10.1083/jcb.201112015;
RA   Ulbricht T., Alzrigat M., Horch A., Reuter N., von Mikecz A.,
RA   Steimle V., Schmitt E., Kraemer O.H., Stamminger T., Hemmerich P.;
RT   "PML promotes MHC class II gene expression by stabilizing the class II
RT   transactivator.";
RL   J. Cell Biol. 199:49-63(2012).
RN   [13]
RP   FUNCTION AS KINASE, CATALYTIC ACTIVITY, AND AUTOPHOSPHORYLATION.
RX   PubMed=24036077; DOI=10.1016/j.bbagrm.2013.09.001;
RA   Soe K.C., Devaiah B.N., Singer D.S.;
RT   "Transcriptional coactivator CIITA, a functional homolog of TAF1, has
RT   kinase activity.";
RL   Biochim. Biophys. Acta 1829:1184-1190(2013).
RN   [14]
RP   VARIANT BLS2 GROUP A SER-962.
RX   PubMed=10501838; DOI=10.1007/s002510050579;
RA   Quan V., Towey M., Sacks S., Kelly A.P.;
RT   "Absence of MHC class II gene expression in a patient with a single
RT   amino acid substitution in the class II transactivator protein
RT   CIITA.";
RL   Immunogenetics 49:957-963(1999).
RN   [15]
RP   VARIANT BLS2 GROUP A PRO-469.
RX   PubMed=11466404; DOI=10.4049/jimmunol.167.3.1787;
RA   Wiszniewski W., Fondaneche M.-C., Le Deist F., Kanariou M., Selz F.,
RA   Brousse N., Steimle V., Barbieri G., Alcaide-Loridan C., Charron D.,
RA   Fischer A., Lisowska-Grospierre B.;
RT   "Mutation in the class II trans-activator leading to a mild
RT   immunodeficiency.";
RL   J. Immunol. 167:1787-1794(2001).
RN   [16]
RP   ERRATUM.
RA   Wiszniewski W., Fondaneche M.-C., Le Deist F., Kanariou M., Selz F.,
RA   Brousse N., Steimle V., Barbieri G., Alcaide-Loridan C., Charron D.,
RA   Fischer A., Lisowska-Grospierre B.;
RL   J. Immunol. 169:607-607(2002).
RN   [17]
RP   VARIANTS BLS2 GROUP A 964-LEU--ASP-991 DEL AND ILE-1027 DEL.
RX   PubMed=11862382; DOI=10.1007/s00251-001-0395-7;
RA   Dziembowska M., Fondaneche M.-C., Vedrenne J., Barbieri G.,
RA   Wiszniewski W., Picard C., Cant A.J., Steimle V., Charron D.,
RA   Alcaide-Loridan C., Fischer A., Lisowska-Grospierre B.;
RT   "Three novel mutations of the CIITA gene in MHC class II-deficient
RT   patients with a severe immunodeficiency.";
RL   Immunogenetics 53:821-829(2002).
CC   -!- FUNCTION: Essential for transcriptional activity of the HLA class
CC       II promoter; activation is via the proximal promoter. No DNA
CC       binding of in vitro translated CIITA was detected. May act in a
CC       coactivator-like fashion through protein-protein interactions by
CC       contacting factors binding to the proximal MHC class II promoter,
CC       to elements of the transcription machinery, or both. Alternatively
CC       it may activate HLA class II transcription by modifying proteins
CC       that bind to the MHC class II promoter. Also mediates enhanced MHC
CC       class I transcription; the promoter element requirements for
CC       CIITA-mediated transcription are distinct from those of
CC       constitutive MHC class I transcription, and CIITA can functionally
CC       replace TAF1 at these genes. Exhibits intrinsic GTP-stimulated
CC       acetyltransferase activity. Exhibits serine/threonine protein
CC       kinase activity: can phosphorylate the TFIID component TAF7, the
CC       RAP74 subunit of the general transcription factor TFIIF, histone
CC       H2B at 'Ser-37' and other histones (in vitro).
CC       {ECO:0000269|PubMed:11172716, ECO:0000269|PubMed:16600381,
CC       ECO:0000269|PubMed:17493635, ECO:0000269|PubMed:24036077}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:24036077}.
CC   -!- SUBUNIT: Interacts with ZXDA and ZXDC. Interacts with PML (isoform
CC       PML-2). {ECO:0000269|PubMed:16600381, ECO:0000269|PubMed:17493635,
CC       ECO:0000269|PubMed:23007646}.
CC   -!- INTERACTION:
CC       Q96EB6:SIRT1; NbExp=4; IntAct=EBI-1538819, EBI-1802965;
CC       P98168:ZXDA; NbExp=4; IntAct=EBI-1538819, EBI-1538980;
CC       Q2QGD7:ZXDC; NbExp=6; IntAct=EBI-1538819, EBI-1538838;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23007646}.
CC       Nucleus, PML body {ECO:0000269|PubMed:23007646}. Note=Recruited to
CC       PML body by PML.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P33076-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P33076-2; Sequence=VSP_055099, VSP_055102, VSP_055103;
CC       Name=3; Synonyms=hCIITA';
CC         IsoId=P33076-3; Sequence=VSP_055099, VSP_055100, VSP_055101;
CC         Note=Exhibits dominant-negative suppression of MHC class II gene
CC         expression.;
CC       Name=4;
CC         IsoId=P33076-4; Sequence=VSP_055102, VSP_055103;
CC   -!- DOMAIN: The acetyltransferase domain is necessary for activation
CC       of both class I and class II transcription.
CC   -!- DOMAIN: The GTP-binding motif doesn't confer GTPase activity but
CC       promotes nuclear localization.
CC   -!- PTM: Autophosphorylated, affecting interaction with TAF7.
CC   -!- DISEASE: Bare lymphocyte syndrome 2 (BLS2) [MIM:209920]: A severe
CC       combined immunodeficiency disease with early onset. It is
CC       characterized by a profound defect in constitutive and interferon-
CC       gamma induced MHC II expression, absence of cellular and humoral
CC       T-cell response to antigen challenge, hypogammaglobulinemia and
CC       impaired antibody production. The consequence include extreme
CC       susceptibility to viral, bacterial and fungal infections.
CC       {ECO:0000269|PubMed:10501838, ECO:0000269|PubMed:11466404,
CC       ECO:0000269|PubMed:11862382, ECO:0000269|PubMed:7749984,
CC       ECO:0000269|PubMed:8402893}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=CIITAbase; Note=CIITA mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/CIITAbase/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MHC2TAID260.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X74301; CAA52354.1; -; mRNA.
DR   EMBL; U18259; AAA88861.1; -; mRNA.
DR   EMBL; U18288; AAA88862.1; -; mRNA.
DR   EMBL; AY084054; AAM15723.1; -; mRNA.
DR   EMBL; AF410154; AAL04118.1; -; mRNA.
DR   EMBL; EF064747; ABK41930.1; -; Genomic_DNA.
DR   EMBL; AC133065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85169.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85172.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85173.1; -; Genomic_DNA.
DR   CCDS; CCDS10544.1; -. [P33076-1]
DR   CCDS; CCDS66943.1; -. [P33076-3]
DR   PIR; A48843; A48843.
DR   RefSeq; NP_000237.2; NM_000246.3.
DR   RefSeq; NP_001273332.1; NM_001286403.1. [P33076-3]
DR   UniGene; Hs.592051; -.
DR   UniGene; Hs.701991; -.
DR   ProteinModelPortal; P33076; -.
DR   BioGrid; 110416; 24.
DR   ELM; P33076; -.
DR   IntAct; P33076; 3.
DR   STRING; 9606.ENSP00000316328; -.
DR   iPTMnet; P33076; -.
DR   PhosphoSitePlus; P33076; -.
DR   BioMuta; CIITA; -.
DR   DMDM; 317373472; -.
DR   MaxQB; P33076; -.
DR   PaxDb; P33076; -.
DR   PeptideAtlas; P33076; -.
DR   PRIDE; P33076; -.
DR   DNASU; 4261; -.
DR   Ensembl; ENST00000381835; ENSP00000371257; ENSG00000179583. [P33076-3]
DR   GeneID; 4261; -.
DR   KEGG; hsa:4261; -.
DR   UCSC; uc002dak.5; human. [P33076-1]
DR   CTD; 4261; -.
DR   DisGeNET; 4261; -.
DR   EuPathDB; HostDB:ENSG00000179583.17; -.
DR   GeneCards; CIITA; -.
DR   HGNC; HGNC:7067; CIITA.
DR   HPA; CAB016084; -.
DR   MalaCards; CIITA; -.
DR   MIM; 209920; phenotype.
DR   MIM; 600005; gene.
DR   neXtProt; NX_P33076; -.
DR   OpenTargets; ENSG00000179583; -.
DR   Orphanet; 572; Immunodeficiency by defective expression of HLA class 2.
DR   PharmGKB; PA30795; -.
DR   eggNOG; KOG4308; Eukaryota.
DR   eggNOG; ENOG410ZBX3; LUCA.
DR   GeneTree; ENSGT00860000133673; -.
DR   HOGENOM; HOG000107439; -.
DR   HOVERGEN; HBG000174; -.
DR   InParanoid; P33076; -.
DR   KO; K08060; -.
DR   PhylomeDB; P33076; -.
DR   TreeFam; TF352118; -.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   SIGNOR; P33076; -.
DR   ChiTaRS; CIITA; human.
DR   GeneWiki; CIITA; -.
DR   GenomeRNAi; 4261; -.
DR   PRO; PR:P33076; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000179583; -.
DR   CleanEx; HS_CIITA; -.
DR   ExpressionAtlas; P33076; baseline and differential.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0033613; F:activating transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0032403; F:protein complex binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0032966; P:negative regulation of collagen biosynthetic process; IC:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0045345; P:positive regulation of MHC class I biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0045348; P:positive regulation of MHC class II biosynthetic process; IC:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0046677; P:response to antibiotic; IDA:MGI.
DR   GO; GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008095; MHC_II_transact.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13516; LRR_6; 3.
DR   PRINTS; PR01719; MHCIIACTVATR.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50837; NACHT; 1.
PE   1: Evidence at protein level;
KW   Activator; Acyltransferase; Alternative splicing; ATP-binding;
KW   Complete proteome; Disease mutation; GTP-binding; Kinase;
KW   Leucine-rich repeat; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; SCID; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN         1   1130       MHC class II transactivator.
FT                                /FTId=PRO_0000089241.
FT   DOMAIN      414    724       NACHT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00136}.
FT   REPEAT      985   1008       LRR 1.
FT   REPEAT     1016   1037       LRR 2.
FT   REPEAT     1045   1066       LRR 3.
FT   REPEAT     1073   1093       LRR 4.
FT   NP_BIND     420    427       GTP.
FT   REGION       94    132       Required for acetyltransferase activity.
FT   COMPBIAS     52    137       Asp/Glu-rich (acidic).
FT   VAR_SEQ     161    210       AEPPTVVTGSLLVRPVSDCSTLPCLPLPALFNQEPASGQMR
FT                                LEKTDQIPM -> V (in isoform 2 and isoform
FT                                3). {ECO:0000303|PubMed:12919287,
FT                                ECO:0000303|PubMed:7749984}.
FT                                /FTId=VSP_055099.
FT   VAR_SEQ     336    350       EPVEQFYRSLQDTYG -> GLAWSPCLGLRPSLH (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:12919287}.
FT                                /FTId=VSP_055100.
FT   VAR_SEQ     351    885       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12919287}.
FT                                /FTId=VSP_055101.
FT   VAR_SEQ     887    930       AALSDTVALWESLQQHGETKLLQAAEEKFTIEPFKAKSLKD
FT                                VED -> WGEGLGRDILVLGINCGLGAKPSALWGPFSMQSS
FT                                RVGQNGFSPF (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:12859996,
FT                                ECO:0000303|PubMed:7749984}.
FT                                /FTId=VSP_055102.
FT   VAR_SEQ     931   1128       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:12859996,
FT                                ECO:0000303|PubMed:7749984}.
FT                                /FTId=VSP_055103.
FT   VARIANT      45     45       L -> V (in dbSNP:rs2229317).
FT                                /FTId=VAR_029270.
FT   VARIANT     120    120       K -> IE (in BLS2).
FT                                /FTId=VAR_005127.
FT   VARIANT     174    174       R -> G (in dbSNP:rs8046121).
FT                                {ECO:0000269|PubMed:12859996,
FT                                ECO:0000269|PubMed:7749984,
FT                                ECO:0000269|PubMed:8402893,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_047907.
FT   VARIANT     469    469       L -> P (in BLS2; mild immunodeficiency;
FT                                has residual MHC class II trans
FT                                activation activity).
FT                                {ECO:0000269|PubMed:11466404}.
FT                                /FTId=VAR_015551.
FT   VARIANT     500    500       G -> A (in dbSNP:rs4774).
FT                                {ECO:0000269|PubMed:12859996,
FT                                ECO:0000269|PubMed:7749984,
FT                                ECO:0000269|PubMed:8402893}.
FT                                /FTId=VAR_005128.
FT   VARIANT     658    658       A -> G (in dbSNP:rs2229319).
FT                                /FTId=VAR_015552.
FT   VARIANT     781    781       S -> L (in dbSNP:rs13330686).
FT                                /FTId=VAR_060104.
FT   VARIANT     782    782       V -> A (in dbSNP:rs13336804).
FT                                /FTId=VAR_057711.
FT   VARIANT     900    900       Q -> R (in dbSNP:rs7197779).
FT                                {ECO:0000269|PubMed:12919287,
FT                                ECO:0000269|PubMed:7749984,
FT                                ECO:0000269|PubMed:8402893,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_047908.
FT   VARIANT     940    963       Missing (in BLS2).
FT                                {ECO:0000269|PubMed:8402893}.
FT                                /FTId=VAR_005129.
FT   VARIANT     962    962       F -> S (in BLS2).
FT                                {ECO:0000269|PubMed:10501838}.
FT                                /FTId=VAR_015553.
FT   VARIANT     964    991       Missing (in BLS2).
FT                                /FTId=VAR_015554.
FT   VARIANT    1027   1027       Missing (in BLS2).
FT                                {ECO:0000269|PubMed:11862382}.
FT                                /FTId=VAR_015555.
FT   MUTAGEN     420    421       Missing: Strongly reduces GTP-binding and
FT                                abolishes transactivation at MHC
FT                                promoters. {ECO:0000269|PubMed:10464099}.
FT   MUTAGEN     561    561       D->A: Strongly reduces GTP-binding and
FT                                abolishes transactivation at MHC
FT                                promoters. {ECO:0000269|PubMed:10464099}.
FT   CONFLICT   1020   1021       LN -> RS (in Ref. 4; ABK41930).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1130 AA;  123514 MW;  7A61CAA4F3FFECE0 CRC64;
     MRCLAPRPAG SYLSEPQGSS QCATMELGPL EGGYLELLNS DADPLCLYHF YDQMDLAGEE
     EIELYSEPDT DTINCDQFSR LLCDMEGDEE TREAYANIAE LDQYVFQDSQ LEGLSKDIFK
     HIGPDEVIGE SMEMPAEVGQ KSQKRPFPEE LPADLKHWKP AEPPTVVTGS LLVRPVSDCS
     TLPCLPLPAL FNQEPASGQM RLEKTDQIPM PFSSSSLSCL NLPEGPIQFV PTISTLPHGL
     WQISEAGTGV SSIFIYHGEV PQASQVPPPS GFTVHGLPTS PDRPGSTSPF APSATDLPSM
     PEPALTSRAN MTEHKTSPTQ CPAAGEVSNK LPKWPEPVEQ FYRSLQDTYG AEPAGPDGIL
     VEVDLVQARL ERSSSKSLER ELATPDWAER QLAQGGLAEV LLAAKEHRRP RETRVIAVLG
     KAGQGKSYWA GAVSRAWACG RLPQYDFVFS VPCHCLNRPG DAYGLQDLLF SLGPQPLVAA
     DEVFSHILKR PDRVLLILDG FEELEAQDGF LHSTCGPAPA EPCSLRGLLA GLFQKKLLRG
     CTLLLTARPR GRLVQSLSKA DALFELSGFS MEQAQAYVMR YFESSGMTEH QDRALTLLRD
     RPLLLSHSHS PTLCRAVCQL SEALLELGED AKLPSTLTGL YVGLLGRAAL DSPPGALAEL
     AKLAWELGRR HQSTLQEDQF PSADVRTWAM AKGLVQHPPR AAESELAFPS FLLQCFLGAL
     WLALSGEIKD KELPQYLALT PRKKRPYDNW LEGVPRFLAG LIFQPPARCL GALLGPSAAA
     SVDRKQKVLA RYLKRLQPGT LRARQLLELL HCAHEAEEAG IWQHVVQELP GRLSFLGTRL
     TPPDAHVLGK ALEAAGQDFS LDLRSTGICP SGLGSLVGLS CVTRFRAALS DTVALWESLQ
     QHGETKLLQA AEEKFTIEPF KAKSLKDVED LGKLVQTQRT RSSSEDTAGE LPAVRDLKKL
     EFALGPVSGP QAFPKLVRIL TAFSSLQHLD LDALSENKIG DEGVSQLSAT FPQLKSLETL
     NLSQNNITDL GAYKLAEALP SLAASLLRLS LYNNCICDVG AESLARVLPD MVSLRVMDVQ
     YNKFTAAGAQ QLAASLRRCP HVETLAMWTP TIPFSVQEHL QQQDSRISLR
//
ID   Q66X48_HUMAN            Unreviewed;      1107 AA.
AC   Q66X48;
DT   11-OCT-2004, integrated into UniProtKB/TrEMBL.
DT   11-OCT-2004, sequence version 1.
DT   28-FEB-2018, entry version 87.
DE   SubName: Full=CIITA IV {ECO:0000313|EMBL:AAU06586.1};
GN   Name=MHC2TA {ECO:0000313|EMBL:AAU06586.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAU06586.1};
RN   [1] {ECO:0000313|EMBL:AAU06586.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Jiang Y., Chou K., Song L., Gong W., Zhou Y., Wang B., Xin L., Lu L.,
RA   Ding Q., Jiao Z.;
RT   "CIITA IV from THP1 cell line.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY699071; AAU06586.1; -; mRNA.
DR   RefSeq; NP_000237.2; NM_000246.3.
DR   UniGene; Hs.592051; -.
DR   UniGene; Hs.701991; -.
DR   ProteinModelPortal; Q66X48; -.
DR   PeptideAtlas; Q66X48; -.
DR   PRIDE; Q66X48; -.
DR   DNASU; 4261; -.
DR   GeneID; 4261; -.
DR   KEGG; hsa:4261; -.
DR   CTD; 4261; -.
DR   PharmGKB; PA30795; -.
DR   eggNOG; KOG4308; Eukaryota.
DR   eggNOG; ENOG410ZBX3; LUCA.
DR   HOVERGEN; HBG000174; -.
DR   KO; K08060; -.
DR   ChiTaRS; CIITA; human.
DR   GenomeRNAi; 4261; -.
DR   Genevisible; Q66X48; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008095; MHC_II_transact.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13516; LRR_6; 3.
DR   PRINTS; PR01719; MHCIIACTVATR.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50837; NACHT; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00700025};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00700025};
KW   Repeat {ECO:0000256|SAAS:SAAS00508757}.
FT   DOMAIN      391    701       NACHT. {ECO:0000259|PROSITE:PS50837}.
SQ   SEQUENCE   1107 AA;  120936 MW;  16A1103F13FC3663 CRC64;
     MELGPLEGGY LEPLNSDADP LCLYHFYDQM DLAGEEEIEL YSEPDTDTIN CDQFSRLLCD
     MEGDEETREA YANIAELDQY VFQDSQLEGL SKDIFIEHIG PDEVIGESME MPAEVGQKSQ
     KRPFPEELPA DLKHWKPAEP PTVVAGSLLV GPVSDCSTLS CLPLPALFNQ EPASGQMRLE
     KTDQIPMPFS SSSLSCLNLP EGPIQFVPTI STLPHGLWQI SEAGTGVSSI FIYHGEVPQA
     SQVPPPSGFT VHGLPTSPDR PGSTSPFAPS ATDLPSMPEP ALTSRANMTE HKTSPTQCPA
     AGEVSNKLPK WPEPVEQFYR SLQDTYGAEP AGPDGILVEV DLVQARLERS SSKGLERELA
     TPDWAERQLA QGGLAEVLLA AKEHRRPRET RVIAVLGKAG QGKSYWAGAV SRAWACGRLP
     QYDFVFSVPC HCLNRPGDAY GLQDLLFSLG PQPLVAADEV FSHILKRPDR VLLILDGFEE
     LEAQDGFLHS TCGPAPAEPC SLRGLLAGLF QKKLLRGCTL LLTARPRGRL VQSLSKADAL
     FELSGFSMEQ AQAYVMRYFE SSGMTEHQDR ALTLLRDRPL LLSHSHSPTL CRAVCQLSEA
     LLELGEDAKL PSTLTGLYVG LLGRAALGSP PGALAELAKL AWELGRRHQS TLQEDQFPSA
     DVRTWAMAKG LVQHPPRAAE SELAFPSFLL QCFLGALWLA LSGEIKDKEL PQYLALTPRK
     KRPYDNWLEG VPRFLAGLIF QPPARCLGAL LGPSAAASVD RKQKVLARYL KRLQPGTLRA
     RQLLELLHCA HEAEEAGIWQ HVVQELPGRL SFLGTRLTPL DAHVLGKALE AAGQDFSLDL
     RSTGICPSGL GSLVGLSCVT RFRAALSDTV ALWESLRQHG ETKLLQAAEE KFTIEPFKAK
     SLKDVEDLGK LVQTQRTRSS SEDTAGELPA VRDLKKLEFA LGPVSGPQAF PKLVRILTAF
     SSLQHLDLDA LSENKIGDEG VSQLSATFPQ LKSLETLNLS QNNITDLGAY KLAEALPSLA
     ASLLRLSLYN NCICDVGAES LARVLPDMVS LRVMDVQYNK FTAAGAQQLA ASLRRCPHVE
     TLAMWTPTIP FSVQEHLQQQ DSRISLR
//
ID   A0A087WVQ6_HUMAN        Unreviewed;      1679 AA.
AC   A0A087WVQ6;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 36.
DE   RecName: Full=Clathrin heavy chain {ECO:0000256|PIRNR:PIRNR002290};
GN   Name=CLTC {ECO:0000313|EMBL:EAW94397.1,
GN   ECO:0000313|Ensembl:ENSP00000479606};
GN   ORFNames=hCG_1818599 {ECO:0000313|EMBL:EAW94397.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479606, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW94397.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW94397.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000479606, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [8] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [10] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large scale characterization of plant versus mammal
RT   proteins reveals similar and idiosyncratic N-alpha-acetylation
RT   features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15] {ECO:0000313|Ensembl:ENSP00000479606}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [16] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Clathrin is the major protein of the polyhedral coat of
CC       coated pits and vesicles. {ECO:0000256|PIRNR:PIRNR002290}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane
CC       {ECO:0000256|PIRNR:PIRNR002290}; Peripheral membrane protein
CC       {ECO:0000256|PIRNR:PIRNR002290}; Cytoplasmic side
CC       {ECO:0000256|PIRNR:PIRNR002290}. Membrane, coated pit
CC       {ECO:0000256|PIRNR:PIRNR002290}; Peripheral membrane protein
CC       {ECO:0000256|PIRNR:PIRNR002290}; Cytoplasmic side
CC       {ECO:0000256|PIRNR:PIRNR002290}.
CC   -!- SIMILARITY: Belongs to the clathrin heavy chain family.
CC       {ECO:0000256|PIRNR:PIRNR002290}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC091271; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94397.1; -; Genomic_DNA.
DR   RefSeq; NP_001275582.1; NM_001288653.1.
DR   UniGene; Hs.491351; -.
DR   PeptideAtlas; A0A087WVQ6; -.
DR   Ensembl; ENST00000621829; ENSP00000479606; ENSG00000141367.
DR   GeneID; 1213; -.
DR   UCSC; uc002ixr.1; human.
DR   CTD; 1213; -.
DR   EuPathDB; HostDB:ENSG00000141367.11; -.
DR   HGNC; HGNC:2092; CLTC.
DR   OpenTargets; ENSG00000141367; -.
DR   eggNOG; KOG0985; Eukaryota.
DR   eggNOG; ENOG410XPH1; LUCA.
DR   GeneTree; ENSGT00400000022107; -.
DR   OMA; VQQCTAF; -.
DR   OrthoDB; EOG091G009O; -.
DR   ChiTaRS; CLTC; human.
DR   GenomeRNAi; 1213; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000141367; -.
DR   GO; GO:0030132; C:clathrin coat of coated pit; IEA:InterPro.
DR   GO; GO:0030130; C:clathrin coat of trans-Golgi network vesicle; IEA:InterPro.
DR   GO; GO:0071439; C:clathrin complex; IEA:InterPro.
DR   GO; GO:0005768; C:endosome; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; IDA:HPA.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:0032051; F:clathrin light chain binding; IEA:InterPro.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0048268; P:clathrin coat assembly; IEA:InterPro.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:UniProtKB-UniRule.
DR   GO; GO:0016192; P:vesicle-mediated transport; IEA:InterPro.
DR   Gene3D; 1.25.40.10; -; 4.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000547; Clathrin_H-chain/VPS_repeat.
DR   InterPro; IPR015348; Clathrin_H-chain_linker_core.
DR   InterPro; IPR022365; Clathrin_H-chain_propeller_rpt.
DR   InterPro; IPR016341; Clathrin_heavy_chain.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF00637; Clathrin; 7.
DR   Pfam; PF09268; Clathrin-link; 1.
DR   Pfam; PF01394; Clathrin_propel; 5.
DR   PIRSF; PIRSF002290; Clathrin_H_chain; 1.
DR   SMART; SM00299; CLH; 7.
DR   SUPFAM; SSF48371; SSF48371; 6.
DR   PROSITE; PS50236; CHCR; 7.
PE   1: Evidence at protein level;
KW   Coated pit {ECO:0000256|PIRNR:PIRNR002290};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Cytoplasmic vesicle {ECO:0000256|PIRNR:PIRNR002290};
KW   Membrane {ECO:0000256|PIRNR:PIRNR002290};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WVQ6,
KW   ECO:0000213|MaxQB:A0A087WVQ6, ECO:0000213|PeptideAtlas:A0A087WVQ6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      335    358       Clathrin-link.
FT                                {ECO:0000259|Pfam:PF09268}.
FT   REPEAT      541    687       CHCR. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01006}.
FT   REPEAT      690    832       CHCR. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01006}.
FT   REPEAT      837    976       CHCR. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01006}.
FT   REPEAT      983   1128       CHCR. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01006}.
FT   REPEAT     1132   1273       CHCR. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01006}.
FT   REPEAT     1278   1424       CHCR. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01006}.
FT   REPEAT     1427   1570       CHCR. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01006}.
SQ   SEQUENCE   1679 AA;  192058 MW;  9E4E36D1E25FB0DA CRC64;
     MAQILPIRFQ EHLQLQNLGI NPANIGFSTL TMESDKFICI REKVGEQAQV VIIDMNDPSN
     PIRRPISADS AIMNPASKVI ALKGIKESGK TLQIFNIEMK SKMKAHTMTD DVTFWKWISL
     NTVALVTDNA VYHWSMEGES QPVKMFDRHS SLAGCQIINY RTDAKQKWLL LTGISAQQNR
     VVGAMQLYSV DRKVSQPIEG HAASFAQFKM EGNAEESTLF CFAVRGQAGG KLHIIEVGTP
     PTGNQPFPKK AVDVFFPPEA QNDFPVAMQI SEKHDVVFLI TKYGYIHLYD LETGTCIYMN
     RISGETIFVT APHEATAGII GVNRKGQVLS VCVEEENIIP YITNVLQNPD LALRMAVRNN
     LAGAEELFAR KFNALFAQGN YSEAAKVAAN APKGILRTPD TIRRFQSVPA QPGQTSPLLQ
     YFGILLDQGQ LNKYESLELC RPVLQQGRKQ LLEKWLKEDK LECSEELGDL VKSVDPTLAL
     SVYLRANVPN KVIQCFAETG QVQKIVLYAK KVGYTPDWIF LLRNVMRISP DQGQQFAQML
     VQDEEPLADI TQIVDVFMEY NLIQQCTAFL LDALKNNRPS EGPLQTRLLE MNLMHAPQVA
     DAILGNQMFT HYDRAHIAQL CEKAGLLQRA LEHFTDLYDI KRAVVHTHLL NPEWLVNYFG
     SLSVEDSLEC LRAMLSANIR QNLQICVQVA SKYHEQLSTQ SLIELFESFK SFEGLFYFLG
     SIVNFSQDPD VHFKYIQAAC KTGQIKEVER ICRESNCYDP ERVKNFLKEA KLTDQLPLII
     VCDRFDFVHD LVLYLYRNNL QKYIEIYVQK VNPSRLPVVI GGLLDVDCSE DVIKNLILVV
     RGQFSTDELV AEVEKRNRLK LLLPWLEARI HEGCEEPATH NALAKIYIDS NNNPERFLRE
     NPYYDSRVVG KYCEKRDPHL ACVAYERGQC DLELINVCNE NSLFKSLSRY LVRRKDPELW
     GSVLLESNPY RRPLIDQVVQ TALSETQDPE EVSVTVKAFM TADLPNELIE LLEKIVLDNS
     VFSEHRNLQN LLILTAIKAD RTRVMEYINR LDNYDAPDIA NIAISNELFE EAFAIFRKFD
     VNTSAVQVLI EHIGNLDRAY EFAERCNEPA VWSQLAKAQL QKGMVKEAID SYIKADDPSS
     YMEVVQAANT SGNWEELVKY LQMARKKARE SYVETELIFA LAKTNRLAEL EEFINGPNNA
     HIQQVGDRCY DEKMYDAAKL LYNNVSNFGR LASTLVHLGE YQAAVDGARK ANSTRTWKEV
     CFACVDGKEF RLAQMCGLHI VVHADELEEL INYYQDRGYF EELITMLEAA LGLERAHMGM
     FTELAILYSK FKPQKMREHL ELFWSRVNIP KVLRAAEQAH LWAELVFLYD KYEEYDNAII
     TMMNHPTDAW KEGQFKDIIT KVANVELYYR AIQFYLEFKP LLLNDLLMVL SPRLDHTRAV
     NYFSKVKQLP LVKPYLRSVQ NHNNKSVNES LNNLFITEED YQALRTSIDA YDNFDNISLA
     QRLEKHELIE FRRIAAYLFK GNNRWKQSVE LCKKDSLYKD AMQYASESKD TELAEELLQW
     FLQEEKRECF GACLFTCYDL LRPDVVLETA WRHNIMDFAM PYFIQVMKEY LTKVDKLDAS
     ESLRKEEEQA TETQPIVYGQ PQLMLTAGPS VAVPPQAPFG YGYTAPPYGQ PQPGFGYSM
//
ID   CLH1_HUMAN              Reviewed;        1675 AA.
AC   Q00610; D3DU00; Q6N0A0; Q86TF2;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   28-FEB-2018, entry version 187.
DE   RecName: Full=Clathrin heavy chain 1;
DE   AltName: Full=Clathrin heavy chain on chromosome 17;
DE            Short=CLH-17;
GN   Name=CLTC; Synonyms=CLH17, CLTCL2, KIAA0034;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y.,
RA   Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I.
RT   The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by
RT   analysis of randomly sampled cDNA clones from human immature myeloid
RT   cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=PNS, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 560-864 (ISOFORMS 1/2).
RC   TISSUE=Colon;
RX   PubMed=1765375; DOI=10.1016/0888-7543(91)90115-U;
RA   Dodge G.R., Kovalszky I., McBride O.W., Yi H.F., Chu M.-L., Saitta B.,
RA   Stokes D.G., Iozzo R.V.;
RT   "Human clathrin heavy chain (CLTC): partial molecular cloning,
RT   expression, and mapping of the gene to human chromosome 17q11-qter.";
RL   Genomics 11:174-178(1991).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-8.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-8; 64-78; 87-96; 164-205; 228-245; 270-278;
RP   298-320; 355-382; 469-481; 507-519; 572-610; 626-638; 799-806;
RP   831-852; 855-865; 882-903; 1011-1037; 1074-1101; 1123-1130; 1166-1179;
RP   1183-1204; 1216-1245; 1312-1326; 1398-1406; 1435-1453; 1482-1498;
RP   1502-1508; 1510-1516 AND 1610-1620, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma, Hepatoma, and Mammary carcinoma;
RA   Bienvenut W.V., Calvo F., Matallanas D., Cooper W.N., Boldt K.,
RA   von Kriegsheim A.F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [8]
RP   INTERACTION WITH HIP1.
RX   PubMed=11532990; DOI=10.1093/hmg/10.17.1807;
RA   Waelter S., Scherzinger E., Hasenbank R., Nordhoff E., Lurz R.,
RA   Goehler H., Gauss C., Sathasivam K., Bates G.P., Lehrach H.,
RA   Wanker E.E.;
RT   "The huntingtin interacting protein HIP1 is a clathrin and alpha-
RT   adaptin-binding protein involved in receptor-mediated endocytosis.";
RL   Hum. Mol. Genet. 10:1807-1817(2001).
RN   [9]
RP   INTERACTION WITH ERBB2.
RX   PubMed=16314522; DOI=10.1128/MCB.25.24.11005-11018.2005;
RA   Giri D.K., Ali-Seyed M., Li L.Y., Lee D.F., Ling P., Bartholomeusz G.,
RA   Wang S.C., Hung M.C.;
RT   "Endosomal transport of ErbB-2: mechanism for nuclear entry of the
RT   cell surface receptor.";
RL   Mol. Cell. Biol. 25:11005-11018(2005).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15858577; DOI=10.1038/nature03502;
RA   Royle S.J., Bright N.A., Lagnado L.;
RT   "Clathrin is required for the function of the mitotic spindle.";
RL   Nature 434:1152-1157(2005).
RN   [11]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=16968737; DOI=10.1242/jcs.03192;
RA   Royle S.J., Lagnado L.;
RT   "Trimerisation is important for the function of clathrin at the
RT   mitotic spindle.";
RL   J. Cell Sci. 119:4071-4078(2006).
RN   [12]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [13]
RP   INTERACTION WITH FKBP6.
RX   PubMed=18529014; DOI=10.1021/bi8001506;
RA   Jarczowski F., Fischer G., Edlich F.;
RT   "FKBP36 forms complexes with clathrin and Hsp72 in spermatocytes.";
RL   Biochemistry 47:6946-6952(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1494, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-634 AND TYR-1477, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-856; LYS-1441 AND LYS-1501,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH ATG16L1.
RX   PubMed=20639872; DOI=10.1038/ncb2078;
RA   Ravikumar B., Moreau K., Jahreiss L., Puri C., Rubinsztein D.C.;
RT   "Plasma membrane contributes to the formation of pre-autophagosomal
RT   structures.";
RL   Nat. Cell Biol. 12:747-757(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=21297582; DOI=10.1038/emboj.2011.15;
RA   Booth D.G., Hood F.E., Prior I.A., Royle S.J.;
RT   "A TACC3/ch-TOG/clathrin complex stabilises kinetochore fibres by
RT   inter-microtubule bridging.";
RL   EMBO J. 30:906-919(2011).
RN   [23]
RP   INTERACTION WITH RFTN1.
RX   PubMed=21266579; DOI=10.1074/jbc.M110.185793;
RA   Watanabe A., Tatematsu M., Saeki K., Shibata S., Shime H.,
RA   Yoshimura A., Obuse C., Seya T., Matsumoto M.;
RT   "Raftlin is involved in the nucleocapture complex to induce poly(I:C)-
RT   mediated TLR3 activation.";
RL   J. Biol. Chem. 286:10702-10711(2011).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [26]
RP   INTERACTION WITH TACC3, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   PRO-65; SER-67; THR-87; GLN-89; LYS-96; LYS-98 AND 480-LYS--VAL-484.
RX   PubMed=23918938; DOI=10.1083/jcb.201211127;
RA   Hood F.E., Williams S.J., Burgess S.G., Richards M.W., Roth D.,
RA   Straube A., Pfuhl M., Bayliss R., Royle S.J.;
RT   "Coordination of adjacent domains mediates TACC3-ch-TOG-clathrin
RT   assembly and mitotic spindle binding.";
RL   J. Cell Biol. 202:463-478(2013).
RN   [27]
RP   FUNCTION OF THE TACC3/CH-TOG/CLATHRIN COMPLEX.
RX   PubMed=23532825; DOI=10.1242/jcs.124834;
RA   Cheeseman L.P., Harry E.F., McAinsh A.D., Prior I.A., Royle S.J.;
RT   "Specific removal of TACC3-ch-TOG-clathrin at metaphase deregulates
RT   kinetochore fiber tension.";
RL   J. Cell Sci. 126:2102-2113(2013).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-394; SER-1229
RP   AND SER-1494, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394 AND SER-1494, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   SUBCELLULAR LOCATION.
RX   PubMed=25596274; DOI=10.1242/bio.201410843;
RA   Gutierrez-Caballero C., Burgess S.G., Bayliss R., Royle S.J.;
RT   "TACC3-ch-TOG track the growing tips of microtubules independently of
RT   clathrin and Aurora-A phosphorylation.";
RL   Biol. Open 4:170-179(2015).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [32]
RP   INTERACTION WITH RFTN1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=27022195; DOI=10.4049/jimmunol.1501734;
RA   Tatematsu M., Yoshida R., Morioka Y., Ishii N., Funami K.,
RA   Watanabe A., Saeki K., Seya T., Matsumoto M.;
RT   "Raftlin controls lipopolysaccharide-induced TLR4 internalization and
RT   TICAM-1 signaling in a cell type-specific manner.";
RL   J. Immunol. 196:3865-3876(2016).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 1-364 IN COMPLEX WITH
RP   INHIBITORS, AND WD40-LIKE REPEATS.
RX   PubMed=21816279; DOI=10.1016/j.cell.2011.06.025;
RA   von Kleist L., Stahlschmidt W., Bulut H., Gromova K., Puchkov D.,
RA   Robertson M.J., MacGregor K.A., Tomilin N., Pechstein A., Chau N.,
RA   Chircop M., Sakoff J., von Kries J.P., Saenger W., Krausslich H.G.,
RA   Shupliakov O., Robinson P.J., McCluskey A., Haucke V.;
RT   "Role of the clathrin terminal domain in regulating coated pit
RT   dynamics revealed by small molecule inhibition.";
RL   Cell 146:471-484(2011).
RN   [34]
RP   INTERACTION WITH USP2.
RX   PubMed=26756164; DOI=10.1371/journal.pone.0145155;
RA   Pouly D., Chenaux S., Martin V., Babis M., Koch R., Nagoshi E.,
RA   Katanaev V.L., Gachon F., Staub O.;
RT   "USP2-45 is a circadian clock output effector regulating calcium
RT   absorption at the post-translational level.";
RL   PLoS ONE 11:E0145155-E0145155(2016).
CC   -!- FUNCTION: Clathrin is the major protein of the polyhedral coat of
CC       coated pits and vesicles. Two different adapter protein complexes
CC       link the clathrin lattice either to the plasma membrane or to the
CC       trans-Golgi network. Acts as component of the TACC3/ch-
CC       TOG/clathrin complex proposed to contribute to stabilization of
CC       kinetochore fibers of the mitotic spindle by acting as inter-
CC       microtubule bridge (PubMed:15858577, PubMed:16968737,
CC       PubMed:21297582). The TACC3/ch-TOG/clathrin complex is required
CC       for the maintenance of kinetochore fiber tension
CC       (PubMed:23532825). Plays a role in early autophagosome formation
CC       (PubMed:20639872). {ECO:0000269|PubMed:15858577,
CC       ECO:0000269|PubMed:16968737, ECO:0000269|PubMed:20639872,
CC       ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:23532825}.
CC   -!- SUBUNIT: Clathrin triskelions, composed of 3 heavy chains and 3
CC       light chains, are the basic subunits of the clathrin coat
CC       (PubMed:16968737). In the presence of light chains, hub assembly
CC       is influenced by both the pH and the concentration of calcium.
CC       Interacts with HIP1 (PubMed:11532990). Interacts with DENND1A,
CC       DENND1B and DENND1C (By similarity). May interact with OCRL (By
CC       similarity). Interacts with ERBB2 (PubMed:16314522). Interacts
CC       with FKBP6 (PubMed:18529014). Interacts with CKAP5 and TACC3
CC       forming the TACC3/ch-TOG/clathrin complex located at spindle
CC       inter-microtubules bridges; the complex implicates clathrin
CC       triskelions; TACC3 and CLTC are proposed to form a composite
CC       microtubule interaction surface (PubMed:21297582). Interacts with
CC       ATG16L1 (via N-terminus) (PubMed:20639872). Interacts with RFTN1;
CC       the interaction occurs in response to pathogens (PubMed:27022195,
CC       PubMed:21266579). Interacts with USP2 isoform 4 (PubMed:26756164).
CC       {ECO:0000250|UniProtKB:P49951, ECO:0000250|UniProtKB:Q68FD5,
CC       ECO:0000269|PubMed:11532990, ECO:0000269|PubMed:16314522,
CC       ECO:0000269|PubMed:16968737, ECO:0000269|PubMed:18529014,
CC       ECO:0000269|PubMed:20639872, ECO:0000269|PubMed:21266579,
CC       ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:26756164,
CC       ECO:0000269|PubMed:27022195}.
CC   -!- INTERACTION:
CC       O00291:HIP1; NbExp=2; IntAct=EBI-354967, EBI-473886;
CC       P10242:MYB; NbExp=4; IntAct=EBI-354967, EBI-298355;
CC       Q01968:OCRL; NbExp=10; IntAct=EBI-354967, EBI-6148898;
CC       Q07912:TNK2; NbExp=2; IntAct=EBI-354967, EBI-603457;
CC       O75674:TOM1L1; NbExp=4; IntAct=EBI-354967, EBI-712991;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:17081065}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17081065}; Cytoplasmic side
CC       {ECO:0000269|PubMed:17081065}. Membrane, coated pit
CC       {ECO:0000269|PubMed:17081065}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17081065}; Cytoplasmic side
CC       {ECO:0000269|PubMed:17081065}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:15858577, ECO:0000269|PubMed:16968737,
CC       ECO:0000269|PubMed:23918938}. Note=Cytoplasmic face of coated pits
CC       and vesicles. Identified by mass spectrometry in melanosome
CC       fractions from stage I to stage IV. In complex with TACC3 and
CC       CKAP5 (forming the TACC3/ch-TOG/clathrin complex) localized to
CC       inter-microtubule bridges in mitotic spindles.
CC       {ECO:0000269|PubMed:25596274}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q00610-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00610-2; Sequence=VSP_011570, VSP_011571;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The N-terminal seven-bladed beta-propeller is formed by
CC       WD40-like repeats, and projects inward from the polyhedral outer
CC       clathrin coat. It constitutes a major protein-protein interaction
CC       node.
CC   -!- SIMILARITY: Belongs to the clathrin heavy chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA04801.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CLTCID360.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Clathrin entry;
CC       URL="https://en.wikipedia.org/wiki/Clathrin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D21260; BAA04801.2; ALT_INIT; mRNA.
DR   EMBL; BX640615; CAE45761.1; -; mRNA.
DR   EMBL; CH471109; EAW94396.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94399.1; -; Genomic_DNA.
DR   EMBL; BC051800; AAH51800.1; -; mRNA.
DR   EMBL; BC054489; AAH54489.1; -; mRNA.
DR   EMBL; X55878; CAA39363.1; -; mRNA.
DR   CCDS; CCDS32696.1; -. [Q00610-1]
DR   PIR; A40573; A40573.
DR   RefSeq; NP_004850.1; NM_004859.3. [Q00610-1]
DR   UniGene; Hs.491351; -.
DR   PDB; 2XZG; X-ray; 1.70 A; A=1-364.
DR   PDB; 4G55; X-ray; 1.69 A; A=1-364.
DR   PDBsum; 2XZG; -.
DR   PDBsum; 4G55; -.
DR   ProteinModelPortal; Q00610; -.
DR   SMR; Q00610; -.
DR   BioGrid; 107623; 314.
DR   CORUM; Q00610; -.
DR   ELM; Q00610; -.
DR   IntAct; Q00610; 198.
DR   MINT; Q00610; -.
DR   STRING; 9606.ENSP00000269122; -.
DR   BindingDB; Q00610; -.
DR   ChEMBL; CHEMBL3108634; -.
DR   iPTMnet; Q00610; -.
DR   PhosphoSitePlus; Q00610; -.
DR   SwissPalm; Q00610; -.
DR   BioMuta; CLTC; -.
DR   DMDM; 1705916; -.
DR   EPD; Q00610; -.
DR   MaxQB; Q00610; -.
DR   PaxDb; Q00610; -.
DR   PeptideAtlas; Q00610; -.
DR   PRIDE; Q00610; -.
DR   DNASU; 1213; -.
DR   Ensembl; ENST00000269122; ENSP00000269122; ENSG00000141367. [Q00610-1]
DR   Ensembl; ENST00000393043; ENSP00000376763; ENSG00000141367. [Q00610-2]
DR   GeneID; 1213; -.
DR   KEGG; hsa:1213; -.
DR   UCSC; uc002ixp.4; human. [Q00610-1]
DR   CTD; 1213; -.
DR   DisGeNET; 1213; -.
DR   EuPathDB; HostDB:ENSG00000141367.11; -.
DR   GeneCards; CLTC; -.
DR   H-InvDB; HIX0039315; -.
DR   HGNC; HGNC:2092; CLTC.
DR   HPA; CAB010389; -.
DR   HPA; CAB011571; -.
DR   HPA; CAB017155; -.
DR   HPA; HPA059143; -.
DR   MalaCards; CLTC; -.
DR   MIM; 118955; gene.
DR   neXtProt; NX_Q00610; -.
DR   OpenTargets; ENSG00000141367; -.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   Orphanet; 319308; Translocation renal cell carcinoma.
DR   PharmGKB; PA26618; -.
DR   eggNOG; KOG0985; Eukaryota.
DR   eggNOG; ENOG410XPH1; LUCA.
DR   GeneTree; ENSGT00400000022107; -.
DR   HOGENOM; HOG000188877; -.
DR   HOVERGEN; HBG005344; -.
DR   InParanoid; Q00610; -.
DR   KO; K04646; -.
DR   PhylomeDB; Q00610; -.
DR   TreeFam; TF300059; -.
DR   Reactome; R-HSA-168275; Entry of Influenza Virion into Host Cell via Endocytosis.
DR   Reactome; R-HSA-177504; Retrograde neurotrophin signalling.
DR   Reactome; R-HSA-190873; Gap junction degradation.
DR   Reactome; R-HSA-196025; Formation of annular gap junctions.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-HSA-5140745; WNT5A-dependent internalization of FZD2, FZD5 and ROR2.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8866427; VLDLR internalisation and degradation.
DR   Reactome; R-HSA-8964038; LDL clearance.
DR   SignaLink; Q00610; -.
DR   SIGNOR; Q00610; -.
DR   ChiTaRS; CLTC; human.
DR   EvolutionaryTrace; Q00610; -.
DR   GeneWiki; CLTC; -.
DR   GenomeRNAi; 1213; -.
DR   PRO; PR:Q00610; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000141367; -.
DR   CleanEx; HS_CLTC; -.
DR   ExpressionAtlas; Q00610; baseline and differential.
DR   Genevisible; Q00610; HS.
DR   GO; GO:0030118; C:clathrin coat; IMP:CAFA.
DR   GO; GO:0030132; C:clathrin coat of coated pit; IEA:InterPro.
DR   GO; GO:0030130; C:clathrin coat of trans-Golgi network vesicle; IEA:InterPro.
DR   GO; GO:0071439; C:clathrin complex; IDA:FlyBase.
DR   GO; GO:0045334; C:clathrin-coated endocytic vesicle; NAS:ARUK-UCL.
DR   GO; GO:0030669; C:clathrin-coated endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0036020; C:endolysosome membrane; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; IDA:HPA.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:1990498; C:mitotic spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0032051; F:clathrin light chain binding; IPI:FlyBase.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; NAS:UniProtKB.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:UniProtKB.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0048268; P:clathrin coat assembly; IMP:CAFA.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IMP:ARUK-UCL.
DR   GO; GO:0006886; P:intracellular protein transport; NAS:UniProtKB.
DR   GO; GO:0034383; P:low-density lipoprotein particle clearance; TAS:Reactome.
DR   GO; GO:0032802; P:low-density lipoprotein particle receptor catabolic process; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0007018; P:microtubule-based movement; TAS:Reactome.
DR   GO; GO:0000278; P:mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:1900126; P:negative regulation of hyaluronan biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1903077; P:negative regulation of protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IMP:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IMP:UniProtKB.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; IMP:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   GO; GO:0045056; P:transcytosis; IMP:ARUK-UCL.
DR   GO; GO:0033572; P:transferrin transport; IMP:BHF-UCL.
DR   GO; GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; TAS:Reactome.
DR   Gene3D; 1.25.40.10; -; 4.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000547; Clathrin_H-chain/VPS_repeat.
DR   InterPro; IPR015348; Clathrin_H-chain_linker_core.
DR   InterPro; IPR022365; Clathrin_H-chain_propeller_rpt.
DR   InterPro; IPR016341; Clathrin_heavy_chain.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF00637; Clathrin; 7.
DR   Pfam; PF09268; Clathrin-link; 1.
DR   Pfam; PF01394; Clathrin_propel; 5.
DR   PIRSF; PIRSF002290; Clathrin_H_chain; 1.
DR   SMART; SM00299; CLH; 7.
DR   SUPFAM; SSF48371; SSF48371; 6.
DR   PROSITE; PS50236; CHCR; 7.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Autophagy;
KW   Cell cycle; Cell division; Coated pit; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Direct protein sequencing;
KW   Membrane; Mitosis; Phosphoprotein; Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.7}.
FT   CHAIN         2   1675       Clathrin heavy chain 1.
FT                                /FTId=PRO_0000205778.
FT   REPEAT      537    683       CHCR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01006,
FT                                ECO:0000269|PubMed:21816279}.
FT   REPEAT      686    828       CHCR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01006,
FT                                ECO:0000269|PubMed:21816279}.
FT   REPEAT      833    972       CHCR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01006,
FT                                ECO:0000269|PubMed:21816279}.
FT   REPEAT      979   1124       CHCR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01006,
FT                                ECO:0000269|PubMed:21816279}.
FT   REPEAT     1128   1269       CHCR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01006,
FT                                ECO:0000269|PubMed:21816279}.
FT   REPEAT     1274   1420       CHCR 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01006,
FT                                ECO:0000269|PubMed:21816279}.
FT   REPEAT     1423   1566       CHCR 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01006,
FT                                ECO:0000269|PubMed:21816279}.
FT   REGION        2    479       Globular terminal domain.
FT   REGION       24     67       WD40-like repeat 1.
FT   REGION       68    107       WD40-like repeat 2.
FT   REGION      108    149       WD40-like repeat 3.
FT   REGION      150    195       WD40-like repeat 4.
FT   REGION      196    257       WD40-like repeat 5.
FT   REGION      258    301       WD40-like repeat 6.
FT   REGION      302    330       WD40-like repeat 7.
FT   REGION      449    465       Binding site for the uncoating ATPase,
FT                                involved in lattice disassembly.
FT                                {ECO:0000255}.
FT   REGION      457    507       Involved in spindle localization and
FT                                interaction with TACC3.
FT                                {ECO:0000269|PubMed:23918938}.
FT   REGION      480    523       Flexible linker.
FT   REGION      524   1675       Heavy chain arm.
FT   REGION      524    634       Distal segment.
FT   REGION      639   1675       Proximal segment.
FT   REGION     1213   1522       Involved in binding clathrin light chain.
FT                                {ECO:0000250}.
FT   REGION     1550   1675       Trimerization. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES      67     67       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     105    105       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES     184    184       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES     394    394       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     634    634       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     737    737       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES     856    856       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     899    899       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1167   1167       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1206   1206       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1229   1229       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1441   1441       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1441   1441       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1477   1477       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1487   1487       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1494   1494       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1501   1501       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ    1636   1639       QPQL -> NLSL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011570.
FT   VAR_SEQ    1640   1675       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011571.
FT   MUTAGEN      65     65       P->N: Disrupts spindle localization.
FT                                {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN      67     67       S->G: Disrupts spindle localization.
FT                                {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN      87     87       T->A: Disrupts spindle localization.
FT                                {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN      89     89       Q->A: Disrupts spindle localization.
FT                                {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN      96     96       K->E: Disrupts spindle localization.
FT                                {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN      98     98       K->E: Disrupts spindle localization.
FT                                {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     444    444       R->E: Disrupts spindle localization; when
FT                                associated with E-445, E-500 E-506 and E-
FT                                507. {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     445    445       K->E: Disrupts spindle localization; when
FT                                associated with E-444, E-500, E-506 and
FT                                E-507. {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     480    484       LRANV->ERGQC: Disrupts spindle
FT                                localization and interaction with TACC3.
FT                                {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     481    481       R->E: Disrupts spindle localization; when
FT                                associated with E-487, E-500, E-506 and
FT                                E-507. {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     487    487       K->E: Disrupts spindle localization; when
FT                                associated with E-481, E-500, E-506 and
FT                                E-507. {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     500    500       K->E: Disrupts spindle localization; when
FT                                associated with E-444, E-445, E-506 and
FT                                E-507. {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     500    500       K->E: Disrupts spindle localization; when
FT                                associated with E-481, E-487, E-506 and
FT                                E-507. {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     506    506       K->E: Disrupts spindle localization; when
FT                                associated with E-444, E-445, E-500 and
FT                                E-507. {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     506    506       K->E: Disrupts spindle localization; when
FT                                associated with E-481, E-487, E-500 and
FT                                E-507. {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     507    507       K->E: Disrupts spindle localization; when
FT                                associated with E-444, E-445, E-500 and
FT                                E-506. {ECO:0000269|PubMed:23918938}.
FT   MUTAGEN     507    507       K->E: Disrupts spindle localization; when
FT                                associated with E-481, E-487, E-500 and
FT                                E-506. {ECO:0000269|PubMed:23918938}.
FT   CONFLICT    560    560       Q -> R (in Ref. 5; CAA39363).
FT                                {ECO:0000305}.
FT   CONFLICT    817    817       G -> V (in Ref. 5; CAA39363).
FT                                {ECO:0000305}.
FT   CONFLICT    923    923       R -> H (in Ref. 2; CAE45761).
FT                                {ECO:0000305}.
FT   CONFLICT   1563   1563       R -> G (in Ref. 2; CAE45761).
FT                                {ECO:0000305}.
FT   CONFLICT   1652   1652       Q -> R (in Ref. 2; CAE45761).
FT                                {ECO:0000305}.
FT   STRAND        6     14       {ECO:0000244|PDB:4G55}.
FT   HELIX        15     18       {ECO:0000244|PDB:4G55}.
FT   HELIX        22     24       {ECO:0000244|PDB:4G55}.
FT   TURN         27     29       {ECO:0000244|PDB:4G55}.
FT   STRAND       30     34       {ECO:0000244|PDB:4G55}.
FT   STRAND       37     44       {ECO:0000244|PDB:4G55}.
FT   STRAND       47     54       {ECO:0000244|PDB:4G55}.
FT   STRAND       62     65       {ECO:0000244|PDB:4G55}.
FT   STRAND       69     73       {ECO:0000244|PDB:4G55}.
FT   STRAND       75     84       {ECO:0000244|PDB:4G55}.
FT   STRAND       87     92       {ECO:0000244|PDB:4G55}.
FT   TURN         93     96       {ECO:0000244|PDB:4G55}.
FT   STRAND       97    103       {ECO:0000244|PDB:4G55}.
FT   STRAND      108    113       {ECO:0000244|PDB:4G55}.
FT   STRAND      115    133       {ECO:0000244|PDB:4G55}.
FT   STRAND      139    143       {ECO:0000244|PDB:4G55}.
FT   HELIX       146    148       {ECO:0000244|PDB:4G55}.
FT   STRAND      152    158       {ECO:0000244|PDB:4G55}.
FT   STRAND      164    173       {ECO:0000244|PDB:4G55}.
FT   STRAND      176    185       {ECO:0000244|PDB:4G55}.
FT   TURN        186    189       {ECO:0000244|PDB:4G55}.
FT   STRAND      190    194       {ECO:0000244|PDB:4G55}.
FT   STRAND      197    204       {ECO:0000244|PDB:4G55}.
FT   STRAND      213    222       {ECO:0000244|PDB:4G55}.
FT   STRAND      225    232       {ECO:0000244|PDB:4G55}.
FT   STRAND      246    250       {ECO:0000244|PDB:4G55}.
FT   STRAND      261    267       {ECO:0000244|PDB:4G55}.
FT   TURN        268    271       {ECO:0000244|PDB:4G55}.
FT   STRAND      272    277       {ECO:0000244|PDB:4G55}.
FT   STRAND      280    286       {ECO:0000244|PDB:4G55}.
FT   TURN        287    289       {ECO:0000244|PDB:4G55}.
FT   STRAND      292    297       {ECO:0000244|PDB:4G55}.
FT   STRAND      303    309       {ECO:0000244|PDB:4G55}.
FT   HELIX       310    312       {ECO:0000244|PDB:4G55}.
FT   STRAND      314    319       {ECO:0000244|PDB:4G55}.
FT   STRAND      323    329       {ECO:0000244|PDB:4G55}.
FT   TURN        331    333       {ECO:0000244|PDB:4G55}.
FT   HELIX       334    340       {ECO:0000244|PDB:4G55}.
FT   HELIX       345    354       {ECO:0000244|PDB:4G55}.
SQ   SEQUENCE   1675 AA;  191615 MW;  6C4F2D54950079E2 CRC64;
     MAQILPIRFQ EHLQLQNLGI NPANIGFSTL TMESDKFICI REKVGEQAQV VIIDMNDPSN
     PIRRPISADS AIMNPASKVI ALKAGKTLQI FNIEMKSKMK AHTMTDDVTF WKWISLNTVA
     LVTDNAVYHW SMEGESQPVK MFDRHSSLAG CQIINYRTDA KQKWLLLTGI SAQQNRVVGA
     MQLYSVDRKV SQPIEGHAAS FAQFKMEGNA EESTLFCFAV RGQAGGKLHI IEVGTPPTGN
     QPFPKKAVDV FFPPEAQNDF PVAMQISEKH DVVFLITKYG YIHLYDLETG TCIYMNRISG
     ETIFVTAPHE ATAGIIGVNR KGQVLSVCVE EENIIPYITN VLQNPDLALR MAVRNNLAGA
     EELFARKFNA LFAQGNYSEA AKVAANAPKG ILRTPDTIRR FQSVPAQPGQ TSPLLQYFGI
     LLDQGQLNKY ESLELCRPVL QQGRKQLLEK WLKEDKLECS EELGDLVKSV DPTLALSVYL
     RANVPNKVIQ CFAETGQVQK IVLYAKKVGY TPDWIFLLRN VMRISPDQGQ QFAQMLVQDE
     EPLADITQIV DVFMEYNLIQ QCTAFLLDAL KNNRPSEGPL QTRLLEMNLM HAPQVADAIL
     GNQMFTHYDR AHIAQLCEKA GLLQRALEHF TDLYDIKRAV VHTHLLNPEW LVNYFGSLSV
     EDSLECLRAM LSANIRQNLQ ICVQVASKYH EQLSTQSLIE LFESFKSFEG LFYFLGSIVN
     FSQDPDVHFK YIQAACKTGQ IKEVERICRE SNCYDPERVK NFLKEAKLTD QLPLIIVCDR
     FDFVHDLVLY LYRNNLQKYI EIYVQKVNPS RLPVVIGGLL DVDCSEDVIK NLILVVRGQF
     STDELVAEVE KRNRLKLLLP WLEARIHEGC EEPATHNALA KIYIDSNNNP ERFLRENPYY
     DSRVVGKYCE KRDPHLACVA YERGQCDLEL INVCNENSLF KSLSRYLVRR KDPELWGSVL
     LESNPYRRPL IDQVVQTALS ETQDPEEVSV TVKAFMTADL PNELIELLEK IVLDNSVFSE
     HRNLQNLLIL TAIKADRTRV MEYINRLDNY DAPDIANIAI SNELFEEAFA IFRKFDVNTS
     AVQVLIEHIG NLDRAYEFAE RCNEPAVWSQ LAKAQLQKGM VKEAIDSYIK ADDPSSYMEV
     VQAANTSGNW EELVKYLQMA RKKARESYVE TELIFALAKT NRLAELEEFI NGPNNAHIQQ
     VGDRCYDEKM YDAAKLLYNN VSNFGRLAST LVHLGEYQAA VDGARKANST RTWKEVCFAC
     VDGKEFRLAQ MCGLHIVVHA DELEELINYY QDRGYFEELI TMLEAALGLE RAHMGMFTEL
     AILYSKFKPQ KMREHLELFW SRVNIPKVLR AAEQAHLWAE LVFLYDKYEE YDNAIITMMN
     HPTDAWKEGQ FKDIITKVAN VELYYRAIQF YLEFKPLLLN DLLMVLSPRL DHTRAVNYFS
     KVKQLPLVKP YLRSVQNHNN KSVNESLNNL FITEEDYQAL RTSIDAYDNF DNISLAQRLE
     KHELIEFRRI AAYLFKGNNR WKQSVELCKK DSLYKDAMQY ASESKDTELA EELLQWFLQE
     EKRECFGACL FTCYDLLRPD VVLETAWRHN IMDFAMPYFI QVMKEYLTKV DKLDASESLR
     KEEEQATETQ PIVYGQPQLM LTAGPSVAVP PQAPFGYGYT APPYGQPQPG FGYSM
//
ID   CLH2_HUMAN              Reviewed;        1640 AA.
AC   P53675; B7Z7U5; Q14017; Q15808; Q15809;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   28-FEB-2018, entry version 169.
DE   RecName: Full=Clathrin heavy chain 2;
DE   AltName: Full=Clathrin heavy chain on chromosome 22;
DE            Short=CLH-22;
GN   Name=CLTCL1; Synonyms=CLH22, CLTCL, CLTD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=8733128; DOI=10.1093/hmg/5.5.617;
RA   Sirotkin H., Morrow B., Dasgupta R., Goldberg R., Patangali S.R.,
RA   Shi G., Cannizzaro L., Shprintzen R., Weissman S., Kucherlapati R.;
RT   "Isolation of a new clathrin heavy chain gene with muscle-specific
RT   expression from the region commonly deleted in velo-cardio-facial
RT   syndrome.";
RL   Hum. Mol. Genet. 5:617-624(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE [MRNA]
RP   OF 1451-1640 (ISOFORM 2).
RC   TISSUE=Fetal brain, and Skeletal muscle;
RX   PubMed=8733129; DOI=10.1093/hmg/5.5.625;
RA   Kedra D., Peyrard M., Fransson I., Collins J.E., Dunham I., Roe B.A.,
RA   Dumanski J.P.;
RT   "Characterization of a second human clathrin heavy chain polypeptide
RT   gene (CLH-22) from chromosome 22q11.";
RL   Hum. Mol. Genet. 5:625-631(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT LYS-691.
RX   PubMed=8844170; DOI=10.1006/geno.1996.0386;
RA   Long K.R., Trofatter J.A., Ramesh V., McCormick M.K., Buckler A.J.;
RT   "Cloning and characterization of a novel human clathrin heavy chain
RT   gene (CLTCL).";
RL   Genomics 35:466-472(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
CC   -!- FUNCTION: Clathrin is the major protein of the polyhedral coat of
CC       coated pits and vesicles. Two different adapter protein complexes
CC       link the clathrin lattice either to the plasma membrane or to the
CC       trans-Golgi network (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Clathrin triskelions, composed of 3 heavy chains and 3
CC       light chains, are the basic subunits of the clathrin coat. In the
CC       presence of light chains, hub assembly is influenced by both the
CC       pH and the concentration of calcium (By similarity). May interact
CC       with OCRL (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}; Cytoplasmic side
CC       {ECO:0000250}. Membrane, coated pit {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}.
CC       Note=Cytoplasmic face of coated pits and vesicles. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Long, Brain;
CC         IsoId=P53675-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short, Muscle;
CC         IsoId=P53675-2; Sequence=VSP_001100;
CC   -!- TISSUE SPECIFICITY: Maximal levels in skeletal muscle. High levels
CC       in heart and testis. Low expression detected in all other tissues.
CC   -!- DOMAIN: The C-terminal third of the heavy chains forms the hub of
CC       the triskelion. This region contains the trimerization domain and
CC       the light-chain binding domain involved in the assembly of the
CC       clathrin lattice.
CC   -!- DOMAIN: The N-terminal seven-bladed beta-propeller is formed by
CC       WD40-like repeats, and projects inward from the polyhedral outer
CC       clathrin coat. It constitutes a major protein-protein interaction
CC       node (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the clathrin heavy chain family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CLTCL1ID361.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U41763; AAC50494.1; -; mRNA.
DR   EMBL; X95486; CAA64752.1; -; mRNA.
DR   EMBL; X95487; CAA64753.1; -; mRNA.
DR   EMBL; U60802; AAB40908.1; -; mRNA.
DR   EMBL; U60803; AAB40909.1; -; mRNA.
DR   EMBL; AK302506; BAH13731.1; -; mRNA.
DR   EMBL; CH471176; EAX03047.1; -; Genomic_DNA.
DR   CCDS; CCDS46662.2; -. [P53675-1]
DR   CCDS; CCDS54497.2; -. [P53675-2]
DR   PIR; G02757; G02757.
DR   PIR; T09522; T09522.
DR   RefSeq; NP_001826.3; NM_001835.3. [P53675-2]
DR   RefSeq; NP_009029.3; NM_007098.3. [P53675-1]
DR   UniGene; Hs.368266; -.
DR   ProteinModelPortal; P53675; -.
DR   SMR; P53675; -.
DR   BioGrid; 113854; 83.
DR   IntAct; P53675; 29.
DR   MINT; P53675; -.
DR   STRING; 9606.ENSP00000445677; -.
DR   iPTMnet; P53675; -.
DR   PhosphoSitePlus; P53675; -.
DR   SwissPalm; P53675; -.
DR   BioMuta; CLTCL1; -.
DR   DMDM; 2506298; -.
DR   EPD; P53675; -.
DR   MaxQB; P53675; -.
DR   PaxDb; P53675; -.
DR   PeptideAtlas; P53675; -.
DR   PRIDE; P53675; -.
DR   DNASU; 8218; -.
DR   Ensembl; ENST00000427926; ENSP00000441158; ENSG00000070371. [P53675-1]
DR   Ensembl; ENST00000621271; ENSP00000485020; ENSG00000070371. [P53675-2]
DR   GeneID; 8218; -.
DR   KEGG; hsa:8218; -.
DR   UCSC; uc032qgb.2; human. [P53675-1]
DR   CTD; 8218; -.
DR   DisGeNET; 8218; -.
DR   EuPathDB; HostDB:ENSG00000070371.15; -.
DR   GeneCards; CLTCL1; -.
DR   H-InvDB; HIX0016234; -.
DR   HGNC; HGNC:2093; CLTCL1.
DR   HPA; HPA075795; -.
DR   MalaCards; CLTCL1; -.
DR   MIM; 601273; gene.
DR   neXtProt; NX_P53675; -.
DR   OpenTargets; ENSG00000070371; -.
DR   PharmGKB; PA26619; -.
DR   eggNOG; KOG0985; Eukaryota.
DR   eggNOG; ENOG410XPH1; LUCA.
DR   GeneTree; ENSGT00400000022107; -.
DR   HOGENOM; HOG000188877; -.
DR   HOVERGEN; HBG005344; -.
DR   InParanoid; P53675; -.
DR   KO; K04646; -.
DR   OMA; HYRTDEY; -.
DR   OrthoDB; EOG091G009O; -.
DR   PhylomeDB; P53675; -.
DR   TreeFam; TF300059; -.
DR   Reactome; R-HSA-190873; Gap junction degradation.
DR   Reactome; R-HSA-196025; Formation of annular gap junctions.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   SIGNOR; P53675; -.
DR   ChiTaRS; CLTCL1; human.
DR   GenomeRNAi; 8218; -.
DR   PRO; PR:P53675; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000070371; -.
DR   CleanEx; HS_CLTCL1; -.
DR   ExpressionAtlas; P53675; baseline and differential.
DR   Genevisible; P53675; HS.
DR   GO; GO:0030130; C:clathrin coat of trans-Golgi network vesicle; IEA:InterPro.
DR   GO; GO:0071439; C:clathrin complex; IEA:InterPro.
DR   GO; GO:0045334; C:clathrin-coated endocytic vesicle; NAS:ARUK-UCL.
DR   GO; GO:0005905; C:clathrin-coated pit; IDA:UniProtKB.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IDA:UniProtKB.
DR   GO; GO:0030135; C:coated vesicle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0097443; C:sorting endosome; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0032051; F:clathrin light chain binding; IEA:InterPro.
DR   GO; GO:0004871; F:signal transducer activity; TAS:ProtInc.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0048268; P:clathrin coat assembly; IEA:InterPro.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0000278; P:mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0046326; P:positive regulation of glucose import; IMP:UniProtKB.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   Gene3D; 1.25.40.10; -; 4.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000547; Clathrin_H-chain/VPS_repeat.
DR   InterPro; IPR015348; Clathrin_H-chain_linker_core.
DR   InterPro; IPR022365; Clathrin_H-chain_propeller_rpt.
DR   InterPro; IPR016341; Clathrin_heavy_chain.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF00637; Clathrin; 7.
DR   Pfam; PF09268; Clathrin-link; 1.
DR   Pfam; PF01394; Clathrin_propel; 4.
DR   PIRSF; PIRSF002290; Clathrin_H_chain; 1.
DR   SMART; SM00299; CLH; 7.
DR   SUPFAM; SSF48371; SSF48371; 6.
DR   PROSITE; PS50236; CHCR; 7.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coated pit; Complete proteome;
KW   Cytoplasmic vesicle; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q00610}.
FT   CHAIN         2   1640       Clathrin heavy chain 2.
FT                                /FTId=PRO_0000205786.
FT   REPEAT      537    683       CHCR 1.
FT   REPEAT      686    828       CHCR 2.
FT   REPEAT      833    972       CHCR 3.
FT   REPEAT      979   1124       CHCR 4.
FT   REPEAT     1128   1269       CHCR 5.
FT   REPEAT     1274   1420       CHCR 6.
FT   REPEAT     1423   1566       CHCR 7.
FT   REGION        2    479       Globular terminal domain.
FT   REGION       24     67       WD40-like repeat 1.
FT   REGION       68    107       WD40-like repeat 2.
FT   REGION      108    149       WD40-like repeat 3.
FT   REGION      150    195       WD40-like repeat 4.
FT   REGION      196    257       WD40-like repeat 5.
FT   REGION      258    301       WD40-like repeat 6.
FT   REGION      302    330       WD40-like repeat 7.
FT   REGION      449    465       Binding site for the uncoating ATPase,
FT                                involved in lattice disassembly.
FT                                {ECO:0000255}.
FT   REGION      480    523       Flexible linker.
FT   REGION      524   1640       Heavy chain arm.
FT   REGION      524    634       Distal segment.
FT   REGION      639   1640       Proximal segment.
FT   REGION     1213   1522       Involved in binding clathrin light chain.
FT                                {ECO:0000250}.
FT   REGION     1551   1640       Trimerization. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   MOD_RES      67     67       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   MOD_RES     184    184       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES     394    394       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   MOD_RES     634    634       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   MOD_RES     737    737       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES     856    856       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   MOD_RES     899    899       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1167   1167       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1206   1206       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1229   1229       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   MOD_RES    1441   1441       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   MOD_RES    1441   1441       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1477   1477       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   MOD_RES    1487   1487       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q68FD5}.
FT   MOD_RES    1494   1494       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   MOD_RES    1501   1501       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q00610}.
FT   VAR_SEQ    1479   1535       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:8733129,
FT                                ECO:0000303|PubMed:8844170}.
FT                                /FTId=VSP_001100.
FT   VARIANT      61     61       P -> L (in dbSNP:rs3747059).
FT                                /FTId=VAR_055653.
FT   VARIANT     205    205       K -> R (in dbSNP:rs5746697).
FT                                /FTId=VAR_055654.
FT   VARIANT     279    279       Y -> C (in dbSNP:rs807459).
FT                                /FTId=VAR_055655.
FT   VARIANT     691    691       E -> K (in dbSNP:rs1060374).
FT                                {ECO:0000269|PubMed:8844170}.
FT                                /FTId=VAR_055656.
FT   VARIANT     941    941       K -> R (in dbSNP:rs35398725).
FT                                /FTId=VAR_055657.
FT   VARIANT     945    945       R -> H (in dbSNP:rs36077768).
FT                                /FTId=VAR_055658.
FT   VARIANT    1046   1046       R -> C (in dbSNP:rs712952).
FT                                /FTId=VAR_055659.
FT   VARIANT    1195   1195       N -> S (in dbSNP:rs807547).
FT                                /FTId=VAR_059214.
FT   VARIANT    1316   1316       M -> V (in dbSNP:rs1061325).
FT                                /FTId=VAR_059215.
FT   VARIANT    1394   1394       I -> T (in dbSNP:rs1633399).
FT                                /FTId=VAR_059216.
FT   VARIANT    1592   1592       V -> M (in dbSNP:rs2073738).
FT                                /FTId=VAR_059217.
FT   VARIANT    1620   1620       R -> H (in dbSNP:rs5748024).
FT                                /FTId=VAR_059218.
FT   CONFLICT    193    193       P -> H (in Ref. 1; AAC50494).
FT                                {ECO:0000305}.
FT   CONFLICT    215    215       L -> H (in Ref. 1; AAC50494).
FT                                {ECO:0000305}.
FT   CONFLICT    320    320       K -> T (in Ref. 2; CAA64752).
FT                                {ECO:0000305}.
FT   CONFLICT    530    530       L -> Q (in Ref. 1; AAC50494).
FT                                {ECO:0000305}.
FT   CONFLICT   1474   1474       E -> K (in Ref. 3; AAB40908/AAB40909).
FT                                {ECO:0000305}.
FT   CONFLICT   1620   1640       RKQEEHVTEPAPLVFDFDGHE -> PPSKRSM (in Ref.
FT                                3; AAB40908/AAB40909). {ECO:0000305}.
SQ   SEQUENCE   1640 AA;  187030 MW;  C661E1AB989D8E7F CRC64;
     MAQILPVRFQ EHFQLQNLGI NPANIGFSTL TMESDKFICI REKVGEQAQV TIIDMSDPMA
     PIRRPISAES AIMNPASKVI ALKAGKTLQI FNIEMKSKMK AHTMAEEVIF WKWVSVNTVA
     LVTETAVYHW SMEGDSQPMK MFDRHTSLVG CQVIHYRTDE YQKWLLLVGI SAQQNRVVGA
     MQLYSVDRKV SQPIEGHAAA FAEFKMEGNA KPATLFCFAV RNPTGGKLHI IEVGQPAAGN
     QPFVKKAVDV FFPPEAQNDF PVAMQIGAKH GVIYLITKYG YLHLYDLESG VCICMNRISA
     DTIFVTAPHK PTSGIIGVNK KGQVLSVCVE EDNIVNYATN VLQNPDLGLR LAVRSNLAGA
     EKLFVRKFNT LFAQGSYAEA AKVAASAPKG ILRTRETVQK FQSIPAQSGQ ASPLLQYFGI
     LLDQGQLNKL ESLELCHLVL QQGRKQLLEK WLKEDKLECS EELGDLVKTT DPMLALSVYL
     RANVPSKVIQ CFAETGQFQK IVLYAKKVGY TPDWIFLLRG VMKISPEQGL QFSRMLVQDE
     EPLANISQIV DIFMENSLIQ QCTSFLLDAL KNNRPAEGLL QTWLLEMNLV HAPQVADAIL
     GNKMFTHYDR AHIAQLCEKA GLLQQALEHY TDLYDIKRAV VHTHLLNPEW LVNFFGSLSV
     EDSVECLHAM LSANIRQNLQ LCVQVASKYH EQLGTQALVE LFESFKSYKG LFYFLGSIVN
     FSQDPDVHLK YIQAACKTGQ IKEVERICRE SSCYNPERVK NFLKEAKLTD QLPLIIVCDR
     FGFVHDLVLY LYRNNLQRYI EIYVQKVNPS RTPAVIGGLL DVDCSEEVIK HLIMAVRGQF
     STDELVAEVE KRNRLKLLLP WLESQIQEGC EEPATHNALA KIYIDSNNSP ECFLRENAYY
     DSSVVGRYCE KRDPHLACVA YERGQCDLEL IKVCNENSLF KSEARYLVCR KDPELWAHVL
     EETNPSRRQL IDQVVQTALS ETRDPEEISV TVKAFMTADL PNELIELLEK IVLDNSVFSE
     HRNLQNLLIL TAIKADRTRV MEYISRLDNY DALDIASIAV SSALYEEAFT VFHKFDMNAS
     AIQVLIEHIG NLDRAYEFAE RCNEPAVWSQ LAQAQLQKDL VKEAINSYIR GDDPSSYLEV
     VQSASRSNNW EDLVKFLQMA RKKGRESYIE TELIFALAKT SRVSELEDFI NGPNNAHIQQ
     VGDRCYEEGM YEAAKLLYSN VSNFARLAST LVHLGEYQAA VDNSRKASST RTWKEVCFAC
     MDGQEFRFAQ LCGLHIVIHA DELEELMCYY QDRGYFEELI LLLEAALGLE RAHMGMFTEL
     AILYSKFKPQ KMLEHLELFW SRVNIPKVLR AAEQAHLWAE LVFLYDKYEE YDNAVLTMMS
     HPTEAWKEGQ FKDIITKVAN VELCYRALQF YLDYKPLLIN DLLLVLSPRL DHTWTVSFFS
     KAGQLPLVKP YLRSVQSHNN KSVNEALNHL LTEEEDYQGL RASIDAYDNF DNISLAQQLE
     KHQLMEFRCI AAYLYKGNNW WAQSVELCKK DHLYKDAMQH AAESRDAELA QKLLQWFLEE
     GKRECFAACL FTCYDLLRPD MVLELAWRHN LVDLAMPYFI QVMREYLSKV DKLDALESLR
     KQEEHVTEPA PLVFDFDGHE
//
ID   A0A0S2Z4K2_HUMAN        Unreviewed;       177 AA.
AC   A0A0S2Z4K2;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 13.
DE   SubName: Full=CCHC-type zinc finger nucleic acid binding protein isoform 3 {ECO:0000313|EMBL:ALQ33857.1};
DE   Flags: Fragment;
GN   Name=CNBP {ECO:0000313|EMBL:ALQ33857.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33857.1};
RN   [1] {ECO:0000313|EMBL:ALQ33857.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178399; ALQ33857.1; -; mRNA.
DR   RefSeq; NP_003409.1; NM_003418.4.
DR   UniGene; Hs.518249; -.
DR   ProteinModelPortal; A0A0S2Z4K2; -.
DR   SMR; A0A0S2Z4K2; -.
DR   GeneID; 7555; -.
DR   KEGG; hsa:7555; -.
DR   CTD; 7555; -.
DR   KO; K09250; -.
DR   PhylomeDB; A0A0S2Z4K2; -.
DR   ChiTaRS; CNBP; human.
DR   ExpressionAtlas; A0A0S2Z4K2; baseline and differential.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   Pfam; PF00098; zf-CCHC; 7.
DR   SMART; SM00343; ZnF_C2HC; 7.
DR   SUPFAM; SSF57756; SSF57756; 4.
DR   PROSITE; PS50158; ZF_CCHC; 7.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00047};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00047};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00047}.
FT   DOMAIN        6     20       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN       54     67       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN       74     89       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN       98    111       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN      118    134       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN      136    152       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN      158    171       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   NON_TER     177    177       {ECO:0000313|EMBL:ALQ33857.1}.
SQ   SEQUENCE   177 AA;  19463 MW;  996F398285F52618 CRC64;
     MSSNECFKCG RSGHWARECP TGGGRGRGMR SRGRGGFTSD RGFQFVSSSL PDICYRCGES
     GHLAKDCDLQ EDACYNCGRG GHIAKDCKEP KREREQCCYN CGKPGHLARD CDHADEQKCY
     SCGEFGHIQK DCTKVKCYRC GETGHVAINC SKTSEVNCYR CGESGHLARE CTIEATA
//
ID   A0A0S2Z4Q3_HUMAN        Unreviewed;       170 AA.
AC   A0A0S2Z4Q3;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 13.
DE   SubName: Full=CCHC-type zinc finger nucleic acid binding protein isoform 1 {ECO:0000313|EMBL:ALQ33855.1};
DE   Flags: Fragment;
GN   Name=CNBP {ECO:0000313|EMBL:ALQ33855.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33855.1};
RN   [1] {ECO:0000313|EMBL:ALQ33855.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178397; ALQ33855.1; -; mRNA.
DR   RefSeq; NP_001120668.1; NM_001127196.1.
DR   UniGene; Hs.518249; -.
DR   ProteinModelPortal; A0A0S2Z4Q3; -.
DR   SMR; A0A0S2Z4Q3; -.
DR   GeneID; 7555; -.
DR   CTD; 7555; -.
DR   ChiTaRS; CNBP; human.
DR   ExpressionAtlas; A0A0S2Z4Q3; baseline and differential.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   Pfam; PF00098; zf-CCHC; 7.
DR   SMART; SM00343; ZnF_C2HC; 7.
DR   SUPFAM; SSF57756; SSF57756; 4.
DR   PROSITE; PS50158; ZF_CCHC; 7.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00047};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00047};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00047}.
FT   DOMAIN        6     20       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN       47     60       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN       67     82       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN       91    104       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN      111    127       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN      129    145       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   DOMAIN      151    164       CCHC-type. {ECO:0000259|PROSITE:PS50158}.
FT   NON_TER     170    170       {ECO:0000313|EMBL:ALQ33855.1}.
SQ   SEQUENCE   170 AA;  18742 MW;  152BEC42881358E8 CRC64;
     MSSNECFKCG RSGHWARECP TGGGRGRGMR SRGRGFQFVS SSLPDICYRC GESGHLAKDC
     DLQEDACYNC GRGGHIAKDC KEPKREREQC CYNCGKPGHL ARDCDHADEQ KCYSCGEFGH
     IQKDCTKVKC YRCGETGHVA INCSKTSEVN CYRCGESGHL ARECTIEATA
//
ID   CNBP_HUMAN              Reviewed;         177 AA.
AC   P62633; A8K7V4; B2RAV9; B4DP17; D3DNB9; D3DNC0; D3DNC1; E9PDR7;
AC   P20694; Q4JGY0; Q4JGY1; Q5QJR0; Q5U0E9; Q6PJI7; Q96NV3;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 141.
DE   RecName: Full=Cellular nucleic acid-binding protein;
DE            Short=CNBP;
DE   AltName: Full=Zinc finger protein 9;
GN   Name=CNBP; Synonyms=RNF163, ZNF9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2562787; DOI=10.1126/science.2562787;
RA   Rajavashisth T.B., Taylor A.K., Andalibi A., Svenson K.L., Lusis A.J.;
RT   "Identification of a zinc finger protein that binds to the sterol
RT   regulatory element.";
RL   Science 245:640-643(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=7590281; DOI=10.1016/0378-1119(95)00421-2;
RA   Flink I.L., Morkin E.;
RT   "Organization of the gene encoding cellular nucleic acid-binding
RT   protein.";
RL   Gene 163:279-282(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND DISEASE.
RX   PubMed=11486088; DOI=10.1126/science.1062125;
RA   Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W.,
RA   Naylor S.L., Day J.W., Ranum L.P.;
RT   "Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of
RT   ZNF9.";
RL   Science 293:864-867(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4; 5 AND 8).
RA   Yang F., Yan H., Zhang S.;
RT   "Cloning of novel transcript variants of human cellular nucleic acid
RT   binding protein.";
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3; 6 AND 7).
RC   TISSUE=Placenta, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   METHYLATION AT ARG-25 AND ARG-27, AND MUTAGENESIS OF ARG-25 AND
RP   ARG-27.
RX   PubMed=24726729; DOI=10.1016/j.febslet.2014.03.052;
RA   Wei H.M., Hu H.H., Chang G.Y., Lee Y.J., Li Y.C., Chang H.H., Li C.;
RT   "Arginine methylation of the cellular nucleic acid binding protein
RT   does not affect its subcellular localization but impedes RNA
RT   binding.";
RL   FEBS Lett. 588:1542-1548(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-79, METHYLATION [LARGE SCALE
RP   ANALYSIS] AT ARG-32 AND ARG-34 (ISOFORMS 2; 5 AND 8), METHYLATION
RP   [LARGE SCALE ANALYSIS] AT ARG-80 (ISOFORM 4), METHYLATION [LARGE SCALE
RP   ANALYSIS] AT ARG-73 (ISOFORM 8), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Single-stranded DNA-binding protein, with specificity to
CC       the sterol regulatory element (SRE). Involved in sterol-mediated
CC       repression.
CC   -!- INTERACTION:
CC       Q63009:Prmt1 (xeno); NbExp=2; IntAct=EBI-1047529, EBI-78708;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Endoplasmic
CC       reticulum {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=P62633-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P62633-2; Sequence=VSP_010981;
CC         Note=Contains a omega-N-methylarginine at position 32. Contains
CC         a omega-N-methylarginine at position 34.
CC         {ECO:0000244|PubMed:24129315};
CC       Name=3;
CC         IsoId=P62633-3; Sequence=VSP_010982;
CC       Name=4;
CC         IsoId=P62633-4; Sequence=VSP_043304;
CC         Note=Contains a omega-N-methylarginine at position 80.
CC         {ECO:0000244|PubMed:24129315};
CC       Name=5;
CC         IsoId=P62633-5; Sequence=VSP_010981, VSP_043424;
CC         Note=No experimental confirmation available. Contains a
CC         omega-N-methylarginine at position 32. Contains a
CC         omega-N-methylarginine at position 34.
CC         {ECO:0000244|PubMed:24129315};
CC       Name=6;
CC         IsoId=P62633-6; Sequence=VSP_043424;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=P62633-7; Sequence=VSP_055084;
CC         Note=No experimental confirmation available.;
CC       Name=8;
CC         IsoId=P62633-8; Sequence=VSP_010981, VSP_043304;
CC         Note=Contains a omega-N-methylarginine at position 32. Contains
CC         a omega-N-methylarginine at position 34. Contains a
CC         omega-N-methylarginine at position 73.
CC         {ECO:0000244|PubMed:24129315};
CC   -!- TISSUE SPECIFICITY: Present in all tissues examined.
CC   -!- PTM: Arginine methylation by PRMT1 in the Arg/Gly-rich region
CC       impedes RNA binding. {ECO:0000269|PubMed:24726729}.
CC   -!- DISEASE: Dystrophia myotonica 2 (DM2) [MIM:602668]: A multisystem
CC       disease characterized by the association of proximal muscle
CC       weakness with myotonia, cardiac manifestations and cataract.
CC       Additional features can include hyperhidrosis, testicular atrophy,
CC       insulin resistance and diabetes and central nervous system
CC       anomalies in rare cases. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry. The causative
CC       mutation is a CCTG expansion (mean approximately 5000 repeats)
CC       located in intron 1 of the CNBP gene.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M28372; AAA61975.1; -; mRNA.
DR   EMBL; U19765; AAA91782.1; -; Genomic_DNA.
DR   EMBL; AY329622; AAR89462.1; -; Genomic_DNA.
DR   EMBL; DQ092366; AAY96754.1; -; mRNA.
DR   EMBL; DQ092367; AAY96755.1; -; mRNA.
DR   EMBL; DQ091187; AAY89856.1; -; mRNA.
DR   EMBL; AK054592; BAB70769.1; -; mRNA.
DR   EMBL; AK298154; BAG60429.1; -; mRNA.
DR   EMBL; AK292119; BAF84808.1; -; mRNA.
DR   EMBL; AK314380; BAG37006.1; -; mRNA.
DR   EMBL; BT019613; AAV38419.1; -; mRNA.
DR   EMBL; AC108673; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79271.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79272.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79273.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79274.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79275.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79277.1; -; Genomic_DNA.
DR   EMBL; BC000288; AAH00288.1; -; mRNA.
DR   EMBL; BC014911; AAH14911.1; -; mRNA.
DR   EMBL; BC093058; AAH93058.1; -; mRNA.
DR   CCDS; CCDS3056.1; -. [P62633-1]
DR   CCDS; CCDS46906.1; -. [P62633-6]
DR   CCDS; CCDS46907.1; -. [P62633-4]
DR   CCDS; CCDS46908.1; -. [P62633-5]
DR   CCDS; CCDS54637.1; -. [P62633-2]
DR   PIR; A32760; A32760.
DR   RefSeq; NP_001120664.1; NM_001127192.1. [P62633-6]
DR   RefSeq; NP_001120665.1; NM_001127193.1. [P62633-4]
DR   RefSeq; NP_001120666.1; NM_001127194.1. [P62633-5]
DR   RefSeq; NP_001120667.1; NM_001127195.1. [P62633-8]
DR   RefSeq; NP_001120668.1; NM_001127196.1. [P62633-2]
DR   RefSeq; NP_003409.1; NM_003418.4. [P62633-1]
DR   UniGene; Hs.518249; -.
DR   ProteinModelPortal; P62633; -.
DR   SMR; P62633; -.
DR   BioGrid; 113387; 157.
DR   IntAct; P62633; 11.
DR   MINT; P62633; -.
DR   STRING; 9606.ENSP00000410769; -.
DR   iPTMnet; P62633; -.
DR   PhosphoSitePlus; P62633; -.
DR   SwissPalm; P62633; -.
DR   BioMuta; CNBP; -.
DR   DMDM; 50401852; -.
DR   EPD; P62633; -.
DR   MaxQB; P62633; -.
DR   PaxDb; P62633; -.
DR   PeptideAtlas; P62633; -.
DR   PRIDE; P62633; -.
DR   DNASU; 7555; -.
DR   Ensembl; ENST00000422453; ENSP00000410619; ENSG00000169714. [P62633-1]
DR   Ensembl; ENST00000441626; ENSP00000410769; ENSG00000169714. [P62633-6]
DR   Ensembl; ENST00000446936; ENSP00000400444; ENSG00000169714. [P62633-5]
DR   Ensembl; ENST00000451728; ENSP00000399488; ENSG00000169714. [P62633-4]
DR   Ensembl; ENST00000500450; ENSP00000426223; ENSG00000169714. [P62633-7]
DR   Ensembl; ENST00000502976; ENSP00000421323; ENSG00000169714. [P62633-2]
DR   Ensembl; ENST00000504813; ENSP00000422110; ENSG00000169714. [P62633-3]
DR   GeneID; 7555; -.
DR   KEGG; hsa:7555; -.
DR   UCSC; uc003elq.5; human. [P62633-1]
DR   CTD; 7555; -.
DR   DisGeNET; 7555; -.
DR   EuPathDB; HostDB:ENSG00000169714.16; -.
DR   GeneCards; CNBP; -.
DR   GeneReviews; CNBP; -.
DR   HGNC; HGNC:13164; CNBP.
DR   HPA; HPA063097; -.
DR   MalaCards; CNBP; -.
DR   MIM; 116955; gene.
DR   MIM; 602668; phenotype.
DR   neXtProt; NX_P62633; -.
DR   OpenTargets; ENSG00000169714; -.
DR   Orphanet; 606; Proximal myotonic myopathy.
DR   PharmGKB; PA37737; -.
DR   eggNOG; KOG4400; Eukaryota.
DR   eggNOG; COG5082; LUCA.
DR   GeneTree; ENSGT00510000047065; -.
DR   HOGENOM; HOG000186262; -.
DR   HOVERGEN; HBG000397; -.
DR   InParanoid; P62633; -.
DR   KO; K09250; -.
DR   OMA; RRECDEK; -.
DR   OrthoDB; EOG091G0LZK; -.
DR   PhylomeDB; P62633; -.
DR   TreeFam; TF316974; -.
DR   SIGNOR; P62633; -.
DR   ChiTaRS; CNBP; human.
DR   GeneWiki; CNBP; -.
DR   GenomeRNAi; 7555; -.
DR   PRO; PR:P62633; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000169714; -.
DR   CleanEx; HS_CNBP; -.
DR   ExpressionAtlas; P62633; baseline and differential.
DR   Genevisible; P62633; HS.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; TAS:ProtInc.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   Pfam; PF00098; zf-CCHC; 7.
DR   SMART; SM00343; ZnF_C2HC; 7.
DR   SUPFAM; SSF57756; SSF57756; 4.
DR   PROSITE; PS50158; ZF_CCHC; 7.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Cytoplasm;
KW   DNA-binding; Endoplasmic reticulum; Metal-binding; Methylation;
KW   Phosphoprotein; Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    177       Cellular nucleic acid-binding protein.
FT                                /FTId=PRO_0000089965.
FT   ZN_FING       4     21       CCHC-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   ZN_FING      52     69       CCHC-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   ZN_FING      72     89       CCHC-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   ZN_FING      96    113       CCHC-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   ZN_FING     117    134       CCHC-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   ZN_FING     135    152       CCHC-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   ZN_FING     156    173       CCHC-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   COMPBIAS     22     42       Arg/Gly-rich.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES       8      8       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P53996}.
FT   MOD_RES      25     25       Omega-N-methylarginine; by PRMT1.
FT                                {ECO:0000269|PubMed:24726729}.
FT   MOD_RES      27     27       Omega-N-methylarginine; by PRMT1.
FT                                {ECO:0000269|PubMed:24726729}.
FT   MOD_RES      49     49       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P53996}.
FT   MOD_RES      79     79       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   VAR_SEQ      35     51       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055084.
FT   VAR_SEQ      36     42       Missing (in isoform 2, isoform 5 and
FT                                isoform 8). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_010981.
FT   VAR_SEQ      42     51       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_010982.
FT   VAR_SEQ      72     72       D -> DE (in isoform 4 and isoform 8).
FT                                {ECO:0000303|Ref.4, ECO:0000303|Ref.6}.
FT                                /FTId=VSP_043304.
FT   VAR_SEQ      72     72       D -> DVE (in isoform 5 and isoform 6).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_043424.
FT   MUTAGEN      25     25       R->K: Significantly reduces methylation;
FT                                when associated with K-27.
FT                                {ECO:0000269|PubMed:24726729}.
FT   MUTAGEN      27     27       R->K: Significantly reduces methylation;
FT                                when associated with K-25.
FT                                {ECO:0000269|PubMed:24726729}.
FT   CONFLICT      6      6       C -> R (in Ref. 5; BAF84808).
FT                                {ECO:0000305}.
SQ   SEQUENCE   177 AA;  19463 MW;  996F398285F52618 CRC64;
     MSSNECFKCG RSGHWARECP TGGGRGRGMR SRGRGGFTSD RGFQFVSSSL PDICYRCGES
     GHLAKDCDLQ EDACYNCGRG GHIAKDCKEP KREREQCCYN CGKPGHLARD CDHADEQKCY
     SCGEFGHIQK DCTKVKCYRC GETGHVAINC SKTSEVNCYR CGESGHLARE CTIEATA
//
ID   B2RA75_HUMAN            Unreviewed;       519 AA.
AC   B2RA75;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   28-FEB-2018, entry version 62.
DE   SubName: Full=cDNA, FLJ94739, highly similar to Homo sapiens cAMP responsive element binding protein 3-like 1 (CREB3L1), mRNA {ECO:0000313|EMBL:BAG36772.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG36772.1};
RN   [1] {ECO:0000313|EMBL:BAG36772.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG36772.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK314072; BAG36772.1; -; mRNA.
DR   RefSeq; NP_443086.1; NM_052854.3.
DR   UniGene; Hs.405961; -.
DR   PeptideAtlas; B2RA75; -.
DR   GeneID; 90993; -.
DR   KEGG; hsa:90993; -.
DR   CTD; 90993; -.
DR   eggNOG; KOG0709; Eukaryota.
DR   eggNOG; ENOG410ZZQM; LUCA.
DR   HOVERGEN; HBG057480; -.
DR   KO; K09048; -.
DR   GenomeRNAi; 90993; -.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0035497; F:cAMP response element binding; IEA:InterPro.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:InterPro.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:InterPro.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR001630; Leuzip_CREB.
DR   InterPro; IPR029805; OASIS.
DR   PANTHER; PTHR22952:SF24; PTHR22952:SF24; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   PRINTS; PR00041; LEUZIPPRCREB.
DR   SMART; SM00338; BRLZ; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      290    353       BZIP. {ECO:0000259|PROSITE:PS50217}.
FT   COILED      336    359       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   519 AA;  57063 MW;  3D37E8B9195453D0 CRC64;
     MDAVLEPFPA DRLFPGSSFL DLGDLNESDF LNNAHFPEHL DHFTENMEDF SNDLFSSFFD
     DPVLDEKSPL LDMELDSPTP GIQAEHSYSL SGDSAPQSPL VPIKMEDTTQ DAEHGAWALG
     HKLCSIMVKQ EQSPELPVDP LAAPSAMAAA AAMATTPLLG LSPLSRLPIP HQAPGEMTQL
     PVIKAEPLEV NQFLKVTPED LVQMPPTPPS SHGSDSDGSQ SPRSLPPSSP VRPMARSSTA
     ISTSPLLTAP HKLQGTSGPL LLTEEEKRTL IAEGYPIPTK LPLTKAEEKA LKRVRRKIKN
     KISAQESRRK KKEYVECLEK KVETFTSENN ELWKKVETLE NANRTLLQQL QKLQTLVTNK
     ISRPYKMAAT QTGTCLMVAA LCFVLVLGSL VPCLPEFSSG SQTVKEDPLV ADGVYTASQM
     PSRSLLFYDD GAGLWEDGRS TLLPMEPPDG WEINPGGPAE QRPRDHLQHD HLDSTHETTK
     YLSEAWPKDS GNGTSPDFSH SKEWFHDRDL GPNTTIKLS
//
ID   CR3L1_HUMAN             Reviewed;         519 AA.
AC   Q96BA8; Q8N2D5; Q96CP0;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-FEB-2018, entry version 144.
DE   RecName: Full=Cyclic AMP-responsive element-binding protein 3-like protein 1;
DE            Short=cAMP-responsive element-binding protein 3-like protein 1;
DE   AltName: Full=Old astrocyte specifically-induced substance;
DE            Short=OASIS;
DE   Contains:
DE     RecName: Full=Processed cyclic AMP-responsive element-binding protein 3-like protein 1;
GN   Name=CREB3L1; Synonyms=OASIS; ORFNames=PSEC0238;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DNA-BINDING, ALTERNATIVE
RP   SPLICING (ISOFORM 2), SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12054625; DOI=10.1016/S0006-291X(02)00253-X;
RA   Omori Y., Imai J., Suzuki Y., Watanabe S., Tanigami A., Sugano S.;
RT   "OASIS is a transcriptional activator of CREB/ATF family with a
RT   transmembrane domain.";
RL   Biochem. Biophys. Res. Commun. 293:470-477(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 253-519.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF PRO-392; ARG-423 AND LEU-426, AND
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=16417584; DOI=10.1111/j.1471-4159.2005.03596.x;
RA   Murakami T., Kondo S., Ogata M., Kanemoto S., Saito A., Wanaka A.,
RA   Imaizumi K.;
RT   "Cleavage of the membrane-bound transcription factor OASIS in response
RT   to endoplasmic reticulum stress.";
RL   J. Neurochem. 96:1090-1100(2006).
RN   [5]
RP   FUNCTION IN VIRAL INFECTIONS, IDENTIFICATION OF TARGET GENES,
RP   SUBCELLULAR LOCATION, PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF
RP   PRO-392; PRO-395 AND ARG-423.
RX   PubMed=21767813; DOI=10.1016/j.chom.2011.06.006;
RA   Denard B., Seemann J., Chen Q., Gay A., Huang H., Chen Y., Ye J.;
RT   "The membrane-bound transcription factor CREB3L1 is activated in
RT   response to virus infection to inhibit proliferation of virus-infected
RT   cells.";
RL   Cell Host Microbe 10:65-74(2011).
RN   [6]
RP   UBIQUITINATION.
RX   PubMed=22705851; DOI=10.1038/cdd.2012.77;
RA   Kondo S., Hino S.I., Saito A., Kanemoto S., Kawasaki N., Asada R.,
RA   Izumi S., Iwamoto H., Oki M., Miyagi H., Kaneko M., Nomura Y.,
RA   Urano F., Imaizumi K.;
RT   "Activation of OASIS family, ER stress transducers, is dependent on
RT   its stabilization.";
RL   Cell Death Differ. 19:1939-1949(2012).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, AND
RP   INTERACTION WITH SMAD4.
RX   PubMed=25310401; DOI=10.1371/journal.pone.0108528;
RA   Chen Q., Lee C.E., Denard B., Ye J.;
RT   "Sustained induction of collagen synthesis by TGF-beta requires
RT   regulated intramembrane proteolysis of CREB3L1.";
RL   PLoS ONE 9:E108528-E108528(2014).
RN   [8]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=27499293; DOI=10.1016/j.molcel.2016.06.032;
RA   Chen Q., Denard B., Lee C.E., Han S., Ye J.S., Ye J.;
RT   "Inverting the topology of a transmembrane protein by regulating the
RT   translocation of the first transmembrane helix.";
RL   Mol. Cell 63:567-578(2016).
RN   [9]
RP   POSSIBLE INVOLVEMENT IN OI16, AND SUBCELLULAR LOCATION.
RX   PubMed=24079343; DOI=10.1186/1750-1172-8-154;
RA   Symoens S., Malfait F., D'hondt S., Callewaert B., Dheedene A.,
RA   Steyaert W., Baechinger H.P., De Paepe A., Kayserili H., Coucke P.J.;
RT   "Deficiency for the ER-stress transducer OASIS causes severe recessive
RT   osteogenesis imperfecta in humans.";
RL   Orphanet J. Rare Dis. 8:154-154(2013).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-184, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Transcription factor involved in unfolded protein
CC       response (UPR). Binds the DNA consensus sequence 5'-GTGXGCXGC-3'
CC       (PubMed:21767813). In the absence of endoplasmic reticulum (ER)
CC       stress, inserted into ER membranes, with N-terminal DNA-binding
CC       and transcription activation domains oriented toward the cytosolic
CC       face of the membrane. In response to ER stress, transported to the
CC       Golgi, where it is cleaved in a site-specific manner by resident
CC       proteases S1P/MBTPS1 and S2P/MBTPS2. The released N-terminal
CC       cytosolic domain is translocated to the nucleus to effect
CC       transcription of specific target genes. Plays a critical role in
CC       bone formation through the transcription of COL1A1, and possibly
CC       COL1A2, and the secretion of bone matrix proteins. Directly binds
CC       to the UPR element (UPRE)-like sequence in an osteoblast-specific
CC       COL1A1 promoter region and induces its transcription. Does not
CC       regulate COL1A1 in other tissues, such as skin (By similarity).
CC       Required to protect astrocytes from ER stress-induced cell death.
CC       In astrocytes, binds to the cAMP response element (CRE) of the
CC       BiP/HSPA5 promoter and participate in its transcriptional
CC       activation (By similarity). Required for TGFB1 to activate genes
CC       involved in the assembly of collagen extracellular matrix
CC       (PubMed:25310401). {ECO:0000250|UniProtKB:Q9Z125,
CC       ECO:0000269|PubMed:12054625, ECO:0000269|PubMed:21767813,
CC       ECO:0000269|PubMed:25310401}.
CC   -!- FUNCTION: (Microbial infection) May play a role in limiting virus
CC       spread by inhibiting proliferation of virus-infected cells. Upon
CC       infection with diverse DNA and RNA viruses, inhibits cell-cycle
CC       progression by binding to promoters and activating transcription
CC       of genes encoding cell-cycle inhibitors, such as p21/CDKN1A
CC       (PubMed:21767813). {ECO:0000269|PubMed:21767813}.
CC   -!- SUBUNIT: Interacts with SMAD4, the interaction takes place upon
CC       TGFB1 induction and SMAD4 acts as CREB3L1 coactivator to induce
CC       the expression of genes involved in assembly of collagen
CC       extracellular matrix. {ECO:0000269|PubMed:25310401}.
CC   -!- INTERACTION:
CC       P01031:C5; NbExp=3; IntAct=EBI-6942903, EBI-8558308;
CC       A0A0S2Z5R8:CD99L2; NbExp=3; IntAct=EBI-6942903, EBI-16434925;
CC       Q9BXR6:CFHR5; NbExp=5; IntAct=EBI-6942903, EBI-11579371;
CC       Q15125:EBP; NbExp=4; IntAct=EBI-6942903, EBI-3915253;
CC       Q92520:FAM3C; NbExp=3; IntAct=EBI-6942903, EBI-2876774;
CC       Q9UGM5:FETUB; NbExp=4; IntAct=EBI-6942903, EBI-13049494;
CC       Q9H0Q3:FXYD6; NbExp=5; IntAct=EBI-6942903, EBI-713304;
CC       O00155:GPR25; NbExp=5; IntAct=EBI-6942903, EBI-10178951;
CC       Q8N5M9:JAGN1; NbExp=3; IntAct=EBI-6942903, EBI-10266796;
CC       Q6N075:MFSD5; NbExp=3; IntAct=EBI-6942903, EBI-3920969;
CC       Q99735:MGST2; NbExp=4; IntAct=EBI-6942903, EBI-11324706;
CC       Q8IXM6:NRM; NbExp=3; IntAct=EBI-6942903, EBI-10262547;
CC       E9PRZ2:PGAP2; NbExp=3; IntAct=EBI-6942903, EBI-16438210;
CC       Q9UHJ9:PGAP2; NbExp=3; IntAct=EBI-6942903, EBI-10321427;
CC       Q9UHJ9-5:PGAP2; NbExp=5; IntAct=EBI-6942903, EBI-12092917;
CC       Q6IB11:PGRMC1; NbExp=3; IntAct=EBI-6942903, EBI-10249941;
CC       P26678:PLN; NbExp=3; IntAct=EBI-6942903, EBI-692836;
CC       P60201:PLP1; NbExp=3; IntAct=EBI-6942903, EBI-8653150;
CC       P60201-2:PLP1; NbExp=11; IntAct=EBI-6942903, EBI-12188331;
CC       O43741:PRKAB2; NbExp=3; IntAct=EBI-6942903, EBI-1053424;
CC       Q06455-4:RUNX1T1; NbExp=3; IntAct=EBI-6942903, EBI-10224192;
CC       Q8IWU4:SLC30A8; NbExp=8; IntAct=EBI-6942903, EBI-10262251;
CC       Q969S0:SLC35B4; NbExp=5; IntAct=EBI-6942903, EBI-10281213;
CC       Q9NP94:SLC39A2; NbExp=4; IntAct=EBI-6942903, EBI-12898013;
CC       P02786:TFRC; NbExp=4; IntAct=EBI-6942903, EBI-355727;
CC       P17152:TMEM11; NbExp=3; IntAct=EBI-6942903, EBI-723946;
CC       Q9BVK8:TMEM147; NbExp=5; IntAct=EBI-6942903, EBI-348587;
CC       A2RU14:TMEM218; NbExp=5; IntAct=EBI-6942903, EBI-10173151;
CC       Q8WY98:TMEM234; NbExp=3; IntAct=EBI-6942903, EBI-8642211;
CC       P30536:TSPO; NbExp=5; IntAct=EBI-6942903, EBI-6623146;
CC       O95159:ZFPL1; NbExp=4; IntAct=EBI-6942903, EBI-718439;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12054625, ECO:0000269|PubMed:16417584,
CC       ECO:0000269|PubMed:25310401}; Single-pass type II membrane
CC       protein. Note=ER membrane resident protein. Upon ER stress,
CC       translocated to the Golgi apparatus where it is cleaved. The
CC       cytosolic N-terminal fragment (processed cyclic AMP-responsive
CC       element-binding protein 3-like protein 1) is transported into the
CC       nucleus. {ECO:0000269|PubMed:12054625,
CC       ECO:0000269|PubMed:16417584, ECO:0000269|PubMed:21767813,
CC       ECO:0000269|PubMed:25310401}.
CC   -!- SUBCELLULAR LOCATION: Processed cyclic AMP-responsive element-
CC       binding protein 3-like protein 1: Nucleus
CC       {ECO:0000269|PubMed:24079343, ECO:0000269|PubMed:25310401}.
CC       Note=Upon ER stress, transported into the nucleus.
CC       {ECO:0000269|PubMed:12054625, ECO:0000269|PubMed:21767813,
CC       ECO:0000269|PubMed:24079343, ECO:0000269|PubMed:25310401}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96BA8-1; Sequence=Displayed;
CC       Name=2; Synonyms=OASISv1;
CC         IsoId=Q96BA8-2; Sequence=VSP_025632;
CC   -!- TISSUE SPECIFICITY: Expressed in several tissues, with highest
CC       levels in pancreas and prostate. Expressed at relatively lower
CC       levels in brain. {ECO:0000269|PubMed:12054625}.
CC   -!- PTM: Upon ER stress, translocated to the Golgi apparatus, where it
CC       is processed by regulated intramembrane proteolysis (RIP) to
CC       release the cytosol-facing N-terminal transcription factor domain.
CC       The cleavage is performed sequentially by site-1 and site-2
CC       proteases (S1P/MBTPS1 and S2P/MBTPS2). RIP is induced by TGFB1 and
CC       ceramide (PubMed:25310401, PubMed:27499293).
CC       {ECO:0000269|PubMed:16417584, ECO:0000269|PubMed:21767813,
CC       ECO:0000269|PubMed:25310401, ECO:0000269|PubMed:27499293}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q9Z125}.
CC   -!- PTM: Ubiquitinated by HRD1/SYVN1; undergoes 'Lys-48'-linked
CC       ubiquitination, followed by rapid proteasomal degradation under
CC       normal conditions. Upon ER stress, SYVN1 E3 ubiquitin-protein
CC       ligase dissociates from its substrate, ubiquitination does not
CC       occur and CREB3L1 is stabilized. {ECO:0000269|PubMed:22705851}.
CC   -!- DISEASE: Osteogenesis imperfecta 16 (OI16) [MIM:616229]: An
CC       autosomal recessive form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI16 is a severe form.
CC       {ECO:0000269|PubMed:24079343}. Note=The disease may be caused by
CC       mutations affecting the gene represented in this entry. OI16
CC       affected patients show a genomic deletion encompassing CREB3L1 and
CC       the first exon of DGKZ. The absence of this exon does not affect
CC       all DGKZ isoforms, some are still produced at normal level. It
CC       cannot be ruled out that DGKZ could contribute to the phenotype,
CC       but in view of its role in bone formation, CREB3L1 is a strong
CC       OI16-causing candidate (PubMed:24079343). This hypothesis is
CC       corroborated by the observation of CREB3L1 knockout mice which
CC       exhibit features reminiscent of severe human osteogenesis
CC       imperfecta. {ECO:0000269|PubMed:24079343}.
CC   -!- SIMILARITY: Belongs to the bZIP family. ATF subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11681.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB063321; BAC01278.1; -; mRNA.
DR   EMBL; BC014097; AAH14097.1; -; mRNA.
DR   EMBL; BC015781; AAH15781.1; -; mRNA.
DR   EMBL; AK075538; BAC11681.1; ALT_INIT; mRNA.
DR   CCDS; CCDS53620.1; -. [Q96BA8-1]
DR   RefSeq; NP_443086.1; NM_052854.3. [Q96BA8-1]
DR   UniGene; Hs.405961; -.
DR   ProteinModelPortal; Q96BA8; -.
DR   SMR; Q96BA8; -.
DR   BioGrid; 124786; 31.
DR   IntAct; Q96BA8; 152.
DR   MINT; Q96BA8; -.
DR   STRING; 9606.ENSP00000434939; -.
DR   iPTMnet; Q96BA8; -.
DR   PhosphoSitePlus; Q96BA8; -.
DR   DMDM; 74751763; -.
DR   EPD; Q96BA8; -.
DR   MaxQB; Q96BA8; -.
DR   PaxDb; Q96BA8; -.
DR   PeptideAtlas; Q96BA8; -.
DR   PRIDE; Q96BA8; -.
DR   DNASU; 90993; -.
DR   Ensembl; ENST00000621158; ENSP00000481956; ENSG00000157613. [Q96BA8-1]
DR   GeneID; 90993; -.
DR   KEGG; hsa:90993; -.
DR   UCSC; uc021qik.3; human. [Q96BA8-1]
DR   CTD; 90993; -.
DR   DisGeNET; 90993; -.
DR   EuPathDB; HostDB:ENSG00000157613.10; -.
DR   GeneCards; CREB3L1; -.
DR   HGNC; HGNC:18856; CREB3L1.
DR   HPA; CAB026151; -.
DR   HPA; HPA024069; -.
DR   MalaCards; CREB3L1; -.
DR   MIM; 616215; gene.
DR   MIM; 616229; phenotype.
DR   neXtProt; NX_Q96BA8; -.
DR   OpenTargets; ENSG00000157613; -.
DR   Orphanet; 79105; Myxofibrosarcoma.
DR   Orphanet; 216812; Osteogenesis imperfecta type 3.
DR   PharmGKB; PA134960108; -.
DR   eggNOG; KOG0709; Eukaryota.
DR   eggNOG; ENOG410ZZQM; LUCA.
DR   GeneTree; ENSGT00520000055538; -.
DR   HOGENOM; HOG000060150; -.
DR   HOVERGEN; HBG057480; -.
DR   InParanoid; Q96BA8; -.
DR   KO; K09048; -.
DR   OMA; EPPDGWE; -.
DR   OrthoDB; EOG091G081Z; -.
DR   PhylomeDB; Q96BA8; -.
DR   TreeFam; TF316079; -.
DR   Reactome; R-HSA-8874211; CREB3 factors activate genes.
DR   SIGNOR; Q96BA8; -.
DR   ChiTaRS; CREB3L1; human.
DR   GenomeRNAi; 90993; -.
DR   PRO; PR:Q96BA8; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000157613; -.
DR   CleanEx; HS_CREB3L1; -.
DR   ExpressionAtlas; Q96BA8; baseline and differential.
DR   Genevisible; Q96BA8; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0035497; F:cAMP response element binding; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0046332; F:SMAD binding; IPI:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; ISS:UniProtKB.
DR   GO; GO:0070278; P:extracellular matrix constituent secretion; ISS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0001649; P:osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1990440; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; ISS:ParkinsonsUK-UCL.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR001630; Leuzip_CREB.
DR   InterPro; IPR029805; OASIS.
DR   PANTHER; PTHR22952:SF24; PTHR22952:SF24; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   PRINTS; PR00041; LEUZIPPRCREB.
DR   SMART; SM00338; BRLZ; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Complete proteome;
KW   Developmental protein; DNA-binding; Endoplasmic reticulum;
KW   Glycoprotein; Isopeptide bond; Membrane; Nucleus;
KW   Osteogenesis imperfecta; Polymorphism; Reference proteome;
KW   Signal-anchor; Transcription; Transcription regulation; Transmembrane;
KW   Transmembrane helix; Ubl conjugation; Unfolded protein response.
FT   CHAIN         1    519       Cyclic AMP-responsive element-binding
FT                                protein 3-like protein 1.
FT                                /FTId=PRO_0000288064.
FT   CHAIN         1      ?       Processed cyclic AMP-responsive element-
FT                                binding protein 3-like protein 1.
FT                                /FTId=PRO_0000296206.
FT   TOPO_DOM      1    374       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    375    395       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM    396    519       Lumenal. {ECO:0000255}.
FT   DOMAIN      290    353       bZIP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00978}.
FT   REGION        1     60       Required for transcriptional activation.
FT   REGION      292    321       Basic motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00978}.
FT   REGION      332    353       Leucine-zipper. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00978}.
FT   MOTIF       392    395       S2P recognition.
FT                                {ECO:0000303|PubMed:21767813}.
FT   MOTIF       423    426       S1P recognition.
FT                                {ECO:0000303|PubMed:21767813}.
FT   COMPBIAS    146    154       Poly-Ala.
FT   SITE        426    427       Cleavage; by S1P. {ECO:0000250}.
FT   CARBOHYD    492    492       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    513    513       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CROSSLNK    184    184       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     111    198       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_025632.
FT   VARIANT     411    411       A -> T (in dbSNP:rs35652107).
FT                                /FTId=VAR_032392.
FT   MUTAGEN     392    392       P->A: Abolishes proteolytic cleavage by
FT                                S2P; when associated with A-395.
FT                                {ECO:0000269|PubMed:21767813}.
FT   MUTAGEN     392    392       P->L: Abolishes proteolytic cleavage by
FT                                S2P. {ECO:0000269|PubMed:16417584}.
FT   MUTAGEN     395    395       P->A: Abolishes proteolytic cleavage by
FT                                S2P; when associated with A-392.
FT                                {ECO:0000269|PubMed:21767813}.
FT   MUTAGEN     423    423       R->A: Abolishes proteolytic cleavage by
FT                                S1P. {ECO:0000269|PubMed:16417584,
FT                                ECO:0000269|PubMed:21767813}.
FT   MUTAGEN     426    426       L->V: Abolishes proteolytic cleavage by
FT                                S1P. {ECO:0000269|PubMed:16417584}.
FT   CONFLICT    249    249       A -> P (in Ref. 2; AAH14097).
FT                                {ECO:0000305}.
SQ   SEQUENCE   519 AA;  57005 MW;  D08133CD8B02A3AC CRC64;
     MDAVLEPFPA DRLFPGSSFL DLGDLNESDF LNNAHFPEHL DHFTENMEDF SNDLFSSFFD
     DPVLDEKSPL LDMELDSPTP GIQAEHSYSL SGDSAPQSPL VPIKMEDTTQ DAEHGAWALG
     HKLCSIMVKQ EQSPELPVDP LAAPSAMAAA AAMATTPLLG LSPLSRLPIP HQAPGEMTQL
     PVIKAEPLEV NQFLKVTPED LVQMPPTPPS SHGSDSDGSQ SPRSLPPSSP VRPMARSSTA
     ISTSPLLTAP HKLQGTSGPL LLTEEEKRTL IAEGYPIPTK LPLTKAEEKA LKRVRRKIKN
     KISAQESRRK KKEYVECLEK KVETFTSENN ELWKKVETLE NANRTLLQQL QKLQTLVTNK
     ISRPYKMAAT QTGTCLMVAA LCFVLVLGSL VPCLPEFSSG SQTVKEDPLA ADGVYTASQM
     PSRSLLFYDD GAGLWEDGRS TLLPMEPPDG WEINPGGPAE QRPRDHLQHD HLDSTHETTK
     YLSEAWPKDG GNGTSPDFSH SKEWFHDRDL GPNTTIKLS
//
ID   DDX10_HUMAN             Reviewed;         875 AA.
AC   Q13206; B2RCQ3; Q5BJD8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   28-FEB-2018, entry version 164.
DE   RecName: Full=Probable ATP-dependent RNA helicase DDX10;
DE            EC=3.6.4.13;
DE   AltName: Full=DEAD box protein 10;
GN   Name=DDX10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8660968; DOI=10.1006/geno.1996.0184;
RA   Savitsky K., Ziv Y., Bar-Shira A., Gilad S., Tagle D.A., Smith S.,
RA   Uziel T., Sfez S., Nahmias J., Sartiel A., Eddy R.L., Shows T.B.,
RA   Collins F.S., Shiloh Y., Rotman G.;
RT   "A human gene (DDX10) encoding a putative DEAD-box RNA helicase at
RT   11q22-q23.";
RL   Genomics 33:199-206(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Arai Y., Kaneko Y., Kubo T., Arai K., Hosoda F., Ohki M.;
RT   "Molecular analysis of the chromosomal breakpoints and identification
RT   of the repetitive sequences near the breakpoints of NUP98 in therapy-
RT   related leukemia with inv(11)(p15q22).";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-4, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-539 AND SER-831, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-539, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-539, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-780, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; SER-539; THR-577 AND
RP   SER-831, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-649, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 47-280 IN COMPLEX WITH ADP.
RX   PubMed=20941364; DOI=10.1371/journal.pone.0012791;
RA   Schutz P., Karlberg T., van den Berg S., Collins R., Lehtio L.,
RA   Hogbom M., Holmberg-Schiavone L., Tempel W., Park H.W.,
RA   Hammarstrom M., Moche M., Thorsell A.G., Schuler H.;
RT   "Comparative structural analysis of human DEAD-box RNA helicases.";
RL   PLoS ONE 5:E12791-E12791(2010).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-566.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Putative ATP-dependent RNA helicase.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC   -!- TISSUE SPECIFICITY: High in testis but widely expressed.
CC   -!- DOMAIN: The Q motif is unique to and characteristic of the DEAD
CC       box family of RNA helicases and controls ATP binding and
CC       hydrolysis.
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. DDX10/DBP4
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/DDX10ID35.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U28042; AAC50823.1; -; mRNA.
DR   EMBL; AB040537; BAB18536.1; -; mRNA.
DR   EMBL; AK315216; BAG37650.1; -; mRNA.
DR   EMBL; CH471065; EAW67122.1; -; Genomic_DNA.
DR   EMBL; BC091521; AAH91521.1; -; mRNA.
DR   EMBL; BC093654; AAH93654.1; -; mRNA.
DR   EMBL; BC093656; AAH93656.1; -; mRNA.
DR   CCDS; CCDS8342.1; -.
DR   RefSeq; NP_004389.2; NM_004398.3.
DR   UniGene; Hs.591931; -.
DR   PDB; 2PL3; X-ray; 2.15 A; A=47-280.
DR   PDBsum; 2PL3; -.
DR   ProteinModelPortal; Q13206; -.
DR   SMR; Q13206; -.
DR   BioGrid; 108027; 35.
DR   IntAct; Q13206; 7.
DR   STRING; 9606.ENSP00000314348; -.
DR   iPTMnet; Q13206; -.
DR   PhosphoSitePlus; Q13206; -.
DR   BioMuta; DDX10; -.
DR   DMDM; 76803554; -.
DR   SWISS-2DPAGE; Q13206; -.
DR   EPD; Q13206; -.
DR   MaxQB; Q13206; -.
DR   PaxDb; Q13206; -.
DR   PeptideAtlas; Q13206; -.
DR   PRIDE; Q13206; -.
DR   Ensembl; ENST00000322536; ENSP00000314348; ENSG00000178105.
DR   GeneID; 1662; -.
DR   KEGG; hsa:1662; -.
DR   UCSC; uc001pkm.4; human.
DR   CTD; 1662; -.
DR   DisGeNET; 1662; -.
DR   EuPathDB; HostDB:ENSG00000178105.9; -.
DR   GeneCards; DDX10; -.
DR   HGNC; HGNC:2735; DDX10.
DR   HPA; HPA004691; -.
DR   MIM; 601235; gene.
DR   neXtProt; NX_Q13206; -.
DR   OpenTargets; ENSG00000178105; -.
DR   PharmGKB; PA27200; -.
DR   eggNOG; KOG0342; Eukaryota.
DR   eggNOG; COG0513; LUCA.
DR   GeneTree; ENSGT00550000074980; -.
DR   HOGENOM; HOG000268801; -.
DR   HOVERGEN; HBG102756; -.
DR   InParanoid; Q13206; -.
DR   KO; K14776; -.
DR   OMA; YGTLHQD; -.
DR   OrthoDB; EOG091G06N7; -.
DR   PhylomeDB; Q13206; -.
DR   TreeFam; TF315215; -.
DR   ChiTaRS; DDX10; human.
DR   EvolutionaryTrace; Q13206; -.
DR   GeneWiki; DDX10; -.
DR   GenomeRNAi; 1662; -.
DR   PRO; PR:Q13206; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000178105; -.
DR   CleanEx; HS_DDX10; -.
DR   ExpressionAtlas; Q13206; baseline and differential.
DR   Genevisible; Q13206; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005730; C:nucleolus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004004; F:ATP-dependent RNA helicase activity; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003724; F:RNA helicase activity; TAS:ProtInc.
DR   GO; GO:0010501; P:RNA secondary structure unwinding; IBA:GO_Central.
DR   CDD; cd00079; HELICc; 1.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR025313; DUF4217.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000629; RNA-helicase_DEAD-box_CS.
DR   InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF13959; DUF4217; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM01178; DUF4217; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00039; DEAD_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51195; Q_MOTIF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Helicase;
KW   Hydrolase; Isopeptide bond; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; RNA-binding; Ubl conjugation.
FT   CHAIN         1    875       Probable ATP-dependent RNA helicase
FT                                DDX10.
FT                                /FTId=PRO_0000055083.
FT   DOMAIN      100    274       Helicase ATP-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN      287    448       Helicase C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00542}.
FT   NP_BIND      89     91       ATP.
FT   NP_BIND     113    120       ATP.
FT   MOTIF        69     97       Q motif.
FT   MOTIF       222    225       DEAD box.
FT   BINDING      96     96       ATP.
FT   MOD_RES       4      4       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18220336}.
FT   MOD_RES       7      7       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     539    539       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     555    555       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q80Y44}.
FT   MOD_RES     577    577       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     780    780       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     831    831       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    649    649       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT     566    566       L -> V (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035840.
FT   CONFLICT    647    647       D -> A (in Ref. 1; AAC50823).
FT                                {ECO:0000305}.
FT   CONFLICT    658    658       E -> D (in Ref. 1; AAC50823).
FT                                {ECO:0000305}.
FT   CONFLICT    661    661       K -> N (in Ref. 1; AAC50823).
FT                                {ECO:0000305}.
FT   HELIX        47     58       {ECO:0000244|PDB:2PL3}.
FT   TURN         59     62       {ECO:0000244|PDB:2PL3}.
FT   HELIX        65     67       {ECO:0000244|PDB:2PL3}.
FT   HELIX        71     73       {ECO:0000244|PDB:2PL3}.
FT   HELIX        78     86       {ECO:0000244|PDB:2PL3}.
FT   HELIX        94    104       {ECO:0000244|PDB:2PL3}.
FT   STRAND      109    112       {ECO:0000244|PDB:2PL3}.
FT   HELIX       119    133       {ECO:0000244|PDB:2PL3}.
FT   HELIX       138    140       {ECO:0000244|PDB:2PL3}.
FT   STRAND      144    147       {ECO:0000244|PDB:2PL3}.
FT   HELIX       151    164       {ECO:0000244|PDB:2PL3}.
FT   TURN        165    167       {ECO:0000244|PDB:2PL3}.
FT   STRAND      172    175       {ECO:0000244|PDB:2PL3}.
FT   HELIX       182    188       {ECO:0000244|PDB:2PL3}.
FT   STRAND      192    196       {ECO:0000244|PDB:2PL3}.
FT   HELIX       198    207       {ECO:0000244|PDB:2PL3}.
FT   STRAND      218    221       {ECO:0000244|PDB:2PL3}.
FT   HELIX       224    229       {ECO:0000244|PDB:2PL3}.
FT   TURN        230    232       {ECO:0000244|PDB:2PL3}.
FT   HELIX       233    241       {ECO:0000244|PDB:2PL3}.
FT   STRAND      247    255       {ECO:0000244|PDB:2PL3}.
FT   HELIX       258    266       {ECO:0000244|PDB:2PL3}.
FT   STRAND      272    275       {ECO:0000244|PDB:2PL3}.
SQ   SEQUENCE   875 AA;  100888 MW;  B61BF325921C62FD CRC64;
     MGKTANSPGS GARPDPVRSF NRWKKKHSHR QNKKKQLRKQ LKKPEWQVER ESISRLMQNY
     EKINVNEITR FSDFPLSKKT LKGLQEAQYR LVTEIQKQTI GLALQGKDVL GAAKTGSGKT
     LAFLVPVLEA LYRLQWTSTD GLGVLIISPT RELAYQTFEV LRKVGKNHDF SAGLIIGGKD
     LKHEAERINN INILVCTPGR LLQHMDETVS FHATDLQMLV LDEADRILDM GFADTMNAVI
     ENLPKKRQTL LFSATQTKSV KDLARLSLKN PEYVWVHEKA KYSTPATLEQ NYIVCELQQK
     ISVLYSFLRS HLKKKSIVFF SSCKEVQYLY RVFCRLRPGV SILALHGRQQ QMRRMEVYNE
     FVRKRAAVLF ATDIAARGLD FPAVNWVLQF DCPEDANTYI HRAGRTARYK EDGEALLILL
     PSEKAMVQQL LQKKVPVKEI KINPEKLIDV QKKLESILAQ DQDLKERAQR CFVSYVRSVY
     LMKDKEVFDV SKLPIPEYAL SLGLAVAPRV RFLQKMQKQP TKELVRSQAD KVIEPRAPSL
     TNDEVEEFRA YFNEKMSILQ KGGKRLEGTE HRQDNDTGNE EQEEEEDDEE EMEEKLAKAK
     GSQAPSLPNT SEAQKIKEVP TQFLDRDEEE EDADFLKVKR HNVFGLDLKD EKTLQKKEPS
     KSSIKKKMTK VAEAKKVMKR NFKVNKKITF TDEGELVQQW PQMQKSAIKD AEEDDDTGGI
     NLHKAKERLQ EEDKFDKEEY RKKIKAKHRE KRLKEREARR EANKRQAKAK DEEEAFLDWS
     DDDDDDDDGF DPSTLPDPDK YRSSEDSDSE DMENKISDTK KKQGMKKRSN SEVEDVGPTS
     HNRKKARWDT LEPLDTGLSL AEDEELVLHL LRSQS
//
ID   B4E2U8_HUMAN            Unreviewed;       578 AA.
AC   B4E2U8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 59.
DE   SubName: Full=cDNA FLJ54478, highly similar to Transcription factor COE1 {ECO:0000313|EMBL:BAG65260.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65260.1};
RN   [1] {ECO:0000313|EMBL:BAG65260.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG65260.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU004489}.
CC   -!- SIMILARITY: Belongs to the COE family.
CC       {ECO:0000256|RuleBase:RU004489}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK304438; BAG65260.1; -; mRNA.
DR   RefSeq; NP_001277289.1; NM_001290360.2.
DR   UniGene; Hs.573143; -.
DR   UniGene; Hs.733761; -.
DR   PeptideAtlas; B4E2U8; -.
DR   GeneID; 1879; -.
DR   CTD; 1879; -.
DR   eggNOG; KOG3836; Eukaryota.
DR   eggNOG; ENOG410XQ9Z; LUCA.
DR   HOVERGEN; HBG005108; -.
DR   GenomeRNAi; 1879; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd01175; IPT_COE; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 4.10.280.10; -; 2.
DR   InterPro; IPR032200; COE_DBD.
DR   InterPro; IPR032201; COE_HLH.
DR   InterPro; IPR038006; COE_IPT.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR003523; Transcription_factor_COE.
DR   InterPro; IPR018350; Transcription_factor_COE_CS.
DR   PANTHER; PTHR10747; PTHR10747; 1.
DR   Pfam; PF16422; COE1_DBD; 1.
DR   Pfam; PF16423; COE1_HLH; 1.
DR   Pfam; PF01833; TIG; 1.
DR   SMART; SM00429; IPT; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS01345; COE; 1.
PE   2: Evidence at transcript level;
KW   Developmental protein {ECO:0000256|RuleBase:RU004489};
KW   DNA-binding {ECO:0000256|RuleBase:RU004489};
KW   Metal-binding {ECO:0000256|RuleBase:RU004489};
KW   Nucleus {ECO:0000256|RuleBase:RU004489};
KW   Transcription {ECO:0000256|RuleBase:RU004489};
KW   Transcription regulation {ECO:0000256|RuleBase:RU004489};
KW   Zinc {ECO:0000256|RuleBase:RU004489};
KW   Zinc-finger {ECO:0000256|RuleBase:RU004489}.
FT   DOMAIN      248    332       IPT/TIG. {ECO:0000259|SMART:SM00429}.
SQ   SEQUENCE   578 AA;  63026 MW;  F617F7E252D128C5 CRC64;
     MKEEPLGSGM NAVRTWMQGA GVLDANTAAQ SGVGLARAHF EKQPPSNLRK SNFFHFVLAL
     YDRQGQPVEI ERTAFVGFVE KEKEANSEKT NNGIHYRLQL LYSNGIRTEQ DFYVRLIDSM
     TKQAIVYEGQ DKNPEMCRVL LTHEIMCSRC CDKKSCGNRN ETPSDPVIID RFFLKFFLKC
     NQNCLKNAGN PRDMRRFQVV VSTTVNVDGH VLAVSDNMFV HNNSKHGRRA RRLDPSEGTP
     SYLEHAATPC IKAISPSEGW TTGGATVIII GDNFFDGLQV IFGTMLVWSE LITPHAIRVQ
     TPPRHIPGVV EVTLSYKSKQ FCKGTPGRFI YTALNEPTID YGFQRLQKVI PRHPGDPERL
     PKEVILKRAA DLVEALYGMP HNNQEIILKR AADIAEALYS VPRNHNQLPA LANTSVHAGM
     MGVNSFSGQL AVNVSEASQA TNQGFTRNSS SVSPHGYVPS TTPQQTNYNS VTTSMNGYGS
     AAMSNLGGSP TFLNGSAANS PYAIVPSSPT MASSTSLPSN CSSSSGIFSF SPANMVSAVK
     QKSAFAPVVR PQTSPPPTCT STNGNSLQAI SGMIVPPM
//
ID   COE1_HUMAN              Reviewed;         591 AA.
AC   Q9UH73; Q8IW11;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   28-FEB-2018, entry version 147.
DE   RecName: Full=Transcription factor COE1;
DE            Short=O/E-1;
DE            Short=OE-1;
DE   AltName: Full=Early B-cell factor;
GN   Name=EBF1; Synonyms=COE1, EBF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-591 (ISOFORM 1).
RX   PubMed=10942392;
RA   Gisler R., Jacobsen S.E., Sigvardsson M.;
RT   "Cloning of human early B-cell factor and identification of target
RT   genes suggest a conserved role in B-cell development in man and
RT   mouse.";
RL   Blood 96:1457-1464(2000).
RN   [3]
RP   INTERACTION WITH ZNF521.
RX   PubMed=14630787; DOI=10.1182/blood-2003-07-2388;
RA   Bond H.M., Mesuraca M., Carbone E., Bonelli P., Agosti V., Amodio N.,
RA   De Rosa G., Di Nicola M., Gianni A.M., Moore M.A., Hata A., Grieco M.,
RA   Morrone G., Venuta S.;
RT   "Early hematopoietic zinc finger protein (EHZF), the human homolog to
RT   mouse Evi3, is highly expressed in primitive human hematopoietic
RT   cells.";
RL   Blood 103:2062-2070(2004).
RN   [4]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-16, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [6]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-16, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 10-351 IN COMPLEX WITH ZINC
RP   IONS.
RX   PubMed=20592035; DOI=10.1074/jbc.C110.150482;
RA   Siponen M.I., Wisniewska M., Lehtio L., Johansson I., Svensson L.,
RA   Raszewski G., Nilsson L., Sigvardsson M., Berglund H.;
RT   "Structural determination of functional domains in early B-cell factor
RT   (EBF) family of transcription factors reveals similarities to Rel DNA-
RT   binding proteins and a novel dimerization motif.";
RL   J. Biol. Chem. 285:25875-25879(2010).
CC   -!- FUNCTION: Transcriptional activator which recognizes variations of
CC       the palindromic sequence 5'-ATTCCCNNGGGAATT-3'. {ECO:0000250}.
CC   -!- SUBUNIT: Forms either a homodimer or a heterodimer with a related
CC       family member (By similarity). Interacts with ZNF423 and ZNF521,
CC       leading to prevent EBF1 to bind DNA and activate target genes.
CC       {ECO:0000250, ECO:0000269|PubMed:14630787,
CC       ECO:0000269|PubMed:20592035}.
CC   -!- INTERACTION:
CC       Q8N5M1:ATPAF2; NbExp=6; IntAct=EBI-765426, EBI-1166928;
CC       Q8IX15-3:HOMEZ; NbExp=3; IntAct=EBI-765426, EBI-10172004;
CC       P78424:POU6F2; NbExp=4; IntAct=EBI-765426, EBI-12029004;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UH73-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UH73-2; Sequence=VSP_012304, VSP_012305;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the COE family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC038805; AAH38805.1; -; mRNA.
DR   EMBL; BC041178; AAH41178.1; -; mRNA.
DR   EMBL; AF208502; AAF19643.1; -; mRNA.
DR   CCDS; CCDS4343.1; -. [Q9UH73-1]
DR   CCDS; CCDS78081.1; -. [Q9UH73-2]
DR   RefSeq; NP_076870.1; NM_024007.4. [Q9UH73-1]
DR   RefSeq; NP_874367.1; NM_182708.2. [Q9UH73-2]
DR   UniGene; Hs.573143; -.
DR   UniGene; Hs.733761; -.
DR   PDB; 3LYR; X-ray; 2.51 A; A=10-250.
DR   PDB; 3MQI; X-ray; 2.30 A; A/B/C=258-351.
DR   PDBsum; 3LYR; -.
DR   PDBsum; 3MQI; -.
DR   ProteinModelPortal; Q9UH73; -.
DR   SMR; Q9UH73; -.
DR   BioGrid; 108211; 10.
DR   IntAct; Q9UH73; 6.
DR   STRING; 9606.ENSP00000322898; -.
DR   iPTMnet; Q9UH73; -.
DR   PhosphoSitePlus; Q9UH73; -.
DR   SwissPalm; Q9UH73; -.
DR   BioMuta; EBF1; -.
DR   DMDM; 47117917; -.
DR   PaxDb; Q9UH73; -.
DR   PeptideAtlas; Q9UH73; -.
DR   PRIDE; Q9UH73; -.
DR   DNASU; 1879; -.
DR   Ensembl; ENST00000313708; ENSP00000322898; ENSG00000164330. [Q9UH73-1]
DR   Ensembl; ENST00000380654; ENSP00000370029; ENSG00000164330. [Q9UH73-2]
DR   GeneID; 1879; -.
DR   KEGG; hsa:1879; -.
DR   UCSC; uc003lxl.7; human. [Q9UH73-1]
DR   CTD; 1879; -.
DR   DisGeNET; 1879; -.
DR   EuPathDB; HostDB:ENSG00000164330.16; -.
DR   GeneCards; EBF1; -.
DR   HGNC; HGNC:3126; EBF1.
DR   HPA; HPA061169; -.
DR   MIM; 164343; gene.
DR   neXtProt; NX_Q9UH73; -.
DR   OpenTargets; ENSG00000164330; -.
DR   PharmGKB; PA162384225; -.
DR   eggNOG; KOG3836; Eukaryota.
DR   eggNOG; ENOG410XQ9Z; LUCA.
DR   GeneTree; ENSGT00390000014051; -.
DR   HOGENOM; HOG000092311; -.
DR   HOVERGEN; HBG005108; -.
DR   InParanoid; Q9UH73; -.
DR   KO; K09103; -.
DR   OMA; HAATPCI; -.
DR   OrthoDB; EOG091G0A9D; -.
DR   PhylomeDB; Q9UH73; -.
DR   TreeFam; TF313391; -.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   SIGNOR; Q9UH73; -.
DR   ChiTaRS; EBF1; human.
DR   EvolutionaryTrace; Q9UH73; -.
DR   GeneWiki; EBF1; -.
DR   GenomeRNAi; 1879; -.
DR   PRO; PR:Q9UH73; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164330; -.
DR   CleanEx; HS_EBF1; -.
DR   ExpressionAtlas; Q9UH73; baseline and differential.
DR   Genevisible; Q9UH73; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0070742; F:C2H2 zinc finger domain binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd01175; IPT_COE; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 4.10.280.10; -; 2.
DR   InterPro; IPR032200; COE_DBD.
DR   InterPro; IPR032201; COE_HLH.
DR   InterPro; IPR038006; COE_IPT.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR003523; Transcription_factor_COE.
DR   InterPro; IPR018350; Transcription_factor_COE_CS.
DR   PANTHER; PTHR10747; PTHR10747; 1.
DR   Pfam; PF16422; COE1_DBD; 1.
DR   Pfam; PF16423; COE1_HLH; 1.
DR   Pfam; PF01833; TIG; 1.
DR   SMART; SM00429; IPT; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS01345; COE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Complete proteome; Developmental protein; DNA-binding;
KW   Isopeptide bond; Metal-binding; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    591       Transcription factor COE1.
FT                                /FTId=PRO_0000107825.
FT   DOMAIN      262    345       IPT/TIG.
FT   ZN_FING     151    170       C5-type. {ECO:0000255}.
FT   REGION       63     66       Interaction with DNA. {ECO:0000250}.
FT   REGION      197    204       Interaction with DNA. {ECO:0000250}.
FT   REGION      236    239       Interaction with DNA. {ECO:0000250}.
FT   COMPBIAS    462    550       Pro/Ser/Thr-rich.
FT   SITE        163    163       Interaction with DNA. {ECO:0000250}.
FT   SITE        172    172       Interaction with DNA. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   CROSSLNK     16     16       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK     16     16       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     162    184       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012304.
FT   VAR_SEQ     252    259       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012305.
FT   CONFLICT    112    112       L -> I (in Ref. 2; AAF19643).
FT                                {ECO:0000305}.
FT   CONFLICT    147    147       N -> S (in Ref. 2; AAF19643).
FT                                {ECO:0000305}.
FT   CONFLICT    228    229       VS -> AP (in Ref. 2; AAF19643).
FT                                {ECO:0000305}.
FT   CONFLICT    305    306       IT -> TG (in Ref. 2; AAF19643).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       A -> S (in Ref. 2; AAF19643).
FT                                {ECO:0000305}.
FT   CONFLICT    347    347       L -> R (in Ref. 2; AAF19643).
FT                                {ECO:0000305}.
FT   HELIX        25     31       {ECO:0000244|PDB:3LYR}.
FT   STRAND       36     38       {ECO:0000244|PDB:3LYR}.
FT   HELIX        39     43       {ECO:0000244|PDB:3LYR}.
FT   TURN         44     46       {ECO:0000244|PDB:3LYR}.
FT   STRAND       49     56       {ECO:0000244|PDB:3LYR}.
FT   STRAND       60     63       {ECO:0000244|PDB:3LYR}.
FT   STRAND       66     76       {ECO:0000244|PDB:3LYR}.
FT   STRAND       83     93       {ECO:0000244|PDB:3LYR}.
FT   HELIX        95     97       {ECO:0000244|PDB:3LYR}.
FT   HELIX        99    101       {ECO:0000244|PDB:3LYR}.
FT   STRAND      108    115       {ECO:0000244|PDB:3LYR}.
FT   STRAND      121    132       {ECO:0000244|PDB:3LYR}.
FT   TURN        133    135       {ECO:0000244|PDB:3LYR}.
FT   STRAND      152    155       {ECO:0000244|PDB:3LYR}.
FT   HELIX       158    160       {ECO:0000244|PDB:3LYR}.
FT   HELIX       162    165       {ECO:0000244|PDB:3LYR}.
FT   TURN        171    175       {ECO:0000244|PDB:3LYR}.
FT   STRAND      181    183       {ECO:0000244|PDB:3LYR}.
FT   TURN        184    186       {ECO:0000244|PDB:3LYR}.
FT   STRAND      187    194       {ECO:0000244|PDB:3LYR}.
FT   STRAND      211    219       {ECO:0000244|PDB:3LYR}.
FT   STRAND      223    228       {ECO:0000244|PDB:3LYR}.
FT   STRAND      232    235       {ECO:0000244|PDB:3LYR}.
FT   STRAND      263    268       {ECO:0000244|PDB:3MQI}.
FT   STRAND      271    273       {ECO:0000244|PDB:3MQI}.
FT   STRAND      279    286       {ECO:0000244|PDB:3MQI}.
FT   STRAND      292    295       {ECO:0000244|PDB:3MQI}.
FT   STRAND      298    300       {ECO:0000244|PDB:3MQI}.
FT   STRAND      302    306       {ECO:0000244|PDB:3MQI}.
FT   STRAND      309    313       {ECO:0000244|PDB:3MQI}.
FT   STRAND      321    329       {ECO:0000244|PDB:3MQI}.
FT   STRAND      340    345       {ECO:0000244|PDB:3MQI}.
SQ   SEQUENCE   591 AA;  64464 MW;  E47797B6FC1E5071 CRC64;
     MFGIQESIQR SGSSMKEEPL GSGMNAVRTW MQGAGVLDAN TAAQSGVGLA RAHFEKQPPS
     NLRKSNFFHF VLALYDRQGQ PVEIERTAFV GFVEKEKEAN SEKTNNGIHY RLQLLYSNGI
     RTEQDFYVRL IDSMTKQAIV YEGQDKNPEM CRVLLTHEIM CSRCCDKKSC GNRNETPSDP
     VIIDRFFLKF FLKCNQNCLK NAGNPRDMRR FQVVVSTTVN VDGHVLAVSD NMFVHNNSKH
     GRRARRLDPS EGTPSYLEHA TPCIKAISPS EGWTTGGATV IIIGDNFFDG LQVIFGTMLV
     WSELITPHAI RVQTPPRHIP GVVEVTLSYK SKQFCKGTPG RFIYTALNEP TIDYGFQRLQ
     KVIPRHPGDP ERLPKEVILK RAADLVEALY GMPHNNQEII LKRAADIAEA LYSVPRNHNQ
     LPALANTSVH AGMMGVNSFS GQLAVNVSEA SQATNQGFTR NSSSVSPHGY VPSTTPQQTN
     YNSVTTSMNG YGSAAMSNLG GSPTFLNGSA ANSPYAIVPS SPTMASSTSL PSNCSSSSGI
     FSFSPANMVS AVKQKSAFAP VVRPQTSPPP TCTSTNGNSL QAISGMIVPP M
//
ID   EIF3E_HUMAN             Reviewed;         445 AA.
AC   P60228; O43902; Q64058; Q64059; Q64252; Q6FG33; Q8WVK4;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 1.
DT   28-FEB-2018, entry version 160.
DE   RecName: Full=Eukaryotic translation initiation factor 3 subunit E {ECO:0000255|HAMAP-Rule:MF_03004};
DE            Short=eIF3e {ECO:0000255|HAMAP-Rule:MF_03004};
DE   AltName: Full=Eukaryotic translation initiation factor 3 subunit 6 {ECO:0000255|HAMAP-Rule:MF_03004};
DE   AltName: Full=Viral integration site protein INT-6 homolog;
DE   AltName: Full=eIF-3 p48 {ECO:0000255|HAMAP-Rule:MF_03004};
GN   Name=EIF3E {ECO:0000255|HAMAP-Rule:MF_03004};
GN   Synonyms=EIF3S6 {ECO:0000255|HAMAP-Rule:MF_03004},
GN   INT6 {ECO:0000255|HAMAP-Rule:MF_03004};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 280-289 AND 427-436,
RP   INTERACTION WITH EIF3A, IDENTIFICATION IN THE EIF-3 COMPLEX, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=9295280; DOI=10.1074/jbc.272.38.23477;
RA   Asano K., Merrick W.C., Hershey J.W.B.;
RT   "The translation initiation factor eIF3-p48 subunit is encoded by int-
RT   6, a site of frequent integration by the mouse mammary tumor virus
RT   genome.";
RL   J. Biol. Chem. 272:23477-23480(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Lung;
RX   PubMed=9403073; DOI=10.1006/geno.1997.4996;
RA   Miyazaki S., Imatani A., Ballard L., Marchetti A., Buttitta F.,
RA   Albertsen H., Nevanlinna H.A., Gallahan D., Callahan R.;
RT   "The chromosome location of the human homolog of the mouse mammary
RT   tumor-associated gene INT6 and its status in human breast
RT   carcinomas.";
RL   Genomics 46:155-158(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH TAX-1, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=8688078; DOI=10.1126/science.273.5277.951;
RA   Desbois C., Rousset R., Bantignies F., Jalinot P.;
RT   "Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I
RT   Tax oncoprotein.";
RL   Science 273:951-953(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH TAX-1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12386384; DOI=10.1007/BF02253422;
RA   Neuvert C., Jin D.-Y., Semmes O.J., Diella F., Callahan R.,
RA   Jeang K.-T.;
RT   "Divergent subcellular locations of HTLV-I Tax and Int-6: a contrast
RT   between in vitro protein-protein binding and intracellular protein
RT   colocalization.";
RL   J. Biomed. Sci. 4:229-234(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-185.
RC   TISSUE=Bone marrow, Brain, Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-9; 60-71; 164-172; 256-265 AND 370-376, CLEAVAGE
RP   OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Mammary carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E., Matallanas D., Cooper W.N.,
RA   Kolch W.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [9]
RP   INTERACTION WITH EIF3C AND TRIM27, AND SUBCELLULAR LOCATION.
RX   PubMed=10504338;
RA   Morris-Desbois C., Bochard V., Reynaud C., Jalinot P.;
RT   "Interaction between the Ret finger protein and the Int-6 gene product
RT   and co-localisation into nuclear bodies.";
RL   J. Cell Sci. 112:3331-3342(1999).
RN   [10]
RP   INTERACTION WITH EIF3B.
RX   PubMed=11457827; DOI=10.1074/jbc.M102161200;
RA   Shalev A., Valasek L., Pise-Masison C.A., Radonovich M., Phan L.,
RA   Clayton J., He H., Brady J.N., Hinnebusch A.G., Asano K.;
RT   "Saccharomyces cerevisiae protein Pci8p and human protein eIF3e/Int-6
RT   interact with the eIF3 core complex by binding to cognate eIF3b
RT   subunits.";
RL   J. Biol. Chem. 276:34948-34957(2001).
RN   [11]
RP   INTERACTION WITH EIF3L.
RX   PubMed=11590142; DOI=10.1074/jbc.M104966200;
RA   Morris-Desbois C., Rety S., Ferro M., Garin J., Jalinot P.;
RT   "The human protein HSPC021 interacts with Int-6 and is associated with
RT   eukaryotic translation initiation factor 3.";
RL   J. Biol. Chem. 276:45988-45995(2001).
RN   [12]
RP   INTERACTION WITH COPS3; COPS6; COPS7 AND PSMC6.
RX   PubMed=12220626; DOI=10.1016/S0014-5793(02)03147-2;
RA   Hoareau Alves K., Bochard V., Rety S., Jalinot P.;
RT   "Association of the mammalian proto-oncoprotein Int-6 with the three
RT   protein complexes eIF3, COP9 signalosome and 26S proteasome.";
RL   FEBS Lett. 527:15-21(2002).
RN   [13]
RP   CHARACTERIZATION OF THE EIF-3 COMPLEX.
RX   PubMed=15703437; DOI=10.1261/rna.7215305;
RA   Kolupaeva V.G., Unbehaun A., Lomakin I.B., Hellen C.U.T.,
RA   Pestova T.V.;
RT   "Binding of eukaryotic initiation factor 3 to ribosomal 40S subunits
RT   and its role in ribosomal dissociation and anti-association.";
RL   RNA 11:470-486(2005).
RN   [14]
RP   INTERACTION WITH IFIT1.
RX   PubMed=16023166; DOI=10.1016/j.virol.2005.06.011;
RA   Terenzi F., Pal S., Sen G.C.;
RT   "Induction and mode of action of the viral stress-inducible murine
RT   proteins, P56 and P54.";
RL   Virology 340:116-124(2005).
RN   [15]
RP   INTERACTION WITH EIF4G1, IDENTIFICATION IN THE EIF-3 COMPLEX, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16766523; DOI=10.1074/jbc.M605418200;
RA   LeFebvre A.K., Korneeva N.L., Trutschl M., Cvek U., Duzan R.D.,
RA   Bradley C.A., Hershey J.W.B., Rhoads R.E.;
RT   "Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e
RT   subunit.";
RL   J. Biol. Chem. 281:22917-22932(2006).
RN   [16]
RP   INTERACTION WITH IFIT2.
RX   PubMed=16973618; DOI=10.1074/jbc.M605771200;
RA   Terenzi F., Hui D.J., Merrick W.C., Sen G.C.;
RT   "Distinct induction patterns and functions of two closely related
RT   interferon-inducible human genes, ISG54 and ISG56.";
RL   J. Biol. Chem. 281:34064-34071(2006).
RN   [17]
RP   FUNCTION, AND CHARACTERIZATION OF THE EIF-3 COMPLEX.
RX   PubMed=17581632; DOI=10.1038/sj.emboj.7601765;
RA   Masutani M., Sonenberg N., Yokoyama S., Imataka H.;
RT   "Reconstitution reveals the functional core of mammalian eIF3.";
RL   EMBO J. 26:3373-3383(2007).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH EIF3A; EIF3B; EIF3C; EIF4G1; NCBP1 AND
RP   UPF2.
RX   PubMed=17468741; DOI=10.1038/sj.embor.7400955;
RA   Morris C., Wittmann J., Jaeck H.-M., Jalinot P.;
RT   "Human INT6/eIF3e is required for nonsense-mediated mRNA decay.";
RL   EMBO Rep. 8:596-602(2007).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH EPAS1.
RX   PubMed=17324924; DOI=10.1074/jbc.M700423200;
RA   Chen L., Uchida K., Endler A., Shibasaki F.;
RT   "Mammalian tumor suppressor Int6 specifically targets hypoxia
RT   inducible factor 2 alpha for degradation by hypoxia- and pVHL-
RT   independent regulation.";
RL   J. Biol. Chem. 282:12707-12716(2007).
RN   [20]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-312.
RX   PubMed=17761670; DOI=10.1074/jbc.M706276200;
RA   Sha Z., Yen H.-C.S., Scheel H., Suo J., Hofmann K., Chang E.C.;
RT   "Isolation of the Schizosaccharomyces pombe proteasome subunit Rpn7
RT   and a structure-function study of the proteasome-COP9-initiation
RT   factor domain.";
RL   J. Biol. Chem. 282:32414-32423(2007).
RN   [21]
RP   IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3
RP   COMPLEX, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   MASS SPECTROMETRY.
RX   PubMed=17322308; DOI=10.1074/mcp.M600399-MCP200;
RA   Damoc E., Fraser C.S., Zhou M., Videler H., Mayeur G.L.,
RA   Hershey J.W.B., Doudna J.A., Robinson C.V., Leary J.A.;
RT   "Structural characterization of the human eukaryotic initiation factor
RT   3 protein complex by mass spectrometry.";
RL   Mol. Cell. Proteomics 6:1135-1146(2007).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH MCM7.
RX   PubMed=17310990; DOI=10.1038/sj.onc.1210314;
RA   Buchsbaum S., Morris C., Bochard V., Jalinot P.;
RT   "Human INT6 interacts with MCM7 and regulates its stability during S
RT   phase of the cell cycle.";
RL   Oncogene 26:5132-5144(2007).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [25]
RP   IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3
RP   COMPLEX, MASS SPECTROMETRY, AND INTERACTION WITH EIF3B.
RX   PubMed=18599441; DOI=10.1073/pnas.0801313105;
RA   Zhou M., Sandercock A.M., Fraser C.S., Ridlova G., Stephens E.,
RA   Schenauer M.R., Yokoi-Fong T., Barsky D., Leary J.A., Hershey J.W.B.,
RA   Doudna J.A., Robinson C.V.;
RT   "Mass spectrometry reveals modularity and a complete subunit
RT   interaction map of the eukaryotic translation factor eIF3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:18139-18144(2008).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-442, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [33]
RP   FUNCTION, AND IDENTIFICATION IN THE EIF-3 COMPLEX.
RX   PubMed=25849773; DOI=10.1038/nature14267;
RA   Lee A.S., Kranzusch P.J., Cate J.H.;
RT   "eIF3 targets cell-proliferation messenger RNAs for translational
RT   activation or repression.";
RL   Nature 522:111-114(2015).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [35]
RP   FUNCTION.
RX   PubMed=27462815; DOI=10.1038/nature18954;
RA   Lee A.S., Kranzusch P.J., Doudna J.A., Cate J.H.;
RT   "eIF3d is an mRNA cap-binding protein that is required for specialized
RT   translation initiation.";
RL   Nature 536:96-99(2016).
RN   [36]
RP   3D-STRUCTURE MODELING, AND ELECTRON MICROSCOPY.
RX   PubMed=16322461; DOI=10.1126/science.1118977;
RA   Siridechadilok B., Fraser C.S., Hall R.J., Doudna J.A., Nogales E.;
RT   "Structural roles for human translation factor eIF3 in initiation of
RT   protein synthesis.";
RL   Science 310:1513-1515(2005).
CC   -!- FUNCTION: Component of the eukaryotic translation initiation
CC       factor 3 (eIF-3) complex, which is required for several steps in
CC       the initiation of protein synthesis (PubMed:17581632,
CC       PubMed:25849773, PubMed:27462815). The eIF-3 complex associates
CC       with the 40S ribosome and facilitates the recruitment of eIF-1,
CC       eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-
CC       initiation complex (43S PIC). The eIF-3 complex stimulates mRNA
CC       recruitment to the 43S PIC and scanning of the mRNA for AUG
CC       recognition. The eIF-3 complex is also required for disassembly
CC       and recycling of post-termination ribosomal complexes and
CC       subsequently prevents premature joining of the 40S and 60S
CC       ribosomal subunits prior to initiation (PubMed:17581632). The eIF-
CC       3 complex specifically targets and initiates translation of a
CC       subset of mRNAs involved in cell proliferation, including cell
CC       cycling, differentiation and apoptosis, and uses different modes
CC       of RNA stem-loop binding to exert either translational activation
CC       or repression (PubMed:25849773). Required for nonsense-mediated
CC       mRNA decay (NMD); may act in conjunction with UPF2 to divert mRNAs
CC       from translation to the NMD pathway (PubMed:17468741). May
CC       interact with MCM7 and EPAS1 and regulate the proteasome-mediated
CC       degradation of these proteins (PubMed:17310990, PubMed:17324924).
CC       {ECO:0000255|HAMAP-Rule:MF_03004, ECO:0000269|PubMed:17310990,
CC       ECO:0000269|PubMed:17324924, ECO:0000269|PubMed:17468741,
CC       ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773,
CC       ECO:0000269|PubMed:27462815}.
CC   -!- SUBUNIT: Component of the eukaryotic translation initiation factor
CC       3 (eIF-3) complex, which is composed of 13 subunits: EIF3A, EIF3B,
CC       EIF3C, EIF3D, EIF3E, EIF3F, EIF3G, EIF3H, EIF3I, EIF3J, EIF3K,
CC       EIF3L and EIF3M. The eIF-3 complex appears to include 3 stable
CC       modules: module A is composed of EIF3A, EIF3B, EIF3G and EIF3I;
CC       module B is composed of EIF3F, EIF3H, and EIF3M; and module C is
CC       composed of EIF3C, EIF3D, EIF3E, EIF3K and EIF3L. EIF3C of module
CC       C binds EIF3B of module A and EIF3H of module B, thereby linking
CC       the three modules. EIF3J is a labile subunit that binds to the
CC       eIF-3 complex via EIF3B. The eIF-3 complex interacts with RPS6KB1
CC       under conditions of nutrient depletion. Mitogenic stimulation
CC       leads to binding and activation of a complex composed of MTOR and
CC       RPTOR, leading to phosphorylation and release of RPS6KB1 and
CC       binding of EIF4B to eIF-3. Interacts with COPS3, COPS6, COPS7
CC       (COPS7A or COPS7B), EIF4G1, EPAS1, MCM7, NCBP1, PSMC6, TRIM27 and
CC       UPF2. Interacts with the HTLV-1 protein Tax-1. Interacts with
CC       IFIT1 and IFIT2. {ECO:0000255|HAMAP-Rule:MF_03004,
CC       ECO:0000269|PubMed:10504338, ECO:0000269|PubMed:11457827,
CC       ECO:0000269|PubMed:11590142, ECO:0000269|PubMed:12220626,
CC       ECO:0000269|PubMed:12386384, ECO:0000269|PubMed:16023166,
CC       ECO:0000269|PubMed:16766523, ECO:0000269|PubMed:16973618,
CC       ECO:0000269|PubMed:17310990, ECO:0000269|PubMed:17322308,
CC       ECO:0000269|PubMed:17324924, ECO:0000269|PubMed:17468741,
CC       ECO:0000269|PubMed:18599441, ECO:0000269|PubMed:25849773,
CC       ECO:0000269|PubMed:8688078, ECO:0000269|PubMed:9295280}.
CC   -!- INTERACTION:
CC       Q8IY42:C4orf19; NbExp=3; IntAct=EBI-347740, EBI-10216552;
CC       P55884:EIF3B; NbExp=6; IntAct=EBI-347740, EBI-366696;
CC       Q99613:EIF3C; NbExp=13; IntAct=EBI-347740, EBI-353741;
CC       O15371:EIF3D; NbExp=5; IntAct=EBI-347740, EBI-353818;
CC       Q9UBQ5:EIF3K; NbExp=5; IntAct=EBI-347740, EBI-354344;
CC       Q9Y262:EIF3L; NbExp=6; IntAct=EBI-347740, EBI-373519;
CC       Q99814:EPAS1; NbExp=10; IntAct=EBI-347740, EBI-447470;
CC       Q9Q2G4:ORF (xeno); NbExp=5; IntAct=EBI-347740, EBI-6248094;
CC       Q59EK9:RUNDC3A; NbExp=4; IntAct=EBI-347740, EBI-747225;
CC       P14373:TRIM27; NbExp=7; IntAct=EBI-347740, EBI-719493;
CC       Q8IUH5:ZDHHC17; NbExp=2; IntAct=EBI-347740, EBI-524753;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus, PML body.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at highest
CC       levels in appendix, lymph, pancreas, skeletal muscle, spleen and
CC       thymus. {ECO:0000269|PubMed:8688078, ECO:0000269|PubMed:9295280}.
CC   -!- MASS SPECTROMETRY: Mass=52131.8; Method=Unknown; Range=1-445;
CC       Evidence={ECO:0000269|PubMed:17322308};
CC   -!- MASS SPECTROMETRY: Mass=52133.4; Mass_error=0.2; Method=MALDI;
CC       Range=1-445; Evidence={ECO:0000269|PubMed:18599441};
CC   -!- SIMILARITY: Belongs to the eIF-3 subunit E family.
CC       {ECO:0000255|HAMAP-Rule:MF_03004}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U54562; AAC51760.1; -; mRNA.
DR   EMBL; U94174; AAC51917.1; -; Genomic_DNA.
DR   EMBL; U94162; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94163; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94164; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94165; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94166; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94167; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94168; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94169; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94170; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94171; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94172; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94173; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94175; AAC51919.1; -; mRNA.
DR   EMBL; U62962; AAB58251.1; -; mRNA.
DR   EMBL; U85947; AAB88873.1; -; mRNA.
DR   EMBL; CR542275; CAG47071.1; -; mRNA.
DR   EMBL; CH471060; EAW91918.1; -; Genomic_DNA.
DR   EMBL; BC000734; AAH00734.1; -; mRNA.
DR   EMBL; BC008419; AAH08419.1; -; mRNA.
DR   EMBL; BC016706; AAH16706.1; -; mRNA.
DR   EMBL; BC017887; AAH17887.1; -; mRNA.
DR   EMBL; BC021679; AAH21679.1; -; mRNA.
DR   CCDS; CCDS6308.1; -.
DR   RefSeq; NP_001559.1; NM_001568.2.
DR   UniGene; Hs.405590; -.
DR   PDB; 3J8B; EM; -; E=1-395.
DR   PDB; 3J8C; EM; -; E=1-395.
DR   PDBsum; 3J8B; -.
DR   PDBsum; 3J8C; -.
DR   ProteinModelPortal; P60228; -.
DR   SMR; P60228; -.
DR   BioGrid; 109857; 106.
DR   CORUM; P60228; -.
DR   DIP; DIP-32691N; -.
DR   IntAct; P60228; 56.
DR   MINT; P60228; -.
DR   STRING; 9606.ENSP00000220849; -.
DR   iPTMnet; P60228; -.
DR   PhosphoSitePlus; P60228; -.
DR   SwissPalm; P60228; -.
DR   BioMuta; EIF3E; -.
DR   DMDM; 41019126; -.
DR   EPD; P60228; -.
DR   MaxQB; P60228; -.
DR   PaxDb; P60228; -.
DR   PeptideAtlas; P60228; -.
DR   PRIDE; P60228; -.
DR   DNASU; 3646; -.
DR   Ensembl; ENST00000220849; ENSP00000220849; ENSG00000104408.
DR   GeneID; 3646; -.
DR   KEGG; hsa:3646; -.
DR   UCSC; uc003ymu.4; human.
DR   CTD; 3646; -.
DR   DisGeNET; 3646; -.
DR   EuPathDB; HostDB:ENSG00000104408.9; -.
DR   GeneCards; EIF3E; -.
DR   HGNC; HGNC:3277; EIF3E.
DR   HPA; HPA023973; -.
DR   MIM; 602210; gene.
DR   neXtProt; NX_P60228; -.
DR   OpenTargets; ENSG00000104408; -.
DR   PharmGKB; PA27705; -.
DR   eggNOG; KOG2758; Eukaryota.
DR   eggNOG; ENOG410XQK5; LUCA.
DR   GeneTree; ENSGT00390000002661; -.
DR   HOVERGEN; HBG001097; -.
DR   InParanoid; P60228; -.
DR   KO; K03250; -.
DR   OMA; GFFRTQV; -.
DR   OrthoDB; EOG091G075K; -.
DR   PhylomeDB; P60228; -.
DR   TreeFam; TF101518; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72695; Formation of the ternary complex, and subsequently, the 43S complex.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   ChiTaRS; EIF3E; human.
DR   GeneWiki; EIF3S6; -.
DR   GenomeRNAi; 3646; -.
DR   PRO; PR:P60228; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000104408; -.
DR   CleanEx; HS_EIF3E; -.
DR   ExpressionAtlas; P60228; baseline and differential.
DR   Genevisible; P60228; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005852; C:eukaryotic translation initiation factor 3 complex; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003743; F:translation initiation factor activity; IC:UniProtKB.
DR   GO; GO:0045947; P:negative regulation of translational initiation; NAS:UniProtKB.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB.
DR   GO; GO:1902416; P:positive regulation of mRNA binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0045727; P:positive regulation of translation; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0006446; P:regulation of translational initiation; NAS:UniProtKB.
DR   GO; GO:0006413; P:translational initiation; IDA:UniProtKB.
DR   Gene3D; 1.10.10.10; -; 1.
DR   HAMAP; MF_03004; eIF3e; 1.
DR   InterPro; IPR016650; eIF3e.
DR   InterPro; IPR019010; eIF3e_N.
DR   InterPro; IPR000717; PCI_dom.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR10317; PTHR10317; 1.
DR   Pfam; PF09440; eIF3_N; 1.
DR   Pfam; PF01399; PCI; 1.
DR   PIRSF; PIRSF016255; eIF3e_su6; 1.
DR   SMART; SM01186; eIF3_N; 1.
DR   SMART; SM00088; PINT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS50250; PCI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Initiation factor; Nucleus; Phosphoprotein;
KW   Polymorphism; Protein biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000255|HAMAP-Rule:MF_03004,
FT                                ECO:0000269|PubMed:17322308,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    445       Eukaryotic translation initiation factor
FT                                3 subunit E.
FT                                /FTId=PRO_0000123515.
FT   DOMAIN      221    398       PCI. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01185}.
FT   REGION        4    128       Sufficient for interaction with EPAS1.
FT                                {ECO:0000269|PubMed:17324924}.
FT   REGION        9    195       Sufficient for interaction with TRIM27.
FT                                {ECO:0000269|PubMed:10504338}.
FT   REGION      351    445       Sufficient for interaction with MCM7.
FT                                {ECO:0000269|PubMed:17310990}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000255|HAMAP-Rule:MF_03004,
FT                                ECO:0000269|PubMed:17322308,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES     399    399       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     439    439       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P60229}.
FT   MOD_RES     442    442       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     445    445       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P60229}.
FT   VARIANT     185    185       A -> V (in dbSNP:rs17856554).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_046480.
FT   MUTAGEN     312    312       L->D: Promotes nuclear accumulation.
FT                                {ECO:0000269|PubMed:17761670}.
FT   HELIX         6     12       {ECO:0000244|PDB:3J8B}.
FT   HELIX        16     19       {ECO:0000244|PDB:3J8B}.
FT   HELIX        21     29       {ECO:0000244|PDB:3J8B}.
FT   HELIX        35     45       {ECO:0000244|PDB:3J8B}.
FT   HELIX        51     58       {ECO:0000244|PDB:3J8B}.
FT   HELIX        67     92       {ECO:0000244|PDB:3J8B}.
FT   HELIX       124    140       {ECO:0000244|PDB:3J8B}.
FT   HELIX       144    152       {ECO:0000244|PDB:3J8B}.
FT   HELIX       161    165       {ECO:0000244|PDB:3J8B}.
FT   HELIX       166    179       {ECO:0000244|PDB:3J8B}.
FT   HELIX       182    194       {ECO:0000244|PDB:3J8B}.
FT   STRAND      200    202       {ECO:0000244|PDB:3J8B}.
FT   HELIX       205    218       {ECO:0000244|PDB:3J8B}.
FT   HELIX       232    236       {ECO:0000244|PDB:3J8B}.
FT   STRAND      246    248       {ECO:0000244|PDB:3J8B}.
FT   HELIX       250    262       {ECO:0000244|PDB:3J8B}.
FT   TURN        265    267       {ECO:0000244|PDB:3J8B}.
FT   HELIX       270    273       {ECO:0000244|PDB:3J8B}.
FT   HELIX       274    278       {ECO:0000244|PDB:3J8B}.
FT   HELIX       281    289       {ECO:0000244|PDB:3J8B}.
FT   HELIX       291    301       {ECO:0000244|PDB:3J8B}.
FT   HELIX       305    319       {ECO:0000244|PDB:3J8B}.
FT   TURN        323    325       {ECO:0000244|PDB:3J8B}.
FT   HELIX       326    328       {ECO:0000244|PDB:3J8B}.
FT   HELIX       329    347       {ECO:0000244|PDB:3J8B}.
FT   STRAND      349    352       {ECO:0000244|PDB:3J8B}.
FT   HELIX       353    359       {ECO:0000244|PDB:3J8B}.
FT   STRAND      360    362       {ECO:0000244|PDB:3J8B}.
FT   HELIX       364    376       {ECO:0000244|PDB:3J8B}.
FT   TURN        386    389       {ECO:0000244|PDB:3J8B}.
FT   STRAND      390    392       {ECO:0000244|PDB:3J8B}.
SQ   SEQUENCE   445 AA;  52221 MW;  A5368651DD0DDD0C CRC64;
     MAEYDLTTRI AHFLDRHLVF PLLEFLSVKE IYNEKELLQG KLDLLSDTNM VDFAMDVYKN
     LYSDDIPHAL REKRTTVVAQ LKQLQAETEP IVKMFEDPET TRQMQSTRDG RMLFDYLADK
     HGFRQEYLDT LYRYAKFQYE CGNYSGAAEY LYFFRVLVPA TDRNALSSLW GKLASEILMQ
     NWDAAMEDLT RLKETIDNNS VSSPLQSLQQ RTWLIHWSLF VFFNHPKGRD NIIDLFLYQP
     QYLNAIQTMC PHILRYLTTA VITNKDVRKR RQVLKDLVKV IQQESYTYKD PITEFVECLY
     VNFDFDGAQK KLRECESVLV NDFFLVACLE DFIENARLFI FETFCRIHQC ISINMLADKL
     NMTPEEAERW IVNLIRNARL DAKIDSKLGH VVMGNNAVSP YQQVIEKTKS LSFRSQMLAM
     NIEKKLNQNS RSEAPNWATQ DSGFY
//
ID   ELL_HUMAN               Reviewed;         621 AA.
AC   P55199;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-FEB-2018, entry version 156.
DE   RecName: Full=RNA polymerase II elongation factor ELL;
DE   AltName: Full=Eleven-nineteen lysine-rich leukemia protein;
GN   Name=ELL; Synonyms=C19orf17;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=7991593; DOI=10.1073/pnas.91.25.12110;
RA   Thirman M.J., Levitan D.A., Kobayashi H., Simon M.C., Rowley J.D.;
RT   "Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in
RT   acute myeloid leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:12110-12114(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION IN TRANSCRIPTION ELONGATION.
RX   PubMed=8596958; DOI=10.1126/science.271.5257.1873;
RA   Shilatifard A., Lane W.S., Jackson K.W., Conaway R.C., Conaway J.W.;
RT   "An RNA polymerase II elongation factor encoded by the human ELL
RT   gene.";
RL   Science 271:1873-1876(1996).
RN   [4]
RP   INTERACTION WITH EAF1, AND SUBCELLULAR LOCATION.
RX   PubMed=11418481; DOI=10.1182/blood.V98.1.201;
RA   Simone F., Polak P.E., Kaberlein J.J., Luo R.T., Levitan D.A.,
RA   Thirman M.J.;
RT   "EAF1, a novel ELL-associated factor that is delocalized by expression
RT   of the MLL-ELL fusion protein.";
RL   Blood 98:201-209(2001).
RN   [5]
RP   INTERACTION WITH EAF2, AND SUBCELLULAR LOCATION.
RX   PubMed=12446457; DOI=10.1182/blood-2002-06-1664;
RA   Simone F., Luo R.T., Polak P.E., Kaberlein J.J., Thirman M.J.;
RT   "ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with
RT   alternative ELL binding properties.";
RL   Blood 101:2355-2362(2003).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12686606; DOI=10.1091/mbc.E02-07-0394;
RA   Polak P.E., Simone F., Kaberlein J.J., Luo R.T., Thirman M.J.;
RT   "ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL
RT   leukemia.";
RL   Mol. Biol. Cell 14:1517-1528(2003).
RN   [7]
RP   FUNCTION IN TRANSCRIPTION.
RX   PubMed=16006523; DOI=10.1073/pnas.0503017102;
RA   Kong S.E., Banks C.A., Shilatifard A., Conaway J.W., Conaway R.C.;
RT   "ELL-associated factors 1 and 2 are positive regulators of RNA
RT   polymerase II elongation factor ELL.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:10094-10098(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-561, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20471948; DOI=10.1016/j.molcel.2010.04.013;
RA   He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J.,
RA   Alber T., Zhou Q.;
RT   "HIV-1 Tat and host AFF4 recruit two transcription elongation factors
RT   into a bifunctional complex for coordinated activation of HIV-1
RT   transcription.";
RL   Mol. Cell 38:428-438(2010).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20159561; DOI=10.1016/j.molcel.2010.01.026;
RA   Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S.,
RA   Florens L., Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A.;
RT   "AFF4, a component of the ELL/P-TEFb elongation complex and a shared
RT   subunit of MLL chimeras, can link transcription elongation to
RT   leukemia.";
RL   Mol. Cell 37:429-437(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN THE SEC COMPLEX,
RP   IDENTIFICATION IN THE LEC COMPLEX, AND INTERACTION WITH ICE1 AND ICE2.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L.,
RA   Washburn M.P., Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA
RT   transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [14]
RP   FUNCTION.
RX   PubMed=22252557; DOI=10.1038/ncomms1652;
RA   Byun J.S., Fufa T.D., Wakano C., Fernandez A., Haggerty C.M.,
RA   Sung M.H., Gardner K.;
RT   "ELL facilitates RNA polymerase II pause site entry and release.";
RL   Nat. Commun. 3:633-633(2012).
RN   [15]
RP   REVIEW ON THE SUPER ELONGATION COMPLEX.
RX   PubMed=22895430; DOI=10.1038/nrm3417;
RA   Luo Z., Lin C., Shilatifard A.;
RT   "The super elongation complex (SEC) family in transcriptional
RT   control.";
RL   Nat. Rev. Mol. Cell Biol. 13:543-547(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180 AND SER-309, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN THE LEC COMPLEX, AND
RP   INTERACTION WITH ICE1.
RX   PubMed=23932780; DOI=10.1016/j.molcel.2013.07.003;
RA   Hu D., Smith E.R., Garruss A.S., Mohaghegh N., Varberg J.M., Lin C.,
RA   Jackson J., Gao X., Saraf A., Florens L., Washburn M.P.,
RA   Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex functions at initiation and elongation
RT   phases of snRNA gene transcription.";
RL   Mol. Cell 51:493-505(2013).
RN   [19]
RP   INTERACTION WITH USPL1.
RX   PubMed=24413172; DOI=10.1242/jcs.141788;
RA   Hutten S., Chachami G., Winter U., Melchior F., Lamond A.I.;
RT   "A role for the Cajal-body-associated SUMO isopeptidase USPL1 in snRNA
RT   transcription mediated by RNA polymerase II.";
RL   J. Cell Sci. 127:1065-1078(2014).
RN   [20]
RP   STRUCTURE BY NMR OF 197-297.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the helical domain in human eleven-nineteen
RT   lysine-rich leukemia protein ELL.";
RL   Submitted (MAY-2007) to the PDB data bank.
CC   -!- FUNCTION: Elongation factor component of the super elongation
CC       complex (SEC), a complex required to increase the catalytic rate
CC       of RNA polymerase II transcription by suppressing transient
CC       pausing by the polymerase at multiple sites along the DNA.
CC       Elongation factor component of the little elongation complex
CC       (LEC), a complex required to regulate small nuclear RNA (snRNA)
CC       gene transcription by RNA polymerase II and III (PubMed:22195968,
CC       PubMed:23932780). Specifically required for stimulating the
CC       elongation step of RNA polymerase II- and III-dependent snRNA gene
CC       transcription (PubMed:23932780). ELL also plays an early role
CC       before its assembly into in the SEC complex by stabilizing RNA
CC       polymerase II recruitment/initiation and entry into the pause
CC       site. Required to stabilize the pre-initiation complex and early
CC       elongation. {ECO:0000269|PubMed:16006523,
CC       ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948,
CC       ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:22252557,
CC       ECO:0000269|PubMed:23932780, ECO:0000269|PubMed:8596958}.
CC   -!- SUBUNIT: Component of the super elongation complex (SEC), at least
CC       composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the
CC       P-TEFb complex and ELL (ELL, ELL2 or ELL3). Component of the
CC       little elongation complex (LEC), at least composed of ELL (ELL,
CC       ELL2 or ELL3), ZC3H8, ICE1 and ICE2. Interacts with AFF4; the
CC       interaction is direct. Interacts with EAF1 and EAF2. Interacts
CC       with ICE1 (via N-terminus domain). Interacts with ICE2. Interacts
CC       with USPL1 (PubMed:24413172). {ECO:0000269|PubMed:11418481,
CC       ECO:0000269|PubMed:12446457, ECO:0000269|PubMed:20159561,
CC       ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:22195968,
CC       ECO:0000269|PubMed:23932780, ECO:0000269|PubMed:24413172}.
CC   -!- INTERACTION:
CC       P62136:PPP1CA; NbExp=2; IntAct=EBI-1245868, EBI-357253;
CC       Q96H20:SNF8; NbExp=3; IntAct=EBI-1245868, EBI-747719;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11418481,
CC       ECO:0000269|PubMed:12446457}. Nucleus speckle
CC       {ECO:0000269|PubMed:11418481, ECO:0000269|PubMed:12446457}.
CC       Nucleus, Cajal body {ECO:0000269|PubMed:12686606,
CC       ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23932780}.
CC       Note=Colocalizes with EAF2 to nuclear speckles (PubMed:12446457).
CC       Colocalizes with coilin in subnuclear cajal and histone locus
CC       bodies (PubMed:12686606). Translocates in the LEC complex to cajal
CC       and histone locus bodies at snRNA genes in a ICE1-dependent
CC       manner. Associates to transcriptionally active chromatin at snRNA
CC       genes(PubMed:23932780). {ECO:0000269|PubMed:12446457,
CC       ECO:0000269|PubMed:12686606, ECO:0000269|PubMed:23932780}.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested. Highest
CC       levels found in placenta, skeletal muscle, testis and peripheral
CC       blood leukocytes.
CC   -!- DISEASE: Note=A chromosomal aberration involving ELL is found in
CC       acute leukemias. Translocation t(11;19)(q23;p13.1) with
CC       KMT2A/MLL1. The result is a rogue activator protein.
CC       {ECO:0000269|PubMed:7991593}.
CC   -!- SIMILARITY: Belongs to the ELL/occludin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ELLID10.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U16282; AAA57120.1; -; mRNA.
DR   EMBL; BC049195; AAH49195.1; -; mRNA.
DR   CCDS; CCDS12380.1; -.
DR   PIR; I38880; I38880.
DR   RefSeq; NP_006523.1; NM_006532.3.
DR   UniGene; Hs.515260; -.
DR   PDB; 2DOA; NMR; -; A=200-292.
DR   PDBsum; 2DOA; -.
DR   ProteinModelPortal; P55199; -.
DR   SMR; P55199; -.
DR   BioGrid; 113828; 50.
DR   CORUM; P55199; -.
DR   IntAct; P55199; 29.
DR   MINT; P55199; -.
DR   STRING; 9606.ENSP00000262809; -.
DR   iPTMnet; P55199; -.
DR   PhosphoSitePlus; P55199; -.
DR   BioMuta; ELL; -.
DR   DMDM; 1706635; -.
DR   EPD; P55199; -.
DR   MaxQB; P55199; -.
DR   PaxDb; P55199; -.
DR   PeptideAtlas; P55199; -.
DR   PRIDE; P55199; -.
DR   Ensembl; ENST00000262809; ENSP00000262809; ENSG00000105656.
DR   GeneID; 8178; -.
DR   KEGG; hsa:8178; -.
DR   UCSC; uc002njh.3; human.
DR   CTD; 8178; -.
DR   DisGeNET; 8178; -.
DR   EuPathDB; HostDB:ENSG00000105656.12; -.
DR   GeneCards; ELL; -.
DR   H-InvDB; HIX0038310; -.
DR   HGNC; HGNC:23114; ELL.
DR   HPA; HPA046076; -.
DR   MIM; 600284; gene.
DR   neXtProt; NX_P55199; -.
DR   OpenTargets; ENSG00000105656; -.
DR   PharmGKB; PA134939610; -.
DR   eggNOG; KOG4796; Eukaryota.
DR   eggNOG; ENOG410ZNGU; LUCA.
DR   GeneTree; ENSGT00550000074378; -.
DR   HOGENOM; HOG000112356; -.
DR   HOVERGEN; HBG005578; -.
DR   InParanoid; P55199; -.
DR   KO; K15183; -.
DR   OMA; CIQQYVS; -.
DR   OrthoDB; EOG091G043D; -.
DR   PhylomeDB; P55199; -.
DR   TreeFam; TF326161; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SIGNOR; P55199; -.
DR   ChiTaRS; ELL; human.
DR   EvolutionaryTrace; P55199; -.
DR   GeneWiki; ELL_(gene); -.
DR   GenomeRNAi; 8178; -.
DR   PRO; PR:P55199; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105656; -.
DR   CleanEx; HS_ELL; -.
DR   ExpressionAtlas; P55199; baseline and differential.
DR   Genevisible; P55199; HS.
DR   GO; GO:0015030; C:Cajal body; IDA:UniProtKB.
DR   GO; GO:0035363; C:histone locus body; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0035327; C:transcriptionally active chromatin; IDA:UniProtKB.
DR   GO; GO:0019902; F:phosphatase binding; IDA:UniProtKB.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0032786; P:positive regulation of DNA-templated transcription, elongation; TAS:ProtInc.
DR   GO; GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0045945; P:positive regulation of transcription from RNA polymerase III promoter; IMP:UniProtKB.
DR   GO; GO:0042795; P:snRNA transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0042796; P:snRNA transcription from RNA polymerase III promoter; IMP:UniProtKB.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome.
DR   InterPro; IPR031184; ELL.
DR   InterPro; IPR031176; ELL/occludin.
DR   InterPro; IPR019464; ELL_N.
DR   InterPro; IPR010844; Occludin_ELL.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR23288; PTHR23288; 1.
DR   PANTHER; PTHR23288:SF9; PTHR23288:SF9; 1.
DR   Pfam; PF10390; ELL; 1.
DR   Pfam; PF07303; Occludin_ELL; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosomal rearrangement;
KW   Complete proteome; Nucleus; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    621       RNA polymerase II elongation factor ELL.
FT                                /FTId=PRO_0000146733.
FT   MOTIF       445    459       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   SITE         46     46       KMT2A/MLL1 fusion point (in acute myeloid
FT                                leukemia patient).
FT                                {ECO:0000269|PubMed:7991593}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     180    180       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     309    309       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     561    561       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   VARIANT     297    297       S -> N (in dbSNP:rs2303694).
FT                                /FTId=VAR_053072.
FT   VARIANT     387    387       R -> W (in dbSNP:rs35245196).
FT                                /FTId=VAR_053073.
FT   HELIX       207    217       {ECO:0000244|PDB:2DOA}.
FT   HELIX       222    232       {ECO:0000244|PDB:2DOA}.
FT   HELIX       236    248       {ECO:0000244|PDB:2DOA}.
FT   STRAND      249    252       {ECO:0000244|PDB:2DOA}.
FT   STRAND      254    256       {ECO:0000244|PDB:2DOA}.
FT   STRAND      258    260       {ECO:0000244|PDB:2DOA}.
FT   HELIX       265    268       {ECO:0000244|PDB:2DOA}.
FT   HELIX       279    291       {ECO:0000244|PDB:2DOA}.
SQ   SEQUENCE   621 AA;  68265 MW;  EB4A3F94CA8A411F CRC64;
     MAALKEDRSY GLSCGRVSDG SKVSVFHVKL TDSALRAFES YRARQDSVSL RPSIRFQGSQ
     GHISIPQPDC PAEARTFSFY LSNIGRDNPQ GSFDCIQQYV SSHGEVHLDC LGSIQDKITV
     CATDDSYQKA RQSMAQAEEE TRSRSAIVIK AGGRYLGKKV QFRKPAPGAT DAVPSRKRAT
     PINLASAIRK SGASAVSGGS GVSQRPFRDR VLHLLALRPY RKAELLLRLQ KDGLTQADKD
     ALDGLLQQVA NMSAKDGTCT LQDCMYKDVQ KDWPGYSEGD QQLLKRVLVR KLCQPQSTGS
     LLGDPAASSP PGERGRSASP PQKRLQPPDF IDPLANKKPR ISHFTQRAQP AVNGKLGVPN
     GREALLPTPG PPASTDTLSS STHLPPRLEP PRAHDPLADV SNDLGHSGRD CEHGEAAAPA
     PTVRLGLPLL TDCAQPSRPH GSPSRSKPKK KSKKHKDKER AAEDKPRAQL PDCAPATHAT
     PGAPADTPGL NGTCSVSSVP TSTSETPDYL LKYAAISSSE QRQSYKNDFN AEYSEYRDLH
     ARIERITRRF TQLDAQLRQL SQGSEEYETT RGQILQEYRK IKKTNTNYSQ EKHRCEYLHS
     KLAHIKRLIA EYDQRQLQAW P
//
ID   U3KQ90_HUMAN            Unreviewed;       488 AA.
AC   U3KQ90;
DT   13-NOV-2013, integrated into UniProtKB/TrEMBL.
DT   19-FEB-2014, sequence version 2.
DT   28-FEB-2018, entry version 37.
DE   SubName: Full=RNA polymerase II elongation factor ELL {ECO:0000313|Ensembl:ENSP00000475648};
GN   Name=ELL {ECO:0000313|Ensembl:ENSP00000475648};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000475648, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000475648, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y.,
RA   Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000475648}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2013) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000475648}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC010335; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_016882824.1; XM_017027335.1.
DR   UniGene; Hs.515260; -.
DR   ProteinModelPortal; U3KQ90; -.
DR   PeptideAtlas; U3KQ90; -.
DR   PRIDE; U3KQ90; -.
DR   Ensembl; ENST00000596124; ENSP00000475648; ENSG00000105656.
DR   GeneID; 8178; -.
DR   UCSC; uc002njg.4; human.
DR   CTD; 8178; -.
DR   EuPathDB; HostDB:ENSG00000105656.12; -.
DR   HGNC; HGNC:23114; ELL.
DR   OpenTargets; ENSG00000105656; -.
DR   eggNOG; KOG4796; Eukaryota.
DR   eggNOG; ENOG410ZNGU; LUCA.
DR   GeneTree; ENSGT00550000074378; -.
DR   ChiTaRS; ELL; human.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105656; -.
DR   ExpressionAtlas; U3KQ90; baseline and differential.
DR   GO; GO:0008023; C:transcription elongation factor complex; IEA:InterPro.
DR   GO; GO:0042795; P:snRNA transcription from RNA polymerase II promoter; IEA:InterPro.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; IEA:InterPro.
DR   InterPro; IPR031184; ELL.
DR   InterPro; IPR031176; ELL/occludin.
DR   InterPro; IPR019464; ELL_N.
DR   InterPro; IPR010844; Occludin_ELL.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR23288; PTHR23288; 1.
DR   PANTHER; PTHR23288:SF9; PTHR23288:SF9; 1.
DR   Pfam; PF10390; ELL; 1.
DR   Pfam; PF07303; Occludin_ELL; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:U3KQ90,
KW   ECO:0000213|MaxQB:U3KQ90, ECO:0000213|PeptideAtlas:U3KQ90};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        1    159       ELL. {ECO:0000259|Pfam:PF10390}.
FT   DOMAIN      380    481       Occludin_ELL. {ECO:0000259|Pfam:PF07303}.
SQ   SEQUENCE   488 AA;  53600 MW;  4EC28927F531E6E6 CRC64;
     MAQAEEETRS RSAIVIKAGG RYLGKKVQFR KPAPGATDAV PSRKRATPIN LASAIRKSGA
     SAVSGGSGVS QRPFRDRVLH LLALRPYRKA ELLLRLQKDG LTQADKDALD GLLQQVANMS
     AKDGTCTLQD CMYKDVQKDW PGYSEGDQQL LKRVLVRKLC QPQSTGSLLG DPAASSPPGE
     RGRSASPPQK RLQPPDFIDP LANKKPRISH FTQRAQPAVN GKLGVPNGRE ALLPTPGPPA
     STDTLSSSTH LPPRLEPPRA HDPLADVSND LGHSGRDCEH GEAAAPAPTV RLGLPLLTDC
     AQPSRPHGSP SRSKPKKKSK KHKDKERAAE DKPRAQLPDC APATHATPGA PADTPGLNGT
     CSVSSVPTST SETPDYLLKY AAISSSEQRQ SYKNDFNAEY SEYRDLHARI ERITRRFTQL
     DAQLRQLSQG SEEYETTRGQ ILQEYRKIKK TNTNYSQEKH RCEYLHSKLA HIKRLIAEYD
     QRQLQAWP
//
ID   EP300_HUMAN             Reviewed;        2414 AA.
AC   Q09472; B1AKC2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   28-FEB-2018, entry version 228.
DE   RecName: Full=Histone acetyltransferase p300;
DE            Short=p300 HAT;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:23415232, ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:8945521};
DE   AltName: Full=E1A-associated protein p300;
DE   AltName: Full=Histone butyryltransferase p300;
DE            EC=2.3.1.- {ECO:0000269|PubMed:17267393};
DE   AltName: Full=Histone crotonyltransferase p300;
DE            EC=2.3.1.- {ECO:0000269|PubMed:25818647};
DE   AltName: Full=Protein propionyltransferase p300;
DE            EC=2.3.1.- {ECO:0000269|PubMed:17267393};
GN   Name=EP300; Synonyms=P300;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PRO-2223.
RX   PubMed=7523245; DOI=10.1101/gad.8.8.869;
RA   Eckner R., Ewen M.E., Newsome D., Gerdes M., Decaprio J.A.,
RA   Lawrence J.B., Livingston D.M.;
RT   "Molecular cloning and functional analysis of the adenovirus E1A-
RT   associated 300-kD protein (p300) reveals a protein with properties of
RT   a transcriptional adaptor.";
RL   Genes Dev. 8:869-884(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 27-42, AND CHROMOSOMAL TRANSLOCATION
RP   WITH KAT6A.
RX   PubMed=10824998;
RX   DOI=10.1002/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO;2-2;
RA   Chaffanet M., Gressin L., Preudhomme C., Soenen-Cornu V., Birnbaum D.,
RA   Pebusque M.-J.;
RT   "MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).";
RL   Genes Chromosomes Cancer 28:138-144(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 552-660.
RX   PubMed=7870179; DOI=10.1038/374085a0;
RA   Lundblad J.R., Kwok R.P.S., Laurance M.E., Harter M.L., Goodman R.H.;
RT   "Adenoviral E1A-associated protein p300 as a functional homologue of
RT   the transcriptional co-activator CBP.";
RL   Nature 374:85-88(1995).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE, INTERACTION WITH CARM1, METHYLATION AT
RP   ARG-580 AND ARG-604, AND FUNCTION.
RX   PubMed=11701890; DOI=10.1126/science.1065961;
RA   Xu W., Chen H., Du K., Asahara H., Tini M., Emerson B.M., Montminy M.,
RA   Evans R.M.;
RT   "A transcriptional switch mediated by cofactor methylation.";
RL   Science 294:2507-2511(2001).
RN   [7]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=8945521; DOI=10.1016/S0092-8674(00)82001-2;
RA   Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y.;
RT   "The transcriptional coactivators p300 and CBP are histone
RT   acetyltransferases.";
RL   Cell 87:953-959(1996).
RN   [8]
RP   INTERACTION WITH PCAF.
RX   PubMed=8684459; DOI=10.1038/382319a0;
RA   Yang X.-J., Ogryzko V.V., Nishikawa J., Howard B.H., Nakatani Y.;
RT   "A p300/CBP-associated factor that competes with the adenoviral
RT   oncoprotein E1A.";
RL   Nature 382:319-324(1996).
RN   [9]
RP   INTERACTION WITH HIF1A AND CREBBP.
RX   PubMed=8917528; DOI=10.1073/pnas.93.23.12969;
RA   Arany Z., Huang L.E., Eckner R., Bhattacharya S., Jiang C.,
RA   Goldberg M.A., Bunn H.F., Livingston D.M.;
RT   "An essential role for p300/CBP in the cellular response to hypoxia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:12969-12973(1996).
RN   [10]
RP   INTERACTION WITH HTLV-1 TAX.
RX   PubMed=9528808; DOI=10.1128/MCB.18.4.2392;
RA   Bex F., Yin M.-J., Burny A., Gaynor R.B.;
RT   "Differential transcriptional activation by human T-cell leukemia
RT   virus type 1 Tax mutants is mediated by distinct interactions with
RT   CREB binding protein and p300.";
RL   Mol. Cell. Biol. 18:2392-2405(1998).
RN   [11]
RP   INTERACTION WITH NR3C1.
RX   PubMed=9590696; DOI=10.1038/30032;
RA   Fryer C.J., Archer T.K.;
RT   "Chromatin remodelling by the glucocorticoid receptor requires the
RT   BRG1 complex.";
RL   Nature 393:88-91(1998).
RN   [12]
RP   INTERACTION WITH HIV-1 TAT, AND FUNCTION (MICROBIAL INFECTION).
RX   PubMed=10545121; DOI=10.1093/emboj/18.21.6106;
RA   Kiernan R.E., Vanhulle C., Schiltz L., Adam E., Xiao H., Maudoux F.,
RA   Calomme C., Burny A., Nakatani Y., Jeang K.-T., Benkirane M.,
RA   Van Lint C.;
RT   "HIV-1 tat transcriptional activity is regulated by acetylation.";
RL   EMBO J. 18:6106-6118(1999).
RN   [13]
RP   INTERACTION WITH CITED2 AND HIF1A, AND MUTAGENESIS OF 371-THR--LEU-376
RP   AND 413-VAL--LYS-418.
RX   PubMed=9887100; DOI=10.1101/gad.13.1.64;
RA   Bhattacharya S., Michels C.M., Leung M.K., Arany Z.P., Kung A.L.,
RA   Livingston D.M.;
RT   "Functional role of p35srj, a novel p300/CBP binding protein, during
RT   transactivation by HIF-1.";
RL   Genes Dev. 13:64-75(1999).
RN   [14]
RP   INTERACTION WITH RORA.
RX   PubMed=9862959; DOI=10.1093/nar/27.2.411;
RA   Lau P., Bailey P., Dowhan D.H., Muscat G.E.;
RT   "Exogenous expression of a dominant negative RORalpha1 vector in
RT   muscle cells impairs differentiation: RORalpha1 directly interacts
RT   with p300 and myoD.";
RL   Nucleic Acids Res. 27:411-420(1999).
RN   [15]
RP   INTERACTION WITH CITED1.
RX   PubMed=10722728; DOI=10.1074/jbc.275.12.8825;
RA   Yahata T., de Caestecker M.P., Lechleider R.J., Andriole S.,
RA   Roberts A.B., Isselbacher K.J., Shioda T.;
RT   "The MSG1 non-DNA-binding transactivator binds to the p300/CBP
RT   coactivators, enhancing their functional link to the Smad
RT   transcription factors.";
RL   J. Biol. Chem. 275:8825-8834(2000).
RN   [16]
RP   FUNCTION IN TRANSCRIPTIONAL REPRESSION.
RX   PubMed=10733570; DOI=10.1128/MCB.20.8.2676-2686.2000;
RA   Snowden A.W., Anderson L.A., Webster G.A., Perkins N.D.;
RT   "A novel transcriptional repression domain mediates p21(WAF1/CIP1)
RT   induction of p300 transactivation.";
RL   Mol. Cell. Biol. 20:2676-2686(2000).
RN   [17]
RP   ERRATUM.
RA   Snowden A.W., Anderson L.A., Webster G.A., Perkins N.D.;
RL   Mol. Cell. Biol. 20:5360-5360(2000).
RN   [18]
RP   INTERACTION WITH EID1.
RX   PubMed=11073989; DOI=10.1128/MCB.20.23.8889-8902.2000;
RA   Miyake S., Sellers W.R., Safran M., Li X., Zhao W., Grossman S.R.,
RA   Gan J., DeCaprio J.A., Adams P.D., Kaelin W.G. Jr.;
RT   "Cells degrade a novel inhibitor of differentiation with E1A-like
RT   properties upon exiting the cell cycle.";
RL   Mol. Cell. Biol. 20:8889-8902(2000).
RN   [19]
RP   INTERACTION WITH EID1.
RX   PubMed=11073990; DOI=10.1128/MCB.20.23.8903-8915.2000;
RA   MacLellan W.R., Xiao G., Abdellatif M., Schneider M.D.;
RT   "A novel Rb- and p300-binding protein inhibits transactivation by
RT   MyoD.";
RL   Mol. Cell. Biol. 20:8903-8915(2000).
RN   [20]
RP   INTERACTION WITH NCOA6.
RX   PubMed=10823961; DOI=10.1073/pnas.97.11.6212;
RA   Ko L., Cardona G.R., Chin W.W.;
RT   "Thyroid hormone receptor-binding protein, an LXXLL motif-containing
RT   protein, functions as a general coactivator.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:6212-6217(2000).
RN   [21]
RP   INTERACTION WITH HIV-1 TAT, AND FUNCTION (MICROBIAL INFECTION).
RX   PubMed=11080476; DOI=10.1006/viro.2000.0593;
RA   Deng L., de la Fuente C., Fu P., Wang L., Donnelly R., Wade J.D.,
RA   Lambert P., Li H., Lee C.-G., Kashanchi F.;
RT   "Acetylation of HIV-1 Tat by CBP/P300 increases transcription of
RT   integrated HIV-1 genome and enhances binding to core histones.";
RL   Virology 277:278-295(2000).
RN   [22]
RP   INTERACTION WITH ESR1.
RX   PubMed=11581164; DOI=10.1101/gad.906301;
RA   Yahata T., Shao W., Endoh H., Hur J., Coser K.R., Sun H., Ueda Y.,
RA   Kato S., Isselbacher K.J., Brown M., Shioda T.;
RT   "Selective coactivation of estrogen-dependent transcription by CITED1
RT   CBP/p300-binding protein.";
RL   Genes Dev. 15:2598-2612(2001).
RN   [23]
RP   PHOSPHORYLATION AT SER-89, MUTAGENESIS OF SER-89, AND INTERACTION WITH
RP   PPARG.
RX   PubMed=11518699; DOI=10.1074/jbc.C100316200;
RA   Yang W., Hong Y.H., Shen X.Q., Frankowski C., Camp H.S., Leff T.;
RT   "Regulation of transcription by AMP-activated protein kinase:
RT   phosphorylation of p300 blocks its interaction with nuclear
RT   receptors.";
RL   J. Biol. Chem. 276:38341-38344(2001).
RN   [24]
RP   INTERACTION WITH SRCAP.
RX   PubMed=11581372; DOI=10.1128/JVI.75.21.10033-10040.2001;
RA   Xu X., Chackalaparampil I., Monroy M.A., Cannella M.T., Pesek E.,
RA   Chrivia J., Yaciuk P.;
RT   "Adenovirus DNA binding protein interacts with the SNF2-related CBP
RT   activator protein (SrCap) and inhibits SrCap-mediated transcription.";
RL   J. Virol. 75:10033-10040(2001).
RN   [25]
RP   INTERACTION WITH HTLV-1 TAX.
RX   PubMed=11463834; DOI=10.1128/MCB.21.16.5520-5530.2001;
RA   Scoggin K.E.S., Ulloa A., Nyborg J.K.;
RT   "The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to
RT   mediate transcriptional activation.";
RL   Mol. Cell. Biol. 21:5520-5530(2001).
RN   [26]
RP   INTERACTION WITH HTLV-1 ACCESSORY PROTEIN P30II.
RX   PubMed=11559821; DOI=10.1128/JVI.75.20.9885-9895.2001;
RA   Zhang W., Nisbet J.W., Albrecht B., Ding W., Kashanchi F.,
RA   Bartoe J.T., Lairmore M.D.;
RT   "Human T-lymphotropic virus type 1 p30(II) regulates gene
RT   transcription by binding CREB binding protein/p300.";
RL   J. Virol. 75:9885-9895(2001).
RN   [27]
RP   INTERACTION WITH TRERF1.
RX   PubMed=11349124; DOI=10.1074/jbc.M100113200;
RA   Gizard F., Lavallee B., DeWitte F., Hum D.W.;
RT   "A novel zinc finger protein TReP-132 interacts with CBP/p300 to
RT   regulate human CYP11A1 gene expression.";
RL   J. Biol. Chem. 276:33881-33892(2001).
RN   [28]
RP   INTERACTION WITH PELP1.
RX   PubMed=11481323; DOI=10.1074/jbc.M103783200;
RA   Vadlamudi R.K., Wang R.-A., Mazumdar A., Kim Y.-S., Shin J., Sahin A.,
RA   Kumar R.;
RT   "Molecular cloning and characterization of PELP1, a novel human
RT   coregulator of estrogen receptor alpha.";
RL   J. Biol. Chem. 276:38272-38279(2001).
RN   [29]
RP   INTERACTION WITH DTX1.
RX   PubMed=11564735; DOI=10.1074/jbc.M105245200;
RA   Yamamoto N., Yamamoto S., Inagaki F., Kawaichi M., Fukamizu A.,
RA   Kishi N., Matsuno K., Nakamura K., Weinmaster G., Okano H.,
RA   Nakafuku M.;
RT   "Role of Deltex-1 as a transcriptional regulator downstream of the
RT   Notch receptor.";
RL   J. Biol. Chem. 276:45031-45040(2001).
RN   [30]
RP   FUNCTION, AND INTERACTION WITH FEN1.
RX   PubMed=11430825; DOI=10.1016/S1097-2765(01)00272-6;
RA   Hasan S., Stucki M., Hassa P.O., Imhof R., Gehrig P., Hunziker P.,
RA   Hubscher U., Hottiger M.O.;
RT   "Regulation of human flap endonuclease-1 activity by acetylation
RT   through the transcriptional coactivator p300.";
RL   Mol. Cell 7:1221-1231(2001).
RN   [31]
RP   INTERACTION WITH HADV5 E1A.
RX   PubMed=11433299; DOI=10.1038/35083062;
RA   Chan H.M., Krstic-Demonacos M., Smith L., Demonacos C.,
RA   La Thangue N.B.;
RT   "Acetylation control of the retinoblastoma tumour-suppressor
RT   protein.";
RL   Nat. Cell Biol. 3:667-674(2001).
RN   [32]
RP   INTERACTION WITH SPIB.
RX   PubMed=11864910;
RA   Yamamoto H., Kihara-Negishi F., Yamada T., Suzuki M., Nakano T.,
RA   Oikawa T.;
RT   "Interaction between the hematopoietic Ets transcription factor Spi-B
RT   and the coactivator CREB-binding protein associated with negative
RT   cross-talk with c-Myb.";
RL   Cell Growth Differ. 13:69-75(2002).
RN   [33]
RP   INTERACTION WITH CITED4.
RX   PubMed=11744733; DOI=10.1074/jbc.M110850200;
RA   Braganca J., Swingler T., Marques F.I.R., Jones T., Eloranta J.J.,
RA   Hurst H.C., Shioda T., Bhattacharya S.;
RT   "Human CREB-binding protein/p300-interacting transactivator with ED-
RT   rich tail (CITED) 4, a new member of the CITED family, functions as a
RT   co-activator for transcription factor AP-2.";
RL   J. Biol. Chem. 277:8559-8565(2002).
RN   [34]
RP   INTERACTION WITH HNRNPU.
RX   PubMed=11909954;
RA   Martens J.H., Verlaan M., Kalkhoven E., Dorsman J.C., Zantema A.;
RT   "Scaffold/matrix attachment region elements interact with a p300-
RT   scaffold attachment factor A complex and are bound by acetylated
RT   nucleosomes.";
RL   Mol. Cell. Biol. 22:2598-2606(2002).
RN   [35]
RP   IDENTIFICATION IN A COMPLEX WITH CARM1 AND NCOA2.
RX   PubMed=11997499; DOI=10.1128/MCB.22.11.3621-3632.2002;
RA   Lee Y.-H., Koh S.S., Zhang X., Cheng X., Stallcup M.R.;
RT   "Synergy among nuclear receptor coactivators: selective requirement
RT   for protein methyltransferase and acetyltransferase activities.";
RL   Mol. Cell. Biol. 22:3621-3632(2002).
RN   [36]
RP   FUNCTION IN BCL6 ACETYLATION.
RX   PubMed=12402037; DOI=10.1038/ng1018;
RA   Bereshchenko O.R., Gu W., Dalla-Favera R.;
RT   "Acetylation inactivates the transcriptional repressor BCL6.";
RL   Nat. Genet. 32:606-613(2002).
RN   [37]
RP   INTERACTION WITH ING4 AND ING5.
RX   PubMed=12750254;
RA   Shiseki M., Nagashima M., Pedeux R.M., Kitahama-Shiseki M., Miura K.,
RA   Okamura S., Onogi H., Higashimoto Y., Appella E., Yokota J.,
RA   Harris C.C.;
RT   "p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.";
RL   Cancer Res. 63:2373-2378(2003).
RN   [38]
RP   PHOSPHORYLATION, AND INTERACTION WITH TCF7L2 AND LEF1.
RX   PubMed=12446687; DOI=10.1074/jbc.M210081200;
RA   Hecht A., Stemmler M.P.;
RT   "Identification of a promoter-specific transcriptional activation
RT   domain at the C-terminus of the Wnt effector protein T-cell factor
RT   4.";
RL   J. Biol. Chem. 278:3776-3785(2003).
RN   [39]
RP   FUNCTION, INTERACTION WITH CITED2 AND TFAP2A, AND MUTAGENESIS OF
RP   ASP-1399.
RX   PubMed=12586840; DOI=10.1074/jbc.M208144200;
RA   Braganca J., Eloranta J.J., Bamforth S.D., Ibbitt J.C., Hurst H.C.,
RA   Bhattacharya S.;
RT   "Physical and functional interactions among AP-2 transcription
RT   factors, p300/CREB-binding protein, and CITED2.";
RL   J. Biol. Chem. 278:16021-16029(2003).
RN   [40]
RP   INTERACTION WITH SP3.
RX   PubMed=12837748; DOI=10.1074/jbc.M305961200;
RA   Ammanamanchi S., Freeman J.W., Brattain M.G.;
RT   "Acetylated SP3 is a transcriptional activator.";
RL   J. Biol. Chem. 278:35775-35780(2003).
RN   [41]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH ALX1, AND REGION.
RX   PubMed=12929931; DOI=10.1359/jbmr.2003.18.8.1419;
RA   Iioka T., Furukawa K., Yamaguchi A., Shindo H., Yamashita S.,
RA   Tsukazaki T.;
RT   "P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1),
RT   paired-like homeoprotein, through acetylation of the conserved lysine
RT   residue adjacent to the homeodomain.";
RL   J. Bone Miner. Res. 18:1419-1429(2003).
RN   [42]
RP   INTERACTION WITH SATB1.
RX   PubMed=14605447; DOI=10.1111/j.1348-0421.2003.tb03438.x;
RA   Fujii Y., Kumatori A., Nakamura M.;
RT   "SATB1 makes a complex with p300 and represses gp91(phox) promoter
RT   activity.";
RL   Microbiol. Immunol. 47:803-811(2003).
RN   [43]
RP   SUMOYLATION AT LYS-1020 AND LYS-1024, AND MUTAGENESIS OF LYS-1020 AND
RP   LYS-1024.
RX   PubMed=12718889; DOI=10.1016/S1097-2765(03)00141-2;
RA   Girdwood D., Bumpass D., Vaughan O.A., Thain A., Anderson L.A.,
RA   Snowden A.W., Garcia-Wilson E., Perkins N.D., Hay R.T.;
RT   "P300 transcriptional repression is mediated by SUMO modification.";
RL   Mol. Cell 11:1043-1054(2003).
RN   [44]
RP   INTERACTION WITH DDX5.
RX   PubMed=12527917; DOI=10.1038/sj.onc.1206067;
RA   Rossow K.L., Janknecht R.;
RT   "Synergism between p68 RNA helicase and the transcriptional
RT   coactivators CBP and p300.";
RL   Oncogene 22:151-156(2003).
RN   [45]
RP   INTERACTION WITH TP53, AND FUNCTION.
RX   PubMed=15186775; DOI=10.1016/j.cell.2004.05.009;
RA   An W., Kim J., Roeder R.G.;
RT   "Ordered cooperative functions of PRMT1, p300, and CARM1 in
RT   transcriptional activation by p53.";
RL   Cell 117:735-748(2004).
RN   [46]
RP   INTERACTION WITH SRY.
RX   PubMed=15297880; DOI=10.1038/sj.emboj.7600352;
RA   Thevenet L., Mejean C., Moniot B., Bonneaud N., Galeotti N.,
RA   Aldrian-Herrada G., Poulat F., Berta P., Benkirane M.,
RA   Boizet-Bonhoure B.;
RT   "Regulation of human SRY subcellular distribution by its
RT   acetylation/deacetylation.";
RL   EMBO J. 23:3336-3345(2004).
RN   [47]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NPAS2;
RP   ARNTL/BMAL1 AND CLOCK.
RX   PubMed=14645221; DOI=10.1074/jbc.M311973200;
RA   Curtis A.M., Seo S.B., Westgate E.J., Rudic R.D., Smyth E.M.,
RA   Chakravarti D., FitzGerald G.A., McNamara P.;
RT   "Histone acetyltransferase-dependent chromatin remodeling and the
RT   vascular clock.";
RL   J. Biol. Chem. 279:7091-7097(2004).
RN   [48]
RP   INTERACTION WITH ELF3.
RX   PubMed=15075319; DOI=10.1074/jbc.M401356200;
RA   Wang H., Fang R., Cho J.-Y., Libermann T.A., Oettgen P.;
RT   "Positive and negative modulation of the transcriptional activity of
RT   the ETS factor ESE-1 through interaction with p300, CREB-binding
RT   protein, and Ku 70/86.";
RL   J. Biol. Chem. 279:25241-25250(2004).
RN   [49]
RP   INTERACTION WITH IRF1.
RX   PubMed=15509808; DOI=10.1128/MCB.24.22.10083-10098.2004;
RA   Dornan D., Eckert M., Wallace M., Shimizu H., Ramsay E., Hupp T.R.,
RA   Ball K.L.;
RT   "Interferon regulatory factor 1 binding to p300 stimulates DNA-
RT   dependent acetylation of p53.";
RL   Mol. Cell. Biol. 24:10083-10098(2004).
RN   [50]
RP   ACETYLATION AT LYS-1499; LYS-1549; LYS-1554; LYS-1558 AND LYS-1560.
RX   PubMed=15004546; DOI=10.1038/nsmb740;
RA   Thompson P.R., Wang D., Wang L., Fulco M., Pediconi N., Zhang D.,
RA   An W., Ge Q., Roeder R.G., Wong J., Levrero M., Sartorelli V.,
RA   Cotter R.J., Cole P.A.;
RT   "Regulation of the p300 HAT domain via a novel activation loop.";
RL   Nat. Struct. Mol. Biol. 11:308-315(2004).
RN   [51]
RP   INTERACTION WITH NEUROD1 AND TCF3.
RX   PubMed=14752053; DOI=10.1210/me.2003-0311;
RA   Kim J.Y., Chu K., Kim H.J., Seong H.A., Park K.C., Sanyal S.,
RA   Takeda J., Ha H., Shong M., Tsai M.J., Choi H.S.;
RT   "Orphan nuclear receptor small heterodimer partner, a novel
RT   corepressor for a basic helix-loop-helix transcription factor
RT   BETA2/neuroD.";
RL   Mol. Endocrinol. 18:776-790(2004).
RN   [52]
RP   INTERACTION WITH SS18L1/CREST.
RX   PubMed=14716005; DOI=10.1126/science.1089845;
RA   Aizawa H., Hu S.-C., Bobb K., Balakrishnan K., Ince G., Gurevich I.,
RA   Cowan M., Ghosh A.;
RT   "Dendrite development regulated by CREST, a calcium-regulated
RT   transcriptional activator.";
RL   Science 303:197-202(2004).
RN   [53]
RP   INVOLVEMENT IN RSTS2.
RX   PubMed=15706485; DOI=10.1086/429130;
RA   Roelfsema J.H., White S.J., Ariyuerek Y., Bartholdi D., Niedrist D.,
RA   Papadia F., Bacino C.A., den Dunnen J.T., van Ommen G.-J.B.,
RA   Breuning M.H., Hennekam R.C., Peters D.J.M.;
RT   "Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both
RT   the CBP and EP300 genes cause disease.";
RL   Am. J. Hum. Genet. 76:572-580(2005).
RN   [54]
RP   DEACETYLATION BY SIRT1, ACETYLATION AT LYS-1020 AND LYS-1024, AND
RP   MUTAGENESIS OF LYS-1020 AND LYS-1024.
RX   PubMed=15632193; DOI=10.1074/jbc.M408748200;
RA   Bouras T., Fu M., Sauve A.A., Wang F., Quong A.A., Perkins N.D.,
RA   Hay R.T., Gu W., Pestell R.G.;
RT   "SIRT1 deacetylation and repression of p300 involves lysine residues
RT   1020/1024 within the cell cycle regulatory domain 1.";
RL   J. Biol. Chem. 280:10264-10276(2005).
RN   [55]
RP   INTERACTION WITH FOXO1, FUNCTION, AND MUTAGENESIS OF ASP-1399.
RX   PubMed=15890677; DOI=10.1210/me.2004-0292;
RA   Perrot V., Rechler M.M.;
RT   "The coactivator p300 directly acetylates the forkhead transcription
RT   factor Foxo1 and stimulates Foxo1-induced transcription.";
RL   Mol. Endocrinol. 19:2283-2298(2005).
RN   [56]
RP   METHYLATION AT ARG-2142, CITRULLINATION AT ARG-2142, INTERACTION WITH
RP   NCOA2, AND MUTAGENESIS OF ARG-2056; ARG-2088 AND ARG-2142.
RX   PubMed=15731352; DOI=10.1073/pnas.0407159102;
RA   Lee Y.-H., Coonrod S.A., Kraus W.L., Jelinek M.A., Stallcup M.R.;
RT   "Regulation of coactivator complex assembly and function by protein
RT   arginine methylation and demethylimination.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:3611-3616(2005).
RN   [57]
RP   INTERACTION WITH BCL11B.
RX   PubMed=16809611; DOI=10.1182/blood-2006-05-021790;
RA   Cismasiu V.B., Ghanta S., Duque J., Albu D.I., Chen H.M., Kasturi R.,
RA   Avram D.;
RT   "BCL11B participates in the activation of IL2 gene expression in CD4+
RT   T lymphocytes.";
RL   Blood 108:2695-2702(2006).
RN   [58]
RP   SUBCELLULAR LOCATION, INTERACTION WITH ROCK2, AND PHOSPHORYLATION AT
RP   SER-89.
RX   PubMed=16574662; DOI=10.1074/jbc.M510954200;
RA   Tanaka T., Nishimura D., Wu R.C., Amano M., Iso T., Kedes L.,
RA   Nishida H., Kaibuchi K., Hamamori Y.;
RT   "Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase.";
RL   J. Biol. Chem. 281:15320-15329(2006).
RN   [59]
RP   INTERACTION WITH CITED1.
RX   PubMed=16864582; DOI=10.1074/jbc.M602631200;
RA   Shi G., Boyle S.C., Sparrow D.B., Dunwoodie S.L., Shioda T.,
RA   de Caestecker M.P.;
RT   "The transcriptional activity of CITED1 is regulated by
RT   phosphorylation in a cell cycle-dependent manner.";
RL   J. Biol. Chem. 281:27426-27435(2006).
RN   [60]
RP   ACETYLATION AT LYS-1336 AND LYS-1473, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=17065153; DOI=10.1074/jbc.M608813200;
RA   Karanam B., Jiang L., Wang L., Kelleher N.L., Cole P.A.;
RT   "Kinetic and mass spectrometric analysis of p300 histone
RT   acetyltransferase domain autoacetylation.";
RL   J. Biol. Chem. 281:40292-40301(2006).
RN   [61]
RP   FUNCTION IN ACETYLATION OF HDAC1.
RX   PubMed=16762839; DOI=10.1016/j.molcel.2006.04.019;
RA   Qiu Y., Zhao Y., Becker M., John S., Parekh B.S., Huang S.,
RA   Hendarwanto A., Martinez E.D., Chen Y., Lu H., Adkins N.L.,
RA   Stavreva D.A., Wiench M., Georgel P.T., Schiltz R.L., Hager G.L.;
RT   "HDAC1 acetylation is linked to progressive modulation of steroid
RT   receptor-induced gene transcription.";
RL   Mol. Cell 22:669-679(2006).
RN   [62]
RP   INTERACTION WITH SP1.
RX   PubMed=16478997; DOI=10.1128/MCB.26.5.1770-1785.2006;
RA   Hung J.J., Wang Y.T., Chang W.C.;
RT   "Sp1 deacetylation induced by phorbol ester recruits p300 to activate
RT   12(S)-lipoxygenase gene transcription.";
RL   Mol. Cell. Biol. 26:1770-1785(2006).
RN   [63]
RP   FUNCTION, AND INTERACTION WITH MTA1.
RX   PubMed=16617102; DOI=10.1073/pnas.0601989103;
RA   Gururaj A.E., Singh R.R., Rayala S.K., Holm C., den Hollander P.,
RA   Zhang H., Balasenthil S., Talukder A.H., Landberg G., Kumar R.;
RT   "MTA1, a transcriptional activator of breast cancer amplified sequence
RT   3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:6670-6675(2006).
RN   [64]
RP   ERRATUM.
RA   Gururaj A.E., Singh R.R., Rayala S.K., Holm C., den Hollander P.,
RA   Zhang H., Balasenthil S., Talukder A.H., Landberg G., Kumar R.;
RL   Proc. Natl. Acad. Sci. U.S.A. 110:4147-4148(2013).
RN   [65]
RP   INTERACTION WITH DDIT3.
RX   PubMed=17872950; DOI=10.1074/jbc.M703735200;
RA   Ohoka N., Hattori T., Kitagawa M., Onozaki K., Hayashi H.;
RT   "Critical and functional regulation of CHOP (C/EBP homologous protein)
RT   through the N-terminal portion.";
RL   J. Biol. Chem. 282:35687-35694(2007).
RN   [66]
RP   INTERACTION WITH DDX17.
RX   PubMed=17226766; DOI=10.1002/jcb.21250;
RA   Shin S., Janknecht R.;
RT   "Concerted activation of the Mdm2 promoter by p72 RNA helicase and the
RT   coactivators p300 and P/CAF.";
RL   J. Cell. Biochem. 101:1252-1265(2007).
RN   [67]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=17267393; DOI=10.1074/mcp.M700021-MCP200;
RA   Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C.,
RA   Falck J.R., Peng J., Gu W., Zhao Y.;
RT   "Lysine propionylation and butyrylation are novel post-translational
RT   modifications in histones.";
RL   Mol. Cell. Proteomics 6:812-819(2007).
RN   [68]
RP   FUNCTION IN ACETYLATION OF SIRT2.
RX   PubMed=18722353; DOI=10.1016/j.bbrc.2008.08.042;
RA   Han Y., Jin Y.H., Kim Y.J., Kang B.Y., Choi H.J., Kim D.W., Yeo C.Y.,
RA   Lee K.Y.;
RT   "Acetylation of Sirt2 by p300 attenuates its deacetylase activity.";
RL   Biochem. Biophys. Res. Commun. 375:576-580(2008).
RN   [69]
RP   PHOSPHORYLATION BY HIPK2.
RX   PubMed=18695000; DOI=10.1182/blood-2008-01-134122;
RA   Wee H.-J., Voon D.C.-C., Bae S.-C., Ito Y.;
RT   "PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by
RT   HIPK2: implications for leukemogenesis.";
RL   Blood 112:3777-3787(2008).
RN   [70]
RP   FBXO3-MEDIATED DEGRADATION.
RX   PubMed=18809579; DOI=10.1128/MCB.00897-08;
RA   Shima Y., Shima T., Chiba T., Irimura T., Pandolfi P.P.,
RA   Kitabayashi I.;
RT   "PML activates transcription by protecting HIPK2 and p300 from
RT   SCFFbx3-mediated degradation.";
RL   Mol. Cell. Biol. 28:7126-7138(2008).
RN   [71]
RP   ACETYLATION AT LYS-418; LYS-423; LYS-1542; LYS-1546; LYS-1549;
RP   LYS-1699; LYS-1704 AND LYS-1707, DEACETYLATION BY SIRT2, AND FUNCTION
RP   IN TRANSCRIPTIONAL REGULATION.
RX   PubMed=18995842; DOI=10.1016/j.molcel.2008.09.018;
RA   Black J.C., Mosley A., Kitada T., Washburn M., Carey M.;
RT   "The SIRT2 deacetylase regulates autoacetylation of p300.";
RL   Mol. Cell 32:449-455(2008).
RN   [72]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [73]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [74]
RP   INTERACTION WITH SENP3, AND SUMOYLATION.
RX   PubMed=19680224; DOI=10.1038/emboj.2009.210;
RA   Huang C., Han Y., Wang Y., Sun X., Yan S., Yeh E.T.H., Chen Y.,
RA   Cang H., Li H., Shi G., Cheng J., Tang X., Yi J.;
RT   "SENP3 is responsible for HIF-1 transactivation under mild oxidative
RT   stress via p300 de-SUMOylation.";
RL   EMBO J. 28:2748-2762(2009).
RN   [75]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [76]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-636; LYS-977; LYS-1542;
RP   LYS-1546; LYS-1554; LYS-1555; LYS-1558; LYS-1560 AND LYS-1583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [77]
RP   IDENTIFICATION IN COMPLEX WITH CCNT1; CDK9 AND GATA4.
RX   PubMed=20081228; DOI=10.1074/jbc.M109.070458;
RA   Sunagawa Y., Morimoto T., Takaya T., Kaichi S., Wada H., Kawamura T.,
RA   Fujita M., Shimatsu A., Kita T., Hasegawa K.;
RT   "Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex
RT   required for phenylephrine-induced hypertrophy in cardiomyocytes.";
RL   J. Biol. Chem. 285:9556-9568(2010).
RN   [78]
RP   FUNCTION IN ACETYLATION OF MEF2D.
RX   PubMed=21030595; DOI=10.1074/jbc.M110.153270;
RA   Chini C.C., Escande C., Nin V., Chini E.N.;
RT   "HDAC3 is negatively regulated by the nuclear protein DBC1.";
RL   J. Biol. Chem. 285:40830-40837(2010).
RN   [79]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [80]
RP   FUNCTION IN ACETYLATION OF XBP1.
RX   PubMed=20955178; DOI=10.1042/BJ20101293;
RA   Wang F.M., Chen Y.J., Ouyang H.J.;
RT   "Regulation of unfolded protein response modulator XBP1s by
RT   acetylation and deacetylation.";
RL   Biochem. J. 433:245-252(2011).
RN   [81]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1038, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [82]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [83]
RP   INTERACTION WITH ALKBH4.
RX   PubMed=23145062; DOI=10.1371/journal.pone.0049045;
RA   Bjornstad L.G., Meza T.J., Otterlei M., Olafsrud S.M.,
RA   Meza-Zepeda L.A., Falnes P.O.;
RT   "Human ALKBH4 interacts with proteins associated with transcription.";
RL   PLoS ONE 7:E49045-E49045(2012).
RN   [84]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=23415232; DOI=10.1016/j.cell.2013.01.032;
RA   Tropberger P., Pott S., Keller C., Kamieniarz-Gdula K., Caron M.,
RA   Richter F., Li G., Mittler G., Liu E.T., Buhler M., Margueron R.,
RA   Schneider R.;
RT   "Regulation of transcription through acetylation of H3K122 on the
RT   lateral surface of the histone octamer.";
RL   Cell 152:859-872(2013).
RN   [85]
RP   FUNCTION AS ACETYLTRANSFERASE OF H3K27.
RX   PubMed=23911289; DOI=10.1016/j.celrep.2013.06.016;
RA   Hatzi K., Jiang Y., Huang C., Garrett-Bakelman F., Gearhart M.D.,
RA   Giannopoulou E.G., Zumbo P., Kirouac K., Bhaskara S., Polo J.M.,
RA   Kormaksson M., Mackerell A.D. Jr., Xue F., Mason C.E., Hiebert S.W.,
RA   Prive G.G., Cerchietti L., Bardwell V.J., Elemento O., Melnick A.;
RT   "A hybrid mechanism of action for BCL6 in B cells defined by formation
RT   of functionally distinct complexes at enhancers and promoters.";
RL   Cell Rep. 4:578-588(2013).
RN   [86]
RP   INTERACTION WITH KLF15.
RX   PubMed=23999430; DOI=10.1172/JCI68552;
RA   Lu Y., Zhang L., Liao X., Sangwung P., Prosdocimo D.A., Zhou G.,
RA   Votruba A.R., Brian L., Han Y.J., Gao H., Wang Y., Shimizu K.,
RA   Weinert-Stein K., Khrestian M., Simon D.I., Freedman N.J., Jain M.K.;
RT   "Kruppel-like factor 15 is critical for vascular inflammation.";
RL   J. Clin. Invest. 123:4232-4241(2013).
RN   [87]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1038 AND SER-1726, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [88]
RP   INTERACTION WITH HDAC4 AND HDAC5.
RX   PubMed=24413532; DOI=10.1158/0008-5472.CAN-13-2020;
RA   Kang H.J., Lee M.H., Kang H.L., Kim S.H., Ahn J.R., Na H., Na T.Y.,
RA   Kim Y.N., Seong J.K., Lee M.O.;
RT   "Differential regulation of estrogen receptor alpha expression in
RT   breast cancer cells by metastasis-associated protein 1.";
RL   Cancer Res. 74:1484-1494(2014).
RN   [89]
RP   INTERACTION WITH ZNF451, AND FUNCTION.
RX   PubMed=24324267; DOI=10.1074/jbc.M113.526905;
RA   Feng Y., Wu H., Xu Y., Zhang Z., Liu T., Lin X., Feng X.H.;
RT   "Zinc finger protein 451 is a novel Smad corepressor in transforming
RT   growth factor-beta signaling.";
RL   J. Biol. Chem. 289:2072-2083(2014).
RN   [90]
RP   INTERACTION WITH ZBTB48.
RX   PubMed=24382891; DOI=10.1074/jbc.M113.526855;
RA   Yoon J.H., Choi W.I., Jeon B.N., Koh D.I., Kim M.K., Kim M.H., Kim J.,
RA   Hur S.S., Kim K.S., Hur M.W.;
RT   "Human Kruppel-related 3 (HKR3) is a novel transcription activator of
RT   alternate reading frame (ARF) gene.";
RL   J. Biol. Chem. 289:4018-4031(2014).
RN   [91]
RP   ACETYLATION, DEACETYLATION BY SIRT2, AND INTERACTION WITH EP300.
RX   PubMed=24177535; DOI=10.1016/j.jmb.2013.10.027;
RA   Rack J.G., Vanlinden M.R., Lutter T., Aasland R., Ziegler M.;
RT   "Constitutive nuclear localization of an alternatively spliced
RT   sirtuin-2 isoform.";
RL   J. Mol. Biol. 426:1677-1691(2014).
RN   [92]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1038, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [93]
RP   INTERACTION WITH TRIP4.
RX   PubMed=25219498; DOI=10.1016/j.molcel.2014.08.007;
RA   Yoo H.M., Kang S.H., Kim J.Y., Lee J.E., Seong M.W., Lee S.W.,
RA   Ka S.H., Sou Y.S., Komatsu M., Tanaka K., Lee S.T., Noh D.Y.,
RA   Baek S.H., Jeon Y.J., Chung C.H.;
RT   "Modification of ASC1 by UFM1 is crucial for ERalpha transactivation
RT   and breast cancer development.";
RL   Mol. Cell 56:261-274(2014).
RN   [94]
RP   FUNCTION AS ACETYLTRANSFERASE OF PCNA, AND INTERACTION WITH PCNA.
RX   PubMed=24939902; DOI=10.1093/nar/gku533;
RA   Cazzalini O., Sommatis S., Tillhon M., Dutto I., Bachi A., Rapp A.,
RA   Nardo T., Scovassi A.I., Necchi D., Cardoso M.C., Stivala L.A.,
RA   Prosperi E.;
RT   "CBP and p300 acetylate PCNA to link its degradation with nucleotide
RT   excision repair synthesis.";
RL   Nucleic Acids Res. 42:8433-8448(2014).
RN   [95]
RP   INTERACTION WITH ZBTB49.
RX   PubMed=25245946; DOI=10.1093/nar/gku857;
RA   Jeon B.N., Kim M.K., Yoon J.H., Kim M.Y., An H., Noh H.J., Choi W.I.,
RA   Koh D.I., Hur M.W.;
RT   "Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating
RT   transcription of p21/CDKN1A and RB upon exposure to genotoxic
RT   stress.";
RL   Nucleic Acids Res. 42:11447-11461(2014).
RN   [96]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=25818647; DOI=10.1016/j.molcel.2015.02.029;
RA   Sabari B.R., Tang Z., Huang H., Yong-Gonzalez V., Molina H.,
RA   Kong H.E., Dai L., Shimada M., Cross J.R., Zhao Y., Roeder R.G.,
RA   Allis C.D.;
RT   "Intracellular crotonyl-CoA stimulates transcription through p300-
RT   catalyzed histone crotonylation.";
RL   Mol. Cell 58:203-215(2015).
RN   [97]
RP   INTERACTION WITH STAT1.
RX   PubMed=26479788; DOI=10.1038/ni.3279;
RA   Zhang Y., Mao D., Roswit W.T., Jin X., Patel A.C., Patel D.A.,
RA   Agapov E., Wang Z., Tidwell R.M., Atkinson J.J., Huang G.,
RA   McCarthy R., Yu J., Yun N.E., Paessler S., Lawson T.G., Omattage N.S.,
RA   Brett T.J., Holtzman M.J.;
RT   "PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C
RT   protease to enhance interferon signaling and control viral
RT   infection.";
RL   Nat. Immunol. 16:1215-1227(2015).
RN   [98]
RP   INTERACTION WITH BCL11B.
RX   PubMed=27959755; DOI=10.1056/NEJMoa1509164;
RA   Punwani D., Zhang Y., Yu J., Cowan M.J., Rana S., Kwan A.,
RA   Adhikari A.N., Lizama C.O., Mendelsohn B.A., Fahl S.P., Chellappan A.,
RA   Srinivasan R., Brenner S.E., Wiest D.L., Puck J.M.;
RT   "Multisystem anomalies in severe combined immunodeficiency with mutant
RT   BCL11B.";
RL   N. Engl. J. Med. 375:2165-2176(2016).
RN   [99]
RP   INTERACTION WITH HSF1.
RX   PubMed=27189267; DOI=10.1038/srep26294;
RA   Pan X.Y., Zhao W., Zeng X.Y., Lin J., Li M.M., Shen X.T., Liu S.W.;
RT   "Heat shock factor 1 mediates latent HIV reactivation.";
RL   Sci. Rep. 6:26294-26294(2016).
RN   [100]
RP   STRUCTURE BY NMR OF 302-418 IN COMPLEX WITH HIF1A PEPTIDE AND ZINC
RP   IONS.
RX   PubMed=11959990; DOI=10.1073/pnas.082117899;
RA   Freedman S.J., Sun Z.-Y.J., Poy F., Kung A.L., Livingston D.M.,
RA   Wagner G., Eck M.J.;
RT   "Structural basis for recruitment of CBP/p300 by hypoxia-inducible
RT   factor-1 alpha.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:5367-5372(2002).
RN   [101]
RP   STRUCTURE BY NMR OF 323-423 IN COMPLEX WITH 216-259 OF CITED2 AND ZINC
RP   IONS, INTERACTION WITH CITED2, AND MUTAGENESIS OF LEU-344 AND LEU-345.
RX   PubMed=12778114; DOI=10.1038/nsb936;
RA   Freedman S.J., Sun Z.Y., Kung A.L., France D.S., Wagner G., Eck M.J.;
RT   "Structural basis for negative regulation of hypoxia-inducible factor-
RT   1alpha by CITED2.";
RL   Nat. Struct. Biol. 10:504-512(2003).
RN   [102]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1287-1666 IN COMPLEX WITH
RP   LYS-COA, AND MUTAGENESIS OF THR-1357; SER-1396; TYR-1397; GLU-1505;
RP   ASP-1625 AND ASP-1628.
RX   PubMed=18273021; DOI=10.1038/nature06546;
RA   Liu X., Wang L., Zhao K., Thompson P.R., Hwang Y., Marmorstein R.,
RA   Cole P.A.;
RT   "The structural basis of protein acetylation by the p300/CBP
RT   transcriptional coactivator.";
RL   Nature 451:846-850(2008).
RN   [103]
RP   STRUCTURE BY NMR OF 1723-1812, AND INTERACTION WITH TP53.
RX   PubMed=19217391; DOI=10.1016/j.str.2008.12.009;
RA   Feng H., Jenkins L.M.M., Durell S.R., Hayashi R., Mazur S.J.,
RA   Cherry S., Tropea J.E., Miller M., Wlodawer A., Appella E., Bai Y.;
RT   "Structural basis for p300 Taz2-p53 TAD1 binding and modulation by
RT   phosphorylation.";
RL   Structure 17:202-210(2009).
RN   [104]
RP   X-RAY CRYSTALLOGRAPHY (2.33 ANGSTROMS) OF 1040-1161.
RX   PubMed=22464331; DOI=10.1016/j.cell.2012.02.013;
RA   Filippakopoulos P., Picaud S., Mangos M., Keates T., Lambert J.P.,
RA   Barsyte-Lovejoy D., Felletar I., Volkmer R., Muller S., Pawson T.,
RA   Gingras A.C., Arrowsmith C.H., Knapp S.;
RT   "Histone recognition and large-scale structural analysis of the human
RT   bromodomain family.";
RL   Cell 149:214-231(2012).
RN   [105]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 1043-1519 AND 1581-1666 OF
RP   MUTANT PHE-1467 IN COMPLEX WITH ZINC, CATALYTIC ACTIVITY, FUNCTION,
RP   AUTOACETYLATION, AND MUTAGENESIS OF PHE-1170; CYS-1204; GLU-1242;
RP   ASP-1399; TYR-1467 AND 1645-ARG-ARG-1646.
RX   PubMed=23934153; DOI=10.1038/nsmb.2642;
RA   Delvecchio M., Gaucher J., Aguilar-Gurrieri C., Ortega E., Panne D.;
RT   "Structure of the p300 catalytic core and implications for chromatin
RT   targeting and HAT regulation.";
RL   Nat. Struct. Mol. Biol. 20:1040-1046(2013).
RN   [106]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 1287-1664 OF MUTANT PHE-1467
RP   IN COMPLEX WITH ACETYL-COA AND COENZYME A.
RX   PubMed=24819397; DOI=10.1021/bi500380f;
RA   Maksimoska J., Segura-Pena D., Cole P.A., Marmorstein R.;
RT   "Structure of the p300 histone acetyltransferase bound to acetyl-
RT   coenzyme A and its analogues.";
RL   Biochemistry 53:3415-3422(2014).
RN   [107]
RP   VARIANTS PRO-827; GLY-1013; TYR-1650 AND GLN-2221, AND POSSIBLE
RP   INVOLVEMENT IN CANCER.
RX   PubMed=10700188; DOI=10.1038/73536;
RA   Gayther S.A., Batley S.J., Linger L., Bannister A., Thorpe K.,
RA   Chin S.-F., Daigo Y., Russell P., Wilson A., Sowter H.M.,
RA   Delhanty J.D.A., Ponder B.A.J., Kouzarides T., Caldas C.;
RT   "Mutations truncating the EP300 acetylase in human cancers.";
RL   Nat. Genet. 24:300-303(2000).
RN   [108]
RP   VARIANT ILE-1511.
RX   PubMed=24476420; DOI=10.1111/cge.12348;
RA   Negri G., Milani D., Colapietro P., Forzano F., Della Monica M.,
RA   Rusconi D., Consonni L., Caffi L.G., Finelli P., Scarano G.,
RA   Magnani C., Selicorni A., Spena S., Larizza L., Gervasini C.;
RT   "Clinical and molecular characterization of Rubinstein-Taybi syndrome
RT   patients carrying distinct novel mutations of the EP300 gene.";
RL   Clin. Genet. 87:148-154(2015).
CC   -!- FUNCTION: Functions as histone acetyltransferase and regulates
CC       transcription via chromatin remodeling (PubMed:23415232,
CC       PubMed:23934153, PubMed:8945521). Acetylates all four core
CC       histones in nucleosomes. Histone acetylation gives an epigenetic
CC       tag for transcriptional activation (PubMed:23415232,
CC       PubMed:23934153, PubMed:8945521). Mediates cAMP-gene regulation by
CC       binding specifically to phosphorylated CREB protein. Mediates
CC       acetylation of histone H3 at 'Lys-122' (H3K122ac), a modification
CC       that localizes at the surface of the histone octamer and
CC       stimulates transcription, possibly by promoting nucleosome
CC       instability. Mediates acetylation of histone H3 at 'Lys-27'
CC       (H3K27ac) (PubMed:23911289). Also functions as acetyltransferase
CC       for nonhistone targets. Acetylates 'Lys-131' of ALX1 and acts as
CC       its coactivator (PubMed:12929931). Acetylates SIRT2 and is
CC       proposed to indirectly increase the transcriptional activity of
CC       TP53 through acetylation and subsequent attenuation of SIRT2
CC       deacetylase function (PubMed:18722353). Acetylates HDAC1 leading
CC       to its inactivation and modulation of transcription
CC       (PubMed:16762839). Acts as a TFAP2A-mediated transcriptional
CC       coactivator in presence of CITED2 (PubMed:12586840). Plays a role
CC       as a coactivator of NEUROD1-dependent transcription of the
CC       secretin and p21 genes and controls terminal differentiation of
CC       cells in the intestinal epithelium. Promotes cardiac myocyte
CC       enlargement. Can also mediate transcriptional repression.
CC       Acetylates FOXO1 and enhances its transcriptional activity
CC       (PubMed:15890677). Acetylates BCL6 wich disrupts its ability to
CC       recruit histone deacetylases and hinders its transcriptional
CC       repressor activity (PubMed:12402037). Participates in CLOCK or
CC       NPAS2-regulated rhythmic gene transcription; exhibits a circadian
CC       association with CLOCK or NPAS2, correlating with increase in
CC       PER1/2 mRNA and histone H3 acetylation on the PER1/2 promoter
CC       (PubMed:14645221). Acetylates MTA1 at 'Lys-626' which is essential
CC       for its transcriptional coactivator activity (PubMed:16617102).
CC       Acetylates XBP1 isoform 2; acetylation increases protein stability
CC       of XBP1 isoform 2 and enhances its transcriptional activity
CC       (PubMed:20955178). Acetylates PCNA; acetylation promotes removal
CC       of chromatin-bound PCNA and its degradation during nucleotide
CC       excision repair (NER) (PubMed:24939902). Acetylates MEF2D
CC       (PubMed:21030595). In addition to protein acetyltransferase, can
CC       use different acyl-CoA substrates, such as (2E)-butenoyl-CoA
CC       (crotonyl-CoA), butanoyl-CoA (butyryl-CoA) or propanoyl-CoA
CC       (propionyl-CoA), and is able to mediate protein crotonylation,
CC       butyrylation or propionylation, respectively (PubMed:25818647,
CC       PubMed:17267393). Acts as a histone crotonyltransferase;
CC       crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors (PubMed:25818647).
CC       Histone crotonyltransferase activity is dependent on the
CC       concentration of (2E)-butenoyl-CoA (crotonyl-CoA) substrate and
CC       such activity is weak when (E)-but-2-enoyl-CoA (crotonyl-CoA)
CC       concentration is low (PubMed:25818647). Also acts as a histone
CC       butyryltransferase; butyrylation marks active promoters
CC       (PubMed:17267393). {ECO:0000250|UniProtKB:B2RWS6,
CC       ECO:0000269|PubMed:10733570, ECO:0000269|PubMed:11430825,
CC       ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:12402037,
CC       ECO:0000269|PubMed:12586840, ECO:0000269|PubMed:12929931,
CC       ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:15186775,
CC       ECO:0000269|PubMed:15890677, ECO:0000269|PubMed:16617102,
CC       ECO:0000269|PubMed:16762839, ECO:0000269|PubMed:17267393,
CC       ECO:0000269|PubMed:18722353, ECO:0000269|PubMed:18995842,
CC       ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:23415232,
CC       ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:23934153,
CC       ECO:0000269|PubMed:24939902, ECO:0000269|PubMed:25818647,
CC       ECO:0000269|PubMed:8945521, ECO:0000305|PubMed:20955178}.
CC   -!- FUNCTION: (Microbial infection) In case of HIV-1 infection, it is
CC       recruited by the viral protein Tat. Regulates Tat's
CC       transactivating activity and may help inducing chromatin
CC       remodeling of proviral genes. Binds to and may be involved in the
CC       transforming capacity of the adenovirus E1A protein.
CC       {ECO:0000269|PubMed:10545121, ECO:0000269|PubMed:11080476}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:23415232,
CC       ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:8945521}.
CC   -!- CATALYTIC ACTIVITY: (2E)-butenoyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-(2E)-butenoyl-L-lysine.
CC       {ECO:0000269|PubMed:25818647}.
CC   -!- CATALYTIC ACTIVITY: Butanoyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-butanoyl-L-lysine. {ECO:0000250|UniProtKB:B2RWS6}.
CC   -!- CATALYTIC ACTIVITY: Propanoyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-propanoyl-L-lysine. {ECO:0000269|PubMed:17267393}.
CC   -!- SUBUNIT: Interacts with phosphorylated CREB1. Interacts with
CC       HIF1A; the interaction is stimulated in response to hypoxia and
CC       inhibited by CITED2. Interacts (via N-terminus) with TFAP2A (via
CC       N-terminus); the interaction requires CITED2. Interacts (via CH1
CC       domain) with CITED2 (via C-terminus). Interacts with CITED1
CC       (unphosphorylated form preferentially and via C-terminus).
CC       Interacts with ESR1; the interaction is estrogen-dependent and
CC       enhanced by CITED1. Interacts with DTX1, EID1, ELF3, FEN1, LEF1,
CC       NCOA1, NCOA6, NR3C1, PCAF, PELP1, PRDM6, SP1, SP3, SPIB, SRY,
CC       TCF7L2, TP53, DDX5, DDX17, SATB1, SRCAP, TTC5, JMY and TRERF1. The
CC       TAZ-type 1 domain interacts with HIF1A. Probably part of a complex
CC       with HIF1A and CREBBP. Part of a complex containing CARM1 and
CC       NCOA2/GRIP1. Interacts with ING4 and this interaction may be
CC       indirect. Interacts with ING5. Interacts with the C-terminal
CC       region of CITED4. Non-sumoylated EP300 preferentially interacts
CC       with SENP3. Interacts with SS18L1/CREST. Interacts with ALX1 (via
CC       homeobox domain). Interacts with NEUROD1; the interaction is
CC       inhibited by NR0B2. Interacts with TCF3. Interacts (via CREB-
CC       binding domain) with MYOCD (via C-terminus). Binds to HIPK2.
CC       Interacts with ROCK2 and PPARG. Forms a complex made of CDK9,
CC       CCNT1/cyclin-T1, EP300 and GATA4 that stimulates hypertrophy in
CC       cardiomyocytes. Interacts with IRF1 and this interaction enhances
CC       acetylation of p53/TP53 and stimulation of its activity. Interacts
CC       with FOXO1; the interaction acetylates FOXO1 and enhances its
CC       transcriptional activity. Interacts with ALKBH4 and DDIT3/CHOP.
CC       Interacts with KLF15. Interacts with CEBPB and RORA. Interacts
CC       with HTLV-1 Tax and p30II. Interacts with and acetylates HIV-1
CC       Tat. Interacts with NPAS2, ARNTL/BMAL1 and CLOCK. Interacts with
CC       SIRT2 isoform 1, isoform 2 and isoform 5. Interacts with MTA1.
CC       Interacts with HDAC4 and HDAC5 in the presence of TFAP2C
CC       (PubMed:10545121, PubMed:10722728, PubMed:10823961,
CC       PubMed:11073989, PubMed:11073990, PubMed:11080476,
CC       PubMed:11349124, PubMed:11430825, PubMed:11463834,
CC       PubMed:11481323, PubMed:11518699, PubMed:11559821,
CC       PubMed:11564735, PubMed:11581164, PubMed:11581372,
CC       PubMed:11701890, PubMed:11744733, PubMed:11864910,
CC       PubMed:11959990, PubMed:11997499, PubMed:12446687,
CC       PubMed:12527917, PubMed:12586840, PubMed:12750254,
CC       PubMed:12778114, PubMed:12837748, PubMed:12929931,
CC       PubMed:14605447, PubMed:14645221, PubMed:14716005,
CC       PubMed:14752053, PubMed:15075319, PubMed:15186775,
CC       PubMed:15297880, PubMed:15509808, PubMed:15731352,
CC       PubMed:15890677, PubMed:16478997, PubMed:16574662,
CC       PubMed:16617102, PubMed:16864582, PubMed:17226766,
CC       PubMed:17872950, PubMed:18273021, PubMed:19217391,
CC       PubMed:19680224, PubMed:20081228, PubMed:23145062,
CC       PubMed:23999430, PubMed:24177535, PubMed:24413532, PubMed:8684459,
CC       PubMed:8917528, PubMed:9528808, PubMed:9590696, PubMed:9862959,
CC       PubMed:9887100). Interacts with TRIP4 (PubMed:25219498). Directly
CC       interacts with ZBTB49; this interaction leads to synergistic
CC       transactivation of CDKN1A (PubMed:25245946). Interacts with NR4A3
CC       (By similarity). Interacts with ZNF451 (PubMed:24324267).
CC       Interacts with ATF5; EP300 is required for ATF5 and CEBPB
CC       interaction and DNA binding (By similarity). Interacts with HSF1
CC       (PubMed:27189267). Interacts with ZBTB48/TZAP (PubMed:24382891).
CC       Interacts with STAT1; the interaction is enhanced upon IFN-gamma
CC       stimulation (PubMed:26479788). Interacts with HNRNPU (via C-
CC       terminus); this interaction enhances DNA-binding of HNRNPU to
CC       nuclear scaffold/matrix attachment region (S/MAR) elements
CC       (PubMed:11909954). Interacts with BCL11B (PubMed:27959755,
CC       PubMed:16809611). {ECO:0000250|UniProtKB:B2RWS6,
CC       ECO:0000269|PubMed:10545121, ECO:0000269|PubMed:10722728,
CC       ECO:0000269|PubMed:10823961, ECO:0000269|PubMed:11073989,
CC       ECO:0000269|PubMed:11073990, ECO:0000269|PubMed:11080476,
CC       ECO:0000269|PubMed:11349124, ECO:0000269|PubMed:11430825,
CC       ECO:0000269|PubMed:11463834, ECO:0000269|PubMed:11481323,
CC       ECO:0000269|PubMed:11518699, ECO:0000269|PubMed:11559821,
CC       ECO:0000269|PubMed:11564735, ECO:0000269|PubMed:11581164,
CC       ECO:0000269|PubMed:11581372, ECO:0000269|PubMed:11701890,
CC       ECO:0000269|PubMed:11744733, ECO:0000269|PubMed:11864910,
CC       ECO:0000269|PubMed:11909954, ECO:0000269|PubMed:11959990,
CC       ECO:0000269|PubMed:11997499, ECO:0000269|PubMed:12446687,
CC       ECO:0000269|PubMed:12527917, ECO:0000269|PubMed:12586840,
CC       ECO:0000269|PubMed:12750254, ECO:0000269|PubMed:12778114,
CC       ECO:0000269|PubMed:12837748, ECO:0000269|PubMed:12929931,
CC       ECO:0000269|PubMed:14605447, ECO:0000269|PubMed:14645221,
CC       ECO:0000269|PubMed:14716005, ECO:0000269|PubMed:14752053,
CC       ECO:0000269|PubMed:15075319, ECO:0000269|PubMed:15186775,
CC       ECO:0000269|PubMed:15297880, ECO:0000269|PubMed:15509808,
CC       ECO:0000269|PubMed:15731352, ECO:0000269|PubMed:15890677,
CC       ECO:0000269|PubMed:16478997, ECO:0000269|PubMed:16574662,
CC       ECO:0000269|PubMed:16617102, ECO:0000269|PubMed:16809611,
CC       ECO:0000269|PubMed:16864582, ECO:0000269|PubMed:17226766,
CC       ECO:0000269|PubMed:17872950, ECO:0000269|PubMed:18273021,
CC       ECO:0000269|PubMed:19217391, ECO:0000269|PubMed:19680224,
CC       ECO:0000269|PubMed:20081228, ECO:0000269|PubMed:23145062,
CC       ECO:0000269|PubMed:23999430, ECO:0000269|PubMed:24177535,
CC       ECO:0000269|PubMed:24382891, ECO:0000269|PubMed:24413532,
CC       ECO:0000269|PubMed:25219498, ECO:0000269|PubMed:25245946,
CC       ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:27189267,
CC       ECO:0000269|PubMed:27959755, ECO:0000269|PubMed:8684459,
CC       ECO:0000269|PubMed:8917528, ECO:0000269|PubMed:9528808,
CC       ECO:0000269|PubMed:9590696, ECO:0000269|PubMed:9862959,
CC       ECO:0000269|PubMed:9887100}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human adenovirus 5
CC       E1A protein; this interaction stimulates the acetylation of RB1 by
CC       recruiting EP300 and RB1 into a multimeric-protein complex.
CC       {ECO:0000269|PubMed:11433299}.
CC   -!- INTERACTION:
CC       P03070:- (xeno); NbExp=2; IntAct=EBI-447295, EBI-617698;
CC       P03255:- (xeno); NbExp=3; IntAct=EBI-447295, EBI-2603114;
CC       P03255-2:- (xeno); NbExp=3; IntAct=EBI-447295, EBI-6859460;
CC       P03259:- (xeno); NbExp=3; IntAct=EBI-447295, EBI-6947456;
CC       Q9NXW9:ALKBH4; NbExp=4; IntAct=EBI-447295, EBI-8637516;
CC       P27695:APEX1; NbExp=8; IntAct=EBI-447295, EBI-1048805;
CC       Q9UBL3:ASH2L; NbExp=5; IntAct=EBI-447295, EBI-540797;
CC       Q8WXX7:AUTS2; NbExp=3; IntAct=EBI-447295, EBI-2875359;
CC       K4P3M7:BICP0 (xeno); NbExp=4; IntAct=EBI-447295, EBI-11296047;
CC       Q9NPI1:BRD7; NbExp=3; IntAct=EBI-447295, EBI-711221;
CC       P24941:CDK2; NbExp=5; IntAct=EBI-447295, EBI-375096;
CC       Q99967:CITED2; NbExp=3; IntAct=EBI-447295, EBI-937732;
CC       P61201:COPS2; NbExp=2; IntAct=EBI-447295, EBI-1050386;
CC       P16220:CREB1; NbExp=2; IntAct=EBI-447295, EBI-711855;
CC       Q01147:Creb1 (xeno); NbExp=2; IntAct=EBI-447295, EBI-2291098;
CC       P17844:DDX5; NbExp=4; IntAct=EBI-447295, EBI-351962;
CC       P03122:E2 (xeno); NbExp=3; IntAct=EBI-447295, EBI-7028618;
CC       P06422:E2 (xeno); NbExp=7; IntAct=EBI-447295, EBI-7136851;
CC       P06790:E2 (xeno); NbExp=6; IntAct=EBI-447295, EBI-7010629;
CC       P03372:ESR1; NbExp=2; IntAct=EBI-447295, EBI-78473;
CC       Q01844:EWSR1; NbExp=2; IntAct=EBI-447295, EBI-739737;
CC       P35637:FUS; NbExp=4; IntAct=EBI-447295, EBI-400434;
CC       Q00403:GTF2B; NbExp=2; IntAct=EBI-447295, EBI-389564;
CC       Q16665:HIF1A; NbExp=20; IntAct=EBI-447295, EBI-447269;
CC       Q61221:Hif1a (xeno); NbExp=2; IntAct=EBI-447295, EBI-298954;
CC       Q9H2X6:HIPK2; NbExp=4; IntAct=EBI-447295, EBI-348345;
CC       Q9QXM1:Jmy (xeno); NbExp=16; IntAct=EBI-447295, EBI-866001;
CC       Q92831:KAT2B; NbExp=2; IntAct=EBI-447295, EBI-477430;
CC       P55209:NAP1L1; NbExp=3; IntAct=EBI-447295, EBI-356392;
CC       O60934:NBN; NbExp=5; IntAct=EBI-447295, EBI-494844;
CC       Q9Y6Q9:NCOA3; NbExp=2; IntAct=EBI-447295, EBI-81196;
CC       P20265:POU3F2; NbExp=3; IntAct=EBI-447295, EBI-1167176;
CC       Q96KQ4:PPP1R13B; NbExp=2; IntAct=EBI-447295, EBI-1105153;
CC       Q8WUF5:PPP1R13L; NbExp=2; IntAct=EBI-447295, EBI-5550163;
CC       Q13761:RUNX3; NbExp=7; IntAct=EBI-447295, EBI-925990;
CC       Q96EB6:SIRT1; NbExp=2; IntAct=EBI-447295, EBI-1802965;
CC       Q13309:SKP2; NbExp=3; IntAct=EBI-447295, EBI-456291;
CC       O95863:SNAI1; NbExp=3; IntAct=EBI-447295, EBI-1045459;
CC       P42226:STAT6; NbExp=2; IntAct=EBI-447295, EBI-1186478;
CC       P04608:tat (xeno); NbExp=3; IntAct=EBI-447295, EBI-6164389;
CC       Q9UL17:TBX21; NbExp=5; IntAct=EBI-447295, EBI-3922312;
CC       P56279:TCL1A; NbExp=4; IntAct=EBI-447295, EBI-749995;
CC       P05549:TFAP2A; NbExp=7; IntAct=EBI-447295, EBI-347351;
CC       P04637:TP53; NbExp=20; IntAct=EBI-447295, EBI-366083;
CC       Q13625:TP53BP2; NbExp=2; IntAct=EBI-447295, EBI-77642;
CC       O15350:TP73; NbExp=2; IntAct=EBI-447295, EBI-389606;
CC       P11473:VDR; NbExp=3; IntAct=EBI-447295, EBI-286357;
CC       P67809:YBX1; NbExp=2; IntAct=EBI-447295, EBI-354065;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12929931}.
CC       Nucleus {ECO:0000269|PubMed:12929931, ECO:0000269|PubMed:14645221,
CC       ECO:0000269|PubMed:16574662}. Chromosome
CC       {ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:25818647}.
CC       Note=Localizes to active chromatin: Colocalizes with histone H3
CC       acetylated and/or crotonylated at 'Lys-18' (H3K18ac and H3K18cr,
CC       respectively) (PubMed:25818647). In the presence of ALX1
CC       relocalizes from the cytoplasm to the nucleus. Colocalizes with
CC       ROCK2 in the nucleus (PubMed:12929931).
CC       {ECO:0000269|PubMed:12929931, ECO:0000269|PubMed:25818647}.
CC   -!- DOMAIN: The CRD1 domain (cell cycle regulatory domain 1) mediates
CC       transcriptional repression of a subset of p300 responsive genes;
CC       it can be de-repressed by CDKN1A/p21WAF1 at least at some
CC       promoters. It conatins sumoylation and acetylation sites and the
CC       same lysine residues may be targeted for the respective
CC       modifications. It is proposed that deacetylation by SIRT1 allows
CC       sumoylation leading to suppressed activity.
CC   -!- PTM: Acetylated on Lys at up to 17 positions by intermolecular
CC       autocatalysis. Deacetylated in the transcriptional repression
CC       domain (CRD1) by SIRT1, preferentially at Lys-1020. Deacetylated
CC       by SIRT2, preferentially at Lys-418, Lys-423, Lys-1542, Lys-1546,
CC       Lys-1549, Lys-1699, Lys-1704 and Lys-1707.
CC       {ECO:0000269|PubMed:15004546, ECO:0000269|PubMed:15632193,
CC       ECO:0000269|PubMed:17065153, ECO:0000269|PubMed:18995842,
CC       ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:24177535}.
CC   -!- PTM: Citrullinated at Arg-2142 by PADI4, which impairs methylation
CC       by CARM1 and promotes interaction with NCOA2/GRIP1.
CC       {ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:15731352}.
CC   -!- PTM: Methylated at Arg-580 and Arg-604 in the KIX domain by CARM1,
CC       which blocks association with CREB, inhibits CREB signaling and
CC       activates apoptotic response. Also methylated at Arg-2142 by
CC       CARM1, which impairs interaction with NCOA2/GRIP1.
CC       {ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:15731352}.
CC   -!- PTM: Sumoylated; sumoylation in the transcriptional repression
CC       domain (CRD1) mediates transcriptional repression. Desumoylated by
CC       SENP3 through the removal of SUMO2 and SUMO3.
CC       {ECO:0000269|PubMed:12718889, ECO:0000269|PubMed:19680224}.
CC   -!- PTM: Probable target of ubiquitination by FBXO3, leading to rapid
CC       proteasome-dependent degradation.
CC   -!- PTM: Phosphorylated by HIPK2 in a RUNX1-dependent manner. This
CC       phosphorylation that activates EP300 happens when RUNX1 is
CC       associated with DNA and CBFB. Phosphorylated by ROCK2 and this
CC       enhances its activity. Phosphorylation at Ser-89 by AMPK reduces
CC       interaction with nuclear receptors, such as PPARG.
CC       {ECO:0000269|PubMed:11518699, ECO:0000269|PubMed:12446687,
CC       ECO:0000269|PubMed:16574662, ECO:0000269|PubMed:18695000}.
CC   -!- DISEASE: Note=Defects in EP300 may play a role in epithelial
CC       cancer.
CC   -!- DISEASE: Note=Chromosomal aberrations involving EP300 may be a
CC       cause of acute myeloid leukemias. Translocation t(8;22)(p11;q13)
CC       with KAT6A.
CC   -!- DISEASE: Rubinstein-Taybi syndrome 2 (RSTS2) [MIM:613684]: A
CC       disorder characterized by craniofacial abnormalities, postnatal
CC       growth deficiency, broad thumbs, broad big toes, mental
CC       retardation and a propensity for development of malignancies. Some
CC       individuals with RSTS2 have less severe mental impairment, more
CC       severe microcephaly, and a greater degree of changes in facial
CC       bone structure than RSTS1 patients. {ECO:0000269|PubMed:15706485}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/P300ID97.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P300/CBP entry;
CC       URL="https://en.wikipedia.org/wiki/P300/CBP";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U01877; AAA18639.1; -; mRNA.
DR   EMBL; AL080243; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL096765; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035658; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60408.1; -; Genomic_DNA.
DR   CCDS; CCDS14010.1; -.
DR   PIR; A54277; A54277.
DR   RefSeq; NP_001420.2; NM_001429.3.
DR   UniGene; Hs.517517; -.
DR   UniGene; Hs.655211; -.
DR   PDB; 1L3E; NMR; -; B=323-423.
DR   PDB; 1P4Q; NMR; -; B=323-423.
DR   PDB; 2K8F; NMR; -; A=1723-1812.
DR   PDB; 2MH0; NMR; -; B=1723-1812.
DR   PDB; 2MZD; NMR; -; A=1723-1812.
DR   PDB; 3BIY; X-ray; 1.70 A; A=1287-1666.
DR   PDB; 3I3J; X-ray; 2.33 A; A/B/C/D/E/F/G/H/I/J/K/L=1040-1161.
DR   PDB; 3IO2; X-ray; 2.50 A; A=1723-1836.
DR   PDB; 3P57; X-ray; 2.19 A; P=1726-1835.
DR   PDB; 3T92; X-ray; 1.50 A; A=1723-1818.
DR   PDB; 4BHW; X-ray; 2.80 A; A/B=1043-1519, A/B=1581-1666.
DR   PDB; 4PZR; X-ray; 2.10 A; A=1287-1664.
DR   PDB; 4PZS; X-ray; 1.94 A; A=1287-1664.
DR   PDB; 4PZT; X-ray; 2.80 A; A=1287-1664.
DR   PDB; 5BT3; X-ray; 1.05 A; A=1048-1161.
DR   PDB; 5KJ2; X-ray; 1.95 A; A=1287-1522, A=1555-1666.
DR   PDB; 5LKT; X-ray; 2.04 A; A=1043-1519, A=1581-1666.
DR   PDB; 5LKU; X-ray; 3.50 A; A=1043-1519, A=1581-1666.
DR   PDB; 5LKX; X-ray; 2.52 A; A=1043-1519, A=1581-1666.
DR   PDB; 5LKZ; X-ray; 2.50 A; A=1043-1519, A=1581-1666.
DR   PDB; 5LPK; X-ray; 2.10 A; A/B/C/D/E/F/G=1040-1161.
DR   PDB; 5LPM; X-ray; 1.50 A; A/B=1048-1161.
DR   PDB; 5NU5; X-ray; 1.60 A; A/B=1048-1161.
DR   PDBsum; 1L3E; -.
DR   PDBsum; 1P4Q; -.
DR   PDBsum; 2K8F; -.
DR   PDBsum; 2MH0; -.
DR   PDBsum; 2MZD; -.
DR   PDBsum; 3BIY; -.
DR   PDBsum; 3I3J; -.
DR   PDBsum; 3IO2; -.
DR   PDBsum; 3P57; -.
DR   PDBsum; 3T92; -.
DR   PDBsum; 4BHW; -.
DR   PDBsum; 4PZR; -.
DR   PDBsum; 4PZS; -.
DR   PDBsum; 4PZT; -.
DR   PDBsum; 5BT3; -.
DR   PDBsum; 5KJ2; -.
DR   PDBsum; 5LKT; -.
DR   PDBsum; 5LKU; -.
DR   PDBsum; 5LKX; -.
DR   PDBsum; 5LKZ; -.
DR   PDBsum; 5LPK; -.
DR   PDBsum; 5LPM; -.
DR   PDBsum; 5NU5; -.
DR   DisProt; DP00633; -.
DR   ProteinModelPortal; Q09472; -.
DR   SMR; Q09472; -.
DR   BioGrid; 108347; 497.
DR   CORUM; Q09472; -.
DR   DIP; DIP-257N; -.
DR   IntAct; Q09472; 198.
DR   MINT; Q09472; -.
DR   STRING; 9606.ENSP00000263253; -.
DR   BindingDB; Q09472; -.
DR   ChEMBL; CHEMBL3784; -.
DR   GuidetoPHARMACOLOGY; 2735; -.
DR   iPTMnet; Q09472; -.
DR   PhosphoSitePlus; Q09472; -.
DR   BioMuta; EP300; -.
DR   DMDM; 223590203; -.
DR   EPD; Q09472; -.
DR   MaxQB; Q09472; -.
DR   PaxDb; Q09472; -.
DR   PeptideAtlas; Q09472; -.
DR   PRIDE; Q09472; -.
DR   Ensembl; ENST00000263253; ENSP00000263253; ENSG00000100393.
DR   GeneID; 2033; -.
DR   KEGG; hsa:2033; -.
DR   UCSC; uc003azl.5; human.
DR   CTD; 2033; -.
DR   DisGeNET; 2033; -.
DR   EuPathDB; HostDB:ENSG00000100393.10; -.
DR   GeneCards; EP300; -.
DR   GeneReviews; EP300; -.
DR   H-InvDB; HIX0203186; -.
DR   HGNC; HGNC:3373; EP300.
DR   HPA; CAB000146; -.
DR   HPA; HPA003128; -.
DR   HPA; HPA004112; -.
DR   MalaCards; EP300; -.
DR   MIM; 602700; gene.
DR   MIM; 613684; phenotype.
DR   neXtProt; NX_Q09472; -.
DR   OpenTargets; ENSG00000100393; -.
DR   Orphanet; 353284; Rubinstein-Taybi syndrome due to EP300 haploinsufficiency.
DR   PharmGKB; PA27807; -.
DR   eggNOG; KOG1778; Eukaryota.
DR   eggNOG; COG5076; LUCA.
DR   GeneTree; ENSGT00760000119206; -.
DR   HOGENOM; HOG000111353; -.
DR   HOVERGEN; HBG000185; -.
DR   InParanoid; Q09472; -.
DR   KO; K04498; -.
DR   OMA; GQVSNPP; -.
DR   OrthoDB; EOG091G0L04; -.
DR   PhylomeDB; Q09472; -.
DR   TreeFam; TF101097; -.
DR   BRENDA; 2.3.1.48; 2681.
DR   Reactome; R-HSA-1234158; Regulation of gene expression by Hypoxia-inducible Factor.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-156711; Polo-like kinase mediated events.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2197563; NOTCH2 intracellular domain regulates transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-3134973; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.
DR   Reactome; R-HSA-6804758; Regulation of TP53 Activity through Acetylation.
DR   Reactome; R-HSA-6804760; Regulation of TP53 Activity through Methylation.
DR   Reactome; R-HSA-6811555; PI5P Regulates TP53 Acetylation.
DR   Reactome; R-HSA-8866907; Activation of the TFAP2 (AP-2) family of transcription factors.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   Reactome; R-HSA-8941856; RUNX3 regulates NOTCH signaling.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8951936; RUNX3 regulates p14-ARF.
DR   Reactome; R-HSA-9013508; NOTCH3 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-918233; TRAF3-dependent IRF activation pathway.
DR   Reactome; R-HSA-933541; TRAF6 mediated IRF7 activation.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SignaLink; Q09472; -.
DR   SIGNOR; Q09472; -.
DR   ChiTaRS; EP300; human.
DR   EvolutionaryTrace; Q09472; -.
DR   GeneWiki; EP300; -.
DR   GenomeRNAi; 2033; -.
DR   PRO; PR:Q09472; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100393; -.
DR   CleanEx; HS_EP300; -.
DR   ExpressionAtlas; Q09472; baseline and differential.
DR   Genevisible; Q09472; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000123; C:histone acetyltransferase complex; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0016407; F:acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0033613; F:activating transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0050681; F:androgen receptor binding; IPI:BHF-UCL.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; IEA:Ensembl.
DR   GO; GO:0001047; F:core promoter binding; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0140069; F:histone butyryltransferase activity; IEA:Ensembl.
DR   GO; GO:0140068; F:histone crotonyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0004468; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; IDA:UniProtKB.
DR   GO; GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IEA:Ensembl.
DR   GO; GO:0140065; F:peptide butyryltransferase activity; IDA:UniProtKB.
DR   GO; GO:0034212; F:peptide N-acetyltransferase activity; TAS:Reactome.
DR   GO; GO:0061733; F:peptide-lysine-N-acetyltransferase activity; TAS:Reactome.
DR   GO; GO:0097157; F:pre-mRNA intronic binding; IEA:Ensembl.
DR   GO; GO:0008022; F:protein C-terminus binding; IDA:MGI.
DR   GO; GO:0061920; F:protein propionyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0097677; F:STAT family protein binding; IPI:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0009887; P:animal organ morphogenesis; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; IEA:Ensembl.
DR   GO; GO:1904837; P:beta-catenin-TCF complex assembly; TAS:Reactome.
DR   GO; GO:0034644; P:cellular response to UV; IDA:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome.
DR   GO; GO:0045444; P:fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0016573; P:histone acetylation; IDA:UniProtKB.
DR   GO; GO:0043969; P:histone H2B acetylation; IDA:UniProtKB.
DR   GO; GO:0043967; P:histone H4 acetylation; IMP:UniProtKB.
DR   GO; GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0006475; P:internal protein amino acid acetylation; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0010742; P:macrophage derived foam cell differentiation; IDA:UniProtKB.
DR   GO; GO:0035855; P:megakaryocyte development; IEA:Ensembl.
DR   GO; GO:0018076; P:N-terminal peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0140067; P:peptidyl-lysine butyrylation; IDA:UniProtKB.
DR   GO; GO:0140066; P:peptidyl-lysine crotonylation; IDA:UniProtKB.
DR   GO; GO:0061921; P:peptidyl-lysine propionylation; IDA:UniProtKB.
DR   GO; GO:0030220; P:platelet formation; IEA:Ensembl.
DR   GO; GO:0043923; P:positive regulation by host of viral transcription; IDA:BHF-UCL.
DR   GO; GO:0051091; P:positive regulation of DNA binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0045815; P:positive regulation of gene expression, epigenetic; IDA:UniProtKB.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0006990; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; ISS:UniProtKB.
DR   GO; GO:0007221; P:positive regulation of transcription of Notch receptor target; TAS:Reactome.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0006473; P:protein acetylation; IDA:UniProtKB.
DR   GO; GO:0031648; P:protein destabilization; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0010506; P:regulation of autophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; TAS:Reactome.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0090043; P:regulation of tubulin deacetylation; IDA:UniProtKB.
DR   GO; GO:0043627; P:response to estrogen; IDA:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd15802; RING_CBP-p300; 1.
DR   Gene3D; 1.10.1630.10; -; 1.
DR   Gene3D; 1.20.1020.10; -; 2.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR031162; CBP_P300_HAT.
DR   InterPro; IPR013178; Histone_AcTrfase_Rtt109/CBP.
DR   InterPro; IPR003101; KIX_dom.
DR   InterPro; IPR036529; KIX_dom_sf.
DR   InterPro; IPR009110; Nuc_rcpt_coact.
DR   InterPro; IPR014744; Nuc_rcpt_coact_CREBbp.
DR   InterPro; IPR037073; Nuc_rcpt_coact_CREBbp_sf.
DR   InterPro; IPR010303; RING_CBP-p300.
DR   InterPro; IPR035898; TAZ_dom_sf.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR000197; Znf_TAZ.
DR   InterPro; IPR000433; Znf_ZZ.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF09030; Creb_binding; 1.
DR   Pfam; PF06001; DUF902; 1.
DR   Pfam; PF08214; HAT_KAT11; 1.
DR   Pfam; PF02172; KIX; 1.
DR   Pfam; PF02135; zf-TAZ; 2.
DR   Pfam; PF00569; ZZ; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM01250; KAT11; 1.
DR   SMART; SM00551; ZnF_TAZ; 2.
DR   SMART; SM00291; ZnF_ZZ; 1.
DR   SUPFAM; SSF47040; SSF47040; 1.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57933; SSF57933; 2.
DR   SUPFAM; SSF69125; SSF69125; 1.
DR   PROSITE; PS00633; BROMODOMAIN_1; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS51727; CBP_P300_HAT; 1.
DR   PROSITE; PS50952; KIX; 1.
DR   PROSITE; PS50134; ZF_TAZ; 2.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Biological rhythms;
KW   Bromodomain; Cell cycle; Chromosomal rearrangement; Chromosome;
KW   Citrullination; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Host-virus interaction;
KW   Isopeptide bond; Metal-binding; Methylation; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   CHAIN         2   2414       Histone acetyltransferase p300.
FT                                /FTId=PRO_0000211193.
FT   DOMAIN      566    645       KIX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00311}.
FT   DOMAIN     1067   1139       Bromo. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00035}.
FT   DOMAIN     1287   1663       CBP/p300-type HAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01065}.
FT   ZN_FING     331    417       TAZ-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00203}.
FT   ZN_FING    1664   1707       ZZ-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00228}.
FT   ZN_FING    1728   1809       TAZ-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00203}.
FT   REGION        2    149       Interaction with RORA.
FT                                {ECO:0000269|PubMed:9862959}.
FT   REGION        2    139       Interaction with ALX1.
FT                                {ECO:0000269|PubMed:12929931}.
FT   REGION     1017   1029       CRD1; mediates transcriptional
FT                                repression.
FT   REGION     1397   1399       Interaction with histone.
FT                                {ECO:0000269|PubMed:18273021}.
FT   REGION     1398   1400       Acetyl-CoA binding.
FT                                {ECO:0000269|PubMed:24819397}.
FT   REGION     1410   1411       Acetyl-CoA binding.
FT                                {ECO:0000269|PubMed:24819397}.
FT   REGION     1572   1818       Binding region for E1A adenovirus.
FT   REGION     2003   2212       Interaction with HTLV-1 Tax.
FT   REGION     2041   2240       Interaction with NCOA2.
FT                                {ECO:0000269|PubMed:15731352}.
FT   MOTIF        11     17       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    797    800       Poly-Ser.
FT   COMPBIAS   1519   1526       Poly-Glu.
FT   COMPBIAS   2066   2069       Poly-Gln.
FT   COMPBIAS   2190   2195       Poly-Gln.
FT   METAL       347    347       Zinc 1.
FT   METAL       351    351       Zinc 1.
FT   METAL       364    364       Zinc 1.
FT   METAL       369    369       Zinc 1.
FT   METAL       378    378       Zinc 2.
FT   METAL       382    382       Zinc 2.
FT   METAL       388    388       Zinc 2.
FT   METAL       393    393       Zinc 2.
FT   METAL       402    402       Zinc 3.
FT   METAL       406    406       Zinc 3.
FT   METAL       411    411       Zinc 3.
FT   METAL       414    414       Zinc 3.
FT   BINDING    1457   1457       Acetyl-CoA; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:24819397}.
FT   BINDING    1462   1462       Acetyl-CoA.
FT                                {ECO:0000269|PubMed:24819397}.
FT   BINDING    1466   1466       Acetyl-CoA.
FT                                {ECO:0000269|PubMed:24819397}.
FT   SITE         31     32       Breakpoint for translocation to form
FT                                KAT6A-EP300 and EP300-KAT6A.
FT   SITE       2088   2088       Interaction with NCOA2.
FT   SITE       2142   2142       Interaction with NCOA2.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   MOD_RES      89     89       Phosphoserine; by AMPK.
FT                                {ECO:0000269|PubMed:11518699,
FT                                ECO:0000269|PubMed:16574662}.
FT   MOD_RES     418    418       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:18995842}.
FT   MOD_RES     423    423       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:18995842}.
FT   MOD_RES     499    499       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:B2RWS6}.
FT   MOD_RES     580    580       Omega-N-methylated arginine; by CARM1.
FT                                {ECO:0000269|PubMed:11701890}.
FT   MOD_RES     604    604       Omega-N-methylated arginine; by CARM1.
FT                                {ECO:0000269|PubMed:11701890}.
FT   MOD_RES     636    636       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     977    977       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1020   1020       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:15632193}.
FT   MOD_RES    1024   1024       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:15632193}.
FT   MOD_RES    1038   1038       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1180   1180       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:B2RWS6}.
FT   MOD_RES    1336   1336       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:17065153}.
FT   MOD_RES    1473   1473       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:17065153}.
FT   MOD_RES    1499   1499       N6-acetyllysine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15004546}.
FT   MOD_RES    1542   1542       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:18995842}.
FT   MOD_RES    1546   1546       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:18995842}.
FT   MOD_RES    1549   1549       N6-acetyllysine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15004546,
FT                                ECO:0000269|PubMed:18995842}.
FT   MOD_RES    1554   1554       N6-acetyllysine; by autocatalysis.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:15004546}.
FT   MOD_RES    1555   1555       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1558   1558       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:15004546}.
FT   MOD_RES    1560   1560       N6-acetyllysine; by autocatalysis.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:15004546}.
FT   MOD_RES    1583   1583       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1699   1699       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:18995842}.
FT   MOD_RES    1704   1704       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:18995842}.
FT   MOD_RES    1707   1707       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:18995842}.
FT   MOD_RES    1726   1726       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2142   2142       Asymmetric dimethylarginine; by CARM1;
FT                                alternate. {ECO:0000269|PubMed:15731352}.
FT   MOD_RES    2142   2142       Citrulline; by PADI4; alternate.
FT                                {ECO:0000269|PubMed:15731352}.
FT   CROSSLNK   1020   1020       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK   1024   1024       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   VARIANT     289    289       M -> V (in dbSNP:rs2230111).
FT                                /FTId=VAR_055554.
FT   VARIANT     827    827       L -> P (in a breast cancer sample).
FT                                {ECO:0000269|PubMed:10700188}.
FT                                /FTId=VAR_014428.
FT   VARIANT     997    997       I -> V (in dbSNP:rs20551).
FT                                /FTId=VAR_020425.
FT   VARIANT    1013   1013       E -> G (in a breast cancer sample).
FT                                {ECO:0000269|PubMed:10700188}.
FT                                /FTId=VAR_014429.
FT   VARIANT    1511   1511       N -> I. {ECO:0000269|PubMed:24476420}.
FT                                /FTId=VAR_074021.
FT   VARIANT    1650   1650       S -> Y (in a pancreatic cancer sample).
FT                                {ECO:0000269|PubMed:10700188}.
FT                                /FTId=VAR_014430.
FT   VARIANT    2174   2174       T -> S (in dbSNP:rs5758252).
FT                                /FTId=VAR_038376.
FT   VARIANT    2221   2221       P -> Q (in a colorectal cancer sample;
FT                                dbSNP:rs28937578).
FT                                {ECO:0000269|PubMed:10700188}.
FT                                /FTId=VAR_014431.
FT   VARIANT    2223   2223       Q -> P (in dbSNP:rs1046088).
FT                                {ECO:0000269|PubMed:7523245}.
FT                                /FTId=VAR_038377.
FT   MUTAGEN      89     89       S->A: Abolishes AMPK-mediated
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:11518699}.
FT   MUTAGEN      89     89       S->D: Phosphomimetic mutant that leads to
FT                                descreased interaction with nuclear
FT                                receptors. {ECO:0000269|PubMed:11518699}.
FT   MUTAGEN     344    344       L->A: Inhibits interaction with HIF1A and
FT                                transcription activation; when associated
FT                                with A-345.
FT                                {ECO:0000269|PubMed:12778114}.
FT   MUTAGEN     345    345       L->A: Inhibits interaction with HIF1A and
FT                                transcription activation; when associated
FT                                with A-344.
FT                                {ECO:0000269|PubMed:12778114}.
FT   MUTAGEN     371    376       TMKNVL->NAAIRS: Inhibits interaction with
FT                                HIF1A. Reduces interaction with CITED2.
FT                                {ECO:0000269|PubMed:9887100}.
FT   MUTAGEN     413    418       VCLPLK->NAAIRS: Inhibits interaction with
FT                                HIF1A. Does not inhibit interaction with
FT                                CITED2. {ECO:0000269|PubMed:9887100}.
FT   MUTAGEN    1020   1020       K->A: Abolishes sumoylation and
FT                                transcriptional repression when
FT                                associated with A-1024.
FT                                {ECO:0000269|PubMed:12718889,
FT                                ECO:0000269|PubMed:15632193}.
FT   MUTAGEN    1020   1020       K->R: Abolishes sumoylation and
FT                                transcriptional repression; when
FT                                associated with R-1024.
FT                                {ECO:0000269|PubMed:12718889,
FT                                ECO:0000269|PubMed:15632193}.
FT   MUTAGEN    1024   1024       K->A: Abolishes sumoylation and
FT                                transcriptional repression; when
FT                                associated with A-1020.
FT                                {ECO:0000269|PubMed:12718889,
FT                                ECO:0000269|PubMed:15632193}.
FT   MUTAGEN    1024   1024       K->R: Abolishes sumoylation and
FT                                transcriptional repression; when
FT                                associated with R-1020.
FT                                {ECO:0000269|PubMed:12718889,
FT                                ECO:0000269|PubMed:15632193}.
FT   MUTAGEN    1170   1170       F->E: Increased acetyltransferase
FT                                activity. {ECO:0000269|PubMed:23934153}.
FT   MUTAGEN    1204   1204       C->R: Increased acetyltransferase
FT                                activity. {ECO:0000269|PubMed:23934153}.
FT   MUTAGEN    1242   1242       E->K: Increased acetyltransferase
FT                                activity. {ECO:0000269|PubMed:23934153}.
FT   MUTAGEN    1357   1357       T->L: 40% decrease in activity.
FT                                {ECO:0000269|PubMed:18273021}.
FT   MUTAGEN    1357   1357       T->R: 40% decrease in activity. 90%
FT                                decrease in activity; when associated
FT                                with R-1505; R-1625 and R-1628.
FT                                {ECO:0000269|PubMed:18273021}.
FT   MUTAGEN    1396   1396       S->R: Loss of activity; when associated
FT                                with R-1397.
FT                                {ECO:0000269|PubMed:18273021}.
FT   MUTAGEN    1396   1396       S->W: Loss of activity; when associated
FT                                with W-1396.
FT                                {ECO:0000269|PubMed:18273021}.
FT   MUTAGEN    1397   1397       Y->R: Loss of activity; when associated
FT                                with R-1396.
FT                                {ECO:0000269|PubMed:18273021}.
FT   MUTAGEN    1397   1397       Y->W: Loss of activity; when associated
FT                                with W-1397.
FT                                {ECO:0000269|PubMed:18273021}.
FT   MUTAGEN    1399   1399       D->Y: Abolishes autoacetylation. Does not
FT                                interact with TFAP2A and inhibits
FT                                transcriptional coactivation of TFAP2A by
FT                                CITED2. Does not inhibit interaction with
FT                                CITED2, DNA-binding of TFAP2A or nuclear
FT                                localization of TFAP2A or CITED2. No
FT                                enhancement of FOXO1-mediated
FT                                transcriptional activity. No inhibition
FT                                of insulin-mediated translocation to the
FT                                cytoplasm. {ECO:0000269|PubMed:12586840,
FT                                ECO:0000269|PubMed:15890677,
FT                                ECO:0000269|PubMed:23934153}.
FT   MUTAGEN    1467   1467       Y->F: Abolishes autoacetylation. Loss of
FT                                acetyltransferase activity.
FT                                {ECO:0000269|PubMed:23934153}.
FT   MUTAGEN    1505   1505       E->R: 90% decrease in activity; when
FT                                associated with R-1625 and R-1628. 90%
FT                                decrease in activity; when associated
FT                                with R-1357; R-1625 and R-1628.
FT                                {ECO:0000269|PubMed:18273021}.
FT   MUTAGEN    1625   1625       D->R: 70% decrease in activity; when
FT                                associated with R-1628. 90% decrease in
FT                                activity; when associated with R-1505 and
FT                                R-1628. 90% decrease in activity; when
FT                                associated with R-1357; R-1505 and R-
FT                                1628. {ECO:0000269|PubMed:18273021}.
FT   MUTAGEN    1628   1628       D->R: 70% decrease in activity; when
FT                                associated with R-1625. 90% decrease in
FT                                activity; when associated with E-1505 and
FT                                R-1625. 90% decrease in activity; when
FT                                associated with R-1357; R-1505 and R-
FT                                1625. {ECO:0000269|PubMed:18273021}.
FT   MUTAGEN    1645   1646       RR->EE: Increased acetyltransferase
FT                                activity. {ECO:0000269|PubMed:23934153}.
FT   MUTAGEN    2056   2056       R->K: No effect on interaction with
FT                                NCOA2. {ECO:0000269|PubMed:15731352}.
FT   MUTAGEN    2088   2088       R->K: Abolishes interaction with NCOA2.
FT                                {ECO:0000269|PubMed:15731352}.
FT   MUTAGEN    2142   2142       R->K: Strongly reduces interaction with
FT                                NCOA2. {ECO:0000269|PubMed:15731352}.
FT   CONFLICT    169    169       M -> T (in Ref. 1; AAA18639).
FT                                {ECO:0000305}.
FT   CONFLICT    204    204       N -> D (in Ref. 1; AAA18639).
FT                                {ECO:0000305}.
FT   CONFLICT    928    928       T -> N (in Ref. 1; AAA18639).
FT                                {ECO:0000305}.
FT   CONFLICT   1924   1924       A -> T (in Ref. 1; AAA18639).
FT                                {ECO:0000305}.
FT   HELIX       332    334       {ECO:0000244|PDB:1L3E}.
FT   HELIX       335    355       {ECO:0000244|PDB:1L3E}.
FT   TURN        356    358       {ECO:0000244|PDB:1L3E}.
FT   HELIX       367    379       {ECO:0000244|PDB:1L3E}.
FT   STRAND      386    389       {ECO:0000244|PDB:1L3E}.
FT   HELIX       391    405       {ECO:0000244|PDB:1L3E}.
FT   STRAND      408    410       {ECO:0000244|PDB:1P4Q}.
FT   HELIX       414    418       {ECO:0000244|PDB:1L3E}.
FT   HELIX      1051   1066       {ECO:0000244|PDB:5BT3}.
FT   TURN       1069   1072       {ECO:0000244|PDB:5BT3}.
FT   HELIX      1073   1075       {ECO:0000244|PDB:5BT3}.
FT   HELIX      1081   1084       {ECO:0000244|PDB:5BT3}.
FT   HELIX      1089   1092       {ECO:0000244|PDB:5BT3}.
FT   HELIX      1099   1107       {ECO:0000244|PDB:5BT3}.
FT   HELIX      1114   1131       {ECO:0000244|PDB:5BT3}.
FT   HELIX      1137   1160       {ECO:0000244|PDB:5BT3}.
FT   HELIX      1165   1168       {ECO:0000244|PDB:5LKT}.
FT   HELIX      1182   1190       {ECO:0000244|PDB:5LKT}.
FT   HELIX      1197   1205       {ECO:0000244|PDB:5LKT}.
FT   HELIX      1208   1216       {ECO:0000244|PDB:5LKT}.
FT   STRAND     1218   1221       {ECO:0000244|PDB:4BHW}.
FT   HELIX      1225   1245       {ECO:0000244|PDB:5LKT}.
FT   TURN       1248   1250       {ECO:0000244|PDB:4BHW}.
FT   STRAND     1255   1257       {ECO:0000244|PDB:5LKX}.
FT   STRAND     1264   1272       {ECO:0000244|PDB:5LKT}.
FT   HELIX      1273   1278       {ECO:0000244|PDB:5LKT}.
FT   HELIX      1290   1292       {ECO:0000244|PDB:5KJ2}.
FT   HELIX      1297   1313       {ECO:0000244|PDB:3BIY}.
FT   STRAND     1321   1334       {ECO:0000244|PDB:3BIY}.
FT   TURN       1336   1338       {ECO:0000244|PDB:5LKT}.
FT   HELIX      1339   1342       {ECO:0000244|PDB:3BIY}.
FT   TURN       1343   1347       {ECO:0000244|PDB:3BIY}.
FT   STRAND     1351   1366       {ECO:0000244|PDB:3BIY}.
FT   STRAND     1369   1381       {ECO:0000244|PDB:3BIY}.
FT   STRAND     1392   1400       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1407   1409       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1410   1428       {ECO:0000244|PDB:3BIY}.
FT   STRAND     1432   1436       {ECO:0000244|PDB:3BIY}.
FT   STRAND     1439   1441       {ECO:0000244|PDB:5LKX}.
FT   STRAND     1446   1450       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1460   1476       {ECO:0000244|PDB:3BIY}.
FT   STRAND     1478   1480       {ECO:0000244|PDB:5LKT}.
FT   STRAND     1482   1485       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1486   1493       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1498   1500       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1508   1517       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1582   1590       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1592   1594       {ECO:0000244|PDB:3BIY}.
FT   STRAND     1595   1601       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1603   1606       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1622   1624       {ECO:0000244|PDB:3BIY}.
FT   STRAND     1625   1627       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1628   1636       {ECO:0000244|PDB:3BIY}.
FT   HELIX      1644   1662       {ECO:0000244|PDB:3BIY}.
FT   TURN       1726   1728       {ECO:0000244|PDB:2MZD}.
FT   HELIX      1730   1747       {ECO:0000244|PDB:3T92}.
FT   HELIX      1756   1770       {ECO:0000244|PDB:3T92}.
FT   TURN       1774   1778       {ECO:0000244|PDB:3T92}.
FT   HELIX      1780   1793       {ECO:0000244|PDB:3T92}.
FT   STRAND     1799   1802       {ECO:0000244|PDB:2MZD}.
FT   HELIX      1806   1818       {ECO:0000244|PDB:3T92}.
SQ   SEQUENCE   2414 AA;  264161 MW;  8E869E1F174A6FEB CRC64;
     MAENVVEPGP PSAKRPKLSS PALSASASDG TDFGSLFDLE HDLPDELINS TELGLTNGGD
     INQLQTSLGM VQDAASKHKQ LSELLRSGSS PNLNMGVGGP GQVMASQAQQ SSPGLGLINS
     MVKSPMTQAG LTSPNMGMGT SGPNQGPTQS TGMMNSPVNQ PAMGMNTGMN AGMNPGMLAA
     GNGQGIMPNQ VMNGSIGAGR GRQNMQYPNP GMGSAGNLLT EPLQQGSPQM GGQTGLRGPQ
     PLKMGMMNNP NPYGSPYTQN PGQQIGASGL GLQIQTKTVL SNNLSPFAMD KKAVPGGGMP
     NMGQQPAPQV QQPGLVTPVA QGMGSGAHTA DPEKRKLIQQ QLVLLLHAHK CQRREQANGE
     VRQCNLPHCR TMKNVLNHMT HCQSGKSCQV AHCASSRQII SHWKNCTRHD CPVCLPLKNA
     GDKRNQQPIL TGAPVGLGNP SSLGVGQQSA PNLSTVSQID PSSIERAYAA LGLPYQVNQM
     PTQPQVQAKN QQNQQPGQSP QGMRPMSNMS ASPMGVNGGV GVQTPSLLSD SMLHSAINSQ
     NPMMSENASV PSLGPMPTAA QPSTTGIRKQ WHEDITQDLR NHLVHKLVQA IFPTPDPAAL
     KDRRMENLVA YARKVEGDMY ESANNRAEYY HLLAEKIYKI QKELEEKRRT RLQKQNMLPN
     AAGMVPVSMN PGPNMGQPQP GMTSNGPLPD PSMIRGSVPN QMMPRITPQS GLNQFGQMSM
     AQPPIVPRQT PPLQHHGQLA QPGALNPPMG YGPRMQQPSN QGQFLPQTQF PSQGMNVTNI
     PLAPSSGQAP VSQAQMSSSS CPVNSPIMPP GSQGSHIHCP QLPQPALHQN SPSPVPSRTP
     TPHHTPPSIG AQQPPATTIP APVPTPPAMP PGPQSQALHP PPRQTPTPPT TQLPQQVQPS
     LPAAPSADQP QQQPRSQQST AASVPTPTAP LLPPQPATPL SQPAVSIEGQ VSNPPSTSST
     EVNSQAIAEK QPSQEVKMEA KMEVDQPEPA DTQPEDISES KVEDCKMEST ETEERSTELK
     TEIKEEEDQP STSATQSSPA PGQSKKKIFK PEELRQALMP TLEALYRQDP ESLPFRQPVD
     PQLLGIPDYF DIVKSPMDLS TIKRKLDTGQ YQEPWQYVDD IWLMFNNAWL YNRKTSRVYK
     YCSKLSEVFE QEIDPVMQSL GYCCGRKLEF SPQTLCCYGK QLCTIPRDAT YYSYQNRYHF
     CEKCFNEIQG ESVSLGDDPS QPQTTINKEQ FSKRKNDTLD PELFVECTEC GRKMHQICVL
     HHEIIWPAGF VCDGCLKKSA RTRKENKFSA KRLPSTRLGT FLENRVNDFL RRQNHPESGE
     VTVRVVHASD KTVEVKPGMK ARFVDSGEMA ESFPYRTKAL FAFEEIDGVD LCFFGMHVQE
     YGSDCPPPNQ RRVYISYLDS VHFFRPKCLR TAVYHEILIG YLEYVKKLGY TTGHIWACPP
     SEGDDYIFHC HPPDQKIPKP KRLQEWYKKM LDKAVSERIV HDYKDIFKQA TEDRLTSAKE
     LPYFEGDFWP NVLEESIKEL EQEEEERKRE ENTSNESTDV TKGDSKNAKK KNNKKTSKNK
     SSLSRGNKKK PGMPNVSNDL SQKLYATMEK HKEVFFVIRL IAGPAANSLP PIVDPDPLIP
     CDLMDGRDAF LTLARDKHLE FSSLRRAQWS TMCMLVELHT QSQDRFVYTC NECKHHVETR
     WHCTVCEDYD LCITCYNTKN HDHKMEKLGL GLDDESNNQQ AAATQSPGDS RRLSIQRCIQ
     SLVHACQCRN ANCSLPSCQK MKRVVQHTKG CKRKTNGGCP ICKQLIALCC YHAKHCQENK
     CPVPFCLNIK QKLRQQQLQH RLQQAQMLRR RMASMQRTGV VGQQQGLPSP TPATPTTPTG
     QQPTTPQTPQ PTSQPQPTPP NSMPPYLPRT QAAGPVSQGK AAGQVTPPTP PQTAQPPLPG
     PPPAAVEMAM QIQRAAETQR QMAHVQIFQR PIQHQMPPMT PMAPMGMNPP PMTRGPSGHL
     EPGMGPTGMQ QQPPWSQGGL PQPQQLQSGM PRPAMMSVAQ HGQPLNMAPQ PGLGQVGISP
     LKPGTVSQQA LQNLLRTLRS PSSPLQQQQV LSILHANPQL LAAFIKQRAA KYANSNPQPI
     PGQPGMPQGQ PGLQPPTMPG QQGVHSNPAM QNMNPMQAGV QRAGLPQQQP QQQLQPPMGG
     MSPQAQQMNM NHNTMPSQFR DILRRQQMMQ QQQQQGAGPG IGPGMANHNQ FQQPQGVGYP
     PQQQQRMQHH MQQMQQGNMG QIGQLPQALG AEAGASLQAY QQRLLQQQMG SPVQPNPMSP
     QQHMLPNQAQ SPHLQGQQIP NSLSNQVRSP QPVPSPRPQS QPPHSSPSPR MQPQPSPHHV
     SPQTSSPHPG LVAAQANPME QGHFASPDQN SMLSQLASNP GMANLHGASA TDLGLSTDNS
     DLNSNLSQST LDIH
//
ID   Q7Z6C1_HUMAN            Unreviewed;      1553 AA.
AC   Q7Z6C1;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   31-JAN-2018, entry version 96.
DE   SubName: Full=EP300 protein {ECO:0000313|EMBL:AAH53889.1};
DE   Flags: Fragment;
GN   Name=EP300 {ECO:0000313|EMBL:AAH53889.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH53889.1};
RN   [1] {ECO:0000313|EMBL:AAH53889.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin {ECO:0000313|EMBL:AAH53889.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC053889; AAH53889.1; -; mRNA.
DR   RefSeq; NP_001420.2; NM_001429.3.
DR   UniGene; Hs.517517; -.
DR   UniGene; Hs.655211; -.
DR   ProteinModelPortal; Q7Z6C1; -.
DR   PeptideAtlas; Q7Z6C1; -.
DR   PRIDE; Q7Z6C1; -.
DR   GeneID; 2033; -.
DR   KEGG; hsa:2033; -.
DR   CTD; 2033; -.
DR   PharmGKB; PA27807; -.
DR   eggNOG; KOG1778; Eukaryota.
DR   eggNOG; COG5076; LUCA.
DR   HOVERGEN; HBG000185; -.
DR   KO; K04498; -.
DR   ChiTaRS; EP300; human.
DR   GenomeRNAi; 2033; -.
DR   Genevisible; Q7Z6C1; HS.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0003712; F:transcription cofactor activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd15802; RING_CBP-p300; 1.
DR   Gene3D; 1.20.1020.10; -; 1.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR031162; CBP_P300_HAT.
DR   InterPro; IPR013178; Histone_AcTrfase_Rtt109/CBP.
DR   InterPro; IPR003101; KIX_dom.
DR   InterPro; IPR036529; KIX_dom_sf.
DR   InterPro; IPR010303; RING_CBP-p300.
DR   InterPro; IPR035898; TAZ_dom_sf.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR000197; Znf_TAZ.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF06001; DUF902; 1.
DR   Pfam; PF08214; HAT_KAT11; 1.
DR   Pfam; PF02172; KIX; 1.
DR   Pfam; PF02135; zf-TAZ; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM01250; KAT11; 1.
DR   SMART; SM00551; ZnF_TAZ; 1.
DR   SUPFAM; SSF47040; SSF47040; 1.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57933; SSF57933; 1.
DR   PROSITE; PS00633; BROMODOMAIN_1; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS51727; CBP_P300_HAT; 1.
DR   PROSITE; PS50952; KIX; 1.
DR   PROSITE; PS50134; ZF_TAZ; 1.
PE   2: Evidence at transcript level;
KW   Acyltransferase {ECO:0000256|PROSITE-ProRule:PRU01065};
KW   Bromodomain {ECO:0000256|PROSITE-ProRule:PRU00035};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00203};
KW   Transferase {ECO:0000256|PROSITE-ProRule:PRU01065};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00203};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00203}.
FT   DOMAIN      331    417       TAZ-type. {ECO:0000259|PROSITE:PS50134}.
FT   DOMAIN      566    645       KIX. {ECO:0000259|PROSITE:PS50952}.
FT   DOMAIN     1067   1139       Bromo. {ECO:0000259|PROSITE:PS50014}.
FT   DOMAIN     1287   1553       CBP/p300-type HAT.
FT                                {ECO:0000259|PROSITE:PS51727}.
FT   ZN_FING     331    417       TAZ-type. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00203}.
FT   REGION     1398   1400       Acetyl-CoA binding. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01065}.
FT   REGION     1410   1411       Acetyl-CoA binding. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01065}.
FT   COILED     1009   1029       {ECO:0000256|SAM:Coils}.
FT   COILED     1513   1540       {ECO:0000256|SAM:Coils}.
FT   BINDING    1457   1457       Acetyl-CoA; via carbonyl oxygen.
FT                                {ECO:0000256|PROSITE-ProRule:PRU01065}.
FT   BINDING    1462   1462       Acetyl-CoA. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01065}.
FT   BINDING    1466   1466       Acetyl-CoA. {ECO:0000256|PROSITE-
FT                                ProRule:PRU01065}.
FT   NON_TER    1553   1553       {ECO:0000313|EMBL:AAH53889.1}.
SQ   SEQUENCE   1553 AA;  170081 MW;  BEFFB9C8206AD891 CRC64;
     MAENVVEPGP PSAKRPKLSS PALSASASDG TDFGSLFDLE HDLPDELINS TELGLTNGGD
     INQLQTSLGM VQDAASKHKQ LSELLRSGSS PNLNMGVGGP GQVMASQAQQ SSPGLGLINS
     MVKSPMTQAG LTSPNMGMGT SGPNQGPTQS TGMMNSPVNQ PAMGMNTGMN AGMNPGMLAA
     GNGQGIMPNQ VMNGSIGAGR GRQNMQYPNP GMGSAGNLLT EPLQQGSPQM GGQTGLRGPQ
     PLKMGMMNNP NPYGSPYTQN PGQQIGASGL GLQIQTKTVL SNNLSPFAMD KKAVPGGGMP
     NMGQQPAPQV QQPGLVTPVA QGMGSGAHTA DPEKRKLIQQ QLVLLLHAHK CQRREQANGE
     VRQCNLPHCR TMKNVLNHMT HCQSGKSCQV AHCASSRQII SHWKNCTRHD CPVCLPLKNA
     GDKRNQQPIL TGAPVGLGNP SSLGVGQQSA PNLSTVSQID PSSIERAYAA LGLPYQVNQM
     PTQPQVQAKN QQNQQPGQSP QGMRPMSNMS ASPMGVNGGV GVQTPSLLSD SMLHSAINSQ
     NPMMSENASV PSLGPMPTAA QPSTTGIRKQ WHEDITQDLR NHLVHKLVQA IFPTPDPAAL
     KDRRMENLVA YARKVEGDMY ESANNRAEYY HLLAEKIYKI QKELEEKRRT RLQKQNMLPN
     AAGMVPVSMN PGPNMGQPQP GMTSNGPLPD PSMIRGSVPN QMMPRITPQS GLNQFGQMSM
     AQPPIVPRQT PPLQHHGQLA QPGALNPPMG YGPRMQQPSN QGQFLPQTQF PSQGMNVTNI
     PLAPSSGQAP VSQAQMSSSS CPVNSPIMPP GSQGSHIHCP QLPQPALHQN SPSPVPSRTP
     TPHHTPPSIG AQQPPATTIP APVPTPPAMP PGPQSQALHP PPRQTPTPPT TQLPQQVQPS
     LPAAPSADQP QQQPRSQQST AASVPTPTAP LLPPQPATPL SQPAVSIEGQ VSNPPSTSST
     EVNSQAIAEK QPSQEVKMEA KMEVDQPEPA DTQPEDISES KVEDCKMEST ETEERSTELK
     TEIKEEEDQP STSATQSSPA PGQSKKKIFK PEELRQALMP TLEALYRQDP ESLPFRQPVD
     PQLLGIPDYF DIVKSPMDLS TIKRKLDTGQ YQEPWQYVDD IWLMFNNAWL YNRKTSRVYK
     YCSKLSEVFE QEIDPVMQSL GYCCGRKLEF SPQTLCCYGK QLCTIPRDAT YYSYQNRYHF
     CEKCFNEIQG ESVSLGDDPS QPQTTINKEQ FSKRKNDTLD PELFVECTEC GRKMHQICVL
     HHEIIWPAGF VCDGCLKKSA RTRKENKFSA KRLPSTRLGT FLENRVNDFL RRQNHPESGE
     VTVRVVHASD KTVEVKPGMK ARFVDSGEMA ESFPYRTKAL FAFEEIDGVD LCFFGMHVQE
     YGSDCPPPNQ RRVYISYLDS VHFFRPKCLR TAVYHEILIG YLEYVKKLGY TTGHIWACPP
     SEGDDYIFHC HPPDQKIPKP KRLQEWYKKM LDKAVSERIV HDYKDIFKQA TEDRLTSAKE
     LPYFEGDFWP NVLEESIKEL EQEEEERKRE ENTSNESTDV TKGDSKNAKK KKK
//
ID   B7Z240_HUMAN            Unreviewed;       573 AA.
AC   B7Z240;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   31-JAN-2018, entry version 39.
DE   SubName: Full=cDNA FLJ55050, highly similar to Epidermal growth factor receptor substrate 15 {ECO:0000313|EMBL:BAH11726.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11726.1};
RN   [1] {ECO:0000313|EMBL:BAH11726.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAH11726.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294297; BAH11726.1; -; mRNA.
DR   RefSeq; NP_001153441.1; NM_001159969.1.
DR   UniGene; Hs.83722; -.
DR   ProteinModelPortal; B7Z240; -.
DR   PeptideAtlas; B7Z240; -.
DR   PRIDE; B7Z240; -.
DR   GeneID; 2060; -.
DR   CTD; 2060; -.
DR   PharmGKB; PA27838; -.
DR   eggNOG; KOG0998; Eukaryota.
DR   eggNOG; ENOG410XTDR; LUCA.
DR   HOGENOM; HOG000004804; -.
DR   HOVERGEN; HBG005591; -.
DR   GenomeRNAi; 2060; -.
DR   Genevisible; B7Z240; HS.
DR   InterPro; IPR003903; UIM_dom.
DR   SMART; SM00726; UIM; 3.
DR   PROSITE; PS50330; UIM; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Receptor {ECO:0000313|EMBL:BAH11726.1}.
FT   COILED       26    151       {ECO:0000256|SAM:Coils}.
FT   COILED      159    179       {ECO:0000256|SAM:Coils}.
FT   COILED      537    558       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   573 AA;  63622 MW;  7C74EA492335003C CRC64;
     MILMVRDCLK SQHRDPHCDP SDKREKNNVE QDLKEKEDTI KQRTSEVQDL QDEVQRENTN
     LQKLQAQKQQ VQELLDELDE QKAQLEEQLK EVRKKCAEEA QLISSLKAEL TSQESQISTY
     EEELAKAREE LSRLQQETAE LEESVESGKA QLEPLQQHLQ DSQQEISSMQ MKLMEMKDLE
     NHNSQLNWCS SPHSILVNGA TDYCSLSTSS SETANLNEHV EGQSNLESEP IHQESPARSS
     PELLPSGVTD ENEVTTAVTE KVCSELDNNR HSKEEDPFNV DSSSLTGPVA DTNLDFFQSD
     PFVGSDPFKD DPFGKIDPFG GDPFKGSDPF ASDCFFRQST DPFATSSTDP FSAANNSSIT
     SVETLKHNDP FAPGGTVVAA SDSATDPFAS VFGNESFGGG FADFSTLSKV NNEDPFRSAT
     SSSVSNVVIT KNVFEETSVK SEDEPPALPP KIGTPTRPCP LPPGKRSINK LDSPDPFKLN
     DPFQPFPGND SPKEIDPEIF CDPFTSATTT TNKEADPSNF ANFSAYPSEE DMIEWAKRES
     EREEEQRLAR LNQQEQEDLE LAIALSKSEI SEA
//
ID   EPS15_HUMAN             Reviewed;         896 AA.
AC   P42566; B2R8J7; D3DPJ2; Q5SRH4;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 2.
DT   28-FEB-2018, entry version 194.
DE   RecName: Full=Epidermal growth factor receptor substrate 15;
DE            Short=Protein Eps15;
DE   AltName: Full=Protein AF-1p;
GN   Name=EPS15; Synonyms=AF1P;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-822.
RC   TISSUE=Melanoma;
RX   PubMed=8183552;
RA   Wong W.T., Kraus M.H., Carlomagno F., Zelano A., Druck T., Croce C.M.,
RA   Huebner K., di Fiore P.P.;
RT   "The human eps15 gene, encoding a tyrosine kinase substrate, is
RT   conserved in evolution and maps to 1p31-p32.";
RL   Oncogene 9:1591-1597(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8134107;
RA   Bernard O.A., Mauchauffe M., Mecucci C., van den Berghe H., Berger R.;
RT   "A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related
RT   to AF-4, AF-9 nor ENL.";
RL   Oncogene 9:1039-1045(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Kronstein R., Grossklaus S., Schnittler H.-J.;
RT   "Eps15 in human umbilical vein endothelial cells.";
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   INTERACTION WITH CRK.
RX   PubMed=8662907; DOI=10.1074/jbc.271.24.14468;
RA   Matsuda M., Ota S., Tanimura R., Nakamura H., Matuoka K., Takenawa T.,
RA   Nagashima K., Kurata T.;
RT   "Interaction between the amino-terminal SH3 domain of CRK and its
RT   natural target proteins.";
RL   J. Biol. Chem. 271:14468-14472(1996).
RN   [9]
RP   INTERACTION WITH EPN1.
RX   PubMed=9723620; DOI=10.1038/29555;
RA   Chen H., Fre S., Slepnev V.I., Capua M.R., Takei K., Butler M.H.,
RA   Di Fiore P.P., De Camilli P.;
RT   "Epsin is an EH-domain-binding protein implicated in clathrin-mediated
RT   endocytosis.";
RL   Nature 394:793-797(1998).
RN   [10]
RP   INTERACTION WITH HGS AND STAM2.
RX   PubMed=12551915; DOI=10.1074/jbc.M210843200;
RA   Bache K.G., Raiborg C., Mehlum A., Stenmark H.;
RT   "STAM and Hrs are subunits of a multivalent ubiquitin-binding complex
RT   on early endosomes.";
RL   J. Biol. Chem. 278:12513-12521(2003).
RN   [11]
RP   INTERACTION WITH SH3BP4.
RX   PubMed=16325581; DOI=10.1016/j.cell.2005.10.021;
RA   Tosoni D., Puri C., Confalonieri S., Salcini A.E., De Camilli P.,
RA   Tacchetti C., Di Fiore P.P.;
RT   "TTP specifically regulates the internalization of the transferrin
RT   receptor.";
RL   Cell 123:875-888(2005).
RN   [12]
RP   INTERACTION WITH UBQLN1, AND SUBCELLULAR LOCATION.
RX   PubMed=16159959; DOI=10.1242/jcs.02571;
RA   Regan-Klapisz E., Sorokina I., Voortman J., de Keizer P.,
RA   Roovers R.C., Verheesen P., Urbe S., Fallon L., Fon E.A., Verkleij A.,
RA   Benmerah A., van Bergen en Henegouwen P.M.;
RT   "Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates
RT   via a UIM-UBL interaction.";
RL   J. Cell Sci. 118:4437-4450(2005).
RN   [13]
RP   INTERACTION WITH ERBB2.
RX   PubMed=16314522; DOI=10.1128/MCB.25.24.11005-11018.2005;
RA   Giri D.K., Ali-Seyed M., Li L.Y., Lee D.F., Ling P., Bartholomeusz G.,
RA   Wang S.C., Hung M.C.;
RT   "Endosomal transport of ErbB-2: mechanism for nuclear entry of the
RT   cell surface receptor.";
RL   Mol. Cell. Biol. 25:11005-11018(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-485, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [16]
RP   FUNCTION, ALTERNATIVE SPLICING (ISOFORM 2), SUBCELLULAR LOCATION
RP   (ISOFORM 2), AND INTERACTION WITH HSG AND AP2A2.
RX   PubMed=18362181; DOI=10.1083/jcb.200708115;
RA   Roxrud I., Raiborg C., Pedersen N.M., Stang E., Stenmark H.;
RT   "An endosomally localized isoform of Eps15 interacts with Hrs to
RT   mediate degradation of epidermal growth factor receptor.";
RL   J. Cell Biol. 180:1205-1218(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-796 AND SER-814, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [18]
RP   INTERACTION WITH UBQLN1 AND UBQLN2.
RX   PubMed=18199683; DOI=10.1091/mbc.E07-08-0775;
RA   N'Diaye E.N., Hanyaloglu A.C., Kajihara K.K., Puthenveedu M.A., Wu P.,
RA   von Zastrow M., Brown E.J.;
RT   "The ubiquitin-like protein PLIC-2 is a negative regulator of G
RT   protein-coupled receptor endocytosis.";
RL   Mol. Biol. Cell 19:1252-1260(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; SER-323; SER-485
RP   AND SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   FUNCTION.
RX   PubMed=19458185; DOI=10.1091/mbc.E09-03-0256;
RA   Mettlen M., Stoeber M., Loerke D., Antonescu C.N., Danuser G.,
RA   Schmid S.L.;
RT   "Endocytic accessory proteins are functionally distinguished by their
RT   differential effects on the maturation of clathrin-coated pits.";
RL   Mol. Biol. Cell 20:3251-3260(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; SER-323; SER-324;
RP   SER-814 AND TYR-849, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-467; SER-470;
RP   SER-790; SER-796 AND SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   INTERACTION WITH FCHO2.
RX   PubMed=20448150; DOI=10.1126/science.1188462;
RA   Henne W.M., Boucrot E., Meinecke M., Evergren E., Vallis Y.,
RA   Mittal R., McMahon H.T.;
RT   "FCHo proteins are nucleators of clathrin-mediated endocytosis.";
RL   Science 328:1281-1284(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   INTERACTION WITH FCHO2.
RX   PubMed=21762413; DOI=10.1111/j.1365-2443.2011.01536.x;
RA   Uezu A., Umeda K., Tsujita K., Suetsugu S., Takenawa T., Nakanishi H.;
RT   "Characterization of the EFC/F-BAR domain protein, FCHO2.";
RL   Genes Cells 16:868-878(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-485; SER-790;
RP   SER-796 AND SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH DAB2.
RX   PubMed=22648170; DOI=10.1091/mbc.E11-12-1007;
RA   Teckchandani A., Mulkearns E.E., Randolph T.W., Toida N., Cooper J.A.;
RT   "The clathrin adaptor Dab2 recruits EH domain scaffold proteins to
RT   regulate integrin beta1 endocytosis.";
RL   Mol. Biol. Cell 23:2905-2916(2012).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [31]
RP   INTERACTION WITH FCHO1.
RX   PubMed=22484487; DOI=10.1038/ncb2473;
RA   Umasankar P.K., Sanker S., Thieman J.R., Chakraborty S., Wendland B.,
RA   Tsang M., Traub L.M.;
RT   "Distinct and separable activities of the endocytic clathrin-coat
RT   components Fcho1/2 and AP-2 in developmental patterning.";
RL   Nat. Cell Biol. 14:488-501(2012).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-746; THR-777;
RP   SER-790; SER-796 AND SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; THR-777; SER-796
RP   AND SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   INTERACTION WITH CORO7.
RX   PubMed=24768539; DOI=10.1016/j.molcel.2014.03.035;
RA   Yuan W.C., Lee Y.R., Lin S.Y., Chang L.Y., Tan Y.P., Hung C.C.,
RA   Kuo J.C., Liu C.H., Lin M.Y., Xu M., Chen Z.J., Chen R.H.;
RT   "K33-linked polyubiquitination of coronin 7 by Cul3-KLHL20 ubiquitin
RT   E3 ligase regulates protein trafficking.";
RL   Mol. Cell 54:586-600(2014).
RN   [36]
RP   INTERACTION WITH VACCINIA VIRUS PROTEIN A36.
RX   PubMed=27670116; DOI=10.1038/nmicrobiol.2016.141;
RA   Snetkov X., Weisswange I., Pfanzelter J., Humphries A.C., Way M.;
RT   "NPF motifs in the vaccinia virus protein A36 recruit intersectin-1 to
RT   promote Cdc42:N-WASP-mediated viral release from infected cells.";
RL   Nat. Microbiol. 1:16141-16141(2016).
RN   [37]
RP   STRUCTURE BY NMR OF 121-215 IN COMPLEX WITH CALCIUM IONS.
RX   PubMed=9721102; DOI=10.1126/science.281.5381.1357;
RA   de Beer T., Carter R.E., Lobel-Rice K.E., Sorkin A., Overduin M.;
RT   "Structure and Asn-Pro-Phe binding pocket of the Eps15 homology
RT   domain.";
RL   Science 281:1357-1360(1998).
RN   [38]
RP   STRUCTURE BY NMR OF 217-311 IN COMPLEX WITH CALCIUM IONS.
RX   PubMed=10757979; DOI=10.1021/bi9927383;
RA   Enmon J.L., de Beer T., Overduin M.;
RT   "Solution structure of Eps15's third EH domain reveals coincident Phe-
RT   Trp and Asn-Pro-Phe binding sites.";
RL   Biochemistry 39:4309-4319(2000).
RN   [39]
RP   STRUCTURE BY NMR OF 121-215 IN COMPLEX WITH PEPTIDE LIGAND AND CALCIUM
RP   IONS, AND DOMAIN.
RX   PubMed=11062555; DOI=10.1038/80924;
RA   de Beer T., Hoofnagle A.N., Enmon J.L., Bowers R.C., Yamabhai M.,
RA   Kay B.K., Overduin M.;
RT   "Molecular mechanism of NPF recognition by EH domains.";
RL   Nat. Struct. Biol. 7:1018-1022(2000).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 719-730 IN COMPLEX WITH
RP   AP2B1, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   FUNCTION.
RX   PubMed=16903783; DOI=10.1371/journal.pbio.0040262;
RA   Schmid E.M., Ford M.G.J., Burtey A., Praefcke G.J.K., Peak-Chew S.-Y.,
RA   Mills I.G., Benmerah A., McMahon H.T.;
RT   "Role of the AP2 beta-appendage hub in recruiting partners for
RT   clathrin-coated vesicle assembly.";
RL   PLoS Biol. 4:E262-E262(2006).
RN   [41]
RP   STRUCTURE BY NMR OF 121-215 IN COMPLEX WITH STON2 AND CALCIUM IONS,
RP   MUTAGENESIS OF VAL-154 AND TRP-169, AND SUBCELLULAR LOCATION.
RX   PubMed=18200045; DOI=10.1038/sj.emboj.7601980;
RA   Rumpf J., Simon B., Jung N., Maritzen T., Haucke V., Sattler M.,
RA   Groemping Y.;
RT   "Structure of the Eps15-stonin2 complex provides a molecular
RT   explanation for EH-domain ligand specificity.";
RL   EMBO J. 27:558-569(2008).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 645-654, AND INTERACTION
RP   WITH SGIP1.
RX   PubMed=26822536; DOI=10.1038/srep19565;
RA   Shimada A., Yamaguchi A., Kohda D.;
RT   "Structural basis for the recognition of two consecutive mutually
RT   interacting DPF motifs by the SGIP1 mu homology domain.";
RL   Sci. Rep. 6:19565-19565(2016).
CC   -!- FUNCTION: Involved in cell growth regulation. May be involved in
CC       the regulation of mitogenic signals and control of cell
CC       proliferation. Involved in the internalization of ligand-inducible
CC       receptors of the receptor tyrosine kinase (RTK) type, in
CC       particular EGFR. Plays a role in the assembly of clathrin-coated
CC       pits (CCPs). Acts as a clathrin adapter required for post-Golgi
CC       trafficking. Seems to be involved in CCPs maturation including
CC       invagination or budding. Involved in endocytosis of integrin beta-
CC       1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1
CC       as DAB2-dependent cargo but not TFR seems to require association
CC       with DAB2. {ECO:0000269|PubMed:16903783,
CC       ECO:0000269|PubMed:18362181, ECO:0000269|PubMed:19458185,
CC       ECO:0000269|PubMed:22648170}.
CC   -!- SUBUNIT: Interacts with SGIP1 (PubMed:26822536). Interacts with
CC       HGS; the interaction bridges the interaction of STAM or STAM2 with
CC       EPS15. Isoform 2 interacts with HGS and AP2A2. Part of a complex
CC       at least composed of EPS15, HGS, and either STAM or STAM2. Binds
CC       AP2A2. Interacts with AP2B1; clathrin competes with EPS15. Binds
CC       STON2 and EPN1. Interacts (via its SH3-binding sites) with CRK.
CC       Interacts with SH3BP4/TTP. Interacts with ERBB2. Interacts with
CC       FCHO1. Interacts with FCHO2. Interacts (via EH domains) with DAB2.
CC       Interacts (via UIM repeats) with CORO7 (when ubiquitinated at
CC       'Lys-472'). Interacts (via UIM domains) with UBQLN1 (via
CC       ubiquitin-like domain) and can interact with both the
CC       ubiquitinated and the non-ubiquitinated forms of UBQLN1. Interacts
CC       with UBQLN2 (By similarity) (PubMed:10757979, PubMed:11062555,
CC       PubMed:12551915, PubMed:16159959, PubMed:16314522,
CC       PubMed:16325581, PubMed:16903783, PubMed:18199683,
CC       PubMed:18200045, PubMed:18362181, PubMed:20448150,
CC       PubMed:21762413, PubMed:22484487, PubMed:22648170,
CC       PubMed:24768539, PubMed:8662907, PubMed:9721102, PubMed:9723620).
CC       Interacts with vaccinia virus protein A36 (PubMed:27670116).
CC       {ECO:0000250|UniProtKB:P42567, ECO:0000269|PubMed:10757979,
CC       ECO:0000269|PubMed:11062555, ECO:0000269|PubMed:12551915,
CC       ECO:0000269|PubMed:16159959, ECO:0000269|PubMed:16314522,
CC       ECO:0000269|PubMed:16325581, ECO:0000269|PubMed:16903783,
CC       ECO:0000269|PubMed:18199683, ECO:0000269|PubMed:18200045,
CC       ECO:0000269|PubMed:18362181, ECO:0000269|PubMed:20448150,
CC       ECO:0000269|PubMed:21762413, ECO:0000269|PubMed:22484487,
CC       ECO:0000269|PubMed:22648170, ECO:0000269|PubMed:24768539,
CC       ECO:0000269|PubMed:26822536, ECO:0000269|PubMed:27670116,
CC       ECO:0000269|PubMed:8662907, ECO:0000269|PubMed:9721102,
CC       ECO:0000269|PubMed:9723620}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with vaccinia virus
CC       protein A36 (PubMed:27670116). {ECO:0000269|PubMed:27670116}.
CC   -!- INTERACTION:
CC       Q0JRZ9:FCHO2; NbExp=3; IntAct=EBI-396684, EBI-2609756;
CC       Q3UQN2:Fcho2 (xeno); NbExp=3; IntAct=EBI-396684, EBI-6094986;
CC       Q15811:ITSN1; NbExp=2; IntAct=EBI-396684, EBI-602041;
CC       P16333:NCK1; NbExp=2; IntAct=EBI-396684, EBI-389883;
CC       Q9QZS3-1:Numb (xeno); NbExp=3; IntAct=EBI-396684, EBI-9547433;
CC       Q9QZS3-2:Numb (xeno); NbExp=3; IntAct=EBI-396684, EBI-3896014;
CC       P26045:PTPN3; NbExp=4; IntAct=EBI-15895294, EBI-1047946;
CC       Q8WXE9:STON2; NbExp=17; IntAct=EBI-396684, EBI-539742;
CC       Q9UMX0:UBQLN1; NbExp=5; IntAct=EBI-396684, EBI-741480;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral
CC       membrane protein; Cytoplasmic side. Membrane, clathrin-coated pit.
CC       Note=Recruited to the plasma membrane upon EGFR activation and
CC       localizes to coated pits. Colocalizes with UBQLN1 in ubiquitin-
CC       rich cytoplasmic aggregates that are not endocytic compartments
CC       and in cytoplasmic juxtanuclear structures called aggresomes.
CC       {ECO:0000269|PubMed:16159959}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Early endosome membrane
CC       {ECO:0000269|PubMed:18362181}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:18362181}; Cytoplasmic side
CC       {ECO:0000269|PubMed:18362181}. Note=Colocalizes with HGS on
CC       bilayered clathrin coats on endosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P42566-1; Sequence=Displayed;
CC       Name=2; Synonyms=Eps15b;
CC         IsoId=P42566-2; Sequence=VSP_036168, VSP_036169;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- DOMAIN: The EH domain interacts with Asn-Pro-Phe (NPF) motifs of
CC       target proteins. {ECO:0000269|PubMed:11062555}.
CC   -!- DOMAIN: The UIM (ubiquitin-interacting motif) repeats specifically
CC       bind 'Lys-33'-linked ubiquitin. {ECO:0000269|PubMed:11062555,
CC       ECO:0000269|PubMed:24768539}.
CC   -!- PTM: Phosphorylation on Tyr-849 is involved in the internalization
CC       of EGFR. Not required for membrane translocation after EGF
CC       treatment or for targeting to coated pits, but essential for a
CC       subsequent step in EGFR endocytosis (By similarity).
CC       Phosphorylated on serine upon DNA damage, probably by ATM or ATR.
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250|UniProtKB:P42567}.
CC   -!- DISEASE: Note=A chromosomal aberration involving EPS15 is found in
CC       acute leukemias. Translocation t(1;11)(p32;q23) with KMT2A/MLL1.
CC       The result is a rogue activator protein.
CC   -!- CAUTION: Studies in clathrin-mediated endocytosis of ITGB1 and TFR
CC       used a siRNA mixture of EPS15 and EPS15L1, and a Dab2 mutant with
CC       impaired binding to EH domain-containing proteins EPS15 and ITSN1
CC       suggesting a partially overlapping role of the EH domain-
CC       containing proteins. {ECO:0000305|PubMed:22648170}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF1pID11.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07707; AAA52101.1; -; mRNA.
DR   EMBL; Z29064; CAA82305.1; -; mRNA.
DR   EMBL; AK313396; BAG36194.1; -; mRNA.
DR   EMBL; DQ367924; ABD34786.1; -; mRNA.
DR   EMBL; BX647676; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL671986; CAI13030.1; -; Genomic_DNA.
DR   EMBL; AC104170; CAI13030.1; JOINED; Genomic_DNA.
DR   EMBL; CH471059; EAX06823.1; -; Genomic_DNA.
DR   CCDS; CCDS557.1; -. [P42566-1]
DR   PIR; S43074; S43074.
DR   RefSeq; NP_001153441.1; NM_001159969.1. [P42566-2]
DR   RefSeq; NP_001972.1; NM_001981.2. [P42566-1]
DR   UniGene; Hs.83722; -.
DR   PDB; 1C07; NMR; -; A=217-311.
DR   PDB; 1EH2; NMR; -; A=121-218.
DR   PDB; 1F8H; NMR; -; A=121-215.
DR   PDB; 1FF1; NMR; -; A=121-215.
DR   PDB; 2IV9; X-ray; 1.90 A; P=723-730.
DR   PDB; 2JXC; NMR; -; A=121-215.
DR   PDB; 4RH5; X-ray; 1.60 A; B=846-854.
DR   PDB; 4RH9; X-ray; 1.60 A; B=846-854.
DR   PDB; 4RHG; X-ray; 1.58 A; B=846-854.
DR   PDB; 4S0G; X-ray; 1.72 A; B=846-854.
DR   PDB; 5AWT; X-ray; 2.70 A; B=640-649.
DR   PDB; 5AWU; X-ray; 2.70 A; B=645-654.
DR   PDB; 5JP2; X-ray; 2.40 A; E/F=615-637.
DR   PDBsum; 1C07; -.
DR   PDBsum; 1EH2; -.
DR   PDBsum; 1F8H; -.
DR   PDBsum; 1FF1; -.
DR   PDBsum; 2IV9; -.
DR   PDBsum; 2JXC; -.
DR   PDBsum; 4RH5; -.
DR   PDBsum; 4RH9; -.
DR   PDBsum; 4RHG; -.
DR   PDBsum; 4S0G; -.
DR   PDBsum; 5AWT; -.
DR   PDBsum; 5AWU; -.
DR   PDBsum; 5JP2; -.
DR   ProteinModelPortal; P42566; -.
DR   SMR; P42566; -.
DR   BioGrid; 108374; 162.
DR   CORUM; P42566; -.
DR   DIP; DIP-33064N; -.
DR   ELM; P42566; -.
DR   IntAct; P42566; 79.
DR   MINT; P42566; -.
DR   STRING; 9606.ENSP00000360798; -.
DR   iPTMnet; P42566; -.
DR   PhosphoSitePlus; P42566; -.
DR   BioMuta; EPS15; -.
DR   DMDM; 67476728; -.
DR   OGP; P42566; -.
DR   EPD; P42566; -.
DR   MaxQB; P42566; -.
DR   PaxDb; P42566; -.
DR   PeptideAtlas; P42566; -.
DR   PRIDE; P42566; -.
DR   Ensembl; ENST00000371733; ENSP00000360798; ENSG00000085832. [P42566-1]
DR   GeneID; 2060; -.
DR   KEGG; hsa:2060; -.
DR   UCSC; uc001csq.2; human. [P42566-1]
DR   CTD; 2060; -.
DR   DisGeNET; 2060; -.
DR   EuPathDB; HostDB:ENSG00000085832.16; -.
DR   GeneCards; EPS15; -.
DR   HGNC; HGNC:3419; EPS15.
DR   HPA; CAB010164; -.
DR   HPA; HPA008451; -.
DR   MIM; 600051; gene.
DR   neXtProt; NX_P42566; -.
DR   OpenTargets; ENSG00000085832; -.
DR   PharmGKB; PA27838; -.
DR   eggNOG; KOG0998; Eukaryota.
DR   eggNOG; ENOG410XTDR; LUCA.
DR   GeneTree; ENSGT00760000118985; -.
DR   HOGENOM; HOG000004804; -.
DR   HOVERGEN; HBG005591; -.
DR   InParanoid; P42566; -.
DR   KO; K12472; -.
DR   OMA; YYRQVDT; -.
DR   OrthoDB; EOG091G01RG; -.
DR   PhylomeDB; P42566; -.
DR   TreeFam; TF324293; -.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   Reactome; R-HSA-6807004; Negative regulation of MET activity.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8875360; InlB-mediated entry of Listeria monocytogenes into host cell.
DR   SignaLink; P42566; -.
DR   SIGNOR; P42566; -.
DR   ChiTaRS; EPS15; human.
DR   EvolutionaryTrace; P42566; -.
DR   GeneWiki; EPS15; -.
DR   GenomeRNAi; 2060; -.
DR   PRO; PR:P42566; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000085832; -.
DR   CleanEx; HS_EPS15; -.
DR   ExpressionAtlas; P42566; baseline and differential.
DR   Genevisible; P42566; HS.
DR   GO; GO:0016235; C:aggresome; IDA:UniProtKB.
DR   GO; GO:0030122; C:AP-2 adaptor complex; IEA:Ensembl.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0009925; C:basal plasma membrane; IEA:Ensembl.
DR   GO; GO:0060170; C:ciliary membrane; IEA:Ensembl.
DR   GO; GO:0005905; C:clathrin-coated pit; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HGNC.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0048268; P:clathrin coat assembly; IDA:BHF-UCL.
DR   GO; GO:0032456; P:endocytic recycling; IC:BHF-UCL.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0006895; P:Golgi to endosome transport; IMP:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0001921; P:positive regulation of receptor recycling; IEA:Ensembl.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0019065; P:receptor-mediated endocytosis of virus by host cell; IMP:CACAO.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0016050; P:vesicle organization; TAS:UniProtKB.
DR   GO; GO:0046718; P:viral entry into host cell; IMP:CACAO.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR000261; EH_dom.
DR   InterPro; IPR003903; UIM_dom.
DR   Pfam; PF12763; EF-hand_4; 3.
DR   SMART; SM00054; EFh; 3.
DR   SMART; SM00027; EH; 3.
DR   SMART; SM00726; UIM; 3.
DR   SUPFAM; SSF47473; SSF47473; 3.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 4.
DR   PROSITE; PS50031; EH; 3.
DR   PROSITE; PS50330; UIM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Calcium;
KW   Cell membrane; Chromosomal rearrangement; Coated pit;
KW   Complete proteome; Cytoplasm; Endocytosis; Endosome;
KW   Host-virus interaction; Membrane; Metal-binding; Phosphoprotein;
KW   Polymorphism; Protein transport; Proto-oncogene; Reference proteome;
KW   Repeat; SH3-binding; Transport; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    896       Epidermal growth factor receptor
FT                                substrate 15.
FT                                /FTId=PRO_0000146116.
FT   DOMAIN       15    104       EH 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00077}.
FT   DOMAIN      128    216       EH 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00077}.
FT   DOMAIN      160    195       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      223    258       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      224    314       EH 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00077}.
FT   REPEAT      599    601       1.
FT   REPEAT      623    625       2.
FT   REPEAT      629    631       3.
FT   REPEAT      634    636       4.
FT   REPEAT      640    642       5.
FT   REPEAT      645    647       6.
FT   REPEAT      651    653       7.
FT   REPEAT      664    666       8.
FT   REPEAT      672    674       9.
FT   REPEAT      692    694       10.
FT   REPEAT      709    711       11.
FT   REPEAT      737    739       12.
FT   REPEAT      798    800       13.
FT   REPEAT      804    806       14.
FT   REPEAT      825    827       15.
FT   DOMAIN      851    870       UIM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00213}.
FT   DOMAIN      877    896       UIM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00213}.
FT   CA_BIND     173    184       1.
FT   CA_BIND     236    247       2.
FT   REGION        2    330       Interaction with DAB2. {ECO:0000250}.
FT   REGION      599    827       15 X 3 AA repeats of D-P-F.
FT   MOTIF       768    774       SH3-binding.
FT   COMPBIAS    768    850       Pro-rich.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     108    108       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     140    140       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     324    324       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     467    467       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     470    470       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     485    485       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     562    562       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P42567}.
FT   MOD_RES     563    563       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P42567}.
FT   MOD_RES     746    746       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     777    777       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     779    779       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P42567}.
FT   MOD_RES     790    790       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     796    796       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     814    814       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     849    849       Phosphotyrosine; by EGFR.
FT                                {ECO:0000244|PubMed:19690332}.
FT   VAR_SEQ       1    314       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_036168.
FT   VAR_SEQ     315    346       SLQKNIIGSSPVADFSAIKELDTLNNEIVDLQ -> MYLKS
FT                                DSGLGGWITIPAVADVLKYSCIVCWSS (in isoform
FT                                2). {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_036169.
FT   VARIANT     822    822       I -> M (in dbSNP:rs17567).
FT                                {ECO:0000269|PubMed:8183552}.
FT                                /FTId=VAR_016142.
FT   MUTAGEN     154    154       V->E: Loss of interaction with STON2 NPF
FT                                motifs. {ECO:0000269|PubMed:18200045}.
FT   MUTAGEN     169    169       W->A: Loss of interaction with STON2 NPF
FT                                motifs. {ECO:0000269|PubMed:18200045}.
FT   CONFLICT    446    446       Missing (in Ref. 5; BX647676).
FT                                {ECO:0000305}.
FT   HELIX       126    136       {ECO:0000244|PDB:1EH2}.
FT   STRAND      142    144       {ECO:0000244|PDB:1EH2}.
FT   STRAND      145    147       {ECO:0000244|PDB:2JXC}.
FT   HELIX       148    156       {ECO:0000244|PDB:1EH2}.
FT   TURN        157    159       {ECO:0000244|PDB:1EH2}.
FT   HELIX       162    172       {ECO:0000244|PDB:1EH2}.
FT   STRAND      177    179       {ECO:0000244|PDB:1EH2}.
FT   HELIX       182    197       {ECO:0000244|PDB:1EH2}.
FT   TURN        207    209       {ECO:0000244|PDB:1EH2}.
FT   HELIX       212    214       {ECO:0000244|PDB:1F8H}.
FT   HELIX       223    235       {ECO:0000244|PDB:1C07}.
FT   STRAND      240    243       {ECO:0000244|PDB:1C07}.
FT   HELIX       245    253       {ECO:0000244|PDB:1C07}.
FT   TURN        254    256       {ECO:0000244|PDB:1C07}.
FT   HELIX       259    269       {ECO:0000244|PDB:1C07}.
FT   STRAND      274    278       {ECO:0000244|PDB:1C07}.
FT   TURN        279    281       {ECO:0000244|PDB:1C07}.
FT   HELIX       282    293       {ECO:0000244|PDB:1C07}.
FT   TURN        305    307       {ECO:0000244|PDB:1C07}.
FT   TURN        624    627       {ECO:0000244|PDB:5JP2}.
FT   TURN        630    633       {ECO:0000244|PDB:5JP2}.
FT   HELIX       723    726       {ECO:0000244|PDB:2IV9}.
SQ   SEQUENCE   896 AA;  98656 MW;  A1B9FE15B47ABAFF CRC64;
     MAAAAQLSLT QLSSGNPVYE KYYRQVDTGN TGRVLASDAA AFLKKSGLPD LILGKIWDLA
     DTDGKGILNK QEFFVALRLV ACAQNGLEVS LSSLNLAVPP PRFHDTSSPL LISGTSAAEL
     PWAVKPEDKA KYDAIFDSLS PVNGFLSGDK VKPVLLNSKL PVDILGRVWE LSDIDHDGML
     DRDEFAVAMF LVYCALEKEP VPMSLPPALV PPSKRKTWVV SPAEKAKYDE IFLKTDKDMD
     GFVSGLEVRE IFLKTGLPST LLAHIWSLCD TKDCGKLSKD QFALAFHLIS QKLIKGIDPP
     HVLTPEMIPP SDRASLQKNI IGSSPVADFS AIKELDTLNN EIVDLQREKN NVEQDLKEKE
     DTIKQRTSEV QDLQDEVQRE NTNLQKLQAQ KQQVQELLDE LDEQKAQLEE QLKEVRKKCA
     EEAQLISSLK AELTSQESQI STYEEELAKA REELSRLQQE TAELEESVES GKAQLEPLQQ
     HLQDSQQEIS SMQMKLMEMK DLENHNSQLN WCSSPHSILV NGATDYCSLS TSSSETANLN
     EHVEGQSNLE SEPIHQESPA RSSPELLPSG VTDENEVTTA VTEKVCSELD NNRHSKEEDP
     FNVDSSSLTG PVADTNLDFF QSDPFVGSDP FKDDPFGKID PFGGDPFKGS DPFASDCFFR
     QSTDPFATSS TDPFSAANNS SITSVETLKH NDPFAPGGTV VAASDSATDP FASVFGNESF
     GGGFADFSTL SKVNNEDPFR SATSSSVSNV VITKNVFEET SVKSEDEPPA LPPKIGTPTR
     PCPLPPGKRS INKLDSPDPF KLNDPFQPFP GNDSPKEKDP EIFCDPFTSA TTTTNKEADP
     SNFANFSAYP SEEDMIEWAK RESEREEEQR LARLNQQEQE DLELAIALSK SEISEA
//
ID   A0A0S2Z3C9_HUMAN        Unreviewed;       452 AA.
AC   A0A0S2Z3C9;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 18.
DE   SubName: Full=Ets variant 6 isoform 1 {ECO:0000313|EMBL:ALQ33507.1};
DE   Flags: Fragment;
GN   Name=ETV6 {ECO:0000313|EMBL:ALQ33507.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33507.1};
RN   [1] {ECO:0000313|EMBL:ALQ33507.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU004019,
CC       ECO:0000256|SAAS:SAAS00594387}.
CC   -!- SIMILARITY: Belongs to the ETS family.
CC       {ECO:0000256|RuleBase:RU004019, ECO:0000256|SAAS:SAAS00594391}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178049; ALQ33507.1; -; mRNA.
DR   RefSeq; NP_001978.1; NM_001987.4.
DR   UniGene; Hs.504765; -.
DR   ProteinModelPortal; A0A0S2Z3C9; -.
DR   SMR; A0A0S2Z3C9; -.
DR   GeneID; 2120; -.
DR   KEGG; hsa:2120; -.
DR   CTD; 2120; -.
DR   KO; K03211; -.
DR   OMA; HQEPYPL; -.
DR   PhylomeDB; A0A0S2Z3C9; -.
DR   ChiTaRS; ETV6; human.
DR   ExpressionAtlas; A0A0S2Z3C9; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0097152; P:mesenchymal cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0022008; P:neurogenesis; IEA:Ensembl.
DR   GO; GO:0007296; P:vitellogenesis; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR000418; Ets_dom.
DR   InterPro; IPR003118; Pointed_dom.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00178; Ets; 1.
DR   Pfam; PF02198; SAM_PNT; 1.
DR   PRINTS; PR00454; ETSDOMAIN.
DR   SMART; SM00413; ETS; 1.
DR   SMART; SM00251; SAM_PNT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS00346; ETS_DOMAIN_2; 1.
DR   PROSITE; PS50061; ETS_DOMAIN_3; 1.
DR   PROSITE; PS51433; PNT; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|RuleBase:RU004019,
KW   ECO:0000256|SAAS:SAAS00594397};
KW   Nucleus {ECO:0000256|RuleBase:RU004019,
KW   ECO:0000256|SAAS:SAAS00594400}.
FT   DOMAIN       40    124       PNT. {ECO:0000259|PROSITE:PS51433}.
FT   DOMAIN      339    420       ETS. {ECO:0000259|PROSITE:PS50061}.
FT   NON_TER     452    452       {ECO:0000313|EMBL:ALQ33507.1}.
SQ   SEQUENCE   452 AA;  53000 MW;  DEC45682ECADECBB CRC64;
     MSETPAQCSI KQERISYTPP ESPVPSYASS TPLHVPVPRA LRMEEDSIRL PAHLRLQPIY
     WSRDDVAQWL KWAENEFSLR PIDSNTFEMN GKALLLLTKE DFRYRSPHSG DVLYELLQHI
     LKQRKPRILF SPFFHPGNSI HTQPEVILHQ NHEEDNCVQR TPRPSVDNVH HNPPTIELLH
     RSRSPITTNH RPSPDPEQRP LRSPLDNMIR RLSPAERAQG PRPHQENNHQ ESYPLSVSPM
     ENNHCPASSE SHPKPSSPRQ ESTRVIQLMP SPIMHPLILN PRHSVDFKQS RLSEDGLHRE
     GKPINLSHRE DLAYMNHIMV SVSPPEEHAM PIGRIADCRL LWDYVYQLLS DSRYENFIRW
     EDKESKIFRI VDPNGLARLW GNHKNRTNMT YEKMSRALRH YYKLNIIRKE PGQRLLFRFM
     KTPDEIMSGR TDRLEHLESQ ELDEQIYQED EC
//
ID   ETV6_HUMAN              Reviewed;         452 AA.
AC   P41212; A3QVP6; A8K076; Q9UMF6; Q9UMF7; Q9UMG0;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   28-FEB-2018, entry version 191.
DE   RecName: Full=Transcription factor ETV6;
DE   AltName: Full=ETS translocation variant 6;
DE   AltName: Full=ETS-related protein Tel1;
DE            Short=Tel;
GN   Name=ETV6; Synonyms=TEL, TEL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH PDGFRB.
RX   PubMed=8168137; DOI=10.1016/0092-8674(94)90322-0;
RA   Golub T.R., Barker G.F., Lovett M., Gilliland D.G.;
RT   "Fusion of PDGF receptor beta to a novel ets-like gene, tel, in
RT   chronic myelomonocytic leukemia with t(5;12) chromosomal
RT   translocation.";
RL   Cell 77:307-316(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 56-109; 111-336 AND 338-452.
RX   PubMed=8743990; DOI=10.1101/gr.6.5.404;
RA   Baens M., Peeters P., Guo C., Aerssens J., Marynen P.;
RT   "Genomic organization of TEL: the human ETS-variant gene 6.";
RL   Genome Res. 6:404-413(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 56-452, AND CHROMOSOMAL TRANSLOCATION
RP   WITH PAX5.
RX   PubMed=17344859; DOI=10.1038/nature05690;
RA   Mullighan C.G., Goorha S., Radtke I., Miller C.B., Coustan-Smith E.,
RA   Dalton J.D., Girtman K., Mathew S., Ma J., Pounds S.B., Su X.,
RA   Pui C.-H., Relling M.V., Evans W.E., Shurtleff S.A., Downing J.R.;
RT   "Genome-wide analysis of genetic alterations in acute lymphoblastic
RT   leukaemia.";
RL   Nature 446:758-764(2007).
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION WITH MN1.
RX   PubMed=7731705;
RA   Buijs A., Sherr S., van Baal S., van Bezouw S., van der Plas D.,
RA   Geurts van Kessel A., Riegman P., Lekanne Deprez R., Zwarthoff E.,
RA   Hagemeijer A.;
RT   "Translocation (12;22) (p13;q11) in myeloproliferative disorders
RT   results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on
RT   22q11.";
RL   Oncogene 10:1511-1519(1995).
RN   [8]
RP   CHROMOSOMAL TRANSLOCATION WITH AML1.
RX   PubMed=7761424; DOI=10.1073/pnas.92.11.4917;
RA   Golub T.R., Barker G.F., Bohlander S.K., Hiebert S.W., Ward D.C.,
RA   Bray-Ward P., Morgan E., Raimondi S.C., Rowley J.D., Gilliland D.G.;
RT   "Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute
RT   lymphoblastic leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:4917-4921(1995).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION WITH AML1.
RX   PubMed=7780150;
RA   Romana S.P., Mauchauffe M., le Coniat M., Chumakov I., le Paslier D.,
RA   Berger R., Bernard O.A.;
RT   "The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1
RT   gene fusion.";
RL   Blood 85:3662-3670(1995).
RN   [10]
RP   CHROMOSOMAL TRANSLOCATIONS WITH JAK2.
RX   PubMed=9326218;
RA   Peeters P., Raynaud S.D., Cools J., Wlodarska I., Grosgeorge J.,
RA   Philip P., Monpoux F., Van Rompaey L., Baens M., Van Den Berghe H.,
RA   Marynen P.;
RT   "Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-
RT   associated kinase JAK2 as a result of t(9;12) in a lymphoid and
RT   t(9;15;12) in a myeloid leukemia.";
RL   Blood 90:2535-2540(1997).
RN   [11]
RP   CHROMOSOMAL TRANSLOCATION WITH ACSL6.
RX   PubMed=10502316;
RX   DOI=10.1002/(SICI)1098-2264(199911)26:3<192::AID-GCC2>3.0.CO;2-E;
RA   Yagasaki F., Jinnai I., Yoshida S., Yokoyama Y., Matsuda A.,
RA   Kusumoto S., Kobayashi H., Terasaki H., Ohyashiki K., Asou N.,
RA   Murohashi I., Bessho M., Hirashima K.;
RT   "Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and
RT   acute myelogenous leukemia with t(5;12)(q31;p13).";
RL   Genes Chromosomes Cancer 26:192-202(1999).
RN   [12]
RP   CHROMOSOMAL TRANSLOCATION WITH CHIC2.
RX   PubMed=10477709;
RA   Cools J., Bilhou-Nabera C., Wlodarska I., Cabrol C., Talmant P.,
RA   Bernard P., Hagemeijer A., Marynen P.;
RT   "Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with
RT   a t(4;12)(q11-q12;p13).";
RL   Blood 94:1820-1824(1999).
RN   [13]
RP   PHOSPHORYLATION AT SER-22 AND SER-257, AND MUTAGENESIS OF SER-213;
RP   SER-238 AND SER-257.
RX   PubMed=12435397; DOI=10.1016/S0006-291X(02)02588-3;
RA   Arai H., Maki K., Waga K., Sasaki K., Nakamura Y., Imai Y.,
RA   Kurokawa M., Hirai H., Mitani K.;
RT   "Functional regulation of TEL by p38-induced phosphorylation.";
RL   Biochem. Biophys. Res. Commun. 299:116-125(2002).
RN   [14]
RP   CHROMOSOMAL TRANSLOCATION WITH MDS2.
RX   PubMed=12203785; DOI=10.1002/gcc.10090;
RA   Odero M.D., Vizmanos J.L., Roman J.P., Lahortiga I., Panizo C.,
RA   Calasanz M.J., Zeleznik-Le N.J., Rowley J.D., Novo F.J.;
RT   "A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a
RT   patient with myelodysplastic syndrome.";
RL   Genes Chromosomes Cancer 35:11-19(2002).
RN   [15]
RP   INVOLVEMENT IN MPE, AND CHROMOSOMAL TRANSLOCATION WITH PDGFRB.
RX   PubMed=12181402; DOI=10.1056/NEJMoa020150;
RA   Apperley J.F., Gardembas M., Melo J.V., Russell-Jones R., Bain B.J.,
RA   Baxter E.J., Chase A., Chessells J.M., Colombat M., Dearden C.E.,
RA   Dimitrijevic S., Mahon F.-X., Marin D., Nikolova Z., Olavarria E.,
RA   Silberman S., Schultheis B., Cross N.C.P., Goldman J.M.;
RT   "Response to imatinib mesylate in patients with chronic
RT   myeloproliferative diseases with rearrangements of the platelet-
RT   derived growth factor receptor beta.";
RL   N. Engl. J. Med. 347:481-487(2002).
RN   [16]
RP   INTERACTION WITH L3MBTL1.
RX   PubMed=12588862; DOI=10.1074/jbc.M300592200;
RA   Boccuni P., MacGrogan D., Scandura J.M., Nimer S.D.;
RT   "The human L(3)MBT Polycomb group protein is a transcriptional
RT   repressor and interacts physically and functionally with TEL (ETV6).";
RL   J. Biol. Chem. 278:15412-15420(2003).
RN   [17]
RP   INTERACTION WITH HDAC9.
RX   PubMed=12590135; DOI=10.1074/jbc.M212935200;
RA   Petrie K., Guidez F., Howell L., Healy L., Waxman S., Greaves M.,
RA   Zelent A.;
RT   "The histone deacetylase 9 gene encodes multiple protein isoforms.";
RL   J. Biol. Chem. 278:16059-16072(2003).
RN   [18]
RP   INVOLVEMENT IN AML, VARIANT GLY-344 INS, AND CHARACTERIZATION OF
RP   VARIANT GLY-344 INS.
RX   PubMed=15806161; DOI=10.1038/sj.onc.1208588;
RA   Barjesteh van Waalwijk van Doorn-Khosrovani S., Spensberger D.,
RA   de Knegt Y., Tang M., Loewenberg B., Delwel R.;
RT   "Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of
RT   ETV6 protein in acute myeloid leukemia.";
RL   Oncogene 24:4129-4137(2005).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18 AND SER-22, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-11 AND LYS-302, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 AND SER-213, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11 AND LYS-288, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [29]
RP   FUNCTION, INVOLVEMENT IN THC5, VARIANTS THC5 LEU-214; GLN-369 AND
RP   CYS-399, AND CHARACTERIZATION OF VARIANTS THC5 LEU-214; GLN-369 AND
RP   CYS-399.
RX   PubMed=25581430; DOI=10.1038/ng.3177;
RA   Zhang M.Y., Churpek J.E., Keel S.B., Walsh T., Lee M.K., Loeb K.R.,
RA   Gulsuner S., Pritchard C.C., Sanchez-Bonilla M., Delrow J.J.,
RA   Basom R.S., Forouhar M., Gyurkocza B., Schwartz B.S., Neistadt B.,
RA   Marquez R., Mariani C.J., Coats S.A., Hofmann I., Lindsley R.C.,
RA   Williams D.A., Abkowitz J.L., Horwitz M.S., King M.C., Godley L.A.,
RA   Shimamura A.;
RT   "Germline ETV6 mutations in familial thrombocytopenia and hematologic
RT   malignancy.";
RL   Nat. Genet. 47:180-185(2015).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11; LYS-288; LYS-302;
RP   LYS-403 AND LYS-421, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [31]
RP   STRUCTURE BY NMR OF 338-442.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of ets domain transcriptional factor ETV6
RT   protein.";
RL   Submitted (DEC-2006) to the PDB data bank.
CC   -!- FUNCTION: Transcriptional repressor; binds to the DNA sequence 5'-
CC       CCGGAAGT-3'. Plays a role in hematopoiesis and malignant
CC       transformation. {ECO:0000269|PubMed:25581430}.
CC   -!- SUBUNIT: Can form homodimers or heterodimers with TEL2 or FLI1.
CC       Interacts with L3MBTL1 and HDAC9. {ECO:0000269|PubMed:12588862,
CC       ECO:0000269|PubMed:12590135}.
CC   -!- INTERACTION:
CC       Q9BXS5:AP1M1; NbExp=3; IntAct=EBI-1372759, EBI-541426;
CC       A0A0S2Z4M1:AXIN1; NbExp=3; IntAct=EBI-1372759, EBI-16429430;
CC       Q9UKV0-3:HDAC9; NbExp=3; IntAct=EBI-1372759, EBI-765476;
CC       Q96HA8:WDYHV1; NbExp=3; IntAct=EBI-1372759, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Phosphorylation of Ser-257 by MAPK14 (p38) inhibits ETV6
CC       transcriptional repression. {ECO:0000269|PubMed:12435397}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in
CC       a form of chronic myelomonocytic leukemia (CMML). Translocation
CC       t(5;12)(q33;p13) with PDGFRB. It is characterized by abnormal
CC       clonal myeloid proliferation and by progression to acute
CC       myelogenous leukemia (AML). {ECO:0000269|PubMed:8168137}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving ETV6 are found in
CC       acute myeloid leukemia (AML). Translocation t(12;22)(p13;q11) with
CC       MN1 (PubMed:7731705). Translocation t(4;12)(q12;p13) with CHIC2
CC       (PubMed:10477709). {ECO:0000269|PubMed:10477709,
CC       ECO:0000269|PubMed:7731705}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving ETV6 are found in
CC       childhood acute lymphoblastic leukemia (ALL). Translocations
CC       t(12;21)(p12;q22) and t(12;21)(p13;q22) with RUNX1/AML1.
CC       {ECO:0000269|PubMed:7761424}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in
CC       a form of pre-B acute lymphoid leukemia. Translocation
CC       t(9;12)(p24;p13) with JAK2. {ECO:0000269|PubMed:9326218}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 and JAK2 is
CC       found in an atypical chronic myelogenous leukemia. Translocation
CC       t(9;15;12)(p24;q15;p13). {ECO:0000269|PubMed:9326218}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in
CC       myelodysplastic syndrome (MDS) with basophilia. Translocation
CC       t(5;12)(q31;p13) with ACSL6. {ECO:0000269|PubMed:10502316}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in
CC       acute eosinophilic leukemia (AEL). Translocation t(5;12)(q31;p13)
CC       with ACSL6. {ECO:0000269|PubMed:10502316}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in
CC       myelodysplastic syndrome (MDS). Translocation t(1;12)(p36.1;p13)
CC       with MDS2. {ECO:0000269|PubMed:12203785}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in
CC       acute lymphoblastic leukemia. Translocation t(9;12)(p13;p13) with
CC       PAX5. {ECO:0000269|PubMed:17344859}.
CC   -!- DISEASE: Myeloproliferative disorder chronic with eosinophilia
CC       (MPE) [MIM:131440]: A hematologic disorder characterized by
CC       malignant eosinophils proliferation.
CC       {ECO:0000269|PubMed:12181402}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis. A chromosomal
CC       aberration involving ETV6 is found in many instances of
CC       myeloproliferative disorder chronic with eosinophilia.
CC       Translocation t(5;12) with PDGFRB on chromosome 5 creating an
CC       ETV6-PDGFRB fusion protein. {ECO:0000269|PubMed:12181402}.
CC   -!- DISEASE: Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype
CC       of acute leukemia, a cancer of the white blood cells. AML is a
CC       malignant disease of bone marrow characterized by maturational
CC       arrest of hematopoietic precursors at an early stage of
CC       development. Clonal expansion of myeloid blasts occurs in bone
CC       marrow, blood, and other tissue. Myelogenous leukemias develop
CC       from changes in cells that normally produce neutrophils,
CC       basophils, eosinophils and monocytes.
CC       {ECO:0000269|PubMed:15806161}. Note=The gene represented in this
CC       entry is involved in disease pathogenesis.
CC   -!- DISEASE: Thrombocytopenia 5 (THC5) [MIM:616216]: Thrombocytopenia
CC       is defined by a decrease in the number of platelets in circulating
CC       blood, resulting in the potential for increased bleeding and
CC       decreased ability for clotting. THC5 is an autosomal dominant
CC       disorder, associated with an increased susceptibility to the
CC       development of hematologic and solid malignancies.
CC       {ECO:0000269|PubMed:25581430}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ETS family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABI30005.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ETV6ID38.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U11732; AAA19786.1; -; mRNA.
DR   EMBL; AK289441; BAF82130.1; -; mRNA.
DR   EMBL; CH471094; EAW96240.1; -; Genomic_DNA.
DR   EMBL; BC043399; AAH43399.1; -; mRNA.
DR   EMBL; U61375; AAC50690.1; -; Genomic_DNA.
DR   EMBL; U63312; AAB17134.1; -; Genomic_DNA.
DR   EMBL; U63313; AAB17135.1; -; Genomic_DNA.
DR   EMBL; DQ841178; ABI30005.1; ALT_INIT; mRNA.
DR   CCDS; CCDS8643.1; -.
DR   RefSeq; NP_001978.1; NM_001987.4.
DR   UniGene; Hs.504765; -.
DR   PDB; 1JI7; X-ray; 1.45 A; A/B/C=47-123.
DR   PDB; 1LKY; X-ray; 2.30 A; A/B/C/D/E/F=47-123.
DR   PDB; 2DAO; NMR; -; A=338-442.
DR   PDB; 2QAR; X-ray; 2.40 A; A/B/D/E=47-124.
DR   PDB; 2QB0; X-ray; 2.56 A; A/C=47-123.
DR   PDB; 2QB1; X-ray; 2.61 A; A/B=47-121.
DR   PDB; 5L0P; X-ray; 2.30 A; A=47-356.
DR   PDBsum; 1JI7; -.
DR   PDBsum; 1LKY; -.
DR   PDBsum; 2DAO; -.
DR   PDBsum; 2QAR; -.
DR   PDBsum; 2QB0; -.
DR   PDBsum; 2QB1; -.
DR   PDBsum; 5L0P; -.
DR   ProteinModelPortal; P41212; -.
DR   SMR; P41212; -.
DR   BioGrid; 108421; 34.
DR   DIP; DIP-17028N; -.
DR   ELM; P41212; -.
DR   IntAct; P41212; 15.
DR   MINT; P41212; -.
DR   STRING; 9606.ENSP00000379658; -.
DR   BindingDB; P41212; -.
DR   ChEMBL; CHEMBL2401606; -.
DR   iPTMnet; P41212; -.
DR   PhosphoSitePlus; P41212; -.
DR   BioMuta; ETV6; -.
DR   DMDM; 730927; -.
DR   EPD; P41212; -.
DR   MaxQB; P41212; -.
DR   PaxDb; P41212; -.
DR   PeptideAtlas; P41212; -.
DR   PRIDE; P41212; -.
DR   DNASU; 2120; -.
DR   Ensembl; ENST00000396373; ENSP00000379658; ENSG00000139083.
DR   GeneID; 2120; -.
DR   KEGG; hsa:2120; -.
DR   UCSC; uc001qzz.4; human.
DR   CTD; 2120; -.
DR   DisGeNET; 2120; -.
DR   EuPathDB; HostDB:ENSG00000139083.10; -.
DR   GeneCards; ETV6; -.
DR   HGNC; HGNC:3495; ETV6.
DR   HPA; HPA000264; -.
DR   MalaCards; ETV6; -.
DR   MIM; 131440; phenotype.
DR   MIM; 600618; gene.
DR   MIM; 601626; phenotype.
DR   MIM; 616216; phenotype.
DR   neXtProt; NX_P41212; -.
DR   OpenTargets; ENSG00000139083; -.
DR   Orphanet; 98823; Chronic myelomonocytic leukemia.
DR   Orphanet; 2665; Congenital mesoblastic nephroma.
DR   Orphanet; 2030; Fibrosarcoma.
DR   Orphanet; 99860; Precursor B-cell acute lymphoblastic leukemia.
DR   Orphanet; 314950; Primary hypereosinophilic syndrome.
DR   PharmGKB; PA27909; -.
DR   eggNOG; KOG3804; Eukaryota.
DR   eggNOG; ENOG4111K4J; LUCA.
DR   GeneTree; ENSGT00760000118996; -.
DR   HOGENOM; HOG000012982; -.
DR   HOVERGEN; HBG005617; -.
DR   InParanoid; P41212; -.
DR   KO; K03211; -.
DR   OMA; HQEPYPL; -.
DR   OrthoDB; EOG091G05Q3; -.
DR   PhylomeDB; P41212; -.
DR   TreeFam; TF318679; -.
DR   SIGNOR; P41212; -.
DR   ChiTaRS; ETV6; human.
DR   EvolutionaryTrace; P41212; -.
DR   GeneWiki; ETV6; -.
DR   GenomeRNAi; 2120; -.
DR   PRO; PR:P41212; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139083; -.
DR   CleanEx; HS_ETV6; -.
DR   ExpressionAtlas; P41212; baseline and differential.
DR   Genevisible; P41212; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; IC:NTNU_SB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0071425; P:hematopoietic stem cell proliferation; IMP:UniProtKB.
DR   GO; GO:0097152; P:mesenchymal cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0022008; P:neurogenesis; IEA:Ensembl.
DR   GO; GO:0007296; P:vitellogenesis; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR000418; Ets_dom.
DR   InterPro; IPR003118; Pointed_dom.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00178; Ets; 1.
DR   Pfam; PF02198; SAM_PNT; 1.
DR   PRINTS; PR00454; ETSDOMAIN.
DR   SMART; SM00413; ETS; 1.
DR   SMART; SM00251; SAM_PNT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS00346; ETS_DOMAIN_2; 1.
DR   PROSITE; PS50061; ETS_DOMAIN_3; 1.
DR   PROSITE; PS51433; PNT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosomal rearrangement;
KW   Complete proteome; Disease mutation; DNA-binding; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Proto-oncogene; Reference proteome;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN         1    452       Transcription factor ETV6.
FT                                /FTId=PRO_0000204121.
FT   DOMAIN       40    124       PNT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00762}.
FT   DNA_BIND    339    420       ETS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00237}.
FT   SITE         11     12       Breakpoint for translocation to form
FT                                CHIC2-ETV6 in AML.
FT   SITE         54     55       Breakpoint for translocation to form
FT                                ETV6-MDS2 in MDS.
FT   SITE         55     56       Breakpoint for translocation to form
FT                                PAX5-ETV6.
FT   SITE        336    337       Breakpoint for translocation to form
FT                                ETV6-AML1 in ALL.
FT   MOD_RES      11     11       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      18     18       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:12435397}.
FT   MOD_RES     213    213       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     238    238       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97360}.
FT   MOD_RES     257    257       Phosphoserine; by MAPK14.
FT                                {ECO:0000269|PubMed:12435397}.
FT   MOD_RES     302    302       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97360}.
FT   CROSSLNK     11     11       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    288    288       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    302    302       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    403    403       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    421    421       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT     214    214       P -> L (in THC5; abrogates DNA binding;
FT                                alters subcellular location; decreases
FT                                transcriptional repression in a dominant-
FT                                negative fashion; dbSNP:rs724159947).
FT                                {ECO:0000269|PubMed:25581430}.
FT                                /FTId=VAR_073322.
FT   VARIANT     344    344       Y -> YG (in one individual with AML;
FT                                somatic mutation; unable to repress
FT                                transcription).
FT                                {ECO:0000269|PubMed:15806161}.
FT                                /FTId=VAR_034600.
FT   VARIANT     369    369       R -> Q (in THC5; abrogates DNA binding;
FT                                alters subcellular location; decreases
FT                                transcriptional repression in a dominant-
FT                                negative fashion; dbSNP:rs724159946).
FT                                {ECO:0000269|PubMed:25581430}.
FT                                /FTId=VAR_073323.
FT   VARIANT     399    399       R -> C (in THC5; abrogates DNA binding;
FT                                alters subcellular location; decreases
FT                                transcriptional repression in a dominant-
FT                                negative fashion; dbSNP:rs724159945).
FT                                {ECO:0000269|PubMed:25581430}.
FT                                /FTId=VAR_073324.
FT   MUTAGEN      22     22       S->A: No effect.
FT   MUTAGEN     213    213       S->A: No effect.
FT                                {ECO:0000269|PubMed:12435397}.
FT   MUTAGEN     238    238       S->A: No effect.
FT                                {ECO:0000269|PubMed:12435397}.
FT   MUTAGEN     257    257       S->A: No phosphorylation by MAPK14.
FT                                {ECO:0000269|PubMed:12435397}.
FT   HELIX        12     18       {ECO:0000244|PDB:5L0P}.
FT   TURN         20     22       {ECO:0000244|PDB:5L0P}.
FT   HELIX        23     27       {ECO:0000244|PDB:5L0P}.
FT   HELIX        30     38       {ECO:0000244|PDB:5L0P}.
FT   HELIX        52     54       {ECO:0000244|PDB:1JI7}.
FT   HELIX        58     60       {ECO:0000244|PDB:1JI7}.
FT   HELIX        63     76       {ECO:0000244|PDB:1JI7}.
FT   TURN         84     87       {ECO:0000244|PDB:1JI7}.
FT   HELIX        91     94       {ECO:0000244|PDB:1JI7}.
FT   HELIX        99    105       {ECO:0000244|PDB:1JI7}.
FT   TURN        107    109       {ECO:0000244|PDB:1JI7}.
FT   HELIX       110    122       {ECO:0000244|PDB:1JI7}.
FT   HELIX       341    350       {ECO:0000244|PDB:2DAO}.
FT   HELIX       352    354       {ECO:0000244|PDB:2DAO}.
FT   TURN        355    357       {ECO:0000244|PDB:2DAO}.
FT   STRAND      358    362       {ECO:0000244|PDB:2DAO}.
FT   HELIX       363    365       {ECO:0000244|PDB:2DAO}.
FT   STRAND      367    371       {ECO:0000244|PDB:2DAO}.
FT   HELIX       373    383       {ECO:0000244|PDB:2DAO}.
FT   HELIX       391    403       {ECO:0000244|PDB:2DAO}.
FT   STRAND      406    408       {ECO:0000244|PDB:2DAO}.
FT   STRAND      411    419       {ECO:0000244|PDB:2DAO}.
FT   HELIX       424    426       {ECO:0000244|PDB:2DAO}.
FT   STRAND      430    432       {ECO:0000244|PDB:2DAO}.
FT   HELIX       434    438       {ECO:0000244|PDB:2DAO}.
SQ   SEQUENCE   452 AA;  53000 MW;  DEC45682ECADECBB CRC64;
     MSETPAQCSI KQERISYTPP ESPVPSYASS TPLHVPVPRA LRMEEDSIRL PAHLRLQPIY
     WSRDDVAQWL KWAENEFSLR PIDSNTFEMN GKALLLLTKE DFRYRSPHSG DVLYELLQHI
     LKQRKPRILF SPFFHPGNSI HTQPEVILHQ NHEEDNCVQR TPRPSVDNVH HNPPTIELLH
     RSRSPITTNH RPSPDPEQRP LRSPLDNMIR RLSPAERAQG PRPHQENNHQ ESYPLSVSPM
     ENNHCPASSE SHPKPSSPRQ ESTRVIQLMP SPIMHPLILN PRHSVDFKQS RLSEDGLHRE
     GKPINLSHRE DLAYMNHIMV SVSPPEEHAM PIGRIADCRL LWDYVYQLLS DSRYENFIRW
     EDKESKIFRI VDPNGLARLW GNHKNRTNMT YEKMSRALRH YYKLNIIRKE PGQRLLFRFM
     KTPDEIMSGR TDRLEHLESQ ELDEQIYQED EC
//
ID   EXT1_HUMAN              Reviewed;         746 AA.
AC   Q16394; B2R7V2; Q9BVI9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-MAR-2002, sequence version 2.
DT   28-FEB-2018, entry version 182.
DE   RecName: Full=Exostosin-1;
DE            EC=2.4.1.224;
DE            EC=2.4.1.225;
DE   AltName: Full=Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;
DE   AltName: Full=Multiple exostoses protein 1;
DE   AltName: Full=Putative tumor suppressor protein EXT1;
GN   Name=EXT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=7550340; DOI=10.1038/ng1095-137;
RA   Ahn J., Luedecke H.-J., Lindow S., Horton W.A., Lee B., Wagner M.J.,
RA   Horsthemke B., Wells D.E.;
RT   "Cloning of the putative tumour suppressor gene for hereditary
RT   multiple exostoses (EXT1).";
RL   Nat. Genet. 11:137-143(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-320.
RC   TISSUE=Lung;
RX   PubMed=9119404; DOI=10.1006/geno.1996.4577;
RA   Luedecke H.-J., Ahn J., Lin X., Hill A., Wagner M.J., Schomburg L.,
RA   Horsthemke B., Wells D.E.;
RT   "Genomic organization and promoter structure of the human EXT1 gene.";
RL   Genomics 40:351-354(1997).
RN   [6]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=10679296; DOI=10.1006/bbrc.2000.2219;
RA   Kobayashi S., Morimoto K., Shimizu T., Takahashi M., Kurosawa H.,
RA   Shirasawa T.;
RT   "Association of EXT1 and EXT2, hereditary multiple exostoses gene
RT   products, in Golgi apparatus.";
RL   Biochem. Biophys. Res. Commun. 268:860-867(2000).
RN   [7]
RP   FUNCTION.
RX   PubMed=11518722; DOI=10.1172/JCI13737;
RA   Duncan G., McCormick C., Tufaro F.;
RT   "The link between heparan sulfate and hereditary bone disease: finding
RT   a function for the EXT family of putative tumor suppressor proteins.";
RL   J. Clin. Invest. 108:511-516(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=22660413; DOI=10.1038/ncb2502;
RA   Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G.,
RA   Geeraerts A., Ivarsson Y., Depoortere F., Coomans C., Vermeiren E.,
RA   Zimmermann P., David G.;
RT   "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.";
RL   Nat. Cell Biol. 14:677-685(2012).
RN   [9]
RP   REVIEW ON VARIANTS.
RX   PubMed=10679937;
RX   DOI=10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K;
RA   Wuyts W., Van Hul W.;
RT   "Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2
RT   genes.";
RL   Hum. Mutat. 15:220-227(2000).
RN   [10]
RP   VARIANTS EXT1 GLY-280 AND HIS-340.
RA   Raskind W.H., Matsushita M., Conrad E.U. III, Wells D.E.,
RA   Sandell L.J., Wagner M.J., Houck J.;
RT   "Spectrum of EXT1 mutations in hereditary multiple exostoses.";
RL   Am. J. Hum. Genet. 59:A280-A280(1996).
RN   [11]
RP   VARIANT EXT1 LEU-340.
RX   PubMed=8981950;
RA   Hecht J.T., Hogue D.A., Wang Y., Blanton S.H., Wagner M.J.,
RA   Strong L.C., Raskind W.H., Hansen M.F., Wells D.E.;
RT   "Hereditary multiple exostoses (EXT): mutational studies of familial
RT   EXT1 cases and EXT-associated malignancies.";
RL   Am. J. Hum. Genet. 60:80-86(1997).
RN   [12]
RP   VARIANTS EXT1 ASP-339 AND CYS-340.
RX   PubMed=9326317; DOI=10.1086/515505;
RA   Philippe C., Porter D.E., Emerton M.E., Wells D.E., Simpson A.H.R.W.,
RA   Monaco A.P.;
RT   "Mutation screening of the EXT1 and EXT2 genes in patients with
RT   hereditary multiple exostoses.";
RL   Am. J. Hum. Genet. 61:520-528(1997).
RN   [13]
RP   VARIANTS EXT1 GLY-280 AND SER-340.
RX   PubMed=9463333; DOI=10.1086/301726;
RA   Wuyts W., van Hul W., de Boulle K., Hendrickx J., Bakker E.,
RA   Vanhoenacker F., Mollica F., Luedecke H.-J., Sayli B.S.,
RA   Pazzaglia U.E., Mortier G., Hamel B.C.J., Conrad E.U. III,
RA   Matsushita M., Raskind W.H., Willems P.J.;
RT   "Mutations in the EXT1 and EXT2 genes in hereditary multiple
RT   exostoses.";
RL   Am. J. Hum. Genet. 62:346-354(1998).
RN   [14]
RP   VARIANTS EXT1 GLY-280; SER-280; HIS-340 AND HIS-627 DEL.
RX   PubMed=9521425;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:3<231::AID-HUMU8>3.0.CO;2-K;
RA   Raskind W.H., Conrad E.U. III, Matsushita M., Wijsman E.M.,
RA   Wells D.E., Chapman N., Sandell L.J., Wagner M.J., Houck J.;
RT   "Evaluation of locus heterogeneity and EXT1 mutations in 34 families
RT   with hereditary multiple exostoses.";
RL   Hum. Mutat. 11:231-239(1998).
RN   [15]
RP   VARIANTS EXT1 HIS-164; 235-PRO--LYS-239 DEL AND SER-316.
RX   PubMed=10441575; DOI=10.1086/302532;
RA   Bovee J.V.M.G., Cleton-Jansen A.-M., Wuyts W., Caethoven G.,
RA   Taminiau A.H.M., Bakker E., van Hul W., Cornelisse C.J.,
RA   Hogendoorn P.C.W.;
RT   "EXT-mutation analysis and loss of heterozygosity in sporadic and
RT   hereditary osteochondromas and secondary chondrosarcomas.";
RL   Am. J. Hum. Genet. 65:689-698(1999).
RN   [16]
RP   VARIANTS EXT1 VAL-486 AND LEU-496.
RX   PubMed=10480354; DOI=10.1007/s004399900058;
RA   Xu L., Xia J., Jiang H., Zhou J., Li H., Wang D., Pan Q., Long Z.,
RA   Fan C., Deng H.-X.;
RT   "Mutation analysis of hereditary multiple exostoses in the Chinese.";
RL   Hum. Genet. 105:45-50(1999).
RN   [17]
RP   VARIANT EXT1 215-MET--SER-221 DEL, AND VARIANT OSTEOCHONDROMA
RP   215-MET--SER-222 DELINS ILE.
RX   PubMed=11169766;
RX   DOI=10.1002/1097-0169(200102)48:2<149::AID-CM1005>3.0.CO;2-3;
RA   Bernard M.A., Hall C.E., Hogue D.A., Cole W.G., Scott A., Snuggs M.B.,
RA   Clines G.A., Luedecke H.-J., Lovett M., Van Winkle W.B., Hecht J.T.;
RT   "Diminished levels of the putative tumor suppressor proteins EXT1 and
RT   EXT2 in exostosis chondrocytes.";
RL   Cell Motil. Cytoskeleton 48:149-162(2001).
RN   [18]
RP   CHARACTERIZATION OF VARIANTS, AND MUTAGENESIS OF GLN-27; ASP-164;
RP   ASN-316; ALA-486 AND PRO-496.
RX   PubMed=11391482; DOI=10.1086/321278;
RA   Cheung P.K., McCormick C., Crawford B.E., Esko J.D., Tufaro F.,
RA   Duncan G.;
RT   "Etiological point mutations in the hereditary multiple exostoses gene
RT   EXT1: a functional analysis of heparan sulfate polymerase activity.";
RL   Am. J. Hum. Genet. 69:55-66(2001).
CC   -!- FUNCTION: Glycosyltransferase required for the biosynthesis of
CC       heparan-sulfate. The EXT1/EXT2 complex possesses substantially
CC       higher glycosyltransferase activity than EXT1 or EXT2 alone.
CC       Appears to be a tumor suppressor. Required for the exosomal
CC       release of SDCBP, CD63 and syndecan (PubMed:22660413).
CC       {ECO:0000269|PubMed:11518722, ECO:0000269|PubMed:22660413}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-D-glucosamine + beta-D-
CC       glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-proteoglycan =
CC       UDP + N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-
CC       (1->4)-N-acetyl-alpha-D-glucosaminyl-proteoglycan.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucuronate + N-acetyl-alpha-D-
CC       glucosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan = UDP + beta-
CC       D-glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-
CC       glucuronosyl-proteoglycan.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q9ES89};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Forms a homo/hetero-oligomeric complex with EXT2.
CC       {ECO:0000269|PubMed:10679296}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10679296}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:10679296}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:10679296}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:10679296}. Note=The EXT1/EXT2 complex
CC       is localized in the Golgi apparatus.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Hereditary multiple exostoses 1 (EXT1) [MIM:133700]: EXT
CC       is a genetically heterogeneous bone disorder caused by genes
CC       segregating on human chromosomes 8, 11, and 19 and designated
CC       EXT1, EXT2 and EXT3 respectively. EXT is a dominantly inherited
CC       skeletal disorder primarily affecting endochondral bone during
CC       growth. The disease is characterized by formation of numerous
CC       cartilage-capped, benign bone tumors (osteocartilaginous exostoses
CC       or osteochondromas) that are often accompanied by skeletal
CC       deformities and short stature. In a small percentage of cases
CC       exostoses have exhibited malignant transformation resulting in an
CC       osteosarcoma or chondrosarcoma. Osteochondromas development can
CC       also occur as a sporadic event. {ECO:0000269|PubMed:10441575,
CC       ECO:0000269|PubMed:10480354, ECO:0000269|PubMed:11169766,
CC       ECO:0000269|PubMed:8981950, ECO:0000269|PubMed:9326317,
CC       ECO:0000269|PubMed:9463333, ECO:0000269|PubMed:9521425,
CC       ECO:0000269|Ref.10}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Tricho-rhino-phalangeal syndrome 2 (TRPS2) [MIM:150230]:
CC       A syndrome that combines the clinical features of tricho-rhino-
CC       phalangeal syndrome type 1 and multiple exostoses type 1. Affected
CC       individuals manifest multiple dysmorphic facial features including
CC       large, laterally protruding ears, a bulbous nose, an elongated
CC       upper lip, as well as sparse scalp hair, winged scapulae, multiple
CC       cartilaginous exostoses, redundant skin, and mental retardation.
CC       Note=The gene represented in this entry is involved in disease
CC       pathogenesis. A chromosomal aberration resulting in the loss of
CC       functional copies of TRPS1 and EXT1 has been found in TRPS2
CC       patients.
CC   -!- DISEASE: Chondrosarcoma (CHDSA) [MIM:215300]: A malignant neoplasm
CC       derived from cartilage cells. Chondrosarcomas range from slow-
CC       growing non-metastasizing lesions to highly aggressive
CC       metastasizing sarcomas. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 47 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EXT1ID212.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S79639; AAB62283.1; -; mRNA.
DR   EMBL; AK313129; BAG35949.1; -; mRNA.
DR   EMBL; CH471060; EAW91972.1; -; Genomic_DNA.
DR   EMBL; BC001174; AAH01174.1; -; mRNA.
DR   EMBL; U70539; AAC51154.1; -; Genomic_DNA.
DR   CCDS; CCDS6324.1; -.
DR   RefSeq; NP_000118.2; NM_000127.2.
DR   UniGene; Hs.492618; -.
DR   ProteinModelPortal; Q16394; -.
DR   SMR; Q16394; -.
DR   BioGrid; 108432; 28.
DR   IntAct; Q16394; 2.
DR   STRING; 9606.ENSP00000367446; -.
DR   CAZy; GT47; Glycosyltransferase Family 47.
DR   CAZy; GT64; Glycosyltransferase Family 64.
DR   iPTMnet; Q16394; -.
DR   PhosphoSitePlus; Q16394; -.
DR   BioMuta; EXT1; -.
DR   DMDM; 20141422; -.
DR   EPD; Q16394; -.
DR   MaxQB; Q16394; -.
DR   PaxDb; Q16394; -.
DR   PeptideAtlas; Q16394; -.
DR   PRIDE; Q16394; -.
DR   DNASU; 2131; -.
DR   Ensembl; ENST00000378204; ENSP00000367446; ENSG00000182197.
DR   GeneID; 2131; -.
DR   KEGG; hsa:2131; -.
DR   UCSC; uc003yok.3; human.
DR   CTD; 2131; -.
DR   DisGeNET; 2131; -.
DR   EuPathDB; HostDB:ENSG00000182197.10; -.
DR   GeneCards; EXT1; -.
DR   GeneReviews; EXT1; -.
DR   HGNC; HGNC:3512; EXT1.
DR   HPA; HPA044394; -.
DR   MalaCards; EXT1; -.
DR   MIM; 133700; phenotype.
DR   MIM; 150230; phenotype.
DR   MIM; 215300; phenotype.
DR   MIM; 608177; gene.
DR   neXtProt; NX_Q16394; -.
DR   OpenTargets; ENSG00000182197; -.
DR   Orphanet; 55880; Chondrosarcoma.
DR   Orphanet; 502; Langer-Giedion syndrome.
DR   Orphanet; 321; Multiple osteochondromas.
DR   PharmGKB; PA27924; -.
DR   eggNOG; KOG1021; Eukaryota.
DR   eggNOG; ENOG410XTFH; LUCA.
DR   GeneTree; ENSGT00550000074496; -.
DR   HOGENOM; HOG000266990; -.
DR   HOVERGEN; HBG003459; -.
DR   InParanoid; Q16394; -.
DR   KO; K02366; -.
DR   OMA; SHYWDDS; -.
DR   OrthoDB; EOG091G0BDR; -.
DR   PhylomeDB; Q16394; -.
DR   TreeFam; TF314231; -.
DR   BioCyc; MetaCyc:HS00012-MONOMER; -.
DR   BRENDA; 2.4.1.224; 2681.
DR   BRENDA; 2.4.1.225; 2681.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   Reactome; R-HSA-3656253; Defective EXT1 causes exostoses 1, TRPS2 and CHDS.
DR   SIGNOR; Q16394; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; EXT1; human.
DR   GeneWiki; EXT1; -.
DR   GenomeRNAi; 2131; -.
DR   PRO; PR:Q16394; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000182197; -.
DR   CleanEx; HS_EXT1; -.
DR   ExpressionAtlas; Q16394; baseline and differential.
DR   Genevisible; Q16394; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:ProtInc.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
DR   GO; GO:0000139; C:Golgi membrane; TAS:BHF-UCL.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0008375; F:acetylglucosaminyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0050508; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0042328; F:heparan sulfate N-acetylglucosaminyltransferase activity; NAS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050509; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0016757; F:transferase activity, transferring glycosyl groups; IDA:BHF-UCL.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0033692; P:cellular polysaccharide biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0072498; P:embryonic skeletal joint development; IEA:Ensembl.
DR   GO; GO:0007492; P:endoderm development; IEA:Ensembl.
DR   GO; GO:0007369; P:gastrulation; IEA:Ensembl.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0015014; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0007498; P:mesoderm development; IEA:Ensembl.
DR   GO; GO:0021772; P:olfactory bulb development; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; IMP:BHF-UCL.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR004263; Exostosin.
DR   InterPro; IPR027670; Exostosin-1.
DR   InterPro; IPR015338; EXT_C.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR11062:SF97; PTHR11062:SF97; 1.
DR   Pfam; PF03016; Exostosin; 1.
DR   Pfam; PF09258; Glyco_transf_64; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Glycosyltransferase;
KW   Golgi apparatus; Hereditary multiple exostoses; Manganese; Membrane;
KW   Metal-binding; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix; Tumor suppressor.
FT   CHAIN         1    746       Exostosin-1.
FT                                /FTId=PRO_0000149648.
FT   TOPO_DOM      1      7       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      8     28       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     29    746       Lumenal. {ECO:0000255}.
FT   REGION      544    549       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   REGION      565    567       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   REGION      650    654       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   REGION      688    701       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   ACT_SITE    654    654       {ECO:0000250|UniProtKB:Q9ES89}.
FT   METAL       567    567       Manganese; catalytic.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   BINDING     518    518       Substrate.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   BINDING     595    595       Substrate.
FT                                {ECO:0000250|UniProtKB:Q9ES89}.
FT   CARBOHYD     89     89       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    330    330       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    652    704       {ECO:0000250|UniProtKB:Q9ES89}.
FT   VARIANT      27     27       Q -> K (in EXT1; no loss of activity).
FT                                /FTId=VAR_012815.
FT   VARIANT     164    164       D -> H (in EXT1; loss of activity).
FT                                {ECO:0000269|PubMed:10441575}.
FT                                /FTId=VAR_012816.
FT   VARIANT     215    222       MLAKASIS -> I (in isolated
FT                                osteochondroma; somatic mutation).
FT                                {ECO:0000269|PubMed:11169766}.
FT                                /FTId=VAR_012818.
FT   VARIANT     215    221       Missing (in EXT1).
FT                                /FTId=VAR_012817.
FT   VARIANT     235    239       Missing (in multiple osteochondromas).
FT                                {ECO:0000269|PubMed:10441575}.
FT                                /FTId=VAR_012819.
FT   VARIANT     280    280       R -> G (in EXT1; loss of activity).
FT                                {ECO:0000269|PubMed:9463333,
FT                                ECO:0000269|PubMed:9521425,
FT                                ECO:0000269|Ref.10}.
FT                                /FTId=VAR_002370.
FT   VARIANT     280    280       R -> S (in EXT1; loss of activity).
FT                                {ECO:0000269|PubMed:9521425}.
FT                                /FTId=VAR_002371.
FT   VARIANT     316    316       N -> S (in chondrosarcoma; no loss of
FT                                activity). {ECO:0000269|PubMed:10441575}.
FT                                /FTId=VAR_012820.
FT   VARIANT     339    339       G -> D (in EXT1; loss of activity;
FT                                dbSNP:rs119103288).
FT                                {ECO:0000269|PubMed:9326317}.
FT                                /FTId=VAR_002372.
FT   VARIANT     340    340       R -> C (in EXT1; loss of activity; still
FT                                able to form an oligomeric complex;
FT                                dbSNP:rs119103290).
FT                                {ECO:0000269|PubMed:9326317}.
FT                                /FTId=VAR_002373.
FT   VARIANT     340    340       R -> H (in EXT1; loss of activity;
FT                                dbSNP:rs119103287).
FT                                {ECO:0000269|PubMed:9521425,
FT                                ECO:0000269|Ref.10}.
FT                                /FTId=VAR_002374.
FT   VARIANT     340    340       R -> L (in EXT1; loss of activity;
FT                                dbSNP:rs119103287).
FT                                {ECO:0000269|PubMed:8981950}.
FT                                /FTId=VAR_002375.
FT   VARIANT     340    340       R -> S (in EXT1; loss of activity).
FT                                {ECO:0000269|PubMed:9463333}.
FT                                /FTId=VAR_002376.
FT   VARIANT     486    486       A -> V (in EXT1; no loss of activity;
FT                                dbSNP:rs188859975).
FT                                {ECO:0000269|PubMed:10480354}.
FT                                /FTId=VAR_012821.
FT   VARIANT     496    496       P -> L (in EXT1; no loss of activity).
FT                                {ECO:0000269|PubMed:10480354}.
FT                                /FTId=VAR_012822.
FT   VARIANT     627    627       Missing (in EXT1; loss of activity).
FT                                {ECO:0000269|PubMed:9521425}.
FT                                /FTId=VAR_002377.
FT   MUTAGEN      27     27       Q->A,P: No effect on heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   MUTAGEN      27     27       Missing: No effect on heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   MUTAGEN     164    164       D->E: Abolishes heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   MUTAGEN     164    164       Missing: Abolishes heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   MUTAGEN     316    316       N->A: No effect on heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   MUTAGEN     316    316       Missing: No effect on heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   MUTAGEN     486    486       A->H: No effect on heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   MUTAGEN     486    486       Missing: No effect on heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   MUTAGEN     496    496       P->H: No effect on heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   MUTAGEN     496    496       Missing: No effect on heparan-sulfate
FT                                biosynthesis.
FT                                {ECO:0000269|PubMed:11391482}.
FT   CONFLICT     60     61       DA -> EP (in Ref. 1 and 3).
FT                                {ECO:0000305}.
SQ   SEQUENCE   746 AA;  86255 MW;  842CD7E6C1312C1A CRC64;
     MQAKKRYFIL LSAGSCLALL FYFGGLQFRA SRSHSRREEH SGRNGLHHPS PDHFWPRFPD
     ALRPFVPWDQ LENEDSSVHI SPRQKRDANS SIYKGKKCRM ESCFDFTLCK KNGFKVYVYP
     QQKGEKIAES YQNILAAIEG SRFYTSDPSQ ACLFVLSLDT LDRDQLSPQY VHNLRSKVQS
     LHLWNNGRNH LIFNLYSGTW PDYTEDVGFD IGQAMLAKAS ISTENFRPNF DVSIPLFSKD
     HPRTGGERGF LKFNTIPPLR KYMLVFKGKR YLTGIGSDTR NALYHVHNGE DVVLLTTCKH
     GKDWQKHKDS RCDRDNTEYE KYDYREMLHN ATFCLVPRGR RLGSFRFLEA LQAACVPVML
     SNGWELPFSE VINWNQAAVI GDERLLLQIP STIRSIHQDK ILALRQQTQF LWEAYFSSVE
     KIVLTTLEII QDRIFKHISR NSLIWNKHPG GLFVLPQYSS YLGDFPYYYA NLGLKPPSKF
     TAVIHAVTPL VSQSQPVLKL LVAAAKSQYC AQIIVLWNCD KPLPAKHRWP ATAVPVVVIE
     GESKVMSSRF LPYDNIITDA VLSLDEDTVL STTEVDFAFT VWQSFPERIV GYPARSHFWD
     NSKERWGYTS KWTNDYSMVL TGAAIYHKYY HYLYSHYLPA SLKNMVDQLA NCEDILMNFL
     VSAVTKLPPI KVTQKKQYKE TMMGQTSRAS RWADPDHFAQ RQSCMNTFAS WFGYMPLIHS
     QMRLDPVLFK DQVSILRKKY RDIERL
//
ID   A0A024R366_HUMAN        Unreviewed;       147 AA.
AC   A0A024R366;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 30.
DE   SubName: Full=Fragile histidine triad gene, isoform CRA_a {ECO:0000313|EMBL:EAW65394.1};
GN   Name=FHIT {ECO:0000313|EMBL:EAW65394.1};
GN   ORFNames=hCG_1997982 {ECO:0000313|EMBL:EAW65394.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW65394.1};
RN   [1] {ECO:0000313|EMBL:EAW65394.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW65394.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471055; EAW65394.1; -; Genomic_DNA.
DR   RefSeq; NP_001159715.1; NM_001166243.2.
DR   RefSeq; NP_001307828.1; NM_001320899.1.
DR   RefSeq; NP_001307829.1; NM_001320900.1.
DR   RefSeq; NP_002003.1; NM_002012.3.
DR   UniGene; Hs.655995; -.
DR   ProteinModelPortal; A0A024R366; -.
DR   SMR; A0A024R366; -.
DR   PRIDE; A0A024R366; -.
DR   GeneID; 2272; -.
DR   KEGG; hsa:2272; -.
DR   CTD; 2272; -.
DR   EuPathDB; HostDB:ENSG00000189283.9; -.
DR   eggNOG; KOG3379; Eukaryota.
DR   eggNOG; COG0537; LUCA.
DR   KO; K01522; -.
DR   OMA; KFGPFEV; -.
DR   OrthoDB; EOG091G0RR0; -.
DR   PhylomeDB; A0A024R366; -.
DR   ChiTaRS; FHIT; human.
DR   GenomeRNAi; 2272; -.
DR   Bgee; ENSG00000189283; -.
DR   ExpressionAtlas; A0A024R366; baseline and differential.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0003824; F:catalytic activity; IEA:InterPro.
DR   Gene3D; 3.30.428.10; -; 1.
DR   InterPro; IPR019808; Histidine_triad_CS.
DR   InterPro; IPR001310; Histidine_triad_HIT.
DR   InterPro; IPR011146; HIT-like.
DR   InterPro; IPR036265; HIT-like_sf.
DR   PANTHER; PTHR23089; PTHR23089; 1.
DR   Pfam; PF01230; HIT; 1.
DR   SUPFAM; SSF54197; SSF54197; 1.
DR   PROSITE; PS00892; HIT_1; 1.
DR   PROSITE; PS51084; HIT_2; 1.
PE   4: Predicted;
FT   DOMAIN        2    109       HIT. {ECO:0000259|PROSITE:PS51084}.
FT   MOTIF        94     98       Histidine triad motif.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00464}.
SQ   SEQUENCE   147 AA;  16858 MW;  14D85961A19ECF3E CRC64;
     MSFRFGQHLI KPSVVFLKTE LSFALVNRKP VVPGHVLVCP LRPVERFHDL RPDEVADLFQ
     TTQRVGTVVE KHFHGTSLTF SMQDGPEAGQ TVKHVHVHVL PRKAGDFHRN DSIYEELQKH
     DKEDFPASWR SEEEMAAEAA ALRVYFQ
//
ID   FHIT_HUMAN              Reviewed;         147 AA.
AC   P49789; A2IAS9; A2IAT0; A2IAT6; A8K1A9; Q45QG9; Q6IU12;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-FEB-2018, entry version 167.
DE   RecName: Full=Bis(5'-adenosyl)-triphosphatase;
DE            EC=3.6.1.29;
DE   AltName: Full=AP3A hydrolase;
DE            Short=AP3Aase;
DE   AltName: Full=Diadenosine 5',5'''-P1,P3-triphosphate hydrolase;
DE   AltName: Full=Dinucleosidetriphosphatase;
DE   AltName: Full=Fragile histidine triad protein;
GN   Name=FHIT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=8598045; DOI=10.1016/S0092-8674(00)81034-X;
RA   Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J.,
RA   Siprashvili Z., Mori M., McCue P., Druck T., Croce C.M., Huebner K.;
RT   "The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal
RT   carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract
RT   cancers.";
RL   Cell 84:587-597(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9012482;
RA   Druck T., Hadaczek P., Fu T.B., Ohta M., Siprashvili Z., Baffa R.,
RA   Negrini M., Kastury K., Veronese M.L., Rosen D., Rothstein J.,
RA   McCue P., Cotticelli M.G., Inoue H., Croce C.M., Huebner K.;
RT   "Structure and expression of the human FHIT gene in normal and tumor
RT   cells.";
RL   Cancer Res. 57:504-512(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=24722188; DOI=10.1038/ncomms4650;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF
RP   94-146.
RA   Naqvi S.R.A., Malik A., Kukreti H., Chaudhary A., Anand R., Deo S.S.,
RA   Shukla N.K., Husain S.A., Pasha S.T.;
RT   "Mutational analysis of FHIT gene.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-35; HIS-94;
RP   HIS-96 AND HIS-98.
RX   PubMed=8794732; DOI=10.1021/bi961415t;
RA   Barnes L.D., Garrison P.N., Siprashvili Z., Guranowski A.,
RA   Robinson A.K., Ingram S.W., Croce C.M., Ohta M., Huebner K.;
RT   "Fhit, a putative tumor suppressor in humans, is a dinucleoside
RT   5',5''-P1,P3-triphosphate hydrolase.";
RL   Biochemistry 35:11529-11535(1996).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION WITH RNF139.
RX   PubMed=9689122; DOI=10.1073/pnas.95.16.9572;
RA   Gemmill R.M., West J.D., Boldog F., Tanaka N., Robinson L.J.,
RA   Smith D.I., Li F., Drabkin H.A.;
RT   "The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a
RT   patched-related gene, TRC8.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:9572-9577(1998).
RN   [10]
RP   INTERACTION WITH UBE2I.
RX   PubMed=11085938; DOI=10.1042/bj3520443;
RA   Shi Y., Zou M., Farid N.R., Paterson M.C.;
RT   "Association of FHIT (fragile histidine triad), a candidate tumour
RT   suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.";
RL   Biochem. J. 352:443-448(2000).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ILE-10; LEU-25 AND
RP   HIS-96.
RX   PubMed=12574506; DOI=10.1073/pnas.0437915100;
RA   Trapasso F., Krakowiak A., Cesari R., Arkles J., Yendamuri S.,
RA   Ishii H., Vecchione A., Kuroki T., Bieganowski P., Pace H.C.,
RA   Huebner K., Croce C.M., Brenner C.;
RT   "Designed FHIT alleles establish that Fhit-induced apoptosis in cancer
RT   cells is limited by substrate binding.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:1592-1597(2003).
RN   [12]
RP   ACTIVE SITE, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-96.
RX   PubMed=15182206; DOI=10.1021/bi049762n;
RA   Huang K., Arabshahi A., Wei Y., Frey P.A.;
RT   "The mechanism of action of the fragile histidine triad, Fhit:
RT   isolation of a covalent adenylyl enzyme and chemical rescue of H96G-
RT   Fhit.";
RL   Biochemistry 43:7637-7642(2004).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MDM2.
RX   PubMed=15313915; DOI=10.1158/0008-5472.CAN-04-0195;
RA   Nishizaki M., Sasaki J., Fang B., Atkinson E.N., Minna J.D.,
RA   Roth J.A., Ji L.;
RT   "Synergistic tumor suppression by coexpression of FHIT and p53
RT   coincides with FHIT-mediated MDM2 inactivation and p53 stabilization
RT   in human non-small cell lung cancer cells.";
RL   Cancer Res. 64:5745-5752(2004).
RN   [14]
RP   PHOSPHORYLATION BY SRC, SUBUNIT, SUBCELLULAR LOCATION, MASS
RP   SPECTROMETRY, DISEASE, PHOSPHORYLATION AT TYR-114 AND TYR-145, AND
RP   MUTAGENESIS OF TYR-114 AND TYR-145.
RX   PubMed=15007172; DOI=10.1073/pnas.0400481101;
RA   Pekarsky Y., Garrison P.N., Palamarchuk A., Zanesi N., Aqeilan R.I.,
RA   Huebner K., Barnes L.D., Croce C.M.;
RT   "Fhit is a physiological target of the protein kinase Src.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:3775-3779(2004).
RN   [15]
RP   MUTAGENESIS OF TYR-114, AND FUNCTION.
RX   PubMed=16407838; DOI=10.1038/sj.onc.1209323;
RA   Semba S., Trapasso F., Fabbri M., McCorkell K.A., Volinia S.,
RA   Druck T., Iliopoulos D., Pekarsky Y., Ishii H., Garrison P.N.,
RA   Barnes L.D., Croce C.M., Huebner K.;
RT   "Fhit modulation of the Akt-survivin pathway in lung cancer cells:
RT   Fhit-tyrosine 114 (Y114) is essential.";
RL   Oncogene 25:2860-2872(2006).
RN   [16]
RP   INTERACTION WITH CTNNB1, IDENTIFICATION IN A COMPLEX WITH CTNNB1 AND
RP   LEF1, AND FUNCTION.
RX   PubMed=18077326; DOI=10.1073/pnas.0703664105;
RA   Weiske J., Albring K.F., Huber O.;
RT   "The tumor suppressor Fhit acts as a repressor of beta-catenin
RT   transcriptional activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:20344-20349(2007).
RN   [17]
RP   SUBCELLULAR LOCATION, AND FUNCTION IN APOPTOSIS.
RX   PubMed=19622739; DOI=10.1073/pnas.0906484106;
RA   Rimessi A., Marchi S., Fotino C., Romagnoli A., Huebner K.,
RA   Croce C.M., Pinton P., Rizzuto R.;
RT   "Intramitochondrial calcium regulation by the FHIT gene product
RT   sensitizes to apoptosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12753-12758(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS).
RX   PubMed=9261067; DOI=10.1016/S0969-2126(97)00231-1;
RA   Lima C.D., D'Amico K.L., Naday I., Rosenbaum G., Westbrook E.M.,
RA   Hendrickson W.A.;
RT   "MAD analysis of FHIT, a putative human tumor suppressor from the HIT
RT   protein family.";
RL   Structure 5:763-774(1997).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEXES WITH SUBSTRATES,
RP   CATALYTIC ACTIVITY, FUNCTION, SUBUNIT, AND ACTIVE SITE.
RX   PubMed=9323207; DOI=10.1126/science.278.5336.286;
RA   Lima C.D., Klein M.G., Hendrickson W.A.;
RT   "Structure-based analysis of catalysis and substrate definition in the
RT   HIT protein family.";
RL   Science 278:286-290(1997).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEXES WITH SUBSTRATE
RP   ANALOGS, SUBUNIT, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-96.
RX   PubMed=9576908; DOI=10.1073/pnas.95.10.5484;
RA   Pace H.C., Garrison P.N., Robinson A.K., Barnes L.D., Draganescu A.,
RA   Roesler A., Blackburn G.M., Siprashvili Z., Croce C.M., Huebner K.,
RA   Brenner C.;
RT   "Genetic, biochemical, and crystallographic characterization of Fhit-
RT   substrate complexes as the active signaling form of Fhit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:5484-5489(1998).
CC   -!- FUNCTION: Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A)
CC       to yield AMP and ADP. Can also hydrolyze P(1)-P(4)-bis(5'-
CC       adenosyl) tetraphosphate (Ap4A), but has extremely low activity
CC       with ATP. Modulates transcriptional activation by CTNNB1 and
CC       thereby contributes to regulate the expression of genes essential
CC       for cell proliferation and survival, such as CCND1 and BIRC5.
CC       Plays a role in the induction of apoptosis via SRC and AKT1
CC       signaling pathways. Inhibits MDM2-mediated proteasomal degradation
CC       of p53/TP53 and thereby plays a role in p53/TP53-mediated
CC       apoptosis. Induction of apoptosis depends on the ability of FHIT
CC       to bind P(1)-P(3)-bis(5'-adenosyl) triphosphate or related
CC       compounds, but does not require its catalytic activity, it may in
CC       part come from the mitochondrial form, which sensitizes the low-
CC       affinity Ca(2+) transporters, enhancing mitochondrial calcium
CC       uptake. Functions as tumor suppressor.
CC       {ECO:0000269|PubMed:12574506, ECO:0000269|PubMed:15313915,
CC       ECO:0000269|PubMed:16407838, ECO:0000269|PubMed:18077326,
CC       ECO:0000269|PubMed:19622739, ECO:0000269|PubMed:8794732,
CC       ECO:0000269|PubMed:9323207}.
CC   -!- CATALYTIC ACTIVITY: P(1)-P(3)-bis(5'-adenosyl) triphosphate +
CC       H(2)O = ADP + AMP. {ECO:0000269|PubMed:12574506,
CC       ECO:0000269|PubMed:15182206, ECO:0000269|PubMed:8794732,
CC       ECO:0000269|PubMed:9323207, ECO:0000269|PubMed:9576908}.
CC   -!- SUBUNIT: Homodimer. Interacts with UBE2I. Interacts with MDM2.
CC       Interacts with CTNNB1. Identified in a complex with CTNNB1 and
CC       LEF1. {ECO:0000269|PubMed:11085938, ECO:0000269|PubMed:15007172,
CC       ECO:0000269|PubMed:15313915, ECO:0000269|PubMed:18077326,
CC       ECO:0000269|PubMed:9323207, ECO:0000269|PubMed:9576908}.
CC   -!- INTERACTION:
CC       Self; NbExp=9; IntAct=EBI-741760, EBI-741760;
CC       P35222:CTNNB1; NbExp=4; IntAct=EBI-741760, EBI-491549;
CC       Q9UJU2:LEF1; NbExp=2; IntAct=EBI-741760, EBI-926131;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Mitochondrion. Nucleus.
CC   -!- TISSUE SPECIFICITY: Low levels expressed in all tissues tested.
CC       Phospho-FHIT observed in liver and kidney, but not in brain and
CC       lung. Phospho-FHIT undetected in all tested human tumor cell
CC       lines.
CC   -!- PTM: Phosphorylation at Tyr-114 by SRC is required for induction
CC       of apoptosis. {ECO:0000269|PubMed:15007172}.
CC   -!- MASS SPECTROMETRY: Mass=16733; Method=MALDI; Range=2-147;
CC       Evidence={ECO:0000269|PubMed:15007172};
CC   -!- DISEASE: Note=A chromosomal aberration involving FHIT has been
CC       found in a lymphoblastoid cell line established from a family with
CC       renal cell carcinoma and thyroid carcinoma. Translocation
CC       t(3;8)(p14.2;q24.1) with RNF139. Although the 3p14.2 breakpoint
CC       has been shown to interrupt FHIT in its 5-prime non-coding region,
CC       it is unlikely that FHIT is causally related to renal or other
CC       malignancies. {ECO:0000269|PubMed:15007172}.
CC   -!- DISEASE: Note=Associated with digestive tract cancers. Numerous
CC       tumor types are found to have aberrant forms of FHIT protein due
CC       to deletions in a coding region of chromosome 3p14.2 including the
CC       fragile site locus FRA3B. {ECO:0000269|PubMed:15007172}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FHITID192ch3p14.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U46922; AAA99013.1; -; mRNA.
DR   EMBL; U76271; AAB52539.1; -; Genomic_DNA.
DR   EMBL; U76267; AAB52539.1; JOINED; Genomic_DNA.
DR   EMBL; U76268; AAB52539.1; JOINED; Genomic_DNA.
DR   EMBL; U76269; AAB52539.1; JOINED; Genomic_DNA.
DR   EMBL; U76270; AAB52539.1; JOINED; Genomic_DNA.
DR   EMBL; KJ534835; AHW56475.1; -; mRNA.
DR   EMBL; AY625256; AAT37530.1; -; Genomic_DNA.
DR   EMBL; DQ120721; AAZ23623.1; -; mRNA.
DR   EMBL; EF186677; ABM65879.1; -; Genomic_DNA.
DR   EMBL; EF183457; ABM66086.1; -; Genomic_DNA.
DR   EMBL; EF183458; ABM66087.1; -; Genomic_DNA.
DR   EMBL; EF183459; ABM66088.1; -; Genomic_DNA.
DR   EMBL; EF183461; ABM66090.1; -; Genomic_DNA.
DR   EMBL; EF183464; ABM66093.1; -; Genomic_DNA.
DR   EMBL; AK289824; BAF82513.1; -; mRNA.
DR   EMBL; CH471055; EAW65393.1; -; Genomic_DNA.
DR   EMBL; BC032336; AAH32336.1; -; mRNA.
DR   CCDS; CCDS2894.1; -.
DR   PIR; A58802; A58802.
DR   RefSeq; NP_001159715.1; NM_001166243.2.
DR   RefSeq; NP_001307828.1; NM_001320899.1.
DR   RefSeq; NP_001307829.1; NM_001320900.1.
DR   RefSeq; NP_002003.1; NM_002012.3.
DR   UniGene; Hs.655995; -.
DR   PDB; 1FHI; X-ray; 3.10 A; A=1-147.
DR   PDB; 1FIT; X-ray; 1.85 A; A=1-147.
DR   PDB; 2FHI; X-ray; 2.60 A; A=1-147.
DR   PDB; 2FIT; X-ray; 1.90 A; A=1-147.
DR   PDB; 3FIT; X-ray; 2.40 A; A=1-147.
DR   PDB; 4FIT; X-ray; 2.50 A; A=1-147.
DR   PDB; 5FIT; X-ray; 2.30 A; A=1-147.
DR   PDB; 6FIT; X-ray; 2.60 A; A=1-147.
DR   PDBsum; 1FHI; -.
DR   PDBsum; 1FIT; -.
DR   PDBsum; 2FHI; -.
DR   PDBsum; 2FIT; -.
DR   PDBsum; 3FIT; -.
DR   PDBsum; 4FIT; -.
DR   PDBsum; 5FIT; -.
DR   PDBsum; 6FIT; -.
DR   ProteinModelPortal; P49789; -.
DR   SMR; P49789; -.
DR   BioGrid; 108563; 14.
DR   DIP; DIP-29947N; -.
DR   IntAct; P49789; 5.
DR   STRING; 9606.ENSP00000342087; -.
DR   BindingDB; P49789; -.
DR   ChEMBL; CHEMBL1795151; -.
DR   DrugBank; DB02373; Adenosine Monotungstate.
DR   DrugBank; DB04389; Ado-P-Ch2-P-Ps-Ado.
DR   DrugBank; DB04173; Fructose.
DR   iPTMnet; P49789; -.
DR   PhosphoSitePlus; P49789; -.
DR   BioMuta; FHIT; -.
DR   DMDM; 1706794; -.
DR   EPD; P49789; -.
DR   PaxDb; P49789; -.
DR   PeptideAtlas; P49789; -.
DR   PRIDE; P49789; -.
DR   DNASU; 2272; -.
DR   Ensembl; ENST00000468189; ENSP00000417480; ENSG00000189283.
DR   Ensembl; ENST00000476844; ENSP00000417557; ENSG00000189283.
DR   Ensembl; ENST00000492590; ENSP00000418582; ENSG00000189283.
DR   GeneID; 2272; -.
DR   KEGG; hsa:2272; -.
DR   UCSC; uc003dkx.5; human.
DR   CTD; 2272; -.
DR   DisGeNET; 2272; -.
DR   EuPathDB; HostDB:ENSG00000189283.9; -.
DR   GeneCards; FHIT; -.
DR   HGNC; HGNC:3701; FHIT.
DR   HPA; CAB002684; -.
DR   HPA; HPA018840; -.
DR   HPA; HPA018909; -.
DR   MalaCards; FHIT; -.
DR   MIM; 601153; gene.
DR   neXtProt; NX_P49789; -.
DR   OpenTargets; ENSG00000189283; -.
DR   Orphanet; 151; Familial renal cell carcinoma.
DR   PharmGKB; PA28140; -.
DR   eggNOG; KOG3379; Eukaryota.
DR   eggNOG; COG0537; LUCA.
DR   GeneTree; ENSGT00510000047967; -.
DR   HOGENOM; HOG000164170; -.
DR   HOVERGEN; HBG051614; -.
DR   KO; K01522; -.
DR   OMA; KFGPFEV; -.
DR   OrthoDB; EOG091G0RR0; -.
DR   PhylomeDB; P49789; -.
DR   TreeFam; TF105432; -.
DR   BRENDA; 3.6.1.29; 2681.
DR   SABIO-RK; P49789; -.
DR   SIGNOR; P49789; -.
DR   ChiTaRS; FHIT; human.
DR   EvolutionaryTrace; P49789; -.
DR   GeneWiki; FHIT; -.
DR   GenomeRNAi; 2272; -.
DR   PRO; PR:P49789; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000189283; -.
DR   CleanEx; HS_FHIT; -.
DR   ExpressionAtlas; P49789; baseline and differential.
DR   Genevisible; P49789; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0047710; F:bis(5'-adenosyl)-triphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0003824; F:catalytic activity; TAS:ProtInc.
DR   GO; GO:0016787; F:hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0009117; P:nucleotide metabolic process; TAS:ProtInc.
DR   GO; GO:0006163; P:purine nucleotide metabolic process; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.428.10; -; 1.
DR   InterPro; IPR019808; Histidine_triad_CS.
DR   InterPro; IPR001310; Histidine_triad_HIT.
DR   InterPro; IPR011146; HIT-like.
DR   InterPro; IPR036265; HIT-like_sf.
DR   PANTHER; PTHR23089; PTHR23089; 1.
DR   Pfam; PF01230; HIT; 1.
DR   SUPFAM; SSF54197; SSF54197; 1.
DR   PROSITE; PS00892; HIT_1; 1.
DR   PROSITE; PS51084; HIT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Chromosomal rearrangement; Complete proteome;
KW   Cytoplasm; Hydrolase; Manganese; Mitochondrion; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Tumor suppressor.
FT   CHAIN         1    147       Bis(5'-adenosyl)-triphosphatase.
FT                                /FTId=PRO_0000109789.
FT   DOMAIN        2    109       HIT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00464}.
FT   NP_BIND      89     92       Substrate. {ECO:0000244|PDB:5FIT,
FT                                ECO:0000269|PubMed:9323207}.
FT   MOTIF        94     98       Histidine triad motif.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00464}.
FT   ACT_SITE     96     96       Tele-AMP-histidine intermediate.
FT                                {ECO:0000269|PubMed:15182206,
FT                                ECO:0000269|PubMed:9323207}.
FT   BINDING       8      8       Substrate. {ECO:0000244|PDB:3FIT,
FT                                ECO:0000269|PubMed:9261067}.
FT   BINDING      27     27       Substrate. {ECO:0000244|PDB:5FIT,
FT                                ECO:0000269|PubMed:9323207}.
FT   BINDING      83     83       Substrate. {ECO:0000244|PDB:5FIT,
FT                                ECO:0000269|PubMed:9323207}.
FT   BINDING      98     98       Substrate. {ECO:0000244|PDB:5FIT,
FT                                ECO:0000269|PubMed:9323207}.
FT   SITE        114    114       Important for induction of apoptosis.
FT   MOD_RES     114    114       Phosphotyrosine; by SRC.
FT                                {ECO:0000269|PubMed:15007172}.
FT   MOD_RES     145    145       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:15007172}.
FT   MUTAGEN      10     10       I->W: Strongly reduces affinity for
FT                                substrates and impairs apoptosis; when
FT                                associated with W-25.
FT                                {ECO:0000269|PubMed:12574506}.
FT   MUTAGEN      25     25       L->W: Reduces affinity for substrates and
FT                                impairs apoptosis. Strongly reduces
FT                                affinity for substrates and impairs
FT                                apoptosis; when associated with W-10.
FT                                {ECO:0000269|PubMed:12574506}.
FT   MUTAGEN      35     35       H->N: 50% decrease in catalytic activity.
FT                                No loss in substrate binding.
FT                                {ECO:0000269|PubMed:8794732}.
FT   MUTAGEN      94     94       H->N: 75% decrease in catalytic activity.
FT                                No loss in substrate binding.
FT                                {ECO:0000269|PubMed:8794732}.
FT   MUTAGEN      96     96       H->D: Loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12574506,
FT                                ECO:0000269|PubMed:15182206,
FT                                ECO:0000269|PubMed:8794732,
FT                                ECO:0000269|PubMed:9576908}.
FT   MUTAGEN      96     96       H->G: Total loss of catalytic activity.
FT                                Rescuable with free imidazole.
FT                                {ECO:0000269|PubMed:12574506,
FT                                ECO:0000269|PubMed:15182206,
FT                                ECO:0000269|PubMed:8794732,
FT                                ECO:0000269|PubMed:9576908}.
FT   MUTAGEN      96     96       H->N: Total loss of catalytic activity.
FT                                No loss in substrate binding.
FT                                {ECO:0000269|PubMed:12574506,
FT                                ECO:0000269|PubMed:15182206,
FT                                ECO:0000269|PubMed:8794732,
FT                                ECO:0000269|PubMed:9576908}.
FT   MUTAGEN      98     98       H->N: 98% decrease in catalytic activity.
FT                                {ECO:0000269|PubMed:8794732}.
FT   MUTAGEN     114    114       Y->A: Impairs induction of apoptosis.
FT                                Strongly reduced affinity for substrates.
FT                                {ECO:0000269|PubMed:15007172,
FT                                ECO:0000269|PubMed:16407838}.
FT   MUTAGEN     114    114       Y->D: Impairs induction of apoptosis.
FT                                Reduces affinity for substrates.
FT                                {ECO:0000269|PubMed:15007172,
FT                                ECO:0000269|PubMed:16407838}.
FT   MUTAGEN     114    114       Y->F: Loss of phosphorylation by SRC.
FT                                Impairs induction of apoptosis.
FT                                {ECO:0000269|PubMed:15007172,
FT                                ECO:0000269|PubMed:16407838}.
FT   MUTAGEN     145    145       Y->F: No effect on phosphorylation by
FT                                SRC. {ECO:0000269|PubMed:15007172}.
FT   CONFLICT    146    146       F -> S (in Ref. 5; BAF82513).
FT                                {ECO:0000305}.
FT   STRAND        3      5       {ECO:0000244|PDB:1FIT}.
FT   STRAND        8     10       {ECO:0000244|PDB:1FIT}.
FT   HELIX        12     14       {ECO:0000244|PDB:1FIT}.
FT   STRAND       15     18       {ECO:0000244|PDB:1FIT}.
FT   STRAND       20     26       {ECO:0000244|PDB:1FIT}.
FT   STRAND       36     42       {ECO:0000244|PDB:1FIT}.
FT   HELIX        47     49       {ECO:0000244|PDB:1FIT}.
FT   HELIX        52     72       {ECO:0000244|PDB:1FIT}.
FT   STRAND       76     82       {ECO:0000244|PDB:1FIT}.
FT   HELIX        86     88       {ECO:0000244|PDB:1FIT}.
FT   STRAND       92     94       {ECO:0000244|PDB:1FIT}.
FT   STRAND       97    102       {ECO:0000244|PDB:1FIT}.
FT   HELIX       132    144       {ECO:0000244|PDB:1FIT}.
SQ   SEQUENCE   147 AA;  16858 MW;  14D85961A19ECF3E CRC64;
     MSFRFGQHLI KPSVVFLKTE LSFALVNRKP VVPGHVLVCP LRPVERFHDL RPDEVADLFQ
     TTQRVGTVVE KHFHGTSLTF SMQDGPEAGQ TVKHVHVHVL PRKAGDFHRN DSIYEELQKH
     DKEDFPASWR SEEEMAAEAA ALRVYFQ
//
ID   FUS_HUMAN               Reviewed;         526 AA.
AC   P35637; Q9H4A8;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   28-FEB-2018, entry version 201.
DE   RecName: Full=RNA-binding protein FUS;
DE   AltName: Full=75 kDa DNA-pairing protein;
DE   AltName: Full=Oncogene FUS;
DE   AltName: Full=Oncogene TLS;
DE   AltName: Full=POMp75;
DE   AltName: Full=Translocated in liposarcoma protein;
GN   Name=FUS; Synonyms=TLS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RX   PubMed=8510758; DOI=10.1038/363640a0;
RA   Crozat A., Aman P., Mandahl N., Ron D.;
RT   "Fusion of CHOP to a novel RNA-binding protein in human myxoid
RT   liposarcoma.";
RL   Nature 363:640-644(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), AND CHROMOSOMAL
RP   TRANSLOCATION WITH DDIT3.
RX   PubMed=7503811; DOI=10.1038/ng0693-175;
RA   Rabbitts T.H., Forster A., Larson R., Nathan P.;
RT   "Fusion of the dominant negative transcription regulator CHOP with a
RT   novel gene FUS by translocation t(12;16) in malignant liposarcoma.";
RL   Nat. Genet. 4:175-180(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS LONG AND SHORT).
RX   PubMed=9795213; DOI=10.1016/S0378-1119(98)00463-6;
RA   Morohoshi F., Ootsuka Y., Arai K., Ichikawa H., Mitani S.,
RA   Munakata N., Ohki M.;
RT   "Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.";
RL   Gene 221:191-198(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Lung, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 85-310, CHROMOSOMAL TRANSLOCATION WITH
RP   ATF1, AND INVOLVEMENT IN AFH.
RX   PubMed=11063792; DOI=10.1016/S0165-4608(00)00237-5;
RA   Waters B.L., Panagopoulos I., Allen E.F.;
RT   "Genetic characterization of angiomatoid fibrous histiocytoma
RT   identifies fusion of the FUS and ATF-1 genes induced by a chromosomal
RT   translocation involving bands 12q13 and 16p11.";
RL   Cancer Genet. Cytogenet. 121:109-116(2000).
RN   [7]
RP   PROTEIN SEQUENCE OF 235-244; 307-312; 335-345 AND 349-357, AND
RP   CHARACTERIZATION.
RX   PubMed=10567410; DOI=10.1074/jbc.274.48.34337;
RA   Baechtold H., Kuroda M., Sok J., Ron D., Lopez B.S., Akhmedov A.T.;
RT   "Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein
RT   TLS/FUS and is able to promote D-loop formation.";
RL   J. Biol. Chem. 274:34337-34342(1999).
RN   [8]
RP   PROTEIN SEQUENCE OF 265-276; 317-331 AND 335-357, AND IDENTIFICATION.
RX   PubMed=10442642; DOI=10.1038/sj.onc.1203048;
RA   Bertrand P., Akhmedov A.T., Delacote F., Durrbach A., Lopez B.S.;
RT   "Human POMp75 is identified as the pro-oncoprotein TLF/FUS: both
RT   POMp75 and POMp100 DNA homologous pairing activities are associated to
RT   cell proliferation.";
RL   Oncogene 18:4515-4521(1999).
RN   [9]
RP   PROTEIN SEQUENCE OF 349-357, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   CHROMOSOMAL TRANSLOCATION WITH ERG.
RX   PubMed=8187069;
RA   Ichikawa H., Shimizu K., Hayashi Y., Ohki M.;
RT   "An RNA-binding protein gene, TLS/FUS, is fused to ERG in human
RT   myeloid leukemia with t(16;21) chromosomal translocation.";
RL   Cancer Res. 54:2865-2868(1994).
RN   [11]
RP   INTERACTION WITH SF1.
RX   PubMed=9660765; DOI=10.1074/jbc.273.29.18086;
RA   Zhang D., Paley A.J., Childs G.;
RT   "The transcriptional repressor ZFM1 interacts with and modulates the
RT   ability of EWS to activate transcription.";
RL   J. Biol. Chem. 273:18086-18091(1998).
RN   [12]
RP   INTERACTION WITH SFRS13A.
RX   PubMed=9774382; DOI=10.1074/jbc.273.43.27761;
RA   Yang L., Embree L.J., Tsai S., Hickstein D.D.;
RT   "Oncoprotein TLS interacts with serine-arginine proteins involved in
RT   RNA splicing.";
RL   J. Biol. Chem. 273:27761-27764(1998).
RN   [13]
RP   METHYLATION AT ARG-242; ARG-244; ARG-248; ARG-251; ARG-259; ARG-377;
RP   ARG-383; ARG-386; ARG-388; ARG-394; ARG-407; ARG-473; ARG-476;
RP   ARG-481; ARG-485; ARG-487; ARG-491; ARG-495; ARG-498 AND ARG-503, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12964758; DOI=10.1021/ac026283q;
RA   Rappsilber J., Friesen W.J., Paushkin S., Dreyfuss G., Mann M.;
RT   "Detection of arginine dimethylated peptides by parallel precursor ion
RT   scanning mass spectrometry in positive ion mode.";
RL   Anal. Chem. 75:3107-3114(2003).
RN   [14]
RP   INTERACTION WITH SARNP.
RX   PubMed=17196963; DOI=10.1016/j.yexcr.2006.11.014;
RA   Sugiura T., Sakurai K., Nagano Y.;
RT   "Intracellular characterization of DDX39, a novel growth-associated
RT   RNA helicase.";
RL   Exp. Cell Res. 313:782-790(2007).
RN   [15]
RP   INTERACTION WITH TDRD3.
RX   PubMed=18632687; DOI=10.1093/hmg/ddn203;
RA   Goulet I., Boisvenue S., Mokas S., Mazroui R., Cote J.;
RT   "TDRD3, a novel Tudor domain-containing protein, localizes to
RT   cytoplasmic stress granules.";
RL   Hum. Mol. Genet. 17:3055-3074(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277 AND THR-286, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-216; ARG-218 AND ARG-503,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   INTERACTION WITH LRSAM1.
RX   PubMed=27615052; DOI=10.1002/ana.24776;
RA   Hu B., Arpag S., Zuchner S., Li J.;
RT   "A novel missense mutation of CMT2P alters transcription machinery.";
RL   Ann. Neurol. 80:834-845(2016).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-334, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [26]
RP   STRUCTURE BY NMR OF 282-370.
RG   Northeast structural genomics consortium (NESG);
RT   "Northeast structural genomics consortium target HR6430A.";
RL   Submitted (MAY-2011) to the PDB data bank.
RN   [27]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-312.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [28]
RP   VARIANTS ALS6 CYS-244; SER-514; CYS-515; LYS-518; CYS-521; GLY-521;
RP   HIS-521; GLY-522; SER-524; THR-524 AND LEU-525, VARIANT GLN-517,
RP   SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANT ALS6 GLY-521, AND
RP   CHARACTERIZATION OF VARIANT GLN-517.
RX   PubMed=19251627; DOI=10.1126/science.1166066;
RA   Kwiatkowski T.J. Jr., Bosco D.A., Leclerc A.L., Tamrazian E.,
RA   Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J.,
RA   Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P.,
RA   de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J.,
RA   Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R.,
RA   Landers J.E., Brown R.H. Jr.;
RT   "Mutations in the FUS/TLS gene on chromosome 16 cause familial
RT   amyotrophic lateral sclerosis.";
RL   Science 323:1205-1208(2009).
RN   [29]
RP   VARIANTS ALS6 GLY-514; CYS-521 AND HIS-521, SUBCELLULAR LOCATION, AND
RP   CHARACTERIZATION OF VARIANTS ALS6 CYS-521 AND HIS-521.
RX   PubMed=19251628; DOI=10.1126/science.1165942;
RA   Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L.,
RA   Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J.,
RA   Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N.,
RA   Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C.,
RA   Shaw C.E.;
RT   "Mutations in FUS, an RNA processing protein, cause familial
RT   amyotrophic lateral sclerosis type 6.";
RL   Science 323:1208-1211(2009).
RN   [30]
RP   VARIANTS ALS6 SER-191; CYS-216; VAL-225; CYS-230; CYS-234; ASP-507 AND
RP   CYS-521.
RX   PubMed=19861302; DOI=10.1136/jmg.2009.071027;
RA   Corrado L., Del Bo R., Castellotti B., Ratti A., Cereda C., Penco S.,
RA   Soraru G., Carlomagno Y., Ghezzi S., Pensato V., Colombrita C.,
RA   Gagliardi S., Cozzi L., Orsetti V., Mancuso M., Siciliano G.,
RA   Mazzini L., Comi G.P., Gellera C., Ceroni M., D'Alfonso S., Silani V.;
RT   "Mutations of FUS gene in sporadic amyotrophic lateral sclerosis.";
RL   J. Med. Genet. 47:190-194(2010).
RN   [31]
RP   VARIANT ALS6 HIS-521, AND VARIANT VAL-254.
RX   PubMed=20124201; DOI=10.1212/WNL.0b013e3181ccc732;
RA   Van Langenhove T., van der Zee J., Sleegers K., Engelborghs S.,
RA   Vandenberghe R., Gijselinck I., Van den Broeck M., Mattheijssens M.,
RA   Peeters K., De Deyn P.P., Cruts M., Van Broeckhoven C.;
RT   "Genetic contribution of FUS to frontotemporal lobar degeneration.";
RL   Neurology 74:366-371(2010).
RN   [32]
RP   VARIANTS ETM4 CYS-216 AND LEU-431.
RX   PubMed=22863194; DOI=10.1016/j.ajhg.2012.07.002;
RA   Merner N.D., Girard S.L., Catoire H., Bourassa C.V., Belzil V.V.,
RA   Riviere J.B., Hince P., Levert A., Dionne-Laporte A., Spiegelman D.,
RA   Noreau A., Diab S., Szuto A., Fournier H., Raelson J., Belouchi M.,
RA   Panisset M., Cossette P., Dupre N., Bernard G., Chouinard S.,
RA   Dion P.A., Rouleau G.A.;
RT   "Exome sequencing identifies fus mutations as a cause of essential
RT   tremor.";
RL   Am. J. Hum. Genet. 91:313-319(2012).
RN   [33]
RP   VARIANTS ALS6 HIS-521 AND TYR-526 EXT.
RX   PubMed=27604643; DOI=10.1038/srep32478;
RA   Hou L., Jiao B., Xiao T., Zhou L., Zhou Z., Du J., Yan X., Wang J.,
RA   Tang B., Shen L.;
RT   "Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic
RT   lateral sclerosis in central-southern China.";
RL   Sci. Rep. 6:32478-32478(2016).
CC   -!- FUNCTION: Binds both single-stranded and double-stranded DNA and
CC       promotes ATP-independent annealing of complementary single-
CC       stranded DNAs and D-loop formation in superhelical double-stranded
CC       DNA. May play a role in maintenance of genomic integrity.
CC   -!- SUBUNIT: Component of nuclear riboprotein complexes. Interacts
CC       with ILF3, TDRD3 and SF1. Interacts through its C-terminus with
CC       SFRS13A. Interacts with OTUB1 and SARNP.Interacts with LRSAM1
CC       (PubMed:27615052). {ECO:0000269|PubMed:17196963,
CC       ECO:0000269|PubMed:18632687, ECO:0000269|PubMed:27615052,
CC       ECO:0000269|PubMed:9660765, ECO:0000269|PubMed:9774382}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-400434, EBI-400434;
CC       P45481:Crebbp (xeno); NbExp=4; IntAct=EBI-400434, EBI-296306;
CC       Q9NRR4:DROSHA; NbExp=2; IntAct=EBI-400434, EBI-528367;
CC       Q09472:EP300; NbExp=4; IntAct=EBI-400434, EBI-447295;
CC       Q01844:EWSR1; NbExp=5; IntAct=EBI-400434, EBI-739737;
CC       Q92993:KAT5; NbExp=2; IntAct=EBI-400434, EBI-399080;
CC       Q15149:PLEC; NbExp=4; IntAct=EBI-400434, EBI-297903;
CC       Q92804:TAF15; NbExp=5; IntAct=EBI-400434, EBI-2255091;
CC       Q92973-2:TNPO1; NbExp=2; IntAct=EBI-400434, EBI-11022821;
CC       Q9H3D4:TP63; NbExp=2; IntAct=EBI-400434, EBI-2337775;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19251627,
CC       ECO:0000269|PubMed:19251628}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P35637-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P35637-2; Sequence=VSP_005798;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Arg-216 and Arg-218 are dimethylated, probably to asymmetric
CC       dimethylarginine.
CC   -!- DISEASE: Note=A chromosomal aberration involving FUS is found in a
CC       patient with malignant myxoid liposarcoma. Translocation
CC       t(12;16)(q13;p11) with DDIT3. {ECO:0000269|PubMed:7503811}.
CC   -!- DISEASE: Note=A chromosomal aberration involving FUS is a cause of
CC       acute myeloid leukemia (AML). Translocation t(16;21)(p11;q22) with
CC       ERG. {ECO:0000269|PubMed:8187069}.
CC   -!- DISEASE: Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A
CC       distinct variant of malignant fibrous histiocytoma that typically
CC       occurs in children and adolescents and is manifest by nodular
CC       subcutaneous growth. Characteristic microscopic features include
CC       lobulated sheets of histiocyte-like cells intimately associated
CC       with areas of hemorrhage and cystic pseudovascular spaces, as well
CC       as a striking cuffing of inflammatory cells, mimicking a lymph
CC       node metastasis. {ECO:0000269|PubMed:11063792}. Note=The gene
CC       represented in this entry is involved in disease pathogenesis. A
CC       chromosomal aberration involving FUS is found in a patient with
CC       angiomatoid fibrous histiocytoma. Translocation
CC       t(12;16)(q13;p11.2) with ATF1 generates a chimeric FUS/ATF1
CC       protein. {ECO:0000269|PubMed:11063792}.
CC   -!- DISEASE: Amyotrophic lateral sclerosis 6, with or without
CC       frontotemporal dementia (ALS6) [MIM:608030]: A neurodegenerative
CC       disorder affecting upper motor neurons in the brain and lower
CC       motor neurons in the brain stem and spinal cord, resulting in
CC       fatal paralysis. Sensory abnormalities are absent. The pathologic
CC       hallmarks of the disease include pallor of the corticospinal tract
CC       due to loss of motor neurons, presence of ubiquitin-positive
CC       inclusions within surviving motor neurons, and deposition of
CC       pathologic aggregates. The etiology of amyotrophic lateral
CC       sclerosis is likely to be multifactorial, involving both genetic
CC       and environmental factors. The disease is inherited in 5-10% of
CC       the cases. {ECO:0000269|PubMed:19251627,
CC       ECO:0000269|PubMed:19251628, ECO:0000269|PubMed:19861302,
CC       ECO:0000269|PubMed:20124201, ECO:0000269|PubMed:27604643}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Tremor, hereditary essential 4 (ETM4) [MIM:614782]: A
CC       common movement disorder mainly characterized by postural tremor
CC       of the arms. Head, legs, trunk, voice, jaw, and facial muscles
CC       also may be involved. The condition can be aggravated by emotions,
CC       hunger, fatigue and temperature extremes, and may cause a
CC       functional disability or even incapacitation. Inheritance is
CC       autosomal dominant. {ECO:0000269|PubMed:22863194}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the RRM TET family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FUSID44.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S62140; AAB27102.1; -; mRNA.
DR   EMBL; S62138; AAB27103.1; ALT_SEQ; mRNA.
DR   EMBL; X71427; CAA50558.1; ALT_SEQ; mRNA.
DR   EMBL; X71428; CAA50559.1; ALT_SEQ; mRNA.
DR   EMBL; AF071213; AAC35285.1; -; Genomic_DNA.
DR   EMBL; AF071213; AAC35284.1; -; Genomic_DNA.
DR   EMBL; AC009088; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000402; AAH00402.1; -; mRNA.
DR   EMBL; BC002459; AAH02459.1; -; mRNA.
DR   EMBL; AJ295163; CAC15058.1; ALT_TERM; mRNA.
DR   CCDS; CCDS10707.1; -. [P35637-1]
DR   CCDS; CCDS58454.1; -. [P35637-2]
DR   PIR; S33798; S33798.
DR   PIR; S33799; S33799.
DR   RefSeq; NP_001164105.1; NM_001170634.1. [P35637-2]
DR   RefSeq; NP_004951.1; NM_004960.3. [P35637-1]
DR   UniGene; Hs.46894; -.
DR   PDB; 2LA6; NMR; -; A=282-370.
DR   PDB; 2LCW; NMR; -; A=278-385.
DR   PDB; 4FDD; X-ray; 2.30 A; B=498-526.
DR   PDB; 4FQ3; X-ray; 3.00 A; B=495-526.
DR   PDB; 5W3N; NMR; -; A/B/C/D/E/F/G/H/I=2-214.
DR   PDBsum; 2LA6; -.
DR   PDBsum; 2LCW; -.
DR   PDBsum; 4FDD; -.
DR   PDBsum; 4FQ3; -.
DR   PDBsum; 5W3N; -.
DR   DisProt; DP01102; -.
DR   ProteinModelPortal; P35637; -.
DR   SMR; P35637; -.
DR   BioGrid; 108797; 341.
DR   CORUM; P35637; -.
DR   DIP; DIP-29857N; -.
DR   IntAct; P35637; 66.
DR   MINT; P35637; -.
DR   STRING; 9606.ENSP00000254108; -.
DR   iPTMnet; P35637; -.
DR   PhosphoSitePlus; P35637; -.
DR   SwissPalm; P35637; -.
DR   BioMuta; FUS; -.
DR   DMDM; 544357; -.
DR   EPD; P35637; -.
DR   PaxDb; P35637; -.
DR   PeptideAtlas; P35637; -.
DR   PRIDE; P35637; -.
DR   TopDownProteomics; P35637-1; -. [P35637-1]
DR   TopDownProteomics; P35637-2; -. [P35637-2]
DR   DNASU; 2521; -.
DR   Ensembl; ENST00000254108; ENSP00000254108; ENSG00000089280. [P35637-1]
DR   Ensembl; ENST00000380244; ENSP00000369594; ENSG00000089280. [P35637-2]
DR   GeneID; 2521; -.
DR   KEGG; hsa:2521; -.
DR   UCSC; uc002ebh.4; human. [P35637-1]
DR   CTD; 2521; -.
DR   DisGeNET; 2521; -.
DR   EuPathDB; HostDB:ENSG00000089280.18; -.
DR   GeneCards; FUS; -.
DR   GeneReviews; FUS; -.
DR   HGNC; HGNC:4010; FUS.
DR   HPA; CAB033036; -.
DR   HPA; CAB058691; -.
DR   HPA; HPA008784; -.
DR   MalaCards; FUS; -.
DR   MIM; 137070; gene.
DR   MIM; 608030; phenotype.
DR   MIM; 612160; phenotype.
DR   MIM; 614782; phenotype.
DR   neXtProt; NX_P35637; -.
DR   OpenTargets; ENSG00000089280; -.
DR   Orphanet; 803; Amyotrophic lateral sclerosis.
DR   Orphanet; 275872; Frontotemporal dementia with motor neuron disease.
DR   Orphanet; 862; Hereditary essential tremor.
DR   Orphanet; 300605; Juvenile amyotrophic lateral sclerosis.
DR   Orphanet; 79105; Myxofibrosarcoma.
DR   Orphanet; 99967; Myxoid/round cell liposarcoma.
DR   PharmGKB; PA28425; -.
DR   eggNOG; ENOG410IP58; Eukaryota.
DR   eggNOG; ENOG4111GEG; LUCA.
DR   GeneTree; ENSGT00530000063105; -.
DR   HOGENOM; HOG000038010; -.
DR   HOVERGEN; HBG095056; -.
DR   InParanoid; P35637; -.
DR   KO; K13098; -.
DR   PhylomeDB; P35637; -.
DR   TreeFam; TF322599; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   SIGNOR; P35637; -.
DR   ChiTaRS; FUS; human.
DR   GeneWiki; FUS; -.
DR   GenomeRNAi; 2521; -.
DR   PRO; PR:P35637; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000089280; -.
DR   CleanEx; HS_FUS; -.
DR   ExpressionAtlas; P35637; baseline and differential.
DR   Genevisible; P35637; HS.
DR   GO; GO:0044327; C:dendritic spine head; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:CACAO.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005844; C:polysome; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0030331; F:estrogen receptor binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031489; F:myosin V binding; IEA:Ensembl.
DR   GO; GO:0046965; F:retinoid X receptor binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:CACAO.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:Ensembl.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR034459; FUS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034870; TET_fam.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   PANTHER; PTHR23238; PTHR23238; 1.
DR   PANTHER; PTHR23238:SF5; PTHR23238:SF5; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   Pfam; PF00641; zf-RanBP; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00547; ZnF_RBZ; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   SUPFAM; SSF90209; SSF90209; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 1.
DR   PROSITE; PS50199; ZF_RANBP2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amyotrophic lateral sclerosis;
KW   Chromosomal rearrangement; Complete proteome;
KW   Direct protein sequencing; Disease mutation; DNA-binding;
KW   Isopeptide bond; Metal-binding; Methylation; Neurodegeneration;
KW   Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Repeat; RNA-binding; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    526       RNA-binding protein FUS.
FT                                /FTId=PRO_0000081591.
FT   DOMAIN      285    371       RRM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   ZN_FING     422    453       RanBP2-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00322}.
FT   COMPBIAS      1    165       Gln/Gly/Ser/Tyr-rich.
FT   COMPBIAS    166    267       Gly-rich.
FT   COMPBIAS    371    526       Arg/Gly-rich.
FT   SITE        175    175       Breakpoint for translocation to form
FT                                chimeric FUS/ATF1 protein.
FT   SITE        266    267       Breakpoint for translocation to form
FT                                FUS/TLS-CHOP oncogene.
FT   MOD_RES     216    216       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     216    216       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     218    218       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     218    218       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     221    221       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     242    242       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     244    244       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     248    248       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     251    251       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     259    259       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     277    277       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     286    286       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     340    340       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     377    377       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     383    383       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     386    386       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     388    388       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     394    394       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     407    407       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     407    407       Omega-N-methylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:P56959}.
FT   MOD_RES     473    473       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     476    476       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     481    481       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     485    485       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     487    487       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     491    491       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     495    495       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     498    498       Asymmetric dimethylarginine.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     503    503       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000269|PubMed:12964758}.
FT   MOD_RES     503    503       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   CROSSLNK    334    334       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ      64     65       TG -> S (in isoform Short).
FT                                {ECO:0000303|PubMed:7503811}.
FT                                /FTId=VSP_005798.
FT   VARIANT     191    191       G -> S (in ALS6; dbSNP:rs148758737).
FT                                {ECO:0000269|PubMed:19861302}.
FT                                /FTId=VAR_068918.
FT   VARIANT     216    216       R -> C (in ALS6 and ETM4;
FT                                dbSNP:rs267606832).
FT                                {ECO:0000269|PubMed:19861302,
FT                                ECO:0000269|PubMed:22863194}.
FT                                /FTId=VAR_068919.
FT   VARIANT     225    225       G -> V (in ALS6).
FT                                {ECO:0000269|PubMed:19861302}.
FT                                /FTId=VAR_068920.
FT   VARIANT     230    230       G -> C (in ALS6; dbSNP:rs748374535).
FT                                {ECO:0000269|PubMed:19861302}.
FT                                /FTId=VAR_068921.
FT   VARIANT     234    234       R -> C (in ALS6; dbSNP:rs777819849).
FT                                {ECO:0000269|PubMed:19861302}.
FT                                /FTId=VAR_068922.
FT   VARIANT     244    244       R -> C (in ALS6).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054837.
FT   VARIANT     254    254       M -> V (found in a patient with
FT                                frontotemporal lobar degeneration;
FT                                dbSNP:rs752076094).
FT                                {ECO:0000269|PubMed:20124201}.
FT                                /FTId=VAR_065229.
FT   VARIANT     312    312       K -> Q (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035481.
FT   VARIANT     431    431       P -> L (in ETM4; dbSNP:rs186547381).
FT                                {ECO:0000269|PubMed:22863194}.
FT                                /FTId=VAR_068923.
FT   VARIANT     507    507       G -> D (in ALS6; dbSNP:rs267606831).
FT                                {ECO:0000269|PubMed:19861302}.
FT                                /FTId=VAR_068924.
FT   VARIANT     514    514       R -> G (in ALS6).
FT                                {ECO:0000269|PubMed:19251628}.
FT                                /FTId=VAR_054838.
FT   VARIANT     514    514       R -> S (in ALS6).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054839.
FT   VARIANT     515    515       G -> C (in ALS6).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054840.
FT   VARIANT     517    517       H -> Q (does not affect protein nuclear
FT                                localization; dbSNP:rs121909667).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054841.
FT   VARIANT     518    518       R -> K (in ALS6; dbSNP:rs121909669).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054842.
FT   VARIANT     521    521       R -> C (in ALS6; results in aberrant
FT                                trafficking and cytoplasmic retention of
FT                                the protein; dbSNP:rs121909668).
FT                                {ECO:0000269|PubMed:19251627,
FT                                ECO:0000269|PubMed:19251628,
FT                                ECO:0000269|PubMed:19861302}.
FT                                /FTId=VAR_054843.
FT   VARIANT     521    521       R -> G (in ALS6; results in aberrant
FT                                trafficking and cytoplasmic retention of
FT                                the protein; dbSNP:rs121909668).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054844.
FT   VARIANT     521    521       R -> H (in ALS6; results in aberrant
FT                                trafficking and cytoplasmic retention of
FT                                the protein; dbSNP:rs121909671).
FT                                {ECO:0000269|PubMed:19251627,
FT                                ECO:0000269|PubMed:19251628,
FT                                ECO:0000269|PubMed:20124201,
FT                                ECO:0000269|PubMed:27604643}.
FT                                /FTId=VAR_054845.
FT   VARIANT     522    522       R -> G (in ALS6).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054846.
FT   VARIANT     524    524       R -> S (in ALS6; dbSNP:rs886041389).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054847.
FT   VARIANT     524    524       R -> T (in ALS6).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054848.
FT   VARIANT     525    525       P -> L (in ALS6; dbSNP:rs886041390).
FT                                {ECO:0000269|PubMed:19251627}.
FT                                /FTId=VAR_054849.
FT   VARIANT     526    526       Y -> YY (in ALS6; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27604643}.
FT                                /FTId=VAR_077328.
FT   CONFLICT    338    338       T -> N (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       38     40       {ECO:0000244|PDB:5W3N}.
FT   STRAND       47     49       {ECO:0000244|PDB:5W3N}.
FT   STRAND       59     64       {ECO:0000244|PDB:5W3N}.
FT   STRAND       67     70       {ECO:0000244|PDB:5W3N}.
FT   STRAND       73     75       {ECO:0000244|PDB:5W3N}.
FT   STRAND       93     95       {ECO:0000244|PDB:5W3N}.
FT   STRAND      285    290       {ECO:0000244|PDB:2LA6}.
FT   HELIX       298    305       {ECO:0000244|PDB:2LA6}.
FT   TURN        306    308       {ECO:0000244|PDB:2LA6}.
FT   TURN        315    318       {ECO:0000244|PDB:2LA6}.
FT   STRAND      319    326       {ECO:0000244|PDB:2LA6}.
FT   TURN        328    330       {ECO:0000244|PDB:2LA6}.
FT   STRAND      332    343       {ECO:0000244|PDB:2LA6}.
FT   HELIX       344    354       {ECO:0000244|PDB:2LA6}.
FT   STRAND      358    363       {ECO:0000244|PDB:2LA6}.
FT   STRAND      365    368       {ECO:0000244|PDB:2LA6}.
FT   STRAND      379    381       {ECO:0000244|PDB:2LCW}.
FT   HELIX       514    521       {ECO:0000244|PDB:4FDD}.
SQ   SEQUENCE   526 AA;  53426 MW;  88C8E263B7905549 CRC64;
     MASNDYTQQA TQSYGAYPTQ PGQGYSQQSS QPYGQQSYSG YSQSTDTSGY GQSSYSSYGQ
     SQNTGYGTQS TPQGYGSTGG YGSSQSSQSS YGQQSSYPGY GQQPAPSSTS GSYGSSSQSS
     SYGQPQSGSY SQQPSYGGQQ QSYGQQQSYN PPQGYGQQNQ YNSSSGGGGG GGGGGNYGQD
     QSSMSSGGGS GGGYGNQDQS GGGGSGGYGQ QDRGGRGRGG SGGGGGGGGG GYNRSSGGYE
     PRGRGGGRGG RGGMGGSDRG GFNKFGGPRD QGSRHDSEQD NSDNNTIFVQ GLGENVTIES
     VADYFKQIGI IKTNKKTGQP MINLYTDRET GKLKGEATVS FDDPPSAKAA IDWFDGKEFS
     GNPIKVSFAT RRADFNRGGG NGRGGRGRGG PMGRGGYGGG GSGGGGRGGF PSGGGGGGGQ
     QRAGDWKCPN PTCENMNFSW RNECNQCKAP KPDGPGGGPG GSHMGGNYGD DRRGGRGGYD
     RGGYRGRGGD RGGFRGGRGG GDRGGFGPGK MDSRGEHRQD RRERPY
//
ID   Q13344_HUMAN            Unreviewed;       528 AA.
AC   Q13344;
DT   01-NOV-1996, integrated into UniProtKB/TrEMBL.
DT   01-NOV-1996, sequence version 1.
DT   28-FEB-2018, entry version 97.
DE   SubName: Full=Fus-like protein {ECO:0000313|EMBL:AAA79948.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAA79948.1};
RN   [1] {ECO:0000313|EMBL:AAA79948.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Itoh K., Kawase M.;
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U36561; AAA79948.1; -; mRNA.
DR   PIR; G02127; G02127.
DR   RefSeq; NP_001164408.1; NM_001170937.1.
DR   UniGene; Hs.46894; -.
DR   ProteinModelPortal; Q13344; -.
DR   IntAct; Q13344; 1.
DR   MINT; Q13344; -.
DR   MaxQB; Q13344; -.
DR   PeptideAtlas; Q13344; -.
DR   PRIDE; Q13344; -.
DR   DNASU; 2521; -.
DR   GeneID; 2521; -.
DR   CTD; 2521; -.
DR   PharmGKB; PA28425; -.
DR   eggNOG; ENOG410IP58; Eukaryota.
DR   eggNOG; ENOG4111GEG; LUCA.
DR   HOGENOM; HOG000038010; -.
DR   GenomeRNAi; 2521; -.
DR   Genevisible; Q13344; HS.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR034459; FUS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034870; TET_fam.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   PANTHER; PTHR23238; PTHR23238; 1.
DR   PANTHER; PTHR23238:SF5; PTHR23238:SF5; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   Pfam; PF00641; zf-RanBP; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00547; ZnF_RBZ; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   SUPFAM; SSF90209; SSF90209; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 1.
DR   PROSITE; PS50199; ZF_RANBP2_2; 1.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830}.
FT   DOMAIN      288    374       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      425    456       RanBP2-type.
FT                                {ECO:0000259|PROSITE:PS50199}.
FT   NON_TER     528    528       {ECO:0000313|EMBL:AAA79948.1}.
SQ   SEQUENCE   528 AA;  53377 MW;  43CFD6CBDA57A258 CRC64;
     MASNDYTQQA TQSYGAYPTQ PGQGYSQQSS QPYGQQSYSG YSQSTDTGYG QSSYSSYGQS
     QNTGYGTQSA PQGYGSTGGY GSSQSSQSSY GQQSSYPGYG PQPTPSSTSG SYGSSSQTSS
     YGQPPSYGQQ PSYGGQQQSY GQQQSYNPSG YGQQNQYNSS SSGSGGGGSY GQDQSSMSGS
     GGGGGGGGGG GSGGGGGYGN QDQSGGGGGG YGQQDRGGRG RGRSSGGGGG SGGGYNRSSG
     GYEPRGRGGG RGGRGGMGGS DRGGFNKFGG PRDQGSRHDS EQDNSDNNTI FVQGLGENVT
     IESVADYFKQ IGIIKTNKKT GQPMINLYTD RETGKLKGEA TVSFDDPPSA KAAIDWFDGK
     EFSGNPIKVS FATRRADFNR GGGNGRGGRG RGGPMGRGGY GGGGSGGGGR GGFPSGGGGG
     GGQQRAGDWK CPNPTCENMN FSWRNECNQC KAPKPDGPGG GPGGSHMGGN YGDDRRGGRG
     GYDRGGYRGR GGDRGGFRGG RGGGDRGGFG PGKMDSRGEH RQDRRERP
//
ID   Q6IBQ5_HUMAN            Unreviewed;       526 AA.
AC   Q6IBQ5;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 115.
DE   SubName: Full=FUS protein {ECO:0000313|EMBL:CAG33028.1};
DE   SubName: Full=Fusion (Involved in t(1216) in malignant liposarcoma), isoform CRA_a {ECO:0000313|EMBL:EAW52150.1};
DE   SubName: Full=Fusion, derived from t(12;16) malignant liposarcoma {ECO:0000313|EMBL:AAP35795.1};
GN   Name=FUS {ECO:0000313|EMBL:CAG33028.1};
GN   ORFNames=hCG_21147 {ECO:0000313|EMBL:EAW52150.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG33028.1};
RN   [1] {ECO:0000313|EMBL:EAW52150.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAP35795.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:CAG33028.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW52150.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BT007131; AAP35795.1; -; mRNA.
DR   EMBL; CR456747; CAG33028.1; -; mRNA.
DR   EMBL; CH471192; EAW52150.1; -; Genomic_DNA.
DR   RefSeq; NP_004951.1; NM_004960.3.
DR   UniGene; Hs.46894; -.
DR   SMR; Q6IBQ5; -.
DR   MaxQB; Q6IBQ5; -.
DR   DNASU; 2521; -.
DR   GeneID; 2521; -.
DR   KEGG; hsa:2521; -.
DR   UCSC; uc002ebf.3; human.
DR   CTD; 2521; -.
DR   EuPathDB; HostDB:ENSG00000089280.18; -.
DR   PharmGKB; PA28425; -.
DR   eggNOG; ENOG410IP58; Eukaryota.
DR   eggNOG; ENOG4111GEG; LUCA.
DR   HOVERGEN; HBG095056; -.
DR   KO; K13098; -.
DR   ChiTaRS; FUS; human.
DR   GenomeRNAi; 2521; -.
DR   Bgee; ENSG00000089280; -.
DR   GO; GO:0044327; C:dendritic spine head; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005844; C:polysome; IEA:Ensembl.
DR   GO; GO:0030331; F:estrogen receptor binding; IEA:Ensembl.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031489; F:myosin V binding; IEA:Ensembl.
DR   GO; GO:0046965; F:retinoid X receptor binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; IEA:Ensembl.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR034459; FUS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034870; TET_fam.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   PANTHER; PTHR23238; PTHR23238; 1.
DR   PANTHER; PTHR23238:SF5; PTHR23238:SF5; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   Pfam; PF00641; zf-RanBP; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00547; ZnF_RBZ; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   SUPFAM; SSF90209; SSF90209; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 1.
DR   PROSITE; PS50199; ZF_RANBP2_2; 1.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830}.
FT   DOMAIN      285    371       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      422    453       RanBP2-type.
FT                                {ECO:0000259|PROSITE:PS50199}.
SQ   SEQUENCE   526 AA;  53426 MW;  88C8E263B7905549 CRC64;
     MASNDYTQQA TQSYGAYPTQ PGQGYSQQSS QPYGQQSYSG YSQSTDTSGY GQSSYSSYGQ
     SQNTGYGTQS TPQGYGSTGG YGSSQSSQSS YGQQSSYPGY GQQPAPSSTS GSYGSSSQSS
     SYGQPQSGSY SQQPSYGGQQ QSYGQQQSYN PPQGYGQQNQ YNSSSGGGGG GGGGGNYGQD
     QSSMSSGGGS GGGYGNQDQS GGGGSGGYGQ QDRGGRGRGG SGGGGGGGGG GYNRSSGGYE
     PRGRGGGRGG RGGMGGSDRG GFNKFGGPRD QGSRHDSEQD NSDNNTIFVQ GLGENVTIES
     VADYFKQIGI IKTNKKTGQP MINLYTDRET GKLKGEATVS FDDPPSAKAA IDWFDGKEFS
     GNPIKVSFAT RRADFNRGGG NGRGGRGRGG PMGRGGYGGG GSGGGGRGGF PSGGGGGGGQ
     QRAGDWKCPN PTCENMNFSW RNECNQCKAP KPDGPGGGPG GSHMGGNYGD DRRGGRGGYD
     RGGYRGRGGD RGGFRGGRGG GDRGGFGPGK MDSRGEHRQD RRERPY
//
ID   C9JTB0_HUMAN            Unreviewed;       174 AA.
AC   C9JTB0;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   03-NOV-2009, sequence version 1.
DT   31-JAN-2018, entry version 49.
DE   SubName: Full=DNA-binding protein Ikaros {ECO:0000313|Ensembl:ENSP00000388478};
GN   Name=IKZF1 {ECO:0000313|Ensembl:ENSP00000388478};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000388478, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000388478}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000313|Ensembl:ENSP00000388478}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000388478}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC124014; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AUXG01000057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001278774.1; NM_001291845.1.
DR   UniGene; Hs.435949; -.
DR   UniGene; Hs.488251; -.
DR   UniGene; Hs.646004; -.
DR   UniGene; Hs.731495; -.
DR   ProteinModelPortal; C9JTB0; -.
DR   EPD; C9JTB0; -.
DR   MaxQB; C9JTB0; -.
DR   PeptideAtlas; C9JTB0; -.
DR   PRIDE; C9JTB0; -.
DR   Ensembl; ENST00000413698; ENSP00000388478; ENSG00000185811.
DR   GeneID; 10320; -.
DR   UCSC; uc003tov.2; human.
DR   CTD; 10320; -.
DR   EuPathDB; HostDB:ENSG00000185811.16; -.
DR   HGNC; HGNC:13176; IKZF1.
DR   OpenTargets; ENSG00000185811; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00550000074392; -.
DR   ChiTaRS; IKZF1; human.
DR   GenomeRNAi; 10320; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000185811; -.
DR   ExpressionAtlas; C9JTB0; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:C9JTB0,
KW   ECO:0000213|MaxQB:C9JTB0, ECO:0000213|PeptideAtlas:C9JTB0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   174 AA;  19628 MW;  A4F62FEE7226F3D5 CRC64;
     MDADEGQDMS QVSGKESPPV SDTPDEGDEP MPIPEDLSTT SGGQQSSKSD RVVVTYGADD
     FRDFHAIIPK SFSRKYMPCF WKTKACLHLL SCKYRTCMFL HQPPRYIKYS LFYSLDTYHI
     IFGYLYHKVQ NEGLGSCAVS WEHGSGVTVR VGVTVALMGL LLRRCCWTAL RLLL
//
ID   IKZF1_HUMAN             Reviewed;         519 AA.
AC   Q13422; A4D260; B4E0Z1; D3DVM5; O00598; Q53XL2; Q69BM4; Q8WVA3;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-FEB-2018, entry version 174.
DE   RecName: Full=DNA-binding protein Ikaros;
DE   AltName: Full=Ikaros family zinc finger protein 1;
DE   AltName: Full=Lymphoid transcription factor LyF-1;
GN   Name=IKZF1; Synonyms=IK1, IKAROS, LYF1, ZNFN1A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Bone marrow;
RX   PubMed=8964602; DOI=10.1016/0165-2478(95)02479-4;
RA   Nietfeld W., Meyerhans A.;
RT   "Cloning and sequencing of hIk-1, a cDNA encoding a human homologue of
RT   mouse Ikaros/LyF-1.";
RL   Immunol. Lett. 49:139-141(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8543809;
RA   Molnar A., Wu P., Largespada D.A., Vortkamp A., Scherer S.,
RA   Copeland N.G., Jenkins N.A., Bruns G., Georgopoulos K.;
RT   "The Ikaros gene encodes a family of lymphocyte-restricted zinc finger
RT   DNA binding proteins, highly conserved in human and mouse.";
RL   J. Immunol. 156:585-592(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IKX).
RA   Sanchez-Tapia E.M., Rodriguez R.E., Gonzalez-Sarmiento R.;
RT   "Molecular misreading is involved in generation of Ikaros diversity.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IK2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IK7).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IK7).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   IDENTIFICATION IN THE NURD COMPLEX, INTERACTION WITH SMARCA4 AND CHD4,
RP   AND FUNCTION.
RX   PubMed=10204490; DOI=10.1016/S1074-7613(00)80034-5;
RA   Kim J., Sif S., Jones B., Jackson A., Koipally J., Heller E.,
RA   Winandy S., Viel A., Sawyer A., Ikeda T., Kingston R.,
RA   Georgopoulos K.;
RT   "Ikaros DNA-binding proteins direct formation of chromatin remodeling
RT   complexes in lymphocytes.";
RL   Immunity 10:345-355(1999).
RN   [11]
RP   INVOLVEMENT IN B-CELL NON-HODGKIN LYMPHOMA, AND CHROMOSOMAL
RP   TRANSLOCATION WITH BCL6.
RX   PubMed=10753856;
RA   Hosokawa Y., Maeda Y., Ichinohasama R., Miura I., Taniwaki M.,
RA   Seto M.;
RT   "The Ikaros gene, a central regulator of lymphoid differentiation,
RT   fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in
RT   a patient with diffuse large B-cell lymphoma.";
RL   Blood 95:2719-2721(2000).
RN   [12]
RP   INTERACTION WITH IKZF4 AND IKZF5.
RX   PubMed=10978333; DOI=10.1074/jbc.M005457200;
RA   Perdomo J., Holmes M., Chong B., Crossley M.;
RT   "Eos and pegasus, two members of the Ikaros family of proteins with
RT   distinct DNA binding activities.";
RL   J. Biol. Chem. 275:38347-38354(2000).
RN   [13]
RP   FUNCTION, ALTERNATIVE SPLICING, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=17135265; DOI=10.1074/jbc.M605627200;
RA   Ronni T., Payne K.J., Ho S., Bradley M.N., Dorsam G., Dovat S.;
RT   "Human Ikaros function in activated T cells is regulated by
RT   coordinated expression of its largest isoforms.";
RL   J. Biol. Chem. 282:2538-2547(2007).
RN   [14]
RP   FUNCTION, AND ALTERNATIVE SPLICING.
RX   PubMed=17934067; DOI=10.1182/blood-2007-07-098202;
RA   Dijon M., Bardin F., Murati A., Batoz M., Chabannon C., Tonnelle C.;
RT   "The role of Ikaros in human erythroid differentiation.";
RL   Blood 111:1138-1146(2008).
RN   [15]
RP   FUNCTION IN GAMMA SATELLITE DNA-BINDING.
RX   PubMed=19141594; DOI=10.1101/gr.086496.108;
RA   Kim J.-H., Ebersole T., Kouprina N., Noskov V.N., Ohzeki J.-I.,
RA   Masumoto H., Mravinac B., Sullivan B.A., Pavlicek A., Dovat S.,
RA   Pack S.D., Kwon Y.-W., Flanagan P.T., Loukinov D., Lobanenkov V.,
RA   Larionov V.;
RT   "Human gamma-satellite DNA maintains open chromatin structure and
RT   protects a transgene from epigenetic silencing.";
RL   Genome Res. 19:533-544(2009).
RN   [16]
RP   INVOLVEMENT IN ACUTE LYMPHOBLASIC LEUKEMIA.
RX   PubMed=19129520; DOI=10.1056/NEJMoa0808253;
RA   Mullighan C.G., Su X., Zhang J., Radtke I., Phillips L.A.,
RA   Miller C.B., Ma J., Liu W., Cheng C., Schulman B.A., Harvey R.C.,
RA   Chen I.-M., Clifford R.J., Carroll W.L., Reaman G., Bowman W.P.,
RA   Devidas M., Gerhard D.S., Yang W., Relling M.V., Shurtleff S.A.,
RA   Campana D., Borowitz M.J., Pui C.H., Smith M., Hunger S.P.,
RA   Willman C.L., Downing J.R.;
RT   "Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.";
RL   N. Engl. J. Med. 360:470-480(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63; SER-258; SER-361 AND
RP   SER-364, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   FUNCTION IN DNA-BINDING, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=22106042; DOI=10.1002/pbc.23406;
RA   Li Z., Song C., Ouyang H., Lai L., Payne K.J., Dovat S.;
RT   "Cell cycle-specific function of Ikaros in human leukemia.";
RL   Pediatr. Blood Cancer 59:69-76(2012).
RN   [20]
RP   PHOSPHORYLATION AT SER-361 AND SER-364 BY SYK, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=23071339; DOI=10.1073/pnas.1209828109;
RA   Uckun F.M., Ma H., Zhang J., Ozer Z., Dovat S., Mao C., Ishkhanian R.,
RA   Goodman P., Qazi S.;
RT   "Serine phosphorylation by SYK is critical for nuclear localization
RT   and transcription factor function of Ikaros.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:18072-18077(2012).
RN   [21]
RP   INVOLVEMENT IN CVID13, VARIANT CVID13 CYS-210, CHARACTERIZATION OF
RP   VARIANT CVID13 CYS-210, AND SUBCELLULAR LOCATION.
RX   PubMed=21548011; DOI=10.1002/pbc.23160;
RA   Goldman F.D., Gurel Z., Al-Zubeidi D., Fried A.J., Icardi M., Song C.,
RA   Dovat S.;
RT   "Congenital pancytopenia and absence of B lymphocytes in a neonate
RT   with a mutation in the Ikaros gene.";
RL   Pediatr. Blood Cancer 58:591-597(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63; SER-261; SER-289;
RP   SER-298; SER-364; SER-368; SER-427 AND SER-445, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-445, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   VARIANTS CVID13 GLN-162; LEU-162; ARG-167 AND GLN-184,
RP   CHARACTERIZATION OF VARIANTS CVID13 GLN-162; LEU-162; ARG-167; GLN-184
RP   AND CYS-210, AND MUTAGENESIS OF ASN-159 AND HIS-191.
RX   PubMed=26981933; DOI=10.1056/NEJMoa1512234;
RA   Kuehn H.S., Boisson B., Cunningham-Rundles C., Reichenbach J.,
RA   Stray-Pedersen A., Gelfand E.W., Maffucci P., Pierce K.R.,
RA   Abbott J.K., Voelkerding K.V., South S.T., Augustine N.H., Bush J.S.,
RA   Dolen W.K., Wray B.B., Itan Y., Cobat A., Sorte H.S., Ganesan S.,
RA   Prader S., Martins T.B., Lawrence M.G., Orange J.S., Calvo K.R.,
RA   Niemela J.E., Casanova J.L., Fleisher T.A., Hill H.R., Kumanovics A.,
RA   Conley M.E., Rosenzweig S.D.;
RT   "Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.";
RL   N. Engl. J. Med. 374:1032-1043(2016).
CC   -!- FUNCTION: Transcription regulator of hematopoietic cell
CC       differentiation (PubMed:17934067). Binds gamma-satellite DNA
CC       (PubMed:17135265, PubMed:19141594). Plays a role in the
CC       development of lymphocytes, B- and T-cells. Binds and activates
CC       the enhancer (delta-A element) of the CD3-delta gene. Repressor of
CC       the TDT (fikzfterminal deoxynucleotidyltransferase) gene during
CC       thymocyte differentiation. Regulates transcription through
CC       association with both HDAC-dependent and HDAC-independent
CC       complexes. Targets the 2 chromatin-remodeling complexes, NuRD and
CC       BAF (SWI/SNF), in a single complex (PYR complex), to the beta-
CC       globin locus in adult erythrocytes. Increases normal apoptosis in
CC       adult erythroid cells. Confers early temporal competence to
CC       retinal progenitor cells (RPCs) (By similarity). Function is
CC       isoform-specific and is modulated by dominant-negative inactive
CC       isoforms (PubMed:17135265, PubMed:17934067).
CC       {ECO:0000250|UniProtKB:Q03267, ECO:0000269|PubMed:10204490,
CC       ECO:0000269|PubMed:17135265, ECO:0000269|PubMed:17934067,
CC       ECO:0000269|PubMed:19141594}.
CC   -!- SUBUNIT: Heterodimer formed by the various isoforms; this
CC       modulates transcription regulator activity (PubMed:17135265,
CC       PubMed:17934067). Heterodimer with other IKAROS family members.
CC       Interacts with IKZF4 AND IKZF5 (PubMed:10978333). Component of the
CC       chromatin-remodeling NuRD repressor complex which includes at
CC       least HDAC1, HDAC2, RBBP4, RBBP7, IKZF1, MTA2, MBD2, MBD3, MTA1L1,
CC       CHD3 and CHD4. Interacts directly with the CHD4 component of the
CC       NuRD complex. Interacts directly with SMARCA4; the interaction
CC       associates IKFZ1 with the BAF complex (PubMed:10204490). Interacts
CC       with SUMO1; the interaction sumoylates IKAROS, promoted by PIAS2
CC       and PIAS3. Interacts with PIAS2 (isoform alpha); the interaction
CC       promotes sumoylation and reduces transcription repression.
CC       Interacts, to a lesser extent, with PIAS3. Interacts with PPP1CC;
CC       the interaction targets PPP1CC to pericentromeric heterochromatin,
CC       dephosphorylates IKAROS, stabilizes it and prevents it from
CC       degradation. Interacts with IKZF3 (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:10204490, ECO:0000269|PubMed:10978333,
CC       ECO:0000305|PubMed:17135265, ECO:0000305|PubMed:17934067}.
CC   -!- INTERACTION:
CC       A8K932:-; NbExp=3; IntAct=EBI-745305, EBI-10174671;
CC       Q8WTP8:AEN; NbExp=3; IntAct=EBI-745305, EBI-8637627;
CC       Q96Q83:ALKBH3; NbExp=3; IntAct=EBI-745305, EBI-6658697;
CC       Q9BXS5:AP1M1; NbExp=3; IntAct=EBI-745305, EBI-541426;
CC       Q9H6L4:ARMC7; NbExp=3; IntAct=EBI-745305, EBI-742909;
CC       Q13895:BYSL; NbExp=5; IntAct=EBI-745305, EBI-358049;
CC       Q9NX04:C1orf109; NbExp=3; IntAct=EBI-745305, EBI-8643161;
CC       Q8IYL3:C1orf174; NbExp=3; IntAct=EBI-745305, EBI-715898;
CC       Q9H7E9:C8orf33; NbExp=3; IntAct=EBI-745305, EBI-715389;
CC       Q9HC52:CBX8; NbExp=3; IntAct=EBI-745305, EBI-712912;
CC       Q8IYX8-2:CEP57L1; NbExp=3; IntAct=EBI-745305, EBI-10181988;
CC       P61024:CKS1B; NbExp=3; IntAct=EBI-745305, EBI-456371;
CC       Q96SW2-2:CRBN; NbExp=2; IntAct=EBI-11522367, EBI-10693561;
CC       Q13363-2:CTBP1; NbExp=4; IntAct=EBI-11522367, EBI-10171858;
CC       P56545:CTBP2; NbExp=5; IntAct=EBI-745305, EBI-741533;
CC       P56545-3:CTBP2; NbExp=3; IntAct=EBI-745305, EBI-10171902;
CC       O43602:DCX; NbExp=4; IntAct=EBI-745305, EBI-8646694;
CC       P26196:DDX6; NbExp=3; IntAct=EBI-745305, EBI-351257;
CC       Q92630:DYRK2; NbExp=3; IntAct=EBI-745305, EBI-749432;
CC       Q3B820:FAM161A; NbExp=3; IntAct=EBI-745305, EBI-719941;
CC       Q7L5A3:FAM214B; NbExp=4; IntAct=EBI-745305, EBI-745689;
CC       Q9Y247:FAM50B; NbExp=4; IntAct=EBI-745305, EBI-742802;
CC       Q5TZK3:FAM74A6; NbExp=3; IntAct=EBI-745305, EBI-10247271;
CC       P61328:FGF12; NbExp=3; IntAct=EBI-745305, EBI-6657662;
CC       Q96NE9:FRMD6; NbExp=3; IntAct=EBI-745305, EBI-741729;
CC       O76003:GLRX3; NbExp=3; IntAct=EBI-745305, EBI-374781;
CC       Q8NEA9:GMCL1P1; NbExp=4; IntAct=EBI-11522367, EBI-745707;
CC       Q9H1K1:ISCU; NbExp=3; IntAct=EBI-745305, EBI-1047335;
CC       A0A0S2Z5S9:LHX4; NbExp=3; IntAct=EBI-11522367, EBI-16429099;
CC       Q8TAP4:LMO3; NbExp=3; IntAct=EBI-745305, EBI-742259;
CC       Q9Y4Z0:LSM4; NbExp=3; IntAct=EBI-745305, EBI-372521;
CC       Q9UI95:MAD2L2; NbExp=3; IntAct=EBI-745305, EBI-77889;
CC       Q96EZ8:MCRS1; NbExp=3; IntAct=EBI-745305, EBI-348259;
CC       Q9UBU8:MORF4L1; NbExp=3; IntAct=EBI-745305, EBI-399246;
CC       Q15014:MORF4L2; NbExp=3; IntAct=EBI-745305, EBI-399257;
CC       Q13330:MTA1; NbExp=3; IntAct=EBI-745305, EBI-714236;
CC       Q9HC98:NEK6; NbExp=3; IntAct=EBI-745305, EBI-740364;
CC       Q9Y5B8:NME7; NbExp=5; IntAct=EBI-11522367, EBI-744782;
CC       Q9BVI4:NOC4L; NbExp=3; IntAct=EBI-745305, EBI-395927;
CC       Q13526:PIN1; NbExp=3; IntAct=EBI-745305, EBI-714158;
CC       Q96T60:PNKP; NbExp=3; IntAct=EBI-745305, EBI-1045072;
CC       O43741:PRKAB2; NbExp=3; IntAct=EBI-745305, EBI-1053424;
CC       P25786:PSMA1; NbExp=3; IntAct=EBI-745305, EBI-359352;
CC       P25789:PSMA4; NbExp=3; IntAct=EBI-745305, EBI-359310;
CC       O75771:RAD51D; NbExp=4; IntAct=EBI-745305, EBI-1055693;
CC       A0A0S2Z4G9:RNF6; NbExp=3; IntAct=EBI-11522367, EBI-16428950;
CC       P57060:RWDD2B; NbExp=4; IntAct=EBI-745305, EBI-724442;
CC       Q9NUL5:RYDEN; NbExp=3; IntAct=EBI-745305, EBI-10313866;
CC       Q9BWG6:SCNM1; NbExp=3; IntAct=EBI-745305, EBI-748391;
CC       O00560:SDCBP; NbExp=3; IntAct=EBI-745305, EBI-727004;
CC       Q9H788:SH2D4A; NbExp=3; IntAct=EBI-745305, EBI-747035;
CC       P62306:SNRPF; NbExp=4; IntAct=EBI-11522367, EBI-356900;
CC       Q13573:SNW1; NbExp=3; IntAct=EBI-745305, EBI-632715;
CC       Q9H0A9:SPATC1L; NbExp=3; IntAct=EBI-745305, EBI-372911;
CC       Q9BSW7:SYT17; NbExp=3; IntAct=EBI-745305, EBI-745392;
CC       Q15560:TCEA2; NbExp=4; IntAct=EBI-11522367, EBI-710310;
CC       Q7KZS0:UBE2I; NbExp=3; IntAct=EBI-745305, EBI-10180829;
CC       Q15007:WTAP; NbExp=6; IntAct=EBI-11522367, EBI-751647;
CC       Q96NC0:ZMAT2; NbExp=3; IntAct=EBI-745305, EBI-2682299;
CC       Q8TAU3:ZNF417; NbExp=3; IntAct=EBI-745305, EBI-740727;
CC       Q9P0T4:ZNF581; NbExp=3; IntAct=EBI-745305, EBI-745520;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17135265,
CC       ECO:0000269|PubMed:21548011, ECO:0000269|PubMed:22106042,
CC       ECO:0000269|PubMed:23071339}. Note=In resting lymphocytes,
CC       distributed diffusely throughout the nucleus. Localizes to
CC       pericentromeric heterochromatin in proliferating cells. This
CC       localization requires DNA binding which is regulated by
CC       phosphorylation / dephosphorylation events.
CC       {ECO:0000269|PubMed:17135265, ECO:0000269|PubMed:22106042}.
CC   -!- SUBCELLULAR LOCATION: Isoform Ik2: Nucleus. Note=In resting
CC       lymphocytes, distributed diffusely throughout the nucleus.
CC       Localizes to pericentromeric heterochromatin in proliferating
CC       cells. This localization requires DNA binding which is regulated
CC       by phosphorylation / dephosphorylation events (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform Ik6: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=Ik1;
CC         IsoId=Q13422-1; Sequence=Displayed;
CC       Name=Ik2;
CC         IsoId=Q13422-2; Sequence=VSP_006848;
CC       Name=Ik3;
CC         IsoId=Q13422-3; Sequence=VSP_006850;
CC       Name=Ik4;
CC         IsoId=Q13422-4; Sequence=VSP_006847, VSP_006850;
CC       Name=Ik5;
CC         IsoId=Q13422-5; Sequence=VSP_006852;
CC       Name=Ik6;
CC         IsoId=Q13422-6; Sequence=VSP_006849;
CC       Name=Ik7;
CC         IsoId=Q13422-7; Sequence=VSP_006851;
CC       Name=Ikx;
CC         IsoId=Q13422-8; Sequence=VSP_006851, VSP_053404, VSP_053405;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in thymus, spleen and
CC       peripheral blood Leukocytes and lymph nodes. Lower expression in
CC       bone marrow and small intestine. {ECO:0000269|PubMed:8543809,
CC       ECO:0000269|PubMed:8964602}.
CC   -!- DOMAIN: The N-terminal zinc-fingers 2 and 3 are required for DNA
CC       binding as well as for targeting IKFZ1 to pericentromeric
CC       heterochromatin. {ECO:0000250}.
CC   -!- DOMAIN: The C-terminal zinc-finger domain is required for
CC       dimerization. {ECO:0000250}.
CC   -!- PTM: Phosphorylation controls cell-cycle progression from late
CC       G(1) stage to S stage. Hyperphosphorylated during G2/M phase.
CC       Dephosphorylated state during late G(1) phase. Phosphorylation on
CC       Thr-140 is required for DNA and pericentromeric location during
CC       mitosis. CK2 is the main kinase, in vitro. GSK3 and CDK may also
CC       contribute to phosphorylation of the C-terminal serine and
CC       threonine residues. Phosphorylation on these C-terminal residues
CC       reduces the DNA-binding ability. Phosphorylation/dephosphorylation
CC       events on Ser-13 and Ser-295 regulate TDT expression during
CC       thymocyte differentiation. Dephosphorylation by protein
CC       phosphatase 1 regulates stability and pericentromeric
CC       heterochromatin location. Phosphorylated in both lymphoid and non-
CC       lymphoid tissues (By similarity). Phosphorylation at Ser-361 and
CC       Ser-364 downstream of SYK induces nuclear translocation.
CC       {ECO:0000250, ECO:0000269|PubMed:22106042,
CC       ECO:0000269|PubMed:23071339}.
CC   -!- PTM: Sumoylated. Simulataneous sumoylation on the 2 sites results
CC       in a loss of both HDAC-dependent and HDAC-independent repression.
CC       Has no effect on pericentromeric heterochromatin location.
CC       Desumoylated by SENP1 (By similarity). {ECO:0000250}.
CC   -!- PTM: Polyubiquitinated. {ECO:0000250}.
CC   -!- DISEASE: Note=Defects in IKZF1 are frequent occurrences (28.6%) in
CC       acute lymphoblasic leukemia (ALL). Such alterations or deletions
CC       lead to poor prognosis for ALL.
CC   -!- DISEASE: Note=Chromosomal aberrations involving IKZF1 are a cause
CC       of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation
CC       t(3;7)(q27;p12), with BCL6.
CC   -!- DISEASE: Immunodeficiency, common variable, 13 (CVID13)
CC       [MIM:616873]: A primary immunodeficiency characterized by antibody
CC       deficiency, hypogammaglobulinemia, recurrent bacterial infections
CC       and an inability to mount an antibody response to antigen. CVID13
CC       is an autosomal dominant disease associated with a striking
CC       decrease in B-cell numbers. {ECO:0000269|PubMed:21548011,
CC       ECO:0000269|PubMed:26981933}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Ikaros C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/IkarosID258.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U40462; AAC50459.1; -; mRNA.
DR   EMBL; S80876; AAB50683.1; -; mRNA.
DR   EMBL; AY377974; AAR84585.1; -; mRNA.
DR   EMBL; AK303586; BAG64603.1; -; mRNA.
DR   EMBL; BT009836; AAP88838.1; -; mRNA.
DR   EMBL; AC124014; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471128; EAW60977.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW60978.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW60981.1; -; Genomic_DNA.
DR   EMBL; CH236955; EAL23900.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW60979.1; -; Genomic_DNA.
DR   EMBL; BC018349; AAH18349.1; -; mRNA.
DR   CCDS; CCDS59055.1; -. [Q13422-7]
DR   CCDS; CCDS69299.1; -. [Q13422-5]
DR   CCDS; CCDS75596.1; -. [Q13422-1]
DR   CCDS; CCDS75597.1; -. [Q13422-3]
DR   CCDS; CCDS78233.1; -. [Q13422-2]
DR   RefSeq; NP_001207694.1; NM_001220765.2. [Q13422-7]
DR   RefSeq; NP_001207696.1; NM_001220767.2.
DR   RefSeq; NP_001207697.1; NM_001220768.2. [Q13422-3]
DR   RefSeq; NP_001207699.1; NM_001220770.2.
DR   RefSeq; NP_001207700.1; NM_001220771.2. [Q13422-5]
DR   RefSeq; NP_001278766.1; NM_001291837.1. [Q13422-7]
DR   RefSeq; NP_001278767.1; NM_001291838.1. [Q13422-2]
DR   RefSeq; NP_001278768.1; NM_001291839.1.
DR   RefSeq; NP_001278769.1; NM_001291840.1. [Q13422-6]
DR   RefSeq; NP_001278770.1; NM_001291841.1.
DR   RefSeq; NP_001278771.1; NM_001291842.1.
DR   RefSeq; NP_001278772.1; NM_001291843.1.
DR   RefSeq; NP_001278773.1; NM_001291844.1.
DR   RefSeq; NP_006051.1; NM_006060.5. [Q13422-1]
DR   RefSeq; XP_011513370.1; XM_011515068.2. [Q13422-1]
DR   RefSeq; XP_011513371.1; XM_011515069.2. [Q13422-1]
DR   RefSeq; XP_011513377.1; XM_011515075.2. [Q13422-2]
DR   RefSeq; XP_011513378.1; XM_011515076.2. [Q13422-2]
DR   RefSeq; XP_016867157.1; XM_017011668.1. [Q13422-2]
DR   UniGene; Hs.435949; -.
DR   UniGene; Hs.488251; -.
DR   UniGene; Hs.646004; -.
DR   UniGene; Hs.731495; -.
DR   ProteinModelPortal; Q13422; -.
DR   SMR; Q13422; -.
DR   BioGrid; 115604; 123.
DR   DIP; DIP-41110N; -.
DR   ELM; Q13422; -.
DR   IntAct; Q13422; 96.
DR   MINT; Q13422; -.
DR   STRING; 9606.ENSP00000331614; -.
DR   iPTMnet; Q13422; -.
DR   PhosphoSitePlus; Q13422; -.
DR   BioMuta; IKZF1; -.
DR   DMDM; 3913926; -.
DR   EPD; Q13422; -.
DR   MaxQB; Q13422; -.
DR   PaxDb; Q13422; -.
DR   PeptideAtlas; Q13422; -.
DR   PRIDE; Q13422; -.
DR   DNASU; 10320; -.
DR   Ensembl; ENST00000331340; ENSP00000331614; ENSG00000185811. [Q13422-1]
DR   Ensembl; ENST00000343574; ENSP00000342750; ENSG00000185811. [Q13422-2]
DR   Ensembl; ENST00000349824; ENSP00000342485; ENSG00000185811. [Q13422-5]
DR   Ensembl; ENST00000357364; ENSP00000349928; ENSG00000185811. [Q13422-3]
DR   Ensembl; ENST00000359197; ENSP00000352123; ENSG00000185811. [Q13422-7]
DR   Ensembl; ENST00000438033; ENSP00000396554; ENSG00000185811. [Q13422-2]
DR   Ensembl; ENST00000439701; ENSP00000413025; ENSG00000185811. [Q13422-7]
DR   GeneID; 10320; -.
DR   KEGG; hsa:10320; -.
DR   UCSC; uc003tow.5; human. [Q13422-1]
DR   CTD; 10320; -.
DR   DisGeNET; 10320; -.
DR   EuPathDB; HostDB:ENSG00000185811.16; -.
DR   GeneCards; IKZF1; -.
DR   HGNC; HGNC:13176; IKZF1.
DR   HPA; CAB009247; -.
DR   HPA; HPA035221; -.
DR   HPA; HPA035222; -.
DR   MalaCards; IKZF1; -.
DR   MIM; 603023; gene.
DR   MIM; 616873; phenotype.
DR   neXtProt; NX_Q13422; -.
DR   OpenTargets; ENSG00000185811; -.
DR   Orphanet; 317473; Pancytopenia due to IKZF1 mutations.
DR   Orphanet; 99860; Precursor B-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA37748; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00550000074392; -.
DR   HOVERGEN; HBG004752; -.
DR   InParanoid; Q13422; -.
DR   KO; K09220; -.
DR   OMA; GDKCLSD; -.
DR   OrthoDB; EOG091G05E2; -.
DR   PhylomeDB; Q13422; -.
DR   TreeFam; TF331189; -.
DR   Reactome; R-HSA-9013508; NOTCH3 Intracellular Domain Regulates Transcription.
DR   SignaLink; Q13422; -.
DR   SIGNOR; Q13422; -.
DR   ChiTaRS; IKZF1; human.
DR   GeneWiki; IKZF1; -.
DR   GenomeRNAi; 10320; -.
DR   PRO; PR:Q13422; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000185811; -.
DR   CleanEx; HS_IKZF1; -.
DR   ExpressionAtlas; Q13422; baseline and differential.
DR   Genevisible; Q13422; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0031618; C:nuclear pericentric heterochromatin; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IBA:GO_Central.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0016569; P:covalent chromatin modification; IEA:UniProtKB-KW.
DR   GO; GO:0030218; P:erythrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0030098; P:lymphocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0007498; P:mesoderm development; TAS:ProtInc.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0051291; P:protein heterooligomerization; IMP:CAFA.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00355; ZnF_C2H2; 6.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Cell cycle; Chromatin regulator;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm;
KW   Developmental protein; Disease mutation; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    519       DNA-binding protein Ikaros.
FT                                /FTId=PRO_0000047094.
FT   ZN_FING     117    139       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     145    167       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     173    195       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     201    224       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     462    484       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     490    514       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   REGION      154    163       Required for both high-affinity DNA
FT                                binding and pericentromeric
FT                                heterochromatin localization.
FT                                {ECO:0000250}.
FT   REGION      180    195       Required for both high-affinity DNA
FT                                binding and pericentromeric
FT                                heterochromatin localization.
FT                                {ECO:0000250}.
FT   REGION      468    471       Required for binding PP1CC.
FT                                {ECO:0000250}.
FT   COMPBIAS    373    376       Poly-Leu.
FT   SITE        159    159       Required for both pericentromeric
FT                                heterochromatin localization and complete
FT                                DNA binding. {ECO:0000250}.
FT   SITE        162    162       Required for both pericentromeric
FT                                heterochromatin localization and complete
FT                                DNA binding. {ECO:0000250}.
FT   SITE        188    188       Required for both pericentromeric
FT                                heterochromatin localization and DNA
FT                                binding. {ECO:0000250}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES      23     23       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES      63     63       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     101    101       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     140    140       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     168    168       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     196    196       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     258    258       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     261    261       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     289    289       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     295    295       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     298    298       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     361    361       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000269|PubMed:23071339}.
FT   MOD_RES     364    364       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:23071339}.
FT   MOD_RES     368    368       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     389    389       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     391    391       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     393    393       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     397    397       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     398    398       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     402    402       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03267}.
FT   MOD_RES     427    427       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     445    445       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   CROSSLNK     58     58       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250}.
FT   CROSSLNK    241    241       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000250}.
FT   VAR_SEQ      10     53       Missing (in isoform Ik4). {ECO:0000305}.
FT                                /FTId=VSP_006847.
FT   VAR_SEQ      54    283       Missing (in isoform Ik6). {ECO:0000305}.
FT                                /FTId=VSP_006849.
FT   VAR_SEQ      54    140       Missing (in isoform Ik2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_006848.
FT   VAR_SEQ     141    283       Missing (in isoform Ik5). {ECO:0000305}.
FT                                /FTId=VSP_006852.
FT   VAR_SEQ     197    283       Missing (in isoform Ik3 and isoform Ik4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_006850.
FT   VAR_SEQ     197    238       Missing (in isoform Ik7 and isoform Ikx).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3, ECO:0000303|Ref.5}.
FT                                /FTId=VSP_006851.
FT   VAR_SEQ     260    268       RSLVLDRLA -> ISRAGQTSK (in isoform Ikx).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_053404.
FT   VAR_SEQ     269    519       Missing (in isoform Ikx).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_053405.
FT   VARIANT     162    162       R -> L (in CVID13; abolishes binding to
FT                                DNA; has diffuse nuclear localization;
FT                                dbSNP:rs770551610).
FT                                {ECO:0000269|PubMed:26981933}.
FT                                /FTId=VAR_076401.
FT   VARIANT     162    162       R -> Q (in CVID13; abolishes binding to
FT                                DNA; has diffuse nuclear localization;
FT                                dbSNP:rs770551610).
FT                                {ECO:0000269|PubMed:26981933}.
FT                                /FTId=VAR_076402.
FT   VARIANT     167    167       H -> R (in CVID13; abolishes binding to
FT                                DNA; has diffuse nuclear localization;
FT                                dbSNP:rs869312884).
FT                                {ECO:0000269|PubMed:26981933}.
FT                                /FTId=VAR_076403.
FT   VARIANT     184    184       R -> Q (in CVID13; abolishes binding to
FT                                DNA; has diffuse nuclear localization;
FT                                dbSNP:rs869312885).
FT                                {ECO:0000269|PubMed:26981933}.
FT                                /FTId=VAR_076404.
FT   VARIANT     210    210       Y -> C (in CVID13; decreases binding to
FT                                pericentromeric heterochromatin DNA; has
FT                                diffuse nuclear localization;
FT                                dbSNP:rs869312883).
FT                                {ECO:0000269|PubMed:21548011,
FT                                ECO:0000269|PubMed:26981933}.
FT                                /FTId=VAR_076405.
FT   MUTAGEN     159    159       N->A: Abolishes binding to DNA and has
FT                                diffuse nuclear localization.
FT                                {ECO:0000269|PubMed:26981933}.
FT   MUTAGEN     191    191       H->R: Abolishes binding to DNA and has
FT                                diffuse nuclear localization.
FT                                {ECO:0000269|PubMed:26981933}.
FT   CONFLICT     11     12       QV -> FS (in Ref. 2; AAB50683).
FT                                {ECO:0000305}.
FT   CONFLICT    214    214       S -> T (in Ref. 2; AAB50683).
FT                                {ECO:0000305}.
FT   CONFLICT    245    245       N -> K (in Ref. 2; AAB50683).
FT                                {ECO:0000305}.
FT   CONFLICT    296    296       Missing (in Ref. 2; AAB50683).
FT                                {ECO:0000305}.
FT   CONFLICT    298    298       S -> T (in Ref. 2; AAB50683).
FT                                {ECO:0000305}.
FT   CONFLICT    352    355       KPLA -> RRS (in Ref. 2; AAB50683).
FT                                {ECO:0000305}.
FT   CONFLICT    372    372       N -> Y (in Ref. 2; AAB50683).
FT                                {ECO:0000305}.
FT   CONFLICT    420    426       PHARNGL -> RRAQRV (in Ref. 2; AAB50683).
FT                                {ECO:0000305}.
SQ   SEQUENCE   519 AA;  57528 MW;  7B0129C4E3FE41A8 CRC64;
     MDADEGQDMS QVSGKESPPV SDTPDEGDEP MPIPEDLSTT SGGQQSSKSD RVVASNVKVE
     TQSDEENGRA CEMNGEECAE DLRMLDASGE KMNGSHRDQG SSALSGVGGI RLPNGKLKCD
     ICGIICIGPN VLMVHKRSHT GERPFQCNQC GASFTQKGNL LRHIKLHSGE KPFKCHLCNY
     ACRRRDALTG HLRTHSVGKP HKCGYCGRSY KQRSSLEEHK ERCHNYLESM GLPGTLYPVI
     KEETNHSEMA EDLCKIGSER SLVLDRLASN VAKRKSSMPQ KFLGDKGLSD TPYDSSASYE
     KENEMMKSHV MDQAINNAIN YLGAESLRPL VQTPPGGSEV VPVISPMYQL HKPLAEGTPR
     SNHSAQDSAV ENLLLLSKAK LVPSEREASP SNSCQDSTDT ESNNEEQRSG LIYLTNHIAP
     HARNGLSLKE EHRAYDLLRA ASENSQDALR VVSTSGEQMK VYKCEHCRVL FLDHVMYTIH
     MGCHGFRDPF ECNMCGYHSQ DRYEFSSHIT RGEHRFHMS
//
ID   R9R4D9_HUMAN            Unreviewed;       268 AA.
AC   R9R4D9;
DT   18-SEP-2013, integrated into UniProtKB/TrEMBL.
DT   18-SEP-2013, sequence version 1.
DT   28-FEB-2018, entry version 41.
DE   SubName: Full=DNA-binding protein Ikaros {ECO:0000313|Ensembl:ENSP00000483016};
DE   SubName: Full=IKAROS family zinc finger 1 isoform 14 {ECO:0000313|EMBL:AGI59420.1};
GN   Name=IKZF1 {ECO:0000313|EMBL:AGI59420.1,
GN   ECO:0000313|Ensembl:ENSP00000483016};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AGI59420.1};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000483016}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|EMBL:AGI59420.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Capece D., Zazzeroni F., Mancarelli M.M., Verzella D., Fischietti M.,
RA   Di Tommaso A., Plebani S., Di Ianni M., Gulino A., Alesse E.;
RT   "A novel, non-canonical splice variant of Ikaros gene is aberrantly
RT   expressed in B-cell lymphoproliferative disorders.";
RL   Submitted (AUG-2012) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8] {ECO:0000313|Ensembl:ENSP00000483016}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC124014; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AUXG01000057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; JX459579; AGI59420.1; -; mRNA.
DR   RefSeq; NP_001207694.1; NM_001220765.2.
DR   RefSeq; NP_001207696.1; NM_001220767.2.
DR   RefSeq; NP_001207697.1; NM_001220768.2.
DR   RefSeq; NP_001207699.1; NM_001220770.2.
DR   RefSeq; NP_001207700.1; NM_001220771.2.
DR   RefSeq; NP_001278766.1; NM_001291837.1.
DR   RefSeq; NP_001278767.1; NM_001291838.1.
DR   RefSeq; NP_001278768.1; NM_001291839.1.
DR   RefSeq; NP_001278769.1; NM_001291840.1.
DR   RefSeq; NP_001278770.1; NM_001291841.1.
DR   RefSeq; NP_001278771.1; NM_001291842.1.
DR   RefSeq; NP_001278772.1; NM_001291843.1.
DR   RefSeq; NP_001278773.1; NM_001291844.1.
DR   RefSeq; NP_006051.1; NM_006060.5.
DR   UniGene; Hs.435949; -.
DR   UniGene; Hs.488251; -.
DR   UniGene; Hs.646004; -.
DR   UniGene; Hs.731495; -.
DR   PeptideAtlas; R9R4D9; -.
DR   Ensembl; ENST00000612658; ENSP00000483016; ENSG00000185811.
DR   GeneID; 10320; -.
DR   KEGG; hsa:10320; -.
DR   UCSC; uc064dpn.1; human.
DR   CTD; 10320; -.
DR   EuPathDB; HostDB:ENSG00000185811.16; -.
DR   HGNC; HGNC:13176; IKZF1.
DR   OpenTargets; ENSG00000185811; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00550000074392; -.
DR   KO; K09220; -.
DR   ChiTaRS; IKZF1; human.
DR   GenomeRNAi; 10320; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000185811; -.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00355; ZnF_C2H2; 3.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 2.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Proteomics identification {ECO:0000213|EPD:R9R4D9,
KW   ECO:0000213|MaxQB:R9R4D9, ECO:0000213|PeptideAtlas:R9R4D9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN       78    100       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
SQ   SEQUENCE   268 AA;  30031 MW;  3A4F6647250035C0 CRC64;
     MDADEGQDMS QVSGKESPPV SDTPDEGDEP MPIPEDLSTT SGGQQSSKSD RVVVTYGADD
     FRDFHAIIPK SFSRERPFQC NQCGASFTQK GNLLRHIKLH KPLAEGTPRS NHSAQDSAVE
     NLLLLSKAKL VPSEREASPS NSCQDSTDTE SNNEEQRSGL IYLTNHIAPH ARNGLSLKEE
     HRAYDLLRAA SENSQDALRV VSTSGEQMKV YKCEHCRVLF LDHVMYTIHM GCHGFRDPFE
     CNMCGYHSQD RYEFSSHITR GEHRFHMS
//
ID   B2RWN8_HUMAN            Unreviewed;      2073 AA.
AC   B2RWN8;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   28-FEB-2018, entry version 73.
DE   RecName: Full=Histone acetyltransferase {ECO:0000256|RuleBase:RU361211};
DE            EC=2.3.1.48 {ECO:0000256|RuleBase:RU361211};
GN   Name=MYST4 {ECO:0000313|EMBL:AAI50619.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI50619.1};
RN   [1] {ECO:0000313|EMBL:AAI50619.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAI50619.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine. {ECO:0000256|RuleBase:RU361211}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU361211}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family.
CC       {ECO:0000256|RuleBase:RU361211}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC150618; AAI50619.1; -; mRNA.
DR   RefSeq; NP_001243397.1; NM_001256468.1.
DR   RefSeq; NP_001243398.1; NM_001256469.1.
DR   RefSeq; NP_036462.2; NM_012330.3.
DR   UniGene; Hs.35758; -.
DR   UniGene; Hs.599543; -.
DR   UniGene; Hs.740873; -.
DR   PeptideAtlas; B2RWN8; -.
DR   PRIDE; B2RWN8; -.
DR   GeneID; 23522; -.
DR   KEGG; hsa:23522; -.
DR   CTD; 23522; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   eggNOG; COG5027; LUCA.
DR   HOVERGEN; HBG052563; -.
DR   KO; K11306; -.
DR   ChiTaRS; KAT6B; human.
DR   GenomeRNAi; 23522; -.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 1.10.10.10; -; 2.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF00628; PHD; 1.
DR   SMART; SM00526; H15; 1.
DR   SMART; SM00249; PHD; 2.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51504; H15; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077};
KW   Nucleus {ECO:0000256|RuleBase:RU361211};
KW   Transferase {ECO:0000313|EMBL:AAI50619.1};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077}.
FT   DOMAIN      103    176       H15. {ECO:0000259|PROSITE:PS51504}.
FT   DOMAIN      213    272       PHD-type. {ECO:0000259|PROSITE:PS50016}.
FT   DOMAIN      269    320       PHD-type. {ECO:0000259|PROSITE:PS50016}.
FT   DOMAIN      715    989       MYST-type HAT.
FT                                {ECO:0000259|PROSITE:PS51726}.
FT   COILED      994   1021       {ECO:0000256|SAM:Coils}.
FT   COILED     1061   1109       {ECO:0000256|SAM:Coils}.
FT   COILED     1347   1374       {ECO:0000256|SAM:Coils}.
FT   ACT_SITE    891    891       Proton donor/acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR602717-51}.
SQ   SEQUENCE   2073 AA;  231390 MW;  1BBC7262B7F3D81D CRC64;
     MVKLANPLYI EWILEAIQKI KKQKQRPSEE RICHAVSTSH GLDKKTVSEQ LELSVQDGSV
     LKVTNKGLAS YKDPDNPGRF SSVKPGTFPK SAKGSRGSCN DLRNVDWNKL LRRAIEGLEE
     PNGSSLKNIE KYLRSQSDLT STTNNPAFQQ RLRLGAKRAV NNGRLLKDGP QYRVNYGSLD
     GKGAPQYPSA FPSSLPPVSL LPHEKDQPRA DPIPICSFCL GTKESNREKK PEELLSCADC
     GSSGHPSCLK FCPELTTNVK ALRWQCIECK TCSACRVQGR NADNMLFCDS CDRGFHMECC
     DPPLSRMPKG MWICQVCRPK KKGRKLLHEK AAQIKRRYAK PIGRPKNKLK QRLLSVTSDE
     GSMNAFTGRG SPGRGQKTKV CTTPSSGHAA SGKDSSSRLA VTDPTRPGAT TKITTTSTYI
     SASTLKVNKK TKGLIDGLTK FFTPSPDGRR SRGEIIDFSK HYRPRKKVSQ KQSCTSHVLA
     TGTTQKLKPP PSSLPPPTPI SGQSPSSQKS STATSSPSPQ SSSSQCSVPS LSSLTTNSQL
     KALFDGLSHI YTTQGQSRKK GHPSYAPPKR MRRKTELSST AKSKAHFFGK RDIRSRFISH
     SSSSSWGMAR GSIFKAIAHF KRTTFLKKHR MLGRLKYKVT PQMGTPSPGK GSLTDGRIKP
     DQDDDTEIKI NIKQESADVN VIGNKDVVTE EDLDVFKQAQ ELSWEKIECE SGVEDCGRYP
     SVIEFGKYEI QTWYSSPYPQ EYARLPKLYL CEFCLKYMKS KNILLRHSKK CGWFHPPANE
     IYRRKDLSVF EVDGNMSKIY CQNLCLLAKL FLDHKTLYYD VEPFLFYVLT KNDEKGCHLV
     GYFSKEKLCQ QKYNVSCIMI MPQHQRQGFG RFLIDFSYLL SRREGQAGSP EKPLSDLGRL
     SYLAYWKSVI LEYLYHHHER HISIKAISRA TGMCPHDIAT TLQHLHMIDK RDGRFVIIRR
     EKLILSHMEK LKTCSRANEL DPDSLRWTPI LISNAAVSEE EREAEKEAER LMEQASCWEK
     EEQEILSTRA NSRQSPAKVQ SKNKYLHSPE SRPVTGERGQ LLELSKESSE EEEEEEDEEE
     EEEEEEEEED EEEEEEEEEE EEEENIQSSP PRLTKPQSVA IKRKRPFVLK KKRGRKRRRI
     NSSVTTETIS ETTEVLNEPF DNSDEERPMP QLEPTCEIEV EEDGRKPVLR KAFQHQPGKK
     RQTEEEEGKD NHCFKNADPC RNNMNDDSSN LKEGSKDNPE PLKCKQVWPK GTKRGLSKWR
     QNKERKTGFK LNLYTPPETP MEPDEQVTVE EQKETSEGKT SPSPIRIEEE VKETGEALLP
     QEENRREETC APVSPNTSPG EKPEDDLIKP EEEEEEEEEE EEEEEEEEGE EEEGGGNVEK
     DPDGAKSQEK EEPEISTEKE DSARLDDHEE EEEEDEEPSH NEDHDADDED DSHMESAEVE
     KEELPRESFK EVLENQETFL DLNVQPGHSN PEVLMDCGVD LTASCNSEPK ELAGDPEAVP
     ESDEEPPPGE QAQKQDQKNS KEVDTEFKEG NPATMEIDSE TVQAVQSLTQ ESSEQDDTFQ
     DCAETQEACR SLQNYTRADQ SPQIATTLDD CQQSDHSSPV SSVHSHPGQS VRSVNSPSVP
     ALENSYAQIS PDQSAISVPS LQNMETSPMM DVPSVSDHSQ QVVDSGFSDL GSIESTTENY
     ENPSSYDSTM GGSICGNGSS QNSCSYSNLT SSSLTQSSCA VTQQMSNISG SCSMLQQTSI
     SSPPTCSVKS PQGCVVERPP SSSQQLAQCS MAANFTPPMQ LAEIPETSNA NIGLYERMGQ
     SDFGAGHYPQ PSATFSLAKL QQLTNTLIDH SLPYSHSAAV TSYANSASLS TPLSNTGLVQ
     LSQSPHSVPG GPQAQATMTP PPNLTPPPMN LPPPLLQRNM AASNIGISHS QRLQTQIASK
     GHISMRTKSA SLSPAAATHQ SQIYGRSQTV AMQGPARTLT MQRGMNMSVN LMPAPAYNVN
     SVNMNMNTLN AMNGYSMSQP MMNSGYHSNH GYMNQTPQYP MQMQMGMMGT QPYAQQPMQT
     PPHGNMMYTA PGHHGYMNTG MSKQSLNGSY MRR
//
ID   KAT6B_HUMAN             Reviewed;        2073 AA.
AC   Q8WYB5; O15087; Q86Y05; Q8WU81; Q9UKW2; Q9UKW3; Q9UKX0;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 3.
DT   28-FEB-2018, entry version 155.
DE   RecName: Full=Histone acetyltransferase KAT6B;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:10497217};
DE   AltName: Full=Histone acetyltransferase MOZ2;
DE   AltName: Full=MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4;
DE            Short=MYST-4;
DE   AltName: Full=Monocytic leukemia zinc finger protein-related factor;
GN   Name=KAT6B; Synonyms=KIAA0383, MORF, MOZ2, MYST4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), TISSUE SPECIFICITY,
RP   AUTOACETYLATION, CATALYTIC ACTIVITY, DOMAIN, AND FUNCTION.
RC   TISSUE=Bone marrow;
RX   PubMed=10497217; DOI=10.1074/jbc.274.40.28528;
RA   Champagne N., Bertos N.R., Pelletier N., Wang A.H., Vezmar M.,
RA   Yang Y., Heng H.H., Yang X.-J.;
RT   "Identification of a human histone acetyltransferase related to
RT   monocytic leukemia zinc finger protein.";
RL   J. Biol. Chem. 274:28528-28536(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Borrow J., Housman D.E.;
RT   "Structure and function of the human MYST family: MOZ2, MYST1 and
RT   MYST2.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-322 AND 1187-2073.
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1136-1287, AND CHROMOSOMAL TRANSLOCATION
RP   WITH CREBBP.
RX   PubMed=11157802; DOI=10.1093/hmg/10.4.395;
RA   Panagopoulos I., Fioretos T., Isaksson M., Samuelsson U.,
RA   Billstroem R., Stroembeck B., Mitelman F., Johansson B.;
RT   "Fusion of the MORF and CBP genes in acute myeloid leukemia with the
RT   t(10;16)(q22;p13).";
RL   Hum. Mol. Genet. 10:395-404(2001).
RN   [7]
RP   INTERACTION WITH RUNX1 AND RUNX2, AUTOACETYLATION, AND FUNCTION.
RX   PubMed=11965546; DOI=10.1038/sj.onc.1205367;
RA   Pelletier N., Champagne N., Stifani S., Yang X.-J.;
RT   "MOZ and MORF histone acetyltransferases interact with the Runt-domain
RT   transcription factor Runx2.";
RL   Oncogene 21:2729-2740(2002).
RN   [8]
RP   FUNCTION, AND IDENTIFICATION IN THE MOZ/MORF COMPLEX.
RX   PubMed=16387653; DOI=10.1016/j.molcel.2005.12.007;
RA   Doyon Y., Cayrou C., Ullah M., Landry A.-J., Cote V., Selleck W.,
RA   Lane W.S., Tan S., Yang X.-J., Cote J.;
RT   "ING tumor suppressor proteins are critical regulators of chromatin
RT   acetylation required for genome expression and perpetuation.";
RL   Mol. Cell 21:51-64(2006).
RN   [9]
RP   IDENTIFICATION IN THE MOZ/MORF COMPLEX, AND INTERACTION WITH BRPF1.
RX   PubMed=18794358; DOI=10.1128/MCB.01297-08;
RA   Ullah M., Pelletier N., Xiao L., Zhao S.P., Wang K., Degerny C.,
RA   Tahmasebi S., Cayrou C., Doyon Y., Goh S.-L., Champagne N., Cote J.,
RA   Yang X.-J.;
RT   "Molecular architecture of quartet MOZ/MORF histone acetyltransferase
RT   complexes.";
RL   Mol. Cell. Biol. 28:6828-6843(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1038; LYS-1042 AND LYS-1044,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   INVOLVEMENT IN SBBYSS, AND VARIANT LYS-360.
RX   PubMed=22077973; DOI=10.1016/j.ajhg.2011.10.008;
RA   Clayton-Smith J., O'Sullivan J., Daly S., Bhaskar S., Day R.,
RA   Anderson B., Voss A.K., Thomas T., Biesecker L.G., Smith P., Fryer A.,
RA   Chandler K.E., Kerr B., Tassabehji M., Lynch S.A.,
RA   Krajewska-Walasek M., McKee S., Smith J., Sweeney E., Mansour S.,
RA   Mohammed S., Donnai D., Black G.;
RT   "Whole-exome-sequencing identifies mutations in histone
RT   acetyltransferase gene KAT6B in individuals with the Say-Barber-
RT   Biesecker variant of Ohdo syndrome.";
RL   Am. J. Hum. Genet. 89:675-681(2011).
RN   [12]
RP   INVOLVEMENT IN GTPTS.
RX   PubMed=22265014; DOI=10.1016/j.ajhg.2011.11.023;
RA   Campeau P.M., Kim J.C., Lu J.T., Schwartzentruber J.A.,
RA   Abdul-Rahman O.A., Schlaubitz S., Murdock D.M., Jiang M.M.,
RA   Lammer E.J., Enns G.M., Rhead W.J., Rowland J., Robertson S.P.,
RA   Cormier-Daire V., Bainbridge M.N., Yang X.J., Gingras M.C.,
RA   Gibbs R.A., Rosenblatt D.S., Majewski J., Lee B.H.;
RT   "Mutations in KAT6B, encoding a histone acetyltransferase, cause
RT   Genitopatellar syndrome.";
RL   Am. J. Hum. Genet. 90:282-289(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-355; SER-647 AND
RP   SER-1048, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-673, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-673, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-673, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-483.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Histone acetyltransferase which may be involved in both
CC       positive and negative regulation of transcription. Required for
CC       RUNX2-dependent transcriptional activation. May be involved in
CC       cerebral cortex development. Component of the MOZ/MORF complex
CC       which has a histone H3 acetyltransferase activity.
CC       {ECO:0000269|PubMed:10497217, ECO:0000269|PubMed:11965546,
CC       ECO:0000269|PubMed:16387653}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:10497217}.
CC   -!- SUBUNIT: Component of the MOZ/MORF complex composed at least of
CC       ING5, KAT6A, KAT6B, MEAF6 and one of BRPF1, BRD1/BRPF2 and BRPF3.
CC       Interacts with RUNX1 and RUNX2. {ECO:0000269|PubMed:11965546,
CC       ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:18794358}.
CC   -!- INTERACTION:
CC       P56559:ARL4C; NbExp=4; IntAct=EBI-948029, EBI-946814;
CC       P36894:BMPR1A; NbExp=4; IntAct=EBI-948029, EBI-1029237;
CC       Q96E66:LRTOMT; NbExp=4; IntAct=EBI-948029, EBI-13044658;
CC       P00540:MOS; NbExp=4; IntAct=EBI-948029, EBI-1757866;
CC       Q5VWQ0:RSBN1; NbExp=4; IntAct=EBI-948029, EBI-1210591;
CC       Q9HCY8:S100A14; NbExp=4; IntAct=EBI-948029, EBI-751842;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Beta;
CC         IsoId=Q8WYB5-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha;
CC         IsoId=Q8WYB5-2; Sequence=VSP_014587;
CC       Name=3;
CC         IsoId=Q8WYB5-3; Sequence=VSP_014586;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with high levels in
CC       heart, pancreas, testis and ovary. {ECO:0000269|PubMed:10497217}.
CC   -!- DOMAIN: The N-terminus is involved in transcriptional activation
CC       while the C-terminus is involved in transcriptional repression.
CC       {ECO:0000269|PubMed:10497217}.
CC   -!- PTM: Autoacetylated (PubMed:10497217 and PubMed:11965546).
CC       Autoacetylation at Lys-815 is required for proper function.
CC       {ECO:0000250|UniProtKB:Q9H7Z6, ECO:0000269|PubMed:10497217,
CC       ECO:0000269|PubMed:11965546}.
CC   -!- DISEASE: Note=A chromosomal aberration involving KAT6B may be a
CC       cause acute myeloid leukemias. Translocation t(10;16)(q22;p13)
CC       with CREBBP. {ECO:0000269|PubMed:11157802}.
CC   -!- DISEASE: Ohdo syndrome, SBBYS variant (SBBYSS) [MIM:603736]: A
CC       syndrome characterized by distinctive facial appearance with
CC       severe blepharophimosis, an immobile mask-like face, a bulbous
CC       nasal tip, and a small mouth with a thin upper lip. The condition
CC       presents in infancy with severe hypotonia and feeding problems.
CC       Associated skeletal problems include joint laxity, abnormally long
CC       thumbs and great toes, and dislocated or hypoplastic patellae.
CC       Structural cardiac defects are present in around 50% of cases, and
CC       dental anomalies, including small and pointed teeth, are common.
CC       Optic atrophy and conductive or sensorineural deafness are
CC       repeatedly reported. Many affected individuals have abnormalities
CC       of thyroid structure or function. SBBYSS is usually associated
CC       with severe mental retardation, delayed motor milestones, and
CC       significantly impaired speech. {ECO:0000269|PubMed:22077973}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Genitopatellar syndrome (GTPTS) [MIM:606170]: A rare
CC       disorder consisting of microcephaly, severe psychomotor
CC       retardation, and characteristic coarse facial features, including
CC       broad nose and small or retracted chin, associated with congenital
CC       flexion contractures of the lower extremities, abnormal or missing
CC       patellae, and urogenital anomalies. {ECO:0000269|PubMed:22265014}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF00100.1; Type=Frameshift; Positions=550, 562; Evidence={ECO:0000305};
CC       Sequence=AAH14143.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH48199.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MYST4ID41488ch10q22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF113514; AAF00095.1; -; mRNA.
DR   EMBL; AF119230; AAF00099.1; -; mRNA.
DR   EMBL; AF119231; AAF00100.1; ALT_FRAME; mRNA.
DR   EMBL; AF217500; AAL56647.1; -; mRNA.
DR   EMBL; AB002381; BAA20837.2; -; mRNA.
DR   EMBL; BC014143; AAH14143.1; ALT_SEQ; mRNA.
DR   EMBL; BC021128; AAH21128.1; -; mRNA.
DR   EMBL; BC048199; AAH48199.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS58084.1; -. [Q8WYB5-3]
DR   CCDS; CCDS58085.1; -. [Q8WYB5-2]
DR   CCDS; CCDS7345.1; -. [Q8WYB5-1]
DR   RefSeq; NP_001243397.1; NM_001256468.1. [Q8WYB5-2]
DR   RefSeq; NP_001243398.1; NM_001256469.1. [Q8WYB5-3]
DR   RefSeq; NP_036462.2; NM_012330.3. [Q8WYB5-1]
DR   RefSeq; XP_005269721.1; XM_005269664.2. [Q8WYB5-1]
DR   RefSeq; XP_016871489.1; XM_017016000.1. [Q8WYB5-1]
DR   RefSeq; XP_016871490.1; XM_017016001.1. [Q8WYB5-1]
DR   RefSeq; XP_016871491.1; XM_017016002.1. [Q8WYB5-1]
DR   RefSeq; XP_016871492.1; XM_017016003.1. [Q8WYB5-1]
DR   RefSeq; XP_016871494.1; XM_017016005.1. [Q8WYB5-2]
DR   RefSeq; XP_016871495.1; XM_017016006.1. [Q8WYB5-3]
DR   RefSeq; XP_016871496.1; XM_017016007.1. [Q8WYB5-3]
DR   RefSeq; XP_016871497.1; XM_017016008.1. [Q8WYB5-3]
DR   UniGene; Hs.35758; -.
DR   UniGene; Hs.599543; -.
DR   UniGene; Hs.740873; -.
DR   PDB; 5U2J; X-ray; 1.60 A; A/B=211-320.
DR   PDBsum; 5U2J; -.
DR   ProteinModelPortal; Q8WYB5; -.
DR   SMR; Q8WYB5; -.
DR   BioGrid; 117069; 10.
DR   CORUM; Q8WYB5; -.
DR   IntAct; Q8WYB5; 54.
DR   STRING; 9606.ENSP00000287239; -.
DR   ChEMBL; CHEMBL3774300; -.
DR   iPTMnet; Q8WYB5; -.
DR   PhosphoSitePlus; Q8WYB5; -.
DR   BioMuta; KAT6B; -.
DR   DMDM; 143811424; -.
DR   EPD; Q8WYB5; -.
DR   MaxQB; Q8WYB5; -.
DR   PaxDb; Q8WYB5; -.
DR   PeptideAtlas; Q8WYB5; -.
DR   PRIDE; Q8WYB5; -.
DR   Ensembl; ENST00000287239; ENSP00000287239; ENSG00000156650. [Q8WYB5-1]
DR   Ensembl; ENST00000372711; ENSP00000361796; ENSG00000156650. [Q8WYB5-2]
DR   Ensembl; ENST00000372714; ENSP00000361799; ENSG00000156650. [Q8WYB5-3]
DR   Ensembl; ENST00000372724; ENSP00000361809; ENSG00000156650. [Q8WYB5-3]
DR   Ensembl; ENST00000372725; ENSP00000361810; ENSG00000156650. [Q8WYB5-3]
DR   Ensembl; ENST00000628038; ENSP00000485896; ENSG00000281813. [Q8WYB5-3]
DR   Ensembl; ENST00000628523; ENSP00000487238; ENSG00000281813. [Q8WYB5-3]
DR   Ensembl; ENST00000629233; ENSP00000487219; ENSG00000281813. [Q8WYB5-3]
DR   Ensembl; ENST00000629879; ENSP00000486731; ENSG00000281813. [Q8WYB5-2]
DR   Ensembl; ENST00000630001; ENSP00000486595; ENSG00000281813. [Q8WYB5-1]
DR   GeneID; 23522; -.
DR   KEGG; hsa:23522; -.
DR   UCSC; uc001jwm.3; human. [Q8WYB5-1]
DR   CTD; 23522; -.
DR   DisGeNET; 23522; -.
DR   EuPathDB; HostDB:ENSG00000156650.12; -.
DR   GeneCards; KAT6B; -.
DR   GeneReviews; KAT6B; -.
DR   HGNC; HGNC:17582; KAT6B.
DR   HPA; HPA006104; -.
DR   MalaCards; KAT6B; -.
DR   MIM; 603736; phenotype.
DR   MIM; 605880; gene.
DR   MIM; 606170; phenotype.
DR   neXtProt; NX_Q8WYB5; -.
DR   OpenTargets; ENSG00000156650; -.
DR   Orphanet; 3047; Blepharophimosis-intellectual disability syndrome, SBBYS type.
DR   Orphanet; 85201; Genitopatellar syndrome.
DR   Orphanet; 648; Noonan syndrome.
DR   PharmGKB; PA134880712; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   eggNOG; COG5027; LUCA.
DR   GeneTree; ENSGT00910000144012; -.
DR   HOVERGEN; HBG052563; -.
DR   InParanoid; Q8WYB5; -.
DR   KO; K11306; -.
DR   OMA; QSSCAVT; -.
DR   OrthoDB; EOG091G00D2; -.
DR   PhylomeDB; Q8WYB5; -.
DR   TreeFam; TF106483; -.
DR   BRENDA; 2.3.1.48; 2681.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SIGNOR; Q8WYB5; -.
DR   ChiTaRS; KAT6B; human.
DR   GeneWiki; MYST4; -.
DR   GenomeRNAi; 23522; -.
DR   PRO; PR:Q8WYB5; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000156650; -.
DR   CleanEx; HS_MYST4; -.
DR   Genevisible; Q8WYB5; HS.
DR   GO; GO:0070776; C:MOZ/MORF histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; TAS:UniProtKB.
DR   GO; GO:0016407; F:acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0008134; F:transcription factor binding; IDA:UniProtKB.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0016573; P:histone acetylation; IDA:UniProtKB.
DR   GO; GO:0043966; P:histone H3 acetylation; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; NAS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.10; -; 2.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF00628; PHD; 1.
DR   SMART; SM00526; H15; 1.
DR   SMART; SM00249; PHD; 2.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51504; H15; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Acyltransferase;
KW   Alternative splicing; Chromatin regulator; Chromosomal rearrangement;
KW   Complete proteome; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Transferase; Ubl conjugation;
KW   Zinc; Zinc-finger.
FT   CHAIN         1   2073       Histone acetyltransferase KAT6B.
FT                                /FTId=PRO_0000051575.
FT   DOMAIN      103    176       H15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00837}.
FT   DOMAIN      715    989       MYST-type HAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063}.
FT   ZN_FING     213    272       PHD-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00146}.
FT   ZN_FING     269    320       PHD-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00146}.
FT   ZN_FING     748    773       C2HC MYST-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063}.
FT   REGION      361    717       Negatively regulates HAT activity.
FT   REGION      718   1008       Catalytic.
FT   REGION      752   1008       Interaction with BRPF1.
FT                                {ECO:0000269|PubMed:18794358}.
FT   REGION      856    860       Acetyl-CoA binding.
FT                                {ECO:0000250|UniProtKB:Q92794}.
FT   REGION      865    871       Acetyl-CoA binding.
FT                                {ECO:0000250|UniProtKB:Q92794}.
FT   REGION     1560   2073       Interaction with RUNX1 and RUNX2.
FT                                {ECO:0000269|PubMed:11965546}.
FT   COMPBIAS    492    533       Ser-rich.
FT   COMPBIAS    521    524       Poly-Ser.
FT   COMPBIAS    599    605       Poly-Ser.
FT   COMPBIAS   1070   1104       Poly-Glu.
FT   COMPBIAS   1204   1207       Poly-Glu.
FT   COMPBIAS   1351   1373       Poly-Glu.
FT   COMPBIAS   1409   1417       Poly-Glu.
FT   COMPBIAS   1594   1763       Ser-rich.
FT   COMPBIAS   1961   2061       Met-rich.
FT   ACT_SITE    891    891       Proton donor/acceptor.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   BINDING     895    895       Acetyl-CoA.
FT                                {ECO:0000250|UniProtKB:Q92794}.
FT   SITE       1222   1223       Breakpoint for translocation to form
FT                                KAT6B-CREBBP.
FT   MOD_RES     355    355       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     647    647       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     815    815       N6-acetyllysine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:Q92794}.
FT   MOD_RES    1038   1038       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1042   1042       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1044   1044       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1048   1048       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    673    673       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     373    664       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10497217,
FT                                ECO:0000303|PubMed:9205841}.
FT                                /FTId=VSP_014586.
FT   VAR_SEQ     482    664       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10497217}.
FT                                /FTId=VSP_014587.
FT   VARIANT     360    360       E -> K. {ECO:0000269|PubMed:22077973}.
FT                                /FTId=VAR_067315.
FT   VARIANT     483    483       T -> A (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036361.
FT   VARIANT    1217   1217       A -> S (in dbSNP:rs57372986).
FT                                /FTId=VAR_061367.
FT   VARIANT    1499   1499       V -> I (in dbSNP:rs3740321).
FT                                /FTId=VAR_050217.
FT   CONFLICT    123    123       G -> R (in Ref. 2; AAL56647).
FT                                {ECO:0000305}.
FT   CONFLICT    231    231       P -> A (in Ref. 2; AAL56647).
FT                                {ECO:0000305}.
FT   CONFLICT    843    843       F -> L (in Ref. 1; AAF00095/AAF00099/
FT                                AAF00100 and 3; BAA20837). {ECO:0000305}.
FT   CONFLICT    931    933       TGM -> RHV (in Ref. 2; AAL56647).
FT                                {ECO:0000305}.
FT   CONFLICT    934    934       Missing (in Ref. 2; AAL56647).
FT                                {ECO:0000305}.
FT   CONFLICT   1152   1152       T -> S (in Ref. 2; AAL56647).
FT                                {ECO:0000305}.
FT   CONFLICT   1625   1625       S -> T (in Ref. 2; AAL56647).
FT                                {ECO:0000305}.
FT   CONFLICT   1731   1731       S -> T (in Ref. 2; AAL56647).
FT                                {ECO:0000305}.
FT   STRAND      214    216       {ECO:0000244|PDB:5U2J}.
FT   TURN        217    219       {ECO:0000244|PDB:5U2J}.
FT   TURN        238    240       {ECO:0000244|PDB:5U2J}.
FT   HELIX       246    249       {ECO:0000244|PDB:5U2J}.
FT   HELIX       253    260       {ECO:0000244|PDB:5U2J}.
FT   TURN        267    269       {ECO:0000244|PDB:5U2J}.
FT   TURN        273    275       {ECO:0000244|PDB:5U2J}.
FT   HELIX       282    284       {ECO:0000244|PDB:5U2J}.
FT   TURN        289    291       {ECO:0000244|PDB:5U2J}.
FT   HELIX       297    299       {ECO:0000244|PDB:5U2J}.
FT   STRAND      300    302       {ECO:0000244|PDB:5U2J}.
FT   TURN        315    317       {ECO:0000244|PDB:5U2J}.
SQ   SEQUENCE   2073 AA;  231378 MW;  AEE267B9DA444B08 CRC64;
     MVKLANPLYT EWILEAIQKI KKQKQRPSEE RICHAVSTSH GLDKKTVSEQ LELSVQDGSV
     LKVTNKGLAS YKDPDNPGRF SSVKPGTFPK SAKGSRGSCN DLRNVDWNKL LRRAIEGLEE
     PNGSSLKNIE KYLRSQSDLT STTNNPAFQQ RLRLGAKRAV NNGRLLKDGP QYRVNYGSLD
     GKGAPQYPSA FPSSLPPVSL LPHEKDQPRA DPIPICSFCL GTKESNREKK PEELLSCADC
     GSSGHPSCLK FCPELTTNVK ALRWQCIECK TCSACRVQGR NADNMLFCDS CDRGFHMECC
     DPPLSRMPKG MWICQVCRPK KKGRKLLHEK AAQIKRRYAK PIGRPKNKLK QRLLSVTSDE
     GSMNAFTGRG SPGRGQKTKV CTTPSSGHAA SGKDSSSRLA VTDPTRPGAT TKITTTSTYI
     SASTLKVNKK TKGLIDGLTK FFTPSPDGRR SRGEIIDFSK HYRPRKKVSQ KQSCTSHVLA
     TGTTQKLKPP PSSLPPPTPI SGQSPSSQKS STATSSPSPQ SSSSQCSVPS LSSLTTNSQL
     KALFDGLSHI YTTQGQSRKK GHPSYAPPKR MRRKTELSST AKSKAHFFGK RDIRSRFISH
     SSSSSWGMAR GSIFKAIAHF KRTTFLKKHR MLGRLKYKVT PQMGTPSPGK GSLTDGRIKP
     DQDDDTEIKI NIKQESADVN VIGNKDVVTE EDLDVFKQAQ ELSWEKIECE SGVEDCGRYP
     SVIEFGKYEI QTWYSSPYPQ EYARLPKLYL CEFCLKYMKS KNILLRHSKK CGWFHPPANE
     IYRRKDLSVF EVDGNMSKIY CQNLCLLAKL FLDHKTLYYD VEPFLFYVLT KNDEKGCHLV
     GYFSKEKLCQ QKYNVSCIMI MPQHQRQGFG RFLIDFSYLL SRREGQAGSP EKPLSDLGRL
     SYLAYWKSVI LEYLYHHHER HISIKAISRA TGMCPHDIAT TLQHLHMIDK RDGRFVIIRR
     EKLILSHMEK LKTCSRANEL DPDSLRWTPI LISNAAVSEE EREAEKEAER LMEQASCWEK
     EEQEILSTRA NSRQSPAKVQ SKNKYLHSPE SRPVTGERGQ LLELSKESSE EEEEEEDEEE
     EEEEEEEEED EEEEEEEEEE EEEENIQSSP PRLTKPQSVA IKRKRPFVLK KKRGRKRRRI
     NSSVTTETIS ETTEVLNEPF DNSDEERPMP QLEPTCEIEV EEDGRKPVLR KAFQHQPGKK
     RQTEEEEGKD NHCFKNADPC RNNMNDDSSN LKEGSKDNPE PLKCKQVWPK GTKRGLSKWR
     QNKERKTGFK LNLYTPPETP MEPDEQVTVE EQKETSEGKT SPSPIRIEEE VKETGEALLP
     QEENRREETC APVSPNTSPG EKPEDDLIKP EEEEEEEEEE EEEEEEEEGE EEEGGGNVEK
     DPDGAKSQEK EEPEISTEKE DSARLDDHEE EEEEDEEPSH NEDHDADDED DSHMESAEVE
     KEELPRESFK EVLENQETFL DLNVQPGHSN PEVLMDCGVD LTASCNSEPK ELAGDPEAVP
     ESDEEPPPGE QAQKQDQKNS KEVDTEFKEG NPATMEIDSE TVQAVQSLTQ ESSEQDDTFQ
     DCAETQEACR SLQNYTRADQ SPQIATTLDD CQQSDHSSPV SSVHSHPGQS VRSVNSPSVP
     ALENSYAQIS PDQSAISVPS LQNMETSPMM DVPSVSDHSQ QVVDSGFSDL GSIESTTENY
     ENPSSYDSTM GGSICGNGSS QNSCSYSNLT SSSLTQSSCA VTQQMSNISG SCSMLQQTSI
     SSPPTCSVKS PQGCVVERPP SSSQQLAQCS MAANFTPPMQ LAEIPETSNA NIGLYERMGQ
     SDFGAGHYPQ PSATFSLAKL QQLTNTLIDH SLPYSHSAAV TSYANSASLS TPLSNTGLVQ
     LSQSPHSVPG GPQAQATMTP PPNLTPPPMN LPPPLLQRNM AASNIGISHS QRLQTQIASK
     GHISMRTKSA SLSPAAATHQ SQIYGRSQTV AMQGPARTLT MQRGMNMSVN LMPAPAYNVN
     SVNMNMNTLN AMNGYSMSQP MMNSGYHSNH GYMNQTPQYP MQMQMGMMGT QPYAQQPMQT
     PPHGNMMYTA PGHHGYMNTG MSKQSLNGSY MRR
//
ID   C9K080_HUMAN            Unreviewed;       623 AA.
AC   C9K080;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 2.
DT   28-FEB-2018, entry version 74.
DE   SubName: Full=Leucine-rich repeats and immunoglobulin-like domains protein 3 {ECO:0000313|Ensembl:ENSP00000413143};
GN   Name=LRIG3 {ECO:0000313|Ensembl:ENSP00000413143};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000413143, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000413143, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000413143}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000413143}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC078963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF511180; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_016874279.1; XM_017018790.1.
DR   UniGene; Hs.253736; -.
DR   ProteinModelPortal; C9K080; -.
DR   MaxQB; C9K080; -.
DR   PeptideAtlas; C9K080; -.
DR   PRIDE; C9K080; -.
DR   Ensembl; ENST00000433272; ENSP00000413143; ENSG00000139263.
DR   GeneID; 121227; -.
DR   UCSC; uc058qes.1; human.
DR   CTD; 121227; -.
DR   EuPathDB; HostDB:ENSG00000139263.11; -.
DR   HGNC; HGNC:30991; LRIG3.
DR   OpenTargets; ENSG00000139263; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; KOG4194; Eukaryota.
DR   eggNOG; COG4886; LUCA.
DR   GeneTree; ENSGT00760000118777; -.
DR   HOGENOM; HOG000205744; -.
DR   ChiTaRS; LRIG3; human.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139263; -.
DR   ExpressionAtlas; C9K080; baseline and differential.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.80.10.10; -; 4.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   Pfam; PF13855; LRR_8; 4.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00369; LRR_TYP; 14.
DR   SMART; SM00082; LRRCT; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS51450; LRR; 15.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|SAAS:SAAS01010727};
KW   Immunoglobulin domain {ECO:0000256|SAAS:SAAS01010457};
KW   Leucine-rich repeat {ECO:0000256|SAAS:SAAS00488662};
KW   Proteomics identification {ECO:0000213|MaxQB:C9K080,
KW   ECO:0000213|PeptideAtlas:C9K080};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00597472};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25    623       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002997948.
FT   DOMAIN      499    598       Ig-like. {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   623 AA;  69407 MW;  FAE71746C0CEA045 CRC64;
     MSAPSLRARA AGLGLLLCAV LGRAGRSDSG GRGELGQPSG VAAERPCPTT CRCLGDLLDC
     SRKRLARLPE PLPSWVARLD LSHNRLSFIK ASSMSHLQSL REVKLNNNEL ETIPNLGPVS
     ANITLLSLAG NRIVEILPEH LKEFQSLETL DLSSNNISEL QTAFPALQLK YLYLNSNRVT
     SMEPGYFDNL ANTLLVLKLN RNRISAIPPK MFKLPQLQHL ELNRNKIKNV DGLTFQGLGA
     LKSLKMQRNG VTKLMDGAFW GLSNMEILQL DHNNLTEITK GWLYGLLMLQ ELHLSQNAIN
     RISPDAWEFC QKLSELDLTF NHLSRLDDSS FLGLSLLNTL HIGNNRVSYI ADCAFRGLSS
     LKTLDLKNNE ISWTIEDMNG AFSGLDKLRR LILQGNRIRS ITKKAFTGLD ALEHLDLSDN
     AIMSLQGNAF SQMKKLQQLH LNTSSLLCDC QLKWLPQWVA ENNFQSFVNA SCAHPQLLKG
     RSIFAVSPDG FVCDDFPKPQ ITVQPETQSA IKGSNLSFIC SAASSSDSPM TFAWKKDNEL
     LHDAEMENYA HLRAQGGEVM EYTTILRLRE VEFASEGKYQ CVISNHFGSS YSVKAKLTVN
     IPHLTLPFPT FHSTKLRFLV ICI
//
ID   LRIG3_HUMAN             Reviewed;        1119 AA.
AC   Q6UXM1; Q6UXL7; Q8NC72;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 128.
DE   RecName: Full=Leucine-rich repeats and immunoglobulin-like domains protein 3;
DE            Short=LIG-3;
DE   Flags: Precursor;
GN   Name=LRIG3; Synonyms=LIG3; ORFNames=UNQ287/PRO326/PRO335;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=15203213; DOI=10.1016/j.ygeno.2004.01.013;
RA   Guo D., Holmlund C., Henriksson R., Hedman H.;
RT   "The LRIG gene family has three vertebrate paralogs widely expressed
RT   in human and mouse tissues and a homolog in Ascidiacea.";
RL   Genomics 84:157-165(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 400-1119.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- FUNCTION: May play a role in craniofacial and inner ear
CC       morphogenesis during embryonic development. May act within the
CC       otic vesicle epithelium to control formation of the lateral
CC       semicircular canal in the inner ear, possibly by restricting the
CC       expression of NTN1 (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with EGFR, ERBB2 and ERBB4 (in vitro).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass
CC       type I membrane protein {ECO:0000250}. Cytoplasmic vesicle
CC       membrane {ECO:0000250}; Single-pass type I membrane protein
CC       {ECO:0000250}. Note=Detected in cytoplasmic vesicles when
CC       coexpressed with ERBB4. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6UXM1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6UXM1-2; Sequence=VSP_015097;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:15203213}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11295.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY505340; AAR98629.1; -; mRNA.
DR   EMBL; AY358288; AAQ88655.1; -; mRNA.
DR   EMBL; AY358295; AAQ88662.1; -; mRNA.
DR   EMBL; AK074921; BAC11295.1; ALT_INIT; mRNA.
DR   CCDS; CCDS44933.1; -. [Q6UXM1-2]
DR   CCDS; CCDS8960.1; -. [Q6UXM1-1]
DR   RefSeq; NP_001129523.1; NM_001136051.2. [Q6UXM1-2]
DR   RefSeq; NP_700356.2; NM_153377.4. [Q6UXM1-1]
DR   UniGene; Hs.253736; -.
DR   ProteinModelPortal; Q6UXM1; -.
DR   SMR; Q6UXM1; -.
DR   BioGrid; 125712; 20.
DR   IntAct; Q6UXM1; 1.
DR   STRING; 9606.ENSP00000326759; -.
DR   iPTMnet; Q6UXM1; -.
DR   PhosphoSitePlus; Q6UXM1; -.
DR   BioMuta; LRIG3; -.
DR   DMDM; 73621176; -.
DR   EPD; Q6UXM1; -.
DR   MaxQB; Q6UXM1; -.
DR   PaxDb; Q6UXM1; -.
DR   PeptideAtlas; Q6UXM1; -.
DR   PRIDE; Q6UXM1; -.
DR   Ensembl; ENST00000320743; ENSP00000326759; ENSG00000139263. [Q6UXM1-1]
DR   Ensembl; ENST00000379141; ENSP00000368436; ENSG00000139263. [Q6UXM1-2]
DR   GeneID; 121227; -.
DR   KEGG; hsa:121227; -.
DR   UCSC; uc001sqr.5; human. [Q6UXM1-1]
DR   CTD; 121227; -.
DR   DisGeNET; 121227; -.
DR   EuPathDB; HostDB:ENSG00000139263.11; -.
DR   GeneCards; LRIG3; -.
DR   HGNC; HGNC:30991; LRIG3.
DR   HPA; HPA010773; -.
DR   MIM; 608870; gene.
DR   neXtProt; NX_Q6UXM1; -.
DR   OpenTargets; ENSG00000139263; -.
DR   PharmGKB; PA134864136; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; KOG4194; Eukaryota.
DR   eggNOG; COG4886; LUCA.
DR   GeneTree; ENSGT00760000118777; -.
DR   HOGENOM; HOG000113380; -.
DR   HOVERGEN; HBG052353; -.
DR   InParanoid; Q6UXM1; -.
DR   OMA; MEPGYFD; -.
DR   OrthoDB; EOG091G04H0; -.
DR   PhylomeDB; Q6UXM1; -.
DR   TreeFam; TF325380; -.
DR   SIGNOR; Q6UXM1; -.
DR   ChiTaRS; LRIG3; human.
DR   GenomeRNAi; 121227; -.
DR   PRO; PR:Q6UXM1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139263; -.
DR   CleanEx; HS_LIG3; -.
DR   CleanEx; HS_LRIG3; -.
DR   ExpressionAtlas; Q6UXM1; baseline and differential.
DR   Genevisible; Q6UXM1; HS.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032474; P:otolith morphogenesis; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 3.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF13855; LRR_8; 4.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00369; LRR_TYP; 14.
DR   SMART; SM00082; LRRCT; 1.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS51450; LRR; 15.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasmic vesicle; Developmental protein; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Leucine-rich repeat; Membrane;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25   1119       Leucine-rich repeats and immunoglobulin-
FT                                like domains protein 3.
FT                                /FTId=PRO_0000014831.
FT   TRANSMEM    810    830       Helical. {ECO:0000255}.
FT   DOMAIN       38     74       LRRNT.
FT   REPEAT       75     96       LRR 1.
FT   REPEAT       99    120       LRR 2.
FT   REPEAT      122    142       LRR 3.
FT   REPEAT      146    167       LRR 4.
FT   REPEAT      168    189       LRR 5.
FT   REPEAT      193    214       LRR 6.
FT   REPEAT      216    237       LRR 7.
FT   REPEAT      240    261       LRR 8.
FT   REPEAT      264    285       LRR 9.
FT   REPEAT      288    309       LRR 10.
FT   REPEAT      312    333       LRR 11.
FT   REPEAT      336    357       LRR 12.
FT   REPEAT      360    382       LRR 13.
FT   REPEAT      387    408       LRR 14.
FT   REPEAT      411    432       LRR 15.
FT   DOMAIN      444    495       LRRCT.
FT   DOMAIN      499    598       Ig-like C2-type 1.
FT   DOMAIN      603    692       Ig-like C2-type 2.
FT   DOMAIN      697    783       Ig-like C2-type 3.
FT   CARBOHYD    122    122       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    156    156       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    274    274       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    442    442       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    469    469       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    515    515       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    688    688       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    729    729       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    905    905       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    987    987       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    999    999       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1016   1016       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    520    581       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    624    676       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    718    767       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ       1     79       MSAPSLRARAAGLGLLLCAVLGRAGRSDSGGRGELGQPSGV
FT                                AAERPCPTTCRCLGDLLDCSRKRLARLPEPLPSWVARL ->
FT                                MVDVLLLFSLCLLFHISRP (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_015097.
SQ   SEQUENCE   1119 AA;  123434 MW;  EB3B6A391F3C8713 CRC64;
     MSAPSLRARA AGLGLLLCAV LGRAGRSDSG GRGELGQPSG VAAERPCPTT CRCLGDLLDC
     SRKRLARLPE PLPSWVARLD LSHNRLSFIK ASSMSHLQSL REVKLNNNEL ETIPNLGPVS
     ANITLLSLAG NRIVEILPEH LKEFQSLETL DLSSNNISEL QTAFPALQLK YLYLNSNRVT
     SMEPGYFDNL ANTLLVLKLN RNRISAIPPK MFKLPQLQHL ELNRNKIKNV DGLTFQGLGA
     LKSLKMQRNG VTKLMDGAFW GLSNMEILQL DHNNLTEITK GWLYGLLMLQ ELHLSQNAIN
     RISPDAWEFC QKLSELDLTF NHLSRLDDSS FLGLSLLNTL HIGNNRVSYI ADCAFRGLSS
     LKTLDLKNNE ISWTIEDMNG AFSGLDKLRR LILQGNRIRS ITKKAFTGLD ALEHLDLSDN
     AIMSLQGNAF SQMKKLQQLH LNTSSLLCDC QLKWLPQWVA ENNFQSFVNA SCAHPQLLKG
     RSIFAVSPDG FVCDDFPKPQ ITVQPETQSA IKGSNLSFIC SAASSSDSPM TFAWKKDNEL
     LHDAEMENYA HLRAQGGEVM EYTTILRLRE VEFASEGKYQ CVISNHFGSS YSVKAKLTVN
     MLPSFTKTPM DLTIRAGAMA RLECAAVGHP APQIAWQKDG GTDFPAARER RMHVMPEDDV
     FFIVDVKIED IGVYSCTAQN SAGSISANAT LTVLETPSFL RPLLDRTVTK GETAVLQCIA
     GGSPPPKLNW TKDDSPLVVT ERHFFAAGNQ LLIIVDSDVS DAGKYTCEMS NTLGTERGNV
     RLSVIPTPTC DSPQMTAPSL DDDGWATVGV VIIAVVCCVV GTSLVWVVII YHTRRRNEDC
     SITNTDETNL PADIPSYLSS QGTLADRQDG YVSSESGSHH QFVTSSGAGF FLPQHDSSGT
     CHIDNSSEAD VEAATDLFLC PFLGSTGPMY LKGNVYGSDP FETYHTGCSP DPRTVLMDHY
     EPSYIKKKEC YPCSHPSEES CERSFSNISW PSHVRKLLNT SYSHNEGPGM KNLCLNKSSL
     DFSANPEPAS VASSNSFMGT FGKALRRPHL DAYSSFGQPS DCQPRAFYLK AHSSPDLDSG
     SEEDGKERTD FQEENHICTF KQTLENYRTP NFQSYDLDT
//
ID   A0A0S2Z4A4_HUMAN        Unreviewed;       283 AA.
AC   A0A0S2Z4A4;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 10.
DE   SubName: Full=Myeloid leukemia factor 1 isoform 2 {ECO:0000313|EMBL:ALQ33645.1};
DE   SubName: Full=Myeloid leukemia factor 1, isoform CRA_c {ECO:0000313|EMBL:EAW78687.1};
DE   Flags: Fragment;
GN   Name=MLF1 {ECO:0000313|EMBL:ALQ33645.1};
GN   ORFNames=hCG_16019 {ECO:0000313|EMBL:EAW78687.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33645.1};
RN   [1] {ECO:0000313|EMBL:EAW78687.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW78687.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33645.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178187; ALQ33645.1; -; mRNA.
DR   EMBL; CH471052; EAW78687.1; -; Genomic_DNA.
DR   RefSeq; XP_005247536.1; XM_005247479.4.
DR   UniGene; Hs.85195; -.
DR   PeptideAtlas; A0A0S2Z4A4; -.
DR   GeneID; 4291; -.
DR   CTD; 4291; -.
DR   ChiTaRS; MLF1; human.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
FT   NON_TER     283    283       {ECO:0000313|EMBL:ALQ33645.1}.
SQ   SEQUENCE   283 AA;  32098 MW;  2CC61F7F1D330F16 CRC64;
     MFRMLNSSFE DDPFFSESIL AHRENMRQMI RSFSEPFGRD LLSISDGRGR AHNRRGHNDG
     EDSLTATSCS LVPFGDFGGM HTDVSSFQTM DQMVSNMRNY MQKLERNFGQ LSVDPNGHSF
     CSSSVMTYSK IGDEPPKVFQ ASTQTRRAPG GIKETRKAMR DSDSGLEKMA IGHHIHDRAH
     VIKKSKNKKT GDEEVNQEFI NMNESDAHAF DEEWQSEVLK YKPGRHNLGN TRMRSVGHEN
     PGSRELKRRE KPQQSPAIEH GRRSNVLGDK LHIKGSSVKS NKK
//
ID   A0A0S2Z4U8_HUMAN        Unreviewed;       268 AA.
AC   A0A0S2Z4U8;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 18.
DE   SubName: Full=Myeloid leukemia factor 1 isoform 1 {ECO:0000313|EMBL:ALQ33644.1};
DE   SubName: Full=Myeloid leukemia factor 1, isoform CRA_a {ECO:0000313|EMBL:EAW78685.1};
DE   Flags: Fragment;
GN   Name=MLF1 {ECO:0000313|EMBL:ALQ33644.1};
GN   ORFNames=hCG_16019 {ECO:0000313|EMBL:EAW78685.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33644.1};
RN   [1] {ECO:0000313|EMBL:EAW78685.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW78685.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33644.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178186; ALQ33644.1; -; mRNA.
DR   EMBL; CH471052; EAW78685.1; -; Genomic_DNA.
DR   RefSeq; NP_071888.1; NM_022443.4.
DR   UniGene; Hs.85195; -.
DR   SMR; A0A0S2Z4U8; -.
DR   GeneID; 4291; -.
DR   KEGG; hsa:4291; -.
DR   CTD; 4291; -.
DR   KO; K15622; -.
DR   ChiTaRS; MLF1; human.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
FT   NON_TER     268    268       {ECO:0000313|EMBL:ALQ33644.1}.
SQ   SEQUENCE   268 AA;  30627 MW;  08774217329F737A CRC64;
     MFRMLNSSFE DDPFFSESIL AHRENMRQMI RSFSEPFGRD LLSISDGRGR AHNRRGHNDG
     EDSLTHTDVS SFQTMDQMVS NMRNYMQKLE RNFGQLSVDP NGHSFCSSSV MTYSKIGDEP
     PKVFQASTQT RRAPGGIKET RKAMRDSDSG LEKMAIGHHI HDRAHVIKKS KNKKTGDEEV
     NQEFINMNES DAHAFDEEWQ SEVLKYKPGR HNLGNTRMRS VGHENPGSRE LKRREKPQQS
     PAIEHGRRSN VLGDKLHIKG SSVKSNKK
//
ID   A0A140VKD2_HUMAN        Unreviewed;       243 AA.
AC   A0A140VKD2;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   07-JUN-2017, entry version 10.
DE   SubName: Full=Testis tissue sperm-binding protein Li 49e {ECO:0000313|EMBL:AEE61269.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61269.1};
RN   [1] {ECO:0000313|EMBL:AEE61269.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005672; AEE61269.1; -; mRNA.
DR   RefSeq; NP_001123628.1; NM_001130156.2.
DR   RefSeq; NP_001123629.1; NM_001130157.2.
DR   RefSeq; XP_011511155.1; XM_011512853.2.
DR   UniGene; Hs.85195; -.
DR   SMR; A0A140VKD2; -.
DR   GeneID; 4291; -.
DR   CTD; 4291; -.
DR   ExpressionAtlas; A0A140VKD2; baseline and differential.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   243 AA;  27625 MW;  061E87A385C3E063 CRC64;
     MRQMIRSFSE PFGRDLLSIS DGRGRAHNRR GHNDGEDSLT HTDVSSFQTM DQMVSNMRNY
     MQKLERNFGQ LSVDPNGHSF CSSSVMTYSK IGDEPPKVFQ ASTQTRRAPG GIKETRKAMR
     DSDSGLEKMA IGHHIHDRAH VIKKSKNKKT GDEEVNQEFI NMNESDAHAF DEEWQSEVLK
     YKPGRHNLGN TRMRSVGHEN PGSRELKRRE KPQQSPAIEH GRRSNVLGDK LHIKGSSVKS
     NKK
//
ID   B2RD48_HUMAN            Unreviewed;       268 AA.
AC   B2RD48;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   07-JUN-2017, entry version 37.
DE   SubName: Full=cDNA, FLJ96451, highly similar to Homo sapiens myeloid leukemia factor 1 (MLF1), mRNA {ECO:0000313|EMBL:BAG37795.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG37795.1};
RN   [1] {ECO:0000313|EMBL:BAG37795.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Colon {ECO:0000313|EMBL:BAG37795.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK315402; BAG37795.1; -; mRNA.
DR   RefSeq; NP_071888.1; NM_022443.4.
DR   UniGene; Hs.85195; -.
DR   PeptideAtlas; B2RD48; -.
DR   PRIDE; B2RD48; -.
DR   GeneID; 4291; -.
DR   KEGG; hsa:4291; -.
DR   CTD; 4291; -.
DR   HOVERGEN; HBG019060; -.
DR   KO; K15622; -.
DR   GenomeRNAi; 4291; -.
DR   Genevisible; B2RD48; HS.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   268 AA;  30615 MW;  08706B173293837A CRC64;
     MFRMLNSSFE DDPFFSESTL AHRENMRQMI RSFSEPFGRD LLSISDGRGR AHNRRGHNDG
     EDSLTHTDVS SFQTMDQMVS NMRNYMQKLE RNFGQLSVDP NGHSFCSSSV MTYSKIGDEP
     PKVFQASTQT RRAPGGIKET RKAMRDSDSG LEKMAIGHHI HDRAHVIKKS KNKKTGDEEV
     NQEFINMNES DAHAFDEEWQ SEVLKYKPGR HNLGNTRMRS VGHENPGSRE LKRREKPQQS
     PAIEHGRRSN VLGDKLHIKG SSVKSNKK
//
ID   MLF1_HUMAN              Reviewed;         268 AA.
AC   P58340; E9PEU9; Q2TLE3; Q2TLE5; Q8N8F8; Q96MH1;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2001, sequence version 1.
DT   28-FEB-2018, entry version 133.
DE   RecName: Full=Myeloid leukemia factor 1;
DE   AltName: Full=Myelodysplasia-myeloid leukemia factor 1;
GN   Name=MLF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION.
RC   TISSUE=Skeletal muscle, and Testis;
RX   PubMed=8570204;
RA   Yoneda-Kato N., Look A.T., Kirstein M.N., Valentine M.B.,
RA   Raimondi S.C., Cohen K.J., Carroll A.J., Morris S.W.;
RT   "The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid
RT   leukemia produces a novel fusion gene, NPM-MLF1.";
RL   Oncogene 12:265-275(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 5).
RA   Feng X., Ling S., Zhang H., Song X., Wang G., Chen K., Zhu C.;
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 4 AND 5).
RC   TISSUE=Brain, and Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH CENPU.
RX   PubMed=15116101; DOI=10.1038/sj.onc.1207448;
RA   Hanissian S.H., Akbar U., Teng B., Janjetovic Z., Hoffmann A.,
RA   Hitzler J.K., Iscove N., Hamre K., Du X., Tong Y., Mukatira S.,
RA   Robertson J.H., Morris S.W.;
RT   "cDNA cloning and characterization of a novel gene encoding the MLF1-
RT   interacting protein MLF1IP.";
RL   Oncogene 23:3700-3707(2004).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH COPS3.
RX   PubMed=15861129; DOI=10.1038/sj.emboj.7600656;
RA   Yoneda-Kato N., Tomoda K., Umehara M., Arata Y., Kato J.-Y.;
RT   "Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9
RT   signalosome subunit 3.";
RL   EMBO J. 24:1739-1749(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8 AND SER-32, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 29-42 IN COMPLEX WITH YWHAE,
RP   AND PHOSPHORYLATION AT SER-34.
RX   PubMed=22151054; DOI=10.1111/j.1742-4658.2011.08445.x;
RA   Molzan M., Weyand M., Rose R., Ottmann C.;
RT   "Structural insights of the MLF1/14-3-3 interaction.";
RL   FEBS J. 279:563-571(2012).
CC   -!- FUNCTION: Involved in lineage commitment of primary hemopoietic
CC       progenitors by restricting erythroid formation and enhancing
CC       myeloid formation. Interferes with erythropoietin-induced
CC       erythroid terminal differentiation by preventing cells from
CC       exiting the cell cycle through suppression of CDKN1B/p27Kip1
CC       levels. Suppresses RFWD2/COP1 activity via CSN3 which activates
CC       p53 and induces cell cycle arrest. Binds DNA and affects the
CC       expression of a number of genes so may function as a transcription
CC       factor in the nucleus. {ECO:0000269|PubMed:15861129}.
CC   -!- SUBUNIT: Interacts with CENPU. Also interacts with NRBP1/MADM,
CC       YWHAZ/14-3-3-zeta and HNRPUL2/MANP. NRBP1 recruits a serine kinase
CC       which phosphorylates both itself and MLF1. Phosphorylated MLF1
CC       then binds to YWHAZ and is retained in the cytoplasm. Retained in
CC       the nucleus by binding to HNRPUL2. Binds to COPS3/CSN3 which is
CC       required for suppression of RFWD2 and activation of p53.
CC       {ECO:0000269|PubMed:15116101, ECO:0000269|PubMed:15861129,
CC       ECO:0000269|PubMed:22151054}.
CC   -!- INTERACTION:
CC       A8K1F4:-; NbExp=2; IntAct=EBI-721328, EBI-9357094;
CC       O75190:DNAJB6; NbExp=2; IntAct=EBI-721328, EBI-1053164;
CC       P43364:MAGEA11; NbExp=4; IntAct=EBI-721328, EBI-739552;
CC       Q13200:PSMD2; NbExp=2; IntAct=EBI-721328, EBI-357648;
CC       P62258:YWHAE; NbExp=3; IntAct=EBI-721328, EBI-356498;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9QWV4}.
CC       Nucleus {ECO:0000250|UniProtKB:Q9QWV4}. Note=Shuttles between the
CC       cytoplasm and nucleus. {ECO:0000250|UniProtKB:Q9QWV4}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P58340-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P58340-2; Sequence=VSP_043130, VSP_043131;
CC       Name=3;
CC         IsoId=P58340-3; Sequence=VSP_043725, VSP_043726;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P58340-5; Sequence=VSP_043130;
CC       Name=4;
CC         IsoId=P58340-4; Sequence=VSP_043130, VSP_043726;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Most abundant in testis, ovary, skeletal
CC       muscle, heart, kidney and colon. Low expression in spleen, thymus
CC       and peripheral blood leukocytes.
CC   -!- PTM: Phosphorylation is required for binding to YWHAZ.
CC       {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLF1 is a cause
CC       of myelodysplastic syndrome (MDS). Translocation t(3;5)(q25.1;q34)
CC       with NPM1/NPM. {ECO:0000269|PubMed:8570204}.
CC   -!- SIMILARITY: Belongs to the MLF family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MLF1ID18.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L49054; AAA99997.1; -; mRNA.
DR   EMBL; AY848700; AAX46015.1; -; mRNA.
DR   EMBL; AY848702; AAX46017.1; -; mRNA.
DR   EMBL; AK056948; BAB71320.1; -; mRNA.
DR   EMBL; AK096889; BAC04885.1; -; mRNA.
DR   EMBL; AK297488; BAG59906.1; -; mRNA.
DR   EMBL; AC025033; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106707; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78689.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78690.1; -; Genomic_DNA.
DR   EMBL; BC007045; AAH07045.1; -; mRNA.
DR   CCDS; CCDS3182.1; -. [P58340-1]
DR   CCDS; CCDS46945.1; -. [P58340-5]
DR   CCDS; CCDS56286.1; -. [P58340-3]
DR   CCDS; CCDS56287.1; -. [P58340-4]
DR   CCDS; CCDS56288.1; -. [P58340-2]
DR   RefSeq; NP_001123628.1; NM_001130156.2. [P58340-5]
DR   RefSeq; NP_001123629.1; NM_001130157.2. [P58340-5]
DR   RefSeq; NP_001182361.1; NM_001195432.1. [P58340-3]
DR   RefSeq; NP_001182362.1; NM_001195433.1. [P58340-2]
DR   RefSeq; NP_001182363.1; NM_001195434.1. [P58340-4]
DR   RefSeq; NP_071888.1; NM_022443.4. [P58340-1]
DR   RefSeq; XP_005247537.1; XM_005247480.2. [P58340-4]
DR   RefSeq; XP_011511154.1; XM_011512852.2. [P58340-4]
DR   RefSeq; XP_011511155.1; XM_011512853.2. [P58340-5]
DR   UniGene; Hs.85195; -.
DR   PDB; 3UAL; X-ray; 1.80 A; P=29-42.
DR   PDB; 3UBW; X-ray; 1.90 A; P=29-42.
DR   PDBsum; 3UAL; -.
DR   PDBsum; 3UBW; -.
DR   ProteinModelPortal; P58340; -.
DR   SMR; P58340; -.
DR   BioGrid; 110437; 72.
DR   ELM; P58340; -.
DR   IntAct; P58340; 86.
DR   MINT; P58340; -.
DR   iPTMnet; P58340; -.
DR   PhosphoSitePlus; P58340; -.
DR   BioMuta; MLF1; -.
DR   DMDM; 17368170; -.
DR   EPD; P58340; -.
DR   MaxQB; P58340; -.
DR   PeptideAtlas; P58340; -.
DR   PRIDE; P58340; -.
DR   Ensembl; ENST00000355893; ENSP00000348157; ENSG00000178053. [P58340-1]
DR   Ensembl; ENST00000359117; ENSP00000352025; ENSG00000178053. [P58340-5]
DR   Ensembl; ENST00000392822; ENSP00000376568; ENSG00000178053. [P58340-3]
DR   Ensembl; ENST00000469452; ENSP00000418595; ENSG00000178053. [P58340-2]
DR   Ensembl; ENST00000471745; ENSP00000420134; ENSG00000178053. [P58340-4]
DR   Ensembl; ENST00000478894; ENSP00000417777; ENSG00000178053. [P58340-4]
DR   Ensembl; ENST00000482628; ENSP00000417141; ENSG00000178053. [P58340-5]
DR   Ensembl; ENST00000484955; ENSP00000417835; ENSG00000178053. [P58340-5]
DR   Ensembl; ENST00000618075; ENSP00000484169; ENSG00000178053. [P58340-2]
DR   Ensembl; ENST00000619577; ENSP00000483337; ENSG00000178053. [P58340-4]
DR   GeneID; 4291; -.
DR   KEGG; hsa:4291; -.
DR   UCSC; uc003fbx.4; human. [P58340-1]
DR   CTD; 4291; -.
DR   DisGeNET; 4291; -.
DR   EuPathDB; HostDB:ENSG00000178053.17; -.
DR   GeneCards; MLF1; -.
DR   HGNC; HGNC:7125; MLF1.
DR   HPA; HPA069479; -.
DR   MalaCards; MLF1; -.
DR   MIM; 601402; gene.
DR   neXtProt; NX_P58340; -.
DR   OpenTargets; ENSG00000178053; -.
DR   PharmGKB; PA30843; -.
DR   GeneTree; ENSGT00390000005023; -.
DR   HOGENOM; HOG000045671; -.
DR   HOVERGEN; HBG019060; -.
DR   InParanoid; P58340; -.
DR   KO; K15622; -.
DR   OMA; LENTRMR; -.
DR   OrthoDB; EOG091G0JFX; -.
DR   PhylomeDB; P58340; -.
DR   TreeFam; TF317561; -.
DR   SIGNOR; P58340; -.
DR   ChiTaRS; MLF1; human.
DR   GeneWiki; MLF1; -.
DR   GenomeRNAi; 4291; -.
DR   PRO; PR:P58340; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000178053; -.
DR   CleanEx; HS_MLF1; -.
DR   ExpressionAtlas; P58340; baseline and differential.
DR   Genevisible; P58340; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0002318; P:myeloid progenitor cell differentiation; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; ISS:UniProtKB.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm;
KW   Developmental protein; Differentiation; DNA-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    268       Myeloid leukemia factor 1.
FT                                /FTId=PRO_0000220752.
FT   REGION       50    125       Interaction with COPS3.
FT                                {ECO:0000269|PubMed:15861129}.
FT   SITE         16     17       Breakpoint for translocation to form NPM-
FT                                MLF1.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      32     32       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      34     34       Phosphoserine.
FT                                {ECO:0000269|PubMed:22151054}.
FT   VAR_SEQ       1     25       Missing (in isoform 2, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_043130.
FT   VAR_SEQ       1     15       MFRMLNSSFEDDPFF -> MLKEVLQREGKSYKSETLMYIK
FT                                KARASENKL (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043725.
FT   VAR_SEQ      65     65       T -> TATSCSLVPFGDFGGM (in isoform 3 and
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043726.
FT   VAR_SEQ      94    136       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_043131.
FT   VARIANT     226    226       P -> T (in dbSNP:rs15967).
FT                                /FTId=VAR_022070.
SQ   SEQUENCE   268 AA;  30627 MW;  08774217329F737A CRC64;
     MFRMLNSSFE DDPFFSESIL AHRENMRQMI RSFSEPFGRD LLSISDGRGR AHNRRGHNDG
     EDSLTHTDVS SFQTMDQMVS NMRNYMQKLE RNFGQLSVDP NGHSFCSSSV MTYSKIGDEP
     PKVFQASTQT RRAPGGIKET RKAMRDSDSG LEKMAIGHHI HDRAHVIKKS KNKKTGDEEV
     NQEFINMNES DAHAFDEEWQ SEVLKYKPGR HNLGNTRMRS VGHENPGSRE LKRREKPQQS
     PAIEHGRRSN VLGDKLHIKG SSVKSNKK
//
ID   Q2TLE4_HUMAN            Unreviewed;       243 AA.
AC   Q2TLE4;
DT   24-JAN-2006, integrated into UniProtKB/TrEMBL.
DT   24-JAN-2006, sequence version 1.
DT   07-JUN-2017, entry version 53.
DE   SubName: Full=Myeloid leukemia factor 1 variant 2 {ECO:0000313|EMBL:AAX46016.1};
GN   Name=MLF1 {ECO:0000313|EMBL:AAX46016.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAX46016.1};
RN   [1] {ECO:0000313|EMBL:AAX46016.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Feng X., Ling S., Zhang H., Song X., Wang G., Chen K., Zhu C.;
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY848701; AAX46016.1; -; mRNA.
DR   RefSeq; NP_001123629.1; NM_001130157.2.
DR   UniGene; Hs.85195; -.
DR   SMR; Q2TLE4; -.
DR   PeptideAtlas; Q2TLE4; -.
DR   PRIDE; Q2TLE4; -.
DR   GeneID; 4291; -.
DR   CTD; 4291; -.
DR   PharmGKB; PA30843; -.
DR   HOVERGEN; HBG019060; -.
DR   ChiTaRS; MLF1; human.
DR   GenomeRNAi; 4291; -.
DR   Genevisible; Q2TLE4; HS.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   243 AA;  27615 MW;  05D187A3860CE17C CRC64;
     MRQMIRSFSE PFGRDLLSIS DGRGRAHNRR GHNDGEDSLT HTDVSSFQTM DQMVSNMRNY
     MQKLERNFGQ LSVDPNGHSF CSSSVMTYSK IGDEPPKVFQ ASTQTRRASG GIKETRKAMR
     DSDSGLEKMA IGHHIHDRAH VIKKSKNKKT GDEEVNQEFI NMNESDAHAF DEEWQSEVLK
     YKPGRHNLGN TRMRSVGHEN PGSRELKRRE KPQQSPAIEH GRRSNVLGDK LHIKGSSVKS
     NKK
//
ID   Q5HYH4_HUMAN            Unreviewed;       256 AA.
AC   Q5HYH4;
DT   15-FEB-2005, integrated into UniProtKB/TrEMBL.
DT   15-FEB-2005, sequence version 1.
DT   31-JAN-2018, entry version 59.
DE   SubName: Full=Uncharacterized protein DKFZp313B1621 {ECO:0000313|EMBL:CAI46058.1};
GN   Name=DKFZp313B1621 {ECO:0000313|EMBL:CAI46058.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAI46058.1};
RN   [1] {ECO:0000313|EMBL:CAI46058.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adipose {ECO:0000313|EMBL:CAI46058.1};
RG   The German cDNA Consortium;
RA   Poustka A., Albert R., Moosmayer P., Schupp I., Wellenreuther R.,
RA   Mewes H.W., Weil B., Amid C., Osanger A., Fobo G., Han M., Wiemann S.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX647666; CAI46058.1; -; mRNA.
DR   RefSeq; NP_001123628.1; NM_001130156.2.
DR   RefSeq; NP_001123629.1; NM_001130157.2.
DR   RefSeq; NP_001182361.1; NM_001195432.1.
DR   RefSeq; NP_001182362.1; NM_001195433.1.
DR   RefSeq; NP_001182363.1; NM_001195434.1.
DR   RefSeq; NP_071888.1; NM_022443.4.
DR   UniGene; Hs.85195; -.
DR   SMR; Q5HYH4; -.
DR   PeptideAtlas; Q5HYH4; -.
DR   GeneID; 4291; -.
DR   KEGG; hsa:4291; -.
DR   CTD; 4291; -.
DR   PharmGKB; PA30843; -.
DR   eggNOG; KOG4049; Eukaryota.
DR   eggNOG; ENOG4111J7M; LUCA.
DR   HOGENOM; HOG000045671; -.
DR   HOVERGEN; HBG019060; -.
DR   KO; K15622; -.
DR   GenomeRNAi; 4291; -.
DR   Genevisible; Q5HYH4; HS.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   256 AA;  28808 MW;  63B188D3DFA82062 CRC64;
     MRQMIRSFSE PFGRDLLSIS DGRGRAHNRR GHNDGEDSLT ATSCSLVPFG DFGHTDVSSF
     QTMDQMVSNM RNYMQKLERN FGQLSVDPNG HSFCSSSVMT YSKIGDEPPK VFQASTQTRR
     APGGIKETRK AMRDSDSGLE KMAIGHHIHD RAHVIKKSKN KKTGDEEVNQ EFINMNESDA
     HAFDEEWQSE VLKYKPGRHN LGNTRMRSVG HENPGSRELK RGEKPQQSPA IEHGRRSNVL
     GDKLHIKGSS VKSNKK
//
ID   A0A024R1N1_HUMAN        Unreviewed;      1960 AA.
AC   A0A024R1N1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 36.
DE   SubName: Full=Myosin, heavy polypeptide 9, non-muscle, isoform CRA_a {ECO:0000313|EMBL:EAW60098.1};
GN   Name=MYH9 {ECO:0000313|EMBL:EAW60098.1};
GN   ORFNames=hCG_41454 {ECO:0000313|EMBL:EAW60098.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW60098.1};
RN   [1] {ECO:0000313|EMBL:EAW60098.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW60098.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000256|PROSITE-ProRule:PRU00782,
CC       ECO:0000256|SAAS:SAAS00912437}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471095; EAW60098.1; -; Genomic_DNA.
DR   RefSeq; NP_002464.1; NM_002473.5.
DR   RefSeq; XP_011528499.1; XM_011530197.2.
DR   RefSeq; XP_016884292.1; XM_017028803.1.
DR   RefSeq; XP_016884293.1; XM_017028804.1.
DR   RefSeq; XP_016884294.1; XM_017028805.1.
DR   RefSeq; XP_016884295.1; XM_017028806.1.
DR   UniGene; Hs.474751; -.
DR   ProteinModelPortal; A0A024R1N1; -.
DR   SMR; A0A024R1N1; -.
DR   PRIDE; A0A024R1N1; -.
DR   GeneID; 4627; -.
DR   KEGG; hsa:4627; -.
DR   CTD; 4627; -.
DR   EuPathDB; HostDB:ENSG00000100345.20; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   KO; K10352; -.
DR   OMA; GDSEHKR; -.
DR   OrthoDB; EOG091G009J; -.
DR   PhylomeDB; A0A024R1N1; -.
DR   ChiTaRS; MYH9; human.
DR   GenomeRNAi; 4627; -.
DR   Bgee; ENSG00000100345; -.
DR   ExpressionAtlas; A0A024R1N1; baseline and differential.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0005913; C:cell-cell adherens junction; IEA:Ensembl.
DR   GO; GO:0030863; C:cortical cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0016460; C:myosin II complex; IEA:Ensembl.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0005819; C:spindle; IEA:Ensembl.
DR   GO; GO:0001725; C:stress fiber; IEA:Ensembl.
DR   GO; GO:0001931; C:uropod; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003774; F:motor activity; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0000904; P:cell morphogenesis involved in differentiation; IEA:Ensembl.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0051295; P:establishment of meiotic spindle localization; IEA:Ensembl.
DR   GO; GO:0001768; P:establishment of T cell polarity; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0000212; P:meiotic spindle organization; IEA:Ensembl.
DR   GO; GO:0007520; P:myoblast fusion; IEA:Ensembl.
DR   GO; GO:1903919; P:negative regulation of actin filament severing; IEA:Ensembl.
DR   GO; GO:0006911; P:phagocytosis, engulfment; IEA:Ensembl.
DR   GO; GO:1903923; P:positive regulation of protein processing in phagocytic vesicle; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0032796; P:uropod organization; IEA:Ensembl.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 3.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
PE   3: Inferred from homology;
KW   Actin-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00912434};
KW   ATP-binding {ECO:0000256|SAAS:SAAS00966798};
KW   Coiled coil {ECO:0000256|SAAS:SAAS00099041, ECO:0000256|SAM:Coils};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00966753};
KW   Myosin {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00966753};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00966798}.
FT   DOMAIN       81    776       Myosin motor.
FT                                {ECO:0000259|PROSITE:PS51456}.
FT   NP_BIND     174    181       ATP. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00782}.
FT   REGION      654    676       Actin-binding. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00782}.
FT   COILED      840    986       {ECO:0000256|SAM:Coils}.
FT   COILED      994   1014       {ECO:0000256|SAM:Coils}.
FT   COILED     1022   1158       {ECO:0000256|SAM:Coils}.
FT   COILED     1166   1235       {ECO:0000256|SAM:Coils}.
FT   COILED     1240   1267       {ECO:0000256|SAM:Coils}.
FT   COILED     1303   1372       {ECO:0000256|SAM:Coils}.
FT   COILED     1380   1435       {ECO:0000256|SAM:Coils}.
FT   COILED     1450   1568       {ECO:0000256|SAM:Coils}.
FT   COILED     1577   1758       {ECO:0000256|SAM:Coils}.
FT   COILED     1766   1800       {ECO:0000256|SAM:Coils}.
FT   COILED     1802   1920       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1960 AA;  226532 MW;  588F84BB8C106E6F CRC64;
     MAQQAADKYL YVDKNFINNP LAQADWAAKK LVWVPSDKSG FEPASLKEEV GEEAIVELVE
     NGKKVKVNKD DIQKMNPPKF SKVEDMAELT CLNEASVLHN LKERYYSGLI YTYSGLFCVV
     INPYKNLPIY SEEIVEMYKG KKRHEMPPHI YAITDTAYRS MMQDREDQSI LCTGESGAGK
     TENTKKVIQY LAYVASSHKS KKDQGELERQ LLQANPILEA FGNAKTVKND NSSRFGKFIR
     INFDVNGYIV GANIETYLLE KSRAIRQAKE ERTFHIFYYL LSGAGEHLKT DLLLEPYNKY
     RFLSNGHVTI PGQQDKDMFQ ETMEAMRIMG IPEEEQMGLL RVISGVLQLG NIVFKKERNT
     DQASMPDNTA AQKVSHLLGI NVTDFTRGIL TPRIKVGRDY VQKAQTKEQA DFAIEALAKA
     TYERMFRWLV LRINKALDKT KRQGASFIGI LDIAGFEIFD LNSFEQLCIN YTNEKLQQLF
     NHTMFILEQE EYQREGIEWN FIDFGLDLQP CIDLIEKPAG PPGILALLDE ECWFPKATDK
     SFVEKVMQEQ GTHPKFQKPK QLKDKADFCI IHYAGKVDYK ADEWLMKNMD PLNDNIATLL
     HQSSDKFVSE LWKDVDRIIG LDQVAGMSET ALPGAFKTRK GMFRTVGQLY KEQLAKLMAT
     LRNTNPNFVR CIIPNHEKKA GKLDPHLVLD QLRCNGVLEG IRICRQGFPN RVVFQEFRQR
     YEILTPNSIP KGFMDGKQAC VLMIKALELD SNLYRIGQSK VFFRAGVLAH LEEERDLKIT
     DVIIGFQACC RGYLARKAFA KRQQQLTAMK VLQRNCAAYL KLRNWQWWRL FTKVKPLLQV
     SRQEEEMMAK EEELVKVREK QLAAENRLTE METLQSQLMA EKLQLQEQLQ AETELCAEAE
     ELRARLTAKK QELEEICHDL EARVEEEEER CQHLQAEKKK MQQNIQELEE QLEEEESARQ
     KLQLEKVTTE AKLKKLEEEQ IILEDQNCKL AKEKKLLEDR IAEFTTNLTE EEEKSKSLAK
     LKNKHEAMIT DLEERLRREE KQRQELEKTR RKLEGDSTDL SDQIAELQAQ IAELKMQLAK
     KEEELQAALA RVEEEAAQKN MALKKIRELE SQISELQEDL ESERASRNKA EKQKRDLGEE
     LEALKTELED TLDSTAAQQE LRSKREQEVN ILKKTLEEEA KTHEAQIQEM RQKHSQAVEE
     LAEQLEQTKR VKANLEKAKQ TLENERGELA NEVKVLLQGK GDSEHKRKKV EAQLQELQVK
     FNEGERVRTE LADKVTKLQV ELDNVTGLLS QSDSKSSKLT KDFSALESQL QDTQELLQEE
     NRQKLSLSTK LKQVEDEKNS FREQLEEEEE AKHNLEKQIA TLHAQVADMK KKMEDSVGCL
     ETAEEVKRKL QKDLEGLSQR HEEKVAAYDK LEKTKTRLQQ ELDDLLVDLD HQRQSACNLE
     KKQKKFDQLL AEEKTISAKY AEERDRAEAE AREKETKALS LARALEEAME QKAELERLNK
     QFRTEMEDLM SSKDDVGKSV HELEKSKRAL EQQVEEMKTQ LEELEDELQA TEDAKLRLEV
     NLQAMKAQFE RDLQGRDEQS EEKKKQLVRQ VREMEAELED ERKQRSMAVA ARKKLEMDLK
     DLEAHIDSAN KNRDEAIKQL RKLQAQMKDC MRELDDTRAS REEILAQAKE NEKKLKSMEA
     EMIQLQEELA AAERAKRQAQ QERDELADEI ANSSGKGALA LEEKRRLEAR IAQLEEELEE
     EQGNTELIND RLKKANLQID QINTDLNLER SHAQKNENAR QQLERQNKEL KVKLQEMEGT
     VKSKYKASIT ALEAKIAQLE EQLDNETKER QAACKQVRRT EKKLKDVLLQ VDDERRNAEQ
     YKDQADKAST RLKQLKRQLE EAEEEAQRAN ASRRKLQREL EDATETADAM NREVSSLKNK
     LRRGDLPFVV PRRMARKGAG DGSDEEVDGK ADGAEAKPAE
//
ID   MYH9_HUMAN              Reviewed;        1960 AA.
AC   P35579; A8K6E4; O60805; Q60FE2; Q86T83;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   28-FEB-2018, entry version 212.
DE   RecName: Full=Myosin-9;
DE   AltName: Full=Cellular myosin heavy chain, type A;
DE   AltName: Full=Myosin heavy chain 9;
DE   AltName: Full=Myosin heavy chain, non-muscle IIa;
DE   AltName: Full=Non-muscle myosin heavy chain A;
DE            Short=NMMHC-A;
DE   AltName: Full=Non-muscle myosin heavy chain IIa;
DE            Short=NMMHC II-a;
DE            Short=NMMHC-IIA;
GN   Name=MYH9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16106752; DOI=10.1093/dnares/12.1.53;
RA   Kato S., Ohtoko K., Ohtake H., Kimura T.;
RT   "Vector-capping: a simple method for preparing a high-quality full-
RT   length cDNA library.";
RL   DNA Res. 12:53-62(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Yamakawa H., Kikuno R.F., Nagase T., Ohara O.;
RT   "Multiplex amplification and cloning of 5'-ends of cDNA by ligase-free
RT   recombination: Preparation of full-lemgth cDNA clones encoding motor
RT   proteins.";
RL   Submitted (JAN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-1337, AND TISSUE SPECIFICITY.
RX   PubMed=1912569;
RA   Toothaker L.E., Gonzalez D.A., Tung N., Lemons R.S., le Beau M.M.,
RA   Arnaout M.A., Clayton L.K., Tenen D.G.;
RT   "Cellular myosin heavy chain in human leukocytes: isolation of 5' cDNA
RT   clones, characterization of the protein, chromosomal localization, and
RT   upregulation during myeloid differentiation.";
RL   Blood 78:1826-1833(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1009.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-715.
RX   PubMed=1860190; DOI=10.1161/01.RES.69.2.530;
RA   Simons M., Wang M., McBride O.W., Kawamoto S., Yamakawa K., Gdula D.,
RA   Adelstein R.S., Weir L.;
RT   "Human nonmuscle myosin heavy chains are encoded by two genes located
RT   on different chromosomes.";
RL   Circ. Res. 69:530-539(1991).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-47; 67-74; 126-139; 187-199; 203-225; 241-261;
RP   290-299; 328-355; 359-387; 408-419; 476-494; 546-555; 581-613;
RP   618-637; 645-651; 657-670; 683-693; 712-718; 721-731; 746-755;
RP   765-775; 802-810; 824-829; 834-842; 861-867; 924-930; 995-1014;
RP   1042-1048; 1052-1075; 1081-1099; 1136-1162; 1166-1191; 1261-1266;
RP   1278-1295; 1302-1322; 1393-1400; 1405-1413; 1418-1433; 1484-1492;
RP   1504-1513; 1519-1525; 1529-1555; 1558-1566; 1606-1612; 1614-1638;
RP   1642-1648; 1662-1669; 1704-1724; 1794-1802; 1807-1828; 1857-1867;
RP   1899-1912; 1923-1932 AND 1951-1960, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys R.;
RL   Submitted (AUG-2005) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 714-1960.
RX   PubMed=1967836; DOI=10.1073/pnas.87.3.1164;
RA   Saez C.G., Myers J.C., Shows T.B., Leinwand L.A.;
RT   "Human nonmuscle myosin heavy chain mRNA: generation of diversity
RT   through alternative polyadenylylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:1164-1168(1990).
RN   [12]
RP   INTERACTION WITH SVIL.
RX   PubMed=12917436; DOI=10.1074/jbc.M305311200;
RA   Chen Y., Takizawa N., Crowley J.L., Oh S.W., Gatto C.L., Kambara T.,
RA   Sato O., Li X.-D., Ikebe M., Luna E.J.;
RT   "F-actin and myosin II binding domains in supervillin.";
RL   J. Biol. Chem. 278:46094-46106(2003).
RN   [13]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [17]
RP   INTERACTION WITH SVIL.
RX   PubMed=17925381; DOI=10.1242/jcs.008219;
RA   Takizawa N., Ikebe R., Ikebe M., Luna E.J.;
RT   "Supervillin slows cell spreading by facilitating myosin II activation
RT   at the cell periphery.";
RL   J. Cell Sci. 120:3792-3803(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [20]
RP   ASSOCIATION WITH END STAGE RENAL DISEASE.
RX   PubMed=18794856; DOI=10.1038/ng.226;
RA   Kopp J.B., Smith M.W., Nelson G.W., Johnson R.C., Freedman B.I.,
RA   Bowden D.W., Oleksyk T., McKenzie L.M., Kajiyama H., Ahuja T.S.,
RA   Berns J.S., Briggs W., Cho M.E., Dart R.A., Kimmel P.L., Korbet S.M.,
RA   Michel D.M., Mokrzycki M.H., Schelling J.R., Simon E., Trachtman H.,
RA   Vlahov D., Winkler C.A.;
RT   "MYH9 is a major-effect risk gene for focal segmental
RT   glomerulosclerosis.";
RL   Nat. Genet. 40:1175-1184(2008).
RN   [21]
RP   ASSOCIATION WITH END STAGE RENAL DISEASE.
RX   PubMed=18794854; DOI=10.1038/ng.232;
RA   Kao W.H., Klag M.J., Meoni L.A., Reich D., Berthier-Schaad Y., Li M.,
RA   Coresh J., Patterson N., Tandon A., Powe N.R., Fink N.E., Sadler J.H.,
RA   Weir M.R., Abboud H.E., Adler S.G., Divers J., Iyengar S.K.,
RA   Freedman B.I., Kimmel P.L., Knowler W.C., Kohn O.F., Kramp K.,
RA   Leehey D.J., Nicholas S.B., Pahl M.V., Schelling J.R., Sedor J.R.,
RA   Thornley-Brown D., Winkler C.A., Smith M.W., Parekh R.S.;
RT   "MYH9 is associated with nondiabetic end-stage renal disease in
RT   African Americans.";
RL   Nat. Genet. 40:1185-1192(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   ASSOCIATION WITH END STAGE RENAL DISEASE.
RX   PubMed=19177153; DOI=10.1038/ki.2008.701;
RA   Freedman B.I., Hicks P.J., Bostrom M.A., Cunningham M.E., Liu Y.,
RA   Divers J., Kopp J.B., Winkler C.A., Nelson G.W., Langefeld C.D.,
RA   Bowden D.W.;
RT   "Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are
RT   strongly associated with end-stage renal disease historically
RT   attributed to hypertension in African Americans.";
RL   Kidney Int. 75:736-745(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-11 AND SER-1943, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8; LYS-102; LYS-299;
RP   LYS-1024; LYS-1357; LYS-1392; LYS-1404; LYS-1410; LYS-1459 AND
RP   LYS-1638, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [29]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20052411; DOI=10.1371/journal.pone.0008560;
RA   Betapudi V.;
RT   "Myosin II motor proteins with different functions determine the fate
RT   of lamellipodia extension during cell spreading.";
RL   PLoS ONE 5:E8560-E8560(2010).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1714 AND SER-1943, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [33]
RP   INTERACTION WITH HTRA3.
RX   PubMed=22229724; DOI=10.2144/000113798;
RA   Singh H., Makino S., Endo Y., Li Y., Stephens A.N., Nie G.;
RT   "Application of the wheat-germ cell-free translation system to produce
RT   high temperature requirement A3 (HtrA3) proteases.";
RL   BioTechniques 52:23-28(2012).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-754; SER-1714 AND
RP   SER-1943, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-628 AND SER-1943, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [38]
RP   SUBCELLULAR LOCATION, AND UBIQUITINATION.
RX   PubMed=27331610; DOI=10.7554/eLife.15258;
RA   Li T., Giagtzoglou N., Eberl D.F., Jaiswal S.N., Cai T., Godt D.,
RA   Groves A.K., Bellen H.J.;
RT   "The E3 ligase Ubr3 regulates Usher syndrome and MYH9 disorder
RT   proteins in the auditory organs of Drosophila and mammals.";
RL   Elife 5:E15258-E15258(2016).
RN   [39]
RP   INTERACTION WITH C9ORF135.
RX   PubMed=28345668; DOI=10.1038/srep45311;
RA   Zhou S., Liu Y., Ma Y., Zhang X., Li Y., Wen J.;
RT   "C9ORF135 encodes a membrane protein whose expression is related to
RT   pluripotency in human embryonic stem cells.";
RL   Sci. Rep. 7:45311-45311(2017).
RN   [40]
RP   VARIANT DFNA17 HIS-705.
RX   PubMed=11023810; DOI=10.1086/321212;
RA   Lalwani A.K., Goldstein J.A., Kelley M.J., Luxford W., Castelein C.M.,
RA   Mhatre A.N.;
RT   "Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in
RT   nonmuscle myosin MYH9.";
RL   Am. J. Hum. Genet. 67:1121-1128(2000).
RN   [41]
RP   VARIANTS MHA/FTNS/SBS LYS-93; CYS-702; CYS-1165; HIS-1424 AND
RP   LYS-1841.
RX   PubMed=10973259; DOI=10.1038/79063;
RA   Seri M., Cusano M., Gangarossa S., Caridi G., Bordo D., Lo Nigro C.,
RA   Ghiggeri G.M., Ravazzolo R., Savino M., Del Vecchio M., d'Apolito M.,
RA   Iolascon A., Zelante L.L., Savoia A., Balduini C.L., Noris P.,
RA   Magrini U., Belletti S., Heath K.E., Babcock M., Glucksman M.J.,
RA   Aliprandis E., Bizzaro N., Desnick R.J., Martignetti J.A.;
RT   "Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and
RT   Sebastian syndromes.";
RL   Nat. Genet. 26:103-105(2000).
RN   [42]
RP   VARIANTS MHA ILE-1155 AND LYS-1841.
RX   PubMed=10973260; DOI=10.1038/79069;
RA   Kelley M.J., Jawien W., Ortel T.L., Korczak J.F.;
RT   "Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-
RT   Hegglin anomaly.";
RL   Nat. Genet. 26:106-108(2000).
RN   [43]
RP   VARIANTS MHA/SBS/FTNS/EPSTN ASN-373; CYS-702; HIS-702; ASN-1424;
RP   HIS-1424 AND LYS-1841, AND VARIANT EPSTNS PRO-1114.
RX   PubMed=11590545; DOI=10.1086/324267;
RA   Heath K.E., Campos-Barros A., Toren A., Rozenfeld-Granot G.,
RA   Carlsson L.E., Savige J., Denison J.C., Gregory M.C., White J.G.,
RA   Barker D.F., Greinacher A., Epstein C.J., Glucksman M.J.,
RA   Martignetti J.A.;
RT   "Nonmuscle myosin heavy chain IIA mutations define a spectrum of
RT   autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and
RT   Fechtner, Sebastian, Epstein, and Alport-like syndromes.";
RL   Am. J. Hum. Genet. 69:1033-1045(2001).
RN   [44]
RP   VARIANTS MHA/FTNS/SBS THR-95; CYS-1165; LEU-1165; 1205-LEU--GLN-1207
RP   DEL; HIS-1424; ASN-1424; TYR-1424 AND LYS-1841, AND VARIANT VAL-1626.
RX   PubMed=11776386; DOI=10.1007/s100380170007;
RA   Kunishima S., Matsushita T., Kojima T., Amemiya N., Choi Y.M.,
RA   Hosaka N., Inoue M., Jung Y., Mamiya S., Matsumoto K., Miyajima Y.,
RA   Zhang G., Ruan C., Saito K., Song K.S., Yoon H.-J., Kamiya T.,
RA   Saito H.;
RT   "Identification of six novel MYH9 mutations and genotype-phenotype
RT   relationships in autosomal dominant macrothrombocytopenia with
RT   leukocyte inclusions.";
RL   J. Hum. Genet. 46:722-729(2001).
RN   [45]
RP   VARIANT EPSTNS HIS-702.
RX   PubMed=11935325; DOI=10.1007/s00439-001-0659-1;
RA   Seri M., Savino M., Bordo D., Cusano R., Rocca B., Meloni I.,
RA   Di Bari F., Koivisto P.A., Bolognesi M., Ghiggeri G.M., Landolfi R.,
RA   Balduini C.L., Zelante L., Ravazzolo R., Renieri A., Savoia A.;
RT   "Epstein syndrome: another renal disorder with mutations in the
RT   nonmuscle myosin heavy chain 9 gene.";
RL   Hum. Genet. 110:182-186(2002).
RN   [46]
RP   VARIANTS FTNS LEU-1165; ASN-1424 AND LYS-1841, VARIANTS EPSTNS LEU-96;
RP   TRP-1400 AND LYS-1841, AND TISSUE SPECIFICITY.
RX   PubMed=11752022;
RA   Arrondel C., Vodovar N., Knebelmann B., Gruenfeld J.-P., Gubler M.-C.,
RA   Antignac C., Heidet L.;
RT   "Expression of the nonmuscle myosin heavy chain IIA in the human
RT   kidney and screening for MYH9 mutations in Epstein and Fechtner
RT   syndromes.";
RL   J. Am. Soc. Nephrol. 13:65-74(2002).
RN   [47]
RP   CHARACTERIZATION OF VARIANT ASN-1424.
RX   PubMed=12649151; DOI=10.1182/blood-2002-09-2783;
RA   Deutsch S., Rideau A., Bochaton-Piallat M.-L., Merla G., Geinoz A.,
RA   Gabbiani G., Schwede T., Matthes T., Antonarakis S.E., Beris P.;
RT   "Asp1424Asn MYH9 mutation results in an unstable protein responsible
RT   for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.";
RL   Blood 102:529-534(2003).
RN   [48]
RP   VARIANT FTNS/SBS CYS-1165, VARIANTS SBS LEU-1165 AND
RP   1205-LEU--GLN-1207 DEL, VARIANTS MHA HIS-1424; ASN-1424; TYR-1424 AND
RP   LYS-1841, VARIANT EPS VAL-1816, AND VARIANT FTNS/MHA LYS-1841.
RX   PubMed=12533692;
RA   Kunishima S., Matsushita T., Kojima T., Sako M., Kimura F., Jo E.-K.,
RA   Inoue C., Kamiya T., Saito H.;
RT   "Immunofluorescence analysis of neutrophil nonmuscle myosin heavy
RT   chain-A in MYH9 disorders: association of subcellular localization
RT   with MYH9 mutations.";
RL   Lab. Invest. 83:115-122(2003).
RN   [49]
RP   VARIANT EPSTNS HIS-702, VARIANTS FTNS GLN-910; ILE-1155 AND HIS-1424,
RP   VARIANTS MHA/SBS 1066-GLU--ALA-1072 DEL AND ASN-1424, AND VARIANT
RP   EPSTNS/FTNS/MHA/SBS CYS-702.
RX   PubMed=12792306; DOI=10.1097/00005792-200305000-00006;
RA   Seri M., Pecci A., Di Bari F., Cusano R., Savino M., Panza E.,
RA   Nigro A., Noris P., Gangarossa S., Rocca B., Gresele P., Bizzaro N.,
RA   Malatesta P., Koivisto P.A., Longo I., Musso R., Pecoraro C.,
RA   Iolascon A., Magrini U., Rodriguez Soriano J., Renieri A.,
RA   Ghiggeri G.M., Ravazzolo R., Balduini C.L., Savoia A.;
RT   "MYH9-related disease: may-Hegglin anomaly, Sebastian syndrome,
RT   Fechtner syndrome, and Epstein syndrome are not distinct entities but
RT   represent a variable expression of a single illness.";
RL   Medicine (Baltimore) 82:203-215(2003).
RN   [50]
RP   VARIANT MPSD ASN-1424.
RX   PubMed=12621333; DOI=10.1097/00129492-200303000-00013;
RA   Mhatre A.N., Kim Y., Brodie H.A., Lalwani A.K.;
RT   "Macrothrombocytopenia and progressive deafness is due to a mutation
RT   in MYH9.";
RL   Otol. Neurotol. 24:205-209(2003).
RN   [51]
RP   VARIANT EPSTNS LEU-96.
RX   PubMed=16969870; DOI=10.1002/ajmg.a.31454;
RA   Utsch B., DiFeo A., Kujat A., Karle S., Schuster V., Lenk H.,
RA   Jacobs U., Mueller M., Doetsch J., Rascher W., Reutter H.,
RA   Martignetti J.A., Ludwig M., Troebs R.-B.;
RT   "Bladder exstrophy and Epstein type congenital macrothrombocytopenia:
RT   evidence for a common cause?";
RL   Am. J. Med. Genet. A 140:2251-2253(2006).
RN   [52]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-810.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [53]
RP   POSITION OF MUTATIONS IN MYH9-RELATED DISEASE.
RX   PubMed=18059020; DOI=10.1002/humu.20661;
RA   Pecci A., Panza E., Pujol-Moix N., Klersy C., Di Bari F., Bozzi V.,
RA   Gresele P., Lethagen S., Fabris F., Dufour C., Granata A., Doubek M.,
RA   Pecoraro C., Koivisto P.A., Heller P.G., Iolascon A., Alvisi P.,
RA   Schwabe D., De Candia E., Rocca B., Russo U., Ramenghi U., Noris P.,
RA   Seri M., Balduini C.L., Savoia A.;
RT   "Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations
RT   predicts the natural history of MYH9-related disease.";
RL   Hum. Mutat. 29:409-417(2008).
CC   -!- FUNCTION: Cellular myosin that appears to play a role in
CC       cytokinesis, cell shape, and specialized functions such as
CC       secretion and capping. During cell spreading, plays an important
CC       role in cytoskeleton reorganization, focal contacts formation (in
CC       the margins but not the central part of spreading cells), and
CC       lamellipodial retraction; this function is mechanically
CC       antagonized by MYH10. {ECO:0000269|PubMed:20052411}.
CC   -!- SUBUNIT: Myosin is a hexameric protein that consists of 2 heavy
CC       chain subunits (MHC), 2 alkali light chain subunits (MLC) and 2
CC       regulatory light chain subunits (MLC-2). Interacts with RASIP1 (By
CC       similarity). Interacts with DDR1 (By similarity). Interacts with
CC       SLC6A4 (By similarity). Interacts with PDLIM2 (By similarity).
CC       Interacts with SVIL (PubMed:12917436, PubMed:17925381). Interacts
CC       with HTRA3 (PubMed:22229724). Interacts with Myo7a (By
CC       similarity). Interacts with C9orf135 (PubMed:28345668).
CC       {ECO:0000250|UniProtKB:Q62812, ECO:0000250|UniProtKB:Q8VDD5,
CC       ECO:0000269|PubMed:12917436, ECO:0000269|PubMed:17925381,
CC       ECO:0000269|PubMed:22229724, ECO:0000269|PubMed:28345668}.
CC   -!- INTERACTION:
CC       P61073:CXCR4; NbExp=5; IntAct=EBI-350338, EBI-489411;
CC       P62993:GRB2; NbExp=3; IntAct=EBI-350338, EBI-401755;
CC       O00255:MEN1; NbExp=3; IntAct=EBI-350338, EBI-592789;
CC       O00255-2:MEN1; NbExp=4; IntAct=EBI-350338, EBI-9869387;
CC       P19338:NCL; NbExp=3; IntAct=EBI-350338, EBI-346967;
CC       P26447:S100A4; NbExp=11; IntAct=EBI-350338, EBI-717058;
CC       O46385:SVIL (xeno); NbExp=2; IntAct=EBI-350338, EBI-6995105;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q8VDD5}. Cytoplasm, cell cortex
CC       {ECO:0000250|UniProtKB:Q8VDD5}. Note=Colocalizes with actin
CC       filaments at lamellipodia margins and at the leading edge of
CC       migrating cells (PubMed:20052411). In retinal pigment epithelial
CC       cells, predominantly localized to stress fiber-like structures
CC       with some localization to cytoplasmic puncta (PubMed:27331610).
CC       {ECO:0000269|PubMed:20052411, ECO:0000269|PubMed:27331610}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P35579-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35579-2; Sequence=VSP_035409, VSP_035410;
CC   -!- TISSUE SPECIFICITY: In the kidney, expressed in the glomeruli.
CC       Also expressed in leukocytes. {ECO:0000269|PubMed:11752022,
CC       ECO:0000269|PubMed:1912569}.
CC   -!- DOMAIN: The rodlike tail sequence is highly repetitive, showing
CC       cycles of a 28-residue repeat pattern composed of 4 heptapeptides,
CC       characteristic for alpha-helical coiled coils.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: Ubiquitination. {ECO:0000269|PubMed:27331610}.
CC   -!- DISEASE: May-Hegglin anomaly (MHA) [MIM:155100]: A disorder
CC       characterized by thrombocytopenia, giant platelets and Dohle body-
CC       like inclusions in peripheral blood leukocytes. appearing as
CC       highly parallel paracrystalline bodies.
CC       {ECO:0000269|PubMed:10973259, ECO:0000269|PubMed:10973260,
CC       ECO:0000269|PubMed:11590545, ECO:0000269|PubMed:11776386,
CC       ECO:0000269|PubMed:12533692, ECO:0000269|PubMed:12792306}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Sebastian syndrome (SBS) [MIM:605249]: Autosomal dominant
CC       macrothrombocytopenia characterized by thrombocytopenia, giant
CC       platelets and leukocyte inclusions that are smaller and less
CC       organized than in May-Hegglin anomaly.
CC       {ECO:0000269|PubMed:12533692}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Fechtner syndrome (FTNS) [MIM:153640]: Autosomal dominant
CC       macrothrombocytopenia characterized by thrombocytopenia, giant
CC       platelets and leukocyte inclusions that are small and poorly
CC       organized. Additionally, FTNS is distinguished by Alport-like
CC       clinical features of sensorineural deafness, cataracts and
CC       nephritis. {ECO:0000269|PubMed:10973259,
CC       ECO:0000269|PubMed:11752022, ECO:0000269|PubMed:11776386,
CC       ECO:0000269|PubMed:12533692, ECO:0000269|PubMed:12792306}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Epstein syndrome (EPSTNS) [MIM:153650]: An autosomal
CC       dominant disorder characterized by the association of
CC       macrothrombocytopathy, sensorineural hearing loss and nephritis.
CC       {ECO:0000269|PubMed:11590545, ECO:0000269|PubMed:11752022,
CC       ECO:0000269|PubMed:11935325, ECO:0000269|PubMed:12533692,
CC       ECO:0000269|PubMed:12792306, ECO:0000269|PubMed:16969870}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Deafness, autosomal dominant, 17 (DFNA17) [MIM:603622]: A
CC       form of deafness characterized by progressive high frequency
CC       hearing impairment and cochleosaccular degeneration.
CC       {ECO:0000269|PubMed:11023810}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Macrothrombocytopenia and progressive sensorineural
CC       deafness (MPSD) [MIM:600208]: An autosomal dominant disorder
CC       characterized by the association of macrothrombocytopathy and
CC       progressive sensorineural hearing loss without renal dysfunction.
CC       {ECO:0000269|PubMed:12621333}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Subjects with mutations in the motor domain of MYH9
CC       present with severe thrombocytopenia and develop nephritis and
CC       deafness before the age of 40 years, while those with mutations in
CC       the tail domain have a much lower risk of noncongenital
CC       complications and significantly higher platelet counts. The
CC       clinical course of patients with mutations in the four most
CC       frequently affected residues of MYH9 (responsible for 70% of MYH9-
CC       related cases) were evaluated. Mutations at residue 1933 do not
CC       induce kidney damage or cataracts and cause deafness only in the
CC       elderly, those in position 702 result in severe thrombocytopenia
CC       and produce nephritis and deafness at a juvenile age, while
CC       alterations at residue 1424 or 1841 result in intermediate
CC       clinical pictures.
CC   -!- DISEASE: Note=Genetic variations in MYH9 are associated with non-
CC       diabetic end stage renal disease (ESRD).
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD89954.1; Type=Frameshift; Positions=1890; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MYH9ID481.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR456526; CAG30412.1; -; mRNA.
DR   EMBL; AB191263; BAD52439.1; -; mRNA.
DR   EMBL; AL832639; CAD89954.1; ALT_FRAME; mRNA.
DR   EMBL; AB290175; BAG06729.1; -; mRNA.
DR   EMBL; Z82215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60096.1; -; Genomic_DNA.
DR   EMBL; M81105; AAA59888.1; -; mRNA.
DR   EMBL; AK291609; BAF84298.1; -; mRNA.
DR   EMBL; M69180; AAA61765.1; -; mRNA.
DR   EMBL; M31013; AAA36349.1; -; mRNA.
DR   CCDS; CCDS13927.1; -. [P35579-1]
DR   PIR; A61231; A61231.
DR   RefSeq; NP_002464.1; NM_002473.5. [P35579-1]
DR   RefSeq; XP_011528499.1; XM_011530197.2. [P35579-1]
DR   RefSeq; XP_016884292.1; XM_017028803.1. [P35579-1]
DR   RefSeq; XP_016884293.1; XM_017028804.1. [P35579-1]
DR   RefSeq; XP_016884294.1; XM_017028805.1. [P35579-1]
DR   RefSeq; XP_016884295.1; XM_017028806.1. [P35579-1]
DR   UniGene; Hs.474751; -.
DR   PDB; 2LNK; NMR; -; C=1897-1935.
DR   PDB; 3ZWH; X-ray; 1.94 A; Q=1893-1937.
DR   PDB; 4CFQ; X-ray; 1.37 A; Q/R=1893-1937.
DR   PDB; 4CFR; X-ray; 1.40 A; Q=1893-1937.
DR   PDB; 4ETO; X-ray; 1.54 A; P=1908-1923.
DR   PDBsum; 2LNK; -.
DR   PDBsum; 3ZWH; -.
DR   PDBsum; 4CFQ; -.
DR   PDBsum; 4CFR; -.
DR   PDBsum; 4ETO; -.
DR   ProteinModelPortal; P35579; -.
DR   SMR; P35579; -.
DR   BioGrid; 110712; 315.
DR   CORUM; P35579; -.
DR   DIP; DIP-33103N; -.
DR   IntAct; P35579; 275.
DR   MINT; P35579; -.
DR   STRING; 9606.ENSP00000216181; -.
DR   ChEMBL; CHEMBL2189151; -.
DR   CarbonylDB; P35579; -.
DR   iPTMnet; P35579; -.
DR   PhosphoSitePlus; P35579; -.
DR   SwissPalm; P35579; -.
DR   BioMuta; MYH9; -.
DR   DMDM; 6166599; -.
DR   EPD; P35579; -.
DR   PaxDb; P35579; -.
DR   PeptideAtlas; P35579; -.
DR   PRIDE; P35579; -.
DR   TopDownProteomics; P35579-1; -. [P35579-1]
DR   DNASU; 4627; -.
DR   Ensembl; ENST00000216181; ENSP00000216181; ENSG00000100345. [P35579-1]
DR   GeneID; 4627; -.
DR   KEGG; hsa:4627; -.
DR   UCSC; uc003apg.4; human. [P35579-1]
DR   CTD; 4627; -.
DR   DisGeNET; 4627; -.
DR   EuPathDB; HostDB:ENSG00000100345.20; -.
DR   GeneCards; MYH9; -.
DR   GeneReviews; MYH9; -.
DR   HGNC; HGNC:7579; MYH9.
DR   HPA; CAB015386; -.
DR   HPA; HPA001644; -.
DR   MalaCards; MYH9; -.
DR   MIM; 153640; phenotype.
DR   MIM; 153650; phenotype.
DR   MIM; 155100; phenotype.
DR   MIM; 160775; gene.
DR   MIM; 600208; phenotype.
DR   MIM; 603622; phenotype.
DR   MIM; 605249; phenotype.
DR   neXtProt; NX_P35579; -.
DR   OpenTargets; ENSG00000100345; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   Orphanet; 182050; MYH9-related disease.
DR   PharmGKB; PA31377; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   GeneTree; ENSGT00760000118919; -.
DR   HOGENOM; HOG000173958; -.
DR   HOVERGEN; HBG004704; -.
DR   InParanoid; P35579; -.
DR   KO; K10352; -.
DR   OMA; GDSEHKR; -.
DR   OrthoDB; EOG091G009J; -.
DR   PhylomeDB; P35579; -.
DR   TreeFam; TF333601; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-416572; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5625900; RHO GTPases activate CIT.
DR   Reactome; R-HSA-5627117; RHO GTPases Activate ROCKs.
DR   Reactome; R-HSA-5627123; RHO GTPases activate PAKs.
DR   SIGNOR; P35579; -.
DR   ChiTaRS; MYH9; human.
DR   GeneWiki; MYH9; -.
DR   GenomeRNAi; 4627; -.
DR   PMAP-CutDB; P35579; -.
DR   PRO; PR:P35579; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100345; -.
DR   CleanEx; HS_MYH9; -.
DR   ExpressionAtlas; P35579; baseline and differential.
DR   Genevisible; P35579; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0042641; C:actomyosin; IDA:UniProtKB.
DR   GO; GO:0005826; C:actomyosin contractile ring; IDA:UniProtKB.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0031252; C:cell leading edge; IDA:UniProtKB.
DR   GO; GO:0005913; C:cell-cell adherens junction; IEA:Ensembl.
DR   GO; GO:0032154; C:cleavage furrow; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0016460; C:myosin II complex; IDA:UniProtKB.
DR   GO; GO:0097513; C:myosin II filament; IDA:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IEA:Ensembl.
DR   GO; GO:0001725; C:stress fiber; IDA:UniProtKB.
DR   GO; GO:0001931; C:uropod; IDA:MGI.
DR   GO; GO:0003779; F:actin binding; IDA:MGI.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0030898; F:actin-dependent ATPase activity; IDA:MGI.
DR   GO; GO:0043531; F:ADP binding; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IDA:MGI.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0000146; F:microfilament motor activity; IDA:UniProtKB.
DR   GO; GO:0003774; F:motor activity; NAS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0043495; F:protein membrane anchor; IMP:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0030048; P:actin filament-based movement; IDA:UniProtKB.
DR   GO; GO:0031032; P:actomyosin structure organization; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IDA:UniProtKB.
DR   GO; GO:0043534; P:blood vessel endothelial cell migration; IMP:UniProtKB.
DR   GO; GO:0032506; P:cytokinetic process; IMP:UniProtKB.
DR   GO; GO:0051295; P:establishment of meiotic spindle localization; IEA:Ensembl.
DR   GO; GO:0001768; P:establishment of T cell polarity; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; NAS:UniProtKB.
DR   GO; GO:0000212; P:meiotic spindle organization; IEA:Ensembl.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB.
DR   GO; GO:0030224; P:monocyte differentiation; IEP:UniProtKB.
DR   GO; GO:0007520; P:myoblast fusion; IEA:Ensembl.
DR   GO; GO:1903919; P:negative regulation of actin filament severing; IMP:UniProtKB.
DR   GO; GO:0006911; P:phagocytosis, engulfment; ISS:UniProtKB.
DR   GO; GO:0070527; P:platelet aggregation; HMP:UniProtKB.
DR   GO; GO:0030220; P:platelet formation; IMP:UniProtKB.
DR   GO; GO:1903923; P:positive regulation of protein processing in phagocytic vesicle; ISS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IMP:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:0032796; P:uropod organization; IEA:Ensembl.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 3.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alport syndrome;
KW   Alternative splicing; ATP-binding; Calmodulin-binding; Cataract;
KW   Cell adhesion; Cell shape; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Deafness; Direct protein sequencing; Disease mutation;
KW   Methylation; Motor protein; Myosin; Non-syndromic deafness;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.10}.
FT   CHAIN         2   1960       Myosin-9.
FT                                /FTId=PRO_0000123416.
FT   DOMAIN       27     77       Myosin N-terminal SH3-like.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01190}.
FT   DOMAIN       81    776       Myosin motor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00782}.
FT   DOMAIN      779    808       IQ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   NP_BIND     174    181       ATP. {ECO:0000255}.
FT   REGION      654    676       Actin-binding.
FT   COILED      837   1926       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine. {ECO:0000269|Ref.10}.
FT   MOD_RES       8      8       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      11     11       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     102    102       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     299    299       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     435    435       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P35580}.
FT   MOD_RES     613    613       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES     628    628       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     754    754       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     850    850       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES     860    860       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES     975    975       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES    1024   1024       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1114   1114       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES    1234   1234       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q61879}.
FT   MOD_RES    1249   1249       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES    1357   1357       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1392   1392       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1404   1404       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1410   1410       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1459   1459       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1638   1638       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1669   1669       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES    1714   1714       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1793   1793       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES    1802   1802       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES    1845   1845       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDD5}.
FT   MOD_RES    1923   1923       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q61879}.
FT   MOD_RES    1943   1943       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17487921,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1    136       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_035409.
FT   VAR_SEQ     980   1421       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_035410.
FT   VARIANT      93     93       N -> K (in MHA; dbSNP:rs121913655).
FT                                {ECO:0000269|PubMed:10973259}.
FT                                /FTId=VAR_010791.
FT   VARIANT      95     95       A -> T (in MHA).
FT                                {ECO:0000269|PubMed:11776386}.
FT                                /FTId=VAR_018308.
FT   VARIANT      96     96       S -> L (in EPSTNS; dbSNP:rs121913657).
FT                                {ECO:0000269|PubMed:11752022,
FT                                ECO:0000269|PubMed:16969870}.
FT                                /FTId=VAR_018309.
FT   VARIANT     373    373       K -> N (in MHA and SBS).
FT                                {ECO:0000269|PubMed:11590545}.
FT                                /FTId=VAR_018310.
FT   VARIANT     702    702       R -> C (in EPSTNS, FTNS, MHA and SBS;
FT                                dbSNP:rs80338826).
FT                                {ECO:0000269|PubMed:10973259,
FT                                ECO:0000269|PubMed:11590545,
FT                                ECO:0000269|PubMed:12792306}.
FT                                /FTId=VAR_010792.
FT   VARIANT     702    702       R -> H (in EPSTNS; dbSNP:rs80338827).
FT                                {ECO:0000269|PubMed:11590545,
FT                                ECO:0000269|PubMed:11935325,
FT                                ECO:0000269|PubMed:12792306}.
FT                                /FTId=VAR_018311.
FT   VARIANT     705    705       R -> H (in DFNA17; dbSNP:rs80338828).
FT                                {ECO:0000269|PubMed:11023810}.
FT                                /FTId=VAR_010793.
FT   VARIANT     810    810       K -> N (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036006.
FT   VARIANT     910    910       K -> Q (in FTNS; dbSNP:rs554332083).
FT                                {ECO:0000269|PubMed:12792306}.
FT                                /FTId=VAR_044226.
FT   VARIANT     967    967       V -> E (in dbSNP:rs16996652).
FT                                /FTId=VAR_044227.
FT   VARIANT    1066   1072       Missing (in MHA and SBS).
FT                                {ECO:0000269|PubMed:12792306}.
FT                                /FTId=VAR_044228.
FT   VARIANT    1114   1114       S -> P (in EPSTNS; dbSNP:rs200901330).
FT                                {ECO:0000269|PubMed:11590545}.
FT                                /FTId=VAR_018312.
FT   VARIANT    1155   1155       T -> I (in MHA and FTNS;
FT                                dbSNP:rs121913656).
FT                                {ECO:0000269|PubMed:10973260,
FT                                ECO:0000269|PubMed:12792306}.
FT                                /FTId=VAR_010794.
FT   VARIANT    1165   1165       R -> C (in FTNS and SBS;
FT                                dbSNP:rs80338829).
FT                                {ECO:0000269|PubMed:10973259,
FT                                ECO:0000269|PubMed:11776386,
FT                                ECO:0000269|PubMed:12533692}.
FT                                /FTId=VAR_010795.
FT   VARIANT    1165   1165       R -> L (in FTNS, MHA and SBS;
FT                                dbSNP:rs80338830).
FT                                {ECO:0000269|PubMed:11752022,
FT                                ECO:0000269|PubMed:11776386,
FT                                ECO:0000269|PubMed:12533692}.
FT                                /FTId=VAR_018313.
FT   VARIANT    1205   1207       Missing (in SBS).
FT                                {ECO:0000269|PubMed:11776386,
FT                                ECO:0000269|PubMed:12533692}.
FT                                /FTId=VAR_018314.
FT   VARIANT    1400   1400       R -> W (in EPSTNS; unknown pathological
FT                                significance; might contribute to
FT                                pathogenicity when associated with L-96;
FT                                dbSNP:rs76368635).
FT                                {ECO:0000269|PubMed:11752022}.
FT                                /FTId=VAR_018315.
FT   VARIANT    1424   1424       D -> H (in FTNS and MHA;
FT                                dbSNP:rs80338831).
FT                                {ECO:0000269|PubMed:10973259,
FT                                ECO:0000269|PubMed:11590545,
FT                                ECO:0000269|PubMed:11776386,
FT                                ECO:0000269|PubMed:12533692,
FT                                ECO:0000269|PubMed:12792306}.
FT                                /FTId=VAR_010796.
FT   VARIANT    1424   1424       D -> N (in FTNS, MHA, SBS and MPSD;
FT                                results in reduced protein levels;
FT                                dbSNP:rs80338831).
FT                                {ECO:0000269|PubMed:11590545,
FT                                ECO:0000269|PubMed:11752022,
FT                                ECO:0000269|PubMed:11776386,
FT                                ECO:0000269|PubMed:12533692,
FT                                ECO:0000269|PubMed:12621333,
FT                                ECO:0000269|PubMed:12649151,
FT                                ECO:0000269|PubMed:12792306}.
FT                                /FTId=VAR_018316.
FT   VARIANT    1424   1424       D -> Y (in MHA; dbSNP:rs80338831).
FT                                {ECO:0000269|PubMed:11776386,
FT                                ECO:0000269|PubMed:12533692}.
FT                                /FTId=VAR_018317.
FT   VARIANT    1626   1626       I -> V (in dbSNP:rs2269529).
FT                                {ECO:0000269|PubMed:11776386}.
FT                                /FTId=VAR_018318.
FT   VARIANT    1816   1816       I -> V (in EPSTNS; dbSNP:rs762773112).
FT                                {ECO:0000269|PubMed:12533692}.
FT                                /FTId=VAR_030385.
FT   VARIANT    1841   1841       E -> K (in FTNS, SBS, MHA and EPSTNS;
FT                                dbSNP:rs80338834).
FT                                {ECO:0000269|PubMed:10973259,
FT                                ECO:0000269|PubMed:10973260,
FT                                ECO:0000269|PubMed:11590545,
FT                                ECO:0000269|PubMed:11752022,
FT                                ECO:0000269|PubMed:11776386,
FT                                ECO:0000269|PubMed:12533692}.
FT                                /FTId=VAR_010797.
FT   CONFLICT     53     55       EAI -> RGH (in Ref. 9). {ECO:0000305}.
FT   CONFLICT    660    660       T -> S (in Ref. 9). {ECO:0000305}.
FT   CONFLICT    869    869       T -> M (in Ref. 11; AAA36349).
FT                                {ECO:0000305}.
FT   CONFLICT    931    931       C -> Y (in Ref. 11; AAA36349).
FT                                {ECO:0000305}.
FT   CONFLICT   1000   1000       R -> I (in Ref. 8; BAF84298).
FT                                {ECO:0000305}.
FT   CONFLICT   1240   1241       KG -> GR (in Ref. 11; AAA36349).
FT                                {ECO:0000305}.
FT   CONFLICT   1350   1350       E -> EE (in Ref. 11). {ECO:0000305}.
FT   CONFLICT   1462   1462       E -> G (in Ref. 1; CAD89954).
FT                                {ECO:0000305}.
FT   CONFLICT   1546   1546       D -> G (in Ref. 1; CAD89954).
FT                                {ECO:0000305}.
FT   CONFLICT   1764   1764       T -> A (in Ref. 11; AAA36349).
FT                                {ECO:0000305}.
FT   CONFLICT   1771   1771       S -> G (in Ref. 11; AAA36349).
FT                                {ECO:0000305}.
FT   STRAND     1895   1897       {ECO:0000244|PDB:4CFR}.
FT   HELIX      1899   1903       {ECO:0000244|PDB:4CFR}.
FT   HELIX      1904   1921       {ECO:0000244|PDB:4CFQ}.
FT   STRAND     1922   1925       {ECO:0000244|PDB:2LNK}.
SQ   SEQUENCE   1960 AA;  226532 MW;  588F84BB8C106E6F CRC64;
     MAQQAADKYL YVDKNFINNP LAQADWAAKK LVWVPSDKSG FEPASLKEEV GEEAIVELVE
     NGKKVKVNKD DIQKMNPPKF SKVEDMAELT CLNEASVLHN LKERYYSGLI YTYSGLFCVV
     INPYKNLPIY SEEIVEMYKG KKRHEMPPHI YAITDTAYRS MMQDREDQSI LCTGESGAGK
     TENTKKVIQY LAYVASSHKS KKDQGELERQ LLQANPILEA FGNAKTVKND NSSRFGKFIR
     INFDVNGYIV GANIETYLLE KSRAIRQAKE ERTFHIFYYL LSGAGEHLKT DLLLEPYNKY
     RFLSNGHVTI PGQQDKDMFQ ETMEAMRIMG IPEEEQMGLL RVISGVLQLG NIVFKKERNT
     DQASMPDNTA AQKVSHLLGI NVTDFTRGIL TPRIKVGRDY VQKAQTKEQA DFAIEALAKA
     TYERMFRWLV LRINKALDKT KRQGASFIGI LDIAGFEIFD LNSFEQLCIN YTNEKLQQLF
     NHTMFILEQE EYQREGIEWN FIDFGLDLQP CIDLIEKPAG PPGILALLDE ECWFPKATDK
     SFVEKVMQEQ GTHPKFQKPK QLKDKADFCI IHYAGKVDYK ADEWLMKNMD PLNDNIATLL
     HQSSDKFVSE LWKDVDRIIG LDQVAGMSET ALPGAFKTRK GMFRTVGQLY KEQLAKLMAT
     LRNTNPNFVR CIIPNHEKKA GKLDPHLVLD QLRCNGVLEG IRICRQGFPN RVVFQEFRQR
     YEILTPNSIP KGFMDGKQAC VLMIKALELD SNLYRIGQSK VFFRAGVLAH LEEERDLKIT
     DVIIGFQACC RGYLARKAFA KRQQQLTAMK VLQRNCAAYL KLRNWQWWRL FTKVKPLLQV
     SRQEEEMMAK EEELVKVREK QLAAENRLTE METLQSQLMA EKLQLQEQLQ AETELCAEAE
     ELRARLTAKK QELEEICHDL EARVEEEEER CQHLQAEKKK MQQNIQELEE QLEEEESARQ
     KLQLEKVTTE AKLKKLEEEQ IILEDQNCKL AKEKKLLEDR IAEFTTNLTE EEEKSKSLAK
     LKNKHEAMIT DLEERLRREE KQRQELEKTR RKLEGDSTDL SDQIAELQAQ IAELKMQLAK
     KEEELQAALA RVEEEAAQKN MALKKIRELE SQISELQEDL ESERASRNKA EKQKRDLGEE
     LEALKTELED TLDSTAAQQE LRSKREQEVN ILKKTLEEEA KTHEAQIQEM RQKHSQAVEE
     LAEQLEQTKR VKANLEKAKQ TLENERGELA NEVKVLLQGK GDSEHKRKKV EAQLQELQVK
     FNEGERVRTE LADKVTKLQV ELDNVTGLLS QSDSKSSKLT KDFSALESQL QDTQELLQEE
     NRQKLSLSTK LKQVEDEKNS FREQLEEEEE AKHNLEKQIA TLHAQVADMK KKMEDSVGCL
     ETAEEVKRKL QKDLEGLSQR HEEKVAAYDK LEKTKTRLQQ ELDDLLVDLD HQRQSACNLE
     KKQKKFDQLL AEEKTISAKY AEERDRAEAE AREKETKALS LARALEEAME QKAELERLNK
     QFRTEMEDLM SSKDDVGKSV HELEKSKRAL EQQVEEMKTQ LEELEDELQA TEDAKLRLEV
     NLQAMKAQFE RDLQGRDEQS EEKKKQLVRQ VREMEAELED ERKQRSMAVA ARKKLEMDLK
     DLEAHIDSAN KNRDEAIKQL RKLQAQMKDC MRELDDTRAS REEILAQAKE NEKKLKSMEA
     EMIQLQEELA AAERAKRQAQ QERDELADEI ANSSGKGALA LEEKRRLEAR IAQLEEELEE
     EQGNTELIND RLKKANLQID QINTDLNLER SHAQKNENAR QQLERQNKEL KVKLQEMEGT
     VKSKYKASIT ALEAKIAQLE EQLDNETKER QAACKQVRRT EKKLKDVLLQ VDDERRNAEQ
     YKDQADKAST RLKQLKRQLE EAEEEAQRAN ASRRKLQREL EDATETADAM NREVSSLKNK
     LRRGDLPFVV PRRMARKGAG DGSDEEVDGK ADGAEAKPAE
//
ID   NAB2_HUMAN              Reviewed;         525 AA.
AC   Q15742; B2RAK3; O76006; Q14797;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-FEB-2018, entry version 148.
DE   RecName: Full=NGFI-A-binding protein 2;
DE   AltName: Full=EGR-1-binding protein 2;
DE   AltName: Full=Melanoma-associated delayed early response protein;
DE            Short=Protein MADER;
GN   Name=NAB2; Synonyms=MADER;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta;
RX   PubMed=8668170; DOI=10.1128/MCB.16.7.3545;
RA   Svaren J., Sevetson B.R., Apel E.D., Zimonjic D.B., Popescu N.C.,
RA   Milbrandt J.;
RT   "NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by
RT   proliferative and differentiative stimuli.";
RL   Mol. Cell. Biol. 16:3545-3553(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1).
RA   Gerlinger M., Johnson J.P.;
RT   "Genomic organization of the Mader/NAB2 gene.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 50-525 (ISOFORM 1).
RX   PubMed=8649813;
RA   Kirsch K.H., Korradi Y., Johnson J.P.;
RT   "Mader: a novel nuclear protein over expressed in human melanomas.";
RL   Oncogene 12:963-971(1996).
RN   [7]
RP   PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 3).
RA   Johnson J.P.;
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9126479; DOI=10.1006/geno.1997.4609;
RA   Svaren J., Apel E.D., Simburger K.S., Jenkins N.A., Gilbert D.J.,
RA   Copeland N.G., Milbrandt J.;
RT   "The Nab2 and Stat6 genes share a common transcription termination
RT   region.";
RL   Genomics 41:33-39(1997).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   SUMOYLATION AT LYS-379 AND LYS-517 BY EGR2.
RX   PubMed=21836637; DOI=10.1038/embor.2011.152;
RA   Garcia-Gutierrez P., Juarez-Vicente F., Gallardo-Chamizo F.,
RA   Charnay P., Garcia-Dominguez M.;
RT   "The transcription factor Krox20 is an E3 ligase that sumoylates its
RT   Nab coregulators.";
RL   EMBO Rep. 12:1018-1023(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159 AND SER-162, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-159; SER-162 AND
RP   SER-171, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-171, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-517, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Acts as a transcriptional repressor for zinc finger
CC       transcription factors EGR1 and EGR2. Isoform 2 lacks repression
CC       ability (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homomultimers may associate with EGR1 bound to DNA.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-8641936, EBI-8641936;
CC       G2XKQ0:-; NbExp=3; IntAct=EBI-8641936, EBI-10175576;
CC       Q08117:AES; NbExp=3; IntAct=EBI-8641936, EBI-717810;
CC       Q8TD31-3:CCHCR1; NbExp=3; IntAct=EBI-8641936, EBI-10175300;
CC       Q2TBE0:CWF19L2; NbExp=3; IntAct=EBI-8641936, EBI-5453285;
CC       Q96CN9:GCC1; NbExp=3; IntAct=EBI-8641936, EBI-746252;
CC       Q96AA8:JAKMIP2; NbExp=3; IntAct=EBI-8641936, EBI-752007;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-8641936, EBI-10171774;
CC       Q96BZ8:LENG1; NbExp=5; IntAct=EBI-8641936, EBI-726510;
CC       P33993:MCM7; NbExp=3; IntAct=EBI-8641936, EBI-355924;
CC       Q9UBU8:MORF4L1; NbExp=3; IntAct=EBI-8641936, EBI-399246;
CC       Q14511:NEDD9; NbExp=4; IntAct=EBI-8641936, EBI-2108053;
CC       Q9Y5B8:NME7; NbExp=5; IntAct=EBI-8641936, EBI-744782;
CC       Q7Z3S9:NOTCH2NL; NbExp=3; IntAct=EBI-8641936, EBI-945833;
CC       O43189:PHF1; NbExp=5; IntAct=EBI-8641936, EBI-530034;
CC       Q8TCD6:PHOSPHO2; NbExp=5; IntAct=EBI-8641936, EBI-2861380;
CC       Q13526:PIN1; NbExp=7; IntAct=EBI-8641936, EBI-714158;
CC       P40937:RFC5; NbExp=5; IntAct=EBI-8641936, EBI-712376;
CC       Q9BWG6:SCNM1; NbExp=3; IntAct=EBI-8641936, EBI-748391;
CC       Q9NZD8:SPG21; NbExp=4; IntAct=EBI-8641936, EBI-742688;
CC       Q8N8B7:TCEANC; NbExp=3; IntAct=EBI-8641936, EBI-954696;
CC       Q9BT92:TCHP; NbExp=5; IntAct=EBI-8641936, EBI-740781;
CC       Q8IUE0:TGIF2LY; NbExp=5; IntAct=EBI-8641936, EBI-8063723;
CC       Q6DKK2:TTC19; NbExp=3; IntAct=EBI-8641936, EBI-948354;
CC       Q8IZ13:ZBED8; NbExp=5; IntAct=EBI-8641936, EBI-7186123;
CC       Q96E35:ZMYND19; NbExp=6; IntAct=EBI-8641936, EBI-746595;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Isoform 2 is not
CC       localized to the nucleus. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q15742-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15742-2; Sequence=VSP_003385, VSP_003386;
CC       Name=3;
CC         IsoId=Q15742-3; Sequence=VSP_003387;
CC   -!- TISSUE SPECIFICITY: Widely expressed at low levels. Highly
CC       expressed in melanoma cell lines.
CC   -!- INDUCTION: By serum and phorbol myristate acetate (PMA)
CC       stimulation.
CC   -!- DOMAIN: The NAB conserved domain 1 (NCD1) interacts with EGR1
CC       inhibitory domain and mediates multimerization.
CC   -!- DOMAIN: The NAB conserved domain 2 (NCD2) is necessary for
CC       transcriptional repression.
CC   -!- PTM: Sumoylation by EGR2 represses EGR2 transcriptional activity
CC       in hindbrain. {ECO:0000269|PubMed:21836637}.
CC   -!- SIMILARITY: Belongs to the NAB family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U48361; AAC50589.1; -; mRNA.
DR   EMBL; AF268380; AAF72545.1; -; Genomic_DNA.
DR   EMBL; AK314229; BAG36900.1; -; mRNA.
DR   EMBL; CH471054; EAW96989.1; -; Genomic_DNA.
DR   EMBL; BC065931; AAH65931.1; -; mRNA.
DR   EMBL; X70991; CAA50318.1; -; mRNA.
DR   EMBL; AJ011081; CAA09472.1; -; Genomic_DNA.
DR   CCDS; CCDS81701.1; -. [Q15742-3]
DR   CCDS; CCDS8930.1; -. [Q15742-1]
DR   RefSeq; NP_001317234.1; NM_001330305.1. [Q15742-3]
DR   RefSeq; NP_005958.1; NM_005967.3. [Q15742-1]
DR   UniGene; Hs.159223; -.
DR   ProteinModelPortal; Q15742; -.
DR   SMR; Q15742; -.
DR   BioGrid; 110747; 45.
DR   IntAct; Q15742; 68.
DR   MINT; Q15742; -.
DR   STRING; 9606.ENSP00000300131; -.
DR   iPTMnet; Q15742; -.
DR   PhosphoSitePlus; Q15742; -.
DR   BioMuta; NAB2; -.
DR   DMDM; 12643729; -.
DR   EPD; Q15742; -.
DR   MaxQB; Q15742; -.
DR   PaxDb; Q15742; -.
DR   PeptideAtlas; Q15742; -.
DR   PRIDE; Q15742; -.
DR   Ensembl; ENST00000300131; ENSP00000300131; ENSG00000166886. [Q15742-1]
DR   Ensembl; ENST00000342556; ENSP00000341491; ENSG00000166886. [Q15742-3]
DR   GeneID; 4665; -.
DR   KEGG; hsa:4665; -.
DR   UCSC; uc001smz.3; human. [Q15742-1]
DR   CTD; 4665; -.
DR   DisGeNET; 4665; -.
DR   EuPathDB; HostDB:ENSG00000166886.12; -.
DR   GeneCards; NAB2; -.
DR   HGNC; HGNC:7627; NAB2.
DR   HPA; CAB004510; -.
DR   HPA; HPA027464; -.
DR   MalaCards; NAB2; -.
DR   MIM; 602381; gene.
DR   neXtProt; NX_Q15742; -.
DR   OpenTargets; ENSG00000166886; -.
DR   Orphanet; 2126; Solitary fibrous tumor.
DR   PharmGKB; PA31432; -.
DR   eggNOG; KOG3835; Eukaryota.
DR   eggNOG; ENOG410YKFH; LUCA.
DR   GeneTree; ENSGT00390000006330; -.
DR   HOGENOM; HOG000026777; -.
DR   HOVERGEN; HBG003127; -.
DR   InParanoid; Q15742; -.
DR   OMA; HARTNAD; -.
DR   OrthoDB; EOG091G0NQE; -.
DR   PhylomeDB; Q15742; -.
DR   TreeFam; TF315501; -.
DR   SIGNOR; Q15742; -.
DR   ChiTaRS; NAB2; human.
DR   GeneWiki; NAB2; -.
DR   GenomeRNAi; 4665; -.
DR   PRO; PR:Q15742; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000166886; -.
DR   CleanEx; HS_NAB2; -.
DR   Genevisible; Q15742; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0001958; P:endochondral ossification; IEA:Ensembl.
DR   GO; GO:0042552; P:myelination; IEA:Ensembl.
DR   GO; GO:0016480; P:negative regulation of transcription from RNA polymerase III promoter; IDA:MGI.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:1902949; P:positive regulation of tau-protein kinase activity; ISS:ARUK-UCL.
DR   GO; GO:0045682; P:regulation of epidermis development; IEA:Ensembl.
DR   GO; GO:0014037; P:Schwann cell differentiation; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR006989; NAB_co-repressor_dom.
DR   InterPro; IPR006988; Nab_N.
DR   Pfam; PF04904; NCD1; 1.
DR   Pfam; PF04905; NCD2; 1.
DR   ProDom; PD342192; Nab_N; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    525       NGFI-A-binding protein 2.
FT                                /FTId=PRO_0000077042.
FT   REGION       35    113       NCD1.
FT   REGION      267    356       NCD2.
FT   REGION      353    384       Necessary for nuclear localization.
FT                                {ECO:0000250}.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     157    157       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61127}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     171    171       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     479    479       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61127}.
FT   CROSSLNK    379    379       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000269|PubMed:21836637}.
FT   CROSSLNK    517    517       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000269|PubMed:21836637}.
FT   CROSSLNK    517    517       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     320    322       LTI -> ASP (in isoform 2).
FT                                {ECO:0000303|PubMed:8668170}.
FT                                /FTId=VSP_003385.
FT   VAR_SEQ     323    525       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8668170}.
FT                                /FTId=VSP_003386.
FT   VAR_SEQ     426    489       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_003387.
FT   CONFLICT    257    258       PR -> Q (in Ref. 6 and 7). {ECO:0000305}.
SQ   SEQUENCE   525 AA;  56594 MW;  38CF6CFEFE3756F9 CRC64;
     MHRAPSPTAE QPPGGGDSAR RTLQPRLKPS ARAMALPRTL GELQLYRVLQ RANLLSYYET
     FIQQGGDDVQ QLCEAGEEEF LEIMALVGMA TKPLHVRRLQ KALREWATNP GLFSQPVPAV
     PVSSIPLFKI SETAGTRKGS MSNGHGSPGE KAGSARSFSP KSPLELGEKL SPLPGGPGAG
     DPRIWPGRST PESDVGAGGE EEAGSPPFSP PAGGGVPEGT GAGGLAAGGT GGGPDRLEPE
     MVRMVVESVE RIFRSFPRGD AGEVTSLLKL NKKLARSVGH IFEMDDNDSQ KEEEIRKYSI
     IYGRFDSKRR EGKQLSLHEL TINEAAAQFC MRDNTLLLRR VELFSLSRQV ARESTYLSSL
     KGSRLHPEEL GGPPLKKLKQ EVGEQSHPEI QQPPPGPESY VPPYRPSLEE DSASLSGESL
     DGHLQAVGSC PRLTPPPADL PLALPAHGLW SRHILQQTLM DEGLRLARLV SHDRVGRLSP
     CVPAKPPLAE FEEGLLDRCP APGPHPALVE GRRSSVKVEA EASRQ
//
ID   A0A024QZI5_HUMAN        Unreviewed;       614 AA.
AC   A0A024QZI5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 32.
DE   SubName: Full=Nuclear receptor coactivator 4, isoform CRA_a {ECO:0000313|EMBL:EAW53688.1};
GN   Name=NCOA4 {ECO:0000313|EMBL:EAW53688.1};
GN   ORFNames=hCG_1982904 {ECO:0000313|EMBL:EAW53688.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW53688.1};
RN   [1] {ECO:0000313|EMBL:EAW53688.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW53688.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471260; EAW53687.1; -; Genomic_DNA.
DR   EMBL; CH471260; EAW53688.1; -; Genomic_DNA.
DR   RefSeq; NP_001138734.1; NM_001145262.1.
DR   RefSeq; NP_001138735.1; NM_001145263.1.
DR   RefSeq; NP_005428.1; NM_005437.3.
DR   UniGene; Hs.643658; -.
DR   UniGene; Hs.709644; -.
DR   SMR; A0A024QZI5; -.
DR   GeneID; 8031; -.
DR   KEGG; hsa:8031; -.
DR   CTD; 8031; -.
DR   EuPathDB; HostDB:ENSG00000266412.5; -.
DR   eggNOG; ENOG410IHT6; Eukaryota.
DR   eggNOG; ENOG410YJ5B; LUCA.
DR   KO; K09289; -.
DR   ChiTaRS; NCOA4; human.
DR   GenomeRNAi; 8031; -.
DR   Bgee; ENSG00000266412; -.
DR   InterPro; IPR022174; ARA70.
DR   Pfam; PF12489; ARA70; 2.
PE   4: Predicted;
KW   Receptor {ECO:0000313|EMBL:EAW53688.1}.
SQ   SEQUENCE   614 AA;  69726 MW;  36B6D97C7D072BFF CRC64;
     MNTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL
     ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV
     CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE
     KRGCISMPEQ KSASGIVAVP FSEWLLGSKP ASGYQAPYIP STDPQDWLTQ KQTLENSQTS
     SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD
     LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTDSCTNC QGNQPKGVEI
     ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE
     NCEKEALYKW LLKKEGKDKN GMPVEPKPEP EKHKDSLNMW LCPRKEVIEQ TKAPKAMTPS
     RIADSFQVIK NSPLSEWLIR PPYKEGSPKE VPGTEDRAGK QKFKSPMNTS WCSFNTADWV
     LPGKKMGNLS QLSSGEDKWL LRKKAQEVLL NSPLQEEHNF PPDHYGLPAV CDLFACMQLK
     VDKEKWLYRT PLQM
//
ID   B2R5V0_HUMAN            Unreviewed;       614 AA.
AC   B2R5V0;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   31-JAN-2018, entry version 38.
DE   SubName: Full=cDNA, FLJ92637, highly similar to Homo sapiens nuclear receptor coactivator 4 (NCOA4), mRNA {ECO:0000313|EMBL:BAG35247.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG35247.1};
RN   [1] {ECO:0000313|EMBL:BAG35247.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAG35247.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK312325; BAG35247.1; -; mRNA.
DR   RefSeq; NP_001138735.1; NM_001145263.1.
DR   UniGene; Hs.643658; -.
DR   UniGene; Hs.709644; -.
DR   PeptideAtlas; B2R5V0; -.
DR   DNASU; 8031; -.
DR   GeneID; 8031; -.
DR   CTD; 8031; -.
DR   PharmGKB; PA31473; -.
DR   eggNOG; ENOG410IHT6; Eukaryota.
DR   eggNOG; ENOG410YJ5B; LUCA.
DR   HOVERGEN; HBG052584; -.
DR   GenomeRNAi; 8031; -.
DR   Genevisible; B2R5V0; HS.
DR   InterPro; IPR022174; ARA70.
DR   Pfam; PF12489; ARA70; 2.
PE   2: Evidence at transcript level;
KW   Receptor {ECO:0000313|EMBL:BAG35247.1}.
SQ   SEQUENCE   614 AA;  69779 MW;  781C7862CA0D4311 CRC64;
     MNTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL
     ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV
     CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE
     KRGRISMPEQ KSASGIVAVP FSEWLLGSKP ASGYQAPYIP STDPQDWLTQ KQTLENSQTS
     SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD
     LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTDSCTNC QGNQPKGVEI
     ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE
     NCEKEALYKW LLKKEGKDKN GMPVEPKPEP EKHKDSLNMW LCPRKEVIEQ TKAPKAMTPS
     RIADSFQVIK NSPLSEWLIR PPYKEGSPKE VPGTEDRAGK QKFKSPMNTS WCSFNTADWV
     LPGKKMGNLS QLSSGEDKWL LRKKAQEVLL NSPLQEEHNF PPDHYGLPAV CDLFACMQLK
     VDKEKWLYRT PLQM
//
ID   NCOA4_HUMAN             Reviewed;         614 AA.
AC   Q13772; A8K8W5; B4E260; E9PAV7; J3KQN8; Q14239;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-FEB-2018, entry version 178.
DE   RecName: Full=Nuclear receptor coactivator 4;
DE            Short=NCoA-4;
DE   AltName: Full=Androgen receptor coactivator 70 kDa protein;
DE            Short=70 kDa AR-activator;
DE            Short=70 kDa androgen receptor coactivator;
DE   AltName: Full=Androgen receptor-associated protein of 70 kDa;
DE   AltName: Full=Ret-activating protein ELE1;
GN   Name=NCOA4; Synonyms=ARA70, ELE1, RFG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Prostatic carcinoma;
RX   PubMed=8643607; DOI=10.1073/pnas.93.11.5517;
RA   Yeh S., Chang C.;
RT   "Cloning and characterization of a specific coactivator, ARA70, for
RT   the androgen receptor in human prostate cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:5517-5521(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL REARRANGEMENT WITH RET.
RC   TISSUE=Thyroid;
RX   PubMed=8290261;
RA   Santoro M., Dathan N.A., Berlingieri M.T., Bongarzone I., Paulin C.,
RA   Grieco M., Pierotti M.A., Vecchio G., Fusco A.;
RT   "Molecular characterization of RET/PTC3; a novel rearranged version of
RT   the RETproto-oncogene in a human thyroid papillary carcinoma.";
RL   Oncogene 9:509-516(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS ALPHA; 3 AND 4).
RC   TISSUE=Testis, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-238, AND CHROMOSOMAL REARRANGEMENT
RP   WITH RET.
RC   TISSUE=Thyroid tumor;
RX   PubMed=8187085;
RA   Bongarzone I., Butti M.G., Coronelli S., Borrello M.G., Santoro M.,
RA   Mondellini P., Pilotti S., Fusco A., Della Porta G., Pierotti M.A.;
RT   "Frequent activation of ret protooncogene by fusion with a new
RT   activating gene in papillary thyroid carcinomas.";
RL   Cancer Res. 54:2979-2985(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA), AND VARIANTS
RP   LEU-94; LEU-154; ARG-350 AND PRO-561.
RC   TISSUE=Cervix carcinoma, Mammary cancer, and Prostatic carcinoma;
RX   PubMed=9892017; DOI=10.1210/mend.13.1.0214;
RA   Alen P., Claessens F., Schoenmakers E., Swinnen J.V., Verhoeven G.,
RA   Rombauts W., Peeters B.;
RT   "Interaction of the putative androgen receptor-specific coactivator
RT   ARA70/ELE1alpha with multiple steroid receptors and identification of
RT   an internally deleted ELE1beta isoform.";
RL   Mol. Endocrinol. 13:117-128(1999).
RN   [10]
RP   FUNCTION.
RX   PubMed=10347167; DOI=10.1074/jbc.274.23.16147;
RA   Heinlein C.A., Ting H.-J., Yeh S., Chang C.;
RT   "Identification of ARA70 as a ligand-enhanced coactivator for the
RT   peroxisome proliferator-activated receptor gamma.";
RL   J. Biol. Chem. 274:16147-16152(1999).
CC   -!- FUNCTION: Enhances the androgen receptor transcriptional activity
CC       in prostate cancer cells. Ligand-independent coactivator of the
CC       peroxisome proliferator-activated receptor (PPAR) gamma.
CC       {ECO:0000269|PubMed:10347167}.
CC   -!- SUBUNIT: Interacts with the androgen receptor and the retinoid X
CC       receptor (RXR) in a ligand-dependent manner.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Alpha;
CC         IsoId=Q13772-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=Q13772-2; Sequence=VSP_003409;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q13772-3; Sequence=VSP_046348;
CC         Note=No experimental confirmation available. Ref.3 (BAG65022)
CC         sequence is in conflict in position: 8:F->V. {ECO:0000305};
CC       Name=4;
CC         IsoId=Q13772-4; Sequence=VSP_046348, VSP_046349;
CC         Note=No experimental confirmation available. Ref.3 (AK310849)
CC         sequence is in conflict in position: 8:F->V. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Widely expressed. Also detected in adipose
CC       tissues and in different cell lines. Isoform Beta is only
CC       expressed in testis.
CC   -!- DISEASE: Note=A chromosomal aberration involving NCOA4 is found in
CC       papillary thyroid carcinomas (PTCs). Inversion
CC       inv(10)(q11.2;q11.2) generates the RET/NCOA4 (PTC3) oncogene.
CC       {ECO:0000269|PubMed:8187085, ECO:0000269|PubMed:8290261}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NCOA4ID218ch10q11.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L49399; AAC37591.1; -; mRNA.
DR   EMBL; X77548; CAA54673.1; -; mRNA.
DR   EMBL; AK292480; BAF85169.1; -; mRNA.
DR   EMBL; AK304123; BAG65022.1; -; mRNA.
DR   EMBL; AK310849; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL162047; CAB82390.1; -; mRNA.
DR   EMBL; AL450342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471260; EAW53686.1; -; Genomic_DNA.
DR   EMBL; BC001562; AAH01562.1; -; mRNA.
DR   EMBL; X71413; CAA50536.1; -; mRNA.
DR   CCDS; CCDS73092.1; -. [Q13772-1]
DR   CCDS; CCDS73093.1; -. [Q13772-3]
DR   CCDS; CCDS73094.1; -. [Q13772-4]
DR   PIR; S61532; S61532.
DR   RefSeq; NP_001138732.1; NM_001145260.1. [Q13772-4]
DR   RefSeq; NP_001138733.1; NM_001145261.1. [Q13772-3]
DR   RefSeq; NP_001138734.1; NM_001145262.1. [Q13772-1]
DR   RefSeq; NP_001138735.1; NM_001145263.1. [Q13772-1]
DR   RefSeq; NP_005428.1; NM_005437.3. [Q13772-1]
DR   UniGene; Hs.643658; -.
DR   UniGene; Hs.709644; -.
DR   PDB; 1T5Z; X-ray; 2.30 A; B=322-336.
DR   PDBsum; 1T5Z; -.
DR   ProteinModelPortal; Q13772; -.
DR   SMR; Q13772; -.
DR   BioGrid; 113726; 34.
DR   DIP; DIP-5957N; -.
DR   IntAct; Q13772; 12.
DR   STRING; 9606.ENSP00000395465; -.
DR   iPTMnet; Q13772; -.
DR   PhosphoSitePlus; Q13772; -.
DR   BioMuta; NCOA4; -.
DR   DMDM; 8928226; -.
DR   MaxQB; Q13772; -.
DR   PaxDb; Q13772; -.
DR   PeptideAtlas; Q13772; -.
DR   PRIDE; Q13772; -.
DR   DNASU; 8031; -.
DR   Ensembl; ENST00000578454; ENSP00000463027; ENSG00000266412. [Q13772-4]
DR   Ensembl; ENST00000579039; ENSP00000463455; ENSG00000266412. [Q13772-3]
DR   Ensembl; ENST00000581486; ENSP00000462943; ENSG00000266412. [Q13772-1]
DR   Ensembl; ENST00000583565; ENSP00000463476; ENSG00000266412. [Q13772-1]
DR   Ensembl; ENST00000585132; ENSP00000464054; ENSG00000266412. [Q13772-1]
DR   GeneID; 8031; -.
DR   KEGG; hsa:8031; -.
DR   UCSC; uc001jis.5; human. [Q13772-1]
DR   CTD; 8031; -.
DR   DisGeNET; 8031; -.
DR   EuPathDB; HostDB:ENSG00000266412.5; -.
DR   GeneCards; NCOA4; -.
DR   HGNC; HGNC:7671; NCOA4.
DR   HPA; HPA051260; -.
DR   HPA; HPA065208; -.
DR   MalaCards; NCOA4; -.
DR   MIM; 601984; gene.
DR   neXtProt; NX_Q13772; -.
DR   OpenTargets; ENSG00000266412; -.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   PharmGKB; PA31473; -.
DR   eggNOG; ENOG410IHT6; Eukaryota.
DR   eggNOG; ENOG410YJ5B; LUCA.
DR   GeneTree; ENSGT00390000008403; -.
DR   HOGENOM; HOG000013175; -.
DR   HOVERGEN; HBG052584; -.
DR   InParanoid; Q13772; -.
DR   KO; K09289; -.
DR   OMA; PLQEEHN; -.
DR   OrthoDB; EOG091G049Z; -.
DR   PhylomeDB; Q13772; -.
DR   TreeFam; TF333204; -.
DR   SIGNOR; Q13772; -.
DR   ChiTaRS; NCOA4; human.
DR   EvolutionaryTrace; Q13772; -.
DR   GeneWiki; NCOA4; -.
DR   GenomeRNAi; 8031; -.
DR   PRO; PR:Q13772; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000266412; -.
DR   CleanEx; HS_NCOA4; -.
DR   ExpressionAtlas; Q13772; baseline and differential.
DR   Genevisible; Q13772; HS.
DR   GO; GO:0044754; C:autolysosome; IDA:MGI.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; TAS:ProtInc.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0006622; P:protein targeting to lysosome; IDA:MGI.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR022174; ARA70.
DR   Pfam; PF12489; ARA70; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Polymorphism;
KW   Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    614       Nuclear receptor coactivator 4.
FT                                /FTId=PRO_0000094410.
FT   SITE        238    239       Breakpoint for rearrangement to form
FT                                RET/PTC3 oncogene.
FT   VAR_SEQ       1      1       M -> MGAQLTTFALAGAVRRM (in isoform 3 and
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046348.
FT   VAR_SEQ     239    565       Missing (in isoform Beta).
FT                                {ECO:0000303|PubMed:9892017}.
FT                                /FTId=VSP_003409.
FT   VAR_SEQ     614    614       M -> AYFKMNFQDVTVGNFQIPCGF (in isoform
FT                                4). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046349.
FT   VARIANT      94     94       S -> L. {ECO:0000269|PubMed:9892017}.
FT                                /FTId=VAR_009190.
FT   VARIANT     154    154       F -> L. {ECO:0000269|PubMed:9892017}.
FT                                /FTId=VAR_009191.
FT   VARIANT     350    350       C -> R. {ECO:0000269|PubMed:9892017}.
FT                                /FTId=VAR_009192.
FT   VARIANT     474    474       P -> R (in dbSNP:rs1132111).
FT                                /FTId=VAR_014928.
FT   VARIANT     561    561       L -> P. {ECO:0000269|PubMed:9892017}.
FT                                /FTId=VAR_009193.
FT   MUTAGEN      95     96       LL->AA: Decreased interaction with PPAR
FT                                and RXR.
FT   CONFLICT     71     71       Y -> H (in Ref. 3; BAG65022).
FT                                {ECO:0000305}.
FT   CONFLICT    162    162       I -> T (in Ref. 8; CAA50536).
FT                                {ECO:0000305}.
FT   CONFLICT    183    183       G -> S (in Ref. 8; CAA50536).
FT                                {ECO:0000305}.
FT   CONFLICT    271    271       K -> R (in Ref. 3; AK310849).
FT                                {ECO:0000305}.
FT   HELIX       327    333       {ECO:0000244|PDB:1T5Z}.
SQ   SEQUENCE   614 AA;  69726 MW;  36B6D97C7D072BFF CRC64;
     MNTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL
     ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV
     CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE
     KRGCISMPEQ KSASGIVAVP FSEWLLGSKP ASGYQAPYIP STDPQDWLTQ KQTLENSQTS
     SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD
     LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTDSCTNC QGNQPKGVEI
     ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE
     NCEKEALYKW LLKKEGKDKN GMPVEPKPEP EKHKDSLNMW LCPRKEVIEQ TKAPKAMTPS
     RIADSFQVIK NSPLSEWLIR PPYKEGSPKE VPGTEDRAGK QKFKSPMNTS WCSFNTADWV
     LPGKKMGNLS QLSSGEDKWL LRKKAQEVLL NSPLQEEHNF PPDHYGLPAV CDLFACMQLK
     VDKEKWLYRT PLQM
//
ID   Q96E88_HUMAN            Unreviewed;       575 AA.
AC   Q96E88;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   31-JAN-2018, entry version 90.
DE   SubName: Full=NCOA4 protein {ECO:0000313|EMBL:AAH12736.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH12736.1};
RN   [1] {ECO:0000313|EMBL:AAH12736.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta {ECO:0000313|EMBL:AAH12736.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC012736; AAH12736.1; -; mRNA.
DR   RefSeq; NP_001138732.1; NM_001145260.1.
DR   RefSeq; NP_001138733.1; NM_001145261.1.
DR   RefSeq; NP_001138734.1; NM_001145262.1.
DR   RefSeq; NP_001138735.1; NM_001145263.1.
DR   RefSeq; NP_005428.1; NM_005437.3.
DR   UniGene; Hs.643658; -.
DR   UniGene; Hs.709644; -.
DR   ProteinModelPortal; Q96E88; -.
DR   IntAct; Q96E88; 3.
DR   MaxQB; Q96E88; -.
DR   PeptideAtlas; Q96E88; -.
DR   PRIDE; Q96E88; -.
DR   DNASU; 8031; -.
DR   GeneID; 8031; -.
DR   KEGG; hsa:8031; -.
DR   CTD; 8031; -.
DR   PharmGKB; PA31473; -.
DR   eggNOG; ENOG410IHT6; Eukaryota.
DR   eggNOG; ENOG410YJ5B; LUCA.
DR   HOGENOM; HOG000013175; -.
DR   HOVERGEN; HBG052584; -.
DR   KO; K09289; -.
DR   GenomeRNAi; 8031; -.
DR   Genevisible; Q96E88; HS.
DR   InterPro; IPR022174; ARA70.
DR   Pfam; PF12489; ARA70; 2.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   575 AA;  65295 MW;  E5E449EF7CED5F3D CRC64;
     MNTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL
     ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV
     CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE
     KRGCISMPEQ KSASGIVAVP FSEWLLGSKP ASGYQAPYIP STDPQDWLTQ KQTLENSQTS
     SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD
     LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTDSCTNC QGNQPKGVEI
     ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE
     NCEKEALYKW LLKKEGKDKN GMPVEPKPEP EKHKDSLNMW LCPRKEVIEQ TKAPKAMTPS
     RIADSFQVIK NSPLSEWLIR PPYKEGSPKE VPGTEDRAGK QKYYLIHLYR RNITSPQTIM
     ASLQFVISLP VCSLKLIKRS GYIELLYRCE GMDKS
//
ID   B3KWB2_HUMAN            Unreviewed;       205 AA.
AC   B3KWB2;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 52.
DE   SubName: Full=cDNA FLJ42719 fis, clone BRAMY3010492, highly similar to Protein NDRG1 {ECO:0000313|EMBL:BAG54074.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54074.1};
RN   [1] {ECO:0000313|EMBL:BAG54074.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAG54074.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK124709; BAG54074.1; -; mRNA.
DR   RefSeq; XP_011515094.1; XM_011516792.1.
DR   UniGene; Hs.372914; -.
DR   UniGene; Hs.618002; -.
DR   ProteinModelPortal; B3KWB2; -.
DR   SMR; B3KWB2; -.
DR   ESTHER; human-NDRG1; Ndr_family.
DR   PeptideAtlas; B3KWB2; -.
DR   PRIDE; B3KWB2; -.
DR   GeneID; 10397; -.
DR   CTD; 10397; -.
DR   eggNOG; KOG2931; Eukaryota.
DR   eggNOG; ENOG410XSPF; LUCA.
DR   HOVERGEN; HBG052591; -.
DR   GenomeRNAi; 10397; -.
DR   GO; GO:0045576; P:mast cell activation; IEA:InterPro.
DR   GO; GO:0032287; P:peripheral nervous system myelin maintenance; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:InterPro.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR004142; NDRG.
DR   InterPro; IPR030693; NDRG1.
DR   PANTHER; PTHR11034; PTHR11034; 1.
DR   PANTHER; PTHR11034:SF18; PTHR11034:SF18; 1.
DR   Pfam; PF03096; Ndr; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   205 AA;  22079 MW;  3F215ECBAAC88105 CRC64;
     MVVSHLFGKE EMQSNVEVVH TYRQHIVNDM NPGNLHLFIN AYNSRRDLEI ERPMPGTHTV
     TLQCPALLVV GDSSPAVDAV VECNSKLDPT KTTLLKMADC GGLPQISQPA KLAEAFKYFV
     QGMGYMPSAS MTRLMRSRTA SGSSVTSLDG TRSRSHTSEG TRSRSHTSEG TRSRSHTSEG
     AHLDITPNSG AAGNSAGPKS MEVSC
//
ID   Q8N959_HUMAN            Unreviewed;       323 AA.
AC   Q8N959;
DT   01-OCT-2002, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2002, sequence version 1.
DT   28-FEB-2018, entry version 79.
DE   SubName: Full=cDNA FLJ38330 fis, clone FCBBF3025280, highly similar to NDRG1 PROTEIN {ECO:0000313|EMBL:BAC04597.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAC04597.1};
RN   [1] {ECO:0000313|EMBL:BAC04597.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAC04597.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK095649; BAC04597.1; -; mRNA.
DR   RefSeq; NP_001245361.1; NM_001258432.1.
DR   RefSeq; NP_001245362.1; NM_001258433.1.
DR   UniGene; Hs.372914; -.
DR   UniGene; Hs.618002; -.
DR   ProteinModelPortal; Q8N959; -.
DR   ESTHER; human-NDRG1; Ndr_family.
DR   PeptideAtlas; Q8N959; -.
DR   PRIDE; Q8N959; -.
DR   GeneID; 10397; -.
DR   CTD; 10397; -.
DR   eggNOG; KOG2931; Eukaryota.
DR   eggNOG; ENOG410XSPF; LUCA.
DR   HOVERGEN; HBG052591; -.
DR   GenomeRNAi; 10397; -.
DR   GO; GO:0045576; P:mast cell activation; IEA:InterPro.
DR   GO; GO:0032287; P:peripheral nervous system myelin maintenance; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:InterPro.
DR   Gene3D; 3.40.50.1820; -; 2.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR004142; NDRG.
DR   InterPro; IPR030693; NDRG1.
DR   PANTHER; PTHR11034; PTHR11034; 2.
DR   PANTHER; PTHR11034:SF18; PTHR11034:SF18; 2.
DR   Pfam; PF03096; Ndr; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   323 AA;  35226 MW;  EA130D129F3B92E8 CRC64;
     MSREMQDVDL AEVKPLVEKG ETITGLLQEF DVQEQDIETL HGSVHVTLCG TPKGNRPVIL
     TYHDIGMNHK TCYILTRFAL NNPEMVEGLV LINVNPCAEG WMDWAASKIS GWTQALPDMV
     VSHLFGKEEM QSNVEVVHTY RQHIVNDMNP GNLHLFINAY NSRRDLEIER PMPGTHTVTL
     QCPALLVVGD SSPAVDAVVE CNSKLDPTKT TLLKMADCGG LPQISQPAKL AEAFKYFVQG
     MGYMPSASMT RLMRSRTASG SSVTSLDGTR SRSHTSEGTR SRSHTSEGTR SRSHTSEGAH
     LDITPNSGAA GNSAGPKSME VSC
//
ID   NDRG1_HUMAN             Reviewed;         394 AA.
AC   Q92597; B3KR80; B7Z446; O15207; Q6IBG2; Q9NYR6; Q9UK29;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   28-FEB-2018, entry version 173.
DE   RecName: Full=Protein NDRG1;
DE   AltName: Full=Differentiation-related gene 1 protein;
DE            Short=DRG-1;
DE   AltName: Full=N-myc downstream-regulated gene 1 protein;
DE   AltName: Full=Nickel-specific induction protein Cap43;
DE   AltName: Full=Reducing agents and tunicamycin-responsive protein;
DE            Short=RTP;
DE   AltName: Full=Rit42;
GN   Name=NDRG1; Synonyms=CAP43, DRG1, RTP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=8939898; DOI=10.1074/jbc.271.47.29659;
RA   Kokame K., Kato H., Miyata T.;
RT   "Homocysteine-respondent genes in vascular endothelial cells
RT   identified by differential display analysis. GRP78/BiP and novel
RT   genes.";
RL   J. Biol. Chem. 271:29659-29665(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9251681;
RA   van Belzen N., Dinjens W.N.M., Diesveld M.P.G., Groen N.A.,
RA   van der Made A.C.J., Nozawa Y., Vlietstra R., Trapman J., Bosman F.T.;
RT   "A novel gene which is up-regulated during colon epithelial cell
RT   differentiation and down-regulated in colorectal neoplasms.";
RL   Lab. Invest. 77:85-92(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   INDUCTION.
RC   TISSUE=Lung;
RX   PubMed=9605764;
RA   Zhou D., Salnikow K., Costa M.;
RT   "Cap43, a novel gene specifically induced by Ni2+ compounds.";
RL   Cancer Res. 58:2182-2189(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INDUCTION.
RX   PubMed=10395947; DOI=10.1016/S0167-4889(99)00056-7;
RA   Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., Commes T.;
RT   "Differential expression of the RTP/Drg1/Ndr1 gene product in
RT   proliferating and growth arrested cells.";
RL   Biochim. Biophys. Acta 1450:364-373(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-21 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Angelicheva D., Kalaydjieva L.;
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 4-19; 54-70; 133-148; 199-212; 286-300; 307-322;
RP   328-341 AND 364-388, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=9766676;
RA   Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A.,
RA   Lee S.W.;
RT   "Inhibition of tumor cell growth by RTP/rit42 and its responsiveness
RT   to p53 and DNA damage.";
RL   Cancer Res. 58:4439-4444(1998).
RN   [13]
RP   INVOLVEMENT IN CMT4D.
RX   PubMed=10831399; DOI=10.1086/302978;
RA   Kalaydjieva L., Gresham D., Gooding R., Heather L., Baas F.,
RA   de Jonge R., Blechschmidt K., Angelicheva D., Chandler D., Worsley P.,
RA   Rosenthal A., King R.H.M., Thomas P.K.;
RT   "N-myc downstream-regulated gene 1 is mutated in hereditary motor and
RT   sensory neuropathy-Lom.";
RL   Am. J. Hum. Genet. 67:47-58(2000).
RN   [14]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=10860807; DOI=10.1006/bbrc.2000.2833;
RA   Agarwala K.L., Kokame K., Kato H., Miyata T.;
RT   "Phosphorylation of RTP, an ER stress-responsive cytoplasmic
RT   protein.";
RL   Biochem. Biophys. Res. Commun. 272:641-647(2000).
RN   [15]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12432451; DOI=10.1007/s00418-002-0460-9;
RA   Lachat P., Shaw P., Gebhard S., van Belzen N., Chaubert P.,
RA   Bosman F.T.;
RT   "Expression of NDRG1, a differentiation-related gene, in human
RT   tissues.";
RL   Histochem. Cell Biol. 118:399-408(2002).
RN   [16]
RP   PHOSPHORYLATION AT THR-328; SER-330; THR-346; THR-356 AND THR-366.
RX   PubMed=15461589; DOI=10.1042/BJ20041057;
RA   Murray J.T., Campbell D.G., Morrice N., Auld G.C., Shpiro N.,
RA   Marquez R., Peggie M., Bain J., Bloomberg G.B., Grahammer F., Lang F.,
RA   Wulff P., Kuhl D., Cohen P.;
RT   "Exploitation of KESTREL to identify NDRG family members as
RT   physiological substrates for SGK1 and GSK3.";
RL   Biochem. J. 384:477-488(2004).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15247272; DOI=10.1074/jbc.M400781200;
RA   Kim K.T., Ongusaha P.P., Hong Y.K., Kurdistani S.K., Nakamura M.,
RA   Lu K.P., Lee S.W.;
RT   "Function of Drg1/Rit42 in p53-dependent mitotic spindle checkpoint.";
RL   J. Biol. Chem. 279:38597-38602(2004).
RN   [18]
RP   FUNCTION.
RX   PubMed=15377670; DOI=10.1074/jbc.M400386200;
RA   Stein S., Thomas E.K., Herzog B., Westfall M.D., Rocheleau J.V.,
RA   Jackson R.S. II, Wang M., Liang P.;
RT   "NDRG1 is necessary for p53-dependent apoptosis.";
RL   J. Biol. Chem. 279:48930-48940(2004).
RN   [19]
RP   INTERACTION WITH APOA1; APOA2; PRA1 AND RTN1, AND POSSIBLE FUNCTION.
RX   PubMed=15922294; DOI=10.1016/j.bbrc.2005.05.050;
RA   Hunter M., Angelicheva D., Tournev I., Ingley E., Chan D.C.,
RA   Watts G.F., Kremensky I., Kalaydjieva L.;
RT   "NDRG1 interacts with APO A-I and A-II and is a functional candidate
RT   for the HDL-C QTL on 8q24.";
RL   Biochem. Biophys. Res. Commun. 332:982-992(2005).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330 AND SER-333, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [23]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=17316623; DOI=10.1016/j.febslet.2007.01.080;
RA   Sibold S., Roh V., Keogh A., Studer P., Tiffon C., Angst E.,
RA   Vorburger S.A., Weimann R., Candinas D., Stroka D.;
RT   "Hypoxia increases cytoplasmic expression of NDRG1, but is
RT   insufficient for its membrane localization in human hepatocellular
RT   carcinoma.";
RL   FEBS Lett. 581:989-994(2007).
RN   [24]
RP   INTERACTION WITH RAB4A, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=17786215; DOI=10.1371/journal.pone.0000844;
RA   Kachhap S.K., Faith D., Qian D.Z., Shabbeer S., Galloway N.L.,
RA   Pili R., Denmeade S.R., DeMarzo A.M., Carducci M.A.;
RT   "The N-Myc down regulated Gene1 (NDRG1) is a Rab4a effector involved
RT   in vesicular recycling of E-cadherin.";
RL   PLoS ONE 2:E844-E844(2007).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; SER-330; SER-333;
RP   SER-336; SER-364 AND THR-375, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [27]
RP   PHOSPHORYLATION AT THR-346; THR-356 AND THR-366.
RX   PubMed=18787837; DOI=10.1007/s00424-008-0587-1;
RA   Inglis S.K., Gallacher M., Brown S.G., McTavish N., Getty J.,
RA   Husband E.M., Murray J.T., Wilson S.M.;
RT   "SGK1 activity in Na+ absorbing airway epithelial cells monitored by
RT   assaying NDRG1-Thr346/356/366 phosphorylation.";
RL   Pflugers Arch. 457:1287-1301(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-328 AND SER-330, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=21708134; DOI=10.1016/j.bbrc.2011.06.092;
RA   McCaig C., Potter L., Abramczyk O., Murray J.T.;
RT   "Phosphorylation of NDRG1 is temporally and spatially controlled
RT   during the cell cycle.";
RL   Biochem. Biophys. Res. Commun. 411:227-234(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-328; SER-330;
RP   SER-333; SER-336; SER-364; THR-366 AND THR-375, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-328; SER-332 AND
RP   SER-333, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Stress-responsive protein involved in hormone responses,
CC       cell growth, and differentiation. Acts as a tumor suppressor in
CC       many cell types. Necessary but not sufficient for p53/TP53-
CC       mediated caspase activation and apoptosis. Has a role in cell
CC       trafficking, notably of the Schwann cell, and is necessary for the
CC       maintenance and development of the peripheral nerve myelin sheath.
CC       Required for vesicular recycling of CDH1 and TF. May also function
CC       in lipid trafficking. Protects cells from spindle disruption
CC       damage. Functions in p53/TP53-dependent mitotic spindle
CC       checkpoint. Regulates microtubule dynamics and maintains euploidy.
CC       {ECO:0000269|PubMed:15247272, ECO:0000269|PubMed:15377670,
CC       ECO:0000269|PubMed:17786215, ECO:0000269|PubMed:9766676}.
CC   -!- SUBUNIT: Interacts with RAB4A (membrane-bound form); the
CC       interaction involves NDRG1 in vesicular recycling of CDH1.
CC       {ECO:0000269|PubMed:15922294, ECO:0000269|PubMed:17786215}.
CC   -!- INTERACTION:
CC       Q9Y3D8:AK6; NbExp=3; IntAct=EBI-10278703, EBI-2896123;
CC       P27824:CANX; NbExp=2; IntAct=EBI-716486, EBI-355947;
CC       P12956:XRCC6; NbExp=2; IntAct=EBI-716486, EBI-353208;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome. Nucleus. Cell membrane.
CC       Note=Mainly cytoplasmic but differentially localized to other
CC       regions. Associates with the plasma membrane in intestinal
CC       epithelia and lactating mammary gland. Translocated to the nucleus
CC       in a p53/TP53-dependent manner. In prostate epithelium and
CC       placental chorion, located in both the cytoplasm and in the
CC       nucleus. No nuclear localization in colon epithelium cells. In
CC       intestinal mucosa, prostate and renal cortex, located
CC       predominantly adjacent to adherens junctions. Cytoplasmic with
CC       granular staining in proximal tubular cells of the kidney and
CC       salivary gland ducts. Recruits to the membrane of
CC       recycling/sorting and late endosomes via binding to
CC       phosphatidylinositol 4-phosphate. Associates with microtubules.
CC       Colocalizes with TUBG1 in the centrosome. Cytoplasmic location
CC       increased with hypoxia. Phosphorylated form found associated with
CC       centromeres during S-phase of mitosis and with the plasma
CC       membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q92597-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92597-2; Sequence=VSP_045038;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q92597-3; Sequence=VSP_045037;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; expressed most prominently in
CC       placental membranes and prostate, kidney, small intestine, and
CC       ovary tissues. Also expressed in heart, brain, skeletal muscle,
CC       lung, liver and pancreas. Low levels in peripheral blood
CC       leukocytes and in tissues of the immune system. Expressed mainly
CC       in epithelial cells. Also found in Schwann cells of peripheral
CC       neurons. Reduced expression in adenocarcinomas compared to normal
CC       tissues. In colon, prostate and placental membranes, the cells
CC       that border the lumen show the highest expression.
CC       {ECO:0000269|PubMed:12432451, ECO:0000269|PubMed:8939898,
CC       ECO:0000269|PubMed:9251681, ECO:0000269|PubMed:9605764}.
CC   -!- INDUCTION: By homocysteine, 2-mercaptoethanol, tunicamycin in
CC       endothelial cells. Induced approximately 20-fold during in vitro
CC       differentiation of the colon carcinoma cell lines HT-29-D4 and
CC       Caco-2. Induced by oxidative stress in colon cancers. Decreased
CC       expression in colon adenomas and adenocarcinomas. Induced by
CC       nickel compounds in all tested cell lines. The primary signal for
CC       its induction is an elevation of free intracellular calcium ion
CC       caused by nickel ion exposure. Okadaic acid, a serine/threonine
CC       phosphatase inhibitor, induced its expression more rapidly and
CC       more efficiently than nickel. {ECO:0000269|PubMed:10395947,
CC       ECO:0000269|PubMed:17316623, ECO:0000269|PubMed:8939898,
CC       ECO:0000269|PubMed:9251681, ECO:0000269|PubMed:9605764,
CC       ECO:0000269|PubMed:9766676}.
CC   -!- PTM: Under stress conditions, phosphorylated in the C-terminal on
CC       many serine and threonine residues. Phosphorylated in vitro by
CC       PKA. Phosphorylation enhanced by increased intracellular cAMP
CC       levels. Homocysteine induces dephosphorylation. Phosphorylation by
CC       SGK1 is cell cycle dependent. {ECO:0000269|PubMed:10860807,
CC       ECO:0000269|PubMed:15461589, ECO:0000269|PubMed:18787837,
CC       ECO:0000269|PubMed:21708134}.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 4D (CMT4D) [MIM:601455]: A
CC       recessive demyelinating form of Charcot-Marie-Tooth disease, a
CC       disorder of the peripheral nervous system, characterized by
CC       progressive weakness and atrophy, initially of the peroneal
CC       muscles and later of the distal muscles of the arms. Charcot-
CC       Marie-Tooth disease is classified in two main groups on the basis
CC       of electrophysiologic properties and histopathology: primary
CC       peripheral demyelinating neuropathies (designated CMT1 when they
CC       are dominantly inherited) and primary peripheral axonal
CC       neuropathies (CMT2). Demyelinating neuropathies are characterized
CC       by severely reduced nerve conduction velocities (less than 38
CC       m/sec), segmental demyelination and remyelination with onion bulb
CC       formations on nerve biopsy, slowly progressive distal muscle
CC       atrophy and weakness, absent deep tendon reflexes, and hollow
CC       feet. By convention autosomal recessive forms of demyelinating
CC       Charcot-Marie-Tooth disease are designated CMT4.
CC       {ECO:0000269|PubMed:10831399}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NDRG family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NDRG1ID41512ch8q24.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D87953; BAA13505.1; -; mRNA.
DR   EMBL; X92845; CAA63430.1; -; mRNA.
DR   EMBL; AF004162; AAC13419.1; -; mRNA.
DR   EMBL; AF186190; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR456842; CAG33123.1; -; mRNA.
DR   EMBL; AK091147; BAG52292.1; -; mRNA.
DR   EMBL; AK126924; BAG54400.1; -; mRNA.
DR   EMBL; AK296794; BAH12432.1; -; mRNA.
DR   EMBL; AF192304; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471060; EAW92164.1; -; Genomic_DNA.
DR   EMBL; BC003175; AAH03175.1; -; mRNA.
DR   EMBL; AF230380; AAF71305.1; -; mRNA.
DR   CCDS; CCDS34945.1; -. [Q92597-1]
DR   CCDS; CCDS59112.1; -. [Q92597-3]
DR   CCDS; CCDS59113.1; -. [Q92597-2]
DR   RefSeq; NP_001128714.1; NM_001135242.1. [Q92597-1]
DR   RefSeq; NP_001245361.1; NM_001258432.1. [Q92597-2]
DR   RefSeq; NP_001245362.1; NM_001258433.1. [Q92597-3]
DR   RefSeq; NP_006087.2; NM_006096.3. [Q92597-1]
DR   UniGene; Hs.372914; -.
DR   UniGene; Hs.618002; -.
DR   ProteinModelPortal; Q92597; -.
DR   SMR; Q92597; -.
DR   BioGrid; 115669; 111.
DR   IntAct; Q92597; 66.
DR   STRING; 9606.ENSP00000319977; -.
DR   ESTHER; human-NDRG1; Ndr_family.
DR   MEROPS; S33.988; -.
DR   iPTMnet; Q92597; -.
DR   PhosphoSitePlus; Q92597; -.
DR   SwissPalm; Q92597; -.
DR   BioMuta; NDRG1; -.
DR   DMDM; 6166568; -.
DR   EPD; Q92597; -.
DR   MaxQB; Q92597; -.
DR   PaxDb; Q92597; -.
DR   PeptideAtlas; Q92597; -.
DR   PRIDE; Q92597; -.
DR   TopDownProteomics; Q92597-1; -. [Q92597-1]
DR   DNASU; 10397; -.
DR   Ensembl; ENST00000323851; ENSP00000319977; ENSG00000104419. [Q92597-1]
DR   Ensembl; ENST00000414097; ENSP00000404854; ENSG00000104419. [Q92597-1]
DR   Ensembl; ENST00000522476; ENSP00000427894; ENSG00000104419. [Q92597-2]
DR   Ensembl; ENST00000537882; ENSP00000437443; ENSG00000104419. [Q92597-3]
DR   GeneID; 10397; -.
DR   KEGG; hsa:10397; -.
DR   UCSC; uc003yug.3; human. [Q92597-1]
DR   CTD; 10397; -.
DR   DisGeNET; 10397; -.
DR   EuPathDB; HostDB:ENSG00000104419.14; -.
DR   GeneCards; NDRG1; -.
DR   GeneReviews; NDRG1; -.
DR   HGNC; HGNC:7679; NDRG1.
DR   HPA; HPA006881; -.
DR   MalaCards; NDRG1; -.
DR   MIM; 601455; phenotype.
DR   MIM; 605262; gene.
DR   neXtProt; NX_Q92597; -.
DR   OpenTargets; ENSG00000104419; -.
DR   Orphanet; 99950; Charcot-Marie-Tooth disease type 4D.
DR   PharmGKB; PA31482; -.
DR   eggNOG; KOG2931; Eukaryota.
DR   eggNOG; ENOG410XSPF; LUCA.
DR   GeneTree; ENSGT00390000001874; -.
DR   HOGENOM; HOG000230891; -.
DR   HOVERGEN; HBG052591; -.
DR   InParanoid; Q92597; -.
DR   KO; K18266; -.
DR   OMA; NNVEVVH; -.
DR   OrthoDB; EOG091G09VW; -.
DR   PhylomeDB; Q92597; -.
DR   TreeFam; TF313168; -.
DR   Reactome; R-HSA-6803205; TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain.
DR   SIGNOR; Q92597; -.
DR   ChiTaRS; NDRG1; human.
DR   GeneWiki; NDRG1; -.
DR   GenomeRNAi; 10397; -.
DR   PRO; PR:Q92597; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000104419; -.
DR   CleanEx; HS_DRG1; -.
DR   CleanEx; HS_NDRG1; -.
DR   ExpressionAtlas; Q92597; baseline and differential.
DR   Genevisible; Q92597; HS.
DR   GO; GO:0005913; C:cell-cell adherens junction; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:UniProtKB.
DR   GO; GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IDA:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB.
DR   GO; GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IEP:UniProtKB.
DR   GO; GO:0045576; P:mast cell activation; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0032287; P:peripheral nervous system myelin maintenance; IEA:Ensembl.
DR   GO; GO:0090232; P:positive regulation of spindle checkpoint; IDA:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0010038; P:response to metal ion; TAS:ProtInc.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR004142; NDRG.
DR   InterPro; IPR030693; NDRG1.
DR   PANTHER; PTHR11034; PTHR11034; 1.
DR   PANTHER; PTHR11034:SF18; PTHR11034:SF18; 1.
DR   Pfam; PF03096; Ndr; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell membrane;
KW   Charcot-Marie-Tooth disease; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Membrane; Microtubule;
KW   Neurodegeneration; Neuropathy; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    394       Protein NDRG1.
FT                                /FTId=PRO_0000159573.
FT   REPEAT      339    348       1.
FT   REPEAT      349    358       2.
FT   REPEAT      359    368       3.
FT   REGION      339    368       3 X 10 AA tandem repeats of G-T-R-S-R-S-
FT                                H-T-S-E.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     319    319       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62433}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     328    328       Phosphothreonine; by SGK1.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:15461589}.
FT   MOD_RES     330    330       Phosphoserine; by SGK1.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:15461589}.
FT   MOD_RES     332    332       Phosphoserine; by SGK1.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     333    333       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     335    335       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q62433}.
FT   MOD_RES     336    336       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     340    340       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q62433}.
FT   MOD_RES     342    342       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62433}.
FT   MOD_RES     346    346       Phosphothreonine; by SGK1.
FT                                {ECO:0000269|PubMed:15461589,
FT                                ECO:0000269|PubMed:18787837}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6JE36}.
FT   MOD_RES     356    356       Phosphothreonine; by SGK1.
FT                                {ECO:0000269|PubMed:15461589,
FT                                ECO:0000269|PubMed:18787837}.
FT   MOD_RES     362    362       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6JE36}.
FT   MOD_RES     364    364       Phosphoserine; by SGK1.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     366    366       Phosphothreonine; by SGK1.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:15461589,
FT                                ECO:0000269|PubMed:18787837}.
FT   MOD_RES     375    375       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     81       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045037.
FT   VAR_SEQ       1     66       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045038.
FT   VARIANT      67     67       M -> V (in dbSNP:rs2233319).
FT                                /FTId=VAR_050234.
FT   VARIANT     111    111       M -> L (in dbSNP:rs2233328).
FT                                /FTId=VAR_050235.
FT   CONFLICT    145    145       I -> T (in Ref. 2; CAA63430).
FT                                {ECO:0000305}.
SQ   SEQUENCE   394 AA;  42835 MW;  4C816B9C85E3756F CRC64;
     MSREMQDVDL AEVKPLVEKG ETITGLLQEF DVQEQDIETL HGSVHVTLCG TPKGNRPVIL
     TYHDIGMNHK TCYNPLFNYE DMQEITQHFA VCHVDAPGQQ DGAASFPAGY MYPSMDQLAE
     MLPGVLQQFG LKSIIGMGTG AGAYILTRFA LNNPEMVEGL VLINVNPCAE GWMDWAASKI
     SGWTQALPDM VVSHLFGKEE MQSNVEVVHT YRQHIVNDMN PGNLHLFINA YNSRRDLEIE
     RPMPGTHTVT LQCPALLVVG DSSPAVDAVV ECNSKLDPTK TTLLKMADCG GLPQISQPAK
     LAEAFKYFVQ GMGYMPSASM TRLMRSRTAS GSSVTSLDGT RSRSHTSEGT RSRSHTSEGT
     RSRSHTSEGA HLDITPNSGA AGNSAGPKSM EVSC
//
ID   NF1_HUMAN               Reviewed;        2839 AA.
AC   P21359; O00662; Q14284; Q14930; Q14931; Q9UMK3;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   28-FEB-2018, entry version 215.
DE   RecName: Full=Neurofibromin;
DE   AltName: Full=Neurofibromatosis-related protein NF-1;
DE   Contains:
DE     RecName: Full=Neurofibromin truncated;
GN   Name=NF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=1457041; DOI=10.1089/dna.1992.11.727;
RA   Bernards A., Haase V.H., Murthy A.E., Menon A., Hannigan G.E.,
RA   Gusella J.F.;
RT   "Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and
RT   absence of expression in a neuroblastoma line.";
RL   DNA Cell Biol. 11:727-734(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2134734; DOI=10.1126/science.2134734;
RA   Wallace M.R., Marchuk D.A., Andersen L.B., Letcher R., Odeh H.M.,
RA   Saulino A.M., Fountain J.W., Brereton A., Nicholson J., Mitchell A.L.,
RA   Brownstein B.H., Collins F.S.;
RT   "Type 1 neurofibromatosis gene: identification of a large transcript
RT   disrupted in three NF1 patients.";
RL   Science 249:181-186(1990).
RN   [3]
RP   ERRATUM.
RX   PubMed=2125369;
RA   Wallace M.R., Marchuk D.A., Andersen L.B., Letcher R., Odeh H.M.,
RA   Saulino A.M., Fountain J.W., Brereton A., Nicholson J., Mitchell A.L.,
RA   Brownstein B.H., Collins F.S.;
RL   Science 250:1749-1749(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1783401; DOI=10.1016/0888-7543(91)90017-9;
RA   Marchuk D.A., Saulino A.M., Tavakkol R., Swaroop M., Wallace M.R.,
RA   Andersen L.B., Mitchell A.L., Gutmann D.H., Boguski M.S.,
RA   Collins F.S.;
RT   "cDNA cloning of the type 1 neurofibromatosis gene: complete sequence
RT   of the NF1 gene product.";
RL   Genomics 11:931-940(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND ALTERNATIVE SPLICING.
RC   TISSUE=Placenta;
RX   PubMed=1339276; DOI=10.1016/0006-291X(92)91294-Z;
RA   Suzuki H., Takahashi K., Kubota Y., Shibahara S.;
RT   "Molecular cloning of a cDNA coding for neurofibromatosis type 1
RT   protein isoform lacking the domain related to ras GTPase-activating
RT   protein.";
RL   Biochem. Biophys. Res. Commun. 187:984-990(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Kidney;
RX   PubMed=7570581; DOI=10.1620/tjem.175.225;
RA   Suzuki H., Takahashi K., Shibahara S.;
RT   "Evidence for the presence of two amino-terminal isoforms of
RT   neurofibromin, a gene product responsible for neurofibromatosis type
RT   1.";
RL   Tohoku J. Exp. Med. 175:225-233(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-80; LEU-678;
RP   HIS-1422 AND LEU-2511.
RG   NIEHS SNPs program;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 335-2839 (ISOFORM 1), AND
RP   VARIANT NF1 PRO-1953.
RX   PubMed=2114220; DOI=10.1016/0092-8674(90)90253-B;
RA   Cawthon R.M., Weiss R., Xu G., Viskochil D., Culver M., Stevens J.,
RA   Robertson M., Dunn D., Gesteland R., O'Connell P., White R.;
RT   "A major segment of the neurofibromatosis type 1 gene: cDNA sequence,
RT   genomic structure, and point mutations.";
RL   Cell 62:193-201(1990).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 335-2839 (ISOFORMS 1 AND 6).
RX   PubMed=2116237; DOI=10.1016/0092-8674(90)90024-9;
RA   Xu G., O'Connell P., Viskochil D., Cawthon R.M., Robertson M.,
RA   Culver M., Dunn D., Stevens J., Gesteland R., White R., Weiss R.;
RT   "The neurofibromatosis type 1 gene encodes a protein related to GAP.";
RL   Cell 62:599-608(1990).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 707-782.
RX   PubMed=9002664; DOI=10.1093/hmg/6.1.9;
RA   Regnier V., Meddeb M., Lecointre G., Richard F., Duverger A.,
RA   Nguyen V.C., Dutrillaux B., Bernheim A., Danglot G.;
RT   "Emergence and scattering of multiple neurofibromatosis (NF1)-related
RT   sequences during hominoid evolution suggest a process of
RT   pericentromeric interchromosomal transposition.";
RL   Hum. Mol. Genet. 6:9-16(1997).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 751-1611 (ISOFORMS 1 AND 2).
RX   PubMed=7774960; DOI=10.1016/0888-7543(95)80104-T;
RA   Li Y., O'Connell P., Breidenbach H.H., Cawthon R.M., Stevens J.,
RA   Xu G., Neil S., Robertson M., White R., Viskochil D.;
RT   "Genomic organization of the neurofibromatosis 1 gene (NF1).";
RL   Genomics 25:9-18(1995).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1090-1598 (ISOFORM 4).
RX   PubMed=2121370; DOI=10.1016/0092-8674(90)90150-D;
RA   Martin G.A., Viskochil D., Bollag G., McCabe P.C., Crosier W.J.,
RA   Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R.M.,
RA   Innis M., McCormick F.;
RT   "The GAP-related domain of the neurofibromatosis type 1 gene product
RT   interacts with ras p21.";
RL   Cell 63:843-849(1990).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1168-1566 (ISOFORMS 1 AND 2).
RX   PubMed=1923522;
RA   Nishi T., Lee P.S., Oka K., Levin V.A., Tanase S., Morino Y., Saya H.;
RT   "Differential expression of two types of the neurofibromatosis type 1
RT   (NF1) gene transcripts related to neuronal differentiation.";
RL   Oncogene 6:1555-1559(1991).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1371-1391 (ISOFORM 2), FUNCTION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=8417346; DOI=10.1128/MCB.13.1.487;
RA   Andersen L.B., Ballester R., Marchuk D.A., Chang E., Gutmann D.H.,
RA   Saulino A.M., Camonis J., Wigler M., Collins F.S.;
RT   "A conserved alternative splice in the von Recklinghausen
RT   neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both
RT   of which have GTPase-activating protein activity.";
RL   Mol. Cell. Biol. 13:487-495(1993).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1371-1391 (ISOFORM 2).
RX   PubMed=1662505; DOI=10.1016/0006-291X(91)92029-J;
RA   Suzuki Y., Suzuki H., Kayama T., Yoshimoto T., Shibahara S.;
RT   "Brain tumors predominantly express the neurofibromatosis type 1 gene
RT   transcripts containing the 63 base insert in the region coding for
RT   GTPase activating protein-related domain.";
RL   Biochem. Biophys. Res. Commun. 181:955-961(1991).
RN   [18]
RP   FUNCTION.
RX   PubMed=2121371; DOI=10.1016/0092-8674(90)90151-4;
RA   Ballester R., Marchuk D.A., Boguski M.S., Saulino A.M., Letcher R.,
RA   Wigler M., Collins F.S.;
RT   "The NF1 locus encodes a protein functionally related to mammalian GAP
RT   and yeast IRA proteins.";
RL   Cell 63:851-859(1990).
RN   [19]
RP   RNA EDITING.
RX   PubMed=8602361; DOI=10.1093/nar/24.3.478;
RA   Skuse G.R., Cappione A.J., Sowden M., Metheny L.J., Smith H.C.;
RT   "The neurofibromatosis type I messenger RNA undergoes base-
RT   modification RNA editing.";
RL   Nucleic Acids Res. 24:478-485(1996).
RN   [20]
RP   RNA EDITING.
RX   PubMed=11727199; DOI=10.1086/337952;
RA   Mukhopadhyay D., Anant S., Lee R.M., Kennedy S., Viskochil D.,
RA   Davidson N.O.;
RT   "C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that
RT   express both the type II transcript and apobec-1, the catalytic
RT   subunit of the apolipoprotein B mRNA-editing enzyme.";
RL   Am. J. Hum. Genet. 70:38-50(2002).
RN   [21]
RP   REVIEW ON VARIANTS.
RX   PubMed=7981724; DOI=10.1002/humu.1380040202;
RA   Upadhyaya M., Shaw D.J., Harper P.S.;
RT   "Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis
RT   and polymorphisms in the NF1 gene.";
RL   Hum. Mutat. 4:83-101(1994).
RN   [22]
RP   REVIEW ON VARIANTS.
RX   PubMed=8825042; DOI=10.1136/jmg.33.1.2;
RA   Shen M.H., Harper P.S., Upadhyaya M.;
RT   "Molecular genetics of neurofibromatosis type 1 (NF1).";
RL   J. Med. Genet. 33:2-17(1996).
RN   [23]
RP   SUBCELLULAR LOCATION, AND NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=14988005; DOI=10.1016/S0014-5793(04)00078-X;
RA   Vandenbroucke I., Van Oostveldt P., Coene E., De Paepe A.,
RA   Messiaen L.;
RT   "Neurofibromin is actively transported to the nucleus.";
RL   FEBS Lett. 560:98-102(2004).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864; SER-2188; SER-2515;
RP   SER-2521 AND SER-2543, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864; SER-876 AND
RP   SER-2515, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864 AND SER-2817, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2543 AND SER-2817, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [33]
RP   INTERACTION WITH HTR6.
RX   PubMed=23027611; DOI=10.1002/emmm.201201410;
RA   Meffre J., Chaumont-Dubel S., Mannoury la Cour C., Loiseau F.,
RA   Watson D.J., Dekeyne A., Seveno M., Rivet J.M., Gaven F., Deleris P.,
RA   Herve D., Fone K.C., Bockaert J., Millan M.J., Marin P.;
RT   "5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed
RT   cognition in schizophrenia.";
RL   EMBO Mol. Med. 4:1043-1056(2012).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864; SER-876; SER-2188;
RP   SER-2515; SER-2521; SER-2523; SER-2543; THR-2565; SER-2597 AND
RP   SER-2802, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2543 AND SER-2817, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1198-1551.
RX   PubMed=9687500; DOI=10.1093/emboj/17.15.4313;
RA   Scheffzek K., Ahmadian M.R., Wiesmuller L., Kabsch W., Stege P.,
RA   Schmitz F., Wittinghofer A.;
RT   "Structural analysis of the GAP-related domain from neurofibromin and
RT   its implications.";
RL   EMBO J. 17:4313-4327(1998).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1581-1837, LIPID-BINDING,
RP   DOMAIN, AND MUTAGENESIS OF LYS-1691; ARG-1695; ARG-1769 AND LYS-1771.
RX   PubMed=16397625; DOI=10.1038/sj.embor.7400602;
RA   D'Angelo I., Welti S., Bonneau F., Scheffzek K.;
RT   "A novel bipartite phospholipid-binding module in the
RT   neurofibromatosis type 1 protein.";
RL   EMBO Rep. 7:174-179(2006).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1566-1837 IN COMPLEX WITH
RP   PHOSPHOLIPID, LIPID-BINDING, AND DOMAIN.
RX   PubMed=17187824; DOI=10.1016/j.jmb.2006.11.055;
RA   Welti S., Fraterman S., D'Angelo I., Wilm M., Scheffzek K.;
RT   "The sec14 homology module of neurofibromin binds cellular
RT   glycerophospholipids: mass spectrometry and structure of a lipid
RT   complex.";
RL   J. Mol. Biol. 366:551-562(2007).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.19 ANGSTROMS) OF 1581-1837 OF VARIANT NF1
RP   VAL-1605 AND MUTANT LYS-1771 DEL IN COMPLEX WITH LIPID,
RP   CHARACTERIZATION OF VARIANT NF1 VAL-1605, MUTAGENESIS OF LYS-1771,
RP   LIPID-BINDING, AND DOMAIN.
RX   PubMed=21089070; DOI=10.1002/humu.21405;
RA   Welti S., Kuhn S., D'Angelo I., Brugger B., Kaufmann D., Scheffzek K.;
RT   "Structural and biochemical consequences of NF1 associated
RT   nontruncating mutations in the Sec14-PH module of neurofibromin.";
RL   Hum. Mutat. 32:191-197(2011).
RN   [40]
RP   VARIANT GLU-1444.
RX   PubMed=1568247; DOI=10.1016/0092-8674(92)90408-5;
RA   Li Y., Bollag G., Clark R., Stevens J., Conroy L., Fults D., Ward K.,
RA   Friedman E., Samowitz W., Robertson M., Bradley P., McCormick F.,
RA   White R., Cawthon R.M.;
RT   "Somatic mutations in the neurofibromatosis 1 gene in human tumors.";
RL   Cell 69:275-281(1992).
RN   [41]
RP   VARIANTS NF1 MET-2164 AND ASN-2192.
RX   PubMed=1302608; DOI=10.1093/hmg/1.9.735;
RA   Upadhyaya M., Shen M.H., Cherryson A., Farnham J., Maynard J.,
RA   Huson S.M., Harper P.S.;
RT   "Analysis of mutations at the neurofibromatosis 1 (NF1) locus.";
RL   Hum. Mol. Genet. 1:735-740(1992).
RN   [42]
RP   VARIANT GLY-HIS-GLU-GLN-GLN-LYS-LEU-PRO-ALA-ALA-THR-LEU-ALA-LEU-1733
RP   INS.
RX   PubMed=8317503;
RA   Tassabehji M., Strachan T., Sharland M., Colley A., Donnai D.,
RA   Harris R., Thakker N.;
RT   "Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon
RT   in a family with features of Watson syndrome and Noonan syndrome.";
RL   Am. J. Hum. Genet. 53:90-95(1993).
RN   [43]
RP   VARIANT MET-991 DEL.
RX   PubMed=7904209; DOI=10.1093/hmg/2.11.1861;
RA   Shen M.H., Harper P.S., Upadhyaya M.;
RT   "Neurofibromatosis type 1 (NF1): the search for mutations by PCR-
RT   heteroduplex analysis on Hydrolink gels.";
RL   Hum. Mol. Genet. 2:1861-1864(1993).
RN   [44]
RP   VARIANTS NF1 ASP-1166 AND ARG-1440.
RX   PubMed=7981679; DOI=10.1093/hmg/3.7.1109;
RA   Purandare S.M., Lanyon W.G., Connor J.M.;
RT   "Characterisation of inherited and sporadic mutations in
RT   neurofibromatosis type-1.";
RL   Hum. Mol. Genet. 3:1109-1115(1994).
RN   [45]
RP   VARIANT NF1 2387-ASN-PHE-2388 DEL.
RX   PubMed=8081387; DOI=10.1002/humu.1380030404;
RA   Abernathy C.R., Colman S.D., Kousseff B.G., Wallace M.R.;
RT   "Two NF1 mutations: frameshift in the GAP-related domain, and loss of
RT   two codons toward the 3' end of the gene.";
RL   Hum. Mutat. 3:347-352(1994).
RN   [46]
RP   VARIANT NF1 ALA-2631.
RX   PubMed=8544190; DOI=10.1136/jmg.32.9.706;
RA   Upadhyaya M., Maynard J., Osborn M.J., Huson S.M., Ponder M.,
RA   Ponder B.A.J., Harper P.S.;
RT   "Characterisation of germline mutations in the neurofibromatosis type
RT   1 (NF1) gene.";
RL   J. Med. Genet. 32:706-710(1995).
RN   [47]
RP   VARIANT NF1 ARG-629.
RX   PubMed=8834249; DOI=10.1007/BF02267073;
RA   Gasparini P., D'Agruma L., de Cillis G.P., Balestrazzi P.,
RA   Mingarelli R., Zelante L.;
RT   "Scanning the first part of the neurofibromatosis type 1 gene by RNA-
RT   SSCP: identification of three novel mutations and of two new
RT   polymorphisms.";
RL   Hum. Genet. 97:492-495(1996).
RN   [48]
RP   VARIANT NF1 ARG-1035.
RX   PubMed=8807336;
RX   DOI=10.1002/(SICI)1098-1004(1996)8:1<51::AID-HUMU7>3.0.CO;2-S;
RA   Wu R., Legius E., Robberecht W., Dumoulin M., Cassiman J.-J.,
RA   Fryns J.-P.;
RT   "Neurofibromatosis type I gene mutation in a patient with features of
RT   LEOPARD syndrome.";
RL   Hum. Mutat. 8:51-56(1996).
RN   [49]
RP   VARIANTS NF1 SER-1412; GLN-1440; GLU-1444 AND GLY-1489.
RX   PubMed=9003501; DOI=10.1007/s004390050317;
RA   Upadhyaya M., Osborn M.J., Maynard J., Kim M.R., Tamanoi F.,
RA   Cooper D.N.;
RT   "Mutational and functional analysis of the neurofibromatosis type 1
RT   (NF1) gene.";
RL   Hum. Genet. 99:88-92(1997).
RN   [50]
RP   VARIANTS NF1 ARG-844 AND PRO-898.
RX   PubMed=9150739; DOI=10.1007/s004390050427;
RA   Maynard J., Krawczak M., Upadhyaya M.;
RT   "Characterization and significance of nine novel mutations in exon 16
RT   of the neurofibromatosis type 1 (NF1) gene.";
RL   Hum. Genet. 99:674-676(1997).
RN   [51]
RP   VARIANT NF1 ARG-1952.
RX   PubMed=9101300;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:4<366::AID-HUMU12>3.0.CO;2-0;
RA   Hudson J., Wu C.L., Tassabehji M., Summers E.M., Simon S., Super M.,
RA   Donnai D., Thakker N.;
RT   "Novel and recurrent mutations in the neurofibromatosis type 1 (NF1)
RT   gene.";
RL   Hum. Mutat. 9:366-367(1997).
RN   [52]
RP   VARIANTS NF1 GLY-338 AND TRP-1611.
RX   PubMed=9298829;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:3<248::AID-HUMU14>3.3.CO;2-D;
RA   Upadhyaya M., Maynard J., Osborn M.J., Harper P.S.;
RT   "Six novel mutations in the neurofibromatosis type 1 (NF1) gene.";
RL   Hum. Mutat. 10:248-250(1997).
RN   [53]
RP   VARIANT NF1 PRO-1276.
RX   PubMed=9668168; DOI=10.1093/hmg/7.8.1261;
RA   Klose A., Ahmadian M.R., Schuelke M., Scheffzek K., Hoffmeyer S.,
RA   Gewies A., Schmitz F., Kaufmann D., Peters H., Wittinghofer A.,
RA   Nuernberg P.;
RT   "Selective disactivation of neurofibromin GAP activity in
RT   neurofibromatosis type 1 (NF1).";
RL   Hum. Mol. Genet. 7:1261-1268(1998).
RN   [54]
RP   VARIANT NF1 GLY-1204, AND VARIANT HIS-765.
RX   PubMed=10336779;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:5<411::AID-HUMU11>3.0.CO;2-2;
RA   Krkljus S., Abernathy C.R., Johnson J.S., Williams C.A.,
RA   Driscoll D.J., Zori R., Stalker H.J., Rasmussen S.A., Collins F.S.,
RA   Kousseff B.G., Baumbach L., Wallace M.R.;
RT   "Analysis of CpG C-to-T mutations in neurofibromatosis type 1.";
RL   Hum. Mutat. 11:411-411(1998).
RN   [55]
RP   VARIANT NF1 PRO-508.
RX   PubMed=11258625;
RA   Messiaen L.M., Callens T., Roux K.J., Mortier G.R., De Paepe A.,
RA   Abramowicz M., Pericak-Vance M.A., Vance J.M., Wallace M.R.;
RT   "Exon 10b of the NF1 gene represents a mutational hotspot and harbors
RT   a recurrent missense mutation Y489C associated with aberrant
RT   splicing.";
RL   Genet. Med. 1:248-253(1999).
RN   [56]
RP   VARIANT NF1 PRO-1446.
RX   PubMed=10220149;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:4<337::AID-HUMU12>3.0.CO;2-F;
RA   Peters H., Hess D., Fahsold R., Schuelke M.;
RT   "A novel mutation L1425P in the GAP-region of the NF1 gene detected by
RT   temperature gradient gel electrophoresis (TGGE).";
RL   Hum. Mutat. 13:337-337(1999).
RN   [57]
RP   VARIANTS NF1 PRO-216; PRO-357; CYS-491; PRO-549; THR-581; ARG-583;
RP   PHE-665; PRO-695; PRO-763; SER-777; LYS-780; PRO-781; PRO-847;
RP   SER-1156; PRO-1250; GLN-1276; PRO-1276; PRO-1446; VAL-1605 AND
RP   ILE-2507, AND VARIANT GLU-176.
RX   PubMed=10712197; DOI=10.1086/302809;
RA   Fahsold R., Hoffmeyer S., Mischung C., Gille C., Ehlers C.,
RA   Kuecuekceylan N., Abdel-Nour M., Gewies A., Peters H., Kaufmann D.,
RA   Buske A., Tinschert S., Nuernberg P.;
RT   "Minor lesion mutational spectrum of the entire NF1 gene does not
RT   explain its high mutability but points to a functional domain upstream
RT   of the GAP-related domain.";
RL   Am. J. Hum. Genet. 66:790-818(2000).
RN   [58]
RP   VARIANTS NF1 SER-117; TRP-1204; PRO-1446 AND 2387-ASN-PHE-2388 DEL.
RX   PubMed=10607834; DOI=10.1093/hmg/9.2.237;
RA   Ars E., Serra E., Garcia J., Kruyer H., Gaona A., Lazaro C.,
RA   Estivill X.;
RT   "Mutations affecting mRNA splicing are the most common molecular
RT   defects in patients with neurofibromatosis type 1.";
RL   Hum. Mol. Genet. 9:237-247(2000).
RN   [59]
RP   ERRATUM.
RA   Ars E., Serra E., Garcia J., Kruyer H., Gaona A., Lazaro C.,
RA   Estivill X.;
RL   Hum. Mol. Genet. 9:659-659(2000).
RN   [60]
RP   VARIANT NF1 PHE-844.
RX   PubMed=10980545;
RX   DOI=10.1002/1098-1004(200009)16:3<274::AID-HUMU21>3.3.CO;2-6;
RA   Boulandet E.G., Pantel J., Cazeneuve C., Van Gijn M., Vidaud D.,
RA   Lemay S., Martin J., Zeller J., Revuz J., Goossens M., Amselem S.,
RA   Wolkenstein P.;
RT   "NF1 gene analysis focused on CpG-rich exons in a cohort of 93
RT   patients with neurofibromatosis type 1.";
RL   Hum. Mutat. 16:274-275(2000).
RN   [61]
RP   VARIANT SPINAL FSNF PRO-2088.
RX   PubMed=11704931; DOI=10.1086/324648;
RA   Kaufmann D., Mueller R., Bartelt B., Wolf M., Kunzi-Rapp K.,
RA   Hanemann C.O., Fahsold R., Hein C., Vogel W., Assum G.;
RT   "Spinal neurofibromatosis without cafe-au-lait macules in two families
RT   with null mutations of the NF1 gene.";
RL   Am. J. Hum. Genet. 69:1395-1400(2001).
RN   [62]
RP   VARIANTS NF1 LYS-780; CYS-784; PRO-1147; CYS-1193; ARG-1444; SER-1785;
RP   ASN-2012 AND LYS-2357.
RX   PubMed=11735023; DOI=10.1007/s004390100594;
RA   Han S.S., Cooper D.N., Upadhyaya M.N.;
RT   "Evaluation of denaturing high performance liquid chromatography
RT   (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (
RT   NF1) gene.";
RL   Hum. Genet. 109:487-497(2001).
RN   [63]
RP   VARIANTS NF1 PHE-82; ARG-784 AND GLU-1444.
RX   PubMed=11857752; DOI=10.1002/humu.9018;
RA   Kluwe L., Friedrich R.E., Korf B., Fahsold R., Mautner V.-F.;
RT   "NF1 mutations in neurofibromatosis 1 patients with plexiform
RT   neurofibromas.";
RL   Hum. Mutat. 19:309-309(2002).
RN   [64]
RP   VARIANT NFNS GLU-1459 DEL.
RX   PubMed=12707950; DOI=10.1002/ajmg.a.20023;
RA   Baralle D., Mattocks C., Kalidas K., Elmslie F., Whittaker J.,
RA   Lees M., Ragge N., Patton M.A., Winter R.M., ffrench-Constant C.;
RT   "Different mutations in the NF1 gene are associated with
RT   neurofibromatosis-Noonan syndrome (NFNS).";
RL   Am. J. Med. Genet. A 119:1-8(2003).
RN   [65]
RP   VARIANTS NF1 TYR-93; VAL-604; ARG-844 AND PRO-898, AND VARIANTS
RP   ASP-74; GLU-176; ARG-712 AND GLN-1276.
RX   PubMed=12522551; DOI=10.1007/s00439-002-0858-4;
RA   Wang Q., Montmain G., Ruano E., Upadhyaya M., Dudley S., Liskay R.M.,
RA   Thibodeau S.N., Puisieux A.;
RT   "Neurofibromatosis type 1 gene as a mutational target in a mismatch
RT   repair-deficient cell type.";
RL   Hum. Genet. 112:117-123(2003).
RN   [66]
RP   VARIANTS NF1 LYS-780; PRO-847; GLU-848 AND ARG-968; ASN-1444; LEU-1953
RP   DEL AND ARG-2001.
RX   PubMed=12552569; DOI=10.1002/humu.9111;
RA   De Luca A., Buccino A., Gianni D., Mangino M., Giustini S.,
RA   Richetta A., Divona L., Calvieri S., Mingarelli R., Dallapiccola B.;
RT   "NF1 gene analysis based on DHPLC.";
RL   Hum. Mutat. 21:171-172(2003).
RN   [67]
RP   VARIANTS NF1 ARG-578; PRO-920 AND ALA-2221.
RX   PubMed=12746402; DOI=10.1136/jmg.40.5.368;
RA   Kluwe L., Tatagiba M., Fuensterer C., Mautner V.F.;
RT   "NF1 mutations and clinical spectrum in patients with spinal
RT   neurofibromas.";
RL   J. Med. Genet. 40:368-371(2003).
RN   [68]
RP   VARIANT NF1 VAL-186, AND CHARACTERIZATION OF VARIANT NF1 VAL-186.
RX   PubMed=15523642; DOI=10.1002/humu.20103;
RA   Zatkova A., Messiaen L., Vandenbroucke I., Wieser R., Fonatsch C.,
RA   Krainer A.R., Wimmer K.;
RT   "Disruption of exonic splicing enhancer elements is the principal
RT   cause of exon skipping associated with seven nonsense or missense
RT   alleles of NF1.";
RL   Hum. Mutat. 24:491-501(2004).
RN   [69]
RP   VARIANTS NF1 ASN-157; ARG-629; SER-777; LYS-780; ARG-784; PRO-847;
RP   GLU-848; ARG-968; ASN-1444; LEU-1953 DEL AND ARG-2001, AND VARIANT
RP   GLU-176.
RX   PubMed=15146469; DOI=10.1002/humu.9245;
RA   De Luca A., Schirinzi A., Buccino A., Bottillo I., Sinibaldi L.,
RA   Torrente I., Ciavarella A., Dottorini T., Porciello R., Giustini S.,
RA   Calvieri S., Dallapiccola B.;
RT   "Novel and recurrent mutations in the NF1 gene in Italian patients
RT   with neurofibromatosis type 1.";
RL   Hum. Mutat. 23:629-629(2004).
RN   [70]
RP   VARIANTS NF1 ARG-31; PRO-145; ARG-324; VAL-337; CYS-489; PRO-532;
RP   ARG-574; ARG-629; PHE-665; PHE-844; PRO-844; MET-991 DEL; VAL-1073;
RP   ARG-1196; GLY-1276; GLN-1276; GLU-1430; GLU-1459 DEL AND GLY-1489, AND
RP   VARIANTS GLU-176 AND CYS-873.
RX   PubMed=15060124; DOI=10.1136/jmg.2003.011890;
RA   Mattocks C., Baralle D., Tarpey P., ffrench-Constant C., Bobrow M.,
RA   Whittaker J.;
RT   "Automated comparative sequence analysis identifies mutations in 89%
RT   of NF1 patients and confirms a mutation cluster in exons 11-17
RT   distinct from the GAP related domain.";
RL   J. Med. Genet. 41:E48-E48(2004).
RN   [71]
RP   VARIANT NF1 PRO-1243.
RX   PubMed=15520408; DOI=10.1136/jmg.2004.021683;
RA   Ferner R.E., Hughes R.A.C., Hall S.M., Upadhyaya M., Johnson M.R.;
RT   "Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).";
RL   J. Med. Genet. 41:837-841(2004).
RN   [72]
RP   VARIANT NF1 ARG-844.
RX   PubMed=15948193; DOI=10.1002/ajmg.a.30813;
RA   Bertola D.R., Pereira A.C., Passetti F., de Oliveira P.S.L.,
RA   Messiaen L., Gelb B.D., Kim C.A., Krieger J.E.;
RT   "Neurofibromatosis-Noonan syndrome: molecular evidence of the
RT   concurrence of both disorders in a patient.";
RL   Am. J. Med. Genet. A 136:242-245(2005).
RN   [73]
RP   VARIANTS NFNS ARG-194; GLU-1444; THR-1451; LEU-1453 AND GLU-1459 DEL.
RX   PubMed=16380919; DOI=10.1086/498454;
RA   De Luca A., Bottillo I., Sarkozy A., Carta C., Neri C., Bellacchio E.,
RA   Schirinzi A., Conti E., Zampino G., Battaglia A., Majore S.,
RA   Rinaldi M.M., Carella M., Marino B., Pizzuti A., Digilio M.C.,
RA   Tartaglia M., Dallapiccola B.;
RT   "NF1 gene mutations represent the major molecular event underlying
RT   neurofibromatosis-Noonan syndrome.";
RL   Am. J. Hum. Genet. 77:1092-1101(2005).
RN   [74]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-1187; LEU-1951 AND ARG-2745.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [75]
RP   VARIANT NF1 MET-991 DEL.
RX   PubMed=17160901; DOI=10.1086/510781;
RA   Upadhyaya M., Huson S.M., Davies M., Thomas N., Chuzhanova N.,
RA   Giovannini S., Evans D.G., Howard E., Kerr B., Griffiths S.,
RA   Consoli C., Side L., Adams D., Pierpont M., Hachen R., Barnicoat A.,
RA   Li H., Wallace P., Van Biervliet J.P., Stevenson D., Viskochil D.,
RA   Baralle D., Haan E., Riccardi V., Turnpenny P., Lazaro C.,
RA   Messiaen L.;
RT   "An absence of cutaneous neurofibromas associated with a 3-bp inframe
RT   deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of
RT   a clinically significant NF1 genotype-phenotype correlation.";
RL   Am. J. Hum. Genet. 80:140-151(2007).
RN   [76]
RP   VARIANT NFNS PHE-1411.
RX   PubMed=19845691; DOI=10.1111/j.1399-0004.2009.01233.x;
RA   Nystrom A.M., Ekvall S., Allanson J., Edeby C., Elinder M.,
RA   Holmstrom G., Bondeson M.L., Anneren G.;
RT   "Noonan syndrome and neurofibromatosis type I in a family with a novel
RT   mutation in NF1.";
RL   Clin. Genet. 76:524-534(2009).
RN   [77]
RP   VARIANT NF1 THR-160.
RX   PubMed=21838856; DOI=10.1186/1897-4287-9-6;
RA   Ponti G., Losi L., Martorana D., Priola M., Boni E., Pollio A.,
RA   Neri T.M., Seidenari S.;
RT   "Clinico-pathological and biomolecular findings in Italian patients
RT   with multiple cutaneous neurofibromas.";
RL   Hered. Cancer Clin. Pract. 9:6-6(2011).
RN   [78]
RP   VARIANTS GLU-176; THR-330; ASP-393; LEU-393; PRO-519; THR-776 AND
RP   PHE-1484.
RX   PubMed=22108604; DOI=10.1038/ejhg.2011.207;
RA   Thomas L., Spurlock G., Eudall C., Thomas N.S., Mort M., Hamby S.E.,
RA   Chuzhanova N., Brems H., Legius E., Cooper D.N., Upadhyaya M.;
RT   "Exploring the somatic NF1 mutational spectrum associated with NF1
RT   cutaneous neurofibromas.";
RL   Eur. J. Hum. Genet. 20:411-419(2012).
RN   [79]
RP   VARIANTS NF1 TRP-93; ARG-1048; ARG-1189; ARG-1661 (ISOFORM 1) AND
RP   THR-1918 (ISOFORM 1).
RX   PubMed=23758643; DOI=10.1111/ahg.12026;
RA   Nemethova M., Bolcekova A., Ilencikova D., Durovcikova D.,
RA   Hlinkova K., Hlavata A., Kovacs L., Kadasi L., Zatkova A.;
RT   "Thirty-nine novel neurofibromatosis 1 (NF1) gene mutations identified
RT   in Slovak patients.";
RL   Ann. Hum. Genet. 77:364-379(2013).
RN   [80]
RP   VARIANT NF1 PRO-2125.
RX   PubMed=24413922; DOI=10.1007/s00381-013-2352-9;
RA   Ben-Salem S., Al-Shamsi A.M., Ali B.R., Al-Gazali L.;
RT   "The mutational spectrum of the NF1 gene in neurofibromatosis type I
RT   patients from UAE.";
RL   Childs Nerv. Syst. 30:1183-1189(2014).
CC   -!- FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater
CC       affinity for Ras GAP, but lower specific activity. May be a
CC       regulator of Ras activity. {ECO:0000269|PubMed:2121371,
CC       ECO:0000269|PubMed:8417346}.
CC   -!- SUBUNIT: Interacts with HTR6 (PubMed:23027611).
CC       {ECO:0000269|PubMed:23027611}.
CC   -!- INTERACTION:
CC       P05067:APP; NbExp=3; IntAct=EBI-1172917, EBI-77613;
CC       P34741:SDC2; NbExp=4; IntAct=EBI-1172917, EBI-1172957;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14988005}.
CC       Nucleus, nucleolus {ECO:0000269|PubMed:14988005}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=2; Synonyms=Type II;
CC         IsoId=P21359-1; Sequence=Displayed;
CC       Name=1; Synonyms=Type I;
CC         IsoId=P21359-2; Sequence=VSP_001628;
CC         Note=Variant in position: 1661:C->R (in NF1). Variant in
CC         position: 1918:I->T (in NF1). {ECO:0000269|PubMed:23758643};
CC       Name=3;
CC         IsoId=P21359-3; Sequence=VSP_001629, VSP_001630;
CC       Name=4;
CC         IsoId=P21359-4; Sequence=VSP_001631, VSP_001632;
CC       Name=5;
CC         IsoId=P21359-5; Sequence=VSP_043467, VSP_043468;
CC       Name=6;
CC         IsoId=P21359-6; Sequence=VSP_001628, VSP_053587;
CC   -!- TISSUE SPECIFICITY: Detected in brain, peripheral nerve, lung,
CC       colon and muscle. {ECO:0000269|PubMed:8417346}.
CC   -!- DOMAIN: Binds phospholipids via its C-terminal CRAL-TRIO domain.
CC       Binds primarily glycerophospholipids with monounsaturated C18:1
CC       and/or C16:1 fatty acid moieties and a phosphatidylethanolamine or
CC       phosphatidylcholine headgroup. Has lesser affinity for lipids
CC       containing phosphatidylserine and phosphatidylinositol.
CC       {ECO:0000269|PubMed:16397625, ECO:0000269|PubMed:17187824,
CC       ECO:0000269|PubMed:21089070}.
CC   -!- RNA EDITING: Modified_positions=1306 {ECO:0000269|PubMed:11727199,
CC       ECO:0000269|PubMed:8602361}; Note=The stop codon (UGA) at position
CC       1306 is created by RNA editing. Various levels of RNA editing
CC       occurs in peripheral nerve-sheath tumor samples (PNSTs) from
CC       patients with NF1. Preferentially observed in transcripts
CC       containing exon 23A.;
CC   -!- DISEASE: Neurofibromatosis 1 (NF1) [MIM:162200]: A disease
CC       characterized by patches of skin pigmentation (cafe-au-lait
CC       spots), Lisch nodules of the iris, tumors in the peripheral
CC       nervous system and fibromatous skin tumors. Individuals with the
CC       disorder have increased susceptibility to the development of
CC       benign and malignant tumors. {ECO:0000269|PubMed:10220149,
CC       ECO:0000269|PubMed:10336779, ECO:0000269|PubMed:10607834,
CC       ECO:0000269|PubMed:10712197, ECO:0000269|PubMed:10980545,
CC       ECO:0000269|PubMed:11258625, ECO:0000269|PubMed:11735023,
CC       ECO:0000269|PubMed:11857752, ECO:0000269|PubMed:12522551,
CC       ECO:0000269|PubMed:12552569, ECO:0000269|PubMed:12746402,
CC       ECO:0000269|PubMed:1302608, ECO:0000269|PubMed:15060124,
CC       ECO:0000269|PubMed:15146469, ECO:0000269|PubMed:15520408,
CC       ECO:0000269|PubMed:15523642, ECO:0000269|PubMed:15948193,
CC       ECO:0000269|PubMed:17160901, ECO:0000269|PubMed:21089070,
CC       ECO:0000269|PubMed:2114220, ECO:0000269|PubMed:21838856,
CC       ECO:0000269|PubMed:23758643, ECO:0000269|PubMed:24413922,
CC       ECO:0000269|PubMed:7981679, ECO:0000269|PubMed:8081387,
CC       ECO:0000269|PubMed:8544190, ECO:0000269|PubMed:8807336,
CC       ECO:0000269|PubMed:8834249, ECO:0000269|PubMed:9003501,
CC       ECO:0000269|PubMed:9101300, ECO:0000269|PubMed:9150739,
CC       ECO:0000269|PubMed:9298829, ECO:0000269|PubMed:9668168}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An
CC       aggressive pediatric myelodysplastic syndrome/myeloproliferative
CC       disorder characterized by malignant transformation in the
CC       hematopoietic stem cell compartment with proliferation of
CC       differentiated progeny. Patients have splenomegaly, enlarged lymph
CC       nodes, rashes, and hemorrhages. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Watson syndrome (WTSN) [MIM:193520]: A syndrome
CC       characterized by the presence of pulmonary stenosis, cafe-au-lait
CC       spots, and mental retardation. It is considered as an atypical
CC       form of neurofibromatosis. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Familial spinal neurofibromatosis (FSNF) [MIM:162210]:
CC       Considered to be an alternative form of neurofibromatosis, showing
CC       multiple spinal tumors. {ECO:0000269|PubMed:11704931}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]:
CC       Characterized by manifestations of both NF1 and Noonan syndrome
CC       (NS). NS is a disorder characterized by dysmorphic facial
CC       features, short stature, hypertelorism, cardiac anomalies,
CC       deafness, motor delay, and a bleeding diathesis.
CC       {ECO:0000269|PubMed:12707950, ECO:0000269|PubMed:16380919,
CC       ECO:0000269|PubMed:19845691}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease
CC       characterized by malignant lesions arising from the inner wall of
CC       the large intestine (the colon) and the rectum. Genetic
CC       alterations are often associated with progression from
CC       premalignant lesion (adenoma) to invasive adenocarcinoma. Risk
CC       factors for cancer of the colon and rectum include colon polyps,
CC       long-standing ulcerative colitis, and genetic family history.
CC       Note=The gene represented in this entry may be involved in disease
CC       pathogenesis.
CC   -!- CAUTION: Was originally thought to be associated with LEOPARD
CC       (LS), an autosomal dominant syndrome.
CC       {ECO:0000305|PubMed:8807336}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA59923.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NF1ID134.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nf1/";
CC   -!- WEB RESOURCE: Name=Mendelian genes neurofibromin 1 (NF1);
CC       Note=Leiden Open Variation Database (LOVD);
CC       URL="http://www.lovd.nl/NF1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M89914; AAA59925.1; -; mRNA.
DR   EMBL; M82814; AAA59924.1; -; mRNA.
DR   EMBL; M60496; AAA59928.1; -; mRNA.
DR   EMBL; D12625; BAA02150.1; -; mRNA.
DR   EMBL; M38106; AAA74897.1; -; mRNA.
DR   EMBL; M38107; AAB59558.1; -; mRNA.
DR   EMBL; D42072; BAA07669.1; -; mRNA.
DR   EMBL; AY796305; AAV50004.1; -; Genomic_DNA.
DR   EMBL; AC004222; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079915; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC134669; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135724; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471147; EAW80272.1; -; Genomic_DNA.
DR   EMBL; CH471147; EAW80275.1; -; Genomic_DNA.
DR   EMBL; AH000834; AAA18483.1; -; Genomic_DNA.
DR   EMBL; Y07853; CAA69179.1; -; Genomic_DNA.
DR   EMBL; U17690; AAB48380.1; -; Genomic_DNA.
DR   EMBL; U17680; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17681; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17682; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17683; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17684; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17685; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17686; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17687; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17688; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17689; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17690; AAB48379.1; -; Genomic_DNA.
DR   EMBL; U17680; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17681; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17682; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17683; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17684; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17685; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17687; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17688; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17689; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17656; AAB48373.1; -; Genomic_DNA.
DR   EMBL; U17659; AAB48374.1; -; Genomic_DNA.
DR   EMBL; U17662; AAB48375.1; -; Genomic_DNA.
DR   EMBL; U17668; AAB48376.1; -; Genomic_DNA.
DR   EMBL; U17667; AAB48376.1; JOINED; Genomic_DNA.
DR   EMBL; U17673; AAB48377.1; -; Genomic_DNA.
DR   EMBL; U17677; AAB48378.1; -; Genomic_DNA.
DR   EMBL; U17676; AAB48378.1; JOINED; Genomic_DNA.
DR   EMBL; M60915; AAA59921.1; -; mRNA.
DR   EMBL; M60915; AAA59922.1; -; mRNA.
DR   EMBL; M61213; AAA59923.1; ALT_INIT; mRNA.
DR   EMBL; S51751; AAB24636.1; -; mRNA.
DR   EMBL; D10490; BAA01371.1; -; mRNA.
DR   CCDS; CCDS11264.1; -. [P21359-2]
DR   CCDS; CCDS42292.1; -. [P21359-1]
DR   CCDS; CCDS45645.1; -. [P21359-5]
DR   PIR; B55282; B55282.
DR   PIR; I78852; I78852.
DR   RefSeq; NP_000258.1; NM_000267.3. [P21359-2]
DR   RefSeq; NP_001035957.1; NM_001042492.2. [P21359-1]
DR   RefSeq; NP_001121619.1; NM_001128147.2. [P21359-5]
DR   UniGene; Hs.113577; -.
DR   PDB; 1NF1; X-ray; 2.50 A; A=1198-1551.
DR   PDB; 2D4Q; X-ray; 2.30 A; A/B=1581-1837.
DR   PDB; 2E2X; X-ray; 2.50 A; A/B=1566-1837.
DR   PDB; 3P7Z; X-ray; 2.65 A; A/B=1566-1837.
DR   PDB; 3PEG; X-ray; 2.52 A; A=1566-1837.
DR   PDB; 3PG7; X-ray; 2.19 A; A/B=1581-1837.
DR   PDBsum; 1NF1; -.
DR   PDBsum; 2D4Q; -.
DR   PDBsum; 2E2X; -.
DR   PDBsum; 3P7Z; -.
DR   PDBsum; 3PEG; -.
DR   PDBsum; 3PG7; -.
DR   ProteinModelPortal; P21359; -.
DR   SMR; P21359; -.
DR   BioGrid; 110836; 107.
DR   IntAct; P21359; 12.
DR   MINT; P21359; -.
DR   STRING; 9606.ENSP00000351015; -.
DR   iPTMnet; P21359; -.
DR   PhosphoSitePlus; P21359; -.
DR   BioMuta; NF1; -.
DR   DMDM; 548350; -.
DR   EPD; P21359; -.
DR   MaxQB; P21359; -.
DR   PaxDb; P21359; -.
DR   PeptideAtlas; P21359; -.
DR   PRIDE; P21359; -.
DR   Ensembl; ENST00000356175; ENSP00000348498; ENSG00000196712. [P21359-2]
DR   Ensembl; ENST00000358273; ENSP00000351015; ENSG00000196712. [P21359-1]
DR   Ensembl; ENST00000431387; ENSP00000412921; ENSG00000196712. [P21359-5]
DR   Ensembl; ENST00000487476; ENSP00000491589; ENSG00000196712. [P21359-3]
DR   GeneID; 4763; -.
DR   KEGG; hsa:4763; -.
DR   UCSC; uc002hgf.3; human. [P21359-1]
DR   CTD; 4763; -.
DR   DisGeNET; 4763; -.
DR   EuPathDB; HostDB:ENSG00000196712.16; -.
DR   GeneCards; NF1; -.
DR   GeneReviews; NF1; -.
DR   HGNC; HGNC:7765; NF1.
DR   HPA; HPA045502; -.
DR   MalaCards; NF1; -.
DR   MIM; 114500; phenotype.
DR   MIM; 162200; phenotype.
DR   MIM; 162210; phenotype.
DR   MIM; 193520; phenotype.
DR   MIM; 601321; phenotype.
DR   MIM; 607785; phenotype.
DR   MIM; 613113; gene.
DR   neXtProt; NX_P21359; -.
DR   OpenTargets; ENSG00000196712; -.
DR   Orphanet; 97685; 17q11 microdeletion syndrome.
DR   Orphanet; 139474; 17q11.2 microduplication syndrome.
DR   Orphanet; 86834; Juvenile myelomonocytic leukemia.
DR   Orphanet; 363700; Neurofibromatosis type 1 due to NF1mutation or intragenic deletion.
DR   Orphanet; 638; Neurofibromatosis-Noonan syndrome.
DR   PharmGKB; PA31572; -.
DR   eggNOG; KOG1826; Eukaryota.
DR   eggNOG; ENOG410XRPJ; LUCA.
DR   GeneTree; ENSGT00550000074797; -.
DR   HOGENOM; HOG000047020; -.
DR   HOVERGEN; HBG006486; -.
DR   InParanoid; P21359; -.
DR   KO; K08052; -.
DR   OMA; YYAKPYE; -.
DR   OrthoDB; EOG091G03FI; -.
DR   PhylomeDB; P21359; -.
DR   TreeFam; TF300302; -.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   Reactome; R-HSA-6802953; RAS signaling downstream of NF1 loss-of-function variants.
DR   SignaLink; P21359; -.
DR   SIGNOR; P21359; -.
DR   ChiTaRS; NF1; human.
DR   EvolutionaryTrace; P21359; -.
DR   GeneWiki; Neurofibromin_1; -.
DR   GenomeRNAi; 4763; -.
DR   PRO; PR:P21359; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000196712; -.
DR   CleanEx; HS_NF1; -.
DR   ExpressionAtlas; P21359; baseline and differential.
DR   Genevisible; P21359; HS.
DR   GO; GO:0030424; C:axon; IDA:HGNC.
DR   GO; GO:0005737; C:cytoplasm; ISS:HGNC.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IDA:HGNC.
DR   GO; GO:0031235; C:intrinsic component of the cytoplasmic side of the plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:HGNC.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:UniProtKB.
DR   GO; GO:0031210; F:phosphatidylcholine binding; IDA:UniProtKB.
DR   GO; GO:0008429; F:phosphatidylethanolamine binding; IDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISS:HGNC.
DR   GO; GO:0030325; P:adrenal gland development; ISS:HGNC.
DR   GO; GO:0021764; P:amygdala development; IEA:Ensembl.
DR   GO; GO:0048844; P:artery morphogenesis; ISS:HGNC.
DR   GO; GO:0007420; P:brain development; ISS:HGNC.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; ISS:HGNC.
DR   GO; GO:0007154; P:cell communication; ISS:HGNC.
DR   GO; GO:0034605; P:cellular response to heat; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; ISS:HGNC.
DR   GO; GO:0050890; P:cognition; IMP:HGNC.
DR   GO; GO:0030199; P:collagen fibril organization; ISS:HGNC.
DR   GO; GO:0030198; P:extracellular matrix organization; ISS:HGNC.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl.
DR   GO; GO:0021897; P:forebrain astrocyte development; ISS:HGNC.
DR   GO; GO:0048853; P:forebrain morphogenesis; ISS:HGNC.
DR   GO; GO:0061534; P:gamma-aminobutyric acid secretion, neurotransmission; IEA:Ensembl.
DR   GO; GO:0061535; P:glutamate secretion, neurotransmission; IEA:Ensembl.
DR   GO; GO:0048820; P:hair follicle maturation; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; ISS:HGNC.
DR   GO; GO:0001889; P:liver development; ISS:HGNC.
DR   GO; GO:0000165; P:MAPK cascade; ISS:HGNC.
DR   GO; GO:0001656; P:metanephros development; ISS:HGNC.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; ISS:HGNC.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:MGI.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:HGNC.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; ISS:UniProtKB.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; ISS:HGNC.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; IMP:MGI.
DR   GO; GO:0007406; P:negative regulation of neuroblast proliferation; ISS:HGNC.
DR   GO; GO:0046929; P:negative regulation of neurotransmitter secretion; IEA:Ensembl.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:HGNC.
DR   GO; GO:0045671; P:negative regulation of osteoclast differentiation; IEA:Ensembl.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:HGNC.
DR   GO; GO:0035021; P:negative regulation of Rac protein signal transduction; IEA:Ensembl.
DR   GO; GO:0046580; P:negative regulation of Ras protein signal transduction; IBA:GO_Central.
DR   GO; GO:0042992; P:negative regulation of transcription factor import into nucleus; ISS:HGNC.
DR   GO; GO:0021915; P:neural tube development; IEA:Ensembl.
DR   GO; GO:0098597; P:observational learning; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; ISS:HGNC.
DR   GO; GO:0007422; P:peripheral nervous system development; ISS:HGNC.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; ISS:HGNC.
DR   GO; GO:0043473; P:pigmentation; ISS:HGNC.
DR   GO; GO:0045762; P:positive regulation of adenylate cyclase activity; ISS:HGNC.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:HGNC.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISS:HGNC.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISS:HGNC.
DR   GO; GO:0045765; P:regulation of angiogenesis; IMP:HGNC.
DR   GO; GO:0043535; P:regulation of blood vessel endothelial cell migration; IMP:HGNC.
DR   GO; GO:0045124; P:regulation of bone resorption; ISS:HGNC.
DR   GO; GO:0001952; P:regulation of cell-matrix adhesion; ISS:HGNC.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0045685; P:regulation of glial cell differentiation; ISS:HGNC.
DR   GO; GO:0043087; P:regulation of GTPase activity; IMP:HGNC.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl.
DR   GO; GO:1900271; P:regulation of long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; ISS:HGNC.
DR   GO; GO:0014044; P:Schwann cell development; ISS:HGNC.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0048745; P:smooth muscle tissue development; ISS:HGNC.
DR   GO; GO:0021510; P:spinal cord development; ISS:HGNC.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISS:HGNC.
DR   GO; GO:0008542; P:visual learning; ISS:HGNC.
DR   GO; GO:0042060; P:wound healing; ISS:HGNC.
DR   CDD; cd00170; SEC14; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.40.525.10; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR001251; CRAL-TRIO_dom.
DR   InterPro; IPR036865; CRAL-TRIO_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR023152; RasGAP_CS.
DR   InterPro; IPR001936; RasGAP_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   Pfam; PF13716; CRAL_TRIO_2; 1.
DR   Pfam; PF00616; RasGAP; 1.
DR   SMART; SM00323; RasGAP; 1.
DR   SMART; SM00516; SEC14; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF48371; SSF48371; 4.
DR   PROSITE; PS50191; CRAL_TRIO; 1.
DR   PROSITE; PS00509; RAS_GTPASE_ACTIV_1; 1.
DR   PROSITE; PS50018; RAS_GTPASE_ACTIV_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; GTPase activation; Lipid-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; RNA editing;
KW   Tumor suppressor.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P97526}.
FT   CHAIN         2   2839       Neurofibromin.
FT                                /FTId=PRO_0000010773.
FT   CHAIN         2   1305       Neurofibromin truncated.
FT                                /FTId=PRO_0000010774.
FT   DOMAIN     1235   1451       Ras-GAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00167}.
FT   DOMAIN     1580   1738       CRAL-TRIO. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00056}.
FT   REGION     1580   1837       Lipid binding.
FT   MOTIF      2555   2571       Bipartite nuclear localization signal.
FT   COMPBIAS   1352   1355       Poly-Ser.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:P97526}.
FT   MOD_RES     864    864       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     876    876       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2188   2188       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2467   2467       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q04690}.
FT   MOD_RES    2514   2514       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q04690}.
FT   MOD_RES    2515   2515       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2521   2521       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2523   2523       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2543   2543       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2565   2565       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2597   2597       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2802   2802       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2817   2817       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     548    551       ALLV -> VRGK (in isoform 3).
FT                                {ECO:0000303|PubMed:1339276}.
FT                                /FTId=VSP_001629.
FT   VAR_SEQ     552   2839       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:1339276}.
FT                                /FTId=VSP_001630.
FT   VAR_SEQ     574    593       SSQMLFYICKKLTSHQMLSS -> RYMYFYFLNSTFKFYFV
FT                                FLS (in isoform 5).
FT                                {ECO:0000303|PubMed:7570581}.
FT                                /FTId=VSP_043467.
FT   VAR_SEQ     594   2839       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:7570581}.
FT                                /FTId=VSP_043468.
FT   VAR_SEQ    1371   1391       Missing (in isoform 1 and isoform 6).
FT                                {ECO:0000303|PubMed:1457041,
FT                                ECO:0000303|PubMed:1783401,
FT                                ECO:0000303|PubMed:1923522,
FT                                ECO:0000303|PubMed:2114220,
FT                                ECO:0000303|PubMed:2116237,
FT                                ECO:0000303|PubMed:2134734}.
FT                                /FTId=VSP_001628.
FT   VAR_SEQ    1591   1598       SIFYQAGT -> TPPPEPET (in isoform 4).
FT                                {ECO:0000303|PubMed:2121370}.
FT                                /FTId=VSP_001631.
FT   VAR_SEQ    1599   2839       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:2121370}.
FT                                /FTId=VSP_001632.
FT   VAR_SEQ    2792   2792       P -> PASLPCSNSAVFMQLFPHQ (in isoform 6).
FT                                {ECO:0000303|PubMed:2116237}.
FT                                /FTId=VSP_053587.
FT   VARIANT      31     31       H -> R (in NF1; dbSNP:rs199474725).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032459.
FT   VARIANT      74     74       A -> D (in mismatch repair deficient
FT                                cancer cells; dbSNP:rs199474726).
FT                                {ECO:0000269|PubMed:12522551}.
FT                                /FTId=VAR_017550.
FT   VARIANT      80     80       Y -> C (in dbSNP:rs4795581).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_022254.
FT   VARIANT      80     80       Y -> S (in dbSNP:rs4795581).
FT                                /FTId=VAR_049135.
FT   VARIANT      82     82       S -> F (in NF1; dbSNP:rs199474729).
FT                                {ECO:0000269|PubMed:11857752}.
FT                                /FTId=VAR_021730.
FT   VARIANT      93     93       C -> W (in NF1).
FT                                {ECO:0000269|PubMed:23758643}.
FT                                /FTId=VAR_071668.
FT   VARIANT      93     93       C -> Y (in NF1; dbSNP:rs199474728).
FT                                {ECO:0000269|PubMed:12522551}.
FT                                /FTId=VAR_017551.
FT   VARIANT     117    117       I -> S (in NF1; dbSNP:rs199474731).
FT                                {ECO:0000269|PubMed:10607834}.
FT                                /FTId=VAR_010989.
FT   VARIANT     145    145       L -> P (in NF1; dbSNP:rs199474734).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032460.
FT   VARIANT     157    157       I -> N (in NF1; dbSNP:rs199474744).
FT                                {ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021731.
FT   VARIANT     160    160       R -> T (in NF1; dbSNP:rs199474752).
FT                                {ECO:0000269|PubMed:21838856}.
FT                                /FTId=VAR_065888.
FT   VARIANT     176    176       D -> E (found in mismatch repair
FT                                deficient cancer cells; also found in a
FT                                cutaneous neurofibroma from a patient
FT                                with neurofibromatosis; somatic mutation;
FT                                dbSNP:rs112306990).
FT                                {ECO:0000269|PubMed:10712197,
FT                                ECO:0000269|PubMed:12522551,
FT                                ECO:0000269|PubMed:15060124,
FT                                ECO:0000269|PubMed:15146469,
FT                                ECO:0000269|PubMed:22108604}.
FT                                /FTId=VAR_017552.
FT   VARIANT     186    186       D -> V (in NF1; reduced splicing
FT                                enhancement).
FT                                {ECO:0000269|PubMed:15523642}.
FT                                /FTId=VAR_032461.
FT   VARIANT     194    194       L -> R (in NFNS; dbSNP:rs199474753).
FT                                {ECO:0000269|PubMed:16380919}.
FT                                /FTId=VAR_032462.
FT   VARIANT     216    216       L -> P (in NF1; dbSNP:rs199474756).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021732.
FT   VARIANT     324    324       C -> R (in NF1; dbSNP:rs199474735).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032463.
FT   VARIANT     330    330       A -> T (in a cutaneous neurofibroma from
FT                                a patient with neurofibromatosis; somatic
FT                                mutation; dbSNP:rs199474767).
FT                                {ECO:0000269|PubMed:22108604}.
FT                                /FTId=VAR_067201.
FT   VARIANT     337    337       E -> V (in NF1; dbSNP:rs199474736).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032464.
FT   VARIANT     338    338       D -> G (in NF1; dbSNP:rs199474773).
FT                                {ECO:0000269|PubMed:9298829}.
FT                                /FTId=VAR_010990.
FT   VARIANT     357    357       L -> P (in NF1; dbSNP:rs137854563).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021733.
FT   VARIANT     393    393       H -> D (in a cutaneous neurofibroma from
FT                                a patient with neurofibromatosis; somatic
FT                                mutation; dbSNP:rs199474768).
FT                                {ECO:0000269|PubMed:22108604}.
FT                                /FTId=VAR_067202.
FT   VARIANT     393    393       H -> L (in a cutaneous neurofibroma from
FT                                a patient with neurofibromatosis; somatic
FT                                mutation; dbSNP:rs199474769).
FT                                {ECO:0000269|PubMed:22108604}.
FT                                /FTId=VAR_067203.
FT   VARIANT     489    489       Y -> C (in NF1; dbSNP:rs137854557).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032465.
FT   VARIANT     491    491       Y -> C (in NF1; dbSNP:rs199474757).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021734.
FT   VARIANT     508    508       L -> P (in NF1; dbSNP:rs137854558).
FT                                {ECO:0000269|PubMed:11258625}.
FT                                /FTId=VAR_010991.
FT   VARIANT     519    519       Q -> P (in a cutaneous neurofibroma from
FT                                a patient with neurofibromatosis; somatic
FT                                mutation; dbSNP:rs199474770).
FT                                {ECO:0000269|PubMed:22108604}.
FT                                /FTId=VAR_067204.
FT   VARIANT     532    532       L -> P (in NF1; dbSNP:rs199474737).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032466.
FT   VARIANT     549    549       L -> P (in NF1; dbSNP:rs199474758).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021735.
FT   VARIANT     574    574       S -> R (in NF1).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032467.
FT   VARIANT     578    578       L -> R (in NF1; dbSNP:rs199474774).
FT                                {ECO:0000269|PubMed:12746402}.
FT                                /FTId=VAR_021736.
FT   VARIANT     581    581       I -> T (in NF1; dbSNP:rs199474759).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021737.
FT   VARIANT     583    583       K -> R (in NF1; dbSNP:rs199474760).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021738.
FT   VARIANT     604    604       L -> V (in NF1; dbSNP:rs142712751).
FT                                {ECO:0000269|PubMed:12522551}.
FT                                /FTId=VAR_017553.
FT   VARIANT     629    629       G -> R (in NF1; affects splicing by
FT                                creating a novel splice acceptor site;
FT                                dbSNP:rs199474738).
FT                                {ECO:0000269|PubMed:15060124,
FT                                ECO:0000269|PubMed:15146469,
FT                                ECO:0000269|PubMed:8834249}.
FT                                /FTId=VAR_002653.
FT   VARIANT     665    665       S -> F (in NF1; unknown pathological
FT                                significance; dbSNP:rs145891889).
FT                                {ECO:0000269|PubMed:10712197,
FT                                ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_021739.
FT   VARIANT     678    678       P -> L (in dbSNP:rs17881753).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_022255.
FT   VARIANT     695    695       L -> P (in NF1; dbSNP:rs199474761).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021740.
FT   VARIANT     712    712       H -> R (in mismatch repair deficient
FT                                cancer cells; dbSNP:rs199474727).
FT                                {ECO:0000269|PubMed:12522551}.
FT                                /FTId=VAR_017554.
FT   VARIANT     763    763       L -> P (in NF1; dbSNP:rs199474762).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021741.
FT   VARIANT     765    765       R -> H (in dbSNP:rs199474777).
FT                                {ECO:0000269|PubMed:10336779}.
FT                                /FTId=VAR_021742.
FT   VARIANT     776    776       A -> T (in a cutaneous neurofibroma from
FT                                a patient with neurofibromatosis; somatic
FT                                mutation; dbSNP:rs199474771).
FT                                {ECO:0000269|PubMed:22108604}.
FT                                /FTId=VAR_067205.
FT   VARIANT     777    777       W -> S (in NF1; dbSNP:rs199474745).
FT                                {ECO:0000269|PubMed:10712197,
FT                                ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021743.
FT   VARIANT     780    780       T -> K (in NF1; dbSNP:rs199474746).
FT                                {ECO:0000269|PubMed:10712197,
FT                                ECO:0000269|PubMed:11735023,
FT                                ECO:0000269|PubMed:12552569,
FT                                ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021744.
FT   VARIANT     781    781       H -> P (in NF1; dbSNP:rs199474763).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021745.
FT   VARIANT     784    784       W -> C (in NF1; dbSNP:rs199474778).
FT                                {ECO:0000269|PubMed:11735023}.
FT                                /FTId=VAR_021746.
FT   VARIANT     784    784       W -> R (in NF1; dbSNP:rs199474730).
FT                                {ECO:0000269|PubMed:11857752,
FT                                ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021747.
FT   VARIANT     844    844       L -> F (in NF1; dbSNP:rs199474785).
FT                                {ECO:0000269|PubMed:10980545,
FT                                ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_010992.
FT   VARIANT     844    844       L -> P (in NF1; dbSNP:rs137854566).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032468.
FT   VARIANT     844    844       L -> R (in NF1; sporadic;
FT                                dbSNP:rs137854566).
FT                                {ECO:0000269|PubMed:12522551,
FT                                ECO:0000269|PubMed:15948193,
FT                                ECO:0000269|PubMed:9150739}.
FT                                /FTId=VAR_002654.
FT   VARIANT     847    847       L -> P (in NF1; dbSNP:rs199474747).
FT                                {ECO:0000269|PubMed:10712197,
FT                                ECO:0000269|PubMed:12552569,
FT                                ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021748.
FT   VARIANT     848    848       G -> E (in NF1; dbSNP:rs199474748).
FT                                {ECO:0000269|PubMed:12552569,
FT                                ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021749.
FT   VARIANT     873    873       R -> C (in dbSNP:rs199474739).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032469.
FT   VARIANT     898    898       L -> P (in NF1; sporadic;
FT                                dbSNP:rs199474786).
FT                                {ECO:0000269|PubMed:12522551,
FT                                ECO:0000269|PubMed:9150739}.
FT                                /FTId=VAR_002655.
FT   VARIANT     920    920       L -> P (in NF1; patient with cafe-au-lait
FT                                spots; may be a distinct form of NF1;
FT                                dbSNP:rs199474775).
FT                                {ECO:0000269|PubMed:12746402}.
FT                                /FTId=VAR_021750.
FT   VARIANT     968    968       M -> R (in NF1; dbSNP:rs199474749).
FT                                {ECO:0000269|PubMed:12552569,
FT                                ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021751.
FT   VARIANT     991    991       Missing (in NF1; most patients carrying
FT                                the mutation do not manifest cutaneous
FT                                neurofibromas).
FT                                {ECO:0000269|PubMed:15060124,
FT                                ECO:0000269|PubMed:17160901,
FT                                ECO:0000269|PubMed:7904209}.
FT                                /FTId=VAR_002656.
FT   VARIANT    1035   1035       M -> R (in NF1; dbSNP:rs137854553).
FT                                {ECO:0000269|PubMed:8807336}.
FT                                /FTId=VAR_002657.
FT   VARIANT    1048   1048       W -> R (in NF1).
FT                                {ECO:0000269|PubMed:23758643}.
FT                                /FTId=VAR_071669.
FT   VARIANT    1073   1073       M -> V (in NF1; dbSNP:rs199474740).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032470.
FT   VARIANT    1147   1147       L -> P (in NF1; dbSNP:rs199474779).
FT                                {ECO:0000269|PubMed:11735023}.
FT                                /FTId=VAR_021752.
FT   VARIANT    1156   1156       N -> S (in NF1; dbSNP:rs199474764).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021753.
FT   VARIANT    1166   1166       G -> D (in NF1; dbSNP:rs199474787).
FT                                {ECO:0000269|PubMed:7981679}.
FT                                /FTId=VAR_010993.
FT   VARIANT    1187   1187       L -> I (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035543.
FT   VARIANT    1189   1189       Q -> R (in NF1; dbSNP:rs752039618).
FT                                {ECO:0000269|PubMed:23758643}.
FT                                /FTId=VAR_071670.
FT   VARIANT    1193   1193       F -> C (in NF1; dbSNP:rs199474780).
FT                                {ECO:0000269|PubMed:11735023}.
FT                                /FTId=VAR_021754.
FT   VARIANT    1196   1196       L -> R (in NF1; dbSNP:rs199474741).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032471.
FT   VARIANT    1204   1204       R -> G (in NF1; dbSNP:rs199474732).
FT                                {ECO:0000269|PubMed:10336779}.
FT                                /FTId=VAR_021755.
FT   VARIANT    1204   1204       R -> W (in NF1; dbSNP:rs199474732).
FT                                {ECO:0000269|PubMed:10607834}.
FT                                /FTId=VAR_010994.
FT   VARIANT    1243   1243       L -> P (in NF1; with neurofibromatous
FT                                neuropathy; dbSNP:rs137854564).
FT                                {ECO:0000269|PubMed:15520408}.
FT                                /FTId=VAR_032472.
FT   VARIANT    1250   1250       R -> P (in NF1; dbSNP:rs199474765).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021756.
FT   VARIANT    1276   1276       R -> G (in NF1; dbSNP:rs199474742).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032473.
FT   VARIANT    1276   1276       R -> P (in NF1; complete loss of GAP
FT                                activity; dbSNP:rs137854556).
FT                                {ECO:0000269|PubMed:10712197,
FT                                ECO:0000269|PubMed:9668168}.
FT                                /FTId=VAR_010995.
FT   VARIANT    1276   1276       R -> Q (in NF1 and mismatch repair
FT                                deficient cancer cells;
FT                                dbSNP:rs137854556).
FT                                {ECO:0000269|PubMed:10712197,
FT                                ECO:0000269|PubMed:12522551,
FT                                ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_017555.
FT   VARIANT    1411   1411       L -> F (in NFNS; dbSNP:rs199474789).
FT                                {ECO:0000269|PubMed:19845691}.
FT                                /FTId=VAR_065236.
FT   VARIANT    1412   1412       R -> S (in NF1; significant reduction of
FT                                GAP activity; dbSNP:rs137854554).
FT                                {ECO:0000269|PubMed:9003501}.
FT                                /FTId=VAR_010996.
FT   VARIANT    1422   1422       Y -> H (in dbSNP:rs17884349).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_022256.
FT   VARIANT    1430   1430       K -> E (in NF1).
FT                                {ECO:0000269|PubMed:15060124}.
FT                                /FTId=VAR_032474.
FT   VARIANT    1440   1440       K -> Q (in NF1; dbSNP:rs199474790).
FT                                {ECO:0000269|PubMed:9003501}.
FT                                /FTId=VAR_010997.
FT   VARIANT    1440   1440       K -> R (in NF1; dbSNP:rs199474788).
FT                                {ECO:0000269|PubMed:7981679}.
FT                                /FTId=VAR_002658.
FT   VARIANT    1444   1444       K -> E (in NF1 and NFNS; significant
FT                                reduction of intrinsic GAP activity;
FT                                dbSNP:rs137854550).
FT                                {ECO:0000269|PubMed:11857752,
FT                                ECO:0000269|PubMed:1568247,
FT                                ECO:0000269|PubMed:16380919,
FT                                ECO:0000269|PubMed:9003501}.
FT                                /FTId=VAR_002659.
FT   VARIANT    1444   1444       K -> N (in NF1; dbSNP:rs199474750).
FT                                {ECO:0000269|PubMed:12552569,
FT                                ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021757.
FT   VARIANT    1444   1444       K -> R (in NF1; dbSNP:rs199474781).
FT                                {ECO:0000269|PubMed:11735023}.
FT                                /FTId=VAR_021758.
FT   VARIANT    1446   1446       L -> P (in NF1; dbSNP:rs199474733).
FT                                {ECO:0000269|PubMed:10220149,
FT                                ECO:0000269|PubMed:10607834,
FT                                ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_008129.
FT   VARIANT    1451   1451       N -> T (in NFNS; dbSNP:rs199474754).
FT                                {ECO:0000269|PubMed:16380919}.
FT                                /FTId=VAR_032475.
FT   VARIANT    1453   1453       V -> L (in NFNS; dbSNP:rs199474755).
FT                                {ECO:0000269|PubMed:16380919}.
FT                                /FTId=VAR_032476.
FT   VARIANT    1459   1459       Missing (in NFNS).
FT                                {ECO:0000269|PubMed:12707950,
FT                                ECO:0000269|PubMed:15060124,
FT                                ECO:0000269|PubMed:16380919}.
FT                                /FTId=VAR_032477.
FT   VARIANT    1484   1484       S -> F (in a cutaneous neurofibroma from
FT                                a patient with neurofibromatosis; somatic
FT                                mutation; dbSNP:rs199474772).
FT                                {ECO:0000269|PubMed:22108604}.
FT                                /FTId=VAR_067206.
FT   VARIANT    1489   1489       S -> G (in NF1; dbSNP:rs199474743).
FT                                {ECO:0000269|PubMed:15060124,
FT                                ECO:0000269|PubMed:9003501}.
FT                                /FTId=VAR_010998.
FT   VARIANT    1605   1605       I -> V (in NF1; reduces protein
FT                                stability; dbSNP:rs199474766).
FT                                {ECO:0000269|PubMed:10712197,
FT                                ECO:0000269|PubMed:21089070}.
FT                                /FTId=VAR_021759.
FT   VARIANT    1611   1611       R -> W (in NF1).
FT                                {ECO:0000269|PubMed:9298829}.
FT                                /FTId=VAR_002660.
FT   VARIANT    1733   1733       L -> LGHEQQKLPAATLAL (in NF1).
FT                                {ECO:0000269|PubMed:8317503}.
FT                                /FTId=VAR_002661.
FT   VARIANT    1785   1785       A -> S (in NF1; dbSNP:rs199474782).
FT                                {ECO:0000269|PubMed:11735023}.
FT                                /FTId=VAR_021760.
FT   VARIANT    1951   1951       P -> L (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035544.
FT   VARIANT    1952   1952       W -> R (in NF1; dbSNP:rs199474791).
FT                                {ECO:0000269|PubMed:9101300}.
FT                                /FTId=VAR_002662.
FT   VARIANT    1953   1953       L -> P (in NF1; dbSNP:rs199474792).
FT                                {ECO:0000269|PubMed:2114220}.
FT                                /FTId=VAR_002663.
FT   VARIANT    1953   1953       Missing (in NF1).
FT                                {ECO:0000269|PubMed:12552569,
FT                                ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021761.
FT   VARIANT    2001   2001       G -> R (in NF1; dbSNP:rs199474751).
FT                                {ECO:0000269|PubMed:12552569,
FT                                ECO:0000269|PubMed:15146469}.
FT                                /FTId=VAR_021762.
FT   VARIANT    2012   2012       D -> N (in NF1; dbSNP:rs199474783).
FT                                {ECO:0000269|PubMed:11735023}.
FT                                /FTId=VAR_021763.
FT   VARIANT    2088   2088       L -> P (in FSNF; no cafe-au-lait macules;
FT                                null mutation; 50% reduction of protein
FT                                level; dbSNP:rs137854561).
FT                                {ECO:0000269|PubMed:11704931}.
FT                                /FTId=VAR_017669.
FT   VARIANT    2125   2125       L -> P (in NF1).
FT                                {ECO:0000269|PubMed:24413922}.
FT                                /FTId=VAR_071671.
FT   VARIANT    2164   2164       L -> M (in NF1; dbSNP:rs137854551).
FT                                {ECO:0000269|PubMed:1302608}.
FT                                /FTId=VAR_002664.
FT   VARIANT    2192   2192       Y -> N (in NF1; dbSNP:rs267606598).
FT                                {ECO:0000269|PubMed:1302608}.
FT                                /FTId=VAR_002665.
FT   VARIANT    2221   2221       P -> A (in NF1; dbSNP:rs199474776).
FT                                {ECO:0000269|PubMed:12746402}.
FT                                /FTId=VAR_021764.
FT   VARIANT    2357   2357       E -> K (in NF1; dbSNP:rs199474784).
FT                                {ECO:0000269|PubMed:11735023}.
FT                                /FTId=VAR_021765.
FT   VARIANT    2387   2388       Missing (in NF1).
FT                                {ECO:0000269|PubMed:10607834,
FT                                ECO:0000269|PubMed:8081387}.
FT                                /FTId=VAR_002666.
FT   VARIANT    2507   2507       T -> I (in NF1; dbSNP:rs149055633).
FT                                {ECO:0000269|PubMed:10712197}.
FT                                /FTId=VAR_021766.
FT   VARIANT    2511   2511       V -> L (in dbSNP:rs2230850).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_022257.
FT   VARIANT    2631   2631       T -> A (in NF1; dbSNP:rs199474793).
FT                                {ECO:0000269|PubMed:8544190}.
FT                                /FTId=VAR_002667.
FT   VARIANT    2745   2745       G -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035545.
FT   MUTAGEN    1691   1691       K->A: Reduces phospholipid binding; when
FT                                associated with A-1695; A-1769 and A-
FT                                1771. {ECO:0000269|PubMed:16397625}.
FT   MUTAGEN    1695   1695       R->A: Reduces phospholipid binding; when
FT                                associated with A-1691; A-1769 and A-
FT                                1771. {ECO:0000269|PubMed:16397625}.
FT   MUTAGEN    1769   1769       R->A: Reduces phospholipid binding; when
FT                                associated with A-1691; A-1695 and A-
FT                                1771. {ECO:0000269|PubMed:16397625}.
FT   MUTAGEN    1771   1771       K->A: Reduces phospholipid binding; when
FT                                associated with A-1691; A-169 and A-1769.
FT                                {ECO:0000269|PubMed:16397625,
FT                                ECO:0000269|PubMed:21089070}.
FT   MUTAGEN    1771   1771       Missing: Reduces protein stability.
FT                                {ECO:0000269|PubMed:16397625,
FT                                ECO:0000269|PubMed:21089070}.
FT   CONFLICT    496    496       M -> I (in Ref. 11; AAA74897/AAB59558).
FT                                {ECO:0000305}.
FT   CONFLICT   1094   1095       EL -> ST (in Ref. 14; AAA59923).
FT                                {ECO:0000305}.
FT   CONFLICT   1576   1576       H -> HH (in Ref. 11; AAA74897/AAB59558).
FT                                {ECO:0000305}.
FT   HELIX      1208   1216       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1224   1228       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1233   1235       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1236   1248       {ECO:0000244|PDB:1NF1}.
FT   TURN       1249   1251       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1253   1263       {ECO:0000244|PDB:1NF1}.
FT   STRAND     1266   1270       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1282   1293       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1296   1299       {ECO:0000244|PDB:1NF1}.
FT   STRAND     1300   1302       {ECO:0000244|PDB:1NF1}.
FT   TURN       1335   1337       {ECO:0000244|PDB:1NF1}.
FT   TURN       1339   1342       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1343   1352       {ECO:0000244|PDB:1NF1}.
FT   TURN       1353   1356       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1361   1370       {ECO:0000244|PDB:1NF1}.
FT   TURN       1394   1396       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1402   1412       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1414   1419       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1434   1440       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1442   1451       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1462   1464       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1465   1470       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1472   1481       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1510   1514       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1517   1520       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1535   1544       {ECO:0000244|PDB:1NF1}.
FT   HELIX      1569   1578       {ECO:0000244|PDB:3P7Z}.
FT   TURN       1582   1586       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1587   1590       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1592   1598       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1604   1609       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1610   1612       {ECO:0000244|PDB:3PG7}.
FT   TURN       1615   1617       {ECO:0000244|PDB:2D4Q}.
FT   HELIX      1620   1631       {ECO:0000244|PDB:3PG7}.
FT   TURN       1632   1636       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1639   1644       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1650   1652       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1656   1661       {ECO:0000244|PDB:3PG7}.
FT   TURN       1662   1664       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1668   1672       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1674   1681       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1684   1692       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1694   1697       {ECO:0000244|PDB:3PG7}.
FT   TURN       1698   1702       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1706   1711       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1714   1717       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1721   1723       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1728   1732       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1738   1749       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1751   1757       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1759   1767       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1770   1772       {ECO:0000244|PDB:2D4Q}.
FT   STRAND     1775   1777       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1780   1784       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1785   1787       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1788   1795       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1798   1803       {ECO:0000244|PDB:3PG7}.
FT   STRAND     1810   1813       {ECO:0000244|PDB:3PG7}.
FT   HELIX      1817   1833       {ECO:0000244|PDB:3PG7}.
SQ   SEQUENCE   2839 AA;  319372 MW;  C079475139DBD51E CRC64;
     MAAHRPVEWV QAVVSRFDEQ LPIKTGQQNT HTKVSTEHNK ECLINISKYK FSLVISGLTT
     ILKNVNNMRI FGEAAEKNLY LSQLIILDTL EKCLAGQPKD TMRLDETMLV KQLLPEICHF
     LHTCREGNQH AAELRNSASG VLFSLSCNNF NAVFSRISTR LQELTVCSED NVDVHDIELL
     QYINVDCAKL KRLLKETAFK FKALKKVAQL AVINSLEKAF WNWVENYPDE FTKLYQIPQT
     DMAECAEKLF DLVDGFAEST KRKAAVWPLQ IILLILCPEI IQDISKDVVD ENNMNKKLFL
     DSLRKALAGH GGSRQLTESA AIACVKLCKA STYINWEDNS VIFLLVQSMV VDLKNLLFNP
     SKPFSRGSQP ADVDLMIDCL VSCFRISPHN NQHFKICLAQ NSPSTFHYVL VNSLHRIITN
     SALDWWPKID AVYCHSVELR NMFGETLHKA VQGCGAHPAI RMAPSLTFKE KVTSLKFKEK
     PTDLETRSYK YLLLSMVKLI HADPKLLLCN PRKQGPETQG STAELITGLV QLVPQSHMPE
     IAQEAMEALL VLHQLDSIDL WNPDAPVETF WEISSQMLFY ICKKLTSHQM LSSTEILKWL
     REILICRNKF LLKNKQADRS SCHFLLFYGV GCDIPSSGNT SQMSMDHEEL LRTPGASLRK
     GKGNSSMDSA AGCSGTPPIC RQAQTKLEVA LYMFLWNPDT EAVLVAMSCF RHLCEEADIR
     CGVDEVSVHN LLPNYNTFME FASVSNMMST GRAALQKRVM ALLRRIEHPT AGNTEAWEDT
     HAKWEQATKL ILNYPKAKME DGQAAESLHK TIVKRRMSHV SGGGSIDLSD TDSLQEWINM
     TGFLCALGGV CLQQRSNSGL ATYSPPMGPV SERKGSMISV MSSEGNADTP VSKFMDRLLS
     LMVCNHEKVG LQIRTNVKDL VGLELSPALY PMLFNKLKNT ISKFFDSQGQ VLLTDTNTQF
     VEQTIAIMKN LLDNHTEGSS EHLGQASIET MMLNLVRYVR VLGNMVHAIQ IKTKLCQLVE
     VMMARRDDLS FCQEMKFRNK MVEYLTDWVM GTSNQAADDD VKCLTRDLDQ ASMEAVVSLL
     AGLPLQPEEG DGVELMEAKS QLFLKYFTLF MNLLNDCSEV EDESAQTGGR KRGMSRRLAS
     LRHCTVLAMS NLLNANVDSG LMHSIGLGYH KDLQTRATFM EVLTKILQQG TEFDTLAETV
     LADRFERLVE LVTMMGDQGE LPIAMALANV VPCSQWDELA RVLVTLFDSR HLLYQLLWNM
     FSKEVELADS MQTLFRGNSL ASKIMTFCFK VYGATYLQKL LDPLLRIVIT SSDWQHVSFE
     VDPTRLEPSE SLEENQRNLL QMTEKFFHAI ISSSSEFPPQ LRSVCHCLYQ ATCHSLLNKA
     TVKEKKENKK SVVSQRFPQN SIGAVGSAMF LRFINPAIVS PYEAGILDKK PPPRIERGLK
     LMSKILQSIA NHVLFTKEEH MRPFNDFVKS NFDAARRFFL DIASDCPTSD AVNHSLSFIS
     DGNVLALHRL LWNNQEKIGQ YLSSNRDHKA VGRRPFDKMA TLLAYLGPPE HKPVADTHWS
     SLNLTSSKFE EFMTRHQVHE KEEFKALKTL SIFYQAGTSK AGNPIFYYVA RRFKTGQING
     DLLIYHVLLT LKPYYAKPYE IVVDLTHTGP SNRFKTDFLS KWFVVFPGFA YDNVSAVYIY
     NCNSWVREYT KYHERLLTGL KGSKRLVFID CPGKLAEHIE HEQQKLPAAT LALEEDLKVF
     HNALKLAHKD TKVSIKVGST AVQVTSAERT KVLGQSVFLN DIYYASEIEE ICLVDENQFT
     LTIANQGTPL TFMHQECEAI VQSIIHIRTR WELSQPDSIP QHTKIRPKDV PGTLLNIALL
     NLGSSDPSLR SAAYNLLCAL TCTFNLKIEG QLLETSGLCI PANNTLFIVS ISKTLAANEP
     HLTLEFLEEC ISGFSKSSIE LKHLCLEYMT PWLSNLVRFC KHNDDAKRQR VTAILDKLIT
     MTINEKQMYP SIQAKIWGSL GQITDLLDVV LDSFIKTSAT GGLGSIKAEV MADTAVALAS
     GNVKLVSSKV IGRMCKIIDK TCLSPTPTLE QHLMWDDIAI LARYMLMLSF NNSLDVAAHL
     PYLFHVVTFL VATGPLSLRA STHGLVINII HSLCTCSQLH FSEETKQVLR LSLTEFSLPK
     FYLLFGISKV KSAAVIAFRS SYRDRSFSPG SYERETFALT SLETVTEALL EIMEACMRDI
     PTCKWLDQWT ELAQRFAFQY NPSLQPRALV VFGCISKRVS HGQIKQIIRI LSKALESCLK
     GPDTYNSQVL IEATVIALTK LQPLLNKDSP LHKALFWVAV AVLQLDEVNL YSAGTALLEQ
     NLHTLDSLRI FNDKSPEEVF MAIRNPLEWH CKQMDHFVGL NFNSNFNFAL VGHLLKGYRH
     PSPAIVARTV RILHTLLTLV NKHRNCDKFE VNTQSVAYLA ALLTVSEEVR SRCSLKHRKS
     LLLTDISMEN VPMDTYPIHH GDPSYRTLKE TQPWSSPKGS EGYLAATYPT VGQTSPRARK
     SMSLDMGQPS QANTKKLLGT RKSFDHLISD TKAPKRQEME SGITTPPKMR RVAETDYEME
     TQRISSSQQH PHLRKVSVSE SNVLLDEEVL TDPKIQALLL TVLATLVKYT TDEFDQRILY
     EYLAEASVVF PKVFPVVHNL LDSKINTLLS LCQDPNLLNP IHGIVQSVVY HEESPPQYQT
     SYLQSFGFNG LWRFAGPFSK QTQIPDYAEL IVKFLDALID TYLPGIDEET SEESLLTPTS
     PYPPALQSQL SITANLNLSN SMTSLATSQH SPGIDKENVE LSPTTGHCNS GRTRHGSASQ
     VQKQRSAGSF KRNSIKKIV
//
ID   A0A024QY88_HUMAN        Unreviewed;       241 AA.
AC   A0A024QY88;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 29.
DE   SubName: Full=Neuregulin 1 isoform HRG-beta3 {ECO:0000313|EMBL:DAA00043.1};
DE   SubName: Full=Neuregulin 1, isoform CRA_g {ECO:0000313|EMBL:EAW63413.1};
GN   Name=NRG1 {ECO:0000313|EMBL:DAA00043.1};
GN   ORFNames=hCG_14780 {ECO:0000313|EMBL:EAW63413.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:DAA00043.1};
RN   [1] {ECO:0000313|EMBL:EAW63413.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:DAA00043.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12145742; DOI=10.1086/342734;
RA   Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S.,
RA   Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S.,
RA   Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H.,
RA   Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B.,
RA   Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D.,
RA   Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J.,
RA   Johannesson G., Andresson T., Gudbjartsson D., Manolescu A.,
RA   Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H.,
RA   Stefansson K.;
RT   "Neuregulin 1 and susceptibility to Schizophrenia.";
RL   Am. J. Hum. Genet. 71:877-892(2002).
RN   [3] {ECO:0000313|EMBL:EAW63413.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BK000383; DAA00043.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63413.1; -; Genomic_DNA.
DR   RefSeq; NP_039252.2; NM_013958.3.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   SMR; A0A024QY88; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   4: Predicted;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DOMAIN       37    128       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      178    222       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    212    221       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   241 AA;  26143 MW;  D2450DB340E6B64D CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCPNEFTGDR CQNYVMASFY STSTPFLSLP
     E
//
ID   A5YAK6_HUMAN            Unreviewed;       214 AA.
AC   A5YAK6;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 38.
DE   SubName: Full=Neuregulin 1 variant fetal a IV 1 {ECO:0000313|EMBL:ABQ53541.1};
GN   Name=NRG1 {ECO:0000313|EMBL:ABQ53541.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ53541.1};
RN   [1] {ECO:0000313|EMBL:ABQ53541.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABQ53541.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J.,
RA   Weinberger D.R., Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional
RT   promoter variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF372275; ABQ53541.1; -; mRNA.
DR   RefSeq; NP_001309130.1; NM_001322201.1.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   ProteinModelPortal; A5YAK6; -.
DR   MaxQB; A5YAK6; -.
DR   PeptideAtlas; A5YAK6; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HOVERGEN; HBG053796; -.
DR   ChiTaRS; NRG1; human.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       16    107       Ig-like. {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   214 AA;  23059 MW;  2FE14468A5E76AB0 CRC64;
     MGKGRAGRVG TTALPPQLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNEIITGMPA
     STEGAYVSSA TSTSTTGASH LVKCAEKEKT FCVNGGECFM VKDLSNPSRY LCKGGGAVPE
     ESADHNRHLH RPPCGRHHVF GGLLQNQETA EKAA
//
ID   A5YAK8_HUMAN            Unreviewed;       197 AA.
AC   A5YAK8;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 39.
DE   SubName: Full=Neuregulin 1 variant fetal c IV 2 {ECO:0000313|EMBL:ABQ53543.1};
GN   Name=NRG1 {ECO:0000313|EMBL:ABQ53543.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ53543.1};
RN   [1] {ECO:0000313|EMBL:ABQ53543.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABQ53543.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J.,
RA   Weinberger D.R., Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional
RT   promoter variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF372277; ABQ53543.1; -; mRNA.
DR   RefSeq; NP_001309131.1; NM_001322202.1.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   PeptideAtlas; A5YAK8; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HOVERGEN; HBG053796; -.
DR   ChiTaRS; NRG1; human.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       16    107       Ig-like. {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   197 AA;  21422 MW;  817A13843DF40CEE CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNATSTSTTG
     TSHLVKCAEK EKTFCVNGGE CFMVKDLSNP SRYLCKGGGA VPEESADHNR HLHRPPCGRH
     HVFGGLLQNQ ETAEKAA
//
ID   A6MW54_HUMAN            Unreviewed;       454 AA.
AC   A6MW54;
DT   24-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 59.
DE   SubName: Full=Neuregulin 1 type IV fetal A beta 1a {ECO:0000313|EMBL:ABR13842.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABR13842.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABR13842.1};
RN   [1] {ECO:0000313|EMBL:ABR13842.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABR13842.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J.,
RA   Weinberger D.R., Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional
RT   promoter variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF517295; ABR13842.1; -; mRNA.
DR   RefSeq; NP_001309134.1; NM_001322205.1.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   ProteinModelPortal; A6MW54; -.
DR   PeptideAtlas; A6MW54; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HOGENOM; HOG000273863; -.
DR   HOVERGEN; HBG006531; -.
DR   ChiTaRS; NRG1; human.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    193    215       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       16    107       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      123    167       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    157    166       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   NON_TER     454    454       {ECO:0000313|EMBL:ABR13842.1}.
SQ   SEQUENCE   454 AA;  50514 MW;  129727D7A36393FF CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVIGKLGND SASANITIVE SNATSTSTTG
     TSHLVKCAEK EKAFCVNGGE CFMVKDLSNP SRYLCKCPNE FTGDRCQNYV MASFYKHLGI
     EFMEAEELYQ KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM
     NIANGPHHPN PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT
     PSHSWSNGHT ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE
     TPDSYRDSPH SERYVSAMTT PARMSPVDFH TPSSPKSPPS EMSPPVSSMT VSMPSMAVSP
     FMEEERPLLL VTPPRPREKK FDHHPQQFSS FHHN
//
ID   A6MW55_HUMAN            Unreviewed;       498 AA.
AC   A6MW55;
DT   24-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2007, sequence version 1.
DT   31-JAN-2018, entry version 71.
DE   SubName: Full=Neuregulin 1 type IV fetal B beta 1a {ECO:0000313|EMBL:ABR13843.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABR13843.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABR13843.1};
RN   [1] {ECO:0000313|EMBL:ABR13843.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABR13843.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J.,
RA   Weinberger D.R., Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional
RT   promoter variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF517296; ABR13843.1; -; mRNA.
DR   RefSeq; NP_001153471.1; NM_001159999.2.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   ProteinModelPortal; A6MW55; -.
DR   PeptideAtlas; A6MW55; -.
DR   PRIDE; A6MW55; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   HOGENOM; HOG000273863; -.
DR   HOVERGEN; HBG006531; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; A6MW55; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    227    249       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       16    107       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      157    201       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    191    200       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   NON_TER     498    498       {ECO:0000313|EMBL:ABR13843.1}.
SQ   SEQUENCE   498 AA;  55035 MW;  90574C187B0C5E7C CRC64;
     MGKGRAGRVG TTALPPQLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKD
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNEIITGMPA
     STEGAYVSSE SPIRISVSTE GANTSSSTST STTGTSHLVK CAEKEKTFCV NGGECFMVKD
     LSNPSRYLCK CPNEFTGDRC QNYVMASFYK HLGIEFMEAE ELYQKRVLTI TGICIALLVV
     GIMCVVAYCK TKKQRKKLHD RLRQSLRSER NNMMNIANGP HHPNPPPENV QLVNQYASKN
     VISSEHIVER EAETPFSTSH YTSTAHHSTT VTQTPSHSWS NEHTESILSE SHSVIVMSSV
     ENSRHSSPTG GPRGRLNGTG GPRECNSFLR HARETPDSYR DSPHSERYVS AMTTPARMSP
     VDFHTPSSPK SPPSEMSPPV SSMTVSMPSM AVSPFMEEER PLLLVTPPRL REKKFDHHPQ
     QFSSFHHNPA HDSNSLPA
//
ID   A6MW56_HUMAN            Unreviewed;       481 AA.
AC   A6MW56;
DT   24-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2007, sequence version 1.
DT   25-OCT-2017, entry version 68.
DE   SubName: Full=Neuregulin 1 type IV fetal C beta 1a {ECO:0000313|EMBL:ABR13844.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABR13844.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABR13844.1};
RN   [1] {ECO:0000313|EMBL:ABR13844.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABR13844.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J.,
RA   Weinberger D.R., Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional
RT   promoter variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF517297; ABR13844.1; -; mRNA.
DR   RefSeq; NP_001153467.1; NM_001159995.2.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   PeptideAtlas; A6MW56; -.
DR   PRIDE; A6MW56; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   HOGENOM; HOG000273863; -.
DR   HOVERGEN; HBG006531; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; A6MW56; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    210    232       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       16    107       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      140    184       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    174    183       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   NON_TER     481    481       {ECO:0000313|EMBL:ABR13844.1}.
SQ   SEQUENCE   481 AA;  53253 MW;  0E5B8B7386B8A340 CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNEIITGMPA
     STEGAYVSSA ASTSTTGTSH LVKCAEKEKT FCVNGGECFM VKDLSNPSRY LCKCPNEFTG
     DRCQNYVMAS FYKHLGIEFM EAEELYQKRV LTITGICIAL LVVGIMCVVA YCKTKKQRKK
     LHDRLRQSPR SERNNTMNIA NGPHHPNPPP ENVQLVNQYV SKNVISSEHI VEREAETSFP
     TSHYTSTAHH STTVTQTPSH SWSNGHTESI LSESHSVIVM SSVENSRHSS PTGGPRGRLN
     GTGGPRECNS YLRHARETPD SYRDSPHSER YVSVMTTPAR MSPVDFHTPS SPKSPPSEMS
     PPVSSMTVSM PSMAVSPFME EERPLLLVTP PRLREKKFDH HPQQFSSFHH NPAHDSNSLP
     A
//
ID   B0FWZ3_HUMAN            Unreviewed;       206 AA.
AC   B0FWZ3;
DT   26-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   26-FEB-2008, sequence version 1.
DT   25-OCT-2017, entry version 57.
DE   SubName: Full=Heregulin-beta 3 protein isoform {ECO:0000313|EMBL:ABY70644.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABY70644.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABY70644.1};
RN   [1] {ECO:0000313|EMBL:ABY70644.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain hippocampus {ECO:0000313|EMBL:ABY70644.1};
RA   Tan W., Dean M., Weinberger D.R., Law A.J.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU359055; ABY70644.1; -; mRNA.
DR   RefSeq; NP_001153477.1; NM_001160005.1.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   SMR; B0FWZ3; -.
DR   PeptideAtlas; B0FWZ3; -.
DR   PRIDE; B0FWZ3; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HOVERGEN; HBG053796; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B0FWZ3; HS.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DOMAIN       36    127       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      143    187       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    177    186       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:ABY70644.1}.
SQ   SEQUENCE   206 AA;  22584 MW;  A564911EBD44BBBA CRC64;
     SERKEGRGKG KGKKKERGSG KKPESAAGSQ SPALPPRLKE MKSQESAAGS KLVLRCETSS
     EYSSLRFKWF KNGNELNRKN KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND
     SASANITIVE SNATSTSTTG TSHLVKCAEK EKTFCVNGGE CFMVKDLSNP SRYLCKCPNE
     FTGDRCQNYV MASFYSTSTP FLSLPE
//
ID   B0FYA7_HUMAN            Unreviewed;       193 AA.
AC   B0FYA7;
DT   26-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   26-FEB-2008, sequence version 1.
DT   25-OCT-2017, entry version 59.
DE   SubName: Full=Heregulin-gamma protein isoform 1 {ECO:0000313|EMBL:ABY66348.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABY66348.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABY66348.1};
RN   [1] {ECO:0000313|EMBL:ABY66348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABY66348.1};
RA   Tan W., Dean M., Weinberger D.R., Law A.J.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU363508; ABY66348.1; -; mRNA.
DR   RefSeq; NP_001153474.1; NM_001160002.1.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   PeptideAtlas; B0FYA7; -.
DR   PRIDE; B0FYA7; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   HOVERGEN; HBG053796; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B0FYA7; HS.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       36    127       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:ABY66348.1}.
SQ   SEQUENCE   193 AA;  20891 MW;  8403AAC43EE97A77 CRC64;
     SERKEGRGKG KGKKKERGSG KKPESAAGSQ SPALPPRLKE MKSQESAAGS KLVLRCETSS
     EYSSLRFKWF KNGNELNRKN KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND
     SASANITIVE SNEIITGMPA STEGAYVSSA TSTSTTGTSH LVKCAEKEKT FCVNGGECFM
     VKDLSNPSRY LCK
//
ID   B0FYA8_HUMAN            Unreviewed;       176 AA.
AC   B0FYA8;
DT   26-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   26-FEB-2008, sequence version 1.
DT   25-OCT-2017, entry version 53.
DE   SubName: Full=Heregulin-gamma protein isoform 2 {ECO:0000313|EMBL:ABY66349.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABY66349.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABY66349.1};
RN   [1] {ECO:0000313|EMBL:ABY66349.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABY66349.1};
RA   Tan W., Dean M., Weinberger D.R., Law A.J.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU363509; ABY66349.1; -; mRNA.
DR   RefSeq; NP_001153479.1; NM_001160007.1.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   ProteinModelPortal; B0FYA8; -.
DR   PeptideAtlas; B0FYA8; -.
DR   PRIDE; B0FYA8; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HOVERGEN; HBG053796; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B0FYA8; HS.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       36    127       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:ABY66349.1}.
SQ   SEQUENCE   176 AA;  19196 MW;  4EEB2167FA7B0CB0 CRC64;
     SERKEGRGKG KGKKKERGSG KKPESAAGSQ SPALPPRLKE MKSQESAAGS KLVLRCETSS
     EYSSLRFKWF KNGNELNRKN KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND
     SASANITIVE SNATSTSTTG TSHLVKCAEK EKTFCVNGGE CFMVKDLSNP SRYLCK
//
ID   B0FYA9_HUMAN            Unreviewed;       458 AA.
AC   B0FYA9;
DT   26-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   26-FEB-2008, sequence version 1.
DT   31-JAN-2018, entry version 67.
DE   SubName: Full=Neuregulin 1 isoform ndf43-beta2 {ECO:0000313|EMBL:ABY66350.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABY66350.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABY66350.1};
RN   [1] {ECO:0000313|EMBL:ABY66350.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain hippocampus {ECO:0000313|EMBL:ABY66350.1};
RA   Tan W., Dean M., Weinberger D.R., Law A.J.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU363510; ABY66350.1; -; mRNA.
DR   RefSeq; NP_001153476.1; NM_001160004.2.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   ProteinModelPortal; B0FYA9; -.
DR   PeptideAtlas; B0FYA9; -.
DR   PRIDE; B0FYA9; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   HOGENOM; HOG000273863; -.
DR   HOVERGEN; HBG006531; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B0FYA9; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    239    261       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       36    127       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      177    221       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    211    220       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:ABY66350.1}.
SQ   SEQUENCE   458 AA;  50555 MW;  F092E3E0F16F9BBB CRC64;
     SERKEGRGKG KGKKKERGSG KKPESAAGSQ SPALPPRLKE MKSQESAAGS KLVLRCETSS
     EYSSLRFKWF KNGNELNRKN KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND
     SASANITIVE SNEIITGMPA STEGAYVSSE SPIRISVSTE GANTSSSTST STTGTSHLVK
     CAEKEKTFCV NGGECFMVKD LSNPSRYLCK CPNEFTGDRC QNYVMASFYK AEELYQKRVL
     TITGICIALL VVGIMCVVAY CKTKKQRKKL HDRLRQSLRS ERNNMMNIAN GPHHPNPPPE
     NVQLVNQYVS KNVISSEHIV EREAETSFST SHYTSTAHHS TTVTQTPSHS WSNGHTESIL
     SESHSVIVMS SVENSRHSSP TGGPRGRLNG TGGPRECNSF LRHARETPDS YRDSPHSERH
     NLIAELRRNK AHRSKCMQIQ LSATHLRSSS IPHLGFIL
//
ID   B7Z1D7_HUMAN            Unreviewed;       308 AA.
AC   B7Z1D7;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   25-OCT-2017, entry version 46.
DE   SubName: Full=cDNA FLJ52471, highly similar to Homo sapiens neuregulin 1 (NRG1), transcript variant ndf43, mRNA {ECO:0000313|EMBL:BAH11473.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11473.1};
RN   [1] {ECO:0000313|EMBL:BAH11473.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK293240; BAH11473.1; -; mRNA.
DR   RefSeq; NP_001153468.1; NM_001159996.2.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   iPTMnet; B7Z1D7; -.
DR   PeptideAtlas; B7Z1D7; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   HOVERGEN; HBG006531; -.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B7Z1D7; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     89    111       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       24     68       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID     58     67       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   308 AA;  34403 MW;  99F17E85A38C99BC CRC64;
     MQIPKHISIE DITATSTSTT GTSHLVKCAE KEKTFCVNGG ECFMVKDLSN PSRYLCKCQP
     GFTGARCTEN VPMKVQNQEK AEELYQKRVL TITGICIALL VVGIMCVVAY CKTKKQRKKL
     HDRLRQSLRS ERNNMMNIAN GPHHPNPPPE NVQLVNQYVS KNVISSEHIV EREAETSFST
     SHYTSTAHHS TTVTQTPSHS WSNGHTESIL SKSHSVIVMS SVENSRHSSP TGGPRGRLNG
     TGGPRECNSF LRHARETPDS YRDSPHSERH NLIAELRRNK AHRSKCMQIQ LSATHLRSSS
     IPHLGFIL
//
ID   B7Z1E3_HUMAN            Unreviewed;       483 AA.
AC   B7Z1E3;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   28-FEB-2018, entry version 69.
DE   SubName: Full=cDNA FLJ53967, highly similar to Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|EMBL:BAH11479.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11479.1};
RN   [1] {ECO:0000313|EMBL:BAH11479.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK293270; BAH11479.1; -; mRNA.
DR   RefSeq; NP_001309126.1; NM_001322197.1.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   ProteinModelPortal; B7Z1E3; -.
DR   SMR; B7Z1E3; -.
DR   MaxQB; B7Z1E3; -.
DR   PeptideAtlas; B7Z1E3; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   HOVERGEN; HBG006531; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     86    108       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       24     68       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID     58     67       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   483 AA;  53725 MW;  39B94B909F1D3DE0 CRC64;
     MQIPKHISIE DITATSTSTT GTSHLVKCAE KEKTFCVNGG ECFMVKDLSN PSRYLCKCPN
     EFTGDRCQNY VMASFYKAEE LYQKRVLTIT GICIALLVVG IMCVVAYCKT KKQRKKLHDR
     LRQSLRSERN NMMNIANGPH HPNPPPENVQ LVNQYVSKNV ISSEHIVERE AETSFSTSHY
     TSTAHHSTTV TQTPSHSWSN GHTESILSES HSVIVMSSVE NSRHSSPTGG PRGRLNGTGG
     PRECNSFLRH ARETPDSYRD SPHSERYVSA MTTPARMSPV DFHTPSSPKS PPSEMSPPVS
     SMTVSMPSMA VSPFMEEERP LLLVTPPRLR EKKFDHHPQQ FSSFHHNPAH DSNSLPASPL
     RIVEDEEYET TQEYEPAQEP VKKLANSRRA KRTKPNGHIA NRLEVDSNTS SQSSNSESET
     EDERVGEDTP FLGIQNPLAA SLEATPAFRL ADSRTNPAGR FSTQEEIQAR LSSVIANQDP
     IAV
//
ID   E3SFM9_HUMAN            Unreviewed;       590 AA.
AC   E3SFM9;
DT   11-JAN-2011, integrated into UniProtKB/TrEMBL.
DT   11-JAN-2011, sequence version 1.
DT   25-OCT-2017, entry version 31.
DE   SubName: Full=Neuregulin 1 type IV beta 1a {ECO:0000313|EMBL:ADN85612.1};
GN   Name=NRG1 {ECO:0000313|EMBL:ADN85612.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADN85612.1};
RN   [1] {ECO:0000313|EMBL:ADN85612.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ADN85612.1};
RX   PubMed=20218976; DOI=10.1111/j.1471-4159.2010.06677.x;
RA   Shamir A., Buonanno A.;
RT   "Molecular and cellular characterization of Neuregulin-1 type IV
RT   isoforms.";
RL   J. Neurochem. 113:1163-1176(2010).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ983557; ADN85612.1; -; mRNA.
DR   RefSeq; NP_001153467.1; NM_001159995.2.
DR   RefSeq; NP_001153471.1; NM_001159999.2.
DR   RefSeq; NP_001153473.1; NM_001160001.2.
DR   RefSeq; NP_001309130.1; NM_001322201.1.
DR   RefSeq; NP_001309131.1; NM_001322202.1.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   PeptideAtlas; E3SFM9; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   ChiTaRS; NRG1; human.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    193    215       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       16    107       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      123    167       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    157    166       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   590 AA;  65446 MW;  FBC248D48892ADBD CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNATSTSTTG
     TSHLVKCAEK EKTFCVNGGE CFMVKDLSNP SRYLCKCPNE FTGDRCQNYV MASFYKHLGI
     EFMEAEELYQ KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM
     NIANGPHHPN PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT
     PSHSWSNGHT ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE
     TPDSYRDSPH SERYVSAMTT PARMSPVDFH TPSSPKSPPS EMSPPVSSMT VSMPSMAVSP
     FMEEERPLLL VTPPRLREKK FDHHPQQFSS FHHNPAHDSN SLPASPLRIV EDEEYETTQE
     YEPAQEPVKK LANSRRAKRT KPNGHVANRL EVDSNTSSQS SNSESETEDE RVGEDTPFLG
     IQNPLAASLE ATPAFRLADS RTNPAGRFST QEEIQARLSS VIANQDPIAV
//
ID   F6RJN6_HUMAN            Unreviewed;       308 AA.
AC   F6RJN6;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 29.
DE   SubName: Full=Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|Ensembl:ENSP00000439276};
GN   Name=NRG1 {ECO:0000313|Ensembl:ENSP00000439276};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000439276, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000439276}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Glockner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000439276}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000439276}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001153468.1; NM_001159996.2.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   ProteinModelPortal; F6RJN6; -.
DR   PeptideAtlas; F6RJN6; -.
DR   Ensembl; ENST00000539990; ENSP00000439276; ENSG00000157168.
DR   GeneID; 3084; -.
DR   UCSC; uc011lbg.2; human.
DR   CTD; 3084; -.
DR   EuPathDB; HostDB:ENSG00000157168.18; -.
DR   HGNC; HGNC:7997; NRG1.
DR   OpenTargets; ENSG00000157168; -.
DR   GeneTree; ENSGT00900000140940; -.
DR   HOVERGEN; HBG006531; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000157168; -.
DR   ExpressionAtlas; F6RJN6; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:F6RJN6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     89    111       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       24     68       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID     58     67       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   308 AA;  34404 MW;  915B562729A4339C CRC64;
     MQIPKHISIE DITATSTSTT GTSHLVKCAE KEKTFCVNGG ECFMVKDLSN PSRYLCKCQP
     GFTGARCTEN VPMKVQNQEK AEELYQKRVL TITGICIALL VVGIMCVVAY CKTKKQRKKL
     HDRLRQSLRS ERNNMMNIAN GPHHPNPPPE NVQLVNQYVS KNVISSEHIV EREAETSFST
     SHYTSTAHHS TTVTQTPSHS WSNGHTESIL SESHSVIVMS SVENSRHSSP TGGPRGRLNG
     TGGPRECNSF LRHARETPDS YRDSPHSERH NLIAELRRNK AHRSKCMQIQ LSATHLRSSS
     IPHLGFIL
//
ID   NRG1_HUMAN              Reviewed;         640 AA.
AC   Q02297; A5YAK4; A5YAK5; A8K1L2; B7Z4Z3; E9PHH4; O14667; P98202;
AC   Q02298; Q02299; Q07110; Q07111; Q12779; Q12780; Q12781; Q12782;
AC   Q12783; Q12784; Q15491; Q7RTV9; Q7RTW0; Q7RTW1; Q7RTW2; Q8NFN1;
AC   Q8NFN2; Q8NFN3; Q9UPE3;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-FEB-2018, entry version 208.
DE   RecName: Full=Pro-neuregulin-1, membrane-bound isoform;
DE            Short=Pro-NRG1;
DE   Contains:
DE     RecName: Full=Neuregulin-1;
DE     AltName: Full=Acetylcholine receptor-inducing activity;
DE              Short=ARIA;
DE     AltName: Full=Breast cancer cell differentiation factor p45;
DE     AltName: Full=Glial growth factor;
DE     AltName: Full=Heregulin;
DE              Short=HRG;
DE     AltName: Full=Neu differentiation factor;
DE     AltName: Full=Sensory and motor neuron-derived factor;
DE   Flags: Precursor;
GN   Name=NRG1; Synonyms=GGF, HGL, HRGA, NDF, SMDF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 6; 7 AND 8), AND PARTIAL
RP   PROTEIN SEQUENCE.
RX   PubMed=1350381; DOI=10.1126/science.256.5060.1205;
RA   Holmes W.E., Sliwkowski M.X., Akita R.W., Henzel W.J., Lee J.,
RA   Park J.W., Yansura D., Abadi N., Raab H., Lewis G.D., Shepard H.M.,
RA   Kuang W.-J., Wood W.I., Goeddel D.V., Vandlen R.L.;
RT   "Identification of heregulin, a specific activator of p185erbB2.";
RL   Science 256:1205-1210(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4; 6; 7 AND 8).
RC   TISSUE=Kidney adenocarcinoma, and Pituitary;
RX   PubMed=7509448; DOI=10.1128/MCB.14.3.1909;
RA   Wen D., Suggs S.V., Karunagaran D., Liu N., Cupples R.L., Luo Y.,
RA   Janssen A.M., Ben-Baruch N., Trollinger D.B., Jacobsen V.L.,
RA   Meng S.-Y., Lu H.S., Hu S., Chang D., Yang W., Yanigahara D.,
RA   Koski R.A., Yarden Y.;
RT   "Structural and functional aspects of the multiplicity of Neu
RT   differentiation factors.";
RL   Mol. Cell. Biol. 14:1909-1919(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 8 AND 9).
RC   TISSUE=Brain;
RX   PubMed=8096067; DOI=10.1038/362312a0;
RA   Marchionni M.A., Goodearl A.D.J., Chen M.S., Bermingham-McDonogh O.,
RA   Kirk C., Hendricks M., Danehy F., Misumi D., Sudhalter J.,
RA   Kobayashi K., Wroblewski D., Lynch C., Baldasarre M., Hiles I.,
RA   Davis J.B., Hsuan J.J., Totty N.F., Otsu M., McBurney R.N.,
RA   Waterfield M.D., Stroobant P., Gwynne D.;
RT   "Glial growth factors are alternatively spliced erbB2 ligands
RT   expressed in the nervous system.";
RL   Nature 362:312-318(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 10).
RC   TISSUE=Brain stem, and Cerebellum;
RX   PubMed=7782315; DOI=10.1074/jbc.270.24.14523;
RA   Ho W.-H., Armanini M.P., Nuijens A., Phillips H.S., Osheroff P.L.;
RT   "Sensory and motor neuron-derived factor. A novel heregulin variant
RT   highly expressed in sensory and motor neurons.";
RL   J. Biol. Chem. 270:14523-14532(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 10 AND 12), AND
RP   VARIANT THR-289.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF GAMMA-HEREGULIN FUSION PROTEIN.
RC   TISSUE=Mammary cancer;
RX   PubMed=9333014; DOI=10.1038/sj.onc.1201317;
RA   Schaefer G., Fitzpatrick V.D., Sliwkowski M.X.;
RT   "Gamma-heregulin: a novel heregulin isoform that is an autocrine
RT   growth factor for the human breast cancer cell line, MDA-MB-175.";
RL   Oncogene 15:1385-1394(1997).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 3; 8 AND 9), AND
RP   SUSCEPTIBILITY TO SCHIZOPHRENIA.
RX   PubMed=12145742; DOI=10.1086/342734;
RA   Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S.,
RA   Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S.,
RA   Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H.,
RA   Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B.,
RA   Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Brunner D.,
RA   Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G.,
RA   Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E.,
RA   Kong A., Gulcher J.R., Petursson H., Stefansson K.;
RT   "Neuregulin 1 and susceptibility to Schizophrenia.";
RL   Am. J. Hum. Genet. 71:877-892(2002).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 11), ALTERNATIVE SPLICING,
RP   VARIANTS GLN-38 AND THR-289, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RC   TISSUE=Hippocampus, and Prefrontal cortex;
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J.,
RA   Weinberger D.R., Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional
RT   promoter variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 10).
RC   TISSUE=Brain, and Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-211 (ISOFORM 1).
RA   Schoumacher F., Herzer S., Flury N., Kueng W., Mueller H.,
RA   Eppenberger U.;
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   PROTEIN SEQUENCE OF 20-28.
RX   PubMed=7689552;
RA   Culouscou J.-M., Plowman G.D., Carlton G.W., Green J.M., Shoyab M.;
RT   "Characterization of a breast cancer cell differentiation factor that
RT   specifically activates the HER4/p180erbB4 receptor.";
RL   J. Biol. Chem. 268:18407-18410(1993).
RN   [14]
RP   PARTIAL PROTEIN SEQUENCE (ISOFORM 1), FUNCTION, AND GLYCOSYLATION.
RX   PubMed=1348215; DOI=10.1016/0092-8674(92)90131-U;
RA   Peles E., Bacus S.S., Koski R.A., Lu H.S., Wen D., Ogden S.G.,
RA   Levy R.B., Yarden Y.;
RT   "Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein
RT   that induces differentiation of mammary tumor cells.";
RL   Cell 69:205-216(1992).
RN   [15]
RP   BINDING TO ERBB4, AND FUNCTION.
RX   PubMed=7902537; DOI=10.1038/366473a0;
RA   Plowman G.D., Green J.M., Culouscou J.M., Carlton G.W., Rothwell V.M.,
RA   Buckley S.;
RT   "Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.";
RL   Nature 366:473-475(1993).
RN   [16]
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=10523851; DOI=10.1038/sj.onc.1202950;
RA   Wang X.-Z., Jolicoeur E.M., Conte N., Chaffanet M., Zhang Y.,
RA   Mozziconacci M.-J., Feiner H., Birnbaum D., Pebusque M.-J., Ron D.;
RT   "Gamma-heregulin is the product of a chromosomal translocation fusing
RT   the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell
RT   line.";
RL   Oncogene 18:5718-5721(1999).
RN   [17]
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=10597312; DOI=10.1038/sj.onc.1203136;
RA   Liu X., Baker E., Eyre H.J., Sutherland G.R., Zhou M.;
RT   "Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from
RT   a chromosome translocation.";
RL   Oncogene 18:7110-7114(1999).
RN   [18]
RP   BINDING TO ERBB4.
RX   PubMed=10867024; DOI=10.1074/jbc.C901015199;
RA   Sweeney C., Lai C., Riese D.J. II, Diamonti A.J., Cantley L.C.,
RA   Carraway K.L. III;
RT   "Ligand discrimination in signaling through an ErbB4 receptor
RT   homodimer.";
RL   J. Biol. Chem. 275:19803-19807(2000).
RN   [19]
RP   FUNCTION, BINDING TO ERBB3 AND INTEGRINS, IDENTIFICATION IN A TERNARY
RP   COMPLEX WITH ERBB3 AND INTEGRINS, AND MUTAGENESIS OF LYS-181; LYS-185
RP   AND LYS-187.
RX   PubMed=20682778; DOI=10.1074/jbc.M110.113878;
RA   Ieguchi K., Fujita M., Ma Z., Davari P., Taniguchi Y., Sekiguchi K.,
RA   Wang B., Takada Y.K., Takada Y.;
RT   "Direct binding of the EGF-like domain of neuregulin-1 to integrins
RT   ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB
RT   signaling.";
RL   J. Biol. Chem. 285:31388-31398(2010).
RN   [20]
RP   STRUCTURE BY NMR OF 175-241 (ISOFORM 1).
RX   PubMed=8062828;
RA   Nagata K., Kohda D., Hatanaka H., Ichikawa S., Matsuda S.,
RA   Yamamoto T., Suzuki A., Inagaki F.;
RT   "Solution structure of the epidermal growth factor-like domain of
RT   heregulin-alpha, a ligand for p180erbB-4.";
RL   EMBO J. 13:3517-3523(1994).
RN   [21]
RP   STRUCTURE BY NMR OF 177-239 (ISOFORM 1), AND DISULFIDE BONDS.
RX   PubMed=8639490; DOI=10.1021/bi952626l;
RA   Jacobsen N.E., Abadi N., Sliwkowski M.X., Reilly D., Skelton N.J.,
RA   Fairbrother W.J.;
RT   "High-resolution solution structure of the EGF-like domain of
RT   heregulin-alpha.";
RL   Biochemistry 35:3402-3417(1996).
CC   -!- FUNCTION: Direct ligand for ERBB3 and ERBB4 tyrosine kinase
CC       receptors. Concomitantly recruits ERBB1 and ERBB2 coreceptors,
CC       resulting in ligand-stimulated tyrosine phosphorylation and
CC       activation of the ERBB receptors. The multiple isoforms perform
CC       diverse functions such as inducing growth and differentiation of
CC       epithelial, glial, neuronal, and skeletal muscle cells; inducing
CC       expression of acetylcholine receptor in synaptic vesicles during
CC       the formation of the neuromuscular junction; stimulating
CC       lobuloalveolar budding and milk production in the mammary gland
CC       and inducing differentiation of mammary tumor cells; stimulating
CC       Schwann cell proliferation; implication in the development of the
CC       myocardium such as trabeculation of the developing heart. Isoform
CC       10 may play a role in motor and sensory neuron development. Binds
CC       to ERBB4 (PubMed:10867024, PubMed:7902537). Binds to ERBB3
CC       (PubMed:20682778). Acts as a ligand for integrins and binds (via
CC       EGF domain) to integrins ITGAV:ITGB3 or ITGA6:ITGB4. Its binding
CC       to integrins and subsequent ternary complex formation with
CC       integrins and ERRB3 are essential for NRG1-ERBB signaling. Induces
CC       the phosphorylation and activation of MAPK3/ERK1, MAPK1/ERK2 and
CC       AKT1 (PubMed:20682778). Ligand-dependent ERBB4 endocytosis is
CC       essential for the NRG1-mediated activation of these kinases in
CC       neurons (By similarity). {ECO:0000250|UniProtKB:P43322,
CC       ECO:0000269|PubMed:10867024, ECO:0000269|PubMed:1348215,
CC       ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:7902537}.
CC   -!- SUBUNIT: The cytoplasmic domain interacts with the LIM domain
CC       region of LIMK1 (By similarity). Forms a ternary complex with
CC       ERBB3 and ITGAV:ITGB3 or ITGA6:ITGB4 (PubMed:20682778).
CC       {ECO:0000250|UniProtKB:P43322, ECO:0000269|PubMed:20682778}.
CC   -!- INTERACTION:
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-2460927, EBI-641062;
CC       P21860:ERBB3; NbExp=3; IntAct=EBI-2460927, EBI-720706;
CC   -!- SUBCELLULAR LOCATION: Pro-neuregulin-1, membrane-bound isoform:
CC       Cell membrane; Single-pass type I membrane protein. Note=Does not
CC       seem to be active.
CC   -!- SUBCELLULAR LOCATION: Neuregulin-1: Secreted.
CC   -!- SUBCELLULAR LOCATION: Isoform 8: Nucleus. Note=May be nuclear.
CC   -!- SUBCELLULAR LOCATION: Isoform 9: Secreted. Note=Has a signal
CC       peptide.
CC   -!- SUBCELLULAR LOCATION: Isoform 10: Membrane; Single-pass type I
CC       membrane protein. Note=May possess an internal uncleaved signal
CC       sequence.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=11;
CC         Comment=Additional isoforms seem to exist. Isoforms have been
CC         classified as type I NRGs (isoforms with an Ig domain and a
CC         glycosylation domain, isoforms 1-8), type II NRGs (isoforms with
CC         an Ig domain but no glycosylation domain, isoform 9), type III
CC         NRGs (isoforms with a Cys-rich domain, isoform 10) and type IV
CC         NRGs (isoforms with additional 5' exons, isoform 11). All these
CC         isoforms perform distinct tissue-specific functions.;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=Q02297-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha1A;
CC         IsoId=Q02297-2; Sequence=VSP_003431;
CC       Name=3; Synonyms=Alpha2B;
CC         IsoId=Q02297-3; Sequence=VSP_003434, VSP_003435;
CC       Name=4; Synonyms=Alpha3;
CC         IsoId=Q02297-4; Sequence=VSP_003432, VSP_003433;
CC       Name=6; Synonyms=Beta1, Beta1A;
CC         IsoId=Q02297-6; Sequence=VSP_003428;
CC       Name=7; Synonyms=Beta2;
CC         IsoId=Q02297-7; Sequence=VSP_003427;
CC       Name=8; Synonyms=Beta3, GGFHFB1;
CC         IsoId=Q02297-8; Sequence=VSP_003429, VSP_003430;
CC       Name=9; Synonyms=GGF2, GGFHPP2;
CC         IsoId=Q02297-9; Sequence=VSP_003425, VSP_003426, VSP_003429,
CC                                  VSP_003430;
CC       Name=10; Synonyms=SMDF;
CC         IsoId=Q02297-10; Sequence=VSP_037562, VSP_037565, VSP_003429,
CC                                   VSP_003430;
CC         Note=Potential internal signal sequence at positions 76-100.
CC         Variant in position: 46:G->R (in dbSNP:rs3735774). Variant in
CC         position: 127:A->P (in dbSNP:rs34822181).;
CC       Name=11; Synonyms=Type IV-beta1a;
CC         IsoId=Q02297-11; Sequence=VSP_037563, VSP_037564, VSP_003426,
CC                                   VSP_003428;
CC       Name=12;
CC         IsoId=Q02297-12; Sequence=VSP_003427, VSP_046417;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Type I isoforms are the predominant forms
CC       expressed in the endocardium. Isoform alpha is expressed in
CC       breast, ovary, testis, prostate, heart, skeletal muscle, lung,
CC       placenta liver, kidney, salivary gland, small intestine and brain,
CC       but not in uterus, stomach, pancreas, and spleen. Isoform 3 is the
CC       predominant form in mesenchymal cells and in non-neuronal organs,
CC       whereas isoform 6 is the major neuronal form. Isoform 8 is
CC       expressed in spinal cord and brain. Isoform 9 is the major form in
CC       skeletal muscle cells; in the nervous system it is expressed in
CC       spinal cord and brain. Also detected in adult heart, placenta,
CC       lung, liver, kidney, and pancreas. Isoform 10 is expressed in
CC       nervous system: spinal cord motor neurons, dorsal root ganglion
CC       neurons, and brain. Predominant isoform expressed in sensory and
CC       motor neurons. Not detected in adult heart, placenta, lung, liver,
CC       skeletal muscle, kidney, and pancreas. Not expressed in fetal
CC       lung, liver and kidney. Type IV isoforms are brain-specific.
CC       {ECO:0000269|PubMed:17565985}.
CC   -!- DEVELOPMENTAL STAGE: Detectable at early embryonic ages. Isoform
CC       10 is highly expressed in developing spinal motor neurons and in
CC       developing cranial nerve nuclei. Expression is maintained only in
CC       both adult motor neurons and dorsal root ganglion neurons. Type IV
CC       isoforms are expressed in fetal brain.
CC       {ECO:0000269|PubMed:17565985}.
CC   -!- DOMAIN: The cytoplasmic domain may be involved in the regulation
CC       of trafficking and proteolytic processing. Regulation of the
CC       proteolytic processing involves initial intracellular domain
CC       dimerization (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: ERBB receptor binding is elicited entirely by the EGF-like
CC       domain.
CC   -!- PTM: Proteolytic cleavage close to the plasma membrane on the
CC       external face leads to the release of the soluble growth factor
CC       form.
CC   -!- PTM: N- and O-glycosylated. Extensive glycosylation precedes the
CC       proteolytic cleavage (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving NRG1 produces
CC       gamma-heregulin. Translocation t(8;11) with TENM4. The
CC       translocation fuses the 5'-end of TENM4 to NRG1 (isoform 8). The
CC       product of this translocation was first thought to be an
CC       alternatively spliced isoform. Gamma-heregulin is a soluble
CC       activating ligand for the ERBB2-ERBB3 receptor complex and acts as
CC       an autocrine growth factor in a specific breast cancer cell line
CC       (MDA-MB-175). Not detected in breast carcinoma samples, including
CC       ductal, lobular, medullary, and mucinous histological types,
CC       neither in other breast cancer cell lines.
CC   -!- SIMILARITY: Belongs to the neuregulin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA19955.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=AAC51756.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Tipping the mind
CC       - Issue 129 of June 2011;
CC       URL="https://web.expasy.org/spotlight/back_issues/129";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M94165; AAA58638.1; -; mRNA.
DR   EMBL; M94166; AAA58639.1; -; mRNA.
DR   EMBL; M94167; AAA58640.1; -; mRNA.
DR   EMBL; M94168; AAA58641.1; -; mRNA.
DR   EMBL; U02325; AAA19950.1; -; mRNA.
DR   EMBL; U02326; AAA19951.1; -; mRNA.
DR   EMBL; U02327; AAA19952.1; -; mRNA.
DR   EMBL; U02328; AAA19953.1; -; mRNA.
DR   EMBL; U02329; AAA19954.1; -; mRNA.
DR   EMBL; U02330; AAA19955.1; ALT_SEQ; mRNA.
DR   EMBL; L12260; AAB59622.1; -; mRNA.
DR   EMBL; L12261; AAB59358.1; -; mRNA.
DR   EMBL; L41827; AAC41764.1; -; mRNA.
DR   EMBL; AK289927; BAF82616.1; -; mRNA.
DR   EMBL; AK298132; BAH12729.1; -; mRNA.
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068359; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103675; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113209; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF009227; AAC51756.1; ALT_INIT; mRNA.
DR   EMBL; AF491780; AAM71137.1; -; Genomic_DNA.
DR   EMBL; AF491780; AAM71139.1; -; Genomic_DNA.
DR   EMBL; AF491780; AAM71140.1; -; Genomic_DNA.
DR   EMBL; EF372273; ABQ53539.1; -; mRNA.
DR   EMBL; EF372274; ABQ53540.1; -; mRNA.
DR   EMBL; CH471080; EAW63411.1; -; Genomic_DNA.
DR   EMBL; BC064587; AAH64587.1; -; mRNA.
DR   EMBL; BC073871; AAH73871.1; -; mRNA.
DR   EMBL; AF026146; AAD01795.1; -; mRNA.
DR   EMBL; BK000383; DAA00044.1; -; Genomic_DNA.
DR   EMBL; BK000383; DAA00045.1; -; Genomic_DNA.
DR   EMBL; BK000383; DAA00046.1; -; Genomic_DNA.
DR   EMBL; BK000383; DAA00047.1; -; Genomic_DNA.
DR   CCDS; CCDS47836.1; -. [Q02297-9]
DR   CCDS; CCDS55218.1; -. [Q02297-11]
DR   CCDS; CCDS55219.1; -. [Q02297-12]
DR   CCDS; CCDS6083.1; -. [Q02297-6]
DR   CCDS; CCDS6084.1; -. [Q02297-7]
DR   CCDS; CCDS6085.1; -. [Q02297-1]
DR   CCDS; CCDS6086.1; -. [Q02297-3]
DR   CCDS; CCDS6087.1; -. [Q02297-10]
DR   PIR; A43273; A43273.
DR   PIR; A56943; A56943.
DR   PIR; B43273; B43273.
DR   PIR; C43273; C43273.
DR   PIR; D43273; D43273.
DR   PIR; I38403; I38403.
DR   PIR; I38404; I38404.
DR   PIR; I38408; I38408.
DR   PIR; S32357; S32357.
DR   RefSeq; NP_001153467.1; NM_001159995.2.
DR   RefSeq; NP_001153471.1; NM_001159999.2.
DR   RefSeq; NP_001153473.1; NM_001160001.2. [Q02297-11]
DR   RefSeq; NP_001153477.1; NM_001160005.1.
DR   RefSeq; NP_001153480.1; NM_001160008.1. [Q02297-12]
DR   RefSeq; NP_001309134.1; NM_001322205.1.
DR   RefSeq; NP_001309135.1; NM_001322206.1.
DR   RefSeq; NP_001309136.1; NM_001322207.1.
DR   RefSeq; NP_039250.2; NM_013956.4. [Q02297-6]
DR   RefSeq; NP_039251.2; NM_013957.4. [Q02297-7]
DR   RefSeq; NP_039252.2; NM_013958.3. [Q02297-8]
DR   RefSeq; NP_039253.1; NM_013959.3. [Q02297-10]
DR   RefSeq; NP_039254.1; NM_013960.4. [Q02297-3]
DR   RefSeq; NP_039256.2; NM_013962.2. [Q02297-9]
DR   RefSeq; NP_039258.1; NM_013964.4. [Q02297-1]
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   PDB; 1HAE; NMR; -; A=177-239.
DR   PDB; 1HAF; NMR; -; A=177-239.
DR   PDB; 1HRE; NMR; -; A=175-241.
DR   PDB; 1HRF; NMR; -; A=175-241.
DR   PDB; 3U7U; X-ray; 3.03 A; G/H/I/J/K/L=175-212.
DR   PDBsum; 1HAE; -.
DR   PDBsum; 1HAF; -.
DR   PDBsum; 1HRE; -.
DR   PDBsum; 1HRF; -.
DR   PDBsum; 3U7U; -.
DR   ProteinModelPortal; Q02297; -.
DR   SMR; Q02297; -.
DR   BioGrid; 109332; 71.
DR   CORUM; Q02297; -.
DR   DIP; DIP-355N; -.
DR   IntAct; Q02297; 13.
DR   MINT; Q02297; -.
DR   STRING; 9606.ENSP00000349275; -.
DR   iPTMnet; Q02297; -.
DR   PhosphoSitePlus; Q02297; -.
DR   BioMuta; NRG1; -.
DR   DMDM; 9297018; -.
DR   MaxQB; Q02297; -.
DR   PaxDb; Q02297; -.
DR   PeptideAtlas; Q02297; -.
DR   PRIDE; Q02297; -.
DR   DNASU; 3084; -.
DR   Ensembl; ENST00000287842; ENSP00000287842; ENSG00000157168. [Q02297-6]
DR   Ensembl; ENST00000356819; ENSP00000349275; ENSG00000157168. [Q02297-7]
DR   Ensembl; ENST00000405005; ENSP00000384620; ENSG00000157168. [Q02297-1]
DR   Ensembl; ENST00000519301; ENSP00000429582; ENSG00000157168. [Q02297-11]
DR   Ensembl; ENST00000520407; ENSP00000434640; ENSG00000157168. [Q02297-9]
DR   Ensembl; ENST00000520502; ENSP00000433289; ENSG00000157168. [Q02297-10]
DR   Ensembl; ENST00000521670; ENSP00000428828; ENSG00000157168. [Q02297-3]
DR   Ensembl; ENST00000523079; ENSP00000430120; ENSG00000157168. [Q02297-12]
DR   GeneID; 3084; -.
DR   KEGG; hsa:3084; -.
DR   UCSC; uc003xip.4; human. [Q02297-1]
DR   CTD; 3084; -.
DR   DisGeNET; 3084; -.
DR   EuPathDB; HostDB:ENSG00000157168.18; -.
DR   GeneCards; NRG1; -.
DR   HGNC; HGNC:7997; NRG1.
DR   HPA; HPA010964; -.
DR   MalaCards; NRG1; -.
DR   MIM; 142445; gene.
DR   neXtProt; NX_Q02297; -.
DR   OpenTargets; ENSG00000157168; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   GeneTree; ENSGT00900000140940; -.
DR   HOGENOM; HOG000273863; -.
DR   HOVERGEN; HBG006531; -.
DR   InParanoid; Q02297; -.
DR   KO; K05455; -.
DR   PhylomeDB; Q02297; -.
DR   TreeFam; TF332469; -.
DR   Reactome; R-HSA-1227986; Signaling by ERBB2.
DR   Reactome; R-HSA-1236394; Signaling by ERBB4.
DR   Reactome; R-HSA-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-HSA-1250342; PI3K events in ERBB4 signaling.
DR   Reactome; R-HSA-1250347; SHC1 events in ERBB4 signaling.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-1306955; GRB7 events in ERBB2 signaling.
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-HSA-1963640; GRB2 events in ERBB2 signaling.
DR   Reactome; R-HSA-1963642; PI3K events in ERBB2 signaling.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-6785631; ERBB2 Regulates Cell Motility.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-8847993; ERBB2 Activates PTK6 Signaling.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   SignaLink; Q02297; -.
DR   SIGNOR; Q02297; -.
DR   ChiTaRS; NRG1; human.
DR   EvolutionaryTrace; Q02297; -.
DR   GeneWiki; Neuregulin_1; -.
DR   GenomeRNAi; 3084; -.
DR   PMAP-CutDB; Q02297; -.
DR   PRO; PR:Q02297; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000157168; -.
DR   CleanEx; HS_NRG1; -.
DR   ExpressionAtlas; Q02297; baseline and differential.
DR   Genevisible; Q02297; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0030673; C:axolemma; IEA:Ensembl.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0045499; F:chemorepellent activity; IEA:Ensembl.
DR   GO; GO:0005125; F:cytokine activity; TAS:BHF-UCL.
DR   GO; GO:0005176; F:ErbB-2 class receptor binding; IEA:Ensembl.
DR   GO; GO:0043125; F:ErbB-3 class receptor binding; IDA:BHF-UCL.
DR   GO; GO:0008083; F:growth factor activity; IDA:BHF-UCL.
DR   GO; GO:0005178; F:integrin binding; IDA:UniProtKB.
DR   GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IDA:BHF-UCL.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; NAS:UniProtKB.
DR   GO; GO:0003712; F:transcription cofactor activity; IDA:MGI.
DR   GO; GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; NAS:UniProtKB.
DR   GO; GO:0000187; P:activation of MAPK activity; IMP:UniProtKB.
DR   GO; GO:0032148; P:activation of protein kinase B activity; IMP:UniProtKB.
DR   GO; GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; IDA:BHF-UCL.
DR   GO; GO:0008366; P:axon ensheathment; IEA:Ensembl.
DR   GO; GO:0003161; P:cardiac conduction system development; IEA:Ensembl.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0060379; P:cardiac muscle cell myoblast differentiation; IDA:BHF-UCL.
DR   GO; GO:0007154; P:cell communication; TAS:BHF-UCL.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0043624; P:cellular protein complex disassembly; IGI:MGI.
DR   GO; GO:0021842; P:chemorepulsion involved in interneuron migration from the subpallium to the cortex; IEA:Ensembl.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   GO; GO:0060956; P:endocardial cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0038127; P:ERBB signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:0038129; P:ERBB3 signaling pathway; IDA:CAFA.
DR   GO; GO:0021781; P:glial cell fate commitment; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0030879; P:mammary gland development; TAS:BHF-UCL.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IDA:BHF-UCL.
DR   GO; GO:1901185; P:negative regulation of ERBB signaling pathway; TAS:Reactome.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IDA:BHF-UCL.
DR   GO; GO:2001223; P:negative regulation of neuron migration; IEA:Ensembl.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl.
DR   GO; GO:0051048; P:negative regulation of secretion; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0007399; P:nervous system development; TAS:BHF-UCL.
DR   GO; GO:0014032; P:neural crest cell development; TAS:BHF-UCL.
DR   GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0045213; P:neurotransmitter receptor metabolic process; IEA:Ensembl.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0007422; P:peripheral nervous system development; IEA:Ensembl.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IEA:Ensembl.
DR   GO; GO:2000727; P:positive regulation of cardiac muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0030307; P:positive regulation of cell growth; IDA:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IEA:Ensembl.
DR   GO; GO:0031643; P:positive regulation of myelination; IEA:Ensembl.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:2000010; P:positive regulation of protein localization to cell surface; IEA:Ensembl.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl.
DR   GO; GO:0051155; P:positive regulation of striated muscle cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:2000145; P:regulation of cell motility; TAS:Reactome.
DR   GO; GO:0043497; P:regulation of protein heterodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0043496; P:regulation of protein homodimerization activity; TAS:BHF-UCL.
DR   GO; GO:0001964; P:startle response; IEA:Ensembl.
DR   GO; GO:0007416; P:synapse assembly; IEA:Ensembl.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0055012; P:ventricular cardiac muscle cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; IDA:BHF-UCL.
DR   GO; GO:0042060; P:wound healing; IDA:BHF-UCL.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane;
KW   Chromosomal rearrangement; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Growth factor; Immunoglobulin domain; Membrane; Nucleus;
KW   Polymorphism; Reference proteome; Secreted; Transmembrane;
KW   Transmembrane helix.
FT   PROPEP        1     19       {ECO:0000269|PubMed:7689552}.
FT                                /FTId=PRO_0000019462.
FT   CHAIN        20    640       Pro-neuregulin-1, membrane-bound isoform.
FT                                /FTId=PRO_0000019463.
FT   CHAIN        20    241       Neuregulin-1.
FT                                /FTId=PRO_0000019464.
FT   TOPO_DOM     20    242       Extracellular. {ECO:0000255}.
FT   TRANSMEM    243    265       Helical; Note=Internal signal sequence.
FT                                {ECO:0000255}.
FT   TOPO_DOM    266    640       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       37    128       Ig-like C2-type.
FT   DOMAIN      178    222       EGF-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   COMPBIAS    165    177       Ser/Thr-rich.
FT   SITE         34     34       Breakpoint for translocation to form
FT                                gamma-heregulin.
FT   CARBOHYD    120    120       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    126    126       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    164    164       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     57    112       {ECO:0000250}.
FT   DISULFID    182    196       {ECO:0000269|PubMed:8639490}.
FT   DISULFID    190    210       {ECO:0000269|PubMed:8639490}.
FT   DISULFID    212    221       {ECO:0000269|PubMed:8639490}.
FT   VAR_SEQ       1    166       Missing (in isoform 10).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7782315}.
FT                                /FTId=VSP_037562.
FT   VAR_SEQ       1     33       MSERKEGRGKGKGKKKERGSGKKPESAAGSQSP -> MRWR
FT                                RAPRRSGRPGPRAQRPGSAARSSPPLPLLPLLLLLGTAALA
FT                                PGAAAGNEAAPAGASVCYSSPPSVGSVQELAQRAAVVIEGK
FT                                VHPQRRQQGALDRKAAAAAGEAGAWGGDREPPAAGPRALGP
FT                                PAEEPLLAANGTVPSWPTAPVPSAGEPGEEAPYLVKVHQVW
FT                                AVKAGGLKKDSLLTVRLGTWGHPAFPSCGRLKEDSRYIFFM
FT                                EPDANSTSRAPAAFRASFPPLETGRNLKKEVSRVLCKRC
FT                                (in isoform 9).
FT                                {ECO:0000303|PubMed:8096067}.
FT                                /FTId=VSP_003425.
FT   VAR_SEQ       1     21       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:17565985}.
FT                                /FTId=VSP_037563.
FT   VAR_SEQ      22     33       KKPESAAGSQSP -> MGKGRAGRVGTT (in isoform
FT                                11). {ECO:0000303|PubMed:17565985}.
FT                                /FTId=VSP_037564.
FT   VAR_SEQ     134    168       EIITGMPASTEGAYVSSESPIRISVSTEGANTSSS -> A
FT                                (in isoform 9 and isoform 11).
FT                                {ECO:0000303|PubMed:17565985,
FT                                ECO:0000303|PubMed:8096067}.
FT                                /FTId=VSP_003426.
FT   VAR_SEQ     167    167       S -> MEIYSPDMSEVAAERSSSPSTQLSADPSLDGLPAAE
FT                                DMPEPQTEDGRTPGLVGLAVPCCACLEAERLRGCLNSEKIC
FT                                IVPILACLVSLCLCIAGLKWVFVDKIFEYDSPTHLDPGGLG
FT                                QDPIISLDATAASAVWVSSEAYTSPVSRAQSESEVQVTVQG
FT                                DKAVVSFEPSAAPTPKNRIFAFSFLPSTAPSFPSPTRNPEV
FT                                RTPKSATQPQTTETNLQTAPKL (in isoform 10).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7782315}.
FT                                /FTId=VSP_037565.
FT   VAR_SEQ     213    241       QPGFTGARCTENVPMKVQNQEKAEELYQK -> PNEFTGDR
FT                                CQNYVMASFYSTSTPFLSLPE (in isoform 8,
FT                                isoform 9 and isoform 10).
FT                                {ECO:0000303|PubMed:1350381,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7509448,
FT                                ECO:0000303|PubMed:7782315,
FT                                ECO:0000303|PubMed:8096067}.
FT                                /FTId=VSP_003429.
FT   VAR_SEQ     213    234       QPGFTGARCTENVPMKVQNQEK -> PNEFTGDRCQNYVMA
FT                                SFYKHLGIEFME (in isoform 6 and isoform
FT                                11). {ECO:0000303|PubMed:1350381,
FT                                ECO:0000303|PubMed:17565985,
FT                                ECO:0000303|PubMed:7509448}.
FT                                /FTId=VSP_003428.
FT   VAR_SEQ     213    233       QPGFTGARCTENVPMKVQNQE -> PNEFTGDRCQNYVMAS
FT                                FY (in isoform 7 and isoform 12).
FT                                {ECO:0000303|PubMed:1350381,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:7509448}.
FT                                /FTId=VSP_003427.
FT   VAR_SEQ     234    247       KAEELYQKRVLTIT -> SAQMSLLVIAAKTT (in
FT                                isoform 4). {ECO:0000303|PubMed:7509448}.
FT                                /FTId=VSP_003432.
FT   VAR_SEQ     234    234       K -> KHLGIEFIE (in isoform 2).
FT                                {ECO:0000303|PubMed:7509448}.
FT                                /FTId=VSP_003431.
FT   VAR_SEQ     242    640       Missing (in isoform 8, isoform 9 and
FT                                isoform 10). {ECO:0000303|PubMed:1350381,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7509448,
FT                                ECO:0000303|PubMed:7782315,
FT                                ECO:0000303|PubMed:8096067}.
FT                                /FTId=VSP_003430.
FT   VAR_SEQ     248    640       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:7509448}.
FT                                /FTId=VSP_003433.
FT   VAR_SEQ     424    640       Missing (in isoform 12).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046417.
FT   VAR_SEQ     424    462       YVSAMTTPARMSPVDFHTPSSPKSPPSEMSPPVSSMTVS
FT                                -> HNLIAELRRNKAHRSKCMQIQLSATHLRSSSIPHLGFI
FT                                L (in isoform 3).
FT                                {ECO:0000303|PubMed:7509448}.
FT                                /FTId=VSP_003434.
FT   VAR_SEQ     463    640       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:7509448}.
FT                                /FTId=VSP_003435.
FT   VARIANT      38     38       R -> Q (in dbSNP:rs3924999).
FT                                {ECO:0000269|PubMed:17565985}.
FT                                /FTId=VAR_009307.
FT   VARIANT     289    289       M -> T (in dbSNP:rs10503929).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17565985}.
FT                                /FTId=VAR_053531.
FT   VARIANT     463    463       M -> K.
FT                                /FTId=VAR_009308.
FT   MUTAGEN     181    181       K->E: Defective in integrin-binding and
FT                                in inducing ERBB3 phosphorylation; when
FT                                associated with or without E-185 or E-
FT                                187. No effect on ERBB3-binding,
FT                                defective in integrin-binding and in
FT                                ternary complex formation with ERBB3 and
FT                                integrins, and defective in inducing
FT                                NRG1-ERBB signaling; when associated with
FT                                E-185 and E-187.
FT                                {ECO:0000269|PubMed:20682778}.
FT   MUTAGEN     185    185       K->E: Defective in integrin-binding and
FT                                in inducing ERBB3 phosphorylation; when
FT                                associated with or without E-181 or E-
FT                                187. No effect on ERBB3-binding,
FT                                defective in integrin-binding and in
FT                                ternary complex formation with ERBB3 and
FT                                integrins, and defective in inducing
FT                                NRG1-ERBB signaling; when associated with
FT                                E-181 and E-187.
FT                                {ECO:0000269|PubMed:20682778}.
FT   MUTAGEN     187    187       K->E: Defective in integrin-binding and
FT                                in inducing ERBB3 phosphorylation; when
FT                                associated with or without E-181 or E-
FT                                185. No effect on ERBB3-binding,
FT                                defective in integrin-binding and in
FT                                ternary complex formation with ERBB3 and
FT                                integrins, and defective in inducing
FT                                NRG1-ERBB signaling; when associated with
FT                                E-181 and E-185.
FT                                {ECO:0000269|PubMed:20682778}.
FT   CONFLICT     94     94       K -> A (in Ref. 2; AAA19953).
FT                                {ECO:0000305}.
FT   CONFLICT    107    107       S -> P (in Ref. 10; ABQ53539).
FT                                {ECO:0000305}.
FT   CONFLICT    261    261       V -> L (in Ref. 10; ABQ53540).
FT                                {ECO:0000305}.
FT   CONFLICT    414    414       S -> F (in Ref. 2; AAA19953).
FT                                {ECO:0000305}.
FT   CONFLICT    535    535       Q -> R (in Ref. 2; AAA19951).
FT                                {ECO:0000305}.
FT   STRAND      179    181       {ECO:0000244|PDB:3U7U}.
FT   TURN        185    189       {ECO:0000244|PDB:3U7U}.
FT   STRAND      190    193       {ECO:0000244|PDB:1HRE}.
FT   STRAND      195    199       {ECO:0000244|PDB:3U7U}.
FT   STRAND      200    204       {ECO:0000244|PDB:1HRE}.
FT   STRAND      208    212       {ECO:0000244|PDB:3U7U}.
FT   STRAND      216    218       {ECO:0000244|PDB:3U7U}.
FT   STRAND      233    235       {ECO:0000244|PDB:1HAF}.
SQ   SEQUENCE   640 AA;  70392 MW;  C30D3F614AADFF62 CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCQPGFTGAR CTENVPMKVQ NQEKAEELYQ
     KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM NIANGPHHPN
     PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT PSHSWSNGHT
     ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE TPDSYRDSPH
     SERYVSAMTT PARMSPVDFH TPSSPKSPPS EMSPPVSSMT VSMPSMAVSP FMEEERPLLL
     VTPPRLREKK FDHHPQQFSS FHHNPAHDSN SLPASPLRIV EDEEYETTQE YEPAQEPVKK
     LANSRRAKRT KPNGHIANRL EVDSNTSSQS SNSESETEDE RVGEDTPFLG IQNPLAASLE
     ATPAFRLADS RTNPAGRFST QEEIQARLSS VIANQDPIAV
//
ID   Q6PK61_HUMAN            Unreviewed;       241 AA.
AC   Q6PK61;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   31-JAN-2018, entry version 88.
DE   SubName: Full=Neuregulin 1 {ECO:0000313|EMBL:AAH06492.1};
GN   Name=NRG1 {ECO:0000313|EMBL:AAH06492.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH06492.1};
RN   [1] {ECO:0000313|EMBL:AAH06492.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary {ECO:0000313|EMBL:AAH06492.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC006492; AAH06492.1; -; mRNA.
DR   RefSeq; NP_001153480.1; NM_001160008.1.
DR   RefSeq; NP_039250.2; NM_013956.4.
DR   RefSeq; NP_039251.2; NM_013957.4.
DR   RefSeq; NP_039254.1; NM_013960.4.
DR   RefSeq; NP_039258.1; NM_013964.4.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   ProteinModelPortal; Q6PK61; -.
DR   PeptideAtlas; Q6PK61; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   KEGG; hsa:3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   HOVERGEN; HBG053796; -.
DR   KO; K05455; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; Q6PK61; HS.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DOMAIN       37    128       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      178    222       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    212    221       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   241 AA;  26114 MW;  FE8B9FDF71B816B1 CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPQLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCPNEFTGDR CQNYVMASFY STSTPFLSLP
     E
//
ID   Q7RTW3_HUMAN            Unreviewed;       637 AA.
AC   Q7RTW3;
DT   15-DEC-2003, integrated into UniProtKB/TrEMBL.
DT   15-DEC-2003, sequence version 1.
DT   25-OCT-2017, entry version 102.
DE   SubName: Full=Neuregulin 1 isoform HRG-beta2 {ECO:0000313|EMBL:DAA00042.1};
DE   SubName: Full=Neuregulin 1, isoform CRA_j {ECO:0000313|EMBL:EAW63416.1};
DE   SubName: Full=cDNA FLJ77413, highly similar to Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta2, mRNA {ECO:0000313|EMBL:BAF83419.1};
GN   Name=NRG1 {ECO:0000313|EMBL:DAA00042.1};
GN   ORFNames=hCG_14780 {ECO:0000313|EMBL:EAW63416.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:DAA00042.1};
RN   [1] {ECO:0000313|EMBL:EAW63416.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:DAA00042.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12145742; DOI=10.1086/342734;
RA   Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S.,
RA   Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S.,
RA   Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H.,
RA   Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B.,
RA   Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D.,
RA   Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J.,
RA   Johannesson G., Andresson T., Gudbjartsson D., Manolescu A.,
RA   Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H.,
RA   Stefansson K.;
RT   "Neuregulin 1 and susceptibility to Schizophrenia.";
RL   Am. J. Hum. Genet. 71:877-892(2002).
RN   [3] {ECO:0000313|EMBL:EAW63416.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAF83419.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK290730; BAF83419.1; -; mRNA.
DR   EMBL; BK000383; DAA00042.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63416.1; -; Genomic_DNA.
DR   RefSeq; NP_039251.2; NM_013957.4.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   HOGENOM; HOG000273863; -.
DR   HOVERGEN; HBG006531; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    240    261       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       37    128       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      178    222       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    212    221       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   637 AA;  70169 MW;  0B89DF6E2ED70333 CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCPNEFTGDR CQNYVMASFY KAEELYQKRV
     LTITGICIAL LVVGIMCVVA YCKTKKQRKK LHDRLRQSLR SERNNTMNIA NGPHHPNPPP
     ENVQLVNQYV SKNVISSEHI VEREAETSFS TSHYTSTAHH STTVTQTPSH SWSNGHTESI
     LSESHSVIVM SSVENSRHSS PTGGPRGRLN GTGGPRECNS FLRHARETPD SYRDSPHSER
     YVSAMTTPAR MSPVDFHTPS SPKSPPSEMS PPVSSMTVSM PSMAVSPFME EERPLLLVTP
     PRLREKKFDH HPQQFSSFHH NPAHDSNSLP ASPLRIVEDE EYETTQEYEP AQEPVKKLAN
     SRRAKRTKPN GHIANRLEVD SNTSSQSSNS ESETEDERVG EDTPFLGIQN PLAASLEATP
     AFRLADSRTN PAGRFSTQEE IQARLSSVIA NQDPIAV
//
ID   Q7RTW5_HUMAN            Unreviewed;       211 AA.
AC   Q7RTW5;
DT   15-DEC-2003, integrated into UniProtKB/TrEMBL.
DT   15-DEC-2003, sequence version 1.
DT   28-FEB-2018, entry version 117.
DE   SubName: Full=Neuregulin 1 isoform HRG-gamma {ECO:0000313|EMBL:DAA00040.1};
DE   SubName: Full=Neuregulin 1, isoform CRA_l {ECO:0000313|EMBL:EAW63418.1};
GN   Name=NRG1 {ECO:0000313|EMBL:DAA00040.1};
GN   ORFNames=hCG_14780 {ECO:0000313|EMBL:EAW63418.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:DAA00040.1};
RN   [1] {ECO:0000313|EMBL:EAW63418.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:DAA00040.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12145742; DOI=10.1086/342734;
RA   Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S.,
RA   Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S.,
RA   Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H.,
RA   Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B.,
RA   Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D.,
RA   Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J.,
RA   Johannesson G., Andresson T., Gudbjartsson D., Manolescu A.,
RA   Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H.,
RA   Stefansson K.;
RT   "Neuregulin 1 and susceptibility to Schizophrenia.";
RL   Am. J. Hum. Genet. 71:877-892(2002).
RN   [3] {ECO:0000313|EMBL:EAW63418.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BK000383; DAA00040.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63418.1; -; Genomic_DNA.
DR   RefSeq; NP_004486.2; NM_004495.3.
DR   UniGene; Hs.453951; -.
DR   UniGene; Hs.668810; -.
DR   SMR; Q7RTW5; -.
DR   PeptideAtlas; Q7RTW5; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   HOVERGEN; HBG053796; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0009790; P:embryo development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   4: Predicted;
FT   DOMAIN       37    128       Ig-like. {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   211 AA;  22755 MW;  E9EA8BF45F2A1090 CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC K
//
ID   PER1_HUMAN              Reviewed;        1290 AA.
AC   O15534; B2RPA8; B4DI49; D3DTR3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   28-FEB-2018, entry version 171.
DE   RecName: Full=Period circadian protein homolog 1;
DE            Short=hPER1;
DE   AltName: Full=Circadian clock protein PERIOD 1;
DE   AltName: Full=Circadian pacemaker protein Rigui;
GN   Name=PER1; Synonyms=KIAA0482, PER, RIGUI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, AND VARIANT PRO-962.
RC   TISSUE=Heart;
RX   PubMed=9323128; DOI=10.1016/S0092-8674(00)80366-9;
RA   Sun Z.S., Albrecht U., Zhuchenko O., Bailey J., Eichele G., Lee C.C.;
RT   "Rigui, a putative mammalian ortholog of the Drosophila period gene.";
RL   Cell 90:1003-1011(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT PRO-962.
RC   TISSUE=Brain;
RX   PubMed=9333243; DOI=10.1038/39086;
RA   Tei H., Okamura H., Shigeyoshi Y., Fukuhara C., Ozawa R., Hirose M.,
RA   Sakaki Y.;
RT   "Circadian oscillation of a mammalian homologue of the Drosophila
RT   period gene.";
RL   Nature 389:512-516(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PRO-962.
RX   PubMed=10940553; DOI=10.1016/S0378-1119(00)00248-1;
RA   Taruscio D., Zoraqi G.K., Falchi M., Iosi F., Paradisi S.,
RA   Di Fiore B., Lavia P., Falbo V.;
RT   "The human Per1 gene: genomic organization and promoter analysis of
RT   the first human orthologue of the Drosophila period gene.";
RL   Gene 253:161-170(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PRO-962.
RX   PubMed=10857746; DOI=10.1006/geno.2000.6166;
RA   Hida A., Koike N., Hirose M., Hattori M., Sakaki Y., Tei H.;
RT   "The human and mouse Period1 genes: five well-conserved E-boxes
RT   additively contribute to the enhancement of mPer1 transcription.";
RL   Genomics 65:224-233(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-962.
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries
RT   from human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [6]
RP   SEQUENCE REVISION.
RA   Nagase T., Kikuno R., Ohara O.;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-962.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-962.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=9427249; DOI=10.1016/S0896-6273(00)80417-1;
RA   Shearman L.P., Zylka M.J., Weaver D.R., Kolakowski L.F. Jr.,
RA   Reppert S.M.;
RT   "Two period homologs: circadian expression and photic regulation in
RT   the suprachiasmatic nuclei.";
RL   Neuron 19:1261-1269(1997).
RN   [12]
RP   PHOSPHORYLATION BY CSNK1E.
RX   PubMed=10790862; DOI=10.1097/00001756-200004070-00011;
RA   Keesler G.A., Camacho F., Guo Y., Virshup D., Mondadori C., Yao Z.;
RT   "Phosphorylation and destabilization of human period I clock protein
RT   by human casein kinase I epsilon.";
RL   NeuroReport 11:951-955(2000).
RN   [13]
RP   PHOSPHORYLATION BY CSNK1D.
RX   PubMed=11165242; DOI=10.1016/S0014-5793(00)02434-0;
RA   Camacho F., Cilio M., Guo Y., Virshup D.M., Patel K., Khorkova O.,
RA   Styren S., Morse B., Yao Z., Keesler G.A.;
RT   "Human casein kinase Idelta phosphorylation of human circadian clock
RT   proteins period 1 and 2.";
RL   FEBS Lett. 489:159-165(2001).
RN   [14]
RP   PHOSPHORYLATION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND
RP   INDUCTION.
RX   PubMed=14750904; DOI=10.1042/BJ20031308;
RA   Miyazaki K., Nagase T., Mesaki M., Narukawa J., Ohara O., Ishida N.;
RT   "Phosphorylation of clock protein PER1 regulates its circadian
RT   degradation in normal human fibroblasts.";
RL   Biochem. J. 380:95-103(2004).
RN   [15]
RP   INTERACTION WITH BTRC AND FBXW11, PHOSPHORYLATION AT THR-121; SER-122
RP   AND SER-126, UBIQUITINATION, AND MUTAGENESIS OF 210-SER--THR-213;
RP   714-SER--SER-726 AND 794-PHE--PHE-798.
RX   PubMed=15917222; DOI=10.1074/jbc.M502862200;
RA   Shirogane T., Jin J., Ang X.L., Harper J.W.;
RT   "SCFbeta-TRCP controls clock-dependent transcription via casein kinase
RT   1-dependent degradation of the mammalian period-1 (Per1) protein.";
RL   J. Biol. Chem. 280:26863-26872(2005).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-979 AND SER-980, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704 AND SER-815, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-815, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704 AND SER-815, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   REVIEW.
RX   PubMed=23303907; DOI=10.1152/physrev.00016.2012;
RA   Eckel-Mahan K., Sassone-Corsi P.;
RT   "Metabolism and the circadian clock converge.";
RL   Physiol. Rev. 93:107-135(2013).
RN   [24]
RP   FUNCTION IN HAIR GROWTH, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24005054; DOI=10.1038/jid.2013.366;
RA   Al-Nuaimi Y., Hardman J.A., Biro T., Haslam I.S., Philpott M.P.,
RA   Toth B.I., Farjo N., Farjo B., Baier G., Watson R.E., Grimaldi B.,
RA   Kloepper J.E., Paus R.;
RT   "A meeting of two chronobiological systems: circadian proteins Period1
RT   and BMAL1 modulate the human hair cycle clock.";
RL   J. Invest. Dermatol. 134:610-619(2014).
RN   [25]
RP   REVIEW.
RX   PubMed=23916625; DOI=10.1016/j.tcb.2013.07.002;
RA   Partch C.L., Green C.B., Takahashi J.S.;
RT   "Molecular architecture of the mammalian circadian clock.";
RL   Trends Cell Biol. 24:90-99(2014).
RN   [26]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-696; SER-985 AND LEU-1060.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [27]
RP   VARIANT GLN-422.
RX   PubMed=27717682; DOI=10.1016/j.jstrokecerebrovasdis.2016.09.003;
RA   Mukawa M., Nariai T., Onda H., Yoneyama T., Aihara Y., Hirota K.,
RA   Kudo T., Sumita K., Maehara T., Kawamata T., Kasuya H., Akagawa H.;
RT   "Exome sequencing identified CCER2 as a novel candidate gene for
RT   Moyamoya disease.";
RL   J. Stroke Cerebrovasc. Dis. 26:150-161(2017).
CC   -!- FUNCTION: Transcriptional repressor which forms a core component
CC       of the circadian clock. The circadian clock, an internal time-
CC       keeping system, regulates various physiological processes through
CC       the generation of approximately 24 hour circadian rhythms in gene
CC       expression, which are translated into rhythms in metabolism and
CC       behavior. It is derived from the Latin roots 'circa' (about) and
CC       'diem' (day) and acts as an important regulator of a wide array of
CC       physiological functions including metabolism, sleep, body
CC       temperature, blood pressure, endocrine, immune, cardiovascular,
CC       and renal function. Consists of two major components: the central
CC       clock, residing in the suprachiasmatic nucleus (SCN) of the brain,
CC       and the peripheral clocks that are present in nearly every tissue
CC       and organ system. Both the central and peripheral clocks can be
CC       reset by environmental cues, also known as Zeitgebers (German for
CC       'timegivers'). The predominant Zeitgeber for the central clock is
CC       light, which is sensed by retina and signals directly to the SCN.
CC       The central clock entrains the peripheral clocks through neuronal
CC       and hormonal signals, body temperature and feeding-related cues,
CC       aligning all clocks with the external light/dark cycle. Circadian
CC       rhythms allow an organism to achieve temporal homeostasis with its
CC       environment at the molecular level by regulating gene expression
CC       to create a peak of protein expression once every 24 hours to
CC       control when a particular physiological process is most active
CC       with respect to the solar day. Transcription and translation of
CC       core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2,
CC       PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm
CC       generation, whereas delays imposed by post-translational
CC       modifications (PTMs) are important for determining the period
CC       (tau) of the rhythms (tau refers to the period of a rhythm and is
CC       the length, in time, of one complete cycle). A diurnal rhythm is
CC       synchronized with the day/night cycle, while the ultradian and
CC       infradian rhythms have a period shorter and longer than 24 hours,
CC       respectively. Disruptions in the circadian rhythms contribute to
CC       the pathology of cardiovascular diseases, cancer, metabolic
CC       syndromes and aging. A transcription/translation feedback loop
CC       (TTFL) forms the core of the molecular circadian clock mechanism.
CC       Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or
CC       ARNTL2/BMAL2, form the positive limb of the feedback loop, act in
CC       the form of a heterodimer and activate the transcription of core
CC       clock genes and clock-controlled genes (involved in key metabolic
CC       processes), harboring E-box elements (5'-CACGTG-3') within their
CC       promoters. The core clock genes: PER1/2/3 and CRY1/2 which are
CC       transcriptional repressors form the negative limb of the feedback
CC       loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2
CC       heterodimer inhibiting its activity and thereby negatively
CC       regulating their own expression. This heterodimer also activates
CC       nuclear receptors NR1D1/2 and RORA/B/G, which form a second
CC       feedback loop and which activate and repress ARNTL/BMAL1
CC       transcription, respectively. Regulates circadian target genes
CC       expression at post-transcriptional levels, but may not be required
CC       for the repression at transcriptional level. Controls PER2 protein
CC       decay. Represses CRY2 preventing its repression on CLOCK/ARNTL
CC       target genes such as FXYD5 and SCNN1A in kidney and PPARA in
CC       liver. Besides its involvement in the maintenance of the circadian
CC       clock, has an important function in the regulation of several
CC       processes. Participates in the repression of glucocorticoid
CC       receptor NR3C1/GR-induced transcriptional activity by reducing the
CC       association of NR3C1/GR to glucocorticoid response elements (GREs)
CC       by ARNTL:CLOCK. Plays a role in the modulation of the
CC       neuroinflammatory state via the regulation of inflammatory
CC       mediators release, such as CCL2 and IL6. In spinal astrocytes,
CC       negatively regulates the MAPK14/p38 and MAPK8/JNK MAPK cascades as
CC       well as the subsequent activation of NFkappaB. Coordinately
CC       regulates the expression of multiple genes that are involved in
CC       the regulation of renal sodium reabsorption. Can act as gene
CC       expression activator in a gene and tissue specific manner, in
CC       kidney enhances WNK1 and SLC12A3 expression in collaboration with
CC       CLOCK. Modulates hair follicle cycling. Represses the CLOCK-
CC       ARNTL/BMAL1 induced transcription of BHLHE40/DEC1.
CC       {ECO:0000269|PubMed:24005054}.
CC   -!- SUBUNIT: Homodimer. Component of the circadian core oscillator,
CC       which includes the CRY proteins, CLOCK or NPAS2, ARNTL/BMAL1 or
CC       ARNTL2/BMAL2, CSNK1D and/or CSNK1E, TIMELESS, and the PER
CC       proteins. Interacts directly with TIMELESS, PER2, PER3 and,
CC       through a C-terminal domain, with CRY1 and CRY2. Interacts with
CC       ARNTL/BMAL1 and CLOCK. Interacts with GPRASP1. Interacts
CC       (phosphorylated) with BTRC and FBXW11; the interactions trigger
CC       proteasomal degradation. Interacts with NONO, WDR5 and SFPQ.
CC       Interacts with USP2 (By similarity).
CC       {ECO:0000250|UniProtKB:O35973, ECO:0000269|PubMed:15917222}.
CC   -!- INTERACTION:
CC       Q9R194:Cry2 (xeno); NbExp=3; IntAct=EBI-2557276, EBI-1266619;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Nucleocytoplasmic
CC       shuttling is effected by interaction with other circadian core
CC       oscillator proteins and/or by phosphorylation. Retention of PER1
CC       in the cytoplasm occurs through PER1-PER2 heterodimer formation.
CC       Translocate to the nucleus after phosphorylation by CSNK1D or
CC       CSNK1E. Also translocated to the nucleus by CRY1 or CRY2 (By
CC       similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Rigui 4.7;
CC         IsoId=O15534-1; Sequence=Displayed;
CC       Name=Rigui 3.0;
CC         IsoId=O15534-2; Sequence=Not described;
CC       Name=Rigui 6.6; Synonyms=Truncated;
CC         IsoId=O15534-3; Sequence=Not described;
CC       Name=2;
CC         IsoId=O15534-4; Sequence=VSP_056205, VSP_056206, VSP_056207;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in hair follicles
CC       (at protein level).Found in heart, brain, placenta, lung, liver,
CC       skeletal muscle, pancreas, kidney, spleen, thymus, prostate,
CC       testis, ovary and small intestine. Highest level in skeletal
CC       muscle. {ECO:0000269|PubMed:14750904, ECO:0000269|PubMed:24005054,
CC       ECO:0000269|PubMed:9333243, ECO:0000269|PubMed:9427249}.
CC   -!- INDUCTION: Serum-induced levels in fibroblasts show circadian
CC       oscillations. Maximum levels after 1 hour stimulation, minimum
CC       levels after 12 hours. Another peak is then observed after 20
CC       hours. Protein levels show maximum levels at 6 hours, decrease to
CC       reach minimum levels at 20 hours, and increase again to reach a
CC       second peak after 26 hours. Levels then decrease slightly and then
CC       increase to maximum levels at 32 hours. Levels of phosphorylated
CC       form increase between 3 hours and 12 hours.
CC       {ECO:0000269|PubMed:14750904}.
CC   -!- PTM: Phosphorylated on serine residues by CSNK1D, CSNK1E and
CC       probably also by CSNK1G2. Phosphorylation by CSNK1D or CSNK1E
CC       promotes nuclear location of PER proteins as well as
CC       ubiquitination and subsequent degradation. May be dephosphorylated
CC       by PP1. {ECO:0000269|PubMed:15917222}.
CC   -!- PTM: Ubiquitinated; requires phosphorylation by CSNK1E and
CC       interaction with BTRC and FBXW11. Deubiquitinated by USP2 (By
CC       similarity). {ECO:0000250|UniProtKB:O35973,
CC       ECO:0000269|PubMed:15917222}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC06326.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF022991; AAC51765.1; -; mRNA.
DR   EMBL; AB002107; BAA22633.1; -; mRNA.
DR   EMBL; AF102137; AAF15544.1; -; Genomic_DNA.
DR   EMBL; AB030817; BAA94085.1; -; Genomic_DNA.
DR   EMBL; AB088477; BAC06326.2; ALT_INIT; mRNA.
DR   EMBL; AK295410; BAG58361.1; -; mRNA.
DR   EMBL; AC129492; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90090.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90091.1; -; Genomic_DNA.
DR   EMBL; BC137346; AAI37347.1; -; mRNA.
DR   CCDS; CCDS11131.1; -. [O15534-1]
DR   PIR; T00018; T00018.
DR   RefSeq; NP_002607.2; NM_002616.2. [O15534-1]
DR   RefSeq; XP_005256746.1; XM_005256689.1. [O15534-1]
DR   UniGene; Hs.445534; -.
DR   PDB; 1UL6; Model; -; A=830-845.
DR   PDBsum; 1UL6; -.
DR   ProteinModelPortal; O15534; -.
DR   SMR; O15534; -.
DR   BioGrid; 111210; 45.
DR   DIP; DIP-56603N; -.
DR   IntAct; O15534; 10.
DR   MINT; O15534; -.
DR   STRING; 9606.ENSP00000314420; -.
DR   iPTMnet; O15534; -.
DR   PhosphoSitePlus; O15534; -.
DR   BioMuta; PER1; -.
DR   PaxDb; O15534; -.
DR   PeptideAtlas; O15534; -.
DR   PRIDE; O15534; -.
DR   Ensembl; ENST00000317276; ENSP00000314420; ENSG00000179094. [O15534-1]
DR   Ensembl; ENST00000354903; ENSP00000346979; ENSG00000179094. [O15534-4]
DR   GeneID; 5187; -.
DR   KEGG; hsa:5187; -.
DR   UCSC; uc002gkd.4; human. [O15534-1]
DR   CTD; 5187; -.
DR   DisGeNET; 5187; -.
DR   EuPathDB; HostDB:ENSG00000179094.13; -.
DR   GeneCards; PER1; -.
DR   H-InvDB; HIX0039072; -.
DR   HGNC; HGNC:8845; PER1.
DR   HPA; HPA047947; -.
DR   HPA; HPA067064; -.
DR   MIM; 602260; gene.
DR   neXtProt; NX_O15534; -.
DR   OpenTargets; ENSG00000179094; -.
DR   PharmGKB; PA33184; -.
DR   eggNOG; ENOG410IMRF; Eukaryota.
DR   eggNOG; ENOG410ZBUP; LUCA.
DR   GeneTree; ENSGT00510000046467; -.
DR   HOGENOM; HOG000231111; -.
DR   HOVERGEN; HBG008167; -.
DR   InParanoid; O15534; -.
DR   KO; K21944; -.
DR   OMA; PLFNSRC; -.
DR   OrthoDB; EOG091G00PA; -.
DR   PhylomeDB; O15534; -.
DR   TreeFam; TF318445; -.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   SIGNOR; O15534; -.
DR   ChiTaRS; PER1; human.
DR   GeneWiki; PER1; -.
DR   GenomeRNAi; 5187; -.
DR   PRO; PR:O15534; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000179094; -.
DR   CleanEx; HS_PER1; -.
DR   ExpressionAtlas; O15534; baseline and differential.
DR   Genevisible; O15534; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0031490; F:chromatin DNA binding; ISS:UniProtKB.
DR   GO; GO:0070888; F:E-box binding; IDA:BHF-UCL.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0000989; F:transcription factor activity, transcription factor binding; ISS:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0097167; P:circadian regulation of translation; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEP:UniProtKB.
DR   GO; GO:0009649; P:entrainment of circadian clock; TAS:ProtInc.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0043966; P:histone H3 acetylation; IDA:UniProtKB.
DR   GO; GO:0070932; P:histone H3 deacetylation; ISS:UniProtKB.
DR   GO; GO:0043967; P:histone H4 acetylation; IDA:UniProtKB.
DR   GO; GO:2000323; P:negative regulation of glucocorticoid receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.
DR   GO; GO:0010608; P:posttranscriptional regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:1900015; P:regulation of cytokine production involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0042634; P:regulation of hair cycle; IMP:UniProtKB.
DR   GO; GO:1900744; P:regulation of p38MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0002028; P:regulation of sodium ion transport; ISS:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00130; PAS; 1.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013655; PAS_fold_3.
DR   InterPro; IPR022728; Period_circadian-like_C.
DR   Pfam; PF08447; PAS_3; 1.
DR   Pfam; PF12114; Period_C; 1.
DR   SMART; SM00091; PAS; 2.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Biological rhythms;
KW   Complete proteome; Cytoplasm; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1   1290       Period circadian protein homolog 1.
FT                                /FTId=PRO_0000162627.
FT   DOMAIN      208    275       PAS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN      348    414       PAS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN      422    465       PAC.
FT   REGION        1    151       Interaction with BTRC.
FT                                {ECO:0000269|PubMed:15917222}.
FT   REGION      596    815       Required for phosphorylation by CSNK1E.
FT                                {ECO:0000250}.
FT   REGION     1149   1290       CRY binding domain. {ECO:0000250}.
FT   MOTIF       138    147       Nuclear export signal 1.
FT                                {ECO:0000250|UniProtKB:O54943}.
FT   MOTIF       489    498       Nuclear export signal 2.
FT                                {ECO:0000250|UniProtKB:O35973}.
FT   MOTIF       827    843       Nuclear localization signal.
FT                                {ECO:0000250|UniProtKB:O35973}.
FT   MOTIF       982    989       Nuclear export signal 3.
FT                                {ECO:0000250|UniProtKB:O54943}.
FT   MOTIF      1043   1047       LXXLL.
FT   COMPBIAS     49    129       Ser-rich.
FT   COMPBIAS    653    656       Poly-Ser.
FT   COMPBIAS    848   1013       Pro-rich.
FT   COMPBIAS   1030   1104       Ser-rich.
FT   COMPBIAS   1269   1273       Poly-Glu.
FT   COMPBIAS   1276   1279       Poly-Ser.
FT   MOD_RES     121    121       Phosphothreonine; by CSNK1E.
FT                                {ECO:0000255}.
FT   MOD_RES     122    122       Phosphoserine; by CSNK1E. {ECO:0000255}.
FT   MOD_RES     126    126       Phosphoserine; by CSNK1E. {ECO:0000255}.
FT   MOD_RES     661    661       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35973}.
FT   MOD_RES     663    663       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35973}.
FT   MOD_RES     704    704       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     815    815       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     979    979       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   MOD_RES     980    980       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   VAR_SEQ       1     32       MSGPLEGADGGGDPRPGESFCPGGVPSPGPPQ -> MLEVL
FT                                EEIWSVRARRA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056205.
FT   VAR_SEQ     822    875       CHHGPAPPSRRHHCRSKAKRSRHHQNPRAEAPCYVSHPSPV
FT                                PPSTPWPTPPATT -> SHLGPPGACPLPSLGLDCWGVGLK
FT                                GGVSAPGTQAGVASTTRPCLGTGPSLASPH (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056206.
FT   VAR_SEQ     876   1290       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056207.
FT   VARIANT     422    422       H -> Q (found in a patient with Moyamoya
FT                                disease; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27717682}.
FT                                /FTId=VAR_079176.
FT   VARIANT     696    696       E -> Q (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036038.
FT   VARIANT     962    962       A -> P (in dbSNP:rs2585405).
FT                                {ECO:0000269|PubMed:10857746,
FT                                ECO:0000269|PubMed:10940553,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9323128,
FT                                ECO:0000269|PubMed:9333243,
FT                                ECO:0000269|PubMed:9455484,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_047899.
FT   VARIANT     968    968       R -> H (in dbSNP:rs3027193).
FT                                /FTId=VAR_047900.
FT   VARIANT     985    985       N -> S (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036039.
FT   VARIANT    1060   1060       S -> L (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs761958964).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036040.
FT   MUTAGEN     121    126       TSGCSS->AAGCSA: Strongly decreases
FT                                interaction with BTRC and FBXW11 and
FT                                inhibits degradation promoted by CSNK1E.
FT   MUTAGEN     210    213       SEYT->AEYA: No effect on interaction with
FT                                BTRC and FBXW11.
FT                                {ECO:0000269|PubMed:15917222}.
FT   MUTAGEN     714    726       SVVSVTSQCSFSS->AVVAVTAQCAFAA: No effect
FT                                on interaction with BTRC and FBXW11.
FT                                {ECO:0000269|PubMed:15917222}.
FT   MUTAGEN     794    798       FLSRF->ALSRA: Strongly decreases
FT                                interaction with BTRC and FBXW11.
FT                                {ECO:0000269|PubMed:15917222}.
SQ   SEQUENCE   1290 AA;  136212 MW;  60B844468EEF4D1B CRC64;
     MSGPLEGADG GGDPRPGESF CPGGVPSPGP PQHRPCPGPS LADDTDANSN GSSGNESNGH
     ESRGASQRSS HSSSSGNGKD SALLETTESS KSTNSQSPSP PSSSIAYSLL SASSEQDNPS
     TSGCSSEQSA RARTQKELMT ALRELKLRLP PERRGKGRSG TLATLQYALA CVKQVQANQE
     YYQQWSLEEG EPCSMDMSTY TLEELEHITS EYTLQNQDTF SVAVSFLTGR IVYISEQAAV
     LLRCKRDVFR GTRFSELLAP QDVGVFYGST APSRLPTWGT GASAGSGLRD FTQEKSVFCR
     IRGGPDRDPG PRYQPFRLTP YVTKIRVSDG APAQPCCLLI AERIHSGYEA PRIPPDKRIF
     TTRHTPSCLF QDVDERAAPL LGYLPQDLLG APVLLFLHPE DRPLMLAIHK KILQLAGQPF
     DHSPIRFCAR NGEYVTMDTS WAGFVHPWSR KVAFVLGRHK VRTAPLNEDV FTPPAPSPAP
     SLDTDIQELS EQIHRLLLQP VHSPSPTGLC GVGAVTSPGP LHSPGSSSDS NGGDAEGPGP
     PAPVTFQQIC KDVHLVKHQG QQLFIESRAR PQSRPRLPAT GTFKAKALPC QSPDPELEAG
     SAPVQAPLAL VPEEAERKEA SSCSYQQINC LDSILRYLES CNLPSTTKRK CASSSSYTTS
     SASDDDRQRT GPVSVGTKKD PPSAALSGEG ATPRKEPVVG GTLSPLALAN KAESVVSVTS
     QCSFSSTIVH VGDKKPPESD IIMMEDLPGL APGPAPSPAP SPTVAPDPAP DAYRPVGLTK
     AVLSLHTQKE EQAFLSRFRD LGRLRGLDSS STAPSALGER GCHHGPAPPS RRHHCRSKAK
     RSRHHQNPRA EAPCYVSHPS PVPPSTPWPT PPATTPFPAV VQPYPLPVFS PRGGPQPLPP
     APTSVPPAAF PAPLVTPMVA LVLPNYLFPT PSSYPYGALQ TPAEGPPTPA SHSPSPSLPA
     LAPSPPHRPD SPLFNSRCSS PLQLNLLQLE ELPRAEGAAV AGGPGSSAGP PPPSAEAAEP
     EARLAEVTES SNQDALSGSS DLLELLLQED SRSGTGSAAS GSLGSGLGSG SGSGSHEGGS
     TSASITRSSQ SSHTSKYFGS IDSSEAEAGA ARGGAEPGDQ VIKYVLQDPI WLLMANADQR
     VMMTYQVPSR DMTSVLKQDR ERLRAMQKQQ PRFSEDQRRE LGAVHSWVRK GQLPRALDVM
     ACVDCGSSTQ DPGHPDDPLF SELDGLGLEP MEEGGGEQGS SGGGSGEGEG CEEAQGGAKA
     SSSQDLAMEE EEEGRSSSSP ALPTAGNCTS
//
ID   PML_HUMAN               Reviewed;         882 AA.
AC   P29590; E9PBR7; P29591; P29592; P29593; Q00755; Q15959; Q59FP9;
AC   Q8WUA0; Q96S41; Q9BPW2; Q9BWP7; Q9BZX6; Q9BZX7; Q9BZX8; Q9BZX9;
AC   Q9BZY0; Q9BZY2; Q9BZY3;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   28-FEB-2018, entry version 220.
DE   RecName: Full=Protein PML;
DE   AltName: Full=Promyelocytic leukemia protein;
DE   AltName: Full=RING finger protein 71;
DE   AltName: Full=Tripartite motif-containing protein 19;
GN   Name=PML; Synonyms=MYL, PP8675, RNF71, TRIM19;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-3), AND DISEASE.
RX   PubMed=1652369; DOI=10.1016/0092-8674(91)90113-D;
RA   de The H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A.;
RT   "The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation
RT   in acute promyelocytic leukemia encodes a functionally altered RAR.";
RL   Cell 66:675-684(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PML-1; PML-5 AND PML-8),
RP   CHROMOSOMAL TRANSLOCATION WITH RARA, DISEASE, AND VARIANT LEU-645.
RX   PubMed=1720570; DOI=10.1126/science.1720570;
RA   Goddard A.D., Borrow J., Freemont P.S., Solomon E.;
RT   "Characterization of a zinc finger gene disrupted by the t(15;17) in
RT   acute promyelocytic leukemia.";
RL   Science 254:1371-1374(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-4).
RX   PubMed=1311253;
RA   Kastner P., Perez A., Lutz Y., Rochette-Egly C., Gaub M.P., Durand B.,
RA   Lanotte M., Berger R., Chambon P.;
RT   "Structure, localization and transcriptional properties of two classes
RT   of retinoic acid receptor alpha fusion proteins in acute promyelocytic
RT   leukemia (APL): structural similarities with a new family of
RT   oncoproteins.";
RL   EMBO J. 11:629-642(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-6).
RX   PubMed=1652368; DOI=10.1016/0092-8674(91)90112-C;
RA   Kakizuka A., Miller W.H. Jr., Umenono K., Warrell R.P. Jr.,
RA   Frankel S.R., Murty V.V., Dmitrovsky E., Evans R.M.;
RT   "Chromosomal translocation t(15;17) in human acute promyelocytic
RT   leukemia fuses RAR alpha with a novel putative transcription factor,
RT   PML.";
RL   Cell 66:663-674(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PML-1; PML-2; PML-4; PML-5;
RP   PML-6; PML-7; PML-8; PML-12 AND PML-14), AND VARIANT LEU-645.
RX   PubMed=11331580; DOI=10.1093/emboj/20.9.2140;
RA   Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L.,
RA   Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A.,
RA   Minucci S., Pelicci P.G., Ballabio A.;
RT   "The tripartite motif family identifies cell compartments.";
RL   EMBO J. 20:2140-2151(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-6).
RA   Goddard A.D., Solomon E.;
RL   Submitted (JAN-1992) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PML-13).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PML-11).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PML-13).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 419-466, AND CHROMOSOMAL
RP   TRANSLOCATION WITH RARA.
RX   PubMed=1312695;
RA   Tong J.H., Dong S., Geng J.P., Huang W., Wang Z.Y., Sun G.L.,
RA   Chen S.J., Chen Z., Larsen C.-J., Berger R.;
RT   "Molecular rearrangements of the MYL gene in acute promyelocytic
RT   leukemia (APL, M3) define a breakpoint cluster region as well as some
RT   molecular variants.";
RL   Oncogene 7:311-316(1992).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 454-503, AND CHROMOSOMAL TRANSLOCATION
RP   WITH RARA.
RX   PubMed=12691149;
RA   Fujita K., Oba R., Harada H., Mori H., Niikura H., Isoyama K.,
RA   Omine M.;
RT   "Cytogenetics, FISH and RT-PCR analysis of acute promyelocytic
RT   leukemia: structure of the fusion point in a case lacking classic
RT   t(15;17) translocation.";
RL   Leuk. Lymphoma 44:111-115(2003).
RN   [13]
RP   SUMOYLATION AT LYS-65; LYS-160 AND LYS-490, MUTAGENESIS OF LYS-65;
RP   LYS-133; LYS-150; LYS-160 AND LYS-490, SUBCELLULAR LOCATION, AND
RP   FUNCTION.
RX   PubMed=9756909; DOI=10.1074/jbc.273.41.26675;
RA   Kamitani T., Kito K., Nguyen H.P., Wada H., Fukuda-Kamitani T.,
RA   Yeh E.T.H.;
RT   "Identification of three major sentrinization sites in PML.";
RL   J. Biol. Chem. 273:26675-26682(1998).
RN   [14]
RP   INTERACTION WITH TRIM27.
RX   PubMed=9570750;
RA   Cao T., Duprez E., Borden K.L., Freemont P.S., Etkin L.D.;
RT   "Ret finger protein is a normal component of PML nuclear bodies and
RT   interacts directly with PML.";
RL   J. Cell Sci. 111:1319-1329(1998).
RN   [15]
RP   INTERACTION WITH LASSA VIRUS Z PROTEIN.
RX   PubMed=9420283;
RA   Borden K.L., Campbell-Dwyer E.J., Salvato M.S.;
RT   "An arenavirus RING (zinc-binding) protein binds the oncoprotein
RT   promyelocyte leukemia protein (PML) and relocates PML nuclear bodies
RT   to the cytoplasm.";
RL   J. Virol. 72:758-766(1998).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH RARA; RXRA AND TRIM24.
RX   PubMed=10610177; DOI=10.1038/15463;
RA   Zhong S., Delva L., Rachez C., Cenciarelli C., Gandini D., Zhang H.,
RA   Kalantry S., Freedman L.P., Pandolfi P.P.;
RT   "A RA-dependent, tumour-growth suppressive transcription complex is
RT   the target of the PML-RARalpha and T18 oncoproteins.";
RL   Nat. Genet. 23:287-295(1999).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH DAXX.
RX   PubMed=10684855; DOI=10.1084/jem.191.4.631;
RA   Zhong S., Salomoni P., Ronchetti S., Guo A., Ruggero D.,
RA   Pandolfi P.P.;
RT   "Promyelocytic leukemia protein (PML) and Daxx participate in a novel
RT   nuclear pathway for apoptosis.";
RL   J. Exp. Med. 191:631-640(2000).
RN   [18]
RP   INTERACTION WITH DAXX, AND SUBCELLULAR LOCATION.
RX   PubMed=10669754; DOI=10.1128/MCB.20.5.1784-1796.2000;
RA   Li H., Leo C., Zhu J., Wu X., O'Neil J., Park E.-J., Chen J.D.;
RT   "Sequestration and inhibition of Daxx-mediated transcriptional
RT   repression by PML.";
RL   Mol. Cell. Biol. 20:1784-1796(2000).
RN   [19]
RP   FUNCTION, INTERACTION WITH TP53, AND SUBCELLULAR LOCATION.
RX   PubMed=11025664; DOI=10.1038/35036365;
RA   Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., Pandolfi P.P.;
RT   "The function of PML in p53-dependent apoptosis.";
RL   Nat. Cell Biol. 2:730-736(2000).
RN   [20]
RP   FUNCTION IN HFV RESTRICTION, INTERACTION WITH HFV BEL1 AND BET, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11432836; DOI=10.1093/emboj/20.13.3495;
RA   Regad T., Saib A., Lallemand-Breitenbach V., Pandolfi P.P., de The H.,
RA   Chelbi-Alix M.K.;
RT   "PML mediates the interferon-induced antiviral state against a complex
RT   retrovirus via its association with the viral transactivator.";
RL   EMBO J. 20:3495-3505(2001).
RN   [21]
RP   NOMENCLATURE OF ISOFORMS PML-1 THROUGH PML-7.
RX   PubMed=11704850; DOI=10.1038/sj.onc.1204765;
RA   Jensen K., Shiels C., Freemont P.S.;
RT   "PML protein isoforms and the RBCC/TRIM motif.";
RL   Oncogene 20:7223-7233(2001).
RN   [22]
RP   INTERACTION WITH SIRT1.
RX   PubMed=12006491; DOI=10.1093/emboj/21.10.2383;
RA   Langley E., Pearson M., Faretta M., Bauer U.-M., Frye R.A.,
RA   Minucci S., Pelicci P.G., Kouzarides T.;
RT   "Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular
RT   senescence.";
RL   EMBO J. 21:2383-2396(2002).
RN   [23]
RP   SUMOYLATION, AND DESUMOYLATION BY SENP2.
RX   PubMed=12419228; DOI=10.1016/S1097-2765(02)00699-8;
RA   Best J.L., Ganiatsas S., Agarwal S., Changou A., Salomoni P.,
RA   Shirihai O., Meluh P.B., Pandolfi P.P., Zon L.I.;
RT   "SUMO-1 protease-1 regulates gene transcription through PML.";
RL   Mol. Cell 10:843-855(2002).
RN   [24]
RP   FUNCTION IN DNA REPAIR, PHOSPHORYLATION AT SER-117 BY CHEK2, AND
RP   INTERACTION WITH CHEK2.
RX   PubMed=12402044; DOI=10.1038/ncb869;
RA   Yang S., Kuo C., Bisi J.E., Kim M.K.;
RT   "PML-dependent apoptosis after DNA damage is regulated by the
RT   checkpoint kinase hCds1/Chk2.";
RL   Nat. Cell Biol. 4:865-870(2002).
RN   [25]
RP   INTERACTION WITH RABIES VIRUS PHOSPHOPROTEINS, SUBCELLULAR LOCATION,
RP   AND FUNCTION.
RX   PubMed=12439746; DOI=10.1038/sj.onc.1205931;
RA   Blondel D., Regad T., Poisson N., Pavie B., Harper F., Pandolfi P.P.,
RA   De The H., Chelbi-Alix M.K.;
RT   "Rabies virus P and small P products interact directly with PML and
RT   reorganize PML nuclear bodies.";
RL   Oncogene 21:7957-7970(2002).
RN   [26]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CHEK2 AND TP53.
RX   PubMed=12810724; DOI=10.1074/jbc.M301264200;
RA   Louria-Hayon I., Grossman T., Sionov R.V., Alsheich O., Pandolfi P.P.,
RA   Haupt Y.;
RT   "The promyelocytic leukemia protein protects p53 from Mdm2-mediated
RT   inhibition and degradation.";
RL   J. Biol. Chem. 278:33134-33141(2003).
RN   [27]
RP   INTERACTION WITH TOPBP1.
RX   PubMed=12773567; DOI=10.1128/MCB.23.12.4247-4256.2003;
RA   Xu Z.-X., Timanova-Atanasova A., Zhao R.-X., Chang K.-S.;
RT   "PML colocalizes with and stabilizes the DNA damage response protein
RT   TopBP1.";
RL   Mol. Cell. Biol. 23:4247-4256(2003).
RN   [28]
RP   INTERACTION WITH SIAH1, AND DEGRADATION.
RX   PubMed=14645235; DOI=10.1074/jbc.M306407200;
RA   Fanelli M., Fantozzi A., De Luca P., Caprodossi S., Matsuzawa S.,
RA   Lazar M.A., Pelicci P.G., Minucci S.;
RT   "The coiled-coil domain is the structural determinant for mammalian
RT   homologues of Drosophila Sina-mediated degradation of promyelocytic
RT   leukemia protein and other tripartite motif proteins by the
RT   proteasome.";
RL   J. Biol. Chem. 279:5374-5379(2004).
RN   [29]
RP   FUNCTION, INTERACTION WITH ELF4, AND SUBCELLULAR LOCATION.
RX   PubMed=14976184; DOI=10.1074/jbc.M312439200;
RA   Suico M.A., Yoshida H., Seki Y., Uchikawa T., Lu Z., Shuto T.,
RA   Matsuzaki K., Nakao M., Li J.-D., Kai H.;
RT   "Myeloid Elf-1-like factor, an ETS transcription factor, up-regulates
RT   lysozyme transcription in epithelial cells through interaction with
RT   promyelocytic leukemia protein.";
RL   J. Biol. Chem. 279:19091-19098(2004).
RN   [30]
RP   INTERACTION WITH ANKRD2.
RX   PubMed=15136035; DOI=10.1016/j.jmb.2004.03.071;
RA   Kojic S., Medeot E., Guccione E., Krmac H., Zara I., Martinelli V.,
RA   Valle G., Faulkner G.;
RT   "The Ankrd2 protein, a link between the sarcomere and the nucleus in
RT   skeletal muscle.";
RL   J. Mol. Biol. 339:313-325(2004).
RN   [31]
RP   FUNCTION, INTERACTION WITH MDM2 AND RPL11, PHOSPHORYLATION BY ATR IN
RP   RESPONSE TO DNA DAMAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=15195100; DOI=10.1038/ncb1147;
RA   Bernardi R., Scaglioni P.P., Bergmann S., Horn H.F., Vousden K.H.,
RA   Pandolfi P.P.;
RT   "PML regulates p53 stability by sequestering Mdm2 to the nucleolus.";
RL   Nat. Cell Biol. 6:665-672(2004).
RN   [32]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CHFR.
RX   PubMed=15467728; DOI=10.1038/nsmb837;
RA   Daniels M.J., Marson A., Venkitaraman A.R.;
RT   "PML bodies control the nuclear dynamics and function of the CHFR
RT   mitotic checkpoint protein.";
RL   Nat. Struct. Mol. Biol. 11:1114-1121(2004).
RN   [33]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TGFBR1; TGFBR2;
RP   SMAD2; SMAD3 AND ZFYVE9/SARA.
RX   PubMed=15356634; DOI=10.1038/nature02783;
RA   Lin H.K., Bergmann S., Pandolfi P.P.;
RT   "Cytoplasmic PML function in TGF-beta signalling.";
RL   Nature 431:205-211(2004).
RN   [34]
RP   INTERACTION OF PML-RARALPHA ONCOPROTEIN WITH UBE2I, SUBCELLULAR
RP   LOCATION, SUMOYLATION, AND MUTAGENESIS OF CYS-88 AND PRO-89.
RX   PubMed=15809060; DOI=10.1016/j.bbrc.2005.03.052;
RA   Kim Y.E., Kim D.Y., Lee J.M., Kim S.T., Han T.H., Ahn J.H.;
RT   "Requirement of the coiled-coil domain of PML-RARalpha oncoprotein for
RT   localization, sumoylation, and inhibition of monocyte
RT   differentiation.";
RL   Biochem. Biophys. Res. Commun. 330:746-754(2005).
RN   [35]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16778193; DOI=10.1158/0008-5472.CAN-05-3792;
RA   Condemine W., Takahashi Y., Zhu J., Puvion-Dutilleul F., Guegan S.,
RA   Janin A., de The H.;
RT   "Characterization of endogenous human promyelocytic leukemia
RT   isoforms.";
RL   Cancer Res. 66:6192-6198(2006).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403; SER-518; SER-527
RP   AND SER-530, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-565
RP   (ISOFORM PML-5), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518;
RP   SER-527 AND SER-530 (ISOFORM PML-6), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [37]
RP   FUNCTION.
RX   PubMed=17030982; DOI=10.1083/jcb.200604009;
RA   Dellaire G., Ching R.W., Ahmed K., Jalali F., Tse K.C., Bristow R.G.,
RA   Bazett-Jones D.P.;
RT   "Promyelocytic leukemia nuclear bodies behave as DNA damage sensors
RT   whose response to DNA double-strand breaks is regulated by NBS1 and
RT   the kinases ATM, Chk2, and ATR.";
RL   J. Cell Biol. 175:55-66(2006).
RN   [38]
RP   FUNCTION IN POLIOVIRUS RESTRICTION.
RX   PubMed=16912307; DOI=10.1128/JVI.00031-06;
RA   Pampin M., Simonin Y., Blondel B., Percherancier Y., Chelbi-Alix M.K.;
RT   "Cross talk between PML and p53 during poliovirus infection:
RT   implications for antiviral defense.";
RL   J. Virol. 80:8582-8592(2006).
RN   [39]
RP   SUBUNIT, SUMOYLATION, SUMO-BINDING MOTIF, MUTAGENESIS OF CYS-57 AND
RP   CYS-60, AND SUBCELLULAR LOCATION.
RX   PubMed=17081985; DOI=10.1016/j.molcel.2006.09.013;
RA   Shen T.H., Lin H.K., Scaglioni P.P., Yung T.M., Pandolfi P.P.;
RT   "The mechanisms of PML-nuclear body formation.";
RL   Mol. Cell 24:331-339(2006).
RN   [40]
RP   INTERACTION WITH PKM, FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND
RP   MUTAGENESIS OF LYS-487 AND LYS-490.
RX   PubMed=18298799; DOI=10.1111/j.1365-2443.2008.01165.x;
RA   Shimada N., Shinagawa T., Ishii S.;
RT   "Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML
RT   tumor suppressor protein.";
RL   Genes Cells 13:245-254(2008).
RN   [41]
RP   ACETYLATION AT LYS-487 AND LYS-515, AND MUTAGENESIS OF LYS-487 AND
RP   LYS-515.
RX   PubMed=18621739; DOI=10.1074/jbc.M802217200;
RA   Hayakawa F., Abe A., Kitabayashi I., Pandolfi P.P., Naoe T.;
RT   "Acetylation of PML is involved in histone deacetylase inhibitor-
RT   mediated apoptosis.";
RL   J. Biol. Chem. 283:24420-24425(2008).
RN   [42]
RP   FUNCTION IN HCMV RESTRICTION.
RX   PubMed=17942542; DOI=10.1128/JVI.01685-07;
RA   Tavalai N., Papior P., Rechter S., Stamminger T.;
RT   "Nuclear domain 10 components promyelocytic leukemia protein and hDaxx
RT   independently contribute to an intrinsic antiviral defense against
RT   human cytomegalovirus infection.";
RL   J. Virol. 82:126-137(2008).
RN   [43]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18716620; DOI=10.1038/nature07290;
RA   Song M.S., Salmena L., Carracedo A., Egia A., Lo-Coco F.,
RA   Teruya-Feldstein J., Pandolfi P.P.;
RT   "The deubiquitinylation and localization of PTEN are regulated by a
RT   HAUSP-PML network.";
RL   Nature 455:813-817(2008).
RN   [44]
RP   POLYUBIQUITINATION AT LYS-380; LYS-400; LYS-401 AND LYS-476 BY RNF4,
RP   PROTEASOMAL DEGRADATION, AND SUMOYLATION.
RX   PubMed=18408734; DOI=10.1038/ncb1716;
RA   Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N.,
RA   Jaffray E.G., Palvimo J.J., Hay R.T.;
RT   "RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for
RT   arsenic-induced PML degradation.";
RL   Nat. Cell Biol. 10:538-546(2008).
RN   [45]
RP   FUNCTION, AND INTERACTION WITH SATB1.
RX   PubMed=17173041; DOI=10.1038/ncb1516;
RA   Kumar P.P., Bischof O., Purbey P.K., Notani D., Urlaub H., Dejean A.,
RA   Galande S.;
RT   "Functional interaction between PML and SATB1 regulates chromatin-loop
RT   architecture and transcription of the MHC class I locus.";
RL   Nat. Cell Biol. 9:45-56(2007).
RN   [46]
RP   FUNCTION IN HHV-1 RESTRICTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18509536; DOI=10.1371/journal.pone.0002277;
RA   McNally B.A., Trgovcich J., Maul G.G., Liu Y., Zheng P.;
RT   "A role for cytoplasmic PML in cellular resistance to viral
RT   infection.";
RL   PLoS ONE 3:E2277-E2277(2008).
RN   [47]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403; SER-518; SER-527
RP   AND SER-530, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [48]
RP   FUNCTION IN INFLUENZA A VIRUS RESTRICTION.
RX   PubMed=19703418; DOI=10.1016/j.bbrc.2009.08.091;
RA   Li W., Wang G., Zhang H., Zhang D., Zeng J., Chen X., Xu Y., Li K.;
RT   "Differential suppressive effect of promyelocytic leukemia protein on
RT   the replication of different subtypes/strains of influenza A virus.";
RL   Biochem. Biophys. Res. Commun. 389:84-89(2009).
RN   [49]
RP   FUNCTION, AND INTERACTION WITH TERT.
RX   PubMed=19567472; DOI=10.1242/jcs.048066;
RA   Oh W., Ghim J., Lee E.W., Yang M.R., Kim E.T., Ahn J.H., Song J.;
RT   "PML-IV functions as a negative regulator of telomerase by interacting
RT   with TERT.";
RL   J. Cell Sci. 122:2613-2622(2009).
RN   [50]
RP   PHOSPHORYLATION AT SER-8 AND SER-38 BY HIPK2, AND INTERACTION WITH
RP   HIPK2.
RX   PubMed=19015637; DOI=10.1038/onc.2008.420;
RA   Gresko E., Ritterhoff S., Sevilla-Perez J., Roscic A., Froebius K.,
RA   Kotevic I., Vichalkovski A., Hess D., Hemmings B.A., Schmitz M.L.;
RT   "PML tumor suppressor is regulated by HIPK2-mediated phosphorylation
RT   in response to DNA damage.";
RL   Oncogene 28:698-708(2009).
RN   [51]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-530, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [52]
RP   INTERACTION WITH MORC3, AND SUBCELLULAR LOCATION.
RX   PubMed=20501696; DOI=10.1242/jcs.063586;
RA   Mimura Y., Takahashi K., Kawata K., Akazawa T., Inoue N.;
RT   "Two-step colocalization of MORC3 with PML nuclear bodies.";
RL   J. Cell Sci. 123:2014-2024(2010).
RN   [53]
RP   FUNCTION IN RABIES VIRUS RESTRICTION.
RX   PubMed=20702643; DOI=10.1128/JVI.01286-10;
RA   Blondel D., Kheddache S., Lahaye X., Dianoux L., Chelbi-Alix M.K.;
RT   "Resistance to rabies virus infection conferred by the PMLIV
RT   isoform.";
RL   J. Virol. 84:10719-10726(2010).
RN   [54]
RP   INTERACTION OF PML-4 AND PML-5 WITH HADV5 E1B-55K.
RX   PubMed=20639899; DOI=10.1038/onc.2010.284;
RA   Wimmer P., Schreiner S., Everett R.D., Sirma H., Groitl P., Dobner T.;
RT   "SUMO modification of E1B-55K oncoprotein regulates isoform-specific
RT   binding to the tumour suppressor protein PML.";
RL   Oncogene 29:5511-5522(2010).
RN   [55]
RP   SUMOYLATION, AND UBIQUITINATION.
RX   PubMed=20943951; DOI=10.1091/mbc.E10-05-0449;
RA   Geoffroy M.C., Jaffray E.G., Walker K.J., Hay R.T.;
RT   "Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear
RT   bodies.";
RL   Mol. Biol. Cell 21:4227-4239(2010).
RN   [56]
RP   INTERACTION WITH CSNK2A1 AND CSNK2A3.
RX   PubMed=20625391; DOI=10.1371/journal.pone.0011418;
RA   Hung M.S., Lin Y.C., Mao J.H., Kim I.J., Xu Z., Yang C.T.,
RA   Jablons D.M., You L.;
RT   "Functional polymorphism of the CK2alpha intronless gene plays
RT   oncogenic roles in lung cancer.";
RL   PLoS ONE 5:E11418-E11418(2010).
RN   [57]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518 AND SER-527, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [58]
RP   INTERACTION WITH UBC9, SUBUNIT, UBIQUITINATION, SUMOYLATION, ARSENIC
RP   BINDING, DOMAIN, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=20378816; DOI=10.1126/science.1183424;
RA   Zhang X.W., Yan X.J., Zhou Z.R., Yang F.F., Wu Z.Y., Sun H.B.,
RA   Liang W.X., Song A.X., Lallemand-Breitenbach V., Jeanne M.,
RA   Zhang Q.Y., Yang H.Y., Huang Q.H., Zhou G.B., Tong J.H., Zhang Y.,
RA   Wu J.H., Hu H.Y., de The H., Chen S.J., Chen Z.;
RT   "Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by
RT   directly binding PML.";
RL   Science 328:240-243(2010).
RN   [59]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [60]
RP   FUNCTION, AND INTERACTION WITH WRN.
RX   PubMed=21639834; DOI=10.1134/S000629791105004X;
RA   Liu J., Song Y., Qian J., Liu B., Dong Y., Tian B., Sun Z.;
RT   "Promyelocytic leukemia protein interacts with werner syndrome
RT   helicase and regulates double-strand break repair in gamma-
RT   irradiation-induced DNA damage responses.";
RL   Biochemistry (Mosc.) 76:550-554(2011).
RN   [61]
RP   UBIQUITINATION, PHOSPHORYLATION AT SER-518, AND MUTAGENESIS OF
RP   SER-518.
RX   PubMed=21840486; DOI=10.1016/j.ccr.2011.07.008;
RA   Yuan W.C., Lee Y.R., Huang S.F., Lin Y.M., Chen T.Y., Chung H.C.,
RA   Tsai C.H., Chen H.Y., Chiang C.T., Lai C.K., Lu L.T., Chen C.H.,
RA   Gu D.L., Pu Y.S., Jou Y.S., Lu K.P., Hsiao P.W., Shih H.M., Chen R.H.;
RT   "A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to
RT   potentiate HIF-1 signaling and prostate cancer progression.";
RL   Cancer Cell 20:214-228(2011).
RN   [62]
RP   REVIEW ON FUNCTION.
RX   PubMed=21475307; DOI=10.1038/cdd.2011.31;
RA   Pinton P., Giorgi C., Pandolfi P.P.;
RT   "The role of PML in the control of apoptotic cell fate: a new key
RT   player at ER-mitochondria sites.";
RL   Cell Death Differ. 18:1450-1456(2011).
RN   [63]
RP   REVIEW ON FUNCTION.
RX   PubMed=21501958; DOI=10.1016/j.ceb.2011.03.011;
RA   Carracedo A., Ito K., Pandolfi P.P.;
RT   "The nuclear bodies inside out: PML conquers the cytoplasm.";
RL   Curr. Opin. Cell Biol. 23:360-366(2011).
RN   [64]
RP   PHOSPHORYLATION AT SER-403; SER-505; SER-518 AND SER-527, AND
RP   INTERACTION WITH PIN1 AND MAPK1.
RX   PubMed=22033920; DOI=10.1074/jbc.M111.289512;
RA   Lim J.H., Liu Y., Reineke E., Kao H.Y.;
RT   "Mitogen-activated protein kinase extracellular signal-regulated
RT   kinase 2 phosphorylates and promotes Pin1 protein-dependent
RT   promyelocytic leukemia protein turnover.";
RL   J. Biol. Chem. 286:44403-44411(2011).
RN   [65]
RP   FUNCTION.
RX   PubMed=21172801; DOI=10.1242/jcs.075390;
RA   Cuchet D., Sykes A., Nicolas A., Orr A., Murray J., Sirma H.,
RA   Heeren J., Bartelt A., Everett R.D.;
RT   "PML isoforms I and II participate in PML-dependent restriction of
RT   HSV-1 replication.";
RL   J. Cell Sci. 124:280-291(2011).
RN   [66]
RP   REVIEW ON FUNCTION IN ANTIVIRAL DEFENSE.
RX   PubMed=21198351; DOI=10.1089/jir.2010.0111;
RA   Geoffroy M.C., Chelbi-Alix M.K.;
RT   "Role of promyelocytic leukemia protein in host antiviral defense.";
RL   J. Interferon Cytokine Res. 31:145-158(2011).
RN   [67]
RP   FUNCTION IN EMCV RESTRICTION, AND INTERACTION WITH EMCV P3D-POL.
RX   PubMed=21994459; DOI=10.1128/JVI.05808-11;
RA   Maroui M.A., Pampin M., Chelbi-Alix M.K.;
RT   "Promyelocytic leukemia isoform IV confers resistance to
RT   encephalomyocarditis virus via the sequestration of 3D polymerase in
RT   nuclear bodies.";
RL   J. Virol. 85:13164-13173(2011).
RN   [68]
RP   SUMOYLATION, AND DESUMOYLATION BY SENP6.
RX   PubMed=21148299; DOI=10.1091/mbc.E10-06-0504;
RA   Hattersley N., Shen L., Jaffray E.G., Hay R.T.;
RT   "The SUMO protease SENP6 is a direct regulator of PML nuclear
RT   bodies.";
RL   Mol. Biol. Cell 22:78-90(2011).
RN   [69]
RP   REVIEW ON FUNCTION.
RX   PubMed=21161613; DOI=10.1007/s12035-010-8156-y;
RA   Salomoni P., Betts-Henderson J.;
RT   "The role of PML in the nervous system.";
RL   Mol. Neurobiol. 43:114-123(2011).
RN   [70]
RP   FUNCTION IN VARICELLA ZOSTER RESTRICTION, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH VZV VP26.
RX   PubMed=21304940; DOI=10.1371/journal.ppat.1001266;
RA   Reichelt M., Wang L., Sommer M., Perrino J., Nour A.M., Sen N.,
RA   Baiker A., Zerboni L., Arvin A.M.;
RT   "Entrapment of viral capsids in nuclear PML cages is an intrinsic
RT   antiviral host defense against Varicella-Zoster virus.";
RL   PLoS Pathog. 7:E1001266-E1001266(2011).
RN   [71]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518; SER-527 AND
RP   SER-530, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [72]
RP   SUMOYLATION AT LYS-65 AND LYS-160, PHOSPHORYLATION AT SER-565,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PIAS1; PIAS2 AND CSNK2A1.
RX   PubMed=22406621; DOI=10.1158/0008-5472.CAN-11-3159;
RA   Rabellino A., Carter B., Konstantinidou G., Wu S.Y., Rimessi A.,
RA   Byers L.A., Heymach J.V., Girard L., Chiang C.M., Teruya-Feldstein J.,
RA   Scaglioni P.P.;
RT   "The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its
RT   oncogenic counterpart PML-RARA.";
RL   Cancer Res. 72:2275-2284(2012).
RN   [73]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MAGEA2.
RX   PubMed=22117195; DOI=10.1038/cdd.2011.173;
RA   Peche L.Y., Scolz M., Ladelfa M.F., Monte M., Schneider C.;
RT   "MageA2 restrains cellular senescence by targeting the function of
RT   PMLIV/p53 axis at the PML-NBs.";
RL   Cell Death Differ. 19:926-936(2012).
RN   [74]
RP   REVIEW ON FUNCTION.
RX   PubMed=22237204; DOI=10.1038/cddis.2011.122;
RA   Salomoni P., Dvorkina M., Michod D.;
RT   "Role of the promyelocytic leukaemia protein in cell death
RT   regulation.";
RL   Cell Death Dis. 3:E247-E247(2012).
RN   [75]
RP   FUNCTION, AND INTERACTION WITH TBX2; TBX3; E2F4 AND RBL2.
RX   PubMed=22002537; DOI=10.1038/emboj.2011.370;
RA   Martin N., Benhamed M., Nacerddine K., Demarque M.D., van Lohuizen M.,
RA   Dejean A., Bischof O.;
RT   "Physical and functional interaction between PML and TBX2 in the
RT   establishment of cellular senescence.";
RL   EMBO J. 31:95-109(2012).
RN   [76]
RP   FUNCTION IN CIRCADIAN CLOCK, SUBCELLULAR LOCATION, INTERACTION WITH
RP   PER2, ACETYLATION AT LYS-487, AND DEACETYLATION BY SIRT1.
RX   PubMed=22274616; DOI=10.1038/emboj.2012.1;
RA   Miki T., Xu Z., Chen-Goodspeed M., Liu M., Van Oort-Jansen A.,
RA   Rea M.A., Zhao Z., Lee C.C., Chang K.S.;
RT   "PML regulates PER2 nuclear localization and circadian function.";
RL   EMBO J. 31:1427-1439(2012).
RN   [77]
RP   REVIEW ON PTM.
RX   PubMed=23316480; DOI=10.3389/fonc.2012.00210;
RA   Cheng X., Kao H.Y.;
RT   "Post-translational modifications of PML: consequences and
RT   implications.";
RL   Front. Oncol. 2:210-210(2012).
RN   [78]
RP   FUNCTION, SUBCELLULAR LOCATION, SUMOYLATION AT LYS-490, AND
RP   INTERACTION WITH HDAC7; RANBP2 AND CTNNB1-TCF7L2 COMPLEX.
RX   PubMed=22155184; DOI=10.1053/j.gastro.2011.11.041;
RA   Satow R., Shitashige M., Jigami T., Fukami K., Honda K.,
RA   Kitabayashi I., Yamada T.;
RT   "Beta-catenin inhibits promyelocytic leukemia protein tumor suppressor
RT   function in colorectal cancer cells.";
RL   Gastroenterology 142:572-581(2012).
RN   [79]
RP   INTERACTION WITH MOMLV IN AND RT, AND SUBCELLULAR LOCATION.
RX   PubMed=22685230; DOI=10.1093/jb/mvs063;
RA   Okino Y., Inayoshi Y., Kojima Y., Kidani S., Kaneoka H., Honkawa A.,
RA   Higuchi H., Nishijima K., Miyake K., Iijima S.;
RT   "Moloney murine leukemia virus integrase and reverse transcriptase
RT   interact with PML proteins.";
RL   J. Biochem. 152:161-169(2012).
RN   [80]
RP   FUNCTION.
RX   PubMed=22589541; DOI=10.1074/jbc.M112.340505;
RA   Cheng X., Liu Y., Chu H., Kao H.Y.;
RT   "Promyelocytic leukemia protein (PML) regulates endothelial cell
RT   network formation and migration in response to tumor necrosis factor
RT   alpha (TNFalpha) and interferon alpha (IFNalpha).";
RL   J. Biol. Chem. 287:23356-23367(2012).
RN   [81]
RP   DOMAIN C-TERMINAL.
RX   PubMed=22773875; DOI=10.1074/jbc.M112.374769;
RA   Geng Y., Monajembashi S., Shao A., Cui D., He W., Chen Z.,
RA   Hemmerich P., Tang J.;
RT   "Contribution of the C-terminal regions of promyelocytic leukemia
RT   protein (PML) isoforms II and V to PML nuclear body formation.";
RL   J. Biol. Chem. 287:30729-30742(2012).
RN   [82]
RP   REVIEW ON UBIQUITINATION.
RX   PubMed=22935031; DOI=10.1186/1423-0127-19-81;
RA   Chen R.H., Lee Y.R., Yuan W.C.;
RT   "The role of PML ubiquitination in human malignancies.";
RL   J. Biomed. Sci. 19:81-81(2012).
RN   [83]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CIITA.
RX   PubMed=23007646; DOI=10.1083/jcb.201112015;
RA   Ulbricht T., Alzrigat M., Horch A., Reuter N., von Mikecz A.,
RA   Steimle V., Schmitt E., Kraemer O.H., Stamminger T., Hemmerich P.;
RT   "PML promotes MHC class II gene expression by stabilizing the class II
RT   transactivator.";
RL   J. Cell Biol. 199:49-63(2012).
RN   [84]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=22886304; DOI=10.1172/JCI62129;
RA   Carracedo A., Weiss D., Leliaert A.K., Bhasin M., de Boer V.C.,
RA   Laurent G., Adams A.C., Sundvall M., Song S.J., Ito K., Finley L.S.,
RA   Egia A., Libermann T., Gerhart-Hines Z., Puigserver P., Haigis M.C.,
RA   Maratos-Flier E., Richardson A.L., Schafer Z.T., Pandolfi P.P.;
RT   "A metabolic prosurvival role for PML in breast cancer.";
RL   J. Clin. Invest. 122:3088-3100(2012).
RN   [85]
RP   INTERACTION WITH HHV-1 ICP0.
RX   PubMed=22875967; DOI=10.1128/JVI.01145-12;
RA   Cuchet-Lourenco D., Vanni E., Glass M., Orr A., Everett R.D.;
RT   "Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML
RT   isoform I and induces its SUMO-independent degradation.";
RL   J. Virol. 86:11209-11222(2012).
RN   [86]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-38; SER-48;
RP   SER-403; SER-505; SER-512; SER-518; SER-527; SER-530 AND THR-867, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [87]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MDM2 AND MAPK7.
RX   PubMed=22869143; DOI=10.1038/onc.2012.332;
RA   Yang Q., Liao L., Deng X., Chen R., Gray N.S., Yates J.R. III,
RA   Lee J.D.;
RT   "BMK1 is involved in the regulation of p53 through disrupting the PML-
RT   MDM2 interaction.";
RL   Oncogene 32:3156-3164(2013).
RN   [88]
RP   UBIQUITINATION BY UHRF1.
RX   PubMed=22945642; DOI=10.1038/onc.2012.406;
RA   Guan D., Factor D., Liu Y., Wang Z., Kao H.Y.;
RT   "The epigenetic regulator UHRF1 promotes ubiquitination-mediated
RT   degradation of the tumor-suppressor protein promyelocytic leukemia
RT   protein.";
RL   Oncogene 32:3819-3828(2013).
RN   [89]
RP   SUMOYLATION, INTERACTION WITH RNF4, AND DOMAIN SIM.
RX   PubMed=23028697; DOI=10.1371/journal.pone.0044949;
RA   Maroui M.A., Kheddache-Atmane S., El Asmi F., Dianoux L., Aubry M.,
RA   Chelbi-Alix M.K.;
RT   "Requirement of PML SUMO interacting motif for RNF4- or arsenic
RT   trioxide-induced degradation of nuclear PML isoforms.";
RL   PLoS ONE 7:E44949-E44949(2012).
RN   [90]
RP   FUNCTION.
RX   PubMed=23219818; DOI=10.1016/j.bbrc.2012.11.108;
RA   Kuroki M., Ariumi Y., Hijikata M., Ikeda M., Dansako H., Wakita T.,
RA   Shimotohno K., Kato N.;
RT   "PML tumor suppressor protein is required for HCV production.";
RL   Biochem. Biophys. Res. Commun. 430:592-597(2013).
RN   [91]
RP   INTERACTION WITH NLRP3.
RX   PubMed=23430110; DOI=10.1182/blood-2012-05-432104;
RA   Lo Y.H., Huang Y.W., Wu Y.H., Tsai C.S., Lin Y.C., Mo S.T., Kuo W.C.,
RA   Chuang Y.T., Jiang S.T., Shih H.M., Lai M.Z.;
RT   "Selective inhibition of the NLRP3 inflammasome by targeting to
RT   promyelocytic leukemia protein in mouse and human.";
RL   Blood 121:3185-3194(2013).
RN   [92]
RP   FUNCTION, AND INTERACTION WITH HUMAN ADENOVIRUS 2 E1A.
RX   PubMed=23135708; DOI=10.1128/JVI.02023-12;
RA   Berscheminski J., Groitl P., Dobner T., Wimmer P., Schreiner S.;
RT   "The adenoviral oncogene E1A-13S interacts with a specific isoform of
RT   the tumor suppressor PML to enhance viral transcription.";
RL   J. Virol. 87:965-977(2013).
RN   [93]
RP   FUNCTION, AND INTERACTION WITH KAT6A.
RX   PubMed=23431171; DOI=10.1073/pnas.1300490110;
RA   Rokudai S., Laptenko O., Arnal S.M., Taya Y., Kitabayashi I.,
RA   Prives C.;
RT   "MOZ increases p53 acetylation and premature senescence through its
RT   complex formation with PML.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:3895-3900(2013).
RN   [94]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-36; SER-403;
RP   SER-518; SER-527 AND SER-530, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [95]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65; LYS-380 AND LYS-490, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [96]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65; LYS-160 AND LYS-490, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [97]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65; LYS-160; LYS-380;
RP   LYS-394; LYS-478 AND LYS-490, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [98]
RP   INTERACTION OF PML-4 AND PML-5 WITH HADV5 E1B-55K.
RX   PubMed=25772236; DOI=10.1038/onc.2015.63;
RA   Wimmer P., Berscheminski J., Blanchette P., Groitl P., Branton P.E.,
RA   Hay R.T., Dobner T., Schreiner S.;
RT   "PML isoforms IV and V contribute to adenovirus-mediated oncogenic
RT   transformation by functionally inhibiting the tumor-suppressor p53.";
RL   Oncogene 35:69-82(2016).
RN   [99]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65; LYS-160; LYS-380;
RP   LYS-394; LYS-401; LYS-460; LYS-476; LYS-478; LYS-487; LYS-490 AND
RP   LYS-497, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [100]
RP   STRUCTURE BY NMR OF 49-104.
RX   PubMed=7729428;
RA   Borden K.L.B., Boddy M.N., Lally J., O'Reilly N.J., Martin S.,
RA   Howe K., Solomon E., Freemont P.S.;
RT   "The solution structure of the RING finger domain from the acute
RT   promyelocytic leukaemia proto-oncoprotein PML.";
RL   EMBO J. 14:1532-1541(1995).
CC   -!- FUNCTION: Functions via its association with PML-nuclear bodies
CC       (PML-NBs) in a wide range of important cellular processes,
CC       including tumor suppression, transcriptional regulation,
CC       apoptosis, senescence, DNA damage response, and viral defense
CC       mechanisms. Acts as the scaffold of PML-NBs allowing other
CC       proteins to shuttle in and out, a process which is regulated by
CC       SUMO-mediated modifications and interactions. Isoform PML-4 has a
CC       multifaceted role in the regulation of apoptosis and growth
CC       suppression: activates RB1 and inhibits AKT1 via interactions with
CC       PP1 and PP2A phosphatases respectively, negatively affects the
CC       PI3K pathway by inhibiting MTOR and activating PTEN, and
CC       positively regulates p53/TP53 by acting at different levels (by
CC       promoting its acetylation and phosphorylation and by inhibiting
CC       its MDM2-dependent degradation). Isoform PML-4 also: acts as a
CC       transcriptional repressor of TBX2 during cellular senescence and
CC       the repression is dependent on a functional RBL2/E2F4 repressor
CC       complex, regulates double-strand break repair in gamma-
CC       irradiation-induced DNA damage responses via its interaction with
CC       WRN, acts as a negative regulator of telomerase by interacting
CC       with TERT, and regulates PER2 nuclear localization and circadian
CC       function. Isoform PML-6 inhibits specifically the activity of the
CC       tetrameric form of PKM. The nuclear isoforms (isoform PML-1,
CC       isoform PML-2, isoform PML-3, isoform PML-4 and isoform PML-5) in
CC       concert with SATB1 are involved in local chromatin-loop remodeling
CC       and gene expression regulation at the MHC-I locus. Isoform PML-2
CC       is required for efficient IFN-gamma induced MHC II gene
CC       transcription via regulation of CIITA. Cytoplasmic PML is involved
CC       in the regulation of the TGF-beta signaling pathway. PML also
CC       regulates transcription activity of ELF4 and can act as an
CC       important mediator for TNF-alpha- and IFN-alpha-mediated
CC       inhibition of endothelial cell network formation and migration.
CC   -!- FUNCTION: Exhibits antiviral activity against both DNA and RNA
CC       viruses. The antiviral activity can involve one or several
CC       isoform(s) and can be enhanced by the permanent PML-NB-associated
CC       protein DAXX or by the recruitment of p53/TP53 within these
CC       structures. Isoform PML-4 restricts varicella zoster virus (VZV)
CC       via sequestration of virion capsids in PML-NBs thereby preventing
CC       their nuclear egress and inhibiting formation of infectious virus
CC       particles. The sumoylated isoform PML-4 restricts rabies virus by
CC       inhibiting viral mRNA and protein synthesis. The cytoplasmic
CC       isoform PML-14 can restrict herpes simplex virus-1 (HHV-1)
CC       replication by sequestering the viral E3 ubiquitin-protein ligase
CC       ICP0 in the cytoplasm. Isoform PML-6 shows restriction activity
CC       towards human cytomegalovirus (HCMV) and influenza A virus strains
CC       PR8(H1N1) and ST364(H3N2). Sumoylated isoform PML-4 and isoform
CC       PML-12 show antiviral activity against encephalomyocarditis virus
CC       (EMCV) by promoting nuclear sequestration of viral polymerase
CC       (P3D-POL) within PML NBs. Isoform PML-3 exhibits antiviral
CC       activity against poliovirus by inducing apoptosis in infected
CC       cells through the recruitment and the activation of p53/TP53 in
CC       the PML-NBs. Isoform PML-3 represses human foamy virus (HFV)
CC       transcription by complexing the HFV transactivator, bel1/tas,
CC       preventing its binding to viral DNA. PML may positively regulate
CC       infectious hepatitis C viral (HCV) production and isoform PML-2
CC       may enhance adenovirus transcription.
CC   -!- SUBUNIT: Key component of PML bodies. PML bodies are formed by the
CC       interaction of PML homodimers (via SUMO-binding motif) with
CC       sumoylated PML, leading to the assembly of higher oligomers.
CC       Several types of PML bodies have been observed. PML bodies can
CC       form hollow spheres that can sequester target proteins inside.
CC       Interacts (via SUMO-binding motif) with sumoylated proteins.
CC       Interacts (via C-terminus) with p53/TP53. Recruits p53/TP53 and
CC       CHEK2 into PML bodies, which promotes p53/TP53 phosphorylation at
CC       'Ser-20' and prevents its proteasomal degradation. Interacts with
CC       MDM2, and sequesters MDM2 in the nucleolus, thereby preventing
CC       ubiquitination of p53/TP53. Interaction with PML-RARA oncoprotein
CC       and certain viral proteins causes disassembly of PML bodies and
CC       abolishes the normal PML function. Interacts with HIPK2, TERT,
CC       SIRT1, TOPBP1, TRIM27 and TRIM69. Interacts with ELF4 (via C-
CC       terminus). Interacts with Lassa virus Z protein and rabies virus
CC       phosphoprotein. Interacts with ITPR3. Interacts (in the cytoplasm)
CC       with TGFBR1, TGFBR2 and PKM. Interacts (via the coiled-coil domain
CC       and when sumoylated) with SATB1. Interacts with UBE2I; the
CC       interaction is enhanced by arsenic binding. Interacts (PML-RARA
CC       oncoprotein, via the coiled-coil domain) with UBE2I; the
CC       interaction is enhanced by arsenic binding and is required for
CC       PML-RARA oncoprotein sumoylation and inhibition of RARA
CC       transactivational activity. Interacts with RB1, PPP1A, SMAD2,
CC       SMAD3, DAXX, RPL11 and MTOR. Interacts with PPARGC1A and KAT2A.
CC       Interacts with CSNK2A1 and CSNK2A3. Interacts with ANKRD2; the
CC       interaction is direct. Interacts (via SUMO-interacting motif) with
CC       sumoylated MORC3 (PubMed:20501696). Isoform PML-1, isoform PML-2,
CC       isoform PML-3, isoform PML-4, isoform PML-5 and isoform PML-6
CC       interact with RNF4. Isoform PML-1 interacts with NLRP3. Isoform
CC       PML-1, isoform PML-2, isoform PML-3, isoform PML-4 and isoform
CC       PML-5 interact with MAGEA2, RBL2, PER2 and E2F4. Isoform PML-2
CC       interacts with CIITA. Isoform PML-2, isoform PML-3 and isoform
CC       PML-4 interact with TBX2. Isoform PML-4 interacts with RANBP2,
CC       HDAC7, KAT6A, WRN, PIN1, TBX3 and phosphorylated MAPK1/ERK2.
CC       Isoform PML-4 interacts with the CTNNB1 and TCF7L2/TCF4 complex.
CC       Isoform PML-4 preferentially interacts with MAPK7/BMK1 although
CC       other isoforms (isoform PML-1, isoform PML-2, isoform PML-3 and
CC       isoform PML-6) also interact with it. Isoform PML-12 interacts
CC       with PIAS1, PIAS2 (isoform PIAS2-alpha) and CSNK2A1/CK2. Isoform
CC       PML-3 interacts with HFV bel1/tas and bet. Isoform PML-4 interacts
CC       with VZV capsid protein VP26/ORF23 capsid protein. Ths sumoylated
CC       isoform PML-4 interacts with encephalomyocarditis virus (EMCV)
CC       RNA-directed RNA polymerase 3D-POL (P3D-POL). Isoform PML-1
CC       interacts with herpes simplex virus-1 (HHV-1) ICP0. Isoform PML-2
CC       interacts with human adenovirus 2 E1A and this interaction
CC       stimulates E1A-dependent transcriptional activation
CC       (PubMed:23135708). Isoform PML-6 interacts with moloney murine
CC       leukemia virus (MoMLV) integrase (IN) and reverse transcriptase
CC       (RT). Isoform PML-4 and isoform PML-5 interact with human
CC       adenovirus 5 E1B-55K protein; these interactions promote efficient
CC       subnuclear targeting of E1B-55K to PML nuclear bodies
CC       (PubMed:20639899, PubMed:25772236). {ECO:0000269|PubMed:10610177,
CC       ECO:0000269|PubMed:10669754, ECO:0000269|PubMed:10684855,
CC       ECO:0000269|PubMed:11025664, ECO:0000269|PubMed:11432836,
CC       ECO:0000269|PubMed:12006491, ECO:0000269|PubMed:12402044,
CC       ECO:0000269|PubMed:12439746, ECO:0000269|PubMed:12773567,
CC       ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:14645235,
CC       ECO:0000269|PubMed:14976184, ECO:0000269|PubMed:15136035,
CC       ECO:0000269|PubMed:15195100, ECO:0000269|PubMed:15356634,
CC       ECO:0000269|PubMed:15467728, ECO:0000269|PubMed:15809060,
CC       ECO:0000269|PubMed:17081985, ECO:0000269|PubMed:17173041,
CC       ECO:0000269|PubMed:18298799, ECO:0000269|PubMed:19015637,
CC       ECO:0000269|PubMed:19567472, ECO:0000269|PubMed:20378816,
CC       ECO:0000269|PubMed:20501696, ECO:0000269|PubMed:20625391,
CC       ECO:0000269|PubMed:20639899, ECO:0000269|PubMed:21304940,
CC       ECO:0000269|PubMed:21639834, ECO:0000269|PubMed:21994459,
CC       ECO:0000269|PubMed:22002537, ECO:0000269|PubMed:22033920,
CC       ECO:0000269|PubMed:22117195, ECO:0000269|PubMed:22155184,
CC       ECO:0000269|PubMed:22274616, ECO:0000269|PubMed:22406621,
CC       ECO:0000269|PubMed:22685230, ECO:0000269|PubMed:22869143,
CC       ECO:0000269|PubMed:22875967, ECO:0000269|PubMed:23007646,
CC       ECO:0000269|PubMed:23028697, ECO:0000269|PubMed:23135708,
CC       ECO:0000269|PubMed:23430110, ECO:0000269|PubMed:23431171,
CC       ECO:0000269|PubMed:25772236, ECO:0000269|PubMed:9420283,
CC       ECO:0000269|PubMed:9570750}.
CC   -!- INTERACTION:
CC       P03243-1:- (xeno); NbExp=3; IntAct=EBI-303996, EBI-1927377;
CC       P04489:- (xeno); NbExp=4; IntAct=EBI-8099068, EBI-6398911;
CC       P27958:- (xeno); NbExp=6; IntAct=EBI-295890, EBI-6377335;
CC       P68400:CSNK2A1; NbExp=2; IntAct=EBI-295890, EBI-347804;
CC       Q9UER7:DAXX; NbExp=6; IntAct=EBI-295890, EBI-77321;
CC       P25445:FAS; NbExp=4; IntAct=EBI-295890, EBI-494743;
CC       Q8UN00:gag-pro-pol (xeno); NbExp=4; IntAct=EBI-295890, EBI-6692904;
CC       Q9Y2M5:KLHL20; NbExp=9; IntAct=EBI-295890, EBI-714379;
CC       Q13164:MAPK7; NbExp=6; IntAct=EBI-295890, EBI-1213983;
CC       Q00987:MDM2; NbExp=6; IntAct=EBI-304008, EBI-389668;
CC       P25788:PSMA3; NbExp=2; IntAct=EBI-295890, EBI-348380;
CC       P63165:SUMO1; NbExp=6; IntAct=EBI-295890, EBI-80140;
CC       Q13207:TBX2; NbExp=2; IntAct=EBI-295890, EBI-2853051;
CC       O14746:TERT; NbExp=7; IntAct=EBI-304008, EBI-1772203;
CC       Q15583:TGIF1; NbExp=3; IntAct=EBI-295890, EBI-714215;
CC       P04637:TP53; NbExp=4; IntAct=EBI-295890, EBI-366083;
CC       Q05516:ZBTB16; NbExp=7; IntAct=EBI-295890, EBI-711925;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleoplasm. Cytoplasm.
CC       Nucleus, PML body {ECO:0000269|PubMed:20501696}. Nucleus,
CC       nucleolus. Endoplasmic reticulum membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}; Cytoplasmic side
CC       {ECO:0000250}. Early endosome membrane; Peripheral membrane
CC       protein; Cytoplasmic side. Note=Isoform PML-1 can shuttle between
CC       the nucleus and cytoplasm. Isoform PML-2, isoform PML-3, isoform
CC       PML-4, isoform PML-5 and isoform PML-6 are nuclear isoforms
CC       whereas isoform PML-7 and isoform PML-14 lacking the nuclear
CC       localization signal are cytoplasmic isoforms. Detected in the
CC       nucleolus after DNA damage. Acetylation at Lys-487 is essential
CC       for its nuclear localization. Within the nucleus, most of PML is
CC       expressed in the diffuse nuclear fraction of the nucleoplasm and
CC       only a small fraction is found in the matrix-associated nuclear
CC       bodies (PML-NBs). The transfer of PML from the nucleoplasm to PML-
CC       NBs depends on its phosphorylation and sumoylation. The B1 box and
CC       the RING finger are also required for the localization in PML-NBs.
CC       Also found in specific membrane structures termed mitochondria-
CC       associated membranes (MAMs) which connect the endoplasmic
CC       reticulum (ER) and the mitochondria. Sequestered in the cytoplasm
CC       by interaction with rabies virus phosphoprotein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=12;
CC       Name=PML-1; Synonyms=PML-I, TRIM19alpha;
CC         IsoId=P29590-1; Sequence=Displayed;
CC       Name=PML-2; Synonyms=PML-II, TRIM19kappa;
CC         IsoId=P29590-8; Sequence=VSP_040595;
CC       Name=PML-3; Synonyms=PML-III;
CC         IsoId=P29590-9; Sequence=VSP_040596, VSP_040597;
CC       Name=PML-4; Synonyms=PML-IV, PML-X, TRIM19zeta;
CC         IsoId=P29590-5; Sequence=VSP_005744, VSP_005745;
CC       Name=PML-5; Synonyms=PML-2, PML-V, TRIM19beta;
CC         IsoId=P29590-2; Sequence=VSP_005739, VSP_005740;
CC         Note=Ref.5 (AAG50181) sequence is in conflict in position:
CC         578:P->A. Contains a phosphoserine at position 565.
CC         {ECO:0000244|PubMed:17081983, ECO:0000305};
CC       Name=PML-6; Synonyms=PML-3B, PML-VI, TRIM19epsilon;
CC         IsoId=P29590-4; Sequence=VSP_005742, VSP_005743;
CC         Note=Contains a phosphoserine at position 518. Contains a
CC         phosphoserine at position 527. Contains a phosphoserine at
CC         position 530. {ECO:0000244|PubMed:17081983};
CC       Name=PML-7; Synonyms=PML-VII, TRIM19theta;
CC         IsoId=P29590-10; Sequence=VSP_040591, VSP_040594;
CC         Note=Ref.5 (AAG50187) sequence is in conflict in position:
CC         419:L->V. {ECO:0000305};
CC       Name=PML-8; Synonyms=PML-2G, PML-IIG, TRIM19gamma;
CC         IsoId=P29590-3; Sequence=VSP_005741;
CC         Note=Non-canonical splice sites. Might alternatively represent a
CC         polymorphic variation.;
CC       Name=PML-11; Synonyms=PML-1A, PML-IA;
CC         IsoId=P29590-11; Sequence=VSP_040590;
CC         Note=No experimental confirmation available.;
CC       Name=PML-12; Synonyms=PML-4A, PML-IVA, TRIM19lambda;
CC         IsoId=P29590-12; Sequence=VSP_040590, VSP_005744, VSP_005745;
CC       Name=PML-13; Synonyms=PML-2A, PML-IIA;
CC         IsoId=P29590-13; Sequence=VSP_040590, VSP_040595;
CC       Name=PML-14; Synonyms=PML-6B, PML-VIB, TRIM19eta, TRIM19iota;
CC         IsoId=P29590-14; Sequence=VSP_040592, VSP_040593;
CC   -!- INDUCTION: By interferons alpha, beta and gamma. Up-regulated by
CC       IRF3 and p53/TP53.
CC   -!- DOMAIN: The coiled-coil domain mediates a strong
CC       homo/multidimerization activity essential for core assembly of
CC       PML-NBs. Interacts with PKM via its coiled-coil domain
CC       (PubMed:18298799). {ECO:0000269|PubMed:18298799}.
CC   -!- DOMAIN: The B box-type zinc binding domain and the coiled-coil
CC       domain mediate its interaction with PIAS1.
CC       {ECO:0000269|PubMed:22406621}.
CC   -!- DOMAIN: Binds arsenic via the RING-type zinc finger. The RING-type
CC       zinc finger is essential for its interaction with HFV bel1/tas
CC       (PubMed:11432836). {ECO:0000269|PubMed:11432836}.
CC   -!- DOMAIN: The unique C-terminal domains of isoform PML-2 and isoform
CC       PML-5 play an important role in regulating the localization,
CC       assembly dynamics, and functions of PML-NBs.
CC       {ECO:0000269|PubMed:22773875}.
CC   -!- DOMAIN: The Sumo interaction motif (SIM) is required for efficient
CC       ubiquitination, recruitment of proteasome components within PML-
CC       NBs and PML degradation in response to arsenic trioxide.
CC       {ECO:0000269|PubMed:23028697}.
CC   -!- PTM: Ubiquitinated; mediated by RNF4, RNF111, UHRF1, UBE3A/E6AP,
CC       BCR(KLHL20) E3 ubiquitin ligase complex E3 ligase complex, SIAH1
CC       or SIAH2 and leading to subsequent proteasomal degradation
CC       (PubMed:18408734, PubMed:21840486, PubMed:22033920).
CC       Ubiquitination by BCR(KLHL20) E3 ubiquitin ligase complex E3
CC       ligase complex requires CDK1/2-mediated phosphorylation at Ser-518
CC       which in turn is recognized by prolyl-isopeptidase PIN1 and PIN1-
CC       catalyzed isomerization further potentiates PML interaction with
CC       KLHL20 (PubMed:21840486, PubMed:22033920). 'Lys-6'-, 'Lys-11'-,
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitination by RNF4 is
CC       polysumoylation-dependent (PubMed:18408734). Ubiquitination by
CC       RNF111 is polysumoylation-dependent (By similarity).
CC       {ECO:0000250|UniProtKB:Q60953, ECO:0000269|PubMed:18408734,
CC       ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22033920}.
CC   -!- PTM: Sumoylation regulates PML's: stability in response to
CC       extracellular or intracellular stimuli, transcription directly and
CC       indirectly, through sequestration of or dissociation of the
CC       transcription factors from PML-NBs, ability to regulate apoptosis
CC       and its anti-viral activities. It is also essential for:
CC       maintaining proper PML nuclear bodies (PML-NBs) structure and
CC       normal function, recruitment of components of PML-NBs, the
CC       turnover and retention of PML in PML-NBs and the integrity of PML-
CC       NBs. Undergoes 'Lys-11'-linked sumoylation. Sumoylation on all
CC       three sites (Lys-65, Lys-160 and Lys-490) is required for nuclear
CC       body formation. Sumoylation on Lys-160 is a prerequisite for
CC       sumoylation on Lys-65. Lys-65 and Lys-160 are sumoylated by PISA1
CC       and PIAS2. PIAS1-mediated sumoylation of PML promotes its
CC       interaction with CSNK2A1/CK2 and phosphorylation at Ser-565 which
CC       in turn triggers its ubiquitin-mediated degradation. PIAS1-
CC       mediated sumoylation of PML-RARA promotes its ubiquitin-mediated
CC       degradation. The PML-RARA fusion protein requires the coiled-coil
CC       domain for sumoylation. Sumoylation at Lys-490 by RANBP2 is
CC       essential for the proper assembly of PML-NBs. DNA damage triggers
CC       its sumoylation while some but not all viral infections can
CC       abolish sumoylation. Desumoylated by SENP1, SENP2, SENP3, SENP5
CC       and SENP6. Arsenic induces PML and PML-RARA polysumoylation and
CC       their subsequent RNF4-dependent ubiquitination and proteasomal
CC       degradation, and is used as treatment in acute promyelocytic
CC       leukemia (APL). The nuclear isoforms (isoform PML-1, isoform PML-
CC       2, isoform PML-3, isoform PML-4, isoform PML-5 and isoform PML-6)
CC       show an increased sumoylation in response to arsenic trioxide. The
CC       cytoplasmic isoform PML-7 is not sumoylated.
CC       {ECO:0000269|PubMed:18408734, ECO:0000269|PubMed:22155184,
CC       ECO:0000269|PubMed:22406621, ECO:0000269|PubMed:9756909}.
CC   -!- PTM: Phosphorylation is a major regulatory mechanism that controls
CC       PML protein abundance and the number and size of PML nuclear
CC       bodies (PML-NBs). Phosphorylated in response to DNA damage,
CC       probably by ATR. HIPK2-mediated phosphorylation at Ser-8, Ser-36
CC       and Ser-38 leads to increased accumulation of PML protein and its
CC       sumoylation and is required for the maximal pro-apoptotic activity
CC       of PML after DNA damage. CHEK2-mediated phosphorylation at Ser-117
CC       is important for PML-mediated apoptosis following DNA damage.
CC       MAPK1-mediated phosphorylations at Ser-403, Ser-505, Ser-527 and
CC       Ser-530 and CDK1/2-mediated phosphorylation at Ser-518 promote
CC       PIN1-dependent PML degradation. CK2-mediated phosphorylation at
CC       Ser-565 primes PML ubiquitination via an unidentified ubiquitin
CC       ligase. {ECO:0000269|PubMed:12402044, ECO:0000269|PubMed:15195100,
CC       ECO:0000269|PubMed:18408734, ECO:0000269|PubMed:19015637,
CC       ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22033920,
CC       ECO:0000269|PubMed:22406621}.
CC   -!- PTM: Acetylation at Lys-487 is essential for its nuclear
CC       localization. Deacetylated at Lys-487 by SIRT1 and this
CC       deacetylation promotes PML control of PER2 nuclear localization.
CC       {ECO:0000269|PubMed:18621739, ECO:0000269|PubMed:22274616}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PML may be a
CC       cause of acute promyelocytic leukemia (APL). Translocation
CC       t(15;17)(q21;q21) with RARA. The PML breakpoints (type A and type
CC       B) lie on either side of an alternatively spliced exon.
CC       {ECO:0000269|PubMed:1652369, ECO:0000269|PubMed:1720570}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA60351.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA60352.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA60388.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA60390.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB62809.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA.; Evidence={ECO:0000305};
CC       Sequence=BAD92648.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PMLID41.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S50913; AAB19601.2; -; mRNA.
DR   EMBL; M79462; AAA60388.1; ALT_INIT; mRNA.
DR   EMBL; M79463; AAA60351.1; ALT_INIT; mRNA.
DR   EMBL; M79464; AAA60390.1; ALT_INIT; mRNA.
DR   EMBL; X63131; CAA44841.1; -; mRNA.
DR   EMBL; M73778; AAA60125.1; -; mRNA.
DR   EMBL; M80185; AAA60352.1; ALT_INIT; mRNA.
DR   EMBL; AF230401; AAG50180.1; -; mRNA.
DR   EMBL; AF230402; AAG50181.1; -; mRNA.
DR   EMBL; AF230403; AAG50182.1; -; mRNA.
DR   EMBL; AF230405; AAG50184.1; -; mRNA.
DR   EMBL; AF230406; AAG50185.1; -; mRNA.
DR   EMBL; AF230407; AAG50186.1; -; mRNA.
DR   EMBL; AF230408; AAG50187.1; -; mRNA.
DR   EMBL; AF230409; AAG50188.1; -; mRNA.
DR   EMBL; AF230410; AAG50189.1; -; mRNA.
DR   EMBL; AF230411; AAG50190.1; -; mRNA.
DR   EMBL; BT009911; AAP88913.1; -; mRNA.
DR   EMBL; AB209411; BAD92648.1; ALT_INIT; mRNA.
DR   EMBL; AC013486; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108137; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000080; AAH00080.2; -; mRNA.
DR   EMBL; BC020994; AAH20994.1; -; mRNA.
DR   EMBL; X64800; CAA46026.1; -; Genomic_DNA.
DR   EMBL; AB067754; BAB62809.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS10255.1; -. [P29590-1]
DR   CCDS; CCDS10256.1; -. [P29590-10]
DR   CCDS; CCDS10257.1; -. [P29590-8]
DR   CCDS; CCDS10258.1; -. [P29590-13]
DR   CCDS; CCDS45297.1; -. [P29590-5]
DR   CCDS; CCDS45298.1; -. [P29590-2]
DR   CCDS; CCDS45299.1; -. [P29590-4]
DR   CCDS; CCDS45300.1; -. [P29590-14]
DR   CCDS; CCDS58386.1; -. [P29590-12]
DR   PIR; A40044; A40044.
DR   PIR; I38054; I38054.
DR   PIR; S19244; S19244.
DR   PIR; S42516; S42516.
DR   PIR; S44381; S44381.
DR   RefSeq; NP_002666.1; NM_002675.3. [P29590-5]
DR   RefSeq; NP_150241.2; NM_033238.2. [P29590-1]
DR   RefSeq; NP_150242.1; NM_033239.2. [P29590-8]
DR   RefSeq; NP_150243.2; NM_033240.2. [P29590-2]
DR   RefSeq; NP_150247.2; NM_033244.3. [P29590-4]
DR   RefSeq; NP_150249.1; NM_033246.2. [P29590-14]
DR   RefSeq; NP_150250.2; NM_033247.2. [P29590-10]
DR   RefSeq; NP_150252.1; NM_033249.2. [P29590-12]
DR   RefSeq; NP_150253.2; NM_033250.2. [P29590-13]
DR   UniGene; Hs.526464; -.
DR   UniGene; Hs.654583; -.
DR   PDB; 1BOR; NMR; -; A=49-104.
DR   PDB; 2MVW; NMR; -; A/B=120-168.
DR   PDB; 2MWX; NMR; -; A=49-104.
DR   PDB; 4WJN; X-ray; 1.50 A; B=547-573.
DR   PDB; 4WJO; X-ray; 1.46 A; B=547-573.
DR   PDBsum; 1BOR; -.
DR   PDBsum; 2MVW; -.
DR   PDBsum; 2MWX; -.
DR   PDBsum; 4WJN; -.
DR   PDBsum; 4WJO; -.
DR   ProteinModelPortal; P29590; -.
DR   SMR; P29590; -.
DR   BioGrid; 111384; 244.
DR   CORUM; P29590; -.
DR   DIP; DIP-33053N; -.
DR   IntAct; P29590; 99.
DR   MINT; P29590; -.
DR   STRING; 9606.ENSP00000268058; -.
DR   iPTMnet; P29590; -.
DR   PhosphoSitePlus; P29590; -.
DR   BioMuta; PML; -.
DR   DMDM; 215274219; -.
DR   EPD; P29590; -.
DR   MaxQB; P29590; -.
DR   PaxDb; P29590; -.
DR   PeptideAtlas; P29590; -.
DR   PRIDE; P29590; -.
DR   DNASU; 5371; -.
DR   Ensembl; ENST00000268058; ENSP00000268058; ENSG00000140464. [P29590-1]
DR   Ensembl; ENST00000268059; ENSP00000268059; ENSG00000140464. [P29590-8]
DR   Ensembl; ENST00000354026; ENSP00000315434; ENSG00000140464. [P29590-13]
DR   Ensembl; ENST00000359928; ENSP00000353004; ENSG00000140464. [P29590-14]
DR   Ensembl; ENST00000395132; ENSP00000378564; ENSG00000140464. [P29590-10]
DR   Ensembl; ENST00000395135; ENSP00000378567; ENSG00000140464. [P29590-5]
DR   Ensembl; ENST00000435786; ENSP00000395576; ENSG00000140464. [P29590-2]
DR   Ensembl; ENST00000436891; ENSP00000394642; ENSG00000140464. [P29590-4]
DR   Ensembl; ENST00000564428; ENSP00000457023; ENSG00000140464. [P29590-12]
DR   Ensembl; ENST00000565898; ENSP00000455838; ENSG00000140464. [P29590-11]
DR   Ensembl; ENST00000567543; ENSP00000456277; ENSG00000140464. [P29590-14]
DR   Ensembl; ENST00000569477; ENSP00000455612; ENSG00000140464. [P29590-9]
DR   Ensembl; ENST00000569965; ENSP00000456486; ENSG00000140464. [P29590-4]
DR   GeneID; 5371; -.
DR   KEGG; hsa:5371; -.
DR   UCSC; uc002awk.4; human. [P29590-1]
DR   CTD; 5371; -.
DR   DisGeNET; 5371; -.
DR   EuPathDB; HostDB:ENSG00000140464.19; -.
DR   GeneCards; PML; -.
DR   HGNC; HGNC:9113; PML.
DR   HPA; CAB010194; -.
DR   HPA; CAB016304; -.
DR   HPA; HPA008312; -.
DR   MalaCards; PML; -.
DR   MIM; 102578; gene.
DR   neXtProt; NX_P29590; -.
DR   OpenTargets; ENSG00000140464; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   PharmGKB; PA33439; -.
DR   eggNOG; KOG2177; Eukaryota.
DR   eggNOG; ENOG4111G04; LUCA.
DR   GeneTree; ENSGT00510000048454; -.
DR   HOVERGEN; HBG000552; -.
DR   InParanoid; P29590; -.
DR   KO; K10054; -.
DR   OMA; METAEPQ; -.
DR   OrthoDB; EOG091G02GY; -.
DR   PhylomeDB; P29590; -.
DR   TreeFam; TF336434; -.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-6804758; Regulation of TP53 Activity through Acetylation.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-HSA-8948747; Regulation of PTEN localization.
DR   SignaLink; P29590; -.
DR   SIGNOR; P29590; -.
DR   ChiTaRS; PML; human.
DR   EvolutionaryTrace; P29590; -.
DR   GeneWiki; Promyelocytic_leukemia_protein; -.
DR   GenomeRNAi; 5371; -.
DR   PMAP-CutDB; P29590; -.
DR   PRO; PR:P29590; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140464; -.
DR   CleanEx; HS_PML; -.
DR   ExpressionAtlas; P29590; baseline and differential.
DR   Genevisible; P29590; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042406; C:extrinsic component of endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0000792; C:heterochromatin; IEA:Ensembl.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0050897; F:cobalt ion binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0046332; F:SMAD binding; IEA:Ensembl.
DR   GO; GO:0032183; F:SUMO binding; IPI:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl.
DR   GO; GO:0007050; P:cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0045165; P:cell fate commitment; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0090398; P:cellular senescence; IDA:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0007182; P:common-partner SMAD protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; ISS:UniProtKB.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0010761; P:fibroblast migration; IEA:Ensembl.
DR   GO; GO:0045087; P:innate immune response; IDA:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; ISS:UniProtKB.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0051457; P:maintenance of protein location in nucleus; IDA:MGI.
DR   GO; GO:0030099; P:myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0050713; P:negative regulation of interleukin-1 beta secretion; IEA:Ensembl.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:2000059; P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0051974; P:negative regulation of telomerase activity; IMP:UniProtKB.
DR   GO; GO:0032211; P:negative regulation of telomere maintenance via telomerase; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0032938; P:negative regulation of translation in response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProtKB.
DR   GO; GO:0030578; P:PML body organization; IDA:UniProtKB.
DR   GO; GO:0060058; P:positive regulation of apoptotic process involved in mammary gland involution; IDA:UniProtKB.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; IMP:UniProtKB.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:0031065; P:positive regulation of histone deacetylation; IDA:UniProtKB.
DR   GO; GO:0045345; P:positive regulation of MHC class I biosynthetic process; IEA:Ensembl.
DR   GO; GO:1904816; P:positive regulation of protein localization to chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0032206; P:positive regulation of telomere maintenance; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0006461; P:protein complex assembly; IDA:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   GO; GO:0006605; P:protein targeting; IDA:UniProtKB.
DR   GO; GO:0010522; P:regulation of calcium ion transport into cytosol; ISS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:2000779; P:regulation of double-strand break repair; IMP:UniProtKB.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0034097; P:response to cytokine; IDA:BHF-UCL.
DR   GO; GO:0010332; P:response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0009411; P:response to UV; IEA:Ensembl.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR021978; DUF3583.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF12126; DUF3583; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   SMART; SM00336; BBOX; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50119; ZF_BBOX; 2.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Antiviral defense; Apoptosis; Biological rhythms;
KW   Chromosomal rearrangement; Coiled coil; Complete proteome; Cytoplasm;
KW   DNA-binding; Endoplasmic reticulum; Endosome; Host-virus interaction;
KW   Immunity; Innate immunity; Isopeptide bond; Membrane; Metal-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Tumor suppressor; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    882       Protein PML.
FT                                /FTId=PRO_0000056001.
FT   ZN_FING      57     92       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     124    166       B box-type 1; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00024}.
FT   ZN_FING     183    236       B box-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00024}.
FT   REGION      448    555       Interaction with PER2.
FT                                {ECO:0000269|PubMed:22274616}.
FT   REGION      556    562       Sumo interaction motif (SIM).
FT   COILED      228    253       {ECO:0000255}.
FT   MOTIF       476    490       Nuclear localization signal.
FT   COMPBIAS      3     46       Pro-rich.
FT   METAL        57     57       Zinc 1.
FT   METAL        60     60       Zinc 1.
FT   METAL        72     72       Zinc 2.
FT   METAL        74     74       Zinc 2.
FT   METAL        77     77       Zinc 1.
FT   METAL        80     80       Zinc 1.
FT   METAL        88     88       Zinc 2.
FT   METAL        91     91       Zinc 2.
FT   SITE        394    395       Breakpoint for translocation to form PML-
FT                                RARA oncogene in type A APL.
FT   SITE        552    553       Breakpoint for translocation to form PML-
FT                                RARA oncogene in type B APL.
FT   MOD_RES       8      8       Phosphoserine; by HIPK2.
FT                                {ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:19015637}.
FT   MOD_RES      36     36       Phosphoserine; by HIPK2 and MAPK1.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      38     38       Phosphoserine; by HIPK2 and MAPK1.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:19015637}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     117    117       Phosphoserine; by CHEK2.
FT                                {ECO:0000269|PubMed:12402044}.
FT   MOD_RES     403    403       Phosphoserine; by MAPK1 and MAPK7.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:22033920}.
FT   MOD_RES     487    487       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:18621739,
FT                                ECO:0000269|PubMed:22274616}.
FT   MOD_RES     493    493       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60953}.
FT   MOD_RES     504    504       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q60953}.
FT   MOD_RES     505    505       Phosphoserine; by MAPK1.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:22033920}.
FT   MOD_RES     512    512       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     515    515       N6-acetyllysine.
FT                                {ECO:0000305|PubMed:18621739}.
FT   MOD_RES     518    518       Phosphoserine; by CDK1 and CDK2.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:21840486,
FT                                ECO:0000269|PubMed:22033920}.
FT   MOD_RES     527    527       Phosphoserine; by MAPK1.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:22033920}.
FT   MOD_RES     530    530       Phosphoserine; by MAPK1.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     565    565       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:22406621}.
FT   MOD_RES     867    867       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK     65     65       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK     65     65       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    160    160       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    160    160       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    380    380       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    380    380       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate. {ECO:0000269|PubMed:18408734}.
FT   CROSSLNK    394    394       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    400    400       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:18408734}.
FT   CROSSLNK    401    401       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    401    401       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate. {ECO:0000269|PubMed:18408734}.
FT   CROSSLNK    460    460       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    476    476       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    476    476       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate. {ECO:0000269|PubMed:18408734}.
FT   CROSSLNK    478    478       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    487    487       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    490    490       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    490    490       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    497    497       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    497    497       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     419    466       Missing (in isoform PML-11, isoform PML-
FT                                12 and isoform PML-13).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.7, ECO:0000303|Ref.8}.
FT                                /FTId=VSP_040590.
FT   VAR_SEQ     419    435       PEEAERVKAQVQALGLA -> LPPPAHALTGPAQSSTH
FT                                (in isoform PML-7).
FT                                {ECO:0000303|PubMed:11331580}.
FT                                /FTId=VSP_040591.
FT   VAR_SEQ     419    423       PEEAE -> RNALW (in isoform PML-14).
FT                                {ECO:0000303|PubMed:11331580}.
FT                                /FTId=VSP_040592.
FT   VAR_SEQ     424    882       Missing (in isoform PML-14).
FT                                {ECO:0000303|PubMed:11331580}.
FT                                /FTId=VSP_040593.
FT   VAR_SEQ     436    882       Missing (in isoform PML-7).
FT                                {ECO:0000303|PubMed:11331580}.
FT                                /FTId=VSP_040594.
FT   VAR_SEQ     553    560       EERVVVIS -> GRERNALW (in isoform PML-6).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:1652368,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_005742.
FT   VAR_SEQ     561    882       Missing (in isoform PML-6).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:1652368,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_005743.
FT   VAR_SEQ     571    882       SSRELDDSSSESSDLQLEGPSTLRVLDENLADPQAEDRPLV
FT                                FFDLKIDNETQKISQLAAVNRESKFRVVIQPEAFFSIYSKA
FT                                VSLEVGLQHFLSFLSSMRRPILACYKLWGPGLPNFFRALED
FT                                INRLWEFQEAISGFLAALPLIRERVPGASSFKLKNLAQTYL
FT                                ARNMSERSAMAAVLAMRDLCRLLEVSPGPQLAQHVYPFSSL
FT                                QCFASLQPLVQAAVLPRAEARLLALHNVSFMELLSAHRRDR
FT                                QGGLKKYSRYLSLQTTTLPPAQPAFNLQALGTYFEGLLEGP
FT                                ALARAEGVSTPLAGRGLAERASQQS -> CMEPMETAEPQS
FT                                SPAHSSPAHSSPAHSSPVQSLLRAQGASSLPCGTYHPPAWP
FT                                PHQPAEQAATPDAEPHSEPPDHQERPAVHRGIRYLLYRAQR
FT                                AIRLRHALRLHPQLHRAPIRTWSPHVVQASTPAITGPLNHP
FT                                ANAQEHPAQLQRGISPPHRIRGAVRSRSRSLRGSSHLSQWL
FT                                NNFFALPFSSMASQLDMSSVVGAGESRAQTLGAGVPPGDSV
FT                                RGSMEASQVQVPLEASPITFPPPCAPERPPISPVPGARQAG
FT                                L (in isoform PML-2 and isoform PML-13).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_040595.
FT   VAR_SEQ     571    882       SSRELDDSSSESSDLQLEGPSTLRVLDENLADPQAEDRPLV
FT                                FFDLKIDNETQKISQLAAVNRESKFRVVIQPEAFFSIYSKA
FT                                VSLEVGLQHFLSFLSSMRRPILACYKLWGPGLPNFFRALED
FT                                INRLWEFQEAISGFLAALPLIRERVPGASSFKLKNLAQTYL
FT                                ARNMSERSAMAAVLAMRDLCRLLEVSPGPQLAQHVYPFSSL
FT                                QCFASLQPLVQAAVLPRAEARLLALHNVSFMELLSAHRRDR
FT                                QGGLKKYSRYLSLQTTTLPPAQPAFNLQALGTYFEGLLEGP
FT                                ALARAEGVSTPLAGRGLAERASQQS -> CMEPMETAEPQS
FT                                SPAHSSPAHSSPVQSLLRAQGASSLPCGTYHPPAWPPHQPA
FT                                EQAATPDAEPHSEPPDHQERPAVHRGIRYLLYRAQRAIRLR
FT                                HALRLHPQLHRAPIRTWSPHVVQASTPAITGPLNHPANAQE
FT                                HPAQLQRGISPPHRIRGAVRSRSRSLRGSSHLSQWLNNFFA
FT                                LPFSSMASQLDMSSVVGAGESRAQTLGAGVPPGDSVRGSME
FT                                ASQVQVPLEASPITFPPPCAPERPPISPVPGARQAGL (in
FT                                isoform PML-8).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:1720570}.
FT                                /FTId=VSP_005741.
FT   VAR_SEQ     571    641       SSRELDDSSSESSDLQLEGPSTLRVLDENLADPQAEDRPLV
FT                                FFDLKIDNETQKISQLAAVNRESKFRVVIQ -> VSSSPQS
FT                                EVLYWKVHGAHGDRRATVLASPLLASPLLASPLLASPVSAE
FT                                STRSLQPALWHIPPPSLASPPAR (in isoform PML-
FT                                3). {ECO:0000303|PubMed:1652369}.
FT                                /FTId=VSP_040596.
FT   VAR_SEQ     571    611       SSRELDDSSSESSDLQLEGPSTLRVLDENLADPQAEDRPLV
FT                                -> VSGPEVQPRTPASPHFRSQGAQPQQVTLRLALRLGNFP
FT                                VRH (in isoform PML-5).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:1720570}.
FT                                /FTId=VSP_005739.
FT   VAR_SEQ     612    882       Missing (in isoform PML-5).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:1720570}.
FT                                /FTId=VSP_005740.
FT   VAR_SEQ     621    633       TQKISQLAAVNRE -> SGFSWGYPHPFLI (in
FT                                isoform PML-4 and isoform PML-12).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:1311253}.
FT                                /FTId=VSP_005744.
FT   VAR_SEQ     634    882       Missing (in isoform PML-4 and isoform
FT                                PML-12). {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:1311253}.
FT                                /FTId=VSP_005745.
FT   VAR_SEQ     642    882       Missing (in isoform PML-3).
FT                                {ECO:0000303|PubMed:1652369}.
FT                                /FTId=VSP_040597.
FT   VARIANT     645    645       F -> L (in dbSNP:rs5742915).
FT                                {ECO:0000269|PubMed:11331580,
FT                                ECO:0000269|PubMed:1720570}.
FT                                /FTId=VAR_052090.
FT   MUTAGEN      57     57       C->S: Strongly reduced sumoylation; when
FT                                associated with S-60.
FT                                {ECO:0000269|PubMed:17081985}.
FT   MUTAGEN      60     60       C->S: Strongly reduced sumoylation; when
FT                                associated with S-57.
FT                                {ECO:0000269|PubMed:17081985}.
FT   MUTAGEN      65     65       K->R: Loss of one sumoylation. No effect
FT                                on nuclear body formation. Loss of 2
FT                                sumoylations; when associated with R-490
FT                                with or without R-133 or R-150. No effect
FT                                on nuclear body formation; when
FT                                associated with R-490. No sumoylation nor
FT                                nuclear body formation; when associated
FT                                with R-160 and R-490.
FT                                {ECO:0000269|PubMed:9756909}.
FT   MUTAGEN      68     68       K->R: No effect on sumoylation levels.
FT   MUTAGEN      88     88       C->S: No nuclear microspeckle location,
FT                                no sumoylation and loss of intrinsic
FT                                transcriptional repressor activity of
FT                                PML-RARA oncoprotein; when associated
FT                                with R-89. {ECO:0000269|PubMed:15809060}.
FT   MUTAGEN      89     89       P->R: No nuclear microspeckle location,
FT                                no sumoylation and loss of intrinsic
FT                                transcriptional repressor activity of
FT                                PML-RARA oncoprotein; when associated
FT                                with S-88. {ECO:0000269|PubMed:15809060}.
FT   MUTAGEN     133    133       K->R: Loss of 2 sumoylations; when
FT                                associated with R-65 and R-490.
FT                                {ECO:0000269|PubMed:9756909}.
FT   MUTAGEN     150    150       K->R: Loss of 2 sumoylations; when
FT                                associated with R-65 and R-490.
FT                                {ECO:0000269|PubMed:9756909}.
FT   MUTAGEN     160    160       K->R: Loss of 2 sumoylations; when
FT                                associated with or without R-65. No
FT                                sumoylation nor nuclear body formation;
FT                                when associated with or without R-65 and
FT                                R-490. {ECO:0000269|PubMed:9756909}.
FT   MUTAGEN     487    487       K->A: Loss of nuclear localization; when
FT                                associated with A-490.
FT                                {ECO:0000269|PubMed:18298799,
FT                                ECO:0000269|PubMed:18621739}.
FT   MUTAGEN     487    487       K->R: Loss of nuclear localization.
FT                                Reduced acetylation. Further decrease in
FT                                acetylation; when associated with R-515.
FT                                {ECO:0000269|PubMed:18298799,
FT                                ECO:0000269|PubMed:18621739}.
FT   MUTAGEN     490    490       K->A: Loss of nuclear localization; when
FT                                associated with A-487.
FT                                {ECO:0000269|PubMed:18298799,
FT                                ECO:0000269|PubMed:9756909}.
FT   MUTAGEN     490    490       K->R: Loss of 2 sumoylations; when
FT                                associated with R-65 with or without R-
FT                                133. No effect on nuclear body formation;
FT                                when associated with R-65. No sumoylation
FT                                nor nuclear body formation; when
FT                                associated with R-65 and R-160.
FT                                {ECO:0000269|PubMed:18298799,
FT                                ECO:0000269|PubMed:9756909}.
FT   MUTAGEN     515    515       K->R: Slightly reduced acetylation.
FT                                Further decrease in acetylation; when
FT                                associated with R-487.
FT                                {ECO:0000269|PubMed:18621739}.
FT   MUTAGEN     518    518       S->A: Abolishes ubiquitination by the
FT                                BCR(KLHL20) E3 ubiquitin ligase complex.
FT                                {ECO:0000269|PubMed:21840486}.
FT   MUTAGEN     556    559       VVVI->AAAS: Abolishes SUMO1 binding.
FT   CONFLICT    224    224       E -> D (in Ref. 7; AAP88913 and 10;
FT                                AAH00080/AAH20994). {ECO:0000305}.
FT   CONFLICT    419    419       P -> A (in Ref. 2; AAA60351/AAA60388/
FT                                AAA60390, 4; AAA60352 and 5; AAG50182/
FT                                AAG50184/AAG50185). {ECO:0000305}.
FT   STRAND       58     60       {ECO:0000244|PDB:1BOR}.
FT   STRAND       82     87       {ECO:0000244|PDB:1BOR}.
FT   HELIX        90     92       {ECO:0000244|PDB:2MWX}.
FT   STRAND       93     96       {ECO:0000244|PDB:1BOR}.
FT   TURN        130    132       {ECO:0000244|PDB:2MVW}.
FT   STRAND      133    140       {ECO:0000244|PDB:2MVW}.
FT   TURN        141    143       {ECO:0000244|PDB:2MVW}.
FT   STRAND      146    148       {ECO:0000244|PDB:2MVW}.
FT   HELIX       149    158       {ECO:0000244|PDB:2MVW}.
FT   STRAND      163    166       {ECO:0000244|PDB:2MVW}.
FT   STRAND      556    558       {ECO:0000244|PDB:4WJO}.
SQ   SEQUENCE   882 AA;  97551 MW;  D50968A977E34287 CRC64;
     MEPAPARSPR PQQDPARPQE PTMPPPETPS EGRQPSPSPS PTERAPASEE EFQFLRCQQC
     QAEAKCPKLL PCLHTLCSGC LEASGMQCPI CQAPWPLGAD TPALDNVFFE SLQRRLSVYR
     QIVDAQAVCT RCKESADFWC FECEQLLCAK CFEAHQWFLK HEARPLAELR NQSVREFLDG
     TRKTNNIFCS NPNHRTPTLT SIYCRGCSKP LCCSCALLDS SHSELKCDIS AEIQQRQEEL
     DAMTQALQEQ DSAFGAVHAQ MHAAVGQLGR ARAETEELIR ERVRQVVAHV RAQERELLEA
     VDARYQRDYE EMASRLGRLD AVLQRIRTGS ALVQRMKCYA SDQEVLDMHG FLRQALCRLR
     QEEPQSLQAA VRTDGFDEFK VRLQDLSSCI TQGKDAAVSK KASPEAASTP RDPIDVDLPE
     EAERVKAQVQ ALGLAEAQPM AVVQSVPGAH PVPVYAFSIK GPSYGEDVSN TTTAQKRKCS
     QTQCPRKVIK MESEEGKEAR LARSSPEQPR PSTSKAVSPP HLDGPPSPRS PVIGSEVFLP
     NSNHVASGAG EAEERVVVIS SSEDSDAENS SSRELDDSSS ESSDLQLEGP STLRVLDENL
     ADPQAEDRPL VFFDLKIDNE TQKISQLAAV NRESKFRVVI QPEAFFSIYS KAVSLEVGLQ
     HFLSFLSSMR RPILACYKLW GPGLPNFFRA LEDINRLWEF QEAISGFLAA LPLIRERVPG
     ASSFKLKNLA QTYLARNMSE RSAMAAVLAM RDLCRLLEVS PGPQLAQHVY PFSSLQCFAS
     LQPLVQAAVL PRAEARLLAL HNVSFMELLS AHRRDRQGGL KKYSRYLSLQ TTTLPPAQPA
     FNLQALGTYF EGLLEGPALA RAEGVSTPLA GRGLAERASQ QS
//
ID   D2KUA6_HUMAN            Unreviewed;       477 AA.
AC   D2KUA6;
DT   02-MAR-2010, integrated into UniProtKB/TrEMBL.
DT   02-MAR-2010, sequence version 1.
DT   28-FEB-2018, entry version 78.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma {ECO:0000256|RuleBase:RU364110};
DE            Short=PPAR-gamma {ECO:0000256|RuleBase:RU364110};
DE   AltName: Full=Nuclear receptor subfamily 1 group C member 3 {ECO:0000256|RuleBase:RU364110};
GN   Name=PPARG {ECO:0000256|RuleBase:RU364110,
GN   ECO:0000313|EMBL:BAI63629.1};
GN   Synonyms=NR1C3 {ECO:0000313|EMBL:ADZ17377.1},
GN   PPAR gamma {ECO:0000313|EMBL:BAM71699.1};
GN   ORFNames=hCG_26772 {ECO:0000313|EMBL:EAW64123.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAI63629.1};
RN   [1] {ECO:0000313|EMBL:EAW64123.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW64123.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAI63629.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Takahashi S., Inoue I., Seo M., Ikeda M., Katayama S.;
RT   "A promoter in the novel exon of hPPARg6 directs the circadian
RT   expression of PPARg6.";
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAM71699.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Takahashi S., Inoue I.;
RT   "PPAR gamma.";
RL   Submitted (JUN-2010) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:ADZ17377.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Heart {ECO:0000313|EMBL:ADZ17377.1};
RA   Kaighin V.A., Martin A.L., Aronstam R.S.;
RT   "Isolation of cDNA coding for multiple human nuclear receptor
RT   clones.";
RL   Submitted (DEC-2010) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:ALQ33725.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- FUNCTION: Nuclear receptor that binds peroxisome proliferators
CC       such as hypolipidemic drugs and fatty acids. Once activated by a
CC       ligand, the nuclear receptor binds to DNA specific PPAR response
CC       elements (PPRE) and modulates the transcription of its target
CC       genes, such as acyl-CoA oxidase. It therefore controls the
CC       peroxisomal beta-oxidation pathway of fatty acids. Key regulator
CC       of adipocyte differentiation and glucose homeostasis. ARF6 acts as
CC       a key regulator of the tissue-specific adipocyte P2 (aP2)
CC       enhancer. Acts as a critical regulator of gut homeostasis by
CC       suppressing NF-kappa-B-mediated proinflammatory responses. Plays a
CC       role in the regulation of cardiovascular circadian rhythms by
CC       regulating the transcription of ARNTL/BMAL1 in the blood vessels.
CC       {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBUNIT: Heterodimer with other nuclear receptors.
CC       {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU364110}.
CC       Nucleus {ECO:0000256|RuleBase:RU004334,
CC       ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00982927}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000256|RuleBase:RU364110}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ692866; ADZ17377.1; -; mRNA.
DR   EMBL; KU178267; ALQ33725.1; -; mRNA.
DR   EMBL; AB472042; BAI63629.1; -; mRNA.
DR   EMBL; AB565476; BAM71699.1; -; mRNA.
DR   EMBL; CH471055; EAW64123.1; -; Genomic_DNA.
DR   RefSeq; NP_005028.4; NM_005037.5.
DR   RefSeq; NP_619725.2; NM_138711.3.
DR   RefSeq; NP_619726.2; NM_138712.3.
DR   RefSeq; XP_011532143.1; XM_011533841.2.
DR   UniGene; Hs.162646; -.
DR   SMR; D2KUA6; -.
DR   DNASU; 5468; -.
DR   GeneID; 5468; -.
DR   CTD; 5468; -.
DR   EuPathDB; HostDB:ENSG00000132170.19; -.
DR   PharmGKB; PA281; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   ChiTaRS; PPARG; human.
DR   GenomeRNAi; 5468; -.
DR   Bgee; ENSG00000132170; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0004879; F:nuclear receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003707; F:steroid hormone receptor activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR003074; 1Cnucl_rcpt.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR003077; PPAR-gamma.
DR   InterPro; IPR022590; PPARgamma_N.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF12577; PPARgamma_N; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01288; PROXISOMEPAR.
DR   PRINTS; PR01291; PROXISOMPAGR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   Activator {ECO:0000256|RuleBase:RU364110};
KW   Biological rhythms {ECO:0000256|RuleBase:RU364110};
KW   Cytoplasm {ECO:0000256|RuleBase:RU364110};
KW   DNA-binding {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS00517091};
KW   Metal-binding {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS00983050};
KW   Receptor {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS00982657, ECO:0000313|EMBL:BAI63629.1};
KW   Transcription {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS00982829};
KW   Transcription regulation {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS00982829};
KW   Zinc {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN      108    182       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DNA_BIND    108    182       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
FT   NON_TER     477    477       {ECO:0000313|EMBL:ALQ33725.1}.
SQ   SEQUENCE   477 AA;  54681 MW;  1061C2074B739E0A CRC64;
     MTMVDTEMPF WPTNFGISSV DLSVMEDHSH SFDIKPFTTV DFSSISTPHY EDIPFTRTDP
     VVADYKYDLK LQEYQSAIKV EPASPPYYSE KTQLYNKPHE EPSNSLMAIE CRVCGDKASG
     FHYGVHACEG CKGFFRRTIR LKLIYDRCDL NCRIHKKSRN KCQYCRFQKC LAVGMSHNAI
     RFGRMPQAEK EKLLAEISSD IDQLNPESAD LRALAKHLYD SYIKSFPLTK AKARAILTGK
     TTDKSPFVIY DMNSLMMGED KIKFKHITPL QEQSKEVAIR IFQGCQFRSV EAVQEITEYA
     KSIPGFVNLD LNDQVTLLKY GVHEIIYTML ASLMNKDGVL ISEGQGFMTR EFLKSLRKPF
     GDFMEPKFEF AVKFNALELD DSDLAIFIAV IILSGDRPGL LNVKPIEDIQ DNLLQALELQ
     LKLNHPESSQ LFAKLLQKMT DLRQIVTEHV QLLQVIKKTE TDMSLHPLLQ EIYKDLY
//
ID   E9PFX5_HUMAN            Unreviewed;       250 AA.
AC   E9PFX5;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-FEB-2018, entry version 67.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma {ECO:0000256|RuleBase:RU364110};
DE            Short=PPAR-gamma {ECO:0000256|RuleBase:RU364110};
DE   AltName: Full=Nuclear receptor subfamily 1 group C member 3 {ECO:0000256|RuleBase:RU364110};
GN   Name=PPARG {ECO:0000256|RuleBase:RU364110,
GN   ECO:0000313|Ensembl:ENSP00000380196};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000380196, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000380196}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000380196}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Nuclear receptor that binds peroxisome proliferators
CC       such as hypolipidemic drugs and fatty acids. Once activated by a
CC       ligand, the nuclear receptor binds to DNA specific PPAR response
CC       elements (PPRE) and modulates the transcription of its target
CC       genes, such as acyl-CoA oxidase. It therefore controls the
CC       peroxisomal beta-oxidation pathway of fatty acids. Key regulator
CC       of adipocyte differentiation and glucose homeostasis. ARF6 acts as
CC       a key regulator of the tissue-specific adipocyte P2 (aP2)
CC       enhancer. Acts as a critical regulator of gut homeostasis by
CC       suppressing NF-kappa-B-mediated proinflammatory responses. Plays a
CC       role in the regulation of cardiovascular circadian rhythms by
CC       regulating the transcription of ARNTL/BMAL1 in the blood vessels.
CC       {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBUNIT: Heterodimer with other nuclear receptors.
CC       {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU364110}.
CC       Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
CC       ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00586772}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000256|RuleBase:RU364110}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000380196}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC090947; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091492; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093174; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317544.1; NM_001330615.1.
DR   RefSeq; XP_011532146.1; XM_011533844.1.
DR   UniGene; Hs.162646; -.
DR   ProteinModelPortal; E9PFX5; -.
DR   SMR; E9PFX5; -.
DR   MaxQB; E9PFX5; -.
DR   PeptideAtlas; E9PFX5; -.
DR   PRIDE; E9PFX5; -.
DR   Ensembl; ENST00000397000; ENSP00000380196; ENSG00000132170.
DR   GeneID; 5468; -.
DR   UCSC; uc003bwv.4; human.
DR   CTD; 5468; -.
DR   EuPathDB; HostDB:ENSG00000132170.19; -.
DR   HGNC; HGNC:9236; PPARG.
DR   OpenTargets; ENSG00000132170; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   GeneTree; ENSGT00870000136388; -.
DR   ChiTaRS; PPARG; human.
DR   GenomeRNAi; 5468; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000132170; -.
DR   ExpressionAtlas; E9PFX5; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0004879; F:nuclear receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR003074; 1Cnucl_rcpt.
DR   InterPro; IPR003077; PPAR-gamma.
DR   InterPro; IPR022590; PPARgamma_N.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF12577; PPARgamma_N; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01288; PROXISOMEPAR.
DR   PRINTS; PR01291; PROXISOMPAGR.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00399; ZnF_C4; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|RuleBase:RU364110};
KW   Biological rhythms {ECO:0000256|RuleBase:RU364110};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Cytoplasm {ECO:0000256|RuleBase:RU364110};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517091};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517080};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:E9PFX5};
KW   Receptor {ECO:0000256|RuleBase:RU364110};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517167};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517167};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN      108    182       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DNA_BIND    108    182       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
SQ   SEQUENCE   250 AA;  28535 MW;  F3340CD1975E9AF6 CRC64;
     MTMVDTEMPF WPTNFGISSV DLSVMEDHSH SFDIKPFTTV DFSSISTPHY EDIPFTRTDP
     VVADYKYDLK LQEYQSAIKV EPASPPYYSE KTQLYNKPHE EPSNSLMAIE CRVCGDKASG
     FHYGVHACEG CKGFFRRTIR LKLIYDRCDL NCRIHKKSRN KCQYCRFQKC LAVGMSHNAI
     RFGRMPQAEK EKLLAEISSD IDQLNPESAD LRALAKHLYD SYIKSFPLTK AKARAILTGK
     TTDKSTAQVC
//
ID   PPARG_HUMAN             Reviewed;         505 AA.
AC   P37231; A8K3G6; B5BUA1; O00684; O00710; O14515; Q0QJH8; Q15178;
AC   Q15179; Q15180; Q15832; Q86U60; Q96J12;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 3.
DT   28-FEB-2018, entry version 240.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma;
DE            Short=PPAR-gamma;
DE   AltName: Full=Nuclear receptor subfamily 1 group C member 3;
GN   Name=PPARG; Synonyms=NR1C3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=9065481; DOI=10.1074/jbc.272.12.8071;
RA   Mukherjee R., Jow L., Croston G.E., Paterniti J.R. Jr.;
RT   "Identification, characterization, and tissue distribution of human
RT   peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2
RT   versus PPARgamma1 and activation with retinoid X receptor agonists and
RT   antagonists.";
RL   J. Biol. Chem. 272:8071-8076(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Adipose tissue;
RX   PubMed=8702406; DOI=10.1006/bbrc.1996.1044;
RA   Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M.D.,
RA   Moller D.E., Berger J.;
RT   "Molecular cloning, expression and characterization of human
RT   peroxisome proliferator activated receptors gamma 1 and gamma 2.";
RL   Biochem. Biophys. Res. Commun. 224:431-437(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Adipose tissue;
RX   PubMed=9144532; DOI=10.1006/bbrc.1997.6446;
RA   Yanase T., Yashiro T., Takitani K., Kato S., Taniguchi S.,
RA   Takayanagi R., Nawata H.;
RT   "Differential expression of PPAR gamma1 and gamma2 isoforms in human
RT   adipose tissue.";
RL   Biochem. Biophys. Res. Commun. 233:320-324(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7787419;
RA   Greene M.E., Blumberg B., McBride O.W., Yi H.F., Kronquist K.,
RA   Kwan K., Hsieh L., Greene G., Nimer S.D.;
RT   "Isolation of the human peroxisome proliferator activated receptor
RT   gamma cDNA: expression in hematopoietic cells and chromosomal
RT   mapping.";
RL   Gene Expr. 4:281-299(1995).
RN   [5]
RP   SEQUENCE REVISION TO 36; 37; 213; 214 AND 240.
RA   Greene M.E.;
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=9356045; DOI=10.2337/diab.46.11.1904;
RA   Okazawa H., Mori H., Tamori Y., Araki S., Niki T., Masugi J.,
RA   Kawanishi M., Kubota T., Shinoda H., Kasuga M.;
RT   "No coding mutations are detected in the peroxisome proliferator-
RT   activated receptor-gamma gene in Japanese patients with lipoatrophic
RT   diabetes.";
RL   Diabetes 46:1904-1906(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=8706692; DOI=10.1111/j.1432-1033.1996.0001u.x;
RA   Lambe K.G., Tugwood J.D.;
RT   "A human peroxisome-proliferator-activated receptor-gamma is activated
RT   by inducers of adipogenesis, including thiazolidinedione drugs.";
RL   Eur. J. Biochem. 239:1-7(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=16842753; DOI=10.1016/j.bbrc.2006.06.147;
RA   Kim H.J., Woo I.S., Kang E.S., Eun S.Y., Kim H.J., Lee J.H.,
RA   Chang K.C., Kim J.H., Seo H.G.;
RT   "Identification of a truncated alternative splicing variant of human
RT   PPARgamma1 that exhibits dominant negative activity.";
RL   Biochem. Biophys. Res. Commun. 347:698-706(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human Protein Factory: an infrastructure to convert the human
RT   transcriptome into the in vitro-expressed human proteome of versatile
RT   utility.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-12.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [16]
RP   INTERACTION WITH NCOA6.
RX   PubMed=10681503; DOI=10.1074/jbc.275.8.5308;
RA   Caira F., Antonson P., Pelto-Huikko M., Treuter E., Gustafsson J.-A.;
RT   "Cloning and characterization of RAP250, a nuclear receptor
RT   coactivator.";
RL   J. Biol. Chem. 275:5308-5317(2000).
RN   [17]
RP   POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO GLIOMA.
RX   PubMed=10851250; DOI=10.1136/jmg.37.6.410;
RA   Zhou X.P., Smith W.M., Gimm O., Mueller E., Gao X., Sarraf P.,
RA   Prior T.W., Plass C., von Deimling A., Black P.M., Yates A.J., Eng C.;
RT   "Over-representation of PPARgamma sequence variants in sporadic cases
RT   of glioblastoma multiforme: preliminary evidence for common low
RT   penetrance modifiers for brain tumour risk in the general
RT   population.";
RL   J. Med. Genet. 37:410-414(2000).
RN   [18]
RP   INTERACTION WITH PRMT2.
RX   PubMed=12039952; DOI=10.1074/jbc.M201053200;
RA   Qi C., Chang J., Zhu Y., Yeldandi A.V., Rao S.M., Zhu Y.-J.;
RT   "Identification of protein arginine methyltransferase 2 as a
RT   coactivator for estrogen receptor alpha.";
RL   J. Biol. Chem. 277:28624-28630(2002).
RN   [19]
RP   INTERACTION WITH NOCA7.
RX   PubMed=11971969; DOI=10.1128/MCB.22.10.3358-3372.2002;
RA   Shao W., Halachmi S., Brown M.;
RT   "ERAP140, a conserved tissue-specific nuclear receptor coactivator.";
RL   Mol. Cell. Biol. 22:3358-3372(2002).
RN   [20]
RP   INTERACTION WITH DNTTIP2.
RX   PubMed=15047147; DOI=10.1016/j.bbrc.2004.02.179;
RA   Bu H., Kashireddy P., Chang J., Zhu Y.T., Zhang Z., Zheng W.,
RA   Rao S.M., Zhu Y.-J.;
RT   "ERBP, a novel estrogen receptor binding protein enhancing the
RT   activity of estrogen receptor.";
RL   Biochem. Biophys. Res. Commun. 317:54-59(2004).
RN   [21]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=15687259; DOI=10.1101/gad.1240705;
RA   Drori S., Girnun G.D., Tou L., Szwaya J.D., Mueller E., Xia K.,
RA   Shivdasani R.A., Spiegelman B.M.;
RT   "Hic-5 regulates an epithelial program mediated by PPARgamma.";
RL   Genes Dev. 19:362-375(2005).
RN   [22]
RP   INTERACTION WITH HELZ2.
RX   PubMed=16239304; DOI=10.1210/en.2005-0450;
RA   Tomaru T., Satoh T., Yoshino S., Ishizuka T., Hashimoto K., Monden T.,
RA   Yamada M., Mori M.;
RT   "Isolation and characterization of a transcriptional cofactor and its
RT   novel isoform that bind the DNA-binding domain of peroxisome
RT   proliferator-activated receptor gamma.";
RL   Endocrinology 147:377-388(2006).
RN   [23]
RP   FUNCTION, INTERACTION WITH PDPK1, AND ENZYME REGULATION.
RX   PubMed=16150867; DOI=10.1210/me.2005-0197;
RA   Yin Y., Yuan H., Wang C., Pattabiraman N., Rao M., Pestell R.G.,
RA   Glazer R.I.;
RT   "3-phosphoinositide-dependent protein kinase-1 activates the
RT   peroxisome proliferator-activated receptor-gamma and promotes
RT   adipocyte differentiation.";
RL   Mol. Endocrinol. 20:268-278(2006).
RN   [24]
RP   INTERACTION WITH MAP2K1/MEK1, AND SUBCELLULAR LOCATION.
RX   PubMed=17101779; DOI=10.1128/MCB.00601-06;
RA   Burgermeister E., Chuderland D., Hanoch T., Meyer M., Liscovitch M.,
RA   Seger R.;
RT   "Interaction with MEK causes nuclear export and downregulation of
RT   peroxisome proliferator-activated receptor gamma.";
RL   Mol. Cell. Biol. 27:803-817(2007).
RN   [25]
RP   FUNCTION.
RX   PubMed=20829347; DOI=10.1074/jbc.M110.136259;
RA   Park S.H., Choi H.J., Yang H., Do K.H., Kim J., Lee D.W., Moon Y.;
RT   "Endoplasmic reticulum stress-activated C/EBP homologous protein
RT   enhances nuclear factor-kappaB signals via repression of peroxisome
RT   proliferator-activated receptor gamma.";
RL   J. Biol. Chem. 285:35330-35339(2010).
RN   [26]
RP   INTERACTION WITH ASXL1 AND ASXL2.
RX   PubMed=21047783; DOI=10.1074/jbc.M110.177816;
RA   Park U.H., Yoon S.K., Park T., Kim E.J., Um S.J.;
RT   "Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles
RT   in adipogenesis via reciprocal regulation of peroxisome proliferator-
RT   activated receptor {gamma}.";
RL   J. Biol. Chem. 286:1354-1363(2011).
RN   [27]
RP   INTERACTION WITH ACTN4.
RX   PubMed=22351778; DOI=10.1074/jbc.M112.345421;
RA   Khurana S., Chakraborty S., Lam M., Liu Y., Su Y.T., Zhao X.,
RA   Saleem M.A., Mathieson P.W., Bruggeman L.A., Kao H.Y.;
RT   "Familial focal segmental glomerulosclerosis (FSGS)-linked alpha-
RT   actinin 4 (ACTN4) protein mutants lose ability to activate
RT   transcription by nuclear hormone receptors.";
RL   J. Biol. Chem. 287:12027-12035(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   FUNCTION, INTERACTION WITH HELZ2 AND THRAP3, AND SUBCELLULAR LOCATION.
RX   PubMed=23525231; DOI=10.1210/me.2012-1332;
RA   Katano-Toki A., Satoh T., Tomaru T., Yoshino S., Ishizuka T.,
RA   Ishii S., Ozawa A., Shibusawa N., Tsuchiya T., Saito T., Shimizu H.,
RA   Hashimoto K., Okada S., Yamada M., Mori M.;
RT   "THRAP3 interacts with HELZ2 and plays a novel role in adipocyte
RT   differentiation.";
RL   Mol. Endocrinol. 27:769-780(2013).
RN   [30]
RP   FUNCTION (MICROBIAL INFECTION), AND INDUCTION (MICROBIAL INFECTION).
RC   TISSUE=Macrophage;
RX   PubMed=25504154; DOI=10.3892/mmr.2014.3070;
RA   Liu L., Liu J., Niu G., Xu Q., Chen Q.;
RT   "Mycobacterium tuberculosis 19-kDa lipoprotein induces Toll-like
RT   receptor 2-dependent peroxisome proliferator-activated receptor gamma
RT   expression and promotes inflammatory responses in human macrophages.";
RL   Mol. Med. Report. 11:2921-2926(2015).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 232-505.
RX   PubMed=9813012; DOI=10.1074/jbc.273.47.31108;
RA   Uppenberg J., Svensson C., Jaki M., Bertilsson G., Jendeberg L.,
RA   Berkenstam A.;
RT   "Crystal structure of the ligand binding domain of the human nuclear
RT   receptor PPARgamma.";
RL   J. Biol. Chem. 273:31108-31112(1998).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 235-504 IN COMPLEXES WITH THE
RP   SYNTHETIC AGONIST ROSIGLITAZONE AND NCOA1, AND SUBUNIT.
RX   PubMed=9744270; DOI=10.1038/25931;
RA   Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H.,
RA   Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V.;
RT   "Ligand binding and co-activator assembly of the peroxisome
RT   proliferator-activated receptor-gamma.";
RL   Nature 395:137-143(1998).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEXES WITH RXRA AND
RP   SYNTHETIC AGONISTS.
RX   PubMed=10882139; DOI=10.1016/S1097-2765(00)80448-7;
RA   Gampe R.T. Jr., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K.,
RA   Milburn M.V., Kliewer S.A., Willson T.M., Xu H.E.;
RT   "Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the
RT   molecular basis of heterodimerization among nuclear receptors.";
RL   Mol. Cell 5:545-555(2000).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 234-505 IN COMPLEXES WITH
RP   SYNTHETIC AGONIST AND NCOA1.
RX   PubMed=11698662; DOI=10.1073/pnas.241410198;
RA   Xu H.E., Lambert M.H., Montana V.G., Plunket K.D., Moore L.B.,
RA   Collins J.L., Oplinger J.A., Kliewer S.A., Gampe R.T. Jr., McKee D.D.,
RA   Moore J.T., Willson T.M.;
RT   "Structural determinants of ligand binding selectivity between the
RT   peroxisome proliferator-activated receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13919-13924(2001).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 225-505 IN COMPLEX WITH
RP   SYNTHETIC AGONIST.
RX   PubMed=11587644; DOI=10.1016/S0969-2126(01)00634-7;
RA   Cronet P., Petersen J.F.W., Folmer R., Blomberg N., Sjoeblom K.,
RA   Karlsson U., Lindstedt E.-L., Bamberg K.;
RT   "Structure of the PPARalpha and -gamma ligand binding domain in
RT   complex with AZ 242; ligand selectivity and agonist activation in the
RT   PPAR family.";
RL   Structure 9:699-706(2001).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 230-505 IN COMPLEX WITH
RP   SYNTHETIC AGONIST.
RX   PubMed=12672231; DOI=10.1021/jm021027r;
RA   Ebdrup S., Pettersson I., Rasmussen H.B., Deussen H.-J.,
RA   Frost Jensen A., Mortensen S.B., Fleckner J., Pridal L., Nygaard L.,
RA   Sauerberg P.;
RT   "Synthesis and biological and structural characterization of the dual-
RT   acting peroxisome proliferator-activated receptor alpha/gamma agonist
RT   ragaglitazar.";
RL   J. Med. Chem. 46:1306-1317(2003).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 232-505 IN COMPLEX WITH NCOA2
RP   AND SYNTHETIC AGONIST.
RX   PubMed=15258145; DOI=10.1074/jbc.M401552200;
RA   Oestberg T., Svensson S., Selen G., Uppenberg J., Thor M., Sundbom M.,
RA   Sydow-Baeckman M., Gustavsson A.-L., Jendeberg L.;
RT   "A new class of peroxisome proliferator-activated receptor agonists
RT   with a novel binding epitope shows antidiabetic effects.";
RL   J. Biol. Chem. 279:41124-41130(2004).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 235-505 IN COMPLEX WITH RXRA;
RP   NCOA1 AND SYNTHETIC AGONIST.
RX   PubMed=15056000; DOI=10.1021/jm030565g;
RA   Haffner C.D., Lenhard J.M., Miller A.B., McDougald D.L., Dwornik K.,
RA   Ittoop O.R., Gampe R.T. Jr., Xu H.E., Blanchard S., Montana V.G.,
RA   Consler T.G., Bledsoe R.K., Ayscue A., Croom D.;
RT   "Structure-based design of potent retinoid X receptor alpha
RT   agonists.";
RL   J. Med. Chem. 47:2010-2029(2004).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 231-505 IN COMPLEX WITH
RP   SYNTHETIC AGONIST.
RX   PubMed=15974597; DOI=10.1021/jm0502135;
RA   Shi G.Q., Dropinski J.F., McKeever B.M., Xu S., Becker J.W.,
RA   Berger J.P., MacNaul K.L., Elbrecht A., Zhou G., Doebber T.W.,
RA   Wang P., Chao Y.-S., Forrest M., Heck J.V., Moller D.E., Jones A.B.;
RT   "Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a
RT   novel class of PPARalpha/gamma dual agonists with potent
RT   antihyperglycemic and lipid modulating activity.";
RL   J. Med. Chem. 48:4457-4468(2005).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 234-505 IN COMPLEX WITH
RP   SYNTHETIC AGONIST AND NR0B2.
RX   PubMed=15976031; DOI=10.1073/pnas.0501204102;
RA   Li Y., Choi M., Suino K., Kovach A., Daugherty J., Kliewer S.A.,
RA   Xu H.E.;
RT   "Structural and biochemical basis for selective repression of the
RT   orphan nuclear receptor liver receptor homolog 1 by small heterodimer
RT   partner.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:9505-9510(2005).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 234-505 IN COMPLEX WITH
RP   SYNTHETIC AGONIST AND NCOA1.
RX   PubMed=16919947; DOI=10.1016/j.bmcl.2006.08.003;
RA   Hopkins C.R., O'neil S.V., Laufersweiler M.C., Wang Y., Pokross M.,
RA   Mekel M., Evdokimov A., Walter R., Kontoyianni M., Petrey M.E.,
RA   Sabatakos G., Roesgen J.T., Richardson E., Demuth T.P. Jr.;
RT   "Design and synthesis of novel N-sulfonyl-2-indole carboxamides as
RT   potent PPAR-gamma binding agents with potential application to the
RT   treatment of osteoporosis.";
RL   Bioorg. Med. Chem. Lett. 16:5659-5663(2006).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) OF 235-505 IN COMPLEX WITH
RP   SYNTHETIC AGONIST.
RX   PubMed=16451087; DOI=10.1021/jm0510373;
RA   Mahindroo N., Wang C.-C., Liao C.-C., Huang C.-F., Lu I.-L.,
RA   Lien T.-W., Peng Y.-H., Huang W.-J., Lin Y.-T., Hsu M.-C., Lin C.-H.,
RA   Tsai C.-H., Hsu J.-T., Chen X., Lyu P.-C., Chao Y.-S., Wu S.-Y.,
RA   Hsieh H.-P.;
RT   "Indol-1-yl acetic acids as peroxisome proliferator-activated receptor
RT   agonists: design, synthesis, structural biology, and molecular docking
RT   studies.";
RL   J. Med. Chem. 49:1212-1216(2006).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.54 ANGSTROMS) OF 235-505 IN COMPLEX WITH
RP   SYNTHETIC AGONIST.
RX   PubMed=16640330; DOI=10.1021/jm051129s;
RA   Lu I.-L., Huang C.-F., Peng Y.-H., Lin Y.-T., Hsieh H.-P., Chen C.-T.,
RA   Lien T.-W., Lee H.-J., Mahindroo N., Prakash E., Yueh A., Chen H.-Y.,
RA   Goparaju C.M.V., Chen X., Liao C.-C., Chao Y.-S., Hsu J.-T., Wu S.-Y.;
RT   "Structure-based drug design of a novel family of PPARgamma partial
RT   agonists: virtual screening, X-ray crystallography, and in vitro/in
RT   vivo biological activities.";
RL   J. Med. Chem. 49:2703-2712(2006).
RN   [44]
RP   VARIANT ALA-12.
RX   PubMed=9425261; DOI=10.1006/bbrc.1997.7798;
RA   Yen C.-J., Beamer B.A., Negri C., Silver K., Brown K.A., Yarnall D.P.,
RA   Burns D.K., Roth J., Shuldiner A.R.;
RT   "Molecular scanning of the human peroxisome proliferator activated
RT   receptor gamma (hPPAR-gamma) gene in diabetic Caucasians:
RT   identification of a pro12ala PPAR-gamma-2 missense mutation.";
RL   Biochem. Biophys. Res. Commun. 241:270-274(1997).
RN   [45]
RP   VARIANT OBESITY GLN-113.
RX   PubMed=9753710; DOI=10.1056/NEJM199810013391403;
RA   Ristow M., Muller-Wieland D., Pfeiffer A., Krone W., Kahn C.R.;
RT   "Obesity associated with a mutation in a genetic regulator of
RT   adipocyte differentiation.";
RL   N. Engl. J. Med. 339:953-959(1998).
RN   [46]
RP   INVOLVEMENT IN BMIQ1, AND VARIANT ALA-12.
RX   PubMed=9806549; DOI=10.1038/3099;
RA   Deeb S.S., Fajas L., Nemoto M., Pihlajamaeki J., Mykkaenen L.,
RA   Kuusisto J., Laakso M., Fujimoto W., Auwerx J.;
RT   "A Pro12Ala substitution in PPARgamma2 associated with decreased
RT   receptor activity, lower body mass index and improved insulin
RT   sensitivity.";
RL   Nat. Genet. 20:284-287(1998).
RN   [47]
RP   VARIANT ALA-12.
RX   PubMed=10407229; DOI=10.1530/eje.0.1410090;
RA   Hamann A., Munzberg H., Buttron P., Busing B., Hinney A., Mayer H.,
RA   Siegfried W., Hebebrand J., Greten H.;
RT   "Missense variants in the human peroxisome proliferator-activated
RT   receptor-gamma2 gene in lean and obese subjects.";
RL   Eur. J. Endocrinol. 141:90-92(1999).
RN   [48]
RP   INVOLVEMENT IN BMIQ1, AND VARIANT ALA-12.
RX   PubMed=10523018; DOI=10.1210/jcem.84.10.6061;
RA   Valve R., Sivenius K., Miettinen R., Pihlajamaeki J., Rissanen A.,
RA   Deeb S.S., Auwerx J., Uusitupa M., Laakso M.;
RT   "Two polymorphisms in the peroxisome proliferator-activated receptor-
RT   gamma gene are associated with severe overweight among obese women.";
RL   J. Clin. Endocrinol. Metab. 84:3708-3712(1999).
RN   [49]
RP   VARIANTS COLON CANCER PRO-314 AND HIS-316, AND VARIANT ALA-12.
RX   PubMed=10394368; DOI=10.1016/S1097-2765(01)80012-5;
RA   Sarraf P., Mueller E., Smith W.M., Wright H.M., Kum J.B.,
RA   Aaltonen L.A., de la Chapelle A., Spiegelman B.M., Eng C.;
RT   "Loss-of-function mutations in PPAR-gamma associated with human colon
RT   cancer.";
RL   Mol. Cell 3:799-804(1999).
RN   [50]
RP   VARIANTS DIABETES MET-318 AND LEU-495.
RX   PubMed=10622252; DOI=10.1038/47254;
RA   Barroso I., Gurnell M., Crowley V.E.F., Agostini M., Schwabel J.W.,
RA   Soos M.A., Masien G.L., Williams T.D.M., Lewis H., Schafer A.J.,
RA   Chatterjee V.K.K., O'Rahilly S.;
RT   "Dominant negative mutations in human PPAR-gamma associated with
RT   severe insulin resistance, diabetes mellitus and hypertension.";
RL   Nature 402:880-883(1999).
RN   [51]
RP   VARIANT FPLD3 LEU-388.
RX   PubMed=12453919; DOI=10.2337/diabetes.51.12.3586;
RA   Hegele R.A., Cao H., Frankowski C., Mathews S.T., Leff T.;
RT   "PPARG F388L, a transactivation-deficient mutant, in familial partial
RT   lipodystrophy.";
RL   Diabetes 51:3586-3590(2002).
RN   [52]
RP   VARIANT FPLD3 CYS-425.
RX   PubMed=11788685; DOI=10.1210/jcem.87.1.8290;
RA   Agarwal A.K., Garg A.;
RT   "A novel heterozygous mutation in peroxisome proliferator-activated
RT   receptor-gamma gene in a patient with familial partial
RT   lipodystrophy.";
RL   J. Clin. Endocrinol. Metab. 87:408-411(2002).
RN   [53]
RP   ASSOCIATION OF VARIANT ALA-12 WITH BMI.
RX   PubMed=14569127; DOI=10.1136/jmg.40.10.773;
RA   Masud S., Ye S.;
RT   "Effect of the peroxisome proliferator activated receptor-gamma gene
RT   Pro12Ala variant on body mass index: a meta-analysis.";
RL   J. Med. Genet. 40:773-780(2003).
RN   [54]
RP   ASSOCIATION OF VARIANT ALA-12 WITH CIMT.
RX   PubMed=15356014; DOI=10.1210/jc.2003-032120;
RA   Temelkova-Kurktschiev T., Hanefeld M., Chinetti G., Zawadzki C.,
RA   Haulon S., Kubaszek A., Koehler C., Leonhardt W., Staels B.,
RA   Laakso M.;
RT   "Ala12Ala genotype of the peroxisome proliferator-activated receptor
RT   gamma2 protects against atherosclerosis.";
RL   J. Clin. Endocrinol. Metab. 89:4238-4242(2004).
RN   [55]
RP   VARIANT ALA-12.
RX   PubMed=15562396; DOI=10.1016/j.metabol.2004.06.019;
RA   Kim K.S., Choi S.M., Shin S.U., Yang H.S., Yoon Y.;
RT   "Effects of peroxisome proliferator-activated receptor-gamma 2
RT   Pro12Ala polymorphism on body fat distribution in female Korean
RT   subjects.";
RL   Metabolism 53:1538-1543(2004).
CC   -!- FUNCTION: Nuclear receptor that binds peroxisome proliferators
CC       such as hypolipidemic drugs and fatty acids. Once activated by a
CC       ligand, the nuclear receptor binds to DNA specific PPAR response
CC       elements (PPRE) and modulates the transcription of its target
CC       genes, such as acyl-CoA oxidase. It therefore controls the
CC       peroxisomal beta-oxidation pathway of fatty acids. Key regulator
CC       of adipocyte differentiation and glucose homeostasis. ARF6 acts as
CC       a key regulator of the tissue-specific adipocyte P2 (aP2)
CC       enhancer. Acts as a critical regulator of gut homeostasis by
CC       suppressing NF-kappa-B-mediated proinflammatory responses. Plays a
CC       role in the regulation of cardiovascular circadian rhythms by
CC       regulating the transcription of ARNTL/BMAL1 in the blood vessels
CC       (By similarity). {ECO:0000250|UniProtKB:P37238,
CC       ECO:0000269|PubMed:16150867, ECO:0000269|PubMed:20829347,
CC       ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:9065481}.
CC   -!- FUNCTION: (Microbial infection) Upon treatment with M.tuberculosis
CC       or its lipoprotein LpqH, phosphorylation of MAPK p38 and IL-6
CC       production are modulated, probably via this protein.
CC       {ECO:0000269|PubMed:25504154}.
CC   -!- ENZYME REGULATION: PDPK1 activates its transcriptional activity
CC       independently of its kinase activity.
CC       {ECO:0000269|PubMed:16150867}.
CC   -!- SUBUNIT: Interacts with FOXO1 (acetylated form) (By similarity).
CC       Heterodimer with other nuclear receptors, such as RXRA. The
CC       heterodimer with the retinoic acid receptor RXRA is called
CC       adipocyte-specific transcription factor ARF6. Interacts with NCOA6
CC       coactivator, leading to a strong increase in transcription of
CC       target genes. Interacts with coactivator PPARBP, leading to a mild
CC       increase in transcription of target genes. Interacts with NOCA7 in
CC       a ligand-inducible manner. Interacts with NCOA1 and NCOA2 LXXLL
CC       motifs. Interacts with ASXL1, ASXL2, DNTTIP2, FAM120B,
CC       MAP2K1/MEK1, NR0B2, PDPK1, PRDM16, PRMT2 and TGFB1I1. Interacts
CC       (when activated by agonist) with PPP5C. Interacts with HELZ2 and
CC       THRAP3; the interaction stimulates the transcriptional activity of
CC       PPARG. Interacts with PER2, the interaction is ligand dependent
CC       and blocks PPARG recruitment to target promoters. Interacts with
CC       NOCT. Interacts with ACTN4. {ECO:0000250,
CC       ECO:0000269|PubMed:10681503, ECO:0000269|PubMed:11587644,
CC       ECO:0000269|PubMed:11971969, ECO:0000269|PubMed:12039952,
CC       ECO:0000269|PubMed:12672231, ECO:0000269|PubMed:15047147,
CC       ECO:0000269|PubMed:15056000, ECO:0000269|PubMed:15258145,
CC       ECO:0000269|PubMed:15687259, ECO:0000269|PubMed:15974597,
CC       ECO:0000269|PubMed:15976031, ECO:0000269|PubMed:16150867,
CC       ECO:0000269|PubMed:16239304, ECO:0000269|PubMed:16451087,
CC       ECO:0000269|PubMed:16640330, ECO:0000269|PubMed:16919947,
CC       ECO:0000269|PubMed:17101779, ECO:0000269|PubMed:21047783,
CC       ECO:0000269|PubMed:22351778, ECO:0000269|PubMed:23525231,
CC       ECO:0000269|PubMed:9744270}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-781384, EBI-781384;
CC       Q00535:CDK5; NbExp=2; IntAct=EBI-781416, EBI-1041567;
CC       P10909:CLU; NbExp=3; IntAct=EBI-781384, EBI-1104674;
CC       O60869:EDF1; NbExp=4; IntAct=EBI-781384, EBI-781301;
CC       P42858:HTT; NbExp=4; IntAct=EBI-781384, EBI-466029;
CC       P19793:RXRA; NbExp=6; IntAct=EBI-15664691, EBI-78598;
CC       Q6STE5-1:SMARCD3; NbExp=3; IntAct=EBI-781384, EBI-488506;
CC       Q6STE5-2:SMARCD3; NbExp=3; IntAct=EBI-781384, EBI-488511;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Redistributed from
CC       the nucleus to the cytosol through a MAP2K1/MEK1-dependent manner.
CC       NOCT enhances its nuclear translocation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=2;
CC         IsoId=P37231-1; Sequence=Displayed;
CC       Name=1; Synonyms=PPARgamma1(wt);
CC         IsoId=P37231-2; Sequence=VSP_003645;
CC       Name=3; Synonyms=PPARgamma1(tr);
CC         IsoId=P37231-3; Sequence=VSP_003645, VSP_043906, VSP_043907;
CC         Note=Exhibits dominant negative activity over isoform 1.;
CC   -!- TISSUE SPECIFICITY: Highest expression in adipose tissue. Lower in
CC       skeletal muscle, spleen, heart and liver. Also detectable in
CC       placenta, lung and ovary. {ECO:0000269|PubMed:9065481}.
CC   -!- INDUCTION: (Microbial infection) Expression increases when
CC       incubated with M.tuberculosis or its lipoprotein LpqH; induction
CC       is TLR2-dependent (at protein level).
CC       {ECO:0000269|PubMed:25504154}.
CC   -!- PTM: O-GlcNAcylation at Thr-84 reduces transcriptional activity in
CC       adipocytes. {ECO:0000250}.
CC   -!- PTM: Phosphorylated in basal conditions and dephosphorylated when
CC       treated with the ligand. May be dephosphorylated by PPP5C. The
CC       phosphorylated form may be inactive and dephosphorylation at Ser-
CC       112 induces adipogenic activity (By similarity). {ECO:0000250}.
CC   -!- POLYMORPHISM: Genetic variations in PPARG define the body mass
CC       index quantitative trait locus 1 (BMIQ1) [MIM:606641]. The body
CC       max index (BMI) reflects the amount of fat, lean mass, and body
CC       build. {ECO:0000269|PubMed:10523018, ECO:0000269|PubMed:14569127}.
CC   -!- POLYMORPHISM: Genetic variations in PPARG influence the carotid
CC       intimal medial thickness (CIMT) [MIM:609338]. CIMT is a measure of
CC       atherosclerosis that is independently associated with traditional
CC       atherosclerotic cardiovascular disease risk factors and coronary
CC       atherosclerotic burden. 35 to 45% of the variability in
CC       multivariable-adjusted CIMT is explained by genetic factors.
CC       {ECO:0000269|PubMed:15356014}.
CC   -!- DISEASE: Note=Defects in PPARG can lead to type 2 insulin-
CC       resistant diabetes and hyptertension. PPARG mutations may be
CC       associated with colon cancer. {ECO:0000269|PubMed:10394368}.
CC   -!- DISEASE: Obesity (OBESITY) [MIM:601665]: A condition characterized
CC       by an increase of body weight beyond the limitation of skeletal
CC       and physical requirements, as the result of excessive accumulation
CC       of body fat. {ECO:0000269|PubMed:9753710}. Note=Disease
CC       susceptibility may be associated with variations affecting the
CC       gene represented in this entry.
CC   -!- DISEASE: Lipodystrophy, familial partial, 3 (FPLD3) [MIM:604367]:
CC       A form of lipodystrophy characterized by marked loss of
CC       subcutaneous fat from the extremities. Facial adipose tissue may
CC       be increased, decreased or normal. Affected individuals show an
CC       increased preponderance of insulin resistance, diabetes mellitus
CC       and dyslipidemia. {ECO:0000269|PubMed:11788685,
CC       ECO:0000269|PubMed:12453919}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Glioma 1 (GLM1) [MIM:137800]: Gliomas are benign or
CC       malignant central nervous system neoplasms derived from glial
CC       cells. They comprise astrocytomas and glioblastoma multiforme that
CC       are derived from astrocytes, oligodendrogliomas derived from
CC       oligodendrocytes and ependymomas derived from ependymocytes.
CC       {ECO:0000269|PubMed:10851250}. Note=Disease susceptibility may be
CC       associated with variations affecting the gene represented in this
CC       entry. Polymorphic PPARG alleles have been found to be
CC       significantly over-represented among a cohort of American patients
CC       with sporadic glioblastoma multiforme suggesting a possible
CC       contribution to disease susceptibility.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN38992.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA23354.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAF83270.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA62153.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PPARGID383ch3p25.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Peroxisome proliferator-
CC       activated receptor entry;
CC       URL="https://en.wikipedia.org/wiki/Peroxisome_proliferator-activated_receptor";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/pparg/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=PPARG";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U79012; AAC51248.1; -; mRNA.
DR   EMBL; U63415; AAB04028.1; -; mRNA.
DR   EMBL; D83233; BAA18949.1; -; mRNA.
DR   EMBL; L40904; AAA80314.2; -; mRNA.
DR   EMBL; AB005526; BAA23354.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X90563; CAA62152.1; -; mRNA.
DR   EMBL; X90563; CAA62153.1; ALT_INIT; mRNA.
DR   EMBL; DQ356894; ABC97372.1; -; mRNA.
DR   EMBL; BT007281; AAP35945.1; -; mRNA.
DR   EMBL; AK290581; BAF83270.1; ALT_INIT; mRNA.
DR   EMBL; AB451337; BAG70151.1; -; mRNA.
DR   EMBL; AB451486; BAG70300.1; -; mRNA.
DR   EMBL; AY157024; AAN38992.2; ALT_INIT; Genomic_DNA.
DR   EMBL; AC090947; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091492; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093174; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64124.1; -; Genomic_DNA.
DR   EMBL; BC006811; AAH06811.1; -; mRNA.
DR   CCDS; CCDS2609.1; -. [P37231-1]
DR   CCDS; CCDS2610.2; -. [P37231-2]
DR   PIR; JC4859; JC4859.
DR   PIR; PC4290; PC4290.
DR   PIR; PC4429; PC4429.
DR   RefSeq; NP_005028.4; NM_005037.5. [P37231-2]
DR   RefSeq; NP_056953.2; NM_015869.4. [P37231-1]
DR   RefSeq; NP_619725.2; NM_138711.3. [P37231-2]
DR   RefSeq; NP_619726.2; NM_138712.3. [P37231-2]
DR   RefSeq; XP_011532143.1; XM_011533841.2.
DR   UniGene; Hs.162646; -.
DR   PDB; 1FM6; X-ray; 2.10 A; D/X=234-505.
DR   PDB; 1FM9; X-ray; 2.10 A; D=234-505.
DR   PDB; 1I7I; X-ray; 2.35 A; A/B=225-505.
DR   PDB; 1K74; X-ray; 2.30 A; D=234-505.
DR   PDB; 1KNU; X-ray; 2.50 A; A/B=232-505.
DR   PDB; 1NYX; X-ray; 2.65 A; A/B=230-505.
DR   PDB; 1PRG; X-ray; 2.20 A; A/B=235-504.
DR   PDB; 1RDT; X-ray; 2.40 A; D=235-505.
DR   PDB; 1WM0; X-ray; 2.90 A; X=232-505.
DR   PDB; 1ZEO; X-ray; 2.50 A; A/B=231-505.
DR   PDB; 1ZGY; X-ray; 1.80 A; A=234-505.
DR   PDB; 2ATH; X-ray; 2.28 A; A/B=235-505.
DR   PDB; 2F4B; X-ray; 2.07 A; A/B=235-505.
DR   PDB; 2FVJ; X-ray; 1.99 A; A=235-505.
DR   PDB; 2G0G; X-ray; 2.54 A; A/B=235-505.
DR   PDB; 2G0H; X-ray; 2.30 A; A/B=235-505.
DR   PDB; 2GTK; X-ray; 2.10 A; A=235-505.
DR   PDB; 2HFP; X-ray; 2.00 A; A=234-505.
DR   PDB; 2HWQ; X-ray; 1.97 A; A/B=235-505.
DR   PDB; 2HWR; X-ray; 2.34 A; A/B=235-505.
DR   PDB; 2I4J; X-ray; 2.10 A; A/B=223-504.
DR   PDB; 2I4P; X-ray; 2.10 A; A/B=223-504.
DR   PDB; 2I4Z; X-ray; 2.25 A; A/B=223-504.
DR   PDB; 2OM9; X-ray; 2.80 A; A/B/C/D=232-505.
DR   PDB; 2P4Y; X-ray; 2.25 A; A/B=231-505.
DR   PDB; 2POB; X-ray; 2.30 A; A/B=234-505.
DR   PDB; 2PRG; X-ray; 2.30 A; A/B=235-505.
DR   PDB; 2Q59; X-ray; 2.20 A; A/B=233-505.
DR   PDB; 2Q5P; X-ray; 2.30 A; A/B=233-505.
DR   PDB; 2Q5S; X-ray; 2.05 A; A/B=233-505.
DR   PDB; 2Q61; X-ray; 2.20 A; A/B=233-505.
DR   PDB; 2Q6R; X-ray; 2.41 A; A/B=233-505.
DR   PDB; 2Q6S; X-ray; 2.40 A; A/B=233-505.
DR   PDB; 2Q8S; X-ray; 2.30 A; A/B=235-505.
DR   PDB; 2QMV; NMR; -; A=235-504.
DR   PDB; 2VSR; X-ray; 2.05 A; A/B=232-505.
DR   PDB; 2VST; X-ray; 2.35 A; A/B=232-505.
DR   PDB; 2VV0; X-ray; 2.55 A; A/B=232-505.
DR   PDB; 2VV1; X-ray; 2.20 A; A/B=232-505.
DR   PDB; 2VV2; X-ray; 2.75 A; A/B=232-505.
DR   PDB; 2VV3; X-ray; 2.85 A; A/B=232-505.
DR   PDB; 2VV4; X-ray; 2.35 A; A/B=232-505.
DR   PDB; 2XKW; X-ray; 2.02 A; A/B=232-505.
DR   PDB; 2YFE; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 2ZK0; X-ray; 2.36 A; A/B=223-504.
DR   PDB; 2ZK1; X-ray; 2.61 A; A/B=223-504.
DR   PDB; 2ZK2; X-ray; 2.26 A; A/B=223-504.
DR   PDB; 2ZK3; X-ray; 2.58 A; A/B=223-504.
DR   PDB; 2ZK4; X-ray; 2.57 A; A/B=223-504.
DR   PDB; 2ZK5; X-ray; 2.45 A; A/B=223-504.
DR   PDB; 2ZK6; X-ray; 2.41 A; A/B=223-504.
DR   PDB; 2ZNO; X-ray; 2.40 A; A/B=223-504.
DR   PDB; 2ZVT; X-ray; 1.90 A; A/B=223-504.
DR   PDB; 3ADS; X-ray; 2.25 A; A/B=223-505.
DR   PDB; 3ADT; X-ray; 2.70 A; A/B=223-505.
DR   PDB; 3ADU; X-ray; 2.77 A; A/B=223-505.
DR   PDB; 3ADV; X-ray; 2.27 A; A/B=223-505.
DR   PDB; 3ADW; X-ray; 2.07 A; A/B=223-505.
DR   PDB; 3ADX; X-ray; 1.95 A; A/B=223-505.
DR   PDB; 3AN3; X-ray; 2.30 A; A/B=223-504.
DR   PDB; 3AN4; X-ray; 2.30 A; A/B=223-504.
DR   PDB; 3B0Q; X-ray; 2.10 A; A/B=231-504.
DR   PDB; 3B0R; X-ray; 2.15 A; A/B=231-504.
DR   PDB; 3B1M; X-ray; 1.60 A; A=234-505.
DR   PDB; 3B3K; X-ray; 2.60 A; A/B=223-504.
DR   PDB; 3BC5; X-ray; 2.27 A; A=231-505.
DR   PDB; 3CDP; X-ray; 2.80 A; A/B=223-504.
DR   PDB; 3CDS; X-ray; 2.65 A; A/B=223-504.
DR   PDB; 3CS8; X-ray; 2.30 A; A=234-504.
DR   PDB; 3CWD; X-ray; 2.40 A; A/B=236-505.
DR   PDB; 3D6D; X-ray; 2.40 A; A/B=223-504.
DR   PDB; 3DZU; X-ray; 3.20 A; D=102-505.
DR   PDB; 3DZY; X-ray; 3.10 A; D=102-505.
DR   PDB; 3E00; X-ray; 3.10 A; D=102-505.
DR   PDB; 3ET0; X-ray; 2.40 A; A/B=235-505.
DR   PDB; 3ET3; X-ray; 1.95 A; A=235-505.
DR   PDB; 3FEJ; X-ray; 2.01 A; A=235-505.
DR   PDB; 3FUR; X-ray; 2.30 A; A=234-505.
DR   PDB; 3G9E; X-ray; 2.30 A; A=235-505.
DR   PDB; 3GBK; X-ray; 2.30 A; A/B=235-505.
DR   PDB; 3H0A; X-ray; 2.10 A; D=234-505.
DR   PDB; 3HO0; X-ray; 2.60 A; A/B=223-504.
DR   PDB; 3HOD; X-ray; 2.10 A; A/B=223-504.
DR   PDB; 3IA6; X-ray; 2.31 A; A/B=235-505.
DR   PDB; 3K8S; X-ray; 2.55 A; A/B=234-505.
DR   PDB; 3KMG; X-ray; 2.10 A; A/D=234-505.
DR   PDB; 3LMP; X-ray; 1.90 A; A=234-505.
DR   PDB; 3NOA; X-ray; 1.98 A; A/B=235-505.
DR   PDB; 3OSI; X-ray; 2.70 A; A/B=224-504.
DR   PDB; 3OSW; X-ray; 2.55 A; A/B=224-504.
DR   PDB; 3PBA; X-ray; 2.30 A; A/B=224-505.
DR   PDB; 3PO9; X-ray; 2.35 A; A/B=224-505.
DR   PDB; 3PRG; X-ray; 2.90 A; A=232-505.
DR   PDB; 3QT0; X-ray; 2.50 A; A=235-505.
DR   PDB; 3R5N; X-ray; 2.00 A; A=232-505.
DR   PDB; 3R8A; X-ray; 2.41 A; A/B=235-505.
DR   PDB; 3R8I; X-ray; 2.30 A; A/B=223-505.
DR   PDB; 3S9S; X-ray; 2.55 A; A=234-505.
DR   PDB; 3SZ1; X-ray; 2.30 A; A/B=232-505.
DR   PDB; 3T03; X-ray; 2.10 A; A/B=234-505.
DR   PDB; 3TY0; X-ray; 2.00 A; A/B=231-505.
DR   PDB; 3U9Q; X-ray; 1.52 A; A=236-504.
DR   PDB; 3V9T; X-ray; 1.65 A; A=234-505.
DR   PDB; 3V9V; X-ray; 1.60 A; A=234-505.
DR   PDB; 3V9Y; X-ray; 2.10 A; A=234-505.
DR   PDB; 3VJH; X-ray; 2.22 A; A/B=223-504.
DR   PDB; 3VJI; X-ray; 2.61 A; A/B=223-504.
DR   PDB; 3VN2; X-ray; 2.18 A; A=225-505.
DR   PDB; 3VSO; X-ray; 2.00 A; A/B=223-504.
DR   PDB; 3VSP; X-ray; 2.40 A; A/B=223-504.
DR   PDB; 3WJ4; X-ray; 1.95 A; A/B=235-505.
DR   PDB; 3WJ5; X-ray; 1.89 A; A/B=235-505.
DR   PDB; 3WMH; X-ray; 2.10 A; A/B=223-504.
DR   PDB; 3X1H; X-ray; 2.30 A; A/B=232-505.
DR   PDB; 3X1I; X-ray; 2.40 A; A/B=232-505.
DR   PDB; 4A4V; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 4A4W; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 4CI5; X-ray; 1.77 A; A/B=234-505.
DR   PDB; 4E4K; X-ray; 2.50 A; A/B=223-505.
DR   PDB; 4E4Q; X-ray; 2.50 A; A/B=223-505.
DR   PDB; 4EM9; X-ray; 2.10 A; A/B=235-505.
DR   PDB; 4EMA; X-ray; 2.54 A; A/B=235-505.
DR   PDB; 4F9M; X-ray; 1.90 A; A=234-505.
DR   PDB; 4FGY; X-ray; 2.84 A; A=235-504.
DR   PDB; 4HEE; X-ray; 2.50 A; X=235-505.
DR   PDB; 4JAZ; X-ray; 2.85 A; A/B=223-505.
DR   PDB; 4JL4; X-ray; 2.50 A; A/B=223-505.
DR   PDB; 4L96; X-ray; 2.38 A; A=235-505.
DR   PDB; 4L98; X-ray; 2.28 A; A/B=235-505.
DR   PDB; 4O8F; X-ray; 2.60 A; A/B=223-505.
DR   PDB; 4OJ4; X-ray; 2.30 A; A=232-505.
DR   PDB; 4PRG; X-ray; 2.90 A; A/B/C/D=235-504.
DR   PDB; 4PVU; X-ray; 2.60 A; A/B=223-505.
DR   PDB; 4PWL; X-ray; 2.60 A; A/B=223-505.
DR   PDB; 4R06; X-ray; 2.22 A; A/B=233-505.
DR   PDB; 4R2U; X-ray; 2.30 A; A/D=231-505.
DR   PDB; 4R6S; X-ray; 2.30 A; A/B=231-505.
DR   PDB; 4XLD; X-ray; 2.45 A; A=231-505.
DR   PDB; 4XTA; X-ray; 2.50 A; A/B=232-505.
DR   PDB; 4XUH; X-ray; 2.22 A; A/B=232-505.
DR   PDB; 4XUM; X-ray; 2.40 A; A/B=232-505.
DR   PDB; 4Y29; X-ray; 1.98 A; A=236-504.
DR   PDB; 4YT1; X-ray; 2.20 A; A/B=223-504.
DR   PDB; 5AZV; X-ray; 2.70 A; A/B=232-505.
DR   PDB; 5DSH; X-ray; 2.95 A; A=223-505.
DR   PDB; 5DV3; X-ray; 2.75 A; A=223-505.
DR   PDB; 5DV6; X-ray; 2.80 A; A=223-505.
DR   PDB; 5DV8; X-ray; 2.75 A; A=223-505.
DR   PDB; 5DVC; X-ray; 2.30 A; A=223-505.
DR   PDB; 5DWL; X-ray; 2.20 A; A=223-505.
DR   PDB; 5F9B; X-ray; 2.25 A; A/B=223-505.
DR   PDB; 5GTN; X-ray; 1.85 A; A=223-505.
DR   PDB; 5GTO; X-ray; 2.10 A; A=223-505.
DR   PDB; 5GTP; X-ray; 2.35 A; A=223-505.
DR   PDB; 5HZC; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 5JI0; X-ray; 1.98 A; D=234-505.
DR   PDB; 5LSG; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 5TTO; X-ray; 2.25 A; A/B=233-505.
DR   PDB; 5TWO; X-ray; 1.93 A; A=234-505.
DR   PDB; 5U5L; X-ray; 2.55 A; A/B=233-505.
DR   PDB; 5UGM; X-ray; 2.10 A; A/B=235-505.
DR   PDB; 5WQX; X-ray; 2.29 A; A/B=232-505.
DR   PDB; 5WR0; X-ray; 2.85 A; A/B=232-505.
DR   PDB; 5WR1; X-ray; 2.34 A; A/B=232-505.
DR   PDB; 5Y2O; X-ray; 1.80 A; A/B=235-505.
DR   PDB; 5Y2T; X-ray; 1.70 A; A/B=235-505.
DR   PDB; 6F2L; X-ray; 2.10 A; A/B=223-505.
DR   PDBsum; 1FM6; -.
DR   PDBsum; 1FM9; -.
DR   PDBsum; 1I7I; -.
DR   PDBsum; 1K74; -.
DR   PDBsum; 1KNU; -.
DR   PDBsum; 1NYX; -.
DR   PDBsum; 1PRG; -.
DR   PDBsum; 1RDT; -.
DR   PDBsum; 1WM0; -.
DR   PDBsum; 1ZEO; -.
DR   PDBsum; 1ZGY; -.
DR   PDBsum; 2ATH; -.
DR   PDBsum; 2F4B; -.
DR   PDBsum; 2FVJ; -.
DR   PDBsum; 2G0G; -.
DR   PDBsum; 2G0H; -.
DR   PDBsum; 2GTK; -.
DR   PDBsum; 2HFP; -.
DR   PDBsum; 2HWQ; -.
DR   PDBsum; 2HWR; -.
DR   PDBsum; 2I4J; -.
DR   PDBsum; 2I4P; -.
DR   PDBsum; 2I4Z; -.
DR   PDBsum; 2OM9; -.
DR   PDBsum; 2P4Y; -.
DR   PDBsum; 2POB; -.
DR   PDBsum; 2PRG; -.
DR   PDBsum; 2Q59; -.
DR   PDBsum; 2Q5P; -.
DR   PDBsum; 2Q5S; -.
DR   PDBsum; 2Q61; -.
DR   PDBsum; 2Q6R; -.
DR   PDBsum; 2Q6S; -.
DR   PDBsum; 2Q8S; -.
DR   PDBsum; 2QMV; -.
DR   PDBsum; 2VSR; -.
DR   PDBsum; 2VST; -.
DR   PDBsum; 2VV0; -.
DR   PDBsum; 2VV1; -.
DR   PDBsum; 2VV2; -.
DR   PDBsum; 2VV3; -.
DR   PDBsum; 2VV4; -.
DR   PDBsum; 2XKW; -.
DR   PDBsum; 2YFE; -.
DR   PDBsum; 2ZK0; -.
DR   PDBsum; 2ZK1; -.
DR   PDBsum; 2ZK2; -.
DR   PDBsum; 2ZK3; -.
DR   PDBsum; 2ZK4; -.
DR   PDBsum; 2ZK5; -.
DR   PDBsum; 2ZK6; -.
DR   PDBsum; 2ZNO; -.
DR   PDBsum; 2ZVT; -.
DR   PDBsum; 3ADS; -.
DR   PDBsum; 3ADT; -.
DR   PDBsum; 3ADU; -.
DR   PDBsum; 3ADV; -.
DR   PDBsum; 3ADW; -.
DR   PDBsum; 3ADX; -.
DR   PDBsum; 3AN3; -.
DR   PDBsum; 3AN4; -.
DR   PDBsum; 3B0Q; -.
DR   PDBsum; 3B0R; -.
DR   PDBsum; 3B1M; -.
DR   PDBsum; 3B3K; -.
DR   PDBsum; 3BC5; -.
DR   PDBsum; 3CDP; -.
DR   PDBsum; 3CDS; -.
DR   PDBsum; 3CS8; -.
DR   PDBsum; 3CWD; -.
DR   PDBsum; 3D6D; -.
DR   PDBsum; 3DZU; -.
DR   PDBsum; 3DZY; -.
DR   PDBsum; 3E00; -.
DR   PDBsum; 3ET0; -.
DR   PDBsum; 3ET3; -.
DR   PDBsum; 3FEJ; -.
DR   PDBsum; 3FUR; -.
DR   PDBsum; 3G9E; -.
DR   PDBsum; 3GBK; -.
DR   PDBsum; 3H0A; -.
DR   PDBsum; 3HO0; -.
DR   PDBsum; 3HOD; -.
DR   PDBsum; 3IA6; -.
DR   PDBsum; 3K8S; -.
DR   PDBsum; 3KMG; -.
DR   PDBsum; 3LMP; -.
DR   PDBsum; 3NOA; -.
DR   PDBsum; 3OSI; -.
DR   PDBsum; 3OSW; -.
DR   PDBsum; 3PBA; -.
DR   PDBsum; 3PO9; -.
DR   PDBsum; 3PRG; -.
DR   PDBsum; 3QT0; -.
DR   PDBsum; 3R5N; -.
DR   PDBsum; 3R8A; -.
DR   PDBsum; 3R8I; -.
DR   PDBsum; 3S9S; -.
DR   PDBsum; 3SZ1; -.
DR   PDBsum; 3T03; -.
DR   PDBsum; 3TY0; -.
DR   PDBsum; 3U9Q; -.
DR   PDBsum; 3V9T; -.
DR   PDBsum; 3V9V; -.
DR   PDBsum; 3V9Y; -.
DR   PDBsum; 3VJH; -.
DR   PDBsum; 3VJI; -.
DR   PDBsum; 3VN2; -.
DR   PDBsum; 3VSO; -.
DR   PDBsum; 3VSP; -.
DR   PDBsum; 3WJ4; -.
DR   PDBsum; 3WJ5; -.
DR   PDBsum; 3WMH; -.
DR   PDBsum; 3X1H; -.
DR   PDBsum; 3X1I; -.
DR   PDBsum; 4A4V; -.
DR   PDBsum; 4A4W; -.
DR   PDBsum; 4CI5; -.
DR   PDBsum; 4E4K; -.
DR   PDBsum; 4E4Q; -.
DR   PDBsum; 4EM9; -.
DR   PDBsum; 4EMA; -.
DR   PDBsum; 4F9M; -.
DR   PDBsum; 4FGY; -.
DR   PDBsum; 4HEE; -.
DR   PDBsum; 4JAZ; -.
DR   PDBsum; 4JL4; -.
DR   PDBsum; 4L96; -.
DR   PDBsum; 4L98; -.
DR   PDBsum; 4O8F; -.
DR   PDBsum; 4OJ4; -.
DR   PDBsum; 4PRG; -.
DR   PDBsum; 4PVU; -.
DR   PDBsum; 4PWL; -.
DR   PDBsum; 4R06; -.
DR   PDBsum; 4R2U; -.
DR   PDBsum; 4R6S; -.
DR   PDBsum; 4XLD; -.
DR   PDBsum; 4XTA; -.
DR   PDBsum; 4XUH; -.
DR   PDBsum; 4XUM; -.
DR   PDBsum; 4Y29; -.
DR   PDBsum; 4YT1; -.
DR   PDBsum; 5AZV; -.
DR   PDBsum; 5DSH; -.
DR   PDBsum; 5DV3; -.
DR   PDBsum; 5DV6; -.
DR   PDBsum; 5DV8; -.
DR   PDBsum; 5DVC; -.
DR   PDBsum; 5DWL; -.
DR   PDBsum; 5F9B; -.
DR   PDBsum; 5GTN; -.
DR   PDBsum; 5GTO; -.
DR   PDBsum; 5GTP; -.
DR   PDBsum; 5HZC; -.
DR   PDBsum; 5JI0; -.
DR   PDBsum; 5LSG; -.
DR   PDBsum; 5TTO; -.
DR   PDBsum; 5TWO; -.
DR   PDBsum; 5U5L; -.
DR   PDBsum; 5UGM; -.
DR   PDBsum; 5WQX; -.
DR   PDBsum; 5WR0; -.
DR   PDBsum; 5WR1; -.
DR   PDBsum; 5Y2O; -.
DR   PDBsum; 5Y2T; -.
DR   PDBsum; 6F2L; -.
DR   DisProt; DP00718; -.
DR   ProteinModelPortal; P37231; -.
DR   SMR; P37231; -.
DR   BioGrid; 111464; 138.
DR   DIP; DIP-35528N; -.
DR   ELM; P37231; -.
DR   IntAct; P37231; 37.
DR   MINT; P37231; -.
DR   STRING; 9606.ENSP00000287820; -.
DR   BindingDB; P37231; -.
DR   ChEMBL; CHEMBL235; -.
DR   DrugBank; DB08760; (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid.
DR   DrugBank; DB07842; (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid.
DR   DrugBank; DB08121; (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid.
DR   DrugBank; DB07675; (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID.
DR   DrugBank; DB04270; (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid.
DR   DrugBank; DB07863; 2-chloro-5-nitro-N-phenylbenzamide.
DR   DrugBank; DB04689; 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID.
DR   DrugBank; DB07053; 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID.
DR   DrugBank; DB07723; 3-(5-methoxy-1H-indol-3-yl)propanoic acid.
DR   DrugBank; DB08302; 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid.
DR   DrugBank; DB08560; 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE.
DR   DrugBank; DB07724; 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid.
DR   DrugBank; DB08915; Aleglitazar.
DR   DrugBank; DB01014; Balsalazide.
DR   DrugBank; DB01393; Bezafibrate.
DR   DrugBank; DB05854; CLX-0921.
DR   DrugBank; DB07509; difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron.
DR   DrugBank; DB05187; GFT505.
DR   DrugBank; DB01067; Glipizide.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB00159; Icosapent.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB00244; Mesalazine.
DR   DrugBank; DB01252; Mitiglinide.
DR   DrugBank; DB00731; Nateglinide.
DR   DrugBank; DB01132; Pioglitazone.
DR   DrugBank; DB04971; Reglixane.
DR   DrugBank; DB00912; Repaglinide.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB00795; Sulfasalazine.
DR   DrugBank; DB05490; T131.
DR   DrugBank; DB00966; Telmisartan.
DR   DrugBank; DB00197; Troglitazone.
DR   GuidetoPHARMACOLOGY; 595; -.
DR   SwissLipids; SLP:000000396; -.
DR   iPTMnet; P37231; -.
DR   PhosphoSitePlus; P37231; -.
DR   BioMuta; PPARG; -.
DR   DMDM; 13432234; -.
DR   EPD; P37231; -.
DR   MaxQB; P37231; -.
DR   PaxDb; P37231; -.
DR   PeptideAtlas; P37231; -.
DR   PRIDE; P37231; -.
DR   DNASU; 5468; -.
DR   Ensembl; ENST00000287820; ENSP00000287820; ENSG00000132170. [P37231-1]
DR   Ensembl; ENST00000309576; ENSP00000312472; ENSG00000132170. [P37231-2]
DR   Ensembl; ENST00000396999; ENSP00000380195; ENSG00000132170. [P37231-3]
DR   Ensembl; ENST00000397010; ENSP00000380205; ENSG00000132170. [P37231-2]
DR   Ensembl; ENST00000397012; ENSP00000380207; ENSG00000132170. [P37231-2]
DR   Ensembl; ENST00000397015; ENSP00000380210; ENSG00000132170. [P37231-2]
DR   GeneID; 5468; -.
DR   KEGG; hsa:5468; -.
DR   UCSC; uc003bwr.4; human. [P37231-1]
DR   CTD; 5468; -.
DR   DisGeNET; 5468; -.
DR   EuPathDB; HostDB:ENSG00000132170.19; -.
DR   GeneCards; PPARG; -.
DR   HGNC; HGNC:9236; PPARG.
DR   HPA; CAB004282; -.
DR   HPA; HPA051239; -.
DR   HPA; HPA063663; -.
DR   MalaCards; PPARG; -.
DR   MIM; 137800; phenotype.
DR   MIM; 601487; gene.
DR   MIM; 601665; phenotype.
DR   MIM; 604367; phenotype.
DR   MIM; 606641; phenotype.
DR   MIM; 609338; phenotype.
DR   neXtProt; NX_P37231; -.
DR   OpenTargets; ENSG00000132170; -.
DR   Orphanet; 528; Berardinelli-Seip congenital lipodystrophy.
DR   Orphanet; 79083; Familial partial lipodystrophy associated with PPARG mutations.
DR   Orphanet; 251579; Giant cell glioblastoma.
DR   Orphanet; 251576; Gliosarcoma.
DR   PharmGKB; PA281; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   GeneTree; ENSGT00870000136388; -.
DR   HOGENOM; HOG000119407; -.
DR   HOVERGEN; HBG106004; -.
DR   InParanoid; P37231; -.
DR   KO; K08530; -.
DR   OMA; PLQEQSK; -.
DR   OrthoDB; EOG091G05U8; -.
DR   PhylomeDB; P37231; -.
DR   TreeFam; TF316304; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-HSA-8943724; Regulation of PTEN gene transcription.
DR   SignaLink; P37231; -.
DR   SIGNOR; P37231; -.
DR   ChiTaRS; PPARG; human.
DR   EvolutionaryTrace; P37231; -.
DR   GeneWiki; Peroxisome_proliferator-activated_receptor_gamma; -.
DR   GenomeRNAi; 5468; -.
DR   PRO; PR:P37231; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000132170; -.
DR   ExpressionAtlas; P37231; baseline and differential.
DR   Genevisible; P37231; HS.
DR   GO; GO:0005829; C:cytosol; ISS:BHF-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0043234; C:protein complex; IDA:CAFA.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IDA:BHF-UCL.
DR   GO; GO:0033613; F:activating transcription factor binding; IDA:BHF-UCL.
DR   GO; GO:0051393; F:alpha-actinin binding; IPI:UniProtKB.
DR   GO; GO:0050544; F:arachidonic acid binding; ISS:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0050692; F:DBD domain binding; IDA:CAFA.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0003690; F:double-stranded DNA binding; IMP:CAFA.
DR   GO; GO:0008144; F:drug binding; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0050693; F:LBD domain binding; IDA:CAFA.
DR   GO; GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0004879; F:nuclear receptor activity; IDA:BHF-UCL.
DR   GO; GO:0042277; F:peptide binding; IDA:CAFA.
DR   GO; GO:0004955; F:prostaglandin receptor activity; TAS:BHF-UCL.
DR   GO; GO:0008022; F:protein C-terminus binding; IDA:CAFA.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:CAFA.
DR   GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
DR   GO; GO:0043621; F:protein self-association; IDA:CAFA.
DR   GO; GO:0046965; F:retinoid X receptor binding; IDA:BHF-UCL.
DR   GO; GO:0003707; F:steroid hormone receptor activity; IEA:InterPro.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL.
DR   GO; GO:0008270; F:zinc ion binding; IDA:CAFA.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0045165; P:cell fate commitment; ISS:BHF-UCL.
DR   GO; GO:0048469; P:cell maturation; IDA:BHF-UCL.
DR   GO; GO:0071455; P:cellular response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; IDA:BHF-UCL.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0071306; P:cellular response to vitamin E; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0019395; P:fatty acid oxidation; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IMP:BHF-UCL.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0045087; P:innate immune response; TAS:BHF-UCL.
DR   GO; GO:0055088; P:lipid homeostasis; TAS:BHF-UCL.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0042953; P:lipoprotein transport; IDA:BHF-UCL.
DR   GO; GO:0015909; P:long-chain fatty acid transport; ISS:BHF-UCL.
DR   GO; GO:0045713; P:low-density lipoprotein particle receptor biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0010742; P:macrophage derived foam cell differentiation; IDA:UniProtKB.
DR   GO; GO:0030224; P:monocyte differentiation; IDA:BHF-UCL.
DR   GO; GO:0002674; P:negative regulation of acute inflammatory response; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IDA:BHF-UCL.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:BHF-UCL.
DR   GO; GO:0030308; P:negative regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0010887; P:negative regulation of cholesterol storage; IDA:BHF-UCL.
DR   GO; GO:0032966; P:negative regulation of collagen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0060965; P:negative regulation of gene silencing by miRNA; IMP:BHF-UCL.
DR   GO; GO:0060336; P:negative regulation of interferon-gamma-mediated signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL.
DR   GO; GO:2000230; P:negative regulation of pancreatic stellate cell proliferation; IEA:Ensembl.
DR   GO; GO:0010871; P:negative regulation of receptor biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0010891; P:negative regulation of sequestering of triglyceride; IDA:BHF-UCL.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0051974; P:negative regulation of telomerase activity; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL.
DR   GO; GO:1905563; P:negative regulation of vascular endothelial cell proliferation; IMP:BHF-UCL.
DR   GO; GO:1904706; P:negative regulation of vascular smooth muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0035357; P:peroxisome proliferator activated receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0001890; P:placenta development; ISS:BHF-UCL.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IMP:CAFA.
DR   GO; GO:0051091; P:positive regulation of DNA binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:HGNC.
DR   GO; GO:0046321; P:positive regulation of fatty acid oxidation; IEA:Ensembl.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0060100; P:positive regulation of phagocytosis, engulfment; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:CAFA.
DR   GO; GO:1905461; P:positive regulation of vascular associated smooth muscle cell apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0061614; P:pri-miRNA transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:BHF-UCL.
DR   GO; GO:0060694; P:regulation of cholesterol transporter activity; IC:BHF-UCL.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0060850; P:regulation of transcription involved in cell fate commitment; ISS:UniProtKB.
DR   GO; GO:0031000; P:response to caffeine; IEA:Ensembl.
DR   GO; GO:0009409; P:response to cold; IEA:Ensembl.
DR   GO; GO:0043627; P:response to estrogen; IEA:Ensembl.
DR   GO; GO:0035902; P:response to immobilization stress; IEA:Ensembl.
DR   GO; GO:0033993; P:response to lipid; ISS:BHF-UCL.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:1901558; P:response to metformin; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; TAS:ProtInc.
DR   GO; GO:0032526; P:response to retinoic acid; IDA:UniProtKB.
DR   GO; GO:0042594; P:response to starvation; IEA:Ensembl.
DR   GO; GO:0033189; P:response to vitamin A; IEA:Ensembl.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; IDA:BHF-UCL.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0050872; P:white fat cell differentiation; ISS:HGNC.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR003074; 1Cnucl_rcpt.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR003077; PPAR-gamma.
DR   InterPro; IPR022590; PPARgamma_N.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF12577; PPARgamma_N; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01288; PROXISOMEPAR.
DR   PRINTS; PR01291; PROXISOMPAGR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Biological rhythms;
KW   Complete proteome; Cytoplasm; Diabetes mellitus; Disease mutation;
KW   DNA-binding; Glycoprotein; Metal-binding; Nucleus; Obesity;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN         1    505       Peroxisome proliferator-activated
FT                                receptor gamma.
FT                                /FTId=PRO_0000053492.
FT   DOMAIN      238    503       NR LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01189}.
FT   DNA_BIND    136    210       Nuclear receptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   ZN_FING     139    159       NR C4-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   ZN_FING     176    198       NR C4-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   REGION      205    280       Interaction with FAM120B. {ECO:0000250}.
FT   BINDING     317    317       Synthetic agonist.
FT                                {ECO:0000269|PubMed:11587644,
FT                                ECO:0000269|PubMed:12672231,
FT                                ECO:0000269|PubMed:15056000,
FT                                ECO:0000269|PubMed:15258145,
FT                                ECO:0000269|PubMed:15974597,
FT                                ECO:0000269|PubMed:15976031,
FT                                ECO:0000269|PubMed:16451087,
FT                                ECO:0000269|PubMed:16640330,
FT                                ECO:0000269|PubMed:16919947}.
FT   BINDING     351    351       Synthetic agonist.
FT                                {ECO:0000269|PubMed:11587644,
FT                                ECO:0000269|PubMed:12672231,
FT                                ECO:0000269|PubMed:15056000,
FT                                ECO:0000269|PubMed:15258145,
FT                                ECO:0000269|PubMed:15974597,
FT                                ECO:0000269|PubMed:15976031,
FT                                ECO:0000269|PubMed:16451087,
FT                                ECO:0000269|PubMed:16640330,
FT                                ECO:0000269|PubMed:16919947}.
FT   BINDING     477    477       Synthetic agonist.
FT                                {ECO:0000269|PubMed:11587644,
FT                                ECO:0000269|PubMed:12672231,
FT                                ECO:0000269|PubMed:15056000,
FT                                ECO:0000269|PubMed:15258145,
FT                                ECO:0000269|PubMed:15974597,
FT                                ECO:0000269|PubMed:15976031,
FT                                ECO:0000269|PubMed:16451087,
FT                                ECO:0000269|PubMed:16640330,
FT                                ECO:0000269|PubMed:16919947}.
FT   BINDING     501    501       Synthetic agonist.
FT                                {ECO:0000269|PubMed:11587644,
FT                                ECO:0000269|PubMed:12672231,
FT                                ECO:0000269|PubMed:15056000,
FT                                ECO:0000269|PubMed:15258145,
FT                                ECO:0000269|PubMed:15974597,
FT                                ECO:0000269|PubMed:15976031,
FT                                ECO:0000269|PubMed:16451087,
FT                                ECO:0000269|PubMed:16640330,
FT                                ECO:0000269|PubMed:16919947}.
FT   MOD_RES     112    112       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD     84     84       O-linked (GlcNAc) threonine.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     28       Missing (in isoform 1 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16842753,
FT                                ECO:0000303|PubMed:7787419,
FT                                ECO:0000303|PubMed:8702406,
FT                                ECO:0000303|PubMed:8706692,
FT                                ECO:0000303|PubMed:9065481}.
FT                                /FTId=VSP_003645.
FT   VAR_SEQ     207    213       AIRFGRM -> EELQKDS (in isoform 3).
FT                                {ECO:0000303|PubMed:16842753}.
FT                                /FTId=VSP_043906.
FT   VAR_SEQ     214    504       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:16842753}.
FT                                /FTId=VSP_043907.
FT   VARIANT      12     12       P -> A (polymorphism; significant
FT                                independent determinant of CIMT; may
FT                                protect from early atherosclerosis in
FT                                subject at risk for diabetes; associated
FT                                with BMI; dbSNP:rs1801282).
FT                                {ECO:0000269|PubMed:10394368,
FT                                ECO:0000269|PubMed:10407229,
FT                                ECO:0000269|PubMed:15562396,
FT                                ECO:0000269|PubMed:9425261,
FT                                ECO:0000269|Ref.12}.
FT                                /FTId=VAR_010723.
FT   VARIANT      40     40       P -> A (in dbSNP:rs1805192).
FT                                /FTId=VAR_016116.
FT   VARIANT     113    113       P -> Q (in obesity; dbSNP:rs1800571).
FT                                {ECO:0000269|PubMed:9753710}.
FT                                /FTId=VAR_010724.
FT   VARIANT     314    314       Q -> P (in colon cancer; sporadic;
FT                                somatic mutation; loss of ligand-binding;
FT                                dbSNP:rs28936407).
FT                                {ECO:0000269|PubMed:10394368}.
FT                                /FTId=VAR_010725.
FT   VARIANT     316    316       R -> H (in colon cancer; sporadic;
FT                                somatic mutation; partial loss of ligand-
FT                                binding; dbSNP:rs28936407).
FT                                {ECO:0000269|PubMed:10394368}.
FT                                /FTId=VAR_010726.
FT   VARIANT     318    318       V -> M (in diabetes; dbSNP:rs72551362).
FT                                {ECO:0000269|PubMed:10622252}.
FT                                /FTId=VAR_010727.
FT   VARIANT     388    388       F -> L (in FPLD3; dbSNP:rs72551363).
FT                                {ECO:0000269|PubMed:12453919}.
FT                                /FTId=VAR_022700.
FT   VARIANT     425    425       R -> C (in FPLD3; dbSNP:rs72551364).
FT                                {ECO:0000269|PubMed:11788685}.
FT                                /FTId=VAR_022701.
FT   VARIANT     495    495       P -> L (in diabetes; dbSNP:rs121909244).
FT                                {ECO:0000269|PubMed:10622252}.
FT                                /FTId=VAR_010728.
FT   CONFLICT     36     37       MP -> IA (in Ref. 3; BAA18949).
FT                                {ECO:0000305}.
FT   CONFLICT    213    214       MP -> IA (in Ref. 3; BAA18949).
FT                                {ECO:0000305}.
FT   CONFLICT    240    240       R -> RQ (in Ref. 3; BAA18949).
FT                                {ECO:0000305}.
FT   STRAND      140    142       {ECO:0000244|PDB:3DZY}.
FT   STRAND      148    150       {ECO:0000244|PDB:3DZU}.
FT   STRAND      151    154       {ECO:0000244|PDB:3DZY}.
FT   HELIX       157    167       {ECO:0000244|PDB:3DZY}.
FT   TURN        168    170       {ECO:0000244|PDB:3DZY}.
FT   HELIX       186    188       {ECO:0000244|PDB:3DZY}.
FT   HELIX       191    200       {ECO:0000244|PDB:3DZY}.
FT   HELIX       205    207       {ECO:0000244|PDB:3DZY}.
FT   TURN        214    217       {ECO:0000244|PDB:3DZY}.
FT   HELIX       218    220       {ECO:0000244|PDB:3DZY}.
FT   TURN        222    226       {ECO:0000244|PDB:3DZY}.
FT   TURN        228    231       {ECO:0000244|PDB:3DZY}.
FT   HELIX       237    253       {ECO:0000244|PDB:3U9Q}.
FT   HELIX       258    265       {ECO:0000244|PDB:3U9Q}.
FT   STRAND      266    268       {ECO:0000244|PDB:5F9B}.
FT   STRAND      269    271       {ECO:0000244|PDB:3U9Q}.
FT   STRAND      275    277       {ECO:0000244|PDB:3U9Q}.
FT   HELIX       280    286       {ECO:0000244|PDB:3U9Q}.
FT   TURN        287    289       {ECO:0000244|PDB:3V9T}.
FT   STRAND      290    292       {ECO:0000244|PDB:1ZGY}.
FT   STRAND      294    296       {ECO:0000244|PDB:1ZGY}.
FT   HELIX       298    300       {ECO:0000244|PDB:5TWO}.
FT   STRAND      301    303       {ECO:0000244|PDB:1FM6}.
FT   HELIX       305    329       {ECO:0000244|PDB:3U9Q}.
FT   HELIX       334    336       {ECO:0000244|PDB:3U9Q}.
FT   HELIX       339    360       {ECO:0000244|PDB:3U9Q}.
FT   STRAND      361    363       {ECO:0000244|PDB:3DZU}.
FT   STRAND      366    369       {ECO:0000244|PDB:3U9Q}.
FT   TURN        370    373       {ECO:0000244|PDB:3U9Q}.
FT   STRAND      374    377       {ECO:0000244|PDB:3U9Q}.
FT   HELIX       378    383       {ECO:0000244|PDB:3U9Q}.
FT   TURN        385    387       {ECO:0000244|PDB:5GTN}.
FT   HELIX       388    390       {ECO:0000244|PDB:3U9Q}.
FT   HELIX       393    403       {ECO:0000244|PDB:3U9Q}.
FT   HELIX       409    420       {ECO:0000244|PDB:3U9Q}.
FT   STRAND      423    425       {ECO:0000244|PDB:3ADT}.
FT   HELIX       431    452       {ECO:0000244|PDB:3U9Q}.
FT   STRAND      454    456       {ECO:0000244|PDB:3SZ1}.
FT   HELIX       459    486       {ECO:0000244|PDB:3U9Q}.
FT   STRAND      488    490       {ECO:0000244|PDB:2HWQ}.
FT   HELIX       491    493       {ECO:0000244|PDB:4L98}.
FT   HELIX       495    501       {ECO:0000244|PDB:3U9Q}.
SQ   SEQUENCE   505 AA;  57620 MW;  3933EFF36A0E4CAF CRC64;
     MGETLGDSPI DPESDSFTDT LSANISQEMT MVDTEMPFWP TNFGISSVDL SVMEDHSHSF
     DIKPFTTVDF SSISTPHYED IPFTRTDPVV ADYKYDLKLQ EYQSAIKVEP ASPPYYSEKT
     QLYNKPHEEP SNSLMAIECR VCGDKASGFH YGVHACEGCK GFFRRTIRLK LIYDRCDLNC
     RIHKKSRNKC QYCRFQKCLA VGMSHNAIRF GRMPQAEKEK LLAEISSDID QLNPESADLR
     ALAKHLYDSY IKSFPLTKAK ARAILTGKTT DKSPFVIYDM NSLMMGEDKI KFKHITPLQE
     QSKEVAIRIF QGCQFRSVEA VQEITEYAKS IPGFVNLDLN DQVTLLKYGV HEIIYTMLAS
     LMNKDGVLIS EGQGFMTREF LKSLRKPFGD FMEPKFEFAV KFNALELDDS DLAIFIAVII
     LSGDRPGLLN VKPIEDIQDN LLQALELQLK LNHPESSQLF AKLLQKMTDL RQIVTEHVQL
     LQVIKKTETD MSLHPLLQEI YKDLY
//
ID   Q4W448_HUMAN            Unreviewed;       248 AA.
AC   Q4W448;
DT   05-JUL-2005, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2005, sequence version 1.
DT   28-FEB-2018, entry version 115.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma {ECO:0000256|RuleBase:RU364110};
DE            Short=PPAR-gamma {ECO:0000256|RuleBase:RU364110};
DE   AltName: Full=Nuclear receptor subfamily 1 group C member 3 {ECO:0000256|RuleBase:RU364110};
GN   Name=PPARG {ECO:0000256|RuleBase:RU364110,
GN   ECO:0000313|EMBL:CAG29019.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG29019.1};
RN   [1] {ECO:0000313|EMBL:CAG29019.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Colon carcinoma {ECO:0000313|EMBL:CAG29019.1};
RA   Casamassimi A., Migliore C., Ciccodicola A.;
RT   "Human peroxisome proliferative activated receptor gamma.";
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Nuclear receptor that binds peroxisome proliferators
CC       such as hypolipidemic drugs and fatty acids. Once activated by a
CC       ligand, the nuclear receptor binds to DNA specific PPAR response
CC       elements (PPRE) and modulates the transcription of its target
CC       genes, such as acyl-CoA oxidase. It therefore controls the
CC       peroxisomal beta-oxidation pathway of fatty acids. Key regulator
CC       of adipocyte differentiation and glucose homeostasis. ARF6 acts as
CC       a key regulator of the tissue-specific adipocyte P2 (aP2)
CC       enhancer. Acts as a critical regulator of gut homeostasis by
CC       suppressing NF-kappa-B-mediated proinflammatory responses. Plays a
CC       role in the regulation of cardiovascular circadian rhythms by
CC       regulating the transcription of ARNTL/BMAL1 in the blood vessels.
CC       {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBUNIT: Heterodimer with other nuclear receptors.
CC       {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU364110}.
CC       Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
CC       ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00586772}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000256|RuleBase:RU364110}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ698135; CAG29019.1; -; mRNA.
DR   RefSeq; NP_001317544.1; NM_001330615.1.
DR   UniGene; Hs.162646; -.
DR   ProteinModelPortal; Q4W448; -.
DR   SMR; Q4W448; -.
DR   PeptideAtlas; Q4W448; -.
DR   PRIDE; Q4W448; -.
DR   GeneID; 5468; -.
DR   CTD; 5468; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   HOVERGEN; HBG082808; -.
DR   ChiTaRS; PPARG; human.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004879; F:nuclear receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR003074; 1Cnucl_rcpt.
DR   InterPro; IPR003077; PPAR-gamma.
DR   InterPro; IPR022590; PPARgamma_N.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF12577; PPARgamma_N; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01288; PROXISOMEPAR.
DR   PRINTS; PR01291; PROXISOMPAGR.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00399; ZnF_C4; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   Activator {ECO:0000256|RuleBase:RU364110};
KW   Biological rhythms {ECO:0000256|RuleBase:RU364110};
KW   Cytoplasm {ECO:0000256|RuleBase:RU364110};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517091};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517080};
KW   Receptor {ECO:0000256|RuleBase:RU364110, ECO:0000313|EMBL:CAG29019.1};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517167};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517167};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN      106    180       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DNA_BIND    106    180       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
SQ   SEQUENCE   248 AA;  28302 MW;  E72235D1B2B56AF6 CRC64;
     MVDTEMPFWP TNFGISSVDL SVMEDHSHSF DIKPFTTVDF SSISTPHYED IPFTRTDPVV
     ADYKYDLKLQ EYQSAIKVEP ASPPYYSEKT QLYNKPHEEP SNSLMAIECR VCGDKASGFH
     YGVHACEGCK GFFRRTIRLK LIYDRCDLNC RIHKKSRNKC QYCRFQKCLA VGMSHNAIRF
     GRMPQAEKEK LLAEISSDID QLNPESADLR ALAKHLYDSY IKSFPLTKAK ARAILTGKTT
     DKSTAQVC
//
ID   B4DHC3_HUMAN            Unreviewed;       876 AA.
AC   B4DHC3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 65.
DE   SubName: Full=cDNA FLJ61254, highly similar to Receptor-type tyrosine-protein phosphatase kappa (EC 3.1.3.48) {ECO:0000313|EMBL:BAG58084.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58084.1};
RN   [1] {ECO:0000313|EMBL:BAG58084.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG58084.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK295028; BAG58084.1; -; mRNA.
DR   RefSeq; NP_001278911.1; NM_001291982.1.
DR   RefSeq; NP_001278912.1; NM_001291983.1.
DR   RefSeq; NP_002835.2; NM_002844.3.
DR   UniGene; Hs.155919; -.
DR   ProteinModelPortal; B4DHC3; -.
DR   PeptideAtlas; B4DHC3; -.
DR   PRIDE; B4DHC3; -.
DR   DNASU; 5796; -.
DR   GeneID; 5796; -.
DR   CTD; 5796; -.
DR   PharmGKB; PA34019; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   HOVERGEN; HBG062785; -.
DR   GenomeRNAi; 5796; -.
DR   Genevisible; B4DHC3; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00629; MAM; 1.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00137; MAM; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:BAG58084.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28    876       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002803003.
FT   TRANSMEM    754    775       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       34    194       MAM. {ECO:0000259|PROSITE:PS50060}.
FT   DOMAIN      196    281       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      294    389       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      392    488       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      491    595       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
SQ   SEQUENCE   876 AA;  97451 MW;  526727F962ECBF1E CRC64;
     MDTTAAAALP AFVALLLLSP WPLLGSAQGQ FSAGGCTFDD GPGACDYHQD LYDDFEWVHV
     SAQEPHYLPP EMPQGSYMIV DSSDHDPGEK ARLQLPTMKE NDTHCIDFSY LLYSQKGLNP
     GTLNILVRVN KGPLANPIWN VTGFTGRDWL RAELAVSTFW PNEYQVIFEA EVSGGRSGYI
     AIDDIQVLSY PCDKSPHFLR LGDVEVNAGQ NATFQCIATG RDAVHNKLWL QRRNGEDIPV
     AQTKNINHRR FAASFRLQEV TKTDQDLYRC VTQSERGSGV SNFAQLIVRE PPRPIAPPQL
     LGVGPTYLLI QLNANSIIGD GPIILKEVEY RMTSGSWTET HAVNAPTYKL WHLDPDTEYE
     IRVLLTRPGE GGTGLPGPPL ITRTKCAEPM RTPKTLKIAE IQARRIAVDW ESLGYNITRC
     HTFNVTICYH YFRGHNESKA DCLDMDPKAP QHVVNHLPPY TNVSLKMILT NPEGRKESEE
     TIIQTDEDVP GPVPVKSLQG TSFENKIFLN WKEPLDPNGI ITQYEISYSS IRSFDPAVPV
     AGPPQTVSNL WNSTHHVFMH LHPGTTYQFF IRASTVKGFG PATAINVTTN ISAPTLPDYE
     GVDASLNETA TTITVLLRPA QAKGAPISAY QIVVEELHPH RTKREAGAME CYQVPVTYQN
     AMSGGAPYYF AAELPPGNLP EPAPFTVGDN RTYQGFWNPP LAPRKGYNIY FQAMSSVEKE
     TKTQCVRIAT KAAATEEPEV IPDPAKQTDR VVKIAGISAG ILVFILLLLV VILIVKKRRS
     YYSYSYYLKL AKKRKDAMGN TRQEMTHMVN AMDRSYADQS TLHAEDPLSI TFMDQHNFSP
     RLPNDPLVPT AVLVPITGRK NVYHGDNNSF FAISYL
//
ID   PTPRK_HUMAN             Reviewed;        1439 AA.
AC   Q15262; B2RTQ8; B7ZMG0; Q14763; Q5TG10; Q5TG11;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   28-FEB-2018, entry version 186.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase kappa;
DE            Short=Protein-tyrosine phosphatase kappa;
DE            Short=R-PTP-kappa;
DE            EC=3.1.3.48;
DE   Flags: Precursor;
GN   Name=PTPRK; Synonyms=PTPK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8663237; DOI=10.1074/jbc.271.28.16712;
RA   Fuchs M., Mueller T., Lerch M., Ullrich A.;
RT   "Association of human protein-tyrosine phosphatase kappa with members
RT   of the armadillo family.";
RL   J. Biol. Chem. 271:16712-16719(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Foreskin;
RX   PubMed=9047348; DOI=10.1016/S0378-1119(96)00684-1;
RA   Yang Y., Gil M.C., Choi E.Y., Park S.H., Pyun K.H., Ha H.;
RT   "Molecular cloning and chromosomal localization of a human gene
RT   homologous to the murine R-PTP-kappa, a receptor-type protein tyrosine
RT   phosphatase.";
RL   Gene 186:77-82(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION IN EGFR REGULATION.
RX   PubMed=19836242; DOI=10.1016/j.cub.2009.09.048;
RA   Tarcic G., Boguslavsky S.K., Wakim J., Kiuchi T., Liu A., Reinitz F.,
RA   Nathanson D., Takahashi T., Mischel P.S., Ng T., Yarden Y.;
RT   "An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase
RT   controlling EGFR endocytosis.";
RL   Curr. Biol. 19:1788-1798(2009).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-416.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-416.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 865-1154.
RX   PubMed=19167335; DOI=10.1016/j.cell.2008.11.038;
RA   Barr A.J., Ugochukwu E., Lee W.H., King O.N.F., Filippakopoulos P.,
RA   Alfano I., Savitsky P., Burgess-Brown N.A., Mueller S., Knapp S.;
RT   "Large-scale structural analysis of the classical human protein
RT   tyrosine phosphatome.";
RL   Cell 136:352-363(2009).
CC   -!- FUNCTION: Regulation of processes involving cell contact and
CC       adhesion such as growth control, tumor invasion, and metastasis.
CC       Negative regulator of EGFR signaling pathway. Forms complexes with
CC       beta-catenin and gamma-catenin/plakoglobin. Beta-catenin may be a
CC       substrate for the catalytic activity of PTPRK/PTP-kappa.
CC       {ECO:0000269|PubMed:19836242}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- INTERACTION:
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-474052, EBI-641062;
CC       P28300:LOX; NbExp=4; IntAct=EBI-474052, EBI-3893481;
CC       Q02763:TEK; NbExp=2; IntAct=EBI-474052, EBI-2257090;
CC   -!- SUBCELLULAR LOCATION: Cell junction, adherens junction. Cell
CC       membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q15262-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15262-2; Sequence=VSP_024819;
CC       Name=3;
CC         IsoId=Q15262-3; Sequence=VSP_024819, VSP_042049;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q15262-4; Sequence=VSP_024819, VSP_054480, VSP_042049;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: High levels in lung, brain and colon; less in
CC       liver, pancreas, stomach, kidney, placenta and mammary carcinoma.
CC   -!- PTM: This protein undergoes proteolytic processing.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 2B subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z70660; CAA94519.1; -; mRNA.
DR   EMBL; L77886; AAC37599.1; -; mRNA.
DR   EMBL; AL035470; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL034349; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590006; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451073; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357621; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035465; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035594; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48086.1; -; Genomic_DNA.
DR   EMBL; BC140775; AAI40776.1; -; mRNA.
DR   EMBL; BC144512; AAI44513.1; -; mRNA.
DR   EMBL; BC144513; AAI44514.1; -; mRNA.
DR   CCDS; CCDS47473.1; -. [Q15262-3]
DR   CCDS; CCDS5137.1; -. [Q15262-2]
DR   CCDS; CCDS75517.1; -. [Q15262-1]
DR   CCDS; CCDS78179.1; -. [Q15262-4]
DR   PIR; JC6312; JC6312.
DR   RefSeq; NP_001129120.1; NM_001135648.2. [Q15262-3]
DR   RefSeq; NP_001278910.1; NM_001291981.1. [Q15262-4]
DR   RefSeq; NP_001278913.1; NM_001291984.1. [Q15262-1]
DR   RefSeq; NP_002835.2; NM_002844.3. [Q15262-2]
DR   UniGene; Hs.155919; -.
DR   PDB; 2C7S; X-ray; 1.95 A; A=865-1154.
DR   PDBsum; 2C7S; -.
DR   ProteinModelPortal; Q15262; -.
DR   SMR; Q15262; -.
DR   BioGrid; 111760; 119.
DR   IntAct; Q15262; 25.
DR   MINT; Q15262; -.
DR   STRING; 9606.ENSP00000357196; -.
DR   DEPOD; Q15262; -.
DR   iPTMnet; Q15262; -.
DR   PhosphoSitePlus; Q15262; -.
DR   BioMuta; PTPRK; -.
DR   DMDM; 146345496; -.
DR   EPD; Q15262; -.
DR   MaxQB; Q15262; -.
DR   PaxDb; Q15262; -.
DR   PeptideAtlas; Q15262; -.
DR   PRIDE; Q15262; -.
DR   DNASU; 5796; -.
DR   Ensembl; ENST00000368213; ENSP00000357196; ENSG00000152894. [Q15262-3]
DR   Ensembl; ENST00000368215; ENSP00000357198; ENSG00000152894. [Q15262-1]
DR   Ensembl; ENST00000368226; ENSP00000357209; ENSG00000152894. [Q15262-2]
DR   Ensembl; ENST00000532331; ENSP00000432973; ENSG00000152894. [Q15262-4]
DR   Ensembl; ENST00000618215; ENSP00000484742; ENSG00000273993. [Q15262-3]
DR   Ensembl; ENST00000618924; ENSP00000483766; ENSG00000273993. [Q15262-2]
DR   Ensembl; ENST00000619256; ENSP00000477791; ENSG00000273993. [Q15262-4]
DR   Ensembl; ENST00000628183; ENSP00000486442; ENSG00000273993. [Q15262-1]
DR   GeneID; 5796; -.
DR   KEGG; hsa:5796; -.
DR   UCSC; uc003qbj.4; human. [Q15262-1]
DR   CTD; 5796; -.
DR   DisGeNET; 5796; -.
DR   EuPathDB; HostDB:ENSG00000152894.14; -.
DR   GeneCards; PTPRK; -.
DR   H-InvDB; HIX0006208; -.
DR   H-InvDB; HIX0033189; -.
DR   HGNC; HGNC:9674; PTPRK.
DR   HPA; HPA054056; -.
DR   HPA; HPA054822; -.
DR   MIM; 602545; gene.
DR   neXtProt; NX_Q15262; -.
DR   OpenTargets; ENSG00000152894; -.
DR   PharmGKB; PA34019; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00760000118900; -.
DR   HOGENOM; HOG000049029; -.
DR   HOVERGEN; HBG062785; -.
DR   InParanoid; Q15262; -.
DR   KO; K06776; -.
DR   PhylomeDB; Q15262; -.
DR   TreeFam; TF312900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   SignaLink; Q15262; -.
DR   SIGNOR; Q15262; -.
DR   ChiTaRS; PTPRK; human.
DR   EvolutionaryTrace; Q15262; -.
DR   GeneWiki; PTPRK; -.
DR   GenomeRNAi; 5796; -.
DR   PRO; PR:Q15262; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000152894; -.
DR   CleanEx; HS_PTPRK; -.
DR   ExpressionAtlas; Q15262; baseline and differential.
DR   Genevisible; Q15262; HS.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031256; C:leading edge membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0001750; C:photoreceptor outer segment; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
DR   GO; GO:0045295; F:gamma-catenin binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IMP:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IDA:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; IDA:UniProtKB.
DR   GO; GO:0048041; P:focal adhesion assembly; IMP:UniProtKB.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010839; P:negative regulation of keratinocyte proliferation; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0034394; P:protein localization to cell surface; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00629; MAM; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00137; MAM; 1.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Hydrolase;
KW   Immunoglobulin domain; Membrane; Phosphoprotein; Protein phosphatase;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27   1439       Receptor-type tyrosine-protein
FT                                phosphatase kappa.
FT                                /FTId=PRO_0000025446.
FT   TOPO_DOM     27    752       Extracellular. {ECO:0000255}.
FT   TRANSMEM    753    774       Helical. {ECO:0000255}.
FT   TOPO_DOM    775   1439       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       31    194       MAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00128}.
FT   DOMAIN      196    281       Ig-like C2-type.
FT   DOMAIN      294    389       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      392    488       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      491    595       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      597    680       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      887   1141       Tyrosine-protein phosphatase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   DOMAIN     1173   1435       Tyrosine-protein phosphatase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION     1082   1088       Substrate binding. {ECO:0000250}.
FT   ACT_SITE   1082   1082       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   ACT_SITE   1376   1376       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   BINDING    1050   1050       Substrate. {ECO:0000250}.
FT   BINDING    1126   1126       Substrate. {ECO:0000250}.
FT   SITE        643    644       Cleavage. {ECO:0000305}.
FT   MOD_RES     856    856       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P35822}.
FT   CARBOHYD    101    101       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    140    140       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    211    211       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    416    416       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    424    424       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    436    436       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    462    462       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    552    552       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    586    586       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    590    590       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    607    607       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    690    690       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    216    270       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ     732    732       A -> AA (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9047348}.
FT                                /FTId=VSP_024819.
FT   VAR_SEQ     831    831       Y -> LPNDPLVPTAVLVPITD (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054480.
FT   VAR_SEQ     946    946       I -> IDIWLYR (in isoform 3 and isoform
FT                                4). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042049.
FT   CONFLICT      9      9       L -> V (in Ref. 2; AAC37599).
FT                                {ECO:0000305}.
FT   CONFLICT    158    158       T -> S (in Ref. 1; CAA94519).
FT                                {ECO:0000305}.
FT   CONFLICT    284    284       A -> P (in Ref. 2; AAC37599).
FT                                {ECO:0000305}.
FT   CONFLICT    422    422       T -> S (in Ref. 2; AAC37599).
FT                                {ECO:0000305}.
FT   CONFLICT    672    674       AEL -> CRT (in Ref. 2; AAC37599).
FT                                {ECO:0000305}.
FT   CONFLICT    715    715       S -> T (in Ref. 2; AAC37599).
FT                                {ECO:0000305}.
FT   CONFLICT   1366   1366       E -> K (in Ref. 2; AAC37599).
FT                                {ECO:0000305}.
FT   HELIX       869    871       {ECO:0000244|PDB:2C7S}.
FT   HELIX       872    879       {ECO:0000244|PDB:2C7S}.
FT   STRAND      883    885       {ECO:0000244|PDB:2C7S}.
FT   HELIX       887    892       {ECO:0000244|PDB:2C7S}.
FT   HELIX       903    906       {ECO:0000244|PDB:2C7S}.
FT   HELIX       908    913       {ECO:0000244|PDB:2C7S}.
FT   HELIX       923    925       {ECO:0000244|PDB:2C7S}.
FT   HELIX       936    939       {ECO:0000244|PDB:2C7S}.
FT   STRAND      942    948       {ECO:0000244|PDB:2C7S}.
FT   STRAND      951    958       {ECO:0000244|PDB:2C7S}.
FT   HELIX       963    965       {ECO:0000244|PDB:2C7S}.
FT   HELIX       966    976       {ECO:0000244|PDB:2C7S}.
FT   STRAND      980    983       {ECO:0000244|PDB:2C7S}.
FT   STRAND      987    989       {ECO:0000244|PDB:2C7S}.
FT   STRAND     1001   1006       {ECO:0000244|PDB:2C7S}.
FT   STRAND     1009   1018       {ECO:0000244|PDB:2C7S}.
FT   STRAND     1020   1031       {ECO:0000244|PDB:2C7S}.
FT   STRAND     1038   1045       {ECO:0000244|PDB:2C7S}.
FT   STRAND     1050   1053       {ECO:0000244|PDB:2C7S}.
FT   HELIX      1058   1070       {ECO:0000244|PDB:2C7S}.
FT   STRAND     1078   1081       {ECO:0000244|PDB:2C7S}.
FT   STRAND     1083   1086       {ECO:0000244|PDB:2C7S}.
FT   HELIX      1087   1105       {ECO:0000244|PDB:2C7S}.
FT   STRAND     1106   1108       {ECO:0000244|PDB:2C7S}.
FT   HELIX      1110   1120       {ECO:0000244|PDB:2C7S}.
FT   HELIX      1128   1144       {ECO:0000244|PDB:2C7S}.
FT   TURN       1150   1153       {ECO:0000244|PDB:2C7S}.
SQ   SEQUENCE   1439 AA;  162102 MW;  EE1EA6EA3CCA31ED CRC64;
     MDTTAAAALP AFVALLLLSP WPLLGSAQGQ FSAGGCTFDD GPGACDYHQD LYDDFEWVHV
     SAQEPHYLPP EMPQGSYMIV DSSDHDPGEK ARLQLPTMKE NDTHCIDFSY LLYSQKGLNP
     GTLNILVRVN KGPLANPIWN VTGFTGRDWL RAELAVSTFW PNEYQVIFEA EVSGGRSGYI
     AIDDIQVLSY PCDKSPHFLR LGDVEVNAGQ NATFQCIATG RDAVHNKLWL QRRNGEDIPV
     AQTKNINHRR FAASFRLQEV TKTDQDLYRC VTQSERGSGV SNFAQLIVRE PPRPIAPPQL
     LGVGPTYLLI QLNANSIIGD GPIILKEVEY RMTSGSWTET HAVNAPTYKL WHLDPDTEYE
     IRVLLTRPGE GGTGLPGPPL ITRTKCAEPM RTPKTLKIAE IQARRIAVDW ESLGYNITRC
     HTFNVTICYH YFRGHNESKA DCLDMDPKAP QHVVNHLPPY TNVSLKMILT NPEGRKESEE
     TIIQTDEDVP GPVPVKSLQG TSFENKIFLN WKEPLDPNGI ITQYEISYSS IRSFDPAVPV
     AGPPQTVSNL WNSTHHVFMH LHPGTTYQFF IRASTVKGFG PATAINVTTN ISAPTLPDYE
     GVDASLNETA TTITVLLRPA QAKGAPISAY QIVVEELHPH RTKREAGAME CYQVPVTYQN
     AMSGGAPYYF AAELPPGNLP EPAPFTVGDN RTYQGFWNPP LAPRKGYNIY FQAMSSVEKE
     TKTQCVRIAT KAATEEPEVI PDPAKQTDRV VKIAGISAGI LVFILLLLVV ILIVKKSKLA
     KKRKDAMGNT RQEMTHMVNA MDRSYADQST LHAEDPLSIT FMDQHNFSPR YENHSATAES
     SRLLDVPRYL CEGTESPYQT GQLHPAIRVA DLLQHINLMK TSDSYGFKEE YESFFEGQSA
     SWDVAKKDQN RAKNRYGNII AYDHSRVILQ PVEDDPSSDY INANYIDGYQ RPSHYIATQG
     PVHETVYDFW RMIWQEQSAC IVMVTNLVEV GRVKCYKYWP DDTEVYGDFK VTCVEMEPLA
     EYVVRTFTLE RRGYNEIREV KQFHFTGWPD HGVPYHATGL LSFIRRVKLS NPPSAGPIVV
     HCSAGAGRTG CYIVIDIMLD MAEREGVVDI YNCVKALRSR RINMVQTEEQ YIFIHDAILE
     ACLCGETAIP VCEFKAAYFD MIRIDSQTNS SHLKDEFQTL NSVTPRLQAE DCSIACLPRN
     HDKNRFMDML PPDRCLPFLI TIDGESSNYI NAALMDSYRQ PAAFIVTQYP LPNTVKDFWR
     LVYDYGCTSI VMLNEVDLSQ GCPQYWPEEG MLRYGPIQVE CMSCSMDCDV INRIFRICNL
     TRPQEGYLMV QQFQYLGWAS HREVPGSKRS FLKLILQVEK WQEECEEGEG RTIIHCLNGG
     GRSGMFCAIG IVVEMVKRQN VVDVFHAVKT LRNSKPNMVE APEQYRFCYD VALEYLESS
//
ID   Q59EZ1_HUMAN            Unreviewed;       742 AA.
AC   Q59EZ1;
DT   26-APR-2005, integrated into UniProtKB/TrEMBL.
DT   26-APR-2005, sequence version 1.
DT   28-FEB-2018, entry version 83.
DE   SubName: Full=Protein tyrosine phosphatase, receptor type, K variant {ECO:0000313|EMBL:BAD92907.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD92907.1};
RN   [1] {ECO:0000313|EMBL:BAD92907.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAD92907.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB209670; BAD92907.1; -; mRNA.
DR   RefSeq; NP_001278912.1; NM_001291983.1.
DR   UniGene; Hs.155919; -.
DR   ProteinModelPortal; Q59EZ1; -.
DR   PeptideAtlas; Q59EZ1; -.
DR   PRIDE; Q59EZ1; -.
DR   DNASU; 5796; -.
DR   GeneID; 5796; -.
DR   CTD; 5796; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   HOVERGEN; HBG062785; -.
DR   GenomeRNAi; 5796; -.
DR   Genevisible; Q59EZ1; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS50060; MAM_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:BAD92907.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    606    627       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       17     46       MAM. {ECO:0000259|PROSITE:PS50060}.
FT   DOMAIN       48    133       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      146    241       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      244    340       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      343    447       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD92907.1}.
SQ   SEQUENCE   742 AA;  83074 MW;  3D283692BC19A3A7 CRC64;
     CMLVLKSLII YHPRCPKVIF EAEVSGGRSG YIAIDDIQVL SYPCDKSPHF LRLGDVEVNA
     GQNATFQCIA TGRDAVHNKL WLQRRNGEDI PVAQTKNINH RRFAASFRLQ EVTKTDQDLY
     RCVTQSERGS GVSNFAQLIV REPPRPIAPP QLLGVGPTYL LIQLNANSII GDGPIILKEV
     EYRMTSGSWT ETHAVNAPTY KLWHLDPDTE YEIRVLLTRP GEGGTGLPGP PLITRTKCAE
     PMRTPKTLKI AEIQARRIAV DWESLGYNIT RCHTFNVTIC YHYFRGHNES KADCLDMDPK
     APQHVVNHLP PYTNVSLKMI LTNPEGRKES EETIIQTDED VPGPVPVKSL QGTSFENKIF
     LNWKEPLDPN GIITQYEISY SSIRSFDPAV PVAGPPQTVS NLWNSTHHVF MHLHPGTTYQ
     FFIRASTVKG FGPATAINVT TNISAPTLPD YEGVDASLNE TATTITVLLR PAQAKGAPIS
     AYQIVVEELH PHRTKREAGA MECYQVPVTY QNAMSGGAPY YFAAELPPGN LPEPAPFTVG
     DNRTYQGFWN PPLAPRKGYN IYFQAMSSVE KETKTQCVRI ATKAAATEEP EVIPDPAKQT
     DRVVKIAGIS AGILVFILLL LVVILIVKKR YICWRRHICI RNIRRSYYSY SYYLKLAKKR
     KDAMGNTRQE MTHMVNAMDR SYADQSTLHA EDPLSITFMD QHNFSPRLPN DPLVPTAVLV
     PITGRKNVYH GDNNSFFAIS YL
//
ID   Q5TG12_HUMAN            Unreviewed;      1458 AA.
AC   Q5TG12;
DT   21-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   21-DEC-2004, sequence version 1.
DT   28-FEB-2018, entry version 131.
DE   SubName: Full=Receptor-type tyrosine-protein phosphatase kappa {ECO:0000313|Ensembl:ENSP00000357193};
GN   Name=PTPRK {ECO:0000313|Ensembl:ENSP00000357193};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000357193, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000357193}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000313|Ensembl:ENSP00000357193}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5] {ECO:0000313|Ensembl:ENSP00000487066}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUN-2015) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000256|SAAS:SAAS00697399}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000357193}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC212491; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035465; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035470; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035594; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357621; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451073; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590006; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458278; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458282; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_011534317.1; XM_011536015.2.
DR   UniGene; Hs.155919; -.
DR   MaxQB; Q5TG12; -.
DR   PeptideAtlas; Q5TG12; -.
DR   Ensembl; ENST00000368210; ENSP00000357193; ENSG00000152894.
DR   Ensembl; ENST00000625760; ENSP00000487066; ENSG00000273993.
DR   GeneID; 5796; -.
DR   UCSC; uc010kfd.2; human.
DR   CTD; 5796; -.
DR   EuPathDB; HostDB:ENSG00000152894.14; -.
DR   HGNC; HGNC:9674; PTPRK.
DR   OpenTargets; ENSG00000152894; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00760000118900; -.
DR   HOVERGEN; HBG062785; -.
DR   ChiTaRS; PTPRK; human.
DR   GenomeRNAi; 5796; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000152894; -.
DR   ExpressionAtlas; Q5TG12; baseline and differential.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00629; MAM; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00137; MAM; 1.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Hydrolase {ECO:0000256|SAAS:SAAS00614364};
KW   Membrane {ECO:0000256|SAAS:SAAS00897767, ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS00614364};
KW   Proteomics identification {ECO:0000213|EPD:Q5TG12,
KW   ECO:0000213|MaxQB:Q5TG12, ECO:0000213|PeptideAtlas:Q5TG12};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28   1458       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5010140467.
FT   TRANSMEM    754    775       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       34    194       MAM. {ECO:0000259|PROSITE:PS50060}.
FT   DOMAIN      196    281       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      294    389       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      392    488       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      491    595       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      900   1160       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1080   1151       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   DOMAIN     1192   1454       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1368   1445       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   ACT_SITE   1101   1101       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
FT   ACT_SITE   1395   1395       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
SQ   SEQUENCE   1458 AA;  164203 MW;  2186B2C9AC4F628E CRC64;
     MDTTAAAALP AFVALLLLSP WPLLGSAQGQ FSAGGCTFDD GPGACDYHQD LYDDFEWVHV
     SAQEPHYLPP EMPQGSYMIV DSSDHDPGEK ARLQLPTMKE NDTHCIDFSY LLYSQKGLNP
     GTLNILVRVN KGPLANPIWN VTGFTGRDWL RAELAVSTFW PNEYQVIFEA EVSGGRSGYI
     AIDDIQVLSY PCDKSPHFLR LGDVEVNAGQ NATFQCIATG RDAVHNKLWL QRRNGEDIPV
     AQTKNINHRR FAASFRLQEV TKTDQDLYRC VTQSERGSGV SNFAQLIVRE PPRPIAPPQL
     LGVGPTYLLI QLNANSIIGD GPIILKEVEY RMTSGSWTET HAVNAPTYKL WHLDPDTEYE
     IRVLLTRPGE GGTGLPGPPL ITRTKCAEPM RTPKTLKIAE IQARRIAVDW ESLGYNITRC
     HTFNVTICYH YFRGHNESKA DCLDMDPKAP QHVVNHLPPY TNVSLKMILT NPEGRKESEE
     TIIQTDEDVP GPVPVKSLQG TSFENKIFLN WKEPLDPNGI ITQYEISYSS IRSFDPAVPV
     AGPPQTVSNL WNSTHHVFMH LHPGTTYQFF IRASTVKGFG PATAINVTTN ISAPTLPDYE
     GVDASLNETA TTITVLLRPA QAKGAPISAY QIVVEELHPH RTKREAGAME CYQVPVTYQN
     AMSGGAPYYF AAELPPGNLP EPAPFTVGDN RTYQGFWNPP LAPRKGYNIY FQAMSSVEKE
     TKTQCVRIAT KAAATEEPEV IPDPAKQTDR VVKIAGISAG ILVFILLLLV VILIVKKSKL
     AKKRKDAMGN TRQEMTHMVN AMDRSYADQS TLHAEDPLSI TFMDQHNFSP RLPNDPLVPT
     AVLDENHSAT AESSRLLDVP RYLCEGTESP YQTGQLHPAI RVADLLQHIN LMKTSDSYGF
     KEEYESFFEG QSASWDVAKK DQNRAKNRYG NIIAYDHSRV ILQPVEDDPS SDYINANYID
     IWLYRDGYQR PSHYIATQGP VHETVYDFWR MIWQEQSACI VMVTNLVEVG RVKCYKYWPD
     DTEVYGDFKV TCVEMEPLAE YVVRTFTLER RGYNEIREVK QFHFTGWPDH GVPYHATGLL
     SFIRRVKLSN PPSAGPIVVH CSAGAGRTGC YIVIDIMLDM AEREGVVDIY NCVKALRSRR
     INMVQTEEQY IFIHDAILEA CLCGETAIPV CEFKAAYFDM IRIDSQTNSS HLKDEFQTLN
     SVTPRLQAED CSIACLPRNH DKNRFMDMLP PDRCLPFLIT IDGESSNYIN AALMDSYRQP
     AAFIVTQYPL PNTVKDFWRL VYDYGCTSIV MLNEVDLSQG CPQYWPEEGM LRYGPIQVEC
     MSCSMDCDVI NRIFRICNLT RPQEGYLMVQ QFQYLGWASH REVPGSKRSF LKLILQVEKW
     QEECEEGEGR TIIHCLNGGG RSGMFCAIGI VVEMVKRQNV VDVFHAVKTL RNSKPNMVEA
     PEQYRFCYDV ALEYLESS
//
ID   Q86WJ2_HUMAN            Unreviewed;      1440 AA.
AC   Q86WJ2;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   28-FEB-2018, entry version 112.
DE   SubName: Full=Mutant receptor type protein tyrosine phosphatase K {ECO:0000313|EMBL:AAO49502.1};
DE            EC=3.1.3.48 {ECO:0000313|EMBL:AAO49502.1};
GN   Name=PTPRK {ECO:0000313|EMBL:AAO49502.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAO49502.1};
RN   [1] {ECO:0000313|EMBL:AAO49502.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Melanoma {ECO:0000313|EMBL:AAO49502.1};
RX   PubMed=12794170;
RA   Novellino L., Renkvist N., Rini F., Mazzocchi A., Rivoltini L.,
RA   Greco A., Deho P., Squarcina P., Robbins P.F., Parmiani G.,
RA   Castelli C.;
RT   "Identification of a mutated receptor-like protein tyrosine
RT   phosphatase kappa as a novel, class II HLA-restricted melanoma
RT   antigen.";
RL   J. Immunol. 170:6363-6370(2003).
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000256|SAAS:SAAS00697399}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF533875; AAO49502.1; -; mRNA.
DR   RefSeq; NP_002835.2; NM_002844.3.
DR   UniGene; Hs.155919; -.
DR   ProteinModelPortal; Q86WJ2; -.
DR   PRIDE; Q86WJ2; -.
DR   DNASU; 5796; -.
DR   GeneID; 5796; -.
DR   CTD; 5796; -.
DR   PharmGKB; PA34019; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   HOVERGEN; HBG062785; -.
DR   ChiTaRS; PTPRK; human.
DR   GenomeRNAi; 5796; -.
DR   Genevisible; Q86WJ2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00629; MAM; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00137; MAM; 1.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000256|SAAS:SAAS00614364};
KW   Membrane {ECO:0000256|SAAS:SAAS00897767, ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS00614364};
KW   Receptor {ECO:0000313|EMBL:AAO49502.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28   1440       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004304137.
FT   TRANSMEM    754    775       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       34    194       MAM. {ECO:0000259|PROSITE:PS50060}.
FT   DOMAIN      196    281       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      294    389       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      392    488       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      491    595       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      888   1142       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1062   1133       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   DOMAIN     1174   1436       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1350   1427       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   ACT_SITE   1083   1083       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
FT   ACT_SITE   1377   1377       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
SQ   SEQUENCE   1440 AA;  162272 MW;  B140BC621878586A CRC64;
     MDTTAAAALP AFVALLLLSP WPLLGSAQGQ FSAGGCTFDD GPGACDYHQD LYDDFEWVHV
     SAQEPHYLPP EMPQGSYMIV DSSDHDPGEK ARLQLPTMKE NDTHCIDFSY LLYSQKGLNP
     GTLNILVRVN KGPLANPIWN VTGFTGRDWL RAELAVSTFW PNEYQVIFEA EVSGGRSGYI
     AIDDIQVLSY PCDKSPHFLR LGDVEVNAGQ NATFQCIATG RDAVHNKLWL QRRNGEDIPV
     AQTKNINHRR FAASFRLQEV TKTDQDLYRC VTQSERGSGV SNFAQLIVRE PPRPIAPPQL
     LGVGPTYLLI QLNANSIIGD GPIILKEVEY RMTSGSWTET HAVNAPTYKL WHLDPDTEYE
     IRVLLTRPGE GGTGLPGPPL ITRTKCAEPM RTPKTLKIAE IQARRIAVDW ESLGYNITRC
     HTFNVTICYH YFRGHNESKA DCLDMDPKAP QHVVNHLPPY TNVSLKMILT NPEGRKESEE
     TIIQTDEDVP GPVPVKSLQG TSFENKIFLN WKEPLDPNGI ITQYEISYSS IRSFDPAVPV
     AGPPQTVSNL WNSTHHVFMH LHPGTTYQFF IRASTVKGFG PATAINVTTN ISAPTLPDYE
     GVDASLNETA TTITVLLRPA QAKGAPISAY QIVVEELHPH RTKREAGAME CYQVPVTYQN
     AMSGGAPYYF AAELPPRNLP EPAPFTVGDN RTYQGFWNPP LAPRKGYNIY FQAMSSVEKE
     TKTQCVRIAT KAAATEEPEV IPDPAKQTDR VVKIAGISAG ILVFILLLLV VILIVKKSKL
     AKKRKDAMGN TRQEMTHMVN AMDRSYADQS TLHAEDPLSI TFMDQHNFSP RYENHSATAE
     SSRLLDVPRY LCEGTESPYQ TGQLHPAIRV ADLLQHINLM KTSDSYGFKE EYESFFEGQS
     ASWDVAKKDQ NRAKNRYGNI IAYDHSRVIL QPVEDDPSSD YINANYIDGY QRPSHYIATQ
     GPVHETVYDF WRMIWQEQSA CIVMVTNLVE VGRVKCYKYW PDDTEVYGDF KVTCVEMEPL
     AEYVVRTFTL ERRGYNEIRE VKQFHFTGWP DHGVPYHATG LLSFIRRVKL SNPPSAGPIV
     VHCSAGAGRT GCYIVIDIML DMAEREGVVD IYNCVKALRS RRINMVQTEE QYIFIHDAIL
     EACLCGETAI PVCEFKAAYF DMIRIDSQTN SSHLKDEFQT LNSVTPRLQA EDCSIACLPR
     NHDKNRFMDM LPPDRCLPFL ITIDGESSNY INAALMDSYR QPAAFIVTQY PLPNTVKDFW
     RLVYDYGCTS IVMLNEVDLS QGCPQYWPEE GMLRYGPIQV ECMSCSMDCD VINRIFRICN
     LTRPQEGYLM VQQFQYLGWA SHREVPGSKR SFLKLILQVE KWQEECEEGE GRTIIHCLNG
     GGRSGMFCAI GIVVEMVKRQ NVVDVFHAVK TLRNSKPNMV EAPEQYRFCY DVALEYLESS
//
ID   A0A024R656_HUMAN        Unreviewed;       350 AA.
AC   A0A024R656;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 30.
DE   SubName: Full=RAD51-like 1 (S. cerevisiae), isoform CRA_a {ECO:0000313|EMBL:EAW80958.1};
GN   Name=RAD51L1 {ECO:0000313|EMBL:EAW80958.1};
GN   ORFNames=hCG_2036537 {ECO:0000313|EMBL:EAW80958.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW80958.1};
RN   [1] {ECO:0000313|EMBL:EAW80958.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW80958.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471061; EAW80958.1; -; Genomic_DNA.
DR   RefSeq; NP_002868.1; NM_002877.5.
DR   UniGene; Hs.172587; -.
DR   ProteinModelPortal; A0A024R656; -.
DR   SMR; A0A024R656; -.
DR   PRIDE; A0A024R656; -.
DR   GeneID; 5890; -.
DR   CTD; 5890; -.
DR   eggNOG; KOG1433; Eukaryota.
DR   eggNOG; COG0468; LUCA.
DR   ChiTaRS; RAD51B; human.
DR   GenomeRNAi; 5890; -.
DR   GO; GO:0033063; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0008094; F:DNA-dependent ATPase activity; IEA:InterPro.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IEA:InterPro.
DR   CDD; cd01123; Rad51_DMC1_radA; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR013632; DNA_recomb/repair_Rad51_C.
DR   InterPro; IPR016467; DNA_recomb/repair_RecA-like.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033925; Rad51_DMC1_RadA.
DR   InterPro; IPR030548; RAD51B.
DR   InterPro; IPR020588; RecA_ATP-bd.
DR   PANTHER; PTHR22942:SF15; PTHR22942:SF15; 1.
DR   Pfam; PF08423; Rad51; 1.
DR   PIRSF; PIRSF005856; Rad51; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50162; RECA_2; 1.
PE   4: Predicted;
FT   DOMAIN       79    259       RECA_2. {ECO:0000259|PROSITE:PS50162}.
SQ   SEQUENCE   350 AA;  38257 MW;  CEA992DDC394F3B0 CRC64;
     MGSKKLKRVG LSQELCDRLS RHQILTCQDF LCLSPLELMK VTGLSYRGVH ELLCMVSRAC
     APKMQTAYGI KAQRSADFSP AFLSTTLSAL DEALHGGVAC GSLTEITGPP GCGKTQFCIM
     MSILATLPTN MGGLEGAVVY IDTESAFSAE RLVEIAESRF PRYFNTEEKL LLTSSKVHLY
     RELTCDEVLQ RIESLEEEII SKGIKLVILD SVASVVRKEF DAQLQGNLKE RNKFLAREAS
     SLKYLAEEFS IPVILTNQIT THLSGALASQ ADLVSPADDL SLSEGTSGSS CVIAALGNTW
     SHSVNTRLIL QYLDSERRQI LIAKSPLAPF TSFVYTIKEE GLVLQAYGNS
//
ID   C9JYJ0_HUMAN            Unreviewed;       425 AA.
AC   C9JYJ0;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   03-NOV-2009, sequence version 1.
DT   31-JAN-2018, entry version 62.
DE   SubName: Full=DNA repair protein RAD51 homolog 2 {ECO:0000313|Ensembl:ENSP00000419881};
GN   Name=RAD51B {ECO:0000313|Ensembl:ENSP00000419881};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000419881, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000419881, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000419881}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000419881}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL121595; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133370; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877523; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455917; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455919; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455920; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001308750.1; NM_001321821.1.
DR   UniGene; Hs.172587; -.
DR   ProteinModelPortal; C9JYJ0; -.
DR   EPD; C9JYJ0; -.
DR   MaxQB; C9JYJ0; -.
DR   PRIDE; C9JYJ0; -.
DR   Ensembl; ENST00000487861; ENSP00000419881; ENSG00000182185.
DR   GeneID; 5890; -.
DR   UCSC; uc059csa.1; human.
DR   CTD; 5890; -.
DR   EuPathDB; HostDB:ENSG00000182185.18; -.
DR   HGNC; HGNC:9822; RAD51B.
DR   OpenTargets; ENSG00000182185; -.
DR   GeneTree; ENSGT00860000133731; -.
DR   HOGENOM; HOG000154062; -.
DR   OrthoDB; EOG091G0G6V; -.
DR   PhylomeDB; C9JYJ0; -.
DR   ChiTaRS; RAD51B; human.
DR   GenomeRNAi; 5890; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000182185; -.
DR   ExpressionAtlas; C9JYJ0; baseline and differential.
DR   GO; GO:0033063; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0008094; F:DNA-dependent ATPase activity; IEA:InterPro.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IEA:InterPro.
DR   CDD; cd01123; Rad51_DMC1_radA; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR013632; DNA_recomb/repair_Rad51_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033925; Rad51_DMC1_RadA.
DR   InterPro; IPR030548; RAD51B.
DR   InterPro; IPR020588; RecA_ATP-bd.
DR   PANTHER; PTHR22942:SF15; PTHR22942:SF15; 1.
DR   Pfam; PF08423; Rad51; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50162; RECA_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:C9JYJ0,
KW   ECO:0000213|MaxQB:C9JYJ0, ECO:0000213|PeptideAtlas:C9JYJ0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       79    259       RECA_2. {ECO:0000259|PROSITE:PS50162}.
SQ   SEQUENCE   425 AA;  46546 MW;  833D0DC6C1A383C4 CRC64;
     MGSKKLKRVG LSQELCDRLS RHQILTCQDF LCLSPLELMK VTGLSYRGVH ELLCMVSRAC
     APKMQTAYGI KAQRSADFSP AFLSTTLSAL DEALHGGVAC GSLTEITGPP GCGKTQFCIM
     MSILATLPTN MGGLEGAVVY IDTESAFSAE RLVEIAESRF PRYFNTEEKL LLTSSKVHLY
     RELTCDEVLQ RIESLEEEII SKGIKLVILD SVASVVRKEF DAQLQGNLKE RNKFLAREAS
     SLKYLAEEFS IPVILTNQIT THLSGALASQ ADLVSPADDL SLSEGTSGSS CVIAALGNTW
     SHSVNTRLIL QYLDSERRQI LIAKSPLAPF TSFVYTIKEE GLVLQVVRTV ARVSPRSECW
     SAADSHPSPT FLIPDVVLRK TRNPRLLPSV SMCPPQMHST VLSSALPPTN WATGIRTETL
     DEHPV
//
ID   RA51B_HUMAN             Reviewed;         384 AA.
AC   O15315; O60914; O75210; Q3Y4F8; Q6FHX8; Q86SY3; Q86SY4; Q86TR0;
AC   Q86U92; Q86U93; Q86U94; Q8N6H4; Q9UPL5;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-NOV-2003, sequence version 2.
DT   28-FEB-2018, entry version 158.
DE   RecName: Full=DNA repair protein RAD51 homolog 2;
DE            Short=R51H2;
DE   AltName: Full=RAD51 homolog B;
DE            Short=Rad51B;
DE   AltName: Full=RAD51-like protein 1;
GN   Name=RAD51B; Synonyms=RAD51L1, REC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9207106; DOI=10.1073/pnas.94.14.7417;
RA   Rice M.C., Smith S.T., Bullrich F., Havre P., Kmiec E.B.;
RT   "Isolation of human and mouse genes based on homology to REC2, a
RT   recombinational repair gene from the fungus Ustilago maydis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7417-7422(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9441753; DOI=10.1006/geno.1997.5062;
RA   Albala J.S., Thelen M.P., Prange C.K., Fan W., Christensen M.,
RA   Thompson L.H., Lennon G.G.;
RT   "Identification of a novel human RAD51 homolog, RAD51B.";
RL   Genomics 46:476-479(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=9512535; DOI=10.1093/nar/26.7.1653;
RA   Cartwright R., Dunn A.M., Simpson P.J., Tambini C.E., Thacker J.;
RT   "Isolation of novel human and mouse genes of the recA/RAD51
RT   recombination-repair gene family.";
RL   Nucleic Acids Res. 26:1653-1659(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 4 AND 5).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MET-9; CYS-82;
RP   TRP-172; CYS-180; ARG-243 AND ALA-250.
RG   NIEHS SNPs program;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 253-310, AND CHROMOSOMAL TRANSLOCATION
RP   WITH HMGA2.
RX   PubMed=12649198;
RA   Quade B.J., Weremowicz S., Neskey D.M., Vanni R., Ladd C., Dal Cin P.,
RA   Morton C.C.;
RT   "Fusion transcripts involving HMGA2 are not a common molecular
RT   mechanism in uterine leiomyomata with rearrangements in 12q15.";
RL   Cancer Res. 63:1351-1358(2003).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE BCDX2 COMPLEX WITH RAD51C; RAD51D
RP   AND XRCC2.
RX   PubMed=11751635; DOI=10.1101/gad.947001;
RA   Masson J.Y., Tarsounas M.C., Stasiak A.Z., Stasiak A., Shah R.,
RA   McIlwraith M.J., Benson F.E., West S.C.;
RT   "Identification and purification of two distinct complexes containing
RT   the five RAD51 paralogs.";
RL   Genes Dev. 15:3296-3307(2001).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH RAD51C.
RX   PubMed=11751636; DOI=10.1101/gad.935501;
RA   Sigurdsson S., Van Komen S., Bussen W., Schild D., Albala J.S.,
RA   Sung P.;
RT   "Mediator function of the human Rad51B-Rad51C complex in Rad51/RPA-
RT   catalyzed DNA strand exchange.";
RL   Genes Dev. 15:3308-3318(2001).
RN   [13]
RP   FUNCTION, AND IDENTIFICATION IN A COMPLEX WITH RAD51C; RAD51D AND
RP   XRCC2.
RX   PubMed=11842113; DOI=10.1093/nar/30.4.1009;
RA   Liu N., Schild D., Thelen M.P., Thompson L.H.;
RT   "Involvement of Rad51C in two distinct protein complexes of Rad51
RT   paralogs in human cells.";
RL   Nucleic Acids Res. 30:1009-1015(2002).
RN   [14]
RP   INTERACTION WITH RAD51C, AND SUBUNIT.
RX   PubMed=11744692; DOI=10.1074/jbc.M108306200;
RA   Miller K.A., Yoshikawa D.M., McConnell I.R., Clark R., Schild D.,
RA   Albala J.S.;
RT   "RAD51C interacts with RAD51B and is central to a larger protein
RT   complex in vivo exclusive of RAD51.";
RL   J. Biol. Chem. 277:8406-8411(2002).
RN   [15]
RP   IDENTIFICATION IN A COMPLEX WITH RAD51C; RAD51D AND XRCC2.
RX   PubMed=11842112; DOI=10.1093/nar/30.4.1001;
RA   Wiese C., Collins D.W., Albala J.S., Thompson L.H., Kronenberg A.,
RA   Schild D.;
RT   "Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human
RT   cells.";
RL   Nucleic Acids Res. 30:1001-1008(2002).
RN   [16]
RP   INTERACTION WITH RAD51 AND RAD51C.
RX   PubMed=12427746; DOI=10.1074/jbc.M211038200;
RA   Lio Y.-C., Mazin A.V., Kowalczykowski S.C., Chen D.J.;
RT   "Complex formation by the human Rad51B and Rad51C DNA repair proteins
RT   and their activities in vitro.";
RL   J. Biol. Chem. 278:2469-2478(2003).
RN   [17]
RP   CHROMOSOMAL TRANSLOCATION WITH HMGA2.
RX   PubMed=9892177;
RA   Schoenmakers E.F.P.M., Huysmans C., Van de Ven W.J.M.;
RT   "Allelic knockout of novel splice variants of human recombination
RT   repair gene RAD51B in t(12;14) uterine leiomyomas.";
RL   Cancer Res. 59:19-23(1999).
RN   [18]
RP   CHROMOSOMAL TRANSLOCATION WITH HMGA1.
RX   PubMed=11978964;
RA   Blank C., Schoenmakers E.F.P.M., Rogalla P., Huys E.H., van Rijk A.A.,
RA   Drieschner N., Bullerdiek J.;
RT   "Intragenic breakpoint within RAD51L1 in a t(6;14)(p21.3;q24) of a
RT   pulmonary chondroid hamartoma.";
RL   Cytogenet. Cell Genet. 95:17-19(2001).
RN   [19]
RP   FUNCTION.
RX   PubMed=12441335; DOI=10.1074/jbc.M210899200;
RA   Yokoyama H., Kurumizaka H., Ikawa S., Yokoyama S., Shibata T.;
RT   "Holliday junction binding activity of the human Rad51B protein.";
RL   J. Biol. Chem. 278:2767-2772(2003).
RN   [20]
RP   INTERACTION WITH RAD51C.
RX   PubMed=14704354; DOI=10.1093/nar/gkg925;
RA   Miller K.A., Sawicka D., Barsky D., Albala J.S.;
RT   "Domain mapping of the Rad51 paralog protein complexes.";
RL   Nucleic Acids Res. 32:169-178(2004).
RN   [21]
RP   PHOSPHORYLATION BY BCR-ABL, AND MUTAGENESIS OF PRO-326.
RX   PubMed=19657362; DOI=10.1038/leu.2009.164;
RA   Slupianek A., Jozwiakowski S.K., Gurdek E., Skorski T.;
RT   "BCR/ABL kinase interacts with and phosphorylates the RAD51 paralog,
RT   RAD51B.";
RL   Leukemia 23:2308-2310(2009).
RN   [22]
RP   INTERACTION WITH SWSAP1.
RX   PubMed=21965664; DOI=10.1074/jbc.M111.271080;
RA   Liu T., Wan L., Wu Y., Chen J., Huang J.;
RT   "hSWS1.SWSAP1 is an evolutionarily conserved complex required for
RT   efficient homologous recombination repair.";
RL   J. Biol. Chem. 286:41758-41766(2011).
RN   [23]
RP   FUNCTION IN MITOTIC CELL PROGRESSION.
RX   PubMed=23108668; DOI=10.1242/jcs.114595;
RA   Rodrigue A., Coulombe Y., Jacquet K., Gagne J.P., Roques C.,
RA   Gobeil S., Poirier G., Masson J.Y.;
RT   "The RAD51 paralogs ensure cellular protection against mitotic defects
RT   and aneuploidy.";
RL   J. Cell Sci. 126:348-359(2013).
RN   [24]
RP   FUNCTION OF THE BCDX2 COMPLEX.
RX   PubMed=23149936; DOI=10.1128/MCB.00465-12;
RA   Chun J., Buechelmaier E.S., Powell S.N.;
RT   "Rad51 paralog complexes BCDX2 and CX3 act at different stages in the
RT   BRCA1-BRCA2-dependent homologous recombination pathway.";
RL   Mol. Cell. Biol. 33:387-395(2013).
RN   [25]
RP   ELECTRON MICROSCOPY OF THE BCDX2 COMPLEX, AND DNA-BINDING OF THE BCDX2
RP   COMPLEX.
RX   PubMed=20207730; DOI=10.1074/jbc.M109.074286;
RA   Compton S.A., Ozgur S., Griffith J.D.;
RT   "Ring-shaped Rad51 paralog protein complexes bind Holliday junctions
RT   and replication forks as visualized by electron microscopy.";
RL   J. Biol. Chem. 285:13349-13356(2010).
CC   -!- FUNCTION: Involved in the homologous recombination repair (HRR)
CC       pathway of double-stranded DNA breaks arising during DNA
CC       replication or induced by DNA-damaging agents. May promote the
CC       assembly of presynaptic RAD51 nucleoprotein filaments. Binds
CC       single-stranded DNA and double-stranded DNA and has DNA-dependent
CC       ATPase activity. Part of the RAD21 paralog protein complex BCDX2
CC       which acts in the BRCA1-BRCA2-dependent HR pathway. Upon DNA
CC       damage, BCDX2 acts downstream of BRCA2 recruitment and upstream of
CC       RAD51 recruitment. BCDX2 binds predominantly to the intersection
CC       of the four duplex arms of the Holliday junction and to junction
CC       of replication forks. The BCDX2 complex was originally reported to
CC       bind single-stranded DNA, single-stranded gaps in duplex DNA and
CC       specifically to nicks in duplex DNA. The BCDX2 subcomplex
CC       RAD51B:RAD51C exhibits single-stranded DNA-dependent ATPase
CC       activity suggesting an involvement in early stages of the HR
CC       pathway. {ECO:0000269|PubMed:11751635,
CC       ECO:0000269|PubMed:11751636, ECO:0000269|PubMed:11842113,
CC       ECO:0000269|PubMed:12441335, ECO:0000269|PubMed:23108668,
CC       ECO:0000269|PubMed:23149936}.
CC   -!- SUBUNIT: Part of the BCDX2 complex consisting of RAD51B, RAD51C,
CC       RAD51D and XRCC2; the complex has a ring-like structure arranged
CC       into a flat disc around a central channel. The BCDX2 subcomplex
CC       RAD51B:RAD51C interacts with RAD51. Interacts with SWSAP1;
CC       involved in homologous recombination repair.
CC       {ECO:0000269|PubMed:11744692, ECO:0000269|PubMed:11751635,
CC       ECO:0000269|PubMed:11751636, ECO:0000269|PubMed:11842112,
CC       ECO:0000269|PubMed:11842113, ECO:0000269|PubMed:12427746,
CC       ECO:0000269|PubMed:14704354, ECO:0000269|PubMed:21965664}.
CC   -!- INTERACTION:
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-2824089, EBI-10175124;
CC       O43502:RAD51C; NbExp=10; IntAct=EBI-2824089, EBI-2267048;
CC       O75771:RAD51D; NbExp=5; IntAct=EBI-2824089, EBI-1055693;
CC       Q6NVH7:SWSAP1; NbExp=2; IntAct=EBI-2824089, EBI-5281637;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O15315-3; Sequence=Displayed;
CC       Name=2; Synonyms=RAD51L1a;
CC         IsoId=O15315-1; Sequence=VSP_008819;
CC       Name=3; Synonyms=RAD51L1b;
CC         IsoId=O15315-2; Sequence=VSP_008818;
CC       Name=4;
CC         IsoId=O15315-4; Sequence=VSP_008820;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=O15315-5; Sequence=VSP_008817, VSP_008818;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in a wide range of tissues.
CC   -!- PTM: Phosphorylated on tyrosine residues by BCR-ALB.
CC       {ECO:0000269|PubMed:19657362}.
CC   -!- DISEASE: Note=A chromosomal aberration involving RAD51B is found
CC       in pulmonary chondroid hamartoma. Translocation t(6;14)(p21;q23-
CC       24) with HMGA1. {ECO:0000269|PubMed:11978964}.
CC   -!- DISEASE: Note=A chromosomal aberration involving RAD51B is found
CC       in uterine leiomyoma. Translocation t(12;14)(q15;q23-24) with
CC       HMGA2. {ECO:0000269|PubMed:12649198, ECO:0000269|PubMed:9892177}.
CC   -!- SIMILARITY: Belongs to the RecA family. RAD51 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD62357.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAD66573.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/rad51l1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U92074; AAB63358.1; -; mRNA.
DR   EMBL; U84138; AAC39723.1; -; mRNA.
DR   EMBL; Y15571; CAA75680.1; -; mRNA.
DR   EMBL; BX161515; CAD61950.1; -; mRNA.
DR   EMBL; BX248061; CAD62357.1; ALT_INIT; mRNA.
DR   EMBL; BX248766; CAD66573.1; ALT_INIT; mRNA.
DR   EMBL; DQ160197; AAZ85144.1; -; Genomic_DNA.
DR   EMBL; AC004518; AAC32426.1; -; Genomic_DNA.
DR   EMBL; AC004518; AAC32425.1; -; Genomic_DNA.
DR   EMBL; CR536560; CAG38797.1; -; mRNA.
DR   EMBL; CH471061; EAW80957.1; -; Genomic_DNA.
DR   EMBL; BC030219; AAH30219.1; -; mRNA.
DR   EMBL; AY138857; AAN60542.1; -; mRNA.
DR   EMBL; AY138858; AAN60543.1; -; mRNA.
DR   EMBL; AY138859; AAN60544.1; -; mRNA.
DR   CCDS; CCDS9789.1; -. [O15315-3]
DR   CCDS; CCDS9790.1; -. [O15315-2]
DR   RefSeq; NP_001308746.1; NM_001321817.1. [O15315-5]
DR   RefSeq; NP_002868.1; NM_002877.5. [O15315-1]
DR   RefSeq; NP_598193.2; NM_133509.3. [O15315-3]
DR   RefSeq; NP_598194.1; NM_133510.3. [O15315-2]
DR   UniGene; Hs.172587; -.
DR   ProteinModelPortal; O15315; -.
DR   SMR; O15315; -.
DR   BioGrid; 111827; 11.
DR   CORUM; O15315; -.
DR   DIP; DIP-41246N; -.
DR   IntAct; O15315; 11.
DR   MINT; O15315; -.
DR   STRING; 9606.ENSP00000419471; -.
DR   iPTMnet; O15315; -.
DR   PhosphoSitePlus; O15315; -.
DR   BioMuta; RAD51B; -.
DR   PaxDb; O15315; -.
DR   PeptideAtlas; O15315; -.
DR   PRIDE; O15315; -.
DR   TopDownProteomics; O15315-2; -. [O15315-2]
DR   DNASU; 5890; -.
DR   Ensembl; ENST00000471583; ENSP00000418859; ENSG00000182185. [O15315-2]
DR   Ensembl; ENST00000487270; ENSP00000419471; ENSG00000182185. [O15315-3]
DR   Ensembl; ENST00000488612; ENSP00000420061; ENSG00000182185. [O15315-4]
DR   GeneID; 5890; -.
DR   KEGG; hsa:5890; -.
DR   UCSC; uc001xkd.4; human. [O15315-3]
DR   CTD; 5890; -.
DR   DisGeNET; 5890; -.
DR   EuPathDB; HostDB:ENSG00000182185.18; -.
DR   GeneCards; RAD51B; -.
DR   H-InvDB; HIX0022466; -.
DR   HGNC; HGNC:9822; RAD51B.
DR   HPA; CAB016191; -.
DR   HPA; HPA051869; -.
DR   MIM; 150699; phenotype.
DR   MIM; 602948; gene.
DR   neXtProt; NX_O15315; -.
DR   OpenTargets; ENSG00000182185; -.
DR   PharmGKB; PA34178; -.
DR   eggNOG; KOG1433; Eukaryota.
DR   eggNOG; COG0468; LUCA.
DR   GeneTree; ENSGT00860000133731; -.
DR   HOVERGEN; HBG061476; -.
DR   InParanoid; O15315; -.
DR   KO; K10869; -.
DR   OMA; RKEFDTQ; -.
DR   PhylomeDB; O15315; -.
DR   TreeFam; TF101219; -.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5693554; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA).
DR   Reactome; R-HSA-5693568; Resolution of D-loop Structures through Holliday Junction Intermediates.
DR   Reactome; R-HSA-5693579; Homologous DNA Pairing and Strand Exchange.
DR   Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SIGNOR; O15315; -.
DR   ChiTaRS; RAD51B; human.
DR   GeneWiki; RAD51L1; -.
DR   GenomeRNAi; 5890; -.
DR   PRO; PR:O15315; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000182185; -.
DR   ExpressionAtlas; O15315; baseline and differential.
DR   Genevisible; O15315; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0033063; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; IDA:UniProtKB.
DR   GO; GO:0005657; C:replication fork; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0000150; F:recombinase activity; IBA:GO_Central.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0006310; P:DNA recombination; TAS:ProtInc.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0000731; P:DNA synthesis involved in DNA repair; TAS:Reactome.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB.
DR   GO; GO:0000707; P:meiotic DNA recombinase assembly; IBA:GO_Central.
DR   GO; GO:0006312; P:mitotic recombination; IBA:GO_Central.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc.
DR   GO; GO:0010212; P:response to ionizing radiation; IBA:GO_Central.
DR   GO; GO:0000732; P:strand displacement; TAS:Reactome.
DR   GO; GO:0042148; P:strand invasion; IBA:GO_Central.
DR   CDD; cd01123; Rad51_DMC1_radA; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR013632; DNA_recomb/repair_Rad51_C.
DR   InterPro; IPR016467; DNA_recomb/repair_RecA-like.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033925; Rad51_DMC1_RadA.
DR   InterPro; IPR030548; RAD51B.
DR   InterPro; IPR020588; RecA_ATP-bd.
DR   PANTHER; PTHR22942:SF15; PTHR22942:SF15; 1.
DR   Pfam; PF08423; Rad51; 1.
DR   PIRSF; PIRSF005856; Rad51; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50162; RECA_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Chromosomal rearrangement;
KW   Complete proteome; DNA damage; DNA recombination; DNA repair;
KW   DNA-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    384       DNA repair protein RAD51 homolog 2.
FT                                /FTId=PRO_0000122939.
FT   NP_BIND     108    115       ATP. {ECO:0000255}.
FT   REGION        1     75       Interaction with RAD51C.
FT   SITE        252    253       Breakpoint for translocation to form
FT                                HMGA2-RAD51B.
FT   VAR_SEQ       1    119       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_008817.
FT   VAR_SEQ     346    384       ETTFCSVTQAELNWAPEILPPQPPEQLGLQMCHHTQLIF
FT                                -> AYGNS (in isoform 2).
FT                                {ECO:0000303|PubMed:9207106,
FT                                ECO:0000303|PubMed:9441753,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_008819.
FT   VAR_SEQ     346    384       ETTFCSVTQAELNWAPEILPPQPPEQLGLQMCHHTQLIF
FT                                -> GQEKP (in isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:9512535,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_008818.
FT   VAR_SEQ     347    384       TTFCSVTQAELNWAPEILPPQPPEQLGLQMCHHTQLIF ->
FT                                FWHICISGFSIQNRLKENES (in isoform 4).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_008820.
FT   VARIANT       9      9       V -> M (in dbSNP:rs34583846).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025243.
FT   VARIANT      82     82       F -> C (in dbSNP:rs35282642).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025244.
FT   VARIANT     172    172       L -> W (in dbSNP:rs34094401).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025245.
FT   VARIANT     180    180       Y -> C (in dbSNP:rs28910275).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025246.
FT   VARIANT     207    207       V -> L (in dbSNP:rs28908168).
FT                                /FTId=VAR_035437.
FT   VARIANT     243    243       K -> R (in dbSNP:rs34594234).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025247.
FT   VARIANT     250    250       S -> A (in dbSNP:rs33929366).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025248.
FT   VARIANT     365    365       P -> R (in dbSNP:rs28908468).
FT                                /FTId=VAR_051730.
FT   MUTAGEN     326    326       P->L: Abolishes interaction with BCR-ABL
FT                                SH3 domain.
FT                                {ECO:0000269|PubMed:19657362}.
FT   CONFLICT    281    281       S -> P (in Ref. 9; AAN60542/AAN60543/
FT                                AAN60544). {ECO:0000305}.
SQ   SEQUENCE   384 AA;  42196 MW;  DB0B9AE82F44A52B CRC64;
     MGSKKLKRVG LSQELCDRLS RHQILTCQDF LCLSPLELMK VTGLSYRGVH ELLCMVSRAC
     APKMQTAYGI KAQRSADFSP AFLSTTLSAL DEALHGGVAC GSLTEITGPP GCGKTQFCIM
     MSILATLPTN MGGLEGAVVY IDTESAFSAE RLVEIAESRF PRYFNTEEKL LLTSSKVHLY
     RELTCDEVLQ RIESLEEEII SKGIKLVILD SVASVVRKEF DAQLQGNLKE RNKFLAREAS
     SLKYLAEEFS IPVILTNQIT THLSGALASQ ADLVSPADDL SLSEGTSGSS CVIAALGNTW
     SHSVNTRLIL QYLDSERRQI LIAKSPLAPF TSFVYTIKEE GLVLQETTFC SVTQAELNWA
     PEILPPQPPE QLGLQMCHHT QLIF
//
ID   RBP2_HUMAN              Reviewed;        3224 AA.
AC   P49792; Q13074; Q15280; Q53TE2; Q59FH7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   28-FEB-2018, entry version 205.
DE   RecName: Full=E3 SUMO-protein ligase RanBP2;
DE            EC=2.3.2.-;
DE   AltName: Full=358 kDa nucleoporin;
DE   AltName: Full=E3 SUMO-protein transferase RanBP2 {ECO:0000305};
DE   AltName: Full=Nuclear pore complex protein Nup358;
DE   AltName: Full=Nucleoporin Nup358;
DE   AltName: Full=Ran-binding protein 2;
DE            Short=RanBP2;
DE   AltName: Full=p270;
GN   Name=RANBP2; Synonyms=NUP358;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND SUBCELLULAR LOCATION.
RX   PubMed=7775481; DOI=10.1074/jbc.270.23.14209;
RA   Wu J., Matunis M.J., Kraemer D., Blobel G., Coutavas E.;
RT   "Nup358, a cytoplasmically exposed nucleoporin with peptide repeats,
RT   Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous
RT   domain, and a leucine-rich region.";
RL   J. Biol. Chem. 270:14209-14213(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT LYS-784, AND SUBCELLULAR LOCATION.
RC   TISSUE=Blood;
RX   PubMed=7603572; DOI=10.1038/376184a0;
RA   Yokoyama N., Hayashi N., Seki T., Nishii K., Hayashida T., Kuma K.,
RA   Miyata T., Fukui M., Nishimoto T., Pante N., Aebi U.;
RT   "A giant nucleopore protein that binds Ran/TC4.";
RL   Nature 376:184-188(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 87-3224.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2205-2546.
RC   TISSUE=Hippocampus;
RX   PubMed=7724562; DOI=10.1073/pnas.92.8.3328;
RA   Beddow A.L., Richards S.A., Orem N.R., Macara I.G.;
RT   "The Ran/TC4 GTPase-binding domain: identification by expression
RT   cloning and characterization of a conserved sequence motif.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:3328-3332(1995).
RN   [6]
RP   FUNCTION, AND SUMOYLATION.
RX   PubMed=11792325; DOI=10.1016/S0092-8674(01)00633-X;
RA   Pichler A., Gast A., Seeler J.S., Dejean A., Melchior F.;
RT   "The nucleoporin RanBP2 has SUMO1 E3 ligase activity.";
RL   Cell 108:109-120(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=12032081; DOI=10.1093/emboj/21.11.2682;
RA   Kirsh O., Seeler J.-S., Pichler A., Gast A., Mueller S., Miska E.,
RA   Mathieu M., Harel-Bellan A., Kouzarides T., Melchior F., Dejean A.;
RT   "The SUMO E3 ligase RanBP2 promotes modification of the HDAC4
RT   deacetylase.";
RL   EMBO J. 21:2682-2691(2002).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11839768; DOI=10.1083/jcb.200106046;
RA   Frosst P., Guan T., Subauste C., Hahn K., Gerace L.;
RT   "Tpr is localized within the nuclear basket of the pore complex and
RT   has a role in nuclear protein export.";
RL   J. Cell Biol. 156:617-630(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [10]
RP   FUNCTION, INTERACTION WITH UBE2I, SUMOYLATION AT LYS-2592, AND
RP   MUTAGENESIS OF PRO-2640; LYS-2645; LEU-2651; LYS-2652; LEU-2653;
RP   PRO-2654; PRO-2655; THR-2656; PHE-2657; PHE-2658; CYS-2659; ASP-2676;
RP   PHE-2677 AND TYR-2689.
RX   PubMed=15378033; DOI=10.1038/nsmb834;
RA   Pichler A., Knipscheer P., Saitoh H., Sixma T.K., Melchior F.;
RT   "The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type.";
RL   Nat. Struct. Mol. Biol. 11:984-991(2004).
RN   [11]
RP   INTERACTION WITH SUMOYLATED RANGAP1, AND MUTAGENESIS OF VAL-2632;
RP   ILE-2634 AND VAL-2635.
RX   PubMed=15388847; DOI=10.1073/pnas.0403498101;
RA   Song J., Durrin L.K., Wilkinson T.A., Krontiris T.G., Chen Y.;
RT   "Identification of a SUMO-binding motif that recognizes SUMO-modified
RT   proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:14373-14378(2004).
RN   [12]
RP   INTERACTION WITH SUMO1 AND UBE2I.
RX   PubMed=15608651; DOI=10.1038/nsmb878;
RA   Tatham M.H., Kim S., Jaffray E., Song J., Chen Y., Hay R.T.;
RT   "Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a
RT   mechanism for SUMO paralog selection.";
RL   Nat. Struct. Mol. Biol. 12:67-74(2005).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16620772; DOI=10.1016/j.abb.2006.03.002;
RA   Li T., Santockyte R., Shen R.-F., Tekle E., Wang G., Yang D.C.H.,
RA   Chock P.B.;
RT   "A general approach for investigating enzymatic pathways and
RT   substrates for ubiquitin-like modifiers.";
RL   Arch. Biochem. Biophys. 453:70-74(2006).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   INTERACTION WITH PRKN, AND UBIQUITINATION.
RX   PubMed=16332688; DOI=10.1074/jbc.M504994200;
RA   Um J.W., Min D.S., Rhim H., Kim J., Paik S.R., Chung K.C.;
RT   "Parkin ubiquitinates and promotes the degradation of RanBP2.";
RL   J. Biol. Chem. 281:3595-3603(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND THR-1144, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-21; SER-781;
RP   SER-948; SER-955; SER-1110; THR-1144; SER-1160; THR-1396; SER-1443;
RP   SER-1456; SER-1509; SER-1573; SER-1869; SER-2270; THR-2613; SER-2668;
RP   SER-2741; THR-2743 AND SER-2900, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   INTERACTION WITH CDCA8.
RX   PubMed=18946085; DOI=10.1091/mbc.E08-05-0511;
RA   Klein U.R., Haindl M., Nigg E.A., Muller S.;
RT   "RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-
RT   deconjugation cycle on Borealin.";
RL   Mol. Biol. Cell 20:410-418(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-21; SER-955;
RP   SER-1107; THR-1396; SER-1871; SER-2270; SER-2668 AND SER-2900, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [24]
RP   FUNCTION, INTERACTION WITH BICD2, AND SUBCELLULAR LOCATION.
RX   PubMed=20386726; DOI=10.1371/journal.pbio.1000350;
RA   Splinter D., Tanenbaum M.E., Lindqvist A., Jaarsma D., Flotho A.,
RA   Yu K.L., Grigoriev I., Engelsma D., Haasdijk E.D., Keijzer N.,
RA   Demmers J., Fornerod M., Melchior F., Hoogenraad C.C., Medema R.H.,
RA   Akhmanova A.;
RT   "Bicaudal D2, dynein, and kinesin-1 associate with nuclear pore
RT   complexes and regulate centrosome and nuclear positioning during
RT   mitotic entry.";
RL   PLoS Biol. 8:E1000350-E1000350(2010).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-21; SER-781;
RP   SER-837; SER-948; SER-955; SER-1110; SER-1160; THR-1412; SER-1509;
RP   SER-1835; SER-2900 AND SER-3207, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1160; SER-1456;
RP   SER-2668; SER-2900 AND SER-3207, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; THR-779; SER-781;
RP   SER-948; SER-955; THR-1098; SER-1103; SER-1107; SER-1110; THR-1144;
RP   SER-1160; SER-1249; THR-1396; THR-1412; SER-1450; SER-1456; SER-1509;
RP   SER-1520; SER-1573; SER-1833; SER-1835; SER-1869; SER-2270; SER-2526;
RP   THR-2613; TYR-2666; SER-2668; SER-2805 AND SER-3207, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-955; SER-1160; SER-1450;
RP   SER-1456; SER-1509; SER-2668 AND SER-2900, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-945 AND ARG-1016, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [31]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1414, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [32]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1605; LYS-1664; LYS-1723;
RP   LYS-2594 AND LYS-2792, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [33]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1414, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [34]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1414; LYS-1605; LYS-1664 AND
RP   LYS-1723, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [35]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1350; LYS-1414; LYS-1596;
RP   LYS-1605; LYS-1655; LYS-1664; LYS-1714; LYS-1723; LYS-2022; LYS-2522;
RP   LYS-2594; LYS-2612; LYS-2792 AND LYS-2815, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.96 ANGSTROMS) OF 1171-1304.
RX   PubMed=10078529; DOI=10.1038/17969;
RA   Vetter I.R., Nowak C., Nishimoto T., Kuhlmann J., Wittinghofer A.;
RT   "Structure of a Ran-binding domain complexed with Ran bound to a GTP
RT   analogue: implications for nuclear transport.";
RL   Nature 398:39-46(1999).
RN   [37]
RP   STRUCTURE BY NMR OF 2028-2154.
RX   PubMed=15826666; DOI=10.1016/j.jmb.2005.02.033;
RA   Geyer J.P., Doker R., Kremer W., Zhao X., Kuhlmann J., Kalbitzer H.R.;
RT   "Solution structure of the Ran-binding domain 2 of RanBP2 and its
RT   interaction with the C terminus of Ran.";
RL   J. Mol. Biol. 348:711-725(2005).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (3.01 ANGSTROMS) OF 2631-2711 IN COMPLEX WITH
RP   SUMO1; RANGAP1 AND UBE2I, SUBUNIT, AND FUNCTION.
RX   PubMed=15931224; DOI=10.1038/nature03588;
RA   Reverter D., Lima C.D.;
RT   "Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-
RT   Nup358 complex.";
RL   Nature 435:687-692(2005).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.29 ANGSTROMS) OF 2631-2695 IN COMPLEX WITH
RP   SUMO1; RANGAP1 AND UBE2I, SUBUNIT, AND FUNCTION.
RX   PubMed=22194619; DOI=10.1074/jbc.M111.321141;
RA   Gareau J.R., Reverter D., Lima C.D.;
RT   "Determinants of small ubiquitin-like modifier 1 (SUMO1) protein
RT   specificity, E3 ligase, and SUMO-RanGAP1 binding activities of
RT   nucleoporin RanBP2.";
RL   J. Biol. Chem. 287:4740-4751(2012).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.15 ANGSTROMS) OF 1-145, AND TPR REPEATS.
RX   PubMed=22959972; DOI=10.1016/j.jmb.2012.08.026;
RA   Kassube S.A., Stuwe T., Lin D.H., Antonuk C.D., Napetschnig J.,
RA   Blobel G., Hoelz A.;
RT   "Crystal structure of the N-terminal domain of Nup358/RanBP2.";
RL   J. Mol. Biol. 423:752-765(2012).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3062-3224, DOMAIN, ABSENCE
RP   OF ROTAMASE ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=23353830; DOI=10.1016/j.jmb.2013.01.021;
RA   Lin D.H., Zimmermann S., Stuwe T., Stuwe E., Hoelz A.;
RT   "Structural and functional analysis of the C-terminal domain of
RT   Nup358/RanBP2.";
RL   J. Mol. Biol. 425:1318-1329(2013).
RN   [42]
RP   VARIANTS IIAE3 MET-585; ILE-653 AND VAL-656.
RX   PubMed=19118815; DOI=10.1016/j.ajhg.2008.12.009;
RA   Neilson D.E., Adams M.D., Orr C.M.D., Schelling D.K., Eiben R.M.,
RA   Kerr D.S., Anderson J., Bassuk A.G., Bye A.M., Childs A.-M.,
RA   Clarke A., Crow Y.J., Di Rocco M., Dohna-Schwake C., Dueckers G.,
RA   Fasano A.E., Gika A.D., Gionnis D., Gorman M.P., Grattan-Smith P.J.,
RA   Hackenberg A., Kuster A., Lentschig M.G., Lopez-Laso E., Marco E.J.,
RA   Mastroyianni S., Perrier J., Schmitt-Mechelke T., Servidei S.,
RA   Skardoutsou A., Uldall P., van der Knaap M.S., Goglin K.C.,
RA   Tefft D.L., Aubin C., de Jager P., Hafler D., Warman M.L.;
RT   "Infection-triggered familial or recurrent cases of acute necrotizing
RT   encephalopathy caused by mutations in a component of the nuclear pore,
RT   RANBP2.";
RL   Am. J. Hum. Genet. 84:44-51(2009).
CC   -!- FUNCTION: E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2
CC       conjugation by UBE2I. Involved in transport factor (Ran-GTP,
CC       karyopherin)-mediated protein import via the F-G repeat-containing
CC       domain which acts as a docking site for substrates. Binds single-
CC       stranded RNA (in vitro). May bind DNA. Component of the nuclear
CC       export pathway. Specific docking site for the nuclear export
CC       factor exportin-1. Sumoylates PML at 'Lys-490' which is essential
CC       for the proper assembly of PML-NB. Recruits BICD2 to the nuclear
CC       envelope and cytoplasmic stacks of nuclear pore complex known as
CC       annulate lamellae during G2 phase of cell cycle (PubMed:20386726).
CC       {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081,
CC       ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224,
CC       ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:22194619}.
CC   -!- PATHWAY: Protein modification; protein sumoylation.
CC   -!- SUBUNIT: Forms a tight complex with RANBP1 and UBE2I. Interacts
CC       with SUMO1 but not SUMO2. Interacts with PRKN. Interacts with
CC       sumoylated RANGAP1. Interacts with CDCA8. Interacts with PML
CC       (isoform PML-4). Interacts with BICD2 (PubMed:20386726).
CC       {ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15388847,
CC       ECO:0000269|PubMed:15608651, ECO:0000269|PubMed:15931224,
CC       ECO:0000269|PubMed:16332688, ECO:0000269|PubMed:18946085,
CC       ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:22194619}.
CC   -!- INTERACTION:
CC       Q8TD16:BICD2; NbExp=2; IntAct=EBI-973138, EBI-2372628;
CC       Q921C5-1:Bicd2 (xeno); NbExp=4; IntAct=EBI-973138, EBI-642995;
CC       P04626:ERBB2; NbExp=3; IntAct=EBI-973138, EBI-641062;
CC       Q53GG5:PDLIM3; NbExp=3; IntAct=EBI-973138, EBI-5658852;
CC       O60260:PRKN; NbExp=11; IntAct=EBI-973138, EBI-716346;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:7775481}.
CC       Nucleus membrane {ECO:0000269|PubMed:11839768}. Nucleus, nuclear
CC       pore complex {ECO:0000269|PubMed:11839768,
CC       ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:23353830,
CC       ECO:0000269|PubMed:7603572}. Nucleus envelope
CC       {ECO:0000269|PubMed:20386726}. Note=Detected in diffuse and
CC       discrete intranuclear foci (PubMed:11839768). Cytoplasmic
CC       filaments (PubMed:7775481). {ECO:0000269|PubMed:11839768,
CC       ECO:0000269|PubMed:7775481}.
CC   -!- DOMAIN: Contains a dozen F-X-F-G repeats in the C-terminal half.
CC       {ECO:0000269|PubMed:23353830}.
CC   -!- DOMAIN: The PPIase cyclophilin-type domain has high structural
CC       similarity with PPIA, but has extremely low and barely detectable
CC       proline isomerase activity (in vitro) (PubMed:23353830). Only
CC       about half of the residues that surround the PPIA active site
CC       cleft are conserved. {ECO:0000269|PubMed:23353830}.
CC   -!- PTM: Polyubiquitinated by PRKN, which leads to proteasomal
CC       degradation. {ECO:0000269|PubMed:16332688}.
CC   -!- PTM: The the inner channel of the NPC has a different redox
CC       environment from the cytoplasm and allows the formation of
CC       interchain disulfide bonds between some nucleoporins, the
CC       significant increase of these linkages upon oxidative stress
CC       reduces the permeability of the NPC.
CC       {ECO:0000250|UniProtKB:Q9ERU9}.
CC   -!- DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3)
CC       [MIM:608033]: A rapidly progressive encephalopathy manifesting in
CC       susceptible individuals with seizures and coma. It can occur
CC       within days in otherwise healthy children after common viral
CC       infections such as influenza and parainfluenza, without evidence
CC       of viral infection of the brain or inflammatory cell infiltration.
CC       Brain T2-weighted magnetic resonance imaging reveals
CC       characteristic symmetric lesions present in the thalami, pons and
CC       brainstem. {ECO:0000269|PubMed:19118815}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC       Mutations in the RANBP2 gene predispose to IIAE3, but by
CC       themselves are insufficient to make the phenotype fully penetrant;
CC       additional genetic and environmental factors are required
CC       (PubMed:19118815). {ECO:0000269|PubMed:19118815}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RANBP2ID483.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L41840; AAC41758.1; -; Genomic_DNA.
DR   EMBL; D42063; BAA07662.1; -; mRNA.
DR   EMBL; AC010095; AAY14984.1; -; Genomic_DNA.
DR   EMBL; AB209483; BAD92720.1; -; mRNA.
DR   EMBL; U19248; AAA85838.1; -; mRNA.
DR   CCDS; CCDS2079.1; -.
DR   PIR; S58884; S58884.
DR   RefSeq; NP_006258.3; NM_006267.4.
DR   UniGene; Hs.199561; -.
DR   UniGene; Hs.715056; -.
DR   PDB; 1RRP; X-ray; 2.96 A; B/D=1171-1304.
DR   PDB; 1XKE; NMR; -; A=2028-2154.
DR   PDB; 1Z5S; X-ray; 3.01 A; D=2631-2711.
DR   PDB; 2LAS; NMR; -; B=2705-2717.
DR   PDB; 3UIN; X-ray; 2.60 A; D=2629-2695.
DR   PDB; 3UIO; X-ray; 2.60 A; D=2631-2695.
DR   PDB; 3UIP; X-ray; 2.29 A; D=2631-2695.
DR   PDB; 4GA0; X-ray; 1.15 A; A=1-145.
DR   PDB; 4I9Y; X-ray; 1.75 A; A/B/C/D/E/F=3062-3224.
DR   PDB; 4L6E; X-ray; 2.50 A; A=2907-3050.
DR   PDB; 4LQW; X-ray; 1.95 A; A/B=3057-3224.
DR   PDB; 5CLL; X-ray; 2.45 A; B/D=1155-1321.
DR   PDB; 5CLQ; X-ray; 3.20 A; B/D=1155-1321.
DR   PDBsum; 1RRP; -.
DR   PDBsum; 1XKE; -.
DR   PDBsum; 1Z5S; -.
DR   PDBsum; 2LAS; -.
DR   PDBsum; 3UIN; -.
DR   PDBsum; 3UIO; -.
DR   PDBsum; 3UIP; -.
DR   PDBsum; 4GA0; -.
DR   PDBsum; 4I9Y; -.
DR   PDBsum; 4L6E; -.
DR   PDBsum; 4LQW; -.
DR   PDBsum; 5CLL; -.
DR   PDBsum; 5CLQ; -.
DR   ProteinModelPortal; P49792; -.
DR   SMR; P49792; -.
DR   BioGrid; 111839; 153.
DR   CORUM; P49792; -.
DR   DIP; DIP-37654N; -.
DR   IntAct; P49792; 67.
DR   MINT; P49792; -.
DR   STRING; 9606.ENSP00000283195; -.
DR   TCDB; 1.I.1.1.3; the eukaryotic nuclear pore complex (e-npc) family.
DR   iPTMnet; P49792; -.
DR   PhosphoSitePlus; P49792; -.
DR   SwissPalm; P49792; -.
DR   BioMuta; RANBP2; -.
DR   DMDM; 83305554; -.
DR   OGP; P49792; -.
DR   EPD; P49792; -.
DR   MaxQB; P49792; -.
DR   PaxDb; P49792; -.
DR   PeptideAtlas; P49792; -.
DR   PRIDE; P49792; -.
DR   Ensembl; ENST00000283195; ENSP00000283195; ENSG00000153201.
DR   GeneID; 5903; -.
DR   KEGG; hsa:5903; -.
DR   UCSC; uc002tem.4; human.
DR   CTD; 5903; -.
DR   DisGeNET; 5903; -.
DR   EuPathDB; HostDB:ENSG00000153201.15; -.
DR   GeneCards; RANBP2; -.
DR   H-InvDB; HIX0002358; -.
DR   HGNC; HGNC:9848; RANBP2.
DR   HPA; CAB034063; -.
DR   HPA; HPA018437; -.
DR   HPA; HPA023960; -.
DR   HPA; HPA049497; -.
DR   HPA; HPA051675; -.
DR   HPA; HPA067564; -.
DR   MalaCards; RANBP2; -.
DR   MIM; 601181; gene.
DR   MIM; 608033; phenotype.
DR   neXtProt; NX_P49792; -.
DR   OpenTargets; ENSG00000153201; -.
DR   Orphanet; 263524; Acute necrotizing encephalopathy of childhood.
DR   Orphanet; 88619; Familial acute necrotizing encephalopathy.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   PharmGKB; PA34209; -.
DR   eggNOG; KOG0864; Eukaryota.
DR   eggNOG; KOG0865; Eukaryota.
DR   eggNOG; COG0652; LUCA.
DR   eggNOG; COG5171; LUCA.
DR   GeneTree; ENSGT00760000119119; -.
DR   HOGENOM; HOG000089994; -.
DR   HOVERGEN; HBG092361; -.
DR   InParanoid; P49792; -.
DR   KO; K12172; -.
DR   OMA; TKKEGQW; -.
DR   OrthoDB; EOG091G0BGL; -.
DR   PhylomeDB; P49792; -.
DR   TreeFam; TF314797; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus.
DR   Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-180746; Nuclear import of Rev protein.
DR   Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs.
DR   Reactome; R-HSA-191859; snRNP Assembly.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   UniPathway; UPA00886; -.
DR   ChiTaRS; RANBP2; human.
DR   EvolutionaryTrace; P49792; -.
DR   GeneWiki; RANBP2; -.
DR   GenomeRNAi; 5903; -.
DR   PRO; PR:P49792; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000153201; -.
DR   CleanEx; HS_RANBP2; -.
DR   ExpressionAtlas; P49792; baseline and differential.
DR   Genevisible; P49792; HS.
DR   GO; GO:0005642; C:annulate lamellae; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:1990723; C:cytoplasmic periphery of the nuclear pore complex; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0042405; C:nuclear inclusion body; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005643; C:nuclear pore; IDA:UniProtKB.
DR   GO; GO:0044614; C:nuclear pore cytoplasmic filaments; IDA:GO_Central.
DR   GO; GO:0044615; C:nuclear pore nuclear basket; IDA:UniProtKB.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:InterPro.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0008536; F:Ran GTPase binding; IPI:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0019789; F:SUMO transferase activity; EXP:Reactome.
DR   GO; GO:0051642; P:centrosome localization; IMP:UniProtKB.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome.
DR   GO; GO:0006406; P:mRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0006607; P:NLS-bearing protein import into nucleus; IMP:GO_Central.
DR   GO; GO:0033133; P:positive regulation of glucokinase activity; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IEA:GOC.
DR   GO; GO:0046604; P:positive regulation of mitotic centrosome separation; IBA:GO_Central.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0016925; P:protein sumoylation; IDA:UniProtKB.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0090526; P:regulation of gluconeogenesis involved in cellular glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0006110; P:regulation of glycolytic process; TAS:Reactome.
DR   GO; GO:0001975; P:response to amphetamine; IEA:Ensembl.
DR   GO; GO:0006405; P:RNA export from nucleus; IBA:GO_Central.
DR   GO; GO:0007062; P:sister chromatid cohesion; TAS:Reactome.
DR   GO; GO:0007051; P:spindle organization; IBA:GO_Central.
DR   GO; GO:0006409; P:tRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0016032; P:viral process; TAS:Reactome.
DR   GO; GO:0019083; P:viral transcription; TAS:Reactome.
DR   Gene3D; 1.25.40.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 4.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom_sf.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   InterPro; IPR022011; IR1-M.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000156; Ran_bind_dom.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   Pfam; PF12185; IR1-M; 2.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   Pfam; PF00638; Ran_BP1; 4.
DR   Pfam; PF00641; zf-RanBP; 8.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SMART; SM00160; RanBD; 4.
DR   SMART; SM00028; TPR; 1.
DR   SMART; SM00547; ZnF_RBZ; 8.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   SUPFAM; SSF50729; SSF50729; 4.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   SUPFAM; SSF90209; SSF90209; 7.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
DR   PROSITE; PS50196; RANBD1; 4.
DR   PROSITE; PS50005; TPR; 1.
DR   PROSITE; PS50293; TPR_REGION; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 8.
DR   PROSITE; PS50199; ZF_RANBP2_2; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Disulfide bond;
KW   Isopeptide bond; Membrane; Metal-binding; Methylation; mRNA transport;
KW   Nuclear pore complex; Nucleus; Phosphoprotein; Polymorphism;
KW   Protein transport; Reference proteome; Repeat; RNA-binding;
KW   TPR repeat; Transferase; Translocation; Transport; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   3224       E3 SUMO-protein ligase RanBP2.
FT                                /FTId=PRO_0000204913.
FT   REPEAT       26     59       TPR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00339,
FT                                ECO:0000269|PubMed:22959972}.
FT   REPEAT       60     93       TPR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00339,
FT                                ECO:0000269|PubMed:22959972}.
FT   REPEAT       94    128       TPR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00339,
FT                                ECO:0000269|PubMed:22959972}.
FT   REPEAT      165    201       TPR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00339,
FT                                ECO:0000269|PubMed:22959972}.
FT   REPEAT      287    319       TPR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00339,
FT                                ECO:0000269|PubMed:22959972}.
FT   REPEAT      583    616       TPR 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00339,
FT                                ECO:0000269|PubMed:22959972}.
FT   REPEAT      648    681       TPR 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00339,
FT                                ECO:0000269|PubMed:22959972}.
FT   DOMAIN     1171   1307       RanBD1 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00164}.
FT   DOMAIN     2012   2148       RanBD1 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00164}.
FT   DOMAIN     2309   2445       RanBD1 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00164}.
FT   REPEAT     2633   2685       1. {ECO:0000269|PubMed:22959972}.
FT   REPEAT     2711   2761       2. {ECO:0000269|PubMed:22959972}.
FT   DOMAIN     2911   3046       RanBD1 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00164}.
FT   DOMAIN     3067   3223       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   ZN_FING    1351   1381       RanBP2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00322}.
FT   ZN_FING    1415   1444       RanBP2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00322}.
FT   ZN_FING    1479   1508       RanBP2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00322}.
FT   ZN_FING    1543   1572       RanBP2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00322}.
FT   ZN_FING    1606   1635       RanBP2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00322}.
FT   ZN_FING    1665   1694       RanBP2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00322}.
FT   ZN_FING    1724   1753       RanBP2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00322}.
FT   ZN_FING    1781   1810       RanBP2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00322}.
FT   REGION     2147   2287       Interaction with BICD2.
FT                                {ECO:0000269|PubMed:20386726}.
FT   REGION     2631   2635       Interaction with sumoylated RANGAP1.
FT   REGION     2633   2761       2 X 50 AA approximate repeats.
FT   REGION     2633   2710       Required for E3 SUMO-ligase activity.
FT   REGION     2633   2685       Interaction with UBE2I.
FT   REGION     2686   2761       Interaction with SUMO1.
FT                                {ECO:0000269|PubMed:15608651}.
FT   MOD_RES      19     19       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES      21     21       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     779    779       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     781    781       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     788    788       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES     837    837       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     945    945       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     948    948       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     955    955       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1016   1016       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    1016   1016       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES    1098   1098       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1103   1103       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1107   1107       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1110   1110       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1144   1144       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1160   1160       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1249   1249       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1396   1396       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1412   1412       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1443   1443       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1450   1450       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1456   1456       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1509   1509       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1520   1520       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1573   1573       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1833   1833       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1835   1835       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1869   1869       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1871   1871       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1977   1977       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2005   2005       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2008   2008       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2153   2153       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2246   2246       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2251   2251       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2270   2270       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2280   2280       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2290   2290       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2293   2293       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2297   2297       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2462   2462       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2493   2493       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2510   2510       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERU9}.
FT   MOD_RES    2526   2526       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2613   2613       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2666   2666       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2668   2668       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2741   2741       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    2743   2743       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    2805   2805       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2900   2900       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    3207   3207       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK   1350   1350       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1414   1414       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1596   1596       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1605   1605       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK   1605   1605       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1655   1655       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1664   1664       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK   1664   1664       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1714   1714       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1723   1723       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK   1723   1723       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   2022   2022       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   2522   2522       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   2592   2592       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:15378033}.
FT   CROSSLNK   2594   2594       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK   2594   2594       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   2612   2612       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   2792   2792       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   2815   2815       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT     548    548       V -> L (in dbSNP:rs1057954).
FT                                /FTId=VAR_029765.
FT   VARIANT     580    580       E -> K (in dbSNP:rs1057956).
FT                                /FTId=VAR_029766.
FT   VARIANT     581    581       C -> Y (in dbSNP:rs1057957).
FT                                /FTId=VAR_029767.
FT   VARIANT     585    585       T -> M (in IIAE3; dbSNP:rs121434502).
FT                                {ECO:0000269|PubMed:19118815}.
FT                                /FTId=VAR_054997.
FT   VARIANT     653    653       T -> I (in IIAE3; dbSNP:rs121434503).
FT                                {ECO:0000269|PubMed:19118815}.
FT                                /FTId=VAR_054998.
FT   VARIANT     656    656       I -> V (in IIAE3; dbSNP:rs121434504).
FT                                {ECO:0000269|PubMed:19118815}.
FT                                /FTId=VAR_054999.
FT   VARIANT     725    725       S -> G (in dbSNP:rs17414315).
FT                                /FTId=VAR_050575.
FT   VARIANT     784    784       R -> K (in dbSNP:rs2912838).
FT                                {ECO:0000269|PubMed:7603572}.
FT                                /FTId=VAR_023939.
FT   VARIANT    1870   1870       P -> L (in dbSNP:rs2889846).
FT                                /FTId=VAR_029768.
FT   VARIANT    1892   1892       P -> A (in dbSNP:rs12770).
FT                                /FTId=VAR_014886.
FT   VARIANT    1892   1892       P -> R (in dbSNP:rs12770).
FT                                /FTId=VAR_050576.
FT   MUTAGEN    2632   2632       V->K: Abolishes interaction with
FT                                sumoylated RANGAP1.
FT                                {ECO:0000269|PubMed:15388847}.
FT   MUTAGEN    2634   2634       I->K: Abolishes interaction with
FT                                sumoylated RANGAP1.
FT                                {ECO:0000269|PubMed:15388847}.
FT   MUTAGEN    2635   2635       V->K: Abolishes interaction with
FT                                sumoylated RANGAP1.
FT                                {ECO:0000269|PubMed:15388847}.
FT   MUTAGEN    2640   2640       P->A: No effect on SUMO E3 ligase
FT                                activity. {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2645   2645       K->A: No effect on SUMO E3 ligase
FT                                activity. {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2651   2651       L->A: Abolishes binding to UBE2I and SUMO
FT                                E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2652   2652       K->A: No effect on SUMO E3 ligase
FT                                activity. {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2653   2653       L->A: Abolishes binding to UBE2I and SUMO
FT                                E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2654   2654       P->A: Impairs SUMO E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2655   2655       P->A: No effect on SUMO E3 ligase
FT                                activity. {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2656   2656       T->A: Impairs SUMO E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2657   2657       F->A: Abolishes binding to UBE2I and SUMO
FT                                E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2658   2658       F->A: Abolishes binding to UBE2I and SUMO
FT                                E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2659   2659       C->S,A: Impairs SUMO E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2676   2676       D->A: Impairs SUMO E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2677   2677       F->A: Impairs SUMO E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   MUTAGEN    2689   2689       Y->A: Impairs SUMO E3 ligase activity.
FT                                {ECO:0000269|PubMed:15378033}.
FT   CONFLICT    777    777       H -> R (in Ref. 1; AAC41758).
FT                                {ECO:0000305}.
FT   CONFLICT   2207   2207       S -> A (in Ref. 5; AAA85838).
FT                                {ECO:0000305}.
FT   CONFLICT   2210   2210       T -> P (in Ref. 5; AAA85838).
FT                                {ECO:0000305}.
FT   CONFLICT   2216   2216       E -> V (in Ref. 5; AAA85838).
FT                                {ECO:0000305}.
FT   CONFLICT   2436   2436       F -> C (in Ref. 5; AAA85838).
FT                                {ECO:0000305}.
FT   CONFLICT   2475   2475       T -> P (in Ref. 5; AAA85838).
FT                                {ECO:0000305}.
FT   CONFLICT   2531   2531       K -> N (in Ref. 5; AAA85838).
FT                                {ECO:0000305}.
FT   CONFLICT   2545   2545       F -> C (in Ref. 5). {ECO:0000305}.
FT   HELIX         5     18       {ECO:0000244|PDB:4GA0}.
FT   HELIX        22     26       {ECO:0000244|PDB:4GA0}.
FT   HELIX        29     38       {ECO:0000244|PDB:4GA0}.
FT   HELIX        42     55       {ECO:0000244|PDB:4GA0}.
FT   HELIX        60     72       {ECO:0000244|PDB:4GA0}.
FT   HELIX        76     89       {ECO:0000244|PDB:4GA0}.
FT   HELIX        94    107       {ECO:0000244|PDB:4GA0}.
FT   HELIX       112    124       {ECO:0000244|PDB:4GA0}.
FT   HELIX       129    141       {ECO:0000244|PDB:4GA0}.
FT   STRAND     1191   1205       {ECO:0000244|PDB:5CLL}.
FT   TURN       1206   1209       {ECO:0000244|PDB:5CLL}.
FT   STRAND     1210   1224       {ECO:0000244|PDB:5CLL}.
FT   TURN       1225   1227       {ECO:0000244|PDB:5CLL}.
FT   STRAND     1230   1236       {ECO:0000244|PDB:5CLL}.
FT   TURN       1237   1239       {ECO:0000244|PDB:5CLL}.
FT   STRAND     1242   1247       {ECO:0000244|PDB:5CLL}.
FT   STRAND     1255   1257       {ECO:0000244|PDB:5CLL}.
FT   STRAND     1260   1270       {ECO:0000244|PDB:5CLL}.
FT   STRAND     1277   1284       {ECO:0000244|PDB:5CLL}.
FT   HELIX      1288   1302       {ECO:0000244|PDB:5CLL}.
FT   STRAND     2028   2030       {ECO:0000244|PDB:1XKE}.
FT   STRAND     2032   2046       {ECO:0000244|PDB:1XKE}.
FT   TURN       2047   2050       {ECO:0000244|PDB:1XKE}.
FT   STRAND     2051   2065       {ECO:0000244|PDB:1XKE}.
FT   STRAND     2071   2077       {ECO:0000244|PDB:1XKE}.
FT   TURN       2078   2081       {ECO:0000244|PDB:1XKE}.
FT   STRAND     2082   2088       {ECO:0000244|PDB:1XKE}.
FT   STRAND     2095   2097       {ECO:0000244|PDB:1XKE}.
FT   STRAND     2105   2111       {ECO:0000244|PDB:1XKE}.
FT   STRAND     2113   2115       {ECO:0000244|PDB:1XKE}.
FT   STRAND     2117   2125       {ECO:0000244|PDB:1XKE}.
FT   HELIX      2129   2145       {ECO:0000244|PDB:1XKE}.
FT   TURN       2146   2148       {ECO:0000244|PDB:1XKE}.
FT   STRAND     2632   2637       {ECO:0000244|PDB:3UIP}.
FT   HELIX      2642   2650       {ECO:0000244|PDB:3UIP}.
FT   HELIX      2657   2661       {ECO:0000244|PDB:3UIP}.
FT   STRAND     2663   2665       {ECO:0000244|PDB:3UIN}.
FT   HELIX      2677   2682       {ECO:0000244|PDB:3UIP}.
FT   TURN       2683   2686       {ECO:0000244|PDB:3UIP}.
FT   STRAND     2710   2712       {ECO:0000244|PDB:2LAS}.
FT   TURN       2926   2929       {ECO:0000244|PDB:4L6E}.
FT   STRAND     2930   2944       {ECO:0000244|PDB:4L6E}.
FT   TURN       2945   2948       {ECO:0000244|PDB:4L6E}.
FT   STRAND     2949   2963       {ECO:0000244|PDB:4L6E}.
FT   TURN       2964   2967       {ECO:0000244|PDB:4L6E}.
FT   STRAND     2968   2974       {ECO:0000244|PDB:4L6E}.
FT   TURN       2976   2978       {ECO:0000244|PDB:4L6E}.
FT   STRAND     2981   2986       {ECO:0000244|PDB:4L6E}.
FT   STRAND     2994   2996       {ECO:0000244|PDB:4L6E}.
FT   STRAND     3000   3009       {ECO:0000244|PDB:4L6E}.
FT   STRAND     3016   3026       {ECO:0000244|PDB:4L6E}.
FT   HELIX      3027   3047       {ECO:0000244|PDB:4L6E}.
FT   STRAND     3065   3072       {ECO:0000244|PDB:4I9Y}.
FT   STRAND     3075   3084       {ECO:0000244|PDB:4I9Y}.
FT   TURN       3086   3088       {ECO:0000244|PDB:4I9Y}.
FT   HELIX      3090   3101       {ECO:0000244|PDB:4I9Y}.
FT   TURN       3102   3104       {ECO:0000244|PDB:4I9Y}.
FT   STRAND     3112   3117       {ECO:0000244|PDB:4I9Y}.
FT   TURN       3118   3120       {ECO:0000244|PDB:4I9Y}.
FT   STRAND     3121   3124       {ECO:0000244|PDB:4I9Y}.
FT   TURN       3127   3129       {ECO:0000244|PDB:4I9Y}.
FT   STRAND     3130   3133       {ECO:0000244|PDB:4I9Y}.
FT   STRAND     3157   3160       {ECO:0000244|PDB:4I9Y}.
FT   STRAND     3168   3170       {ECO:0000244|PDB:4LQW}.
FT   STRAND     3172   3177       {ECO:0000244|PDB:4I9Y}.
FT   HELIX      3180   3182       {ECO:0000244|PDB:4I9Y}.
FT   TURN       3183   3185       {ECO:0000244|PDB:4I9Y}.
FT   STRAND     3188   3194       {ECO:0000244|PDB:4I9Y}.
FT   HELIX      3196   3203       {ECO:0000244|PDB:4I9Y}.
FT   STRAND     3216   3223       {ECO:0000244|PDB:4I9Y}.
SQ   SEQUENCE   3224 AA;  358199 MW;  4CD9A3D5E77183FB CRC64;
     MRRSKADVER YIASVQGSTP SPRQKSMKGF YFAKLYYEAK EYDLAKKYIC TYINVQERDP
     KAHRFLGLLY ELEENTDKAV ECYRRSVELN PTQKDLVLKI AELLCKNDVT DGRAKYWLER
     AAKLFPGSPA IYKLKEQLLD CEGEDGWNKL FDLIQSELYV RPDDVHVNIR LVEVYRSTKR
     LKDAVAHCHE AERNIALRSS LEWNSCVVQT LKEYLESLQC LESDKSDWRA TNTDLLLAYA
     NLMLLTLSTR DVQESRELLQ SFDSALQSVK SLGGNDELSA TFLEMKGHFY MHAGSLLLKM
     GQHSSNVQWR ALSELAALCY LIAFQVPRPK IKLIKGEAGQ NLLEMMACDR LSQSGHMLLN
     LSRGKQDFLK EIVETFANKS GQSALYDALF SSQSPKDTSF LGSDDIGNID VREPELEDLT
     RYDVGAIRAH NGSLQHLTWL GLQWNSLPAL PGIRKWLKQL FHHLPHETSR LETNAPESIC
     ILDLEVFLLG VVYTSHLQLK EKCNSHHSSY QPLCLPLPVC KQLCTERQKS WWDAVCTLIH
     RKAVPGNVAK LRLLVQHEIN TLRAQEKHGL QPALLVHWAE CLQKTGSGLN SFYDQREYIG
     RSVHYWKKVL PLLKIIKKKN SIPEPIDPLF KHFHSVDIQA SEIVEYEEDA HITFAILDAV
     NGNIEDAVTA FESIKSVVSY WNLALIFHRK AEDIENDALS PEEQEECKNY LRKTRDYLIK
     IIDDSDSNLS VVKKLPVPLE SVKEMLNSVM QELEDYSEGG PLYKNGSLRN ADSEIKHSTP
     SPTRYSLSPS KSYKYSPKTP PRWAEDQNSL LKMICQQVEA IKKEMQELKL NSSNSASPHR
     WPTENYGPDS VPDGYQGSQT FHGAPLTVAT TGPSVYYSQS PAYNSQYLLR PAANVTPTKG
     PVYGMNRLPP QQHIYAYPQQ MHTPPVQSSS ACMFSQEMYG PPALRFESPA TGILSPRGDD
     YFNYNVQQTS TNPPLPEPGY FTKPPIAAHA SRSAESKTIE FGKTNFVQPM PGEGLRPSLP
     TQAHTTQPTP FKFNSNFKSN DGDFTFSSPQ VVTQPPPAAY SNSESLLGLL TSDKPLQGDG
     YSGAKPIPGG QTIGPRNTFN FGSKNVSGIS FTENMGSSQQ KNSGFRRSDD MFTFHGPGKS
     VFGTPTLETA NKNHETDGGS AHGDDDDDGP HFEPVVPLPD KIEVKTGEED EEEFFCNRAK
     LFRFDVESKE WKERGIGNVK ILRHKTSGKI RLLMRREQVL KICANHYISP DMKLTPNAGS
     DRSFVWHALD YADELPKPEQ LAIRFKTPEE AALFKCKFEE AQSILKAPGT NVAMASNQAV
     RIVKEPTSHD NKDICKSDAG NLNFEFQVAK KEGSWWHCNS CSLKNASTAK KCVSCQNLNP
     SNKELVGPPL AETVFTPKTS PENVQDRFAL VTPKKEGHWD CSICLVRNEP TVSRCIACQN
     TKSANKSGSS FVHQASFKFG QGDLPKPINS DFRSVFSTKE GQWDCSACLV QNEGSSTKCA
     ACQNPRKQSL PATSIPTPAS FKFGTSETSK TLKSGFEDMF AKKEGQWDCS SCLVRNEANA
     TRCVACQNPD KPSPSTSVPA PASFKFGTSE TSKAPKSGFE GMFTKKEGQW DCSVCLVRNE
     ASATKCIACQ NPGKQNQTTS AVSTPASSET SKAPKSGFEG MFTKKEGQWD CSVCLVRNEA
     SATKCIACQN PGKQNQTTSA VSTPASSETS KAPKSGFEGM FTKKEGQWDC SVCLVRNEAS
     ATKCIACQCP SKQNQTTAIS TPASSEISKA PKSGFEGMFI RKGQWDCSVC CVQNESSSLK
     CVACDASKPT HKPIAEAPSA FTLGSEMKLH DSSGSQVGTG FKSNFSEKAS KFGNTEQGFK
     FGHVDQENSP SFMFQGSSNT EFKSTKEGFS IPVSADGFKF GISEPGNQEK KSEKPLENGT
     GFQAQDISGQ KNGRGVIFGQ TSSTFTFADL AKSTSGEGFQ FGKKDPNFKG FSGAGEKLFS
     SQYGKMANKA NTSGDFEKDD DAYKTEDSDD IHFEPVVQMP EKVELVTGEE DEKVLYSQRV
     KLFRFDAEVS QWKERGLGNL KILKNEVNGK LRMLMRREQV LKVCANHWIT TTMNLKPLSG
     SDRAWMWLAS DFSDGDAKLE QLAAKFKTPE LAEEFKQKFE ECQRLLLDIP LQTPHKLVDT
     GRAAKLIQRA EEMKSGLKDF KTFLTNDQTK VTEEENKGSG TGAAGASDTT IKPNPENTGP
     TLEWDNYDLR EDALDDSVSS SSVHASPLAS SPVRKNLFRF GESTTGFNFS FKSALSPSKS
     PAKLNQSGTS VGTDEESDVT QEEERDGQYF EPVVPLPDLV EVSSGEENEQ VVFSHRAKLY
     RYDKDVGQWK ERGIGDIKIL QNYDNKQVRI VMRRDQVLKL CANHRITPDM TLQNMKGTER
     VWLWTACDFA DGERKVEHLA VRFKLQDVAD SFKKIFDEAK TAQEKDSLIT PHVSRSSTPR
     ESPCGKIAVA VLEETTRERT DVIQGDDVAD ATSEVEVSST SETTPKAVVS PPKFVFGSES
     VKSIFSSEKS KPFAFGNSSA TGSLFGFSFN APLKSNNSET SSVAQSGSES KVEPKKCELS
     KNSDIEQSSD SKVKNLFASF PTEESSINYT FKTPEKAKEK KKPEDSPSDD DVLIVYELTP
     TAEQKALATK LKLPPTFFCY KNRPDYVSEE EEDDEDFETA VKKLNGKLYL DGSEKCRPLE
     ENTADNEKEC IIVWEKKPTV EEKAKADTLK LPPTFFCGVC SDTDEDNGNG EDFQSELQKV
     QEAQKSQTEE ITSTTDSVYT GGTEVMVPSF CKSEEPDSIT KSISSPSVSS ETMDKPVDLS
     TRKEIDTDST SQGESKIVSF GFGSSTGLSF ADLASSNSGD FAFGSKDKNF QWANTGAAVF
     GTQSVGTQSA GKVGEDEDGS DEEVVHNEDI HFEPIVSLPE VEVKSGEEDE EILFKERAKL
     YRWDRDVSQW KERGVGDIKI LWHTMKNYYR ILMRRDQVFK VCANHVITKT MELKPLNVSN
     NALVWTASDY ADGEAKVEQL AVRFKTKEVA DCFKKTFEEC QQNLMKLQKG HVSLAAELSK
     ETNPVVFFDV CADGEPLGRI TMELFSNIVP RTAENFRALC TGEKGFGFKN SIFHRVIPDF
     VCQGGDITKH DGTGGQSIYG DKFEDENFDV KHTGPGLLSM ANQGQNTNNS QFVITLKKAE
     HLDFKHVVFG FVKDGMDTVK KIESFGSPKG SVCRRITITE CGQI
//
ID   RHOH_HUMAN              Reviewed;         191 AA.
AC   Q15669;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   28-FEB-2018, entry version 172.
DE   RecName: Full=Rho-related GTP-binding protein RhoH;
DE   AltName: Full=GTP-binding protein TTF;
DE   AltName: Full=Translocation three four protein;
DE   Flags: Precursor;
GN   Name=RHOH; Synonyms=ARHH, TTF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7784061;
RA   Dallery E., Galiegue-Zouitina S., Collyn-D'Hooghe M., Quief S.,
RA   Denis C., Hildebrand M.-P., Lantoine D., Deweindt C., Tilly H.,
RA   Bastard C., Kerckaert J.-P.;
RT   "TTF, a gene encoding a novel small G protein, fuses to the lymphoma-
RT   associated LAZ3 gene by t(3;4) chromosomal translocation.";
RL   Oncogene 10:2171-2178(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, INTERACTION WITH GDI1 AND GDI2, SUBCELLULAR LOCATION,
RP   INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11809807; DOI=10.1128/MCB.22.4.1158-1171.2002;
RA   Li X., Bu X., Lu B., Avraham H., Flavell R.A., Lim B.;
RT   "The hematopoiesis-specific GTP-binding protein RhoH is GTPase
RT   deficient and modulates activities of other Rho GTPases by an
RT   inhibitory function.";
RL   Mol. Cell. Biol. 22:1158-1171(2002).
RN   [5]
RP   INTERACTION WITH PAK5.
RX   PubMed=17064668; DOI=10.1016/j.bbrc.2006.09.172;
RA   Wu X., Frost J.A.;
RT   "Multiple Rho proteins regulate the subcellular targeting of PAK5.";
RL   Biochem. Biophys. Res. Commun. 351:328-335(2006).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=19414807; DOI=10.4049/jimmunol.0803846;
RA   Daryadel A., Yousefi S., Troi D., Schmid I., Schmidt-Mende J.,
RA   Mordasini C., Dahinden C.A., Ziemiecki A., Simon H.-U.;
RT   "RhoH/TTF negatively regulates leukotriene production in
RT   neutrophils.";
RL   J. Immunol. 182:6527-6532(2009).
CC   -!- FUNCTION: Negative regulator of hematopoietic progenitor cell
CC       proliferation, survival and migration. Critical regulator of
CC       thymocyte development and T-cell antigen receptor (TCR) signaling
CC       by mediating recruitment and activation of ZAP70. Required for
CC       phosphorylation of CD3Z, membrane translocation of ZAP70 and
CC       subsequent activation of the ZAP70-mediated pathways. Essential
CC       for efficient beta-selection and positive selection by promoting
CC       the ZAP70-dependent phosphorylation of the LAT signalosome during
CC       pre-TCR and TCR signaling. Crucial for thymocyte maturation during
CC       DN3 to DN4 transition and during positive selection. Plays
CC       critical roles in mast cell function by facilitating
CC       phosphorylation of SYK in Fc epsilon RI-mediated signal
CC       transduction. Essential for the phosphorylation of LAT, LCP2,
CC       PLCG1 and PLCG2 and for Ca(2+) mobilization in mast cells (By
CC       similarity). Binds GTP but lacks intrinsic GTPase activity and is
CC       resistant to Rho-specific GTPase-activating proteins. Inhibits the
CC       activation of NF-kappa-B by TNF and IKKB and the activation of
CC       CRK/p38 by TNF. Inhibits activities of RAC1, RHOA and CDC42.
CC       Negatively regulates leukotriene production in neutrophils.
CC       {ECO:0000250, ECO:0000269|PubMed:11809807,
CC       ECO:0000269|PubMed:19414807}.
CC   -!- SUBUNIT: Interacts with ZAP70 (via SH2 domains) and the
CC       interaction is enhanced by its phosphorylation by LCK. Interacts
CC       with SYK and the interaction is enhanced by its phosphorylation by
CC       FYN (By similarity). Interacts with GDI1 and GDI2. Interacts with
CC       PAK5 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11809807,
CC       ECO:0000269|PubMed:19414807}. Cell membrane {ECO:0000250}; Lipid-
CC       anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}.
CC       Note=Colocalizes together with ZAP70 in the immunological synapse.
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed only in hematopoietic cells. Present
CC       at very high levels in the thymus, less abundant in the spleen,
CC       and least abundant in the bone marrow. Expressed at a higher level
CC       in the TH1 subtype of T-helper cells than in the TH2
CC       subpopulation. Expressed in neutrophils under inflammatory
CC       conditions, such as cystic fibrosis, ulcerative colitis and
CC       appendicitis. {ECO:0000269|PubMed:11809807,
CC       ECO:0000269|PubMed:19414807}.
CC   -!- INDUCTION: By CSF2/GM-CSF. Down-regulated by phorbol myristate
CC       acetate (PMA). {ECO:0000269|PubMed:11809807,
CC       ECO:0000269|PubMed:19414807}.
CC   -!- DOMAIN: The region involved in interaction with ZAP70 is a non-
CC       canonical immunoreceptor tyrosine-based activation motif (ITAM).
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine by LCK. Phosphorylated by FYN.
CC       Phosphorylation enhances the interactions with ZAP70 and SYK and
CC       is critical for its function in thymocyte development (By
CC       similarity). {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving RHOH is found in
CC       a non-Hodgkin lymphoma cell line. Translocation t(3;4)(q27;p11)
CC       with BCL6.
CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Rho family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RHOHID93.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z35227; CAA84538.1; -; mRNA.
DR   EMBL; AF498975; AAM21122.1; -; mRNA.
DR   EMBL; BC014261; AAH14261.1; -; mRNA.
DR   CCDS; CCDS3458.1; -.
DR   PIR; I38367; I38367.
DR   RefSeq; NP_001265288.1; NM_001278359.1.
DR   RefSeq; NP_001265289.1; NM_001278360.1.
DR   RefSeq; NP_001265290.1; NM_001278361.1.
DR   RefSeq; NP_001265291.1; NM_001278362.1.
DR   RefSeq; NP_001265292.1; NM_001278363.1.
DR   RefSeq; NP_001265293.1; NM_001278364.1.
DR   RefSeq; NP_001265294.1; NM_001278365.1.
DR   RefSeq; NP_001265295.1; NM_001278366.1.
DR   RefSeq; NP_001265296.1; NM_001278367.1.
DR   RefSeq; NP_001265297.1; NM_001278368.1.
DR   RefSeq; NP_001265298.1; NM_001278369.1.
DR   RefSeq; NP_004301.1; NM_004310.4.
DR   RefSeq; XP_011511994.1; XM_011513692.1.
DR   RefSeq; XP_016863677.1; XM_017008188.1.
DR   RefSeq; XP_016863678.1; XM_017008189.1.
DR   UniGene; Hs.654594; -.
DR   UniGene; Hs.738915; -.
DR   ProteinModelPortal; Q15669; -.
DR   SMR; Q15669; -.
DR   BioGrid; 106892; 5.
DR   MINT; Q15669; -.
DR   STRING; 9606.ENSP00000371219; -.
DR   iPTMnet; Q15669; -.
DR   PhosphoSitePlus; Q15669; -.
DR   DMDM; 2500200; -.
DR   PaxDb; Q15669; -.
DR   PeptideAtlas; Q15669; -.
DR   PRIDE; Q15669; -.
DR   DNASU; 399; -.
DR   Ensembl; ENST00000381799; ENSP00000371219; ENSG00000168421.
DR   Ensembl; ENST00000505618; ENSP00000425010; ENSG00000168421.
DR   Ensembl; ENST00000610353; ENSP00000480192; ENSG00000168421.
DR   Ensembl; ENST00000613272; ENSP00000480772; ENSG00000168421.
DR   Ensembl; ENST00000614836; ENSP00000478248; ENSG00000168421.
DR   Ensembl; ENST00000615083; ENSP00000480379; ENSG00000168421.
DR   Ensembl; ENST00000615577; ENSP00000481566; ENSG00000168421.
DR   Ensembl; ENST00000617441; ENSP00000482947; ENSG00000168421.
DR   Ensembl; ENST00000619474; ENSP00000481746; ENSG00000168421.
DR   Ensembl; ENST00000622175; ENSP00000481836; ENSG00000168421.
DR   GeneID; 399; -.
DR   KEGG; hsa:399; -.
DR   CTD; 399; -.
DR   DisGeNET; 399; -.
DR   EuPathDB; HostDB:ENSG00000168421.12; -.
DR   GeneCards; RHOH; -.
DR   HGNC; HGNC:686; RHOH.
DR   HPA; HPA030345; -.
DR   MalaCards; RHOH; -.
DR   MIM; 602037; gene.
DR   neXtProt; NX_Q15669; -.
DR   OpenTargets; ENSG00000168421; -.
DR   Orphanet; 324294; T-cell immunodeficiency with epidermodysplasia verruciformis.
DR   PharmGKB; PA24979; -.
DR   eggNOG; KOG0393; Eukaryota.
DR   eggNOG; COG1100; LUCA.
DR   GeneTree; ENSGT00760000118978; -.
DR   HOGENOM; HOG000233974; -.
DR   HOVERGEN; HBG009351; -.
DR   InParanoid; Q15669; -.
DR   KO; K07873; -.
DR   OMA; QQVFEYA; -.
DR   OrthoDB; EOG091G0KVT; -.
DR   PhylomeDB; Q15669; -.
DR   TreeFam; TF331219; -.
DR   BRENDA; 3.6.5.2; 2681.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   ChiTaRS; RHOH; human.
DR   GeneWiki; RhoH; -.
DR   GenomeRNAi; 399; -.
DR   PRO; PR:Q15669; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000168421; -.
DR   CleanEx; HS_RHOH; -.
DR   ExpressionAtlas; Q15669; baseline and differential.
DR   Genevisible; Q15669; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005525; F:GTP binding; IDA:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0005095; F:GTPase inhibitor activity; NAS:UniProtKB.
DR   GO; GO:0019210; F:kinase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0017048; F:Rho GTPase binding; NAS:UniProtKB.
DR   GO; GO:0045576; P:mast cell activation; IEA:Ensembl.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0030217; P:T cell differentiation; NAS:UniProtKB.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005225; Small_GTP-bd_dom.
DR   InterPro; IPR001806; Small_GTPase.
DR   InterPro; IPR003578; Small_GTPase_Rho.
DR   Pfam; PF00071; Ras; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00231; small_GTP; 1.
DR   PROSITE; PS51420; RHO; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chromosomal rearrangement; Complete proteome;
KW   Cytoplasm; GTP-binding; Lipoprotein; Membrane; Methylation;
KW   Nucleotide-binding; Phosphoprotein; Prenylation; Reference proteome.
FT   CHAIN         1    188       Rho-related GTP-binding protein RhoH.
FT                                /FTId=PRO_0000198867.
FT   PROPEP      189    191       Removed in mature form. {ECO:0000250}.
FT                                /FTId=PRO_0000281218.
FT   NP_BIND      11     18       GTP. {ECO:0000250}.
FT   NP_BIND      58     62       GTP. {ECO:0000250}.
FT   NP_BIND     116    119       GTP. {ECO:0000250}.
FT   REGION       73     86       Interaction with ZAP70. {ECO:0000250}.
FT   MOTIF        33     41       Effector region. {ECO:0000250}.
FT   MOD_RES     188    188       Cysteine methyl ester. {ECO:0000250}.
FT   LIPID       188    188       S-geranylgeranyl cysteine. {ECO:0000250}.
SQ   SEQUENCE   191 AA;  21331 MW;  C5BF8929AD1E59D0 CRC64;
     MLSSIKCVLV GDSAVGKTSL LVRFTSETFP EAYKPTVYEN TGVDVFMDGI QISLGLWDTA
     GNDAFRSIRP LSYQQADVVL MCYSVANHNS FLNLKNKWIG EIRSNLPCTP VLVVATQTDQ
     REMGPHRASC VNAMEGKKLA QDVRAKGYLE CSALSNRGVQ QVFECAVRTA VNQARRRNRR
     RLFSINECKI F
//
ID   Q6ICP4_HUMAN            Unreviewed;       191 AA.
AC   Q6ICP4;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 122.
DE   SubName: Full=ARHH protein {ECO:0000313|EMBL:CAG29345.1};
DE   SubName: Full=Ras homolog gene family, member H, isoform CRA_a {ECO:0000313|EMBL:EAW92960.1};
DE   SubName: Full=cDNA, FLJ94345, Homo sapiens ras homolog gene family, member H (ARHH), mRNA {ECO:0000313|EMBL:BAG36484.1};
DE   Flags: Fragment;
GN   Name=ARHH {ECO:0000313|EMBL:CAG29345.1};
GN   Synonyms=RHOH {ECO:0000313|EMBL:EAW92960.1};
GN   ORFNames=hCG_37394 {ECO:0000313|EMBL:EAW92960.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG29345.1};
RN   [1] {ECO:0000313|EMBL:EAW92960.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:CAG29345.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW92960.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG36484.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK313744; BAG36484.1; -; mRNA.
DR   EMBL; CR450349; CAG29345.1; -; mRNA.
DR   EMBL; CH471069; EAW92960.1; -; Genomic_DNA.
DR   EMBL; CH471069; EAW92961.1; -; Genomic_DNA.
DR   EMBL; CH471069; EAW92962.1; -; Genomic_DNA.
DR   RefSeq; NP_001265288.1; NM_001278359.1.
DR   RefSeq; NP_001265289.1; NM_001278360.1.
DR   RefSeq; NP_001265290.1; NM_001278361.1.
DR   RefSeq; NP_001265291.1; NM_001278362.1.
DR   RefSeq; NP_001265292.1; NM_001278363.1.
DR   RefSeq; NP_001265293.1; NM_001278364.1.
DR   RefSeq; NP_001265294.1; NM_001278365.1.
DR   RefSeq; NP_001265295.1; NM_001278366.1.
DR   RefSeq; NP_001265296.1; NM_001278367.1.
DR   RefSeq; NP_001265297.1; NM_001278368.1.
DR   RefSeq; NP_001265298.1; NM_001278369.1.
DR   RefSeq; NP_004301.1; NM_004310.4.
DR   RefSeq; XP_011511994.1; XM_011513692.1.
DR   RefSeq; XP_016863677.1; XM_017008188.1.
DR   RefSeq; XP_016863678.1; XM_017008189.1.
DR   UniGene; Hs.654594; -.
DR   UniGene; Hs.738915; -.
DR   SMR; Q6ICP4; -.
DR   IntAct; Q6ICP4; 3.
DR   MaxQB; Q6ICP4; -.
DR   DNASU; 399; -.
DR   GeneID; 399; -.
DR   KEGG; hsa:399; -.
DR   UCSC; uc003guz.4; human.
DR   CTD; 399; -.
DR   EuPathDB; HostDB:ENSG00000168421.12; -.
DR   PharmGKB; PA24979; -.
DR   eggNOG; KOG0393; Eukaryota.
DR   eggNOG; COG1100; LUCA.
DR   HOGENOM; HOG000233974; -.
DR   HOVERGEN; HBG009351; -.
DR   KO; K07873; -.
DR   OMA; QQVFEYA; -.
DR   OrthoDB; EOG091G0KVT; -.
DR   ChiTaRS; RHOH; human.
DR   GenomeRNAi; 399; -.
DR   Bgee; ENSG00000168421; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0045576; P:mast cell activation; IEA:Ensembl.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005225; Small_GTP-bd_dom.
DR   InterPro; IPR001806; Small_GTPase.
DR   InterPro; IPR003578; Small_GTPase_Rho.
DR   Pfam; PF00071; Ras; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00231; small_GTP; 1.
DR   PROSITE; PS51420; RHO; 1.
PE   2: Evidence at transcript level;
KW   GTP-binding {ECO:0000256|SAAS:SAAS00512948};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00512948}.
FT   NON_TER     191    191       {ECO:0000313|EMBL:CAG29345.1}.
SQ   SEQUENCE   191 AA;  21331 MW;  C5BF8929AD1E59D0 CRC64;
     MLSSIKCVLV GDSAVGKTSL LVRFTSETFP EAYKPTVYEN TGVDVFMDGI QISLGLWDTA
     GNDAFRSIRP LSYQQADVVL MCYSVANHNS FLNLKNKWIG EIRSNLPCTP VLVVATQTDQ
     REMGPHRASC VNAMEGKKLA QDVRAKGYLE CSALSNRGVQ QVFECAVRTA VNQARRRNRR
     RLFSINECKI F
//
ID   RMI2_HUMAN              Reviewed;         147 AA.
AC   Q96E14; B3KVZ6; Q49AE2; Q8TBL0;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   28-FEB-2018, entry version 117.
DE   RecName: Full=RecQ-mediated genome instability protein 2;
DE            Short=hRMI2;
DE   AltName: Full=BLM-associated protein of 18 kDa;
DE            Short=BLAP18;
GN   Name=RMI2; Synonyms=C16orf75;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung, Lymph, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, IDENTIFICATION IN THE RMI COMPLEX, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF LYS-121.
RX   PubMed=18923082; DOI=10.1101/gad.1708608;
RA   Xu D., Guo R., Sobeck A., Bachrati C.Z., Yang J., Enomoto T.,
RA   Brown G.W., Hoatlin M.E., Hickson I.D., Wang W.;
RT   "RMI, a new OB-fold complex essential for Bloom syndrome protein to
RT   maintain genome stability.";
RL   Genes Dev. 22:2843-2855(2008).
RN   [6]
RP   FUNCTION, IDENTIFICATION IN THE RMI COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, PHOSPHORYLATION, AND MUTAGENESIS OF LYS-24; TRP-59;
RP   LYS-100; LYS-121 AND TRP-135.
RX   PubMed=18923083; DOI=10.1101/gad.1725108;
RA   Singh T.R., Ali A.M., Busygina V., Raynard S., Fan Q., Du C.-H.,
RA   Andreassen P.R., Sung P., Meetei A.R.;
RT   "BLAP18/RMI2, a novel OB-fold-containing protein, is an essential
RT   component of the Bloom helicase-double Holliday junction
RT   dissolvasome.";
RL   Genes Dev. 22:2856-2868(2008).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-7, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   FUNCTION, AND PROBABLE INVOLVEMENT IN BLOOM-LIKE SYNDROME.
RX   PubMed=27977684; DOI=10.1371/journal.pgen.1006483;
RA   Hudson D.F., Amor D.J., Boys A., Butler K., Williams L., Zhang T.,
RA   Kalitsis P.;
RT   "Loss of RMI2 increases genome instability and causes a Bloom-like
RT   syndrome.";
RL   PLoS Genet. 12:E1006483-E1006483(2016).
CC   -!- FUNCTION: Essential component of the RMI complex, a complex that
CC       plays an important role in the processing of homologous
CC       recombination intermediates. It is required to regulate sister
CC       chromatid segregation and to limit DNA crossover. Essential for
CC       the stability, localization, and function of BLM, TOP3A, and
CC       complexes containing BLM. In the RMI complex, it is required to
CC       target BLM to chromatin and stress-induced nuclear foci and
CC       mitotic phosphorylation of BLM. {ECO:0000269|PubMed:18923082,
CC       ECO:0000269|PubMed:18923083, ECO:0000269|PubMed:27977684}.
CC   -!- SUBUNIT: Component of the RMI complex, containing at least TOP3A,
CC       RMI1 and RMI2. The RMI complex interacts with BLM.
CC       {ECO:0000269|PubMed:18923082, ECO:0000269|PubMed:18923083}.
CC   -!- INTERACTION:
CC       Q9H9A7:RMI1; NbExp=13; IntAct=EBI-15876491, EBI-621339;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18923082}.
CC       Note=Colocalizes with BLM at nuclear DNA repair foci.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96E14-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96E14-2; Sequence=VSP_027287;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated during mitosis. {ECO:0000269|PubMed:18923083}.
CC   -!- DISEASE: Note=A homozygous deletion of RMI2 has been found in a
CC       family with a Bloom-like syndrome and is probable responsible for
CC       the phenotype. Patients manifest depigmented skin lesions,
CC       multiple cafe-au-lait macules, and growth deficiency. Cells from
CC       affected individuals show a high rate of sister chromatid exchange
CC       and increased chromosomal breaks. {ECO:0000269|PubMed:27977684}.
CC   -!- SIMILARITY: Belongs to the RMI2 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK123764; BAG53958.1; -; mRNA.
DR   EMBL; AC009121; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85155.1; -; Genomic_DNA.
DR   EMBL; BC013040; AAH13040.2; -; mRNA.
DR   EMBL; BC022427; AAH22427.1; -; mRNA.
DR   EMBL; BC031016; AAH31016.1; -; mRNA.
DR   EMBL; BC039361; AAH39361.1; -; mRNA.
DR   CCDS; CCDS10548.1; -. [Q96E14-1]
DR   RefSeq; NP_689521.1; NM_152308.2. [Q96E14-1]
DR   UniGene; Hs.347524; -.
DR   PDB; 3MXN; X-ray; 1.55 A; B=1-147.
DR   PDB; 3NBH; X-ray; 2.00 A; B=6-147.
DR   PDB; 4DAY; X-ray; 3.30 A; B=1-147.
DR   PDBsum; 3MXN; -.
DR   PDBsum; 3NBH; -.
DR   PDBsum; 4DAY; -.
DR   ProteinModelPortal; Q96E14; -.
DR   SMR; Q96E14; -.
DR   BioGrid; 125466; 15.
DR   DIP; DIP-56480N; -.
DR   IntAct; Q96E14; 8.
DR   MINT; Q96E14; -.
DR   STRING; 9606.ENSP00000310356; -.
DR   iPTMnet; Q96E14; -.
DR   PhosphoSitePlus; Q96E14; -.
DR   BioMuta; RMI2; -.
DR   DMDM; 74731517; -.
DR   EPD; Q96E14; -.
DR   MaxQB; Q96E14; -.
DR   PaxDb; Q96E14; -.
DR   PeptideAtlas; Q96E14; -.
DR   PRIDE; Q96E14; -.
DR   Ensembl; ENST00000312499; ENSP00000310356; ENSG00000175643. [Q96E14-1]
DR   Ensembl; ENST00000572173; ENSP00000461206; ENSG00000175643. [Q96E14-2]
DR   GeneID; 116028; -.
DR   KEGG; hsa:116028; -.
DR   UCSC; uc002daw.2; human. [Q96E14-1]
DR   CTD; 116028; -.
DR   DisGeNET; 116028; -.
DR   EuPathDB; HostDB:ENSG00000175643.8; -.
DR   GeneCards; RMI2; -.
DR   H-InvDB; HIX0012817; -.
DR   HGNC; HGNC:28349; RMI2.
DR   HPA; HPA040995; -.
DR   MIM; 612426; gene.
DR   neXtProt; NX_Q96E14; -.
DR   OpenTargets; ENSG00000175643; -.
DR   PharmGKB; PA145149635; -.
DR   eggNOG; ENOG410IXR6; Eukaryota.
DR   eggNOG; ENOG41120UE; LUCA.
DR   GeneTree; ENSGT00390000001653; -.
DR   HOGENOM; HOG000154149; -.
DR   HOVERGEN; HBG108410; -.
DR   InParanoid; Q96E14; -.
DR   KO; K15365; -.
DR   OMA; AAVWMQG; -.
DR   OrthoDB; EOG091G0SYG; -.
DR   PhylomeDB; Q96E14; -.
DR   TreeFam; TF332971; -.
DR   Reactome; R-HSA-5685938; HDR through Single Strand Annealing (SSA).
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5693554; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA).
DR   Reactome; R-HSA-5693568; Resolution of D-loop Structures through Holliday Junction Intermediates.
DR   Reactome; R-HSA-5693579; Homologous DNA Pairing and Strand Exchange.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   ChiTaRS; RMI2; human.
DR   GenomeRNAi; 116028; -.
DR   PRO; PR:Q96E14; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000175643; -.
DR   CleanEx; HS_C16orf75; -.
DR   ExpressionAtlas; Q96E14; baseline and differential.
DR   Genevisible; Q96E14; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006260; P:DNA replication; TAS:Reactome.
DR   GO; GO:0000731; P:DNA synthesis involved in DNA repair; TAS:Reactome.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0033045; P:regulation of sister chromatid segregation; IMP:UniProtKB.
DR   GO; GO:0000732; P:strand displacement; TAS:Reactome.
DR   InterPro; IPR032245; RMI2.
DR   PANTHER; PTHR33962; PTHR33962; 1.
DR   Pfam; PF16100; RMI2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   DNA replication; DNA-binding; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    147       RecQ-mediated genome instability protein
FT                                2.
FT                                /FTId=PRO_0000297577.
FT   DNA_BIND     44    114       OB.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       7      7       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     98       MAAAADSFSGGPAGVRLPRSPPLKVLAEQLRRDAEGGPGAW
FT                                RLSRAAAGRGPLDLAAVWMQGRVVMADRGEARLRDPSGDFS
FT                                VRGLERVPRGRPCLVP -> MKQTQVGSLFSLGIRNPEPGP
FT                                VSGTAVPRQLAWKS (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027287.
FT   MUTAGEN      24     24       K->A: Abolishes interaction with RMI1,
FT                                TOP3A and BLM.
FT                                {ECO:0000269|PubMed:18923083}.
FT   MUTAGEN      59     59       W->A: According to PubMed:18923083,
FT                                abolishes interaction with RMI1, TOP3A
FT                                and BLM. According to PubMed:18923082,
FT                                does not affects interaction with RMI1
FT                                and TOP3A. {ECO:0000269|PubMed:18923083}.
FT   MUTAGEN     100    100       K->A: Does not affect interaction with
FT                                RMI1, TOP3A and BLM.
FT                                {ECO:0000269|PubMed:18923083}.
FT   MUTAGEN     121    121       K->A: According to PubMed:18923083, does
FT                                not affect interaction with RMI1, TOP3A
FT                                and BLM. According to PubMed:18923082,
FT                                affects interaction with BLM and the BMI
FT                                complex. {ECO:0000269|PubMed:18923082,
FT                                ECO:0000269|PubMed:18923083}.
FT   MUTAGEN     135    135       W->A: Abolishes interaction with RMI1,
FT                                TOP3A and BLM.
FT                                {ECO:0000269|PubMed:18923083}.
FT   HELIX        27     33       {ECO:0000244|PDB:3MXN}.
FT   STRAND       34     36       {ECO:0000244|PDB:3MXN}.
FT   STRAND       40     43       {ECO:0000244|PDB:3NBH}.
FT   TURN         46     49       {ECO:0000244|PDB:3MXN}.
FT   STRAND       56     68       {ECO:0000244|PDB:3MXN}.
FT   STRAND       71     76       {ECO:0000244|PDB:3MXN}.
FT   STRAND       79     84       {ECO:0000244|PDB:3MXN}.
FT   HELIX        86     88       {ECO:0000244|PDB:3MXN}.
FT   STRAND       92     94       {ECO:0000244|PDB:4DAY}.
FT   STRAND      101    110       {ECO:0000244|PDB:3MXN}.
FT   STRAND      112    114       {ECO:0000244|PDB:3MXN}.
FT   STRAND      116    124       {ECO:0000244|PDB:3MXN}.
FT   HELIX       130    143       {ECO:0000244|PDB:3MXN}.
SQ   SEQUENCE   147 AA;  15865 MW;  C385825F9AB4439E CRC64;
     MAAAADSFSG GPAGVRLPRS PPLKVLAEQL RRDAEGGPGA WRLSRAAAGR GPLDLAAVWM
     QGRVVMADRG EARLRDPSGD FSVRGLERVP RGRPCLVPGK YVMVMGVVQA CSPEPCLQAV
     KMTDLSDNPI HESMWELEVE DLHRNIP
//
ID   RL22_HUMAN              Reviewed;         128 AA.
AC   P35268; B2R495; Q6IBD1;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   28-FEB-2018, entry version 173.
DE   RecName: Full=60S ribosomal protein L22;
DE   AltName: Full=EBER-associated protein;
DE            Short=EAP;
DE   AltName: Full=Epstein-Barr virus small RNA-associated protein;
DE   AltName: Full=Heparin-binding protein HBp15;
DE   AltName: Full=Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};
GN   Name=RPL22;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 2-46 AND 108-125.
RC   TISSUE=Placenta;
RX   PubMed=1846807;
RA   Toczyski D.P.W., Steitz J.A.;
RT   "EAP, a highly conserved cellular protein associated with Epstein-Barr
RT   virus small RNAs (EBERs).";
RL   EMBO J. 10:459-466(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Submandibular gland;
RX   PubMed=8135813; DOI=10.1006/bbrc.1994.1286;
RA   Fujita Y., Okamoto T., Noshiro M., Kato Y., Takada K., Sato J.D.,
RA   Ozaki T., McKeehan W.L., Crabb J.W., Whitney R.G.;
RT   "A novel heparin-binding protein, HBp15, is identified as mammalian
RT   ribosomal protein L22.";
RL   Biochem. Biophys. Res. Commun. 199:706-713(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEIN SEQUENCE OF 2-10; 53-65; 70-81 AND 102-113, CLEAVAGE OF
RP   INITIATOR METHIONINE, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Calvo F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Cervix, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   NOMENCLATURE.
RX   PubMed=24524803; DOI=10.1016/j.sbi.2014.01.002;
RA   Ban N., Beckmann R., Cate J.H.D., Dinman J.D., Dragon F., Ellis S.R.,
RA   Lafontaine D.L.J., Lindahl L., Liljas A., Lipton J.M., McAlear M.A.,
RA   Moore P.B., Noller H.F., Ortega J., Panse V.G., Ramakrishnan V.,
RA   Spahn C.M.T., Steitz T.A., Tchorzewski M., Tollervey D., Warren A.J.,
RA   Williamson J.R., Wilson D., Yonath A., Yusupov M.;
RT   "A new system for naming ribosomal proteins.";
RL   Curr. Opin. Struct. Biol. 24:165-169(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   STRUCTURE BY ELECTRON MICROSCOPY (5.0 ANGSTROMS).
RX   PubMed=23636399; DOI=10.1038/nature12104;
RA   Anger A.M., Armache J.P., Berninghausen O., Habeck M., Subklewe M.,
RA   Wilson D.N., Beckmann R.;
RT   "Structures of the human and Drosophila 80S ribosome.";
RL   Nature 497:80-85(2013).
CC   -!- INTERACTION:
CC       P17473:IE (xeno); NbExp=2; IntAct=EBI-354533, EBI-11702772;
CC       O00560:SDCBP; NbExp=4; IntAct=EBI-354533, EBI-727004;
CC       Q9H190:SDCBP2; NbExp=4; IntAct=EBI-354533, EBI-742426;
CC   -!- MISCELLANEOUS: Binds to Epstein-Barr virus small RNAs and to
CC       heparin.
CC   -!- SIMILARITY: Belongs to the eukaryotic ribosomal protein eL22
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X59357; CAA42007.1; -; mRNA.
DR   EMBL; D17652; BAA04545.1; -; mRNA.
DR   EMBL; AK311749; BAG34692.1; -; mRNA.
DR   EMBL; CR456873; CAG33154.1; -; mRNA.
DR   EMBL; AL031847; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471130; EAW71518.1; -; Genomic_DNA.
DR   EMBL; BC035566; AAH35566.1; -; mRNA.
DR   EMBL; BC058887; AAH58887.1; -; mRNA.
DR   EMBL; BC066314; AAH66314.1; -; mRNA.
DR   CCDS; CCDS58.1; -.
DR   PIR; JC2120; JC2120.
DR   RefSeq; NP_000974.1; NM_000983.3.
DR   UniGene; Hs.515329; -.
DR   UniGene; Hs.554762; -.
DR   PDB; 4UG0; EM; -; LU=1-128.
DR   PDB; 4V6X; EM; 5.00 A; CU=1-128.
DR   PDB; 5AJ0; EM; 3.50 A; AU=1-128.
DR   PDB; 5LKS; EM; 3.60 A; LU=1-128.
DR   PDB; 5T2C; EM; 3.60 A; O=1-128.
DR   PDBsum; 4UG0; -.
DR   PDBsum; 4V6X; -.
DR   PDBsum; 5AJ0; -.
DR   PDBsum; 5LKS; -.
DR   PDBsum; 5T2C; -.
DR   ProteinModelPortal; P35268; -.
DR   SMR; P35268; -.
DR   BioGrid; 112066; 207.
DR   CORUM; P35268; -.
DR   IntAct; P35268; 60.
DR   MINT; P35268; -.
DR   STRING; 9606.ENSP00000346088; -.
DR   iPTMnet; P35268; -.
DR   PhosphoSitePlus; P35268; -.
DR   SwissPalm; P35268; -.
DR   BioMuta; RPL22; -.
DR   SWISS-2DPAGE; P35268; -.
DR   EPD; P35268; -.
DR   MaxQB; P35268; -.
DR   PaxDb; P35268; -.
DR   PeptideAtlas; P35268; -.
DR   PRIDE; P35268; -.
DR   TopDownProteomics; P35268; -.
DR   Ensembl; ENST00000234875; ENSP00000346088; ENSG00000116251.
DR   GeneID; 6146; -.
DR   KEGG; hsa:6146; -.
DR   UCSC; uc001amd.4; human.
DR   CTD; 6146; -.
DR   DisGeNET; 6146; -.
DR   EuPathDB; HostDB:ENSG00000116251.9; -.
DR   GeneCards; RPL22; -.
DR   HGNC; HGNC:10315; RPL22.
DR   MIM; 180474; gene.
DR   neXtProt; NX_P35268; -.
DR   OpenTargets; ENSG00000116251; -.
DR   PharmGKB; PA34688; -.
DR   eggNOG; KOG3434; Eukaryota.
DR   eggNOG; ENOG4111UVJ; LUCA.
DR   GeneTree; ENSGT00390000003719; -.
DR   HOGENOM; HOG000198396; -.
DR   HOVERGEN; HBG004373; -.
DR   InParanoid; P35268; -.
DR   KO; K02891; -.
DR   OMA; YQLRFYN; -.
DR   OrthoDB; EOG091G0POE; -.
DR   PhylomeDB; P35268; -.
DR   TreeFam; TF313018; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-156902; Peptide chain elongation.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   Reactome; R-HSA-72764; Eukaryotic Translation Termination.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SIGNOR; P35268; -.
DR   ChiTaRS; RPL22; human.
DR   GeneWiki; RPL22; -.
DR   GenomeRNAi; 6146; -.
DR   PRO; PR:P35268; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116251; -.
DR   CleanEx; HS_RPL22; -.
DR   ExpressionAtlas; P35268; baseline and differential.
DR   Genevisible; P35268; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0022625; C:cytosolic large ribosomal subunit; HDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0030529; C:intracellular ribonucleoprotein complex; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003735; F:structural constituent of ribosome; IBA:GO_Central.
DR   GO; GO:0002181; P:cytoplasmic translation; IBA:GO_Central.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome.
DR   GO; GO:0006364; P:rRNA processing; TAS:Reactome.
DR   GO; GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome.
DR   GO; GO:0006412; P:translation; TAS:ProtInc.
DR   GO; GO:0006413; P:translational initiation; TAS:Reactome.
DR   GO; GO:0019083; P:viral transcription; TAS:Reactome.
DR   InterPro; IPR002671; Ribosomal_L22e.
DR   PANTHER; PTHR10064; PTHR10064; 1.
DR   Pfam; PF01776; Ribosomal_L22e; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Heparin-binding; Phosphoprotein; Reference proteome;
KW   Ribonucleoprotein; Ribosomal protein; RNA-binding.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:1846807,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2    128       60S ribosomal protein L22.
FT                                /FTId=PRO_0000215501.
FT   COMPBIAS    120    128       Asp/Glu-rich (highly acidic).
FT   MOD_RES      62     62       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P67984}.
FT   MOD_RES      66     66       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      69     69       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P67984}.
SQ   SEQUENCE   128 AA;  14787 MW;  0F3ED8BE70C9F962 CRC64;
     MAPVKKLVVK GGKKKKQVLK FTLDCTHPVE DGIMDAANFE QFLQERIKVN GKAGNLGGGV
     VTIERSKSKI TVTSEVPFSK RYLKYLTKKY LKKNNLRDWL RVVANSKESY ELRYFQINQD
     EEEEEDED
//
ID   B3KVP3_HUMAN            Unreviewed;       154 AA.
AC   B3KVP3;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 54.
DE   SubName: Full=cDNA FLJ41031 fis, clone DFNES2000146, highly similar to R-spondin-2 {ECO:0000313|EMBL:BAG53855.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG53855.1};
RN   [1] {ECO:0000313|EMBL:BAG53855.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ninomiya K., Wagatsuma M., Kanda K., Kondo H., Yokoi T., Kodaira H.,
RA   Furuya T., Takahashi M., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Sugiyama T., Irie R.,
RA   Otsuki T., Sato H., Wakamatsu A., Ishii S., Yamamoto J., Isono Y.,
RA   Kawai-Hio Y., Saito K., Nishikawa T., Kimura K., Yamashita H.,
RA   Matsuo K., Nakamura Y., Sekine M., Kikuchi H., Murakawa K.,
RA   Kanehori K., Takahashi-Fujii A., Oshima A., Sugiyama A., Kawakami B.,
RA   Suzuki Y., Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK123027; BAG53855.1; -; mRNA.
DR   RefSeq; NP_001304871.1; NM_001317942.1.
DR   RefSeq; NP_848660.3; NM_178565.4.
DR   UniGene; Hs.444834; -.
DR   PRIDE; B3KVP3; -.
DR   GeneID; 340419; -.
DR   KEGG; hsa:340419; -.
DR   CTD; 340419; -.
DR   PharmGKB; PA142670968; -.
DR   eggNOG; ENOG410IMS2; Eukaryota.
DR   eggNOG; ENOG410ZI6H; LUCA.
DR   HOGENOM; HOG000290668; -.
DR   HOVERGEN; HBG082751; -.
DR   GenomeRNAi; 340419; -.
DR   Genevisible; B3KVP3; HS.
DR   Gene3D; 2.20.100.10; -; 1.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   Pfam; PF15913; Furin-like_2; 1.
DR   SMART; SM00261; FU; 1.
DR   SMART; SM00209; TSP1; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   SUPFAM; SSF82895; SSF82895; 1.
DR   PROSITE; PS50092; TSP1; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED      122    142       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   154 AA;  17916 MW;  7E2A6E14DF6743A8 CRC64;
     MNRCARCRIE NCDSCFSKDF CTKCKVGFYL HRGRCFDECP DGFAPLEETM ECVEGCEVGH
     WSEWGTCSRN NRTCGFKWGL ETRTRQIVKK PVKDTILCPT IAESRRCKMT MRHCPGGKRT
     PKAKEKRNKK KKRKLIERAQ EQHSVFLATD RANQ
//
ID   RSPO2_HUMAN             Reviewed;         243 AA.
AC   Q6UXX9; B3KVP0; Q4G0U4; Q8N6X6;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2007, sequence version 2.
DT   28-FEB-2018, entry version 118.
DE   RecName: Full=R-spondin-2;
DE   AltName: Full=Roof plate-specific spondin-2;
DE            Short=hRspo2;
DE   Flags: Precursor;
GN   Name=RSPO2; ORFNames=UNQ9384/PRO34209;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PRO-186.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PRO-186.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-186.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   PRO-186.
RC   TISSUE=Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INJECTION INTO MICE.
RX   PubMed=16357527; DOI=10.4161/cc.5.1.2305;
RA   Kim K.-A., Zhao J., Andarmani S., Kakitani M., Oshima T.,
RA   Binnerts M.E., Abo A., Tomizuka K., Funk W.D.;
RT   "R-spondin proteins: a novel link to beta-catenin activation.";
RL   Cell Cycle 5:23-26(2006).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH LGR4 AND LGR5.
RX   PubMed=21909076; DOI=10.1038/embor.2011.175;
RA   Glinka A., Dolde C., Kirsch N., Huang Y.L., Kazanskaya O.,
RA   Ingelfinger D., Boutros M., Cruciat C.M., Niehrs C.;
RT   "LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and
RT   Wnt/PCP signalling.";
RL   EMBO Rep. 12:1055-1061(2011).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH LGR4; LGR5 AND LGR6.
RX   PubMed=21727895; DOI=10.1038/nature10337;
RA   de Lau W., Barker N., Low T.Y., Koo B.K., Li V.S., Teunissen H.,
RA   Kujala P., Haegebarth A., Peters P.J., van de Wetering M.,
RA   Stange D.E., van Es J.E., Guardavaccaro D., Schasfoort R.B., Mohri Y.,
RA   Nishimori K., Mohammed S., Heck A.J., Clevers H.;
RT   "Lgr5 homologues associate with Wnt receptors and mediate R-spondin
RT   signalling.";
RL   Nature 476:293-297(2011).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH LGR6.
RX   PubMed=22615920; DOI=10.1371/journal.pone.0037137;
RA   Gong X., Carmon K.S., Lin Q., Thomas A., Yi J., Liu Q.;
RT   "LGR6 is a high affinity receptor of R-spondins and potentially
RT   functions as a tumor suppressor.";
RL   PLoS ONE 7:E37137-E37137(2012).
CC   -!- FUNCTION: Activator of the canonical Wnt signaling pathway by
CC       acting as a ligand for LGR4-6 receptors. Upon binding to LGR4-6
CC       (LGR4, LGR5 or LGR6), LGR4-6 associate with phosphorylated LRP6
CC       and frizzled receptors that are activated by extracellular Wnt
CC       receptors, triggering the canonical Wnt signaling pathway to
CC       increase expression of target genes. Also regulates the canonical
CC       Wnt/beta-catenin-dependent pathway and non-canonical Wnt signaling
CC       by acting as an inhibitor of ZNRF3, an important regulator of the
CC       Wnt signaling pathway. Probably also acts as a ligand for frizzled
CC       and LRP receptors. {ECO:0000269|PubMed:21727895,
CC       ECO:0000269|PubMed:21909076, ECO:0000269|PubMed:22615920}.
CC   -!- SUBUNIT: Interacts with WNT1. Binds heparin (By similarity).
CC       Interacts with LGR4, LGR5 and LGR6. {ECO:0000250,
CC       ECO:0000269|PubMed:21727895, ECO:0000269|PubMed:21909076,
CC       ECO:0000269|PubMed:22615920}.
CC   -!- INTERACTION:
CC       P60372:KRTAP10-4; NbExp=3; IntAct=EBI-8481036, EBI-10178153;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-8481036, EBI-10172290;
CC       P60409-2:KRTAP10-7; NbExp=4; IntAct=EBI-12009390, EBI-10695388;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-8481036, EBI-10172052;
CC       Q9H8W4:PLEKHF2; NbExp=3; IntAct=EBI-8481036, EBI-742388;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6UXX9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6UXX9-2; Sequence=VSP_018321;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q6UXX9-3; Sequence=VSP_018322, VSP_018323;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The FU repeat is required for activation and stabilization
CC       of beta-catenin. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Upon injection into mice, it induces rapid onset of
CC       crypt cell proliferation involving beta-catenin stabilization. It
CC       also displays efficacy in a model of chemotherapy-induced
CC       intestinal mucositis (PubMed:16357527).
CC       {ECO:0000305|PubMed:16357527}.
CC   -!- SIMILARITY: Belongs to the R-spondin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY358166; AAQ88533.1; -; mRNA.
DR   EMBL; AK123023; BAG53852.1; -; mRNA.
DR   EMBL; AC025508; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003479; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471060; EAW91916.1; -; Genomic_DNA.
DR   EMBL; BC027938; AAH27938.1; -; mRNA.
DR   EMBL; BC036554; AAH36554.1; -; mRNA.
DR   CCDS; CCDS6307.1; -. [Q6UXX9-1]
DR   CCDS; CCDS64953.1; -. [Q6UXX9-3]
DR   CCDS; CCDS83314.1; -. [Q6UXX9-2]
DR   RefSeq; NP_001269792.1; NM_001282863.1. [Q6UXX9-3]
DR   RefSeq; NP_001304871.1; NM_001317942.1. [Q6UXX9-2]
DR   RefSeq; NP_848660.3; NM_178565.4. [Q6UXX9-1]
DR   UniGene; Hs.444834; -.
DR   ProteinModelPortal; Q6UXX9; -.
DR   SMR; Q6UXX9; -.
DR   BioGrid; 131049; 10.
DR   IntAct; Q6UXX9; 11.
DR   MINT; Q6UXX9; -.
DR   STRING; 9606.ENSP00000276659; -.
DR   PhosphoSitePlus; Q6UXX9; -.
DR   BioMuta; RSPO2; -.
DR   DMDM; 147744588; -.
DR   PaxDb; Q6UXX9; -.
DR   PeptideAtlas; Q6UXX9; -.
DR   PRIDE; Q6UXX9; -.
DR   Ensembl; ENST00000276659; ENSP00000276659; ENSG00000147655. [Q6UXX9-1]
DR   Ensembl; ENST00000517781; ENSP00000427937; ENSG00000147655. [Q6UXX9-3]
DR   Ensembl; ENST00000517939; ENSP00000428940; ENSG00000147655. [Q6UXX9-2]
DR   GeneID; 340419; -.
DR   KEGG; hsa:340419; -.
DR   UCSC; uc003ymq.4; human. [Q6UXX9-1]
DR   CTD; 340419; -.
DR   DisGeNET; 340419; -.
DR   EuPathDB; HostDB:ENSG00000147655.10; -.
DR   GeneCards; RSPO2; -.
DR   H-InvDB; HIX0007721; -.
DR   HGNC; HGNC:28583; RSPO2.
DR   HPA; CAB025900; -.
DR   HPA; HPA024764; -.
DR   HPA; HPA053068; -.
DR   MIM; 610575; gene.
DR   neXtProt; NX_Q6UXX9; -.
DR   OpenTargets; ENSG00000147655; -.
DR   PharmGKB; PA142670968; -.
DR   eggNOG; ENOG410IMS2; Eukaryota.
DR   eggNOG; ENOG410ZI6H; LUCA.
DR   GeneTree; ENSGT00390000011447; -.
DR   HOGENOM; HOG000290668; -.
DR   HOVERGEN; HBG082751; -.
DR   InParanoid; Q6UXX9; -.
DR   OMA; DNGCIRC; -.
DR   OrthoDB; EOG091G0FYC; -.
DR   PhylomeDB; Q6UXX9; -.
DR   TreeFam; TF331799; -.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   SIGNOR; Q6UXX9; -.
DR   GeneWiki; RSPO2; -.
DR   GenomeRNAi; 340419; -.
DR   PRO; PR:Q6UXX9; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000147655; -.
DR   CleanEx; HS_RSPO2; -.
DR   ExpressionAtlas; Q6UXX9; baseline and differential.
DR   Genevisible; Q6UXX9; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0030282; P:bone mineralization; IEA:Ensembl.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl.
DR   GO; GO:0060437; P:lung growth; IEA:Ensembl.
DR   GO; GO:0042489; P:negative regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0060535; P:trachea cartilage morphogenesis; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 2.20.100.10; -; 1.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   Pfam; PF15913; Furin-like_2; 1.
DR   SMART; SM00261; FU; 2.
DR   SMART; SM00209; TSP1; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   SUPFAM; SSF82895; SSF82895; 1.
DR   PROSITE; PS50092; TSP1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Heparin-binding; Polymorphism; Reference proteome; Secreted;
KW   Sensory transduction; Signal; Wnt signaling pathway.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    243       R-spondin-2.
FT                                /FTId=PRO_0000234439.
FT   REPEAT       90    134       FU.
FT   DOMAIN      144    204       TSP type-1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   CARBOHYD    160    160       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     40     46       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID     43     52       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID     55     74       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID     78     93       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID     96    104       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID    101    110       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID    113    124       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID    128    141       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID    145    187       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID    156    163       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   DISULFID    196    203       {ECO:0000255|PROSITE-ProRule:PRU00210}.
FT   VAR_SEQ       1     67       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018321.
FT   VAR_SEQ      32     95       ASYVSNPICKGCLSCSKDNGCSRCQQKLFFFLRREGMRQYG
FT                                ECLHSCPSGYYGHRAPDMNRCAR -> G (in isoform
FT                                3). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018322.
FT   VAR_SEQ     143    143       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018323.
FT   VARIANT     186    186       L -> P (in dbSNP:rs601558).
FT                                {ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_026247.
SQ   SEQUENCE   243 AA;  28315 MW;  96F44F105B21BB52 CRC64;
     MQFRLFSFAL IILNCMDYSH CQGNRWRRSK RASYVSNPIC KGCLSCSKDN GCSRCQQKLF
     FFLRREGMRQ YGECLHSCPS GYYGHRAPDM NRCARCRIEN CDSCFSKDFC TKCKVGFYLH
     RGRCFDECPD GFAPLEETME CVEGCEVGHW SEWGTCSRNN RTCGFKWGLE TRTRQIVKKP
     VKDTILCPTI AESRRCKMTM RHCPGGKRTP KAKEKRNKKK KRKLIERAQE QHSVFLATDR
     ANQ
//
ID   SFPQ_HUMAN              Reviewed;         707 AA.
AC   P23246; P30808; Q5SZ71;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   28-FEB-2018, entry version 203.
DE   RecName: Full=Splicing factor, proline- and glutamine-rich;
DE   AltName: Full=100 kDa DNA-pairing protein;
DE            Short=hPOMp100;
DE   AltName: Full=DNA-binding p52/p100 complex, 100 kDa subunit;
DE   AltName: Full=Polypyrimidine tract-binding protein-associated-splicing factor {ECO:0000303|PubMed:9848648};
DE            Short=PSF {ECO:0000303|PubMed:8449401};
DE            Short=PTB-associated-splicing factor;
GN   Name=SFPQ; Synonyms=PSF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, ALTERNATIVE
RP   SPLICING, AND FUNCTION.
RC   TISSUE=Fetal brain;
RX   PubMed=8449401; DOI=10.1101/gad.7.3.393;
RA   Patton J.G., Porro E.B., Galceran J., Tempst P., Nadal-Ginard B.;
RT   "Cloning and characterization of PSF, a novel pre-mRNA splicing
RT   factor.";
RL   Genes Dev. 7:393-406(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PROTEIN SEQUENCE OF 33-44; 218-236; 246-267; 272-286; 299-315;
RP   320-330; 350-358; 364-407; 414-425; 431-462; 480-493; 517-536;
RP   549-559; 567-572; 575-581; 600-606; 612-630 AND 667-695, METHYLATION
RP   AT LYS-314; ARG-571; ARG-681 AND ARG-693, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 48-68 AND 213-246, BLOCKAGE OF N-TERMINUS,
RP   DNA-BINDING, AND SUBUNIT.
RX   PubMed=8439294; DOI=10.1042/bj2900267;
RA   Zhang W.-W., Zhang L.-X., Busch R.K., Farres J., Busch H.;
RT   "Purification and characterization of a DNA-binding heterodimer of 52
RT   and 100 kDa from HeLa cells.";
RL   Biochem. J. 290:267-272(1993).
RN   [6]
RP   PROTEIN SEQUENCE OF 292-311; 415-421 AND 503-510, AND IDENTIFICATION
RP   IN U5/4/6 SNRNP COMPLEXES.
RX   PubMed=9409622;
RA   Teigelkamp S., Mundt C., Achsel T., Will C.L., Luehrmann R.;
RT   "The human U5 snRNP-specific 100-kD protein is an RS domain-
RT   containing, putative RNA helicase with significant homology to the
RT   yeast splicing factor Prp28p.";
RL   RNA 3:1313-1326(1997).
RN   [7]
RP   PROTEIN SEQUENCE OF 299-314 AND 480-493, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 312-707.
RC   TISSUE=Fetal skeletal muscle;
RX   PubMed=2480877;
RA   Gower H.J., Moore S.E., Dickson G., Elsom V.L., Nayak R., Walsh F.S.;
RT   "Cloning and characterization of a myoblast cell surface antigen
RT   defined by 24.1D5 monoclonal antibody.";
RL   Development 105:723-731(1989).
RN   [9]
RP   PROTEIN SEQUENCE OF 414-421 AND 427-448, SUBCELLULAR LOCATION,
RP   INTERACTION WITH SNRPA, AND IDENTIFICATION IN A SNRNP-FREE COMPLEX
RP   WITH SNRPA.
RX   PubMed=9848648; DOI=10.1017/S1355838298981183;
RA   Lutz C.S., Cooke C., O'Connor J.P., Kobayashi R., Alwine J.C.;
RT   "The snRNP-free U1A (SF-A) complex(es): identification of the largest
RT   subunit as PSF, the polypyrimidine-tract binding protein-associated
RT   splicing factor.";
RL   RNA 4:1493-1499(1998).
RN   [10]
RP   PROTEIN SEQUENCE OF 600-606 AND 667-677, INTERACTION WITH PTBP1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=10653975;
RX   DOI=10.1002/(SICI)1097-4644(20000315)76:4<559::AID-JCB4>3.0.CO;2-U;
RA   Meissner M., Dechat T., Gerner C., Grimm R., Foisner R., Sauermann G.;
RT   "Differential nuclear localization and nuclear matrix association of
RT   the splicing factors PSF and PTB.";
RL   J. Cell. Biochem. 76:559-566(2000).
RN   [11]
RP   FUNCTION, INTERACTION WITH PRE-MRNA, AND IDENTIFICATION IN SPLICEOSOME
RP   COMPLEX.
RX   PubMed=8045264;
RA   Gozani O., Patton J.G., Reed R.;
RT   "A novel set of spliceosome-associated proteins and the essential
RT   splicing factor PSF bind stably to pre-mRNA prior to catalytic step II
RT   of the splicing reaction.";
RL   EMBO J. 13:3356-3367(1994).
RN   [12]
RP   CHROMOSOMAL TRANSLOCATION WITH TFE3.
RX   PubMed=9393982; DOI=10.1038/sj.onc.1201394;
RA   Clark J., Lu Y.-J., Sidhar S.K., Parker C., Gill S., Smedley D.,
RA   Hamoudi R., Linehan W.M., Shipley J., Cooper C.S.;
RT   "Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3
RT   gene in papillary renal cell carcinoma.";
RL   Oncogene 15:2233-2239(1997).
RN   [13]
RP   INTERACTION WITH TOP1, AND IDENTIFICATION IN A COMPLEX WITH NONO AND
RP   TOP1.
RX   PubMed=9756848; DOI=10.1074/jbc.273.41.26261;
RA   Straub T., Grue P., Uhse A., Lisby M., Knudsen B.R., Tange T.O.,
RA   Westergaard O., Boege F.;
RT   "The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity
RT   by a direct interaction.";
RL   J. Biol. Chem. 273:26261-26264(1998).
RN   [14]
RP   FUNCTION IN DNA UNWINDING.
RX   PubMed=10858305; DOI=10.1021/bi992898e;
RA   Straub T., Knudsen B.R., Boege F.;
RT   "PSF/p54(nrb) stimulates 'jumping' of DNA topoisomerase I between
RT   separate DNA helices.";
RL   Biochemistry 39:7552-7558(2000).
RN   [15]
RP   FUNCTION IN TRANSCRIPTION REGULATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=10847580; DOI=10.1210/mend.14.6.0485;
RA   Urban R.J., Bodenburg Y., Kurosky A., Wood T.G., Gasic S.;
RT   "Polypyrimidine tract-binding protein-associated splicing factor is a
RT   negative regulator of transcriptional activity of the porcine p450scc
RT   insulin-like growth factor response element.";
RL   Mol. Endocrinol. 14:774-782(2000).
RN   [16]
RP   FUNCTION IN HOMOLOGOUS DNA PAIRING, AND PHOSPHORYLATION.
RX   PubMed=10931916; DOI=10.1093/nar/28.16.3022;
RA   Akhmedov A.T., Lopez B.S.;
RT   "Human 100-kDa homologous DNA-pairing protein is the splicing factor
RT   PSF and promotes DNA strand invasion.";
RL   Nucleic Acids Res. 28:3022-3030(2000).
RN   [17]
RP   FUNCTION IN NUCLEAR RETENTION OF A-TO-I EDITED RNAS, AND
RP   IDENTIFICATION IN A COMPLEX WITH NONO AND MATR3.
RX   PubMed=11525732; DOI=10.1016/S0092-8674(01)00466-4;
RA   Zhang Z., Carmichael G.G.;
RT   "The fate of dsRNA in the nucleus: a p54(nrb)-containing complex
RT   mediates the nuclear retention of promiscuously A-to-I edited RNAs.";
RL   Cell 106:465-475(2001).
RN   [18]
RP   INTERACTION WITH SNRNP70, AND PHOSPHORYLATION.
RX   PubMed=11514619; DOI=10.1091/mbc.12.8.2328;
RA   Shav-Tal Y., Cohen M., Lapter S., Dye B., Patton J.G.,
RA   Vandekerckhove J., Zipori D.;
RT   "Nuclear relocalization of the pre-mRNA splicing factor PSF during
RT   apoptosis involves hyperphosphorylation, masking of antigenic
RT   epitopes, and changes in protein interactions.";
RL   Mol. Biol. Cell 12:2328-2340(2001).
RN   [19]
RP   FUNCTION IN TRANSCRIPTION REGULATION, AND INTERACTION WITH RXRA; THRA
RP   AND SIN3A.
RX   PubMed=11259580; DOI=10.1128/MCB.21.7.2298-2311.2001;
RA   Mathur M., Tucker P.W., Samuels H.H.;
RT   "PSF is a novel corepressor that mediates its effect through Sin3A and
RT   the DNA binding domain of nuclear hormone receptors.";
RL   Mol. Cell. Biol. 21:2298-2311(2001).
RN   [20]
RP   FUNCTION IN TRANSCRIPTION REGULATION, INTERACTION WITH NR5A1 AND
RP   SIN3A, AND IDENTIFICATION IN A COMPLEX WITH NONO AND NR5A1.
RX   PubMed=11897684; DOI=10.1210/endo.143.4.8748;
RA   Sewer M.B., Nguyen V.Q., Huang C.J., Tucker P.W., Kagawa N.,
RA   Waterman M.R.;
RT   "Transcriptional activation of human CYP17 in H295R adrenocortical
RT   cells depends on complex formation among p54(nrb)/NonO, protein-
RT   associated splicing factor, and SF-1, a complex that also participates
RT   in repression of transcription.";
RL   Endocrinology 143:1280-1290(2002).
RN   [21]
RP   INTERACTION WITH NONO AND U5 SNRNA, AND IDENTIFICATION IN U5/4/6 SNRNP
RP   AND SPLICEOSOME COMPLEXES.
RX   PubMed=12403470; DOI=10.1017/S1355838202022070;
RA   Peng R., Dye B.T., Perez I., Barnard D.C., Thompson A.B., Patton J.G.;
RT   "PSF and p54nrb bind a conserved stem in U5 snRNA.";
RL   RNA 8:1334-1347(2002).
RN   [22]
RP   FUNCTION IN DNA REPAIR, IDENTIFICATION BY MASS SPECTROMETRY,
RP   DNA-BINDING, AND SUBUNIT.
RX   PubMed=15590677; DOI=10.1074/jbc.M412758200;
RA   Bladen C.L., Udayakumar D., Takeda Y., Dynan W.S.;
RT   "Identification of the polypyrimidine tract binding protein-associated
RT   splicing factor.p54(nrb) complex as a candidate DNA double-strand
RT   break rejoining factor.";
RL   J. Biol. Chem. 280:5205-5210(2005).
RN   [23]
RP   PHOSPHORYLATION AT TYR-293.
RX   PubMed=17537995; DOI=10.1182/blood-2006-01-028647;
RA   Galietta A., Gunby R.H., Redaelli S., Stano P., Carniti C., Bachi A.,
RA   Tucker P.W., Tartari C.J., Huang C.J., Colombo E., Pulford K.,
RA   Puttini M., Piazza R.G., Ruchatz H., Villa A., Donella-Deana A.,
RA   Marin O., Perrotti D., Gambacorti-Passerini C.;
RT   "NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in
RT   anaplastic large-cell lymphoma.";
RL   Blood 110:2600-2609(2007).
RN   [24]
RP   PHOSPHORYLATION AT SER-8 AND SER-283 BY MKNK2.
RX   PubMed=17965020; DOI=10.1074/jbc.M705286200;
RA   Buxade M., Morrice N., Krebs D.L., Proud C.G.;
RT   "The PSF.p54nrb complex is a novel Mnk substrate that binds the mRNA
RT   for tumor necrosis factor alpha.";
RL   J. Biol. Chem. 283:57-65(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-687, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-273 AND THR-687, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [27]
RP   INTERACTION WITH RNF43.
RX   PubMed=18655028; DOI=10.1002/pmic.200800083;
RA   Miyamoto K., Sakurai H., Sugiura T.;
RT   "Proteomic identification of a PSF/p54nrb heterodimer as RNF43
RT   oncoprotein-interacting proteins.";
RL   Proteomics 8:2907-2910(2008).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [29]
RP   PHOSPHORYLATION, INTERACTION WITH PTK6, AND SUBCELLULAR LOCATION.
RX   PubMed=19439179; DOI=10.1016/j.cellsig.2009.04.008;
RA   Lukong K.E., Huot M.E., Richard S.;
RT   "BRK phosphorylates PSF promoting its cytoplasmic localization and
RT   cell cycle arrest.";
RL   Cell. Signal. 21:1415-1422(2009).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-319; LYS-338; LYS-421 AND
RP   LYS-472, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [32]
RP   FUNCTION, PHOSPHORYLATION AT THR-687, INTERACTION WITH THRAP3, AND
RP   MUTAGENESIS OF THR-687.
RX   PubMed=20932480; DOI=10.1016/j.molcel.2010.09.013;
RA   Heyd F., Lynch K.W.;
RT   "Phosphorylation-dependent regulation of PSF by GSK3 controls CD45
RT   alternative splicing.";
RL   Mol. Cell 40:126-137(2010).
RN   [33]
RP   INTERACTION WITH M.TUBERCULOSIS RV3654C (MICROBIAL INFECTION).
RX   PubMed=20454556; DOI=10.1371/journal.pone.0010474;
RA   Danelishvili L., Yamazaki Y., Selker J., Bermudez L.E.;
RT   "Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins
RT   participate in the suppression of macrophage apoptosis.";
RL   PLoS ONE 5:E10474-E10474(2010).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33 AND SER-626, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [36]
RP   INTERACTION WITH PQBP1.
RX   PubMed=21933836; DOI=10.1093/hmg/ddr430;
RA   Kunde S.A., Musante L., Grimme A., Fischer U., Mueller E.,
RA   Wanker E.E., Kalscheuer V.M.;
RT   "The X-chromosome-linked intellectual disability protein PQBP1 is a
RT   component of neuronal RNA granules and regulates the appearance of
RT   stress granules.";
RL   Hum. Mol. Genet. 20:4916-4931(2011).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33; SER-273 AND SER-283,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33; SER-273; SER-283;
RP   THR-368; SER-374; SER-496; SER-626; THR-687 AND TYR-691, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [40]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-236; ARG-242; ARG-245;
RP   ARG-681; ARG-693 AND ARG-695, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [41]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-338, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [42]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-338, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [43]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [44]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PRKDC; XRCC5;
RP   XRCC6; HEXIM1; NONO; PSPC1; RBM14 AND MATR3.
RX   PubMed=28712728; DOI=10.1016/j.molcel.2017.06.020;
RA   Morchikh M., Cribier A., Raffel R., Amraoui S., Cau J., Severac D.,
RA   Dubois E., Schwartz O., Bennasser Y., Benkirane M.;
RT   "HEXIM1 and NEAT1 Long non-coding RNA form a multi-subunit complex
RT   that regulates DNA-mediated innate immune response.";
RL   Mol. Cell 67:387-399(2017).
RN   [45]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-271; LYS-279 AND LYS-338,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [46]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 276-535, COILED COIL,
RP   SUBUNIT, INTERACTION WITH NONO, FUNCTION, DOMAIN, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF LEU-535; LEU-539; LEU-546 AND MET-549.
RX   PubMed=25765647; DOI=10.1093/nar/gkv156;
RA   Lee M., Sadowska A., Bekere I., Ho D., Gully B.S., Lu Y., Iyer K.S.,
RA   Trewhella J., Fox A.H., Bond C.S.;
RT   "The structure of human SFPQ reveals a coiled-coil mediated polymer
RT   essential for functional aggregation in gene regulation.";
RL   Nucleic Acids Res. 43:3826-3840(2015).
CC   -!- FUNCTION: DNA- and RNA binding protein, involved in several
CC       nuclear processes. Essential pre-mRNA splicing factor required
CC       early in spliceosome formation and for splicing catalytic step II,
CC       probably as a heteromer with NONO. Binds to pre-mRNA in
CC       spliceosome C complex, and specifically binds to intronic
CC       polypyrimidine tracts. Involved in regulation of signal-induced
CC       alternative splicing. During splicing of PTPRC/CD45, a
CC       phosphorylated form is sequestered by THRAP3 from the pre-mRNA in
CC       resting T-cells; T-cell activation and subsequent reduced
CC       phosphorylation is proposed to lead to release from THRAP3
CC       allowing binding to pre-mRNA splicing regulatotry elements which
CC       represses exon inclusion. Interacts with U5 snRNA, probably by
CC       binding to a purine-rich sequence located on the 3' side of U5
CC       snRNA stem 1b. May be involved in a pre-mRNA coupled splicing and
CC       polyadenylation process as component of a snRNP-free complex with
CC       SNRPA/U1A. The SFPQ-NONO heteromer associated with MATR3 may play
CC       a role in nuclear retention of defective RNAs. SFPQ may be
CC       involved in homologous DNA pairing; in vitro, promotes the
CC       invasion of ssDNA between a duplex DNA and produces a D-loop
CC       formation. The SFPQ-NONO heteromer may be involved in DNA
CC       unwinding by modulating the function of topoisomerase I/TOP1; in
CC       vitro, stimulates dissociation of TOP1 from DNA after cleavage and
CC       enhances its jumping between separate DNA helices. The SFPQ-NONO
CC       heteromer binds DNA (PubMed:25765647). The SFPQ-NONO heteromer may
CC       be involved in DNA non-homologous end joining (NHEJ) required for
CC       double-strand break repair and V(D)J recombination and may
CC       stabilize paired DNA ends; in vitro, the complex strongly
CC       stimulates DNA end joining, binds directly to the DNA substrates
CC       and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to
CC       establish a functional preligation complex. SFPQ is involved in
CC       transcriptional regulation. Functions as transcriptional activator
CC       (PubMed:25765647). Transcriptional repression is mediated by an
CC       interaction of SFPQ with SIN3A and subsequent recruitment of
CC       histone deacetylases (HDACs). The SFPQ-NONO-NR5A1 complex binds to
CC       the CYP17 promoter and regulates basal and cAMP-dependent
CC       transcriptional activity. SFPQ isoform Long binds to the DNA
CC       binding domains (DBD) of nuclear hormone receptors, like RXRA and
CC       probably THRA, and acts as transcriptional corepressor in absence
CC       of hormone ligands. Binds the DNA sequence 5'-CTGAGTC-3' in the
CC       insulin-like growth factor response element (IGFRE) and inhibits
CC       IGF-I-stimulated transcriptional activity. Regulates the circadian
CC       clock by repressing the transcriptional activator activity of the
CC       CLOCK-ARNTL/BMAL1 heterodimer. Required for the transcriptional
CC       repression of circadian target genes, such as PER1, mediated by
CC       the large PER complex through histone deacetylation (By
CC       similarity). Required for the assembly of nuclear speckles
CC       (PubMed:25765647). Plays a role in the regulation of DNA virus-
CC       mediated innate immune response by assembling into the HDP-RNP
CC       complex, a complex that serves as a platform for IRF3
CC       phosphorylation and subsequent innate immune response activation
CC       through the cGAS-STING pathway (PubMed:28712728).
CC       {ECO:0000250|UniProtKB:Q8VIJ6, ECO:0000269|PubMed:10847580,
CC       ECO:0000269|PubMed:10858305, ECO:0000269|PubMed:10931916,
CC       ECO:0000269|PubMed:11259580, ECO:0000269|PubMed:11525732,
CC       ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:15590677,
CC       ECO:0000269|PubMed:20932480, ECO:0000269|PubMed:25765647,
CC       ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:8045264,
CC       ECO:0000269|PubMed:8449401}.
CC   -!- SUBUNIT: Heterodimer with NONO (PubMed:25765647). Monomer and
CC       component of the SFPQ-NONO complex, which is probably a
CC       heterotetramer of two 52 kDa (NONO) and two 100 kDa (SFPQ)
CC       subunits (PubMed:8439294, PubMed:25765647). The coiled coil domain
CC       mediates interaction with NONO, and can also mediate formation of
CC       long, linear homooligomers (in vitro) (PubMed:25765647). SFPQ is a
CC       component of spliceosome and U5.4/6 snRNP complexes
CC       (PubMed:9409622, PubMed:8045264, PubMed:12403470). Interacts with
CC       SNRPA/U1A (PubMed:9848648). Component of a snRNP-free complex with
CC       SNRPA/U1A (PubMed:9848648). Part of complex consisting of SFPQ,
CC       NONO and MATR3 (PubMed:11525732). Interacts with polypyrimidine
CC       tract-binding protein 1/PTB (PubMed:10653975). Part of a complex
CC       consisting of SFPQ, NONO and NR5A1 (PubMed:11897684). Interacts
CC       with RXRA, probably THRA, and SIN3A (PubMed:11259580). Interacts
CC       with TOP1 (PubMed:9756848). Part of a complex consisting of SFPQ,
CC       NONO and TOP1 (PubMed:9756848). Interacts with SNRNP70 in
CC       apoptotic cells (PubMed:11514619). Interacts with PSPC1. Interacts
CC       with RNF43 (PubMed:18655028). Interacts with PITX3 and NR4A2/NURR1
CC       (By similarity). Interacts with PTK6 (PubMed:19439179). Interacts
CC       with THRAP3; the interaction is dependent on SFPQ phosphorylation
CC       at 'Thr-687' and inhibits binding of SFPQ to a ESS1 exonic
CC       splicing silencer element-containing RNA (PubMed:20932480). The
CC       large PER complex involved in the histone deacetylation is
CC       composed of at least HDAC1, PER2, SFPQ and SIN3A. Interacts with
CC       PER1 and PER2 (By similarity). Interacts with PQBP1
CC       (PubMed:21933836). {ECO:0000250|UniProtKB:Q8VIJ6,
CC       ECO:0000269|PubMed:10653975, ECO:0000269|PubMed:11259580,
CC       ECO:0000269|PubMed:11514619, ECO:0000269|PubMed:11525732,
CC       ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:12403470,
CC       ECO:0000269|PubMed:15590677, ECO:0000269|PubMed:18655028,
CC       ECO:0000269|PubMed:19439179, ECO:0000269|PubMed:20932480,
CC       ECO:0000269|PubMed:21933836, ECO:0000269|PubMed:25765647,
CC       ECO:0000269|PubMed:8045264, ECO:0000269|PubMed:8439294,
CC       ECO:0000269|PubMed:9409622, ECO:0000269|PubMed:9756848,
CC       ECO:0000269|PubMed:9848648}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with M.tuberculosis
CC       protein Rv3654c, which probably leads to the cleavage of PSF,
CC       diminishes the level of caspase-8 in macrophages and suppresses
CC       macrophage apoptosis by blocking the extrinsic pathway. Part of
CC       the HDP-RNP complex composed of at least HEXIM1, PRKDC, XRCC5,
CC       XRCC6, paraspeckle proteins (SFPQ, NONO, PSPC1, RBM14, and MATR3)
CC       and NEAT1 RNA. {ECO:0000269|PubMed:20454556,
CC       ECO:0000269|PubMed:28712728}.
CC   -!- INTERACTION:
CC       Q8AZK7:EBNA-LP (xeno); NbExp=2; IntAct=EBI-355453, EBI-1185167;
CC       P41235:HNF4A; NbExp=2; IntAct=EBI-355453, EBI-1049011;
CC       P26599:PTBP1; NbExp=2; IntAct=EBI-355453, EBI-350540;
CC       Q13882:PTK6; NbExp=5; IntAct=EBI-355453, EBI-1383632;
CC       P28700:Rxra (xeno); NbExp=3; IntAct=EBI-355463, EBI-346715;
CC       Q96ST3:SIN3A; NbExp=2; IntAct=EBI-355453, EBI-347218;
CC       P09012:SNRPA; NbExp=4; IntAct=EBI-355453, EBI-607085;
CC       P04625:THRA (xeno); NbExp=2; IntAct=EBI-355463, EBI-286261;
CC       Q9Y2W1:THRAP3; NbExp=6; IntAct=EBI-355453, EBI-352039;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle
CC       {ECO:0000269|PubMed:25765647}. Nucleus matrix
CC       {ECO:0000269|PubMed:10653975, ECO:0000269|PubMed:19439179,
CC       ECO:0000269|PubMed:9848648}. Cytoplasm
CC       {ECO:0000269|PubMed:19439179}. Note=Predominantly in nuclear
CC       matrix. {ECO:0000269|PubMed:19439179}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Long; Synonyms=A;
CC         IsoId=P23246-1; Sequence=Displayed;
CC       Name=Short; Synonyms=F;
CC         IsoId=P23246-2; Sequence=VSP_005855;
CC   -!- DOMAIN: The coiled coil domain mediates interaction with NONO, and
CC       can also mediate formation of long, linear homooligomers (in
CC       vitro). The coiled coil domain is required for optimal DNA
CC       binding, and optimal transcription activation.
CC       {ECO:0000269|PubMed:25765647}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- PTM: Phosphorylated on multiple serine and threonine residues
CC       during apoptosis. In vitro phosphorylated by PKC. Phosphorylation
CC       stimulates binding to DNA and D-loop formation, but inhibits
CC       binding to RNA. Phosphorylation of C-terminal tyrosines promotes
CC       its cytoplasmic localization, impaired its binding to
CC       polypyrimidine RNA and led to cell cycle arrest. In resting T-
CC       cells is phosphorylated at Thr-687 by GSK3B which is proposed to
CC       promote association with THRAP and to prevent binding to
CC       PTPRC/CD45 pre-mRNA; T-cell activation leads to reduced
CC       phosphorylation at Thr-687. {ECO:0000269|PubMed:10931916,
CC       ECO:0000269|PubMed:11514619, ECO:0000269|PubMed:17537995,
CC       ECO:0000269|PubMed:17965020, ECO:0000269|PubMed:19439179,
CC       ECO:0000269|PubMed:20932480}.
CC   -!- DISEASE: Note=A chromosomal aberration involving SFPQ may be a
CC       cause of papillary renal cell carcinoma (PRCC). Translocation
CC       t(X;1)(p11.2;p34) with TFE3.
CC   -!- CAUTION: Was originally thought to be myoblast cell surface
CC       antigen 24.1D5 and a possible membrane-bound protein ectokinase.
CC       {ECO:0000305|PubMed:2480877}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PSFID167.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X70944; CAA50283.1; -; mRNA.
DR   EMBL; AL590434; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07426.1; -; Genomic_DNA.
DR   EMBL; X16850; CAA34747.1; -; mRNA.
DR   CCDS; CCDS388.1; -. [P23246-1]
DR   PIR; A46302; A46302.
DR   PIR; S29770; S29770.
DR   RefSeq; NP_005057.1; NM_005066.2. [P23246-1]
DR   RefSeq; XP_005271169.1; XM_005271112.4. [P23246-1]
DR   RefSeq; XP_005271170.1; XM_005271113.4. [P23246-1]
DR   RefSeq; XP_005271172.1; XM_005271115.4. [P23246-2]
DR   RefSeq; XP_016857542.1; XM_017002053.1. [P23246-1]
DR   RefSeq; XP_016857543.1; XM_017002054.1. [P23246-1]
DR   UniGene; Hs.355934; -.
DR   UniGene; Hs.611911; -.
DR   PDB; 4WII; X-ray; 2.05 A; A/B=276-535.
DR   PDB; 4WIJ; X-ray; 3.49 A; A/B=276-598.
DR   PDB; 4WIK; X-ray; 3.00 A; A/B=369-598.
DR   PDBsum; 4WII; -.
DR   PDBsum; 4WIJ; -.
DR   PDBsum; 4WIK; -.
DR   ProteinModelPortal; P23246; -.
DR   SMR; P23246; -.
DR   BioGrid; 112319; 199.
DR   CORUM; P23246; -.
DR   DIP; DIP-31272N; -.
DR   IntAct; P23246; 63.
DR   MINT; P23246; -.
DR   STRING; 9606.ENSP00000349748; -.
DR   iPTMnet; P23246; -.
DR   PhosphoSitePlus; P23246; -.
DR   SwissPalm; P23246; -.
DR   BioMuta; SFPQ; -.
DR   DMDM; 1709851; -.
DR   SWISS-2DPAGE; P23246; -.
DR   EPD; P23246; -.
DR   MaxQB; P23246; -.
DR   PaxDb; P23246; -.
DR   PeptideAtlas; P23246; -.
DR   PRIDE; P23246; -.
DR   Ensembl; ENST00000357214; ENSP00000349748; ENSG00000116560. [P23246-1]
DR   GeneID; 6421; -.
DR   KEGG; hsa:6421; -.
DR   UCSC; uc001bys.4; human. [P23246-1]
DR   CTD; 6421; -.
DR   DisGeNET; 6421; -.
DR   EuPathDB; HostDB:ENSG00000116560.10; -.
DR   GeneCards; SFPQ; -.
DR   HGNC; HGNC:10774; SFPQ.
DR   HPA; CAB009886; -.
DR   HPA; HPA047513; -.
DR   HPA; HPA054689; -.
DR   MalaCards; SFPQ; -.
DR   MIM; 605199; gene.
DR   neXtProt; NX_P23246; -.
DR   OpenTargets; ENSG00000116560; -.
DR   Orphanet; 319308; Translocation renal cell carcinoma.
DR   PharmGKB; PA35690; -.
DR   eggNOG; KOG0115; Eukaryota.
DR   eggNOG; ENOG410XQA0; LUCA.
DR   GeneTree; ENSGT00390000005004; -.
DR   HOGENOM; HOG000231095; -.
DR   HOVERGEN; HBG009801; -.
DR   InParanoid; P23246; -.
DR   KO; K13219; -.
DR   OMA; AFERCTE; -.
DR   OrthoDB; EOG091G09T7; -.
DR   PhylomeDB; P23246; -.
DR   TreeFam; TF315795; -.
DR   Reactome; R-HSA-8849468; PTK6 Regulates Proteins Involved in RNA Processing.
DR   SIGNOR; P23246; -.
DR   ChiTaRS; SFPQ; human.
DR   GeneWiki; SFPQ; -.
DR   GenomeRNAi; 6421; -.
DR   PRO; PR:P23246; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116560; -.
DR   CleanEx; HS_SFPQ; -.
DR   ExpressionAtlas; P23246; baseline and differential.
DR   Genevisible; P23246; HS.
DR   GO; GO:0000785; C:chromatin; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0016363; C:nuclear matrix; IDA:BHF-UCL.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042382; C:paraspeckles; IDA:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; ISS:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; ISS:BHF-UCL.
DR   GO; GO:0001047; F:core promoter binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0002218; P:activation of innate immune response; IDA:UniProtKB.
DR   GO; GO:0000380; P:alternative mRNA splicing, via spliceosome; IMP:BHF-UCL.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:MGI.
DR   GO; GO:0070932; P:histone H3 deacetylation; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006397; P:mRNA processing; TAS:ProtInc.
DR   GO; GO:0042754; P:negative regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:1902177; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045876; P:positive regulation of sister chromatid cohesion; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd12948; NOPS_PSF; 1.
DR   CDD; cd12587; RRM1_PSF; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034526; PSF_NOPS.
DR   InterPro; IPR034525; PSF_RRM1.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Biological rhythms; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; DNA damage;
KW   DNA recombination; DNA repair; DNA-binding; Immunity; Innate immunity;
KW   Isopeptide bond; Methylation; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Repressor; RNA-binding;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN         1    707       Splicing factor, proline- and glutamine-
FT                                rich.
FT                                /FTId=PRO_0000081909.
FT   REPEAT        9     11       1.
FT   REPEAT       19     21       2.
FT   REPEAT       25     27       3.
FT   DOMAIN      297    369       RRM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      371    452       RRM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   REGION        9     27       3 X 3 AA repeats of R-G-G.
FT   COILED      497    596       {ECO:0000255,
FT                                ECO:0000269|PubMed:25765647}.
FT   COMPBIAS     10    266       Gln/Glu/Pro-rich.
FT   COMPBIAS     10     15       Poly-Gly.
FT   COMPBIAS     20     27       Poly-Gly.
FT   COMPBIAS     56     65       Poly-Pro.
FT   COMPBIAS     67     71       Poly-Gln.
FT   COMPBIAS     95     98       Poly-Gln.
FT   COMPBIAS     99    103       Poly-Pro.
FT   COMPBIAS    184    188       Poly-Pro.
FT   COMPBIAS    571    574       Poly-Arg.
FT   COMPBIAS    613    616       Poly-Gly.
FT   COMPBIAS    635    641       Poly-Gly.
FT   SITE        662    663       Breakpoint for translocation to form
FT                                SFPQ-TFE3.
FT   MOD_RES       8      8       Phosphoserine; by MKNK2.
FT                                {ECO:0000269|PubMed:17965020}.
FT   MOD_RES       9      9       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8VIJ6}.
FT   MOD_RES       9      9       Omega-N-methylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8VIJ6}.
FT   MOD_RES      33     33       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     208    208       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VIJ6}.
FT   MOD_RES     236    236       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     242    242       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     245    245       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     273    273       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     283    283       Phosphoserine; by MKNK2.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:17965020}.
FT   MOD_RES     293    293       Phosphotyrosine; by ALK.
FT                                {ECO:0000269|PubMed:17537995}.
FT   MOD_RES     314    314       N6,N6-dimethyllysine.
FT                                {ECO:0000269|Ref.4}.
FT   MOD_RES     319    319       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     338    338       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     368    368       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     374    374       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     379    379       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     421    421       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     472    472       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     571    571       Dimethylated arginine.
FT                                {ECO:0000269|Ref.4}.
FT   MOD_RES     626    626       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     681    681       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315,
FT                                ECO:0000269|Ref.4}.
FT   MOD_RES     687    687       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:20932480}.
FT   MOD_RES     691    691       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     693    693       Dimethylated arginine; alternate.
FT                                {ECO:0000269|Ref.4}.
FT   MOD_RES     693    693       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     695    695       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   CROSSLNK    271    271       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    279    279       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    338    338       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     663    707       RTERFGQGGAGPVGGQGPRGMGPGTPAGYGRGREEYEGPNK
FT                                KPRF -> VRMIDVG (in isoform Short).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_005855.
FT   MUTAGEN     535    535       L->A: Impairs DNA binding and ability to
FT                                mediate transcriptional activation; when
FT                                associated with A-539; A-546 and A-549.
FT                                {ECO:0000269|PubMed:25765647}.
FT   MUTAGEN     539    539       L->A: Impairs DNA binding and ability to
FT                                mediate transcriptional activation; when
FT                                associated with A-535; A-546 and A-549.
FT                                {ECO:0000269|PubMed:25765647}.
FT   MUTAGEN     546    546       L->A: Impairs DNA binding and ability to
FT                                mediate transcriptional activation; when
FT                                associated with A-535; A-539 and A-549.
FT                                {ECO:0000269|PubMed:25765647}.
FT   MUTAGEN     549    549       M->A: Impairs DNA binding and ability to
FT                                mediate transcriptional activation; when
FT                                associated with A-535; A-539 and A-546.
FT                                {ECO:0000269|PubMed:25765647}.
FT   MUTAGEN     687    687       T->A: Abolishes phosphorylation by GSK3B.
FT                                Impairs interaction with THRAP3.
FT                                {ECO:0000269|PubMed:20932480}.
FT   MUTAGEN     687    687       T->D: No effect on interaction with
FT                                THRAP3 (phosphomimetic).
FT                                {ECO:0000269|PubMed:20932480}.
FT   CONFLICT    243    243       G -> R (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX       277    283       {ECO:0000244|PDB:4WII}.
FT   HELIX       295    297       {ECO:0000244|PDB:4WII}.
FT   STRAND      298    303       {ECO:0000244|PDB:4WII}.
FT   HELIX       310    316       {ECO:0000244|PDB:4WII}.
FT   HELIX       317    320       {ECO:0000244|PDB:4WII}.
FT   STRAND      326    329       {ECO:0000244|PDB:4WII}.
FT   TURN        330    333       {ECO:0000244|PDB:4WII}.
FT   STRAND      334    338       {ECO:0000244|PDB:4WII}.
FT   HELIX       342    352       {ECO:0000244|PDB:4WII}.
FT   STRAND      356    361       {ECO:0000244|PDB:4WII}.
FT   STRAND      363    366       {ECO:0000244|PDB:4WII}.
FT   STRAND      370    377       {ECO:0000244|PDB:4WII}.
FT   HELIX       384    391       {ECO:0000244|PDB:4WII}.
FT   HELIX       392    394       {ECO:0000244|PDB:4WII}.
FT   STRAND      397    404       {ECO:0000244|PDB:4WII}.
FT   STRAND      406    408       {ECO:0000244|PDB:4WIJ}.
FT   STRAND      410    420       {ECO:0000244|PDB:4WII}.
FT   HELIX       421    433       {ECO:0000244|PDB:4WII}.
FT   STRAND      439    441       {ECO:0000244|PDB:4WII}.
FT   STRAND      446    449       {ECO:0000244|PDB:4WII}.
FT   STRAND      454    457       {ECO:0000244|PDB:4WII}.
FT   HELIX       461    464       {ECO:0000244|PDB:4WII}.
FT   HELIX       468    473       {ECO:0000244|PDB:4WII}.
FT   STRAND      478    480       {ECO:0000244|PDB:4WII}.
FT   HELIX       486    526       {ECO:0000244|PDB:4WII}.
FT   HELIX       555    588       {ECO:0000244|PDB:4WIJ}.
SQ   SEQUENCE   707 AA;  76149 MW;  6D8D5EA95E235847 CRC64;
     MSRDRFRSRG GGGGGFHRRG GGGGRGGLHD FRSPPPGMGL NQNRGPMGPG PGQSGPKPPI
     PPPPPHQQQQ QPPPQQPPPQ QPPPHQPPPH PQPHQQQQPP PPPQDSSKPV VAQGPGPAPG
     VGSAPPASSS APPATPPTSG APPGSGPGPT PTPPPAVTSA PPGAPPPTPP SSGVPTTPPQ
     AGGPPPPPAA VPGPGPGPKQ GPGPGGPKGG KMPGGPKPGG GPGLSTPGGH PKPPHRGGGE
     PRGGRQHHPP YHQQHHQGPP PGGPGGRSEE KISDSEGFKA NLSLLRRPGE KTYTQRCRLF
     VGNLPADITE DEFKRLFAKY GEPGEVFINK GKGFGFIKLE SRALAEIAKA ELDDTPMRGR
     QLRVRFATHA AALSVRNLSP YVSNELLEEA FSQFGPIERA VVIVDDRGRS TGKGIVEFAS
     KPAARKAFER CSEGVFLLTT TPRPVIVEPL EQLDDEDGLP EKLAQKNPMY QKERETPPRF
     AQHGTFEYEY SQRWKSLDEM EKQQREQVEK NMKDAKDKLE SEMEDAYHEH QANLLRQDLM
     RRQEELRRME ELHNQEMQKR KEMQLRQEEE RRRREEEMMI RQREMEEQMR RQREESYSRM
     GYMDPRERDM RMGGGGAMNM GDPYGSGGQK FPPLGGGGGI GYEANPGVPP ATMSGSMMGS
     DMRTERFGQG GAGPVGGQGP RGMGPGTPAG YGRGREEYEG PNKKPRF
//
ID   Q86VG2_HUMAN            Unreviewed;       707 AA.
AC   Q86VG2;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   28-FEB-2018, entry version 94.
DE   SubName: Full=Splicing factor proline/glutamine-rich (Polypyrimidine tract binding protein associated) {ECO:0000313|EMBL:AAH51192.1};
GN   Name=SFPQ {ECO:0000313|EMBL:AAH51192.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH51192.1};
RN   [1] {ECO:0000313|EMBL:AAH51192.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH51192.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC051192; AAH51192.1; -; mRNA.
DR   RefSeq; NP_005057.1; NM_005066.2.
DR   UniGene; Hs.355934; -.
DR   UniGene; Hs.611911; -.
DR   ProteinModelPortal; Q86VG2; -.
DR   IntAct; Q86VG2; 2.
DR   PeptideAtlas; Q86VG2; -.
DR   PRIDE; Q86VG2; -.
DR   GeneID; 6421; -.
DR   KEGG; hsa:6421; -.
DR   CTD; 6421; -.
DR   PharmGKB; PA35690; -.
DR   eggNOG; KOG0115; Eukaryota.
DR   eggNOG; ENOG410XQA0; LUCA.
DR   HOVERGEN; HBG009801; -.
DR   KO; K13219; -.
DR   ChiTaRS; SFPQ; human.
DR   GenomeRNAi; 6421; -.
DR   Genevisible; Q86VG2; HS.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   CDD; cd12948; NOPS_PSF; 1.
DR   CDD; cd12587; RRM1_PSF; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034526; PSF_NOPS.
DR   InterPro; IPR034525; PSF_RRM1.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN      297    369       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      371    452       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   COILED      498    529       {ECO:0000256|SAM:Coils}.
FT   COILED      532    595       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   707 AA;  76188 MW;  B5C287EF61FD1811 CRC64;
     MSRDRFRSRG GGGGGFHRRG GGGGRGGLHD FRSPPPGMGL NQNRGPMGPG PGQSGPKPPI
     PPPPPHQQQQ QPPPQQPPPQ QPPPHQPPPH PQPHQQQQPP PPPQDSSKPV VAQGPGPAPG
     VGSTPPASSS APPATPPTSG APPGSGPGPT PTPPPAVTSA PPGAPPPTPP SSGVPTTPPQ
     AGGPPPPPAA VPGPGPGPKQ GPGPGGPKGG KMPGGPKPGG GPGLSTPGGH PKPPRRGGGE
     PRGGRQHHPP YHQQHHQGPP PGGPGGRSEE KISDSEGFKA NLSLLRRPGE KTYTQRCRLF
     VGNLPADITE DEFKRLFAKY GEPGEVFINK GKGFGFIKLE SRALAEIAKA ELDDTPMRGR
     QLRVRFATHA AALSVRNLSP YVSNELLEEA FSQFGPIERA VVIVDDRGRS TGKGIVEFAS
     KPAARKAFER CSEGVFLLTT TPRPVIVEPL EQLDDEDGLP EKLAQKNPMY QKERETPTRF
     AQHGTFEYEY SQRWKSLDEM EKQQREQVEK NMKDAKDKLE SEMEDAYHEH QANLLRQDLM
     RRQEELRRME ELHNQEMQKR KEMQLRQEEE RRRREEEMMI RQREMEDQMR RQREESYSRM
     GYMDPRERDM RMGGGGAMNM GDPYGSGGQK FPPLGGGGGI GYEANPGVPP ATMSGSMMGS
     DMRTERFGQG GAGPVGGQGP RGMGPGTPAG YGRGREEYEG PNKKPRF
//
ID   NPT2B_HUMAN             Reviewed;         690 AA.
AC   O95436; A5PL17; Q8N2K2; Q8WYA9; Q9P0V7;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   28-FEB-2018, entry version 132.
DE   RecName: Full=Sodium-dependent phosphate transport protein 2B;
DE            Short=Sodium-phosphate transport protein 2B;
DE   AltName: Full=Na(+)-dependent phosphate cotransporter 2B;
DE   AltName: Full=NaPi3b;
DE   AltName: Full=Sodium/phosphate cotransporter 2B;
DE            Short=Na(+)/Pi cotransporter 2B;
DE            Short=NaPi-2b;
DE   AltName: Full=Solute carrier family 34 member 2;
GN   Name=SLC34A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), BIOPHYSICOCHEMICAL PROPERTIES,
RP   TISSUE SPECIFICITY, AND VARIANT GLY-634.
RC   TISSUE=Lung, and Small intestine;
RX   PubMed=10329428; DOI=10.1006/bbrc.1999.0666;
RA   Feild J.A., Zhang L., Brun K.A., Brooks D.P., Edwards R.M.;
RT   "Cloning and functional characterization of a sodium-dependent
RT   phosphate transporter expressed in human lung and small intestine.";
RL   Biochem. Biophys. Res. Commun. 258:578-582(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND
RP   VARIANT GLY-634.
RC   TISSUE=Small intestine;
RX   PubMed=10610722; DOI=10.1006/geno.1999.6009;
RA   Xu H., Bai L., Collins J.F., Ghishan F.K.;
RT   "Molecular cloning, functional characterization, tissue distribution,
RT   and chromosomal localization of a human, small intestinal sodium-
RT   phosphate (Na+-Pi) transporter (SLC34A2).";
RL   Genomics 62:281-284(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   GLY-634.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-592 (ISOFORM 2), AND INDUCTION.
RC   TISSUE=Intestine;
RX   PubMed=11171583;
RA   Xu H., Collins J.F., Bai L., Kiela P.R., Ghishan F.K.;
RT   "Regulation of the human sodium-phosphate cotransporter NaPi-IIb gene
RT   promoter by epidermal growth factor.";
RL   Am. J. Physiol. 280:C628-C636(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 266-690, AND VARIANT
RP   GLY-634.
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH ROS1.
RX   PubMed=12661006; DOI=10.1002/gcc.10207;
RA   Charest A., Lane K., McMahon K., Park J., Preisinger E., Conroy H.,
RA   Housman D.;
RT   "Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma
RT   with an interstitial del(6)(q21q21).";
RL   Genes Chromosomes Cancer 37:58-71(2003).
RN   [8]
RP   VARIANT PALM ARG-106.
RX   PubMed=16960801; DOI=10.1086/508263;
RA   Corut A., Senyigit A., Ugur S.A., Altin S., Ozcelik U., Calisir H.,
RA   Yildirim Z., Gocmen A., Tolun A.;
RT   "Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are
RT   possibly associated with testicular microlithiasis.";
RL   Am. J. Hum. Genet. 79:650-656(2006).
CC   -!- FUNCTION: May be involved in actively transporting phosphate into
CC       cells via Na(+) cotransport. It may be the main phosphate
CC       transport protein in the intestinal brush border membrane. May
CC       have a role in the synthesis of surfactant in lungs' alveoli.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.6. {ECO:0000269|PubMed:10329428};
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=NaPi-3b;
CC         IsoId=O95436-1; Sequence=Displayed;
CC       Name=2; Synonyms=NaPi-2b, NaPi-IIb;
CC         IsoId=O95436-2; Sequence=VSP_016755;
CC   -!- TISSUE SPECIFICITY: Highly expressed in lung. Also detected in
CC       pancreas, kidney, small intestine, ovary, testis, prostate and
CC       mammary gland. In lung, it is found in alveolar type II cells but
CC       not in bronchiolar epithelium. {ECO:0000269|PubMed:10329428,
CC       ECO:0000269|PubMed:10610722}.
CC   -!- INDUCTION: Down-regulated by EGF. {ECO:0000269|PubMed:11171583}.
CC   -!- DISEASE: Pulmonary alveolar microlithiasis (PALM) [MIM:265100]:
CC       Rare disease characterized by the deposition of calcium phosphate
CC       microliths throughout the lungs. Most patients are asymptomatic
CC       for several years or even for decades and generally, the diagnosis
CC       is incidental to clinical investigations unrelated to the disease.
CC       Cases with early-onset or rapid progression are rare. A
CC       'sandstorm-appearing' chest roentgenogram is a typical diagnostic
CC       finding. The onset of this potentially lethal disease varies from
CC       the neonatal period to old age and the disease follows a long-
CC       term, progressive course, resulting in a slow deterioration of
CC       lung functions. Pulmonary alveolar microlithiasis is a recessive
CC       monogenic disease with full penetrance.
CC       {ECO:0000269|PubMed:16960801}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving SLC34A2 is found
CC       in a glioblastoma multiforme cell line U-118MG. Results in the
CC       formation of a SLC34A2-ROS1 chimeric protein that retains a
CC       constitutive kinase activity. {ECO:0000269|PubMed:12661006}.
CC   -!- SIMILARITY: Belongs to the SLC34A transporter family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11354.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF111856; AAC98695.1; -; mRNA.
DR   EMBL; AF146796; AAF31328.1; -; mRNA.
DR   EMBL; AC092436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC142704; AAI42705.1; -; mRNA.
DR   EMBL; BC146666; AAI46667.1; -; mRNA.
DR   EMBL; AH011306; AAL55657.1; -; Genomic_DNA.
DR   EMBL; AK075015; BAC11354.1; ALT_INIT; mRNA.
DR   CCDS; CCDS3435.1; -. [O95436-1]
DR   CCDS; CCDS54750.1; -. [O95436-2]
DR   RefSeq; NP_001171469.1; NM_001177998.1.
DR   RefSeq; NP_001171470.1; NM_001177999.1.
DR   RefSeq; NP_006415.2; NM_006424.2.
DR   UniGene; Hs.479372; -.
DR   ProteinModelPortal; O95436; -.
DR   SMR; O95436; -.
DR   BioGrid; 115819; 15.
DR   IntAct; O95436; 11.
DR   STRING; 9606.ENSP00000371483; -.
DR   TCDB; 2.A.58.1.4; the phosphate:na(+) symporter (pnas) family.
DR   iPTMnet; O95436; -.
DR   PhosphoSitePlus; O95436; -.
DR   BioMuta; SLC34A2; -.
DR   MaxQB; O95436; -.
DR   PaxDb; O95436; -.
DR   PeptideAtlas; O95436; -.
DR   PRIDE; O95436; -.
DR   Ensembl; ENST00000382051; ENSP00000371483; ENSG00000157765. [O95436-1]
DR   Ensembl; ENST00000503434; ENSP00000423021; ENSG00000157765. [O95436-2]
DR   Ensembl; ENST00000504570; ENSP00000425501; ENSG00000157765. [O95436-2]
DR   GeneID; 10568; -.
DR   KEGG; hsa:10568; -.
DR   UCSC; uc003grr.4; human. [O95436-1]
DR   CTD; 10568; -.
DR   DisGeNET; 10568; -.
DR   EuPathDB; HostDB:ENSG00000157765.11; -.
DR   GeneCards; SLC34A2; -.
DR   HGNC; HGNC:11020; SLC34A2.
DR   HPA; HPA037989; -.
DR   MalaCards; SLC34A2; -.
DR   MIM; 265100; phenotype.
DR   MIM; 604217; gene.
DR   neXtProt; NX_O95436; -.
DR   OpenTargets; ENSG00000157765; -.
DR   Orphanet; 60025; Pulmonary alveolar microlithiasis.
DR   PharmGKB; PA35888; -.
DR   eggNOG; ENOG410IE8P; Eukaryota.
DR   eggNOG; COG1283; LUCA.
DR   GeneTree; ENSGT00390000005032; -.
DR   HOGENOM; HOG000006550; -.
DR   HOVERGEN; HBG006527; -.
DR   InParanoid; O95436; -.
DR   KO; K14683; -.
DR   OMA; IWCKTFT; -.
DR   OrthoDB; EOG091G0DR5; -.
DR   PhylomeDB; O95436; -.
DR   TreeFam; TF313981; -.
DR   Reactome; R-HSA-427589; Type II Na+/Pi cotransporters.
DR   Reactome; R-HSA-5619045; Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM).
DR   Reactome; R-HSA-5683826; Surfactant metabolism.
DR   Reactome; R-HSA-5687583; Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM).
DR   SIGNOR; O95436; -.
DR   ChiTaRS; SLC34A2; human.
DR   GeneWiki; SLC34A2; -.
DR   GenomeRNAi; 10568; -.
DR   PRO; PR:O95436; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000157765; -.
DR   CleanEx; HS_SLC34A2; -.
DR   ExpressionAtlas; O95436; baseline and differential.
DR   Genevisible; O95436; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005903; C:brush border; IBA:GO_Central.
DR   GO; GO:0031526; C:brush border membrane; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0042301; F:phosphate ion binding; IDA:UniProtKB.
DR   GO; GO:0031402; F:sodium ion binding; IDA:UniProtKB.
DR   GO; GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005436; F:sodium:phosphate symporter activity; IDA:UniProtKB.
DR   GO; GO:0030643; P:cellular phosphate ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0006817; P:phosphate ion transport; IDA:UniProtKB.
DR   GO; GO:0043627; P:response to estrogen; IEP:UniProtKB.
DR   InterPro; IPR003841; Na/Pi_transpt.
DR   InterPro; IPR029852; Na/Pi_transpt_2B.
DR   PANTHER; PTHR10010; PTHR10010; 1.
DR   PANTHER; PTHR10010:SF23; PTHR10010:SF23; 1.
DR   Pfam; PF02690; Na_Pi_cotrans; 2.
DR   TIGRFAMs; TIGR01013; 2a58; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Disulfide bond; Glycoprotein; Ion transport; Membrane; Polymorphism;
KW   Reference proteome; Sodium; Sodium transport; Symport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    690       Sodium-dependent phosphate transport
FT                                protein 2B.
FT                                /FTId=PRO_0000068613.
FT   TOPO_DOM      1    100       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    101    121       Helical; Name=M1. {ECO:0000255}.
FT   TOPO_DOM    122    135       Extracellular. {ECO:0000255}.
FT   TRANSMEM    136    156       Helical; Name=M2. {ECO:0000255}.
FT   TOPO_DOM    157    212       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    213    233       Helical; Name=M3. {ECO:0000255}.
FT   TOPO_DOM    234    362       Extracellular. {ECO:0000255}.
FT   TRANSMEM    363    383       Helical; Name=M4. {ECO:0000255}.
FT   TOPO_DOM    384    407       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    408    428       Helical; Name=M5. {ECO:0000255}.
FT   TOPO_DOM    429    485       Extracellular. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical; Name=M6. {ECO:0000255}.
FT   TOPO_DOM    507    525       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    526    546       Helical; Name=M7. {ECO:0000255}.
FT   TOPO_DOM    547    552       Extracellular. {ECO:0000255}.
FT   TRANSMEM    553    573       Helical; Name=M8. {ECO:0000255}.
FT   TOPO_DOM    574    689       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    464    467       Poly-Thr.
FT   COMPBIAS    612    644       Cys-rich.
FT   SITE        126    127       Breakpoint for translocation to form a
FT                                SLC34A2-ROS1 fusion protein.
FT   CARBOHYD    295    295       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    308    308       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    313    313       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    321    321       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    340    340       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    303    350       {ECO:0000250}.
FT   VAR_SEQ      38     39       TD -> N (in isoform 2).
FT                                {ECO:0000303|PubMed:10610722,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016755.
FT   VARIANT      45     45       V -> A (in dbSNP:rs35426730).
FT                                /FTId=VAR_034156.
FT   VARIANT     106    106       G -> R (in PALM; dbSNP:rs137853142).
FT                                {ECO:0000269|PubMed:16960801}.
FT                                /FTId=VAR_030677.
FT   VARIANT     634    634       D -> G (in dbSNP:rs6448389).
FT                                {ECO:0000269|PubMed:10329428,
FT                                ECO:0000269|PubMed:10610722,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030678.
FT   CONFLICT    228    228       V -> L (in Ref. 2; AAF31328 and 5;
FT                                AAL55657). {ECO:0000305}.
FT   CONFLICT    330    330       T -> V (in Ref. 6; BAC11354).
FT                                {ECO:0000305}.
FT   CONFLICT    590    595       Missing (in Ref. 6; BAC11354).
FT                                {ECO:0000305}.
FT   CONFLICT    620    620       C -> Y (in Ref. 1; AAC98695).
FT                                {ECO:0000305}.
SQ   SEQUENCE   690 AA;  75759 MW;  3BDB1920CA92C035 CRC64;
     MAPWPELGDA QPNPDKYLEG AAGQQPTAPD KSKETNKTDN TEAPVTKIEL LPSYSTATLI
     DEPTEVDDPW NLPTLQDSGI KWSERDTKGK ILCFFQGIGR LILLLGFLYF FVCSLDILSS
     AFQLVGGKMA GQFFSNSSIM SNPLLGLVIG VLVTVLVQSS STSTSIVVSM VSSSLLTVRA
     AIPIIMGANI GTSITNTIVA LMQVGDRSEF RRAFAGATVH DFFNWLSVLV LLPVEVATHY
     LEIITQLIVE SFHFKNGEDA PDLLKVITKP FTKLIVQLDK KVISQIAMND EKAKNKSLVK
     IWCKTFTNKT QINVTVPSTA NCTSPSLCWT DGIQNWTMKN VTYKENIAKC QHIFVNFHLP
     DLAVGTILLI LSLLVLCGCL IMIVKILGSV LKGQVATVIK KTINTDFPFP FAWLTGYLAI
     LVGAGMTFIV QSSSVFTSAL TPLIGIGVIT IERAYPLTLG SNIGTTTTAI LAALASPGNA
     LRSSLQIALC HFFFNISGIL LWYPIPFTRL PIRMAKGLGN ISAKYRWFAV FYLIIFFFLI
     PLTVFGLSLA GWRVLVGVGV PVVFIIILVL CLRLLQSRCP RVLPKKLQNW NFLPLWMRSL
     KPWDAVVSKF TGCFQMRCCC CCRVCCRACC LLCDCPKCCR CSKCCEDLEE AQEGQDVPVK
     APETFDNITI SREAQGEVPA SDSKTECTAL
//
ID   A0A087WWU8_HUMAN        Unreviewed;       227 AA.
AC   A0A087WWU8;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   28-FEB-2018, entry version 23.
DE   SubName: Full=Tropomyosin alpha-3 chain {ECO:0000313|Ensembl:ENSP00000480520};
GN   Name=TPM3 {ECO:0000313|Ensembl:ENSP00000480520};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000480520, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000480520}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7] {ECO:0000313|Ensembl:ENSP00000480520}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000480520}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL590431; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265119.1; NM_001278190.1.
DR   UniGene; Hs.535581; -.
DR   UniGene; Hs.578978; -.
DR   UniGene; Hs.644306; -.
DR   UniGene; Hs.654421; -.
DR   ProteinModelPortal; A0A087WWU8; -.
DR   SMR; A0A087WWU8; -.
DR   PeptideAtlas; A0A087WWU8; -.
DR   PRIDE; A0A087WWU8; -.
DR   Ensembl; ENST00000611659; ENSP00000480520; ENSG00000143549.
DR   GeneID; 7170; -.
DR   UCSC; uc031ppo.1; human.
DR   CTD; 7170; -.
DR   EuPathDB; HostDB:ENSG00000143549.19; -.
DR   HGNC; HGNC:12012; TPM3.
DR   OpenTargets; ENSG00000143549; -.
DR   GeneTree; ENSGT00550000074494; -.
DR   ChiTaRS; TPM3; human.
DR   GenomeRNAi; 7170; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143549; -.
DR   ExpressionAtlas; A0A087WWU8; baseline and differential.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00486935, ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WWU8,
KW   ECO:0000213|MaxQB:A0A087WWU8, ECO:0000213|PeptideAtlas:A0A087WWU8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   COILED        7     97       {ECO:0000256|SAM:Coils}.
FT   COILED      105    209       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   227 AA;  26421 MW;  0DE260B63E0F1E4D CRC64;
     MAGITTIEAV KRKIQVLQQQ ADDAEERAER LQREVEGERR AREQAEAEVA SLNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRALK DEEKMELQEI QLKEAKHIAE
     EADRKYEEVA RKLVIIEGDL ERTEERAELA ESRCREMDEQ IRLMDQNLKC LSAAEEKAET
     RAEFAERSVA KLEKTIDDLE DKLKCTKEEH LCTQRMLDQT LLDLNEM
//
ID   A0A0S2Z4G4_HUMAN        Unreviewed;       248 AA.
AC   A0A0S2Z4G4;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 10.
DE   SubName: Full=Tropomyosin 3 isoform 1 {ECO:0000313|EMBL:ALQ33826.1};
DE   Flags: Fragment;
GN   Name=TPM3 {ECO:0000313|EMBL:ALQ33826.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33826.1};
RN   [1] {ECO:0000313|EMBL:ALQ33826.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178368; ALQ33826.1; -; mRNA.
DR   RefSeq; NP_705935.1; NM_153649.3.
DR   UniGene; Hs.535581; -.
DR   UniGene; Hs.578978; -.
DR   UniGene; Hs.644306; -.
DR   UniGene; Hs.654421; -.
DR   ProteinModelPortal; A0A0S2Z4G4; -.
DR   SMR; A0A0S2Z4G4; -.
DR   GeneID; 7170; -.
DR   CTD; 7170; -.
DR   ChiTaRS; TPM3; human.
DR   ExpressionAtlas; A0A0S2Z4G4; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00486935, ECO:0000256|SAM:Coils}.
FT   COILED        7     97       {ECO:0000256|SAM:Coils}.
FT   COILED      105    230       {ECO:0000256|SAM:Coils}.
FT   NON_TER     248    248       {ECO:0000313|EMBL:ALQ33826.1}.
SQ   SEQUENCE   248 AA;  29033 MW;  5C049312A337BC19 CRC64;
     MAGITTIEAV KRKIQVLQQQ ADDAEERAER LQREVEGERR AREQAEAEVA SLNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRALK DEEKMELQEI QLKEAKHIAE
     EADRKYEEVA RKLVIIEGDL ERTEERAELA ESRCREMDEQ IRLMDQNLKC LSAAEEKYSQ
     KEDKYEEEIK ILTDKLKEAE TRAEFAERSV AKLEKTIDDL EDKLKCTKEE HLCTQRMLDQ
     TLLDLNEM
//
ID   A0A0S2Z4I4_HUMAN        Unreviewed;       248 AA.
AC   A0A0S2Z4I4;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-FEB-2018, entry version 11.
DE   SubName: Full=Tropomyosin 3 isoform 3 {ECO:0000313|EMBL:ALQ33828.1};
DE   Flags: Fragment;
GN   Name=TPM3 {ECO:0000313|EMBL:ALQ33828.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33828.1};
RN   [1] {ECO:0000313|EMBL:ALQ33828.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178370; ALQ33828.1; -; mRNA.
DR   RefSeq; NP_001036816.1; NM_001043351.1.
DR   UniGene; Hs.535581; -.
DR   UniGene; Hs.578978; -.
DR   UniGene; Hs.644306; -.
DR   UniGene; Hs.654421; -.
DR   ProteinModelPortal; A0A0S2Z4I4; -.
DR   SMR; A0A0S2Z4I4; -.
DR   GeneID; 7170; -.
DR   CTD; 7170; -.
DR   ChiTaRS; TPM3; human.
DR   ExpressionAtlas; A0A0S2Z4I4; baseline and differential.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00486935, ECO:0000256|SAM:Coils}.
FT   COILED        7     97       {ECO:0000256|SAM:Coils}.
FT   COILED      105    230       {ECO:0000256|SAM:Coils}.
FT   NON_TER     248    248       {ECO:0000313|EMBL:ALQ33828.1}.
SQ   SEQUENCE   248 AA;  28870 MW;  179E2D62BC8993F5 CRC64;
     MAGITTIEAV KRKIQVLQQQ ADDAEERAER LQREVEGERR AREQAEAEVA SLNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRALK DEEKMELQEI QLKEAKHIAE
     EADRKYEEVA RKLVIIEGDL ERTEERAELA ESKCSELEEE LKNVTNNLKS LEAQAEKYSQ
     KEDKYEEEIK ILTDKLKEAE TRAEFAERSV AKLEKTIDDL EDKLKCTKEE HLCTQRMLDQ
     TLLDLNEM
//
ID   B4DQ80_HUMAN            Unreviewed;       182 AA.
AC   B4DQ80;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   07-JUN-2017, entry version 33.
DE   SubName: Full=cDNA FLJ50612, highly similar to Rattus norvegicus tropomyosin 3, gamma (Tpm3), transcript variant 2, mRNA {ECO:0000313|EMBL:BAG60842.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG60842.1};
RN   [1] {ECO:0000313|EMBL:BAG60842.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK298678; BAG60842.1; -; mRNA.
DR   RefSeq; NP_001265117.1; NM_001278188.1.
DR   UniGene; Hs.535581; -.
DR   UniGene; Hs.578978; -.
DR   UniGene; Hs.644306; -.
DR   UniGene; Hs.654421; -.
DR   ProteinModelPortal; B4DQ80; -.
DR   SMR; B4DQ80; -.
DR   PeptideAtlas; B4DQ80; -.
DR   PRIDE; B4DQ80; -.
DR   GeneID; 7170; -.
DR   CTD; 7170; -.
DR   HOVERGEN; HBG107404; -.
DR   GenomeRNAi; 7170; -.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00486935, ECO:0000256|SAM:Coils}.
FT   COILED       39    164       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   182 AA;  21353 MW;  DC4A3CC3AA4CFACE CRC64;
     MMQRSELSAS SEKLREKGGP GNRGMKVIEN RALKDEEKME LQEIQLKEAK HIAEEADRKY
     EEVARKLVII EGDLERTEER AELAESRCRE MDEQIRLMDQ NLKCLSAAEE KYSQKEDKYE
     EEIKILTDKL KEAETRAEFA ERSVAKLEKT IDDLEDKLKC TKEEHLCTQR MLDQTLLDLN
     EM
//
ID   TPM3_HUMAN              Reviewed;         285 AA.
AC   P06753; D3DV71; P12324; Q2QD06; Q5VU58; Q5VU63; Q5VU66; Q5VU71;
AC   Q5VU72; Q8TCG3; Q969Q2; Q9NQH8;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2013, sequence version 2.
DT   28-FEB-2018, entry version 205.
DE   RecName: Full=Tropomyosin alpha-3 chain;
DE   AltName: Full=Gamma-tropomyosin;
DE   AltName: Full=Tropomyosin-3;
DE   AltName: Full=Tropomyosin-5;
DE            Short=hTM5;
GN   Name=TPM3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3018581; DOI=10.1038/322648a0;
RA   Reinach F.C., McLeod A.R.;
RT   "Tissue-specific expression of the human tropomyosin gene involved in
RT   the generation of the trk oncogene.";
RL   Nature 322:648-650(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=3024106; DOI=10.1093/nar/14.21.8413;
RA   McLeod A.R., Houlker C., Talbot K.;
RT   "The mRNA and RNA-copy pseudogenes encoding TM30nm, a human
RT   cytoskeletal tropomyosin.";
RL   Nucleic Acids Res. 14:8413-8426(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 2).
RX   PubMed=3418707; DOI=10.1016/0022-2836(88)90633-X;
RA   Clayton L., Reinach F.C., Chumbley G.M., MacLeod A.R.;
RT   "Organization of the hTMnm gene. Implications for the evolution of
RT   muscle and non-muscle tropomyosins.";
RL   J. Mol. Biol. 201:507-515(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 3).
RC   TISSUE=Colon cancer;
RA   Lin J.J.-C., Lin J.L.-C., Geng X., Das K.M.;
RT   "Identification and characterization of a novel tropomyosin isoform
RT   from a colon cancer cell line T84.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Bone, Kidney, Skeletal muscle, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 2-248 (ISOFORM 2), AND
RP   IDENTIFICATION OF RCTPM3.
RX   PubMed=16201836; DOI=10.1371/journal.pbio.0030357;
RA   Marques A.C., Dupanloup I., Vinckenbosch N., Reymond A., Kaessmann H.;
RT   "Emergence of young human genes after a burst of retroposition in
RT   primates.";
RL   PLoS Biol. 3:E357-E357(2005).
RN   [9]
RP   PROTEIN SEQUENCE OF 93-126; 135-150; 154-168 AND 215-245, PARTIAL
RP   PROTEIN SEQUENCE (ISOFORMS 2/3), CLEAVAGE OF INITIATOR METHIONINE
RP   (ISOFORMS 2/3), ACETYLATION AT ALA-2 (ISOFORMS 2/3), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma, and Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (DEC-2005) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 93-119, PARTIAL PROTEIN SEQUENCE (ISOFORMS 2/3),
RP   CLEAVAGE OF INITIATOR METHIONINE (ISOFORMS 2/3), ACETYLATION AT ALA-2
RP   (ISOFORMS 2/3), AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Osteosarcoma;
RA   Bienvenut W.V., Glen H., Brunton V.G., Frame M.C.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [11]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND CHROMOSOMAL
RP   TRANSLOCATION WITH NTRK1.
RX   PubMed=2869410; DOI=10.1038/319743a0;
RA   Martin-Zanca D., Hughes S.H., Barbacid M.;
RT   "A human oncogene formed by the fusion of truncated tropomyosin and
RT   protein tyrosine kinase sequences.";
RL   Nature 319:743-748(1986).
RN   [12]
RP   PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [13]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RC   TISSUE=Skeletal muscle;
RX   PubMed=12574106; DOI=10.1161/01.HYP.0000050646.79785.7C;
RA   Dunn S.A., Mohteshamzadeh M., Daly A.K., Thomas T.H.;
RT   "Altered tropomyosin expression in essential hypertension.";
RL   Hypertension 41:347-354(2003).
RN   [14]
RP   INTERACTION WITH TMOD1.
RX   PubMed=8002995; DOI=10.1006/bbrc.1994.1747;
RA   Sung L.A., Lin J.J.-C.;
RT   "Erythrocyte tropomodulin binds to the N-terminus of hTM5, a
RT   tropomyosin isoform encoded by the gamma-tropomyosin gene.";
RL   Biochem. Biophys. Res. Commun. 201:627-634(1994).
RN   [15]
RP   IDENTIFICATION OF RCTPM3 BY MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RA   Ahamed M.E., Ahmed M.E., Eltoum A.M., Altahir G.O., Ahmed K.M.,
RA   Harbi S.O., Stansalas J., Mohamed A.O.;
RT   "Abnormal proteins in primary breast cancer tissues from 25 Sudanese
RT   patients.";
RL   Eur. J. Inflamm. 6:115-121(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-177 (ISOFORMS 2; 3 AND 6),
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-215 (ISOFORMS 2 AND 5),
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-125 (ISOFORM 7), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   VARIANT NEM1 ARG-9.
RX   PubMed=7704029; DOI=10.1038/ng0195-75;
RA   Laing N.G., Wilton S.D., Akkari P.A., Dorosz S., Boundy K.,
RA   Kneebone C., Blumbergs P., White S., Watkins H., Love D.R., Haan E.;
RT   "A mutation in the alpha tropomyosin gene TPM3 associated with
RT   autosomal dominant nemaline myopathy.";
RL   Nat. Genet. 9:75-79(1995).
RN   [23]
RP   ERRATUM.
RX   PubMed=7663526;
RA   Laing N.G., Wilton S.D., Akkari P.A., Dorosz S., Boundy K.,
RA   Kneebone C., Blumbergs P., White S., Watkins H., Love D.R., Haan E.;
RL   Nat. Genet. 10:249-249(1995).
RN   [24]
RP   CHARACTERIZATION OF VARIANT NEM1 ARG-9.
RX   PubMed=10587521; DOI=10.1172/JCI7842;
RA   Michele D.E., Albayya F.P., Metzger J.M.;
RT   "A nemaline myopathy mutation in alpha-tropomyosin causes defective
RT   regulation of striated muscle force production.";
RL   J. Clin. Invest. 104:1575-1581(1999).
RN   [25]
RP   VARIANT NEM1 HIS-168.
RX   PubMed=17376686; DOI=10.1016/j.nmd.2007.01.017;
RA   Penisson-Besnier I., Monnier N., Toutain A., Dubas F., Laing N.;
RT   "A second pedigree with autosomal dominant nemaline myopathy caused by
RT   TPM3 mutation: a clinical and pathological study.";
RL   Neuromuscul. Disord. 17:330-337(2007).
RN   [26]
RP   VARIANTS CFTD MET-100; CYS-168; GLY-168; GLU-169 AND GLY-245, AND
RP   VARIANT CAPM1 HIS-168.
RX   PubMed=18300303; DOI=10.1002/ana.21308;
RA   Clarke N.F., Kolski H., Dye D.E., Lim E., Smith R.L., Patel R.,
RA   Fahey M.C., Bellance R., Romero N.B., Johnson E.S., Labarre-Vila A.,
RA   Monnier N., Laing N.G., North K.N.;
RT   "Mutations in TPM3 are a common cause of congenital fiber type
RT   disproportion.";
RL   Ann. Neurol. 63:329-337(2008).
RN   [27]
RP   VARIANT CAPM1 CYS-168.
RX   PubMed=19487656; DOI=10.1212/WNL.0b013e3181a82659;
RA   Ohlsson M., Fidzianska A., Tajsharghi H., Oldfors A.;
RT   "TPM3 mutation in one of the original cases of cap disease.";
RL   Neurology 72:1961-1963(2009).
RN   [28]
RP   VARIANT CAPM1 HIS-168.
RX   PubMed=19553118; DOI=10.1016/j.nmd.2009.06.365;
RA   De Paula A.M., Franques J., Fernandez C., Monnier N., Lunardi J.,
RA   Pellissier J.F., Figarella-Branger D., Pouget J.;
RT   "A TPM3 mutation causing cap myopathy.";
RL   Neuromuscul. Disord. 19:685-688(2009).
RN   [29]
RP   VARIANTS CFTD VAL-4; PRO-91; HIS-168 AND LYS-241.
RX   PubMed=19953533; DOI=10.1002/humu.21157;
RA   Lawlor M.W., Dechene E.T., Roumm E., Geggel A.S., Moghadaszadeh B.,
RA   Beggs A.H.;
RT   "Mutations of tropomyosin 3 (TPM3) are common and associated with type
RT   1 myofiber hypotrophy in congenital fiber type disproportion.";
RL   Hum. Mutat. 31:176-183(2010).
RN   [30]
RP   VARIANTS CFTD HIS-168 AND ALA-174.
RX   PubMed=20951040; DOI=10.1016/j.nmd.2010.07.274;
RA   Munot P., Lashley D., Jungbluth H., Feng L., Pitt M., Robb S.A.,
RA   Palace J., Jayawant S., Kennet R., Beeson D., Cullup T., Abbs S.,
RA   Laing N., Sewry C., Muntoni F.;
RT   "Congenital fibre type disproportion associated with mutations in the
RT   tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.";
RL   Neuromuscul. Disord. 20:796-800(2010).
RN   [31]
RP   VARIANTS NEM1 PHE-88 AND CYS-168, VARIANTS CAPM1 PHE-88; ALA-151;
RP   CYS-168 AND ILE-245, VARIANTS CFTD VAL-100; CYS-168 AND HIS-168, AND
RP   VARIANTS CYS-91 AND LYS-253.
RX   PubMed=24692096; DOI=10.1002/humu.22554;
RA   Marttila M., Lehtokari V.L., Marston S., Nyman T.A., Barnerias C.,
RA   Beggs A.H., Bertini E., Ceyhan-Birsoy O., Cintas P., Gerard M.,
RA   Gilbert-Dussardier B., Hogue J.S., Longman C., Eymard B., Frydman M.,
RA   Kang P.B., Klinge L., Kolski H., Lochmueller H., Magy L., Manel V.,
RA   Mayer M., Mercuri E., North K.N., Peudenier-Robert S., Pihko H.,
RA   Probst F.J., Reisin R., Stewart W., Taratuto A.L., de Visser M.,
RA   Wilichowski E., Winer J., Nowak K., Laing N.G., Winder T.L.,
RA   Monnier N., Clarke N.F., Pelin K., Groenholm M.,
RA   Wallgren-Pettersson C.;
RT   "Mutation update and genotype-phenotype correlations of novel and
RT   previously described mutations in TPM2 and TPM3 causing congenital
RT   myopathies.";
RL   Hum. Mutat. 35:779-790(2014).
RN   [32]
RP   VARIANT CAPM1 ILE-149.
RX   PubMed=24239060; DOI=10.1016/j.nmd.2013.10.002;
RA   Schreckenbach T., Schroeder J.M., Voit T., Abicht A., Neuen-Jacob E.,
RA   Roos A., Bulst S., Kuhl C., Schulz J.B., Weis J., Claeys K.G.;
RT   "Novel TPM3 mutation in a family with cap myopathy and review of the
RT   literature.";
RL   Neuromuscul. Disord. 24:117-124(2014).
CC   -!- FUNCTION: Binds to actin filaments in muscle and non-muscle cells.
CC       Plays a central role, in association with the troponin complex, in
CC       the calcium dependent regulation of vertebrate striated muscle
CC       contraction. Smooth muscle contraction is regulated by interaction
CC       with caldesmon. In non-muscle cells is implicated in stabilizing
CC       cytoskeleton actin filaments. {ECO:0000250|UniProtKB:P09493}.
CC   -!- SUBUNIT: Homodimer. Heterodimer of an alpha (TPM1, TPM3 or TPM4)
CC       and a beta (TPM2) chain (By similarity). Interacts with TMOD1
CC       (PubMed:8002995). {ECO:0000250|UniProtKB:P04692,
CC       ECO:0000269|PubMed:8002995}.
CC   -!- INTERACTION:
CC       Q8TAB5:C1orf216; NbExp=3; IntAct=EBI-355607, EBI-747505;
CC       Q8TD31-3:CCHCR1; NbExp=11; IntAct=EBI-355607, EBI-10175300;
CC       Q8IZT9:FAM9C; NbExp=5; IntAct=EBI-355607, EBI-2870039;
CC       Q03933:HSF2; NbExp=8; IntAct=EBI-355607, EBI-2556750;
CC       O14879:IFIT3; NbExp=5; IntAct=EBI-355607, EBI-745127;
CC       Q9BQD3:KXD1; NbExp=10; IntAct=EBI-355607, EBI-739657;
CC       O95447:LCA5L; NbExp=3; IntAct=EBI-355607, EBI-8473670;
CC       Q96LR2:LURAP1; NbExp=3; IntAct=EBI-355607, EBI-741355;
CC       Q9Y6D9:MAD1L1; NbExp=9; IntAct=EBI-355607, EBI-742610;
CC       Q7Z3B4:NUP54; NbExp=6; IntAct=EBI-355607, EBI-741048;
CC       O43482:OIP5; NbExp=8; IntAct=EBI-355607, EBI-536879;
CC       Q8N0S2:SYCE1; NbExp=7; IntAct=EBI-355607, EBI-6872807;
CC       A0A024R4Q5:TFPT; NbExp=6; IntAct=EBI-355607, EBI-11527449;
CC       P0C1Z6:TFPT; NbExp=8; IntAct=EBI-355607, EBI-1245626;
CC       P0C1Z6-2:TFPT; NbExp=3; IntAct=EBI-355607, EBI-10178002;
CC       Q9NVV9:THAP1; NbExp=4; IntAct=EBI-355607, EBI-741515;
CC       P13805-3:TNNT1; NbExp=3; IntAct=EBI-355607, EBI-12151635;
CC       Q8N1B4:VPS52; NbExp=3; IntAct=EBI-355607, EBI-2799833;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Skeletal muscle;
CC         IsoId=P06753-1; Sequence=Displayed;
CC       Name=2; Synonyms=Cytoskeletal, TM30nm;
CC         IsoId=P06753-2; Sequence=VSP_006604, VSP_006605, VSP_006606;
CC         Note=Peptides 2-27, 41-55, 132-153, 163-169, 216-225 and 237-248
CC         have been identified and sequenced by MS. Initiator Met-1 is
CC         removed. Contains a N-acetylalanine at position 2. Ref.8
CC         (ABC40673) sequence is in conflict in position: 33:R->Q. Ref.8
CC         (ABC40673) sequence is in conflict in position: 43:E->K. Ref.8
CC         (ABC40673) sequence is in conflict in position: 66:A->P. Ref.8
CC         (ABC40673) sequence is in conflict in position: 85:D->G. Ref.8
CC         (ABC40673) sequence is in conflict in position: 110:I->L. Ref.8
CC         (ABC40673) sequence is in conflict in position: 135:I->T. Ref.8
CC         (ABC40673) sequence is in conflict in position: 150:A->T. Ref.8
CC         (ABC40673) sequence is in conflict in position: 192:L->F. Ref.8
CC         (ABC40673) sequence is in conflict in position: 196:L->P. Ref.8
CC         (ABC40673) sequence is in conflict in position: 202:R->C. Ref.8
CC         (ABC40673) sequence corresponds to a TPM3 retrocopy (rcTPM3) on
CC         chromosome 16 that is generated by retroposition of reversed
CC         transcribed mRNA back to the genome. rcTPM3 functionality is
CC         uncertain. It has been detected by MS in primary breast cancer
CC         tissues. Contains a N6-acetyllysine at position 177. Contains a
CC         N6-acetyllysine at position 215. {ECO:0000244|PubMed:19608861,
CC         ECO:0000269|Ref.10, ECO:0000269|Ref.9, ECO:0000305};
CC       Name=3;
CC         IsoId=P06753-3; Sequence=VSP_006604, VSP_006605, VSP_006607;
CC         Note=Peptides 2-27, 41-55, 132-153 and 163-169 have been
CC         identified and sequenced by MS. Initiator Met-1 is removed.
CC         Contains a N-acetylalanine at position 2. Contains a
CC         N6-acetyllysine at position 177. {ECO:0000244|PubMed:19608861,
CC         ECO:0000269|Ref.10, ECO:0000269|Ref.9};
CC       Name=4;
CC         IsoId=P06753-4; Sequence=VSP_047302, VSP_047303, VSP_047304,
CC                                  VSP_047305, VSP_047306;
CC         Note=Gene prediction based on EST data.;
CC       Name=5;
CC         IsoId=P06753-5; Sequence=VSP_047302, VSP_047303, VSP_047304,
CC                                  VSP_006606;
CC         Note=Gene prediction based on EST data. Contains a
CC         N6-acetyllysine at position 215. {ECO:0000244|PubMed:19608861};
CC       Name=6;
CC         IsoId=P06753-6; Sequence=VSP_006604, VSP_006605;
CC         Note=No experimental confirmation available. Contains a
CC         N6-acetyllysine at position 177. {ECO:0000244|PubMed:19608861};
CC       Name=7;
CC         IsoId=P06753-7; Sequence=VSP_054792, VSP_006606;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data. Contains a N6-acetyllysine at position 125.
CC         {ECO:0000244|PubMed:19608861};
CC   -!- DOMAIN: The molecule is in a coiled coil structure that is formed
CC       by 2 polypeptide chains. The sequence exhibits a prominent seven-
CC       residues periodicity.
CC   -!- DISEASE: Nemaline myopathy 1 (NEM1) [MIM:609284]: A form of
CC       nemaline myopathy with autosomal dominant or recessive
CC       inheritance. Nemaline myopathies are disorders characterized by
CC       muscle weakness of varying onset and severity, and abnormal
CC       thread-like or rod-shaped structures in muscle fibers on
CC       histologic examination. Autosomal dominant NEM1 is characterized
CC       by a moderate phenotype with onset between birth and early second
CC       decade of life. Weakness is diffuse and symmetric with slow
CC       progression often with need for a wheelchair in adulthood. The
CC       autosomal recessive form has onset at birth with moderate to
CC       severe hypotonia and diffuse weakness. In the most severe cases,
CC       death can occur before 2 years. Less severe cases have delayed
CC       major motor milestones, and these patients may walk, but often
CC       need a wheelchair before 10 years. {ECO:0000269|PubMed:10587521,
CC       ECO:0000269|PubMed:17376686, ECO:0000269|PubMed:24692096,
CC       ECO:0000269|PubMed:7704029}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving TPM3 is found in
CC       papillary thyroid carcinomas (PTCs). A rearrangement with NTRK1
CC       generates the TRK fusion transcript by fusing the amino end of
CC       isoform 2 of TPM3 to the 3'-end of NTRK1.
CC       {ECO:0000269|PubMed:2869410}.
CC   -!- DISEASE: Myopathy, congenital, with fiber-type disproportion
CC       (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which
CC       there is relative hypotrophy of type 1 muscle fibers compared to
CC       type 2 fibers on skeletal muscle biopsy. However, these findings
CC       are not specific and can be found in many different myopathic and
CC       neuropathic conditions. {ECO:0000269|PubMed:18300303,
CC       ECO:0000269|PubMed:19953533, ECO:0000269|PubMed:20951040,
CC       ECO:0000269|PubMed:24692096}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cap myopathy 1 (CAPM1) [MIM:609284]: A rare congenital
CC       skeletal muscle disorder characterized by the presence of cap-like
CC       structures which are well demarcated and peripherally located
CC       under the sarcolemma and show abnormal accumulation of sarcomeric
CC       proteins. Clinical features are early onset of hypotonia and
CC       slowly progressive muscle weakness. Respiratory problems are
CC       common. {ECO:0000269|PubMed:18300303, ECO:0000269|PubMed:19487656,
CC       ECO:0000269|PubMed:19553118, ECO:0000269|PubMed:24239060,
CC       ECO:0000269|PubMed:24692096}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the tropomyosin family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-2 is the initiator.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TPM3ID225.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04201; CAA27798.1; -; mRNA.
DR   EMBL; AY004867; AAF87083.1; -; mRNA.
DR   EMBL; X04588; CAB37185.1; -; mRNA.
DR   EMBL; AL590431; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53229.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53230.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53231.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53235.1; -; Genomic_DNA.
DR   EMBL; BC000771; AAH00771.1; -; mRNA.
DR   EMBL; BC008407; AAH08407.1; -; mRNA.
DR   EMBL; BC008425; AAH08425.1; -; mRNA.
DR   EMBL; BC015403; AAH15403.1; -; mRNA.
DR   EMBL; BC072428; AAH72428.1; -; mRNA.
DR   EMBL; DQ120714; ABC40673.1; -; Genomic_DNA.
DR   EMBL; X03541; CAA27243.1; ALT_TERM; mRNA.
DR   EMBL; AF474157; AAL84570.1; -; mRNA.
DR   CCDS; CCDS1060.1; -. [P06753-2]
DR   CCDS; CCDS41400.1; -. [P06753-5]
DR   CCDS; CCDS41401.1; -. [P06753-4]
DR   CCDS; CCDS41402.1; -. [P06753-3]
DR   CCDS; CCDS41403.1; -. [P06753-1]
DR   CCDS; CCDS60274.1; -. [P06753-7]
DR   CCDS; CCDS60275.1; -. [P06753-6]
DR   PIR; A25530; A25530.
DR   PIR; S06210; A24199.
DR   RefSeq; NP_001036816.1; NM_001043351.1. [P06753-5]
DR   RefSeq; NP_001036817.1; NM_001043352.1. [P06753-3]
DR   RefSeq; NP_001036818.1; NM_001043353.1. [P06753-4]
DR   RefSeq; NP_001265118.1; NM_001278189.1. [P06753-6]
DR   RefSeq; NP_001265120.1; NM_001278191.1. [P06753-7]
DR   RefSeq; NP_689476.2; NM_152263.3. [P06753-1]
DR   RefSeq; NP_705935.1; NM_153649.3. [P06753-2]
DR   UniGene; Hs.535581; -.
DR   UniGene; Hs.578978; -.
DR   UniGene; Hs.644306; -.
DR   UniGene; Hs.654421; -.
DR   ProteinModelPortal; P06753; -.
DR   SMR; P06753; -.
DR   BioGrid; 113023; 133.
DR   IntAct; P06753; 62.
DR   MINT; P06753; -.
DR   STRING; 9606.ENSP00000357516; -.
DR   iPTMnet; P06753; -.
DR   PhosphoSitePlus; P06753; -.
DR   SwissPalm; P06753; -.
DR   DMDM; 519668659; -.
DR   DOSAC-COBS-2DPAGE; P06753; -.
DR   SWISS-2DPAGE; P06753; -.
DR   EPD; P06753; -.
DR   MaxQB; P06753; -.
DR   PaxDb; P06753; -.
DR   PeptideAtlas; P06753; -.
DR   PRIDE; P06753; -.
DR   Ensembl; ENST00000302206; ENSP00000307712; ENSG00000143549. [P06753-7]
DR   Ensembl; ENST00000323144; ENSP00000357518; ENSG00000143549. [P06753-4]
DR   Ensembl; ENST00000328159; ENSP00000357520; ENSG00000143549. [P06753-6]
DR   Ensembl; ENST00000330188; ENSP00000339035; ENSG00000143549. [P06753-5]
DR   Ensembl; ENST00000368530; ENSP00000357516; ENSG00000143549. [P06753-1]
DR   Ensembl; ENST00000368531; ENSP00000357517; ENSG00000143549. [P06753-3]
DR   Ensembl; ENST00000368533; ENSP00000357521; ENSG00000143549. [P06753-2]
DR   GeneID; 7170; -.
DR   KEGG; hsa:7170; -.
DR   UCSC; uc001fdy.2; human. [P06753-1]
DR   CTD; 7170; -.
DR   DisGeNET; 7170; -.
DR   EuPathDB; HostDB:ENSG00000143549.19; -.
DR   GeneCards; TPM3; -.
DR   GeneReviews; TPM3; -.
DR   HGNC; HGNC:12012; TPM3.
DR   HPA; HPA000261; -.
DR   HPA; HPA009066; -.
DR   HPA; HPA047089; -.
DR   HPA; HPA053624; -.
DR   MalaCards; TPM3; -.
DR   MIM; 164970; gene.
DR   MIM; 191030; gene.
DR   MIM; 255310; phenotype.
DR   MIM; 609284; phenotype.
DR   neXtProt; NX_P06753; -.
DR   OpenTargets; ENSG00000143549; -.
DR   Orphanet; 171881; Cap myopathy.
DR   Orphanet; 171439; Childhood-onset nemaline myopathy.
DR   Orphanet; 2020; Congenital fiber-type disproportion myopathy.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   Orphanet; 171433; Intermediate nemaline myopathy.
DR   PharmGKB; PA36692; -.
DR   eggNOG; KOG1003; Eukaryota.
DR   eggNOG; ENOG410XR5K; LUCA.
DR   GeneTree; ENSGT00550000074494; -.
DR   HOGENOM; HOG000231522; -.
DR   HOVERGEN; HBG107404; -.
DR   InParanoid; P06753; -.
DR   KO; K09290; -.
DR   OMA; AVLESKF; -.
DR   OrthoDB; EOG091G0UO7; -.
DR   PhylomeDB; P06753; -.
DR   TreeFam; TF351519; -.
DR   Reactome; R-HSA-390522; Striated Muscle Contraction.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   ChiTaRS; TPM3; human.
DR   GeneWiki; Tropomyosin_3; -.
DR   GenomeRNAi; 7170; -.
DR   PRO; PR:P06753; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143549; -.
DR   CleanEx; HS_TPM3; -.
DR   ExpressionAtlas; P06753; baseline and differential.
DR   Genevisible; P06753; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005884; C:actin filament; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005862; C:muscle thin filament tropomyosin; TAS:UniProtKB.
DR   GO; GO:0001725; C:stress fiber; IDA:MGI.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0008307; F:structural constituent of muscle; IBA:GO_Central.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0006928; P:movement of cell or subcellular component; TAS:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; IBA:GO_Central.
DR   GO; GO:0030049; P:muscle filament sliding; TAS:Reactome.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Alternative splicing;
KW   Chromosomal rearrangement; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Disease mutation;
KW   Muscle protein; Nemaline myopathy; Phosphoprotein; Proto-oncogene;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P09493}.
FT   CHAIN         2    285       Tropomyosin alpha-3 chain.
FT                                /FTId=PRO_0000205632.
FT   COILED        1    285       {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:P09493}.
FT   MOD_RES      54     54       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P07951}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P58774}.
FT   MOD_RES      88     88       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     109    109       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P07951}.
FT   MOD_RES     207    207       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P07951}.
FT   MOD_RES     216    216       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P58775}.
FT   MOD_RES     253    253       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P07951}.
FT   MOD_RES     262    262       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P58775}.
FT   MOD_RES     272    272       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P21107}.
FT   MOD_RES     283    283       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P07951}.
FT   MOD_RES     284    284       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09493}.
FT   VAR_SEQ       1    127       Missing (in isoform 7). {ECO:0000305}.
FT                                /FTId=VSP_054792.
FT   VAR_SEQ       1     81       MMEAIKKKMQMLKLDKENALDRAEQAEAEQKQAEERSKQLE
FT                                DELAAMQKKLKGTEDELDKYSEALKDAQEKLELAEKKAAD
FT                                -> MAGITTIEAVKRKIQVLQQQADDAEERAERLQREVEGE
FT                                RRAREQ (in isoform 2, isoform 3 and
FT                                isoform 6). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:3024106}.
FT                                /FTId=VSP_006604.
FT   VAR_SEQ       1      2       MM -> MAGITTI (in isoform 4 and isoform
FT                                5). {ECO:0000305}.
FT                                /FTId=VSP_047302.
FT   VAR_SEQ       5     21       IKKKMQMLKLDKENALD -> VKRKIQVLQQQADDAEE
FT                                (in isoform 4 and isoform 5).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_047303.
FT   VAR_SEQ      25     81       QAEAEQKQAEERSKQLEDELAAMQKKLKGTEDELDKYSEAL
FT                                KDAQEKLELAEKKAAD -> RLQREVEGERRAREQ (in
FT                                isoform 4 and isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_047304.
FT   VAR_SEQ     190    212       KCSELEEELKNVTNNLKSLEAQA -> RCREMDEQIRLMDQ
FT                                NLKCLSAAE (in isoform 2, isoform 3 and
FT                                isoform 6). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:3024106}.
FT                                /FTId=VSP_006605.
FT   VAR_SEQ     259    285       DELYAQKLKYKAISEELDHALNDMTSI -> ERLYSQLERN
FT                                RLLSNELKLTLHDLCD (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_006607.
FT   VAR_SEQ     259    260       DE -> ER (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_047305.
FT   VAR_SEQ     260    285       ELYAQKLKYKAISEELDHALNDMTSI -> KLKCTKEEHLC
FT                                TQRMLDQTLLDLNEM (in isoform 2, isoform 5
FT                                and isoform 7).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:3024106}.
FT                                /FTId=VSP_006606.
FT   VAR_SEQ     263    285       AQKLKYKAISEELDHALNDMTSI -> SQLERNRLLSNELK
FT                                LTLHDLCD (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_047306.
FT   VARIANT       4      4       A -> V (in CFTD; dbSNP:rs199474711).
FT                                {ECO:0000269|PubMed:19953533}.
FT                                /FTId=VAR_071499.
FT   VARIANT       9      9       M -> R (in NEM1; decrease in the
FT                                sensitivity of contraction to activating
FT                                calcium; dbSNP:rs80358247).
FT                                {ECO:0000269|PubMed:10587521,
FT                                ECO:0000269|PubMed:7704029}.
FT                                /FTId=VAR_013460.
FT   VARIANT      88     88       S -> F (in NEM1 and CAPM1).
FT                                {ECO:0000269|PubMed:24692096}.
FT                                /FTId=VAR_071500.
FT   VARIANT      91     91       R -> C (probable disease-associated
FT                                mutation found in patients with undefined
FT                                congenital myopathy).
FT                                {ECO:0000269|PubMed:24692096}.
FT                                /FTId=VAR_071501.
FT   VARIANT      91     91       R -> P (in CFTD; dbSNP:rs199474713).
FT                                {ECO:0000269|PubMed:19953533}.
FT                                /FTId=VAR_071502.
FT   VARIANT     100    100       L -> M (in CFTD; dbSNP:rs121964853).
FT                                {ECO:0000269|PubMed:18300303}.
FT                                /FTId=VAR_070066.
FT   VARIANT     100    100       L -> V (in CFTD).
FT                                {ECO:0000269|PubMed:24692096}.
FT                                /FTId=VAR_071503.
FT   VARIANT     149    149       L -> I (in CAPM1).
FT                                {ECO:0000269|PubMed:24239060}.
FT                                /FTId=VAR_071504.
FT   VARIANT     151    151       E -> A (in CAPM1).
FT                                {ECO:0000269|PubMed:24692096}.
FT                                /FTId=VAR_071505.
FT   VARIANT     168    168       R -> C (in CFTD, CAPM1 and NEM1; also
FT                                found in patients with undefined
FT                                congenital myopathy; dbSNP:rs121964854).
FT                                {ECO:0000269|PubMed:18300303,
FT                                ECO:0000269|PubMed:19487656,
FT                                ECO:0000269|PubMed:24692096}.
FT                                /FTId=VAR_070067.
FT   VARIANT     168    168       R -> G (in CFTD; dbSNP:rs121964854).
FT                                {ECO:0000269|PubMed:18300303}.
FT                                /FTId=VAR_070068.
FT   VARIANT     168    168       R -> H (in NEM1, CAPM1 and CFTD; also
FT                                found in patients with undefined
FT                                congenital myopathy; dbSNP:rs121964852).
FT                                {ECO:0000269|PubMed:17376686,
FT                                ECO:0000269|PubMed:18300303,
FT                                ECO:0000269|PubMed:19553118,
FT                                ECO:0000269|PubMed:19953533,
FT                                ECO:0000269|PubMed:20951040,
FT                                ECO:0000269|PubMed:24692096}.
FT                                /FTId=VAR_070069.
FT   VARIANT     169    169       K -> E (in CFTD; dbSNP:rs199474715).
FT                                {ECO:0000269|PubMed:18300303}.
FT                                /FTId=VAR_070070.
FT   VARIANT     174    174       E -> A (in CFTD; dbSNP:rs199474716).
FT                                {ECO:0000269|PubMed:20951040}.
FT                                /FTId=VAR_071506.
FT   VARIANT     241    241       E -> K (in CFTD; dbSNP:rs199474717).
FT                                {ECO:0000269|PubMed:19953533}.
FT                                /FTId=VAR_071507.
FT   VARIANT     245    245       R -> G (in CFTD; dbSNP:rs199474718).
FT                                {ECO:0000269|PubMed:18300303}.
FT                                /FTId=VAR_070071.
FT   VARIANT     245    245       R -> I (in CAPM1; dbSNP:rs797046047).
FT                                {ECO:0000269|PubMed:24692096}.
FT                                /FTId=VAR_071508.
FT   VARIANT     253    253       T -> K (probable disease-associated
FT                                mutation found in patients with undefined
FT                                congenital myopathy).
FT                                {ECO:0000269|PubMed:24692096}.
FT                                /FTId=VAR_071509.
FT   CONFLICT    150    150       K -> E (in Ref. 13; CAA27243).
FT                                {ECO:0000305}.
SQ   SEQUENCE   285 AA;  32950 MW;  99EAD24C45460A14 CRC64;
     MMEAIKKKMQ MLKLDKENAL DRAEQAEAEQ KQAEERSKQL EDELAAMQKK LKGTEDELDK
     YSEALKDAQE KLELAEKKAA DAEAEVASLN RRIQLVEEEL DRAQERLATA LQKLEEAEKA
     ADESERGMKV IENRALKDEE KMELQEIQLK EAKHIAEEAD RKYEEVARKL VIIEGDLERT
     EERAELAESK CSELEEELKN VTNNLKSLEA QAEKYSQKED KYEEEIKILT DKLKEAETRA
     EFAERSVAKL EKTIDDLEDE LYAQKLKYKA ISEELDHALN DMTSI
//
ID   B3KN30_HUMAN            Unreviewed;       759 AA.
AC   B3KN30;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 56.
DE   SubName: Full=cDNA FLJ13372 fis, clone PLACE1000706, highly similar to Transcription intermediary factor 1-gamma {ECO:0000313|EMBL:BAG51192.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG51192.1};
RN   [1] {ECO:0000313|EMBL:BAG51192.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAG51192.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK023434; BAG51192.1; -; mRNA.
DR   RefSeq; NP_056990.3; NM_015906.3.
DR   RefSeq; NP_148980.2; NM_033020.2.
DR   UniGene; Hs.26837; -.
DR   MaxQB; B3KN30; -.
DR   PeptideAtlas; B3KN30; -.
DR   PRIDE; B3KN30; -.
DR   GeneID; 51592; -.
DR   KEGG; hsa:51592; -.
DR   CTD; 51592; -.
DR   PharmGKB; PA38118; -.
DR   eggNOG; ENOG410ITFN; Eukaryota.
DR   eggNOG; ENOG410Z421; LUCA.
DR   HOGENOM; HOG000252971; -.
DR   HOVERGEN; HBG054599; -.
DR   KO; K08883; -.
DR   GenomeRNAi; 51592; -.
DR   Genevisible; B3KN30; HS.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF00628; PHD; 1.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM00249; PHD; 1.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
PE   2: Evidence at transcript level;
KW   Bromodomain {ECO:0000256|PROSITE-ProRule:PRU00035};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077}.
FT   DOMAIN      519    566       PHD-type. {ECO:0000259|PROSITE:PS50016}.
FT   DOMAIN      606    678       Bromo. {ECO:0000259|PROSITE:PS50014}.
SQ   SEQUENCE   759 AA;  83900 MW;  E7C568375BD3DC91 CRC64;
     MKLLQQQNDI TGLSRQVKHV MNFTNWAIAS GSSTALLYSK RLITFQLRHI LKARCDPAPA
     ANGAIRFHCD PTFWAKNVVN LGNLVIESKP APGYTPNVVV GQVPPGTNHI SKTPGQINLA
     QLRLQHMQQQ VYAQKHQQLQ QMRMQQPPAP VPTTTTTTQQ HPRQAAPQML QQQPPRLISV
     QTMQRGNMNC GAFQAHQMRL AQNAARIPGI PRHSGPQYSM MQPHLQRQHS NPGHAGPFPV
     VSVHNTTINP TSPTTATMAN ANRGPTSPSV TAIELIPSVT NPENLPSLPD IPPIQANVVP
     MMHSWYEFGA REKTQDQNVL EDAGSSSLDN LLSRYISGSH LPPQPTSTMN PSPGPSALSP
     GSSGLSNSHT PVRPPSTSST GSRGSCGSSG RTAEKTSLSF KSDQVKVKQE PGTEDEICSF
     SGGVKQEKTE DGRRSACMLS SPESSLTPPL STNLHLESEL DALASLENHV KIEPADMNES
     CKQSGLSSLV NGKSPIRSLM HRSARIGGDG NNKDDDPNED WCAVCQNGGD LLCCEKCPKV
     FHLTCHVPTL LSFPSGDWIC TFCRDIGKPE VEYDCDNLQH SKKGKTAQGL SPVDQRKCER
     LLLYLYCHEL SIEFQEPVPA SIPNYYKIIK KPMDLSTVKK KLQKKHSQHY QIPDDFVADV
     RLIFKNCERF NEMMKVVQVY ADTQEINLKA DSEVAQAGKA VALYFEDKLT EIYSDRTFAP
     LPEFEQEEDD GEVTEDSDED FIQPRRKRLK SDERPVHIK
//
ID   TRI33_HUMAN             Reviewed;        1127 AA.
AC   Q9UPN9; O95855; Q5TG72; Q5TG73; Q5TG74; Q9C017; Q9UJ79;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   28-FEB-2018, entry version 182.
DE   RecName: Full=E3 ubiquitin-protein ligase TRIM33;
DE            EC=2.3.2.27;
DE   AltName: Full=Ectodermin homolog;
DE   AltName: Full=RET-fused gene 7 protein;
DE            Short=Protein Rfg7;
DE   AltName: Full=RING-type E3 ubiquitin transferase TRIM33 {ECO:0000305};
DE   AltName: Full=Transcription intermediary factor 1-gamma;
DE            Short=TIF1-gamma;
DE   AltName: Full=Tripartite motif-containing protein 33;
GN   Name=TRIM33; Synonyms=KIAA1113, RFG7, TIF1G;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA), FUNCTION, SUBUNIT, AND
RP   VARIANT THR-840.
RX   PubMed=10022127; DOI=10.1038/sj.onc.1202655;
RA   Venturini L., You J., Stadler M., Galien R., Lallemand V.,
RA   Koken M.H.M., Mattei M.-G., Ganser A., Chambon P., Losson R.,
RA   De The H.;
RT   "TIF1gamma, a novel member of the transcriptional intermediary factor
RT   1 family.";
RL   Oncogene 18:1209-1217(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA), AND VARIANT
RP   THR-840.
RX   PubMed=11331580; DOI=10.1093/emboj/20.9.2140;
RA   Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L.,
RA   Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A.,
RA   Minucci S., Pelicci P.G., Ballabio A.;
RT   "The tripartite motif family identifies cell compartments.";
RL   EMBO J. 20:2140-2151(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA), AND VARIANT
RP   THR-840.
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 76-1127 (ISOFORMS ALPHA AND BETA),
RP   CHROMOSOMAL TRANSLOCATION WITH RET, AND VARIANT THR-840.
RC   TISSUE=Thyroid;
RX   PubMed=10439047; DOI=10.1038/sj.onc.1202824;
RA   Klugbauer S., Rabes H.M.;
RT   "The transcription coactivator HTIF1 and a related protein are fused
RT   to the RET receptor tyrosine kinase in childhood papillary thyroid
RT   carcinomas.";
RL   Oncogene 18:4388-4393(1999).
RN   [6]
RP   SUBUNIT.
RX   PubMed=12096914; DOI=10.1016/S0022-2836(02)00477-1;
RA   Peng H., Feldman I., Rauscher F.J. III;
RT   "Hetero-oligomerization among the TIF family of RBCC/TRIM domain-
RT   containing nuclear cofactors: a potential mechanism for regulating the
RT   switch between coactivation and corepression.";
RL   J. Mol. Biol. 320:629-644(2002).
RN   [7]
RP   FUNCTION AS AN E3 UBIQUITIN-PROTEIN LIGASE, UBIQUITINATION OF SMAD4,
RP   INTERACTION WITH SMAD4, MUTAGENESIS OF CYS-125 AND CYS-128, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15820681; DOI=10.1016/j.cell.2005.01.033;
RA   Dupont S., Zacchigna L., Cordenonsi M., Soligo S., Adorno M.,
RA   Rugge M., Piccolo S.;
RT   "Germ-layer specification and control of cell growth by Ectodermin, a
RT   Smad4 ubiquitin ligase.";
RL   Cell 121:87-99(2005).
RN   [8]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH SMAD2 AND SMAD3,
RP   INTERACTION WITH SMAD2 AND SMAD3, AND SUBCELLULAR LOCATION.
RX   PubMed=16751102; DOI=10.1016/j.cell.2006.03.045;
RA   He W., Dorn D.C., Erdjument-Bromage H., Tempst P., Moore M.A.,
RA   Massague J.;
RT   "Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of
RT   the TGFbeta pathway.";
RL   Cell 125:929-941(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-862; THR-1102 AND
RP   SER-1105, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SMAD2 AND SMAD4.
RX   PubMed=19135894; DOI=10.1016/j.cell.2008.10.051;
RA   Dupont S., Mamidi A., Cordenonsi M., Montagner M., Zacchigna L.,
RA   Adorno M., Martello G., Stinchfield M.J., Soligo S., Morsut L.,
RA   Inui M., Moro S., Modena N., Argenton F., Newfeld S.J., Piccolo S.;
RT   "FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling,
RT   controls Smad4 monoubiquitination.";
RL   Cell 136:123-135(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-763; LYS-769 AND LYS-953,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-862; THR-1102 AND
RP   SER-1105, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-862; THR-1102 AND
RP   SER-1105, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-862; THR-1051 AND
RP   SER-1119, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-515; ARG-535; ARG-577;
RP   ARG-591; ARG-598 AND ARG-604, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-334; LYS-763; LYS-769;
RP   LYS-776; LYS-793; LYS-953; LYS-1007 AND LYS-1057, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-776 AND LYS-793, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-763; LYS-769; LYS-776;
RP   LYS-793; LYS-861; LYS-1057 AND LYS-1118, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-763; LYS-769; LYS-776;
RP   LYS-793 AND LYS-1057, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-329; LYS-481; LYS-504;
RP   LYS-527; LYS-763; LYS-769; LYS-774; LYS-776; LYS-793; LYS-796;
RP   LYS-861; LYS-953; LYS-1043; LYS-1057 AND LYS-1118, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-580; SER-696; LYS-811; SER-885;
RP   MET-961 AND THR-1090.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4
CC       ubiquitination, nuclear exclusion and degradation via the
CC       ubiquitin proteasome pathway. According to PubMed:16751102, does
CC       not promote a decrease in the level of endogenous SMAD4. May act
CC       as a transcriptional repressor. Inhibits the transcriptional
CC       response to TGF-beta/BMP signaling cascade. Plays a role in the
CC       control of cell proliferation. Its association with SMAD2 and
CC       SMAD3 stimulates erythroid differentiation of hematopoietic
CC       stem/progenitor (By similarity). Monoubiquitinates SMAD4 and acts
CC       as an inhibitor of SMAD4-dependent TGF-beta/BMP signaling cascade
CC       (Monoubiquitination of SMAD4 hampers its ability to form a stable
CC       complex with activated SMAD2/3 resulting in inhibition of TGF-
CC       beta/BMP signaling cascade). {ECO:0000250,
CC       ECO:0000269|PubMed:10022127, ECO:0000269|PubMed:15820681,
CC       ECO:0000269|PubMed:16751102, ECO:0000269|PubMed:19135894}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homooligomer and heterooligomer with TRIM24 and TRIM28
CC       family members. Interacts with SMAD4 in unstimulated cells. Found
CC       in a complex with SMAD2 and SMAD3 upon addition of TGF-beta.
CC       Interacts with SMAD2 and SMAD3. Interacts with SMAD4 under basal
CC       and induced conditions and, upon TGF-beta signaling, with
CC       activated SMAD2. Forms a ternary complex with SMAD4 and SMAD2 upon
CC       TGF-beta signaling. {ECO:0000269|PubMed:10022127,
CC       ECO:0000269|PubMed:12096914, ECO:0000269|PubMed:15820681,
CC       ECO:0000269|PubMed:16751102, ECO:0000269|PubMed:19135894}.
CC   -!- INTERACTION:
CC       Q15796:SMAD2; NbExp=6; IntAct=EBI-2214398, EBI-1040141;
CC       Q13485:SMAD4; NbExp=6; IntAct=EBI-2214398, EBI-347263;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15820681,
CC       ECO:0000269|PubMed:16751102, ECO:0000269|PubMed:19135894}. Note=In
CC       discrete nuclear dots resembling nuclear bodies. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha;
CC         IsoId=Q9UPN9-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=Q9UPN9-2; Sequence=VSP_005774;
CC   -!- TISSUE SPECIFICITY: Expressed in stem cells at the bottom of the
CC       crypts of the colon (at protein level). Expressed in colon
CC       adenomas and adenocarcinomas (at protein level). Expressed in
CC       brain, lung, liver, spleen, thymus, prostate, kidney, testis,
CC       heart, placenta, pancreas, small intestine, ovary, colon, skeletal
CC       muscle and hematopoietic progenitors.
CC   -!- PTM: Sumoylated with SUMO1. {ECO:0000250|UniProtKB:Q99PP7}.
CC   -!- DISEASE: Note=A chromosomal aberration involving TRIM33 is found
CC       in papillary thyroid carcinomas (PTCs). Translocation
CC       t(1;10)(p13;q11) with RET. The translocation generates the
CC       TRIM33/RET (PTC7) oncogene. {ECO:0000269|PubMed:10439047}.
CC   -!- SIMILARITY: Belongs to the TRIM/RBCC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD17259.1; Type=Frameshift; Positions=1114; Evidence={ECO:0000305};
CC       Sequence=BAA83065.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAI13548.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI21895.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF119043; AAD17259.1; ALT_FRAME; mRNA.
DR   EMBL; AF220136; AAG53509.1; -; mRNA.
DR   EMBL; AF220137; AAG53510.1; -; mRNA.
DR   EMBL; AB029036; BAA83065.1; ALT_INIT; mRNA.
DR   EMBL; AL390241; CAI13548.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL035410; CAI13548.1; JOINED; Genomic_DNA.
DR   EMBL; AL390241; CAI13550.1; -; Genomic_DNA.
DR   EMBL; AL035410; CAI13550.1; JOINED; Genomic_DNA.
DR   EMBL; AL390241; CAI13551.1; -; Genomic_DNA.
DR   EMBL; AL035410; CAI13551.1; JOINED; Genomic_DNA.
DR   EMBL; AL035410; CAI21895.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL390241; CAI21895.1; JOINED; Genomic_DNA.
DR   EMBL; AL035410; CAI21896.1; -; Genomic_DNA.
DR   EMBL; AL390241; CAI21896.1; JOINED; Genomic_DNA.
DR   EMBL; AL035410; CAI21897.1; -; Genomic_DNA.
DR   EMBL; AL390241; CAI21897.1; JOINED; Genomic_DNA.
DR   EMBL; AJ132948; CAB55313.1; -; mRNA.
DR   CCDS; CCDS872.1; -. [Q9UPN9-1]
DR   CCDS; CCDS873.1; -. [Q9UPN9-2]
DR   RefSeq; NP_056990.3; NM_015906.3. [Q9UPN9-1]
DR   RefSeq; NP_148980.2; NM_033020.2. [Q9UPN9-2]
DR   UniGene; Hs.26837; -.
DR   PDB; 3U5M; X-ray; 3.08 A; A/B/C/D/E/F/G/H/I/J/K/L=882-1087.
DR   PDB; 3U5N; X-ray; 1.95 A; A/B=882-1087.
DR   PDB; 3U5O; X-ray; 2.70 A; A/B/C/D/E/F/G/H=882-1087.
DR   PDB; 3U5P; X-ray; 2.80 A; A/B/C/D/E/F/G/H=882-1087.
DR   PDB; 5MR8; X-ray; 1.74 A; A=882-1090.
DR   PDBsum; 3U5M; -.
DR   PDBsum; 3U5N; -.
DR   PDBsum; 3U5O; -.
DR   PDBsum; 3U5P; -.
DR   PDBsum; 5MR8; -.
DR   ProteinModelPortal; Q9UPN9; -.
DR   SMR; Q9UPN9; -.
DR   BioGrid; 119625; 85.
DR   CORUM; Q9UPN9; -.
DR   DIP; DIP-54262N; -.
DR   IntAct; Q9UPN9; 51.
DR   MINT; Q9UPN9; -.
DR   STRING; 9606.ENSP00000351250; -.
DR   BindingDB; Q9UPN9; -.
DR   ChEMBL; CHEMBL2176772; -.
DR   iPTMnet; Q9UPN9; -.
DR   PhosphoSitePlus; Q9UPN9; -.
DR   BioMuta; TRIM33; -.
DR   DMDM; 313104270; -.
DR   EPD; Q9UPN9; -.
DR   PaxDb; Q9UPN9; -.
DR   PeptideAtlas; Q9UPN9; -.
DR   PRIDE; Q9UPN9; -.
DR   Ensembl; ENST00000358465; ENSP00000351250; ENSG00000197323. [Q9UPN9-1]
DR   Ensembl; ENST00000369543; ENSP00000358556; ENSG00000197323. [Q9UPN9-2]
DR   GeneID; 51592; -.
DR   KEGG; hsa:51592; -.
DR   UCSC; uc001eew.3; human. [Q9UPN9-1]
DR   CTD; 51592; -.
DR   DisGeNET; 51592; -.
DR   EuPathDB; HostDB:ENSG00000197323.10; -.
DR   GeneCards; TRIM33; -.
DR   H-InvDB; HIX0000910; -.
DR   HGNC; HGNC:16290; TRIM33.
DR   HPA; HPA004345; -.
DR   MalaCards; TRIM33; -.
DR   MIM; 605769; gene.
DR   neXtProt; NX_Q9UPN9; -.
DR   OpenTargets; ENSG00000197323; -.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   PharmGKB; PA38118; -.
DR   eggNOG; ENOG410ITFN; Eukaryota.
DR   eggNOG; ENOG410Z421; LUCA.
DR   GeneTree; ENSGT00890000139374; -.
DR   HOVERGEN; HBG054599; -.
DR   InParanoid; Q9UPN9; -.
DR   KO; K08883; -.
DR   OMA; ICLELYC; -.
DR   OrthoDB; EOG091G01KK; -.
DR   PhylomeDB; Q9UPN9; -.
DR   TreeFam; TF106455; -.
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   SignaLink; Q9UPN9; -.
DR   SIGNOR; Q9UPN9; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; TRIM33; human.
DR   GeneWiki; TRIM33; -.
DR   GenomeRNAi; 51592; -.
DR   PMAP-CutDB; Q9UPN9; -.
DR   PRO; PR:Q9UPN9; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000197323; -.
DR   CleanEx; HS_TRIM33; -.
DR   ExpressionAtlas; Q9UPN9; baseline and differential.
DR   Genevisible; Q9UPN9; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0070410; F:co-SMAD binding; IPI:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0070412; F:R-SMAD binding; IPI:BHF-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00021; BBOX; 1.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR003649; Bbox_C.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR027370; Znf-RING_LisH.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF00628; PHD; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00502; BBC; 1.
DR   SMART; SM00336; BBOX; 2.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM00249; PHD; 2.
DR   SMART; SM00184; RING; 2.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS50119; ZF_BBOX; 2.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Bromodomain;
KW   Chromosomal rearrangement; Coiled coil; Complete proteome;
KW   DNA-binding; Isopeptide bond; Metal-binding; Methylation; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   1127       E3 ubiquitin-protein ligase TRIM33.
FT                                /FTId=PRO_0000056395.
FT   DOMAIN      974   1046       Bromo. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00035}.
FT   ZN_FING     125    154       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     212    259       B box-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00024}.
FT   ZN_FING     271    312       B box-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00024}.
FT   ZN_FING     887    934       PHD-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00146}.
FT   REGION        1    147       Necessary for E3 ubiquitin-protein ligase
FT                                activity and repression of SMAD4
FT                                signaling and transcriptional repression.
FT   REGION      299    401       Necessary for oligomerization.
FT   COILED      299    401       {ECO:0000255}.
FT   COMPBIAS     13     18       Poly-Gly.
FT   COMPBIAS     44     49       Poly-Glu.
FT   COMPBIAS    545    550       Poly-Thr.
FT   SITE        964    965       Breakpoint for translocation to form
FT                                TRIM33-RET oncogene.
FT   MOD_RES     515    515       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     515    515       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     535    535       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     577    577       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     591    591       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99PP7}.
FT   MOD_RES     591    591       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     598    598       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     604    604       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     763    763       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     769    769       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     793    793       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99PP7}.
FT   MOD_RES     803    803       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99PP7}.
FT   MOD_RES     815    815       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q99PP7}.
FT   MOD_RES     862    862       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     951    951       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99PP7}.
FT   MOD_RES     953    953       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1051   1051       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1102   1102       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1105   1105       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1119   1119       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    329    329       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    334    334       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   CROSSLNK    481    481       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    504    504       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    527    527       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    763    763       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    769    769       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    774    774       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    776    776       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    776    776       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    793    793       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    793    793       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    796    796       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    861    861       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    953    953       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1007   1007       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   CROSSLNK   1043   1043       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1057   1057       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1118   1118       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ    1041   1057       Missing (in isoform Beta).
FT                                {ECO:0000303|PubMed:10439047,
FT                                ECO:0000303|PubMed:11331580}.
FT                                /FTId=VSP_005774.
FT   VARIANT      67     67       V -> A (in dbSNP:rs6691166).
FT                                /FTId=VAR_029494.
FT   VARIANT     580    580       M -> I (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042376.
FT   VARIANT     696    696       L -> S (in dbSNP:rs56151583).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042377.
FT   VARIANT     811    811       E -> K (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042378.
FT   VARIANT     840    840       I -> T (in dbSNP:rs6537825).
FT                                {ECO:0000269|PubMed:10022127,
FT                                ECO:0000269|PubMed:10439047,
FT                                ECO:0000269|PubMed:10470851,
FT                                ECO:0000269|PubMed:11331580}.
FT                                /FTId=VAR_024616.
FT   VARIANT     885    885       P -> S (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042379.
FT   VARIANT     961    961       V -> M (in dbSNP:rs55688622).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042380.
FT   VARIANT    1090   1090       P -> T (in dbSNP:rs55784699).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042381.
FT   MUTAGEN     125    125       C->A: Abolishes E3 activity but does not
FT                                affect interaction with SMAD4; when
FT                                associated with A-128.
FT                                {ECO:0000269|PubMed:15820681}.
FT   MUTAGEN     128    128       C->A: Abolishes E3 activity but does not
FT                                affect interaction with SMAD4; when
FT                                associated with A-125.
FT                                {ECO:0000269|PubMed:15820681}.
FT   CONFLICT     89     89       V -> E (in Ref. 5; CAB55313).
FT                                {ECO:0000305}.
FT   CONFLICT    451    453       PAA -> LLH (in Ref. 5; CAB55313).
FT                                {ECO:0000305}.
FT   CONFLICT    909    909       F -> S (in Ref. 5; CAB55313).
FT                                {ECO:0000305}.
FT   CONFLICT   1037   1037       R -> T (in Ref. 1; AAD17259).
FT                                {ECO:0000305}.
FT   STRAND      888    890       {ECO:0000244|PDB:3U5N}.
FT   TURN        891    893       {ECO:0000244|PDB:3U5N}.
FT   STRAND      897    901       {ECO:0000244|PDB:3U5N}.
FT   STRAND      903    906       {ECO:0000244|PDB:3U5N}.
FT   TURN        911    913       {ECO:0000244|PDB:3U5N}.
FT   STRAND      914    916       {ECO:0000244|PDB:3U5N}.
FT   STRAND      918    920       {ECO:0000244|PDB:3U5P}.
FT   TURN        929    931       {ECO:0000244|PDB:3U5N}.
FT   STRAND      934    936       {ECO:0000244|PDB:3U5N}.
FT   HELIX       944    947       {ECO:0000244|PDB:3U5O}.
FT   HELIX       960    974       {ECO:0000244|PDB:3U5N}.
FT   HELIX       980    982       {ECO:0000244|PDB:3U5N}.
FT   HELIX       993    996       {ECO:0000244|PDB:3U5N}.
FT   HELIX      1003   1010       {ECO:0000244|PDB:3U5N}.
FT   STRAND     1011   1013       {ECO:0000244|PDB:3U5O}.
FT   HELIX      1021   1045       {ECO:0000244|PDB:3U5N}.
FT   HELIX      1061   1080       {ECO:0000244|PDB:3U5N}.
FT   STRAND     1081   1083       {ECO:0000244|PDB:3U5O}.
SQ   SEQUENCE   1127 AA;  122533 MW;  7A36013799E9933C CRC64;
     MAENKGGGEA ESGGGGSGSA PVTAGAAGPA AQEAEPPLTA VLVEEEEEEG GRAGAEGGAA
     GPDDGGVAAA SSGSAQAASS PAASVGTGVA GGAVSTPAPA PASAPAPGPS AGPPPGPPAS
     LLDTCAVCQQ SLQSRREAEP KLLPCLHSFC LRCLPEPERQ LSVPIPGGSN GDIQQVGVIR
     CPVCRQECRQ IDLVDNYFVK DTSEAPSSSD EKSEQVCTSC EDNASAVGFC VECGEWLCKT
     CIEAHQRVKF TKDHLIRKKE DVSESVGASG QRPVFCPVHK QEQLKLFCET CDRLTCRDCQ
     LLEHKEHRYQ FLEEAFQNQK GAIENLLAKL LEKKNYVHFA ATQVQNRIKE VNETNKRVEQ
     EIKVAIFTLI NEINKKGKSL LQQLENVTKE RQMKLLQQQN DITGLSRQVK HVMNFTNWAI
     ASGSSTALLY SKRLITFQLR HILKARCDPV PAANGAIRFH CDPTFWAKNV VNLGNLVIES
     KPAPGYTPNV VVGQVPPGTN HISKTPGQIN LAQLRLQHMQ QQVYAQKHQQ LQQMRMQQPP
     APVPTTTTTT QQHPRQAAPQ MLQQQPPRLI SVQTMQRGNM NCGAFQAHQM RLAQNAARIP
     GIPRHSGPQY SMMQPHLQRQ HSNPGHAGPF PVVSVHNTTI NPTSPTTATM ANANRGPTSP
     SVTAIELIPS VTNPENLPSL PDIPPIQLED AGSSSLDNLL SRYISGSHLP PQPTSTMNPS
     PGPSALSPGS SGLSNSHTPV RPPSTSSTGS RGSCGSSGRT AEKTSLSFKS DQVKVKQEPG
     TEDEICSFSG GVKQEKTEDG RRSACMLSSP ESSLTPPLST NLHLESELDA LASLENHVKI
     EPADMNESCK QSGLSSLVNG KSPIRSLMHR SARIGGDGNN KDDDPNEDWC AVCQNGGDLL
     CCEKCPKVFH LTCHVPTLLS FPSGDWICTF CRDIGKPEVE YDCDNLQHSK KGKTAQGLSP
     VDQRKCERLL LYLYCHELSI EFQEPVPASI PNYYKIIKKP MDLSTVKKKL QKKHSQHYQI
     PDDFVADVRL IFKNCERFNE MMKVVQVYAD TQEINLKADS EVAQAGKAVA LYFEDKLTEI
     YSDRTFAPLP EFEQEEDDGE VTEDSDEDFI QPRRKRLKSD ERPVHIK
//
ID   WIF1_HUMAN              Reviewed;         379 AA.
AC   Q9Y5W5; Q6UXI1; Q8WVG4;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 3.
DT   28-FEB-2018, entry version 162.
DE   RecName: Full=Wnt inhibitory factor 1;
DE            Short=WIF-1;
DE   Flags: Precursor;
GN   Name=WIF1; ORFNames=UNQ191/PRO217;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10201374; DOI=10.1038/18899;
RA   Hsieh J.-C., Kodjabachian L., Rebbert M.L., Rattner A.,
RA   Smallwood P.M., Samos C.H., Nusse R., Dawid I.B., Nathans J.;
RT   "A new secreted protein that binds to Wnt proteins and inhibits their
RT   activities.";
RL   Nature 398:431-436(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH MYOC.
RX   PubMed=19188438; DOI=10.1128/MCB.01274-08;
RA   Kwon H.S., Lee H.S., Ji Y., Rubin J.S., Tomarev S.I.;
RT   "Myocilin is a modulator of Wnt signaling.";
RL   Mol. Cell. Biol. 29:2139-2154(2009).
RN   [5]
RP   STRUCTURE BY NMR OF 32-181, AND DISULFIDE BOND.
RX   PubMed=16476441; DOI=10.1016/j.jmb.2006.01.047;
RA   Liepinsh E., Banyai L., Patthy L., Otting G.;
RT   "NMR structure of the WIF domain of the human Wnt-inhibitory factor-
RT   1.";
RL   J. Mol. Biol. 357:942-950(2006).
CC   -!- FUNCTION: Binds to WNT proteins and inhibits their activities. May
CC       be involved in mesoderm segmentation.
CC   -!- SUBUNIT: Interacts with MYOC. {ECO:0000269|PubMed:19188438}.
CC   -!- INTERACTION:
CC       A8MQ03:CYSRT1; NbExp=4; IntAct=EBI-3922719, EBI-3867333;
CC       P60410:KRTAP10-8; NbExp=5; IntAct=EBI-3922719, EBI-10171774;
CC       P27467:Wnt3a (xeno); NbExp=8; IntAct=EBI-3922719, EBI-2899665;
CC       P41221:WNT5A; NbExp=2; IntAct=EBI-3922719, EBI-6594545;
CC       P22725:Wnt5a (xeno); NbExp=7; IntAct=EBI-3922719, EBI-1570983;
CC       O00755:WNT7A; NbExp=3; IntAct=EBI-3922719, EBI-727198;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/WIF1ID44085ch12q14.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF122922; AAD25402.1; -; mRNA.
DR   EMBL; AY358344; AAQ88710.1; -; mRNA.
DR   EMBL; BC018037; AAH18037.1; -; mRNA.
DR   CCDS; CCDS8971.1; -.
DR   PIR; A59180; A59180.
DR   RefSeq; NP_009122.2; NM_007191.4.
DR   UniGene; Hs.284122; -.
DR   PDB; 2D3J; NMR; -; A=32-181.
DR   PDB; 2YGN; X-ray; 1.85 A; A=35-178.
DR   PDB; 2YGO; X-ray; 1.85 A; A=35-210.
DR   PDB; 2YGP; X-ray; 2.22 A; A=35-210.
DR   PDB; 2YGQ; X-ray; 3.95 A; A=35-346.
DR   PDBsum; 2D3J; -.
DR   PDBsum; 2YGN; -.
DR   PDBsum; 2YGO; -.
DR   PDBsum; 2YGP; -.
DR   PDBsum; 2YGQ; -.
DR   ProteinModelPortal; Q9Y5W5; -.
DR   SMR; Q9Y5W5; -.
DR   BioGrid; 116366; 10.
DR   DIP; DIP-59097N; -.
DR   IntAct; Q9Y5W5; 15.
DR   MINT; Q9Y5W5; -.
DR   STRING; 9606.ENSP00000286574; -.
DR   iPTMnet; Q9Y5W5; -.
DR   PhosphoSitePlus; Q9Y5W5; -.
DR   BioMuta; WIF1; -.
DR   DMDM; 61252765; -.
DR   PaxDb; Q9Y5W5; -.
DR   PeptideAtlas; Q9Y5W5; -.
DR   PRIDE; Q9Y5W5; -.
DR   DNASU; 11197; -.
DR   Ensembl; ENST00000286574; ENSP00000286574; ENSG00000156076.
DR   GeneID; 11197; -.
DR   KEGG; hsa:11197; -.
DR   UCSC; uc001ssk.4; human.
DR   CTD; 11197; -.
DR   DisGeNET; 11197; -.
DR   EuPathDB; HostDB:ENSG00000156076.9; -.
DR   GeneCards; WIF1; -.
DR   HGNC; HGNC:18081; WIF1.
DR   HPA; HPA039104; -.
DR   MIM; 605186; gene.
DR   neXtProt; NX_Q9Y5W5; -.
DR   OpenTargets; ENSG00000156076; -.
DR   PharmGKB; PA38291; -.
DR   eggNOG; ENOG410IQQ0; Eukaryota.
DR   eggNOG; ENOG41104IN; LUCA.
DR   GeneTree; ENSGT00760000119131; -.
DR   HOVERGEN; HBG017335; -.
DR   InParanoid; Q9Y5W5; -.
DR   KO; K01691; -.
DR   OMA; DKGIMAD; -.
DR   OrthoDB; EOG091G08T8; -.
DR   PhylomeDB; Q9Y5W5; -.
DR   Reactome; R-HSA-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-HSA-3772470; Negative regulation of TCF-dependent signaling by WNT ligand antagonists.
DR   SignaLink; Q9Y5W5; -.
DR   SIGNOR; Q9Y5W5; -.
DR   ChiTaRS; WIF1; human.
DR   EvolutionaryTrace; Q9Y5W5; -.
DR   GeneWiki; WIF1; -.
DR   GenomeRNAi; 11197; -.
DR   PRO; PR:Q9Y5W5; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000156076; -.
DR   CleanEx; HS_WIF1; -.
DR   ExpressionAtlas; Q9Y5W5; baseline and differential.
DR   Genevisible; Q9Y5W5; HS.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0017147; F:Wnt-protein binding; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR003306; WIF.
DR   InterPro; IPR013309; Wnt-inh.
DR   Pfam; PF12661; hEGF; 2.
DR   Pfam; PF02019; WIF; 1.
DR   PRINTS; PR01901; WIFPROTEIN.
DR   ProDom; PD013948; WIF; 1.
DR   SMART; SM00181; EGF; 5.
DR   SMART; SM00469; WIF; 1.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS50814; WIF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Reference proteome;
KW   Repeat; Secreted; Signal; Wnt signaling pathway.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29    379       Wnt inhibitory factor 1.
FT                                /FTId=PRO_0000007775.
FT   DOMAIN       38    177       WIF. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00222}.
FT   DOMAIN      178    210       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      211    242       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      243    271       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      274    306       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      307    338       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   CARBOHYD     88     88       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    245    245       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    140    177       {ECO:0000269|PubMed:16476441}.
FT   DISULFID    182    192       {ECO:0000250}.
FT   DISULFID    186    198       {ECO:0000250}.
FT   DISULFID    200    209       {ECO:0000250}.
FT   DISULFID    214    224       {ECO:0000250}.
FT   DISULFID    218    230       {ECO:0000250}.
FT   DISULFID    232    241       {ECO:0000250}.
FT   DISULFID    246    256       {ECO:0000250}.
FT   DISULFID    250    262       {ECO:0000250}.
FT   DISULFID    278    288       {ECO:0000250}.
FT   DISULFID    282    294       {ECO:0000250}.
FT   DISULFID    296    305       {ECO:0000250}.
FT   DISULFID    310    320       {ECO:0000250}.
FT   DISULFID    314    326       {ECO:0000250}.
FT   DISULFID    328    337       {ECO:0000250}.
FT   CONFLICT    166    166       Q -> K (in Ref. 3; AAH18037).
FT                                {ECO:0000305}.
FT   CONFLICT    178    178       Q -> L (in Ref. 1; AAD25402).
FT                                {ECO:0000305}.
FT   STRAND       36     40       {ECO:0000244|PDB:2YGN}.
FT   HELIX        42     49       {ECO:0000244|PDB:2YGN}.
FT   STRAND       55     59       {ECO:0000244|PDB:2YGN}.
FT   HELIX        65     67       {ECO:0000244|PDB:2YGN}.
FT   STRAND       68     70       {ECO:0000244|PDB:2YGO}.
FT   HELIX        74     76       {ECO:0000244|PDB:2YGN}.
FT   STRAND       85     93       {ECO:0000244|PDB:2YGN}.
FT   STRAND       95     97       {ECO:0000244|PDB:2YGN}.
FT   STRAND       99    109       {ECO:0000244|PDB:2YGN}.
FT   STRAND      111    113       {ECO:0000244|PDB:2D3J}.
FT   STRAND      118    121       {ECO:0000244|PDB:2YGN}.
FT   STRAND      123    126       {ECO:0000244|PDB:2YGN}.
FT   STRAND      131    137       {ECO:0000244|PDB:2YGN}.
FT   STRAND      146    158       {ECO:0000244|PDB:2YGN}.
FT   STRAND      163    165       {ECO:0000244|PDB:2YGN}.
FT   STRAND      173    177       {ECO:0000244|PDB:2YGN}.
FT   TURN        206    209       {ECO:0000244|PDB:2YGO}.
SQ   SEQUENCE   379 AA;  41528 MW;  32ADFA6644833E9D CRC64;
     MARRSAFPAA ALWLWSILLC LLALRAEAGP PQEESLYLWI DAHQARVLIG FEEDILIVSE
     GKMAPFTHDF RKAQQRMPAI PVNIHSMNFT WQAAGQAEYF YEFLSLRSLD KGIMADPTVN
     VPLLGTVPHK ASVVQVGFPC LGKQDGVAAF EVDVIVMNSE GNTILQTPQN AIFFKTCQQA
     ECPGGCRNGG FCNERRICEC PDGFHGPHCE KALCTPRCMN GGLCVTPGFC ICPPGFYGVN
     CDKANCSTTC FNGGTCFYPG KCICPPGLEG EQCEISKCPQ PCRNGGKCIG KSKCKCSKGY
     QGDLCSKPVC EPGCGAHGTC HEPNKCQCQE GWHGRHCNKR YEASLIHALR PAGAQLRQHT
     PSLKKAEERR DPPESNYIW
//
ID   1433E_HUMAN             Reviewed;         255 AA.
AC   P62258; B3KY71; D3DTH5; P29360; P42655; Q4VJB6; Q53XZ5; Q63631;
AC   Q7M4R4;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 164.
DE   RecName: Full=14-3-3 protein epsilon;
DE            Short=14-3-3E;
GN   Name=YWHAE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7644510; DOI=10.1073/pnas.92.17.7892;
RA   Conklin D.S., Galaktionov K., Beach D.;
RT   "14-3-3 proteins associate with cdc25 phosphatases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7892-7896(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8858348; DOI=10.1101/gr.6.8.735;
RA   Chong S.S., Tanigami A., Roschke A.V., Ledbetter D.H.;
RT   "14-3-3 epsilon has no homology to LIS1 and lies telomeric to it on
RT   chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome
RT   region.";
RL   Genome Res. 6:735-741(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8684458; DOI=10.1038/382308a0;
RA   Jin D.-Y., Lyu M.S., Kozak C.A., Jeang K.-T.;
RT   "Function of 14-3-3 proteins.";
RL   Nature 382:308-308(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SV), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=20417184; DOI=10.1016/j.bbrc.2010.04.104;
RA   Han D., Ye G., Liu T., Chen C., Yang X., Wan B., Pan Y., Yu L.;
RT   "Functional identification of a novel 14-3-3 epsilon splicing variant
RT   suggests dimerization is not necessary for 14-3-3 epsilon to inhibit
RT   UV-induced apoptosis.";
RL   Biochem. Biophys. Res. Commun. 396:401-406(2010).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Luk S.C.W., Lee C.Y., Waye M.M.Y.;
RT   "Sequence determination of human epsilon 14-3-3 protein.";
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tanigami A., Chong S.S., Ledbetter D.H.;
RT   "14-3-3 epsilon genomic sequence.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND SV).
RC   TISSUE=Caudate nucleus, Heart, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 1-19.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [12]
RP   PROTEIN SEQUENCE OF 1-56; 62-73; 95-118; 131-193 AND 197-255,
RP   INTERACTION WITH PI4KB; TBC1D22A AND TBC1D22B, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=23572552; DOI=10.1128/mBio.00098-13;
RA   Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L.,
RA   DeRisi J.L.;
RT   "ACBD3 interaction with TBC1 domain 22 protein is differentially
RT   affected by enteroviral and kobuviral 3A protein binding.";
RL   MBio 4:E00098-E00098(2013).
RN   [13]
RP   PROTEIN SEQUENCE OF 1-19; 30-50 AND 131-170, ACETYLATION AT MET-1, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAY-2005) to UniProtKB.
RN   [14]
RP   PROTEIN SEQUENCE OF 50-60, AND INTERACTION WITH KSR1.
RX   PubMed=10409742; DOI=10.1128/MCB.19.8.5523;
RA   Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K.L.;
RT   "Kinase suppressor of Ras forms a multiprotein signaling complex and
RT   modulates MEK localization.";
RL   Mol. Cell. Biol. 19:5523-5534(1999).
RN   [15]
RP   PROTEIN SEQUENCE OF 103-108; 120-123; 131-141 AND 143-153.
RC   TISSUE=Histiocytic lymphoma;
RX   PubMed=2026444;
RA   Demeter J., Medzihradszky D., Kha H., Goetzl E.J., Turck C.W.;
RT   "Isolation and partial characterization of the structures of
RT   fibroblast activating factor-related proteins from U937 cells.";
RL   Immunology 72:350-354(1991).
RN   [16]
RP   PROTEIN SEQUENCE OF 131-141 AND 154-190, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [17]
RP   INTERACTION WITH HCV CORE PROTEIN (MICROBIAL INFECTION).
RX   PubMed=10644344; DOI=10.1128/JVI.74.4.1736-1741.2000;
RA   Aoki H., Hayashi J., Moriyama M., Arakawa Y., Hino O.;
RT   "Hepatitis C virus core protein interacts with 14-3-3 protein and
RT   activates the kinase Raf-1.";
RL   J. Virol. 74:1736-1741(2000).
RN   [18]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [19]
RP   INTERACTION WITH CDKN1B, AND SUBCELLULAR LOCATION.
RX   PubMed=12042314; DOI=10.1074/jbc.M203668200;
RA   Fujita N., Sato S., Katayama K., Tsuruo T.;
RT   "Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3
RT   and cytoplasmic localization.";
RL   J. Biol. Chem. 277:28706-28713(2002).
RN   [20]
RP   FUNCTION, INTERACTION WITH HSF1, AND SUBCELLULAR LOCATION.
RX   PubMed=12917326; DOI=10.1128/MCB.23.17.6013-6026.2003;
RA   Wang X., Grammatikakis N., Siganou A., Calderwood S.K.;
RT   "Regulation of molecular chaperone gene transcription involves the
RT   serine phosphorylation, 14-3-3 epsilon binding, and cytoplasmic
RT   sequestration of heat shock factor 1.";
RL   Mol. Cell. Biol. 23:6013-6026(2003).
RN   [21]
RP   INTERACTION WITH GRB10.
RX   PubMed=15722337; DOI=10.1074/jbc.M501477200;
RA   Urschel S., Bassermann F., Bai R.Y., Munch S., Peschel C., Duyster J.;
RT   "Phosphorylation of grb10 regulates its interaction with 14-3-3.";
RL   J. Biol. Chem. 280:16987-16993(2005).
RN   [22]
RP   INTERACTION WITH ABL1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [23]
RP   INTERACTION WITH YWHAZ.
RX   PubMed=16376338; DOI=10.1016/j.febslet.2005.12.024;
RA   Gu Y.-M., Jin Y.-H., Choi J.-K., Baek K.-H., Yeo C.-Y., Lee K.-Y.;
RT   "Protein kinase A phosphorylates and regulates dimerization of 14-3-3
RT   epsilon.";
RL   FEBS Lett. 580:305-310(2006).
RN   [24]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [25]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [28]
RP   INTERACTION WITH SLITRK1.
RX   PubMed=19640509; DOI=10.1016/j.biopsych.2009.05.033;
RA   Kajiwara Y., Buxbaum J.D., Grice D.E.;
RT   "SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a
RT   phosphorylation-dependent manner.";
RL   Biol. Psychiatry 66:918-925(2009).
RN   [29]
RP   INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50; LYS-69; LYS-118 AND
RP   LYS-123, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-232, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   INTERACTION WITH DAPK2.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with
RT   14-3-3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
RN   [37]
RP   INTERACTION WITH DENND1A.
RX   PubMed=26055712; DOI=10.1074/jbc.M115.636712;
RA   Kulasekaran G., Nossova N., Marat A.L., Lund I., Cremer C.,
RA   Ioannou M.S., McPherson P.S.;
RT   "Phosphorylation-dependent regulation of Connecdenn/DENND1 guanine
RT   nucleotide exchange factors.";
RL   J. Biol. Chem. 290:17999-18008(2015).
RN   [38]
RP   INTERACTION WITH RIPOR2.
RX   PubMed=25588844; DOI=10.1242/jcs.161497;
RA   Gao K., Tang W., Li Y., Zhang P., Wang D., Yu L., Wang C., Wu D.;
RT   "Front-signal-dependent accumulation of the RHOA inhibitor FAM65B at
RT   leading edges polarizes neutrophils.";
RL   J. Cell Sci. 128:992-1000(2015).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [40]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-50, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1-233, IDENTIFICATION BY
RP   MASS SPECTROMETRY, INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner (By
CC       similarity). Positively regulates phosphorylated protein HSF1
CC       nuclear export to the cytoplasm (PubMed:12917326).
CC       {ECO:0000250|UniProtKB:P62261, ECO:0000269|PubMed:12917326}.
CC   -!- SUBUNIT: Homodimer (PubMed:17085597). Heterodimerizes with YWHAZ
CC       (PubMed:16376338). Interacts with PKA-phosphorylated AANAT
CC       (PubMed:11427721). Interacts with ABL1 (phosphorylated form); the
CC       interaction retains it in the cytoplasm (PubMed:15696159).
CC       Interacts with ARHGEF28 (By similarity). Interacts with BEX3 (By
CC       similarity). Weakly interacts with CDKN1B (PubMed:12042314).
CC       Interacts with the 'Thr-369' phosphorylated form of DAPK2
CC       (PubMed:26047703). Interacts with DENND1A (PubMed:26055712).
CC       Interacts with GAB2 (PubMed:19172738). Interacts with
CC       phosphorylated GRB10 (PubMed:15722337). Interacts with KSR1
CC       (PubMed:10409742). Interacts with NDEL1 (By similarity). Interacts
CC       with PI4KB, TBC1D22A and TBC1D22B (PubMed:23572552). Interacts
CC       with the phosphorylated (by AKT1) form of SRPK2 (PubMed:19592491).
CC       Interacts with TIAM2. Interacts with the 'Ser-1134' and 'Ser-1161'
CC       phosphorylated form of SOS1 (By similarity). Interacts with ZFP36
CC       (via phosphorylated form) (By similarity). Interacts with SLITRK1
CC       (PubMed:19640509). Interacts with HSF1 (via phosphorylated form);
CC       this interaction promotes HSF1 sequestration in the cytoplasm in a
CC       ERK-dependent manner (PubMed:12917326). Interacts with RIPOR2
CC       isoform 2 (PubMed:25588844). {ECO:0000250|UniProtKB:P62259,
CC       ECO:0000250|UniProtKB:P62260, ECO:0000269|PubMed:10409742,
CC       ECO:0000269|PubMed:11427721, ECO:0000269|PubMed:12042314,
CC       ECO:0000269|PubMed:12917326, ECO:0000269|PubMed:15696159,
CC       ECO:0000269|PubMed:15722337, ECO:0000269|PubMed:16376338,
CC       ECO:0000269|PubMed:17085597, ECO:0000269|PubMed:19172738,
CC       ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19640509,
CC       ECO:0000269|PubMed:23572552, ECO:0000269|PubMed:25588844,
CC       ECO:0000269|PubMed:26047703, ECO:0000269|PubMed:26055712}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HCV core protein.
CC       {ECO:0000269|PubMed:10644344}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-356498, EBI-356498;
CC       O92972:- (xeno); NbExp=5; IntAct=EBI-356498, EBI-9213553;
CC       Q96AP0:ACD; NbExp=2; IntAct=EBI-356498, EBI-717666;
CC       O14727:APAF1; NbExp=2; IntAct=EBI-356498, EBI-446492;
CC       P10398:ARAF; NbExp=3; IntAct=EBI-356498, EBI-365961;
CC       O00257-3:CBX4; NbExp=2; IntAct=EBI-356498, EBI-4392727;
CC       Q9Y3M2:CBY1; NbExp=3; IntAct=EBI-356498, EBI-947308;
CC       Q86Z20:CCDC125; NbExp=4; IntAct=EBI-356498, EBI-11977221;
CC       O94921:CDK14; NbExp=3; IntAct=EBI-356498, EBI-1043945;
CC       Q9UKT5:FBXO4; NbExp=5; IntAct=EBI-356498, EBI-960409;
CC       P56524:HDAC4; NbExp=4; IntAct=EBI-356498, EBI-308629;
CC       Q14678-2:KANK1; NbExp=3; IntAct=EBI-356498, EBI-6173812;
CC       Q5S007:LRRK2; NbExp=6; IntAct=EBI-356498, EBI-5323863;
CC       Q99759:MAP3K3; NbExp=3; IntAct=EBI-356498, EBI-307281;
CC       O15151:MDM4; NbExp=3; IntAct=EBI-356498, EBI-398437;
CC       P58340:MLF1; NbExp=3; IntAct=EBI-356498, EBI-721328;
CC       O35244:Prdx6 (xeno); NbExp=2; IntAct=EBI-356498, EBI-915490;
CC       P04049:RAF1; NbExp=3; IntAct=EBI-356498, EBI-365996;
CC       P61588:Rnd3 (xeno); NbExp=2; IntAct=EBI-356498, EBI-6930266;
CC       Q99469:STAC; NbExp=2; IntAct=EBI-356498, EBI-2652799;
CC       Q9GZV5:WWTR1; NbExp=3; IntAct=EBI-356498, EBI-747743;
CC       P46937:YAP1; NbExp=5; IntAct=EBI-356498, EBI-1044059;
CC       P31946:YWHAB; NbExp=4; IntAct=EBI-356498, EBI-359815;
CC       P61981:YWHAG; NbExp=5; IntAct=EBI-356498, EBI-359832;
CC       P27348:YWHAQ; NbExp=4; IntAct=EBI-356498, EBI-359854;
CC       P63104:YWHAZ; NbExp=6; IntAct=EBI-356498, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12917326}.
CC       Cytoplasm {ECO:0000269|PubMed:12917326}. Melanosome
CC       {ECO:0000269|PubMed:12042314, ECO:0000269|PubMed:17081065}.
CC       Note=Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV. {ECO:0000269|PubMed:12042314,
CC       ECO:0000269|PubMed:17081065}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P62258-1; Sequence=Displayed;
CC       Name=SV;
CC         IsoId=P62258-2; Sequence=VSP_040621;
CC         Note=Unable to dimerize with YWHAZ.;
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U20972; AAC50175.1; -; mRNA.
DR   EMBL; U54778; AAC50710.1; -; mRNA.
DR   EMBL; U43399; AAC50625.1; -; mRNA.
DR   EMBL; U43430; AAD00026.1; -; mRNA.
DR   EMBL; U28936; AAA75301.1; -; mRNA.
DR   EMBL; AB017103; BAA32538.1; -; Genomic_DNA.
DR   EMBL; AY883089; AAX68683.1; -; mRNA.
DR   EMBL; AK128785; BAG54733.1; -; mRNA.
DR   EMBL; AK295260; BAG58249.1; -; mRNA.
DR   EMBL; AK316185; BAH14556.1; -; mRNA.
DR   EMBL; BT007161; AAP35825.1; -; mRNA.
DR   EMBL; CH471108; EAW90628.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90629.1; -; Genomic_DNA.
DR   EMBL; BC000179; AAH00179.1; -; mRNA.
DR   EMBL; BC001440; AAH01440.1; -; mRNA.
DR   CCDS; CCDS11001.1; -. [P62258-1]
DR   PIR; A61235; A61235.
DR   PIR; I38947; I38947.
DR   RefSeq; NP_006752.1; NM_006761.4. [P62258-1]
DR   UniGene; Hs.513851; -.
DR   PDB; 2BR9; X-ray; 1.75 A; A=1-233.
DR   PDB; 3UAL; X-ray; 1.80 A; A=1-232.
DR   PDB; 3UBW; X-ray; 1.90 A; A=1-234.
DR   PDBsum; 2BR9; -.
DR   PDBsum; 3UAL; -.
DR   PDBsum; 3UBW; -.
DR   ProteinModelPortal; P62258; -.
DR   SMR; P62258; -.
DR   BioGrid; 113363; 427.
DR   CORUM; P62258; -.
DR   DIP; DIP-36676N; -.
DR   ELM; P62258; -.
DR   IntAct; P62258; 180.
DR   MINT; P62258; -.
DR   STRING; 9606.ENSP00000264335; -.
DR   ChEMBL; CHEMBL3329082; -.
DR   DrugBank; DB01780; Fusicoccin.
DR   iPTMnet; P62258; -.
DR   PhosphoSitePlus; P62258; -.
DR   SwissPalm; P62258; -.
DR   BioMuta; YWHAE; -.
DR   DMDM; 51702210; -.
DR   OGP; P42655; -.
DR   UCD-2DPAGE; P62258; -.
DR   EPD; P62258; -.
DR   PaxDb; P62258; -.
DR   PeptideAtlas; P62258; -.
DR   PRIDE; P62258; -.
DR   TopDownProteomics; P62258-1; -. [P62258-1]
DR   DNASU; 7531; -.
DR   Ensembl; ENST00000264335; ENSP00000264335; ENSG00000108953. [P62258-1]
DR   Ensembl; ENST00000571732; ENSP00000461762; ENSG00000108953. [P62258-2]
DR   Ensembl; ENST00000616643; ENSP00000481059; ENSG00000274474. [P62258-2]
DR   Ensembl; ENST00000627231; ENSP00000487356; ENSG00000274474. [P62258-1]
DR   GeneID; 7531; -.
DR   KEGG; hsa:7531; -.
DR   UCSC; uc002fsk.4; human. [P62258-1]
DR   CTD; 7531; -.
DR   DisGeNET; 7531; -.
DR   EuPathDB; HostDB:ENSG00000108953.16; -.
DR   GeneCards; YWHAE; -.
DR   H-InvDB; HIX0013751; -.
DR   H-InvDB; HIX0030006; -.
DR   HGNC; HGNC:12851; YWHAE.
DR   HPA; CAB016200; -.
DR   HPA; CAB021109; -.
DR   HPA; CAB047350; -.
DR   HPA; HPA008445; -.
DR   MalaCards; YWHAE; -.
DR   MIM; 605066; gene.
DR   neXtProt; NX_P62258; -.
DR   OpenTargets; ENSG00000108953; -.
DR   Orphanet; 217385; 17p13.3 microduplication syndrome.
DR   Orphanet; 261257; Distal 17p13.3 microdeletion syndrome.
DR   Orphanet; 531; Miller-Dieker syndrome.
DR   PharmGKB; PA37440; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   GeneTree; ENSGT00760000119116; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P62258; -.
DR   KO; K06630; -.
DR   OMA; IPCATTG; -.
DR   OrthoDB; EOG091G0VKY; -.
DR   PhylomeDB; P62258; -.
DR   TreeFam; TF102003; -.
DR   Reactome; R-HSA-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-2028269; Signaling by Hippo.
DR   Reactome; R-HSA-205025; NADE modulates death signalling.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8862803; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models.
DR   Reactome; R-HSA-8876198; RAB GEFs exchange GTP for GDP on RABs.
DR   SignaLink; P62258; -.
DR   SIGNOR; P62258; -.
DR   ChiTaRS; YWHAE; human.
DR   EvolutionaryTrace; P62258; -.
DR   GeneWiki; YWHAE; -.
DR   GenomeRNAi; 7531; -.
DR   PMAP-CutDB; P62258; -.
DR   PRO; PR:P62258; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108953; -.
DR   CleanEx; HS_YWHAE; -.
DR   ExpressionAtlas; P62258; baseline and differential.
DR   Genevisible; P62258; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0090724; C:central region of growth cone; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005871; C:kinesin complex; IEA:Ensembl.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0005246; F:calcium channel regulator activity; IDA:SynGO-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL.
DR   GO; GO:0050815; F:phosphoserine residue binding; IPI:BHF-UCL.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0035329; P:hippo signaling; TAS:Reactome.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0000165; P:MAPK cascade; IDA:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:1905913; P:negative regulation of calcium ion export across plasma membrane; IDA:SynGO-UCL.
DR   GO; GO:1901020; P:negative regulation of calcium ion transmembrane transporter activity; IDA:SynGO-UCL.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome.
DR   GO; GO:1902309; P:negative regulation of peptidyl-serine dephosphorylation; IDA:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; IDA:UniProtKB.
DR   GO; GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IDA:SynGO-UCL.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IC:BHF-UCL.
DR   GO; GO:0003064; P:regulation of heart rate by hormone; NAS:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:1901016; P:regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0021762; P:substantia nigra development; HEP:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Host-virus interaction;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN         1    255       14-3-3 protein epsilon.
FT                                /FTId=PRO_0000058618.
FT   SITE         57     57       Interaction with phosphoserine on
FT                                interacting protein.
FT   SITE        130    130       Interaction with phosphoserine on
FT                                interacting protein.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.13}.
FT   MOD_RES      50     50       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      65     65       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P62260}.
FT   MOD_RES      69     69       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     118    118       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     123    123       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     131    131       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P62260}.
FT   MOD_RES     137    137       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P62260}.
FT   MOD_RES     210    210       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     232    232       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CROSSLNK     50     50       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     22       Missing (in isoform SV).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:20417184}.
FT                                /FTId=VSP_040621.
FT   CONFLICT    106    107       KH -> NY (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    143    143       E -> F (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    148    148       S -> T (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX         4     17       {ECO:0000244|PDB:2BR9}.
FT   HELIX        20     31       {ECO:0000244|PDB:2BR9}.
FT   HELIX        39     73       {ECO:0000244|PDB:2BR9}.
FT   HELIX        76    106       {ECO:0000244|PDB:2BR9}.
FT   HELIX       108    111       {ECO:0000244|PDB:2BR9}.
FT   HELIX       115    135       {ECO:0000244|PDB:2BR9}.
FT   HELIX       138    162       {ECO:0000244|PDB:2BR9}.
FT   HELIX       168    183       {ECO:0000244|PDB:2BR9}.
FT   HELIX       188    204       {ECO:0000244|PDB:2BR9}.
FT   HELIX       205    208       {ECO:0000244|PDB:2BR9}.
FT   TURN        211    213       {ECO:0000244|PDB:2BR9}.
FT   HELIX       214    231       {ECO:0000244|PDB:2BR9}.
SQ   SEQUENCE   255 AA;  29174 MW;  07817CCBD1F75B26 CRC64;
     MDDREDLVYQ AKLAEQAERY DEMVESMKKV AGMDVELTVE ERNLLSVAYK NVIGARRASW
     RIISSIEQKE ENKGGEDKLK MIREYRQMVE TELKLICCDI LDVLDKHLIP AANTGESKVF
     YYKMKGDYHR YLAEFATGND RKEAAENSLV AYKAASDIAM TELPPTHPIR LGLALNFSVF
     YYEILNSPDR ACRLAKAAFD DAIAELDTLS EESYKDSTLI MQLLRDNLTL WTSDMQGDGE
     EQNKEALQDV EDENQ
//
ID   V9HW98_HUMAN            Unreviewed;       255 AA.
AC   V9HW98;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   31-JAN-2018, entry version 31.
DE   SubName: Full=Epididymis luminal protein 2 {ECO:0000313|EMBL:ACJ13635.1};
GN   Name=HEL2 {ECO:0000313|EMBL:ACJ13635.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13635.1};
RN   [1] {ECO:0000313|EMBL:ACJ13635.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q9NYF3:FAM53C; NbExp=3; IntAct=EBI-10190883, EBI-1644252;
CC       O94875:SORBS2; NbExp=3; IntAct=EBI-10190883, EBI-311323;
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC       {ECO:0000256|RuleBase:RU003466, ECO:0000256|SAAS:SAAS00595241}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU794581; ACJ13635.1; -; mRNA.
DR   RefSeq; NP_006752.1; NM_006761.4.
DR   UniGene; Hs.513851; -.
DR   ProteinModelPortal; V9HW98; -.
DR   SMR; V9HW98; -.
DR   IntAct; V9HW98; 2.
DR   MaxQB; V9HW98; -.
DR   GeneID; 7531; -.
DR   KEGG; hsa:7531; -.
DR   UCSC; uc002fsj.4; human.
DR   CTD; 7531; -.
DR   EuPathDB; HostDB:ENSG00000108953.16; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   KO; K06630; -.
DR   OMA; IPCATTG; -.
DR   OrthoDB; EOG091G0VKY; -.
DR   PhylomeDB; V9HW98; -.
DR   ChiTaRS; YWHAE; human.
DR   GenomeRNAi; 7531; -.
DR   Bgee; ENSG00000108953; -.
DR   ExpressionAtlas; V9HW98; baseline and differential.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0090724; C:central region of growth cone; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005871; C:kinesin complex; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
FT   DOMAIN        4    245       14_3_3. {ECO:0000259|SMART:SM00101}.
SQ   SEQUENCE   255 AA;  29174 MW;  07817CCBD1F75B26 CRC64;
     MDDREDLVYQ AKLAEQAERY DEMVESMKKV AGMDVELTVE ERNLLSVAYK NVIGARRASW
     RIISSIEQKE ENKGGEDKLK MIREYRQMVE TELKLICCDI LDVLDKHLIP AANTGESKVF
     YYKMKGDYHR YLAEFATGND RKEAAENSLV AYKAASDIAM TELPPTHPIR LGLALNFSVF
     YYEILNSPDR ACRLAKAAFD DAIAELDTLS EESYKDSTLI MQLLRDNLTL WTSDMQGDGE
     EQNKEALQDV EDENQ
//
ID   A0A024R3C6_HUMAN        Unreviewed;       673 AA.
AC   A0A024R3C6;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 34.
DE   SubName: Full=Zinc finger and BTB domain containing 16 isoform 1 {ECO:0000313|EMBL:ALQ33858.1};
DE   SubName: Full=Zinc finger and BTB domain containing 16, isoform CRA_a {ECO:0000313|EMBL:EAW67242.1};
GN   Name=ZBTB16 {ECO:0000313|EMBL:EAW67242.1};
GN   ORFNames=hCG_38015 {ECO:0000313|EMBL:EAW67242.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW67242.1};
RN   [1] {ECO:0000313|EMBL:EAW67242.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW67242.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33858.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178400; ALQ33858.1; -; mRNA.
DR   EMBL; CH471065; EAW67241.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67242.1; -; Genomic_DNA.
DR   RefSeq; NP_001018011.1; NM_001018011.1.
DR   RefSeq; NP_005997.2; NM_006006.4.
DR   RefSeq; XP_016873746.1; XM_017018257.1.
DR   RefSeq; XP_016873747.1; XM_017018258.1.
DR   RefSeq; XP_016873748.1; XM_017018259.1.
DR   UniGene; Hs.591945; -.
DR   UniGene; Hs.682144; -.
DR   SMR; A0A024R3C6; -.
DR   GeneID; 7704; -.
DR   KEGG; hsa:7704; -.
DR   CTD; 7704; -.
DR   EuPathDB; HostDB:ENSG00000109906.13; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   KO; K10055; -.
DR   OMA; RELHYVR; -.
DR   OrthoDB; EOG091G11X6; -.
DR   ChiTaRS; ZBTB16; human.
DR   GenomeRNAi; 7704; -.
DR   Bgee; ENSG00000109906; -.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:Ensembl.
DR   GO; GO:0003690; F:double-stranded DNA binding; IEA:Ensembl.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
DR   GO; GO:0035136; P:forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; IEA:Ensembl.
DR   GO; GO:0048133; P:male germ-line stem cell asymmetric division; IEA:Ensembl.
DR   GO; GO:0001823; P:mesonephros development; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0051138; P:positive regulation of NK T cell differentiation; IEA:Ensembl.
DR   GO; GO:0034504; P:protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 9.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 9.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN       34     96       BTB. {ECO:0000259|PROSITE:PS50097}.
FT   DOMAIN      404    431       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      432    459       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      461    488       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      490    517       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      518    545       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      546    573       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      574    601       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      602    629       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      630    657       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   NON_TER     673    673       {ECO:0000313|EMBL:ALQ33858.1}.
SQ   SEQUENCE   673 AA;  74274 MW;  51F8E361FA31239E CRC64;
     MDLTKMGMIQ LQNPSHPTGL LCKANQMRLA GTLCDVVIMV DSQEFHAHRT VLACTSKMFE
     ILFHRNSQHY TLDFLSPKTF QQILEYAYTA TLQAKAEDLD DLLYAAEILE IEYLEEQCLK
     MLETIQASDD NDTEATMADG GAEEEEDRKA RYLKNIFISK HSSEESGYAS VAGQSLPGPM
     VDQSPSVSTS FGLSAMSPTK AAVDSLMTIG QSLLQGTLQP PAGPEEPTLA GGGRHPGVAE
     VKTEMMQVDE VPSQDSPGAA ESSISGGMGD KVEERGKEGP GTPTRSSVIT SARELHYGRE
     ESAEQVPPPA EAGQAPTGRP EHPAPPPEKH LGIYSVLPNH KADAVLSMPS SVTSGLHVQP
     ALAVSMDFST YGGLLPQGFI QRELFSKLGE LAVGMKSESR TIGEQCSVCG VELPDNEAVE
     QHRKLHSGMK TYGCELCGKR FLDSLRLRMH LLAHSAGAKA FVCDQCGAQF SKEDALETHR
     QTHTGTDMAV FCLLCGKRFQ AQSALQQHME VHAGVRSYIC SECNRTFPSH TALKRHLRSH
     TGDHPYECEF CGSCFRDEST LKSHKRIHTG EKPYECNGCG KKFSLKHQLE THYRVHTGEK
     PFECKLCHQR SRDYSAMIKH LRTHNGASPY QCTICTEYCP SLSSMQKHMK GHKPEEIPPD
     WRIEKTYLYL CYV
//
ID   ZBT16_HUMAN             Reviewed;         673 AA.
AC   Q05516; Q8TAL4;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   28-FEB-2018, entry version 195.
DE   RecName: Full=Zinc finger and BTB domain-containing protein 16;
DE   AltName: Full=Promyelocytic leukemia zinc finger protein;
DE   AltName: Full=Zinc finger protein 145;
DE   AltName: Full=Zinc finger protein PLZF;
GN   Name=ZBTB16; Synonyms=PLZF, ZNF145;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PLZFB), ALTERNATIVE SPLICING, AND
RP   CHROMOSOMAL TRANSLOCATION WITH RARA.
RC   TISSUE=Heart ventricle;
RX   PubMed=8384553;
RA   Chen Z., Brand N.J., Chen A., Chen S.-J., Tong J.-H., Wang Z.-Y.,
RA   Waxman S., Zelent A.;
RT   "Fusion between a novel Kruppel-like zinc finger gene and the retinoic
RT   acid receptor-alpha locus due to a variant t(11;17) translocation
RT   associated with acute promyelocytic leukaemia.";
RL   EMBO J. 12:1161-1167(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10500192; DOI=10.1073/pnas.96.20.11422;
RA   Zhang T., Xiong H., Kan L.-X., Zhang C.-K., Jiao X.-F., Fu G.,
RA   Zhang Q.-H., Lu L., Tong J.-H., Gu B.-W., Yu M., Liu J.-X., Licht J.,
RA   Waxman S., Zelent A., Chen E., Chen S.-J.;
RT   "Genomic sequence, structural organization, molecular evolution, and
RT   aberrant rearrangement of promyelocytic leukemia zinc finger gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:11422-11427(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PLZFB).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 424-455.
RX   PubMed=8387545; DOI=10.1172/JCI116453;
RA   Chen S.-J., Zelent A., Tong J.-H., Yu H.-Q., Wang Z.-Y., Derre J.,
RA   Berger R., Waxman S., Chen Z.;
RT   "Rearrangements of the retinoic acid receptor alpha and promyelocytic
RT   leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a
RT   patient with acute promyelocytic leukemia.";
RL   J. Clin. Invest. 91:2260-2267(1993).
RN   [5]
RP   INTERACTION WITH ZBTB32.
RX   PubMed=10572087;
RA   Hoatlin M.E., Zhi Y., Ball H., Silvey K., Melnick A., Stone S.,
RA   Arai S., Hawe N., Owen G., Zelent A., Licht J.D.;
RT   "A novel BTB/POZ transcriptional repressor protein interacts with the
RT   Fanconi anemia group C protein and PLZF.";
RL   Blood 94:3737-3747(1999).
RN   [6]
RP   INTERACTION WITH EPN1.
RX   PubMed=11161217; DOI=10.1126/science.291.5506.1047;
RA   Itoh T., Koshiba S., Kigawa T., Kikuchi A., Yokoyama S., Takenawa T.;
RT   "Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate
RT   binding and endocytosis.";
RL   Science 291:1047-1051(2001).
RN   [7]
RP   FUNCTION AS AN E3 UBIQUITIN-PROTEIN LIGASE, AND INTERACTION WITH CUL3.
RX   PubMed=14528312; DOI=10.1038/ncb1056;
RA   Furukawa M., He Y.J., Borchers C., Xiong Y.;
RT   "Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin
RT   ligases.";
RL   Nat. Cell Biol. 5:1001-1007(2003).
RN   [8]
RP   INTERACTION WITH ATP7B.
RX   PubMed=16676348; DOI=10.1002/jcb.20980;
RA   Ko J.H., Son W., Bae G.Y., Kang J.H., Oh W., Yoo O.J.;
RT   "A new hepatocytic isoform of PLZF lacking the BTB domain interacts
RT   with ATP7B, the Wilson disease protein, and positively regulates ERK
RT   signal transduction.";
RL   J. Cell. Biochem. 99:719-734(2006).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 6-126.
RX   PubMed=9770450; DOI=10.1073/pnas.95.21.12123;
RA   Ahmad K.F., Engel C.K., Prive G.G.;
RT   "Crystal structure of the BTB domain from PLZF.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:12123-12128(1998).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 7-122.
RX   PubMed=10537309;
RA   Li X., Peng H., Schultz D.C., Lopez-Guisa J.M., Rauscher F.J. III,
RA   Marmorstein R.;
RT   "Structure-function studies of the BTB/POZ transcriptional repression
RT   domain from the promyelocytic leukemia zinc finger oncoprotein.";
RL   Cancer Res. 59:5275-5282(1999).
RN   [11]
RP   VARIANT SGYMR VAL-617.
RX   PubMed=18611983; DOI=10.1136/jmg.2008.059451;
RA   Fischer S., Kohlhase J., Boehm D., Schweiger B., Hoffmann D.,
RA   Heitmann M., Horsthemke B., Wieczorek D.;
RT   "Biallelic loss of function of the promyelocytic leukaemia zinc finger
RT   (PLZF) gene causes severe skeletal defects and genital hypoplasia.";
RL   J. Med. Genet. 45:731-737(2008).
CC   -!- FUNCTION: Probable transcription factor. May play a role in
CC       myeloid maturation and in the development and/or maintenance of
CC       other differentiated tissues. Probable substrate-recognition
CC       component of an E3 ubiquitin-protein ligase complex which mediates
CC       the ubiquitination and subsequent proteasomal degradation of
CC       target proteins. {ECO:0000269|PubMed:14528312}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Binds EPN1 (PubMed:11161217). Interacts with ZBTB32 and
CC       CUL3 (PubMed:10572087, PubMed:14528312). Interacts with ATP7B
CC       (PubMed:16676348). {ECO:0000269|PubMed:10572087,
CC       ECO:0000269|PubMed:11161217, ECO:0000269|PubMed:14528312,
CC       ECO:0000269|PubMed:16676348}.
CC   -!- INTERACTION:
CC       Self; NbExp=7; IntAct=EBI-711925, EBI-711925;
CC       Q8NHQ1:CEP70; NbExp=3; IntAct=EBI-711925, EBI-739624;
CC       Q9Y2V7:COG6; NbExp=4; IntAct=EBI-711925, EBI-3866319;
CC       P68104:EEF1A1; NbExp=4; IntAct=EBI-711925, EBI-352162;
CC       O35826:Gne (xeno); NbExp=2; IntAct=EBI-711925, EBI-7109445;
CC       Q08379:GOLGA2; NbExp=7; IntAct=EBI-711925, EBI-618309;
CC       O95872:GPANK1; NbExp=4; IntAct=EBI-711925, EBI-751540;
CC       P09022:Hoxa1 (xeno); NbExp=3; IntAct=EBI-711925, EBI-3957603;
CC       P05231:IL6; NbExp=2; IntAct=EBI-711925, EBI-720533;
CC       Q9BVG8-5:KIFC3; NbExp=4; IntAct=EBI-711925, EBI-14069005;
CC       Q6A162:KRT40; NbExp=8; IntAct=EBI-711925, EBI-10171697;
CC       A0A0C4DGV4:LAMTOR5; NbExp=5; IntAct=EBI-711925, EBI-10173304;
CC       O95751:LDOC1; NbExp=5; IntAct=EBI-711925, EBI-740738;
CC       P29590:PML; NbExp=7; IntAct=EBI-711925, EBI-295890;
CC       P29590-5:PML; NbExp=2; IntAct=EBI-711925, EBI-304008;
CC       Q9H788-2:SH2D4A; NbExp=3; IntAct=EBI-711925, EBI-10308083;
CC       Q9NYJ8:TAB2; NbExp=3; IntAct=EBI-711925, EBI-358708;
CC       Q13077:TRAF1; NbExp=4; IntAct=EBI-711925, EBI-359224;
CC       Q12933:TRAF2; NbExp=4; IntAct=EBI-711925, EBI-355744;
CC       P14373:TRIM27; NbExp=5; IntAct=EBI-711925, EBI-719493;
CC       Q9BYV2:TRIM54; NbExp=5; IntAct=EBI-711925, EBI-2130429;
CC       Q9NP79:VTA1; NbExp=3; IntAct=EBI-711925, EBI-740160;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=PLZFB;
CC         IsoId=Q05516-1; Sequence=Displayed;
CC       Name=PLZFA;
CC         IsoId=Q05516-2; Sequence=VSP_006896;
CC   -!- TISSUE SPECIFICITY: Within the hematopoietic system, PLZF is
CC       expressed in bone marrow, early myeloid cell lines and peripheral
CC       blood mononuclear cells. Also expressed in the ovary, and at lower
CC       levels, in the kidney and lung.
CC   -!- INDUCTION: By retinoic acid.
CC   -!- DISEASE: Skeletal defects, genital hypoplasia, and mental
CC       retardation (SGYMR) [MIM:612447]: A disorder characterized by
CC       mental retardation, craniofacial dysmorphism, microcephaly and
CC       short stature. Additional features include absence of the thumbs,
CC       hypoplasia of the radii and ulnae, additional vertebrae and ribs,
CC       retarded bone age and genital hypoplasia.
CC       {ECO:0000269|PubMed:18611983}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving ZBTB16 may be a
CC       cause of acute promyelocytic leukemia (APL). Translocation
CC       t(11;17)(q32;q21) with RARA. {ECO:0000269|PubMed:8384553}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PLZFID37.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z19002; CAA79489.1; -; mRNA.
DR   EMBL; AF060568; AAD03619.1; -; Genomic_DNA.
DR   EMBL; BC026902; AAH26902.1; -; mRNA.
DR   EMBL; BC029812; AAH29812.1; -; mRNA.
DR   EMBL; S60093; AAC60590.2; -; Genomic_DNA.
DR   CCDS; CCDS8367.1; -. [Q05516-1]
DR   PIR; S36336; S36336.
DR   RefSeq; NP_001018011.1; NM_001018011.1. [Q05516-1]
DR   RefSeq; NP_005997.2; NM_006006.4. [Q05516-1]
DR   RefSeq; XP_016873746.1; XM_017018257.1.
DR   RefSeq; XP_016873747.1; XM_017018258.1.
DR   RefSeq; XP_016873748.1; XM_017018259.1. [Q05516-1]
DR   UniGene; Hs.591945; -.
DR   UniGene; Hs.682144; -.
DR   PDB; 1BUO; X-ray; 1.90 A; A=6-126.
DR   PDB; 1CS3; X-ray; 2.00 A; A=7-122.
DR   PDBsum; 1BUO; -.
DR   PDBsum; 1CS3; -.
DR   ProteinModelPortal; Q05516; -.
DR   SMR; Q05516; -.
DR   BioGrid; 113498; 122.
DR   DIP; DIP-2654N; -.
DR   IntAct; Q05516; 109.
DR   MINT; Q05516; -.
DR   STRING; 9606.ENSP00000338157; -.
DR   iPTMnet; Q05516; -.
DR   PhosphoSitePlus; Q05516; -.
DR   BioMuta; ZBTB16; -.
DR   DMDM; 90109930; -.
DR   EPD; Q05516; -.
DR   PaxDb; Q05516; -.
DR   PeptideAtlas; Q05516; -.
DR   PRIDE; Q05516; -.
DR   DNASU; 7704; -.
DR   Ensembl; ENST00000335953; ENSP00000338157; ENSG00000109906. [Q05516-1]
DR   Ensembl; ENST00000392996; ENSP00000376721; ENSG00000109906. [Q05516-1]
DR   GeneID; 7704; -.
DR   KEGG; hsa:7704; -.
DR   UCSC; uc001pop.4; human. [Q05516-1]
DR   CTD; 7704; -.
DR   DisGeNET; 7704; -.
DR   EuPathDB; HostDB:ENSG00000109906.13; -.
DR   GeneCards; ZBTB16; -.
DR   HGNC; HGNC:12930; ZBTB16.
DR   HPA; CAB004540; -.
DR   HPA; HPA001499; -.
DR   MalaCards; ZBTB16; -.
DR   MIM; 176797; gene.
DR   MIM; 612447; phenotype.
DR   neXtProt; NX_Q05516; -.
DR   OpenTargets; ENSG00000109906; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   PharmGKB; PA37517; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00530000063338; -.
DR   HOGENOM; HOG000130800; -.
DR   HOVERGEN; HBG057844; -.
DR   InParanoid; Q05516; -.
DR   KO; K10055; -.
DR   OMA; RELHYVR; -.
DR   OrthoDB; EOG091G11X6; -.
DR   PhylomeDB; Q05516; -.
DR   TreeFam; TF350825; -.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q05516; -.
DR   SIGNOR; Q05516; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; ZBTB16; human.
DR   EvolutionaryTrace; Q05516; -.
DR   GeneWiki; Zinc_finger_and_BTB_domain-containing_protein_16; -.
DR   GenomeRNAi; 7704; -.
DR   PRO; PR:Q05516; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000109906; -.
DR   CleanEx; HS_ZBTB16; -.
DR   ExpressionAtlas; Q05516; baseline and differential.
DR   Genevisible; Q05516; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016604; C:nuclear body; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IMP:UniProtKB.
DR   GO; GO:0017053; C:transcriptional repressor complex; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001206; F:transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; NAS:UniProtKB.
DR   GO; GO:0051216; P:cartilage development; IDA:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; ISS:UniProtKB.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
DR   GO; GO:0035136; P:forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; IDA:UniProtKB.
DR   GO; GO:0048133; P:male germ-line stem cell asymmetric division; IEA:Ensembl.
DR   GO; GO:0001823; P:mesonephros development; ISS:UniProtKB.
DR   GO; GO:0030099; P:myeloid cell differentiation; TAS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0061036; P:positive regulation of cartilage development; IDA:UniProtKB.
DR   GO; GO:0032332; P:positive regulation of chondrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; IMP:UniProtKB.
DR   GO; GO:0051138; P:positive regulation of NK T cell differentiation; IEA:Ensembl.
DR   GO; GO:0045778; P:positive regulation of ossification; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0034504; P:protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 9.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 9.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Complete proteome; Disease mutation; DNA-binding; Mental retardation;
KW   Metal-binding; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    673       Zinc finger and BTB domain-containing
FT                                protein 16.
FT                                /FTId=PRO_0000047729.
FT   DOMAIN       34     96       BTB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00037}.
FT   ZN_FING     404    426       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     432    454       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     461    483       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     490    512       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     518    540       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     546    568       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     574    596       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     602    624       C2H2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     630    652       C2H2-type 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   SITE        394    395       Breakpoint for translocation to form
FT                                PLZF-RAR-alpha oncogene.
FT   MOD_RES      76     76       Phosphoserine; by PDPK1. {ECO:0000255}.
FT   MOD_RES     184    184       Phosphoserine; by PDPK1. {ECO:0000255}.
FT   MOD_RES     197    197       Phosphoserine; by PDPK1. {ECO:0000255}.
FT   MOD_RES     256    256       Phosphoserine; by PDPK1. {ECO:0000255}.
FT   MOD_RES     282    282       Phosphothreonine; by PDPK1.
FT                                {ECO:0000255}.
FT   MOD_RES     628    628       Phosphoserine; by PDPK1. {ECO:0000255}.
FT   VAR_SEQ     255    377       Missing (in isoform PLZFA).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_006896.
FT   VARIANT     617    617       M -> V (in SGYMR; dbSNP:rs121434606).
FT                                {ECO:0000269|PubMed:18611983}.
FT                                /FTId=VAR_054912.
FT   CONFLICT    580    580       G -> D (in Ref. 1; CAA79489).
FT                                {ECO:0000305}.
FT   HELIX        16     30       {ECO:0000244|PDB:1BUO}.
FT   TURN         31     33       {ECO:0000244|PDB:1BUO}.
FT   STRAND       36     42       {ECO:0000244|PDB:1BUO}.
FT   STRAND       44     47       {ECO:0000244|PDB:1BUO}.
FT   HELIX        49     55       {ECO:0000244|PDB:1BUO}.
FT   HELIX        57     62       {ECO:0000244|PDB:1BUO}.
FT   HELIX        63     65       {ECO:0000244|PDB:1CS3}.
FT   STRAND       68     72       {ECO:0000244|PDB:1BUO}.
FT   HELIX        77     89       {ECO:0000244|PDB:1BUO}.
FT   HELIX        96     98       {ECO:0000244|PDB:1BUO}.
FT   HELIX        99    109       {ECO:0000244|PDB:1BUO}.
FT   HELIX       112    125       {ECO:0000244|PDB:1BUO}.
SQ   SEQUENCE   673 AA;  74274 MW;  51F8E361FA31239E CRC64;
     MDLTKMGMIQ LQNPSHPTGL LCKANQMRLA GTLCDVVIMV DSQEFHAHRT VLACTSKMFE
     ILFHRNSQHY TLDFLSPKTF QQILEYAYTA TLQAKAEDLD DLLYAAEILE IEYLEEQCLK
     MLETIQASDD NDTEATMADG GAEEEEDRKA RYLKNIFISK HSSEESGYAS VAGQSLPGPM
     VDQSPSVSTS FGLSAMSPTK AAVDSLMTIG QSLLQGTLQP PAGPEEPTLA GGGRHPGVAE
     VKTEMMQVDE VPSQDSPGAA ESSISGGMGD KVEERGKEGP GTPTRSSVIT SARELHYGRE
     ESAEQVPPPA EAGQAPTGRP EHPAPPPEKH LGIYSVLPNH KADAVLSMPS SVTSGLHVQP
     ALAVSMDFST YGGLLPQGFI QRELFSKLGE LAVGMKSESR TIGEQCSVCG VELPDNEAVE
     QHRKLHSGMK TYGCELCGKR FLDSLRLRMH LLAHSAGAKA FVCDQCGAQF SKEDALETHR
     QTHTGTDMAV FCLLCGKRFQ AQSALQQHME VHAGVRSYIC SECNRTFPSH TALKRHLRSH
     TGDHPYECEF CGSCFRDEST LKSHKRIHTG EKPYECNGCG KKFSLKHQLE THYRVHTGEK
     PFECKLCHQR SRDYSAMIKH LRTHNGASPY QCTICTEYCP SLSSMQKHMK GHKPEEIPPD
     WRIEKTYLYL CYV
//
ID   A0A024R1F8_HUMAN        Unreviewed;       641 AA.
AC   A0A024R1F8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 35.
DE   SubName: Full=Zinc finger protein 278, isoform CRA_d {ECO:0000313|EMBL:EAW59971.1};
GN   Name=ZNF278 {ECO:0000313|EMBL:EAW59971.1};
GN   ORFNames=hCG_41522 {ECO:0000313|EMBL:EAW59971.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59971.1};
RN   [1] {ECO:0000313|EMBL:EAW59971.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59971.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471095; EAW59968.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59971.1; -; Genomic_DNA.
DR   RefSeq; NP_114439.1; NM_032050.1.
DR   UniGene; Hs.731398; -.
DR   SMR; A0A024R1F8; -.
DR   GeneID; 23598; -.
DR   CTD; 23598; -.
DR   EuPathDB; HostDB:ENSG00000100105.17; -.
DR   ChiTaRS; PATZ1; human.
DR   GenomeRNAi; 23598; -.
DR   Bgee; ENSG00000100105; -.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR000637; HMGI/Y_DNA-bd_CS.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 7.
DR   SUPFAM; SSF54695; SSF54695; 2.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00354; HMGI_Y; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 6.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN       41    130       BTB. {ECO:0000259|PROSITE:PS50097}.
FT   DOMAIN      292    314       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      355    382       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      383    410       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      413    441       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      442    469       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      559    582       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
SQ   SEQUENCE   641 AA;  69079 MW;  29515535E380F0CE CRC64;
     MERVNDASCG PSGCYTYQVS RHSTEMLHNL NQQRKNGGRF CDVLLRVGDE SFPAHRAVLA
     ACSEYFESVF SAQLGDGGAA DGGPADVGGA TAAPGGGAGG SRELEMHTIS SKVFGDILDF
     AYTSRIVVRL ESFPELMTAA KFLLMRSVIE ICQEVIKQSN VQILVPPARA DIMLFRPPGT
     SDLGFPLDMT NGAALAANSN GIAGSMQPEE EAARAAGAAI AGQASLPVLP GVDRLPMVAG
     PLSPQLLTSP FPSVASSAPP LTGKRGRGRP RKANLLDSMF GSPGGLREAG ILPCGLCGKV
     FTDANRLRQH EAQHGVTSLQ LGYIDLPPPR LGENGLPISE DPDGPRKRSR TRKQVACEIC
     GKIFRDVYHL NRHKLSHSGE KPYSCPVCGL RFKRKDRMSY HVRSHDGSVG KPYICQSCGK
     GFSRPDHLNG HIKQVHTSER PHKCQTCNAS FATRDRLRSH LACHEDKVPC QVCGKYLRAA
     YMADHLKKHS EGPSNFCSIC NREGQKCSHQ DPIESSDSYG DLSDASDLKT PEKQSANGSF
     SCDMAVPKNK MESDGEKKYP CPECGSFFRS KSYLNKHIQK VHVRALGGPL GDLGPALGSP
     FSPQQNMSLL ESFGFQIVQS AFASSLVDPE VDQQPMGPEG K
//
ID   A0A024R1H7_HUMAN        Unreviewed;       537 AA.
AC   A0A024R1H7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 35.
DE   SubName: Full=Zinc finger protein 278, isoform CRA_b {ECO:0000313|EMBL:EAW59970.1};
GN   Name=ZNF278 {ECO:0000313|EMBL:EAW59970.1};
GN   ORFNames=hCG_41522 {ECO:0000313|EMBL:EAW59970.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59970.1};
RN   [1] {ECO:0000313|EMBL:EAW59970.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59970.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471095; EAW59966.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59970.1; -; Genomic_DNA.
DR   RefSeq; NP_114441.1; NM_032052.1.
DR   UniGene; Hs.731398; -.
DR   SMR; A0A024R1H7; -.
DR   GeneID; 23598; -.
DR   CTD; 23598; -.
DR   EuPathDB; HostDB:ENSG00000100105.17; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   ChiTaRS; PATZ1; human.
DR   GenomeRNAi; 23598; -.
DR   Bgee; ENSG00000100105; -.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR000637; HMGI/Y_DNA-bd_CS.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 6.
DR   SUPFAM; SSF54695; SSF54695; 2.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00354; HMGI_Y; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 5.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN       41    130       BTB. {ECO:0000259|PROSITE:PS50097}.
FT   DOMAIN      292    314       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      355    382       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      383    410       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      413    441       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      442    469       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
SQ   SEQUENCE   537 AA;  57995 MW;  950792413BF1F5DB CRC64;
     MERVNDASCG PSGCYTYQVS RHSTEMLHNL NQQRKNGGRF CDVLLRVGDE SFPAHRAVLA
     ACSEYFESVF SAQLGDGGAA DGGPADVGGA TAAPGGGAGG SRELEMHTIS SKVFGDILDF
     AYTSRIVVRL ESFPELMTAA KFLLMRSVIE ICQEVIKQSN VQILVPPARA DIMLFRPPGT
     SDLGFPLDMT NGAALAANSN GIAGSMQPEE EAARAAGAAI AGQASLPVLP GVDRLPMVAG
     PLSPQLLTSP FPSVASSAPP LTGKRGRGRP RKANLLDSMF GSPGGLREAG ILPCGLCGKV
     FTDANRLRQH EAQHGVTSLQ LGYIDLPPPR LGENGLPISE DPDGPRKRSR TRKQVACEIC
     GKIFRDVYHL NRHKLSHSGE KPYSCPVCGL RFKRKDRMSY HVRSHDGSVG KPYICQSCGK
     GFSRPDHLNG HIKQVHTSER PHKCQTCNAS FATRDRLRSH LACHEDKVPC QVCGKYLRAA
     YMADHLKKHS EGPSNFCSIC NRGLQAPGAH PEWGSSVPLR QDLWQQRRPE MLTSGSD
//
ID   A0A024R1M5_HUMAN        Unreviewed;       687 AA.
AC   A0A024R1M5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 36.
DE   SubName: Full=Zinc finger protein 278, isoform CRA_c {ECO:0000313|EMBL:EAW59969.1};
GN   Name=ZNF278 {ECO:0000313|EMBL:EAW59969.1};
GN   ORFNames=hCG_41522 {ECO:0000313|EMBL:EAW59969.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59969.1};
RN   [1] {ECO:0000313|EMBL:EAW59969.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59969.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471095; EAW59967.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59969.1; -; Genomic_DNA.
DR   RefSeq; NP_055138.2; NM_014323.2.
DR   UniGene; Hs.731398; -.
DR   SMR; A0A024R1M5; -.
DR   GeneID; 23598; -.
DR   KEGG; hsa:23598; -.
DR   CTD; 23598; -.
DR   EuPathDB; HostDB:ENSG00000100105.17; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   OMA; LDSMMFG; -.
DR   OrthoDB; EOG091G04OT; -.
DR   ChiTaRS; PATZ1; human.
DR   GenomeRNAi; 23598; -.
DR   Bgee; ENSG00000100105; -.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR000637; HMGI/Y_DNA-bd_CS.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF54695; SSF54695; 2.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00354; HMGI_Y; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 7.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN       41    130       BTB. {ECO:0000259|PROSITE:PS50097}.
FT   DOMAIN      292    314       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      355    382       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      383    410       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      413    441       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      442    469       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      495    519       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      605    628       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
SQ   SEQUENCE   687 AA;  74060 MW;  0F1C59A78C6D110A CRC64;
     MERVNDASCG PSGCYTYQVS RHSTEMLHNL NQQRKNGGRF CDVLLRVGDE SFPAHRAVLA
     ACSEYFESVF SAQLGDGGAA DGGPADVGGA TAAPGGGAGG SRELEMHTIS SKVFGDILDF
     AYTSRIVVRL ESFPELMTAA KFLLMRSVIE ICQEVIKQSN VQILVPPARA DIMLFRPPGT
     SDLGFPLDMT NGAALAANSN GIAGSMQPEE EAARAAGAAI AGQASLPVLP GVDRLPMVAG
     PLSPQLLTSP FPSVASSAPP LTGKRGRGRP RKANLLDSMF GSPGGLREAG ILPCGLCGKV
     FTDANRLRQH EAQHGVTSLQ LGYIDLPPPR LGENGLPISE DPDGPRKRSR TRKQVACEIC
     GKIFRDVYHL NRHKLSHSGE KPYSCPVCGL RFKRKDRMSY HVRSHDGSVG KPYICQSCGK
     GFSRPDHLNG HIKQVHTSER PHKCQTCNAS FATRDRLRSH LACHEDKVPC QVCGKYLRAA
     YMADHLKKHS EGPSNFCSIC NRGFSSASYL KVHVKTHHGV PLPQVSRHQE PILNGGAAFH
     CARTYGNKEG QKCSHQDPIE SSDSYGDLSD ASDLKTPEKQ SANGSFSCDM AVPKNKMESD
     GEKKYPCPEC GSFFRSKSYL NKHIQKVHVR ALGGPLGDLG PALGSPFSPQ QNMSLLESFG
     FQIVQSAFAS SLVDPEVDQQ PMGPEGK
//
ID   PATZ1_HUMAN             Reviewed;         687 AA.
AC   Q9HBE1; Q9HBE2; Q9HBE3; Q9P1A9; Q9UDU0; Q9Y529;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-FEB-2018, entry version 164.
DE   RecName: Full=POZ-, AT hook-, and zinc finger-containing protein 1;
DE   AltName: Full=BTB/POZ domain zinc finger transcription factor;
DE   AltName: Full=Protein kinase A RI subunit alpha-associated protein;
DE   AltName: Full=Zinc finger and BTB domain-containing protein 19;
DE   AltName: Full=Zinc finger protein 278;
DE   AltName: Full=Zinc finger sarcoma gene protein;
GN   Name=PATZ1; Synonyms=PATZ, RIAZ, ZBTB19, ZNF278, ZSG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), SUBCELLULAR LOCATION,
RP   FUNCTION, AND INTERACTION WITH RNF4.
RX   PubMed=10713105; DOI=10.1074/jbc.275.11.7894;
RA   Fedele M., Benvenuto G., Pero R., Majello B., Battista S., Lembo F.,
RA   Vollono E., Day P.M., Santoro M., Lania L., Bruni C.B., Fusco A.,
RA   Chiatiotti L.;
RT   "A novel member of the BTB/POZ family, PATZ, associates with the RNF4
RT   RING finger protein and acts as a transcriptional repressor.";
RL   J. Biol. Chem. 275:7894-7901(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), AND CHROMOSOMAL
RP   TRANSLOCATION WITH EWSR1.
RX   PubMed=10949935; DOI=10.1038/sj.onc.1203762;
RA   Mastrangelo T., Modena P., Tornielli S., Bullrich F., Testi A.,
RA   Mezzelani A., Radice P., Azzarelli A., Pilotti S., Croce C.,
RA   Pierotti M., Sozzi G.;
RT   "A novel zinc finger gene is fused to EWS in small round cell tumor.";
RL   Oncogene 19:3799-3804(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 3).
RA   Chin K.-V., Yang W.-L., Kudoh K.;
RT   "Novel cAMP signalling via the regulatory subunit of the cAMP-
RT   dependent protein kinase.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Collins J.E., Huckle E.J.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-112 AND LYS-272, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [11]
RP   STRUCTURE BY NMR OF 359-437.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of zinc finger domains in zinc finger protein
RT   278.";
RL   Submitted (APR-2008) to the PDB data bank.
CC   -!- FUNCTION: Transcriptional repressor.
CC       {ECO:0000269|PubMed:10713105}.
CC   -!- INTERACTION:
CC       P52597:HNRNPF; NbExp=4; IntAct=EBI-11022007, EBI-352986;
CC       P31943:HNRNPH1; NbExp=4; IntAct=EBI-11022007, EBI-351590;
CC       Q8IV03:LURAP1L; NbExp=4; IntAct=EBI-11022007, EBI-12898559;
CC       P0CG21:NHLRC4; NbExp=4; IntAct=EBI-11022007, EBI-12868744;
CC       O75864:PPP1R37; NbExp=4; IntAct=EBI-11022007, EBI-5235692;
CC       Q93062-3:RBPMS; NbExp=5; IntAct=EBI-11022007, EBI-740343;
CC       Q13077:TRAF1; NbExp=4; IntAct=EBI-11022007, EBI-359224;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10713105}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=C;
CC         IsoId=Q9HBE1-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=Q9HBE1-2; Sequence=VSP_008799, VSP_008800;
CC       Name=3; Synonyms=A;
CC         IsoId=Q9HBE1-3; Sequence=VSP_008801;
CC       Name=4; Synonyms=Short;
CC         IsoId=Q9HBE1-4; Sequence=VSP_008802, VSP_008800;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Note=A chromosomal aberration involving PATZ1 is
CC       associated with small round cell sarcoma. Translocation
CC       t(1;22)(p36.1;q12) with EWSR1. {ECO:0000269|PubMed:10949935}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB51404.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF119256; AAF32518.1; -; mRNA.
DR   EMBL; AF254082; AAG09031.1; -; mRNA.
DR   EMBL; AF254083; AAG09032.1; -; mRNA.
DR   EMBL; AF254084; AAG09033.1; -; mRNA.
DR   EMBL; AF254085; AAG09034.1; -; mRNA.
DR   EMBL; AY028384; AAK19024.1; -; mRNA.
DR   EMBL; AL096880; CAB51404.1; ALT_INIT; mRNA.
DR   EMBL; CR456613; CAG30499.1; -; mRNA.
DR   EMBL; AC005003; AAF01349.1; -; Genomic_DNA.
DR   EMBL; BC021091; AAH21091.1; -; mRNA.
DR   CCDS; CCDS13894.1; -. [Q9HBE1-1]
DR   CCDS; CCDS13895.1; -. [Q9HBE1-3]
DR   CCDS; CCDS13896.1; -. [Q9HBE1-4]
DR   CCDS; CCDS46691.1; -. [Q9HBE1-2]
DR   RefSeq; NP_055138.2; NM_014323.2. [Q9HBE1-1]
DR   RefSeq; NP_114439.1; NM_032050.1. [Q9HBE1-3]
DR   RefSeq; NP_114440.1; NM_032051.1. [Q9HBE1-4]
DR   RefSeq; NP_114441.1; NM_032052.1. [Q9HBE1-2]
DR   UniGene; Hs.731398; -.
DR   PDB; 2EPP; NMR; -; A=286-338.
DR   PDB; 2EPQ; NMR; -; A=380-411.
DR   PDB; 2EPR; NMR; -; A=350-384.
DR   PDB; 2EPS; NMR; -; A=408-445.
DR   PDB; 2YT9; NMR; -; A=355-436.
DR   PDBsum; 2EPP; -.
DR   PDBsum; 2EPQ; -.
DR   PDBsum; 2EPR; -.
DR   PDBsum; 2EPS; -.
DR   PDBsum; 2YT9; -.
DR   ProteinModelPortal; Q9HBE1; -.
DR   SMR; Q9HBE1; -.
DR   BioGrid; 117133; 42.
DR   IntAct; Q9HBE1; 74.
DR   MINT; Q9HBE1; -.
DR   STRING; 9606.ENSP00000266269; -.
DR   iPTMnet; Q9HBE1; -.
DR   PhosphoSitePlus; Q9HBE1; -.
DR   BioMuta; PATZ1; -.
DR   DMDM; 38258840; -.
DR   EPD; Q9HBE1; -.
DR   MaxQB; Q9HBE1; -.
DR   PaxDb; Q9HBE1; -.
DR   PeptideAtlas; Q9HBE1; -.
DR   PRIDE; Q9HBE1; -.
DR   DNASU; 23598; -.
DR   Ensembl; ENST00000215919; ENSP00000215919; ENSG00000100105. [Q9HBE1-4]
DR   Ensembl; ENST00000266269; ENSP00000266269; ENSG00000100105. [Q9HBE1-1]
DR   Ensembl; ENST00000351933; ENSP00000337520; ENSG00000100105. [Q9HBE1-3]
DR   Ensembl; ENST00000405309; ENSP00000384173; ENSG00000100105. [Q9HBE1-2]
DR   GeneID; 23598; -.
DR   KEGG; hsa:23598; -.
DR   UCSC; uc003akp.4; human. [Q9HBE1-1]
DR   CTD; 23598; -.
DR   DisGeNET; 23598; -.
DR   EuPathDB; HostDB:ENSG00000100105.17; -.
DR   GeneCards; PATZ1; -.
DR   HGNC; HGNC:13071; PATZ1.
DR   HPA; HPA047893; -.
DR   HPA; HPA048315; -.
DR   MIM; 605165; gene.
DR   neXtProt; NX_Q9HBE1; -.
DR   OpenTargets; ENSG00000100105; -.
DR   PharmGKB; PA162398806; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00530000063522; -.
DR   HOGENOM; HOG000037943; -.
DR   HOVERGEN; HBG056645; -.
DR   InParanoid; Q9HBE1; -.
DR   OMA; LDSMMFG; -.
DR   OrthoDB; EOG091G04OT; -.
DR   PhylomeDB; Q9HBE1; -.
DR   TreeFam; TF331686; -.
DR   SIGNOR; Q9HBE1; -.
DR   ChiTaRS; PATZ1; human.
DR   EvolutionaryTrace; Q9HBE1; -.
DR   GeneWiki; PATZ1; -.
DR   GenomeRNAi; 23598; -.
DR   PRO; PR:Q9HBE1; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100105; -.
DR   CleanEx; HS_PATZ1; -.
DR   ExpressionAtlas; Q9HBE1; baseline and differential.
DR   Genevisible; Q9HBE1; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; NAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR000637; HMGI/Y_DNA-bd_CS.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF54695; SSF54695; 2.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00354; HMGI_Y; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 7.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Complete proteome; DNA-binding; Isopeptide bond; Metal-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    687       POZ-, AT hook-, and zinc finger-
FT                                containing protein 1.
FT                                /FTId=PRO_0000047504.
FT   DOMAIN       41    130       BTB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00037}.
FT   DNA_BIND    264    276       A.T hook.
FT   ZN_FING     292    314       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     355    377       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     383    405       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     413    436       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     442    464       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     495    518       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     605    628       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   MOD_RES     282    282       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    112    112       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    272    272       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     446    537       TCNASFATRDRLRSHLACHEDKVPCQVCGKYLRAAYMADHL
FT                                KKHSEGPSNFCSICNRGFSSASYLKVHVKTHHGVPLPQVSR
FT                                HQEPILNGGA -> VWVGSSSGLPPLEPLPSDLPSWDFAQP
FT                                ALWRSSHSVPDTAFSLSLKKSFPALENLGPAHSSNTLFCPA
FT                                PPGYLRQGWTTPEGSRAFTQWPVG (in isoform 4).
FT                                {ECO:0000303|PubMed:10713105,
FT                                ECO:0000303|PubMed:10949935,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008802.
FT   VAR_SEQ     503    548       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10949935,
FT                                ECO:0000303|PubMed:15461802,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_008801.
FT   VAR_SEQ     504    537       FSSASYLKVHVKTHHGVPLPQVSRHQEPILNGGA -> LQA
FT                                PGAHPEWGSSVPLRQDLWQQRRPEMLTSGSD (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:10949935}.
FT                                /FTId=VSP_008799.
FT   VAR_SEQ     538    687       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:10713105,
FT                                ECO:0000303|PubMed:10949935,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008800.
FT   VARIANT     685    685       E -> D (in dbSNP:rs2240424).
FT                                /FTId=VAR_052724.
FT   CONFLICT     63     63       S -> N (in Ref. 1; AAF32518).
FT                                {ECO:0000305}.
FT   CONFLICT    259    259       P -> L (in Ref. 1; AAF32518).
FT                                {ECO:0000305}.
FT   CONFLICT    394    394       R -> K (in Ref. 1; AAF32518).
FT                                {ECO:0000305}.
FT   TURN        295    297       {ECO:0000244|PDB:2EPP}.
FT   HELIX       304    314       {ECO:0000244|PDB:2EPP}.
FT   TURN        315    317       {ECO:0000244|PDB:2EPP}.
FT   STRAND      354    357       {ECO:0000244|PDB:2EPR}.
FT   TURN        358    361       {ECO:0000244|PDB:2EPR}.
FT   STRAND      362    366       {ECO:0000244|PDB:2EPR}.
FT   HELIX       367    373       {ECO:0000244|PDB:2EPR}.
FT   HELIX       374    376       {ECO:0000244|PDB:2EPR}.
FT   STRAND      382    385       {ECO:0000244|PDB:2EPQ}.
FT   TURN        386    389       {ECO:0000244|PDB:2EPQ}.
FT   STRAND      391    393       {ECO:0000244|PDB:2YT9}.
FT   HELIX       395    405       {ECO:0000244|PDB:2EPQ}.
FT   STRAND      411    413       {ECO:0000244|PDB:2YT9}.
FT   STRAND      416    418       {ECO:0000244|PDB:2EPS}.
FT   STRAND      421    424       {ECO:0000244|PDB:2EPS}.
FT   HELIX       425    434       {ECO:0000244|PDB:2EPS}.
SQ   SEQUENCE   687 AA;  74060 MW;  0F1C59A78C6D110A CRC64;
     MERVNDASCG PSGCYTYQVS RHSTEMLHNL NQQRKNGGRF CDVLLRVGDE SFPAHRAVLA
     ACSEYFESVF SAQLGDGGAA DGGPADVGGA TAAPGGGAGG SRELEMHTIS SKVFGDILDF
     AYTSRIVVRL ESFPELMTAA KFLLMRSVIE ICQEVIKQSN VQILVPPARA DIMLFRPPGT
     SDLGFPLDMT NGAALAANSN GIAGSMQPEE EAARAAGAAI AGQASLPVLP GVDRLPMVAG
     PLSPQLLTSP FPSVASSAPP LTGKRGRGRP RKANLLDSMF GSPGGLREAG ILPCGLCGKV
     FTDANRLRQH EAQHGVTSLQ LGYIDLPPPR LGENGLPISE DPDGPRKRSR TRKQVACEIC
     GKIFRDVYHL NRHKLSHSGE KPYSCPVCGL RFKRKDRMSY HVRSHDGSVG KPYICQSCGK
     GFSRPDHLNG HIKQVHTSER PHKCQTCNAS FATRDRLRSH LACHEDKVPC QVCGKYLRAA
     YMADHLKKHS EGPSNFCSIC NRGFSSASYL KVHVKTHHGV PLPQVSRHQE PILNGGAAFH
     CARTYGNKEG QKCSHQDPIE SSDSYGDLSD ASDLKTPEKQ SANGSFSCDM AVPKNKMESD
     GEKKYPCPEC GSFFRSKSYL NKHIQKVHVR ALGGPLGDLG PALGSPFSPQ QNMSLLESFG
     FQIVQSAFAS SLVDPEVDQQ PMGPEGK
//
ID   A0A024R4J5_HUMAN        Unreviewed;       463 AA.
AC   A0A024R4J5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 36.
DE   SubName: Full=Zinc finger protein 331, isoform CRA_a {ECO:0000313|EMBL:EAW72147.1};
GN   Name=ZNF331 {ECO:0000313|EMBL:EAW72147.1};
GN   ORFNames=hCG_2009080 {ECO:0000313|EMBL:EAW72147.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW72147.1};
RN   [1] {ECO:0000313|EMBL:EAW72147.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW72147.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471135; EAW72144.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW72145.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW72146.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW72147.1; -; Genomic_DNA.
DR   RefSeq; NP_001073375.1; NM_001079906.1.
DR   RefSeq; NP_001073376.1; NM_001079907.1.
DR   RefSeq; NP_001240727.1; NM_001253798.1.
DR   RefSeq; NP_001240728.1; NM_001253799.1.
DR   RefSeq; NP_001240729.1; NM_001253800.1.
DR   RefSeq; NP_001240730.1; NM_001253801.2.
DR   RefSeq; NP_001304042.1; NM_001317113.1.
DR   RefSeq; NP_001304043.1; NM_001317114.1.
DR   RefSeq; NP_001304044.1; NM_001317115.1.
DR   RefSeq; NP_001304045.1; NM_001317116.1.
DR   RefSeq; NP_001304046.1; NM_001317117.1.
DR   RefSeq; NP_001304047.1; NM_001317118.1.
DR   RefSeq; NP_001304048.1; NM_001317119.1.
DR   RefSeq; NP_001304049.1; NM_001317120.1.
DR   RefSeq; NP_001304050.1; NM_001317121.1.
DR   RefSeq; NP_061025.5; NM_018555.5.
DR   RefSeq; XP_011525378.1; XM_011527076.2.
DR   RefSeq; XP_011525380.1; XM_011527078.2.
DR   RefSeq; XP_016882425.1; XM_017026936.1.
DR   RefSeq; XP_016882426.1; XM_017026937.1.
DR   RefSeq; XP_016882427.1; XM_017026938.1.
DR   RefSeq; XP_016882428.1; XM_017026939.1.
DR   RefSeq; XP_016882429.1; XM_017026940.1.
DR   UniGene; Hs.185674; -.
DR   SMR; A0A024R4J5; -.
DR   GeneID; 55422; -.
DR   KEGG; hsa:55422; -.
DR   CTD; 55422; -.
DR   EuPathDB; HostDB:ENSG00000130844.16; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   KO; K09228; -.
DR   OMA; KAFSHGH; -.
DR   OrthoDB; EOG091G02KC; -.
DR   ChiTaRS; ZNF331; human.
DR   GenomeRNAi; 55422; -.
DR   Bgee; ENSG00000130844; -.
DR   GO; GO:0005622; C:intracellular; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 12.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   SUPFAM; SSF57667; SSF57667; 7.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 12.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 12.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370};
KW   Repeat {ECO:0000256|SAAS:SAAS00926344};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370}.
FT   DOMAIN        6     78       KRAB. {ECO:0000259|PROSITE:PS50805}.
FT   DOMAIN      131    158       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      159    186       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      187    214       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      215    242       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      243    270       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      271    298       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      299    326       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      327    354       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      355    382       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      383    410       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      411    438       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      439    463       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
SQ   SEQUENCE   463 AA;  53739 MW;  A9DB42D0870A7767 CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIRASKR NSDRRSKSLG RNWICEGTLE RPQRSRGRYV NQMIINYVKR PATREGTPPR
     THQRHHKENS FECKDCGKAF SRGYQLSQHQ KIHTGEKPYE CKECKKAFRW GNQLTQHQKI
     HTGEKPYECK DCGKAFRWGS SLVIHKRIHT GEKPYECKDC GKAFRRGDEL TQHQRFHTGE
     KDYECKDCGK TFSRVYKLIQ HKRIHSGEKP YECKDCGKAF ICGSSLIQHK RIHTGEKPYE
     CQECGKAFTR VNYLTQHQKI HTGEKPHECK ECGKAFRWGS SLVKHERIHT GEKPYKCTEC
     GKAFNCGYHL TQHERIHTGE TPYKCKECGK AFIYGSSLVK HERIHTGVKP YGCTECGKSF
     SHGHQLTQHQ KTHSGAKSYE CKECGKACNH LNHLREHQRI HNS
//
ID   Q68D63_HUMAN            Unreviewed;       463 AA.
AC   Q68D63;
DT   11-OCT-2004, integrated into UniProtKB/TrEMBL.
DT   11-OCT-2004, sequence version 1.
DT   28-FEB-2018, entry version 104.
DE   SubName: Full=Uncharacterized protein DKFZp686L0787 {ECO:0000313|EMBL:CAH18357.1};
GN   Name=DKFZp686L0787 {ECO:0000313|EMBL:CAH18357.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAH18357.1};
RN   [1] {ECO:0000313|EMBL:CAH18357.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Retina {ECO:0000313|EMBL:CAH18357.1};
RG   The German cDNA Consortium;
RA   Poustka A., Albert R., Moosmayer P., Schupp I., Wellenreuther R.,
RA   Mewes H.W., Weil B., Amid C., Osanger A., Fobo G., Han M., Wiemann S.;
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR749560; CAH18357.1; -; mRNA.
DR   RefSeq; NP_001073375.1; NM_001079906.1.
DR   RefSeq; NP_001073376.1; NM_001079907.1.
DR   RefSeq; NP_001304042.1; NM_001317113.1.
DR   RefSeq; NP_001304043.1; NM_001317114.1.
DR   RefSeq; NP_001304044.1; NM_001317115.1.
DR   RefSeq; NP_001304045.1; NM_001317116.1.
DR   RefSeq; NP_001304046.1; NM_001317117.1.
DR   RefSeq; NP_001304047.1; NM_001317118.1.
DR   RefSeq; NP_001304048.1; NM_001317119.1.
DR   RefSeq; NP_001304049.1; NM_001317120.1.
DR   RefSeq; NP_001304050.1; NM_001317121.1.
DR   RefSeq; NP_061025.5; NM_018555.5.
DR   UniGene; Hs.185674; -.
DR   ProteinModelPortal; Q68D63; -.
DR   PeptideAtlas; Q68D63; -.
DR   DNASU; 55422; -.
DR   GeneID; 55422; -.
DR   KEGG; hsa:55422; -.
DR   CTD; 55422; -.
DR   PharmGKB; PA134866703; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   HOGENOM; HOG000234617; -.
DR   HOVERGEN; HBG018163; -.
DR   KO; K09228; -.
DR   GenomeRNAi; 55422; -.
DR   Genevisible; Q68D63; HS.
DR   GO; GO:0005622; C:intracellular; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 12.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   SUPFAM; SSF57667; SSF57667; 7.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 12.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 12.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370};
KW   Repeat {ECO:0000256|SAAS:SAAS00926344};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370}.
FT   DOMAIN        6     78       KRAB. {ECO:0000259|PROSITE:PS50805}.
FT   DOMAIN      131    158       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      159    186       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      187    214       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      215    242       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      243    270       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      271    298       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      299    326       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      327    354       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      355    382       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      383    410       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      411    438       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      439    463       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
SQ   SEQUENCE   463 AA;  53667 MW;  DBF942D3325C94D2 CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIRASKR NSDRRSKSLG RNWICEGTLE RPQRSRGRYV NQMIINYVKR PATREGTPPR
     THQRHHKENS FECKDCGKAF SRGYQLSQHQ KIHTGEKPYE CKECKKAFRW GNQLTQHQKI
     HTGEKPYECK DCGKAFRWGS SLVIHKRIHT GEKPYECKDC GKAFRRGDEL TQHQRFHTGE
     KDYECKDCGK TFSRVYKLIQ HKRIHSGEKP YECKDCGKAF ICGSSLIQHK RIHTGEKPYE
     CQECGKAFTR VNYLTQHQKI HTGEKPHECK ECGKAFRWGS SLVKHERIHT GEKPYKCTEC
     GKAFNCGYHL TQHERIHTGG TPYKCKECGK AFIYGSSLVK HERIHTGVKP YGCTECGKSF
     SHGHQLTQHQ KTHSGAKSYE CKECGKACNH LNHLREHQRI HNS
//
ID   Q71QC4_HUMAN            Unreviewed;        63 AA.
AC   Q71QC4;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   31-JAN-2018, entry version 57.
DE   SubName: Full=KRAB zinc finger protein {ECO:0000313|EMBL:AAQ03250.1};
DE   Flags: Fragment;
GN   Name=ZNF331 {ECO:0000313|EMBL:AAQ03250.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAQ03250.1};
RN   [1] {ECO:0000313|EMBL:AAQ03250.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03250.1};
RX   PubMed=10502321;
RX   DOI=10.1002/(SICI)1098-2264(199911)26:3<229::AID-GCC7>3.3.CO;2-A;
RA   Rippe V., Belge G., Meiboom M., Kazmierczak B., Fusco A.,
RA   Bullerdiek J.;
RT   "A KRAB zinc finger protein gene is the potential target of 19q13
RT   translocation in benign thyroid tumors.";
RL   Genes Chromosomes Cancer 26:229-236(1999).
RN   [2] {ECO:0000313|EMBL:AAQ03250.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03250.1};
RA   Meiboom M., Gehrken I., Rippe V., Murua Escobar H., Belge G.,
RA   Bullerdiek J.;
RT   "Further molecular characterization of ZNF331 supports its possible
RT   role in the development of thyroid follicular adenomas.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF412403; AAQ03250.1; -; mRNA.
DR   RefSeq; NP_001304049.1; NM_001317120.1.
DR   UniGene; Hs.185674; -.
DR   PeptideAtlas; Q71QC4; -.
DR   GeneID; 55422; -.
DR   CTD; 55422; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   ChiTaRS; ZNF331; human.
DR   GO; GO:0005622; C:intracellular; IEA:InterPro.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   PROSITE; PS50805; KRAB; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN        6     63       KRAB. {ECO:0000259|PROSITE:PS50805}.
FT   NON_TER      63     63       {ECO:0000313|EMBL:AAQ03250.1}.
SQ   SEQUENCE   63 AA;  7211 MW;  355F245688A3518F CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAXRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIH
//
ID   Q71QC5_HUMAN            Unreviewed;        85 AA.
AC   Q71QC5;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 99.
DE   SubName: Full=KRAB zinc finger protein {ECO:0000313|EMBL:AAQ03249.1};
DE   SubName: Full=Zinc finger protein 331 {ECO:0000313|Ensembl:ENSP00000422586};
DE   Flags: Fragment;
GN   Name=ZNF331 {ECO:0000313|EMBL:AAQ03249.1,
GN   ECO:0000313|Ensembl:ENSP00000422586};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAQ03249.1};
RN   [1] {ECO:0000313|EMBL:AAQ03249.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03249.1};
RX   PubMed=10502321;
RX   DOI=10.1002/(SICI)1098-2264(199911)26:3<229::AID-GCC7>3.3.CO;2-A;
RA   Rippe V., Belge G., Meiboom M., Kazmierczak B., Fusco A.,
RA   Bullerdiek J.;
RT   "A KRAB zinc finger protein gene is the potential target of 19q13
RT   translocation in benign thyroid tumors.";
RL   Genes Chromosomes Cancer 26:229-236(1999).
RN   [2] {ECO:0000313|EMBL:AAQ03249.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03249.1};
RA   Meiboom M., Gehrken I., Rippe V., Murua Escobar H., Belge G.,
RA   Bullerdiek J.;
RT   "Further molecular characterization of ZNF331 supports its possible
RT   role in the development of thyroid follicular adenomas.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000422586, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4] {ECO:0000313|Ensembl:ENSP00000422586}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC011487; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF412400; AAQ03247.1; -; mRNA.
DR   EMBL; AF412402; AAQ03249.1; -; mRNA.
DR   RefSeq; NP_001073375.1; NM_001079906.1.
DR   RefSeq; NP_001304050.1; NM_001317121.1.
DR   UniGene; Hs.185674; -.
DR   PeptideAtlas; Q71QC5; -.
DR   DNASU; 55422; -.
DR   Ensembl; ENST00000502616; ENSP00000422586; ENSG00000130844.
DR   GeneID; 55422; -.
DR   KEGG; hsa:55422; -.
DR   UCSC; uc061ckp.1; human.
DR   CTD; 55422; -.
DR   EuPathDB; HostDB:ENSG00000130844.16; -.
DR   HGNC; HGNC:15489; ZNF331.
DR   OpenTargets; ENSG00000130844; -.
DR   PharmGKB; PA134866703; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00840000129704; -.
DR   HOGENOM; HOG000234617; -.
DR   KO; K09228; -.
DR   ChiTaRS; ZNF331; human.
DR   GenomeRNAi; 55422; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130844; -.
DR   ExpressionAtlas; Q71QC5; baseline and differential.
DR   GO; GO:0005622; C:intracellular; IEA:InterPro.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   PROSITE; PS50805; KRAB; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        6     85       KRAB. {ECO:0000259|PROSITE:PS50805}.
FT   NON_TER      85     85       {ECO:0000313|EMBL:AAQ03249.1,
FT                                ECO:0000313|Ensembl:ENSP00000422586}.
SQ   SEQUENCE   85 AA;  9843 MW;  920E20C81F994C0C CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIRASKR NSDRRSKSLG RNWIC
//
ID   Q71QC6_HUMAN            Unreviewed;        66 AA.
AC   Q71QC6;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 97.
DE   SubName: Full=KRAB zinc finger protein {ECO:0000313|EMBL:AAQ03248.1};
DE   SubName: Full=Zinc finger protein 331 {ECO:0000313|Ensembl:ENSP00000425517};
DE   Flags: Fragment;
GN   Name=ZNF331 {ECO:0000313|EMBL:AAQ03248.1,
GN   ECO:0000313|Ensembl:ENSP00000425517};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAQ03248.1};
RN   [1] {ECO:0000313|EMBL:AAQ03248.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03248.1};
RX   PubMed=10502321;
RX   DOI=10.1002/(SICI)1098-2264(199911)26:3<229::AID-GCC7>3.3.CO;2-A;
RA   Rippe V., Belge G., Meiboom M., Kazmierczak B., Fusco A.,
RA   Bullerdiek J.;
RT   "A KRAB zinc finger protein gene is the potential target of 19q13
RT   translocation in benign thyroid tumors.";
RL   Genes Chromosomes Cancer 26:229-236(1999).
RN   [2] {ECO:0000313|EMBL:AAQ03248.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03248.1};
RA   Meiboom M., Gehrken I., Rippe V., Murua Escobar H., Belge G.,
RA   Bullerdiek J.;
RT   "Further molecular characterization of ZNF331 supports its possible
RT   role in the development of thyroid follicular adenomas.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000425517, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4] {ECO:0000313|Ensembl:ENSP00000425517}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC011487; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF412401; AAQ03248.1; -; mRNA.
DR   RefSeq; NP_001073376.1; NM_001079907.1.
DR   RefSeq; NP_001304048.1; NM_001317119.1.
DR   UniGene; Hs.185674; -.
DR   PeptideAtlas; Q71QC6; -.
DR   DNASU; 55422; -.
DR   Ensembl; ENST00000504493; ENSP00000425517; ENSG00000130844.
DR   GeneID; 55422; -.
DR   UCSC; uc061ckq.1; human.
DR   CTD; 55422; -.
DR   EuPathDB; HostDB:ENSG00000130844.16; -.
DR   HGNC; HGNC:15489; ZNF331.
DR   OpenTargets; ENSG00000130844; -.
DR   PharmGKB; PA134866703; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00840000129704; -.
DR   ChiTaRS; ZNF331; human.
DR   GenomeRNAi; 55422; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130844; -.
DR   ExpressionAtlas; Q71QC6; baseline and differential.
DR   GO; GO:0005622; C:intracellular; IEA:InterPro.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   PROSITE; PS50805; KRAB; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        6     66       KRAB. {ECO:0000259|PROSITE:PS50805}.
FT   NON_TER      66     66       {ECO:0000313|EMBL:AAQ03248.1,
FT                                ECO:0000313|Ensembl:ENSP00000425517}.
SQ   SEQUENCE   66 AA;  7626 MW;  03CB87D55F245684 CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIR
//
ID   ZN331_HUMAN             Reviewed;         463 AA.
AC   Q9NQX6; Q96GJ4;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 150.
DE   RecName: Full=Zinc finger protein 331;
DE   AltName: Full=C2H2-like zinc finger protein rearranged in thyroid adenomas;
DE   AltName: Full=Zinc finger protein 361;
DE   AltName: Full=Zinc finger protein 463;
GN   Name=ZNF331; Synonyms=RITA, ZNF361, ZNF463;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   PubMed=10502321;
RX   DOI=10.1002/(SICI)1098-2264(199911)26:3<229::AID-GCC7>3.3.CO;2-A;
RA   Rippe V., Belge G., Meiboom M., Kazmierczak B., Fusco A.,
RA   Bullerdiek J.;
RT   "A KRAB zinc finger protein gene is the potential target of 19q13
RT   translocation in benign thyroid tumors.";
RL   Genes Chromosomes Cancer 26:229-236(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   PubMed=11267678; DOI=10.1016/S0167-4781(01)00172-5;
RA   Wu H., Zhang S., Qiu W., Zhang G., Xia Q., Xiao C., Huang X.,
RA   Huang M., Agen P., Fan T., Yang J., Milunsky A.;
RT   "Isolation, characterization, and mapping of a novel human KRAB zinc
RT   finger protein encoding gene ZNF463.";
RL   Biochim. Biophys. Acta 1518:190-193(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-400, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-109 AND LYS-400, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May be involved in transcriptional regulation. May play
CC       a role in spermatogenesis.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Testis specific.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF272148; AAF78075.1; -; mRNA.
DR   EMBL; AF251515; AAF70179.2; -; mRNA.
DR   EMBL; BC009433; AAH09433.1; -; mRNA.
DR   CCDS; CCDS33102.1; -.
DR   RefSeq; NP_001073375.1; NM_001079906.1.
DR   RefSeq; NP_001073376.1; NM_001079907.1.
DR   RefSeq; NP_001240727.1; NM_001253798.1.
DR   RefSeq; NP_001240728.1; NM_001253799.1.
DR   RefSeq; NP_001240729.1; NM_001253800.1.
DR   RefSeq; NP_001240730.1; NM_001253801.2.
DR   RefSeq; NP_001304042.1; NM_001317113.1.
DR   RefSeq; NP_001304043.1; NM_001317114.1.
DR   RefSeq; NP_001304044.1; NM_001317115.1.
DR   RefSeq; NP_001304045.1; NM_001317116.1.
DR   RefSeq; NP_001304046.1; NM_001317117.1.
DR   RefSeq; NP_001304047.1; NM_001317118.1.
DR   RefSeq; NP_001304048.1; NM_001317119.1.
DR   RefSeq; NP_001304049.1; NM_001317120.1.
DR   RefSeq; NP_001304050.1; NM_001317121.1.
DR   RefSeq; NP_061025.5; NM_018555.5.
DR   RefSeq; XP_011525378.1; XM_011527076.2.
DR   RefSeq; XP_011525380.1; XM_011527078.2.
DR   RefSeq; XP_016882425.1; XM_017026936.1.
DR   RefSeq; XP_016882426.1; XM_017026937.1.
DR   RefSeq; XP_016882427.1; XM_017026938.1.
DR   RefSeq; XP_016882428.1; XM_017026939.1.
DR   RefSeq; XP_016882429.1; XM_017026940.1.
DR   UniGene; Hs.185674; -.
DR   ProteinModelPortal; Q9NQX6; -.
DR   SMR; Q9NQX6; -.
DR   BioGrid; 120663; 62.
DR   IntAct; Q9NQX6; 10.
DR   MINT; Q9NQX6; -.
DR   STRING; 9606.ENSP00000253144; -.
DR   iPTMnet; Q9NQX6; -.
DR   PhosphoSitePlus; Q9NQX6; -.
DR   BioMuta; ZNF331; -.
DR   DMDM; 34925661; -.
DR   EPD; Q9NQX6; -.
DR   PaxDb; Q9NQX6; -.
DR   PeptideAtlas; Q9NQX6; -.
DR   PRIDE; Q9NQX6; -.
DR   DNASU; 55422; -.
DR   Ensembl; ENST00000253144; ENSP00000253144; ENSG00000130844.
DR   Ensembl; ENST00000411977; ENSP00000393336; ENSG00000130844.
DR   Ensembl; ENST00000449416; ENSP00000393817; ENSG00000130844.
DR   Ensembl; ENST00000511154; ENSP00000421014; ENSG00000130844.
DR   Ensembl; ENST00000511593; ENSP00000427439; ENSG00000130844.
DR   Ensembl; ENST00000512387; ENSP00000421728; ENSG00000130844.
DR   Ensembl; ENST00000513999; ENSP00000423156; ENSG00000130844.
DR   GeneID; 55422; -.
DR   KEGG; hsa:55422; -.
DR   UCSC; uc002qbx.2; human.
DR   CTD; 55422; -.
DR   DisGeNET; 55422; -.
DR   EuPathDB; HostDB:ENSG00000130844.16; -.
DR   GeneCards; ZNF331; -.
DR   HGNC; HGNC:15489; ZNF331.
DR   HPA; HPA063157; -.
DR   MIM; 606043; gene.
DR   neXtProt; NX_Q9NQX6; -.
DR   OpenTargets; ENSG00000130844; -.
DR   PharmGKB; PA134866703; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00840000129704; -.
DR   HOGENOM; HOG000234617; -.
DR   HOVERGEN; HBG018163; -.
DR   InParanoid; Q9NQX6; -.
DR   KO; K09228; -.
DR   OMA; KAFSHGH; -.
DR   OrthoDB; EOG091G02KC; -.
DR   PhylomeDB; Q9NQX6; -.
DR   TreeFam; TF341817; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   ChiTaRS; ZNF331; human.
DR   GeneWiki; ZNF331; -.
DR   GenomeRNAi; 55422; -.
DR   PRO; PR:Q9NQX6; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130844; -.
DR   CleanEx; HS_ZNF331; -.
DR   ExpressionAtlas; Q9NQX6; baseline and differential.
DR   Genevisible; Q9NQX6; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 12.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   SUPFAM; SSF57667; SSF57667; 7.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 12.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 12.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Isopeptide bond; Metal-binding;
KW   Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    463       Zinc finger protein 331.
FT                                /FTId=PRO_0000047535.
FT   DOMAIN        6     78       KRAB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00119}.
FT   ZN_FING     131    153       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     159    181       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     187    209       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     215    237       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     243    265       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     271    293       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     299    321       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     327    349       C2H2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     355    377       C2H2-type 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     383    405       C2H2-type 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     411    433       C2H2-type 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     439    461       C2H2-type 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   CROSSLNK    109    109       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    400    400       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CONFLICT     59     59       E -> K (in Ref. 3; AAH09433).
FT                                {ECO:0000305}.
SQ   SEQUENCE   463 AA;  53739 MW;  A9DB42D0870A7767 CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIRASKR NSDRRSKSLG RNWICEGTLE RPQRSRGRYV NQMIINYVKR PATREGTPPR
     THQRHHKENS FECKDCGKAF SRGYQLSQHQ KIHTGEKPYE CKECKKAFRW GNQLTQHQKI
     HTGEKPYECK DCGKAFRWGS SLVIHKRIHT GEKPYECKDC GKAFRRGDEL TQHQRFHTGE
     KDYECKDCGK TFSRVYKLIQ HKRIHSGEKP YECKDCGKAF ICGSSLIQHK RIHTGEKPYE
     CQECGKAFTR VNYLTQHQKI HTGEKPHECK ECGKAFRWGS SLVKHERIHT GEKPYKCTEC
     GKAFNCGYHL TQHERIHTGE TPYKCKECGK AFIYGSSLVK HERIHTGVKP YGCTECGKSF
     SHGHQLTQHQ KTHSGAKSYE CKECGKACNH LNHLREHQRI HNS
//
